{"text_format":"3","workbook":"xlsx","n_sheets":1,"sheets":["Sheet1"],"read":"whole","date_system":"1900"}

{"sheet":"Sheet1","index":0,"n_rows":18715,"n_cols":27,"rows_kept":2250,"cut":true,"bounds":{"rows_first":1000,"rows_last":250,"rows_between":1000,"halvings":1}}
["ProbeName","O1","O2","O3","Y1","Y2","Y3","foldChange","log2FoldChange","regulation","pval","padj","significant","Sequense","Control_Type","TargetID","PrimaryAccession","GeneSymbol","GeneName","Description","Chr","Start","End","GO","KEGG","Probe_Type","Sequence_Source"]
["A_23_P78871",{"v":2,"d":"2.00"},1.94,{"v":2,"d":"2.00"},7.42,7.35,7.41,{"v":0.267808836789901,"d":"0.27"},{"v":-1.90072452936094,"d":"-1.90"},"down",{"v":2.69120004059431e-09,"d":"0.00"},{"v":0.000229271405058351,"d":"0.00"},"yes","TCCAGTTTTCTCATGCGAATATGCACAGTTTTAATTCACGTTGTTACACTAGCCTGCCGA","FALSE","NM_024076","ref|NM_024076|ref|NM_001129994|ref|NM_001129995|ens|ENST00000430256","KCTD15","potassium channel tetramerization domain containing 15","ref|Homo sapiens potassium channel tetramerization domain containing 15 (KCTD15), transcript variant 1, mRNA [NM_024076]","chr19",34304716,34305081,"GO:0007275(multicellular organismal development);GO:0051260(protein homooligomerization)",null,"mRNA","agilent G3 V3"]
["A_33_P3671729",2.03,2.07,2.03,4.86,4.87,4.91,{"v":0.418715846994535,"d":"0.42"},{"v":-1.25595657459326,"d":"-1.26"},"down",{"v":7.82809994603895e-09,"d":"0.00"},{"v":0.000666899318702896,"d":"0.00"},"yes","AAACTTGGCCATGTAGTTGATGAGCGTGTCAGTCTCACAGTTTCGATATAGATCAGCCAG","FALSE","AK126671","gb|AK126671|gb|CU676339","FLJ44715","uncharacterized LOC386671","gb|Homo sapiens cDNA FLJ44715 fis, clone BRACE3021430. [AK126671]","chr10",75504144,75531917,null,null,"mRNA","agilent G3 V3"]
["A_33_P3292478",9.91,{"v":9.9,"d":"9.90"},9.89,11.43,11.46,11.46,{"v":0.864628820960699,"d":"0.86"},{"v":-0.209847168017334,"d":"-0.21"},"down",{"v":9.2366000403743e-09,"d":"0.00"},{"v":0.000786893667239608,"d":"0.00"},"yes","ATGAAGGTCTCCGAGGCTGCCCTGTCTCTCCTTGTCCTCATCCTTATCATTACTTCGGCT","FALSE","ENST00000621559","ens|ENST00000621559|ens|ENST00000611905|ens|ENST00000610493|ref|XM_006725334","CCL16","chemokine (C-C motif) ligand 16","ens|chemokine (C-C motif) ligand 16 [Source:HGNC Symbol;Acc:HGNC:10614] [ENST00000621559]","chr17",34303604,34308497,"GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006935(chemotaxis);GO:0006954(inflammatory response);GO:0006955(immune response);GO:0007154(cell communication);GO:0007267(cell-cell signaling);GO:0008009(chemokine activity);GO:0042056(chemoattractant activity);GO:0050918(positive chemotaxis);GO:0060326(cell chemotaxis)","04060(Cytokine-cytokine receptor interaction);04062(Chemokine signaling pathway)","mRNA","agilent G3 V3"]
["A_23_P21747",9.94,9.94,9.93,10.77,10.78,10.79,{"v":0.921768707482993,"d":"0.92"},{"v":-0.117523303482493,"d":"-0.12"},"down",{"v":1.17109999475673e-08,"d":"0.00"},{"v":0.000997695218533101,"d":"0.00"},"yes","GTATCAAAAGGTTCAGAACGTAGTCTCTACTCTTCCCCTGCCTGCATCAACTGTTGCAAA","FALSE","NM_019855","ref|NM_019855|ens|ENST00000293255|gb|AF169159|gb|AF169158","CABP5","calcium binding protein 5","ref|Homo sapiens calcium binding protein 5 (CABP5), mRNA [NM_019855]","chr19",48533208,48547310,"GO:0005509(calcium ion binding);GO:0005829(cytosol);GO:0007165(signal transduction)",null,"mRNA","agilent G3 V3"]
["A_23_P120931",2.02,1.98,2.01,5.15,5.22,5.12,{"v":0.387992253066494,"d":"0.39"},{"v":-1.36590024807838,"d":"-1.37"},"down",{"v":3.14170000015324e-08,"d":"0.00"},{"v":0.00267650848113055,"d":"0.00"},"yes","TTGGGAAAACTTTGTGTACAATGATAATGAGCCATTCAAGCCTTGGAAGGGATTAAAAAC","FALSE","NM_014508","ref|NM_014508|ens|ENST00000428892|gb|AK313272|gb|AB590057","APOBEC3C","apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C","ref|Homo sapiens apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3C (APOBEC3C), mRNA [NM_014508]","chr22",39410268,39414931,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0009972(cytidine deamination);GO:0010529(negative regulation of transposition);GO:0016032(viral reproduction);GO:0016814(hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines);GO:0045071(negative regulation of viral genome replication);GO:0045087(innate immune response);GO:0051607(defense response to virus);GO:0080111(DNA demethylation)",null,"mRNA","agilent G3 V3"]
["A_23_P67648",6.31,6.41,{"v":6.4,"d":"6.40"},9.79,9.75,{"v":9.8,"d":"9.80"},{"v":0.651670074982958,"d":"0.65"},{"v":-0.617786347692642,"d":"-0.62"},"down",{"v":3.44699999654807e-08,"d":"0.00"},{"v":0.0029366027070592,"d":"0.00"},"yes","AGGGCCGATCCTGTCTGCAGTCACATCTTTGTGGGGCCTGCTGACCCACAAGCTTTTGTT","FALSE","NM_001749","ref|NM_001749|ref|NM_001003962|ref|NM_001302632|ref|NM_001302633","CAPNS1","calpain, small subunit 1","ref|Homo sapiens calpain, small subunit 1 (CAPNS1), transcript variant 1, mRNA [NM_001749]","chr19",36636276,36640482,"GO:0004198(calcium-dependent cysteine-type endopeptidase activity);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006508(proteolysis);GO:0008284(positive regulation of cell proliferation);GO:0016020(membrane);GO:0022617(extracellular matrix disassembly);GO:0030198(extracellular matrix organization);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3320082",1.96,1.92,1.96,3.85,3.86,3.91,{"v":0.502581755593804,"d":"0.50"},{"v":-0.992569794524512,"d":"-0.99"},"down",{"v":5.93200000231775e-08,"d":"0.00"},{"v":0.00505364876197456,"d":"0.01"},"yes","CATATCACAGTATCAGTTAAGGAGCTTGATTTGTTTTTGGCATACTACGTGCAGGAGCAA","FALSE","NM_005596","ref|NM_005596|ref|NM_001190738|ref|NM_001190737|ens|ENST00000622520","NFIB","nuclear factor I/B","ref|Homo sapiens nuclear factor I/B (NFIB), transcript variant 3, mRNA [NM_005596]","chr9",14081842,14398982,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0000981(sequence-specific DNA binding RNA polymerase II transcription factor activity);GO:0001077(RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription);GO:0001106(RNA polymerase II transcription corepressor activity);GO:0002062(chondrocyte differentiation);GO:0003677(DNA binding);GO:0003690(double-stranded DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006260(DNA replication);GO:0006366(transcription from RNA polymerase II promoter);GO:0010001(glial cell differentiation);GO:0021740(principal sensory nucleus of trigeminal nerve development);GO:0021960(anterior commissure morphogenesis);GO:0030902(hindbrain development);GO:0043392(negative regulation of DNA binding);GO:0044300(cerebellar mossy fiber);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0060486(Clara cell differentiation);GO:0060509(Type I pneumocyte differentiation);GO:0060510(Type II pneumocyte differentiation);GO:0061141(lung ciliated cell differentiation);GO:0071679(commissural neuron axon guidance);GO:2000791(negative regulation of mesenchymal cell proliferation involved in lung development);GO:2000795(negative regulation of epithelial cell proliferation involved in lung morphogenesis)",null,"mRNA","agilent G3 V3"]
["A_24_P649747",2.03,1.97,2.02,{"v":4.6,"d":"4.60"},4.52,4.54,{"v":0.440702781844802,"d":"0.44"},{"v":-1.18212209153039,"d":"-1.18"},"down",{"v":6.06029999516977e-08,"d":"0.00"},{"v":0.00516295137488498,"d":"0.01"},"yes","ATAGCTGCCACAGGAGTTGTCCTTGATCTGGATAAATCCATAAAAGTTGTGAAGAAATTA","FALSE","NM_014753","ref|NM_014753|ref|NR_027293|ens|ENST00000443754|ens|ENST00000554269","BMS1","BMS1 ribosome biogenesis factor","ref|Homo sapiens BMS1 ribosome biogenesis factor (BMS1), mRNA [NM_014753]","chr15",21365634,21372686,"GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0042255(ribosome assembly)","03008(Ribosome biogenesis in eukaryotes)","mRNA","agilent G3 V3"]
["A_24_P73290",1.97,2.06,2.02,4.22,{"v":4.2,"d":"4.20"},4.21,{"v":0.47901821060966,"d":"0.48"},{"v":-1.0618475916256,"d":"-1.06"},"down",{"v":6.54859999560387e-08,"d":"0.00"},{"v":0.0055789487942548,"d":"0.01"},"yes","CGCACTGTATTAAATGTAACTTATTTAATGAAATCAGAAGCAGTAGACAGATGTTGGTGC","FALSE","NM_001681","ref|NM_001681|ref|NM_170665|ens|ENST00000377685|ens|ENST00000308664","ATP2A2","ATPase, Ca++ transporting, cardiac muscle, slow twitch 2","ref|Homo sapiens ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 (ATP2A2), transcript variant a, mRNA [NM_001681]","chr12",110719032,110788893,"GO:0002026(regulation of the force of heart contraction);GO:0005388(calcium-transporting ATPase activity);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005887(integral to plasma membrane);GO:0006874(cellular calcium ion homeostasis);GO:0006984(ER-nucleus signaling pathway);GO:0007155(cell adhesion);GO:0007596(blood coagulation);GO:0008022(protein C-terminus binding);GO:0008152(metabolic process);GO:0008544(epidermis development);GO:0010460(positive regulation of heart rate);GO:0010882(regulation of cardiac muscle contraction by calcium ion signaling);GO:0014704(intercalated disc);GO:0014801(longitudinal sarcoplasmic reticulum);GO:0016020(membrane);GO:0016529(sarcoplasmic reticulum);GO:0019899(enzyme binding);GO:0031095(platelet dense tubular network membrane);GO:0032469(endoplasmic reticulum calcium ion homeostasis);GO:0032470(elevation of endoplasmic reticulum calcium ion concentration);GO:0033017(sarcoplasmic reticulum membrane);GO:0034220(ion transmembrane transport);GO:0044548(S100 protein binding);GO:0045822(negative regulation of heart contraction);GO:0046872(metal ion binding);GO:0055085(transmembrane transport);GO:0055119(relaxation of cardiac muscle);GO:0070296(sarcoplasmic reticulum calcium ion transport);GO:0070588(calcium ion transmembrane transport);GO:0086036(regulation of cardiac muscle cell membrane potential);GO:0086039(calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential)","04020(Calcium signaling pathway);04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04919(Thyroid hormone signaling pathway);04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);04972(Pancreatic secretion);05010(Alzheimer's disease);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM))","mRNA","agilent G3 V3"]
["A_23_P23221",{"v":2.2,"d":"2.20"},2.28,2.18,4.88,4.91,4.95,{"v":0.451831750339213,"d":"0.45"},{"v":-1.14614244202381,"d":"-1.15"},"down",{"v":1.02919999966922e-07,"d":"0.00"},{"v":0.00876806355718196,"d":"0.01"},"yes","CCTGCCTTAAGTCAACTTATTTGTTTTTGCCGGGAAAGTCGCTACATGGATCAATGGGTT","FALSE","NM_001924","ref|NM_001924|ref|NM_001199741|ref|NM_001199742|ens|ENST00000370986","GADD45A","growth arrest and DNA-damage-inducible, alpha","ref|Homo sapiens growth arrest and DNA-damage-inducible, alpha (GADD45A), transcript variant 1, mRNA [NM_001924]","chr1",68150880,68153570,"GO:0000079(regulation of cyclin-dependent protein kinase activity);GO:0000185(activation of MAPKKK activity);GO:0001047(core promoter binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006281(DNA repair);GO:0006469(negative regulation of protein kinase activity);GO:0006915(apoptotic process);GO:0007050(cell cycle arrest);GO:0007098(centrosome cycle);GO:0042770(signal transduction in response to DNA damage);GO:0043065(positive regulation of apoptotic process);GO:0046330(positive regulation of JNK cascade);GO:0071260(cellular response to mechanical stimulus);GO:0071479(cellular response to ionizing radiation);GO:1900745(positive regulation of p38MAPK cascade);GO:2000379(positive regulation of reactive oxygen species metabolic process)","04010(MAPK signaling pathway);04068(FoxO signaling pathway);04110(Cell cycle);04115(p53 signaling pathway)","mRNA","agilent G3 V3"]
["A_23_P41588",1.87,1.98,{"v":1.9,"d":"1.90"},5.35,5.43,5.47,{"v":0.353846153846154,"d":"0.35"},{"v":-1.49880585697144,"d":"-1.50"},"down",{"v":1.07670000026872e-07,"d":"0.00"},{"v":0.00917273031228927,"d":"0.01"},"yes","GAAACCAGATACTTAGCCTTCTACTGTAGCTACGGAACCAGATTCTGGTGAATTTGTCCA","FALSE","NM_012208","ref|NM_012208|ref|NM_001278731|ref|NM_001278732|ens|ENST00000230771","HARS2","histidyl-tRNA synthetase 2, mitochondrial","ref|Homo sapiens histidyl-tRNA synthetase 2, mitochondrial (HARS2), transcript variant 1, mRNA [NM_012208]","chr5",140071040,140078889,"GO:0004821(histidine-tRNA ligase activity);GO:0005524(ATP binding);GO:0005759(mitochondrial matrix);GO:0006412(translation);GO:0006418(tRNA aminoacylation for protein translation);GO:0006427(histidyl-tRNA aminoacylation);GO:0010467(gene expression)","00970(Aminoacyl-tRNA biosynthesis)","mRNA","agilent G3 V3"]
["A_23_P118749",1.98,1.92,1.98,5.32,5.19,5.31,{"v":0.371681415929204,"d":"0.37"},{"v":-1.42786153963643,"d":"-1.43"},"down",{"v":1.14320000021984e-07,"d":"0.00"},{"v":0.00973926376187284,"d":"0.01"},"yes","GAAGGACTCGGTGATACCCACTGGGATCTTTTATCCTTTGTTGCAAAAGTGTGGACACTT","FALSE","NM_016041","ref|NM_016041|ens|ENST00000573547|ref|XM_006721539|ref|XM_005256672","DERL2","derlin 2","ref|Homo sapiens derlin 2 (DERL2), mRNA [NM_016041]","chr17",{"v":5378047,"d":"5378047.00"},5389468,"GO:0001967(suckling behavior);GO:0005515(protein binding);GO:0005769(early endosome);GO:0005770(late endosome);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0008284(positive regulation of cell proliferation);GO:0016020(membrane);GO:0030176(integral to endoplasmic reticulum membrane);GO:0030307(positive regulation of cell growth);GO:0030433(ER-associated protein catabolic process);GO:0030968(endoplasmic reticulum unfolded protein response);GO:0030970(retrograde protein transport, ER to cytosol)","04141(Protein processing in endoplasmic reticulum)","mRNA","agilent G3 V3"]
["A_23_P48771",1.95,2.02,1.99,6.03,6.08,{"v":5.9,"d":"5.90"},{"v":0.330927262631871,"d":"0.33"},{"v":-1.59541394544411,"d":"-1.60"},"down",{"v":1.24499999976102e-07,"d":"0.00"},{"v":0.0106065284979641,"d":"0.01"},"yes","GACAAAGGACAACATTTCTCTGGGGCTTTTTAACTTTTATTCCTAAGACTCTAAAGGCGT","FALSE","NM_024952","ref|NM_024952|ref|NM_001286470|ref|NM_001102366|ref|NM_001286471","C14orf159","chromosome 14 open reading frame 159","ref|Homo sapiens chromosome 14 open reading frame 159 (C14orf159), transcript variant 3, mRNA [NM_024952]","chr14",91580784,91691696,"GO:0003674(molecular_function);GO:0005575(cellular_component);GO:0005739(mitochondrion);GO:0008150(biological_process)",null,"mRNA","agilent G3 V3"]
["A_23_P379200",1.96,1.93,1.95,4.31,4.28,4.39,{"v":0.449922958397535,"d":"0.45"},{"v":-1.15225010911912,"d":"-1.15"},"down",{"v":1.24679999990995e-07,"d":"0.00"},{"v":0.0106218632392329,"d":"0.01"},"yes","GGCAAAACAGTACTTCAAAGAAATGTATATGCAGTGAGACATTTCTAGCTTTATTTCCAG","FALSE","NM_175736","ref|NM_175736|ref|NM_198900|gb|AK095874|gb|AB095934","FMNL3","formin-like 3","ref|Homo sapiens formin-like 3 (FMNL3), transcript variant 1, mRNA [NM_175736]","chr12",50031724,50101197,"GO:0003779(actin binding);GO:0005737(cytoplasm);GO:0007010(cytoskeleton organization);GO:0008360(regulation of cell shape);GO:0016477(cell migration);GO:0017048(Rho GTPase binding);GO:0030036(actin cytoskeleton organization);GO:0032794(GTPase activating protein binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3416503",10.86,10.83,10.89,12.59,{"v":12.6,"d":"12.60"},12.65,{"v":0.860993657505285,"d":"0.86"},{"v":-0.215925484813877,"d":"-0.22"},"down",{"v":1.31650000012584e-07,"d":"0.00"},{"v":0.0112156584510721,"d":"0.01"},"yes","TGTTCCAGTCCTCTGTCTACCCTCTCTGCCTCCTGCCTGCAGGTAGATGAGGTGTTTGCA","FALSE","NM_181843","ref|NM_181843|ens|ENST00000534054|ens|ENST00000301490|gb|BC018644","NUDT8","nudix (nucleoside diphosphate linked moiety X)-type motif 8","ref|Homo sapiens nudix (nucleoside diphosphate linked moiety X)-type motif 8 (NUDT8), transcript variant 2, mRNA [NM_181843]","chr11",67395408,67397392,"GO:0005739(mitochondrion);GO:0008152(metabolic process);GO:0016787(hydrolase activity);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P116235",14.11,14.15,14.13,13.23,13.25,13.25,{"v":1.06695192549711,"d":"1.07"},{"v":0.0934951729669966,"d":"0.09"},"up",{"v":1.531700000168e-07,"d":"0.00"},{"v":0.0130490118114313,"d":"0.01"},"yes","AAGGGATTCTGGGAAGCTTGAGCCTCCCCCAAAGCAATGTGAGTCCCAGAGCCCGCTTTT","FALSE","NM_001012334","ref|NM_001012334|ref|NM_001270550|ref|NM_001270551|ref|NM_001012333","MDK","midkine (neurite growth-promoting factor 2)","ref|Homo sapiens midkine (neurite growth-promoting factor 2) (MDK), transcript variant 1, mRNA [NM_001012334]","chr11",46403304,46405372,"GO:0001662(behavioral fear response);GO:0005576(extracellular region);GO:0005737(cytoplasm);GO:0007165(signal transduction);GO:0007219(Notch signaling pathway);GO:0007399(nervous system development);GO:0007614(short-term memory);GO:0008083(growth factor activity);GO:0008201(heparin binding);GO:0009611(response to wounding);GO:0016477(cell migration);GO:0021542(dentate gyrus development);GO:0021681(cerebellar granular layer development);GO:0021987(cerebral cortex development);GO:0030154(cell differentiation);GO:0030325(adrenal gland development);GO:0030421(defecation);GO:0042493(response to drug);GO:0042995(cell projection);GO:0043524(negative regulation of neuron apoptotic process);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0050795(regulation of behavior);GO:0051384(response to glucocorticoid stimulus);GO:0051781(positive regulation of cell division)",null,"mRNA","agilent G3 V3"]
["A_33_P3298425",3.92,3.83,3.94,7.17,7.29,7.28,{"v":0.53771849126035,"d":"0.54"},{"v":-0.895077010495653,"d":"-0.90"},"down",{"v":1.63529999985812e-07,"d":"0.00"},{"v":0.0139316112887913,"d":"0.01"},"yes","AGCTCTCATCAATGGCCATTTGAATTCACTTCAGAGCAATCCACTACTGCCAGACCAGAA","FALSE","NM_006769","ref|NM_006769|ens|ENST00000489303|ens|ENST00000370542|ens|ENST00000370544","LMO4","LIM domain only 4","ref|Homo sapiens LIM domain only 4 (LMO4), mRNA [NM_006769]","chr1",87797464,87810698,"GO:0001158(enhancer sequence-specific DNA binding);GO:0001843(neural tube closure);GO:0003281(ventricular septum development);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005667(transcription factor complex);GO:0006366(transcription from RNA polymerase II promoter);GO:0008134(transcription factor binding);GO:0008270(zinc ion binding);GO:0021514(ventral spinal cord interneuron differentiation);GO:0021522(spinal cord motor neuron differentiation);GO:0021527(spinal cord association neuron differentiation);GO:0031333(negative regulation of protein complex assembly);GO:0042659(regulation of cell fate specification);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048538(thymus development);GO:0050865(regulation of cell activation)",null,"mRNA","agilent G3 V3"]
["A_23_P92994",{"v":1.9,"d":"1.90"},2.03,{"v":2,"d":"2.00"},4.89,4.84,4.82,{"v":0.407560137457045,"d":"0.41"},{"v":-1.29491514324964,"d":"-1.29"},"down",{"v":1.71890000011388e-07,"d":"0.00"},{"v":0.0146438247709701,"d":"0.01"},"yes","TGTTAATAGACATTTTTGCATCGACACTTCAACATTAACACTTTGAAAGTCATGGTCTGG","FALSE","NM_020194","ref|NM_020194|ref|NM_001277061|ref|NM_001277062|ref|NM_001277063","MFF","mitochondrial fission factor","ref|Homo sapiens mitochondrial fission factor (MFF), transcript variant 2, mRNA [NM_020194]","chr2",228192224,228222543,"GO:0000266(mitochondrial fission);GO:0001836(release of cytochrome c from mitochondria);GO:0005515(protein binding);GO:0005741(mitochondrial outer membrane);GO:0005777(peroxisome);GO:0006626(protein targeting to mitochondrion);GO:0008021(synaptic vesicle);GO:0008053(mitochondrial fusion);GO:0010821(regulation of mitochondrion organization);GO:0016559(peroxisome fission);GO:0030054(cell junction);GO:0032592(integral to mitochondrial membrane);GO:0042803(protein homodimerization activity);GO:0043653(mitochondrial fragmentation involved in apoptotic process);GO:0051260(protein homooligomerization);GO:0070584(mitochondrion morphogenesis);GO:0090141(positive regulation of mitochondrial fission);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:0090314(positive regulation of protein targeting to membrane);GO:1900063(regulation of peroxisome organization)",null,"mRNA","agilent G3 V3"]
["A_33_P3384392",2.37,2.52,2.39,{"v":6.8,"d":"6.80"},6.64,6.76,{"v":0.36039603960396,"d":"0.36"},{"v":-1.47234493744046,"d":"-1.47"},"down",{"v":1.78059999966784e-07,"d":"0.00"},{"v":0.0151694655771702,"d":"0.02"},"yes","GGCGTTTCTTTGCCGATTTTTGAATGTGATTTTAAAGAGTGAAAAATGAGACTATGCGTT","FALSE","NM_001619","ref|NM_001619|ens|ENST00000416281|ens|ENST00000308595|gb|AB209588","ADRBK1","adrenergic, beta, receptor kinase 1","ref|Homo sapiens adrenergic, beta, receptor kinase 1 (ADRBK1), mRNA [NM_001619]","chr11",67046944,67053843,"GO:0002029(desensitization of G-protein coupled receptor protein signaling pathway);GO:0003108(negative regulation of the force of heart contraction by chemical signal);GO:0004672(protein kinase activity);GO:0004703(G-protein coupled receptor kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007202(activation of phospholipase C activity);GO:0007213(G-protein coupled acetylcholine receptor signaling pathway);GO:0007217(tachykinin receptor signaling pathway);GO:0007507(heart development);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0016020(membrane);GO:0018105(peptidyl-serine phosphorylation);GO:0018107(peptidyl-threonine phosphorylation);GO:0031623(receptor internalization);GO:0031694(alpha-2A adrenergic receptor binding);GO:0031755(Edg-2 lysophosphatidic acid receptor binding);GO:0033605(positive regulation of catecholamine secretion);GO:0038032(termination of G-protein coupled receptor signaling pathway);GO:0045087(innate immune response);GO:0045988(negative regulation of striated muscle contraction);GO:0047696(beta-adrenergic receptor kinase activity);GO:0048011(nerve growth factor receptor signaling pathway);GO:0060048(cardiac muscle contraction);GO:0072372(primary cilium)","04144(Endocytosis);04062(Chemokine signaling pathway);04724(Glutamatergic synapse);05032(Morphine addiction)","mRNA","agilent G3 V3"]
["A_33_P3387300",2.05,2.17,2.05,4.96,5.03,4.97,{"v":0.419117647058823,"d":"0.42"},{"v":-1.2545728270856,"d":"-1.25"},"down",{"v":1.83659999986041e-07,"d":"0.00"},{"v":0.0156465463788108,"d":"0.02"},"yes","TCTGATGGATGGAATGACTGAATCTGATACAGCTTCAGTTAATGAAAATGGGCTAGGTAT","FALSE","NM_001013438","ref|NM_001013438|ens|ENST00000476672|ens|ENST00000472339|ens|ENST00000445140","FXR1","fragile X mental retardation, autosomal homolog 1","ref|Homo sapiens fragile X mental retardation, autosomal homolog 1 (FXR1), transcript variant 2, mRNA [NM_001013438]","chr3",180685840,180694070,"GO:0002151(G-quadruplex RNA binding);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0003730(mRNA 3'-UTR binding);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005844(polysome);GO:0006915(apoptotic process);GO:0007517(muscle organ development);GO:0016020(membrane);GO:0017148(negative regulation of translation);GO:0030154(cell differentiation);GO:0043034(costamere)","03013(RNA transport)","mRNA","agilent G3 V3"]
["A_23_P104362",1.91,1.98,1.88,6.45,{"v":6.6,"d":"6.60"},6.68,{"v":0.292448048656868,"d":"0.29"},{"v":-1.77374773207808,"d":"-1.77"},"down",{"v":1.87799999995519e-07,"d":"0.00"},{"v":0.0159992453996183,"d":"0.02"},"yes","TTTTAGAAGCAAGTAAATCATCCTCTTTTCAAGAGCAGTGTCCGTGGTGTGCAGTTCCTC","FALSE","NM_004092","ref|NM_004092|ens|ENST00000368547|gb|BC013264|gb|BC008906","ECHS1","enoyl CoA hydratase, short chain, 1, mitochondrial","ref|Homo sapiens enoyl CoA hydratase, short chain, 1, mitochondrial (ECHS1), mRNA [NM_004092]","chr10",135175984,135187193,"GO:0004300(enoyl-CoA hydratase activity);GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0006635(fatty acid beta-oxidation);GO:0044255(cellular lipid metabolic process);GO:0044281(small molecule metabolic process);GO:0070062(extracellular vesicular exosome)","01200(Carbon metabolism);01212(Fatty acid metabolism);00640(Propanoate metabolism);00650(Butanoate metabolism);00062(Fatty acid elongation);00071(Fatty acid degradation);00280(Valine, leucine and isoleucine degradation);00310(Lysine degradation);00380(Tryptophan metabolism);00410(beta-Alanine metabolism)","mRNA","agilent G3 V3"]
["A_33_P3397323",1.95,2.05,2.03,4.87,4.84,4.76,{"v":0.416724257083621,"d":"0.42"},{"v":-1.26283501463164,"d":"-1.26"},"down",{"v":1.93360000011467e-07,"d":"0.00"},{"v":0.0164729184809769,"d":"0.02"},"yes","GACTTGACCATTACACATTCTATGCATGCAAGAAATGCTCATGTGTACCTTATATATATG","FALSE","NM_152355","ref|NM_152355|ens|ENST00000357901|gb|AK092721|gb|BX649086","ZNF441","zinc finger protein 441","ref|Homo sapiens zinc finger protein 441 (ZNF441), mRNA [NM_152355]","chr19",11877907,11894893,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P123732",1.91,1.95,1.91,4.99,5.02,5.15,{"v":0.380606860158311,"d":"0.38"},{"v":-1.39362652952561,"d":"-1.39"},"down",{"v":2.09129999984015e-07,"d":"0.00"},{"v":0.0178164120886382,"d":"0.02"},"yes","TCAATGCTGGAAATCGTTACATTGTTTAGAACATTCTTGCTCATGCCTGTATTTGCACAA","FALSE","NM_001001551","ref|NM_001001551|ref|NM_001256915|ref|NR_046422|ref|NR_046421","IDNK","idnK, gluconokinase homolog (E. coli)","ref|Homo sapiens idnK, gluconokinase homolog (E. coli) (IDNK), transcript variant 1, mRNA [NM_001001551]","chr9",86237968,86259038,"GO:0003674(molecular_function);GO:0005524(ATP binding);GO:0008150(biological_process);GO:0016310(phosphorylation);GO:0046177(D-gluconate catabolic process);GO:0046316(gluconokinase activity)","01200(Carbon metabolism);00030(Pentose phosphate pathway)","mRNA","agilent G3 V3"]
["A_23_P129956",2.07,{"v":2.2,"d":"2.20"},2.07,5.52,5.46,5.58,{"v":0.382850241545894,"d":"0.38"},{"v":-1.38514792735992,"d":"-1.39"},"down",{"v":2.10619999996275e-07,"d":"0.00"},{"v":0.0179433496596827,"d":"0.02"},"yes","ATTAGAGCGCCAAATGGTTTTCTTCTCAATCTTAAAGCAGTATACCTTTCCACAGGCTCG","FALSE","NM_004090","ref|NM_004090|ens|ENST00000226004|gb|AK226170|gb|AK055834","DUSP3","dual specificity phosphatase 3","ref|Homo sapiens dual specificity phosphatase 3 (DUSP3), mRNA [NM_004090]","chr17",41845752,41856303,"GO:0000188(inactivation of MAPK activity);GO:0001701(in utero embryonic development);GO:0001772(immunological synapse);GO:0002224(toll-like receptor signaling pathway);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0002756(MyD88-independent toll-like receptor signaling pathway);GO:0004725(protein tyrosine phosphatase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0008138(protein tyrosine/serine/threonine phosphatase activity);GO:0033549(MAP kinase phosphatase activity);GO:0034134(toll-like receptor 2 signaling pathway);GO:0034138(toll-like receptor 3 signaling pathway);GO:0034142(toll-like receptor 4 signaling pathway);GO:0034146(toll-like receptor 5 signaling pathway);GO:0034162(toll-like receptor 9 signaling pathway);GO:0034166(toll-like receptor 10 signaling pathway);GO:0035335(peptidyl-tyrosine dephosphorylation);GO:0035666(TRIF-dependent toll-like receptor signaling pathway);GO:0038123(toll-like receptor TLR1:TLR2 signaling pathway);GO:0038124(toll-like receptor TLR6:TLR2 signaling pathway);GO:0043409(negative regulation of MAPK cascade);GO:0045087(innate immune response);GO:0045931(positive regulation of mitotic cell cycle);GO:0046329(negative regulation of JNK cascade);GO:0048011(nerve growth factor receptor signaling pathway);GO:0050860(negative regulation of T cell receptor signaling pathway);GO:0050868(negative regulation of T cell activation);GO:0051403(stress-activated MAPK cascade);GO:0070062(extracellular vesicular exosome);GO:0070373(negative regulation of ERK1 and ERK2 cascade)","04010(MAPK signaling pathway)","mRNA","agilent G3 V3"]
["A_23_P68730",2.21,2.26,2.18,6.85,6.62,6.67,{"v":0.330188679245283,"d":"0.33"},{"v":-1.59863743761823,"d":"-1.60"},"down",{"v":2.15350000054571e-07,"d":"0.00"},{"v":0.018346312554649,"d":"0.02"},"yes","TGTGTGGTGACCTTCTGGATGCCTTTAACTTCATGGCTGCGTCATTCCTGATTTAGAACT","FALSE","NM_003681","ref|NM_003681|ens|ENST00000291565|ens|ENST00000468090|ref|XM_005261198","PDXK","pyridoxal (pyridoxine, vitamin B6) kinase","ref|Homo sapiens pyridoxal (pyridoxine, vitamin B6) kinase (PDXK), mRNA [NM_003681]","chr21",45161300,45182188,"GO:0000287(magnesium ion binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006766(vitamin metabolic process);GO:0006767(water-soluble vitamin metabolic process);GO:0008270(zinc ion binding);GO:0008283(cell proliferation);GO:0008478(pyridoxal kinase activity);GO:0009443(pyridoxal 5'-phosphate salvage);GO:0016310(phosphorylation);GO:0030170(pyridoxal phosphate binding);GO:0030955(potassium ion binding);GO:0031402(sodium ion binding);GO:0031403(lithium ion binding);GO:0042803(protein homodimerization activity);GO:0042816(vitamin B6 metabolic process);GO:0042823(pyridoxal phosphate biosynthetic process);GO:0044281(small molecule metabolic process);GO:0070062(extracellular vesicular exosome)","00750(Vitamin B6 metabolism)","mRNA","agilent G3 V3"]
["A_33_P3210585",2.22,2.43,2.38,6.27,6.25,6.31,{"v":0.373340414232608,"d":"0.37"},{"v":-1.42143640554169,"d":"-1.42"},"down",{"v":2.33710000019371e-07,"d":"0.00"},{"v":0.0199104560316503,"d":"0.02"},"yes","GCACTCTCGGTGTGATTTATCGTATGTATCTGATAGGTTTTATGAATTGTTTTGAGTTGT","FALSE","NM_014911","ref|NM_014911|ens|ENST00000339092|gb|AK055622|gb|AK074292","AAK1","AP2 associated kinase 1","ref|Homo sapiens AP2 associated kinase 1 (AAK1), mRNA [NM_014911]","chr2",69685128,69693635,"GO:0004674(protein serine/threonine kinase activity);GO:0005112(Notch binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005905(coated pit);GO:0006468(protein phosphorylation);GO:0006897(endocytosis);GO:0019897(extrinsic to plasma membrane);GO:0030136(clathrin-coated vesicle);GO:0031252(cell leading edge);GO:0032880(regulation of protein localization);GO:0035612(AP-2 adaptor complex binding);GO:0043195(terminal button);GO:0045747(positive regulation of Notch signaling pathway);GO:0046777(protein autophosphorylation);GO:0050821(protein stabilization);GO:2000369(regulation of clathrin-mediated endocytosis)",null,"mRNA","agilent G3 V3"]
["A_32_P96692",1.86,2.02,1.89,4.96,4.93,4.92,{"v":0.389601620526671,"d":"0.39"},{"v":-1.35992841664337,"d":"-1.36"},"down",{"v":2.37189999974241e-07,"d":"0.00"},{"v":0.0202069276678055,"d":"0.02"},"yes","CTGAGCCTGTAGCTAACGCATAAGCACAGTGTATTCAATAAAACATTTTTATTCTGTACA","FALSE","NM_006502","ref|NM_006502|ref|NM_001291970|ref|NM_001291969|tc|THC2532504","POLH","polymerase (DNA directed), eta","ref|Homo sapiens polymerase (DNA directed), eta (POLH), transcript variant 1, mRNA [NM_006502]","chr6",43543876,43588260,"GO:0000731(DNA synthesis involved in DNA repair);GO:0003684(damaged DNA binding);GO:0003887(DNA-directed DNA polymerase activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006260(DNA replication);GO:0006281(DNA repair);GO:0006282(regulation of DNA repair);GO:0006290(pyrimidine dimer repair);GO:0006301(postreplication repair);GO:0010225(response to UV-C);GO:0046872(metal ion binding)","03460(Fanconi anemia pathway)","mRNA","agilent G3 V3"]
["A_23_P132956",2.06,{"v":2.2,"d":"2.20"},2.19,5.89,5.92,6.04,{"v":0.361344537815126,"d":"0.36"},{"v":-1.46855300860585,"d":"-1.47"},"down",{"v":2.45329999981614e-07,"d":"0.00"},{"v":0.0209003986884336,"d":"0.02"},"yes","TCTAACGCTTTAAATGGCTACTTTGGTTTCTGTCTGTAAGTTAAGACCTTGGATGTGGTT","FALSE","NM_004181","ref|NM_004181|ens|ENST00000472501|ens|ENST00000381760|ens|ENST00000284440","UCHL1","ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)","ref|Homo sapiens ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) (UCHL1), mRNA [NM_004181]","chr4",41262656,41270446,"GO:0002931(response to ischemia);GO:0004197(cysteine-type endopeptidase activity);GO:0004843(ubiquitin-specific protease activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007412(axon target recognition);GO:0007628(adult walking behavior);GO:0008242(omega peptidase activity);GO:0008283(cell proliferation);GO:0016579(protein deubiquitination);GO:0016874(ligase activity);GO:0019233(sensory perception of pain);GO:0019896(axon transport of mitochondrion);GO:0030424(axon);GO:0031694(alpha-2A adrenergic receptor binding);GO:0042755(eating behavior);GO:0043025(neuronal cell body);GO:0043130(ubiquitin binding);GO:0043161(proteasomal ubiquitin-dependent protein catabolic process);GO:0043407(negative regulation of MAP kinase activity);GO:0048747(muscle fiber development);GO:0050905(neuromuscular process);GO:0070062(extracellular vesicular exosome)","05012(Parkinson's disease)","mRNA","agilent G3 V3"]
["A_33_P3294578",{"v":2.1,"d":"2.10"},2.08,2.06,4.72,4.69,4.58,{"v":0.446032880629021,"d":"0.45"},{"v":-1.16477802830251,"d":"-1.16"},"down",{"v":2.54180000047732e-07,"d":"0.00"},{"v":0.0216543567440665,"d":"0.02"},"yes","CTGGATTGGATGTTAAGTAAATGCTTGTTCAGTGCCGGTACATTTACTTAAATCTGTTTT","FALSE","NM_002740","ref|NM_002740|ens|ENST00000476635|ens|ENST00000295797|gb|BC042405","PRKCI","protein kinase C, iota","ref|Homo sapiens protein kinase C, iota (PRKCI), mRNA [NM_002740]","chr3",170009424,170023765,"GO:0000139(Golgi membrane);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004697(protein kinase C activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005543(phospholipid binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005923(tight junction);GO:0006468(protein phosphorylation);GO:0006612(protein targeting to membrane);GO:0007010(cytoskeleton organization);GO:0007015(actin filament organization);GO:0010976(positive regulation of neuron projection development);GO:0015630(microtubule cytoskeleton);GO:0016192(vesicle-mediated transport);GO:0016324(apical plasma membrane);GO:0016477(cell migration);GO:0019904(protein domain specific binding);GO:0031252(cell leading edge);GO:0032869(cellular response to insulin stimulus);GO:0034329(cell junction assembly);GO:0034351(negative regulation of glial cell apoptotic process);GO:0035089(establishment of apical/basal cell polarity);GO:0035556(intracellular signal transduction);GO:0042462(eye photoreceptor cell development);GO:0043066(negative regulation of apoptotic process);GO:0043220(Schmidt-Lanterman incisure);GO:0043234(protein complex);GO:0043524(negative regulation of neuron apoptotic process);GO:0045171(intercellular bridge);GO:0045197(establishment or maintenance of epithelial cell apical/basal polarity);GO:0045216(cell-cell junction organization);GO:0046326(positive regulation of glucose import);GO:0046872(metal ion binding);GO:0046903(secretion);GO:0048011(nerve growth factor receptor signaling pathway);GO:0048194(Golgi vesicle budding);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0060252(positive regulation of glial cell proliferation);GO:0061024(membrane organization);GO:0070062(extracellular vesicular exosome);GO:0070555(response to interleukin-1);GO:0070830(tight junction assembly);GO:0090004(positive regulation of establishment of protein localization in plasma membrane);GO:2000353(positive regulation of endothelial cell apoptotic process)","04015(Rap1 signaling pathway);04390(Hippo signaling pathway);04144(Endocytosis);04530(Tight junction);04611(Platelet activation);04910(Insulin signaling pathway)","mRNA","agilent G3 V3"]
["A_33_P3253682",1.85,2.04,1.89,5.69,{"v":5.6,"d":"5.60"},5.66,{"v":0.341002949852507,"d":"0.34"},{"v":-1.55214387552303,"d":"-1.55"},"down",{"v":2.54839999991319e-07,"d":"0.00"},{"v":0.0217105841192604,"d":"0.02"},"yes","CGGTTTTAATTATGTCAGAGATTGCATCATCCTTCTGCTTGTTTACAACTATGATCTTCT","FALSE","NM_032472","ref|NM_032472|ref|NM_130906|ens|ENST00000409449|ens|ENST00000415562","PPIL3","peptidylprolyl isomerase (cyclophilin)-like 3","ref|Homo sapiens peptidylprolyl isomerase (cyclophilin)-like 3 (PPIL3), transcript variant PPIL3a, mRNA [NM_032472]","chr2",201736096,201746465,"GO:0000398(nuclear mRNA splicing, via spliceosome);GO:0000413(protein peptidyl-prolyl isomerization);GO:0003755(peptidyl-prolyl cis-trans isomerase activity);GO:0005515(protein binding);GO:0006457(protein folding);GO:0071013(catalytic step 2 spliceosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3221568",{"v":9.6,"d":"9.60"},9.55,9.58,10.75,10.77,{"v":10.8,"d":"10.80"},{"v":0.888923267326733,"d":"0.89"},{"v":-0.169869205219271,"d":"-0.17"},"down",{"v":2.60289999998164e-07,"d":"0.00"},{"v":0.0221748859698436,"d":"0.02"},"yes","AGAGTTCTGCTGTGTCCTCTGCCCTAGCCCTGGGACCCAGATACCCTAACTCTAGATGCA","FALSE","NM_024742","ref|NM_024742|ens|ENST00000457010|gb|AY217348|gb|AK024430","ARMC5","armadillo repeat containing 5","ref|Homo sapiens armadillo repeat containing 5 (ARMC5), transcript variant 2, mRNA [NM_024742]","chr16",31470144,31478487,"GO:0005737(cytoplasm)",null,"mRNA","agilent G3 V3"]
["A_33_P3287735",2.05,2.17,2.02,5.26,5.23,5.34,{"v":0.394188250157928,"d":"0.39"},{"v":-1.34304332127493,"d":"-1.34"},"down",{"v":2.89519999974175e-07,"d":"0.00"},{"v":0.0246650773577999,"d":"0.02"},"yes","CCGTGAAATCAGTTTCTGTTGGTTTGCGGTTGTGTTTGGTTTTGTTTGTTTCTTTATAAA","FALSE","NM_001099412","ref|NM_001099412|ref|NM_001099413|ref|NM_006766|ens|ENST00000396930","KAT6A","K(lysine) acetyltransferase 6A","ref|Homo sapiens K(lysine) acetyltransferase 6A (KAT6A), transcript variant 1, mRNA [NM_001099412]","chr8",41786996,41909505,"GO:0000786(nucleosome);GO:0003007(heart morphogenesis);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003713(transcription coactivator activity);GO:0004402(histone acetyltransferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005794(Golgi apparatus);GO:0006323(DNA packaging);GO:0006325(chromatin organization);GO:0006334(nucleosome assembly);GO:0006351(transcription, DNA-dependent);GO:0006473(protein acetylation);GO:0008134(transcription factor binding);GO:0008270(zinc ion binding);GO:0016407(acetyltransferase activity);GO:0016573(histone acetylation);GO:0016605(PML body);GO:0030099(myeloid cell differentiation);GO:0035019(somatic stem cell maintenance);GO:0035162(embryonic hemopoiesis);GO:0035909(aorta morphogenesis);GO:0043433(negative regulation of sequence-specific DNA binding transcription factor activity);GO:0043966(histone H3 acetylation);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0060325(face morphogenesis);GO:0070776(MOZ/MORF histone acetyltransferase complex);GO:0090398(cellular senescence)","04550(Signaling pathways regulating pluripotency of stem cells)","mRNA","agilent G3 V3"]
["A_24_P413941",{"v":2,"d":"2.00"},1.93,1.99,4.19,{"v":4.3,"d":"4.30"},4.28,{"v":0.463586530931872,"d":"0.46"},{"v":-1.10908944407377,"d":"-1.11"},"down",{"v":2.89840000000652e-07,"d":"0.00"},{"v":0.0246923391200555,"d":"0.02"},"yes","TTATAATTGTTACATGTTGAATGGGTATTAAGAGTAAGTCACCAGGTACACAAAACTGCC","FALSE","NM_153689","ref|NM_153689|ens|ENST00000319974|gb|BC036456|gb|BQ233689","C2orf69","chromosome 2 open reading frame 69","ref|Homo sapiens chromosome 2 open reading frame 69 (C2orf69), mRNA [NM_153689]","chr2",200775984,200792996,"GO:0005576(extracellular region)",null,"mRNA","agilent G3 V3"]
["A_24_P291401",1.88,2.05,1.96,4.91,4.97,4.92,{"v":0.397972972972973,"d":"0.40"},{"v":-1.32925763668585,"d":"-1.33"},"down",{"v":2.92149999969737e-07,"d":"0.00"},{"v":0.0248891349474218,"d":"0.02"},"yes","TGTGAGTGGGTGTGTGTCATCGATATCCTCATTTTCTATGGCACCTTCAGCTACGAGTTT","FALSE","NM_001031738","ref|NM_001031738|ref|NR_033179|ens|ENST00000422458|ens|ENST00000463363","TMEM150A","transmembrane protein 150A","ref|Homo sapiens transmembrane protein 150A (TMEM150A), transcript variant 1, mRNA [NM_001031738]","chr2",85827048,85828881,"GO:0005764(lysosome);GO:0005886(plasma membrane);GO:0009056(catabolic process);GO:0016021(integral to membrane);GO:0030262(apoptotic nuclear change)",null,"mRNA","agilent G3 V3"]
["A_32_P151875",2.07,2.01,2.06,5.46,{"v":5.5,"d":"5.50"},5.66,{"v":0.369434416365824,"d":"0.37"},{"v":-1.43660982140017,"d":"-1.44"},"down",{"v":3.34230000009761e-07,"d":"0.00"},{"v":0.0284740563908316,"d":"0.03"},"yes","CCAGGTGTTGACTATAACCAGATTTACTCTTTGCTTACTAGGTTTTCCATTGTCACCATT","FALSE","NM_020781","ref|NM_020781|ref|NM_170686|ens|ENST00000426851|gb|AB037760","ZNF398","zinc finger protein 398","ref|Homo sapiens zinc finger protein 398 (ZNF398), transcript variant 2, mRNA [NM_020781]","chr7",148849680,148880116,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_22_P00007343",1.95,1.93,1.96,3.76,3.85,3.87,{"v":0.508710801393728,"d":"0.51"},{"v":-0.975082367795671,"d":"-0.98"},"down",{"v":3.57919999971479e-07,"d":"0.00"},{"v":0.0304922785575702,"d":"0.03"},"yes","AAGAAGTGGCACATGGCATATCACGGGAGCAATGTTGCCGCTGTACGGAGAGTGCTGGAC","FALSE","NM_032442","ref|NM_032442|ref|NM_001005408|ens|ENST00000574120|ens|ENST00000576794","NEURL4","neuralized E3 ubiquitin protein ligase 4","ref|Homo sapiens neuralized E3 ubiquitin protein ligase 4 (NEURL4), transcript variant 1, mRNA [NM_032442]","chr17",{"v":7218950,"d":"7218950.00"},7232638,"GO:0005515(protein binding);GO:0005814(centriole)",null,"mRNA","agilent G3 V3"]
["A_23_P64669",2.24,2.37,2.23,{"v":5.7,"d":"5.70"},5.62,5.78,{"v":0.4,"d":"0.40"},{"v":-1.32192809488736,"d":"-1.32"},"down",{"v":3.79810000006309e-07,"d":"0.00"},{"v":0.0323571533305375,"d":"0.03"},"yes","TGTGACTATCCGTCGAGAGTGATGGTTTTTATCTGTCTTTTGTACATTGTTTTCCCTTTC","FALSE","NM_017612","ref|NM_017612|ens|ENST00000543897|ens|ENST00000536306|ref|XM_006719491","ZCCHC8","zinc finger, CCHC domain containing 8","ref|Homo sapiens zinc finger, CCHC domain containing 8 (ZCCHC8), mRNA [NM_017612]","chr12",122957440,122985518,"GO:0000398(nuclear mRNA splicing, via spliceosome);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0008270(zinc ion binding);GO:0071013(catalytic step 2 spliceosome)",null,"mRNA","agilent G3 V3"]
["A_23_P115824",1.93,2.11,2.03,6.48,6.38,6.26,{"v":0.317468619246862,"d":"0.32"},{"v":-1.65531410172507,"d":"-1.66"},"down",{"v":3.81460000031808e-07,"d":"0.00"},{"v":0.0324977217827098,"d":"0.03"},"yes","TGTCATAGTCAATAAAAACAATCCTGCAGTTGGGTTTTGTATCTGATCCCTGCTTGGAGT","FALSE","NM_012207","ref|NM_012207|ref|NM_021644|ens|ENST00000265866|ens|ENST00000491200","HNRNPH3","heterogeneous nuclear ribonucleoprotein H3 (2H9)","ref|Homo sapiens heterogeneous nuclear ribonucleoprotein H3 (2H9) (HNRNPH3), transcript variant 2H9, mRNA [NM_012207]","chr10",70098560,70102026,"GO:0000166(nucleotide binding);GO:0000398(nuclear mRNA splicing, via spliceosome);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005681(spliceosomal complex);GO:0006396(RNA processing);GO:0008380(RNA splicing);GO:0030855(epithelial cell differentiation)",null,"mRNA","agilent G3 V3"]
["A_24_P129632",2.03,1.96,2.01,{"v":4.6,"d":"4.60"},4.69,4.76,{"v":0.427046263345196,"d":"0.43"},{"v":-1.22753572461241,"d":"-1.23"},"down",{"v":3.83599999986828e-07,"d":"0.00"},{"v":0.0326800347988778,"d":"0.03"},"yes","AGTTTTCTAGCTCAGACAAACTATGAAAAACTGTAGACTATTCTCAAGGTATTAACTCGC","FALSE","NM_004747","ref|NM_004747|ens|ENST00000614211|ens|ENST00000372391|ens|ENST00000475613","DLG5","discs, large homolog 5 (Drosophila)","ref|Homo sapiens discs, large homolog 5 (Drosophila) (DLG5), mRNA [NM_004747]","chr10",79550552,79686378,"GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005913(cell-cell adherens junction);GO:0006461(protein complex assembly);GO:0007165(signal transduction);GO:0008013(beta-catenin binding);GO:0008092(cytoskeletal protein binding);GO:0008285(negative regulation of cell proliferation);GO:0016337(cell-cell adhesion);GO:0030159(receptor signaling complex scaffold activity);GO:0030859(polarized epithelial cell differentiation);GO:0030901(midbrain development);GO:0035556(intracellular signal transduction);GO:0042981(regulation of apoptotic process);GO:0045176(apical protein localization);GO:0045186(zonula adherens assembly);GO:0045197(establishment or maintenance of epithelial cell apical/basal polarity);GO:0060441(epithelial tube branching involved in lung morphogenesis);GO:0071896(protein localization to adherens junction);GO:0072205(metanephric collecting duct development)",null,"mRNA","agilent G3 V3"]
["A_23_P63289",2.63,2.39,2.57,6.34,{"v":6.4,"d":"6.40"},6.39,{"v":0.396759017250392,"d":"0.40"},{"v":-1.33366508293065,"d":"-1.33"},"down",{"v":4.20160000014214e-07,"d":"0.00"},{"v":0.0357946908812109,"d":"0.04"},"yes","CCTGACATTTGTTTTTACTTACAGGTGTTCTGCTGGTGACGGTAGCATTACCCAAATAAA","FALSE","NM_014188","ref|NM_014188|ens|ENST00000378726|ens|ENST00000291386|gb|AK127149","SSU72","SSU72 RNA polymerase II CTD phosphatase homolog (S. cerevisiae)","ref|Homo sapiens SSU72 RNA polymerase II CTD phosphatase homolog (S. cerevisiae) (SSU72), mRNA [NM_014188]","chr1",{"v":1477054,"d":"1477054.00"},1481867,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006378(mRNA polyadenylation);GO:0008420(CTD phosphatase activity);GO:0070940(dephosphorylation of RNA polymerase II C-terminal domain)","03015(mRNA surveillance pathway)","mRNA","agilent G3 V3"]
["A_23_P140309",2.07,1.96,{"v":1.9,"d":"1.90"},{"v":6.8,"d":"6.80"},6.55,{"v":6.6,"d":"6.60"},{"v":0.297243107769424,"d":"0.30"},{"v":-1.7502847365637,"d":"-1.75"},"down",{"v":4.33339999994509e-07,"d":"0.00"},{"v":0.0369175346195322,"d":"0.04"},"yes","CTTTTTCAGAGTCTGGTTAAGCTATGTCATTGTCTACTGCATAGTTTCCTGAGTCTGTTT","FALSE","NM_144578","ref|NM_144578|ens|ENST00000622254|ens|ENST00000395468|gb|AL834285","MAPK1IP1L","mitogen-activated protein kinase 1 interacting protein 1-like","ref|Homo sapiens mitogen-activated protein kinase 1 interacting protein 1-like (MAPK1IP1L), mRNA [NM_144578]","chr14",55518348,55536910,null,null,"mRNA","agilent G3 V3"]
["A_33_P3407195",1.93,1.96,1.92,5.23,5.45,5.39,{"v":0.361543248288737,"d":"0.36"},{"v":-1.46775986027057,"d":"-1.47"},"down",{"v":4.34229999957125e-07,"d":"0.00"},{"v":0.0369933563863474,"d":"0.04"},"yes","CTCAAAATACTATAGTGATTCTGATGATGAGCTTACTGTAGAACAACGACGACAGTCCAT","FALSE","NM_148894","ref|NM_148894|ens|ENST00000040738|ref|XM_005248151|ref|XM_005248150","BOD1L1","biorientation of chromosomes in cell division 1-like 1","ref|Homo sapiens biorientation of chromosomes in cell division 1-like 1 (BOD1L1), mRNA [NM_148894]","chr4",13615130,13629325,"GO:0003677(DNA binding);GO:0005654(nucleoplasm)",null,"mRNA","agilent G3 V3"]
["A_23_P318284",8.35,8.44,8.42,6.84,6.88,6.88,{"v":1.22378640776699,"d":"1.22"},{"v":0.291351780787959,"d":"0.29"},"up",{"v":4.56400000015122e-07,"d":"0.00"},{"v":0.0388820852012883,"d":"0.04"},"yes","CAGCCAATCTGTGAATGTAAAAACTACACTGTTGCCTTGCTAGGATCCACCCTCCTATAA","FALSE","NM_015141","ref|NM_015141|ens|ENST00000474846|ens|ENST00000282541|ref|XM_005264983","GPD1L","glycerol-3-phosphate dehydrogenase 1-like","ref|Homo sapiens glycerol-3-phosphate dehydrogenase 1-like (GPD1L), mRNA [NM_015141]","chr3",32199826,32210198,"GO:0002027(regulation of heart rate);GO:0004367(glycerol-3-phosphate dehydrogenase [NAD+] activity);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005975(carbohydrate metabolic process);GO:0006644(phospholipid metabolic process);GO:0006654(phosphatidic acid biosynthetic process);GO:0006734(NADH metabolic process);GO:0009331(glycerol-3-phosphate dehydrogenase complex);GO:0010765(positive regulation of sodium ion transport);GO:0017080(sodium channel regulator activity);GO:0019432(triglyceride biosynthetic process);GO:0019674(NAD metabolic process);GO:0033137(negative regulation of peptidyl-serine phosphorylation);GO:0042803(protein homodimerization activity);GO:0044255(cellular lipid metabolic process);GO:0044281(small molecule metabolic process);GO:0044325(ion channel binding);GO:0046168(glycerol-3-phosphate catabolic process);GO:0046474(glycerophospholipid biosynthetic process);GO:0051287(NAD binding);GO:0055114(oxidation-reduction process);GO:0060373(regulation of ventricular cardiomyocyte membrane depolarization);GO:0070062(extracellular vesicular exosome);GO:0086005(regulation of ventricular cardiac muscle cell action potential);GO:0090038(negative regulation of protein kinase C signaling cascade);GO:2000010(positive regulation of protein localization at cell surface);GO:2000649(regulation of sodium ion transmembrane transporter activity)","00564(Glycerophospholipid metabolism)","mRNA","agilent G3 V3"]
["A_23_P152995",1.91,2.03,2.01,3.93,{"v":3.9,"d":"3.90"},3.93,{"v":0.505952380952381,"d":"0.51"},{"v":-0.982926486641059,"d":"-0.98"},"down",{"v":4.64490000018358e-07,"d":"0.00"},{"v":0.039571296571564,"d":"0.04"},"yes","TGCTGGAATCTACTAGAACCTTCTAATCCATGTGCTGCTGTGGCATCAGGAAAGGAAGAT","FALSE","NM_001045","ref|NM_001045|ens|ENST00000579221|ens|ENST00000261707|ens|ENST00000401766","SLC6A4","solute carrier family 6 (neurotransmitter transporter), member 4","ref|Homo sapiens solute carrier family 6 (neurotransmitter transporter), member 4 (SLC6A4), mRNA [NM_001045]","chr17",28523396,28562954,"GO:0001666(response to hypoxia);GO:0005335(serotonin:sodium symporter activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0006837(serotonin transport);GO:0007584(response to nutrient);GO:0007613(memory);GO:0007623(circadian rhythm);GO:0008504(monoamine transmembrane transporter activity);GO:0009636(response to toxin);GO:0010008(endosome membrane);GO:0010628(positive regulation of gene expression);GO:0012505(endomembrane system);GO:0015222(serotonin transmembrane transporter activity);GO:0015844(monoamine transport);GO:0017022(myosin binding);GO:0017075(syntaxin-1 binding);GO:0017137(Rab GTPase binding);GO:0019811(cocaine binding);GO:0021794(thalamus development);GO:0021941(negative regulation of cerebellar granule cell precursor proliferation);GO:0032227(negative regulation of synaptic transmission, dopaminergic);GO:0032355(response to estradiol stimulus);GO:0035176(social behavior);GO:0042310(vasoconstriction);GO:0042493(response to drug);GO:0042713(sperm ejaculation);GO:0042803(protein homodimerization activity);GO:0043005(neuron projection);GO:0045121(membrane raft);GO:0045665(negative regulation of neuron differentiation);GO:0045787(positive regulation of cell cycle);GO:0046621(negative regulation of organ growth);GO:0048854(brain morphogenesis);GO:0050998(nitric-oxide synthase binding);GO:0051015(actin filament binding);GO:0051259(protein oligomerization);GO:0051260(protein homooligomerization);GO:0051610(serotonin uptake);GO:0055085(transmembrane transport);GO:0071300(cellular response to retinoic acid);GO:0071321(cellular response to cGMP)","04726(Serotonergic synapse)","mRNA","agilent G3 V3"]
["A_24_P132787",2.06,2.15,2.29,6.15,6.04,6.18,{"v":0.35383777898748,"d":"0.35"},{"v":-1.49884000319553,"d":"-1.50"},"down",{"v":4.82819999980677e-07,"d":"0.00"},{"v":0.0411328842583538,"d":"0.04"},"yes","TAAAAACCTCACATTCTACTTGATTTACACTTCCTAGTCTACATTACATGTGGTTGAAGG","FALSE","NM_021252","ref|NM_021252|ref|NM_001256410|ref|NM_001256411|ref|NM_001256415","RAB18","RAB18, member RAS oncogene family","ref|Homo sapiens RAB18, member RAS oncogene family (RAB18), transcript variant 1, mRNA [NM_021252]","chr10",27793232,27828203,"GO:0001654(eye development);GO:0003924(GTPase activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005622(intracellular);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0006184(GTP catabolic process);GO:0006886(intracellular protein transport);GO:0007264(small GTPase mediated signal transduction);GO:0007420(brain development);GO:0019003(GDP binding);GO:0032482(Rab protein signal transduction);GO:0034389(lipid particle organization);GO:0070062(extracellular vesicular exosome);GO:0071782(endoplasmic reticulum tubular network);GO:0071786(endoplasmic reticulum tubular network organization)",null,"mRNA","agilent G3 V3"]
["A_23_P217098",2.03,2.07,2.23,5.49,5.41,{"v":5.4,"d":"5.40"},{"v":0.388343558282209,"d":"0.39"},{"v":-1.3645945596901,"d":"-1.36"},"down",{"v":5.06520000054245e-07,"d":"0.00"},{"v":0.0431519583646213,"d":"0.04"},"yes","CAGAGTATTCAATGCATGTTGTATGTGCCACCAAGTTACTATTAACTGTTTTTGGAATTG","FALSE","NM_033305","ref|NM_033305|ref|NM_001018037|ens|ENST00000376636|gb|AF337532","VPS13A","vacuolar protein sorting 13 homolog A (S. cerevisiae)","ref|Homo sapiens vacuolar protein sorting 13 homolog A (S. cerevisiae) (VPS13A), transcript variant A, mRNA [NM_033305]","chr9",80004912,80032541,"GO:0005515(protein binding);GO:0005622(intracellular);GO:0006623(protein targeting to vacuole);GO:0006895(Golgi to endosome transport);GO:0007399(nervous system development);GO:0007626(locomotory behavior);GO:0008104(protein localization);GO:0019898(extrinsic to membrane);GO:0031045(dense core granule);GO:0035176(social behavior);GO:0045053(protein retention in Golgi apparatus)",null,"mRNA","agilent G3 V3"]
["A_24_P128524",1.96,2.04,2.07,{"v":4.4,"d":"4.40"},4.53,4.48,{"v":0.452647278150634,"d":"0.45"},{"v":-1.14354081564879,"d":"-1.14"},"down",{"v":5.26430000036271e-07,"d":"0.00"},{"v":0.04484815099309,"d":"0.04"},"yes","AGTAATTATTCTACTCTTCTTTTTACATAAATGTTTATTTAAATATTCTAAATTGGATTT","FALSE","NM_012405","ref|NM_012405|ens|ENST00000343813|ref|XM_005263437|ref|XM_006710518","ICMT","isoprenylcysteine carboxyl methyltransferase","ref|Homo sapiens isoprenylcysteine carboxyl methyltransferase (ICMT), mRNA [NM_012405]","chr1",{"v":6281958,"d":"6281958.00"},6283562,"GO:0001701(in utero embryonic development);GO:0001889(liver development);GO:0003880(protein C-terminal carboxyl O-methyltransferase activity);GO:0004671(protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006464(cellular protein modification process);GO:0006481(C-terminal protein methylation);GO:0006612(protein targeting to membrane);GO:0008140(cAMP response element binding protein binding);GO:0008284(positive regulation of cell proliferation);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0035264(multicellular organism growth);GO:0046578(regulation of Ras protein signal transduction)","00900(Terpenoid backbone biosynthesis)","mRNA","agilent G3 V3"]
["A_33_P3310696",1.86,2.07,1.92,5.36,5.38,5.28,{"v":0.365168539325843,"d":"0.37"},{"v":-1.45336561793794,"d":"-1.45"},"down",{"v":5.29170000040935e-07,"d":"0.00"},{"v":0.0450815798134874,"d":"0.05"},"yes","TTGGGTTTGCAGCCTTTGCTTACACGGTCAAGTACGTGCTGAGGAGCATCGCGCAGGAGT","FALSE","NM_194458","ref|NM_194458|ref|NM_194315|ref|NM_058167|ref|NM_194457","UBE2J2","ubiquitin-conjugating enzyme E2, J2","ref|Homo sapiens ubiquitin-conjugating enzyme E2, J2 (UBE2J2), transcript variant 3, mRNA [NM_194458]","chr1",{"v":1190285,"d":"1190285.00"},1209244,"GO:0000209(protein polyubiquitination);GO:0005524(ATP binding);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006986(response to unfolded protein);GO:0016021(integral to membrane);GO:0016874(ligase activity);GO:0019787(small conjugating protein ligase activity);GO:0030433(ER-associated protein catabolic process);GO:0031625(ubiquitin protein ligase binding)","04141(Protein processing in endoplasmic reticulum);04120(Ubiquitin mediated proteolysis);05012(Parkinson's disease)","mRNA","agilent G3 V3"]
["A_23_P204252",2.06,{"v":2.2,"d":"2.20"},2.19,{"v":4.5,"d":"4.50"},4.47,4.53,{"v":0.477777777777778,"d":"0.48"},{"v":-1.06558834162758,"d":"-1.07"},"down",{"v":5.34050000000619e-07,"d":"0.00"},{"v":0.0454973216500527,"d":"0.05"},"yes","TGTCCACATACAGCCAAAATGCCTATCCAGAAATCCAGTTCGTTGGAAAGGAAAATTGGT","FALSE","NM_002355","ref|NM_002355|ref|NM_001207024|ens|ENST00000000412|ens|ENST00000536844","M6PR","mannose-6-phosphate receptor (cation dependent)","ref|Homo sapiens mannose-6-phosphate receptor (cation dependent) (M6PR), transcript variant 1, mRNA [NM_002355]","chr12",{"v":9092961,"d":"9092961.00"},9102551,"GO:0004888(transmembrane signaling receptor activity);GO:0005537(mannose binding);GO:0005765(lysosomal membrane);GO:0005768(endosome);GO:0005770(late endosome);GO:0005887(integral to plasma membrane);GO:0006898(receptor-mediated endocytosis);GO:0007165(signal transduction);GO:0008333(endosome to lysosome transport);GO:0015578(mannose transmembrane transporter activity);GO:0015761(mannose transport);GO:0016020(membrane);GO:0048471(perinuclear region of cytoplasm)","04145(Phagosome);04142(Lysosome)","mRNA","agilent G3 V3"]
["A_33_P3245575",2.21,2.38,2.23,5.28,5.37,5.39,{"v":0.425187032418953,"d":"0.43"},{"v":-1.23383049743075,"d":"-1.23"},"down",{"v":5.42480000031986e-07,"d":"0.00"},{"v":0.046215498642725,"d":"0.05"},"yes","TGTTTGAGGATGACCTGCGTTTTGAGATCTTCTTCAAGAGACGTCTGATGAACCTCATGC","FALSE","NM_024656","ref|NM_024656|ens|ENST00000597075|ens|ENST00000252599|ref|XM_005260080","COLGALT1","collagen beta(1-O)galactosyltransferase 1","ref|Homo sapiens collagen beta(1-O)galactosyltransferase 1 (COLGALT1), mRNA [NM_024656]","chr19",17687884,17691679,"GO:0005788(endoplasmic reticulum lumen);GO:0016020(membrane);GO:0030198(extracellular matrix organization);GO:0050211(procollagen galactosyltransferase activity)","00310(Lysine degradation);00514(Other types of O-glycan biosynthesis)","mRNA","agilent G3 V3"]
["A_23_P15864",2.34,2.54,{"v":2.4,"d":"2.40"},5.95,6.11,6.04,{"v":0.402209944751381,"d":"0.40"},{"v":-1.31397934177187,"d":"-1.31"},"down",{"v":5.65440000044326e-07,"d":"0.00"},{"v":0.0481715299237763,"d":"0.05"},"yes","GACCCTAAGATGAAGCTGAGCTTTTGATGCCAGGTGCAATCTACTGGAAATGTAGCACTT","FALSE","NM_003927","ref|NM_003927|ens|ENST00000256429|gb|BC032638|gb|AF072242","MBD2","methyl-CpG binding domain protein 2","ref|Homo sapiens methyl-CpG binding domain protein 2 (MBD2), transcript variant 1, mRNA [NM_003927]","chr18",51681624,51686483,"GO:0000118(histone deacetylase complex);GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000790(nuclear chromatin);GO:0000792(heterochromatin);GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0000980(RNA polymerase II distal enhancer sequence-specific DNA binding);GO:0003696(satellite DNA binding);GO:0003729(mRNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-dependent);GO:0008327(methyl-CpG binding);GO:0010467(gene expression);GO:0019904(protein domain specific binding);GO:0030177(positive regulation of Wnt receptor signaling pathway);GO:0031492(nucleosomal DNA binding);GO:0035197(siRNA binding);GO:0040029(regulation of gene expression, epigenetic);GO:0042127(regulation of cell proliferation);GO:0042711(maternal behavior);GO:0043044(ATP-dependent chromatin remodeling);GO:0043234(protein complex);GO:0043623(cellular protein complex assembly);GO:0045814(negative regulation of gene expression, epigenetic);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0070742(C2H2 zinc finger domain binding)",null,"mRNA","agilent G3 V3"]
["A_23_P117494",1.94,2.07,1.92,{"v":6.7,"d":"6.70"},6.52,6.82,{"v":0.295908183632735,"d":"0.30"},{"v":-1.7567784986492,"d":"-1.76"},"down",{"v":5.88370000054184e-07,"d":"0.00"},{"v":0.0501250054146161,"d":"0.05"},"yes","AAGCTACTTTGAAAGTCTGGCCAGTGTCTATTCAGGCCCACTGGGAGTTAGGAAGTATAA","FALSE","NM_005956","ref|NM_005956|ens|ENST00000556284|ens|ENST00000554353|ens|ENST00000216605","MTHFD1","methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase","ref|Homo sapiens methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase (MTHFD1), mRNA [NM_005956]","chr14",64924716,64926721,"GO:0000105(histidine biosynthetic process);GO:0004329(formate-tetrahydrofolate ligase activity);GO:0004477(methenyltetrahydrofolate cyclohydrolase activity);GO:0004486(methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity);GO:0004488(methylenetetrahydrofolate dehydrogenase (NADP+) activity);GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006164(purine nucleotide biosynthetic process);GO:0006730(one-carbon metabolic process);GO:0006766(vitamin metabolic process);GO:0006767(water-soluble vitamin metabolic process);GO:0009086(methionine biosynthetic process);GO:0009396(folic acid-containing compound biosynthetic process);GO:0016020(membrane);GO:0035999(tetrahydrofolate interconversion);GO:0044281(small molecule metabolic process);GO:0046655(folic acid metabolic process);GO:0055114(oxidation-reduction process);GO:0070062(extracellular vesicular exosome)","00670(One carbon pool by folate)","mRNA","agilent G3 V3"]
["A_19_P00321342",13.32,13.36,{"v":13.4,"d":"13.40"},12.24,12.24,12.22,{"v":1.09209809264305,"d":"1.09"},{"v":0.127102445464633,"d":"0.13"},"up",{"v":6.19649999977767e-07,"d":"0.00"},{"v":0.0527898424481059,"d":"0.05"},"yes","GTCCCCTCCATCACACACCTGCAGTTTTTCCATTTGAGTGTAATTCTGTTGGACCTTGAA","FALSE","ENST00000478913","ens|ENST00000478913|ens|ENST00000486641|linc|lnc-SNAPC3-1:1|gb|AL832443","CCDC171","coiled-coil domain containing 171","ens|coiled-coil domain containing 171 [Source:HGNC Symbol;Acc:HGNC:29828] [ENST00000478913]","chr9",16042796,16061318,null,null,"mRNA","agilent G3 V3"]
["A_23_P54816",6.62,{"v":6.8,"d":"6.80"},{"v":6.7,"d":"6.70"},9.45,9.54,9.54,{"v":0.705222572730459,"d":"0.71"},{"v":-0.503849441776192,"d":"-0.50"},"down",{"v":6.3149999995904e-07,"d":"0.00"},{"v":0.0537993794965105,"d":"0.05"},"yes","TCTATAACCTTAGCTAGAGTGTCGCCTTGTGGGTTCCTGTTGCTGAGACTTCCTGGATGG","FALSE","NM_001694","ref|NM_001694|ref|NM_001198569|ref|NR_037141|ens|ENST00000330398","ATP6V0C","ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c","ref|Homo sapiens ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c (ATP6V0C), transcript variant 1, mRNA [NM_001694]","chr16",{"v":2570358,"d":"2570358.00"},2580492,"GO:0005515(protein binding);GO:0005765(lysosomal membrane);GO:0005925(focal adhesion);GO:0006879(cellular iron ion homeostasis);GO:0008286(insulin receptor signaling pathway);GO:0010008(endosome membrane);GO:0015991(ATP hydrolysis coupled proton transport);GO:0015992(proton transport);GO:0016021(integral to membrane);GO:0016032(viral reproduction);GO:0030177(positive regulation of Wnt receptor signaling pathway);GO:0030670(phagocytic vesicle membrane);GO:0031625(ubiquitin protein ligase binding);GO:0033179(proton-transporting V-type ATPase, V0 domain);GO:0033572(transferrin transport);GO:0046933(hydrogen ion transporting ATP synthase activity, rotational mechanism);GO:0046961(proton-transporting ATPase activity, rotational mechanism);GO:0051701(interaction with host);GO:0055085(transmembrane transport);GO:0070062(extracellular vesicular exosome);GO:0090382(phagosome maturation)","00190(Oxidative phosphorylation);04145(Phagosome);04142(Lysosome);04966(Collecting duct acid secretion);04721(Synaptic vesicle cycle);05323(Rheumatoid arthritis);05110(Vibrio cholerae infection);05120(Epithelial cell signaling in Helicobacter pylori infection);05152(Tuberculosis)","mRNA","agilent G3 V3"]
["A_33_P3366589",10.18,10.23,10.27,8.93,8.96,8.95,{"v":1.14307004470939,"d":"1.14"},{"v":0.19291381130275,"d":"0.19"},"up",{"v":6.36030000000787e-07,"d":"0.00"},{"v":0.054185303790067,"d":"0.05"},"yes","AGAAAAAGATTCCCCTTATTCCTGTGTTCCTTAATGTGCTGCACAATGTCATCCCCCCTG","FALSE","NM_001005181","ref|NM_001005181|ens|ENST00000316529|gb|BC136879|gb|BC136880","OR56B4","olfactory receptor, family 56, subfamily B, member 4","ref|Homo sapiens olfactory receptor, family 56, subfamily B, member 4 (OR56B4), mRNA [NM_001005181]","chr11",{"v":6128914,"d":"6128914.00"},6130065,"GO:0004930(G-protein coupled receptor activity);GO:0004984(olfactory receptor activity);GO:0005886(plasma membrane);GO:0007186(G-protein coupled receptor signaling pathway);GO:0016021(integral to membrane);GO:0050911(detection of chemical stimulus involved in sensory perception of smell)","04740(Olfactory transduction)","mRNA","agilent G3 V3"]
["A_23_P353742",2.03,2.16,2.11,6.34,6.54,6.25,{"v":0.32932566649242,"d":"0.33"},{"v":-1.60241313995883,"d":"-1.60"},"down",{"v":6.88780000035472e-07,"d":"0.00"},{"v":0.0586792345430219,"d":"0.06"},"yes","TGGACTCTTAACTGTACGTGTAGTTTCTAGTGGAGAAATCAAGGCTCTGATCATTTTGTT","FALSE","NM_017749","ref|NM_017749|ref|NM_001267782|ref|NM_001300731|ref|NM_001267783","AMBRA1","autophagy/beclin-1 regulator 1","ref|Homo sapiens autophagy/beclin-1 regulator 1 (AMBRA1), transcript variant 2, mRNA [NM_017749]","chr11",46417964,46612914,"GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005776(autophagic vacuole);GO:0005829(cytosol);GO:0005930(axoneme);GO:0006914(autophagy);GO:0008285(negative regulation of cell proliferation);GO:0021915(neural tube development);GO:0030154(cell differentiation);GO:0031625(ubiquitin protein ligase binding);GO:0043231(intracellular membrane-bounded organelle);GO:0043524(negative regulation of neuron apoptotic process);GO:0043552(positive regulation of phosphatidylinositol 3-kinase activity);GO:0045335(phagocytic vesicle);GO:2000785(regulation of autophagic vacuole assembly)",null,"mRNA","agilent G3 V3"]
["A_21_P0009320",{"v":10.2,"d":"10.20"},10.12,10.09,11.76,11.75,{"v":11.8,"d":"11.80"},{"v":0.861229113565562,"d":"0.86"},{"v":-0.215531004728803,"d":"-0.22"},"down",{"v":7.22240000028407e-07,"d":"0.00"},{"v":0.0615297923224201,"d":"0.06"},"yes","AAACTAAGGATTCGGTGTTGGGACCACTCCTGCCCTGACCTGCCCTGTGACTCCGTCATA","FALSE","XR_424825","ref|XR_424825|ref|XR_430803|ref|XR_433389|ref|XR_429967","LOC101929494","uncharacterized LOC101929494","ref|PREDICTED: Homo sapiens uncharacterized LOC101929494 (LOC101929494), transcript variant X6, ncRNA [XR_424825]","chr17",36607552,36608352,null,null,"mRNA","agilent G3 V3"]
["A_23_P209805",1.97,{"v":2,"d":"2.00"},1.94,3.67,3.79,3.75,{"v":0.527207850133809,"d":"0.53"},{"v":-0.923556242627894,"d":"-0.92"},"down",{"v":7.32179999962668e-07,"d":"0.00"},{"v":0.0623766107368195,"d":"0.06"},"yes","CTCATTCAGCTCAAACAGATTTCATAGCCAAAGCAAAAGGACTGGTACGGTAGTCTGTGG","FALSE","NM_005966","ref|NM_005966|ens|ENST00000409581|ens|ENST00000434473|ens|ENST00000337386","NAB1","NGFI-A binding protein 1 (EGR1 binding protein 1)","ref|Homo sapiens NGFI-A binding protein 1 (EGR1 binding protein 1) (NAB1), mRNA [NM_005966]","chr2",191524560,191555999,"GO:0001958(endochondral ossification);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0008134(transcription factor binding);GO:0014037(Schwann cell differentiation);GO:0042552(myelination);GO:0045682(regulation of epidermis development);GO:0045892(negative regulation of transcription, DNA-dependent)",null,"mRNA","agilent G3 V3"]
["A_24_P256243",13.65,13.65,13.72,12.56,12.54,12.57,{"v":1.08893018316963,"d":"1.09"},{"v":0.122911458532459,"d":"0.12"},"up",{"v":7.44519999984483e-07,"d":"0.00"},{"v":0.0634278923586781,"d":"0.06"},"yes","GATGGGAAAGAGCTGTGCCCCCCGGGAAAACCAACTACCTCTGAGAAGATTCACGAGAGA","FALSE","NM_175698","ref|NM_175698|ref|NM_001164417|ref|NM_001278697|ref|NM_001278702","SSX2","synovial sarcoma, X breakpoint 2","ref|Homo sapiens synovial sarcoma, X breakpoint 2 (SSX2), transcript variant 2, mRNA [NM_175698]","chrX",52784780,52787066,"GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent)","05202(Transcriptional misregulation in cancers)","mRNA","agilent G3 V3"]
["A_33_P3379941",2.03,1.88,2.11,6.06,5.86,5.96,{"v":0.33668903803132,"d":"0.34"},{"v":-1.57051134442362,"d":"-1.57"},"down",{"v":7.59660000015927e-07,"d":"0.00"},{"v":0.0647177143813569,"d":"0.06"},"yes","TGTTTAGGGCCTGGGAATTGGCCATGTGTTAATTTATTGAGTGGAGTAGGTGGCTTTTTT","FALSE","NM_014983","ref|NM_014983|ens|ENST00000613459|ref|XM_006714765|ref|XM_006714766","HMGXB3","HMG box domain containing 3","ref|Homo sapiens HMG box domain containing 3 (HMGXB3), mRNA [NM_014983]","chr5",149380288,149432386,"GO:0003677(DNA binding);GO:0005575(cellular_component);GO:0005634(nucleus);GO:0008150(biological_process);GO:0016301(kinase activity);GO:0016310(phosphorylation)",null,"mRNA","agilent G3 V3"]
["A_24_P38815",2.07,2.24,2.11,4.47,{"v":4.5,"d":"4.50"},4.46,{"v":0.478034251675354,"d":"0.48"},{"v":-1.06481410230514,"d":"-1.06"},"down",{"v":7.73849999968768e-07,"d":"0.00"},{"v":0.0659266030473392,"d":"0.07"},"yes","TTCCCTGAGGCTACTTTATTTTGGTATGGCTGAAAAATCCTAGATTTTCTAAACAAAACC","FALSE","NM_000391","ref|NM_000391|ens|ENST00000299427|gb|AY268890|gb|AF017456","TPP1","tripeptidyl peptidase I","ref|Homo sapiens tripeptidyl peptidase I (TPP1), mRNA [NM_000391]","chr11",{"v":6634003,"d":"6634003.00"},6640585,"GO:0004175(endopeptidase activity);GO:0004252(serine-type endopeptidase activity);GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005764(lysosome);GO:0006508(proteolysis);GO:0006629(lipid metabolic process);GO:0006987(activation of signaling protein activity involved in unfolded protein response);GO:0007040(lysosome organization);GO:0007399(nervous system development);GO:0008233(peptidase activity);GO:0008236(serine-type peptidase activity);GO:0008240(tripeptidyl-peptidase activity);GO:0030163(protein catabolic process);GO:0030855(epithelial cell differentiation);GO:0030968(endoplasmic reticulum unfolded protein response);GO:0042277(peptide binding);GO:0042470(melanosome);GO:0043171(peptide catabolic process);GO:0043202(lysosomal lumen);GO:0044267(cellular protein metabolic process);GO:0045453(bone resorption);GO:0046872(metal ion binding);GO:0050885(neuromuscular process controlling balance);GO:0070062(extracellular vesicular exosome)","04142(Lysosome)","mRNA","agilent G3 V3"]
["A_23_P165061",6.19,6.01,6.12,8.75,8.77,8.85,{"v":0.694728858551384,"d":"0.69"},{"v":-0.525478067767616,"d":"-0.53"},"down",{"v":7.80040000036841e-07,"d":"0.00"},{"v":0.0664539477231386,"d":"0.07"},"yes","GTGTCTGTATATAGTCAGCTTATCTCGTGTTCAATCGTCTGATCTCTACAGAGAGAAGTG","FALSE","NM_198969","ref|NM_198969|ref|NM_001130|ref|NM_198970|ens|ENST00000592414","AES","amino-terminal enhancer of split","ref|Homo sapiens amino-terminal enhancer of split (AES), transcript variant 1, mRNA [NM_198969]","chr19",{"v":3053547,"d":"3053547.00"},3056194,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0001501(skeletal system development);GO:0003714(transcription corepressor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0007275(multicellular organismal development);GO:0009887(organ morphogenesis);GO:0010629(negative regulation of gene expression);GO:0016055(Wnt receptor signaling pathway);GO:0031668(cellular response to extracellular stimulus);GO:0032091(negative regulation of protein binding);GO:0040008(regulation of growth);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0060761(negative regulation of response to cytokine stimulus);GO:0070555(response to interleukin-1);GO:0090090(negative regulation of canonical Wnt receptor signaling pathway);GO:2000210(positive regulation of anoikis)",null,"mRNA","agilent G3 V3"]
["A_33_P3351664",13.84,13.87,{"v":13.9,"d":"13.90"},12.83,12.78,12.83,{"v":1.08246618106139,"d":"1.08"},{"v":0.114321952271009,"d":"0.11"},"up",{"v":8.00559999958317e-07,"d":"0.00"},{"v":0.0682021080764489,"d":"0.07"},"yes","AAAGGCTGCCAGAGGCCCCCCAAGATCCGTAACTACAACATTATGGACTGACTTCCTCCC","FALSE","NM_198082","ref|NM_198082|ens|ENST00000389641|ens|ENST00000392347|gb|BC110997","CCDC57","coiled-coil domain containing 57","ref|Homo sapiens coiled-coil domain containing 57 (CCDC57), mRNA [NM_198082]","chr17",80059344,80170689,null,null,"mRNA","agilent G3 V3"]
["A_33_P3368706",2.04,1.97,2.03,5.21,5.45,5.27,{"v":0.379158819836786,"d":"0.38"},{"v":-1.39912581220023,"d":"-1.40"},"down",{"v":8.15960000011273e-07,"d":"0.00"},{"v":0.0695140802809604,"d":"0.07"},"yes","AGGAATCAATATTTCAATATGTTGAGTGTGTGTCCAATGCTATGAAATTAAAATATTAAA","FALSE","NM_001142590","ref|NM_001142590|ref|NM_001142588|ref|NM_014223|ref|NM_001142587","NFYC","nuclear transcription factor Y, gamma","ref|Homo sapiens nuclear transcription factor Y, gamma (NFYC), transcript variant 5, mRNA [NM_001142590]","chr1",41234400,41237273,"GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0006457(protein folding);GO:0008134(transcription factor binding);GO:0016602(CCAAT-binding factor complex);GO:0032993(protein-DNA complex);GO:0043565(sequence-specific DNA binding);GO:0044212(transcription regulatory region DNA binding);GO:0044255(cellular lipid metabolic process);GO:0044281(small molecule metabolic process);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0046982(protein heterodimerization activity)","04612(Antigen processing and presentation);05152(Tuberculosis)","mRNA","agilent G3 V3"]
["A_24_P372048",1.86,2.02,1.91,6.25,5.98,6.21,{"v":0.313991323210412,"d":"0.31"},{"v":-1.6712034024401,"d":"-1.67"},"down",{"v":8.19850000000066e-07,"d":"0.00"},{"v":0.0698454810500057,"d":"0.07"},"yes","GGAAGCTTCTGCTGGGATGGTGTCACCTATGGGTTTTGAACCAGTGTGGTATGGTCCTTG","FALSE","NM_006555","ref|NM_006555|ens|ENST00000421621|ens|ENST00000223369|gb|AK075018","YKT6","YKT6 v-SNARE homolog (S. cerevisiae)","ref|Homo sapiens YKT6 v-SNARE homolog (S. cerevisiae) (YKT6), mRNA [NM_006555]","chr7",44250308,44253891,"GO:0000139(Golgi membrane);GO:0000149(SNARE binding);GO:0005484(SNAP receptor activity);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005768(endosome);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005887(integral to plasma membrane);GO:0006888(ER to Golgi vesicle-mediated transport);GO:0006903(vesicle targeting);GO:0006904(vesicle docking involved in exocytosis);GO:0006906(vesicle fusion);GO:0008152(metabolic process);GO:0015031(protein transport);GO:0019706(protein-cysteine S-palmitoleyltransferase activity);GO:0030659(cytoplasmic vesicle membrane);GO:0031201(SNARE complex);GO:0042147(retrograde transport, endosome to Golgi);GO:0070062(extracellular vesicular exosome)","04130(SNARE interactions in vesicular transport)","mRNA","agilent G3 V3"]
["A_24_P241792",{"v":1.9,"d":"1.90"},2.03,{"v":2,"d":"2.00"},4.24,{"v":4.2,"d":"4.20"},4.13,{"v":0.47175815433572,"d":"0.47"},{"v":-1.0838806398745,"d":"-1.08"},"down",{"v":8.27759999988409e-07,"d":"0.00"},{"v":0.0705193576790125,"d":"0.07"},"yes","CATTATCTGCTTGAAGCACATTTTGCTAATGTTTTATTCAGAATGTATCATAGATATAAT","FALSE","NM_198893","ref|NM_198893|ref|NM_001102603|ref|NM_033288|ens|ENST00000429604","ZNF160","zinc finger protein 160","ref|Homo sapiens zinc finger protein 160 (ZNF160), transcript variant 2, mRNA [NM_198893]","chr19",53569868,53606687,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0030097(hemopoiesis);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3356220",14.21,14.17,14.23,15.23,15.18,15.22,{"v":0.933815472277011,"d":"0.93"},{"v":-0.0987906022674337,"d":"-0.10"},"down",{"v":8.62840000004361e-07,"d":"0.00"},{"v":0.0735079281203715,"d":"0.07"},"yes","CCCCTCCTCCCAGGGCCTCCTGGGGGACCTTTGTATTAAGCCAATTAAAAACATGAATTT","FALSE","NM_001165937","ref|NM_001165937|ref|NM_006804|ref|NM_001165938|ens|ENST00000584850","STARD3","StAR-related lipid transfer (START) domain containing 3","ref|Homo sapiens StAR-related lipid transfer (START) domain containing 3 (STARD3), transcript variant 2, mRNA [NM_001165937]","chr17",37820440,37822808,"GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005765(lysosomal membrane);GO:0006629(lipid metabolic process);GO:0006701(progesterone biosynthetic process);GO:0006839(mitochondrial transport);GO:0008202(steroid metabolic process);GO:0008203(cholesterol metabolic process);GO:0015485(cholesterol binding);GO:0016021(integral to membrane);GO:0017127(cholesterol transporter activity);GO:0030301(cholesterol transport);GO:0031902(late endosome membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P162171",1.87,1.99,1.89,6.56,{"v":6.7,"d":"6.70"},6.35,{"v":0.293217746047935,"d":"0.29"},{"v":-1.76995567436041,"d":"-1.77"},"down",{"v":9.01539999986767e-07,"d":"0.00"},{"v":0.0768048972188726,"d":"0.08"},"yes","GCCTCTTCAAAGTCTCCTGTGACATTTTTTCTTTGGTCAGAAGCCAGGAACTGGTGTCAT","FALSE","NM_006500","ref|NM_006500|ens|ENST00000525586|ens|ENST00000528533|ens|ENST00000264036","MCAM","melanoma cell adhesion molecule","ref|Homo sapiens melanoma cell adhesion molecule (MCAM), mRNA [NM_006500]","chr11",119179696,119184795,"GO:0001525(angiogenesis);GO:0003094(glomerular filtration);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0007155(cell adhesion);GO:0009653(anatomical structure morphogenesis);GO:0009897(external side of plasma membrane);GO:0016021(integral to membrane);GO:0030335(positive regulation of cell migration);GO:0061042(vascular wound healing)",null,"mRNA","agilent G3 V3"]
["A_24_P96593",2.04,2.08,2.03,3.85,3.89,3.99,{"v":0.524296675191816,"d":"0.52"},{"v":-0.931544697801906,"d":"-0.93"},"down",{"v":9.65799999974593e-07,"d":"0.00"},{"v":0.0822793993978355,"d":"0.08"},"yes","TAAAGGTATAGTGGATGCTATTTATGATCCAAGTTTTTACATCACATCCATTGATCTGCC","FALSE","NM_005665","ref|NM_005665|ens|ENST00000540033|ens|ENST00000370331|ref|XM_006710887","EVI5","ecotropic viral integration site 5","ref|Homo sapiens ecotropic viral integration site 5 (EVI5), mRNA [NM_005665]","chr1",92974256,93257961,"GO:0005097(Rab GTPase activator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005794(Golgi apparatus);GO:0005815(microtubule organizing center);GO:0005819(spindle);GO:0005829(cytosol);GO:0007049(cell cycle);GO:0007275(multicellular organismal development);GO:0008283(cell proliferation);GO:0017137(Rab GTPase binding);GO:0032851(positive regulation of Rab GTPase activity);GO:0033126(positive regulation of GTP catabolic process);GO:0042147(retrograde transport, endosome to Golgi);GO:0043231(intracellular membrane-bounded organelle);GO:0051301(cell division)",null,"mRNA","agilent G3 V3"]
["A_33_P3216635",7.68,7.67,7.75,{"v":6.3,"d":"6.30"},6.22,6.27,{"v":1.22937732836615,"d":"1.23"},{"v":0.297927784883365,"d":"0.30"},"up",{"v":9.73140000026795e-07,"d":"0.00"},{"v":0.0829047160222828,"d":"0.08"},"yes","TCAGGACGTGTCTGGACGGGTTGTTTGGAAATTCAAGGGAAGCTTGGGGCTCCTTCCCTG","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_23_P142294",7.08,7.02,7.03,6.24,6.24,6.22,{"v":1.12994652406417,"d":"1.13"},{"v":0.176254497159942,"d":"0.18"},"up",{"v":1.0498000000414e-06,"d":"0.00"},{"v":0.0894356114035271,"d":"0.09"},"yes","CAGATGCTCCCATCCACTATTAATGCACTAGGTGGGAGGAGAGGGCGGCAATGACACTGC","FALSE","NM_014297","ref|NM_014297|ens|ENST00000292147|ref|XM_005258687|ref|XM_005258688","ETHE1","ethylmalonic encephalopathy 1","ref|Homo sapiens ethylmalonic encephalopathy 1 (ETHE1), mRNA [NM_014297]","chr19",44010944,44031357,"GO:0000096(sulfur amino acid metabolic process);GO:0000098(sulfur amino acid catabolic process);GO:0005506(iron ion binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0006749(glutathione metabolic process);GO:0034641(cellular nitrogen compound metabolic process);GO:0044281(small molecule metabolic process);GO:0050313(sulfur dioxygenase activity);GO:0070221(sulfide oxidation, using sulfide:quinone oxidoreductase);GO:0070813(hydrogen sulfide metabolic process)","00920(Sulfur metabolism)","mRNA","agilent G3 V3"]
["A_23_P12874",2.21,2.27,2.18,5.37,{"v":5.2,"d":"5.20"},5.44,{"v":0.415990006246096,"d":"0.42"},{"v":-1.26537922544499,"d":"-1.27"},"down",{"v":1.05719999998755e-06,"d":"0.00"},{"v":0.090066039598939,"d":"0.09"},"yes","TTGCTTCAGATTTTCAGAACTGGGAAGATTTACTGGTGTAACTGGGTTGTTTTTGATGGA","FALSE","NM_012341","ref|NM_012341|ref|XM_006717437|gb|AF325353|gb|AK295231","GTPBP4","GTP binding protein 4","ref|Homo sapiens GTP binding protein 4 (GTPBP4), mRNA [NM_012341]","chr10",{"v":1034348,"d":"1034348.00"},1063708,"GO:0000079(regulation of cyclin-dependent protein kinase activity);GO:0001649(osteoblast differentiation);GO:0003924(GTPase activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0008152(metabolic process);GO:0008156(negative regulation of DNA replication);GO:0008285(negative regulation of cell proliferation);GO:0016020(membrane);GO:0022408(negative regulation of cell-cell adhesion);GO:0030336(negative regulation of cell migration);GO:0031397(negative regulation of protein ubiquitination);GO:0031965(nuclear membrane);GO:0033342(negative regulation of collagen binding);GO:0042254(ribosome biogenesis);GO:0048471(perinuclear region of cytoplasm);GO:0050821(protein stabilization)","03008(Ribosome biogenesis in eukaryotes)","mRNA","agilent G3 V3"]
["A_23_P70583",3.06,3.25,{"v":3.2,"d":"3.20"},5.61,5.64,5.68,{"v":0.561724748966332,"d":"0.56"},{"v":-0.832064727035078,"d":"-0.83"},"down",{"v":1.06050000003854e-06,"d":"0.00"},{"v":0.0903471765032837,"d":"0.09"},"yes","TGATCCGTGGCTTTGGTAGTTCCTGGAAATCATCAGTGGAATCTCTGAGTCAGGATGTAA","FALSE","NM_022553","ref|NM_022553|ref|NM_001289174|ref|NM_001289175|ref|NM_001289176","VPS52","vacuolar protein sorting 52 homolog (S. cerevisiae)","ref|Homo sapiens vacuolar protein sorting 52 homolog (S. cerevisiae) (VPS52), transcript variant 1, mRNA [NM_022553]","chr6",33218380,33239717,"GO:0005515(protein binding);GO:0005794(Golgi apparatus);GO:0010008(endosome membrane);GO:0010668(ectodermal cell differentiation);GO:0015031(protein transport);GO:0019905(syntaxin binding);GO:0048471(perinuclear region of cytoplasm);GO:0048611(embryonic ectodermal digestive tract development)",null,"mRNA","agilent G3 V3"]
["A_24_P407717",2.55,2.76,2.52,6.18,6.24,6.35,{"v":0.417155034629728,"d":"0.42"},{"v":-1.26134443753983,"d":"-1.26"},"down",{"v":1.12990000000757e-06,"d":"0.00"},{"v":0.0962595707006446,"d":"0.10"},"yes","GGTACACAGTGAGAGTACTCACTTTTCACTTGTCTTGCTCTTAGATTGGGCCATGGCTTT","FALSE","NM_002086","ref|NM_002086|ref|NM_203506|ens|ENST00000392562|ens|ENST00000316804","GRB2","growth factor receptor-bound protein 2","ref|Homo sapiens growth factor receptor-bound protein 2 (GRB2), transcript variant 1, mRNA [NM_002086]","chr17",73314160,73315410,"GO:0001784(phosphotyrosine binding);GO:0005070(SH3/SH2 adaptor activity);GO:0005154(epidermal growth factor receptor binding);GO:0005168(neurotrophin TRKA receptor binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007265(Ras protein signal transduction);GO:0007267(cell-cell signaling);GO:0007411(axon guidance);GO:0007568(aging);GO:0007596(blood coagulation);GO:0008180(signalosome);GO:0008286(insulin receptor signaling pathway);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0009967(positive regulation of signal transduction);GO:0012506(vesicle membrane);GO:0016032(viral reproduction);GO:0017124(SH3 domain binding);GO:0019901(protein kinase binding);GO:0019903(protein phosphatase binding);GO:0030168(platelet activation);GO:0030838(positive regulation of actin filament polymerization);GO:0031295(T cell costimulation);GO:0031623(receptor internalization);GO:0038095(Fc-epsilon receptor signaling pathway);GO:0038096(Fc-gamma receptor signaling pathway involved in phagocytosis);GO:0042059(negative regulation of epidermal growth factor receptor signaling pathway);GO:0042770(signal transduction in response to DNA damage);GO:0042802(identical protein binding);GO:0043408(regulation of MAPK cascade);GO:0043560(insulin receptor substrate binding);GO:0045087(innate immune response);GO:0046875(ephrin receptor binding);GO:0048011(nerve growth factor receptor signaling pathway);GO:0048015(phosphatidylinositol-mediated signaling);GO:0048646(anatomical structure formation involved in morphogenesis);GO:0050900(leukocyte migration);GO:0051291(protein heterooligomerization);GO:0060670(branching involved in labyrinthine layer morphogenesis);GO:0070062(extracellular vesicular exosome);GO:0070436(Grb2-EGFR complex);GO:0071479(cellular response to ionizing radiation);GO:2000379(positive regulation of reactive oxygen species metabolic process)","04014(Ras signaling pathway);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04630(Jak-STAT signaling pathway);04068(FoxO signaling pathway);04151(PI3K-Akt signaling pathway);04510(Focal adhesion);04540(Gap junction);04550(Signaling pathways regulating pluripotency of stem cells);04650(Natural killer cell mediated cytotoxicity);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04062(Chemokine signaling pathway);04910(Insulin signaling pathway);04912(GnRH signaling pathway);04915(Estrogen signaling pathway);04917(Prolactin signaling pathway);04722(Neurotrophin signaling pathway);04320(Dorso-ventral axis formation);04380(Osteoclast differentiation);05200(Pathways in cancer);05231(Choline metabolism in cancer);05206(MicroRNAs in cancer);05205(Proteoglycans in cancer);05203(Viral carcinogenesis);05214(Glioma);05221(Acute myeloid leukemia);05220(Chronic myeloid leukemia);05211(Renal cell carcinoma);05215(Prostate cancer);05213(Endometrial cancer);05223(Non-small cell lung cancer);05034(Alcoholism);05161(Hepatitis B);05160(Hepatitis C)","mRNA","agilent G3 V3"]
["A_23_P45389",2.12,2.31,2.26,5.48,{"v":5.3,"d":"5.30"},5.35,{"v":0.414755114693118,"d":"0.41"},{"v":-1.26966832251418,"d":"-1.27"},"down",{"v":1.1381000000199e-06,"d":"0.00"},{"v":0.0969581533016957,"d":"0.10"},"yes","CTTTGAGGAAGCGGTTCGAAGAGTTCTTGCTACCGAGGATAGGTCAGATCATTTGATTCA","FALSE","NM_004251","ref|NM_004251|ref|NM_001195328|ens|ENST00000243325|ens|ENST00000618931","RAB9A","RAB9A, member RAS oncogene family","ref|Homo sapiens RAB9A, member RAS oncogene family (RAB9A), transcript variant 1, mRNA [NM_004251]","chrX",13707305,13727473,"GO:0000139(Golgi membrane);GO:0003924(GTPase activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005764(lysosome);GO:0005770(late endosome);GO:0005774(vacuolar membrane);GO:0005789(endoplasmic reticulum membrane);GO:0005886(plasma membrane);GO:0006886(intracellular protein transport);GO:0008152(metabolic process);GO:0019003(GDP binding);GO:0030670(phagocytic vesicle membrane);GO:0032482(Rab protein signal transduction);GO:0042147(retrograde transport, endosome to Golgi);GO:0045335(phagocytic vesicle);GO:0045921(positive regulation of exocytosis);GO:0070062(extracellular vesicular exosome);GO:0090385(phagosome-lysosome fusion)","05162(Measles)","mRNA","agilent G3 V3"]
["A_24_P309415",1.98,2.12,2.06,5.79,5.52,5.72,{"v":0.361714621256606,"d":"0.36"},{"v":-1.46707617898364,"d":"-1.47"},"down",{"v":1.16230000002382e-06,"d":"0.00"},{"v":0.0990198239020292,"d":"0.10"},"yes","GTTTCCTCTGCATTGGGTTTGAAGTAGTTTAGTTATGTCTTTTTCTCTGTATGTAAGTAG","FALSE","NM_052932","ref|NM_052932|ens|ENST00000398136|ens|ENST00000361236|gb|AK075420","TMEM123","transmembrane protein 123","ref|Homo sapiens transmembrane protein 123 (TMEM123), mRNA [NM_052932]","chr11",102267064,102323775,"GO:0004872(receptor activity);GO:0009897(external side of plasma membrane);GO:0016021(integral to membrane);GO:0070267(oncosis)",null,"mRNA","agilent G3 V3"]
["A_33_P3230498",2.02,1.94,2.01,3.77,{"v":3.9,"d":"3.90"},3.87,{"v":0.517331022530329,"d":"0.52"},{"v":-0.950840387380678,"d":"-0.95"},"down",{"v":1.19229999995252e-06,"d":"0.00"},{"v":0.101575613895955,"d":"0.10"},"yes","TGTTTTCATGATATTCAGTGGGATCAACTCTGCATAGACACACAGACACGCACTGAGACT","FALSE","AK130931","gb|AK130931|tc|THC2487563",null,null,"gb|Homo sapiens cDNA FLJ27421 fis, clone WMC07981. [AK130931]",{"$nulls":5},"mRNA","agilent G3 V3"]
["A_23_P157865",6.28,6.34,6.14,9.77,{"v":9.6,"d":"9.60"},9.81,{"v":0.64290610006854,"d":"0.64"},{"v":-0.637320055402514,"d":"-0.64"},"down",{"v":1.20299999994966e-06,"d":"0.00"},{"v":0.102487178995711,"d":"0.10"},"yes","CAATACAACCAGCCCAACCATCGGTCCACACCTGGGCATTTGGTGAGAATCAAAGCTGAC","FALSE","NM_002160","ref|NM_002160|ens|ENST00000350763|ens|ENST00000535648|ref|XM_006717096","TNC","tenascin C","ref|Homo sapiens tenascin C (TNC), mRNA [NM_002160]","chr9",117782808,117880486,"GO:0001649(osteoblast differentiation);GO:0005576(extracellular region);GO:0005604(basement membrane);GO:0005614(interstitial matrix);GO:0005615(extracellular space);GO:0005925(focal adhesion);GO:0007155(cell adhesion);GO:0007162(negative regulation of cell adhesion);GO:0007528(neuromuscular junction development);GO:0008284(positive regulation of cell proliferation);GO:0009611(response to wounding);GO:0009612(response to mechanical stimulus);GO:0010628(positive regulation of gene expression);GO:0014012(peripheral nervous system axon regeneration);GO:0016020(membrane);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix);GO:0042060(wound healing);GO:0042475(odontogenesis of dentin-containing tooth);GO:0045471(response to ethanol);GO:0045545(syndecan binding);GO:0060447(bud outgrowth involved in lung branching);GO:0060739(mesenchymal-epithelial cell signaling involved in prostate gland development);GO:0060740(prostate gland epithelium morphogenesis);GO:0071300(cellular response to retinoic acid);GO:0071305(cellular response to vitamin D);GO:0071774(response to fibroblast growth factor stimulus);GO:0071799(cellular response to prostaglandin D stimulus)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);05206(MicroRNAs in cancer)","mRNA","agilent G3 V3"]
["A_24_P91310",1.98,1.92,1.97,6.13,6.48,6.19,{"v":0.312234042553191,"d":"0.31"},{"v":-1.67930025345495,"d":"-1.68"},"down",{"v":1.25120000005197e-06,"d":"0.00"},{"v":0.106593481604427,"d":"0.11"},"yes","GTTCAGAGGATCCTGCTGGAGCTGCTGAATCAGATGGATGGATTTGATCAGAATGTCAAT","FALSE","NM_006503","ref|NM_006503|ref|NM_153001|ens|ENST00000601194|ens|ENST00000157812","PSMC4","proteasome (prosome, macropain) 26S subunit, ATPase, 4","ref|Homo sapiens proteasome (prosome, macropain) 26S subunit, ATPase, 4 (PSMC4), transcript variant 1, mRNA [NM_006503]","chr19",40485352,40486085,"GO:0000082(G1/S transition of mitotic cell cycle);GO:0000209(protein polyubiquitination);GO:0000278(mitotic cell cycle);GO:0000502(proteasome complex);GO:0001824(blastocyst development);GO:0002474(antigen processing and presentation of peptide antigen via MHC class I);GO:0002479(antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0006521(regulation of cellular amino acid metabolic process);GO:0006915(apoptotic process);GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest);GO:0010467(gene expression);GO:0016020(membrane);GO:0016032(viral reproduction);GO:0016234(inclusion body);GO:0016887(ATPase activity);GO:0022624(proteasome accessory complex);GO:0031145(anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process);GO:0031597(cytosolic proteasome complex);GO:0034641(cellular nitrogen compound metabolic process);GO:0042590(antigen processing and presentation of exogenous peptide antigen via MHC class I);GO:0042981(regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0044281(small molecule metabolic process);GO:0051436(negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle);GO:0051437(positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle);GO:0051439(regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle);GO:0090090(negative regulation of canonical Wnt receptor signaling pathway);GO:0090263(positive regulation of canonical Wnt receptor signaling pathway)","03050(Proteasome);05169(Epstein-Barr virus infection)","mRNA","agilent G3 V3"]
["A_23_P9823",1.99,2.21,1.96,6.33,6.45,6.19,{"v":0.324723247232472,"d":"0.32"},{"v":-1.62271742271657,"d":"-1.62"},"down",{"v":1.26290000002083e-06,"d":"0.00"},{"v":0.107590239701774,"d":"0.11"},"yes","TCTTGTTCTAGAGGTTTTCTTGTTTTCGAATCTTGCCTGATGAATCCAGCCAGACCAAGG","FALSE","NM_014938","ref|NM_014938|ens|ENST00000538698|ens|ENST00000319080|ref|XM_006719292","MLXIP","MLX interacting protein","ref|Homo sapiens MLX interacting protein (MLXIP), mRNA [NM_014938]","chr12",122617072,122628965,"GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005634(nucleus);GO:0005741(mitochondrial outer membrane);GO:0006351(transcription, DNA-dependent);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0006913(nucleocytoplasmic transport);GO:0046983(protein dimerization activity);GO:1900402(regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter)","04932(Non-alcoholic fatty liver disease (NAFLD))","mRNA","agilent G3 V3"]
["A_19_P00807336",2.37,2.45,2.39,6.07,6.08,5.81,{"v":0.401447661469933,"d":"0.40"},{"v":-1.31671618550032,"d":"-1.32"},"down",{"v":1.27490000001451e-06,"d":"0.00"},{"v":0.108612555701236,"d":"0.11"},"yes","TAATGATATCAATGATGTCAAACAGCTGAAACCTGGCTACTTAGAAGCTACTGTGGACTG","FALSE","NM_021129","ref|NM_021129|ens|ENST00000393779|ens|ENST00000373232|gb|AF108211","PPA1","pyrophosphatase (inorganic) 1","ref|Homo sapiens pyrophosphatase (inorganic) 1 (PPA1), mRNA [NM_021129]","chr10",71962584,71993183,"GO:0000287(magnesium ion binding);GO:0004427(inorganic diphosphatase activity);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006418(tRNA aminoacylation for protein translation);GO:0006796(phosphate-containing compound metabolic process);GO:0010467(gene expression);GO:0070062(extracellular vesicular exosome);GO:0071344(diphosphate metabolic process)","00190(Oxidative phosphorylation)","mRNA","agilent G3 V3"]
["A_33_P3230818",10.28,10.21,10.29,9.19,9.22,9.22,{"v":1.11400651465798,"d":"1.11"},{"v":0.155757669515718,"d":"0.16"},"up",{"v":1.32139999997616e-06,"d":"0.00"},{"v":0.112574030197969,"d":"0.11"},"yes","TTTCAAGCAATCACTGACTTCAATGACCTCCCCAACTCGTTGTTTGCGTGCAATGTTCAC","FALSE","NM_001251973","ref|NM_001251973|ref|NM_001251974|ens|ENST00000371374|ens|ENST00000306764","RCAN2","regulator of calcineurin 2","ref|Homo sapiens regulator of calcineurin 2 (RCAN2), transcript variant 3, mRNA [NM_001251973]","chr6",46190880,46424713,"GO:0000166(nucleotide binding);GO:0005575(cellular_component);GO:0006979(response to oxidative stress);GO:0007614(short-term memory);GO:0031987(locomotion involved in locomotory behavior);GO:0033173(calcineurin-NFAT signaling cascade)","04919(Thyroid hormone signaling pathway)","mRNA","agilent G3 V3"]
["A_33_P3251198",12.14,12.25,12.24,{"v":10.8,"d":"10.80"},10.76,10.79,{"v":1.1323029366306,"d":"1.13"},{"v":0.17925998882869,"d":"0.18"},"up",{"v":1.36849999998745e-06,"d":"0.00"},{"v":0.116586620498931,"d":"0.12"},"yes","GTGGAAAGGCTCCCCCAAAACATTTTCACCTTCATTTTATAAAGCAAAATAAAATGCTTG","FALSE","ENST00000404098","ens|ENST00000404098|gb|AX721082|tc|THC2627213","PLCB1","phospholipase C, beta 1 (phosphoinositide-specific)","ens|phospholipase C, beta 1 (phosphoinositide-specific) [Source:HGNC Symbol;Acc:HGNC:15917] [ENST00000404098]","chr20",{"v":8113302,"d":"8113302.00"},8632165,"GO:0000086(G2/M transition of mitotic cell cycle);GO:0000790(nuclear chromatin);GO:0004435(phosphatidylinositol phospholipase C activity);GO:0004871(signal transducer activity);GO:0005096(GTPase activator activity);GO:0005509(calcium ion binding);GO:0005516(calmodulin binding);GO:0005521(lamin binding);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007165(signal transduction);GO:0007213(G-protein coupled acetylcholine receptor signaling pathway);GO:0007215(glutamate receptor signaling pathway);GO:0007268(synaptic transmission);GO:0007613(memory);GO:0008152(metabolic process);GO:0008277(regulation of G-protein coupled receptor protein signaling pathway);GO:0016042(lipid catabolic process);GO:0016607(nuclear speck);GO:0019899(enzyme binding);GO:0021987(cerebral cortex development);GO:0031965(nuclear membrane);GO:0032735(positive regulation of interleukin-12 production);GO:0035556(intracellular signal transduction);GO:0035722(interleukin-12-mediated signaling pathway);GO:0035723(interleukin-15-mediated signaling pathway);GO:0040019(positive regulation of embryonic development);GO:0042803(protein homodimerization activity);GO:0043547(positive regulation of GTPase activity);GO:0043647(inositol phosphate metabolic process);GO:0044281(small molecule metabolic process);GO:0045444(fat cell differentiation);GO:0045663(positive regulation of myoblast differentiation);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0046330(positive regulation of JNK cascade);GO:0046488(phosphatidylinositol metabolic process);GO:0048009(insulin-like growth factor receptor signaling pathway);GO:0048639(positive regulation of developmental growth);GO:0060466(activation of meiosis involved in egg activation);GO:0070062(extracellular vesicular exosome);GO:0070498(interleukin-1-mediated signaling pathway);GO:0080154(regulation of fertilization);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle);GO:2000344(positive regulation of acrosome reaction);GO:2000438(negative regulation of monocyte extravasation);GO:2000560(positive regulation of CD24 biosynthetic process)","00562(Inositol phosphate metabolism);04015(Rap1 signaling pathway);04310(Wnt signaling pathway);04020(Calcium signaling pathway);04070(Phosphatidylinositol signaling system);04071(Sphingolipid signaling pathway);04022(cGMP - PKG signaling pathway);04540(Gap junction);04611(Platelet activation);04062(Chemokine signaling pathway);04911(Insulin secretion);04922(Glucagon signaling pathway);04912(GnRH signaling pathway);04915(Estrogen signaling pathway);04921(Oxytocin signaling pathway);04918(Thyroid hormone synthesis);04919(Thyroid hormone signaling pathway);04916(Melanogenesis);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);04970(Salivary secretion);04971(Gastric acid secretion);04972(Pancreatic secretion);04961(Endocrine and other factor-regulated calcium reabsorption);04724(Glutamatergic synapse);04725(Cholinergic synapse);04728(Dopaminergic synapse);04726(Serotonergic synapse);04720(Long-term potentiation);04730(Long-term depression);04723(Retrograde endocannabinoid signaling);04750(Inflammatory mediator regulation of TRP channels);04713(Circadian entrainment);05200(Pathways in cancer);05010(Alzheimer's disease);05016(Huntington's disease);05146(Amoebiasis);05142(Chagas disease (American trypanosomiasis));05143(African trypanosomiasis)","mRNA","agilent G3 V3"]
["A_23_P18993",7.36,7.26,7.31,5.61,5.52,5.49,{"v":1.31949458483755,"d":"1.32"},{"v":0.399985429903249,"d":"0.40"},"up",{"v":1.38480000000385e-06,"d":"0.00"},{"v":0.117975266400328,"d":"0.12"},"yes","ATTGCCGTCCCTGAATCCTTTATGAATGAAGTTTCTGTAAATAACCTGGGTGTGGACTTT","FALSE","NM_152622","ref|NM_152622|ref|NM_001297598|ref|NM_001297599|ens|ENST00000452157","MIER3","mesoderm induction early response 1, family member 3","ref|Homo sapiens mesoderm induction early response 1, family member 3 (MIER3), transcript variant 3, mRNA [NM_152622]","chr5",56218412,56236960,"GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent)",null,"mRNA","agilent G3 V3"]
["A_24_P201171",1.98,2.04,2.01,4.02,{"v":4.2,"d":"4.20"},{"v":4.1,"d":"4.10"},{"v":0.489448051948052,"d":"0.49"},{"v":-1.03077234879482,"d":"-1.03"},"down",{"v":1.40110000002025e-06,"d":"0.00"},{"v":0.119363912301725,"d":"0.12"},"yes","TGTGTTGTGTGGGGTCATACATCATCGTGTTTGTAAGAGAAGATGGTCATTTTATTCTCT","FALSE","NM_003165","ref|NM_003165|ref|NM_001032221|ens|ENST00000373302|ens|ENST00000373299","STXBP1","syntaxin binding protein 1","ref|Homo sapiens syntaxin binding protein 1 (STXBP1), transcript variant 1, mRNA [NM_003165]","chr9",130374568,130454995,"GO:0000149(SNARE binding);GO:0002576(platelet degranulation);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006112(energy reserve metabolic process);GO:0006904(vesicle docking involved in exocytosis);GO:0007268(synaptic transmission);GO:0007269(neurotransmitter secretion);GO:0007274(neuromuscular synaptic transmission);GO:0007412(axon target recognition);GO:0010807(regulation of synaptic vesicle priming);GO:0014047(glutamate secretion);GO:0015031(protein transport);GO:0016188(synaptic vesicle maturation);GO:0017075(syntaxin-1 binding);GO:0019901(protein kinase binding);GO:0019904(protein domain specific binding);GO:0019905(syntaxin binding);GO:0031091(platelet alpha granule);GO:0031630(regulation of synaptic vesicle fusion to presynaptic membrane);GO:0032229(negative regulation of synaptic transmission, GABAergic);GO:0035542(regulation of SNARE complex assembly);GO:0042802(identical protein binding);GO:0043234(protein complex);GO:0043524(negative regulation of neuron apoptotic process);GO:0044281(small molecule metabolic process);GO:0045956(positive regulation of calcium ion-dependent exocytosis);GO:0047485(protein N-terminus binding);GO:0050796(regulation of insulin secretion);GO:0050821(protein stabilization);GO:0060292(long term synaptic depression);GO:0070062(extracellular vesicular exosome);GO:0070527(platelet aggregation);GO:0072659(protein localization in plasma membrane)","04721(Synaptic vesicle cycle)","mRNA","agilent G3 V3"]
["A_33_P3405754",7.15,7.11,7.06,8.14,8.12,8.12,{"v":0.874487284659557,"d":"0.87"},{"v":-0.193490687861036,"d":"-0.19"},"down",{"v":1.43900000004749e-06,"d":"0.00"},{"v":0.122592727004045,"d":"0.12"},"yes","TTTGGGACAGTGGTTCCCTTGCCACCTGCCTGCTGTGGATGACAATGAGGGGACTCCATT","FALSE","ENST00000378223","ens|ENST00000378223|gb|BC050721|tc|THC2489059","CEP104","centrosomal protein 104kDa","ens|centrosomal protein 104kDa [Source:HGNC Symbol;Acc:HGNC:24866] [ENST00000378223]","chr1",{"v":3759673,"d":"3759673.00"},3773778,"GO:0005814(centriole);GO:0016594(glycine binding);GO:0016595(glutamate binding);GO:0016596(thienylcyclohexylpiperidine binding)",null,"mRNA","agilent G3 V3"]
["A_23_P367628",1.98,1.86,2.09,5.35,5.53,5.34,{"v":0.365598027127004,"d":"0.37"},{"v":-1.45166980967127,"d":"-1.45"},"down",{"v":1.45849999999559e-06,"d":"0.00"},{"v":0.124253990499624,"d":"0.12"},"yes","CTGAGGGATTGTTGATGGTGAGTTAGACTGTATTTGGCATAGAATTTGGAAATGTAACTT","FALSE","NM_014802","ref|NM_014802|ref|NM_001286174|ref|NM_001286175|ref|NM_001286173","C2CD5","C2 calcium-dependent domain containing 5","ref|Homo sapiens C2 calcium-dependent domain containing 5 (C2CD5), transcript variant 6, mRNA [NM_014802]","chr12",22601516,22697480,"GO:0005509(calcium ion binding);GO:0005544(calcium-dependent phospholipid binding);GO:0005737(cytoplasm);GO:0005815(microtubule organizing center);GO:0005886(plasma membrane);GO:0005938(cell cortex);GO:0006906(vesicle fusion);GO:0010828(positive regulation of glucose transport);GO:0030659(cytoplasmic vesicle membrane);GO:0031340(positive regulation of vesicle fusion);GO:0032587(ruffle membrane);GO:0032869(cellular response to insulin stimulus);GO:0038028(insulin receptor signaling pathway via phosphatidylinositol 3-kinase cascade);GO:0065002(intracellular protein transmembrane transport);GO:0072659(protein localization in plasma membrane);GO:0090314(positive regulation of protein targeting to membrane);GO:2001275(positive regulation of glucose import in response to insulin stimulus)",null,"mRNA","agilent G3 V3"]
["A_21_P0011678",13.14,13.13,13.09,12.42,12.42,12.45,{"v":1.0555108608206,"d":"1.06"},{"v":0.0779414235655988,"d":"0.08"},"up",{"v":1.46369999998175e-06,"d":"0.00"},{"v":0.124696994098445,"d":"0.12"},"yes","TTTTTCTTTGAGAAAGGATTGAGATACGCTCCTGCTGTGCCCCCATCTTTCCTCCAAACT","FALSE","NM_004077","ref|NM_004077|ens|ENST00000351328|ens|ENST00000549143|gb|TCONS_l2_00012362","CS","citrate synthase","ref|Homo sapiens citrate synthase (CS), mRNA [NM_004077]","chr12",56665480,56694175,"GO:0004108(citrate (Si)-synthase activity);GO:0005634(nucleus);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0005975(carbohydrate metabolic process);GO:0006099(tricarboxylic acid cycle);GO:0044237(cellular metabolic process);GO:0044262(cellular carbohydrate metabolic process);GO:0044281(small molecule metabolic process);GO:0070062(extracellular vesicular exosome)","01200(Carbon metabolism);01210(2-Oxocarboxylic acid metabolism);01230(Biosynthesis of amino acids);00020(Citrate cycle (TCA cycle));00630(Glyoxylate and dicarboxylate metabolism)","mRNA","agilent G3 V3"]
["A_23_P75609",1.99,1.86,2.06,4.99,5.13,5.19,{"v":0.386022207707381,"d":"0.39"},{"v":-1.37324424732226,"d":"-1.37"},"down",{"v":1.49390000003802e-06,"d":"0.00"},{"v":0.127269822703239,"d":"0.13"},"yes","CTGGGACACTTTGGGTATATTCATGGGCATTGTTTCCATCTGTCTTTTCTACCTGTGCCA","FALSE","NM_014956","ref|NM_014956|ref|NM_001271933|ens|ENST00000533706|ens|ENST00000278935","CEP164","centrosomal protein 164kDa","ref|Homo sapiens centrosomal protein 164kDa (CEP164), transcript variant 1, mRNA [NM_014956]","chr11",117281824,117283546,"GO:0000086(G2/M transition of mitotic cell cycle);GO:0000278(mitotic cell cycle);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005654(nucleoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0006281(DNA repair);GO:0006996(organelle organization);GO:0007067(mitosis);GO:0042384(cilium assembly);GO:0051301(cell division)",null,"mRNA","agilent G3 V3"]
["A_24_P4661",3.09,3.17,3.22,6.17,6.26,6.02,{"v":0.513821138211382,"d":"0.51"},{"v":-0.960661852049499,"d":"-0.96"},"down",{"v":1.49849999997453e-06,"d":"0.00"},{"v":0.12766171049783,"d":"0.13"},"yes","TATTCTCCTTGGTGGTCTTCTTAAGCAACAGACTCTTCCACAAGACAGTCTACCTGCAGT","FALSE","NM_004879","ref|NM_004879|ref|NM_001290135|ref|NR_110770|ref|NR_110769","EI24","etoposide induced 2.4","ref|Homo sapiens etoposide induced 2.4 (EI24), transcript variant 1, mRNA [NM_004879]","chr11",125439296,125454574,"GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005794(Golgi apparatus);GO:0006914(autophagy);GO:0006915(apoptotic process);GO:0008630(DNA damage response, signal transduction resulting in induction of apoptosis);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0030308(negative regulation of cell growth);GO:0031965(nuclear membrane);GO:0042493(response to drug);GO:0050885(neuromuscular process controlling balance);GO:2001244(positive regulation of intrinsic apoptotic signaling pathway)","04115(p53 signaling pathway)","mRNA","agilent G3 V3"]
["A_23_P410998",1.94,2.12,1.91,5.53,5.65,5.78,{"v":0.352004716981132,"d":"0.35"},{"v":-1.50633333329839,"d":"-1.51"},"down",{"v":1.49979999997107e-06,"d":"0.00"},{"v":0.127772461397536,"d":"0.13"},"yes","TTTTTACAAGTGGAAGAACTAGGATGGCTTTCCAAAGTCTTCTAGAAATGAAGTTCTTTC","FALSE","NM_002868","ref|NM_002868|ref|NM_001252036|ref|NM_001252037|ens|ENST00000553116","RAB5B","RAB5B, member RAS oncogene family","ref|Homo sapiens RAB5B, member RAS oncogene family (RAB5B), transcript variant 1, mRNA [NM_002868]","chr12",56367856,56388490,"GO:0003924(GTPase activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005622(intracellular);GO:0005768(endosome);GO:0005769(early endosome);GO:0005886(plasma membrane);GO:0006184(GTP catabolic process);GO:0006886(intracellular protein transport);GO:0007032(endosome organization);GO:0016020(membrane);GO:0019003(GDP binding);GO:0019882(antigen processing and presentation);GO:0030100(regulation of endocytosis);GO:0030139(endocytic vesicle);GO:0030742(GTP-dependent protein binding);GO:0031901(early endosome membrane);GO:0032482(Rab protein signal transduction);GO:0042470(melanosome);GO:0048227(plasma membrane to endosome transport);GO:0070062(extracellular vesicular exosome)","04014(Ras signaling pathway);04144(Endocytosis);04145(Phagosome);04962(Vasopressin-regulated water reabsorption);05152(Tuberculosis);05146(Amoebiasis)","mRNA","agilent G3 V3"]
["A_23_P14708",1.93,1.94,{"v":1.9,"d":"1.90"},4.33,{"v":4.5,"d":"4.50"},4.55,{"v":0.431240657698057,"d":"0.43"},{"v":-1.21343489199598,"d":"-1.21"},"down",{"v":1.51120000002614e-06,"d":"0.00"},{"v":0.128743661602227,"d":"0.13"},"yes","TCTTTGTACCTCCATACAAGTGTTAGCCTGCCAGGCTGTAAGCTTACCTTAATTAAACTT","FALSE","NM_017661","ref|NM_017661|ref|NM_001288588|ref|NM_001002843|ens|ENST00000267807","ZNF280D","zinc finger protein 280D","ref|Homo sapiens zinc finger protein 280D (ZNF280D), transcript variant 1, mRNA [NM_017661]","chr15",56923496,56927976,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P360245",1.88,1.98,1.88,4.74,4.53,4.71,{"v":0.410586552217453,"d":"0.41"},{"v":-1.28424171869975,"d":"-1.28"},"down",{"v":1.53599999996867e-06,"d":"0.00"},{"v":0.130856447997331,"d":"0.13"},"yes","GGATATATGGTAAAGTTGTTTTGGACTTGTTTTTGCTCAGCATGAAGTTTTATATGCTGC","FALSE","NM_145266","ref|NM_145266|gb|BC017934|tc|THC2463245|tc|THC2694649","NUDCD2","NudC domain containing 2","ref|Homo sapiens NudC domain containing 2 (NUDCD2), mRNA [NM_145266]","chr5",162873536,162887146,"GO:0000777(condensed chromosome kinetochore);GO:0000922(spindle pole);GO:0005515(protein binding);GO:0005622(intracellular);GO:0005737(cytoplasm);GO:0005815(microtubule organizing center);GO:0015630(microtubule cytoskeleton);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_32_P198325",1.91,2.03,2.01,5.63,5.73,5.95,{"v":0.343731946851531,"d":"0.34"},{"v":-1.54064415117133,"d":"-1.54"},"down",{"v":1.54389999995619e-06,"d":"0.00"},{"v":0.131529472696268,"d":"0.13"},"yes","CTACTGACTTGTGATGCTCTCAAGCACATGATAGTGGGCGATGAAGGTCAAGGAGGACTC","FALSE","NM_207644","ref|NM_207644|ens|ENST00000460524|ens|ENST00000404045|ens|ENST00000491910","LRRC75B","leucine rich repeat containing 75B","ref|Homo sapiens leucine rich repeat containing 75B (LRRC75B), mRNA [NM_207644]","chr22",24981630,24989046,null,null,"mRNA","agilent G3 V3"]
["A_33_P3209816",2.13,1.94,1.95,5.07,{"v":5.2,"d":"5.20"},5.27,{"v":0.387387387387387,"d":"0.39"},{"v":-1.36815111164801,"d":"-1.37"},"down",{"v":1.54519999995273e-06,"d":"0.00"},{"v":0.131640223595973,"d":"0.13"},"yes","AAATCTCATTCAGAACAGAGTGTGGCCTGTATTACTCCTACTACAAGCAGATGCTGCAGG","FALSE","NM_207325","ref|NM_207325|ref|NM_001172774|ens|ENST00000342179|ens|ENST00000392250","DPY19L3","dpy-19-like 3 (C. elegans)","ref|Homo sapiens dpy-19-like 3 (C. elegans) (DPY19L3), transcript variant 1, mRNA [NM_207325]","chr19",32896656,32976795,"GO:0000030(mannosyltransferase activity);GO:0005637(nuclear inner membrane);GO:0016021(integral to membrane);GO:0018406(protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan)",null,"mRNA","agilent G3 V3"]
["A_33_P3398533",5.22,5.23,5.28,6.23,{"v":6.3,"d":"6.30"},6.26,{"v":0.837147418839808,"d":"0.84"},{"v":-0.256446396004369,"d":"-0.26"},"down",{"v":1.57450000004555e-06,"d":"0.00"},{"v":0.134136378503881,"d":"0.13"},"yes","TTCCTTTAACTGGCAACCCATCTCTTAATCCGTCAGTATCTCTCCCAGGGTCATTAATAG","FALSE","NM_025138","ref|NM_025138|ens|ENST00000352251|ref|XM_005266545|gb|AK074360","PROSER1","proline and serine rich 1","ref|Homo sapiens proline and serine rich 1 (PROSER1), mRNA [NM_025138]","chr13",39584004,39612252,null,null,"mRNA","agilent G3 V3"]
["A_33_P3231428",8.52,8.55,8.46,9.71,9.75,9.78,{"v":0.87311901504788,"d":"0.87"},{"v":-0.195749773545319,"d":"-0.20"},"down",{"v":1.57590000005037e-06,"d":"0.00"},{"v":0.134255648704291,"d":"0.13"},"yes","AACCTCCTCTATCCTCTGTCTCAGATGTGGCACTCTTGCCACAGTGCTGGCTTTCCCAGT","FALSE","AK126714","gb|AK126714|tc|THC2480753",null,null,"gb|Homo sapiens cDNA FLJ44760 fis, clone BRACE3031579. [AK126714]","chr20",20443848,20447857,null,null,"mRNA","agilent G3 V3"]
["A_23_P255805",2.01,2.12,2.05,5.01,4.89,4.77,{"v":0.421267893660532,"d":"0.42"},{"v":-1.24719012776902,"d":"-1.25"},"down",{"v":1.58380000003788e-06,"d":"0.00"},{"v":0.134928673403227,"d":"0.13"},"yes","CGGAGCTCATATCTTATTGAACACCAGAGAATACACACTAGGGCCCAGTGGTTTTACGAA","FALSE","NM_003416","ref|NM_003416|ref|NM_001282795|ref|NM_001282797|ens|ENST00000528017","ZNF7","zinc finger protein 7","ref|Homo sapiens zinc finger protein 7 (ZNF7), transcript variant 2, mRNA [NM_003416]","chr8",146052944,146068605,"GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0007275(multicellular organismal development);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3279720",13.15,13.13,13.15,12.69,12.69,12.72,{"v":1.03490813648294,"d":"1.03"},{"v":0.049502712727132,"d":"0.05"},"up",{"v":1.61239999996177e-06,"d":"0.00"},{"v":0.137365193196743,"d":"0.14"},"yes","GTTGCCCCCAGCCTGTAAGGCTGGCCTCCCCTACAATCTCAGCCGACAAGAGGGACATCT","FALSE","ENST00000612772","ens|ENST00000612772|tc|THC2679434","ARFRP1","ADP-ribosylation factor related protein 1","ens|ADP-ribosylation factor related protein 1 [Source:HGNC Symbol;Acc:HGNC:662] [ENST00000612772]","chr20",62333048,62338226,"GO:0003924(GTPase activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0007165(signal transduction);GO:0007264(small GTPase mediated signal transduction);GO:0007369(gastrulation);GO:0008152(metabolic process);GO:0016020(membrane);GO:0034067(protein localization in Golgi apparatus);GO:0042147(retrograde transport, endosome to Golgi);GO:0043001(Golgi to plasma membrane protein transport)",null,"mRNA","agilent G3 V3"]
["A_24_P253827",1.87,2.02,1.93,5.15,5.35,5.42,{"v":0.365577889447236,"d":"0.37"},{"v":-1.45174927763536,"d":"-1.45"},"down",{"v":1.65689999997998e-06,"d":"0.00"},{"v":0.141156281698294,"d":"0.14"},"yes","GCAGAAGGTTCACACTGCAAATAGTGTTCTCATCTCAAAGCAAACTATCATTCCAGAAGG","FALSE","NM_001030006","ref|NM_001030006|ref|NM_001282|ens|ENST00000621914|ref|XM_005257937","AP2B1","adaptor-related protein complex 2, beta 1 subunit","ref|Homo sapiens adaptor-related protein complex 2, beta 1 subunit (AP2B1), transcript variant 1, mRNA [NM_001030006]","chr17",33914316,34051108,"GO:0005048(signal sequence binding);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006886(intracellular protein transport);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007268(synaptic transmission);GO:0007411(axon guidance);GO:0008565(protein transporter activity);GO:0016020(membrane);GO:0016032(viral reproduction);GO:0019886(antigen processing and presentation of exogenous peptide antigen via MHC class II);GO:0030122(AP-2 adaptor complex);GO:0030276(clathrin binding);GO:0030666(endocytic vesicle membrane);GO:0030669(clathrin-coated endocytic vesicle membrane);GO:0035615(clathrin adaptor activity);GO:0042059(negative regulation of epidermal growth factor receptor signaling pathway);GO:0043231(intracellular membrane-bounded organelle);GO:0048011(nerve growth factor receptor signaling pathway);GO:0048013(ephrin receptor signaling pathway);GO:0050690(regulation of defense response to virus by virus);GO:0072583(clathrin-mediated endocytosis)","04144(Endocytosis);04961(Endocrine and other factor-regulated calcium reabsorption);04721(Synaptic vesicle cycle);05016(Huntington's disease)","mRNA","agilent G3 V3"]
["A_24_P332230",2.05,{"v":2.2,"d":"2.20"},2.12,4.61,4.44,4.51,{"v":0.46976401179941,"d":"0.47"},{"v":-1.08999190088004,"d":"-1.09"},"down",{"v":1.68150000001699e-06,"d":"0.00"},{"v":0.143252029501447,"d":"0.14"},"yes","TGGAGTTACTTCCCAAAAATGTTAATCACAGCTGGATTGAAAGAGTATTTGGGAAATGTG","FALSE","NM_016648","ref|NM_016648|ref|NM_001267039|ref|NM_015454|ref|NR_049768","LARP7","La ribonucleoprotein domain family, member 7","ref|Homo sapiens La ribonucleoprotein domain family, member 7 (LARP7), transcript variant 1, mRNA [NM_016648]","chr4",113568048,113568494,"GO:0000166(nucleotide binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0006396(RNA processing);GO:0030529(ribonucleoprotein complex)",null,"mRNA","agilent G3 V3"]
["A_24_P76879",2.02,2.13,2.08,5.53,5.69,5.38,{"v":0.375301204819277,"d":"0.38"},{"v":-1.41387917321029,"d":"-1.41"},"down",{"v":1.70190000003956e-06,"d":"0.00"},{"v":0.14498996670337,"d":"0.14"},"yes","ACTATATTCCTAGAAACATAGTTTGAACAACTTGGTCTTTGTTAGGCTTGTCAAATTGCC","FALSE","NM_003309","ref|NM_003309|ens|ENST00000368608|gb|AK026849|gb|AL136629","TSPYL1","TSPY-like 1","ref|Homo sapiens TSPY-like 1 (TSPYL1), mRNA [NM_003309]","chr6",116597744,116601066,"GO:0005634(nucleus);GO:0005730(nucleolus);GO:0006334(nucleosome assembly);GO:0008150(biological_process);GO:0019899(enzyme binding)",null,"mRNA","agilent G3 V3"]
["A_24_P72479",1.92,2.08,1.89,5.26,5.18,5.42,{"v":0.371374527112232,"d":"0.37"},{"v":-1.42905323187352,"d":"-1.43"},"down",{"v":1.74939999997292e-06,"d":"0.00"},{"v":0.149036634197693,"d":"0.15"},"yes","TACTGGCATCGATGGAGCCATGACAATTTGGGATTTCAAGACCCTCGAGTCTTCCATCCA","FALSE","NM_006409","ref|NM_006409|ref|NM_001190996|ens|ENST00000463009|ens|ENST00000432786","ARPC1A","actin related protein 2/3 complex, subunit 1A, 41kDa","ref|Homo sapiens actin related protein 2/3 complex, subunit 1A, 41kDa (ARPC1A), transcript variant 1, mRNA [NM_006409]","chr7",98923536,98963880,"GO:0003779(actin binding);GO:0005829(cytosol);GO:0005885(Arp2/3 protein complex);GO:0007411(axon guidance);GO:0015629(actin cytoskeleton);GO:0030036(actin cytoskeleton organization);GO:0034314(Arp2/3 complex-mediated actin nucleation);GO:0038096(Fc-gamma receptor signaling pathway involved in phagocytosis);GO:0045087(innate immune response);GO:0048013(ephrin receptor signaling pathway);GO:0051015(actin filament binding);GO:0070062(extracellular vesicular exosome)","04810(Regulation of actin cytoskeleton);04666(Fc gamma R-mediated phagocytosis);05130(Pathogenic Escherichia coli infection);05132(Salmonella infection);05131(Shigellosis);05100(Bacterial invasion of epithelial cells)","mRNA","agilent G3 V3"]
["A_33_P3239839",1.91,1.95,1.92,4.07,3.91,{"v":3.9,"d":"3.90"},{"v":0.486531986531987,"d":"0.49"},{"v":-1.03939343830009,"d":"-1.04"},"down",{"v":1.76320000000452e-06,"d":"0.00"},{"v":0.150212297600385,"d":"0.15"},"yes","GGATGGGAATTTTCATGTACATGTGTGGCATGTGGAAAATTTCAAATAAAATGGACTTGA","FALSE","NM_024963","ref|NM_024963|gb|AK001638|gb|BC042819|gb|BC015445","FBXL18","F-box and leucine-rich repeat protein 18","ref|Homo sapiens F-box and leucine-rich repeat protein 18 (FBXL18), mRNA [NM_024963]","chr7",{"v":5515427,"d":"5515427.00"},5553429,null,null,"mRNA","agilent G3 V3"]
["A_33_P3278475",2.85,2.94,3.01,4.97,{"v":4.9,"d":"4.90"},4.87,{"v":0.597014925373134,"d":"0.60"},{"v":-0.74416109557041,"d":"-0.74"},"down",{"v":1.77369999998511e-06,"d":"0.00"},{"v":0.151106824098732,"d":"0.15"},"yes","GTCACAAGTGAACCACTTCTCAGTTGCCAATCTTTGCTCATATTAAAAACAACTTACAAA","FALSE","NM_002158","ref|NM_002158|ens|ENST00000340553|ref|XM_005264283|ref|XM_005264284","FOXN2","forkhead box N2","ref|Homo sapiens forkhead box N2 (FOXN2), mRNA [NM_002158]","chr2",48541848,48606433,"GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0035914(skeletal muscle cell differentiation);GO:0043231(intracellular membrane-bounded organelle);GO:0043565(sequence-specific DNA binding)",null,"mRNA","agilent G3 V3"]
["A_23_P27810",1.95,1.92,1.95,{"v":4.1,"d":"4.10"},4.25,4.05,{"v":0.469354838709677,"d":"0.47"},{"v":-1.09124906236595,"d":"-1.09"},"down",{"v":1.77619999996992e-06,"d":"0.00"},{"v":0.151319806597437,"d":"0.15"},"yes","CAACCTTATGGAGTGAGCAGCCACCTTTGGGCTCATTCTGGACGACGTGTCTTTGACACA","FALSE","NM_032689","ref|NM_032689|ref|NM_001172677|ens|ENST00000395835|ens|ENST00000355202","ZNF607","zinc finger protein 607","ref|Homo sapiens zinc finger protein 607 (ZNF607), transcript variant 1, mRNA [NM_032689]","chr19",38187272,38210089,"GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_24_P343255",2.14,2.34,2.28,{"v":4.9,"d":"4.90"},4.92,5.05,{"v":0.454606590450572,"d":"0.45"},{"v":-1.13730949577023,"d":"-1.14"},"down",{"v":1.82969999995564e-06,"d":"0.00"},{"v":0.155877632096221,"d":"0.16"},"yes","AAGGCCTGGGAGATGAATTTGACCTTATAGATCATTCTGACTTACACATTTTGGACTTTA","FALSE","NM_057161","ref|NM_057161|ref|NR_040101|ens|ENST00000332245|ens|ENST00000326974","KLHDC3","kelch domain containing 3","ref|Homo sapiens kelch domain containing 3 (KLHDC3), transcript variant 1, mRNA [NM_057161]","chr6",42981988,42989028,"GO:0000790(nuclear chromatin);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006987(activation of signaling protein activity involved in unfolded protein response);GO:0007131(reciprocal meiotic recombination);GO:0030968(endoplasmic reticulum unfolded protein response);GO:0044267(cellular protein metabolic process)",null,"mRNA","agilent G3 V3"]
["A_23_P71319",2.04,2.08,2.24,4.99,4.91,4.82,{"v":0.432065217391304,"d":"0.43"},{"v":-1.21067900077266,"d":"-1.21"},"down",{"v":1.86840000004906e-06,"d":"0.00"},{"v":0.15917460120418,"d":"0.16"},"yes","TTTTTTCCTACTACTTTAATCCCTAAAAGAACGCTGTGTGGCTGGGACCTTTAGGAAAGT","FALSE","NM_004462","ref|NM_004462|ref|NM_001287742|ref|NM_001287743|ref|NM_001287745","FDFT1","farnesyl-diphosphate farnesyltransferase 1","ref|Homo sapiens farnesyl-diphosphate farnesyltransferase 1 (FDFT1), transcript variant 3, mRNA [NM_004462]","chr8",11653082,11696476,"GO:0004310(farnesyl-diphosphate farnesyltransferase activity);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006694(steroid biosynthetic process);GO:0006695(cholesterol biosynthetic process);GO:0008299(isoprenoid biosynthetic process);GO:0016021(integral to membrane);GO:0016491(oxidoreductase activity);GO:0044255(cellular lipid metabolic process);GO:0044281(small molecule metabolic process);GO:0045338(farnesyl diphosphate metabolic process);GO:0051996(squalene synthase activity);GO:0055114(oxidation-reduction process)","00100(Steroid biosynthesis)","mRNA","agilent G3 V3"]
["A_23_P9319",2.03,2.06,2.15,4.96,5.13,4.88,{"v":0.416833667334669,"d":"0.42"},{"v":-1.26245628719617,"d":"-1.26"},"down",{"v":1.8867000000089e-06,"d":"0.00"},{"v":0.160733633100758,"d":"0.16"},"yes","CTCTTAGATGATTACAAAGAAGGCGACCTTCGCATTATGCCTGATTCCAATGATTCACCT","FALSE","NM_006717","ref|NM_006717|ens|ENST00000485565|ens|ENST00000485804|ens|ENST00000469017","SPIN1","spindlin 1","ref|Homo sapiens spindlin 1 (SPIN1), mRNA [NM_006717]","chr9",91003336,91093609,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005819(spindle);GO:0007275(multicellular organismal development);GO:0007276(gamete generation);GO:0009303(rRNA transcription);GO:0016055(Wnt receptor signaling pathway);GO:0016568(chromatin modification);GO:0030177(positive regulation of Wnt receptor signaling pathway);GO:0035064(methylated histone residue binding);GO:0051321(meiotic cell cycle)",null,"mRNA","agilent G3 V3"]
["A_33_P3256695",2.39,2.59,2.51,{"v":4.7,"d":"4.70"},4.63,4.69,{"v":0.534236804564907,"d":"0.53"},{"v":-0.904448725551872,"d":"-0.90"},"down",{"v":1.97589999995085e-06,"d":"0.00"},{"v":0.168332848695813,"d":"0.17"},"yes","GTTGCTGGAGGCCCACGTTATGTTTTCTCAGTGTAATTCCTCTTTTTCTTGATAAAAAGA","FALSE","NM_017892","ref|NM_017892|ens|ENST00000410080|tc|THC2658013","PRPF40A","PRP40 pre-mRNA processing factor 40 homolog A (S. cerevisiae)","ref|Homo sapiens PRP40 pre-mRNA processing factor 40 homolog A (S. cerevisiae) (PRPF40A), mRNA [NM_017892]","chr2",153508112,153574495,"GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006397(mRNA processing);GO:0007010(cytoskeleton organization);GO:0007049(cell cycle);GO:0008360(regulation of cell shape);GO:0008380(RNA splicing);GO:0016020(membrane);GO:0016363(nuclear matrix);GO:0016477(cell migration);GO:0016607(nuclear speck);GO:0032465(regulation of cytokinesis);GO:0051301(cell division);GO:0070064(proline-rich region binding)","03040(Spliceosome)","mRNA","agilent G3 V3"]
["A_23_P415558",1.91,2.01,1.97,{"v":4.3,"d":"4.30"},4.41,4.52,{"v":0.445200302343159,"d":"0.45"},{"v":-1.16747352244822,"d":"-1.17"},"down",{"v":1.98110000004803e-06,"d":"0.00"},{"v":0.168775852304092,"d":"0.17"},"yes","CTACTTTGTTACTTAAGGTTGTTCACCTTGTACCAGTGGTTATTTGAGTTTGTTCCTATT","FALSE","NM_012256","ref|NM_012256|ens|ENST00000335870|ref|XM_005250055|ref|XM_006716133","ZNF212","zinc finger protein 212","ref|Homo sapiens zinc finger protein 212 (ZNF212), mRNA [NM_012256]","chr7",148936736,148952700,"GO:0003677(DNA binding);GO:0003712(transcription cofactor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0008270(zinc ion binding);GO:0042802(identical protein binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3228573",8.65,8.78,8.68,10.81,10.79,10.67,{"v":0.809110629067245,"d":"0.81"},{"v":-0.3055911201741,"d":"-0.31"},"down",{"v":2.00419999996093e-06,"d":"0.00"},{"v":0.170743810596672,"d":"0.17"},"yes","TCCGCCAGCCACAGGACCACCTCCTCTGCCAGCAGGAATAAAGACTTGTGCATCCCTCAA","FALSE","NM_001251888","ref|NM_001251888|ref|NM_024083|ref|NR_045351|ens|ENST00000584454","ASPSCR1","alveolar soft part sarcoma chromosome region, candidate 1","ref|Homo sapiens alveolar soft part sarcoma chromosome region, candidate 1 (ASPSCR1), transcript variant 2, mRNA [NM_001251888]","chr17",79974072,79975246,"GO:0003674(molecular_function);GO:0005515(protein binding);GO:0005575(cellular_component);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006886(intracellular protein transport);GO:0008150(biological_process);GO:0009898(internal side of plasma membrane);GO:0012505(endomembrane system);GO:0012506(vesicle membrane);GO:0019898(extrinsic to membrane);GO:0033116(endoplasmic reticulum-Golgi intermediate compartment membrane);GO:0042593(glucose homeostasis);GO:0043231(intracellular membrane-bounded organelle);GO:0046324(regulation of glucose import);GO:0048471(perinuclear region of cytoplasm);GO:0061024(membrane organization)","05202(Transcriptional misregulation in cancers)","mRNA","agilent G3 V3"]
["A_23_P215253",5.92,5.73,5.71,8.13,8.16,8.18,{"v":0.709440130772374,"d":"0.71"},{"v":-0.49524715363491,"d":"-0.50"},"down",{"v":2.07900000004368e-06,"d":"0.00"},{"v":0.177116247003722,"d":"0.18"},"yes","TGTTTATTCACCATCAACAAAGAAGACCACACACTGGGAAACATCATTAAATCACGTGCC","FALSE","ENST00000507355","ens|ENST00000507355|ens|ENST00000502415|gb|AJ277740|gb|AK296066","POLR2J3","polymerase (RNA) II (DNA directed) polypeptide J3","ens|polymerase (RNA) II (DNA directed) polypeptide J3 [Source:HGNC Symbol;Acc:HGNC:33853] [ENST00000507355]","chr7",102281096,102312048,"GO:0003677(DNA binding);GO:0003899(DNA-directed RNA polymerase activity);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0046983(protein dimerization activity)","00230(Purine metabolism);00240(Pyrimidine metabolism);03020(RNA polymerase);05016(Huntington's disease);05169(Epstein-Barr virus infection)","mRNA","agilent G3 V3"]
["A_24_P381224",1.95,2.17,1.93,5.88,5.67,5.93,{"v":0.346109839816934,"d":"0.35"},{"v":-1.53069813733864,"d":"-1.53"},"down",{"v":2.12639999996878e-06,"d":"0.00"},{"v":0.18115439519734,"d":"0.18"},"yes","AAGTTTAGAATTGGAATTACTTCCTTACTAGTGTCTTTTGGCTTAAATTTTGTCTTTTGA","FALSE","NM_172230","ref|NM_172230|ref|NM_032431|ens|ENST00000526060|ens|ENST00000449943","SYVN1","synovial apoptosis inhibitor 1, synoviolin","ref|Homo sapiens synovial apoptosis inhibitor 1, synoviolin (SYVN1), transcript variant 2, mRNA [NM_172230]","chr11",64894752,64901900,"GO:0001701(in utero embryonic development);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006987(activation of signaling protein activity involved in unfolded protein response);GO:0008270(zinc ion binding);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0016567(protein ubiquitination);GO:0016881(acid-amino acid ligase activity);GO:0018279(protein N-linked glycosylation via asparagine);GO:0030433(ER-associated protein catabolic process);GO:0030968(endoplasmic reticulum unfolded protein response);GO:0044267(cellular protein metabolic process)","04141(Protein processing in endoplasmic reticulum);04120(Ubiquitin mediated proteolysis)","mRNA","agilent G3 V3"]
["A_23_P164089",2.04,2.18,2.13,4.53,4.43,4.63,{"v":0.467255334805004,"d":"0.47"},{"v":-1.09771695910786,"d":"-1.10"},"down",{"v":2.20819999996458e-06,"d":"0.00"},{"v":0.188123182596982,"d":"0.19"},"yes","TGGATGTGAATTGTTACTTCAAGTGGCTTTTATTAAGATTTTCTCAGACTTACTTGGAGG","FALSE","NM_001017368","ref|NM_001017368|ref|NR_037714|ref|NR_037713|ens|ENST00000394597","RFFL","ring finger and FYVE-like domain containing E3 ubiquitin protein ligase","ref|Homo sapiens ring finger and FYVE-like domain containing E3 ubiquitin protein ligase (RFFL), transcript variant 2, mRNA [NM_001017368]","chr17",33336132,33390759,"GO:0000139(Golgi membrane);GO:0002020(protease binding);GO:0002039(p53 binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006886(intracellular protein transport);GO:0008270(zinc ion binding);GO:0010008(endosome membrane);GO:0010762(regulation of fibroblast migration);GO:0010804(negative regulation of tumor necrosis factor-mediated signaling pathway);GO:0016020(membrane);GO:0016023(cytoplasmic membrane-bounded vesicle);GO:0016874(ligase activity);GO:0019901(protein kinase binding);GO:0031625(ubiquitin protein ligase binding);GO:0032006(regulation of TOR signaling cascade);GO:0042787(protein ubiquitination involved in ubiquitin-dependent protein catabolic process);GO:0043161(proteasomal ubiquitin-dependent protein catabolic process);GO:0055038(recycling endosome membrane);GO:0070936(protein K48-linked ubiquitination);GO:2001271(negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis)",null,"mRNA","agilent G3 V3"]
["A_33_P3284686",7.37,7.36,7.28,8.74,8.81,8.85,{"v":0.833712121212121,"d":"0.83"},{"v":-0.262378784354258,"d":"-0.26"},"down",{"v":2.21300000002866e-06,"d":"0.00"},{"v":0.188532109002442,"d":"0.19"},"yes","AACTTCCTCCACTCCTTTCAGAATGACAATGATTCTCCAAGCACGACGATGAGTGTGTGA","FALSE","NM_145716","ref|NM_145716|ref|NM_018070|ref|NM_001009955|ens|ENST00000550646","SSBP3","single stranded DNA binding protein 3","ref|Homo sapiens single stranded DNA binding protein 3 (SSBP3), transcript variant 1, mRNA [NM_145716]","chr1",54691104,54822491,"GO:0002244(hemopoietic progenitor cell differentiation);GO:0003697(single-stranded DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006461(protein complex assembly);GO:0008284(positive regulation of cell proliferation);GO:0021501(prechordal plate formation);GO:0021547(midbrain-hindbrain boundary initiation);GO:0043234(protein complex);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0060323(head morphogenesis);GO:2000744(positive regulation of anterior head development)",null,"mRNA","agilent G3 V3"]
["A_23_P94204",{"v":2.2,"d":"2.20"},2.38,2.22,4.84,4.69,4.82,{"v":0.473867595818815,"d":"0.47"},{"v":-1.07744408542535,"d":"-1.08"},"down",{"v":2.21310000003694e-06,"d":"0.00"},{"v":0.188540628303147,"d":"0.19"},"yes","CATTGAGGAAATGAAGACTGGATACTTCTGTATCTGTGAAGTTGGCACAGGTAACATTTG","FALSE","NM_181354","ref|NM_181354|ref|NM_001198533|ref|NM_018002|ref|NM_001198532","OXR1","oxidation resistance 1","ref|Homo sapiens oxidation resistance 1 (OXR1), transcript variant 2, mRNA [NM_181354]","chr8",107371704,107764910,"GO:0003674(molecular_function);GO:0005575(cellular_component);GO:0005730(nucleolus);GO:0005739(mitochondrion);GO:0006979(response to oxidative stress);GO:0007628(adult walking behavior);GO:0016491(oxidoreductase activity);GO:0043524(negative regulation of neuron apoptotic process);GO:0055114(oxidation-reduction process);GO:0071447(cellular response to hydroperoxide)",null,"mRNA","agilent G3 V3"]
["A_24_P135444",3.06,3.13,3.19,5.03,4.94,5.08,{"v":0.623255813953488,"d":"0.62"},{"v":-0.682103659131688,"d":"-0.68"},"down",{"v":2.23040000002506e-06,"d":"0.00"},{"v":0.190014467202135,"d":"0.19"},"yes","CGTCGTGGGGTAACATCTGTTATCAAACTGCTGTCGTTGTTGTGGAAGCATGTAGACTGT","FALSE","NM_001144","ref|NM_001144|ens|ENST00000568325|ens|ENST00000566757|ens|ENST00000290649","AMFR","autocrine motility factor receptor, E3 ubiquitin protein ligase","ref|Homo sapiens autocrine motility factor receptor, E3 ubiquitin protein ligase (AMFR), mRNA [NM_001144]","chr16",56396828,56401515,"GO:0000209(protein polyubiquitination);GO:0000836(Hrd1p ubiquitin ligase complex);GO:0004842(ubiquitin-protein ligase activity);GO:0004872(receptor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005789(endoplasmic reticulum membrane);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006928(cellular component movement);GO:0007165(signal transduction);GO:0007568(aging);GO:0007611(learning or memory);GO:0008270(zinc ion binding);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0016874(ligase activity);GO:0030176(integral to endoplasmic reticulum membrane);GO:0030425(dendrite);GO:0030426(growth cone);GO:0030433(ER-associated protein catabolic process);GO:0030968(endoplasmic reticulum unfolded protein response);GO:0043025(neuronal cell body);GO:0043234(protein complex);GO:0048471(perinuclear region of cytoplasm);GO:0051259(protein oligomerization)","04141(Protein processing in endoplasmic reticulum)","mRNA","agilent G3 V3"]
["A_33_P3212823",10.26,10.31,10.14,12.12,12.06,12.06,{"v":0.847406181015453,"d":"0.85"},{"v":-0.238874443070361,"d":"-0.24"},"down",{"v":2.23980000002566e-06,"d":"0.00"},{"v":0.190815281402186,"d":"0.19"},"yes","ACCTCCCTTAGCTACTCAGGAGGCTGAGGCAGAAAAACCACGCAAACCCAAGAGGCAGAG","FALSE","NM_001135865","ref|NM_001135865|ref|NM_130464|ref|NR_002555|ens|ENST00000451409","NPIPB5","nuclear pore complex interacting protein family, member B5","ref|Homo sapiens nuclear pore complex interacting protein family, member B5 (NPIPB5), mRNA [NM_001135865]","chr16",22524844,22547826,null,null,"mRNA","agilent G3 V3"]
["A_23_P127367",8.21,8.19,8.09,9.65,9.71,9.63,{"v":0.844774060020697,"d":"0.84"},{"v":-0.243362559497419,"d":"-0.24"},"down",{"v":2.25310000001588e-06,"d":"0.00"},{"v":0.191948348301353,"d":"0.19"},"yes","CTGCTGCCTGTCTCCCTGACCCATGATCTGGCAAGTTAGGCACAGTCAGACATGGACAGT","FALSE","NM_021173","ref|NM_021173|ref|NM_001256870|ref|NR_046411|ref|NR_046412","POLD4","polymerase (DNA-directed), delta 4, accessory subunit","ref|Homo sapiens polymerase (DNA-directed), delta 4, accessory subunit (POLD4), transcript variant 1, mRNA [NM_021173]","chr11",67120000,67120996,"GO:0000278(mitotic cell cycle);GO:0000722(telomere maintenance via recombination);GO:0000723(telomere maintenance);GO:0003887(DNA-directed DNA polymerase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006260(DNA replication);GO:0006271(DNA strand elongation involved in DNA replication);GO:0006281(DNA repair);GO:0006283(transcription-coupled nucleotide-excision repair);GO:0006284(base-excision repair);GO:0006289(nucleotide-excision repair);GO:0006297(nucleotide-excision repair, DNA gap filling);GO:0006298(mismatch repair);GO:0032201(telomere maintenance via semi-conservative replication);GO:0071897(DNA biosynthetic process)","00230(Purine metabolism);00240(Pyrimidine metabolism);03030(DNA replication);03410(Base excision repair);03420(Nucleotide excision repair);03430(Mismatch repair);03440(Homologous recombination);05166(HTLV-I infection)","mRNA","agilent G3 V3"]
["A_33_P3354151",13.44,13.49,13.51,12.63,12.58,12.62,{"v":1.0689928628073,"d":"1.07"},{"v":0.0962522208536386,"d":"0.10"},"up",{"v":2.31370000003395e-06,"d":"0.00"},{"v":0.197111044102892,"d":"0.20"},"yes","AACTCTCAGCTGGACACTAGCCCCCCATGCCTGGGTGGGAACAAGAAAACTCTAGGAACC","FALSE","NM_016074","ref|NM_016074|ens|ENST00000369152|ens|ENST00000476344|ref|XM_005245233","BOLA1","bolA family member 1","ref|Homo sapiens bolA family member 1 (BOLA1), mRNA [NM_016074]","chr1",149871184,149872101,"GO:0005576(extracellular region);GO:0005739(mitochondrion)",null,"mRNA","agilent G3 V3"]
["A_24_P294719",2.09,2.25,2.26,4.89,4.76,4.71,{"v":0.459610027855153,"d":"0.46"},{"v":-1.12151781957724,"d":"-1.12"},"down",{"v":2.32779999997934e-06,"d":"0.00"},{"v":0.19831226539824,"d":"0.20"},"yes","AAGCTAAAAAGAACCTAGAACCTTCAATTGAGCAGTTGTGAAAATTGCTAATGGTGCCAA","FALSE","NM_014613","ref|NM_014613|ens|ENST00000261942|gb|AB020694|gb|BC021065","FAF2","Fas associated factor family member 2","ref|Homo sapiens Fas associated factor family member 2 (FAF2), mRNA [NM_014613]","chr5",175875360,175937075,"GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005811(lipid particle);GO:0006986(response to unfolded protein);GO:0031625(ubiquitin protein ligase binding);GO:0034098(Cdc48p-Npl4p-Ufd1p AAA ATPase complex);GO:0034389(lipid particle organization);GO:0035473(lipase binding);GO:0043086(negative regulation of catalytic activity);GO:0043130(ubiquitin binding);GO:0043231(intracellular membrane-bounded organelle);GO:0055102(lipase inhibitor activity)",null,"mRNA","agilent G3 V3"]
["A_33_P3273399",13.28,13.32,13.35,12.62,12.61,{"v":12.6,"d":"12.60"},{"v":1.05604017975152,"d":"1.06"},{"v":0.0786647267659631,"d":"0.08"},"up",{"v":2.36220000005005e-06,"d":"0.00"},{"v":0.201242904604264,"d":"0.20"},"yes","TCTTCAGGCAGTCAAACCAGTGCTTCAGGCGCTCCCCCTTGGCGTGGATGCCCAGAACCA","FALSE","BU739610","gb|BU739610",null,null,"gb|UI-E-EJ0-aho-h-10-0-UI.s1 UI-E-EJ0 Homo sapiens cDNA clone UI-E-EJ0-aho-h-10-0-UI 3', mRNA sequence [BU739610]",{"$nulls":5},"mRNA","agilent G3 V3"]
["A_23_P215875",1.97,{"v":2.1,"d":"2.10"},2.22,5.37,5.32,5.16,{"v":0.396845425867508,"d":"0.40"},{"v":-1.33335091814748,"d":"-1.33"},"down",{"v":2.45939999998779e-06,"d":"0.00"},{"v":0.20952366419896,"d":"0.21"},"yes","AAACGTATAGCTCGTCATCGACATCTACCAAAATCTATCTATAGCCAGATTCAGGAACAG","FALSE","NM_015420","ref|NM_015420|ens|ENST00000518554|ens|ENST00000616836|ens|ENST00000297579","DCAF13","DDB1 and CUL4 associated factor 13","ref|Homo sapiens DDB1 and CUL4 associated factor 13 (DCAF13), mRNA [NM_015420]","chr8",104427640,104455678,"GO:0000462(maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0005730(nucleolus);GO:0016567(protein ubiquitination);GO:0032040(small-subunit processome);GO:0080008(CUL4 RING ubiquitin ligase complex)",null,"mRNA","agilent G3 V3"]
["A_23_P43726",2.06,2.17,2.17,5.04,5.16,5.33,{"v":0.412105602060528,"d":"0.41"},{"v":-1.27891401949994,"d":"-1.28"},"down",{"v":2.46569999995394e-06,"d":"0.00"},{"v":0.210060380096076,"d":"0.21"},"yes","CTTCACTTTCCAAAATAGCTGAGGGTTGTTGGCTTGTTGTAGCTGACCACCAAAAGCAGT","FALSE","NM_015231","ref|NM_015231|ens|ENST00000378460|ref|XM_006718170|gb|AK304308","NUP160","nucleoporin 160kDa","ref|Homo sapiens nucleoporin 160kDa (NUP160), mRNA [NM_015231]","chr11",47799788,47869865,"GO:0000278(mitotic cell cycle);GO:0000776(kinetochore);GO:0005487(nucleocytoplasmic transporter activity);GO:0005515(protein binding);GO:0005635(nuclear envelope);GO:0005643(nuclear pore);GO:0005829(cytosol);GO:0005975(carbohydrate metabolic process);GO:0006406(mRNA export from nucleus);GO:0007077(mitotic nuclear envelope disassembly);GO:0008645(hexose transport);GO:0009405(pathogenesis);GO:0010467(gene expression);GO:0010827(regulation of glucose transport);GO:0015031(protein transport);GO:0015758(glucose transport);GO:0016032(viral reproduction);GO:0019058(viral infectious cycle);GO:0019083(viral transcription);GO:0019221(cytokine-mediated signaling pathway);GO:0031080(Nup107-160 complex);GO:0044281(small molecule metabolic process);GO:0055085(transmembrane transport)","03013(RNA transport)","mRNA","agilent G3 V3"]
["A_24_P320759",2.19,{"v":2.4,"d":"2.40"},2.35,5.78,5.64,5.93,{"v":0.4,"d":"0.40"},{"v":-1.32192809488736,"d":"-1.32"},"down",{"v":2.49860000001156e-06,"d":"0.00"},{"v":0.212863229800985,"d":"0.21"},"yes","CTTACGTACTTTGATAGAACTAAGGAAATAGTGGTTTTGAGTGAAGGGAAAGGAAACCCA","FALSE","NM_024653","ref|NM_024653|ref|NR_038967|ens|ENST00000482465|ens|ENST00000397912","PRKRIP1","PRKR interacting protein 1 (IL11 inducible)","ref|Homo sapiens PRKR interacting protein 1 (IL11 inducible) (PRKRIP1), mRNA [NM_024653]","chr7",102044800,102067113,"GO:0003014(renal system process);GO:0003725(double-stranded RNA binding);GO:0004860(protein kinase inhibitor activity);GO:0005730(nucleolus);GO:0006469(negative regulation of protein kinase activity);GO:0019901(protein kinase binding);GO:0042326(negative regulation of phosphorylation);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P129389",2.79,2.96,2.83,6.35,{"v":6.6,"d":"6.60"},6.68,{"v":0.437086092715232,"d":"0.44"},{"v":-1.19401061996663,"d":"-1.19"},"down",{"v":2.53559999996433e-06,"d":"0.00"},{"v":0.216015370796961,"d":"0.22"},"yes","GCCTTGCCTTAAACTTGCCTGGTTTGTACATTTTTTGCCGGACGCATCAAGAAGCAATCT","FALSE","NM_017740","ref|NM_017740|ref|NM_001145548|ens|ENST00000313732|gb|AK130081","ZDHHC7","zinc finger, DHHC-type containing 7","ref|Homo sapiens zinc finger, DHHC-type containing 7 (ZDHHC7), transcript variant 2, mRNA [NM_017740]","chr16",85007784,85045141,"GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005794(Golgi apparatus);GO:0008270(zinc ion binding);GO:0016021(integral to membrane);GO:0016409(palmitoyltransferase activity);GO:0018230(peptidyl-L-cysteine S-palmitoylation);GO:0018345(protein palmitoylation);GO:0019706(protein-cysteine S-palmitoleyltransferase activity);GO:0043231(intracellular membrane-bounded organelle)",null,"mRNA","agilent G3 V3"]
["A_23_P25253",2.03,1.89,2.22,{"v":5.3,"d":"5.30"},5.23,5.26,{"v":0.388853704876504,"d":"0.39"},{"v":-1.36270061049006,"d":"-1.36"},"down",{"v":2.5430000000215e-06,"d":"0.00"},{"v":0.216645799001832,"d":"0.22"},"yes","CTAATTTCCTGCTGTGAAAACTCATCTTTCATTTTTGCCGTGGATAGGCGCTTTTATTAA","FALSE","NM_015954","ref|NM_015954|ref|NM_001300779|ens|ENST00000428559|gb|AF132960","DERA","deoxyribose-phosphate aldolase (putative)","ref|Homo sapiens deoxyribose-phosphate aldolase (putative) (DERA), transcript variant 1, mRNA [NM_015954]","chr12",16138106,16189274,"GO:0004139(deoxyribose-phosphate aldolase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0009264(deoxyribonucleotide catabolic process);GO:0046121(deoxyribonucleoside catabolic process);GO:0046386(deoxyribose phosphate catabolic process);GO:0070062(extracellular vesicular exosome)","00030(Pentose phosphate pathway)","mRNA","agilent G3 V3"]
["A_24_P270525",2.33,2.54,2.47,5.61,5.37,5.47,{"v":0.446200607902736,"d":"0.45"},{"v":-1.16423561577939,"d":"-1.16"},"down",{"v":2.62669999995246e-06,"d":"0.00"},{"v":0.22377645309595,"d":"0.22"},"yes","TTCTGCGATAATGTGTGGACTTTTGTACTGAATGATGTTGAATTCAGAGAGGTGACAGAA","FALSE","NM_004492","ref|NM_004492|ens|ENST00000396061|ens|ENST00000396063|ens|ENST00000267869","GTF2A2","general transcription factor IIA, 2, 12kDa","ref|Homo sapiens general transcription factor IIA, 2, 12kDa (GTF2A2), mRNA [NM_004492]","chr15",59934412,59949720,"GO:0001103(RNA polymerase II repressing transcription factor binding);GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005672(transcription factor TFIIA complex);GO:0006366(transcription from RNA polymerase II promoter);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0006368(transcription elongation from RNA polymerase II promoter);GO:0008134(transcription factor binding);GO:0010467(gene expression);GO:0016032(viral reproduction);GO:0017025(TBP-class protein binding);GO:0030054(cell junction);GO:0042803(protein homodimerization activity);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046982(protein heterodimerization activity);GO:0051091(positive regulation of sequence-specific DNA binding transcription factor activity);GO:0051123(RNA polymerase II transcriptional preinitiation complex assembly)","03022(Basal transcription factors);05203(Viral carcinogenesis)","mRNA","agilent G3 V3"]
["A_24_P80138",2.02,1.91,2.23,5.21,5.31,5.31,{"v":0.389134554643083,"d":"0.39"},{"v":-1.36165899944228,"d":"-1.36"},"down",{"v":2.71870000001506e-06,"d":"0.00"},{"v":0.231614209101283,"d":"0.23"},"yes","ATTCCGAGGGTGACTGAGGCTACAGCTTCTATCACATGCCGAACTTTCTTGTGACAAATT","FALSE","NM_024065","ref|NM_024065|ref|NR_002941|ens|ENST00000264254|gb|BC001021","PDCL3","phosducin-like 3","ref|Homo sapiens phosducin-like 3 (PDCL3), mRNA [NM_024065]","chr2",101179152,101193197,"GO:0001525(angiogenesis);GO:0001938(positive regulation of endothelial cell proliferation);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006457(protein folding);GO:0006915(apoptotic process);GO:0016032(viral reproduction);GO:0043184(vascular endothelial growth factor receptor 2 binding);GO:0044183(protein binding involved in protein folding);GO:0045766(positive regulation of angiogenesis);GO:0050730(regulation of peptidyl-tyrosine phosphorylation);GO:2000059(negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process)",null,"mRNA","agilent G3 V3"]
["A_21_P0014422",11.34,{"v":11.3,"d":"11.30"},11.31,{"v":12.5,"d":"12.50"},12.56,12.44,{"v":0.905333333333333,"d":"0.91"},{"v":-0.143479021138511,"d":"-0.14"},"down",{"v":2.74789999998859e-06,"d":"0.00"},{"v":0.234101844699028,"d":"0.23"},"yes","TGCTGGTGTATTTCCTGCCCCTGCTGGTGTACTTCCTTCCCCTGCTGGTGCACTTCCTGC","FALSE","ENST00000366413","ens|ENST00000366413|ens|ENST00000607893|ref|XR_159371|ref|XR_158962","LOC646513","VLGN1945","ref|PREDICTED: Homo sapiens VLGN1945 (LOC646513), misc_RNA [XR_159371]","chr22",30831532,30832231,null,null,"mRNA","agilent G3 V3"]
["A_22_P00002244",1.91,1.95,1.91,{"v":3.9,"d":"3.90"},3.86,4.06,{"v":0.488155668358714,"d":"0.49"},{"v":-1.03458681153205,"d":"-1.03"},"down",{"v":2.75679999994782e-06,"d":"0.00"},{"v":0.234860062395555,"d":"0.23"},"yes","TGAGCTTTTTCAAGGCGCTTATTTTATGGCAGCGTATTAAACTTCTTTGATATTCAAGTG","FALSE","XR_424156","ref|XR_424156|ref|XR_428787|ref|XR_432623|linc|lnc-C10orf12-1:1","LOC102724002","uncharacterized LOC102724002","ref|PREDICTED: Homo sapiens uncharacterized LOC102724002 (LOC102724002), ncRNA [XR_424156]","chr10",98753744,98755713,null,null,"mRNA","agilent G3 V3"]
["A_23_P142708",2.01,1.97,2.16,4.24,4.23,4.35,{"v":0.478939157566303,"d":"0.48"},{"v":-1.06208570124856,"d":"-1.06"},"down",{"v":2.81960000003689e-06,"d":"0.00"},{"v":0.240210182803143,"d":"0.24"},"yes","ACCATGTGGAGATGTTTCTGGACTTGCTAGAGCCTGCTTAGCTGCATGTTTTGTAGTTAC","FALSE","NM_030805","ref|NM_030805|ref|NM_001142292|ref|NR_024518|ref|NR_024519","LMAN2L","lectin, mannose-binding 2-like","ref|Homo sapiens lectin, mannose-binding 2-like (LMAN2L), transcript variant 2, mRNA [NM_030805]","chr2",97372784,97405800,"GO:0000139(Golgi membrane);GO:0005537(mannose binding);GO:0005789(endoplasmic reticulum membrane);GO:0005794(Golgi apparatus);GO:0006457(protein folding);GO:0006888(ER to Golgi vesicle-mediated transport);GO:0015031(protein transport);GO:0016021(integral to membrane);GO:0030134(ER to Golgi transport vesicle);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P149206",9.94,9.87,9.93,9.07,{"v":9.1,"d":"9.10"},9.05,{"v":1.09257898603968,"d":"1.09"},{"v":0.127737580548424,"d":"0.13"},"up",{"v":2.84110000003945e-06,"d":"0.00"},{"v":0.242041832303361,"d":"0.24"},"yes","GAGGGGAAACCTTTTTCATTCAACATTGTAGGGGGCAAGCTTTGGTGCGCCCCCTGCTGA","FALSE","NM_003780","ref|NM_003780|ref|NM_030587|ref|NM_001005417|ens|ENST00000356836","B4GALT2","UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2","ref|Homo sapiens UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2 (B4GALT2), transcript variant 2, mRNA [NM_003780]","chr1",44444864,44456839,"GO:0000139(Golgi membrane);GO:0003831(beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity);GO:0003945(N-acetyllactosamine synthase activity);GO:0004461(lactose synthase activity);GO:0005975(carbohydrate metabolic process);GO:0008378(galactosyltransferase activity);GO:0009405(pathogenesis);GO:0016021(integral to membrane);GO:0018146(keratan sulfate biosynthetic process);GO:0018279(protein N-linked glycosylation via asparagine);GO:0030203(glycosaminoglycan metabolic process);GO:0032580(Golgi cisterna membrane);GO:0042339(keratan sulfate metabolic process);GO:0043687(post-translational protein modification);GO:0044267(cellular protein metabolic process);GO:0044281(small molecule metabolic process);GO:0046872(metal ion binding)","00052(Galactose metabolism);00510(N-Glycan biosynthesis);00514(Other types of O-glycan biosynthesis);00533(Glycosaminoglycan biosynthesis - keratan sulfate);00601(Glycosphingolipid biosynthesis - lacto and neolacto series)","mRNA","agilent G3 V3"]
["A_23_P128828",5.77,6.07,5.73,9.79,9.66,9.61,{"v":0.60461114934618,"d":"0.60"},{"v":-0.725920511624465,"d":"-0.73"},"down",{"v":2.86780000002818e-06,"d":"0.00"},{"v":0.2443164854024,"d":"0.24"},"yes","GGGTTTGCGTATATAGAGTTCTCAGACAAAGAGTCAGTGAGGACTTCCTTGGCCTTAGAT","FALSE","NM_004643","ref|NM_004643|ref|NM_001199864|ens|ENST00000554062|ens|ENST00000553960","PABPN1","poly(A) binding protein, nuclear 1","ref|Homo sapiens poly(A) binding protein, nuclear 1 (PABPN1), mRNA [NM_004643]","chr14",23791024,23792694,"GO:0000166(nucleotide binding);GO:0000398(nuclear mRNA splicing, via spliceosome);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006366(transcription from RNA polymerase II promoter);GO:0006369(termination of RNA polymerase II transcription);GO:0006396(RNA processing);GO:0006936(muscle contraction);GO:0008380(RNA splicing);GO:0010467(gene expression);GO:0016973(poly(A)+ mRNA export from nucleus);GO:0019048(virus-host interaction);GO:0019054(modulation by virus of host cellular process);GO:0019058(viral infectious cycle);GO:0030529(ribonucleoprotein complex);GO:0031124(mRNA 3'-end processing);GO:0046778(modification by virus of host mRNA processing)","03015(mRNA surveillance pathway);05164(Influenza A)","mRNA","agilent G3 V3"]
["A_24_P219971",2.46,2.65,2.54,5.79,6.08,5.84,{"v":0.431959345002823,"d":"0.43"},{"v":-1.2110325591719,"d":"-1.21"},"down",{"v":2.87519999997432e-06,"d":"0.00"},{"v":0.244946913597812,"d":"0.24"},"yes","TGTGGTACCTTTGTACATGTTTGATTCTGTATTCTTTATTCCAGTGTGGCATATGTGCCC","FALSE","NM_017896","ref|NM_017896|ens|ENST00000266069|gb|AK025775|gb|BC031819","GID8","GID complex subunit 8","ref|Homo sapiens GID complex subunit 8 (GID8), mRNA [NM_017896]","chr20",61569440,61579827,"GO:0005654(nucleoplasm);GO:0030054(cell junction)",null,"mRNA","agilent G3 V3"]
["A_23_P34877",1.98,{"v":2,"d":"2.00"},{"v":2.1,"d":"2.10"},4.39,4.33,4.55,{"v":0.458176337603617,"d":"0.46"},{"v":-1.12602514192661,"d":"-1.13"},"down",{"v":2.9233999999656e-06,"d":"0.00"},{"v":0.24905321619707,"d":"0.25"},"yes","TGCATCAGACACTGCCACTTCTACTCAGAGGCCACTTAGGAACCTTGTGTCCTATTTAAA","FALSE","NM_022768","ref|NM_022768|ref|NM_001201545|ens|ENST00000487146|ens|ENST00000602849","RBM15","RNA binding motif protein 15","ref|Homo sapiens RNA binding motif protein 15 (RBM15), transcript variant 1, mRNA [NM_022768]","chr1",110881944,110889299,"GO:0000166(nucleotide binding);GO:0001569(patterning of blood vessels);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0007221(positive regulation of transcription of Notch receptor target);GO:0016032(viral reproduction);GO:0031965(nuclear membrane);GO:0045638(negative regulation of myeloid cell differentiation);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0048536(spleen development);GO:0060412(ventricular septum morphogenesis);GO:0060674(placenta blood vessel development)",null,"mRNA","agilent G3 V3"]
["A_33_P3319943",2.29,2.51,2.39,{"v":4.7,"d":"4.70"},4.83,4.74,{"v":0.50385423966363,"d":"0.50"},{"v":-0.988921659036466,"d":"-0.99"},"down",{"v":2.92980000005105e-06,"d":"0.00"},{"v":0.249598451404349,"d":"0.25"},"yes","GCTGTGAGAATGACTTCTATTCAGTGCAAGCTCTATCAGTACTACTTAGATCACTTAACA","FALSE","NM_000489","ref|NM_000489|ref|NM_138270|ens|ENST00000480283|ens|ENST00000395603","ATRX","alpha thalassemia/mental retardation syndrome X-linked","ref|Homo sapiens alpha thalassemia/mental retardation syndrome X-linked (ATRX), transcript variant 1, mRNA [NM_000489]","chrX",76871720,76876000,"GO:0003677(DNA binding);GO:0003678(DNA helicase activity);GO:0003682(chromatin binding);GO:0004386(helicase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005720(nuclear heterochromatin);GO:0006281(DNA repair);GO:0006306(DNA methylation);GO:0006310(DNA recombination);GO:0006334(nucleosome assembly);GO:0006336(DNA replication-independent nucleosome assembly);GO:0006338(chromatin remodeling);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0007283(spermatogenesis);GO:0008270(zinc ion binding);GO:0010571(positive regulation of DNA replication involved in S phase);GO:0015616(DNA translocase activity);GO:0016605(PML body);GO:0030330(DNA damage response, signal transduction by p53 class mediator);GO:0030900(forebrain development);GO:0031297(replication fork processing);GO:0031933(telomeric heterochromatin);GO:0032206(positive regulation of telomere maintenance);GO:0032508(DNA duplex unwinding);GO:0035064(methylated histone residue binding);GO:0042393(histone binding);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0060009(Sertoli cell development);GO:0070087(chromo shadow domain binding);GO:0070603(SWI/SNF-type complex);GO:0072520(seminiferous tubule development);GO:0072711(cellular response to hydroxyurea)",null,"mRNA","agilent G3 V3"]
["A_23_P166663",3.01,3.11,2.85,{"v":6.3,"d":"6.30"},6.45,{"v":6.2,"d":"6.20"},{"v":0.47335092348285,"d":"0.47"},{"v":-1.07901795813919,"d":"-1.08"},"down",{"v":2.95029999997087e-06,"d":"0.00"},{"v":0.251344907897519,"d":"0.25"},"yes","CCTCAGGCTCTACAATCTAGGGGTGGTAAATGTGTTTCCACTATACTTGGGAAAAGGTCA","FALSE","NM_012096","ref|NM_012096|ens|ENST00000288266|gb|AB037849|gb|AF169797","APPL1","adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1","ref|Homo sapiens adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 (APPL1), mRNA [NM_012096]","chr3",57261764,57307496,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0008283(cell proliferation);GO:0008286(insulin receptor signaling pathway);GO:0010008(endosome membrane);GO:0012506(vesicle membrane);GO:0016581(NuRD complex);GO:0031901(early endosome membrane);GO:0042802(identical protein binding);GO:0043065(positive regulation of apoptotic process);GO:0043422(protein kinase B binding);GO:0046324(regulation of glucose import);GO:0070062(extracellular vesicular exosome);GO:0090003(regulation of establishment of protein localization in plasma membrane);GO:0097190(apoptotic signaling pathway)","05200(Pathways in cancer);05210(Colorectal cancer)","mRNA","agilent G3 V3"]
["A_23_P77502",2.02,2.34,1.99,{"v":7.1,"d":"7.10"},7.22,{"v":7.5,"d":"7.50"},{"v":0.291017415215399,"d":"0.29"},{"v":-1.78082260466408,"d":"-1.78"},"down",{"v":2.97959999995268e-06,"d":"0.00"},{"v":0.253841062795968,"d":"0.25"},"yes","CCTGCACCGTCTCACTGTGTGTCTCGTGTCAGTAATTTATATGGTGTTAAAATGTGTATA","FALSE","NM_001009944","ref|NM_001009944|ref|NM_000296|ens|ENST00000262304|ens|ENST00000423118","PKD1","polycystic kidney disease 1 (autosomal dominant)","ref|Homo sapiens polycystic kidney disease 1 (autosomal dominant) (PKD1), transcript variant 1, mRNA [NM_001009944]","chr16",{"v":2140986,"d":"2140986.00"},2159854,"GO:0000139(Golgi membrane);GO:0001502(cartilage condensation);GO:0001701(in utero embryonic development);GO:0001822(kidney development);GO:0001889(liver development);GO:0001892(embryonic placenta development);GO:0002133(polycystin complex);GO:0005262(calcium channel activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0005929(cilium);GO:0006611(protein export from nucleus);GO:0006807(nitrogen compound metabolic process);GO:0006996(organelle organization);GO:0007050(cell cycle arrest);GO:0007156(homophilic cell adhesion);GO:0007160(cell-matrix adhesion);GO:0007161(calcium-independent cell-matrix adhesion);GO:0007204(elevation of cytosolic calcium ion concentration);GO:0007259(JAK-STAT cascade);GO:0007507(heart development);GO:0009653(anatomical structure morphogenesis);GO:0016021(integral to membrane);GO:0016323(basolateral plasma membrane);GO:0016328(lateral plasma membrane);GO:0016337(cell-cell adhesion);GO:0018105(peptidyl-serine phosphorylation);GO:0019901(protein kinase binding);GO:0019904(protein domain specific binding);GO:0021510(spinal cord development);GO:0021915(neural tube development);GO:0030246(carbohydrate binding);GO:0030660(Golgi-associated vesicle membrane);GO:0031512(motile primary cilium);GO:0031659(positive regulation of cyclin-dependent protein kinase activity involved in G1/S);GO:0032092(positive regulation of protein binding);GO:0034405(response to fluid shear stress);GO:0042994(cytoplasmic sequestering of transcription factor);GO:0043588(skin development);GO:0044325(ion channel binding);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048565(digestive tract development);GO:0048754(branching morphogenesis of a tube);GO:0048806(genitalia development);GO:0050982(detection of mechanical stimulus);GO:0051216(cartilage development);GO:0060170(cilium membrane);GO:0060236(regulation of mitotic spindle organization);GO:0060428(lung epithelium development);GO:0060674(placenta blood vessel development);GO:0061136(regulation of proteasomal protein catabolic process);GO:0070062(extracellular vesicular exosome);GO:0070588(calcium ion transmembrane transport);GO:0072164(mesonephric tubule development);GO:0072177(mesonephric duct development);GO:0072205(metanephric collecting duct development);GO:0072218(metanephric ascending thin limb development);GO:0072237(metanephric proximal tubule development);GO:0072287(metanephric distal tubule morphogenesis);GO:0072372(primary cilium)",null,"mRNA","agilent G3 V3"]
["A_23_P332042",2.14,2.16,2.08,4.49,4.74,4.56,{"v":0.462654097171864,"d":"0.46"},{"v":-1.11199412774911,"d":"-1.11"},"down",{"v":3.00090000004971e-06,"d":"0.00"},{"v":0.255655673704235,"d":"0.26"},"yes","CTTTCTGCTTGCAAAGCCTATAGACCCTTCTCAGAGCGGTCCTCATGGCTGGGTTTTCTG","FALSE","NM_004259","ref|NM_004259|ens|ENST00000317905|ens|ENST00000443199|ens|ENST00000578865","RECQL5","RecQ protein-like 5","ref|Homo sapiens RecQ protein-like 5 (RECQL5), transcript variant 1, mRNA [NM_004259]","chr17",73622936,73663269,"GO:0000993(RNA polymerase II core binding);GO:0003676(nucleic acid binding);GO:0003678(DNA helicase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006259(DNA metabolic process);GO:0006260(DNA replication);GO:0006281(DNA repair);GO:0006310(DNA recombination);GO:0007067(mitosis);GO:0008026(ATP-dependent helicase activity);GO:0016591(DNA-directed RNA polymerase II, holoenzyme);GO:0031965(nuclear membrane);GO:0032508(DNA duplex unwinding);GO:0034244(negative regulation of transcription elongation from RNA polymerase II promoter);GO:0051301(cell division);GO:0051304(chromosome separation)",null,"mRNA","agilent G3 V3"]
["A_24_P346368",2.55,2.36,2.64,6.87,7.28,7.04,{"v":0.356300141576215,"d":"0.36"},{"v":-1.48883503815973,"d":"-1.49"},"down",{"v":3.0621000000064e-06,"d":"0.00"},{"v":0.260869485300545,"d":"0.26"},"yes","GTCCTTTCACTGTATGACTTGAATCAGTTTTGATTCTATTTGTAAGTGTTTCTTGTCGTG","FALSE","NM_017994","ref|NM_017994|ens|ENST00000341567|ref|XM_005250482|gb|AK023152","TMEM248","transmembrane protein 248","ref|Homo sapiens transmembrane protein 248 (TMEM248), mRNA [NM_017994]","chr7",66386212,66423538,"GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_22_P00003889",1.92,2.07,1.89,4.89,4.85,{"v":5.1,"d":"5.10"},{"v":0.39622641509434,"d":"0.40"},{"v":-1.33560303178444,"d":"-1.34"},"down",{"v":3.10859999996804e-06,"d":"0.00"},{"v":0.264830959797277,"d":"0.26"},"yes","AACAGCTTTTGGTTCGGACTCGTTCTGTGGGTGTCAATACATGTGAAGTTGGAGTAGTGA","FALSE","NM_020747","ref|NM_020747|ens|ENST00000503896|ens|ENST00000505686|ens|ENST00000613878","ZNF608","zinc finger protein 608","ref|Homo sapiens zinc finger protein 608 (ZNF608), mRNA [NM_020747]","chr5",123972608,124080805,"GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P377888",2.15,2.35,2.24,5.31,5.28,5.07,{"v":0.430395913154534,"d":"0.43"},{"v":-1.21626371610918,"d":"-1.22"},"down",{"v":3.11860000001829e-06,"d":"0.00"},{"v":0.265682889801558,"d":"0.27"},"yes","TTTAACGCTCTCTGTTCTGAAAAAGAGGTGTTTGGTTACGTGTGAGCCAACATCACGTTT","FALSE","NM_014967","ref|NM_014967|ens|ENST00000621063|ens|ENST00000565280|ens|ENST00000362065","FAN1","FANCD2/FANCI-associated nuclease 1","ref|Homo sapiens FANCD2/FANCI-associated nuclease 1 (FAN1), transcript variant 1, mRNA [NM_014967]","chr15",31196116,31235311,"GO:0000287(magnesium ion binding);GO:0000724(double-strand break repair via homologous recombination);GO:0000737(DNA catabolic process, endonucleolytic);GO:0004528(phosphodiesterase I activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006281(DNA repair);GO:0006289(nucleotide-excision repair);GO:0008409(5'-3' exonuclease activity);GO:0017108(5'-flap endonuclease activity);GO:0033683(nucleotide-excision repair, DNA incision);GO:0043130(ubiquitin binding);GO:0045171(intercellular bridge);GO:0070336(flap-structured DNA binding)","03460(Fanconi anemia pathway)","mRNA","agilent G3 V3"]
["A_23_P50426",8.34,8.19,8.16,11.05,10.82,10.95,{"v":0.752285191956124,"d":"0.75"},{"v":-0.410648402370931,"d":"-0.41"},"down",{"v":3.13510000005124e-06,"d":"0.00"},{"v":0.267088574304365,"d":"0.27"},"yes","TGCGCCCATTCTCTTCTCACGCATATCCATGAGCTTTAATTTCACTTTCTGATCACGGTA","FALSE","NM_015493","ref|NM_015493|ref|NM_001136191|ens|ENST00000586659|gb|AB284125","KANK2","KN motif and ankyrin repeat domains 2","ref|Homo sapiens KN motif and ankyrin repeat domains 2 (KANK2), transcript variant 1, mRNA [NM_015493]","chr19",11274944,11305266,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0006351(transcription, DNA-dependent);GO:0006915(apoptotic process);GO:0008285(negative regulation of cell proliferation);GO:0033147(negative regulation of intracellular estrogen receptor signaling pathway);GO:0043069(negative regulation of programmed cell death);GO:0070563(negative regulation of vitamin D receptor signaling pathway);GO:2000134(negative regulation of G1/S transition of mitotic cell cycle)",null,"mRNA","agilent G3 V3"]
["A_23_P152115",8.52,8.58,8.58,9.48,9.51,9.56,{"v":0.899474605954466,"d":"0.90"},{"v":-0.152845543127902,"d":"-0.15"},"down",{"v":3.17289999995918e-06,"d":"0.00"},{"v":0.270308869696522,"d":"0.27"},"yes","ACACTGTCCTGGTGCCCAGCCCAACGTGGTCCAACGTTTTTTTATAATAAAGTCCTCGTT","FALSE","NM_002513","ref|NM_002513|ens|ENST00000568561|ens|ENST00000567271|ens|ENST00000561637","NME3","NME/NM23 nucleoside diphosphate kinase 3","ref|Homo sapiens NME/NM23 nucleoside diphosphate kinase 3 (NME3), mRNA [NM_002513]","chr16",{"v":1820650,"d":"1820650.00"},1821324,"GO:0004550(nucleoside diphosphate kinase activity);GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006163(purine nucleotide metabolic process);GO:0006165(nucleoside diphosphate phosphorylation);GO:0006183(GTP biosynthetic process);GO:0006220(pyrimidine nucleotide metabolic process);GO:0006228(UTP biosynthetic process);GO:0006241(CTP biosynthetic process);GO:0006915(apoptotic process);GO:0009142(nucleoside triphosphate biosynthetic process);GO:0042981(regulation of apoptotic process);GO:0046872(metal ion binding);GO:0070062(extracellular vesicular exosome)","00230(Purine metabolism);00240(Pyrimidine metabolism)","mRNA","agilent G3 V3"]
["A_33_P3244347",12.88,12.86,12.88,12.18,12.12,12.19,{"v":1.05837215675528,"d":"1.06"},{"v":0.0818470133661693,"d":"0.08"},"up",{"v":3.19749999999619e-06,"d":"0.00"},{"v":0.272404617499675,"d":"0.27"},"yes","TTGCCAAATAAGGGTCCCCTCCTCACTGGAGACTACAAGTGGTGGGTCAGGTGGTCCTAG","FALSE","NM_001040716","ref|NM_001040716|ref|NM_000920|ref|NM_022172|ens|ENST00000393960","PC","pyruvate carboxylase","ref|Homo sapiens pyruvate carboxylase (PC), transcript variant 3, mRNA [NM_001040716]","chr11",66615996,66725847,"GO:0003677(DNA binding);GO:0004075(biotin carboxylase activity);GO:0004736(pyruvate carboxylase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0005759(mitochondrial matrix);GO:0005829(cytosol);GO:0005975(carbohydrate metabolic process);GO:0006006(glucose metabolic process);GO:0006090(pyruvate metabolic process);GO:0006094(gluconeogenesis);GO:0006107(oxaloacetate metabolic process);GO:0006629(lipid metabolic process);GO:0006766(vitamin metabolic process);GO:0006767(water-soluble vitamin metabolic process);GO:0006768(biotin metabolic process);GO:0009374(biotin binding);GO:0009405(pathogenesis);GO:0044281(small molecule metabolic process);GO:0046872(metal ion binding)","01200(Carbon metabolism);01230(Biosynthesis of amino acids);00020(Citrate cycle (TCA cycle));00620(Pyruvate metabolism)","mRNA","agilent G3 V3"]
["A_23_P253221",4.26,4.06,3.91,8.21,8.22,7.96,{"v":0.501435014350143,"d":"0.50"},{"v":-0.995865354268797,"d":"-1.00"},"down",{"v":3.38389999998689e-06,"d":"0.00"},{"v":0.288284592698884,"d":"0.29"},"yes","TTGCACTATTCCTTCTCCAAGCCAGAAACCACATTTAATTTCATAAATAAATTTATGAAA","FALSE","NM_032995","ref|NM_032995|ref|NM_015320|ens|ENST00000525839|ens|ENST00000326016","ARHGEF4","Rho guanine nucleotide exchange factor (GEF) 4","ref|Homo sapiens Rho guanine nucleotide exchange factor (GEF) 4 (ARHGEF4), transcript variant 2, mRNA [NM_032995]","chr2",131674224,131804836,"GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0007264(small GTPase mediated signal transduction);GO:0019904(protein domain specific binding);GO:0030032(lamellipodium assembly);GO:0030676(Rac guanyl-nucleotide exchange factor activity);GO:0032587(ruffle membrane);GO:0032855(positive regulation of Rac GTPase activity);GO:0043065(positive regulation of apoptotic process);GO:0043547(positive regulation of GTPase activity);GO:0046847(filopodium assembly);GO:0048011(nerve growth factor receptor signaling pathway);GO:0051056(regulation of small GTPase mediated signal transduction);GO:0097190(apoptotic signaling pathway)","04810(Regulation of actin cytoskeleton)","mRNA","agilent G3 V3"]
["A_24_P1054",13.58,13.65,13.61,12.73,12.72,12.66,{"v":1.07163474153765,"d":"1.07"},{"v":0.0998132580656336,"d":"0.10"},"up",{"v":3.4319999999699e-06,"d":"0.00"},{"v":0.292382375997436,"d":"0.29"},"yes","AGGGCCACCCCCTTAACCCTCGGGACTACTGTGGCTGGACACCTCTGCACGAGGCCTGCA","FALSE","NM_013432","ref|NM_013432|ens|ENST00000613741|ens|ENST00000409379|ens|ENST00000497613","TONSL","tonsoku-like, DNA repair protein","ref|Homo sapiens tonsoku-like, DNA repair protein (TONSL), mRNA [NM_013432]","chr8",145654160,145668239,"GO:0000724(double-strand break repair via homologous recombination);GO:0003714(transcription corepressor activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005662(DNA replication factor A complex);GO:0005737(cytoplasm);GO:0031297(replication fork processing);GO:0035101(FACT complex);GO:0042393(histone binding);GO:0042555(MCM complex);GO:0042994(cytoplasmic sequestering of transcription factor);GO:0043596(nuclear replication fork)",null,"mRNA","agilent G3 V3"]
["A_22_P00022232",1.93,2.07,2.04,4.13,4.33,4.28,{"v":0.474097331240188,"d":"0.47"},{"v":-1.07674482293122,"d":"-1.08"},"down",{"v":3.51980000001806e-06,"d":"0.00"},{"v":0.299862321401538,"d":"0.30"},"yes","TCATGGACACGGACACGGATCTTCATCTGGTTCATTGTATTTATATGTGAGGGATGGATG","FALSE","NM_005772","ref|NM_005772|ref|NM_001286700|ref|NM_001286699|ref|NM_001286701","RCL1","RNA terminal phosphate cyclase-like 1","ref|Homo sapiens RNA terminal phosphate cyclase-like 1 (RCL1), transcript variant 1, mRNA [NM_005772]","chr9",{"v":4792833,"d":"4792833.00"},4861077,"GO:0000480(endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0003723(RNA binding);GO:0003963(RNA-3'-phosphate cyclase activity);GO:0004521(endoribonuclease activity);GO:0005730(nucleolus);GO:0008150(biological_process)","03008(Ribosome biogenesis in eukaryotes)","mRNA","agilent G3 V3"]
["A_33_P3289426",{"v":2,"d":"2.00"},2.29,1.96,5.68,5.52,5.54,{"v":0.373357228195938,"d":"0.37"},{"v":-1.42137143300089,"d":"-1.42"},"down",{"v":3.54769999999505e-06,"d":"0.00"},{"v":0.302239206099578,"d":"0.30"},"yes","CCCAGCACCAGGGCCACTGCTGGCACGTCGTAGACATCCAATAAATATTTTTGGAAGGAG","FALSE","NM_173680","ref|NM_173680|ens|ENST00000329630|gb|BC015152|gb|BC038111","ZNF775","zinc finger protein 775","ref|Homo sapiens zinc finger protein 775 (ZNF775), mRNA [NM_173680]","chr7",150076416,150095719,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P119266",2.04,2.15,2.16,4.74,4.62,4.89,{"v":0.445614035087719,"d":"0.45"},{"v":-1.16613342227994,"d":"-1.17"},"down",{"v":3.55649999994601e-06,"d":"0.00"},{"v":0.3029889044954,"d":"0.30"},"yes","CTGCCCTCTAACTGCTCGGATATCTGGCAGGTTCTGAATGTGAACCAGATAGCTTTCCCT","FALSE","NM_001375","ref|NM_001375|ens|ENST00000588777|ens|ENST00000222219|gb|AK315358","DNASE2","deoxyribonuclease II, lysosomal","ref|Homo sapiens deoxyribonuclease II, lysosomal (DNASE2), mRNA [NM_001375]","chr19",12986759,12992263,"GO:0003677(DNA binding);GO:0004531(deoxyribonuclease II activity);GO:0005622(intracellular);GO:0005764(lysosome);GO:0006259(DNA metabolic process);GO:0006309(apoptotic DNA fragmentation);GO:0030218(erythrocyte differentiation);GO:0070062(extracellular vesicular exosome)","04142(Lysosome)","mRNA","agilent G3 V3"]
["A_24_P339664",1.97,2.23,1.94,6.38,6.27,6.03,{"v":0.328693790149893,"d":"0.33"},{"v":-1.60518389433948,"d":"-1.61"},"down",{"v":3.57959999996993e-06,"d":"0.00"},{"v":0.304956862797438,"d":"0.30"},"yes","TTGTCACCATGAGAGAATTTGGGGAGTGCTTGCATGCTAGCCAGCAGGCTCCTGTCTGGG","FALSE","NM_020170","ref|NM_020170|ens|ENST00000246117|ens|ENST00000591062|ref|XM_005259596","NCLN","nicalin","ref|Homo sapiens nicalin (NCLN), mRNA [NM_020170]","chr19",{"v":3207464,"d":"3207464.00"},3209569,"GO:0005515(protein binding);GO:0005789(endoplasmic reticulum membrane);GO:0009966(regulation of signal transduction);GO:0016020(membrane);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P22672",2.12,2.19,2.45,5.82,5.94,5.72,{"v":0.386727688787185,"d":"0.39"},{"v":-1.37061003321841,"d":"-1.37"},"down",{"v":3.64279999998107e-06,"d":"0.00"},{"v":0.310341060398387,"d":"0.31"},"yes","TAATACTGGATGTATGTAAGTGTTTTACTGCACTGTATTGAATTGGTGTCTTTTGCACAG","FALSE","NM_001257231","ref|NM_001257231|ref|NM_001099922|ref|NM_001257237|ref|NM_001257234","ALG13","ALG13, UDP-N-acetylglucosaminyltransferase subunit","ref|Homo sapiens ALG13, UDP-N-acetylglucosaminyltransferase subunit (ALG13), transcript variant 7, mRNA [NM_001257231]","chrX",110924344,111003873,"GO:0004577(N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity);GO:0005789(endoplasmic reticulum membrane);GO:0006488(dolichol-linked oligosaccharide biosynthetic process);GO:0006508(proteolysis);GO:0008234(cysteine-type peptidase activity);GO:0018279(protein N-linked glycosylation via asparagine);GO:0030246(carbohydrate binding);GO:0030259(lipid glycosylation);GO:0043687(post-translational protein modification);GO:0044267(cellular protein metabolic process)","00510(N-Glycan biosynthesis)","mRNA","agilent G3 V3"]
["A_33_P3218625",{"v":5.1,"d":"5.10"},5.04,4.95,7.32,7.54,7.37,{"v":0.678812415654521,"d":"0.68"},{"v":-0.558915142500307,"d":"-0.56"},"down",{"v":3.72260000003344e-06,"d":"0.00"},{"v":0.317139461802849,"d":"0.32"},"yes","TCCTCCTTGTTTGTTCCTCTGTGTTCTGTGTGCGTCTTAAGCAATAAAGCGTGGCCGTGG","FALSE","NM_001242369","ref|NM_001242369|ref|NM_017586|ref|NM_001242370|ref|NM_001135775","CACFD1","calcium channel flower domain containing 1","ref|Homo sapiens calcium channel flower domain containing 1 (CACFD1), transcript variant 3, mRNA [NM_001242369]","chr9",136325104,136335970,"GO:0003674(molecular_function);GO:0005262(calcium channel activity);GO:0005575(cellular_component);GO:0008150(biological_process);GO:0030285(integral to synaptic vesicle membrane);GO:0048488(synaptic vesicle endocytosis);GO:0070588(calcium ion transmembrane transport)",null,"mRNA","agilent G3 V3"]
["A_23_P31532",9.03,9.03,{"v":9.1,"d":"9.10"},9.94,10.01,9.98,{"v":0.9074507183428,"d":"0.91"},{"v":-0.140108799253369,"d":"-0.14"},"down",{"v":3.740799999985e-06,"d":"0.00"},{"v":0.318689974398722,"d":"0.32"},"yes","CTTCTGTCCCTGCTCAGTCGGCCAAGAAGCCCTGCCCAGTGTCTTGCGAGAAGTAAAGAA","FALSE","NM_080660","ref|NM_080660|ens|ENST00000275766|gb|BC008842|tc|THC2482679","ZC3HAV1L","zinc finger CCCH-type, antiviral 1-like","ref|Homo sapiens zinc finger CCCH-type, antiviral 1-like (ZC3HAV1L), mRNA [NM_080660]","chr7",138710448,138720775,null,null,"mRNA","agilent G3 V3"]
["A_24_P301547",1.93,2.04,2.03,4.27,4.05,4.18,0.48,{"v":-1.05889368905357,"d":"-1.06"},"down",{"v":3.81110000002849e-06,"d":"0.00"},{"v":0.324679042302427,"d":"0.32"},"yes","TTCCGAGGGAGACGACTTACCAGTTTCATTCTGTATCGCAGTCAAGTAGTCAAAGTCTTG","FALSE","NM_017941","ref|NM_017941|ref|NM_001288771|ref|NM_001100622|ref|NM_001288770","C17orf80","chromosome 17 open reading frame 80","ref|Homo sapiens chromosome 17 open reading frame 80 (C17orf80), transcript variant 1, mRNA [NM_017941]","chr17",71228776,71245091,"GO:0003674(molecular_function);GO:0008150(biological_process);GO:0016021(integral to membrane);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3325558",7.71,7.46,7.62,9.86,{"v":9.8,"d":"9.80"},9.83,{"v":0.772804340454391,"d":"0.77"},{"v":-0.37182489779644,"d":"-0.37"},"down",{"v":3.81309999997193e-06,"d":"0.00"},{"v":0.324849428297608,"d":"0.32"},"yes","TATAATCTCCTGGTGTGCCGTTTGCTAAGACCTTTGGAAAAGTGCAGTATTAGGGTGGGA","FALSE","ENST00000367690","ens|ENST00000367690|gb|AF279778|gb|BC062541|gb|AK074409","RABGAP1L","RAB GTPase activating protein 1-like","ens|RAB GTPase activating protein 1-like [Source:HGNC Symbol;Acc:HGNC:24663] [ENST00000367690]","chr1",174244240,174515042,"GO:0005097(Rab GTPase activator activity);GO:0005634(nucleus);GO:0005769(early endosome);GO:0005794(Golgi apparatus);GO:0017137(Rab GTPase binding);GO:0032851(positive regulation of Rab GTPase activity);GO:0032880(regulation of protein localization)",null,"mRNA","agilent G3 V3"]
["A_21_P0007739",{"v":12.6,"d":"12.60"},12.64,12.69,11.84,11.81,11.83,{"v":1.06905298759865,"d":"1.07"},{"v":0.0963333619931736,"d":"0.10"},"up",{"v":3.82119999997599e-06,"d":"0.00"},{"v":0.325539491597954,"d":"0.33"},"yes","ATTTAAAGCAGCTGATCCCAAATACTGGCCCCCACACTAGTTTGGCTCTGTGATCAGATT","FALSE","ENST00000615716","ens|ENST00000615716|linc|lnc-BTG1-1:1|linc|TCONS_00020869",{"$nulls":3},"chr12",92641536,92757608,null,null,"mRNA","agilent G3 V3"]
["A_23_P17393",3.64,3.81,3.66,5.49,5.51,5.59,{"v":0.669680530440024,"d":"0.67"},{"v":-0.578455069566771,"d":"-0.58"},"down",{"v":3.88409999996231e-06,"d":"0.00"},{"v":0.330898131296789,"d":"0.33"},"yes","AGGCAGCCAGTGTGACACTGCTTTAAACTGCATTTTTCTAATGGGCTAAACCCAGATGGT","FALSE","NM_001316","ref|NM_001316|ref|NM_001256135|ref|NR_045796|ens|ENST00000262982","CSE1L","CSE1 chromosome segregation 1-like (yeast)","ref|Homo sapiens CSE1 chromosome segregation 1-like (yeast) (CSE1L), transcript variant 1, mRNA [NM_001316]","chr20",47662864,47713123,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006611(protein export from nucleus);GO:0006915(apoptotic process);GO:0008262(importin-alpha export receptor activity);GO:0008283(cell proliferation);GO:0008536(Ran GTPase binding);GO:0016020(membrane);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3287314",{"v":14.4,"d":"14.40"},14.49,{"v":14.4,"d":"14.40"},13.29,13.35,13.36,{"v":1.08225,"d":"1.08"},{"v":0.114033800550267,"d":"0.11"},"up",{"v":3.90729999999451e-06,"d":"0.00"},{"v":0.332874608899532,"d":"0.33"},"yes","CTCAATGGTGCCCCCCAAAAAGATATCAGATCCTAATAACTGGAACCTGGTAACTTTTTT","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_21_P0011772",6.63,6.55,6.58,7.62,7.66,7.57,{"v":0.864770240700219,"d":"0.86"},{"v":-0.209611218360755,"d":"-0.21"},"down",{"v":3.95129999997135e-06,"d":"0.00"},{"v":0.336623100897559,"d":"0.34"},"yes","TATATCTGGAAGTTCAGAAAGGCCAGTTCCTGCGGCTCCTCTGTGCTGCTGACAGCCAGC","FALSE","NM_001135163","ref|NM_001135163|ens|ENST00000599858|ens|ENST00000602139|ref|XR_243888","SIGLEC11","sialic acid binding Ig-like lectin 11","ref|Homo sapiens sialic acid binding Ig-like lectin 11 (SIGLEC11), transcript variant 2, mRNA [NM_001135163]","chr19",50452248,50464429,"GO:0007155(cell adhesion);GO:0016021(integral to membrane);GO:0030246(carbohydrate binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3285470",11.63,11.66,11.72,10.44,10.32,10.39,{"v":1.1239165329053,"d":"1.12"},{"v":0.16853489851714,"d":"0.17"},"up",{"v":3.96729999996293e-06,"d":"0.00"},{"v":0.337986188896842,"d":"0.34"},"yes","TGAGTCCCCTCCAGGAAGAAGCAGGGGGGAATCTATTTTTTCTCTCCTTTTCTTTTCTTC","FALSE","NM_001702","ref|NM_001702|ens|ENST00000521208|ens|ENST00000323289|ens|ENST00000517894","BAI1","brain-specific angiogenesis inhibitor 1","ref|Homo sapiens brain-specific angiogenesis inhibitor 1 (BAI1), mRNA [NM_001702]","chr8",143545376,143626346,"GO:0004930(G-protein coupled receptor activity);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0005911(cell-cell junction);GO:0007155(cell adhesion);GO:0007165(signal transduction);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007409(axonogenesis);GO:0007422(peripheral nervous system development);GO:0008285(negative regulation of cell proliferation);GO:0016021(integral to membrane);GO:0016525(negative regulation of angiogenesis)","04115(p53 signaling pathway)","mRNA","agilent G3 V3"]
["A_33_P3311668",2.03,2.13,2.12,4.12,4.27,4.06,{"v":0.504417670682731,"d":"0.50"},{"v":-0.987309278063816,"d":"-0.99"},"down",{"v":4.0129999999694e-06,"d":"0.00"},{"v":0.341879508997393,"d":"0.34"},"yes","ATGAGCAGTGACTTTCTACTCTCCATCCAGCAGCCAACAATAGACTTCGTCATTCAGATG","FALSE","AA489744","gb|AA489744",null,null,"gb|aa43c10.r1 Soares_NhHMPu_S1 Homo sapiens cDNA clone IMAGE:823698 5', mRNA sequence [AA489744]","chr12",{"v":3861703,"d":"3861703.00"},3867008,null,null,"mRNA","agilent G3 V3"]
["A_33_P3279949",12.25,12.33,12.25,11.19,11.21,11.27,{"v":1.09385209385209,"d":"1.09"},{"v":0.129417676072092,"d":"0.13"},"up",{"v":4.01729999999212e-06,"d":"0.00"},{"v":0.342245838899329,"d":"0.34"},"yes","GACGAGAAGTTGTTTTGTCAATATGCTGCAAACTCATTTGGCCCCCAAAATCTGACCTGA","FALSE","AK124170","gb|AK124170|tc|THC2486328","LOC100128170","uncharacterized LOC100128170","gb|Homo sapiens cDNA FLJ42176 fis, clone THYMU2030226. [AK124170]","chr20",42574344,42698252,null,null,"mRNA","agilent G3 V3"]
["A_33_P3306113",2.22,2.33,2.58,5.64,5.58,5.69,{"v":0.421643997634536,"d":"0.42"},{"v":-1.24590267796609,"d":"-1.25"},"down",{"v":4.02359999995827e-06,"d":"0.00"},{"v":0.342782554796445,"d":"0.34"},"yes","TTTCTGTCTGCTCTGTTCAGTGAATCATGTGAAGTGCTTGCAAAGGCAGCTTTACACAGT","FALSE","NM_023007","ref|NM_023007|ref|NM_001161465|ens|ENST00000438896|ens|ENST00000620518","JMJD4","jumonji domain containing 4","ref|Homo sapiens jumonji domain containing 4 (JMJD4), transcript variant 1, mRNA [NM_023007]","chr1",227918928,227923112,"GO:0005515(protein binding)",null,"mRNA","agilent G3 V3"]
["A_19_P00808461",2.96,3.02,3.15,4.99,5.12,{"v":5.1,"d":"5.10"},{"v":0.60026298487837,"d":"0.60"},{"v":-0.736333387740274,"d":"-0.74"},"down",{"v":4.02789999998099e-06,"d":"0.00"},{"v":0.34314888469838,"d":"0.34"},"yes","GTGGGAAAACCTTCCATCAGAAGTTGGCCCTAATTGTTCACCAGAGAACTCATATAAGAC","FALSE","NM_001007094","ref|NM_001007094|ref|NM_003421|ref|NM_001178101|ref|NR_026777","ZNF37A","zinc finger protein 37A","ref|Homo sapiens zinc finger protein 37A (ZNF37A), transcript variant 1, mRNA [NM_001007094]","chr10",43016272,43048256,"GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P164000",{"v":2.1,"d":"2.10"},2.28,2.15,5.64,5.32,{"v":5.6,"d":"5.60"},{"v":0.394323671497585,"d":"0.39"},{"v":-1.34254777595289,"d":"-1.34"},"down",{"v":4.03339999999197e-06,"d":"0.00"},{"v":0.343617446199316,"d":"0.34"},"yes","ACTTCGTCGGCAGATCTACAAGGAGCTGTGTCACTGCAAACTCACTGTGTGAGCCTCGTA","FALSE","NM_015670","ref|NM_015670|ens|ENST00000581010|ens|ENST00000429205|ens|ENST00000321337","SENP3","SUMO1/sentrin/SMT3 specific peptidase 3","ref|Homo sapiens SUMO1/sentrin/SMT3 specific peptidase 3 (SENP3), mRNA [NM_015670]","chr17",{"v":7465543,"d":"7465543.00"},7475287,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006508(proteolysis);GO:0008234(cysteine-type peptidase activity);GO:0071339(MLL1 complex)",null,"mRNA","agilent G3 V3"]
["A_24_P204675",13.58,13.57,13.55,14.35,14.33,14.27,{"v":0.947613504074505,"d":"0.95"},{"v":-0.0776293368722164,"d":"-0.08"},"down",{"v":4.04320000002567e-06,"d":"0.00"},{"v":0.344452337602187,"d":"0.34"},"yes","ATAATCTCAAGACACGTGCCGAGTGTTGCTCCATCCCCTTCCACCCTCAGCGGATGATAA","FALSE","NM_001135865","ref|NM_001135865|ref|NM_130464|ref|NR_002555|ens|ENST00000357370","NPIPB5","nuclear pore complex interacting protein family, member B5","ref|Homo sapiens nuclear pore complex interacting protein family, member B5 (NPIPB5), mRNA [NM_001135865]","chr16",22524844,22547841,null,null,"mRNA","agilent G3 V3"]
["A_33_P3292028",1.98,1.98,2.14,4.16,4.31,4.15,{"v":0.483359746434231,"d":"0.48"},{"v":-1.0488307625323,"d":"-1.05"},"down",{"v":4.0688000000344e-06,"d":"0.00"},{"v":0.346633278402931,"d":"0.35"},"yes","TCTTATTCTTTTATAATTATGCGTGGAAGAAGTAGACACATTAAACGATTCCAGTTGGAA","FALSE","NM_139159","ref|NM_139159|ens|ENST00000262960|ref|XR_430158|ref|XM_005259673","DPP9","dipeptidyl-peptidase 9","ref|Homo sapiens dipeptidyl-peptidase 9 (DPP9), mRNA [NM_139159]","chr19",{"v":4675776,"d":"4675776.00"},4714232,"GO:0004177(aminopeptidase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0008236(serine-type peptidase activity);GO:0016020(membrane);GO:0042802(identical protein binding)",null,"mRNA","agilent G3 V3"]
["A_24_P418809",7.48,7.41,7.29,10.07,9.86,10.07,{"v":0.739333333333333,"d":"0.74"},{"v":-0.435703135221533,"d":"-0.44"},"down",{"v":4.10350000001891e-06,"d":"0.00"},{"v":0.349589475501611,"d":"0.35"},"yes","CGAAGATTGAGGACTACTTTCCAGAATTTGCTCGCTACACTACTCCTGAGGATGCTACTC","FALSE","NM_001077489","ref|NM_001077489|ref|NM_001077490|ref|NM_080425|ref|NM_016592","GNAS","GNAS complex locus","ref|Homo sapiens GNAS complex locus (GNAS), transcript variant 7, mRNA [NM_001077489]","chr20",57414772,57486247,"GO:0001726(ruffle);GO:0001894(tissue homeostasis);GO:0001958(endochondral ossification);GO:0003091(renal water homeostasis);GO:0003674(molecular_function);GO:0003924(GTPase activity);GO:0004016(adenylate cyclase activity);GO:0004871(signal transducer activity);GO:0005159(insulin-like growth factor receptor binding);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005576(extracellular region);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005834(heterotrimeric G-protein complex);GO:0005886(plasma membrane);GO:0006112(energy reserve metabolic process);GO:0006171(cAMP biosynthetic process);GO:0006184(GTP catabolic process);GO:0006306(DNA methylation);GO:0006833(water transport);GO:0007189(adenylate cyclase-activating G-protein coupled receptor signaling pathway);GO:0007190(activation of adenylate cyclase activity);GO:0007191(adenylate cyclase-activating dopamine receptor signaling pathway);GO:0007565(female pregnancy);GO:0007596(blood coagulation);GO:0007606(sensory perception of chemical stimulus);GO:0007608(sensory perception of smell);GO:0009306(protein secretion);GO:0016020(membrane);GO:0030133(transport vesicle);GO:0030425(dendrite);GO:0030819(positive regulation of cAMP biosynthetic process);GO:0031224(intrinsic to membrane);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0031698(beta-2 adrenergic receptor binding);GO:0031748(D1 dopamine receptor binding);GO:0031852(mu-type opioid receptor binding);GO:0032320(positive regulation of Ras GTPase activity);GO:0032588(trans-Golgi network membrane);GO:0035116(embryonic hindlimb morphogenesis);GO:0035255(ionotropic glutamate receptor binding);GO:0035264(multicellular organism growth);GO:0040015(negative regulation of multicellular organism growth);GO:0040032(post-embryonic body morphogenesis);GO:0042493(response to drug);GO:0043950(positive regulation of cAMP-mediated signaling);GO:0044281(small molecule metabolic process);GO:0045669(positive regulation of osteoblast differentiation);GO:0045672(positive regulation of osteoclast differentiation);GO:0046872(metal ion binding);GO:0046907(intracellular transport);GO:0048471(perinuclear region of cytoplasm);GO:0048589(developmental growth);GO:0048701(embryonic cranial skeleton morphogenesis);GO:0050796(regulation of insulin secretion);GO:0050890(cognition);GO:0051216(cartilage development);GO:0051430(corticotropin-releasing hormone receptor 1 binding);GO:0055085(transmembrane transport);GO:0060348(bone development);GO:0060789(hair follicle placode formation);GO:0070062(extracellular vesicular exosome);GO:0070527(platelet aggregation);GO:0071107(response to parathyroid hormone stimulus);GO:0071377(cellular response to glucagon stimulus);GO:0071380(cellular response to prostaglandin E stimulus);GO:0071514(genetic imprinting);GO:0071870(cellular response to catecholamine stimulus);GO:0071880(adenylate cyclase-activating adrenergic receptor signaling pathway)","04015(Rap1 signaling pathway);04020(Calcium signaling pathway);04024(cAMP signaling pathway);04540(Gap junction);04611(Platelet activation);04911(Insulin secretion);04922(Glucagon signaling pathway);04923(Regulation of lipolysis in adipocyte);04912(GnRH signaling pathway);04913(Ovarian Steroidogenesis);04915(Estrogen signaling pathway);04921(Oxytocin signaling pathway);04918(Thyroid hormone synthesis);04916(Melanogenesis);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);04970(Salivary secretion);04971(Gastric acid secretion);04972(Pancreatic secretion);04976(Bile secretion);04962(Vasopressin-regulated water reabsorption);04961(Endocrine and other factor-regulated calcium reabsorption);04724(Glutamatergic synapse);04728(Dopaminergic synapse);04726(Serotonergic synapse);04730(Long-term depression);04742(Taste transduction);04750(Inflammatory mediator regulation of TRP channels);04713(Circadian entrainment);05200(Pathways in cancer);05030(Cocaine addiction);05031(Amphetamine addiction);05032(Morphine addiction);05034(Alcoholism);05414(Dilated cardiomyopathy (DCM));05110(Vibrio cholerae infection);05146(Amoebiasis);05142(Chagas disease (American trypanosomiasis))","mRNA","agilent G3 V3"]
["A_33_P3222689",2.02,2.12,2.04,4.57,4.87,4.73,{"v":0.436132674664785,"d":"0.44"},{"v":-1.19716101501364,"d":"-1.20"},"down",{"v":4.21819999996131e-06,"d":"0.00"},{"v":0.359361112596704,"d":"0.36"},"yes","AAATCAGCTGCAAGTAAATCCTTCTGGATGGTGCCACCAAATGTTCCTACAAGTCCGGAA","FALSE","NM_001164416","ref|NM_001164416|ref|XM_006724640|gb|AK093522|gb|AX748182","H2BFM","H2B histone family, member M","ref|Homo sapiens H2B histone family, member M (H2BFM), mRNA [NM_001164416]","chrX",103268272,103297020,"GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005654(nucleoplasm);GO:0046982(protein heterodimerization activity)","05203(Viral carcinogenesis);05322(Systemic lupus erythematosus);05034(Alcoholism)","mRNA","agilent G3 V3"]
["A_33_P3338036",2.37,2.48,{"v":2.4,"d":"2.40"},4.42,4.23,4.38,{"v":0.55640828856485,"d":"0.56"},{"v":-0.845784183665838,"d":"-0.85"},"down",{"v":4.22410000000539e-06,"d":"0.00"},{"v":0.359863751300459,"d":"0.36"},"yes","ACATCTTGCTCATCATCAGCGAATTCATACCGGAGAGTCATCAGTTATTCTCTCCTCTGC","FALSE","NM_001001668","ref|NM_001001668|ens|ENST00000330619|ens|ENST00000391709|ref|XM_006723210","ZNF470","zinc finger protein 470","ref|Homo sapiens zinc finger protein 470 (ZNF470), mRNA [NM_001001668]","chr19",57078888,57094261,"GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_24_P75680",8.23,8.25,8.38,{"v":6.1,"d":"6.10"},6.29,6.18,{"v":1.338718362951,"d":"1.34"},{"v":0.420852481117064,"d":"0.42"},"up",{"v":4.2359999999908e-06,"d":"0.00"},{"v":0.360877547999216,"d":"0.36"},"yes","TTGCCTCCCTAATTTGCATTATTTTCATCTATGAAGCAATAGAAAAACTGATTCACCTGG","FALSE","NM_001258402","ref|NM_001258402|ref|NM_001267615|ref|NM_001258403|ens|ENST00000546663","SLC4A8","solute carrier family 4, sodium bicarbonate cotransporter, member 8","ref|Homo sapiens solute carrier family 4, sodium bicarbonate cotransporter, member 8 (SLC4A8), transcript variant 4, mRNA [NM_001258402]","chr12",51818592,51874006,"GO:0005452(inorganic anion exchanger activity);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0006811(ion transport);GO:0008510(sodium:bicarbonate symporter activity);GO:0015701(bicarbonate transport);GO:0032809(neuronal cell body membrane);GO:0035725(sodium ion transmembrane transport);GO:0043005(neuron projection);GO:0051453(regulation of intracellular pH);GO:0055085(transmembrane transport)",null,"mRNA","agilent G3 V3"]
["A_23_P252642",8.21,8.17,7.88,11.15,11.25,{"v":11.2,"d":"11.20"},{"v":0.72202380952381,"d":"0.72"},{"v":-0.469881682545612,"d":"-0.47"},"down",{"v":4.29520000000405e-06,"d":"0.00"},{"v":0.365920973600345,"d":"0.37"},"yes","GAAAAGATTGAGAAATCGGATGGTTGCCGTGTCTGTGTAGAAAGAAGTAGACATGGGAGA","FALSE","NM_152384","ref|NM_152384|ref|NR_125409|ens|ENST00000481916|ens|ENST00000472667","BBS5","Bardet-Biedl syndrome 5","ref|Homo sapiens Bardet-Biedl syndrome 5 (BBS5), mRNA [NM_152384]","chr2",170336000,170363165,"GO:0001103(RNA polymerase II repressing transcription factor binding);GO:0001947(heart looping);GO:0005515(protein binding);GO:0005622(intracellular);GO:0005829(cytosol);GO:0006996(organelle organization);GO:0007601(visual perception);GO:0015031(protein transport);GO:0032266(phosphatidylinositol-3-phosphate binding);GO:0032402(melanosome transport);GO:0034464(BBSome);GO:0036064(cilium basal body);GO:0042384(cilium assembly);GO:0044458(motile cilium assembly);GO:0050896(response to stimulus);GO:0060170(cilium membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3408655",9.15,9.18,9.32,7.65,7.63,7.59,{"v":1.20900743331876,"d":"1.21"},{"v":0.273823114710397,"d":"0.27"},"up",{"v":4.31119999999563e-06,"d":"0.00"},{"v":0.367284061599628,"d":"0.37"},"yes","TTCTCTGCAATTCACGTTCACAGCAGGACTTGGTCTCTCCCTAGAACCGGCAGGCACAGC","FALSE","AK310676","gb|AK310676","CD2","CD2 molecule","gb|Homo sapiens cDNA, FLJ17718. [AK310676]","chr1",117307496,117310213,"GO:0001766(membrane raft polarization);GO:0004872(receptor activity);GO:0005102(receptor binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0005911(cell-cell junction);GO:0006915(apoptotic process);GO:0007166(cell surface receptor signaling pathway);GO:0007596(blood coagulation);GO:0009897(external side of plasma membrane);GO:0009898(internal side of plasma membrane);GO:0009986(cell surface);GO:0016337(cell-cell adhesion);GO:0030101(natural killer cell activation);GO:0030887(positive regulation of myeloid dendritic cell activation);GO:0032760(positive regulation of tumor necrosis factor production);GO:0034113(heterotypic cell-cell adhesion);GO:0042110(T cell activation);GO:0042803(protein homodimerization activity);GO:0045580(regulation of T cell differentiation);GO:0046658(anchored to plasma membrane);GO:0050900(leukocyte migration);GO:2000484(positive regulation of interleukin-8 secretion)","04514(Cell adhesion molecules (CAMs));04640(Hematopoietic cell lineage)","mRNA","agilent G3 V3"]
["A_33_P3317523",2.39,{"v":2,"d":"2.00"},1.92,6.75,7.01,6.99,{"v":0.304096385542169,"d":"0.30"},{"v":-1.7173994261391,"d":"-1.72"},"down",{"v":4.36390000002618e-06,"d":"0.00"},{"v":0.37177373270223,"d":"0.37"},"yes","CTAATGTAGCTATTTTTCTTGTTGCATCTTTTCTACTTCAGTACACTTGGTGTACTGGGT","FALSE","NM_203401","ref|NM_203401|ref|NM_005563|ref|NM_203399|ens|ENST00000374291","STMN1","stathmin 1","ref|Homo sapiens stathmin 1 (STMN1), transcript variant 1, mRNA [NM_203401]","chr1",26226608,26232644,"GO:0004871(signal transducer activity);GO:0005622(intracellular);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005874(microtubule);GO:0007019(microtubule depolymerization);GO:0007052(mitotic spindle organization);GO:0007165(signal transduction);GO:0007409(axonogenesis);GO:0007420(brain development);GO:0009615(response to virus);GO:0015631(tubulin binding);GO:0016020(membrane);GO:0031115(negative regulation of microtubule polymerization);GO:0031175(neuron projection development);GO:0035556(intracellular signal transduction);GO:0043005(neuron projection);GO:0051272(positive regulation of cellular component movement);GO:0051493(regulation of cytoskeleton organization);GO:0070062(extracellular vesicular exosome)","04010(MAPK signaling pathway);05206(MicroRNAs in cancer)","mRNA","agilent G3 V3"]
["A_23_P90484",2.14,2.34,2.27,4.06,4.15,4.08,{"v":0.549227013832384,"d":"0.55"},{"v":-0.864525508434469,"d":"-0.86"},"down",{"v":4.46600000003627e-06,"d":"0.00"},{"v":0.38047193800309,"d":"0.38"},"yes","TTGCTGCCTCAGAGTCAGTCACTGACCCTGTTATCATTGAGGGTCCCAGTGGGAAGCAGG","FALSE","NM_017827","ref|NM_017827|ref|NM_001145901|ens|ENST00000221431|ens|ENST00000594259","SARS2","seryl-tRNA synthetase 2, mitochondrial","ref|Homo sapiens seryl-tRNA synthetase 2, mitochondrial (SARS2), transcript variant 2, mRNA [NM_017827]","chr19",39406044,39440495,"GO:0004828(serine-tRNA ligase activity);GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0006418(tRNA aminoacylation for protein translation);GO:0006434(seryl-tRNA aminoacylation);GO:0010467(gene expression);GO:0097056(selenocysteinyl-tRNA(Sec) biosynthetic process)","00970(Aminoacyl-tRNA biosynthesis)","mRNA","agilent G3 V3"]
["A_23_P97309",{"v":2,"d":"2.00"},{"v":2,"d":"2.00"},2.18,4.61,4.68,4.46,{"v":0.449454545454545,"d":"0.45"},{"v":-1.15375287539501,"d":"-1.15"},"down",{"v":4.47820000004651e-06,"d":"0.00"},{"v":0.381511292603962,"d":"0.38"},"yes","AGTAACGCGTCTTCCTGAGTGGTGCCAAACAAAAAGGTTCTCAGGTGTTGCCAAATATGT","FALSE","NM_001229","ref|NM_001229|ref|NM_032996|ref|NM_001278054|ref|NR_102732","CASP9","caspase 9, apoptosis-related cysteine peptidase","ref|Homo sapiens caspase 9, apoptosis-related cysteine peptidase (CASP9), transcript variant alpha, mRNA [NM_001229]","chr1",15819438,15850695,"GO:0004197(cysteine-type endopeptidase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0006915(apoptotic process);GO:0006974(response to DNA damage stimulus);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007568(aging);GO:0008047(enzyme activator activity);GO:0008233(peptidase activity);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0008630(DNA damage response, signal transduction resulting in induction of apoptosis);GO:0008635(activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c);GO:0017124(SH3 domain binding);GO:0019901(protein kinase binding);GO:0030220(platelet formation);GO:0032025(response to cobalt ion);GO:0032355(response to estradiol stimulus);GO:0032496(response to lipopolysaccharide);GO:0034349(glial cell apoptotic process);GO:0034644(cellular response to UV);GO:0038095(Fc-epsilon receptor signaling pathway);GO:0042770(signal transduction in response to DNA damage);GO:0043065(positive regulation of apoptotic process);GO:0043293(apoptosome);GO:0043525(positive regulation of neuron apoptotic process);GO:0045087(innate immune response);GO:0046677(response to antibiotic);GO:0048011(nerve growth factor receptor signaling pathway);GO:0048015(phosphatidylinositol-mediated signaling);GO:0071549(cellular response to dexamethasone stimulus);GO:0097190(apoptotic signaling pathway);GO:0097193(intrinsic apoptotic signaling pathway);GO:2001020(regulation of response to DNA damage stimulus)","04370(VEGF signaling pathway);04151(PI3K-Akt signaling pathway);04210(Apoptosis);04115(p53 signaling pathway);04919(Thyroid hormone signaling pathway);05200(Pathways in cancer);05210(Colorectal cancer);05212(Pancreatic cancer);05215(Prostate cancer);05213(Endometrial cancer);05222(Small cell lung cancer);05223(Non-small cell lung cancer);05010(Alzheimer's disease);05012(Parkinson's disease);05014(Amyotrophic lateral sclerosis (ALS));05016(Huntington's disease);05416(Viral myocarditis);05134(Legionellosis);05152(Tuberculosis);05164(Influenza A);05161(Hepatitis B);05145(Toxoplasmosis)","mRNA","agilent G3 V3"]
["A_23_P104372",3.56,3.62,3.43,{"v":5.4,"d":"5.40"},5.51,5.52,{"v":0.6457699330493,"d":"0.65"},{"v":-0.63090782403531,"d":"-0.63"},"down",{"v":4.48819999998573e-06,"d":"0.00"},{"v":0.382363222598784,"d":"0.38"},"yes","CCAGTTTACATTTGGTCTTAATGATCTTGAATAGATCCTCTCTTCATTTTACTCAGCCAG","FALSE","NM_015190","ref|NM_015190|ens|ENST00000372950|ens|ENST00000456064|gb|AK094162","DNAJC9","DnaJ (Hsp40) homolog, subfamily C, member 9","ref|Homo sapiens DnaJ (Hsp40) homolog, subfamily C, member 9 (DNAJC9), mRNA [NM_015190]","chr10",75002584,75008620,"GO:0005634(nucleus);GO:0035176(social behavior)",null,"mRNA","agilent G3 V3"]
["A_33_P3849275",12.38,12.37,12.35,{"v":11.5,"d":"11.50"},{"v":11.4,"d":"11.40"},11.48,{"v":1.07911576497964,"d":"1.08"},{"v":0.109849642030105,"d":"0.11"},"up",{"v":4.5016999999925e-06,"d":"0.00"},{"v":0.383513328099361,"d":"0.38"},"yes","AATATTTTAGCCCCCTCAGATGTTCCTGCAGTGCTGAAATTCATCCTACGGAAGTAACCG","FALSE","NM_001159704","ref|NM_001159704|ref|NM_001159702|ref|NM_001449|ref|NM_001159699","FHL1","four and a half LIM domains 1","ref|Homo sapiens four and a half LIM domains 1 (FHL1), transcript variant 4, mRNA [NM_001159704]","chrX",135229552,135293518,"GO:0003254(regulation of membrane depolarization);GO:0003674(molecular_function);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0007517(muscle organ development);GO:0008270(zinc ion binding);GO:0009887(organ morphogenesis);GO:0010972(negative regulation of G2/M transition of mitotic cell cycle);GO:0030154(cell differentiation);GO:0030308(negative regulation of cell growth);GO:0043268(positive regulation of potassium ion transport);GO:0044325(ion channel binding);GO:2000134(negative regulation of G1/S transition of mitotic cell cycle)",null,"mRNA","agilent G3 V3"]
["A_24_P7157",2.17,2.28,2.14,5.35,5.66,5.33,{"v":0.403304773561811,"d":"0.40"},{"v":-1.31005761313763,"d":"-1.31"},"down",{"v":4.6621000000524e-06,"d":"0.00"},{"v":0.397178285304465,"d":"0.40"},"yes","GATGATGTGCTCATTGAGTGAACAAGGGAAGCAGCTAGCTATCCAGGTGTCTAATATCCT","FALSE","NM_020734","ref|NM_020734|ref|NM_001297776|ref|NR_123740|ens|ENST00000299673","RIMKLB","ribosomal modification protein rimK-like family member B","ref|Homo sapiens ribosomal modification protein rimK-like family member B (RIMKLB), transcript variant 1, mRNA [NM_020734]","chr12",{"v":8850518,"d":"8850518.00"},8929787,"GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0006464(cellular protein modification process);GO:0046872(metal ion binding);GO:0072590(N-acetyl-L-aspartate-L-glutamate ligase activity);GO:0072591(citrate-L-glutamate ligase activity)","00250(Alanine, aspartate and glutamate metabolism)","mRNA","agilent G3 V3"]
["A_22_P00003766",1.95,{"v":2.2,"d":"2.20"},1.92,6.29,6.06,{"v":5.9,"d":"5.90"},{"v":0.332602739726027,"d":"0.33"},{"v":-1.58812804239906,"d":"-1.59"},"down",{"v":4.68669999997839e-06,"d":"0.00"},{"v":0.399274033098159,"d":"0.40"},"yes","GGTACTATATATCATTCCTTCAGAGCACTTAACACAGTTATTTCCTATGTATTTGTCCAG","FALSE","ENST00000615852","ens|ENST00000615852|ref|XR_429898|linc|lnc-CDK12-1:5|linc|lnc-CDK12-1:3",null,null,"ref|PREDICTED: Homo sapiens cyclin-dependent kinase 12 (CDK12), transcript variant X6, misc_RNA [XR_429898]","chr17",37723312,37723812,null,null,"mRNA","agilent G3 V3"]
["A_23_P167096",1.99,2.17,1.96,5.91,5.85,6.25,{"v":0.339811215991116,"d":"0.34"},{"v":-1.55719462321362,"d":"-1.56"},"down",{"v":4.73209999996005e-06,"d":"0.00"},{"v":0.403141795296596,"d":"0.40"},"yes","TTTCTGCCAATGACCAAACAGCCAAGATTTTCCTCTTGTGATTTCTTTAAAAGAATGACT","FALSE","NM_005429","ref|NM_005429|ens|ENST00000618562|gb|U58111|gb|U43142","VEGFC","vascular endothelial growth factor C","ref|Homo sapiens vascular endothelial growth factor C (VEGFC), mRNA [NM_005429]","chr4",177604688,177713881,"GO:0001525(angiogenesis);GO:0001954(positive regulation of cell-matrix adhesion);GO:0002052(positive regulation of neuroblast proliferation);GO:0002576(platelet degranulation);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006929(substrate-dependent cell migration);GO:0007165(signal transduction);GO:0007596(blood coagulation);GO:0008083(growth factor activity);GO:0008284(positive regulation of cell proliferation);GO:0008285(negative regulation of cell proliferation);GO:0009887(organ morphogenesis);GO:0016020(membrane);GO:0016331(morphogenesis of embryonic epithelium);GO:0030168(platelet activation);GO:0030947(regulation of vascular endothelial growth factor receptor signaling pathway);GO:0031093(platelet alpha granule lumen);GO:0031954(positive regulation of protein autophosphorylation);GO:0042056(chemoattractant activity);GO:0042493(response to drug);GO:0043185(vascular endothelial growth factor receptor 3 binding);GO:0043536(positive regulation of blood vessel endothelial cell migration);GO:0045766(positive regulation of angiogenesis);GO:0045776(negative regulation of blood pressure);GO:0048010(vascular endothelial growth factor receptor signaling pathway);GO:0050679(positive regulation of epithelial cell proliferation);GO:0050714(positive regulation of protein secretion);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0050918(positive chemotaxis);GO:0050930(induction of positive chemotaxis);GO:0051781(positive regulation of cell division);GO:0060754(positive regulation of mast cell chemotaxis)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04668(TNF signaling pathway);04151(PI3K-Akt signaling pathway);04060(Cytokine-cytokine receptor interaction);04510(Focal adhesion);05200(Pathways in cancer)","mRNA","agilent G3 V3"]
["A_32_P52330",14.09,14.18,14.12,13.07,13.04,13.13,{"v":1.0802752293578,"d":"1.08"},{"v":0.111398924835857,"d":"0.11"},"up",{"v":4.79679999998428e-06,"d":"0.00"},{"v":0.408653782398661,"d":"0.41"},"yes","TTTGTGAAATTGACCAGCCCCCTCTATAAAACTTACAGTCCCCCATTGGGAAACTGACCA","FALSE","NM_001291291","ref|NM_001291291|ref|NR_111941|ens|ENST00000269720|ens|ENST00000591982","LOC113230","uncharacterized protein LOC113230","ref|Homo sapiens uncharacterized protein LOC113230 (LOC113230), transcript variant 1, mRNA [NM_001291291]","chr19",14183348,14185873,null,null,"mRNA","agilent G3 V3"]
["A_23_P74359",2.35,2.46,2.79,{"v":6.9,"d":"6.90"},6.85,7.13,{"v":0.363984674329502,"d":"0.36"},{"v":-1.45805038823894,"d":"-1.46"},"down",{"v":4.8075999999897e-06,"d":"0.00"},{"v":0.409573866799122,"d":"0.41"},"yes","CCTGAAACATATATTGGCATTTATCAATGGCTCAAATCTTCATTTATCTCTGGCCTTAAC","FALSE","NM_004078","ref|NM_004078|ref|NM_001193571|ref|NM_001193570|ref|NM_001193572","CSRP1","cysteine and glycine-rich protein 1","ref|Homo sapiens cysteine and glycine-rich protein 1 (CSRP1), transcript variant 1, mRNA [NM_004078]","chr1",201452656,201476387,"GO:0005634(nucleus);GO:0005925(focal adhesion);GO:0008270(zinc ion binding);GO:0070062(extracellular vesicular exosome);GO:0070527(platelet aggregation)",null,"mRNA","agilent G3 V3"]
["A_33_P3225843",2.25,2.41,2.34,{"v":5.3,"d":"5.30"},4.99,5.15,{"v":0.453367875647668,"d":"0.45"},{"v":-1.14124592543575,"d":"-1.14"},"down",{"v":4.89709999995647e-06,"d":"0.00"},{"v":0.417198640296291,"d":"0.42"},"yes","TGCAAACTGTGAATATTCTGATGATGCCAGTACAGTTTGATTTATTAAATGTAGGTCCTC","FALSE","NM_173463","ref|NM_173463|ref|NM_001130726|ens|ENST00000504487|ref|XM_005248210","CCDC149","coiled-coil domain containing 149","ref|Homo sapiens coiled-coil domain containing 149 (CCDC149), transcript variant 1, mRNA [NM_173463]","chr4",24809392,24914580,null,null,"mRNA","agilent G3 V3"]
["A_23_P146058",2.07,2.15,2.03,4.26,{"v":4.5,"d":"4.50"},{"v":4.3,"d":"4.30"},{"v":0.478560490045942,"d":"0.48"},{"v":-1.06322680199698,"d":"-1.06"},"down",{"v":1.51116000000062e-05,"d":"0.00"},1,"yes","ACCATCTTCAGGTATGGGATTTCTGAACGTTTCAAATTTCAATCAATGAGCACTGTCAAC","FALSE","NM_001695","ref|NM_001695|ens|ENST00000518738|ens|ENST00000395862|gb|BC010960","ATP6V1C1","ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1","ref|Homo sapiens ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1 (ATP6V1C1), mRNA [NM_001695]","chr8",104076784,104081053,"GO:0005215(transporter activity);GO:0005515(protein binding);GO:0005765(lysosomal membrane);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006879(cellular iron ion homeostasis);GO:0008286(insulin receptor signaling pathway);GO:0008553(hydrogen-exporting ATPase activity, phosphorylative mechanism);GO:0015991(ATP hydrolysis coupled proton transport);GO:0015992(proton transport);GO:0016469(proton-transporting two-sector ATPase complex);GO:0031410(cytoplasmic vesicle);GO:0033180(proton-transporting V-type ATPase, V1 domain);GO:0033572(transferrin transport);GO:0045177(apical part of cell);GO:0046961(proton-transporting ATPase activity, rotational mechanism);GO:0051701(interaction with host);GO:0055085(transmembrane transport);GO:0070062(extracellular vesicular exosome);GO:0090382(phagosome maturation)","00190(Oxidative phosphorylation);04145(Phagosome);04966(Collecting duct acid secretion);04721(Synaptic vesicle cycle);05323(Rheumatoid arthritis);05110(Vibrio cholerae infection);05120(Epithelial cell signaling in Helicobacter pylori infection)","mRNA","agilent G3 V3"]
["A_33_P3398401",12.86,12.88,12.77,11.83,11.85,11.87,{"v":1.08326300984529,"d":"1.08"},{"v":0.115383563290208,"d":"0.12"},"up",{"v":1.51233999999834e-05,"d":"0.00"},1,"yes","GTCCCCTCACCCAGGCTAAACTTGATACTGTATTATTTTGTTCAATGTAAATTGAAGAAA","FALSE","NM_016302","ref|NM_016302|ref|NM_001173482|ens|ENST00000488263|ens|ENST00000231948","CRBN","cereblon","ref|Homo sapiens cereblon (CRBN), transcript variant 1, mRNA [NM_016302]","chr3",{"v":3192544,"d":"3192544.00"},3196654,"GO:0004176(ATP-dependent peptidase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0016567(protein ubiquitination);GO:0031464(Cul4A-RING ubiquitin ligase complex);GO:0032463(negative regulation of protein homooligomerization);GO:0034766(negative regulation of ion transmembrane transport);GO:0043161(proteasomal ubiquitin-dependent protein catabolic process);GO:0046872(metal ion binding);GO:0090073(positive regulation of protein homodimerization activity)",null,"mRNA","agilent G3 V3"]
["A_23_P143274",1.92,2.14,1.89,5.91,5.55,5.86,{"v":0.343533487297922,"d":"0.34"},{"v":-1.54147735653142,"d":"-1.54"},"down",{"v":1.51425999999066e-05,"d":"0.00"},1,"yes","CGTCATCTCTCTTCTGTACCACTAGAGGGAGCTCTGATGCAGCTGGAGAGCAGCGCTCAA","FALSE","NM_024958","ref|NM_024958|ens|ENST00000621012|ens|ENST00000382291|ref|XM_005260834","NRSN2","neurensin 2","ref|Homo sapiens neurensin 2 (NRSN2), mRNA [NM_024958]","chr20",{"v":330370,"d":"330370.00"},335492,"GO:0003674(molecular_function);GO:0005886(plasma membrane);GO:0008150(biological_process);GO:0016021(integral to membrane);GO:0030133(transport vesicle);GO:0043025(neuronal cell body)",null,"mRNA","agilent G3 V3"]
["A_23_P53018",10.99,11.05,10.96,12.28,12.28,12.17,{"v":0.898448135039477,"d":"0.90"},{"v":-0.154492871598479,"d":"-0.15"},"down",{"v":1.52011999999813e-05,"d":"0.00"},1,"yes","TGCTTCCTTCCCTTGCCTTCTCTCAATGGCTCCGATTAAGAAAATTGTGAACTTCTGGAA","FALSE","NM_054108","ref|NM_054108|ref|NM_001146729|ref|NM_001146728|ens|ENST00000301790","HRASLS5","HRAS-like suppressor family, member 5","ref|Homo sapiens HRAS-like suppressor family, member 5 (HRASLS5), transcript variant 1, mRNA [NM_054108]","chr11",63230948,63258437,"GO:0008152(metabolic process);GO:0016746(transferase activity, transferring acyl groups)",null,"mRNA","agilent G3 V3"]
["A_24_P139943",2.13,2.23,{"v":2.1,"d":"2.10"},4.58,4.81,4.86,{"v":0.453333333333333,"d":"0.45"},{"v":-1.14135584924554,"d":"-1.14"},"down",{"v":1.52716999999303e-05,"d":"0.00"},1,"yes","GGGCACAGAGCCAATGTTCGTCATTGCAGCTCTCAGCAAACTGGGTCATAGCTTTCCCCA","FALSE","NM_022460","ref|NM_022460|ens|ENST00000304031|gb|AK024311|gb|BC050636","HS1BP3","HCLS1 binding protein 3","ref|Homo sapiens HCLS1 binding protein 3 (HS1BP3), mRNA [NM_022460]","chr2",20817582,20850849,"GO:0035091(phosphatidylinositol binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3258339",{"v":10.3,"d":"10.30"},10.51,10.45,8.62,8.54,{"v":8.6,"d":"8.60"},{"v":1.21350931677019,"d":"1.21"},{"v":0.279185184885048,"d":"0.28"},"up",{"v":1.52775999999744e-05,"d":"0.00"},1,"yes","TCATGGCCTTCCCCAAAGACTTGTGGAAATGGGCACATGGCTGGAGGTACTGTAAGCCTG","FALSE","NM_001113567","ref|NM_001113567|ref|NM_207387|ens|ENST00000409887|ens|ENST00000470794","LRRC75A","leucine rich repeat containing 75A","ref|Homo sapiens leucine rich repeat containing 75A (LRRC75A), transcript variant 1, mRNA [NM_001113567]","chr17",16346575,16395332,null,null,"mRNA","agilent G3 V3"]
["A_33_P3311770",{"v":2.9,"d":"2.90"},3.07,2.94,4.79,4.67,4.79,{"v":0.625263157894737,"d":"0.63"},{"v":-0.677464582417544,"d":"-0.68"},"down",{"v":1.53081999999527e-05,"d":"0.00"},1,"yes","GGAGAACTAGAACTTATAAACCTCTACTTCAAGTGTGTATCACGTAATTGTTTCCATGAA","FALSE","NM_213603","ref|NM_213603|ens|ENST00000331410|ref|XM_006715930|ref|XM_005250281","ZNF789","zinc finger protein 789","ref|Homo sapiens zinc finger protein 789 (ZNF789), transcript variant 1, mRNA [NM_213603]","chr7",99081280,99084627,"GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P408455",2.39,2.69,{"v":2.4,"d":"2.40"},5.25,5.36,5.31,{"v":0.469849246231156,"d":"0.47"},{"v":-1.08973016065601,"d":"-1.09"},"down",{"v":1.5422499999973e-05,"d":"0.00"},1,"yes","CCATTAACCTACACACTGATTTTTATGCTACTCCTTGTAGAAACAAAATTCTGGTTTGAC","FALSE","NM_001104647","ref|NM_001104647|ref|NM_018155|ens|ENST00000446041|ref|XM_005247575","SLC25A36","solute carrier family 25 (pyrimidine nucleotide carrier), member 36","ref|Homo sapiens solute carrier family 25 (pyrimidine nucleotide carrier), member 36 (SLC25A36), transcript variant 1, mRNA [NM_001104647]","chr3",140660672,140698775,"GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0006864(pyrimidine nucleotide transport);GO:0007005(mitochondrion organization);GO:0015218(pyrimidine nucleotide transmembrane transporter activity);GO:0016021(integral to membrane);GO:0032355(response to estradiol stimulus);GO:0051881(regulation of mitochondrial membrane potential);GO:0055085(transmembrane transport)",null,"mRNA","agilent G3 V3"]
["A_23_P203406",5.24,5.27,5.32,7.47,7.26,7.25,{"v":0.720200181983621,"d":"0.72"},{"v":-0.47353013081205,"d":"-0.47"},"down",{"v":1.544819999999e-05,"d":"0.00"},1,"yes","CCTTTGAGGGGCACTTAAGATGGAGAAATCAGTTGTGGTTTCAGTGAATCATGGTCACCT","FALSE","NM_198335","ref|NM_198335|ref|NM_198334|ref|NM_001278194|ref|NM_001278192","GANAB","glucosidase, alpha; neutral AB","ref|Homo sapiens glucosidase, alpha; neutral AB (GANAB), transcript variant 3, mRNA [NM_198335]","chr11",62393204,62394242,"GO:0005788(endoplasmic reticulum lumen);GO:0005794(Golgi apparatus);GO:0006457(protein folding);GO:0016020(membrane);GO:0017177(glucosidase II complex);GO:0018279(protein N-linked glycosylation via asparagine);GO:0030246(carbohydrate binding);GO:0033919(glucan 1,3-alpha-glucosidase activity);GO:0042470(melanosome);GO:0043687(post-translational protein modification);GO:0044267(cellular protein metabolic process);GO:0070062(extracellular vesicular exosome)","00510(N-Glycan biosynthesis);04141(Protein processing in endoplasmic reticulum)","mRNA","agilent G3 V3"]
["A_32_P514790",2.86,3.13,2.89,5.78,{"v":5.8,"d":"5.80"},5.98,{"v":0.505694760820045,"d":"0.51"},{"v":-0.983661263185252,"d":"-0.98"},"down",{"v":1.54597999999506e-05,"d":"0.00"},1,"yes","AGCACGAAAGGGCTTTCAATGAATTAAGTGAAAACTTTTTCCTTTTTTACAAAAATGCAA","FALSE","NM_001080419","ref|NM_001080419|ens|ENST00000589666|ref|XM_006722144|ref|XM_006722145","UNK","unkempt family zinc finger","ref|Homo sapiens unkempt family zinc finger (UNK), transcript variant 1, mRNA [NM_001080419]","chr17",73780680,73821886,"GO:0008270(zinc ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P72387",1.95,2.02,2.06,4.36,{"v":4.1,"d":"4.10"},4.26,{"v":0.474056603773585,"d":"0.47"},{"v":-1.07686876338427,"d":"-1.08"},"down",{"v":1.55045999999937e-05,"d":"0.00"},1,"yes","AGTAAAAATTTTATGAAAAGAAACTTGCAAGGAAAATCCTAGTTTTCAGTCCACTCGCCC","FALSE","NM_001134647","ref|NM_001134647|ref|NM_198595|ens|ENST00000420658|ens|ENST00000358461","AFAP1","actin filament associated protein 1","ref|Homo sapiens actin filament associated protein 1 (AFAP1), transcript variant A, mRNA [NM_001134647]","chr4",{"v":7760442,"d":"7760442.00"},7941653,"GO:0003779(actin binding);GO:0005737(cytoplasm);GO:0005925(focal adhesion);GO:0009966(regulation of signal transduction);GO:0015629(actin cytoskeleton);GO:0051493(regulation of cytoskeleton organization)",null,"mRNA","agilent G3 V3"]
["A_24_P117138",5.07,5.18,5.21,{"v":6.7,"d":"6.70"},6.58,6.65,{"v":0.775715002508781,"d":"0.78"},{"v":-0.366401390914211,"d":"-0.37"},"down",{"v":1.55092999999384e-05,"d":"0.00"},1,"yes","ATGTTAGAGAACTACAGTAACCTGGTCTTCCTTGGTATTACTGTTTCTAAGCCAGACCTG","FALSE","NM_145297","ref|NM_145297|ens|ENST00000595094|ens|ENST00000291750|ens|ENST00000589903","ZNF626","zinc finger protein 626","ref|Homo sapiens zinc finger protein 626 (ZNF626), transcript variant 2, mRNA [NM_145297]","chrHG730_PATCH",20730870,20772402,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3245665",7.16,7.07,6.97,5.42,{"v":5.5,"d":"5.50"},5.46,{"v":1.29426129426129,"d":"1.29"},{"v":0.372128907809553,"d":"0.37"},"up",{"v":1.56046999999493e-05,"d":"0.00"},1,"yes","TCTGACAGTGACCAGTGCCCATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGA","FALSE","ENST00000390394","ens|ENST00000390394|ens|ENST00000622053|ens|ENST00000379435|gb|AY611541",null,null,"ens|T cell receptor beta variable 20-1 [Source:HGNC Symbol;Acc:HGNC:12196] [ENST00000390394]","chr9",33617760,33618504,null,null,"mRNA","agilent G3 V3"]
["A_24_P408457",2.16,2.26,2.27,4.17,4.22,4.39,{"v":0.523474178403756,"d":"0.52"},{"v":-0.933809720305534,"d":"-0.93"},"down",{"v":1.5621099999974e-05,"d":"0.00"},1,"yes","CTGAGGTCCTTGTATTTAGGGTATGGTGTAAAAACTTACATATGCACATTTTGTTACATC","FALSE","NM_000262","ref|NM_000262|ens|ENST00000396398|ref|XM_005261615|ref|XM_005261616","NAGA","N-acetylgalactosaminidase, alpha-","ref|Homo sapiens N-acetylgalactosaminidase, alpha- (NAGA), mRNA [NM_000262]","chr22",42454360,42466834,"GO:0004557(alpha-galactosidase activity);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0008456(alpha-N-acetylgalactosaminidase activity);GO:0009311(oligosaccharide metabolic process);GO:0016052(carbohydrate catabolic process);GO:0016139(glycoside catabolic process);GO:0019377(glycolipid catabolic process);GO:0042803(protein homodimerization activity);GO:0046477(glycosylceramide catabolic process);GO:0070062(extracellular vesicular exosome)","00603(Glycosphingolipid biosynthesis - globo series);04142(Lysosome)","mRNA","agilent G3 V3"]
["A_23_P20832",6.23,6.29,5.96,9.42,9.57,9.68,{"v":0.644576212068364,"d":"0.64"},{"v":-0.633577147824466,"d":"-0.63"},"down",{"v":1.57008999999153e-05,"d":"0.00"},1,"yes","TTGGAATAAGACTTAGGAGAAAATGGTGCTTCACTAACCCGCTTCCGGTCCAGTCACAAT","FALSE","NM_003127","ref|NM_003127|ref|NM_001130438|ref|NM_001195532|ens|ENST00000372739","SPTAN1","spectrin, alpha, non-erythrocytic 1","ref|Homo sapiens spectrin, alpha, non-erythrocytic 1 (SPTAN1), transcript variant 2, mRNA [NM_003127]","chr9",131314864,131395938,"GO:0003779(actin binding);GO:0005200(structural constituent of cytoskeleton);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005829(cytosol);GO:0005916(fascia adherens);GO:0006915(apoptotic process);GO:0006921(cellular component disassembly involved in apoptotic process);GO:0007411(axon guidance);GO:0008091(spectrin);GO:0015630(microtubule cytoskeleton);GO:0016020(membrane);GO:0016328(lateral plasma membrane);GO:0030018(Z disc);GO:0030507(spectrin binding);GO:0031982(vesicle);GO:0032437(cuticular plate);GO:0043231(intracellular membrane-bounded organelle);GO:0046982(protein heterodimerization activity);GO:0051693(actin filament capping);GO:0070062(extracellular vesicular exosome)","04530(Tight junction)","mRNA","agilent G3 V3"]
["A_33_P3280213",6.33,{"v":6.3,"d":"6.30"},{"v":6.4,"d":"6.40"},7.38,7.31,7.38,{"v":0.862256456728591,"d":"0.86"},{"v":-0.213811068005592,"d":"-0.21"},"down",{"v":1.57022999999201e-05,"d":"0.00"},1,"yes","TGGCCTCAACATCTACAATCTCTATGCCCCGTGTGCTGGAGGGGTGCCCAGCCATTTTAG","FALSE","NM_001127695","ref|NM_001127695|ref|NM_000308|ref|NM_001167594|ens|ENST00000372459","CTSA","cathepsin A","ref|Homo sapiens cathepsin A (CTSA), transcript variant 2, mRNA [NM_001127695]","chr20",44522628,44523889,"GO:0004180(carboxypeptidase activity);GO:0004185(serine-type carboxypeptidase activity);GO:0005654(nucleoplasm);GO:0005764(lysosome);GO:0005783(endoplasmic reticulum);GO:0006488(dolichol-linked oligosaccharide biosynthetic process);GO:0006508(proteolysis);GO:0006665(sphingolipid metabolic process);GO:0006687(glycosphingolipid metabolic process);GO:0006886(intracellular protein transport);GO:0008047(enzyme activator activity);GO:0016020(membrane);GO:0018279(protein N-linked glycosylation via asparagine);GO:0043085(positive regulation of catalytic activity);GO:0043202(lysosomal lumen);GO:0043231(intracellular membrane-bounded organelle);GO:0043687(post-translational protein modification);GO:0044267(cellular protein metabolic process);GO:0044281(small molecule metabolic process);GO:0070062(extracellular vesicular exosome)","04142(Lysosome);04614(Renin-angiotensin system)","mRNA","agilent G3 V3"]
["A_24_P101391",5.69,5.91,{"v":5.9,"d":"5.90"},8.13,{"v":8.3,"d":"8.30"},8.17,{"v":0.711382113821138,"d":"0.71"},{"v":-0.491303393506911,"d":"-0.49"},"down",{"v":1.57315999999019e-05,"d":"0.00"},1,"yes","CATTATAGACGCTATCCACGTCGTGGTCCTCCACGCAATTACCAGCAAAATTACCAGAAT","FALSE","NM_004559","ref|NM_004559|ens|ENST00000444752|ens|ENST00000467957|ens|ENST00000332220","YBX1","Y box binding protein 1","ref|Homo sapiens Y box binding protein 1 (YBX1), mRNA [NM_004559]","chr1",43147904,43169474,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000398(nuclear mRNA splicing, via spliceosome);GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0001077(RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription);GO:0001701(in utero embryonic development);GO:0003677(DNA binding);GO:0003690(double-stranded DNA binding);GO:0003697(single-stranded DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005689(U12-type spliceosomal complex);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-dependent);GO:0006366(transcription from RNA polymerase II promoter);GO:0008380(RNA splicing);GO:0010467(gene expression);GO:0010494(cytoplasmic stress granule);GO:0030529(ribonucleoprotein complex);GO:0031965(nuclear membrane);GO:0043231(intracellular membrane-bounded organelle);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0051154(negative regulation of striated muscle cell differentiation);GO:0051781(positive regulation of cell division);GO:0070062(extracellular vesicular exosome);GO:0070934(CRD-mediated mRNA stabilization);GO:0070937(CRD-mediated mRNA stability complex);GO:0071204(histone pre-mRNA 3'end processing complex)",null,"mRNA","agilent G3 V3"]
["A_23_P75097",11.04,11.01,10.87,12.43,12.49,12.45,{"v":0.880920524484881,"d":"0.88"},{"v":-0.182916227959119,"d":"-0.18"},"down",{"v":1.57323999999681e-05,"d":"0.00"},1,"yes","GCTGAAGCAGCAAGATCACTTGAGCCCAGGAGTTTAAGACCAGCCTGGGCAACATAGCAA","FALSE","NM_024895","ref|NM_024895|ens|ENST00000370215|gb|AK026862|gb|BC005129","PDZD7","PDZ domain containing 7","ref|Homo sapiens PDZ domain containing 7 (PDZD7), transcript variant 2, mRNA [NM_024895]","chr10",102777088,102790914,"GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005929(cilium)",null,"mRNA","agilent G3 V3"]
["A_23_P58102",1.97,{"v":2.1,"d":"2.10"},2.06,4.75,4.66,4.98,{"v":0.425990271021543,"d":"0.43"},{"v":-1.23110761304952,"d":"-1.23"},"down",{"v":1.57626999999216e-05,"d":"0.00"},1,"yes","CACTGCTGGGTTCTCTATGTGGATGTGCTGCTTCTGGAATGTGGTGGAAATTTGTTTGAT","FALSE","NM_015004","ref|NM_015004|ref|NR_023353|ens|ENST00000482004|ens|ENST00000468667","EXOSC7","exosome component 7","ref|Homo sapiens exosome component 7 (EXOSC7), transcript variant 1, mRNA [NM_015004]","chr3",45016732,45054158,"GO:0000175(3'-5'-exoribonuclease activity);GO:0000178(exosome (RNase complex));GO:0000288(nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay);GO:0003723(RNA binding);GO:0004532(exoribonuclease activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006364(rRNA processing);GO:0006401(RNA catabolic process);GO:0010467(gene expression);GO:0043928(exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay)","03018(RNA degradation)","mRNA","agilent G3 V3"]
["A_23_P78122",4.61,4.84,4.75,7.33,7.31,7.54,{"v":0.640216411181244,"d":"0.64"},{"v":-0.643368435769665,"d":"-0.64"},"down",{"v":1.58056999999268e-05,"d":"0.00"},1,"yes","TTGGGGTTGAGGACTTGTGATCAGAAAAACTGAAGATGGAAGTTTTGGCCGGTGCTCATT","FALSE","NM_078471","ref|NM_078471|ref|NM_203318|ref|NM_004740|ens|ENST00000530254","MYO18A","myosin XVIIIA","ref|Homo sapiens myosin XVIIIA (MYO18A), transcript variant 1, mRNA [NM_078471]","chr17",27400536,27418537,"GO:0000139(Golgi membrane);GO:0003677(DNA binding);GO:0003774(motor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005802(trans-Golgi network);GO:0006259(DNA metabolic process);GO:0007030(Golgi organization);GO:0016020(membrane);GO:0016459(myosin complex);GO:0016477(cell migration);GO:0016887(ATPase activity);GO:0031032(actomyosin structure organization);GO:0042641(actomyosin);GO:0043066(negative regulation of apoptotic process);GO:0043531(ADP binding);GO:0048194(Golgi vesicle budding);GO:0050714(positive regulation of protein secretion);GO:0051015(actin filament binding)",null,"mRNA","agilent G3 V3"]
["A_23_P419624",2.94,3.03,2.79,5.12,5.19,5.04,{"v":0.570684039087948,"d":"0.57"},{"v":-0.809235880656368,"d":"-0.81"},"down",{"v":1.58638999999683e-05,"d":"0.00"},1,"yes","TTTTGAGGTTTAGCAATAGCTAGCTATATATGGTAGGTGCCGCTACAGTTTTTATTTAGC","FALSE","NM_006698","ref|NM_006698|ref|NM_001167820|ref|NM_001167823|ref|NM_001167822","BLCAP","bladder cancer associated protein","ref|Homo sapiens bladder cancer associated protein (BLCAP), transcript variant 1, mRNA [NM_006698]","chr20",36145820,36156333,"GO:0005515(protein binding);GO:0007049(cell cycle);GO:0016021(integral to membrane);GO:0030262(apoptotic nuclear change)",null,"mRNA","agilent G3 V3"]
["A_24_P256552",1.93,{"v":2,"d":"2.00"},1.92,4.22,4.48,4.49,{"v":0.443517816527672,"d":"0.44"},{"v":-1.17293603478078,"d":"-1.17"},"down",{"v":1.5914099999903e-05,"d":"0.00"},1,"yes","GGTGGTTTTTAGTTTAATTTTTCTTTTCTAGCTTCCCATCGACGGTCAGTGCGCACGTTG","FALSE","NM_001033505","ref|NM_001033505|ref|NM_001033506|ens|ENST00000526480|ens|ENST00000524556","CSTF3","cleavage stimulation factor, 3' pre-RNA, subunit 3, 77kDa","ref|Homo sapiens cleavage stimulation factor, 3' pre-RNA, subunit 3, 77kDa (CSTF3), transcript variant 2, mRNA [NM_001033505]","chr11",33163154,33183041,"GO:0000398(nuclear mRNA splicing, via spliceosome);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006366(transcription from RNA polymerase II promoter);GO:0006369(termination of RNA polymerase II transcription);GO:0006378(mRNA polyadenylation);GO:0006379(mRNA cleavage);GO:0008380(RNA splicing);GO:0010467(gene expression);GO:0031124(mRNA 3'-end processing)","03015(mRNA surveillance pathway)","mRNA","agilent G3 V3"]
["A_33_P3366064",1.94,1.93,2.14,4.38,4.28,4.48,{"v":0.45738203957382,"d":"0.46"},{"v":-1.12852837961114,"d":"-1.13"},"down",{"v":1.59777999999555e-05,"d":"0.00"},1,"yes","AACAACCCTGCCTTTGGCTTTGTGAGCTCCGAGCCAGGGGATCCAGAGAAAGACACCAAG","FALSE","NM_199181","ref|NM_199181|ens|ENST00000279034|gb|AB527119|gb|BC148414","SOGA1","suppressor of glucose, autophagy associated 1","ref|Homo sapiens suppressor of glucose, autophagy associated 1 (SOGA1), transcript variant 2, mRNA [NM_199181]","chr20",35412184,35444684,"GO:0003674(molecular_function);GO:0005615(extracellular space);GO:0008286(insulin receptor signaling pathway);GO:0010506(regulation of autophagy);GO:0045721(negative regulation of gluconeogenesis);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P373031",{"v":14.7,"d":"14.70"},14.72,14.69,{"v":13.6,"d":"13.60"},13.64,13.73,{"v":1.07664144495973,"d":"1.08"},{"v":0.106537867611916,"d":"0.11"},"up",{"v":1.59918000000037e-05,"d":"0.00"},1,"yes","TGTAGCCCCCTCACCTTTCTGTTTTCACTTTTGCCAATGTACATCGGGTTTGGTTTTCTT","FALSE","NM_000719","ref|NM_000719|ref|NM_199460|ref|NM_001167625|ref|NM_001129827","CACNA1C","calcium channel, voltage-dependent, L type, alpha 1C subunit","ref|Homo sapiens calcium channel, voltage-dependent, L type, alpha 1C subunit (CACNA1C), transcript variant 18, mRNA [NM_000719]","chr12",{"v":2162729,"d":"2162729.00"},2801325,"GO:0002095(caveolar macromolecular signaling complex);GO:0005245(voltage-gated calcium channel activity);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005891(voltage-gated calcium channel complex);GO:0006112(energy reserve metabolic process);GO:0007204(elevation of cytosolic calcium ion concentration);GO:0007268(synaptic transmission);GO:0007411(axon guidance);GO:0007628(adult walking behavior);GO:0008217(regulation of blood pressure);GO:0008331(high voltage-gated calcium channel activity);GO:0008542(visual learning);GO:0010881(regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion);GO:0014069(postsynaptic density);GO:0016021(integral to membrane);GO:0017156(calcium ion-dependent exocytosis);GO:0019229(regulation of vasoconstriction);GO:0019899(enzyme binding);GO:0030018(Z disc);GO:0030073(insulin secretion);GO:0030252(growth hormone secretion);GO:0034765(regulation of ion transmembrane transport);GO:0035585(calcium-mediated signaling using extracellular calcium source);GO:0042593(glucose homeostasis);GO:0043025(neuronal cell body);GO:0043198(dendritic shaft);GO:0044281(small molecule metabolic process);GO:0046620(regulation of organ growth);GO:0046872(metal ion binding);GO:0050796(regulation of insulin secretion);GO:0051393(alpha-actinin binding);GO:0060083(smooth muscle contraction involved in micturition);GO:0060402(calcium ion transport into cytosol);GO:0070509(calcium ion import);GO:0070588(calcium ion transmembrane transport);GO:0086010(membrane depolarization involved in regulation of action potential);GO:0086064(cell communication by electrical coupling involved in cardiac conduction)","04010(MAPK signaling pathway);04020(Calcium signaling pathway);04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04911(Insulin secretion);04912(GnRH signaling pathway);04921(Oxytocin signaling pathway);04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);04724(Glutamatergic synapse);04727(GABAergic synapse);04725(Cholinergic synapse);04728(Dopaminergic synapse);04726(Serotonergic synapse);04720(Long-term potentiation);04723(Retrograde endocannabinoid signaling);04713(Circadian entrainment);05010(Alzheimer's disease);05031(Amphetamine addiction);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM));04930(Type II diabetes mellitus)","mRNA","agilent G3 V3"]
["A_32_P199252",2.08,2.21,2.07,5.01,5.38,5.19,{"v":0.408215661103979,"d":"0.41"},{"v":-1.29259656277731,"d":"-1.29"},"down",{"v":1.60208999999689e-05,"d":"0.00"},1,"yes","TTGGTCAAAAAATGCTTAGAACTCTTTACAGAACTGGCGGAAGATAAAGAGAACTGCAAG","FALSE","NM_001017963","ref|NM_001017963|ref|NM_005348|ens|ENST00000530115|ens|ENST00000557089","HSP90AA1","heat shock protein 90kDa alpha (cytosolic), class A member 1","ref|Homo sapiens heat shock protein 90kDa alpha (cytosolic), class A member 1 (HSP90AA1), transcript variant 1, mRNA [NM_001017963]","chr11",27911548,27912580,"GO:0000086(G2/M transition of mitotic cell cycle);GO:0000166(nucleotide binding);GO:0000278(mitotic cell cycle);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005576(extracellular region);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006839(mitochondrial transport);GO:0006898(receptor-mediated endocytosis);GO:0006986(response to unfolded protein);GO:0006996(organelle organization);GO:0007165(signal transduction);GO:0007411(axon guidance);GO:0016020(membrane);GO:0016887(ATPase activity);GO:0023026(MHC class II protein complex binding);GO:0030235(nitric-oxide synthase regulator activity);GO:0030911(TPR domain binding);GO:0034605(cellular response to heat);GO:0038096(Fc-gamma receptor signaling pathway involved in phagocytosis);GO:0042026(protein refolding);GO:0042470(melanosome);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0044281(small molecule metabolic process);GO:0045040(protein import into mitochondrial outer membrane);GO:0045087(innate immune response);GO:0045429(positive regulation of nitric oxide biosynthetic process);GO:0046209(nitric oxide metabolic process);GO:0048010(vascular endothelial growth factor receptor signaling pathway);GO:0050999(regulation of nitric-oxide synthase activity);GO:0051082(unfolded protein binding);GO:0051131(chaperone-mediated protein complex assembly);GO:0070062(extracellular vesicular exosome);GO:0071682(endocytic vesicle lumen);GO:1900034(regulation of cellular response to heat)","04141(Protein processing in endoplasmic reticulum);04151(PI3K-Akt signaling pathway);04621(NOD-like receptor signaling pathway);04612(Antigen processing and presentation);04915(Estrogen signaling pathway);04914(Progesterone-mediated oocyte maturation);05200(Pathways in cancer);05215(Prostate cancer)","mRNA","agilent G3 V3"]
["A_33_P3224045",5.96,5.92,5.79,7.78,7.83,7.96,{"v":0.749681798896903,"d":"0.75"},{"v":-0.415649718698551,"d":"-0.42"},"down",{"v":1.6033400000004e-05,"d":"0.00"},1,"yes","GGACGCCTAGGCAAGAGCGGCCCTCTGCAGCCAAGAGAAATAAAATACTGGCTTCCAGAT","FALSE","NM_001348","ref|NM_001348|ens|ENST00000301264|ens|ENST00000545797|ref|XM_005259508","DAPK3","death-associated protein kinase 3","ref|Homo sapiens death-associated protein kinase 3 (DAPK3), mRNA [NM_001348]","chr19",{"v":3958452,"d":"3958452.00"},3969826,"GO:0000910(cytokinesis);GO:0004674(protein serine/threonine kinase activity);GO:0004683(calmodulin-dependent protein kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0006468(protein phosphorylation);GO:0006915(apoptotic process);GO:0006940(regulation of smooth muscle contraction);GO:0007088(regulation of mitosis);GO:0007346(regulation of mitotic cell cycle);GO:0008360(regulation of cell shape);GO:0010506(regulation of autophagy);GO:0016568(chromatin modification);GO:0016605(PML body);GO:0017048(Rho GTPase binding);GO:0017148(negative regulation of translation);GO:0030182(neuron differentiation);GO:0030335(positive regulation of cell migration);GO:0035556(intracellular signal transduction);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0042981(regulation of apoptotic process);GO:0043065(positive regulation of apoptotic process);GO:0043519(regulation of myosin II filament organization);GO:0043522(leucine zipper domain binding);GO:0045121(membrane raft);GO:0046777(protein autophosphorylation);GO:0051893(regulation of focal adhesion assembly);GO:0071346(cellular response to interferon-gamma);GO:0090263(positive regulation of canonical Wnt receptor signaling pathway);GO:0097190(apoptotic signaling pathway);GO:2000145(regulation of cell motility);GO:2000249(regulation of actin cytoskeleton reorganization);GO:2001241(positive regulation of extrinsic apoptotic signaling pathway in absence of ligand)","05200(Pathways in cancer);05219(Bladder cancer)","mRNA","agilent G3 V3"]
["A_33_P3283550",{"v":7.2,"d":"7.20"},7.28,7.41,{"v":5.4,"d":"5.40"},5.39,{"v":5.5,"d":"5.50"},{"v":1.34376918354819,"d":"1.34"},{"v":0.426285350655428,"d":"0.43"},"up",{"v":1.60645999999209e-05,"d":"0.00"},1,"yes","GATTTTTTCTTTCAGACCATCCCCAAATGGGCATTCAGGCCACACAAGAGTCCTCACCCC","FALSE","NM_001282322","ref|NM_001282322|ens|ENST00000463881|ens|ENST00000430154|ens|ENST00000470818","RNF212B","ring finger protein 212B","ref|Homo sapiens ring finger protein 212B (RNF212B), mRNA [NM_001282322]","chr14",23709556,23742611,"GO:0008270(zinc ion binding)",null,"mRNA","agilent G3 V3"]
["A_24_P66528",2.35,2.63,2.36,5.26,5.38,5.19,{"v":0.46367656348705,"d":"0.46"},{"v":-1.10880928729397,"d":"-1.11"},"down",{"v":1.6114899999975e-05,"d":"0.00"},1,"yes","TGGTTCTCAAATATAGGCATTCTGATGGGAACTTGTGTGTTAAAGTAACAGATGATTTAG","FALSE","NM_003133","ref|NM_003133|ref|NM_001130440|ens|ENST00000619790|ens|ENST00000445874","SRP9","signal recognition particle 9kDa","ref|Homo sapiens signal recognition particle 9kDa (SRP9), transcript variant 2, mRNA [NM_003133]","chr1",225965632,225977226,"GO:0003723(RNA binding);GO:0005047(signal recognition particle binding);GO:0005785(signal recognition particle receptor complex);GO:0005786(signal recognition particle, endoplasmic reticulum targeting);GO:0005829(cytosol);GO:0006412(translation);GO:0006614(SRP-dependent cotranslational protein targeting to membrane);GO:0008312(7S RNA binding);GO:0010467(gene expression);GO:0044267(cellular protein metabolic process);GO:0045900(negative regulation of translational elongation);GO:0070062(extracellular vesicular exosome)","03060(Protein export)","mRNA","agilent G3 V3"]
["A_33_P3211404",11.72,11.61,11.63,10.43,10.53,10.47,{"v":1.11231307667833,"d":"1.11"},{"v":0.153562912701847,"d":"0.15"},"up",{"v":1.61316999999217e-05,"d":"0.00"},1,"yes","GGGGTTTCCCCCTCTCTGGTTGTAAAAACAACTTGTGTTTATAGAGTACTTTTTAAAAAT","FALSE","XM_005249853","ref|XM_005249853|gb|AK021529|gb|AK294949|gb|AK095394","FBXL18","F-box and leucine-rich repeat protein 18","ref|PREDICTED: Homo sapiens F-box and leucine-rich repeat protein 18 (FBXL18), transcript variant X1, mRNA [XM_005249853]","chr7",{"v":5528994,"d":"5528994.00"},5553423,null,null,"mRNA","agilent G3 V3"]
["A_23_P218111",10.04,10.12,10.08,9.34,9.28,9.32,{"v":1.0823192555476,"d":"1.08"},{"v":0.11412611881161,"d":"0.11"},"up",{"v":1.61331999999348e-05,"d":"0.00"},1,"yes","TGATTGAACAAAATACCAAGTCTCCCCTCTTCATGGGAAAAGTGGTGAATCCCACCCAAA","FALSE","NM_001002236","ref|NM_001002236|ref|NM_001127701|ref|NM_001127705|ref|NM_001127703","SERPINA1","serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1","ref|Homo sapiens serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 (SERPINA1), transcript variant 2, mRNA [NM_001002236]","chr14",94843088,94857029,"GO:0001666(response to hypoxia);GO:0001948(glycoprotein binding);GO:0002020(protease binding);GO:0002576(platelet degranulation);GO:0004867(serine-type endopeptidase inhibitor activity);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005578(proteinaceous extracellular matrix);GO:0005615(extracellular space);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0006953(acute-phase response);GO:0007596(blood coagulation);GO:0010288(response to lead ion);GO:0010951(negative regulation of endopeptidase activity);GO:0030168(platelet activation);GO:0031093(platelet alpha granule lumen);GO:0032355(response to estradiol stimulus);GO:0032496(response to lipopolysaccharide);GO:0033986(response to methanol);GO:0034014(response to triglyceride);GO:0034097(response to cytokine stimulus);GO:0042802(identical protein binding);GO:0046687(response to chromate);GO:0070062(extracellular vesicular exosome);GO:1900004(negative regulation of serine-type endopeptidase activity)","04610(Complement and coagulation cascades)","mRNA","agilent G3 V3"]
["A_24_P179816",5.82,5.84,5.62,7.84,7.74,7.76,{"v":0.740359897172237,"d":"0.74"},{"v":-0.433701343543879,"d":"-0.43"},"down",{"v":1.61424999999271e-05,"d":"0.00"},1,"yes","CCCACGCTTTGGACCTTATGCAGCTCTACACCCACGTGTCTGAGAACTTGCCACCTTATG","FALSE","NM_024330","ref|NM_024330|ens|ENST00000468044|ens|ENST00000576109|ens|ENST00000483574","SLC27A3","solute carrier family 27 (fatty acid transporter), member 3","ref|Homo sapiens solute carrier family 27 (fatty acid transporter), member 3 (SLC27A3), mRNA [NM_024330]","chr1",153747776,153752630,"GO:0000166(nucleotide binding);GO:0001676(long-chain fatty acid metabolic process);GO:0004467(long-chain fatty acid-CoA ligase activity);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0031957(very long-chain fatty acid-CoA ligase activity);GO:0031966(mitochondrial membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P79069",5.93,5.86,5.98,8.18,7.98,7.95,{"v":0.737038573206139,"d":"0.74"},{"v":-0.440187969573848,"d":"-0.44"},"down",{"v":1.61441999999568e-05,"d":"0.00"},1,"yes","ACAGTGGGGAGTGGAGCTGCTGGTCCCAACCACTCTGGCAGTATGAAGTTGCCCAGTAAA","FALSE","NM_022904","ref|NM_022904|ens|ENST00000602101|ens|ENST00000343625|ref|XR_430149","RASAL3","RAS protein activator like 3","ref|Homo sapiens RAS protein activator like 3 (RASAL3), mRNA [NM_022904]","chr19",15562469,15567410,"GO:0005099(Ras GTPase activator activity);GO:0005737(cytoplasm);GO:0007165(signal transduction);GO:0016020(membrane);GO:0031235(intrinsic to internal side of plasma membrane);GO:0032320(positive regulation of Ras GTPase activity);GO:0046580(negative regulation of Ras protein signal transduction);GO:0070062(extracellular vesicular exosome)","04014(Ras signaling pathway)","mRNA","agilent G3 V3"]
["A_24_P28619",2.31,2.46,2.33,{"v":4.5,"d":"4.50"},4.47,{"v":4.3,"d":"4.30"},{"v":0.535041446872645,"d":"0.54"},{"v":-0.902277440978149,"d":"-0.90"},"down",{"v":1.61571999999222e-05,"d":"0.00"},1,"yes","CCTGAAACCAAATCTCTCAGTCTCAAGTGTTATACTATCCAAGTTTTAAATGGAAAGGTA","FALSE","NM_144567","ref|NM_144567|ref|NM_001300755|ref|NM_001300753|ref|NM_001300757","ANGEL2","angel homolog 2 (Drosophila)","ref|Homo sapiens angel homolog 2 (Drosophila) (ANGEL2), transcript variant 1, mRNA [NM_144567]","chr1",213165520,213189168,null,null,"mRNA","agilent G3 V3"]
["A_33_P3236858",{"v":10.2,"d":"10.20"},10.33,10.18,11.66,11.59,11.67,{"v":0.879438717067583,"d":"0.88"},{"v":-0.185345046653566,"d":"-0.19"},"down",{"v":1.61986999999142e-05,"d":"0.00"},1,"yes","AGGACGTCCTTGCTCCCTGCACCCTCACTGTTCTGTGCACTTTTTCTACCTACATAAACA","FALSE","NM_001042454","ref|NM_001042454|ref|NM_015927|ref|NM_001164719|ens|ENST00000564176","TGFB1I1","transforming growth factor beta 1 induced transcript 1","ref|Homo sapiens transforming growth factor beta 1 induced transcript 1 (TGFB1I1), transcript variant 1, mRNA [NM_001042454]","chr16",31483528,31489281,"GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005622(intracellular);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005925(focal adhesion);GO:0006366(transcription from RNA polymerase II promoter);GO:0007155(cell adhesion);GO:0008270(zinc ion binding);GO:0008285(negative regulation of cell proliferation);GO:0009408(response to heat);GO:0010718(positive regulation of epithelial to mesenchymal transition);GO:0016055(Wnt receptor signaling pathway);GO:0016331(morphogenesis of embryonic epithelium);GO:0016363(nuclear matrix);GO:0030511(positive regulation of transforming growth factor beta receptor signaling pathway);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0030521(androgen receptor signaling pathway);GO:0030579(ubiquitin-dependent SMAD protein catabolic process);GO:0030855(epithelial cell differentiation);GO:0031012(extracellular matrix);GO:0045165(cell fate commitment);GO:0045599(negative regulation of fat cell differentiation);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0048495(Roundabout binding);GO:0050681(androgen receptor binding);GO:0070411(I-SMAD binding)",null,"mRNA","agilent G3 V3"]
["A_23_P500985",{"v":6.3,"d":"6.30"},6.33,6.36,5.54,5.51,5.45,{"v":1.15090909090909,"d":"1.15"},{"v":0.202773881016319,"d":"0.20"},"up",{"v":1.62605999999288e-05,"d":"0.00"},1,"yes","CCGGTCAGCAACGGCCTGTCTCCTCAGGTGATGAGCATCTTGGGCAACCCCAGTGCGGTG","FALSE","NM_013945","ref|NM_013945|ref|NM_002584|ens|ENST00000400661|ens|ENST00000375375","PAX7","paired box 7","ref|Homo sapiens paired box 7 (PAX7), transcript variant 2, mRNA [NM_013945]","chr1",18957500,19062632,"GO:0000983(RNA polymerase II core promoter sequence-specific DNA binding transcription factor activity);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005634(nucleus);GO:0006338(chromatin remodeling);GO:0006366(transcription from RNA polymerase II promoter);GO:0009653(anatomical structure morphogenesis);GO:0010453(regulation of cell fate commitment);GO:0014813(satellite cell commitment);GO:0021527(spinal cord association neuron differentiation);GO:0021904(dorsal/ventral neural tube patterning);GO:0031062(positive regulation of histone methylation);GO:0043066(negative regulation of apoptotic process);GO:0043393(regulation of protein binding);GO:0043403(skeletal muscle tissue regeneration);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048663(neuron fate commitment);GO:0048706(embryonic skeletal system development);GO:0051216(cartilage development);GO:0060415(muscle tissue morphogenesis);GO:2000288(positive regulation of myoblast proliferation)","05202(Transcriptional misregulation in cancers)","mRNA","agilent G3 V3"]
["A_24_P293120",1.87,{"v":2,"d":"2.00"},{"v":1.9,"d":"1.90"},3.48,3.65,3.58,{"v":0.53874883286648,"d":"0.54"},{"v":-0.892315256104774,"d":"-0.89"},"down",{"v":1.63935999999421e-05,"d":"0.00"},1,"yes","GCCTGCACAGAGTGCGGTCAGGACTTTGCTCAGGAAGCAGGGCTGCATCAACACTACATT","FALSE","NM_024327","ref|NM_024327|ref|NM_001145347|ens|ENST00000529930|ens|ENST00000533118","ZNF576","zinc finger protein 576","ref|Homo sapiens zinc finger protein 576 (ZNF576), transcript variant 1, mRNA [NM_024327]","chr19",44100756,44105309,"GO:0000981(sequence-specific DNA binding RNA polymerase II transcription factor activity);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0006366(transcription from RNA polymerase II promoter);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P50418",1.94,2.16,2.03,4.04,3.94,4.08,{"v":0.508291873963516,"d":"0.51"},{"v":-0.976270928209304,"d":"-0.98"},"down",{"v":1.65706999999404e-05,"d":"0.00"},1,"yes","AGAAAGCGAGATACAAGATGATTCATGTATAGTCAGGTACCACATAATCATGTTTCAGCA","FALSE","NM_153358","ref|NM_153358|gb|AK297715|gb|AK298597|gb|AK307775","ZNF791","zinc finger protein 791","ref|Homo sapiens zinc finger protein 791 (ZNF791), mRNA [NM_153358]","chr19",12721731,12740676,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P79587",13.86,13.98,13.98,12.48,{"v":12.6,"d":"12.60"},{"v":12.5,"d":"12.50"},{"v":1.11282597126131,"d":"1.11"},{"v":0.154227995169524,"d":"0.15"},"up",{"v":1.66011999999105e-05,"d":"0.00"},1,"yes","AAGGTCCCTCCCCAGACATCTGGACACTGGGCATAGATTTCTCAAGAAGGAAGACTCCCC","FALSE","ENST00000485563","ens|ENST00000485563|ens|ENST00000392027|gb|AK075432|gb|M14169","ALPP","alkaline phosphatase, placental","ens|alkaline phosphatase, placental [Source:HGNC Symbol;Acc:HGNC:439] [ENST00000485563]","chr2",233245952,233247319,"GO:0000287(magnesium ion binding);GO:0004035(alkaline phosphatase activity);GO:0005886(plasma membrane);GO:0008270(zinc ion binding);GO:0009986(cell surface);GO:0016021(integral to membrane);GO:0016311(dephosphorylation);GO:0031225(anchored to membrane)","00790(Folate biosynthesis)","mRNA","agilent G3 V3"]
["A_33_P3423845",13.82,13.82,13.86,12.56,{"v":12.6,"d":"12.60"},12.71,{"v":1.09585423818326,"d":"1.10"},{"v":0.13205591523723,"d":"0.13"},"up",{"v":1.66390999999377e-05,"d":"0.00"},1,"yes","TTGGTAATTACTTGGCACAAGCCCCTGGAGGTGTTTGCCCCCTCTGTGCTACAGCCCACA","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_33_P3416037",2.08,{"v":2,"d":"2.00"},2.23,5.11,5.08,5.39,{"v":0.405006418485237,"d":"0.41"},{"v":-1.30398332307912,"d":"-1.30"},"down",{"v":1.66521999999114e-05,"d":"0.00"},1,"yes","TATCTGGTTATTATCAGGTTCACGCCAACAGTACCTCATTGCTCTTTGGCGACTCTTATT","FALSE","NM_001014812","ref|NM_001014812|ref|NM_032231|ref|NR_110310|ens|ENST00000559705","FAM96A","family with sequence similarity 96, member A","ref|Homo sapiens family with sequence similarity 96, member A (FAM96A), transcript variant 2, mRNA [NM_001014812]","chr15",64367604,64386056,"GO:0003674(molecular_function);GO:0005575(cellular_component);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0007059(chromosome segregation);GO:0008150(biological_process);GO:0016226(iron-sulfur cluster assembly);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P365719",6.82,6.83,{"v":6.7,"d":"6.70"},8.33,8.46,8.32,{"v":0.810434090003983,"d":"0.81"},{"v":-0.30323323411789,"d":"-0.30"},"down",{"v":1.6688399999909e-05,"d":"0.00"},1,"yes","CGCGTCCCTCTTGTGCGGTTCACCACAGTTGTATTTAAGTGATCGTGTGAGTCGTCGTTA","FALSE","NM_003190","ref|NM_003190|ref|NM_172209|ens|ENST00000551943|ens|ENST00000548408","TAPBP","TAP binding protein (tapasin)","ref|Homo sapiens TAP binding protein (tapasin) (TAPBP), transcript variant 1, mRNA [NM_003190]","chr6",33267472,33282164,"GO:0000139(Golgi membrane);GO:0002474(antigen processing and presentation of peptide antigen via MHC class I);GO:0002479(antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006461(protein complex assembly);GO:0006890(retrograde vesicle-mediated transport, Golgi to ER);GO:0006955(immune response);GO:0015433(peptide antigen-transporting ATPase activity);GO:0015833(peptide transport);GO:0016021(integral to membrane);GO:0019885(antigen processing and presentation of endogenous peptide antigen via MHC class I);GO:0042288(MHC class I protein binding);GO:0042590(antigen processing and presentation of exogenous peptide antigen via MHC class I);GO:0042605(peptide antigen binding);GO:0042824(MHC class I peptide loading complex);GO:0042825(TAP complex);GO:0042886(amide transport);GO:0046978(TAP1 binding);GO:0046979(TAP2 binding);GO:0050823(peptide antigen stabilization);GO:0051082(unfolded protein binding);GO:0071556(integral to lumenal side of endoplasmic reticulum membrane)","04612(Antigen processing and presentation)","mRNA","agilent G3 V3"]
["A_33_P3315600",2.04,2.43,1.99,5.87,5.99,5.85,{"v":0.364765669113495,"d":"0.36"},{"v":-1.45495814205799,"d":"-1.45"},"down",{"v":1.67853999999412e-05,"d":"0.00"},1,"yes","TTCTTTGCCTGTTCAGTTACAGAAAGTGGTGCTCAGTTGTAGAATGTATTGTACCTTTTA","FALSE","NM_003403","ref|NM_003403|ens|ENST00000623799|gb|M76541|gb|M77698","YY1","YY1 transcription factor","ref|Homo sapiens YY1 transcription factor (YY1), mRNA [NM_003403]","chr14",100742536,100744130,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000400(four-way junction DNA binding);GO:0000724(double-strand break repair via homologous recombination);GO:0001078(RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription);GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0003713(transcription coactivator activity);GO:0003714(transcription corepressor activity);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0006351(transcription, DNA-dependent);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0006403(RNA localization);GO:0006974(response to DNA damage stimulus);GO:0007283(spermatogenesis);GO:0008270(zinc ion binding);GO:0009952(anterior/posterior pattern specification);GO:0010225(response to UV-C);GO:0010628(positive regulation of gene expression);GO:0016363(nuclear matrix);GO:0030154(cell differentiation);GO:0031011(Ino80 complex);GO:0031519(PcG protein complex);GO:0034644(cellular response to UV);GO:0034696(response to prostaglandin F stimulus);GO:0044212(transcription regulatory region DNA binding);GO:0048593(camera-type eye morphogenesis);GO:0051276(chromosome organization)",null,"mRNA","agilent G3 V3"]
["A_33_P3239287",8.18,8.28,8.35,10.13,{"v":10,"d":"10.00"},10.17,{"v":0.818811881188119,"d":"0.82"},{"v":-0.288396058467882,"d":"-0.29"},"down",{"v":1.67982000000011e-05,"d":"0.00"},1,"yes","CTGTCCTGATCCCCTCTTCTGTATCAGGTTTATTGGTTGTACATATAAATTATACTTTCC","FALSE","NM_001005271","ref|NM_001005271|ref|NM_001005273|ref|NM_005852|ens|ENST00000330494","CHD3","chromodomain helicase DNA binding protein 3","ref|Homo sapiens chromodomain helicase DNA binding protein 3 (CHD3), transcript variant 3, mRNA [NM_001005271]","chr17",{"v":7812819,"d":"7812819.00"},7816078,"GO:0003677(DNA binding);GO:0004003(ATP-dependent DNA helicase activity);GO:0004386(helicase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0006325(chromatin organization);GO:0006333(chromatin assembly or disassembly);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0007051(spindle organization);GO:0008270(zinc ion binding);GO:0016568(chromatin modification);GO:0016581(NuRD complex);GO:0032508(DNA duplex unwinding);GO:0045111(intermediate filament cytoskeleton);GO:0051297(centrosome organization)",null,"mRNA","agilent G3 V3"]
["A_21_P0000195",1.99,1.98,2.14,5.33,5.04,4.98,{"v":0.398045602605863,"d":"0.40"},{"v":-1.32899437043881,"d":"-1.33"},"down",{"v":1.68012999999245e-05,"d":"0.00"},1,"yes","CCAAGCAAAAAACATTTGTAAGATACACGGTATCTATTTGGAGCAACGGTTTTTGTAACT","FALSE","NM_017782","ref|NM_017782|ens|ENST00000328090|ens|ENST00000459693|gb|AK024762","FAM208B","family with sequence similarity 208, member B","ref|Homo sapiens family with sequence similarity 208, member B (FAM208B), mRNA [NM_017782]","chr10",{"v":5726800,"d":"5726800.00"},5805703,"GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm)",null,"mRNA","agilent G3 V3"]
["A_23_P166491",2.24,2.54,2.21,5.13,5.17,5.25,{"v":0.44951768488746,"d":"0.45"},{"v":-1.15355021964253,"d":"-1.15"},"down",{"v":1.68276999999994e-05,"d":"0.00"},1,"yes","ATTCCCGTCTGGTGCTCTGTAAGACCTTCAGGTTGGATGAAGATGGCAAAGTCCTGACCC","FALSE","NM_015705","ref|NM_015705|ref|NM_001301849|ens|ENST00000470518|ens|ENST00000485962","SGSM3","small G protein signaling modulator 3","ref|Homo sapiens small G protein signaling modulator 3 (SGSM3), transcript variant 1, mRNA [NM_015705]","chr22",40766616,40806293,"GO:0005097(Rab GTPase activator activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0007050(cell cycle arrest);GO:0017137(Rab GTPase binding);GO:0032483(regulation of Rab protein signal transduction);GO:0032486(Rap protein signal transduction);GO:0032851(positive regulation of Rab GTPase activity);GO:0033126(positive regulation of GTP catabolic process);GO:0048227(plasma membrane to endosome transport)",null,"mRNA","agilent G3 V3"]
["A_23_P429020",3.11,3.27,2.96,5.63,5.77,5.78,{"v":0.543655413271246,"d":"0.54"},{"v":-0.879235581428802,"d":"-0.88"},"down",{"v":1.68282999999381e-05,"d":"0.00"},1,"yes","CCAAAGTGGAGACATTCTGTGTGTGATTATGCATGAGACTGTACTGGTAAGACTTGTATC","FALSE","NM_181786","ref|NM_181786|ens|ENST00000392153|ens|ENST00000324411|gb|AK301601","HKR1","HKR1, GLI-Kruppel zinc finger family member","ref|Homo sapiens HKR1, GLI-Kruppel zinc finger family member (HKR1), mRNA [NM_181786]","chr19",37852872,37854831,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0007275(multicellular organismal development);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P103034",7.39,7.34,7.24,6.13,6.11,6.16,{"v":1.19402173913043,"d":"1.19"},{"v":0.255829103478901,"d":"0.26"},"up",{"v":1.68810999999769e-05,"d":"0.00"},1,"yes","ATGACTATCCTTCCCTCCAGGCCATGGGATGGGAAGGCAATGAAGTAGGGTCCTTCCACG","FALSE","NM_001886","ref|NM_001886|ens|ENST00000466315|ens|ENST00000354760|ref|XM_006724140","CRYBA4","crystallin, beta A4","ref|Homo sapiens crystallin, beta A4 (CRYBA4), mRNA [NM_001886]","chr22",27017948,27026605,"GO:0003674(molecular_function);GO:0005212(structural constituent of eye lens);GO:0005575(cellular_component);GO:0007601(visual perception);GO:0043010(camera-type eye development)",null,"mRNA","agilent G3 V3"]
["A_23_P125078",2.07,2.06,2.21,6.43,{"v":7,"d":"7.00"},{"v":6.9,"d":"6.90"},{"v":0.311854402361043,"d":"0.31"},{"v":-1.68105546970533,"d":"-1.68"},"down",{"v":1.69307999999813e-05,"d":"0.00"},1,"yes","TACCTGTCCGTCAGTGTGTGGATGTATGTTTACAGTTCTACATAAATGGGATCATTTTAT","FALSE","NM_173626","ref|NM_173626|ref|NM_001166347|ref|NM_001166348|ref|NM_001166349","SLC26A11","solute carrier family 26 (anion exchanger), member 11","ref|Homo sapiens solute carrier family 26 (anion exchanger), member 11 (SLC26A11), transcript variant 2, mRNA [NM_173626]","chr17",78194272,78226515,"GO:0005765(lysosomal membrane);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0008271(secondary active sulfate transmembrane transporter activity);GO:0008272(sulfate transport);GO:0008509(anion transmembrane transporter activity);GO:0015301(anion:anion antiporter activity);GO:0016021(integral to membrane);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P30175",2.43,{"v":2.6,"d":"2.60"},2.66,5.09,5.21,5.36,{"v":0.491060025542784,"d":"0.49"},{"v":-1.02602870932921,"d":"-1.03"},"down",{"v":1.70104999999143e-05,"d":"0.00"},1,"yes","TAGTTGAGGCTAGTCTGGAACCTTTCATTAGAGCAATATTTGGTTATTGCACTTCATTTT","FALSE","NM_018695","ref|NM_018695|ref|NM_001253699|ref|NM_001253697|ref|NM_001253701","ERBB2IP","erbb2 interacting protein","ref|Homo sapiens erbb2 interacting protein (ERBB2IP), transcript variant 2, mRNA [NM_018695]","chr5",65222400,65376850,"GO:0005176(ErbB-2 class receptor binding);GO:0005178(integrin binding);GO:0005200(structural constituent of cytoskeleton);GO:0005515(protein binding);GO:0005604(basement membrane);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006605(protein targeting);GO:0007049(cell cycle);GO:0007155(cell adhesion);GO:0007165(signal transduction);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007229(integrin-mediated signaling pathway);GO:0009925(basal plasma membrane);GO:0016049(cell growth);GO:0030054(cell junction);GO:0030056(hemidesmosome);GO:0031965(nuclear membrane);GO:0045104(intermediate filament cytoskeleton organization);GO:0045175(basal protein localization);GO:0045197(establishment or maintenance of epithelial cell apical/basal polarity)","04621(NOD-like receptor signaling pathway)","mRNA","agilent G3 V3"]
["A_24_P12401",1.91,1.97,{"v":1.9,"d":"1.90"},4.28,{"v":4,"d":"4.00"},4.08,{"v":0.467637540453074,"d":"0.47"},{"v":-1.0965373454037,"d":"-1.10"},"down",{"v":1.70472999999616e-05,"d":"0.00"},1,"yes","AGTGTTTTATATACGGTACTTATTTAATATCCCTTTTTAATTAGAAATTAAAACAGTTAA","FALSE","NM_001025366","ref|NM_001025366|ref|NM_001171623|ref|NM_001171624|ref|NM_003376","VEGFA","vascular endothelial growth factor A","ref|Homo sapiens vascular endothelial growth factor A (VEGFA), transcript variant 1, mRNA [NM_001025366]","chr6",43745456,43754176,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0001525(angiogenesis);GO:0001541(ovarian follicle development);GO:0001569(patterning of blood vessels);GO:0001570(vasculogenesis);GO:0001666(response to hypoxia);GO:0001701(in utero embryonic development);GO:0001822(kidney development);GO:0001934(positive regulation of protein phosphorylation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0001968(fibronectin binding);GO:0002042(cell migration involved in sprouting angiogenesis);GO:0002052(positive regulation of neuroblast proliferation);GO:0002053(positive regulation of mesenchymal cell proliferation);GO:0002092(positive regulation of receptor internalization);GO:0002575(basophil chemotaxis);GO:0002576(platelet degranulation);GO:0002687(positive regulation of leukocyte migration);GO:0003007(heart morphogenesis);GO:0003151(outflow tract morphogenesis);GO:0003169(coronary vein morphogenesis);GO:0005125(cytokine activity);GO:0005161(platelet-derived growth factor receptor binding);GO:0005172(vascular endothelial growth factor receptor binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005578(proteinaceous extracellular matrix);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0007399(nervous system development);GO:0007498(mesoderm development);GO:0007595(lactation);GO:0007596(blood coagulation);GO:0008083(growth factor activity);GO:0008201(heparin binding);GO:0008284(positive regulation of cell proliferation);GO:0008360(regulation of cell shape);GO:0009986(cell surface);GO:0010595(positive regulation of endothelial cell migration);GO:0010628(positive regulation of gene expression);GO:0016020(membrane);GO:0030141(secretory granule);GO:0030168(platelet activation);GO:0030224(monocyte differentiation);GO:0030225(macrophage differentiation);GO:0030324(lung development);GO:0030335(positive regulation of cell migration);GO:0030823(regulation of cGMP metabolic process);GO:0030855(epithelial cell differentiation);GO:0030949(positive regulation of vascular endothelial growth factor receptor signaling pathway);GO:0031077(post-embryonic camera-type eye development);GO:0031093(platelet alpha granule lumen);GO:0031334(positive regulation of protein complex assembly);GO:0031954(positive regulation of protein autophosphorylation);GO:0032147(activation of protein kinase activity);GO:0032793(positive regulation of CREB transcription factor activity);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0035148(tube formation);GO:0035767(endothelial cell chemotaxis);GO:0035924(cellular response to vascular endothelial growth factor stimulus);GO:0038033(positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway);GO:0038084(vascular endothelial growth factor signaling pathway);GO:0038091(positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway);GO:0040007(growth);GO:0042056(chemoattractant activity)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04370(VEGF signaling pathway);04066(HIF-1 signaling pathway);04151(PI3K-Akt signaling pathway);04150(mTOR signaling pathway);04060(Cytokine-cytokine receptor interaction);04510(Focal adhesion);05200(Pathways in cancer);05206(MicroRNAs in cancer);05205(Proteoglycans in cancer);05212(Pancreatic cancer);05211(Renal cell carcinoma);05219(Bladder cancer);05323(Rheumatoid arthritis)","mRNA","agilent G3 V3"]
["A_33_P3249439",{"v":6.3,"d":"6.30"},6.33,6.39,7.74,7.78,7.91,{"v":0.811779769526248,"d":"0.81"},{"v":-0.300839708002572,"d":"-0.30"},"down",{"v":1.70656999999297e-05,"d":"0.00"},1,"yes","AATGTGTACTGAGGAGCCGTGTGTCTGCTCCTGGCTGGCCCGGCCTAATAAAGCAGTGTT","FALSE","NM_001185011","ref|NM_001185011|ref|NM_152299|ens|ENST00000420993|ens|ENST00000299821","NCAPH2","non-SMC condensin II complex, subunit H2","ref|Homo sapiens non-SMC condensin II complex, subunit H2 (NCAPH2), transcript variant 3, mRNA [NM_001185011]","chr22",50960952,50961900,"GO:0000278(mitotic cell cycle);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0016020(membrane);GO:0030261(chromosome condensation)",null,"mRNA","agilent G3 V3"]
["A_33_P3262205",5.44,5.16,5.45,{"v":8,"d":"8.00"},7.95,{"v":8.1,"d":"8.10"},{"v":0.667359667359667,"d":"0.67"},{"v":-0.583463596647739,"d":"-0.58"},"down",{"v":1.70764999999351e-05,"d":"0.00"},1,"yes","ATGTCAGTGATCATTGTGGGTGTGGGTGGTGCTGACTTTGAGGCCATGGAGCAGCTGGAC","FALSE","NM_003915","ref|NM_003915|ref|NM_152927|ref|NM_152928|ref|NM_152925","CPNE1","copine I","ref|Homo sapiens copine I (CPNE1), transcript variant 3, mRNA [NM_003915]","chr20",34213968,34252848,"GO:0001786(phosphatidylserine binding);GO:0005215(transporter activity);GO:0005544(calcium-dependent phospholipid binding);GO:0006629(lipid metabolic process);GO:0016192(vesicle-mediated transport);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_21_P0013791",8.55,8.45,8.39,11.46,11.48,11.81,{"v":0.730647482014389,"d":"0.73"},{"v":-0.452752582850726,"d":"-0.45"},"down",{"v":1.71028000000017e-05,"d":"0.00"},1,"yes","TAACATTCACAGCCACGGAGCTAATCATATTTTATATCTTCTTCGAAACCACACTTATCC","FALSE","ENST00000424002","ens|ENST00000424002|ens|ENST00000361381|linc|TCONS_l2_00030350|gb|AF212044",null,null,"ens|MT-ND4 pseudogene 24 [Source:HGNC Symbol;Acc:HGNC:42220] [ENST00000424002]","chrX",125606864,125607264,null,null,"mRNA","agilent G3 V3"]
["A_33_P3372288",11.68,{"v":11.7,"d":"11.70"},11.75,10.49,10.39,10.54,{"v":1.11807765754297,"d":"1.12"},{"v":0.161020395928175,"d":"0.16"},"up",{"v":1.71773999999569e-05,"d":"0.00"},1,"yes","AGTTGTGAGGAGCCTGTTATGGGTTAAATTGTGCCCCCAAATAAAATATGTTGAAGTCCT","FALSE","ENST00000334937","ens|ENST00000334937|gb|BC039609|tc|THC2535361","ZNF81","zinc finger protein 81","ens|zinc finger protein 81 [Source:HGNC Symbol;Acc:HGNC:13156] [ENST00000334937]","chrX",47696344,47747609,"GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3223678",15.44,{"v":15.5,"d":"15.50"},15.51,16.32,16.34,16.26,{"v":0.949509403107114,"d":"0.95"},{"v":-0.0747458072573716,"d":"-0.07"},"down",{"v":1.71991999999843e-05,"d":"0.00"},1,"yes","CCCGACTTCCCTGCCAGCCCCGCCTCCTGGCTGGATGAGGTAGACCACGCTCAGTTCTGA","FALSE","NM_014564","ref|NM_014564|ref|NM_178138|ens|ENST00000619587|ens|ENST00000371748","LHX3","LIM homeobox 3","ref|Homo sapiens LIM homeobox 3 (LHX3), transcript variant 2, mRNA [NM_014564]","chr9",139088096,139096955,"GO:0001076(RNA polymerase II transcription factor binding transcription factor activity);GO:0001890(placenta development);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0006366(transcription from RNA polymerase II promoter);GO:0008045(motor axon guidance);GO:0008270(zinc ion binding);GO:0009887(organ morphogenesis);GO:0021520(spinal cord motor neuron cell fate specification);GO:0021521(ventral spinal cord interneuron specification);GO:0021526(medial motor column neuron differentiation);GO:0021527(spinal cord association neuron differentiation);GO:0021983(pituitary gland development);GO:0030324(lung development);GO:0043066(negative regulation of apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048839(inner ear development)",null,"mRNA","agilent G3 V3"]
["A_24_P694760",2.02,1.87,2.09,5.22,{"v":5.6,"d":"5.60"},5.56,{"v":0.365079365079365,"d":"0.37"},{"v":-1.4537179674429,"d":"-1.45"},"down",{"v":1.72229999999551e-05,"d":"0.00"},1,"yes","TCAACTTTGCCTTGATAATTATTGTAAACACTTTGTTCATTTTTTCTTTTTTATTCACAA","FALSE","NM_178040","ref|NM_178040|ref|NM_001301248|ref|NM_178039|ref|NR_027948","ERC1","ELKS/RAB6-interacting/CAST family member 1","ref|Homo sapiens ELKS/RAB6-interacting/CAST family member 1 (ERC1), transcript variant epsilon, mRNA [NM_178040]","chr12",{"v":1136913,"d":"1136913.00"},1605090,"GO:0000139(Golgi membrane);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-dependent);GO:0007252(I-kappaB phosphorylation);GO:0007275(multicellular organismal development);GO:0008385(IkappaB kinase complex);GO:0015031(protein transport);GO:0017137(Rab GTPase binding);GO:0030165(PDZ domain binding);GO:0042147(retrograde transport, endosome to Golgi);GO:0042734(presynaptic membrane);GO:0043522(leucine zipper domain binding);GO:0045202(synapse);GO:0051092(positive regulation of NF-kappaB transcription factor activity)","04064(NF-kappa B signaling pathway)","mRNA","agilent G3 V3"]
["A_32_P743407",2.46,2.95,2.72,{"v":6.4,"d":"6.40"},6.48,6.35,{"v":0.422776911076443,"d":"0.42"},{"v":-1.24203150526487,"d":"-1.24"},"down",{"v":1.72998999999896e-05,"d":"0.00"},1,"yes","TCTGTTTCCGTTAGGCCACAGACTCTTCACCTGGCTCTGAAGAGCACTCTTACCTCGGTC","FALSE","NM_032569","ref|NM_032569|ens|ENST00000321919|ref|XM_005255637|ref|XM_005255638","GLYR1","glyoxylate reductase 1 homolog (Arabidopsis)","ref|Homo sapiens glyoxylate reductase 1 homolog (Arabidopsis) (GLYR1), mRNA [NM_032569]","chr16",{"v":4853207,"d":"4853207.00"},4854787,"GO:0003677(DNA binding);GO:0004616(phosphogluconate dehydrogenase (decarboxylating) activity);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0006098(pentose-phosphate shunt);GO:0035064(methylated histone residue binding);GO:0051287(NAD binding)",null,"mRNA","agilent G3 V3"]
["A_23_P114164",2.79,2.67,2.79,4.56,4.78,4.64,{"v":0.590128755364807,"d":"0.59"},{"v":-0.760898336242258,"d":"-0.76"},"down",{"v":1.73326999999279e-05,"d":"0.00"},1,"yes","TACAGTGTAACATTGTGTCAACATTTGCAGATTGACTGTATATGACCTTAATCTTTGTGC","FALSE","NM_013444","ref|NM_013444|ens|ENST00000338222|gb|AK001029|gb|AL442081","UBQLN2","ubiquilin 2","ref|Homo sapiens ubiquilin 2 (UBQLN2), mRNA [NM_013444]","chrX",56590024,56593443,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane)","04141(Protein processing in endoplasmic reticulum)","mRNA","agilent G3 V3"]
["A_33_P3237413",3.39,3.52,3.47,6.06,5.75,5.89,{"v":0.586440677966102,"d":"0.59"},{"v":-0.769942916612479,"d":"-0.77"},"down",{"v":1.75052999999981e-05,"d":"0.00"},1,"yes","CTGCATGAATGCAAAATAAGCCATCTACAGCAAGTGATAAGGAAACTGGACAAAAAAGGA","FALSE","AK124190","gb|AK124190|gb|BQ775441|tc|THC2550171",null,null,"gb|Homo sapiens cDNA FLJ42196 fis, clone THYMU2033816. [AK124190]","chr7",99232904,99235544,null,null,"mRNA","agilent G3 V3"]
["A_33_P3370875",{"v":8.7,"d":"8.70"},8.84,{"v":8.8,"d":"8.80"},7.03,7.19,7.03,{"v":1.23952941176471,"d":"1.24"},{"v":0.309792504344088,"d":"0.31"},"up",{"v":1.75067999999001e-05,"d":"0.00"},1,"yes","CATCTGTAATTATGGAAGATGTTTCAATTTATTAAGGCCTTCCCTAGCTTCTCTCAACAA","FALSE","THC2724751","tc|THC2724751",{"$nulls":3},"chr19",40534168,40562116,null,null,"mRNA","agilent G3 V3"]
["A_33_P3421418",2.05,{"v":2.2,"d":"2.20"},2.07,4.29,4.08,4.29,{"v":0.499210110584518,"d":"0.50"},{"v":-1.00228094125124,"d":"-1.00"},"down",{"v":1.75253999999958e-05,"d":"0.00"},1,"yes","TAAAAAACAGGATGAACAAATTGAGCGGTTTGAGAAAATCCTGCAGCATTCAAGTTTGGT","FALSE","ENST00000456556","ens|ENST00000456556|ens|ENST00000612359|ref|XR_427132|ref|XR_251123",null,null,"ens|ankyrin repeat domain 36C [Source:HGNC Symbol;Acc:HGNC:32946] [ENST00000456556]","chr2",97779232,97915936,null,null,"mRNA","agilent G3 V3"]
["A_23_P1638",1.92,2.14,1.89,5.33,5.62,5.73,{"v":0.356714628297362,"d":"0.36"},{"v":-1.48715771524936,"d":"-1.49"},"down",{"v":1.75812999999581e-05,"d":"0.00"},1,"yes","CTTCTGTTAGCTCTGGACTCTTAACACTTAAGTTACTCTTCTGAAATTGCTAGGACCATT","FALSE","NM_031492","ref|NM_031492|ref|NM_001286135|ens|ENST00000525754|ens|ENST00000310046","RBM4B","RNA binding motif protein 4B","ref|Homo sapiens RNA binding motif protein 4B (RBM4B), transcript variant 1, mRNA [NM_031492]","chr11",66433376,66436306,"GO:0000166(nucleotide binding);GO:0005515(protein binding);GO:0005730(nucleolus);GO:0006397(mRNA processing);GO:0006417(regulation of translation);GO:0007623(circadian rhythm);GO:0008270(zinc ion binding);GO:0008380(RNA splicing);GO:0010628(positive regulation of gene expression);GO:0032922(circadian regulation of gene expression);GO:0043153(entrainment of circadian clock by photoperiod)",null,"mRNA","agilent G3 V3"]
["A_23_P253375",1.87,2.04,1.95,6.03,5.97,6.48,{"v":0.317099567099567,"d":"0.32"},{"v":-1.65699218699381,"d":"-1.66"},"down",{"v":1.75973999999579e-05,"d":"0.00"},1,"yes","AGACCCATGTGATTTCTGCTTTCTTCTTTAGCAAGATATTCTGGTTTCTAGATAAGGAAG","FALSE","NM_001913","ref|NM_001913|ref|NM_181500|ref|NM_001202544|ref|NM_001202545","CUX1","cut-like homeobox 1","ref|Homo sapiens cut-like homeobox 1 (CUX1), transcript variant 2, mRNA [NM_001913]","chr7",101917448,101927224,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001205(RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription);GO:0001822(kidney development);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0006351(transcription, DNA-dependent);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0006891(intra-Golgi vesicle-mediated transport);GO:0007275(multicellular organismal development);GO:0030173(integral to Golgi membrane);GO:0030324(lung development);GO:0042491(auditory receptor cell differentiation);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0050775(positive regulation of dendrite morphogenesis)",null,"mRNA","agilent G3 V3"]
["A_23_P31984",7.35,7.28,7.28,6.24,{"v":6.2,"d":"6.20"},6.32,{"v":1.16791044776119,"d":"1.17"},{"v":0.223929656474846,"d":"0.22"},"up",{"v":1.78134999999635e-05,"d":"0.00"},1,"yes","TGGGTCCACCGCTTTGAGTACGAGGAACACGGGCCTTTCTTCCTCTACAGAAGGTGCTTC","FALSE","NM_006687","ref|NM_006687|ens|ENST00000333999|gb|AK314981|gb|BC014610","ACTL7A","actin-like 7A","ref|Homo sapiens actin-like 7A (ACTL7A), mRNA [NM_006687]","chr9",111624600,111626035,"GO:0001673(male germ cell nucleus);GO:0005200(structural constituent of cytoskeleton);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005856(cytoskeleton);GO:0031514(motile cilium);GO:0043234(protein complex)",null,"mRNA","agilent G3 V3"]
["A_24_P391230",2.02,1.88,{"v":2.2,"d":"2.20"},4.59,4.76,4.63,{"v":0.436337625178827,"d":"0.44"},{"v":-1.19648321292519,"d":"-1.20"},"down",{"v":1.78362999999626e-05,"d":"0.00"},1,"yes","TTGTATTAAGTGTCATAATAGCATCAATGTGCACATTACCAGTATAGACTGTTGGAGTTC","FALSE","NM_052954","ref|NM_052954|ens|ENST00000299340|gb|AF401639|gb|AL833200","CYYR1","cysteine/tyrosine-rich 1","ref|Homo sapiens cysteine/tyrosine-rich 1 (CYYR1), mRNA [NM_052954]","chr21",27838528,27945603,"GO:0003674(molecular_function);GO:0008150(biological_process);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P8571",12.37,12.38,12.47,11.59,11.56,11.59,{"v":1.07138744962579,"d":"1.07"},{"v":0.099480301348759,"d":"0.10"},"up",{"v":1.78454999999467e-05,"d":"0.00"},1,"yes","TGTAGCCACCAGTTCATAGGTGCCAAGTCAATAAAGCATTGTCCCCCGTCTCTTATAACT","FALSE","NM_080744","ref|NM_080744|ens|ENST00000275560|ens|ENST00000492979|gb|AJ312755","SSC4D","scavenger receptor cysteine rich family, 4 domains","ref|Homo sapiens scavenger receptor cysteine rich family, 4 domains (SSC4D), mRNA [NM_080744]","chr7",76018648,76039012,"GO:0005044(scavenger receptor activity);GO:0006898(receptor-mediated endocytosis);GO:0016020(membrane);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P105747",{"v":1.9,"d":"1.90"},2.02,1.99,4.56,4.44,4.78,{"v":0.428882438316401,"d":"0.43"},{"v":-1.22134585252676,"d":"-1.22"},"down",{"v":1.78758999999085e-05,"d":"0.00"},1,"yes","GATTTCCGAAGGCTGACAATCGTTTGTGGAATGTAATCTTGATGCCTTGATACTGAGACT","FALSE","NM_018171","ref|NM_018171|ref|NM_001251905|ref|NM_001251904|ens|ENST00000547790","APPL2","adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2","ref|Homo sapiens adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2 (APPL2), transcript variant 1, mRNA [NM_018171]","chr12",105568112,105583818,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0007049(cell cycle);GO:0007165(signal transduction);GO:0008283(cell proliferation);GO:0010008(endosome membrane);GO:0016581(NuRD complex);GO:0031901(early endosome membrane);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_32_P49350",12.66,12.78,12.76,11.71,11.69,11.75,{"v":1.08677098150782,"d":"1.09"},{"v":0.120047948963213,"d":"0.12"},"up",{"v":1.7923099999928e-05,"d":"0.00"},1,"yes","CAGTCCCCACAAGTTGAGAGAGTGTCTCCCCCTCATCATTTTCATAAGGAACAGACTTAA","FALSE","ENST00000458402","ens|ENST00000458402|ens|ENST00000398541|ens|ENST00000479057|ens|ENST00000508013",null,null,"ens|ribosomal protein S4X pseudogene 2 [Source:HGNC Symbol;Acc:HGNC:16563] [ENST00000458402]","chr20",{"v":4610073,"d":"4610073.00"},4610865,null,null,"mRNA","agilent G3 V3"]
["A_23_P32500",1.96,2.06,2.04,6.69,6.48,6.09,{"v":0.314641744548287,"d":"0.31"},{"v":-1.66821800437051,"d":"-1.67"},"down",{"v":1.80228999999699e-05,"d":"0.00"},1,"yes","GTGGTTAGCCGTATCATTGTGTGGGACATCATGGCCTTCAATGGCATCATCCATGCTCTG","FALSE","NM_015136","ref|NM_015136|ens|ENST00000462741|ens|ENST00000321725|ref|XM_005264974","STAB1","stabilin 1","ref|Homo sapiens stabilin 1 (STAB1), mRNA [NM_015136]","chr3",52555584,52557339,"GO:0005041(low-density lipoprotein receptor activity);GO:0005044(scavenger receptor activity);GO:0005515(protein binding);GO:0005540(hyaluronic acid binding);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0006898(receptor-mediated endocytosis);GO:0006954(inflammatory response);GO:0007155(cell adhesion);GO:0007267(cell-cell signaling);GO:0015035(protein disulfide oxidoreductase activity);GO:0016525(negative regulation of angiogenesis);GO:0030169(low-density lipoprotein particle binding);GO:0030666(endocytic vesicle membrane);GO:0042742(defense response to bacterium);GO:0055114(oxidation-reduction process)",null,"mRNA","agilent G3 V3"]
["A_33_P3324086",2.06,1.94,2.41,5.75,5.64,5.69,{"v":0.375292740046838,"d":"0.38"},{"v":-1.41391171300175,"d":"-1.41"},"down",{"v":1.80911999999589e-05,"d":"0.00"},1,"yes","CCTAACAGTAGCTCTGGGATTTTATCGCCTGTGGATCTAATAAAGTGTCTATTTAAAGTG","FALSE","NM_001031713","ref|NM_001031713|ens|ENST00000488770|ens|ENST00000379170|ref|XR_241912","MCUR1","mitochondrial calcium uniporter regulator 1","ref|Homo sapiens mitochondrial calcium uniporter regulator 1 (MCUR1), mRNA [NM_001031713]","chr6",13791020,13814800,"GO:0005515(protein binding);GO:0006851(mitochondrial calcium ion transport);GO:0031305(integral to mitochondrial inner membrane);GO:0051561(elevation of mitochondrial calcium ion concentration);GO:0070509(calcium ion import)",null,"mRNA","agilent G3 V3"]
["A_33_P3253460",8.86,8.95,8.87,9.88,9.98,9.97,{"v":0.894401609118337,"d":"0.89"},{"v":-0.161005311150627,"d":"-0.16"},"down",{"v":1.81057999999457e-05,"d":"0.00"},1,"yes","AGCTGTGTCCTCTCCTGTCCTGTGCAGTTAATCAGGGCTCCCTGTGGCTTTCAGGAGCAA","FALSE","AK095243","gb|AK095243|tc|THC2483636","LOC100130654","uncharacterized LOC100130654","gb|Homo sapiens cDNA FLJ37924 fis, clone CTONG2000218. [AK095243]","chr17",39805308,39807765,null,null,"mRNA","agilent G3 V3"]
["A_24_P636318",{"v":2.1,"d":"2.10"},2.28,2.14,{"v":4.8,"d":"4.80"},4.89,5.13,{"v":0.439946018893387,"d":"0.44"},{"v":-1.18460157807476,"d":"-1.18"},"down",{"v":1.81394999999585e-05,"d":"0.00"},1,"yes","GGAAACTGCATGTTTCAGAAAGTTTGTCTCTTTTTCCTACTCATTATTTGAAGAAGAGAG","FALSE","NM_001009993","ref|NM_001009993|ens|ENST00000409185|ref|XM_006712263|ref|XM_005263591","FAM168B","family with sequence similarity 168, member B","ref|Homo sapiens family with sequence similarity 168, member B (FAM168B), mRNA [NM_001009993]","chr2",131805448,131851001,"GO:0005886(plasma membrane);GO:0016021(integral to membrane);GO:0030424(axon);GO:0048471(perinuclear region of cytoplasm);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P83073",2.53,2.78,2.56,5.37,5.17,5.42,{"v":0.493107769423559,"d":"0.49"},{"v":-1.02002511071486,"d":"-1.02"},"down",{"v":1.81395999999667e-05,"d":"0.00"},1,"yes","AAACAACTCAAGCATTCTGGTGGCAACATAGAGATTGTAGGCTGCTTCTAAGAAAGTTAT","FALSE","NM_032558","ref|NM_032558|ens|ENST00000428393|ens|ENST00000375344|ref|XM_006717305","HIATL1","hippocampus abundant transcript-like 1","ref|Homo sapiens hippocampus abundant transcript-like 1 (HIATL1), mRNA [NM_032558]","chr9",97136832,97223324,"GO:0005215(transporter activity);GO:0005886(plasma membrane);GO:0016021(integral to membrane);GO:0055085(transmembrane transport)",null,"mRNA","agilent G3 V3"]
["A_23_P82959",11.05,11.09,11.12,10.21,10.17,10.27,{"v":1.08515497553018,"d":"1.09"},{"v":0.117901094709125,"d":"0.12"},"up",{"v":1.81644999999175e-05,"d":"0.00"},1,"yes","GCTGGCTGCTCTCCTGGTGCAGCCTGTGAGGCTCTTAAGACAGGGGCCGCTCCTCCCTCC","FALSE","NM_003923","ref|NM_003923|ens|ENST00000377317|gb|AF076292|gb|BC051376","FOXH1","forkhead box H1","ref|Homo sapiens forkhead box H1 (FOXH1), mRNA [NM_003923]","chr8",145700256,145701206,"GO:0000790(nuclear chromatin);GO:0000981(sequence-specific DNA binding RNA polymerase II transcription factor activity);GO:0001104(RNA polymerase II transcription cofactor activity);GO:0001190(RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription);GO:0001205(RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription);GO:0001947(heart looping);GO:0003139(secondary heart field specification);GO:0003151(outflow tract morphogenesis);GO:0003215(cardiac right ventricle morphogenesis);GO:0003222(ventricular trabecula myocardium morphogenesis);GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0006366(transcription from RNA polymerase II promoter);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0019904(protein domain specific binding);GO:0032444(activin responsive factor complex);GO:0033147(negative regulation of intracellular estrogen receptor signaling pathway);GO:0035054(embryonic heart tube anterior/posterior pattern specification);GO:0035326(enhancer binding);GO:0035909(aorta morphogenesis);GO:0043425(bHLH transcription factor binding);GO:0043565(sequence-specific DNA binding);GO:0044212(transcription regulatory region DNA binding);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046332(SMAD binding);GO:0048318(axial mesoderm development);GO:0050681(androgen receptor binding);GO:0060766(negative regulation of androgen receptor signaling pathway);GO:0070410(co-SMAD binding);GO:0070412(R-SMAD binding);GO:1900164(nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry);GO:2000824(negative regulation of androgen receptor activity)",null,"mRNA","agilent G3 V3"]
["A_33_P3399881",2.04,1.99,2.02,4.32,4.02,4.17,{"v":0.48361310951239,"d":"0.48"},{"v":-1.04807474200386,"d":"-1.05"},"down",{"v":1.82055999999875e-05,"d":"0.00"},1,"yes","AAGGGTAACACAAACTCCAGAGAATATGCTACTTGCAGATTTAATGATTGTATCAACGGT","FALSE","AK123930","gb|AK123930|tc|THC2484316",null,null,"gb|Homo sapiens cDNA FLJ41936 fis, clone PERIC2005370. [AK123930]",{"$nulls":5},"mRNA","agilent G3 V3"]
["A_32_P77098",1.92,2.01,1.89,4.36,4.59,{"v":4.7,"d":"4.70"},{"v":0.426373626373626,"d":"0.43"},{"v":-1.22980989289893,"d":"-1.23"},"down",{"v":1.82125000000033e-05,"d":"0.00"},1,"yes","CAACGTTGAAGCTGCATTTTGGTCAATGTGGGTAACTTACTTTAGAAAATGACTTGAGTT","FALSE","NM_001003682","ref|NM_001003682|ref|NM_001171868|ens|ENST00000420504|ens|ENST00000521452","TMEM200B","transmembrane protein 200B","ref|Homo sapiens transmembrane protein 200B (TMEM200B), transcript variant 2, mRNA [NM_001003682]","chr1",29445946,29449013,"GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_24_P942250",1.89,2.01,1.96,4.94,5.25,5.37,{"v":0.376606683804627,"d":"0.38"},{"v":-1.40886949056394,"d":"-1.41"},"down",{"v":1.8428999999931e-05,"d":"0.00"},1,"yes","GTACTTTGAATTGATAGTCCTTTATGCAATGTCTTAGCAATAGTCTCTATAATGCCCATC","FALSE","NM_025134","ref|NM_025134|ens|ENST00000564845|ens|ENST00000398510|ens|ENST00000219084","CHD9","chromodomain helicase DNA binding protein 9","ref|Homo sapiens chromodomain helicase DNA binding protein 9 (CHD9), mRNA [NM_025134]","chr16",53088944,53361413,"GO:0003677(DNA binding);GO:0004386(helicase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0016568(chromatin modification);GO:0044255(cellular lipid metabolic process);GO:0044281(small molecule metabolic process)",null,"mRNA","agilent G3 V3"]
["A_33_P3414362",2.03,2.07,2.21,4.04,3.93,3.86,{"v":0.533389687235841,"d":"0.53"},{"v":-0.90673816335724,"d":"-0.91"},"down",{"v":1.84742999999044e-05,"d":"0.00"},1,"yes","TGTGTCACATAGTTCTGGGGTTAAGACCAGCTACTCCGGAAGAAGAAGGACAAATTATTA","FALSE","NM_032582","ref|NM_032582|ens|ENST00000300896|gb|BC054344|gb|AK057301","USP32","ubiquitin specific peptidase 32","ref|Homo sapiens ubiquitin specific peptidase 32 (USP32), mRNA [NM_032582]","chr17",58326420,58469336,"GO:0004197(cysteine-type endopeptidase activity);GO:0004843(ubiquitin-specific protease activity);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0016020(membrane);GO:0016579(protein deubiquitination);GO:0043161(proteasomal ubiquitin-dependent protein catabolic process);GO:0061136(regulation of proteasomal protein catabolic process)",null,"mRNA","agilent G3 V3"]
["A_24_P82749",1.97,2.01,2.09,{"v":4.5,"d":"4.50"},4.46,4.21,{"v":0.460895975702354,"d":"0.46"},{"v":-1.11748692400083,"d":"-1.12"},"down",{"v":1.84937999999635e-05,"d":"0.00"},1,"yes","CTCGGGTTCATGACGCTCTCGATATTCCTGTGCAGAAACCTGGACCACGTCTACAACCGG","FALSE","NM_001774","ref|NM_001774|ref|NM_001040031|ens|ENST00000595725|ens|ENST00000426897","CD37","CD37 molecule","ref|Homo sapiens CD37 molecule (CD37), transcript variant 1, mRNA [NM_001774]","chr19",49838684,49843462,"GO:0001772(immunological synapse);GO:0002639(positive regulation of immunoglobulin production);GO:0002920(regulation of humoral immune response);GO:0005515(protein binding);GO:0008285(negative regulation of cell proliferation);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0030886(negative regulation of myeloid dendritic cell activation);GO:0042832(defense response to protozoan);GO:0050688(regulation of defense response to virus);GO:0070062(extracellular vesicular exosome)","04640(Hematopoietic cell lineage)","mRNA","agilent G3 V3"]
["A_23_P431388",2.04,1.88,2.33,6.79,6.61,6.34,{"v":0.31661600810537,"d":"0.32"},{"v":-1.65919389490695,"d":"-1.66"},"down",{"v":1.86075999999424e-05,"d":"0.00"},1,"yes","TGTTTGAACTTCCTGTTTGACAATGTTTGCTGTTGATTTTTTGTTCAATAAAGAATTTGG","FALSE","NM_144569","ref|NM_144569|ref|NM_001281987|ref|NM_001281988|ens|ENST00000473361","SPOCD1","SPOC domain containing 1","ref|Homo sapiens SPOC domain containing 1 (SPOCD1), transcript variant 1, mRNA [NM_144569]","chr1",32256024,32281580,"GO:0006351(transcription, DNA-dependent);GO:0010923(negative regulation of phosphatase activity)",null,"mRNA","agilent G3 V3"]
["A_33_P3681213",2.04,1.98,2.03,3.68,3.86,3.92,{"v":0.527923211169284,"d":"0.53"},{"v":-0.921599996594948,"d":"-0.92"},"down",{"v":1.86220999999209e-05,"d":"0.00"},1,"yes","CCTAATATTATTCTAGATATTCAGCCTGGAGGCAATCATGTAATTGAGGATTCTCACAAA","FALSE","NM_006036","ref|NM_006036|ref|NM_001171606|ref|NM_001171603|ref|NM_001171617","PREPL","prolyl endopeptidase-like","ref|Homo sapiens prolyl endopeptidase-like (PREPL), transcript variant 1, mRNA [NM_006036]","chr2",44544752,44589001,"GO:0004252(serine-type endopeptidase activity);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0006508(proteolysis);GO:0070008(serine-type exopeptidase activity)",null,"mRNA","agilent G3 V3"]
["A_33_P3277407",8.68,8.58,8.64,7.42,7.54,7.52,{"v":1.15213523131673,"d":"1.15"},{"v":0.20431006235299,"d":"0.20"},"up",{"v":1.86724999999832e-05,"d":"0.00"},1,"yes","AATGAATGTCCATCCCCAGATACTTCTCAAAATACTTGTAAAAGTCCTCCAAAAATGAGC","FALSE","NM_182931","ref|NM_182931|ref|NM_018682|ens|ENST00000473063|ens|ENST00000334914","KMT2E","lysine (K)-specific methyltransferase 2E","ref|Homo sapiens lysine (K)-specific methyltransferase 2E (KMT2E), transcript variant 1, mRNA [NM_182931]","chr7",104654640,104752927,"GO:0002446(neutrophil mediated immunity);GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006306(DNA methylation);GO:0006325(chromatin organization);GO:0006351(transcription, DNA-dependent);GO:0007050(cell cycle arrest);GO:0008270(zinc ion binding);GO:0016607(nuclear speck);GO:0019899(enzyme binding);GO:0030218(erythrocyte differentiation);GO:0030854(positive regulation of granulocyte differentiation);GO:0042119(neutrophil activation);GO:0042800(histone methyltransferase activity (H3-K4 specific));GO:0043231(intracellular membrane-bounded organelle);GO:0045171(intercellular bridge);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0048384(retinoic acid receptor signaling pathway);GO:0051568(histone H3-K4 methylation);GO:0070688(MLL5-L complex);GO:0071300(cellular response to retinoic acid)","00310(Lysine degradation)","mRNA","agilent G3 V3"]
["A_33_P3324765",{"v":6.4,"d":"6.40"},6.23,6.28,7.58,7.63,7.65,{"v":0.827209098862642,"d":"0.83"},{"v":-0.273676040264717,"d":"-0.27"},"down",{"v":1.87507999999115e-05,"d":"0.00"},1,"yes","CAACATCTCCTCGTCCGACCTCACAGGCCGACAAGATACCTCTCGCATGTCCACCTCACA","FALSE","NM_001893","ref|NM_001893|ref|NM_139062|ref|NR_110578|ens|ENST00000403276","CSNK1D","casein kinase 1, delta","ref|Homo sapiens casein kinase 1, delta (CSNK1D), transcript variant 1, mRNA [NM_001893]","chr17",80207456,80213422,"GO:0000086(G2/M transition of mitotic cell cycle);GO:0000278(mitotic cell cycle);GO:0001934(positive regulation of protein phosphorylation);GO:0001948(glycoprotein binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005819(spindle);GO:0005829(cytosol);GO:0005876(spindle microtubule);GO:0005886(plasma membrane);GO:0006281(DNA repair);GO:0006468(protein phosphorylation);GO:0006897(endocytosis);GO:0006996(organelle organization);GO:0007165(signal transduction);GO:0008360(regulation of cell shape);GO:0016055(Wnt receptor signaling pathway);GO:0018105(peptidyl-serine phosphorylation);GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0032922(circadian regulation of gene expression);GO:0042277(peptide binding);GO:0042752(regulation of circadian rhythm);GO:0048471(perinuclear region of cytoplasm);GO:0050321(tau-protein kinase activity);GO:0051219(phosphoprotein binding);GO:0051225(spindle assembly);GO:0090263(positive regulation of canonical Wnt receptor signaling pathway)","04340(Hedgehog signaling pathway);04390(Hippo signaling pathway);04540(Gap junction);04710(Circadian rhythm)","mRNA","agilent G3 V3"]
["A_23_P15348",2.11,1.94,{"v":2.5,"d":"2.50"},6.59,6.87,6.63,{"v":0.326032852165256,"d":"0.33"},{"v":-1.61691075230848,"d":"-1.62"},"down",{"v":1.88169999999488e-05,"d":"0.00"},1,"yes","TGCTGTGTTGACTTCCTGTTGTCTTCATCAAAGCTTTTTTCCGTGGTATTCTAAAATTAG","FALSE","NM_015134","ref|NM_015134|ref|NM_201274|ens|ENST00000341712|ens|ENST00000395811","MPRIP","myosin phosphatase Rho interacting protein","ref|Homo sapiens myosin phosphatase Rho interacting protein (MPRIP), transcript variant 1, mRNA [NM_015134]","chr17",16946084,17088369,"GO:0003779(actin binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005925(focal adhesion);GO:0015629(actin cytoskeleton)",null,"mRNA","agilent G3 V3"]
["A_24_P278460",2.04,1.91,2.21,4.19,4.28,4.25,{"v":0.484276729559748,"d":"0.48"},{"v":-1.04609641458945,"d":"-1.05"},"down",{"v":1.88172999999736e-05,"d":"0.00"},1,"yes","ACCCATGGAACAATATGCTTAGGATTACAGGAAGCAGTCCTTACTTACACTTCTTGTCTG","FALSE","NM_032228","ref|NM_032228|ens|ENST00000354817|gb|AL713674|gb|AY600449","FAR1","fatty acyl CoA reductase 1","ref|Homo sapiens fatty acyl CoA reductase 1 (FAR1), mRNA [NM_032228]","chr11",13741450,13753893,"GO:0005777(peroxisome);GO:0005778(peroxisomal membrane);GO:0005782(peroxisomal matrix);GO:0008611(ether lipid biosynthetic process);GO:0010025(wax biosynthetic process);GO:0016021(integral to membrane);GO:0035336(long-chain fatty-acyl-CoA metabolic process);GO:0044255(cellular lipid metabolic process);GO:0044281(small molecule metabolic process);GO:0046474(glycerophospholipid biosynthetic process);GO:0050062(long-chain-fatty-acyl-CoA reductase activity);GO:0055114(oxidation-reduction process);GO:0080019(fatty-acyl-CoA reductase (alcohol-forming) activity)","00072(Synthesis and degradation of ketone bodies);04146(Peroxisome)","mRNA","agilent G3 V3"]
["A_23_P100326",{"v":2,"d":"2.00"},2.33,1.95,5.27,5.21,5.41,{"v":0.395217117684078,"d":"0.40"},{"v":-1.33928266045689,"d":"-1.34"},"down",{"v":1.88463999999389e-05,"d":"0.00"},1,"yes","AGCTAGCTCCAGACATGGGTTGATCACCTAGAGGAGCTCTGGCTAAGGCACAGTTTTCTA","FALSE","NM_001039476","ref|NM_001039476|ref|NM_001243249|ref|NM_001243248|ref|NM_001243247","NPRL3","nitrogen permease regulator-like 3 (S. cerevisiae)","ref|Homo sapiens nitrogen permease regulator-like 3 (S. cerevisiae) (NPRL3), transcript variant 2, mRNA [NM_001039476]","chr16",{"v":135806,"d":"135806.00"},188610,"GO:0003281(ventricular septum development);GO:0003674(molecular_function);GO:0005096(GTPase activator activity);GO:0005575(cellular_component);GO:0008150(biological_process);GO:0035909(aorta morphogenesis);GO:0043547(positive regulation of GTPase activity);GO:0048738(cardiac muscle tissue development);GO:0060021(palate development)",null,"mRNA","agilent G3 V3"]
["A_24_P100996",1.98,1.98,2.12,4.46,4.24,4.53,{"v":0.459561602418745,"d":"0.46"},{"v":-1.12166983283509,"d":"-1.12"},"down",{"v":1.88477999999437e-05,"d":"0.00"},1,"yes","CTCTGTTGATTGACTCCAGTTGAAGGTGAGAAATCTGTACCAATCATTCAAAAAGGGAAT","FALSE","NM_213599","ref|NM_213599|ref|NM_001142649|ens|ENST00000324559|ref|XM_005252820","ANO5","anoctamin 5","ref|Homo sapiens anoctamin 5 (ANO5), transcript variant 1, mRNA [NM_213599]","chr11",22214722,22304903,"GO:0005229(intracellular calcium activated chloride channel activity);GO:0005622(intracellular);GO:0005789(endoplasmic reticulum membrane);GO:0005886(plasma membrane);GO:0006821(chloride transport);GO:0016021(integral to membrane);GO:0031982(vesicle);GO:0034220(ion transmembrane transport);GO:0055085(transmembrane transport)",null,"mRNA","agilent G3 V3"]
["A_33_P3642648",2.92,3.22,2.94,{"v":5.4,"d":"5.40"},5.47,{"v":5.4,"d":"5.40"},{"v":0.558082360172096,"d":"0.56"},{"v":-0.841450048381613,"d":"-0.84"},"down",{"v":1.88495999999816e-05,"d":"0.00"},1,"yes","TGCCAATTGTACTCATTCTGCAGTGCCACAGAACACTACAACTTATTCAAATGGAATCTT","FALSE","NM_006635","ref|NM_006635|gb|AK090816|gb|AX746630|gb|AK074582","ZNF460","zinc finger protein 460","ref|Homo sapiens zinc finger protein 460 (ZNF460), mRNA [NM_006635]","chr19",57791852,57804937,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3412975",6.93,6.64,6.92,9.14,9.22,{"v":9.2,"d":"9.20"},{"v":0.743468795355588,"d":"0.74"},{"v":-0.427655903693044,"d":"-0.43"},"down",{"v":1.88813999999482e-05,"d":"0.00"},1,"yes","GCCGCTGTGTCTCCTTTGTATCCTAAATCTTTATTTTTCTAGGACATGTTATGCCTCCAT","FALSE","NM_175875","ref|NM_175875|ens|ENST00000622857|ens|ENST00000317578|gb|AK074826","SIX5","SIX homeobox 5","ref|Homo sapiens SIX homeobox 5 (SIX5), mRNA [NM_175875]","chr19",46268652,46272113,"GO:0002088(lens development in camera-type eye);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0006351(transcription, DNA-dependent);GO:0007286(spermatid development);GO:0043231(intracellular membrane-bounded organelle);GO:0043565(sequence-specific DNA binding);GO:0045892(negative regulation of transcription, DNA-dependent)",null,"mRNA","agilent G3 V3"]
["A_24_P392690",3.87,4.04,{"v":4,"d":"4.00"},5.45,5.41,5.53,{"v":0.726662599145821,"d":"0.73"},{"v":-0.460642441235345,"d":"-0.46"},"down",{"v":1.89668999999171e-05,"d":"0.00"},1,"yes","AAAGCCTGGACCTCTTTAACTGTGAGGTTACTAACATGAATGACTACGAGAGTGTCTTCA","FALSE","ENST00000568553","ens|ENST00000568553|ens|ENST00000564205|tc|NP1202467",null,null,"ens|acidic (leucine-rich) nuclear phosphoprotein 32 family, member B pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:24267] [ENST00000568553]","chr15",75614112,75614850,null,null,"mRNA","agilent G3 V3"]
["A_23_P208937",{"v":11.5,"d":"11.50"},11.46,{"v":11.5,"d":"11.50"},{"v":10.7,"d":"10.70"},10.79,10.71,{"v":1.07018633540373,"d":"1.07"},{"v":0.0978620132229688,"d":"0.10"},"up",{"v":1.90040999999974e-05,"d":"0.00"},1,"yes","ACATGGTGGGGCAAAAAGACAGCGTCATCCTGAGCGTCAAGTTCTCCCCCTTTGGCCAGT","FALSE","NM_024760","ref|NM_024760|ref|NM_001143986|ens|ENST00000497878|ens|ENST00000452088","TLE6","transducin-like enhancer of split 6","ref|Homo sapiens transducin-like enhancer of split 6 (TLE6), transcript variant 2, mRNA [NM_024760]","chr19",{"v":2977444,"d":"2977444.00"},2995177,"GO:0005634(nucleus);GO:0005938(cell cortex);GO:0006355(regulation of transcription, DNA-dependent);GO:0043234(protein complex);GO:0045666(positive regulation of neuron differentiation)",null,"mRNA","agilent G3 V3"]
["A_23_P55468",1.98,2.16,1.96,5.53,5.62,{"v":5.2,"d":"5.20"},{"v":0.373088685015291,"d":"0.37"},{"v":-1.4224094879352,"d":"-1.42"},"down",{"v":1.9006900000007e-05,"d":"0.00"},1,"yes","GGTTGTTTGGTGTTGTGGGCACAGAGGTGACAGTGTCTCTGCAGGCACTCAGGAAGCTGT","FALSE","NM_013337","ref|NM_013337|ens|ENST00000613269|ens|ENST00000617832|gb|AK000830","TIMM22","translocase of inner mitochondrial membrane 22 homolog (yeast)","ref|Homo sapiens translocase of inner mitochondrial membrane 22 homolog (yeast) (TIMM22), mRNA [NM_013337]","chr17",{"v":900357,"d":"900357.00"},906911,"GO:0005743(mitochondrial inner membrane);GO:0006626(protein targeting to mitochondrion);GO:0015266(protein channel activity);GO:0016021(integral to membrane);GO:0044267(cellular protein metabolic process);GO:0045039(protein import into mitochondrial inner membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P309246",2.07,2.21,2.22,3.66,3.65,3.78,{"v":0.586113615870153,"d":"0.59"},{"v":-0.770747742245893,"d":"-0.77"},"down",{"v":1.90473999999163e-05,"d":"0.00"},1,"yes","CTGTGTGAATTTTACATTATTTGGAGCCTCATCTGTGTCAGGCTATAACATTCTATCCTC","FALSE","NM_145115","ref|NM_145115|ens|ENST00000394150|ens|ENST00000466948|ens|ENST00000485586","ZSCAN25","zinc finger and SCAN domain containing 25","ref|Homo sapiens zinc finger and SCAN domain containing 25 (ZSCAN25), mRNA [NM_145115]","chr7",99217232,99230024,"GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3451157",{"v":8.9,"d":"8.90"},8.74,{"v":8.7,"d":"8.70"},10.32,{"v":10.4,"d":"10.40"},{"v":10.4,"d":"10.40"},{"v":0.846401028277635,"d":"0.85"},{"v":-0.240586714729677,"d":"-0.24"},"down",{"v":1.90881999999615e-05,"d":"0.00"},1,"yes","TAGAAAAAGGGAAAAAATTAGCCGGGTGTGGTAATACATGCCTGTGGTCTCAGCTACTCG","FALSE","AK054980","gb|AK054980|gb|AK074886|tc|THC2513702|tc|THC2478567",null,null,"gb|Homo sapiens cDNA FLJ30418 fis, clone BRACE2008754. [AK054980]","chr12",{"v":8448581,"d":"8448581.00"},8549399,null,null,"mRNA","agilent G3 V3"]
["A_24_P402690",6.54,6.45,6.46,9.03,8.84,{"v":8.7,"d":"8.70"},{"v":0.73202860368837,"d":"0.73"},{"v":-0.450028072616952,"d":"-0.45"},"down",{"v":1.92622999999337e-05,"d":"0.00"},1,"yes","ACTCTTAAATGCTTTGTATATTTTCTCAATTAGATCTCTTTTCAGAAGTGTCTATAGAAC","FALSE","NM_030926","ref|NM_030926|ref|NM_001287241|ref|NM_001287240|ref|NM_001012514","ITM2C","integral membrane protein 2C","ref|Homo sapiens integral membrane protein 2C (ITM2C), transcript variant 1, mRNA [NM_030926]","chr2",231729696,231743963,"GO:0001540(beta-amyloid binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005764(lysosome);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0010977(negative regulation of neuron projection development);GO:0016021(integral to membrane);GO:0030182(neuron differentiation);GO:0048471(perinuclear region of cytoplasm);GO:0070062(extracellular vesicular exosome);GO:2001238(positive regulation of extrinsic apoptotic signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_23_P98248",6.69,{"v":6.6,"d":"6.60"},6.51,8.08,8.07,7.98,{"v":0.820555325321177,"d":"0.82"},{"v":-0.285327485248779,"d":"-0.29"},"down",{"v":1.94084999999289e-05,"d":"0.00"},1,"yes","ACCCTTCTTCCGCTCTGCCAATGGGGTGATTCTGACTCCAGGGAATACTGATGGCTTCCT","FALSE","NM_001033678","ref|NM_001033678|ref|NM_001160389|ref|NM_001160390|ref|NM_031472","TRPT1","tRNA phosphotransferase 1","ref|Homo sapiens tRNA phosphotransferase 1 (TRPT1), transcript variant 1, mRNA [NM_001033678]","chr11",63991272,63993726,"GO:0000215(tRNA 2'-phosphotransferase activity);GO:0006388(tRNA splicing, via endonucleolytic cleavage and ligation);GO:0045859(regulation of protein kinase activity)",null,"mRNA","agilent G3 V3"]
["A_23_P80321",7.45,7.41,7.47,9.18,9.06,8.95,{"v":0.821257815373299,"d":"0.82"},{"v":-0.284092900202287,"d":"-0.28"},"down",{"v":1.95975999999209e-05,"d":"0.00"},1,"yes","GGAACTCAAGGCCCGAAAGATCCCCATCATCATTCGCCGTTACCTGCCAGATGGGAGCTA","FALSE","NM_021974","ref|NM_021974|ref|NM_001301129|ref|NR_125371|ens|ENST00000483713","POLR2F","polymerase (RNA) II (DNA directed) polypeptide F","ref|Homo sapiens polymerase (RNA) II (DNA directed) polypeptide F (POLR2F), transcript variant 1, mRNA [NM_021974]","chr22",38349672,38365319,"GO:0000398(nuclear mRNA splicing, via spliceosome);GO:0001054(RNA polymerase I activity);GO:0001055(RNA polymerase II activity);GO:0001056(RNA polymerase III activity);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005665(DNA-directed RNA polymerase II, core complex);GO:0005666(DNA-directed RNA polymerase III complex);GO:0005730(nucleolus);GO:0005736(DNA-directed RNA polymerase I complex);GO:0005829(cytosol);GO:0006281(DNA repair);GO:0006283(transcription-coupled nucleotide-excision repair);GO:0006289(nucleotide-excision repair);GO:0006360(transcription from RNA polymerase I promoter);GO:0006361(transcription initiation from RNA polymerase I promoter);GO:0006362(transcription elongation from RNA polymerase I promoter);GO:0006363(termination of RNA polymerase I transcription);GO:0006366(transcription from RNA polymerase II promoter);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0006368(transcription elongation from RNA polymerase II promoter);GO:0006370(mRNA capping);GO:0006383(transcription from RNA polymerase III promoter);GO:0006385(transcription elongation from RNA polymerase III promoter);GO:0006386(termination of RNA polymerase III transcription);GO:0008380(RNA splicing);GO:0010467(gene expression);GO:0016032(viral reproduction);GO:0032481(positive regulation of type I interferon production);GO:0034587(piRNA metabolic process);GO:0035019(somatic stem cell maintenance);GO:0040029(regulation of gene expression, epigenetic);GO:0045087(innate immune response);GO:0045814(negative regulation of gene expression, epigenetic);GO:0050434(positive regulation of viral transcription)","00230(Purine metabolism);00240(Pyrimidine metabolism);03020(RNA polymerase);04623(Cytosolic DNA-sensing pathway);05016(Huntington's disease);05169(Epstein-Barr virus infection)","mRNA","agilent G3 V3"]
["A_23_P103099",{"v":2.9,"d":"2.90"},{"v":3,"d":"3.00"},3.13,5.51,5.63,5.82,{"v":0.532429245283019,"d":"0.53"},{"v":-0.909338277082341,"d":"-0.91"},"down",{"v":1.9605699999925e-05,"d":"0.00"},1,"yes","CCTAGATGTAGAAATAATCTTTAATGAACGTGGCTCTAAGGGATTCGGGTTCGTAACTTT","FALSE","NM_001031695","ref|NM_001031695|ref|NM_014309|ref|NM_001082577|ref|NM_001082576","RBFOX2","RNA binding protein, fox-1 homolog (C. elegans) 2","ref|Homo sapiens RNA binding protein, fox-1 homolog (C. elegans) 2 (RBFOX2), transcript variant 1, mRNA [NM_001031695]","chr22",36134784,36236634,"GO:0000166(nucleotide binding);GO:0000381(regulation of alternative nuclear mRNA splicing, via spliceosome);GO:0003714(transcription corepressor activity);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006397(mRNA processing);GO:0008134(transcription factor binding);GO:0008380(RNA splicing);GO:0010724(regulation of definitive erythrocyte differentiation);GO:0016070(RNA metabolic process);GO:0021942(radial glia guided migration of Purkinje cell);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0042127(regulation of cell proliferation);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0048813(dendrite morphogenesis);GO:0050885(neuromuscular process controlling balance)",null,"mRNA","agilent G3 V3"]
["A_22_P00010935",10.62,{"v":10.5,"d":"10.50"},10.59,{"v":9.6,"d":"9.60"},9.66,9.62,{"v":1.09799168975069,"d":"1.10"},{"v":0.134867135216668,"d":"0.13"},"up",{"v":1.97159999999474e-05,"d":"0.00"},1,"yes","AATATGTCGGCGAGCACCCACCCAAATGCAATCATTTGACCCCCTGCGGACGATAGCTGC","FALSE","ENST00000617440","ens|ENST00000617440|linc|lnc-NR2F2-1:1|linc|TCONS_00024016","LOC102724872","uncharacterized LOC102724872",null,"chr15",96886184,96888880,null,null,"mRNA","agilent G3 V3"]
["A_23_P410312",1.87,2.02,1.93,4.14,4.21,3.94,{"v":0.473555736371033,"d":"0.47"},{"v":-1.07839385746438,"d":"-1.08"},"down",{"v":1.97699999999745e-05,"d":"0.00"},1,"yes","TCAAGCACAGCACTGATTTTAACAACCTGCATTTAATGTGAAGTAACCGAAGTAGGATAC","FALSE","NM_207435","ref|NM_207435|ens|ENST00000615315|ens|ENST00000309050|ref|XM_006719396","C12orf76","chromosome 12 open reading frame 76","ref|Homo sapiens chromosome 12 open reading frame 76 (C12orf76), mRNA [NM_207435]","chr12",110479920,110511439,null,null,"mRNA","agilent G3 V3"]
["A_33_P3385561",8.36,8.32,8.15,9.84,9.89,9.92,{"v":0.83743676222597,"d":"0.84"},{"v":-0.255947843256525,"d":"-0.26"},"down",{"v":1.97794999999834e-05,"d":"0.00"},1,"yes","ATCCCAGAAGTTAAGACCAGCCTTGGCAACACAACATGACCCTGTCTCTATAAAGAAAAC","FALSE","AK130932","gb|AK130932",null,null,"gb|Homo sapiens cDNA FLJ27422 fis, clone WMC08087. [AK130932]",{"$nulls":5},"mRNA","agilent G3 V3"]
["A_33_P6549164",11.02,10.88,{"v":10.9,"d":"10.90"},12.56,12.47,12.39,{"v":0.876536611437734,"d":"0.88"},{"v":-0.190113743735338,"d":"-0.19"},"down",{"v":1.98444999999214e-05,"d":"0.00"},1,"yes","AACACAGTGAAACCCCCGTCTCTACTAAAAAATACAAAAAATTATCCCGGCGTGGTGGCG","FALSE","ENST00000473357","ens|ENST00000473357|gb|AK055523","SLC2A11","solute carrier family 2 (facilitated glucose transporter), member 11","ens|solute carrier family 2 (facilitated glucose transporter), member 11 [Source:HGNC Symbol;Acc:HGNC:14239] [ENST00000473357]","chr22",24222596,24225494,"GO:0005886(plasma membrane);GO:0008643(carbohydrate transport);GO:0016021(integral to membrane);GO:0022891(substrate-specific transmembrane transporter activity);GO:0055085(transmembrane transport)",null,"mRNA","agilent G3 V3"]
["A_24_P280762",8.29,8.28,8.45,6.61,6.42,6.53,{"v":1.27914110429448,"d":"1.28"},{"v":0.355175419213586,"d":"0.36"},"up",{"v":1.99414999999536e-05,"d":"0.00"},1,"yes","GCCACACCCTTATTCAGCTGGAGAGTTGGTTCACAGCTACAGGCCAGACTCGTGTGACTG","FALSE","NM_030568","ref|NM_030568|ref|NM_001251874|ref|NM_001126063|ens|ENST00000433730","KHDC1","KH homology domain containing 1","ref|Homo sapiens KH homology domain containing 1 (KHDC1), transcript variant 2, mRNA [NM_030568]","chr6",73951776,73972895,"GO:0003723(RNA binding);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P156667",2.04,2.12,2.14,4.31,4.61,{"v":4.6,"d":"4.60"},{"v":0.465976331360947,"d":"0.47"},{"v":-1.10167141789491,"d":"-1.10"},"down",{"v":1.99469999999646e-05,"d":"0.00"},1,"yes","TCTCCTTCACTTTGGCATCAGTTGTTTTCTATGAAAACAGTGGATTGGTTGGGTTTTGTG","FALSE","NM_002714","ref|NM_002714|ref|NR_072994|ens|ENST00000376511|ens|ENST00000383586","PPP1R10","protein phosphatase 1, regulatory subunit 10","ref|Homo sapiens protein phosphatase 1, regulatory subunit 10 (PPP1R10), transcript variant 1, mRNA [NM_002714]","chr6",30568176,30585021,"GO:0000785(chromatin);GO:0003677(DNA binding);GO:0004864(protein phosphatase inhibitor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-dependent);GO:0006606(protein import into nucleus);GO:0043086(negative regulation of catalytic activity);GO:0046872(metal ion binding);GO:0072357(PTW/PP1 phosphatase complex)",null,"mRNA","agilent G3 V3"]
["A_33_P3283136",10.18,10.23,10.34,8.63,8.57,8.74,{"v":1.18542791056284,"d":"1.19"},{"v":0.245407930862265,"d":"0.25"},"up",{"v":1.99536999999639e-05,"d":"0.00"},1,"yes","CCCTTCGGATTTTTATTGACTCAAAATAGTGCCATTCCCCTTAATGAAATAGATTTTGAG","FALSE","NM_032842","ref|NM_032842|ref|NM_001301163|ens|ENST00000462753|ens|ENST00000473456","TMEM209","transmembrane protein 209","ref|Homo sapiens transmembrane protein 209 (TMEM209), transcript variant 1, mRNA [NM_032842]","chr7",129805928,129845271,"GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3300843",9.47,9.42,{"v":9.5,"d":"9.50"},10.34,10.38,10.28,{"v":0.915806451612903,"d":"0.92"},{"v":-0.126885366437208,"d":"-0.13"},"down",{"v":1.99789999999478e-05,"d":"0.00"},1,"yes","CTCACGCTGAGGGAGGTCAGCTTGAGCCCCTGCCTCACACTGGCCTCTCTCACGCTGAGG","FALSE","ENST00000624628","ens|ENST00000624628|ens|ENST00000601550|ens|ENST00000623699|ens|ENST00000623859",{"$nulls":3},"chrHG736_PATCH",56890420,56891226,null,null,"mRNA","agilent G3 V3"]
["A_33_P3287745",7.15,6.95,7.09,8.46,{"v":8.5,"d":"8.50"},8.51,{"v":0.831959167648214,"d":"0.83"},{"v":-0.265415371902025,"d":"-0.27"},"down",{"v":2.00299999999487e-05,"d":"0.00"},1,"yes","GGACCTGAGCCTCCTGGCTCCCAGCCTGTAAATATGTATAGACCTGTTTTGTCATTTTTT","FALSE","NM_182958","ref|NM_182958|ref|NM_032188|ens|ENST00000448516|ens|ENST00000573144","KAT8","K(lysine) acetyltransferase 8","ref|Homo sapiens K(lysine) acetyltransferase 8 (KAT8), transcript variant 2, mRNA [NM_182958]","chr16",31128984,31142710,"GO:0000123(histone acetyltransferase complex);GO:0000776(kinetochore);GO:0004402(histone acetyltransferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006325(chromatin organization);GO:0006351(transcription, DNA-dependent);GO:0008134(transcription factor binding);GO:0010506(regulation of autophagy);GO:0016407(acetyltransferase activity);GO:0016573(histone acetylation);GO:0019899(enzyme binding);GO:0030099(myeloid cell differentiation);GO:0031965(nuclear membrane);GO:0035064(methylated histone residue binding);GO:0043981(histone H4-K5 acetylation);GO:0043982(histone H4-K8 acetylation);GO:0043984(histone H4-K16 acetylation);GO:0043995(histone acetyltransferase activity (H4-K5 specific));GO:0043996(histone acetyltransferase activity (H4-K8 specific));GO:0045892(negative regulation of transcription, DNA-dependent);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0046872(metal ion binding);GO:0046972(histone acetyltransferase activity (H4-K16 specific));GO:0071339(MLL1 complex);GO:0072487(MSL complex)",null,"mRNA","agilent G3 V3"]
["A_33_P3222937",6.66,6.71,6.53,8.87,8.72,8.62,{"v":0.759252193819153,"d":"0.76"},{"v":-0.397348922897406,"d":"-0.40"},"down",{"v":2.00709999998994e-05,"d":"0.00"},1,"yes","CAGTATATGGTTCTTGGGTATGCCCTACCAGGTGGAATAAAGGACACAGATTTGATTTCT","FALSE","NM_017727","ref|NM_017727|ref|NM_001083590|ens|ENST00000404032|ens|ENST00000321326","TMEM214","transmembrane protein 214","ref|Homo sapiens transmembrane protein 214 (TMEM214), transcript variant 1, mRNA [NM_017727]","chr2",27262788,27263901,"GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005794(Golgi apparatus);GO:0005881(cytoplasmic microtubule);GO:0006915(apoptotic process);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_24_P350228",15.12,15.17,15.14,13.86,13.92,14.03,{"v":1.08658215737862,"d":"1.09"},{"v":0.119797262012605,"d":"0.12"},"up",{"v":2.01059999999087e-05,"d":"0.00"},1,"yes","AATCATTCTCACCTTGTATGCTTTACGAATAGAGCTGTGCCCCCCTGGAAAACGGTTCAT","FALSE","NM_021945","ref|NM_021945|ref|NM_001286456|ref|NM_015482|ref|NM_001286455","SLC22A23","solute carrier family 22, member 23","ref|Homo sapiens solute carrier family 22, member 23 (SLC22A23), transcript variant 2, mRNA [NM_021945]","chr6",{"v":3269196,"d":"3269196.00"},3457256,"GO:0006811(ion transport);GO:0016021(integral to membrane);GO:0022857(transmembrane transporter activity);GO:0055085(transmembrane transport)",null,"mRNA","agilent G3 V3"]
["A_32_P179676",1.94,1.98,1.93,3.62,3.86,3.66,{"v":0.525134649910233,"d":"0.53"},{"v":-0.929240702869265,"d":"-0.93"},"down",{"v":2.01149999999872e-05,"d":"0.00"},1,"yes","AGAATGATGTCTTTTTCTCAATGCAGTGAGTTATAGATTCTCTAGTTTTCTCCCTAGGGA","FALSE","NM_016272","ref|NM_016272|ens|ENST00000602145|ens|ENST00000327492|ref|XM_005261315","TOB2","transducer of ERBB2, 2","ref|Homo sapiens transducer of ERBB2, 2 (TOB2), mRNA [NM_016272]","chr22",41829496,41843027,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0007292(female gamete generation);GO:0008285(negative regulation of cell proliferation);GO:0010468(regulation of gene expression);GO:0042809(vitamin D receptor binding);GO:0045671(negative regulation of osteoclast differentiation);GO:0045778(positive regulation of ossification)","03018(RNA degradation)","mRNA","agilent G3 V3"]
["A_33_P3296024",11.55,11.76,11.56,13.37,13.49,13.48,{"v":0.864402578086267,"d":"0.86"},{"v":-0.210224719836257,"d":"-0.21"},"down",{"v":2.01589999999641e-05,"d":"0.00"},1,"yes","TATCAACTAGCCAGTGACTCGCTCATCTGCCCTGCCCAGGCCCACGTTTTGAAGTTGGAG","FALSE","NM_171999","ref|NM_171999|ens|ENST00000612458|ens|ENST00000616649|ens|ENST00000614625","SALL3","spalt-like transcription factor 3","ref|Homo sapiens spalt-like transcription factor 3 (SALL3), mRNA [NM_171999]","chr18",76751680,76757322,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0021891(olfactory bulb interneuron development);GO:0035136(forelimb morphogenesis);GO:0035137(hindlimb morphogenesis);GO:0045879(negative regulation of smoothened signaling pathway);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_32_P353072",{"v":2.3,"d":"2.30"},2.51,2.38,4.39,4.51,{"v":4.3,"d":"4.30"},{"v":0.54469696969697,"d":"0.54"},{"v":-0.876474253806518,"d":"-0.88"},"down",{"v":2.01959999999168e-05,"d":"0.00"},1,"yes","TGCTCACTTGATTGACTTGGTCAGATATTTGAATGATGGTATTACCTAGATTCTAATCCT","FALSE","NM_018374","ref|NM_018374|ref|NM_001134232|ref|XM_005249789|ref|XM_006715749","TMEM106B","transmembrane protein 106B","ref|Homo sapiens transmembrane protein 106B (TMEM106B), transcript variant 1, mRNA [NM_018374]","chr7",12250926,12282993,"GO:0003674(molecular_function);GO:0005515(protein binding);GO:0005765(lysosomal membrane);GO:0006810(transport);GO:0016021(integral to membrane);GO:0031902(late endosome membrane);GO:0032418(lysosome localization);GO:0043231(intracellular membrane-bounded organelle);GO:0048813(dendrite morphogenesis);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3392952",2.24,2.35,2.24,4.51,4.28,4.56,{"v":0.511610486891386,"d":"0.51"},{"v":-0.966882258284826,"d":"-0.97"},"down",{"v":2.02329999999806e-05,"d":"0.00"},1,"yes","GTCCTAACTTCCACTATTCTAGAAAGTATAGTGGTGATTTGTGTGCAAAGATTTGAAGTT","FALSE","NM_004514","ref|NM_004514|ens|ENST00000335255|ref|XM_006722281|gb|AL832570","FOXK2","forkhead box K2","ref|Homo sapiens forkhead box K2 (FOXK2), mRNA [NM_004514]","chr17",80477592,80562483,"GO:0000287(magnesium ion binding);GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0001077(RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0043231(intracellular membrane-bounded organelle);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription from RNA polymerase II promoter)",null,"mRNA","agilent G3 V3"]
["A_23_P87329",8.53,8.57,8.56,9.12,9.14,9.07,{"v":0.93889498719356,"d":"0.94"},{"v":-0.0909642894335242,"d":"-0.09"},"down",{"v":2.03009999999448e-05,"d":"0.00"},1,"yes","TGCCCAGTCCAGGGCCCTCCTTTCCTATAAGTTCATATTTTGCTTTGAGCCAGCTTTTTA","FALSE","NM_024662","ref|NM_024662|ref|NM_001144030|ens|ENST00000531159|ens|ENST00000615292","NAT10","N-acetyltransferase 10 (GCN5-related)","ref|Homo sapiens N-acetyltransferase 10 (GCN5-related) (NAT10), transcript variant 1, mRNA [NM_024662]","chr11",34163536,34167799,"GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0008080(N-acetyltransferase activity);GO:0008150(biological_process);GO:0008152(metabolic process);GO:0016020(membrane)","03008(Ribosome biogenesis in eukaryotes)","mRNA","agilent G3 V3"]
["A_23_P63681",2.07,2.02,2.22,4.08,3.98,3.89,{"v":0.528033472803347,"d":"0.53"},{"v":-0.921298707885562,"d":"-0.92"},"down",{"v":2.04010000000032e-05,"d":"0.00"},1,"yes","TCCATGTTCTTGCCAGGGAAATGGATTCTTGTCCTGTTGTTGGAGAGTTCCCATGTCAAA","FALSE","NM_004969","ref|NM_004969|ref|NM_001165946|ens|ENST00000496903|ens|ENST00000265986","IDE","insulin-degrading enzyme","ref|Homo sapiens insulin-degrading enzyme (IDE), transcript variant 1, mRNA [NM_004969]","chr10",94211440,94333833,"GO:0001540(beta-amyloid binding);GO:0001948(glycoprotein binding);GO:0004222(metalloendopeptidase activity);GO:0005102(receptor binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005777(peroxisome);GO:0005782(peroxisomal matrix);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006200(ATP catabolic process);GO:0006508(proteolysis);GO:0008270(zinc ion binding);GO:0008286(insulin receptor signaling pathway);GO:0008340(determination of adult lifespan);GO:0009986(cell surface);GO:0010815(bradykinin catabolic process);GO:0010992(ubiquitin homeostasis);GO:0016032(viral reproduction);GO:0016887(ATPase activity);GO:0031597(cytosolic proteasome complex);GO:0031626(beta-endorphin binding);GO:0032461(positive regulation of protein oligomerization);GO:0042277(peptide binding);GO:0042447(hormone catabolic process);GO:0042803(protein homodimerization activity);GO:0043130(ubiquitin binding);GO:0043559(insulin binding);GO:0045861(negative regulation of proteolysis);GO:0050435(beta-amyloid metabolic process);GO:0051260(protein homooligomerization);GO:0051289(protein homotetramerization);GO:0051291(protein heterooligomerization);GO:0051603(proteolysis involved in cellular protein catabolic process)","05010(Alzheimer's disease)","mRNA","agilent G3 V3"]
["A_23_P400459",{"v":2.6,"d":"2.60"},2.79,2.79,4.21,4.27,4.26,{"v":0.642072213500785,"d":"0.64"},{"v":-0.639192529314552,"d":"-0.64"},"down",{"v":2.05289999999358e-05,"d":"0.00"},1,"yes","ACCAGAATGGGAAAAACTATCATTCAGAGATACTGGCCATCAATCAAGTGTTTGATATCC","FALSE","NM_144964","ref|NM_144964|ref|NM_001286951|ref|NR_104612|ens|ENST00000488673","TRMT10B","tRNA methyltransferase 10 homolog B (S. cerevisiae)","ref|Homo sapiens tRNA methyltransferase 10 homolog B (S. cerevisiae) (TRMT10B), transcript variant 1, mRNA [NM_144964]","chr9",37753816,37778019,"GO:0008168(methyltransferase activity);GO:0032259(methylation)",null,"mRNA","agilent G3 V3"]
["A_33_P3354728",1.88,1.99,1.91,3.55,3.63,3.78,{"v":0.527372262773723,"d":"0.53"},{"v":-0.923106400459848,"d":"-0.92"},"down",{"v":2.05359999999599e-05,"d":"0.00"},1,"yes","ATTTTCTGGAAGAAGGCTGAAACTACCCAGATGATTGTGCTAAGGCTGGAATGTAGGGAG","FALSE","ENST00000484315","ens|ENST00000484315",{"$nulls":3},"chr14",65735548,65735816,null,null,"mRNA","agilent G3 V3"]
["A_23_P111288",6.48,6.45,{"v":6.5,"d":"6.50"},7.55,7.51,7.41,{"v":0.864708500222519,"d":"0.86"},{"v":-0.209714223594563,"d":"-0.21"},"down",{"v":2.06229999999419e-05,"d":"0.00"},1,"yes","GTATCTGTAGGTAAATCTCAAGGGTAAAATGTTAGGTGTCAGCTTTCAGGGCTCTGAAAC","FALSE","NM_016462","ref|NM_016462|ref|NM_001165258|ens|ENST00000541412|ens|ENST00000229563","TMEM14C","transmembrane protein 14C","ref|Homo sapiens transmembrane protein 14C (TMEM14C), transcript variant 2, mRNA [NM_016462]","chr6",10723148,10731352,"GO:0006783(heme biosynthetic process);GO:0016021(integral to membrane);GO:0031966(mitochondrial membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3223869",1.88,2.02,1.95,5.59,5.79,5.27,{"v":0.351351351351351,"d":"0.35"},{"v":-1.50901364748786,"d":"-1.51"},"down",{"v":2.06449999999858e-05,"d":"0.00"},1,"yes","ATGAAATGGAATATTCCAATGCTTTTTGTCCAGGGAGATGTCGTTGTCCTGGTTGCCCCT","FALSE","ENST00000436601","ens|ENST00000436601",null,null,"ens|LSM3 pseudogene 3 [Source:HGNC Symbol;Acc:HGNC:44348] [ENST00000436601]","chr2",85329512,85329817,null,null,"mRNA","agilent G3 V3"]
["A_33_P3291394",7.58,7.77,7.64,6.34,6.33,6.37,{"v":1.20745798319328,"d":"1.21"},{"v":0.271972987410236,"d":"0.27"},"up",{"v":2.06619999999491e-05,"d":"0.00"},1,"yes","GCTGATTATTCCTTGGCCTTTCCCTTGTATTTATGCAAGGAAGGATATACTGAGCTGATA","FALSE","NM_007266","ref|NM_007266|ref|NM_001145047|ref|NM_001145048|ref|NM_001145049","GPN1","GPN-loop GTPase 1","ref|Homo sapiens GPN-loop GTPase 1 (GPN1), transcript variant 1, mRNA [NM_007266]","chr2",27851516,27873711,"GO:0003924(GTPase activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0008152(metabolic process)",null,"mRNA","agilent G3 V3"]
["A_23_P93690",6.19,6.08,6.33,8.31,8.35,8.17,{"v":0.749093838099074,"d":"0.75"},{"v":-0.416781640181447,"d":"-0.42"},"down",{"v":2.07389999999918e-05,"d":"0.00"},1,"yes","CCGGACACGGATCACTTTTGTCTGATTCCAGCCTGCTTGCAACCCTGGGGTCCTCTTGTT","FALSE","NM_182776","ref|NM_182776|ref|NM_001278595|ref|NM_005916|ens|ENST00000303887","MCM7","minichromosome maintenance complex component 7","ref|Homo sapiens minichromosome maintenance complex component 7 (MCM7), transcript variant 2, mRNA [NM_182776]","chr7",99690400,99698380,"GO:0000082(G1/S transition of mitotic cell cycle);GO:0000278(mitotic cell cycle);GO:0000785(chromatin);GO:0003677(DNA binding);GO:0003697(single-stranded DNA binding);GO:0004003(ATP-dependent DNA helicase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006260(DNA replication);GO:0006268(DNA unwinding involved in replication);GO:0006270(DNA-dependent DNA replication initiation);GO:0006271(DNA strand elongation involved in DNA replication);GO:0006974(response to DNA damage stimulus);GO:0008283(cell proliferation);GO:0016020(membrane);GO:0042325(regulation of phosphorylation);GO:0042493(response to drug);GO:0042555(MCM complex);GO:0071364(cellular response to epidermal growth factor stimulus)","03030(DNA replication);04110(Cell cycle)","mRNA","agilent G3 V3"]
["A_23_P314835",7.41,7.37,7.45,6.66,6.57,6.61,{"v":1.12046370967742,"d":"1.12"},{"v":0.164095922640115,"d":"0.16"},"up",{"v":2.07859999999949e-05,"d":"0.00"},1,"yes","ATCAGCGTCACCCTTCCAGAATGTTCACGTCCACACCCATTCTTGGCTAATGTAATGAAT","FALSE","NM_178456","ref|NM_178456|ens|ENST00000371168|gb|BC035405|tc|THC2474575","C20orf85","chromosome 20 open reading frame 85","ref|Homo sapiens chromosome 20 open reading frame 85 (C20orf85), mRNA [NM_178456]","chr20",56725960,56736206,null,null,"mRNA","agilent G3 V3"]
["A_33_P3270599",{"v":6.3,"d":"6.30"},6.02,5.82,9.58,9.83,9.63,{"v":0.62465564738292,"d":"0.62"},{"v":-0.678866997467228,"d":"-0.68"},"down",{"v":2.08039999999299e-05,"d":"0.00"},1,"yes","CGAGCAGAGTTTGCCGAGAGGTCTGTGGCAAAGTTGGAGAAAACCATCGATGACCTAGAA","FALSE","NM_001301226","ref|NM_001301226|ref|NM_213674|ref|NM_001301227|ref|NM_003289","TPM2","tropomyosin 2 (beta)","ref|Homo sapiens tropomyosin 2 (beta) (TPM2), transcript variant Tpm2.3, mRNA [NM_001301226]","chr9",35685144,35689922,"GO:0003779(actin binding);GO:0005829(cytosol);GO:0005862(muscle thin filament tropomyosin);GO:0006936(muscle contraction);GO:0008307(structural constituent of muscle);GO:0030049(muscle filament sliding);GO:0043462(regulation of ATPase activity)","04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);05410(Hypertrophic cardiomyopathy (HCM));05414(Dilated cardiomyopathy (DCM))","mRNA","agilent G3 V3"]
["A_33_P3395743",14.72,14.73,14.59,15.97,{"v":15.9,"d":"15.90"},15.87,{"v":0.922496857980729,"d":"0.92"},{"v":-0.116384097517408,"d":"-0.12"},"down",{"v":2.08489999999895e-05,"d":"0.00"},1,"yes","CCTCGCCTCTTCCCCACTAACATCCCAGACTTTAAAATTCAGTAAATCAGATGTACACCG","FALSE","NM_022834","ref|NM_022834|ref|NM_199121|ens|ENST00000338660|ens|ENST00000476993","VWA1","von Willebrand factor A domain containing 1","ref|Homo sapiens von Willebrand factor A domain containing 1 (VWA1), transcript variant 1, mRNA [NM_022834]","chr1",{"v":1370903,"d":"1370903.00"},1378262,"GO:0005604(basement membrane);GO:0005614(interstitial matrix);GO:0005615(extracellular space);GO:0030198(extracellular matrix organization);GO:0042802(identical protein binding);GO:0048266(behavioral response to pain);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P341223",5.03,4.95,5.24,7.53,7.75,7.55,{"v":0.666666666666667,"d":"0.67"},{"v":-0.584962500721156,"d":"-0.58"},"down",{"v":2.10189999999555e-05,"d":"0.00"},1,"yes","GGCAGGTTGACATATTTATTTTTGTCTATTCTGTAGGCTTCCATGTCCAGAATCCTGCTT","FALSE","NM_014851","ref|NM_014851|ens|ENST00000377658|gb|AK090472|gb|AK057164","KLHL21","kelch-like family member 21","ref|Homo sapiens kelch-like family member 21 (KLHL21), mRNA [NM_014851]","chr1",{"v":6650784,"d":"6650784.00"},6663061,"GO:0004842(ubiquitin-protein ligase activity);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005827(polar microtubule);GO:0007067(mitosis);GO:0016567(protein ubiquitination);GO:0031463(Cul3-RING ubiquitin ligase complex);GO:0032465(regulation of cytokinesis);GO:0035853(chromosome passenger complex localization to spindle midzone);GO:0051301(cell division)",null,"mRNA","agilent G3 V3"]
["A_23_P150857",2.02,1.92,2.21,4.63,4.56,{"v":4.4,"d":"4.40"},{"v":0.452538631346578,"d":"0.45"},{"v":-1.14388714054079,"d":"-1.14"},"down",{"v":2.10259999999796e-05,"d":"0.00"},1,"yes","GAACTGAACATTGTTTGTAAGGCTGTGGATGATGGTTACAATGTGCAGCCAGACACCGTG","FALSE","NM_000456","ref|NM_000456|ref|NM_001032386|ref|NM_001032387|ens|ENST00000394115","SUOX","sulfite oxidase","ref|Homo sapiens sulfite oxidase (SUOX), transcript variant 1, mRNA [NM_000456]","chr12",56396000,56400425,"GO:0000096(sulfur amino acid metabolic process);GO:0000098(sulfur amino acid catabolic process);GO:0005758(mitochondrial intermembrane space);GO:0005759(mitochondrial matrix);GO:0008482(sulfite oxidase activity);GO:0009055(electron carrier activity);GO:0020037(heme binding);GO:0030151(molybdenum ion binding);GO:0034641(cellular nitrogen compound metabolic process);GO:0043546(molybdopterin cofactor binding);GO:0044281(small molecule metabolic process);GO:0070221(sulfide oxidation, using sulfide:quinone oxidoreductase)","00920(Sulfur metabolism)","mRNA","agilent G3 V3"]
["A_33_P3296577",2.63,2.68,2.51,4.78,4.57,4.55,{"v":0.562589928057554,"d":"0.56"},{"v":-0.829844370303518,"d":"-0.83"},"down",{"v":2.11109999999071e-05,"d":"0.00"},1,"yes","CAGGGTCATTTTACTTTGAGGCTTTTTGTTTTAAAATGTAGCCAAGGTTTTTACAAAGGG","FALSE","NM_013318","ref|NM_013318|ens|ENST00000357304|ens|ENST00000405995|ens|ENST00000465931","PRRC2B","proline-rich coiled-coil 2B","ref|Homo sapiens proline-rich coiled-coil 2B (PRRC2B), mRNA [NM_013318]","chr9",134322480,134371710,"GO:0005515(protein binding)",null,"mRNA","agilent G3 V3"]
["A_23_P28057",6.58,6.47,{"v":6.6,"d":"6.60"},7.77,7.72,7.66,{"v":0.848812095032397,"d":"0.85"},{"v":-0.23648288100163,"d":"-0.24"},"down",{"v":2.11789999999823e-05,"d":"0.00"},1,"yes","CAGGGCCTGGTCTTTGTTGCACTAACACGTCTCCTCTCTGGGAAACGTCCCTTGTCAGGA","FALSE","NM_003249","ref|NM_003249|ens|ENST00000589087|gb|U29366|gb|Z50115","THOP1","thimet oligopeptidase 1","ref|Homo sapiens thimet oligopeptidase 1 (THOP1), mRNA [NM_003249]","chr19",{"v":2810151,"d":"2810151.00"},2813179,"GO:0004222(metalloendopeptidase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006508(proteolysis);GO:0006518(peptide metabolic process);GO:0035556(intracellular signal transduction);GO:0042277(peptide binding);GO:0046872(metal ion binding)","04614(Renin-angiotensin system);05143(African trypanosomiasis)","mRNA","agilent G3 V3"]
["A_23_P15582",5.62,5.38,5.23,8.28,8.18,8.12,{"v":0.660292921074044,"d":"0.66"},{"v":-0.59882191582469,"d":"-0.60"},"down",{"v":2.12179999999895e-05,"d":"0.00"},1,"yes","TGGAGTAATTGTGCCTGAAGCTCAGCGTGAAGTCTGAAATATGCAACAGAAGAAATATAT","FALSE","NM_022167","ref|NM_022167|ref|NR_110010|ens|ENST00000017003|ens|ENST00000376550","XYLT2","xylosyltransferase II","ref|Homo sapiens xylosyltransferase II (XYLT2), transcript variant 1, mRNA [NM_022167]","chr17",48436340,48438512,"GO:0000139(Golgi membrane);GO:0005575(cellular_component);GO:0005789(endoplasmic reticulum membrane);GO:0006024(glycosaminoglycan biosynthetic process);GO:0008375(acetylglucosaminyltransferase activity);GO:0015012(heparan sulfate proteoglycan biosynthetic process);GO:0016021(integral to membrane);GO:0030158(protein xylosyltransferase activity);GO:0030206(chondroitin sulfate biosynthetic process);GO:0030210(heparin biosynthetic process)","00532(Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate);00534(Glycosaminoglycan biosynthesis - heparan sulfate / heparin)","mRNA","agilent G3 V3"]
["A_23_P168443",1.91,2.09,1.89,4.15,4.38,4.41,{"v":0.455177743431221,"d":"0.46"},{"v":-1.13549807816205,"d":"-1.14"},"down",{"v":2.13019999999453e-05,"d":"0.00"},1,"yes","AGATCTCTGCTGAGGACCTGCTCCGAATCGGAGTCACTCTGGCGGGACACCAGAAGAAAA","FALSE","NM_004444","ref|NM_004444|ens|ENST00000487222|ens|ENST00000358173|ens|ENST00000616502","EPHB4","EPH receptor B4","ref|Homo sapiens EPH receptor B4 (EPHB4), mRNA [NM_004444]","chr7",100400184,100425121,"GO:0001525(angiogenesis);GO:0002042(cell migration involved in sprouting angiogenesis);GO:0003007(heart morphogenesis);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0005003(ephrin receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005576(extracellular region);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0007155(cell adhesion);GO:0007411(axon guidance);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0046777(protein autophosphorylation);GO:0048013(ephrin receptor signaling pathway);GO:0070062(extracellular vesicular exosome)","04360(Axon guidance)","mRNA","agilent G3 V3"]
["A_32_P57057",3.86,3.93,3.82,{"v":5.5,"d":"5.50"},5.59,5.37,{"v":0.705346294046172,"d":"0.71"},{"v":-0.503596363556059,"d":"-0.50"},"down",{"v":2.1324999999961e-05,"d":"0.00"},1,"yes","AATACCAGATGGGAGATCAAAATGTGTATCCTGGACCCATTGATAACTCTGGACTTCTCA","FALSE","NM_006313","ref|NM_006313|ref|NM_001252079|ref|NM_001252078|ens|ENST00000546718","USP15","ubiquitin specific peptidase 15","ref|Homo sapiens ubiquitin specific peptidase 15 (USP15), transcript variant 2, mRNA [NM_006313]","chr12",62654188,62799898,"GO:0004197(cysteine-type endopeptidase activity);GO:0004843(ubiquitin-specific protease activity);GO:0005160(transforming growth factor beta receptor binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0016579(protein deubiquitination);GO:0030509(BMP signaling pathway);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0035520(monoubiquitinated protein deubiquitination);GO:0035616(histone H2B conserved C-terminal lysine deubiquitination);GO:0042802(identical protein binding);GO:0043161(proteasomal ubiquitin-dependent protein catabolic process);GO:0046332(SMAD binding);GO:0060389(pathway-restricted SMAD protein phosphorylation);GO:0061136(regulation of proteasomal protein catabolic process)",null,"mRNA","agilent G3 V3"]
["A_23_P211631",10.01,9.91,9.85,11.89,11.83,11.66,{"v":0.841435839457321,"d":"0.84"},{"v":-0.249074826452422,"d":"-0.25"},"down",{"v":2.16020000000094e-05,"d":"0.00"},1,"yes","GGAATGGCTGGGATTTCTCGGCACTCTGCATCATCCATCTTTTCTTATAGGTGGGAAAAT","FALSE","NM_006486","ref|NM_006486|ens|ENST00000327858|gb|AF126110|gb|AK128725","FBLN1","fibulin 1","ref|Homo sapiens fibulin 1 (FBLN1), transcript variant D, mRNA [NM_006486]","chr22",45898720,45997014,"GO:0005201(extracellular matrix structural constituent);GO:0005509(calcium ion binding);GO:0005576(extracellular region);GO:0005578(proteinaceous extracellular matrix);GO:0005604(basement membrane);GO:0005615(extracellular space);GO:0007566(embryo implantation);GO:0010952(positive regulation of peptidase activity);GO:0016032(viral reproduction);GO:0016504(peptidase activator activity);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_24_P941051",11.96,11.96,12.05,10.85,10.79,10.93,{"v":1.10439054344489,"d":"1.10"},{"v":0.143250439739476,"d":"0.14"},"up",{"v":2.16189999999727e-05,"d":"0.00"},1,"yes","TGCCTCCCCTATATTGGAGAGGATAACTCGCGTTTACATATGTGATAGTTATGCTTAATA","FALSE","NM_015235","ref|NM_015235|ens|ENST00000331173|gb|AB014589|tc|THC2604735","CSTF2T","cleavage stimulation factor, 3' pre-RNA, subunit 2, 64kDa, tau variant","ref|Homo sapiens cleavage stimulation factor, 3' pre-RNA, subunit 2, 64kDa, tau variant (CSTF2T), mRNA [NM_015235]","chr10",53455248,53459355,"GO:0000166(nucleotide binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0006397(mRNA processing)","03015(mRNA surveillance pathway)","mRNA","agilent G3 V3"]
["A_24_P81947",{"v":2.5,"d":"2.50"},2.56,2.94,6.05,5.99,6.21,{"v":0.438356164383562,"d":"0.44"},{"v":-1.18982455888002,"d":"-1.19"},"down",{"v":2.17829999999974e-05,"d":"0.00"},1,"yes","GTAATCTGCTGAGGACCTTTTGTCTAAGATTCAGTAGTGTTTTAAGGTTCTGATATCGAA","FALSE","NM_014325","ref|NM_014325|ref|NM_001276471|ref|NM_001105237|ens|ENST00000420959","CORO1C","coronin, actin binding protein, 1C","ref|Homo sapiens coronin, actin binding protein, 1C (CORO1C), transcript variant 2, mRNA [NM_014325]","chr12",109038888,109125372,"GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0006909(phagocytosis);GO:0007165(signal transduction);GO:0015629(actin cytoskeleton);GO:0030027(lamellipodium);GO:0030036(actin cytoskeleton organization);GO:0051015(actin filament binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3338693",7.48,7.33,7.29,8.83,8.95,8.93,{"v":0.827405466117559,"d":"0.83"},{"v":-0.273333606356316,"d":"-0.27"},"down",{"v":2.1838999999968e-05,"d":"0.00"},1,"yes","CTCCTGTCTCCTCTGTCAGTTTGTGAAGTGATTGACATTTTGTAGCTAGTTTAAAATTAT","FALSE","NM_003081","ref|NM_003081|ref|NM_130811|ens|ENST00000495883|ens|ENST00000254976","SNAP25","synaptosomal-associated protein, 25kDa","ref|Homo sapiens synaptosomal-associated protein, 25kDa (SNAP25), transcript variant 1, mRNA [NM_003081]","chr20",10276878,10288066,"GO:0001504(neurotransmitter uptake);GO:0005484(SNAP receptor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005802(trans-Golgi network);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006112(energy reserve metabolic process);GO:0007268(synaptic transmission);GO:0007269(neurotransmitter secretion);GO:0009405(pathogenesis);GO:0010975(regulation of neuron projection development);GO:0014047(glutamate secretion);GO:0016020(membrane);GO:0016079(synaptic vesicle exocytosis);GO:0016081(synaptic vesicle docking involved in exocytosis);GO:0016082(synaptic vesicle priming);GO:0017075(syntaxin-1 binding);GO:0030054(cell junction);GO:0030426(growth cone);GO:0031083(BLOC-1 complex);GO:0031201(SNARE complex);GO:0031629(synaptic vesicle fusion to presynaptic membrane);GO:0031982(vesicle);GO:0042734(presynaptic membrane);GO:0043005(neuron projection);GO:0044281(small molecule metabolic process);GO:0048306(calcium-dependent protein binding);GO:0048471(perinuclear region of cytoplasm);GO:0050796(regulation of insulin secretion);GO:0060291(long-term synaptic potentiation);GO:0070032(synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex);GO:0070201(regulation of establishment of protein localization)","04911(Insulin secretion);04721(Synaptic vesicle cycle)","mRNA","agilent G3 V3"]
["A_23_P41292",2.57,2.74,2.78,4.39,4.27,4.33,{"v":0.62278675904542,"d":"0.62"},{"v":-0.683189823017903,"d":"-0.68"},"down",{"v":2.18810000000014e-05,"d":"0.00"},1,"yes","CTTGTCTGTGTACAGTTTTTAGAACATTACAAAGGATCTGTTTGCTTAGCTGTCAACAAA","FALSE","NM_001012614","ref|NM_001012614|ref|NM_001328|ens|ENST00000514596|ens|ENST00000382952","CTBP1","C-terminal binding protein 1","ref|Homo sapiens C-terminal binding protein 1 (CTBP1), transcript variant 2, mRNA [NM_001012614]","chr4",{"v":1206063,"d":"1206063.00"},1207542,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0001106(RNA polymerase II transcription corepressor activity);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005829(cytosol);GO:0006351(transcription, DNA-dependent);GO:0006468(protein phosphorylation);GO:0007030(Golgi organization);GO:0008022(protein C-terminus binding);GO:0008134(transcription factor binding);GO:0008285(negative regulation of cell proliferation);GO:0016616(oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor);GO:0017053(transcriptional repressor complex);GO:0019079(viral genome replication);GO:0019904(protein domain specific binding);GO:0031065(positive regulation of histone deacetylation);GO:0035067(negative regulation of histone acetylation);GO:0042803(protein homodimerization activity);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0050872(white fat cell differentiation);GO:0051287(NAD binding);GO:0051726(regulation of cell cycle);GO:0055114(oxidation-reduction process);GO:0070491(repressing transcription factor binding);GO:0090241(negative regulation of histone H4 acetylation)","04310(Wnt signaling pathway);04330(Notch signaling pathway);05200(Pathways in cancer);05220(Chronic myeloid leukemia)","mRNA","agilent G3 V3"]
["A_33_P3752697",7.46,7.26,7.16,9.33,9.39,9.44,{"v":0.776988636363636,"d":"0.78"},{"v":-0.364034595844741,"d":"-0.36"},"down",{"v":2.19079999999039e-05,"d":"0.00"},1,"yes","AAAGCATTTCAAACTTAAAAGCAAAATCTAGCCAGGTGCCGTGGCTCACGCCTGTAATCC","FALSE","AK098235","gb|AK098235|tc|THC2483650",null,null,"gb|Homo sapiens cDNA FLJ40916 fis, clone UTERU2005533. [AK098235]",{"$nulls":5},"mRNA","agilent G3 V3"]
["A_24_P212234",10.05,10.17,10.14,9.16,9.09,9.17,{"v":1.10722100656455,"d":"1.11"},{"v":0.14694321963624,"d":"0.15"},"up",{"v":2.19959999999686e-05,"d":"0.00"},1,"yes","GGCTGGAGATTTTCGACAATTTTGCCGCTTCCCCGAACCTGCTCATGTTGGCCTTTCTCG","FALSE","NM_182632","ref|NM_182632|ens|ENST00000324642|ref|XM_005248298|gb|BC056757","SLC6A18","solute carrier family 6 (neutral amino acid transporter), member 18","ref|Homo sapiens solute carrier family 6 (neutral amino acid transporter), member 18 (SLC6A18), mRNA [NM_182632]","chr5",{"v":1225470,"d":"1225470.00"},1244492,"GO:0003333(amino acid transmembrane transport);GO:0005328(neurotransmitter:sodium symporter activity);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0006811(ion transport);GO:0006836(neurotransmitter transport);GO:0006865(amino acid transport);GO:0031526(brush border membrane);GO:0055085(transmembrane transport)",null,"mRNA","agilent G3 V3"]
["A_21_P0011714",13.26,13.28,13.28,12.36,12.49,12.42,{"v":1.0684196404615,"d":"1.07"},{"v":0.0954784019916528,"d":"0.10"},"up",{"v":2.20139999999036e-05,"d":"0.00"},1,"yes","TACTATTATATGAACACCCCCCAGGTGTGGTCCCACCCCAGTGACCCCCTGGAGATTCTG","FALSE","NM_024318","ref|NM_024318|ens|ENST00000611751|ens|ENST00000618191|ens|ENST00000444199","LILRA6","leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6","ref|Homo sapiens leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 (LILRA6), transcript variant 1, mRNA [NM_024318]","chr19",54742828,54746610,"GO:0002376(immune system process);GO:0016021(integral to membrane)","04380(Osteoclast differentiation)","mRNA","agilent G3 V3"]
["A_23_P120710",2.54,2.59,2.21,6.44,6.46,6.07,{"v":0.386926726410121,"d":"0.39"},{"v":-1.36986771056826,"d":"-1.37"},"down",{"v":2.20239999999539e-05,"d":"0.00"},1,"yes","TCGTTCTGTGTTTGATATTTGTGTAAAGTATGCATGCAGTCTTGTACTGTGACCTAAGAA","FALSE","NM_003316","ref|NM_003316|ref|NM_001001894|ens|ENST00000355666|ens|ENST00000399017","TTC3","tetratricopeptide repeat domain 3","ref|Homo sapiens tetratricopeptide repeat domain 3 (TTC3), transcript variant 1, mRNA [NM_003316]","chr21",38445572,38575404,"GO:0004842(ubiquitin-protein ligase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0005773(vacuole);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0008270(zinc ion binding);GO:0010771(negative regulation of cell morphogenesis involved in differentiation);GO:0016874(ligase activity);GO:0045665(negative regulation of neuron differentiation);GO:0070936(protein K48-linked ubiquitination)",null,"mRNA","agilent G3 V3"]
["A_24_P376391",4.45,4.47,4.82,8.22,7.98,7.89,{"v":0.570361145703611,"d":"0.57"},{"v":-0.810052389420371,"d":"-0.81"},"down",{"v":2.21679999999891e-05,"d":"0.00"},1,"yes","CGAGGCTGTAGCTGGGCTACTTGATCTTGCTGAAAGTGTTTCTAAAGATAGCACCACTTT","FALSE","NM_015103","ref|NM_015103|ens|ENST00000512744|ens|ENST00000504524|ens|ENST00000501038","PLXND1","plexin D1","ref|Homo sapiens plexin D1 (PLXND1), mRNA [NM_015103]","chr3",129274016,129325661,"GO:0001525(angiogenesis);GO:0001569(patterning of blood vessels);GO:0003151(outflow tract morphogenesis);GO:0005515(protein binding);GO:0005622(intracellular);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0007411(axon guidance);GO:0007416(synapse assembly);GO:0017154(semaphorin receptor activity);GO:0019904(protein domain specific binding);GO:0030027(lamellipodium);GO:0030334(regulation of cell migration);GO:0032092(positive regulation of protein binding);GO:0043542(endothelial cell migration);GO:0045765(regulation of angiogenesis);GO:0060666(dichotomous subdivision of terminal units involved in salivary gland branching);GO:0071526(semaphorin-plexin signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_33_P3245066",12.55,12.52,12.59,11.68,11.65,11.76,{"v":1.07324023938444,"d":"1.07"},{"v":0.101973052212062,"d":"0.10"},"up",{"v":2.21830000000089e-05,"d":"0.00"},1,"yes","GCTTCTCACCTGGGAAATACAAAAATAGCCCCTCCTGAAGATAAAATCATTCAGAAACAG","FALSE","NM_001290264","ref|NM_001290264|ref|NM_001110781|ref|NM_182838|ens|ENST00000480991","SLC35E2B","solute carrier family 35, member E2B","ref|Homo sapiens solute carrier family 35, member E2B (SLC35E2B), transcript variant 1, mRNA [NM_001290264]","chr1",{"v":1595221,"d":"1595221.00"},1601578,"GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_24_P177964",8.77,8.64,8.95,10.83,10.78,10.82,{"v":0.812827628738822,"d":"0.81"},{"v":-0.298978653447755,"d":"-0.30"},"down",{"v":2.21990000000005e-05,"d":"0.00"},1,"yes","TTGTTTAAAATGCGGCTGCTCTGCTTCCTGCCTCTGCTTCTGCCGTATCCCTAATAAAAT","FALSE","NM_001037806","ref|NM_001037806|ens|ENST00000335999|ref|XM_006719525|ref|XM_006719524","NCKAP5L","NCK-associated protein 5-like","ref|Homo sapiens NCK-associated protein 5-like (NCKAP5L), mRNA [NM_001037806]","chr12",50184928,50222208,null,null,"mRNA","agilent G3 V3"]
["A_23_P84782",4.71,4.59,4.56,6.35,6.18,6.37,{"v":0.733333333333334,"d":"0.73"},{"v":-0.447458976971221,"d":"-0.45"},"down",{"v":2.22129999999376e-05,"d":"0.00"},1,"yes","CACAGCCAATGACTCAGCATCTTCACGTCACCTACAAGAAGGTGACCCCGTAAACCTAGA","FALSE","NM_015963","ref|NM_015963|ref|NM_001164356|ens|ENST00000612200|ens|ENST00000321679","THAP4","THAP domain containing 4","ref|Homo sapiens THAP domain containing 4 (THAP4), transcript variant 1, mRNA [NM_015963]","chr2",242523840,242556905,"GO:0003677(DNA binding);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_32_P222383",6.16,6.32,{"v":6.2,"d":"6.20"},8.36,8.52,8.23,{"v":0.743926722421346,"d":"0.74"},{"v":-0.426767573561838,"d":"-0.43"},"down",{"v":2.22460000000035e-05,"d":"0.00"},1,"yes","TACTGAAAGTCAGGGTCGGCTTGTGAAAAGTTGTTAAACAACATGCTAAATGTGAAATGT","FALSE","NM_005517","ref|NM_005517|ref|NM_020810|ens|ENST00000619352|ens|ENST00000361427","HMGN2","high mobility group nucleosomal binding domain 2","ref|Homo sapiens high mobility group nucleosomal binding domain 2 (HMGN2), mRNA [NM_005517]","chr1",26799920,26801851,"GO:0000785(chromatin);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0031492(nucleosomal DNA binding)",null,"mRNA","agilent G3 V3"]
["A_23_P4773",2.04,{"v":1.9,"d":"1.90"},2.21,4.54,4.36,4.56,{"v":0.456909361069837,"d":"0.46"},{"v":-1.13002009438371,"d":"-1.13"},"down",{"v":2.22469999999753e-05,"d":"0.00"},1,"yes","CTAGATTCTGCAGTCAAAGATGACTAATATCCTTGCATTTTTGAAATGAAGCCACAGACT","FALSE","NM_006840","ref|NM_006840|ref|NM_001081442|ref|NM_001081443|ens|ENST00000617636","LILRB5","leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5","ref|Homo sapiens leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5 (LILRB5), transcript variant 2, mRNA [NM_006840]","chr19",54754268,54761134,"GO:0002376(immune system process);GO:0004888(transmembrane signaling receptor activity);GO:0006952(defense response);GO:0007166(cell surface receptor signaling pathway);GO:0016021(integral to membrane)","04380(Osteoclast differentiation)","mRNA","agilent G3 V3"]
["A_23_P36562",6.07,6.15,6.13,7.32,7.26,7.43,{"v":0.833711949114039,"d":"0.83"},{"v":-0.262379082160982,"d":"-0.26"},"down",{"v":2.24719999999401e-05,"d":"0.00"},1,"yes","GGACTTCCTGTCCAGCTCCAACCTGCAAAGATCTGTCCTCAGCCTTGCCAGAGATCCAAA","FALSE","NM_002205","ref|NM_002205|ens|ENST00000552564|ens|ENST00000293379|gb|M13918","ITGA5","integrin, alpha 5 (fibronectin receptor, alpha polypeptide)","ref|Homo sapiens integrin, alpha 5 (fibronectin receptor, alpha polypeptide) (ITGA5), mRNA [NM_002205]","chr12",54790008,54792607,"GO:0001525(angiogenesis);GO:0001726(ruffle);GO:0005154(epidermal growth factor receptor binding);GO:0005161(platelet-derived growth factor receptor binding);GO:0005178(integrin binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0005925(focal adhesion);GO:0007044(cell-substrate junction assembly);GO:0007155(cell adhesion);GO:0007157(heterophilic cell-cell adhesion);GO:0007159(leukocyte cell-cell adhesion);GO:0007229(integrin-mediated signaling pathway);GO:0007411(axon guidance);GO:0007596(blood coagulation);GO:0007613(memory);GO:0008305(integrin complex);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0010811(positive regulation of cell-substrate adhesion);GO:0016032(viral reproduction);GO:0030198(extracellular matrix organization);GO:0030335(positive regulation of cell migration);GO:0030949(positive regulation of vascular endothelial growth factor receptor signaling pathway);GO:0031589(cell-substrate adhesion);GO:0032587(ruffle membrane);GO:0033631(cell-cell adhesion mediated by integrin);GO:0034113(heterotypic cell-cell adhesion);GO:0035313(wound healing, spreading of epidermal cells);GO:0035987(endodermal cell differentiation);GO:0043184(vascular endothelial growth factor receptor 2 binding);GO:0045202(synapse);GO:0046872(metal ion binding);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0050900(leukocyte migration);GO:0071062(alphav-beta3 integrin-vitronectin complex);GO:2000811(negative regulation of anoikis)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04145(Phagosome);04810(Regulation of actin cytoskeleton);04510(Focal adhesion);04640(Hematopoietic cell lineage);05206(MicroRNAs in cancer);05205(Proteoglycans in cancer);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM));05131(Shigellosis);05133(Pertussis);05100(Bacterial invasion of epithelial cells)","mRNA","agilent G3 V3"]
["A_33_P3320953",14.07,14.02,13.96,15.44,15.44,15.28,{"v":0.910961871750433,"d":"0.91"},{"v":-0.134537423502976,"d":"-0.13"},"down",{"v":2.24879999999317e-05,"d":"0.00"},1,"yes","CGTTCCACTCCTCCCTGCCTCTGAGCCGAACATGATAATAAAAGCTATTATTGAGCGCTT","FALSE","NM_206833","ref|NM_206833|ens|ENST00000318978|gb|AK098834|gb|BC024148","CTXN1","cortexin 1","ref|Homo sapiens cortexin 1 (CTXN1), mRNA [NM_206833]","chr19",{"v":7989372,"d":"7989372.00"},7991051,"GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3222892",{"v":2.1,"d":"2.10"},1.96,{"v":2.5,"d":"2.50"},5.89,5.78,5.81,{"v":0.375286041189931,"d":"0.38"},{"v":-1.41393746488251,"d":"-1.41"},"down",{"v":2.2522999999941e-05,"d":"0.00"},1,"yes","ACTGATTTTTTATTCTCCAGCTTTCAGTGCCAAAGAGGCCATGCTGAGTTAGGTAGGTGG","FALSE","NM_019848","ref|NM_019848|ref|NM_001142392|ref|NM_001142391|ens|ENST00000393587","SLC10A3","solute carrier family 10, member 3","ref|Homo sapiens solute carrier family 10, member 3 (SLC10A3), transcript variant 1, mRNA [NM_019848]","chrX",153715648,153719002,"GO:0005887(integral to plasma membrane);GO:0008508(bile acid:sodium symporter activity);GO:0015721(bile acid and bile salt transport);GO:0032526(response to retinoic acid);GO:0055085(transmembrane transport)",null,"mRNA","agilent G3 V3"]
["A_33_P3408203",6.46,6.45,6.61,8.03,8.12,8.21,{"v":0.801313628899836,"d":"0.80"},{"v":-0.319561080343446,"d":"-0.32"},"down",{"v":2.26319999999669e-05,"d":"0.00"},1,"yes","CCTTGGTGGTGGTCTCCATCGTGGCCCTGGCTGTCCTTATCATCACATGTGTGCTGATAC","FALSE","NM_003236","ref|NM_003236|ref|NM_001099691|ens|ENST00000418333|ens|ENST00000295400","TGFA","transforming growth factor, alpha","ref|Homo sapiens transforming growth factor, alpha (TGFA), transcript variant 1, mRNA [NM_003236]","chr2",70683496,70780958,"GO:0000187(activation of MAPK activity);GO:0001525(angiogenesis);GO:0001948(glycoprotein binding);GO:0005154(epidermal growth factor receptor binding);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0008083(growth factor activity);GO:0008283(cell proliferation);GO:0009986(cell surface);GO:0016323(basolateral plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0042060(wound healing);GO:0042493(response to drug);GO:0043066(negative regulation of apoptotic process);GO:0045741(positive regulation of epidermal growth factor-activated receptor activity);GO:0045840(positive regulation of mitosis);GO:0048471(perinuclear region of cytoplasm);GO:0050679(positive regulation of epithelial cell proliferation);GO:0060749(mammary gland alveolus development)","04012(ErbB signaling pathway);05200(Pathways in cancer);05212(Pancreatic cancer);05214(Glioma);05211(Renal cell carcinoma);05215(Prostate cancer);05223(Non-small cell lung cancer)","mRNA","agilent G3 V3"]
["A_23_P323166",6.29,6.57,6.07,9.98,{"v":10.1,"d":"10.10"},10.31,{"v":0.622902270483712,"d":"0.62"},{"v":-0.682922263818589,"d":"-0.68"},"down",{"v":2.27019999999856e-05,"d":"0.00"},1,"yes","CCAGAAGTTCCCAGGGGTGATTGTGATGGTGGTTGGGACTGGAGGTTGTATAAGGTGTTC","FALSE","NM_016333","ref|NM_016333|ens|ENST00000574331|ens|ENST00000301740|ref|XR_243270","SRRM2","serine/arginine repetitive matrix 2","ref|Homo sapiens serine/arginine repetitive matrix 2 (SRRM2), mRNA [NM_016333]","chr16",{"v":2821279,"d":"2821279.00"},2822539,"GO:0000398(nuclear mRNA splicing, via spliceosome);GO:0005654(nucleoplasm);GO:0015030(Cajal body);GO:0016607(nuclear speck);GO:0047485(protein N-terminus binding);GO:0070742(C2H2 zinc finger domain binding);GO:0071013(catalytic step 2 spliceosome)",null,"mRNA","agilent G3 V3"]
["A_23_P389907",6.55,6.43,6.45,8.73,8.88,8.55,{"v":0.742737003058104,"d":"0.74"},{"v":-0.429076639912738,"d":"-0.43"},"down",{"v":2.28259999999203e-05,"d":"0.00"},1,"yes","TTTCAGAGTCCCGCAGGTACCCCAGCTCTGCTTGCCGAAACTGGAAGTTATTTATTTTTT","FALSE","NM_002973","ref|NM_002973|ens|ENST00000482777|ens|ENST00000484991|ens|ENST00000483311","ATXN2","ataxin 2","ref|Homo sapiens ataxin 2 (ATXN2), mRNA [NM_002973]","chr12",111890072,112037480,"GO:0002091(negative regulation of receptor internalization);GO:0003723(RNA binding);GO:0005154(epidermal growth factor receptor binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0005844(polysome);GO:0006417(regulation of translation);GO:0008022(protein C-terminus binding);GO:0010494(cytoplasmic stress granule);GO:0016020(membrane);GO:0016070(RNA metabolic process);GO:0021702(cerebellar Purkinje cell differentiation);GO:0030529(ribonucleoprotein complex);GO:0033962(cytoplasmic mRNA processing body assembly);GO:0034063(stress granule assembly);GO:0040015(negative regulation of multicellular organism growth);GO:0048471(perinuclear region of cytoplasm);GO:0048812(neuron projection morphogenesis);GO:0048872(homeostasis of number of cells);GO:0050658(RNA transport);GO:0050905(neuromuscular process)",null,"mRNA","agilent G3 V3"]
["A_33_P3376463",7.37,7.43,7.34,6.32,6.36,6.22,{"v":1.17142857142857,"d":"1.17"},{"v":0.228268987673117,"d":"0.23"},"up",{"v":2.28769999999212e-05,"d":"0.00"},1,"yes","ATGCATACCTTAAAGCTATAGTTCTCTTTAGCCCCGGTAAGATATGCGGTGGGGATGCAT","FALSE","ENST00000475707","ens|ENST00000475707|gb|BC051670|tc|THC2475775","NR2C2","nuclear receptor subfamily 2, group C, member 2","ens|nuclear receptor subfamily 2, group C, member 2 [Source:HGNC Symbol;Acc:HGNC:7972] [ENST00000475707]","chr3",15075831,15079554,"GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0003707(steroid hormone receptor activity);GO:0003713(transcription coactivator activity);GO:0004872(receptor activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-dependent);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0007283(spermatogenesis);GO:0007399(nervous system development);GO:0008270(zinc ion binding);GO:0010467(gene expression);GO:0021549(cerebellum development);GO:0030154(cell differentiation);GO:0040019(positive regulation of embryonic development);GO:0043401(steroid hormone mediated signaling pathway);GO:0043565(sequence-specific DNA binding);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046982(protein heterodimerization activity);GO:0048520(positive regulation of behavior);GO:0051321(meiotic cell cycle)",null,"mRNA","agilent G3 V3"]
["A_33_P3267230",2.41,2.58,2.44,6.86,6.63,{"v":7.3,"d":"7.30"},{"v":0.357383357383357,"d":"0.36"},{"v":-1.48445564231977,"d":"-1.48"},"down",{"v":2.28789999999757e-05,"d":"0.00"},1,"yes","TTAACAACCCAAGCAAGCTTCGCGTCCTCGTTTTATTTTTGGTTAAACTTATGAATATGT","FALSE","NM_001001417","ref|NM_001001417|ref|NM_001291463|ref|NM_001001418|ref|NM_001291459","TBC1D3B","TBC1 domain family, member 3B","ref|Homo sapiens TBC1 domain family, member 3B (TBC1D3B), mRNA [NM_001001417]","chr17",34797172,34808103,"GO:0005097(Rab GTPase activator activity);GO:0005886(plasma membrane);GO:0032851(positive regulation of Rab GTPase activity)",null,"mRNA","agilent G3 V3"]
["A_33_P3344574",15.09,15.13,15.07,13.91,13.95,14.07,{"v":1.08013355592654,"d":"1.08"},{"v":0.111209709203722,"d":"0.11"},"up",{"v":2.29290000000049e-05,"d":"0.00"},1,"yes","GCCACCCCACCCCTGAGCTGAATAAAGATGATTTAAGCATAATAAATCGTTAGTGTGTTC","FALSE","NM_001098668","ref|NM_001098668|ens|ENST00000372325","SFTPA2","surfactant protein A2","ref|Homo sapiens surfactant protein A2 (SFTPA2), mRNA [NM_001098668]","chr10",81315608,81320151,"GO:0005576(extracellular region);GO:0005578(proteinaceous extracellular matrix);GO:0005581(collagen);GO:0005615(extracellular space);GO:0007585(respiratory gaseous exchange);GO:0030246(carbohydrate binding)","04145(Phagosome);05133(Pertussis)","mRNA","agilent G3 V3"]
["A_33_P3318444",11.44,11.68,11.47,13.72,13.52,13.67,{"v":0.845514544121242,"d":"0.85"},{"v":-0.242098523515119,"d":"-0.24"},"down",{"v":2.30219999999282e-05,"d":"0.00"},1,"yes","ATTCCTCAGCAAGAAGAGCTCCCGCTGGCCCTCCATGCTGGACAAGAGCTCCCAGACGCT","FALSE","NM_001146684","ref|NM_001146684|ens|ENST00000399398|ens|ENST00000344001","RNF222","ring finger protein 222","ref|Homo sapiens ring finger protein 222 (RNF222), mRNA [NM_001146684]","chr17",{"v":8294022,"d":"8294022.00"},8296807,"GO:0008270(zinc ion binding);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3354783",10.22,10.29,10.26,9.47,9.37,9.46,{"v":1.08727915194346,"d":"1.09"},{"v":0.1207223906143,"d":"0.12"},"up",{"v":2.30229999998999e-05,"d":"0.00"},1,"yes","AACAGAGAGGATTGCAGGGAGCTGTGTGCTCAGATGCAGCACCCCCATATCGTCACGTCT","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_32_P155247",4.48,4.91,4.87,8.94,8.58,8.98,{"v":0.53811320754717,"d":"0.54"},{"v":-0.894018377894036,"d":"-0.89"},"down",{"v":2.30699999999029e-05,"d":"0.00"},1,"yes","CTTCTATTTCGACCGCGATGATGCGGCTCTGGAAGGCGTGAGCCACTTCTTCCGCGAATT","FALSE","NM_000146","ref|NM_000146|ens|ENST00000427242|ens|ENST00000622577|ens|ENST00000331825","FTL","ferritin, light polypeptide","ref|Homo sapiens ferritin, light polypeptide (FTL), mRNA [NM_000146]","chr19",49468560,49470135,"GO:0005506(iron ion binding);GO:0005515(protein binding);GO:0005829(cytosol);GO:0006826(iron ion transport);GO:0006879(cellular iron ion homeostasis);GO:0006892(post-Golgi vesicle-mediated transport);GO:0006898(receptor-mediated endocytosis);GO:0008043(intracellular ferritin complex);GO:0008199(ferric iron binding);GO:0016020(membrane);GO:0042802(identical protein binding);GO:0055072(iron ion homeostasis);GO:0055085(transmembrane transport);GO:0061024(membrane organization);GO:0070062(extracellular vesicular exosome)","04978(Mineral absorption)","mRNA","agilent G3 V3"]
["A_23_P118690",2.06,{"v":1.9,"d":"1.90"},2.14,5.61,5.14,5.36,{"v":0.378646803227809,"d":"0.38"},{"v":-1.40107534625632,"d":"-1.40"},"down",{"v":2.30809999999249e-05,"d":"0.00"},1,"yes","AGCAGGAACTTTTCCTGAAGTTGCAATTTATACTGTATGGCTTCTTTTTCATGTTTCATC","FALSE","NM_001032293","ref|NM_001032293|ref|NM_001098507|ref|NM_003457|ens|ENST00000394673","ZNF207","zinc finger protein 207","ref|Homo sapiens zinc finger protein 207 (ZNF207), transcript variant 2, mRNA [NM_001032293]","chr17",30677156,30697467,"GO:0000070(mitotic sister chromatid segregation);GO:0000776(kinetochore);GO:0000777(condensed chromosome kinetochore);GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005874(microtubule);GO:0006355(regulation of transcription, DNA-dependent);GO:0007094(mitotic cell cycle spindle assembly checkpoint);GO:0008017(microtubule binding);GO:0008201(heparin binding);GO:0008270(zinc ion binding);GO:0008608(attachment of spindle microtubules to kinetochore);GO:0050821(protein stabilization);GO:0051301(cell division);GO:0051983(regulation of chromosome segregation)",null,"mRNA","agilent G3 V3"]
["A_23_P57667",3.83,{"v":3.6,"d":"3.60"},3.87,7.51,7.26,7.78,{"v":0.501108647450111,"d":"0.50"},{"v":-0.996804660840193,"d":"-1.00"},"down",{"v":2.31269999999562e-05,"d":"0.00"},1,"yes","TATACGGCTATTTCCTATTTTACTGTTCTTCAGATTTAGTACTTGTAAATAAACACACAC","FALSE","NM_032242","ref|NM_032242|ens|ENST00000393409|ref|XM_006713663|gb|AK127254","PLXNA1","plexin A1","ref|Homo sapiens plexin A1 (PLXNA1), mRNA [NM_032242]","chr3",126707440,126756235,"GO:0002116(semaphorin receptor complex);GO:0004872(receptor activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0007275(multicellular organismal development);GO:0007411(axon guidance);GO:0014910(regulation of smooth muscle cell migration);GO:0016021(integral to membrane);GO:0017154(semaphorin receptor activity);GO:0060666(dichotomous subdivision of terminal units involved in salivary gland branching);GO:0070062(extracellular vesicular exosome);GO:0071526(semaphorin-plexin signaling pathway)","04360(Axon guidance)","mRNA","agilent G3 V3"]
["A_33_P3350748",14.67,14.61,14.72,15.57,15.58,{"v":15.5,"d":"15.50"},{"v":0.943193997856377,"d":"0.94"},{"v":-0.0843735573270992,"d":"-0.08"},"down",{"v":2.31399999999216e-05,"d":"0.00"},1,"yes","AAGAAGATTCCCACCCCTGCCTCCCATGCCTGGTCCCAAGACAGTGAGACAGTCTGGAAA","FALSE","NM_005556","ref|NM_005556|ens|ENST00000331817|ens|ENST00000549638|ref|XR_245927","KRT7","keratin 7, type II","ref|Homo sapiens keratin 7, type II (KRT7), mRNA [NM_005556]","chr12",52641704,52642709,"GO:0005198(structural molecule activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005882(intermediate filament);GO:0016032(viral reproduction);GO:0045095(keratin filament);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P255104",{"v":4.6,"d":"4.60"},4.39,4.57,7.72,8.16,7.76,{"v":0.573604060913706,"d":"0.57"},{"v":-0.801872857041189,"d":"-0.80"},"down",{"v":2.34049999999764e-05,"d":"0.00"},1,"yes","CCAAAAGAGTTAAAGGCACGACTGGGATTTCTTCTGAGACTGTGGTGAAACTCCTTCCAA","FALSE","NM_005779","ref|NM_005779|ens|ENST00000380345|ens|ENST00000515007|ref|XM_006714515","LHFPL2","lipoma HMGIC fusion partner-like 2","ref|Homo sapiens lipoma HMGIC fusion partner-like 2 (LHFPL2), mRNA [NM_005779]","chr5",77781040,77944648,"GO:0003674(molecular_function);GO:0005575(cellular_component);GO:0008150(biological_process);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_24_P282578",8.71,8.61,8.67,9.65,9.54,{"v":9.6,"d":"9.60"},{"v":0.902744008336228,"d":"0.90"},{"v":-0.147611155091234,"d":"-0.15"},"down",{"v":2.34209999999679e-05,"d":"0.00"},1,"yes","ATGATTCCTTCCCTCCAGAAGACTTTGGCATTGTGTCTGGAATGCTCAATGTCAAATGGG","FALSE","NM_003145","ref|NM_003145|ens|ENST00000531917|ens|ENST00000531790|ens|ENST00000474377","SSR2","signal sequence receptor, beta (translocon-associated protein beta)","ref|Homo sapiens signal sequence receptor, beta (translocon-associated protein beta) (SSR2), mRNA [NM_003145]","chr1",155988064,155990694,"GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006412(translation);GO:0006613(cotranslational protein targeting to membrane);GO:0006614(SRP-dependent cotranslational protein targeting to membrane);GO:0010467(gene expression);GO:0016021(integral to membrane);GO:0044267(cellular protein metabolic process)","04141(Protein processing in endoplasmic reticulum)","mRNA","agilent G3 V3"]
["A_24_P236522",2.18,2.37,2.21,4.34,4.32,4.57,{"v":0.510959939531368,"d":"0.51"},{"v":-0.968717909996493,"d":"-0.97"},"down",{"v":2.34299999999354e-05,"d":"0.00"},1,"yes","GCCATTGATCTAAAGATGCGTCTTGATTTCAGAAAGGTCCGGAAGTGGAAAGCAGGTTTC","FALSE","NM_001243646","ref|NM_001243646|ref|NM_006110|ens|ENST00000305596|gb|AB033004","CD2BP2","CD2 (cytoplasmic tail) binding protein 2","ref|Homo sapiens CD2 (cytoplasmic tail) binding protein 2 (CD2BP2), transcript variant 2, mRNA [NM_001243646]","chr16",30362088,30366682,"GO:0000244(assembly of spliceosomal tri-snRNP);GO:0000398(nuclear mRNA splicing, via spliceosome);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005682(U5 snRNP);GO:0005737(cytoplasm);GO:0008380(RNA splicing);GO:0010467(gene expression);GO:0010923(negative regulation of phosphatase activity);GO:0016607(nuclear speck);GO:0043021(ribonucleoprotein complex binding);GO:0046540(U4/U6 x U5 tri-snRNP complex)",null,"mRNA","agilent G3 V3"]
["A_23_P252653",4.01,3.93,{"v":4.3,"d":"4.30"},{"v":7,"d":"7.00"},6.98,7.23,{"v":0.577086280056577,"d":"0.58"},{"v":-0.793141062837903,"d":"-0.79"},"down",{"v":2.34539999999228e-05,"d":"0.00"},1,"yes","CATAAGAACTGTGCTGACTTGGAAGGTGCCCTGTGCTATGTCGTGCCTGCAGGGACACGT","FALSE","NM_006374","ref|NM_006374|ref|NM_001271977|ref|NM_001271978|ref|NM_001282305","STK25","serine/threonine kinase 25","ref|Homo sapiens serine/threonine kinase 25 (STK25), transcript variant 4, mRNA [NM_006374]","chr2",242434880,242448010,"GO:0004672(protein kinase activity);GO:0004702(receptor signaling protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0006468(protein phosphorylation);GO:0006915(apoptotic process);GO:0006979(response to oxidative stress);GO:0007163(establishment or maintenance of cell polarity);GO:0007165(signal transduction);GO:0023014(signal transduction by phosphorylation);GO:0032874(positive regulation of stress-activated MAPK cascade);GO:0035556(intracellular signal transduction);GO:0042542(response to hydrogen peroxide);GO:0042803(protein homodimerization activity);GO:0045595(regulation of cell differentiation);GO:0046777(protein autophosphorylation);GO:0046872(metal ion binding);GO:0050772(positive regulation of axonogenesis);GO:0051645(Golgi localization);GO:0051683(establishment of Golgi localization);GO:0070062(extracellular vesicular exosome);GO:0090168(Golgi reassembly)",null,"mRNA","agilent G3 V3"]
["A_23_P50349",10.77,10.67,10.74,9.99,10.01,10.04,{"v":1.07123834886818,"d":"1.07"},{"v":0.0992795132091746,"d":"0.10"},"up",{"v":2.3543999999931e-05,"d":"0.00"},1,"yes","CGGAGTTTGATGAGGATTTCGAGGAGGAACCCACATCCCCCATAGGTCACTGTGTGGCCA","FALSE","NM_004240","ref|NM_004240|ref|NM_001288962|ref|NM_001288963|ref|NR_110231","TRIP10","thyroid hormone receptor interactor 10","ref|Homo sapiens thyroid hormone receptor interactor 10 (TRIP10), transcript variant 2, mRNA [NM_004240]","chr19",{"v":6746319,"d":"6746319.00"},6750384,"GO:0001891(phagocytic cup);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005938(cell cortex);GO:0006897(endocytosis);GO:0007154(cell communication);GO:0007165(signal transduction);GO:0007264(small GTPase mediated signal transduction);GO:0008289(lipid binding);GO:0030036(actin cytoskeleton organization);GO:0042802(identical protein binding);GO:0042995(cell projection);GO:0043231(intracellular membrane-bounded organelle);GO:0048471(perinuclear region of cytoplasm);GO:0051056(regulation of small GTPase mediated signal transduction);GO:0070062(extracellular vesicular exosome)","04910(Insulin signaling pathway)","mRNA","agilent G3 V3"]
["A_33_P3371425",6.88,6.82,6.76,{"v":7.8,"d":"7.80"},7.77,7.71,{"v":0.878865979381443,"d":"0.88"},{"v":-0.186284913162955,"d":"-0.19"},"down",{"v":2.36750000000008e-05,"d":"0.00"},1,"yes","TTCTCATCCACCTTTGAAGACCCGTCCACGGCCACCTACATGCAGTTCCTGAAGGAGGGA","FALSE","NM_020451","ref|NM_020451|ref|NM_206926|ens|ENST00000494537|ens|ENST00000354177","SEPN1","selenoprotein N, 1","ref|Homo sapiens selenoprotein N, 1 (SEPN1), transcript variant 1, mRNA [NM_020451]","chr1",26126668,26144713,"GO:0003674(molecular_function);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005789(endoplasmic reticulum membrane);GO:0008150(biological_process)",null,"mRNA","agilent G3 V3"]
["A_24_P115774",2.24,2.31,2.67,5.48,5.45,5.63,{"v":0.435990338164251,"d":"0.44"},{"v":-1.19763193061215,"d":"-1.20"},"down",{"v":2.36769999999442e-05,"d":"0.00"},1,"yes","GATACCATTTTGGTTAAAGGAAATGCTGCGGCCAACATCTTCAAAAACTGTCTAAAAGAA","FALSE","NM_001166","ref|NM_001166|ref|NM_001256163|ref|NM_001256166|ens|ENST00000613397","BIRC2","baculoviral IAP repeat containing 2","ref|Homo sapiens baculoviral IAP repeat containing 2 (BIRC2), transcript variant 1, mRNA [NM_001166]","chr11",102233472,102248328,"GO:0000209(protein polyubiquitination);GO:0001666(response to hypoxia);GO:0001741(XY body);GO:0001890(placenta development);GO:0002224(toll-like receptor signaling pathway);GO:0002756(MyD88-independent toll-like receptor signaling pathway);GO:0003713(transcription coactivator activity);GO:0004842(ubiquitin-protein ligase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005876(spindle microtubule);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0006915(apoptotic process);GO:0006921(cellular component disassembly involved in apoptotic process);GO:0007166(cell surface receptor signaling pathway);GO:0008270(zinc ion binding);GO:0009898(internal side of plasma membrane);GO:0016874(ligase activity);GO:0034121(regulation of toll-like receptor signaling pathway);GO:0034138(toll-like receptor 3 signaling pathway);GO:0034142(toll-like receptor 4 signaling pathway);GO:0035631(CD40 receptor complex);GO:0035666(TRIF-dependent toll-like receptor signaling pathway);GO:0038061(NIK/NF-kappaB cascade);GO:0039535(regulation of RIG-I signaling pathway);GO:0042127(regulation of cell proliferation);GO:0042981(regulation of apoptotic process);GO:0043027(cysteine-type endopeptidase inhibitor activity involved in apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB cascade);GO:0043161(proteasomal ubiquitin-dependent protein catabolic process);GO:0045087(innate immune response);GO:0045088(regulation of innate immune response);GO:0045121(membrane raft);GO:0045471(response to ethanol);GO:0045595(regulation of cell differentiation);GO:0047485(protein N-terminus binding);GO:0050727(regulation of inflammatory response);GO:0051291(protein heterooligomerization);GO:0051591(response to cAMP);GO:0051726(regulation of cell cycle);GO:0060544(regulation of necroptosis);GO:0060546(negative regulation of necroptosis);GO:0070266(necroptosis);GO:0070424(regulation of nucleotide-binding oligomerization domain containing signaling pathway);GO:0090307(spindle assembly involved in mitosis);GO:2000116(regulation of cysteine-type endopeptidase activity);GO:2000377(regulation of reactive oxygen species metabolic process)","04120(Ubiquitin mediated proteolysis);04390(Hippo signaling pathway);04064(NF-kappa B signaling pathway);04668(TNF signaling pathway);04210(Apoptosis);04510(Focal adhesion);04621(NOD-like receptor signaling pathway);05200(Pathways in cancer);05222(Small cell lung cancer);05145(Toxoplasmosis)","mRNA","agilent G3 V3"]
["A_23_P63929",1.92,2.02,1.98,3.59,3.66,3.84,{"v":0.533814247069432,"d":"0.53"},{"v":-0.90559028453276,"d":"-0.91"},"down",{"v":2.36859999999117e-05,"d":"0.00"},1,"yes","TCTCAAATATATGCTGTGCCTGTACTTATATACAGTCTTTCAAGAGAGATACAAACAAGG","FALSE","NM_018117","ref|NM_018117|ens|ENST00000605543|ens|ENST00000604509|ens|ENST00000497136","WDR11","WD repeat domain 11","ref|Homo sapiens WD repeat domain 11 (WDR11), mRNA [NM_018117]","chr10",122666808,122669035,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005929(cilium);GO:0015630(microtubule cytoskeleton);GO:0016020(membrane);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_24_P236091",2.03,{"v":2.4,"d":"2.40"},1.99,5.72,6.08,6.08,{"v":0.359060402684564,"d":"0.36"},{"v":-1.47770153406102,"d":"-1.48"},"down",{"v":2.37229999999755e-05,"d":"0.00"},1,"yes","TTCATTCATCCCATTAATCATTTCCCCATAACTCAATGGCCTAAAACTGGCCTGACTTGG","FALSE","NM_001975","ref|NM_001975|ens|ENST00000535366|ens|ENST00000541477|ens|ENST00000229277","ENO2","enolase 2 (gamma, neuronal)","ref|Homo sapiens enolase 2 (gamma, neuronal) (ENO2), mRNA [NM_001975]","chr12",{"v":7023753,"d":"7023753.00"},7032347,"GO:0000015(phosphopyruvate hydratase complex);GO:0000287(magnesium ion binding);GO:0001917(photoreceptor inner segment);GO:0004634(phosphopyruvate hydratase activity);GO:0005615(extracellular space);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005975(carbohydrate metabolic process);GO:0006006(glucose metabolic process);GO:0006094(gluconeogenesis);GO:0006096(glycolysis);GO:0009405(pathogenesis);GO:0043204(perikaryon);GO:0044281(small molecule metabolic process);GO:0070062(extracellular vesicular exosome)","01200(Carbon metabolism);01230(Biosynthesis of amino acids);00010(Glycolysis / Gluconeogenesis);03018(RNA degradation);04066(HIF-1 signaling pathway)","mRNA","agilent G3 V3"]
["A_33_P3397443",5.31,5.07,5.07,7.26,7.12,7.11,{"v":0.718939041414612,"d":"0.72"},{"v":-0.476058644636046,"d":"-0.48"},"down",{"v":2.37629999999545e-05,"d":"0.00"},1,"yes","TCGGGAACTCCCATGGTCTTCTCTGCCTGGCCGTGTCTAATAAAAAGTATTTGAACCTTG","FALSE","NM_182687","ref|NM_182687|ref|NM_004203|ref|NM_001258451|ref|NM_001258450","PKMYT1","protein kinase, membrane associated tyrosine/threonine 1","ref|Homo sapiens protein kinase, membrane associated tyrosine/threonine 1 (PKMYT1), transcript variant 2, mRNA [NM_182687]","chr16",{"v":3022996,"d":"3022996.00"},3027527,"GO:0000079(regulation of cyclin-dependent protein kinase activity);GO:0000082(G1/S transition of mitotic cell cycle);GO:0000086(G2/M transition of mitotic cell cycle);GO:0000139(Golgi membrane);GO:0000278(mitotic cell cycle);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0007067(mitosis);GO:0007088(regulation of mitosis);GO:0010923(negative regulation of phosphatase activity);GO:0016020(membrane);GO:0016301(kinase activity);GO:0046872(metal ion binding);GO:0051726(regulation of cell cycle)","04110(Cell cycle);04114(Oocyte meiosis);04914(Progesterone-mediated oocyte maturation)","mRNA","agilent G3 V3"]
["A_24_P98277",2.04,1.89,2.35,6.53,6.71,6.19,{"v":0.323211528564076,"d":"0.32"},{"v":-1.62944943669372,"d":"-1.63"},"down",{"v":2.3854999999906e-05,"d":"0.00"},1,"yes","AGGTTGTTTGGCTTGTTTAACAGCATATACCATCTTCCTATGCATGGAAACTCATTATGA","FALSE","NM_001002296","ref|NM_001002296|ref|NM_016099|ref|NM_001174124|ens|ENST00000523420","GOLGA7","golgin A7","ref|Homo sapiens golgin A7 (GOLGA7), transcript variant 2, mRNA [NM_001002296]","chr8",41348080,41368493,"GO:0002178(palmitoyltransferase complex);GO:0005515(protein binding);GO:0005795(Golgi stack);GO:0018230(peptidyl-L-cysteine S-palmitoylation);GO:0031228(intrinsic to Golgi membrane);GO:0043001(Golgi to plasma membrane protein transport);GO:0050821(protein stabilization);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P390596",2.28,2.29,2.76,5.88,5.86,5.95,{"v":0.414358394573205,"d":"0.41"},{"v":-1.27104894455665,"d":"-1.27"},"down",{"v":2.38649999999563e-05,"d":"0.00"},1,"yes","GGAGAATGTGCAGTTATTTATTATGCGTATTCAGTTTGTAAACGTATCCTCTGTATTCAG","FALSE","NM_006742","ref|NM_006742|ens|ENST00000291041|gb|AJ272212|gb|BC021584","PSKH1","protein serine kinase H1","ref|Homo sapiens protein serine kinase H1 (PSKH1), mRNA [NM_006742]","chr16",67927176,67963581,"GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005575(cellular_component);GO:0005789(endoplasmic reticulum membrane);GO:0005794(Golgi apparatus);GO:0005815(microtubule organizing center);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0016607(nuclear speck)",null,"mRNA","agilent G3 V3"]
["A_33_P3265104",1.94,2.25,{"v":1.9,"d":"1.90"},4.57,4.57,4.46,{"v":0.447794117647059,"d":"0.45"},{"v":-1.15909251823137,"d":"-1.16"},"down",{"v":2.38819999999196e-05,"d":"0.00"},1,"yes","CTCTCTGCCTGGATCGAAACCTGCCAGACATGATGCAGCTATGGAGTGAAATATTTAACA","FALSE","NM_001242307","ref|NM_001242307|ref|NM_014889|ens|ENST00000451454|ens|ENST00000380994","PITRM1","pitrilysin metallopeptidase 1","ref|Homo sapiens pitrilysin metallopeptidase 1 (PITRM1), transcript variant 1, mRNA [NM_001242307]","chr10",{"v":3179922,"d":"3179922.00"},3215003,"GO:0004222(metalloendopeptidase activity);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0006508(proteolysis);GO:0008047(enzyme activator activity);GO:0043085(positive regulation of catalytic activity);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P44244",1.97,2.25,2.03,4.99,4.91,5.27,{"v":0.411997363216875,"d":"0.41"},{"v":-1.27929299069758,"d":"-1.28"},"down",{"v":2.38830000000023e-05,"d":"0.00"},1,"yes","ACTTCTTTGTTGCTTTCTTTTCTATTGAGTCTGGGCTTGTTTGTGTTACTGCATACTGTG","FALSE","NM_003069","ref|NM_003069|ref|NM_001282874|ref|NM_001282875|ens|ENST00000371122","SMARCA1","SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1","ref|Homo sapiens SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 (SMARCA1), transcript variant 1, mRNA [NM_003069]","chrX",128580480,128657460,"GO:0000733(DNA strand renaturation);GO:0003677(DNA binding);GO:0004386(helicase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0006338(chromatin remodeling);GO:0006351(transcription, DNA-dependent);GO:0007420(brain development);GO:0008094(DNA-dependent ATPase activity);GO:0016589(NURF complex);GO:0030182(neuron differentiation);GO:0031491(nucleosome binding);GO:0043044(ATP-dependent chromatin remodeling);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0070615(nucleosome-dependent ATPase activity)",null,"mRNA","agilent G3 V3"]
["A_33_P3366120",7.91,7.82,7.98,9.75,9.74,9.54,{"v":0.816741302101274,"d":"0.82"},{"v":-0.292048909144654,"d":"-0.29"},"down",{"v":2.39169999999289e-05,"d":"0.00"},1,"yes","TCTACAGCGTGTCCTACCTGCTCAAGGACAAGGGGGAGTACACACTGGTGGTCAAATGGG","FALSE","NM_001110556","ref|NM_001110556|ref|NM_001456|ens|ENST00000369850|ens|ENST00000490936","FLNA","filamin A, alpha","ref|Homo sapiens filamin A, alpha (FLNA), transcript variant 2, mRNA [NM_001110556]","chrX",153577024,153586605,"GO:0001837(epithelial to mesenchymal transition);GO:0001948(glycoprotein binding);GO:0002576(platelet degranulation);GO:0004871(signal transducer activity);GO:0005080(protein kinase C binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005802(trans-Golgi network);GO:0005829(cytosol);GO:0005884(actin filament);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0007195(adenylate cyclase-inhibiting dopamine receptor signaling pathway);GO:0007596(blood coagulation);GO:0008134(transcription factor binding);GO:0015629(actin cytoskeleton);GO:0016020(membrane);GO:0017048(Rho GTPase binding);GO:0017160(Ral GTPase binding);GO:0030168(platelet activation);GO:0030863(cortical cytoskeleton);GO:0031267(small GTPase binding);GO:0031523(Myb complex);GO:0031532(actin cytoskeleton reorganization);GO:0031852(mu-type opioid receptor binding);GO:0034329(cell junction assembly);GO:0034394(protein localization at cell surface);GO:0034988(Fc-gamma receptor I complex binding);GO:0042177(negative regulation of protein catabolic process);GO:0042384(cilium assembly);GO:0042789(mRNA transcription from RNA polymerase II promoter);GO:0042803(protein homodimerization activity);GO:0042993(positive regulation of transcription factor import into nucleus);GO:0043025(neuronal cell body);GO:0043113(receptor clustering);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB cascade);GO:0043198(dendritic shaft);GO:0043433(negative regulation of sequence-specific DNA binding transcription factor activity);GO:0045022(early endosome to late endosome transport);GO:0045184(establishment of protein localization);GO:0046332(SMAD binding);GO:0048365(Rac GTPase binding);GO:0048471(perinuclear region of cytoplasm);GO:0050821(protein stabilization);GO:0051015(actin filament binding);GO:0051220(cytoplasmic sequestering of protein);GO:0051764(actin crosslink formation);GO:0070062(extracellular vesicular exosome);GO:0070527(platelet aggregation);GO:0090307(spindle assembly involved in mitosis)","04010(MAPK signaling pathway);04510(Focal adhesion);05205(Proteoglycans in cancer);05132(Salmonella infection)","mRNA","agilent G3 V3"]
["A_23_P14804",4.77,{"v":4.9,"d":"4.90"},4.62,{"v":7.8,"d":"7.80"},{"v":7.7,"d":"7.70"},7.44,{"v":0.622929380993897,"d":"0.62"},{"v":-0.682859474920009,"d":"-0.68"},"down",{"v":2.39479999999404e-05,"d":"0.00"},1,"yes","GGCTTTATAGGAGGAGTATAATGTATGCACTACTGTTTTAAAAGAATTAGTGTGAGTGTG","FALSE","NM_005724","ref|NM_005724|ref|NM_198902|ref|NM_001168412|ens|ENST00000560715","TSPAN3","tetraspanin 3","ref|Homo sapiens tetraspanin 3 (TSPAN3), transcript variant 1, mRNA [NM_005724]","chr15",77338672,77376326,"GO:0003674(molecular_function);GO:0008150(biological_process);GO:0016021(integral to membrane);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P152678",1.99,1.92,1.99,3.66,3.92,{"v":3.9,"d":"3.90"},{"v":0.513937282229965,"d":"0.51"},{"v":-0.960335782426484,"d":"-0.96"},"down",{"v":2.39799999999235e-05,"d":"0.00"},1,"yes","TGGCCACAGATCGTGCTCAGCGTGTATGGACCAGATGTGTTCGGGAACGATGTGGTTCGA","FALSE","NM_015681","ref|NM_015681|ref|NM_001243475|ref|NM_001243473|ens|ENST00000477683","B9D1","B9 protein domain 1","ref|Homo sapiens B9 protein domain 1 (B9D1), transcript variant 2, mRNA [NM_015681]","chr17",19250604,19265932,"GO:0001701(in utero embryonic development);GO:0001944(vasculature development);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006996(organelle organization);GO:0007224(smoothened signaling pathway);GO:0008158(hedgehog receptor activity);GO:0016020(membrane);GO:0032880(regulation of protein localization);GO:0035869(ciliary transition zone);GO:0036038(TCTN-B9D complex);GO:0036064(cilium basal body);GO:0042384(cilium assembly);GO:0042733(embryonic digit morphogenesis);GO:0043010(camera-type eye development);GO:0060271(cilium morphogenesis);GO:0060563(neuroepithelial cell differentiation)",null,"mRNA","agilent G3 V3"]
["A_33_P3272527",8.76,8.73,8.69,9.83,9.85,9.99,{"v":0.88237276710482,"d":"0.88"},{"v":-0.180539829535026,"d":"-0.18"},"down",{"v":2.39969999999978e-05,"d":"0.00"},1,"yes","AATTTTTGCAATGTGGATGTTGTAGAGATTCTGCCTTACCTGCCCTGCCTCACAGCAAGA","FALSE","NM_001206491","ref|NM_001206491|ref|NM_020746|ref|NR_037921|ens|ENST00000416600","MAVS","mitochondrial antiviral signaling protein","ref|Homo sapiens mitochondrial antiviral signaling protein (MAVS), transcript variant 3, mRNA [NM_001206491]","chr20",{"v":3827487,"d":"3827487.00"},3846922,"GO:0001934(positive regulation of protein phosphorylation);GO:0002218(activation of innate immune response);GO:0002230(positive regulation of defense response to virus by host);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005778(peroxisomal membrane);GO:0007165(signal transduction);GO:0016021(integral to membrane);GO:0016032(viral reproduction);GO:0019901(protein kinase binding);GO:0031966(mitochondrial membrane);GO:0032480(negative regulation of type I interferon production);GO:0032727(positive regulation of interferon-alpha production);GO:0032728(positive regulation of interferon-beta production);GO:0032757(positive regulation of interleukin-8 production);GO:0032760(positive regulation of tumor necrosis factor production);GO:0033160(positive regulation of protein import into nucleus, translocation);GO:0039529(RIG-I signaling pathway);GO:0042742(defense response to bacterium);GO:0042993(positive regulation of transcription factor import into nucleus);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB cascade);GO:0045071(negative regulation of viral genome replication);GO:0045087(innate immune response);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0050700(CARD domain binding);GO:0051091(positive regulation of sequence-specific DNA binding transcription factor activity);GO:0051607(defense response to virus);GO:0060340(positive regulation of type I interferon-mediated signaling pathway);GO:0071360(cellular response to exogenous dsRNA);GO:0071651(positive regulation of chemokine (C-C motif) ligand 5 production);GO:0071660(positive regulation of IP-10 production);GO:1900063(regulation of peroxisome organization)","04622(RIG-I-like receptor signaling pathway);04623(Cytosolic DNA-sensing pathway);05162(Measles);05164(Influenza A);05161(Hepatitis B);05160(Hepatitis C);05168(Herpes simplex infection)","mRNA","agilent G3 V3"]
["A_33_P3317406",8.07,7.89,8.09,9.46,{"v":9.4,"d":"9.40"},9.45,{"v":0.849523136700812,"d":"0.85"},{"v":-0.235274855248343,"d":"-0.24"},"down",{"v":2.40089999999915e-05,"d":"0.00"},1,"yes","TGCTGTCCTGCGTCTATCCATGTGGAATGCTGGACAATAAAGCGAGTGCTGCCCACCCTC","FALSE","NM_007103","ref|NM_007103|ref|NM_001166102|ens|ENST00000531250|ens|ENST00000527355","NDUFV1","NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa","ref|Homo sapiens NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa (NDUFV1), transcript variant 1, mRNA [NM_007103]","chr11",67379192,67379868,"GO:0005743(mitochondrial inner membrane);GO:0005747(mitochondrial respiratory chain complex I);GO:0006120(mitochondrial electron transport, NADH to ubiquinone);GO:0008137(NADH dehydrogenase (ubiquinone) activity);GO:0010181(FMN binding);GO:0022904(respiratory electron transport chain);GO:0044237(cellular metabolic process);GO:0044281(small molecule metabolic process);GO:0046872(metal ion binding);GO:0051287(NAD binding);GO:0051539(4 iron, 4 sulfur cluster binding)","00190(Oxidative phosphorylation);05010(Alzheimer's disease);05012(Parkinson's disease);05016(Huntington's disease);04932(Non-alcoholic fatty liver disease (NAFLD))","mRNA","agilent G3 V3"]
["A_24_P237878",8.65,8.62,8.46,10.06,9.96,10.06,{"v":0.855385638297872,"d":"0.86"},{"v":-0.225353109943838,"d":"-0.23"},"down",{"v":2.40849999999515e-05,"d":"0.00"},1,"yes","TGTGCTGGGAGGGTCACCAGGTCCCTTTTCCTTCCTGTGCCCTCTGAAAGCTAAGTGTCT","FALSE","NM_207368","ref|NM_207368|ref|NM_001288799|ref|NM_001288798|ref|NM_001093767","FAM195B","family with sequence similarity 195, member B","ref|Homo sapiens family with sequence similarity 195, member B (FAM195B), transcript variant 1, mRNA [NM_207368]","chr17",79780296,79784533,null,null,"mRNA","agilent G3 V3"]
["A_23_P99632",5.33,{"v":5.5,"d":"5.50"},5.51,6.83,6.79,6.75,{"v":0.802160039273441,"d":"0.80"},{"v":-0.318037996820205,"d":"-0.32"},"down",{"v":2.41269999999849e-05,"d":"0.00"},1,"yes","CAGGCACACTACAAAGAGTATCTTGTGAGCCTCATCAATGCCCACTCGCTGGACCCAGCC","FALSE","NM_017999","ref|NM_017999|ens|ENST00000559449|ens|ENST00000559071|ens|ENST00000559491","RNF31","ring finger protein 31","ref|Homo sapiens ring finger protein 31 (RNF31), mRNA [NM_017999]","chr14",24620428,24636611,"GO:0000209(protein polyubiquitination);GO:0004842(ubiquitin-protein ligase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0009898(internal side of plasma membrane);GO:0016874(ligase activity);GO:0023035(CD40 signaling pathway);GO:0031625(ubiquitin protein ligase binding);GO:0035631(CD40 receptor complex);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB cascade);GO:0043130(ubiquitin binding);GO:0050852(T cell receptor signaling pathway);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0071797(LUBAC complex);GO:0097039(protein linear polyubiquitination)",null,"mRNA","agilent G3 V3"]
["A_23_P201731",2.35,2.42,2.83,6.35,6.53,6.74,{"v":0.387359836901121,"d":"0.39"},{"v":-1.36825371788829,"d":"-1.37"},"down",{"v":2.41439999999482e-05,"d":"0.00"},1,"yes","TGGTTTGCTTAGGAGTTCAGAGTTCCTTCATCATCGAAATAGTGATTAAGTGATCCCAGA","FALSE","NM_004619","ref|NM_004619|ref|NM_001033910|ref|NM_145759|ens|ENST00000336184","TRAF5","TNF receptor-associated factor 5","ref|Homo sapiens TNF receptor-associated factor 5 (TRAF5), transcript variant 1, mRNA [NM_004619]","chr1",211499952,211548282,"GO:0004842(ubiquitin-protein ligase activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006915(apoptotic process);GO:0007165(signal transduction);GO:0008270(zinc ion binding);GO:0008284(positive regulation of cell proliferation);GO:0009898(internal side of plasma membrane);GO:0016567(protein ubiquitination);GO:0031625(ubiquitin protein ligase binding);GO:0031996(thioesterase binding);GO:0035631(CD40 receptor complex);GO:0042981(regulation of apoptotic process);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB cascade);GO:0051091(positive regulation of sequence-specific DNA binding transcription factor activity);GO:0051092(positive regulation of NF-kappaB transcription factor activity)","04064(NF-kappa B signaling pathway);04668(TNF signaling pathway);05200(Pathways in cancer);05203(Viral carcinogenesis);05222(Small cell lung cancer);05168(Herpes simplex infection);05169(Epstein-Barr virus infection)","mRNA","agilent G3 V3"]
["A_33_P3383856",9.61,{"v":9.6,"d":"9.60"},9.56,{"v":8.8,"d":"8.80"},{"v":8.9,"d":"8.90"},8.81,{"v":1.08525084873633,"d":"1.09"},{"v":0.118028550872028,"d":"0.12"},"up",{"v":2.4216999999993e-05,"d":"0.00"},1,"yes","TCTGCCTTGTGGCCCACAATGGCTTTGATTATGATTTCCCCCTGCTGTGTGCCGAGCTGC","FALSE","NM_080701","ref|NM_080701|ens|ENST00000330912|ens|ENST00000338525|ens|ENST00000370212","TREX2","three prime repair exonuclease 2","ref|Homo sapiens three prime repair exonuclease 2 (TREX2), mRNA [NM_080701]","chrX",152710176,152711945,"GO:0000287(magnesium ion binding);GO:0000738(DNA catabolic process, exonucleolytic);GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0006259(DNA metabolic process);GO:0006281(DNA repair);GO:0008296(3'-5'-exodeoxyribonuclease activity);GO:0008853(exodeoxyribonuclease III activity);GO:0042803(protein homodimerization activity)",null,"mRNA","agilent G3 V3"]
["A_32_P181020",5.12,4.78,4.95,7.14,7.07,7.08,{"v":0.697510568341945,"d":"0.70"},{"v":-0.519713018764166,"d":"-0.52"},"down",{"v":2.42339999999563e-05,"d":"0.00"},1,"yes","CTTCCTTAGCTTTGCCCAGAGCACGGTTGTCCAGGATGACCCCAGGCTCGTTCATCTCTT","FALSE","NM_005510","ref|NM_005510|ens|ENST00000474587|ens|ENST00000480240|ens|ENST00000375356","DXO","decapping exoribonuclease","ref|Homo sapiens decapping exoribonuclease (DXO), mRNA [NM_005510]","chrHSCHR6_MHC_MCF",32014034,32015081,"GO:0000166(nucleotide binding);GO:0000287(magnesium ion binding);GO:0003729(mRNA binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006402(mRNA catabolic process);GO:0008152(metabolic process);GO:0008409(5'-3' exonuclease activity);GO:0034353(RNA pyrophosphohydrolase activity);GO:0050779(RNA destabilization);GO:0071028(nuclear mRNA surveillance);GO:0090305(nucleic acid phosphodiester bond hydrolysis)",null,"mRNA","agilent G3 V3"]
["A_23_P103532",13.41,13.47,13.33,12.38,{"v":12.3,"d":"12.30"},12.28,{"v":1.0879329004329,"d":"1.09"},{"v":0.121589579384303,"d":"0.12"},"up",{"v":2.42639999999961e-05,"d":"0.00"},1,"yes","CTGCCACCCCCTGATCTATGGACTCTGGAACAAGACAGTTCGCAAAGAACTACTGGGCAT","FALSE","NM_001267609","ref|NM_001267609|ref|NM_001267610|ref|NM_153832|ref|NM_001267611","GPR161","G protein-coupled receptor 161","ref|Homo sapiens G protein-coupled receptor 161 (GPR161), transcript variant 1, mRNA [NM_001267609]","chr1",168054512,168106536,"GO:0004930(G-protein coupled receptor activity);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007275(multicellular organismal development);GO:0016021(integral to membrane);GO:0030666(endocytic vesicle membrane);GO:0030819(positive regulation of cAMP biosynthetic process);GO:0055037(recycling endosome);GO:0060170(cilium membrane);GO:0072372(primary cilium)",null,"mRNA","agilent G3 V3"]
["A_33_P3242798",2.04,2.11,2.14,4.51,4.86,4.52,{"v":0.4528437724982,"d":"0.45"},{"v":-1.1429146771021,"d":"-1.14"},"down",{"v":2.4292999999953e-05,"d":"0.00"},1,"yes","CCCAAGGGCAGCCTTTGTTACTTTTAAATATTTTCTGTTATTACAAGTGCTCTAATTGTG","FALSE","NM_001875","ref|NM_001875|ref|NM_001122633|ref|NM_001122634|ens|ENST00000233072","CPS1","carbamoyl-phosphate synthase 1, mitochondrial","ref|Homo sapiens carbamoyl-phosphate synthase 1, mitochondrial (CPS1), transcript variant 2, mRNA [NM_001875]","chr2",211536336,211543831,"GO:0000050(urea cycle);GO:0004087(carbamoyl-phosphate synthase (ammonia) activity);GO:0004088(carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity);GO:0004175(endopeptidase activity);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005543(phospholipid binding);GO:0005730(nucleolus);GO:0005743(mitochondrial inner membrane);GO:0005759(mitochondrial matrix);GO:0005980(glycogen catabolic process);GO:0006508(proteolysis);GO:0006526(arginine biosynthetic process);GO:0006543(glutamine catabolic process);GO:0007494(midgut development);GO:0009636(response to toxin);GO:0010043(response to zinc ion);GO:0014075(response to amine stimulus);GO:0016595(glutamate binding);GO:0019240(citrulline biosynthetic process);GO:0019433(triglyceride catabolic process);GO:0032094(response to food);GO:0032403(protein complex binding);GO:0032496(response to lipopolysaccharide);GO:0034641(cellular nitrogen compound metabolic process);GO:0042493(response to drug);GO:0042594(response to starvation);GO:0042645(mitochondrial nucleoid);GO:0043200(response to amino acid stimulus);GO:0043234(protein complex);GO:0044281(small molecule metabolic process);GO:0044344(cellular response to fibroblast growth factor stimulus);GO:0045909(positive regulation of vasodilation);GO:0046209(nitric oxide metabolic process);GO:0050667(homocysteine metabolic process);GO:0055081(anion homeostasis);GO:0060416(response to growth hormone stimulus);GO:0070365(hepatocyte differentiation);GO:0070409(carbamoyl phosphate biosynthetic process);GO:0071320(cellular response to cAMP);GO:0071377(cellular response to glucagon stimulus);GO:0071400(cellular response to oleic acid);GO:0071548(response to dexamethasone stimulus);GO:0072341(modified amino acid binding)","01200(Carbon metabolism);01230(Biosynthesis of amino acids);00910(Nitrogen metabolism);00250(Alanine, aspartate and glutamate metabolism);00330(Arginine and proline metabolism)","mRNA","agilent G3 V3"]
["A_33_P3410849",14.28,14.31,14.18,15.53,15.41,15.41,{"v":0.922761596548004,"d":"0.92"},{"v":-0.115970131636559,"d":"-0.12"},"down",{"v":2.44139999999726e-05,"d":"0.00"},1,"yes","TGTGAAGTCTTCCTCGCCCTCTGCCCTCTTGCTGCTTCTCCACATTGCCAGGAAAAGCTG","FALSE","NM_001013842","ref|NM_001013842|ref|NM_173686|ref|NM_001198827|ens|ENST00000409586","C8orf58","chromosome 8 open reading frame 58","ref|Homo sapiens chromosome 8 open reading frame 58 (C8orf58), transcript variant 1, mRNA [NM_001013842]","chr8",22459308,22460099,null,null,"mRNA","agilent G3 V3"]
["A_23_P391764",2.16,2.31,2.15,{"v":4.8,"d":"4.80"},5.22,5.04,{"v":0.439575033200531,"d":"0.44"},{"v":-1.18581864786471,"d":"-1.19"},"down",{"v":2.44159999999161e-05,"d":"0.00"},1,"yes","CCAATTTACAAACCGGTGGTTTTCTGGTTTGGTTTTGTTTTCTGCTTTTACTTCCATCTC","FALSE","NM_198679","ref|NM_198679|ens|ENST00000372190|ens|ENST00000372189|ref|XM_005272185","RAPGEF1","Rap guanine nucleotide exchange factor (GEF) 1","ref|Homo sapiens Rap guanine nucleotide exchange factor (GEF) 1 (RAPGEF1), transcript variant 2, mRNA [NM_198679]","chr9",134452160,134585229,"GO:0000186(activation of MAPKK activity);GO:0001568(blood vessel development);GO:0005515(protein binding);GO:0005768(endosome);GO:0005769(early endosome);GO:0005829(cytosol);GO:0007165(signal transduction);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0010976(positive regulation of neuron projection development);GO:0016337(cell-cell adhesion);GO:0017034(Rap guanyl-nucleotide exchange factor activity);GO:0017124(SH3 domain binding);GO:0032486(Rap protein signal transduction);GO:0032854(positive regulation of Rap GTPase activity);GO:0046580(negative regulation of Ras protein signal transduction);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0048011(nerve growth factor receptor signaling pathway);GO:0051898(negative regulation of protein kinase B signaling cascade);GO:0061028(establishment of endothelial barrier);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:0071320(cellular response to cAMP);GO:0090090(negative regulation of canonical Wnt receptor signaling pathway);GO:2000178(negative regulation of neural precursor cell proliferation)","04015(Rap1 signaling pathway);04510(Focal adhesion);04910(Insulin signaling pathway);04722(Neurotrophin signaling pathway);05211(Renal cell carcinoma)","mRNA","agilent G3 V3"]
["A_24_P382489",3.78,3.47,3.31,6.62,6.83,6.72,{"v":0.523549826474963,"d":"0.52"},{"v":-0.933601249254508,"d":"-0.93"},"down",{"v":2.44809999999651e-05,"d":"0.00"},1,"yes","CTTTCCTGGGCACTGTGGTTTTATTTCCTAATTGATTTAAGAAATAAACCTGAAGACCGT","FALSE","ENST00000594962","ens|ENST00000594962|ens|ENST00000252595|ref|XM_006722749|gb|AK131101","SLC27A1","solute carrier family 27 (fatty acid transporter), member 1","ens|solute carrier family 27 (fatty acid transporter), member 1 [Source:HGNC Symbol;Acc:HGNC:10995] [ENST00000594962]","chr19",17606224,17616977,"GO:0000166(nucleotide binding);GO:0001579(medium-chain fatty acid transport);GO:0001676(long-chain fatty acid metabolic process);GO:0004467(long-chain fatty acid-CoA ligase activity);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0006646(phosphatidylethanolamine biosynthetic process);GO:0006654(phosphatidic acid biosynthetic process);GO:0006655(phosphatidylglycerol biosynthetic process);GO:0006656(phosphatidylcholine biosynthetic process);GO:0006659(phosphatidylserine biosynthetic process);GO:0006661(phosphatidylinositol biosynthetic process);GO:0009409(response to cold);GO:0015245(fatty acid transporter activity);GO:0015909(long-chain fatty acid transport);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0031652(positive regulation of heat generation);GO:0031957(very long-chain fatty acid-CoA ligase activity);GO:0032049(cardiolipin biosynthetic process);GO:0032868(response to insulin stimulus);GO:0033211(adiponectin-mediated signaling pathway);GO:0042803(protein homodimerization activity);GO:0044255(cellular lipid metabolic process);GO:0044281(small molecule metabolic process);GO:0055085(transmembrane transport);GO:0071072(negative regulation of phospholipid biosynthetic process);GO:0071902(positive regulation of protein serine/threonine kinase activity)","03320(PPAR signaling pathway)","mRNA","agilent G3 V3"]
["A_23_P159125",1.94,2.32,1.89,5.58,5.74,5.96,{"v":0.355902777777778,"d":"0.36"},{"v":-1.49044490193687,"d":"-1.49"},"down",{"v":2.4578999999969e-05,"d":"0.00"},1,"yes","ACTATCTGCCATGTGAGTTGGGCAAATTGTTGACCACCTCTGAGCCTTGAAAAAGTAGGA","FALSE","NM_004695","ref|NM_004695|ref|NM_001271765|ens|ENST00000450736|ens|ENST00000580123","SLC16A5","solute carrier family 16 (monocarboxylate transporter), member 5","ref|Homo sapiens solute carrier family 16 (monocarboxylate transporter), member 5 (SLC16A5), transcript variant 1, mRNA [NM_004695]","chr17",73085032,73102246,"GO:0005887(integral to plasma membrane);GO:0008028(monocarboxylic acid transmembrane transporter activity);GO:0015129(lactate transmembrane transporter activity);GO:0015293(symporter activity);GO:0015355(secondary active monocarboxylate transmembrane transporter activity);GO:0015718(monocarboxylic acid transport);GO:0016020(membrane);GO:0035879(plasma membrane lactate transport)",null,"mRNA","agilent G3 V3"]
["A_23_P44760",2.38,2.58,2.45,3.93,4.06,3.95,{"v":0.620603015075377,"d":"0.62"},{"v":-0.688257388958971,"d":"-0.69"},"down",{"v":2.45969999999041e-05,"d":"0.00"},1,"yes","TACATGCAGAAGTTTGGGGCTGTTTACAAACCCAAAGAGGACACTGAATTAGAGTGACTG","FALSE","NM_014159","ref|NM_014159|ens|ENST00000409792|ens|ENST00000445387|ens|ENST00000330022","SETD2","SET domain containing 2","ref|Homo sapiens SET domain containing 2 (SETD2), mRNA [NM_014159]","chr3",47058180,47205457,"GO:0001525(angiogenesis);GO:0001763(morphogenesis of a branching structure);GO:0001843(neural tube closure);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0006298(mismatch repair);GO:0006325(chromatin organization);GO:0006355(regulation of transcription, DNA-dependent);GO:0006368(transcription elongation from RNA polymerase II promoter);GO:0010793(regulation of mRNA export from nucleus);GO:0018024(histone-lysine N-methyltransferase activity);GO:0030900(forebrain development);GO:0034728(nucleosome organization);GO:0035441(cell migration involved in vasculogenesis);GO:0048332(mesoderm morphogenesis);GO:0048701(embryonic cranial skeleton morphogenesis);GO:0048864(stem cell development);GO:0060039(pericardium development);GO:0060669(embryonic placenta morphogenesis);GO:0060977(coronary vasculature morphogenesis);GO:0097198(histone H3-K36 trimethylation)","00310(Lysine degradation)","mRNA","agilent G3 V3"]
["A_33_P3234197",2.02,1.88,2.28,5.87,5.96,5.53,{"v":0.355990783410138,"d":"0.36"},{"v":-1.4900882045401,"d":"-1.49"},"down",{"v":2.46119999999239e-05,"d":"0.00"},1,"yes","CCCTGCCAAGGTCTTCACTGTATATATTTTGTGTGTTCTTCTGAAACTCTTGATTTCTTA","FALSE","NM_025188","ref|NM_025188|ref|NM_001145635|ens|ENST00000256649|ens|ENST00000369464","TRIM45","tripartite motif containing 45","ref|Homo sapiens tripartite motif containing 45 (TRIM45), transcript variant 1, mRNA [NM_025188]","chr1",117653680,117664384,"GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0045171(intercellular bridge);GO:0060348(bone development)",null,"mRNA","agilent G3 V3"]
["A_23_P73023",7.72,7.64,7.63,8.49,8.59,8.52,{"v":0.898046875,"d":"0.90"},{"v":-0.155137344169182,"d":"-0.16"},"down",{"v":2.47169999999519e-05,"d":"0.00"},1,"yes","TGAGTACCACGTCCTTCAAGAAGAACTTATCGATTCCTCTCCTCTCAGTGACAACCAAAG","FALSE","NM_015173","ref|NM_015173|ref|NM_001253912|ref|NM_001253913|ref|NM_001253914","TBC1D1","TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1","ref|Homo sapiens TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1 (TBC1D1), transcript variant 1, mRNA [NM_015173]","chr4",38134380,38138870,"GO:0005097(Rab GTPase activator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0032851(positive regulation of Rab GTPase activity);GO:0032880(regulation of protein localization);GO:0061024(membrane organization)","04152(AMPK signaling pathway)","mRNA","agilent G3 V3"]
["A_23_P26905",2.38,{"v":2.7,"d":"2.70"},2.39,{"v":5.4,"d":"5.40"},5.18,5.46,{"v":0.46571072319202,"d":"0.47"},{"v":-1.10249399366568,"d":"-1.10"},"down",{"v":2.48279999999212e-05,"d":"0.00"},1,"yes","ATTTCTGTGTGGCCTGGTTATTTGGAAACTATGCAGTCCTCATTGGAACAACTTTATTCG","FALSE","NM_007215","ref|NM_007215|ens|ENST00000577506|ens|ENST00000582501|ens|ENST00000539111","POLG2","polymerase (DNA directed), gamma 2, accessory subunit","ref|Homo sapiens polymerase (DNA directed), gamma 2, accessory subunit (POLG2), mRNA [NM_007215]","chr17",62476464,62480347,"GO:0000262(mitochondrial chromosome);GO:0003677(DNA binding);GO:0003887(DNA-directed DNA polymerase activity);GO:0005515(protein binding);GO:0005759(mitochondrial matrix);GO:0006260(DNA replication);GO:0006261(DNA-dependent DNA replication);GO:0006264(mitochondrial DNA replication);GO:0006281(DNA repair);GO:0006996(organelle organization);GO:0007005(mitochondrion organization);GO:0042645(mitochondrial nucleoid);GO:0042802(identical protein binding);GO:0070062(extracellular vesicular exosome);GO:0071897(DNA biosynthetic process)",null,"mRNA","agilent G3 V3"]
["A_23_P251316",4.84,4.58,4.56,6.76,6.67,6.65,{"v":0.696215139442231,"d":"0.70"},{"v":-0.522394908575335,"d":"-0.52"},"down",{"v":2.48840000000028e-05,"d":"0.00"},1,"yes","TAGAAACTACCAATCCCAACTACGTAATAGGAAAATGTAGGATCAAAAGGCCCATGTATA","FALSE","NM_001331","ref|NM_001331|ref|NM_001085458|ref|NM_001085459|ref|NM_001206885","CTNND1","catenin (cadherin-associated protein), delta 1","ref|Homo sapiens catenin (cadherin-associated protein), delta 1 (CTNND1), transcript variant 3, mRNA [NM_001331]","chr11",57529232,57586651,"GO:0005102(receptor binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0005915(zonula adherens);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0007155(cell adhesion);GO:0007420(brain development);GO:0016055(Wnt receptor signaling pathway);GO:0016337(cell-cell adhesion);GO:0019901(protein kinase binding);GO:0030027(lamellipodium);GO:0030426(growth cone);GO:0030496(midbody);GO:0034329(cell junction assembly);GO:0034332(adherens junction organization);GO:0043197(dendritic spine);GO:0045202(synapse);GO:0045216(cell-cell junction organization);GO:0045296(cadherin binding);GO:0048010(vascular endothelial growth factor receptor signaling pathway);GO:0070062(extracellular vesicular exosome);GO:0090090(negative regulation of canonical Wnt receptor signaling pathway)","04015(Rap1 signaling pathway);04520(Adherens junction);04670(Leukocyte transendothelial migration)","mRNA","agilent G3 V3"]
["A_23_P213863",1.92,2.14,1.89,5.57,5.47,5.98,{"v":0.349588719153937,"d":"0.35"},{"v":-1.51626946349066,"d":"-1.52"},"down",{"v":2.48840000000028e-05,"d":"0.00"},1,"yes","ATTCTGCAAAGCAGACTCGTCAGAAAGTTGCTGTGAACTGGACCAACTTCAGCCTCAAGA","FALSE","NM_001190946","ref|NM_001190946|ref|NR_024019|ens|ENST00000507212|ens|ENST00000504130","FAM193B","family with sequence similarity 193, member B","ref|Homo sapiens family with sequence similarity 193, member B (FAM193B), transcript variant 3, mRNA [NM_001190946]","chr5",176946784,176981508,"GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm)",null,"mRNA","agilent G3 V3"]
["A_23_P434944",{"v":1.9,"d":"1.90"},2.01,1.97,4.03,4.37,4.14,{"v":0.4688995215311,"d":"0.47"},{"v":-1.09264928796567,"d":"-1.09"},"down",{"v":2.49029999999095e-05,"d":"0.00"},1,"yes","TGTGGCTGGTTTAGCTAGAGAGTGAACTCTCAAAGGTATCAAAACTGTGCTTCCATTATT","FALSE","NM_004516","ref|NM_004516|ref|NM_001137673|ref|NM_153464|ens|ENST00000407004","ILF3","interleukin enhancer binding factor 3, 90kDa","ref|Homo sapiens interleukin enhancer binding factor 3, 90kDa (ILF3), transcript variant 2, mRNA [NM_004516]","chr19",10764937,10796443,"GO:0003677(DNA binding);GO:0003723(RNA binding);GO:0003725(double-stranded RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0006351(transcription, DNA-dependent);GO:0006468(protein phosphorylation);GO:0016020(membrane);GO:0017148(negative regulation of translation);GO:0030529(ribonucleoprotein complex);GO:0045071(negative regulation of viral genome replication);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0051607(defense response to virus)",null,"mRNA","agilent G3 V3"]
["A_23_P159671",4.53,{"v":4.5,"d":"4.50"},4.26,6.28,6.36,6.38,{"v":0.698738170347003,"d":"0.70"},{"v":-0.517176141584389,"d":"-0.52"},"down",{"v":3.50530000000626e-05,"d":"0.00"},1,"yes","AGGAGGAATTGGAAATTGGTCTCTTTTGAGTGCAGAGGGAACTGAGACGCCAGCTTAAAT","FALSE","NM_000292","ref|NM_000292|ens|ENST00000469485|ens|ENST00000481718|ens|ENST00000379942","PHKA2","phosphorylase kinase, alpha 2 (liver)","ref|Homo sapiens phosphorylase kinase, alpha 2 (liver) (PHKA2), mRNA [NM_000292]","chrX",18911566,18913360,"GO:0004553(hydrolase activity, hydrolyzing O-glycosyl compounds);GO:0004689(phosphorylase kinase activity);GO:0005516(calmodulin binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005964(phosphorylase kinase complex);GO:0005975(carbohydrate metabolic process);GO:0005980(glycogen catabolic process);GO:0006006(glucose metabolic process);GO:0006091(generation of precursor metabolites and energy);GO:0006464(cellular protein modification process);GO:0006468(protein phosphorylation);GO:0009405(pathogenesis);GO:0044281(small molecule metabolic process)","04020(Calcium signaling pathway);04910(Insulin signaling pathway);04922(Glucagon signaling pathway)","mRNA","agilent G3 V3"]
["A_24_P183292",1.88,1.99,1.91,4.06,4.21,3.88,{"v":0.475720164609054,"d":"0.48"},{"v":-1.07181491599246,"d":"-1.07"},"down",{"v":3.50610000000584e-05,"d":"0.00"},1,"yes","ATGACTTGCAGGCACAATATCTAGTACTGCAACTGCCAGAACTTGGTATTGTAGCTGCTG","FALSE","ENST00000412431","ens|ENST00000412431|linc|lnc-IL17B-2:1|linc|lnc-IL17B-2:2|gb|AF119911","CSNK1A1","casein kinase 1, alpha 1","ens|casein kinase 1, alpha 1 [Source:HGNC Symbol;Acc:HGNC:2451] [ENST00000412431]","chr5",148874848,148931007,"GO:0000777(condensed chromosome kinetochore);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005847(mRNA cleavage and polyadenylation specificity factor complex);GO:0006468(protein phosphorylation);GO:0006909(phagocytosis);GO:0007067(mitosis);GO:0007165(signal transduction);GO:0007166(cell surface receptor signaling pathway);GO:0008360(regulation of cell shape);GO:0016020(membrane);GO:0016055(Wnt receptor signaling pathway);GO:0016607(nuclear speck);GO:0018105(peptidyl-serine phosphorylation);GO:0051301(cell division);GO:0072372(primary cilium);GO:0090263(positive regulation of canonical Wnt receptor signaling pathway)","04310(Wnt signaling pathway);04340(Hedgehog signaling pathway)","mRNA","agilent G3 V3"]
["A_33_P3527721",1.99,1.97,2.15,3.99,4.18,4.27,{"v":0.491157556270096,"d":"0.49"},{"v":-1.02574220031187,"d":"-1.03"},"down",{"v":3.50759999999672e-05,"d":"0.00"},1,"yes","TGTTTGCATTACGCTAGGTCAATTCCATTGTCCTTAAAAAATGAGAACCTTTCTGATTTG","FALSE","AK094436","gb|AK094436|tc|THC2615581","LOC284219","uncharacterized LOC284219","gb|Homo sapiens cDNA FLJ37117 fis, clone BRACE2022270. [AK094436]","chr18",{"v":8765373,"d":"8765373.00"},8767754,null,null,"mRNA","agilent G3 V3"]
["A_23_P76159",1.98,2.16,1.96,4.69,4.45,4.36,{"v":0.451851851851852,"d":"0.45"},{"v":-1.14607825948794,"d":"-1.15"},"down",{"v":3.50810000000479e-05,"d":"0.00"},1,"yes","TATTGTGTTTACTACTTGTGATCATGTAGTTGTGCCTTACTTTGTGAGAAAGGTTAGCTC","FALSE","NM_003566","ref|NM_003566|ref|XM_006719631|gb|AF173389|gb|BX648463","EEA1","early endosome antigen 1","ref|Homo sapiens early endosome antigen 1 (EEA1), mRNA [NM_003566]","chr12",93164416,93323107,"GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005545(1-phosphatidylinositol binding);GO:0005737(cytoplasm);GO:0005769(early endosome);GO:0005829(cytosol);GO:0005969(serine-pyruvate aminotransferase complex);GO:0006897(endocytosis);GO:0006906(vesicle fusion);GO:0008270(zinc ion binding);GO:0016020(membrane);GO:0016189(synaptic vesicle to endosome fusion);GO:0019897(extrinsic to plasma membrane);GO:0030742(GTP-dependent protein binding);GO:0031410(cytoplasmic vesicle);GO:0031901(early endosome membrane);GO:0042803(protein homodimerization activity);GO:0044308(axonal spine);GO:0045022(early endosome to late endosome transport);GO:0055037(recycling endosome);GO:0070062(extracellular vesicular exosome)","04144(Endocytosis);04145(Phagosome);05152(Tuberculosis)","mRNA","agilent G3 V3"]
["A_33_P3236921",7.34,{"v":7.2,"d":"7.20"},{"v":7.2,"d":"7.20"},6.08,5.96,5.99,{"v":1.20576816417083,"d":"1.21"},{"v":0.269952543594967,"d":"0.27"},"up",{"v":3.52810000000536e-05,"d":"0.00"},1,"yes","CAGGTAAATCTGAAGTATCTGCTGAAACTGAAATTCAATTTTAAGACCTCCCTGTGGTAA","FALSE","NM_001618","ref|NM_001618|ens|ENST00000491816|ens|ENST00000463968|ens|ENST00000490921","PARP1","poly (ADP-ribose) polymerase 1","ref|Homo sapiens poly (ADP-ribose) polymerase 1 (PARP1), mRNA [NM_001618]","chr1",226549408,226550861,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000723(telomere maintenance);GO:0003677(DNA binding);GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005730(nucleolus);GO:0006281(DNA repair);GO:0006284(base-excision repair);GO:0006302(double-strand break repair);GO:0006351(transcription, DNA-dependent);GO:0006366(transcription from RNA polymerase II promoter);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0006471(protein ADP-ribosylation);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0008134(transcription factor binding);GO:0008270(zinc ion binding);GO:0010467(gene expression);GO:0016020(membrane);GO:0016540(protein autoprocessing);GO:0019899(enzyme binding);GO:0023019(signal transduction involved in regulation of gene expression);GO:0030225(macrophage differentiation);GO:0032869(cellular response to insulin stimulus);GO:0040009(regulation of growth rate);GO:0042769(DNA damage response, detection of DNA damage);GO:0042802(identical protein binding);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0047485(protein N-terminus binding);GO:0051287(NAD binding);GO:0060391(positive regulation of SMAD protein import into nucleus);GO:0070212(protein poly-ADP-ribosylation);GO:0070412(R-SMAD binding);GO:0071451(cellular response to superoxide);GO:2000679(positive regulation of transcription regulatory region DNA binding)","03410(Base excision repair);04064(NF-kappa B signaling pathway)","mRNA","agilent G3 V3"]
["A_33_P3219303",14.64,14.65,14.61,13.85,13.72,13.75,{"v":1.06243949661181,"d":"1.06"},{"v":0.087380685557661,"d":"0.09"},"up",{"v":3.54080000000145e-05,"d":"0.00"},1,"yes","CCTGTGCCCCCCACAGATGACTCCAAGGAAGCTCAGATGCCTGCAGTCATTAGGTTTTAG","FALSE","NM_001807","ref|NM_001807|ens|ENST00000351304|ens|ENST00000372080|gb|S79774","CEL","carboxyl ester lipase","ref|Homo sapiens carboxyl ester lipase (CEL), mRNA [NM_001807]","chr9",135937360,135947248,"GO:0003824(catalytic activity);GO:0004771(sterol esterase activity);GO:0004806(triglyceride lipase activity);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0006629(lipid metabolic process);GO:0006641(triglyceride metabolic process);GO:0006707(cholesterol catabolic process);GO:0008201(heparin binding);GO:0009062(fatty acid catabolic process);GO:0016787(hydrolase activity);GO:0018350(protein esterification);GO:0030157(pancreatic juice secretion);GO:0030299(intestinal cholesterol absorption);GO:0044241(lipid digestion);GO:0044258(intestinal lipid catabolic process);GO:0044281(small molecule metabolic process);GO:0047372(acylglycerol lipase activity);GO:0052689(carboxylic ester hydrolase activity);GO:0070062(extracellular vesicular exosome)","00100(Steroid biosynthesis);00561(Glycerolipid metabolism);04972(Pancreatic secretion);04975(Fat digestion and absorption)","mRNA","agilent G3 V3"]
["A_23_P51039",5.46,{"v":5.4,"d":"5.40"},5.49,4.13,4.07,4.26,{"v":1.31219903691814,"d":"1.31"},{"v":0.391986567361443,"d":"0.39"},"up",{"v":3.54479999999935e-05,"d":"0.00"},1,"yes","CACCTCGGATGGAGGTTACTCTTTCAAGTATGAGACAGTGCCCAACCTTCTCACGCAGCA","FALSE","NM_002191","ref|NM_002191|ens|ENST00000243786|gb|BT006954|gb|DQ890602","INHA","inhibin, alpha","ref|Homo sapiens inhibin, alpha (INHA), mRNA [NM_002191]","chr2",220436912,220440435,"GO:0001501(skeletal system development);GO:0001541(ovarian follicle development);GO:0001750(photoreceptor outer segment);GO:0001917(photoreceptor inner segment);GO:0005102(receptor binding);GO:0005125(cytokine activity);GO:0005160(transforming growth factor beta receptor binding);GO:0005179(hormone activity);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0007050(cell cycle arrest);GO:0007165(signal transduction);GO:0007166(cell surface receptor signaling pathway);GO:0007267(cell-cell signaling);GO:0007399(nervous system development);GO:0008083(growth factor activity);GO:0008584(male gonad development);GO:0009605(response to external stimulus);GO:0010862(positive regulation of pathway-restricted SMAD protein phosphorylation);GO:0030154(cell differentiation);GO:0030218(erythrocyte differentiation);GO:0034673(inhibin-betaglycan-ActRII complex);GO:0034711(inhibin binding);GO:0042127(regulation of cell proliferation);GO:0042326(negative regulation of phosphorylation);GO:0042541(hemoglobin biosynthetic process);GO:0042981(regulation of apoptotic process);GO:0043025(neuronal cell body);GO:0043408(regulation of MAPK cascade);GO:0043512(inhibin A complex);GO:0045077(negative regulation of interferon-gamma biosynthetic process);GO:0045578(negative regulation of B cell differentiation);GO:0045650(negative regulation of macrophage differentiation);GO:0045786(negative regulation of cell cycle);GO:0046881(positive regulation of follicle-stimulating hormone secretion);GO:0046882(negative regulation of follicle-stimulating hormone secretion);GO:0046982(protein heterodimerization activity);GO:0048468(cell development);GO:0051726(regulation of cell cycle);GO:0060395(SMAD protein signal transduction)",null,"mRNA","agilent G3 V3"]
["A_21_P0011848",2.03,2.42,1.99,5.97,5.77,{"v":5.6,"d":"5.60"},{"v":0.371395617070358,"d":"0.37"},{"v":-1.42897130510722,"d":"-1.43"},"down",{"v":3.55090000000446e-05,"d":"0.00"},1,"yes","ATCTATATTGTTCTCCACAGTTACTGGGTCACCACATAGCAGGCATTCAATAAAAACGTG","FALSE","XM_005263848","ref|XM_005263848|ref|XM_005275929|ref|XM_005276219|linc|TCONS_l2_00013966","LOC100506922","basic proline-rich protein-like","ref|PREDICTED: Homo sapiens basic proline-rich protein-like (LOC100506922), mRNA [XM_005263848]","chr2",128146104,128146926,null,null,"mRNA","agilent G3 V3"]
["A_23_P127385",12.64,12.51,12.62,{"v":11.6,"d":"11.60"},11.53,{"v":11.5,"d":"11.50"},{"v":1.09067282702859,"d":"1.09"},{"v":0.125218396242944,"d":"0.13"},"up",{"v":3.55240000000645e-05,"d":"0.00"},1,"yes","TGGGGAAACCCCTCCCTACTGTTGGATGTATGTGTGACAAGTGTGTCTCCTGTGCTGCGA","FALSE","NM_000256","ref|NM_000256|ens|ENST00000256993|ens|ENST00000399249|ens|ENST00000545968","MYBPC3","myosin binding protein C, cardiac","ref|Homo sapiens myosin binding protein C, cardiac (MYBPC3), mRNA [NM_000256]","chr11",47352956,47374253,"GO:0001671(ATPase activator activity);GO:0002027(regulation of heart rate);GO:0003007(heart morphogenesis);GO:0003779(actin binding);GO:0005829(cytosol);GO:0005863(striated muscle myosin thick filament);GO:0006942(regulation of striated muscle contraction);GO:0007155(cell adhesion);GO:0008307(structural constituent of muscle);GO:0014705(C zone);GO:0017022(myosin binding);GO:0030017(sarcomere);GO:0030049(muscle filament sliding);GO:0031034(myosin filament assembly);GO:0031432(titin binding);GO:0031672(A band);GO:0032036(myosin heavy chain binding);GO:0032781(positive regulation of ATPase activity);GO:0032971(regulation of muscle filament sliding);GO:0042802(identical protein binding);GO:0045214(sarcomere organization);GO:0046872(metal ion binding);GO:0055010(ventricular cardiac muscle tissue morphogenesis);GO:0060048(cardiac muscle contraction)","05410(Hypertrophic cardiomyopathy (HCM));05414(Dilated cardiomyopathy (DCM))","mRNA","agilent G3 V3"]
["A_32_P182662",2.01,1.87,2.12,4.66,5.02,5.01,{"v":0.408441116405718,"d":"0.41"},{"v":-1.2917999900604,"d":"-1.29"},"down",{"v":3.55429999999712e-05,"d":"0.00"},1,"yes","GAACTTCTGTGAATTTTACCACTCAGTAGAAACCATCATAGCTCTGTGTAGCGTATTCAC","FALSE","NM_022831","ref|NM_022831|ens|ENST00000495670|ens|ENST00000474863|gb|AK301870","AIDA","axin interactor, dorsalization associated","ref|Homo sapiens axin interactor, dorsalization associated (AIDA), mRNA [NM_022831]","chr1",222842912,222886526,"GO:0005575(cellular_component);GO:0005737(cytoplasm);GO:0009953(dorsal/ventral pattern formation);GO:0019904(protein domain specific binding);GO:0043496(regulation of protein homodimerization activity);GO:0043508(negative regulation of JUN kinase activity);GO:0046329(negative regulation of JNK cascade)",null,"mRNA","agilent G3 V3"]
["A_24_P284353",{"v":1.9,"d":"1.90"},2.03,{"v":2,"d":"2.00"},4.95,5.45,5.34,{"v":0.376747141041931,"d":"0.38"},{"v":-1.40833153096148,"d":"-1.41"},"down",{"v":3.55819999999785e-05,"d":"0.00"},1,"yes","GGATATGTGTTGGAATAATTACGTCTTGAGTCTGGGATTATCCGCATTGTATTTAGTGCT","FALSE","NM_032354","ref|NM_032354|ref|NM_183065|ens|ENST00000316425|ens|ENST00000533070","TMEM107","transmembrane protein 107","ref|Homo sapiens transmembrane protein 107 (TMEM107), transcript variant 1, mRNA [NM_032354]","chr17",{"v":8077902,"d":"8077902.00"},8079694,"GO:0003674(molecular_function);GO:0005575(cellular_component);GO:0008150(biological_process);GO:0016021(integral to membrane);GO:0021532(neural tube patterning);GO:0042384(cilium assembly);GO:0042733(embryonic digit morphogenesis)",null,"mRNA","agilent G3 V3"]
["A_23_P364890",2.03,{"v":1.9,"d":"1.90"},2.33,{"v":5.3,"d":"5.30"},5.49,5.65,{"v":0.380778588807786,"d":"0.38"},{"v":-1.39297573674906,"d":"-1.39"},"down",{"v":3.55830000000612e-05,"d":"0.00"},1,"yes","CTGGTGCATGCTAGTGGGCATGGGATCAGCCAAGCTTCGTTCCATCTTTTCCTAAAGGTC","FALSE","NM_014771","ref|NM_014771|ref|NM_001207033|ref|NM_001207034|ens|ENST00000357890","RNF40","ring finger protein 40, E3 ubiquitin protein ligase","ref|Homo sapiens ring finger protein 40, E3 ubiquitin protein ligase (RNF40), transcript variant 1, mRNA [NM_014771]","chr16",30773640,30785837,"GO:0000151(ubiquitin ligase complex);GO:0004842(ubiquitin-protein ligase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0008270(zinc ion binding);GO:0010390(histone monoubiquitination);GO:0016020(membrane);GO:0016874(ligase activity);GO:0017075(syntaxin-1 binding);GO:0031625(ubiquitin protein ligase binding);GO:0032403(protein complex binding);GO:0033503(HULC complex);GO:0033523(histone H2B ubiquitination);GO:0042803(protein homodimerization activity);GO:0043005(neuron projection)",null,"mRNA","agilent G3 V3"]
["A_23_P91657",2.11,{"v":2.2,"d":"2.20"},2.42,5.41,{"v":5.5,"d":"5.50"},5.84,{"v":0.401791044776119,"d":"0.40"},{"v":-1.31548268562218,"d":"-1.32"},"down",{"v":3.55859999999764e-05,"d":"0.00"},1,"yes","ATGTACAAGGATTAAATGACAGTGTGACTCTAGATGATCTGGCAGACTTCTTTAAGCAGT","FALSE","NM_013986","ref|NM_013986|ref|NM_005243|ref|NM_001163285|ref|NM_001163286","EWSR1","EWS RNA-binding protein 1","ref|Homo sapiens EWS RNA-binding protein 1 (EWSR1), transcript variant 1, mRNA [NM_013986]","chr22",29663998,29696514,"GO:0000166(nucleotide binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0008270(zinc ion binding);GO:0042802(identical protein binding)","05202(Transcriptional misregulation in cancers)","mRNA","agilent G3 V3"]
["A_22_P00014648",{"v":6.8,"d":"6.80"},6.73,6.65,{"v":5.3,"d":"5.30"},{"v":5.1,"d":"5.10"},5.23,{"v":1.29110684580934,"d":"1.29"},{"v":0.368608396106693,"d":"0.37"},"up",{"v":3.57500000000011e-05,"d":"0.00"},1,"yes","CATCATGAATACAAAGATAAGCAAGACAAACTTCAAGGGGCTCACCACCTAATAAATATT","FALSE","XR_242525","ref|XR_242525|ref|XR_250458|ref|XR_252505|linc|lnc-SLC1A1-1:1","LOC101929330","uncharacterized LOC101929330","ref|PREDICTED: Homo sapiens uncharacterized LOC101929330 (LOC101929330), ncRNA [XR_242525]","chr9",{"v":4299389,"d":"4299389.00"},4307343,null,null,"mRNA","agilent G3 V3"]
["A_23_P37359",6.86,6.63,6.76,8.44,8.39,{"v":8.3,"d":"8.30"},{"v":0.805809789096697,"d":"0.81"},{"v":-0.311488763221306,"d":"-0.31"},"down",{"v":3.57579999999968e-05,"d":"0.00"},1,"yes","CTCGTGACAGAACCTTTCAGCATAACGCCTCACATCCCAAGTCTATACCCTTACCTGAAG","FALSE","NM_014430","ref|NM_014430|ens|ENST00000336557|ens|ENST00000258807|ens|ENST00000554411","CIDEB","cell death-inducing DFFA-like effector b","ref|Homo sapiens cell death-inducing DFFA-like effector b (CIDEB), mRNA [NM_014430]","chr14",24774392,24780628,"GO:0005515(protein binding);GO:0005811(lipid particle);GO:0005829(cytosol);GO:0006915(apoptotic process);GO:0008630(DNA damage response, signal transduction resulting in induction of apoptosis);GO:0010942(positive regulation of cell death);GO:0042802(identical protein binding);GO:0042981(regulation of apoptotic process);GO:0048471(perinuclear region of cytoplasm);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:0097194(execution phase of apoptosis);GO:0097202(activation of cysteine-type endopeptidase activity)",null,"mRNA","agilent G3 V3"]
["A_32_P505730",9.94,9.97,9.86,8.61,8.76,8.75,{"v":1.13973966309342,"d":"1.14"},{"v":0.188704324691605,"d":"0.19"},"up",{"v":3.578999999998e-05,"d":"0.00"},1,"yes","AATATAAAAGCATCATTTCCTTTGAGAAAAACATGTTTCCCCCTTGACTTGCTATTAGGG","FALSE","ENST00000304890","ens|ENST00000304890|ens|ENST00000438214|ens|ENST00000448990|ens|ENST00000452102","HLA-DPB2","major histocompatibility complex, class II, DP beta 2 (pseudogene)","ens|major histocompatibility complex, class II, DP beta 2 (pseudogene) [Source:HGNC Symbol;Acc:HGNC:4941] [ENST00000304890]","chrHSCHR6_MHC_SSTO",33219848,33226556,null,null,"mRNA","agilent G3 V3"]
["A_33_P3359354",13.72,13.75,13.66,12.44,12.39,12.57,{"v":1.09973262032086,"d":"1.10"},{"v":0.137152801725383,"d":"0.14"},"up",{"v":3.58240000000176e-05,"d":"0.00"},1,"yes","TCGAGTTCTGTTTCCGTGGAAAATGTGCACCTTGGAAACCGCATGACAGCCCCCTCGGCA","FALSE","NM_001282671","ref|NM_001282671|ref|NM_001146310|ref|NM_001282672|ref|NM_001282673","C1orf86","chromosome 1 open reading frame 86","ref|Homo sapiens chromosome 1 open reading frame 86 (C1orf86), transcript variant 7, mRNA [NM_001282671]","chr1",{"v":2115917,"d":"2115917.00"},2126180,"GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0006974(response to DNA damage stimulus);GO:0019985(translesion synthesis);GO:0030054(cell junction);GO:0031593(polyubiquitin binding);GO:0043130(ubiquitin binding);GO:0043240(Fanconi anaemia nuclear complex);GO:0046872(metal ion binding);GO:0070530(K63-linked polyubiquitin binding)",null,"mRNA","agilent G3 V3"]
["A_24_P370887",2.32,2.34,2.79,5.87,6.09,5.92,{"v":0.416666666666667,"d":"0.42"},{"v":-1.26303440583379,"d":"-1.26"},"down",{"v":3.58280000000155e-05,"d":"0.00"},1,"yes","AAACTTTGTCATCGGAAAAACTTTTCTTGTATGCATGAGACTCAACATCAGGATCCACAG","FALSE","NM_004781","ref|NM_004781|ens|ENST00000054666|gb|BC003570|gb|BC007050","VAMP3","vesicle-associated membrane protein 3","ref|Homo sapiens vesicle-associated membrane protein 3 (VAMP3), mRNA [NM_004781]","chr1",{"v":7831329,"d":"7831329.00"},7841492,"GO:0000149(SNARE binding);GO:0001921(positive regulation of receptor recycling);GO:0005484(SNAP receptor activity);GO:0005515(protein binding);GO:0005622(intracellular);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006461(protein complex assembly);GO:0006887(exocytosis);GO:0006904(vesicle docking involved in exocytosis);GO:0006906(vesicle fusion);GO:0007269(neurotransmitter secretion);GO:0008021(synaptic vesicle);GO:0009986(cell surface);GO:0016021(integral to membrane);GO:0016192(vesicle-mediated transport);GO:0016324(apical plasma membrane);GO:0017075(syntaxin-1 binding);GO:0017156(calcium ion-dependent exocytosis);GO:0030054(cell junction);GO:0030136(clathrin-coated vesicle);GO:0030141(secretory granule);GO:0030665(clathrin coated vesicle membrane);GO:0031201(SNARE complex);GO:0034446(substrate adhesion-dependent cell spreading);GO:0035493(SNARE complex assembly);GO:0042147(retrograde transport, endosome to Golgi);GO:0043001(Golgi to plasma membrane protein transport);GO:0043005(neuron projection);GO:0043231(intracellular membrane-bounded organelle);GO:0051024(positive regulation of immunoglobulin secretion);GO:0055037(recycling endosome);GO:0061025(membrane fusion);GO:0070254(mucus secretion)","04130(SNARE interactions in vesicular transport);04145(Phagosome)","mRNA","agilent G3 V3"]
["A_23_P105066",5.02,4.48,4.89,8.53,8.63,8.84,{"v":0.553461538461538,"d":"0.55"},{"v":-0.853445031175519,"d":"-0.85"},"down",{"v":3.59690000000246e-05,"d":"0.00"},1,"yes","CTCATGTGTGTAAGCTCATGAAGATCTGCATGAATGAAGACCCTGCAAAGCGACCCAAAT","FALSE","NM_001014795","ref|NM_001014795|ref|NM_004517|ref|NM_001014794|ref|NM_001278441","ILK","integrin-linked kinase","ref|Homo sapiens integrin-linked kinase (ILK), transcript variant 3, mRNA [NM_001014795]","chr11",{"v":6624961,"d":"6624961.00"},6632102,"GO:0001658(branching involved in ureteric bud morphogenesis);GO:0001725(stress fiber);GO:0001954(positive regulation of cell-matrix adhesion);GO:0004674(protein serine/threonine kinase activity);GO:0004871(signal transducer activity);GO:0005178(integrin binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0005925(focal adhesion);GO:0006468(protein phosphorylation);GO:0006469(negative regulation of protein kinase activity);GO:0007050(cell cycle arrest);GO:0007160(cell-matrix adhesion);GO:0007229(integrin-mediated signaling pathway);GO:0007569(cell aging);GO:0008283(cell proliferation);GO:0008284(positive regulation of cell proliferation);GO:0010667(negative regulation of cardiac muscle cell apoptotic process);GO:0010761(fibroblast migration);GO:0014912(negative regulation of smooth muscle cell migration);GO:0016020(membrane);GO:0017124(SH3 domain binding);GO:0018105(peptidyl-serine phosphorylation);GO:0019901(protein kinase binding);GO:0021675(nerve development);GO:0022011(myelination in peripheral nervous system);GO:0030017(sarcomere);GO:0030027(lamellipodium);GO:0030054(cell junction);GO:0030335(positive regulation of cell migration);GO:0030513(positive regulation of BMP signaling pathway);GO:0032288(myelin assembly);GO:0032956(regulation of actin cytoskeleton organization);GO:0034329(cell junction assembly);GO:0034446(substrate adhesion-dependent cell spreading);GO:0042327(positive regulation of phosphorylation);GO:0043025(neuronal cell body);GO:0043034(costamere);GO:0043195(terminal button);GO:0043198(dendritic shaft);GO:0043206(fibril organization);GO:0043234(protein complex);GO:0043406(positive regulation of MAP kinase activity);GO:0043491(protein kinase B signaling cascade);GO:0043524(negative regulation of neuron apoptotic process);GO:0045197(establishment or maintenance of epithelial cell apical/basal polarity);GO:0045663(positive regulation of myoblast differentiation);GO:0045669(positive regulation of osteoblast differentiation);GO:0045773(positive regulation of axon extension);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0048662(negative regulation of smooth muscle cell proliferation);GO:0048812(neuron projection morphogenesis);GO:0050775(positive regulation of dendrite morphogenesis);GO:0051291(protein heterooligomerization);GO:0051897(positive regulation of protein kinase B signaling cascade);GO:0070527(platelet aggregation);GO:0090263(positive regulation of canonical Wnt receptor signaling pathway);GO:2000178(negative regulation of neural precursor cell proliferation)","04510(Focal adhesion);03320(PPAR signaling pathway);05213(Endometrial cancer);05100(Bacterial invasion of epithelial cells)","mRNA","agilent G3 V3"]
["A_32_P3556",{"v":1.9,"d":"1.90"},2.25,1.86,4.93,5.15,4.92,{"v":0.400666666666667,"d":"0.40"},{"v":-1.31952560467206,"d":"-1.32"},"down",{"v":3.61199999999728e-05,"d":"0.00"},1,"yes","TGAAAAGGAAAATGATGCGGTAACAATTCAGGTTTTAAACCAGCTTATCCAAAAGATTCG","FALSE","NM_018206","ref|NM_018206|ens|ENST00000568784|ref|XM_005256045|gb|AB463339","VPS35","vacuolar protein sorting 35 homolog (S. cerevisiae)","ref|Homo sapiens vacuolar protein sorting 35 homolog (S. cerevisiae) (VPS35), mRNA [NM_018206]","chr16",46690056,46723104,"GO:0005515(protein binding);GO:0005765(lysosomal membrane);GO:0005768(endosome);GO:0005769(early endosome);GO:0005770(late endosome);GO:0005829(cytosol);GO:0006886(intracellular protein transport);GO:0008565(protein transporter activity);GO:0030904(retromer complex);GO:0042147(retrograde transport, endosome to Golgi);GO:0045056(transcytosis);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3235990",1.97,1.86,2.11,3.94,{"v":3.9,"d":"3.90"},4.11,{"v":0.497071129707113,"d":"0.50"},{"v":-1.00847578206735,"d":"-1.01"},"down",{"v":3.61279999999686e-05,"d":"0.00"},1,"yes","GCATGTTTGGCGTCATTCCTAAGAGCCATGTAATTTTAAACTTTTAATTGCAGTTAGTGA","FALSE","NM_007039","ref|NM_007039|ens|ENST00000556564|ens|ENST00000328736|ref|XM_005267287","PTPN21","protein tyrosine phosphatase, non-receptor type 21","ref|Homo sapiens protein tyrosine phosphatase, non-receptor type 21 (PTPN21), mRNA [NM_007039]","chr14",88932120,89016966,"GO:0004725(protein tyrosine phosphatase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0006470(protein dephosphorylation);GO:0035335(peptidyl-tyrosine dephosphorylation)",null,"mRNA","agilent G3 V3"]
["A_33_P3248137",8.38,8.45,8.39,9.25,{"v":9.2,"d":"9.20"},9.32,{"v":0.908174288800864,"d":"0.91"},{"v":-0.138958901490626,"d":"-0.14"},"down",{"v":3.61400000000733e-05,"d":"0.00"},1,"yes","GTGCTGTACGCCTGGGACAATGGCCACCAGCTCACCTACACCCTCCACTTCGTGGTCTGA","FALSE","NM_182487","ref|NM_182487|ref|NM_001282715|ens|ENST00000373580|ens|ENST00000288815","OLFML2A","olfactomedin-like 2A","ref|Homo sapiens olfactomedin-like 2A (OLFML2A), transcript variant 1, mRNA [NM_182487]","chr9",127563152,127577164,"GO:0005576(extracellular region);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix);GO:0042803(protein homodimerization activity);GO:0050840(extracellular matrix binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3386572",8.03,8.16,8.05,6.84,6.81,6.95,{"v":1.17669902912621,"d":"1.18"},{"v":0.23474536140237,"d":"0.23"},"up",{"v":3.61690000000303e-05,"d":"0.00"},1,"yes","TTTTTGATTAAATGAATGAGTAAGTTGGGCCTGCTCCCAAGCACTAAGCCCTGAGGTCAG","FALSE","ENST00000497451","ens|ENST00000497451|tc|THC2644690","AGBL4","ATP/GTP binding protein-like 4","ens|ATP/GTP binding protein-like 4 [Source:HGNC Symbol;Acc:HGNC:25892] [ENST00000497451]","chr1",49992900,50317190,"GO:0004181(metallocarboxypeptidase activity);GO:0005794(Golgi apparatus);GO:0005814(centriole);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0008270(zinc ion binding);GO:0015631(tubulin binding);GO:0035609(C-terminal protein deglutamylation);GO:0035610(protein side chain deglutamylation);GO:0036064(cilium basal body)",null,"mRNA","agilent G3 V3"]
["A_24_P317835",{"v":5.3,"d":"5.30"},5.63,5.32,8.35,8.08,8.14,{"v":0.661375661375661,"d":"0.66"},{"v":-0.596458139558986,"d":"-0.60"},"down",{"v":3.63760000000601e-05,"d":"0.00"},1,"yes","TCTTGCTTTGTGTCCCATTCCATCTCTTGAAAAAATGTAGTCTTTGAATGTGTGAAAATC","FALSE","NM_019892","ref|NM_019892|ens|ENST00000371712|ref|XM_005266094|ref|XM_006717187","INPP5E","inositol polyphosphate-5-phosphatase, 72 kDa","ref|Homo sapiens inositol polyphosphate-5-phosphatase, 72 kDa (INPP5E), mRNA [NM_019892]","chr9",139323072,139334274,"GO:0001726(ruffle);GO:0004439(phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity);GO:0004445(inositol-polyphosphate 5-phosphatase activity);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0005930(axoneme);GO:0006644(phospholipid metabolic process);GO:0006661(phosphatidylinositol biosynthetic process);GO:0006996(organelle organization);GO:0008150(biological_process);GO:0032580(Golgi cisterna membrane);GO:0044281(small molecule metabolic process);GO:0046855(inositol phosphate dephosphorylation);GO:0046856(phosphatidylinositol dephosphorylation);GO:0072372(primary cilium)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system)","mRNA","agilent G3 V3"]
["A_33_P3417950",2.47,2.54,2.93,5.89,5.71,5.77,{"v":0.457109959700633,"d":"0.46"},{"v":-1.12938684156743,"d":"-1.13"},"down",{"v":3.63930000000234e-05,"d":"0.00"},1,"yes","GCCTTAGTGGAGATTCCAGGTGAATATTTATGAAAAAGTCAACATTAGAACTGAAAATGG","FALSE","NM_005858","ref|NM_005858|ens|ENST00000598597|ens|ENST00000269701|ref|XM_005259706","AKAP8","A kinase (PRKA) anchor protein 8","ref|Homo sapiens A kinase (PRKA) anchor protein 8 (AKAP8), mRNA [NM_005858]","chr19",15464332,15483962,"GO:0000793(condensed chromosome);GO:0001939(female pronucleus);GO:0003690(double-stranded DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0005794(Golgi apparatus);GO:0007067(mitosis);GO:0007076(mitotic chromosome condensation);GO:0007165(signal transduction);GO:0008270(zinc ion binding);GO:0016020(membrane);GO:0016363(nuclear matrix);GO:0034237(protein kinase A regulatory subunit binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3382856",8.02,7.97,7.95,10.14,9.86,10.17,{"v":0.793503480278422,"d":"0.79"},{"v":-0.333691544203201,"d":"-0.33"},"down",{"v":3.64499999999657e-05,"d":"0.00"},1,"yes","TATTTGACTTTATGCTAGAAGATGAGGCTTCTGGGATAGGCCCAGAAGTTCCTGATGACC","FALSE","NM_133507","ref|NM_133507|ens|ENST00000456569|ens|ENST00000549513|ens|ENST00000441303","DCN","decorin","ref|Homo sapiens decorin (DCN), transcript variant E, mRNA [NM_133507]","chr12",91539040,91572329,"GO:0001822(kidney development);GO:0001890(placenta development);GO:0005518(collagen binding);GO:0005539(glycosaminoglycan binding);GO:0005576(extracellular region);GO:0005578(proteinaceous extracellular matrix);GO:0005589(collagen type VI);GO:0005615(extracellular space);GO:0005796(Golgi lumen);GO:0005975(carbohydrate metabolic process);GO:0007519(skeletal muscle tissue development);GO:0007568(aging);GO:0009405(pathogenesis);GO:0009612(response to mechanical stimulus);GO:0009887(organ morphogenesis);GO:0019800(peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan);GO:0022617(extracellular matrix disassembly);GO:0030198(extracellular matrix organization);GO:0030203(glycosaminoglycan metabolic process);GO:0030204(chondroitin sulfate metabolic process);GO:0030206(chondroitin sulfate biosynthetic process);GO:0030207(chondroitin sulfate catabolic process);GO:0030208(dermatan sulfate biosynthetic process);GO:0031012(extracellular matrix);GO:0032496(response to lipopolysaccharide);GO:0042060(wound healing);GO:0043202(lysosomal lumen);GO:0044281(small molecule metabolic process);GO:0047485(protein N-terminus binding);GO:0050840(extracellular matrix binding)","04350(TGF-beta signaling pathway);05205(Proteoglycans in cancer)","mRNA","agilent G3 V3"]
["A_33_P3273459",2.01,2.04,2.16,4.34,4.09,4.41,{"v":0.483644859813084,"d":"0.48"},{"v":-1.04798002890182,"d":"-1.05"},"down",{"v":3.64689999999834e-05,"d":"0.00"},1,"yes","GAAGCTAAGCTCACCAAAATCCTATTGGTTAATGTTTCTAGTGAATTTCCCAGAAACATT","FALSE","ENST00000466212","ens|ENST00000466212|ref|XR_241189|gb|AK128106|gb|BU624483","SPATA21","spermatogenesis associated 21","ens|spermatogenesis associated 21 [Source:HGNC Symbol;Acc:HGNC:28026] [ENST00000466212]","chr1",16722176,16763888,"GO:0005509(calcium ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P303833",2.91,3.09,2.94,5.84,{"v":6,"d":"6.00"},5.57,{"v":0.513497989661114,"d":"0.51"},{"v":-0.961569466467784,"d":"-0.96"},"down",{"v":3.65050000000755e-05,"d":"0.00"},1,"yes","ATGCATGGTTTATTCCTCTGGCTTGGATGACAACAATACCCATAGTCAATTTTCCTATGT","FALSE","NM_174934","ref|NM_174934|ref|NM_001142349|ref|NM_001142348|ref|NR_024527","SCN4B","sodium channel, voltage gated, type IV beta subunit","ref|Homo sapiens sodium channel, voltage gated, type IV beta subunit (SCN4B), transcript variant 1, mRNA [NM_174934]","chr11",118004096,118013588,"GO:0001518(voltage-gated sodium channel complex);GO:0005248(voltage-gated sodium channel activity);GO:0006814(sodium ion transport);GO:0010765(positive regulation of sodium ion transport);GO:0014704(intercalated disc);GO:0017080(sodium channel regulator activity);GO:0031226(intrinsic to plasma membrane);GO:0035725(sodium ion transmembrane transport);GO:0044325(ion channel binding);GO:0060048(cardiac muscle contraction);GO:0060307(regulation of ventricular cardiomyocyte membrane repolarization);GO:0086002(regulation of cardiac muscle cell action potential involved in contraction);GO:0086006(voltage-gated sodium channel activity involved in regulation of cardiac muscle cell action potential);GO:0086012(membrane depolarization involved in regulation of cardiac muscle cell action potential);GO:0086067(AV node cell to bundle of His cell communication);GO:0086091(regulation of heart rate by cardiac conduction);GO:2000649(regulation of sodium ion transmembrane transporter activity)","04261(Adrenergic signaling in cardiomyocytes)","mRNA","agilent G3 V3"]
["A_23_P60376",8.05,7.91,7.94,9.46,9.68,9.63,{"v":0.830726451164407,"d":"0.83"},{"v":-0.267554602871176,"d":"-0.27"},"down",{"v":3.65820000000072e-05,"d":"0.00"},1,"yes","TATGAGAGCGGACGGGCCATACCCAATAACCAGGTGCTTGGCAAAATCGAGCGGGCCATT","FALSE","NM_153200","ref|NM_153200|ref|NM_003792|ref|NM_001281299|ref|NM_001281298","EDF1","endothelial differentiation-related factor 1","ref|Homo sapiens endothelial differentiation-related factor 1 (EDF1), transcript variant beta, mRNA [NM_153200]","chr9",139756944,139760718,"GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0003713(transcription coactivator activity);GO:0004402(histone acetyltransferase activity);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005669(transcription factor TFIID complex);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0007275(multicellular organismal development);GO:0008168(methyltransferase activity);GO:0019216(regulation of lipid metabolic process);GO:0043388(positive regulation of DNA binding);GO:0043565(sequence-specific DNA binding);GO:0045446(endothelial cell differentiation);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_22_P00024701",8.01,7.98,{"v":8,"d":"8.00"},7.09,7.14,6.99,{"v":1.13053722902922,"d":"1.13"},{"v":0.17700850137867,"d":"0.18"},"up",{"v":3.66150000000731e-05,"d":"0.00"},1,"yes","TGTCGGGCGAGGTGCGGTAGGTCAGGTTGTCCACCTTGAGGGAGGTCATACCCTCCACAT","FALSE","ENST00000588460","ens|ENST00000588460|linc|lnc-METTL23-1:1|gb|CU688225|gb|AF015189","MFSD11","major facilitator superfamily domain containing 11","ens|major facilitator superfamily domain containing 11 [Source:HGNC Symbol;Acc:HGNC:25458] [ENST00000588460]","chr17",74732392,74774654,"GO:0003674(molecular_function);GO:0005575(cellular_component);GO:0008150(biological_process);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P323924",5.31,4.91,4.83,{"v":8.4,"d":"8.40"},8.21,8.25,{"v":0.605390185036203,"d":"0.61"},{"v":-0.724062809405421,"d":"-0.72"},"down",{"v":3.6648000000028e-05,"d":"0.00"},1,"yes","AGAGTTCAGTACCCCGTGCTTTCTTTACACTGGAGAGGAACTAAAAGGATCTCTGTGTCT","FALSE","NM_001002261","ref|NM_001002261|ref|NM_144588|ref|NM_001002262|ref|NM_001174119","ZFYVE27","zinc finger, FYVE domain containing 27","ref|Homo sapiens zinc finger, FYVE domain containing 27 (ZFYVE27), transcript variant 1, mRNA [NM_001002261]","chr10",99496880,99520663,"GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0016021(integral to membrane);GO:0030424(axon);GO:0030425(dendrite);GO:0031175(neuron projection development);GO:0032584(growth cone membrane);GO:0046872(metal ion binding);GO:0048011(nerve growth factor receptor signaling pathway);GO:0055038(recycling endosome membrane);GO:0072659(protein localization in plasma membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3423171",3.08,3.16,2.89,4.74,4.84,4.78,{"v":0.635793871866295,"d":"0.64"},{"v":-0.653368983838829,"d":"-0.65"},"down",{"v":3.6829000000016e-05,"d":"0.00"},1,"yes","AGGAGCTGACCATAGTGGCAGGTGCTGTTTCCAACCAGCTCTTGGTCTGGTACCCAGCAA","FALSE","NM_018031","ref|NM_018031|ens|ENST00000488572|ens|ENST00000472878|ens|ENST00000461687","WDR6","WD repeat domain 6","ref|Homo sapiens WD repeat domain 6 (WDR6), mRNA [NM_018031]","chr3",49045500,49049225,"GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0007050(cell cycle arrest);GO:0008180(signalosome);GO:0008285(negative regulation of cell proliferation);GO:0010507(negative regulation of autophagy)",null,"mRNA","agilent G3 V3"]
["A_33_P3274199",9.65,{"v":9.7,"d":"9.70"},9.79,10.62,10.61,10.67,{"v":0.913479623824451,"d":"0.91"},{"v":-0.130555546587719,"d":"-0.13"},"down",{"v":3.68560000000295e-05,"d":"0.00"},1,"yes","GAAAAGGAGCCGCTTCTGCCTCCCTTGCCAAAACTCCGTTTCTAATTAAATTATTTTTAG","FALSE","NM_138349","ref|NM_138349|ens|ENST00000579674|ens|ENST00000301057|ref|XM_005258063","TP53I13","tumor protein p53 inducible protein 13","ref|Homo sapiens tumor protein p53 inducible protein 13 (TP53I13), mRNA [NM_138349]","chr17",27899448,27900175,"GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3700794",12.31,{"v":12.3,"d":"12.30"},12.21,11.16,11.13,11.27,{"v":1.09713945172825,"d":"1.10"},{"v":0.133746910910083,"d":"0.13"},"up",{"v":3.68670000000515e-05,"d":"0.00"},1,"yes","TAACCGATGTGCTGGAGCTACACGACTGGATGTGCACTCATTTCGAAGAGCCCCCACTGT","FALSE","NM_005371","ref|NM_005371|ref|NM_023033|ens|ENST00000551117|ens|ENST00000257848","METTL1","methyltransferase like 1","ref|Homo sapiens methyltransferase like 1 (METTL1), transcript variant 1, mRNA [NM_005371]","chr12",58163364,58165899,"GO:0000049(tRNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006400(tRNA modification);GO:0008176(tRNA (guanine-N7-)-methyltransferase activity);GO:0030488(tRNA methylation);GO:0043527(tRNA methyltransferase complex)",null,"mRNA","agilent G3 V3"]
["A_24_P258955",2.93,{"v":3,"d":"3.00"},3.07,{"v":4.8,"d":"4.80"},4.69,4.55,{"v":0.641025641025641,"d":"0.64"},{"v":-0.641546029087524,"d":"-0.64"},"down",{"v":3.74730000000101e-05,"d":"0.00"},1,"yes","ACTTTTCACCTTGCAAAGAGATCCAGTACCTAGTATTGGAAGATCCACCTTAACGACCGT","FALSE","NM_020933","ref|NM_020933|ref|NM_001190791|ref|NR_102435|ens|ENST00000360385","ZNF317","zinc finger protein 317","ref|Homo sapiens zinc finger protein 317 (ZNF317), transcript variant 1, mRNA [NM_020933]","chr19",{"v":9268748,"d":"9268748.00"},9274100,"GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_21_P0014872",8.92,9.03,9.11,7.48,7.63,7.49,{"v":1.19734513274336,"d":"1.20"},{"v":0.259839066673987,"d":"0.26"},"up",{"v":3.7477000000008e-05,"d":"0.00"},1,"yes","ATGCATATCTGACTTTACAAACCTAAAAGTTAATCAGCACCTCCCTTATTTTTTAAAAAA","FALSE","AK129697","gb|AK129697|tc|NP852804","LOC100505923","uncharacterized LOC100505923","gb|Homo sapiens cDNA FLJ26186 fis, clone ADG04757. [AK129697]","chr12",48759908,48761738,null,null,"mRNA","agilent G3 V3"]
["A_23_P142255",12.44,12.35,12.42,{"v":11.6,"d":"11.60"},11.55,11.65,{"v":1.06925287356322,"d":"1.07"},{"v":0.0966030843896821,"d":"0.10"},"up",{"v":3.76429999999761e-05,"d":"0.00"},1,"yes","CCCTTTTGAGTCCTCGGGCCCAGAATCGTATCCCAAAGCCCTCCCATGGCCTAGAAAATA","FALSE","NM_020209","ref|NM_020209|ens|ENST00000543264|gb|AK055673|gb|AK056268","SHD","Src homology 2 domain containing transforming protein D","ref|Homo sapiens Src homology 2 domain containing transforming protein D (SHD), mRNA [NM_020209]","chr19",{"v":4288189,"d":"4288189.00"},4290561,"GO:0005515(protein binding)",null,"mRNA","agilent G3 V3"]
["A_23_P255317",7.34,7.48,7.39,6.33,6.35,6.43,{"v":1.16221873364731,"d":"1.16"},{"v":0.216881614569524,"d":"0.22"},"up",{"v":3.76509999999719e-05,"d":"0.00"},1,"yes","ATGTACTGGCTGTATGCAATATTTCTGTTGGATTTGCATGGGTTCTCTCTCTAGAGCAAA","FALSE","NM_004290","ref|NM_004290|ref|NM_183398|ref|NM_183400|ref|NM_183401","RNF14","ring finger protein 14","ref|Homo sapiens ring finger protein 14 (RNF14), transcript variant 1, mRNA [NM_004290]","chr7",134813200,134814437,"GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0007165(signal transduction);GO:0008270(zinc ion binding);GO:0016567(protein ubiquitination);GO:0016874(ligase activity);GO:0019787(small conjugating protein ligase activity);GO:0030521(androgen receptor signaling pathway);GO:0032355(response to estradiol stimulus);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0050681(androgen receptor binding);GO:0060765(regulation of androgen receptor signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_33_P3222769",15.03,15.07,14.96,15.71,15.75,15.71,{"v":0.955268178927284,"d":"0.96"},{"v":-0.0660222872941689,"d":"-0.07"},"down",{"v":3.76920000000336e-05,"d":"0.00"},1,"yes","CCGCTGGGGTCTCCCGCCGTCCTCGCCGTCACCACCGGGTGGAGCCACAGGTCCGTGTGA","FALSE","NM_001013638","ref|NM_001013638|ens|ENST00000301698|gb|BC156145|gb|BC156984","PRR25","proline rich 25","ref|Homo sapiens proline rich 25 (PRR25), mRNA [NM_001013638]","chr16",{"v":855443,"d":"855443.00"},863861,null,null,"mRNA","agilent G3 V3"]
["A_23_P127460",2.98,3.03,3.37,5.92,5.77,5.98,{"v":0.530843237125071,"d":"0.53"},{"v":-0.913642212036241,"d":"-0.91"},"down",{"v":3.81000000000409e-05,"d":"0.00"},1,"yes","AAATCTGATGCTGAGCCAGAGCCTGGGAACCTCTCAGAGAAGGTCTCTCACTTGGAGTCC","FALSE","NM_153253","ref|NM_153253|ref|NM_006747|ens|ENST00000531339|ens|ENST00000529725","SIPA1","signal-induced proliferation-associated 1","ref|Homo sapiens signal-induced proliferation-associated 1 (SIPA1), transcript variant 1, mRNA [NM_153253]","chr11",65405568,65418401,"GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007010(cytoskeleton organization);GO:0007162(negative regulation of cell adhesion);GO:0007165(signal transduction);GO:0008022(protein C-terminus binding);GO:0008283(cell proliferation);GO:0030133(transport vesicle);GO:0030308(negative regulation of cell growth);GO:0032854(positive regulation of Rap GTPase activity);GO:0035556(intracellular signal transduction);GO:0042631(cellular response to water deprivation);GO:0043234(protein complex);GO:0043547(positive regulation of GTPase activity);GO:0045786(negative regulation of cell cycle);GO:0046582(Rap GTPase activator activity);GO:0048471(perinuclear region of cytoplasm)","04015(Rap1 signaling pathway);04670(Leukocyte transendothelial migration)","mRNA","agilent G3 V3"]
["A_32_P192823",1.93,2.04,1.91,{"v":3.9,"d":"3.90"},4.22,3.99,{"v":0.485549132947977,"d":"0.49"},{"v":-1.04231080485796,"d":"-1.04"},"down",{"v":3.82039999999861e-05,"d":"0.00"},1,"yes","GCTCCAAAATACGAGTAATTGACATCTCCATGATCCTTGCAGAAGCCATAAGGAGAACTC","FALSE","NM_175886","ref|NM_175886|ens|ENST00000506618|gb|M57423|gb|BC062797","PRPS1L1","phosphoribosyl pyrophosphate synthetase 1-like 1","ref|Homo sapiens phosphoribosyl pyrophosphate synthetase 1-like 1 (PRPS1L1), mRNA [NM_175886]","chr7",18066404,18067486,"GO:0000287(magnesium ion binding);GO:0004749(ribose phosphate diphosphokinase activity);GO:0005524(ATP binding);GO:0005575(cellular_component);GO:0006015(5-phosphoribose 1-diphosphate biosynthetic process);GO:0009156(ribonucleoside monophosphate biosynthetic process);GO:0009165(nucleotide biosynthetic process);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0042803(protein homodimerization activity)","01200(Carbon metabolism);01230(Biosynthesis of amino acids);00030(Pentose phosphate pathway);00230(Purine metabolism)","mRNA","agilent G3 V3"]
["A_24_P929369",{"v":2.1,"d":"2.10"},2.14,2.06,4.53,{"v":4.9,"d":"4.90"},4.52,{"v":0.451612903225807,"d":"0.45"},{"v":-1.14684138832927,"d":"-1.15"},"down",{"v":3.82410000000499e-05,"d":"0.00"},1,"yes","GAGAGTGCACTGAACCTATTCACATGTCTTTAAGATGTTTTGCTGTGTTAAAATTTTAGG","FALSE","NM_007347","ref|NM_007347|ref|NM_001252127|ens|ENST00000261842|ref|XM_006720447","AP4E1","adaptor-related protein complex 4, epsilon 1 subunit","ref|Homo sapiens adaptor-related protein complex 4, epsilon 1 subunit (AP4E1), transcript variant 1, mRNA [NM_007347]","chr15",51200992,51298091,"GO:0005794(Golgi apparatus);GO:0005905(coated pit);GO:0006886(intracellular protein transport);GO:0016192(vesicle-mediated transport);GO:0030117(membrane coat)","04142(Lysosome)","mRNA","agilent G3 V3"]
["A_23_P206228",2.04,2.46,1.99,5.27,5.22,5.16,{"v":0.414696485623003,"d":"0.41"},{"v":-1.26987227382084,"d":"-1.27"},"down",{"v":3.83090000000141e-05,"d":"0.00"},1,"yes","GGGATCATTATCAGTAATTTCATAGCAACTGTTCTAGTGTTTTGTGTTTTTAAAACAGAA","FALSE","NM_020821","ref|NM_020821|ref|NM_017684|ens|ENST00000560637|ens|ENST00000261517","VPS13C","vacuolar protein sorting 13 homolog C (S. cerevisiae)","ref|Homo sapiens vacuolar protein sorting 13 homolog C (S. cerevisiae) (VPS13C), transcript variant 2A, mRNA [NM_020821]","chr15",62144604,62156959,"GO:0005622(intracellular);GO:0006623(protein targeting to vacuole);GO:0019898(extrinsic to membrane);GO:0045053(protein retention in Golgi apparatus);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P126623",3.74,3.75,4.04,6.39,6.17,{"v":6.4,"d":"6.40"},{"v":0.608122362869198,"d":"0.61"},{"v":-0.717566451246487,"d":"-0.72"},"down",{"v":3.83849999999741e-05,"d":"0.00"},1,"yes","TTTGATCGAAACCCGGAACTTCAGAACCTCCTACTGGACGACTTCTTTAAGTCAGCTGTT","FALSE","NM_002631","ref|NM_002631|ens|ENST00000498356|ens|ENST00000496718|ens|ENST00000270776","PGD","phosphogluconate dehydrogenase","ref|Homo sapiens phosphogluconate dehydrogenase (PGD), mRNA [NM_002631]","chr1",10459175,10480108,"GO:0004616(phosphogluconate dehydrogenase (decarboxylating) activity);GO:0005634(nucleus);GO:0005829(cytosol);GO:0005975(carbohydrate metabolic process);GO:0006098(pentose-phosphate shunt);GO:0009051(pentose-phosphate shunt, oxidative branch);GO:0009405(pathogenesis);GO:0019322(pentose biosynthetic process);GO:0019521(D-gluconate metabolic process);GO:0044281(small molecule metabolic process);GO:0050661(NADP binding);GO:0055114(oxidation-reduction process);GO:0070062(extracellular vesicular exosome)","01200(Carbon metabolism);00030(Pentose phosphate pathway);00480(Glutathione metabolism)","mRNA","agilent G3 V3"]
["A_33_P3245238",6.66,6.66,6.73,5.16,5.12,4.91,{"v":1.31994733377222,"d":"1.32"},{"v":0.400480366840199,"d":"0.40"},"up",{"v":3.8411000000016e-05,"d":"0.00"},1,"yes","GCACTGGCAATTCCAAACAATGTCAGTGTTAAAATGCTTCTCCCTGAAAAAGAGAAAAAA","FALSE","NM_176825","ref|NM_176825|ref|NM_001056|ens|ENST00000326853|ens|ENST00000251481","SULT1C2","sulfotransferase family, cytosolic, 1C, member 2","ref|Homo sapiens sulfotransferase family, cytosolic, 1C, member 2 (SULT1C2), transcript variant 2, mRNA [NM_176825]","chr2",108905096,108926371,"GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006805(xenobiotic metabolic process);GO:0008146(sulfotransferase activity);GO:0009308(amine metabolic process);GO:0044281(small molecule metabolic process);GO:0050427(3'-phosphoadenosine 5'-phosphosulfate metabolic process);GO:0051923(sulfation);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P54900",2.28,{"v":2.5,"d":"2.50"},2.45,5.56,6.05,5.63,{"v":0.419373549883991,"d":"0.42"},{"v":-1.25369222213798,"d":"-1.25"},"down",{"v":3.84559999999645e-05,"d":"0.00"},1,"yes","TCTTGCCTCAGGGAAACGTTTCTTTGATGGGGAGTTTGAGATTTCTTTTCCTTGTTTATG","FALSE","NM_001079514","ref|NM_001079514|ref|NM_001288656|ens|ENST00000396658|ens|ENST00000262376","UBN1","ubinuclein 1","ref|Homo sapiens ubinuclein 1 (UBN1), transcript variant 2, mRNA [NM_001079514]","chr16",{"v":4897912,"d":"4897912.00"},4932357,"GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005923(tight junction);GO:0006336(DNA replication-independent nucleosome assembly);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0010923(negative regulation of phosphatase activity);GO:0016032(viral reproduction);GO:0016568(chromatin modification);GO:0016605(PML body)",null,"mRNA","agilent G3 V3"]
["A_23_P61050",2.36,2.54,{"v":2.4,"d":"2.40"},5.78,5.28,{"v":5.6,"d":"5.60"},{"v":0.438175270108043,"d":"0.44"},{"v":-1.19042003159817,"d":"-1.19"},"down",{"v":3.84709999999844e-05,"d":"0.00"},1,"yes","GAAGTGACTGTATGCCAGTTCCAAGCCTAGGTTTCAAGAGGCCTTATAAATGTCTGTTGG","FALSE","NM_152649","ref|NM_152649|ref|NM_001142497|ens|ENST00000308807|ens|ENST00000570846","MLKL","mixed lineage kinase domain-like","ref|Homo sapiens mixed lineage kinase domain-like (MLKL), transcript variant 1, mRNA [NM_152649]","chr16",74705760,74734812,"GO:0004672(protein kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0019901(protein kinase binding);GO:0032403(protein complex binding);GO:0070207(protein homotrimerization);GO:0070266(necroptosis)","04668(TNF signaling pathway)","mRNA","agilent G3 V3"]
["A_33_P3380625",5.62,5.27,5.25,8.08,7.94,7.92,{"v":0.674185463659148,"d":"0.67"},{"v":-0.568782573665721,"d":"-0.57"},"down",{"v":3.85860000000626e-05,"d":"0.00"},1,"yes","ATCCAGAACTTGGACCAGAGCTGCCAAGGGACGTATATATGCCAGGCCCATGGACCTTGG","FALSE","NM_001291860","ref|NM_001291860|ref|NM_005529|ens|ENST00000374676|ens|ENST00000471322","HSPG2","heparan sulfate proteoglycan 2","ref|Homo sapiens heparan sulfate proteoglycan 2 (HSPG2), transcript variant 1, mRNA [NM_001291860]","chr1",22161902,22165499,"GO:0001523(retinoid metabolic process);GO:0001525(angiogenesis);GO:0001958(endochondral ossification);GO:0002062(chondrocyte differentiation);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005605(basal lamina);GO:0005615(extracellular space);GO:0005796(Golgi lumen);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0005975(carbohydrate metabolic process);GO:0006024(glycosaminoglycan biosynthetic process);GO:0006027(glycosaminoglycan catabolic process);GO:0007420(brain development);GO:0007603(phototransduction, visible light);GO:0008022(protein C-terminus binding);GO:0008104(protein localization);GO:0009405(pathogenesis);GO:0022617(extracellular matrix disassembly);GO:0030198(extracellular matrix organization);GO:0030203(glycosaminoglycan metabolic process);GO:0030204(chondroitin sulfate metabolic process);GO:0031012(extracellular matrix);GO:0042157(lipoprotein metabolic process);GO:0043202(lysosomal lumen);GO:0044281(small molecule metabolic process);GO:0046872(metal ion binding);GO:0048704(embryonic skeletal system morphogenesis);GO:0048738(cardiac muscle tissue development);GO:0060351(cartilage development involved in endochondral bone morphogenesis);GO:0070062(extracellular vesicular exosome)","04512(ECM-receptor interaction);05205(Proteoglycans in cancer);05161(Hepatitis B)","mRNA","agilent G3 V3"]
["A_33_P3419938",7.31,7.04,7.06,9.03,9.16,9.19,{"v":0.781957633308985,"d":"0.78"},{"v":-0.35483765087239,"d":"-0.35"},"down",{"v":3.8646000000031e-05,"d":"0.00"},1,"yes","TGTAATCCTAGCTACTTGGCAGGCTGAGGTGAGAAGATCATTGGAGTTTAGGAATTGGAG","FALSE","NM_000551","ref|NM_000551|ref|NM_198156|ens|ENST00000345392|ens|ENST00000256474","VHL","von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase","ref|Homo sapiens von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase (VHL), transcript variant 1, mRNA [NM_000551]","chr3",10183472,10193766,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000902(cell morphogenesis);GO:0004842(ubiquitin-protein ligase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0006355(regulation of transcription, DNA-dependent);GO:0006508(proteolysis);GO:0008134(transcription factor binding);GO:0008285(negative regulation of cell proliferation);GO:0016020(membrane);GO:0016567(protein ubiquitination);GO:0019899(enzyme binding);GO:0043066(negative regulation of apoptotic process);GO:0045111(intermediate filament cytoskeleton);GO:0045597(positive regulation of cell differentiation);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0050821(protein stabilization);GO:0061418(regulation of transcription from RNA polymerase II promoter in response to hypoxia);GO:0061428(negative regulation of transcription from RNA polymerase II promoter in response to hypoxia);GO:0071456(cellular response to hypoxia)","04120(Ubiquitin mediated proteolysis);04066(HIF-1 signaling pathway);05200(Pathways in cancer);05211(Renal cell carcinoma)","mRNA","agilent G3 V3"]
["A_23_P56127",1.89,1.96,2.31,4.79,4.97,4.83,{"v":0.422206991089788,"d":"0.42"},{"v":-1.24397762722299,"d":"-1.24"},"down",{"v":3.86559999999703e-05,"d":"0.00"},1,"yes","GTCAACTTATTCCTGGTACCCTTCATGGACAGTGAAGCAGAGAGTGAAAACCCACCAAGA","FALSE","NM_019108","ref|NM_019108|ens|ENST00000601170|ref|XM_005259057|gb|AL136606","SMG9","SMG9 nonsense mediated mRNA decay factor","ref|Homo sapiens SMG9 nonsense mediated mRNA decay factor (SMG9), mRNA [NM_019108]","chr19",44237576,44238977,"GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay);GO:0005515(protein binding);GO:0005622(intracellular);GO:0005829(cytosol);GO:0010467(gene expression);GO:0042802(identical protein binding)",null,"mRNA","agilent G3 V3"]
["A_23_P107412",5.04,5.63,5.29,9.32,9.02,9.28,{"v":0.577842143374366,"d":"0.58"},{"v":-0.791252668035705,"d":"-0.79"},"down",{"v":3.87450000000067e-05,"d":"0.00"},1,"yes","CTGAAACCATGATGTACTTTTTCATACATGAGTCTGTCCAGAGTGCTTGCTACCGTGTTC","FALSE","NM_000918","ref|NM_000918|ens|ENST00000473021|ens|ENST00000575069|ens|ENST00000331483","P4HB","prolyl 4-hydroxylase, beta polypeptide","ref|Homo sapiens prolyl 4-hydroxylase, beta polypeptide (P4HB), mRNA [NM_000918]","chr17",79801944,79818408,"GO:0000302(response to reactive oxygen species);GO:0003756(protein disulfide isomerase activity);GO:0004175(endopeptidase activity);GO:0004656(procollagen-proline 4-dioxygenase activity);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005783(endoplasmic reticulum);GO:0005788(endoplasmic reticulum lumen);GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0006457(protein folding);GO:0006508(proteolysis);GO:0016222(procollagen-proline 4-dioxygenase complex);GO:0018401(peptidyl-proline hydroxylation to 4-hydroxy-L-proline);GO:0019899(enzyme binding);GO:0030198(extracellular matrix organization);GO:0034976(response to endoplasmic reticulum stress);GO:0042157(lipoprotein metabolic process);GO:0042470(melanosome);GO:0044281(small molecule metabolic process);GO:0045454(cell redox homeostasis);GO:0046982(protein heterodimerization activity);GO:0070062(extracellular vesicular exosome);GO:0071456(cellular response to hypoxia)","04141(Protein processing in endoplasmic reticulum)","mRNA","agilent G3 V3"]
["A_23_P320878",2.96,3.09,3.16,5.06,5.33,5.08,{"v":0.595345830639948,"d":"0.60"},{"v":-0.7482001353577,"d":"-0.75"},"down",{"v":3.87530000000025e-05,"d":"0.00"},1,"yes","ATTCCGCAAACTCTTGTGATCTTCCAAAATTAGCTCTGATTAGCTTTCACTTCCTGTAGA","FALSE","NM_206914","ref|NM_206914|ref|NM_015433|ens|ENST00000300209|ens|ENST00000333012","METTL21B","methyltransferase like 21B","ref|Homo sapiens methyltransferase like 21B (METTL21B), transcript variant 2, mRNA [NM_206914]","chr12",58166460,58176324,"GO:0005622(intracellular);GO:0005737(cytoplasm);GO:0008168(methyltransferase activity);GO:0032259(methylation)",null,"mRNA","agilent G3 V3"]
["A_23_P216689",2.79,2.92,2.94,4.84,5.04,4.74,{"v":0.591655266757866,"d":"0.59"},{"v":-0.75717127342835,"d":"-0.76"},"down",{"v":3.87699999999658e-05,"d":"0.00"},1,"yes","ATGGGTACTGTATTTGAAAGCTGTTAGCTTTGTCAACACGCATTGTCCTTGTCATTTGGG","FALSE","NM_007371","ref|NM_007371|ens|ENST00000303407|ref|XM_006717291|ref|XM_005272214","BRD3","bromodomain containing 3","ref|Homo sapiens bromodomain containing 3 (BRD3), mRNA [NM_007371]","chr9",136898528,136906916,"GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0016568(chromatin modification);GO:0070577(histone acetyl-lysine binding)",null,"mRNA","agilent G3 V3"]
["A_23_P24077",{"v":6.9,"d":"6.90"},6.86,6.95,7.79,7.86,7.93,{"v":0.878286683630195,"d":"0.88"},{"v":-0.187236164759251,"d":"-0.19"},"down",{"v":3.88119999999992e-05,"d":"0.00"},1,"yes","AGATCTGTCAACAGGTTAAGTCAATCTGGGGCTTCCACTGCCTGCATTCCAGTCCCCAGA","FALSE","NM_022153","ref|NM_022153|ens|ENST00000394957|gb|EF506490|gb|BC020568","C10orf54","chromosome 10 open reading frame 54","ref|Homo sapiens chromosome 10 open reading frame 54 (C10orf54), mRNA [NM_022153]","chr10",73510672,73517387,"GO:0002725(negative regulation of T cell cytokine production);GO:0009897(external side of plasma membrane);GO:0016021(integral to membrane);GO:0030509(BMP signaling pathway);GO:0030513(positive regulation of BMP signaling pathway);GO:0048863(stem cell differentiation);GO:2000562(negative regulation of CD4-positive, alpha-beta T cell proliferation);GO:2000738(positive regulation of stem cell differentiation)",null,"mRNA","agilent G3 V3"]
["A_23_P352389",12.49,12.48,12.53,11.48,11.46,11.61,{"v":1.08538350217077,"d":"1.09"},{"v":0.118204884994985,"d":"0.12"},"up",{"v":3.88540000000326e-05,"d":"0.00"},1,"yes","AAAGAGAATCCATTATTGGTGAAAATCCATTTTAAGCTGTCAGCCCCCACAATCCCAGAG","FALSE","NM_152343","ref|NM_152343|ens|ENST00000586359|ens|ENST00000331780|ens|ENST00000588866","SPATA32","spermatogenesis associated 32","ref|Homo sapiens spermatogenesis associated 32 (SPATA32), mRNA [NM_152343]","chr17",43331760,43339461,"GO:0003779(actin binding);GO:0007283(spermatogenesis);GO:0048471(perinuclear region of cytoplasm)",null,"mRNA","agilent G3 V3"]
["A_24_P397515",10.56,10.53,10.69,{"v":8.7,"d":"8.70"},8.89,8.94,{"v":1.19788918205805,"d":"1.20"},{"v":0.260494449119823,"d":"0.26"},"up",{"v":3.89189999999706e-05,"d":"0.00"},1,"yes","TCCTGCTGGTTTTACTTTAGTCCCTCCATGTCAAAGTGGGCCTGAGAAAAGCTCATACAT","FALSE","NM_006353","ref|NM_006353|ens|ENST00000377575|gb|U90549|gb|BC001282","HMGN4","high mobility group nucleosomal binding domain 4","ref|Homo sapiens high mobility group nucleosomal binding domain 4 (HMGN4), mRNA [NM_006353]","chr6",26538632,26546482,"GO:0000785(chromatin);GO:0005634(nucleus);GO:0031492(nucleosomal DNA binding)",null,"mRNA","agilent G3 V3"]
["A_24_P921155",2.01,2.09,2.09,4.44,4.83,4.83,{"v":0.439007092198582,"d":"0.44"},{"v":-1.18768384807189,"d":"-1.19"},"down",{"v":3.89310000000753e-05,"d":"0.00"},1,"yes","TCTCACCAGCTACAGGAACTGCCTAGCACTTGGGTATGTACAACCTGGAAGAGGTGTGGG","FALSE","NM_015412","ref|NM_015412|ref|NR_027794|ref|NR_027796|ens|ENST00000383675","C3orf17","chromosome 3 open reading frame 17","ref|Homo sapiens chromosome 3 open reading frame 17 (C3orf17), transcript variant 1, mRNA [NM_015412]","chr3",112721288,112738580,"GO:0005634(nucleus);GO:0016021(integral to membrane);GO:0045665(negative regulation of neuron differentiation);GO:0045747(positive regulation of Notch signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_33_P3287770",8.21,8.22,8.19,7.55,7.65,7.61,{"v":1.07935116177115,"d":"1.08"},{"v":0.11016431517232,"d":"0.11"},"up",{"v":3.89350000000732e-05,"d":"0.00"},1,"yes","ATGGGCTCGTGGGGCGGGATGGGACAGGGCACGGGCTCTCAGAAAATAAACTGCTTTATT","FALSE","NM_016111","ref|NM_016111|ens|ENST00000262319|ens|ENST00000568240|ref|XR_429650","TELO2","telomere maintenance 2","ref|Homo sapiens telomere maintenance 2 (TELO2), mRNA [NM_016111]","chr16",{"v":1556535,"d":"1556535.00"},1560458,"GO:0000781(chromosome, telomeric region);GO:0005515(protein binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0031931(TORC1 complex);GO:0031932(TORC2 complex);GO:0032006(regulation of TOR signaling cascade);GO:0032403(protein complex binding);GO:0032947(protein complex scaffold)","03460(Fanconi anemia pathway)","mRNA","agilent G3 V3"]
["A_33_P3378702",5.45,5.11,{"v":5.2,"d":"5.20"},7.89,7.72,8.01,{"v":0.66723116003387,"d":"0.67"},{"v":-0.583741429940781,"d":"-0.58"},"down",{"v":3.90020000000657e-05,"d":"0.00"},1,"yes","TGGGGACACCAACACTGGGTTTTTCTCCTGTTTCTTGGGCTGCTTGTCTCCTGCACATAG","FALSE","AK127786","gb|AK127786",null,null,"gb|Homo sapiens cDNA FLJ45887 fis, clone OCBBF3021502. [AK127786]",{"$nulls":5},"mRNA","agilent G3 V3"]
["A_24_P33461",8.46,8.58,8.48,9.39,9.44,9.49,{"v":0.901129943502825,"d":"0.90"},{"v":-0.150192936318128,"d":"-0.15"},"down",{"v":3.90060000000636e-05,"d":"0.00"},1,"yes","ACAGAATCCTTGGGGTATCTGTCATCCCTCAGCTCCTCTCAGCCACCAGAGCCTTTGCGT","FALSE","ENST00000425471","ens|ENST00000425471|ens|ENST00000505650|ens|ENST00000511063|ref|XR_427803",null,null,"ens|chromosome 5 open reading frame 60 [Source:HGNC Symbol;Acc:HGNC:27753] [ENST00000511063]","chr5",179078304,179079294,null,null,"mRNA","agilent G3 V3"]
["A_33_P3354499",6.99,7.01,6.79,8.73,8.95,8.91,{"v":0.781872884543061,"d":"0.78"},{"v":-0.354994018999298,"d":"-0.35"},"down",{"v":3.91000000000696e-05,"d":"0.00"},1,"yes","TAAATGTTTAGCTTAAGGCCGGGCACAGTGACTCACACTATAATCCCAGCAATTTGGGAG","FALSE","XR_242443","ref|XR_242443|ref|XR_250424|ref|XR_252485|linc|lnc-GPR20-2:1","LOC401480","uncharacterized LOC401480","ref|PREDICTED: Homo sapiens uncharacterized LOC401480 (LOC401480), misc_RNA [XR_242443]","chr8",142400032,142402674,null,null,"mRNA","agilent G3 V3"]
["A_23_P54840",9.09,9.23,9.16,10.15,10.25,10.26,{"v":0.896281800391389,"d":"0.90"},{"v":-0.157975692840677,"d":"-0.16"},"down",{"v":3.9200000000017e-05,"d":"0.00"},1,"yes","AAATGCAACTCCTGCAAGAAGAGCTGCTGCTCCTGCTGCCCCATGAGCTGTGCCAAGTGT","FALSE","NM_005946","ref|NM_005946|ref|NM_176870|ens|ENST00000290705|ens|ENST00000622334","MT1A","metallothionein 1A","ref|Homo sapiens metallothionein 1A (MT1A), mRNA [NM_005946]","chr16",56672576,56673999,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0045926(negative regulation of growth);GO:0048471(perinuclear region of cytoplasm);GO:0071276(cellular response to cadmium ion);GO:0071294(cellular response to zinc ion)","04978(Mineral absorption)","mRNA","agilent G3 V3"]
["A_23_P96777",2.58,2.67,2.95,4.95,4.98,5.03,{"v":0.548128342245989,"d":"0.55"},{"v":-0.867414360382191,"d":"-0.87"},"down",{"v":3.92030000000432e-05,"d":"0.00"},1,"yes","TCTGTTTTTCCAGATGATTCTGTCGTAAAGTGATGCTATGTTGTCGTTACAACATCAAAG","FALSE","NM_020710","ref|NM_020710|gb|AB033011|gb|BC012300|gb|BC031301","LRRC47","leucine rich repeat containing 47","ref|Homo sapiens leucine rich repeat containing 47 (LRRC47), mRNA [NM_020710]","chr1",{"v":3697699,"d":"3697699.00"},3700739,"GO:0004826(phenylalanine-tRNA ligase activity);GO:0005515(protein binding);GO:0008152(metabolic process)",null,"mRNA","agilent G3 V3"]
["A_23_P309779",15.08,15.15,15.09,13.71,13.77,13.92,{"v":1.09468599033816,"d":"1.09"},{"v":0.130517093433828,"d":"0.13"},"up",{"v":3.93899999999725e-05,"d":"0.00"},1,"yes","AAGTCTTTTGTGAGAGGTATTTAAAGTGCTTTGAGACCTGATTCATGCCCCCCAAAGGGT","FALSE","NM_018177","ref|NM_018177|ens|ENST00000513269|ens|ENST00000511480|ens|ENST00000261435","N4BP2","NEDD4 binding protein 2","ref|Homo sapiens NEDD4 binding protein 2 (N4BP2), mRNA [NM_018177]","chr4",40104528,40157017,"GO:0004519(endonuclease activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0016310(phosphorylation);GO:0046404(ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity);GO:0090305(nucleic acid phosphodiester bond hydrolysis)",null,"mRNA","agilent G3 V3"]
["A_33_P3861706",2.98,3.03,3.19,5.32,5.16,5.49,{"v":0.576080150281778,"d":"0.58"},{"v":-0.795658546466858,"d":"-0.80"},"down",{"v":3.94830000000068e-05,"d":"0.00"},1,"yes","GGATGAGCAAGAAGATGTGTTATCTTGTTGTTCAACAGTATTGAGTGTGAAGGAAATTTT","FALSE","NM_017762","ref|NM_017762|ens|ENST00000568604|ens|ENST00000435680|ref|XR_430868","MTMR10","myotubularin related protein 10","ref|Homo sapiens myotubularin related protein 10 (MTMR10), mRNA [NM_017762]","chr15",31231144,31283807,"GO:0016311(dephosphorylation);GO:0016791(phosphatase activity)",null,"mRNA","agilent G3 V3"]
["A_33_P3380652",{"v":8.5,"d":"8.50"},8.41,8.48,7.14,6.98,7.19,{"v":1.1914594087283,"d":"1.19"},{"v":0.252729801864802,"d":"0.25"},"up",{"v":3.9497000000055e-05,"d":"0.00"},1,"yes","ATCTGGTAATTGTCCTGATGATAGATTCCAAGTCAATGGCTTCCCTTGCCATCACGGGAA","FALSE","ENST00000437154","ens|ENST00000437154|ens|ENST00000520448|ref|XM_005273382|ref|XM_006716274","ADAM28","ADAM metallopeptidase domain 28","ens|ADAM metallopeptidase domain 28 [Source:HGNC Symbol;Acc:HGNC:206] [ENST00000437154]","chr8",24151582,24211985,"GO:0004222(metalloendopeptidase activity);GO:0005576(extracellular region);GO:0005886(plasma membrane);GO:0006508(proteolysis);GO:0007283(spermatogenesis);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_32_P139738",2.02,2.12,2.13,4.45,4.09,4.24,{"v":0.490610328638498,"d":"0.49"},{"v":-1.02735048814496,"d":"-1.03"},"down",{"v":3.9580000000039e-05,"d":"0.00"},1,"yes","AGGGCTTTAGCAACCTAGAAGGTACCGTGCGTCTATGAGGTAGTTCTAATTATTTTAAAA","FALSE","ENST00000563904","ens|ENST00000563904|ens|ENST00000564458|ens|ENST00000564795|linc|TCONS_l2_00010106",null,null,"ens|hect domain and RLD 2 pseudogene 4 [Source:HGNC Symbol;Acc:HGNC:4872] [ENST00000563904]","chr15",20644356,20667768,null,null,"mRNA","agilent G3 V3"]
["A_22_P00003871",11.99,12.19,12.11,10.78,10.85,10.87,{"v":1.11661538461538,"d":"1.12"},{"v":0.159132338676155,"d":"0.16"},"up",{"v":3.96730000000733e-05,"d":"0.00"},1,"yes","AGACCAATGGCCAGCCGGGCTCCGACACGCTCTACAATAACGGGCTCTCCCCTTATCCAG","FALSE","NM_001172684","ref|NM_001172684|ref|NM_001172685|ens|ENST00000569547|ens|ENST00000395258","CELF6","CUGBP, Elav-like family member 6","ref|Homo sapiens CUGBP, Elav-like family member 6 (CELF6), transcript variant 2, mRNA [NM_001172684]","chr15",72577064,72612287,"GO:0000166(nucleotide binding);GO:0000381(regulation of alternative nuclear mRNA splicing, via spliceosome);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006397(mRNA processing)",null,"mRNA","agilent G3 V3"]
["A_23_P313031",8.28,{"v":8.3,"d":"8.30"},8.33,7.95,7.91,7.94,{"v":1.04663865546218,"d":"1.05"},{"v":0.0657634480455308,"d":"0.07"},"up",{"v":3.98910000000141e-05,"d":"0.00"},1,"yes","GGCACTGCCCTCCGTGGGGACGTCTGCACTCACAGAATGTCCTCGGCACTGCCCTCCGTG","FALSE","XR_249340","ref|XR_249340|ref|XM_005275941","LOC101930506","uncharacterized LOC101930506","ref|PREDICTED: Homo sapiens uncharacterized LOC101930506 (LOC101930506), misc_RNA [XR_249340]","chr2",242943360,242948160,null,null,"mRNA","agilent G3 V3"]
["A_23_P212792",2.04,1.95,2.36,4.71,{"v":4.6,"d":"4.60"},4.62,{"v":0.455850681981335,"d":"0.46"},{"v":-1.13336676094172,"d":"-1.13"},"down",{"v":3.99899999999898e-05,"d":"0.00"},1,"yes","GTGTATTAGGATGTGGGCTGGTTTGCTTTTCTACCACCTTTGTAATTTTATGTATCCCAT","FALSE","NM_025009","ref|NM_025009|ens|ENST00000506202|ens|ENST00000257287|ref|XM_006714055","CEP135","centrosomal protein 135kDa","ref|Homo sapiens centrosomal protein 135kDa (CEP135), mRNA [NM_025009]","chr4",56831032,56899270,"GO:0000086(G2/M transition of mitotic cell cycle);GO:0000278(mitotic cell cycle);GO:0005515(protein binding);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0006996(organelle organization);GO:0007099(centriole replication);GO:0008022(protein C-terminus binding);GO:0010457(centriole-centriole cohesion)",null,"mRNA","agilent G3 V3"]
["A_24_P87763",6.64,6.33,6.31,9.93,9.93,10.39,{"v":0.637355371900826,"d":"0.64"},{"v":-0.649830090819358,"d":"-0.65"},"down",{"v":4.01119999999811e-05,"d":"0.00"},1,"yes","CATGTTTGTGGTCAAGGCCTATCTGCCCGTCAACGAGTCCTTTGGCTTCACCGCTGACCT","FALSE","NM_001961","ref|NM_001961|ens|ENST00000309311|gb|AB527843|gb|AY942181","EEF2","eukaryotic translation elongation factor 2","ref|Homo sapiens eukaryotic translation elongation factor 2 (EEF2), mRNA [NM_001961]","chr19",{"v":3976054,"d":"3976054.00"},3985467,"GO:0002244(hemopoietic progenitor cell differentiation);GO:0003746(translation elongation factor activity);GO:0003924(GTPase activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005844(polysome);GO:0005886(plasma membrane);GO:0006412(translation);GO:0006414(translational elongation);GO:0008494(translation activator activity);GO:0009405(pathogenesis);GO:0010467(gene expression);GO:0010628(positive regulation of gene expression);GO:0016020(membrane);GO:0016235(aggresome);GO:0017183(peptidyl-diphthamide biosynthetic process from peptidyl-histidine);GO:0019901(protein kinase binding);GO:0030529(ribonucleoprotein complex);GO:0043687(post-translational protein modification);GO:0044267(cellular protein metabolic process);GO:0045727(positive regulation of translation);GO:0070062(extracellular vesicular exosome)","04152(AMPK signaling pathway);04921(Oxytocin signaling pathway)","mRNA","agilent G3 V3"]
["A_33_P3240318",{"v":13.8,"d":"13.80"},13.75,{"v":13.7,"d":"13.70"},{"v":12.9,"d":"12.90"},12.98,12.99,{"v":1.06122974015951,"d":"1.06"},{"v":0.0857370116813431,"d":"0.09"},"up",{"v":4.01279999999726e-05,"d":"0.00"},1,"yes","TTCTCCAGGCTTCCCCTCCCTCGTTTTCAAAGATAAATGAAATAAACGTGCGCGGACTGT","FALSE","NM_005029","ref|NM_005029|ens|ENST00000370002|ens|ENST00000539804|gb|AF041339","PITX3","paired-like homeodomain 3","ref|Homo sapiens paired-like homeodomain 3 (PITX3), mRNA [NM_005029]","chr10",103989944,103991840,"GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0001077(RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription);GO:0002088(lens development in camera-type eye);GO:0002089(lens morphogenesis in camera-type eye);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0007626(locomotory behavior);GO:0009887(organ morphogenesis);GO:0030901(midbrain development);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048666(neuron development);GO:0070306(lens fiber cell differentiation);GO:0071542(dopaminergic neuron differentiation)",null,"mRNA","agilent G3 V3"]
["A_33_P3383436",5.77,{"v":5.7,"d":"5.70"},6.05,7.99,8.06,8.12,{"v":0.724865535788167,"d":"0.72"},{"v":-0.464214698164409,"d":"-0.46"},"down",{"v":4.01469999999904e-05,"d":"0.00"},1,"yes","CACCTCTGCTCACCTTACTGTTCACCTCATCAAATCAGTTCTGCCCTGTGAAAAGATCCA","FALSE","NM_001193636","ref|NM_001193636|ref|NM_001193637|ref|NM_001277864|ref|NM_198083","DHRS4L2","dehydrogenase/reductase (SDR family) member 4 like 2","ref|Homo sapiens dehydrogenase/reductase (SDR family) member 4 like 2 (DHRS4L2), transcript variant 3, mRNA [NM_001193636]","chr14",24521206,24538916,"GO:0005576(extracellular region);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)","00830(Retinol metabolism)","mRNA","agilent G3 V3"]
["A_23_P302116",1.91,2.04,2.02,{"v":4.5,"d":"4.50"},4.69,4.96,{"v":0.421908127208481,"d":"0.42"},{"v":-1.24499921645444,"d":"-1.24"},"down",{"v":4.01669999999799e-05,"d":"0.00"},1,"yes","CGCTGGATCCTGTCAATTGGCCTTAAAGAATATGCAAACAATCTTATAGAGAGTGGTGTT","FALSE","NM_177423","ref|NM_177423|ens|ENST00000389547|gb|AB590441|gb|DQ892401","PPFIA1","protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1","ref|Homo sapiens protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1 (PPFIA1), transcript variant 1, mRNA [NM_177423]","chr11",70217432,70230500,"GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005925(focal adhesion);GO:0007160(cell-matrix adhesion);GO:0007165(signal transduction);GO:0007268(synaptic transmission);GO:0007269(neurotransmitter secretion);GO:0014047(glutamate secretion);GO:0048786(presynaptic active zone);GO:0051497(negative regulation of stress fiber assembly);GO:0090005(negative regulation of establishment of protein localization in plasma membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3376365",12.15,12.15,12.07,11.12,11.11,11.24,{"v":1.08664475649836,"d":"1.09"},{"v":0.119880374769088,"d":"0.12"},"up",{"v":4.03580000000181e-05,"d":"0.00"},1,"yes","CTCCATGCTCAGAACTGCTTCCTACTCTACATCCAGGCTCCTGAGCAGCCCCCAGCTTAA","FALSE","ENST00000377836","ens|ENST00000377836|ens|ENST00000471190|ens|ENST00000377837|gb|BC012091","HES2","hes family bHLH transcription factor 2","ens|hes family bHLH transcription factor 2 [Source:HGNC Symbol;Acc:HGNC:16005] [ENST00000377836]","chr1",{"v":6475292,"d":"6475292.00"},6479979,"GO:0003690(double-stranded DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0008134(transcription factor binding);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0046983(protein dimerization activity)",null,"mRNA","agilent G3 V3"]
["A_24_P261259",9.61,9.57,9.44,8.31,8.36,8.42,{"v":1.1406935033878,"d":"1.14"},{"v":0.189911201317495,"d":"0.19"},"up",{"v":4.04259999999823e-05,"d":"0.00"},1,"yes","AATAACGGGGACCAATATTTTTAACTTTGCCTATTTGTTTTTGGGTGAGTTTCCCCCCTC","FALSE","NM_004566","ref|NM_004566|ref|NM_001282630|ref|NM_001145443|ens|ENST00000379775","PFKFB3","6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3","ref|Homo sapiens 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3), transcript variant 1, mRNA [NM_004566]","chr10",{"v":6186881,"d":"6186881.00"},6277494,"GO:0003873(6-phosphofructo-2-kinase activity);GO:0004331(fructose-2,6-bisphosphate 2-phosphatase activity);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005975(carbohydrate metabolic process);GO:0006000(fructose metabolic process);GO:0006003(fructose 2,6-bisphosphate metabolic process);GO:0006006(glucose metabolic process);GO:0006096(glycolysis);GO:0007420(brain development);GO:0009405(pathogenesis);GO:0016311(dephosphorylation);GO:0044281(small molecule metabolic process);GO:0046835(carbohydrate phosphorylation)","00051(Fructose and mannose metabolism);04066(HIF-1 signaling pathway);04152(AMPK signaling pathway)","mRNA","agilent G3 V3"]
["A_23_P207927",2.04,2.04,2.17,4.69,4.69,4.33,{"v":0.455871626549964,"d":"0.46"},{"v":-1.13330047622978,"d":"-1.13"},"down",{"v":4.04290000000085e-05,"d":"0.00"},1,"yes","AGCTTGAATTCCCGAATCTTCCTGCAAGGTGCATACAAATGCAGCGTGAGAATCCATACA","FALSE","NM_001288770","ref|NM_001288770|ref|NM_017941|ref|NM_001100621|ref|NR_110105","C17orf80","chromosome 17 open reading frame 80","ref|Homo sapiens chromosome 17 open reading frame 80 (C17orf80), transcript variant 4, mRNA [NM_001288770]","chr17",71228776,71245091,"GO:0003674(molecular_function);GO:0008150(biological_process);GO:0016021(integral to membrane);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P119698",6.57,6.59,6.52,8.02,8.19,7.94,{"v":0.814906832298137,"d":"0.81"},{"v":-0.295292968383896,"d":"-0.30"},"down",{"v":4.05850000000374e-05,"d":"0.00"},1,"yes","ATGAAGGAGTCCCTGCTGCTGTCAGAACAGAAGACCTCGCTGCCCTGAGGACAAGCACTT","FALSE","NM_016579","ref|NM_016579|ref|NM_001165895|ens|ENST00000599573|ens|ENST00000596002","CD320","CD320 molecule","ref|Homo sapiens CD320 molecule (CD320), transcript variant 1, mRNA [NM_016579]","chr19",{"v":8367201,"d":"8367201.00"},8373155,"GO:0001558(regulation of cell growth);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0006766(vitamin metabolic process);GO:0006767(water-soluble vitamin metabolic process);GO:0008083(growth factor activity);GO:0009235(cobalamin metabolic process);GO:0010008(endosome membrane);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0030656(regulation of vitamin metabolic process);GO:0031419(cobalamin binding);GO:0044281(small molecule metabolic process);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_24_P70888",3.89,3.25,3.35,7.82,7.58,7.58,{"v":0.456483899042646,"d":"0.46"},{"v":-1.13136412006885,"d":"-1.13"},"down",{"v":4.06809999999869e-05,"d":"0.00"},1,"yes","TCGGGTGTTCACTGTCGAGTCTCGAGTGATTTGAAAATGTGCCTTACGCTGCCACGCTGG","FALSE","NM_012401","ref|NM_012401|ens|ENST00000463165|ens|ENST00000449103|ens|ENST00000359337","PLXNB2","plexin B2","ref|Homo sapiens plexin B2 (PLXNB2), mRNA [NM_012401]","chr22",50713408,50746017,"GO:0001843(neural tube closure);GO:0001932(regulation of protein phosphorylation);GO:0005515(protein binding);GO:0005622(intracellular);GO:0005887(integral to plasma membrane);GO:0007405(neuroblast proliferation);GO:0007420(brain development);GO:0008360(regulation of cell shape);GO:0009986(cell surface);GO:0017154(semaphorin receptor activity);GO:0032319(regulation of Rho GTPase activity);GO:0050772(positive regulation of axonogenesis);GO:0070062(extracellular vesicular exosome);GO:0071526(semaphorin-plexin signaling pathway);GO:2001222(regulation of neuron migration)","04360(Axon guidance)","mRNA","agilent G3 V3"]
["A_23_P42909",7.52,7.35,7.43,5.46,{"v":5.6,"d":"5.60"},5.29,{"v":1.36391437308869,"d":"1.36"},{"v":0.447753074422222,"d":"0.45"},"up",{"v":4.07810000000453e-05,"d":"0.00"},1,"yes","ATTTGGTGACCTACCCCATATCCAATATTTCCAGCGTTAGATTGAGGATGAGGTAGGGAG","FALSE","NM_153345","ref|NM_153345|ref|NM_001282876|ref|NM_001242774|ref|NM_001242775","TMEM139","transmembrane protein 139","ref|Homo sapiens transmembrane protein 139 (TMEM139), transcript variant 1, mRNA [NM_153345]","chr7",142982432,142985141,"GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3395605",8.67,8.45,8.79,{"v":10.9,"d":"10.90"},10.76,10.74,{"v":0.799691358024691,"d":"0.80"},{"v":-0.322484797591893,"d":"-0.32"},"down",{"v":4.08410000000137e-05,"d":"0.00"},1,"yes","ACCTCTGCACAGCTCTCCAGGTGCTGAGATATAATGCACCAGCACAATAAACCTTTATTC","FALSE","NM_181724","ref|NM_181724|ens|ENST00000392806|ref|XM_006719368|ref|XM_006719369","TMEM119","transmembrane protein 119","ref|Homo sapiens transmembrane protein 119 (TMEM119), mRNA [NM_181724]","chr12",108983624,108991900,"GO:0001649(osteoblast differentiation);GO:0003674(molecular_function);GO:0005575(cellular_component);GO:0005783(endoplasmic reticulum);GO:0008150(biological_process);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_32_P18440",4.61,4.47,4.56,6.18,6.43,6.43,{"v":0.716386554621849,"d":"0.72"},{"v":-0.481189834283771,"d":"-0.48"},"down",{"v":4.08739999999685e-05,"d":"0.00"},1,"yes","GAGCACTTAAAGTCCAGTGTTGGCTGTTAGTGTATTTGATATTCTGCCTGTCTCCTCATG","FALSE","NM_032199","ref|NM_032199|ref|NM_001244638|ens|ENST00000279873|gb|BX648835","ARID5B","AT rich interactive domain 5B (MRF1-like)","ref|Homo sapiens AT rich interactive domain 5B (MRF1-like) (ARID5B), transcript variant 1, mRNA [NM_032199]","chr10",63661060,63856703,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001227(RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription);GO:0001822(kidney development);GO:0001889(liver development);GO:0003677(DNA binding);GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006325(chromatin organization);GO:0006351(transcription, DNA-dependent);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0008584(male gonad development);GO:0008585(female gonad development);GO:0009791(post-embryonic development);GO:0010761(fibroblast migration);GO:0030325(adrenal gland development);GO:0035264(multicellular organism growth);GO:0044212(transcription regulatory region DNA binding);GO:0045444(fat cell differentiation);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0048468(cell development);GO:0048644(muscle organ morphogenesis);GO:0048705(skeletal system morphogenesis);GO:0051091(positive regulation of sequence-specific DNA binding transcription factor activity);GO:0060021(palate development);GO:0060325(face morphogenesis);GO:0060612(adipose tissue development);GO:0060613(fat pad development)",null,"mRNA","agilent G3 V3"]
["A_23_P141847",1.94,2.05,2.03,4.87,5.32,5.38,{"v":0.386640976236352,"d":"0.39"},{"v":-1.37093355231934,"d":"-1.37"},"down",{"v":4.0992000000073e-05,"d":"0.00"},1,"yes","GAGGACTGGAAGCCAGTCCTTACGATAAACTCCATAATTTATGGCCTGCAGTATCTCTTC","FALSE","NM_003969","ref|NM_003969|ens|ENST00000253023|gb|AB012191|gb|BT006754","UBE2M","ubiquitin-conjugating enzyme E2M","ref|Homo sapiens ubiquitin-conjugating enzyme E2M (UBE2M), mRNA [NM_003969]","chr19",59067960,59068516,"GO:0004842(ubiquitin-protein ligase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006464(cellular protein modification process);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0016567(protein ubiquitination);GO:0018169(ribosomal S6-glutamic acid ligase activity);GO:0019788(NEDD8 ligase activity);GO:0031625(ubiquitin protein ligase binding);GO:0043525(positive regulation of neuron apoptotic process);GO:0045116(protein neddylation);GO:0070062(extracellular vesicular exosome)","04120(Ubiquitin mediated proteolysis)","mRNA","agilent G3 V3"]
["A_21_P0014717",12.24,12.26,12.16,11.33,11.25,11.37,{"v":1.07982326951399,"d":"1.08"},{"v":0.110795211407791,"d":"0.11"},"up",{"v":4.09930000000447e-05,"d":"0.00"},1,"yes","TTCTGGATGCTCTCAGCATCTATCAGGGAGAGCAGGTGCCCCCATGACATCTCTCTGCAC","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_32_P165974",8.16,8.01,8.17,6.96,6.94,6.85,{"v":1.17301204819277,"d":"1.17"},{"v":0.230217831592079,"d":"0.23"},"up",{"v":4.09980000000143e-05,"d":"0.00"},1,"yes","CTGAGAAAGTATGCCCCACCTATCTTTGGTATATGATAGGTTACATAAAAGGAAGGTATT","FALSE","NM_181874","ref|NM_181874|ref|NM_000844|ens|ENST00000357716|gb|U92458","GRM7","glutamate receptor, metabotropic 7","ref|Homo sapiens glutamate receptor, metabotropic 7 (GRM7), transcript variant 2, mRNA [NM_181874]","chr3",{"v":6902802,"d":"6902802.00"},7783215,"GO:0001642(group III metabotropic glutamate receptor activity);GO:0001661(conditioned taste aversion);GO:0001662(behavioral fear response);GO:0005245(voltage-gated calcium channel activity);GO:0005246(calcium channel regulator activity);GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0005938(cell cortex);GO:0007194(negative regulation of adenylate cyclase activity);GO:0007196(adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway);GO:0007268(synaptic transmission);GO:0007605(sensory perception of sound);GO:0007608(sensory perception of smell);GO:0007614(short-term memory);GO:0008066(glutamate receptor activity);GO:0010855(adenylate cyclase inhibitor activity);GO:0014050(negative regulation of glutamate secretion);GO:0016021(integral to membrane);GO:0016595(glutamate binding);GO:0019226(transmission of nerve impulse);GO:0030165(PDZ domain binding);GO:0030424(axon);GO:0030425(dendrite);GO:0030534(adult behavior);GO:0030818(negative regulation of cAMP biosynthetic process);GO:0031279(regulation of cyclase activity);GO:0032279(asymmetric synapse);GO:0042734(presynaptic membrane);GO:0043198(dendritic shaft);GO:0043235(receptor complex);GO:0045211(postsynaptic membrane);GO:0048786(presynaptic active zone);GO:0051966(regulation of synaptic transmission, glutamatergic);GO:0070588(calcium ion transmembrane transport);GO:0070905(serine binding)","04080(Neuroactive ligand-receptor interaction);04724(Glutamatergic synapse)","mRNA","agilent G3 V3"]
["A_23_P29036",{"v":2,"d":"2.00"},2.21,1.97,5.05,4.88,5.35,{"v":0.404450261780105,"d":"0.40"},{"v":-1.30596580013137,"d":"-1.31"},"down",{"v":4.10299999999975e-05,"d":"0.00"},1,"yes","ATCTCGTTTCCGGAAAAGGAGCAAGAAGATGTTCTCCAAACGCTTTGAACCAAAGCATGG","FALSE","NM_005534","ref|NM_005534|ens|ENST00000290219|ens|ENST00000576463|ref|XM_005260969","IFNGR2","interferon gamma receptor 2 (interferon gamma transducer 1)","ref|Homo sapiens interferon gamma receptor 2 (interferon gamma transducer 1) (IFNGR2), mRNA [NM_005534]","chr21",34775772,34809809,"GO:0004896(cytokine receptor activity);GO:0004906(interferon-gamma receptor activity);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0007166(cell surface receptor signaling pathway);GO:0009615(response to virus);GO:0016021(integral to membrane);GO:0019221(cytokine-mediated signaling pathway);GO:0060333(interferon-gamma-mediated signaling pathway);GO:0060334(regulation of interferon-gamma-mediated signaling pathway)","04630(Jak-STAT signaling pathway);04066(HIF-1 signaling pathway);04060(Cytokine-cytokine receptor interaction);04650(Natural killer cell mediated cytotoxicity);04380(Osteoclast differentiation);05321(Inflammatiory bowel disease (IBD));05132(Salmonella infection);05152(Tuberculosis);05162(Measles);05164(Influenza A);05168(Herpes simplex infection);05145(Toxoplasmosis);05140(Leishmaniasis);05142(Chagas disease (American trypanosomiasis))","mRNA","agilent G3 V3"]
["A_33_P3217347",4.77,4.57,4.58,6.94,6.68,6.67,{"v":0.686052242483982,"d":"0.69"},{"v":-0.54360965390793,"d":"-0.54"},"down",{"v":4.10339999999954e-05,"d":"0.00"},1,"yes","AGGCAAAATCATTTTTGTTGCATGTTATGGGTCGATGTTCCTGTAATTGCAGTGCCGTAA","FALSE","NM_145119","ref|NM_145119|ref|NM_001032396|ref|NM_022368|ens|ENST00000374571","PJA1","praja ring finger 1, E3 ubiquitin protein ligase","ref|Homo sapiens praja ring finger 1, E3 ubiquitin protein ligase (PJA1), transcript variant 1, mRNA [NM_145119]","chrX",68380736,68385636,"GO:0004842(ubiquitin-protein ligase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0016567(protein ubiquitination);GO:0016874(ligase activity);GO:0030163(protein catabolic process)",null,"mRNA","agilent G3 V3"]
["A_33_P3387561",14.88,14.79,14.89,15.98,15.94,15.83,{"v":0.933193717277487,"d":"0.93"},{"v":-0.0997515004704415,"d":"-0.10"},"down",{"v":4.1057000000011e-05,"d":"0.00"},1,"yes","GGAATGCAGGCCCCAGGACCTCCGCCCTCAGACCCAGGAGCCCAGGCCCCCAGCCTCTCC","FALSE","NM_206818","ref|NM_206818|ref|NM_001282349|ref|NM_001282350|ens|ENST00000610577","OSCAR","osteoclast associated, immunoglobulin-like receptor","ref|Homo sapiens osteoclast associated, immunoglobulin-like receptor (OSCAR), transcript variant 1, mRNA [NM_206818]","chr19",54599040,54604132,"GO:0005886(plasma membrane);GO:0016021(integral to membrane);GO:0070062(extracellular vesicular exosome)","04380(Osteoclast differentiation)","mRNA","agilent G3 V3"]
["A_23_P66137",7.28,{"v":7.1,"d":"7.10"},{"v":7.2,"d":"7.20"},8.34,{"v":8.3,"d":"8.30"},{"v":8.4,"d":"8.40"},{"v":0.861821086261981,"d":"0.86"},{"v":-0.214539697444601,"d":"-0.21"},"down",{"v":4.10579999999827e-05,"d":"0.00"},1,"yes","CCTGCTGCCTTCACTCCTTTCTGACCAAGCAACGCTAACTTTTGTACAGATCGATTTGAT","FALSE","NM_014587","ref|NM_014587|ens|ENST00000566034|ens|ENST00000293894|gb|AK024491","SOX8","SRY (sex determining region Y)-box 8","ref|Homo sapiens SRY (sex determining region Y)-box 8 (SOX8), mRNA [NM_014587]","chr16",{"v":1032086,"d":"1032086.00"},1036978,"GO:0000979(RNA polymerase II core promoter sequence-specific DNA binding);GO:0000981(sequence-specific DNA binding RNA polymerase II transcription factor activity);GO:0001649(osteoblast differentiation);GO:0001701(in utero embryonic development);GO:0001755(neural crest cell migration);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006366(transcription from RNA polymerase II promoter);GO:0007165(signal transduction);GO:0007283(spermatogenesis);GO:0007422(peripheral nervous system development);GO:0008134(transcription factor binding);GO:0008584(male gonad development);GO:0010817(regulation of hormone levels);GO:0014015(positive regulation of gliogenesis);GO:0033690(positive regulation of osteoblast proliferation);GO:0035914(skeletal muscle cell differentiation);GO:0043066(negative regulation of apoptotic process);GO:0045165(cell fate commitment);GO:0045444(fat cell differentiation);GO:0045662(negative regulation of myoblast differentiation);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046533(negative regulation of photoreceptor cell differentiation);GO:0046982(protein heterodimerization activity);GO:0048469(cell maturation);GO:0048484(enteric nervous system development);GO:0048709(oligodendrocyte differentiation);GO:0060009(Sertoli cell development);GO:0060018(astrocyte fate commitment);GO:0060041(retina development in camera-type eye);GO:0060221(retinal rod cell differentiation);GO:0060612(adipose tissue development);GO:0061138(morphogenesis of a branching epithelium);GO:0072034(renal vesicle induction);GO:0072197(ureter morphogenesis);GO:0072289(metanephric nephron tubule formation);GO:0090184(positive regulation of kidney development);GO:0090190(positive regulation of branching involved in ureteric bud morphogenesis)",null,"mRNA","agilent G3 V3"]
["A_24_P95029",10.19,10.32,10.29,9.34,9.23,9.26,{"v":1.10671936758893,"d":"1.11"},{"v":0.146289442250656,"d":"0.15"},"up",{"v":4.10969999999899e-05,"d":"0.00"},1,"yes","TGCTTTGATTCCAGCTTTGATGTTCACAAGAAGTGTCCCCTCTGTGAGTTAATGTTTCCT","FALSE","NM_006024","ref|NM_006024|ref|NM_001206901|ref|NM_001079864|ref|NM_001206902","TAX1BP1","Tax1 (human T-cell leukemia virus type I) binding protein 1","ref|Homo sapiens Tax1 (human T-cell leukemia virus type I) binding protein 1 (TAX1BP1), transcript variant 1, mRNA [NM_006024]","chr7",27779714,27868500,"GO:0005515(protein binding);GO:0005829(cytosol);GO:0006915(apoptotic process);GO:0019900(kinase binding);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0032480(negative regulation of type I interferon production);GO:0043066(negative regulation of apoptotic process);GO:0045087(innate immune response);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3290562",6.46,6.32,6.21,8.02,8.16,7.99,{"v":0.785684733140257,"d":"0.79"},{"v":-0.347977567616085,"d":"-0.35"},"down",{"v":4.11030000000423e-05,"d":"0.00"},1,"yes","CACAGATGAACTCTACCTTTGCTTTCAGAACCACTTAGTCCTTTTGTAACAAAGAAAAAA","FALSE","NM_000168","ref|NM_000168|ens|ENST00000395925|ref|XM_005249704|ref|XM_005249703","GLI3","GLI family zinc finger 3","ref|Homo sapiens GLI family zinc finger 3 (GLI3), mRNA [NM_000168]","chr7",42000548,42276612,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0001077(RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription);GO:0001656(metanephros development);GO:0001658(branching involved in ureteric bud morphogenesis);GO:0001701(in utero embryonic development);GO:0002052(positive regulation of neuroblast proliferation);GO:0003682(chromatin binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005929(cilium);GO:0006351(transcription, DNA-dependent);GO:0007224(smoothened signaling pathway);GO:0007411(axon guidance);GO:0007442(hindgut morphogenesis);GO:0007507(heart development);GO:0008013(beta-catenin binding);GO:0008285(negative regulation of cell proliferation);GO:0009952(anterior/posterior pattern specification);GO:0009954(proximal/distal pattern formation);GO:0016485(protein processing);GO:0016592(mediator complex);GO:0016607(nuclear speck);GO:0017053(transcriptional repressor complex);GO:0021631(optic nerve morphogenesis);GO:0021766(hippocampus development);GO:0021775(smoothened signaling pathway involved in ventral spinal cord interneuron specification);GO:0021776(smoothened signaling pathway involved in spinal cord motor neuron cell fate specification);GO:0021798(forebrain dorsal/ventral pattern formation);GO:0021801(cerebral cortex radial glia guided migration);GO:0021861(forebrain radial glial cell differentiation);GO:0022018(lateral ganglionic eminence cell proliferation);GO:0030318(melanocyte differentiation);GO:0030324(lung development);GO:0032332(positive regulation of chondrocyte differentiation);GO:0033077(T cell differentiation in thymus);GO:0035035(histone acetyltransferase binding);GO:0035108(limb morphogenesis);GO:0042060(wound healing);GO:0042307(positive regulation of protein import into nucleus);GO:0042475(odontogenesis of dentin-containing tooth);GO:0042733(embryonic digit morphogenesis);GO:0042826(histone deacetylase binding);GO:0043066(negative regulation of apoptotic process);GO:0043585(nose morphogenesis);GO:0043586(tongue development);GO:0043627(response to estrogen stimulus);GO:0045060(negative thymic T cell selection);GO:0045665(negative regulation of neuron differentiation);GO:0045669(positive regulation of osteoblast differentiation);GO:0045879(negative regulation of smoothened signaling pathway);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046638(positive regulation of alpha-beta T cell differentiation);GO:0046639(negative regulation of alpha-beta T cell differentiation);GO:0046872(metal ion binding);GO:0048557(embryonic digestive tract morphogenesis);GO:0048566(embryonic digestive tract development);GO:0048589(developmental growth);GO:0048593(camera-type eye morphogenesis)","04340(Hedgehog signaling pathway);04024(cAMP signaling pathway);05200(Pathways in cancer);05217(Basal cell carcinoma)","mRNA","agilent G3 V3"]
["A_33_P3380837",{"v":8.8,"d":"8.80"},8.61,{"v":8.6,"d":"8.60"},10.11,10.25,10.24,0.85,{"v":-0.234465253637023,"d":"-0.23"},"down",{"v":4.11209999999773e-05,"d":"0.00"},1,"yes","CAGACTGGGCAACATGGTGAGACTCTGCCTCTACAAAAGAAAAATTAAAAAATTAGCTGG","FALSE","NM_133463","ref|NM_133463|ref|NM_001284355|ens|ENST00000312371|gb|AK289723","AMZ1","archaelysin family metallopeptidase 1","ref|Homo sapiens archaelysin family metallopeptidase 1 (AMZ1), transcript variant 1, mRNA [NM_133463]","chr7",{"v":2727836,"d":"2727836.00"},2752734,"GO:0006508(proteolysis);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P408239",9.34,9.54,9.55,8.11,8.02,8.06,{"v":1.175279040926,"d":"1.18"},{"v":0.233003329697603,"d":"0.23"},"up",{"v":4.11850000000547e-05,"d":"0.00"},1,"yes","CTGTGTTGGAAGGTGACGTCCTCCCTTTAGTTTGTGGCCAACACTTGTTTCTGAAACTTT","FALSE","NM_001252124","ref|NM_001252124|ens|ENST00000493544|gb|AL117400|gb|BC050565","PASK","PAS domain containing serine/threonine kinase","ref|Homo sapiens PAS domain containing serine/threonine kinase (PASK), transcript variant 5, mRNA [NM_001252124]","chr2",242053056,242074184,"GO:0004674(protein serine/threonine kinase activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0006468(protein phosphorylation);GO:0007165(signal transduction);GO:0035091(phosphatidylinositol binding);GO:0043576(regulation of respiratory gaseous exchange);GO:0045719(negative regulation of glycogen biosynthetic process);GO:0045727(positive regulation of translation);GO:0046777(protein autophosphorylation);GO:0070092(regulation of glucagon secretion);GO:2000505(regulation of energy homeostasis)",null,"mRNA","agilent G3 V3"]
["A_32_P165340",2.23,2.45,2.34,4.63,4.68,4.37,{"v":0.513157894736842,"d":"0.51"},{"v":-0.962525294581337,"d":"-0.96"},"down",{"v":4.1354000000049e-05,"d":"0.00"},1,"yes","ACATTGAAATATGTTTTGTATAAATTTGTCATGTTGAACAACATTTTAGCATGGTAAGTT","FALSE","NM_003133","ref|NM_003133|ref|NM_001130440|ens|ENST00000366839|ens|ENST00000304786","SRP9","signal recognition particle 9kDa","ref|Homo sapiens signal recognition particle 9kDa (SRP9), transcript variant 2, mRNA [NM_003133]","chr1",225965536,225978168,"GO:0003723(RNA binding);GO:0005047(signal recognition particle binding);GO:0005785(signal recognition particle receptor complex);GO:0005786(signal recognition particle, endoplasmic reticulum targeting);GO:0005829(cytosol);GO:0006412(translation);GO:0006614(SRP-dependent cotranslational protein targeting to membrane);GO:0008312(7S RNA binding);GO:0010467(gene expression);GO:0044267(cellular protein metabolic process);GO:0045900(negative regulation of translational elongation);GO:0070062(extracellular vesicular exosome)","03060(Protein export)","mRNA","agilent G3 V3"]
["A_24_P254177",2.03,{"v":1.9,"d":"1.90"},2.22,4.85,5.02,5.28,{"v":0.405940594059406,"d":"0.41"},{"v":-1.30065947813371,"d":"-1.30"},"down",{"v":4.14229999999849e-05,"d":"0.00"},1,"yes","TTCAAAGATAGTTTCACTTTGGTCTCTGAATTGAAATGCTGTCTACTGAAAGGGTTTCAG","FALSE","NM_024104","ref|NM_024104|ens|ENST00000397349|ens|ENST00000463051|ens|ENST00000461488","SMIM7","small integral membrane protein 7","ref|Homo sapiens small integral membrane protein 7 (SMIM7), transcript variant 2, mRNA [NM_024104]","chr19",16757818,16770925,"GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3363515",12.42,12.42,12.28,13.31,13.29,13.34,{"v":0.929394091136705,"d":"0.93"},{"v":-0.105637622316401,"d":"-0.11"},"down",{"v":4.15380000000631e-05,"d":"0.00"},1,"yes","CCAGCCTGGGCGACAGAGTGAGTCTCTTGTCTCTCAAAAATTAAAATAAAATAAATAAAT","FALSE","ENST00000557439","ens|ENST00000557439|tc|THC2493575","XRCC3","X-ray repair complementing defective repair in Chinese hamster cells 3","ens|X-ray repair complementing defective repair in Chinese hamster cells 3 [Source:HGNC Symbol;Acc:HGNC:12830] [ENST00000557439]","chr14",104170736,104181820,"GO:0000400(four-way junction DNA binding);GO:0000724(double-strand break repair via homologous recombination);GO:0000737(DNA catabolic process, endonucleolytic);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005657(replication fork);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0006281(DNA repair);GO:0006310(DNA recombination);GO:0006974(response to DNA damage stimulus);GO:0008094(DNA-dependent ATPase activity);GO:0008821(crossover junction endodeoxyribonuclease activity);GO:0010033(response to organic substance);GO:0010824(regulation of centrosome duplication);GO:0033065(Rad51C-XRCC3 complex);GO:0048471(perinuclear region of cytoplasm);GO:0071140(resolution of mitotic recombination intermediates);GO:0090267(positive regulation of mitotic cell cycle spindle assembly checkpoint)","03440(Homologous recombination)","mRNA","agilent G3 V3"]
["A_23_P384650",7.51,7.43,7.55,6.34,6.23,{"v":6.4,"d":"6.40"},{"v":1.1855561412757,"d":"1.19"},{"v":0.245563982366341,"d":"0.25"},"up",{"v":4.15400000000066e-05,"d":"0.00"},1,"yes","CCTTCGTGCCCATCCTCAAGGACTTCTTCGTGCGGCTCACAGATGAGTTCTATGTACTGC","FALSE","NM_138454","ref|NM_138454|ens|ENST00000301944|gb|HQ448672|gb|BC014127","NXNL1","nucleoredoxin-like 1","ref|Homo sapiens nucleoredoxin-like 1 (NXNL1), mRNA [NM_138454]","chr19",17566234,17571763,"GO:0005640(nuclear outer membrane);GO:0005739(mitochondrion);GO:0045494(photoreceptor cell maintenance)",null,"mRNA","agilent G3 V3"]
["A_33_P3398564",7.45,7.29,7.26,9.57,{"v":9.6,"d":"9.60"},{"v":9.3,"d":"9.30"},{"v":0.772743238496663,"d":"0.77"},{"v":-0.371938969330244,"d":"-0.37"},"down",{"v":4.15480000000024e-05,"d":"0.00"},1,"yes","GGCACCTTCTCCTGGTACTCGGCCCAGAGCCTGCGCATAAAGCCACTTTGCCACTTTGCA","FALSE","NM_030649","ref|NM_030649|ens|ENST00000467278|ens|ENST00000492936|ref|XM_006710329","ACAP3","ArfGAP with coiled-coil, ankyrin repeat and PH domains 3","ref|Homo sapiens ArfGAP with coiled-coil, ankyrin repeat and PH domains 3 (ACAP3), mRNA [NM_030649]","chr1",{"v":1227764,"d":"1227764.00"},1243269,"GO:0008060(ARF GTPase activator activity);GO:0008270(zinc ion binding);GO:0032312(regulation of ARF GTPase activity);GO:0043547(positive regulation of GTPase activity)","04144(Endocytosis)","mRNA","agilent G3 V3"]
["A_33_P3404954",7.92,7.98,7.65,9.84,9.82,{"v":9.9,"d":"9.90"},{"v":0.796684709066306,"d":"0.80"},{"v":-0.327919209646006,"d":"-0.33"},"down",{"v":4.16460000000063e-05,"d":"0.00"},1,"yes","ACCAAACGTGTCCACACCTTGATCTTGCACTTCCCAACCTCCAGAACTGTGAGCAAATAA","FALSE","NM_001172702","ref|NM_001172702|ref|NR_033344|ens|ENST00000354886|ens|ENST00000491344","SLC38A6","solute carrier family 38, member 6","ref|Homo sapiens solute carrier family 38, member 6 (SLC38A6), transcript variant 1, mRNA [NM_001172702]","chr14",61448160,61550450,"GO:0003333(amino acid transmembrane transport);GO:0005887(integral to plasma membrane);GO:0006814(sodium ion transport);GO:0015171(amino acid transmembrane transporter activity)",null,"mRNA","agilent G3 V3"]
["A_24_P391104",1.88,2.23,{"v":1.9,"d":"1.90"},5.74,{"v":5.9,"d":"5.90"},5.38,{"v":0.353113983548766,"d":"0.35"},{"v":-1.50179414097478,"d":"-1.50"},"down",{"v":4.1665000000024e-05,"d":"0.00"},1,"yes","CAGTTTTCTCAGTGTTTTCAGCCTGTGAGATAGATGTTTATGGCAAGAAAAAGGAAAAAA","FALSE","NM_002918","ref|NM_002918|ens|ENST00000254325|ref|XM_006722829|ref|XM_006722831","RFX1","regulatory factor X, 1 (influences HLA class II expression)","ref|Homo sapiens regulatory factor X, 1 (influences HLA class II expression) (RFX1), mRNA [NM_002918]","chr19",14072350,14117097,"GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0003705(RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0006366(transcription from RNA polymerase II promoter);GO:0006955(immune response);GO:0043231(intracellular membrane-bounded organelle)",null,"mRNA","agilent G3 V3"]
["A_24_P71700",4.84,4.84,5.12,7.45,7.78,7.51,{"v":0.650835532102023,"d":"0.65"},{"v":-0.619635078375936,"d":"-0.62"},"down",{"v":4.17030000000596e-05,"d":"0.00"},1,"yes","GTGGCAGAATGGCCATGCCCAGGTGTGTGTTGAGACCATTGACAACTGCTCGTGTACAGG","FALSE","NM_145166","ref|NM_145166|ref|XM_005265582|ref|XM_006713415|gb|AB033016","ZBTB47","zinc finger and BTB domain containing 47","ref|Homo sapiens zinc finger and BTB domain containing 47 (ZBTB47), mRNA [NM_145166]","chr3",42695176,42709072,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P130466",{"v":5.7,"d":"5.70"},5.59,5.76,6.65,6.64,6.67,{"v":0.854208416833667,"d":"0.85"},{"v":-0.227339981425726,"d":"-0.23"},"down",{"v":4.17360000000144e-05,"d":"0.00"},1,"yes","ACCCGAGGTTGGTTGGTCCCAAATCTATCAAACTCAGTGCCCTCTTTAGCGACATATTTT","FALSE","NM_021089","ref|NM_021089|gb|M29581|gb|BC039323|gb|AK225825","ZNF8","zinc finger protein 8","ref|Homo sapiens zinc finger protein 8 (ZNF8), mRNA [NM_021089]","chr19",58790320,58807254,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0008270(zinc ion binding);GO:0030509(BMP signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_24_P275873",7.13,7.41,7.29,9.43,9.42,9.21,{"v":0.777975766215253,"d":"0.78"},{"v":-0.362202878629108,"d":"-0.36"},"down",{"v":4.17689999999693e-05,"d":"0.00"},1,"yes","TGACTTGGGGTGGACGCCTCTGCCTTCACTTGAACACAAATGTGCTTCCTATAAAATCAT","FALSE","NM_005993","ref|NM_005993|ens|ENST00000576677|ens|ENST00000576691|ens|ENST00000572389","TBCD","tubulin folding cofactor D","ref|Homo sapiens tubulin folding cofactor D (TBCD), mRNA [NM_005993]","chr17",80897280,80900578,"GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005874(microtubule);GO:0005912(adherens junction);GO:0005923(tight junction);GO:0006457(protein folding);GO:0007023(post-chaperonin tubulin folding pathway);GO:0010812(negative regulation of cell-substrate adhesion);GO:0016328(lateral plasma membrane);GO:0031115(negative regulation of microtubule polymerization);GO:0034333(adherens junction assembly);GO:0043547(positive regulation of GTPase activity);GO:0044267(cellular protein metabolic process);GO:0048487(beta-tubulin binding);GO:0051084('de novo' posttranslational protein folding);GO:0051087(chaperone binding);GO:0055085(transmembrane transport);GO:0070830(tight junction assembly)",null,"mRNA","agilent G3 V3"]
["A_23_P48610",{"v":5.1,"d":"5.10"},5.05,{"v":5.2,"d":"5.20"},6.53,6.67,6.76,{"v":0.769038076152304,"d":"0.77"},{"v":-0.378873065079719,"d":"-0.38"},"down",{"v":4.17940000000394e-05,"d":"0.00"},1,"yes","AGAGCACTGCTGACCATCTGCTTTCCTCCAAGGGTTGCTGTGTCTAGGGTGAAGTAGGCA","FALSE","NM_144568","ref|NM_144568|ref|NM_001100814|ens|ENST00000557041|ens|ENST00000398020","TMEM55B","transmembrane protein 55B","ref|Homo sapiens transmembrane protein 55B (TMEM55B), transcript variant 2, mRNA [NM_144568]","chr14",20926776,20927751,"GO:0005765(lysosomal membrane);GO:0008152(metabolic process);GO:0016021(integral to membrane);GO:0016787(hydrolase activity);GO:0031902(late endosome membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P254852",{"v":8.8,"d":"8.80"},{"v":8.9,"d":"8.90"},8.72,10.24,10.08,10.21,{"v":0.865378316410088,"d":"0.87"},{"v":-0.208597122959952,"d":"-0.21"},"down",{"v":4.19430000000443e-05,"d":"0.00"},1,"yes","TGCCCCTGCCTGTGTCTGGGTTTCTGTTGGCTGTTTTTCTTTTCTTGAGTGGTGATTTTT","FALSE","NM_194248","ref|NM_194248|ref|NM_001287489|ref|NM_194322|ref|NM_004802","OTOF","otoferlin","ref|Homo sapiens otoferlin (OTOF), transcript variant 1, mRNA [NM_194248]","chr2",26680072,26781546,"GO:0003674(molecular_function);GO:0005509(calcium ion binding);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0007605(sensory perception of sound);GO:0016021(integral to membrane);GO:0016079(synaptic vesicle exocytosis);GO:0016323(basolateral plasma membrane);GO:0030054(cell junction);GO:0030672(synaptic vesicle membrane);GO:0035612(AP-2 adaptor complex binding);GO:0061025(membrane fusion)",null,"mRNA","agilent G3 V3"]
["A_33_P3369969",2.49,2.57,2.93,5.58,5.64,5.85,{"v":0.468072642062097,"d":"0.47"},{"v":-1.09519565009976,"d":"-1.10"},"down",{"v":4.1962000000062e-05,"d":"0.00"},1,"yes","GTACTTGGCTACACACAGATTGTATTTTTATTGTTAATGCTCTTCTTATGGATACCTGCA","FALSE","NM_001137675","ref|NM_001137675|ens|ENST00000427980|gb|BC042985|gb|AL833385","ATXN1L","ataxin 1-like","ref|Homo sapiens ataxin 1-like (ATXN1L), mRNA [NM_001137675]","chr16",71879896,71891231,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0003677(DNA binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0006351(transcription, DNA-dependent);GO:0030198(extracellular matrix organization);GO:0030425(dendrite);GO:0048286(lung alveolus development)",null,"mRNA","agilent G3 V3"]
["A_33_P3425356",2.53,{"v":2.8,"d":"2.80"},{"v":2.5,"d":"2.50"},4.87,4.83,5.07,{"v":0.530128639133378,"d":"0.53"},{"v":-0.915585613473748,"d":"-0.92"},"down",{"v":4.1962000000062e-05,"d":"0.00"},1,"yes","CTTGTGTGAAAATCTCTTTTCTACAGATTTTCCAGGGTTTAAGCATTGCTTGCTGTATAA","FALSE","NM_015396","ref|NM_015396|ref|NM_001267041|ref|NM_001282342|ref|NM_001267042","ARMC8","armadillo repeat containing 8","ref|Homo sapiens armadillo repeat containing 8 (ARMC8), transcript variant 2, mRNA [NM_015396]","chr3",137906384,138015263,null,null,"mRNA","agilent G3 V3"]
["A_33_P3401169",12.47,12.52,12.39,11.48,11.39,11.51,{"v":1.08726003490401,"d":"1.09"},{"v":0.120697024267097,"d":"0.12"},"up",{"v":4.20110000000085e-05,"d":"0.00"},1,"yes","AATAATCAATGAGCGATTTTCAGCCCAATGCCCCCAAAACTCACCCTGTACCTTGGAGAT","FALSE","ENST00000331828","ens|ENST00000331828|tc|THC2565247",null,null,"ens|T cell receptor beta variable 21/OR9-2 (pseudogene) [Source:HGNC Symbol;Acc:HGNC:12199] [ENST00000331828]","chr9",33629120,33629584,null,null,"mRNA","agilent G3 V3"]
["A_33_P3257312",3.38,2.92,2.88,6.32,6.49,6.28,{"v":0.480880041906757,"d":"0.48"},{"v":-1.05625104399013,"d":"-1.06"},"down",{"v":4.20859999999967e-05,"d":"0.00"},1,"yes","TGATATCCGTGTGGTTCGATGTATTATTTTTAAGCTCCGTGAGTGCGTGGGTCAGTGTCT","FALSE","NM_015104","ref|NM_015104|ens|ENST00000421419|ens|ENST00000377264|ref|XM_005273849","ATG2A","autophagy related 2A","ref|Homo sapiens autophagy related 2A (ATG2A), mRNA [NM_015104]","chr11",64662008,64684722,"GO:0000045(autophagic vacuole assembly);GO:0000407(pre-autophagosomal structure);GO:0000422(mitochondrion degradation);GO:0005515(protein binding);GO:0005811(lipid particle);GO:0006995(cellular response to nitrogen starvation);GO:0019898(extrinsic to membrane);GO:0034045(pre-autophagosomal structure membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3339051",7.66,7.74,{"v":7.7,"d":"7.70"},9.31,9.37,9.11,{"v":0.831234256926952,"d":"0.83"},{"v":-0.266672982897142,"d":"-0.27"},"down",{"v":4.22119999999859e-05,"d":"0.00"},1,"yes","ACAGTGGTCATGGGGGATGGGGTACTGCCGGTCTGTGTTGTCTTAGAAGTAGATGTGTGA","FALSE","NM_182498","ref|NM_182498|ens|ENST00000300811|ref|XM_005258517|gb|BC015950","ZNF428","zinc finger protein 428","ref|Homo sapiens zinc finger protein 428 (ZNF428), mRNA [NM_182498]","chr19",44111780,44123751,"GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_24_P277807",5.21,5.05,5.09,6.56,6.79,6.69,{"v":0.765968063872255,"d":"0.77"},{"v":-0.384643852937667,"d":"-0.38"},"down",{"v":4.24319999999812e-05,"d":"0.00"},1,"yes","GGCACAGAACGAACGTTGTCTTCACATGTTTTTACAAGATGAAATAATAGATAAAAGCTA","FALSE","NM_003795","ref|NM_003795|ref|NM_001300929|ref|NM_152827|ref|NM_001300928","SNX3","sorting nexin 3","ref|Homo sapiens sorting nexin 3 (SNX3), transcript variant 1, mRNA [NM_003795]","chr6",108533208,108582448,"GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005769(early endosome);GO:0005829(cytosol);GO:0009617(response to bacterium);GO:0010008(endosome membrane);GO:0010314(phosphatidylinositol-5-phosphate binding);GO:0010324(membrane invagination);GO:0010976(positive regulation of neuron projection development);GO:0016050(vesicle organization);GO:0019898(extrinsic to membrane);GO:0019903(protein phosphatase binding);GO:0022615(protein to membrane docking);GO:0030111(regulation of Wnt receptor signaling pathway);GO:0030136(clathrin-coated vesicle);GO:0030904(retromer complex);GO:0031901(early endosome membrane);GO:0032009(early phagosome);GO:0032266(phosphatidylinositol-3-phosphate binding);GO:0032268(regulation of cellular protein metabolic process);GO:0033157(regulation of intracellular protein transport);GO:0033572(transferrin transport);GO:0042177(negative regulation of protein catabolic process);GO:0042541(hemoglobin biosynthetic process);GO:0043231(intracellular membrane-bounded organelle);GO:0046597(negative regulation of viral entry into host cell);GO:0050765(negative regulation of phagocytosis);GO:0051224(negative regulation of protein transport);GO:0070062(extracellular vesicular exosome);GO:0070273(phosphatidylinositol-4-phosphate binding);GO:0070676(intralumenal vesicle formation);GO:0080025(phosphatidylinositol-3,5-bisphosphate binding);GO:2000642(negative regulation of early endosome to late endosome transport)",null,"mRNA","agilent G3 V3"]
["A_23_P45059",{"v":2.4,"d":"2.40"},2.52,2.42,4.67,4.39,4.74,{"v":0.531884057971015,"d":"0.53"},{"v":-0.910816298822319,"d":"-0.91"},"down",{"v":4.24850000000365e-05,"d":"0.00"},1,"yes","GGTTCTTAGAACTTGTTTTAATTTTTGTGGTCCTTCTGTTTATTATAATAGGCGTCCACC","FALSE","NM_001380","ref|NM_001380|ref|NM_001290223|ens|ENST00000280333|gb|D50857","DOCK1","dedicator of cytokinesis 1","ref|Homo sapiens dedicator of cytokinesis 1 (DOCK1), transcript variant 2, mRNA [NM_001380]","chr10",128593976,129250781,"GO:0002244(hemopoietic progenitor cell differentiation);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006911(phagocytosis, engulfment);GO:0006915(apoptotic process);GO:0007165(signal transduction);GO:0007229(integrin-mediated signaling pathway);GO:0007264(small GTPase mediated signal transduction);GO:0007411(axon guidance);GO:0007596(blood coagulation);GO:0016020(membrane);GO:0016477(cell migration);GO:0017124(SH3 domain binding);GO:0038096(Fc-gamma receptor signaling pathway involved in phagocytosis);GO:0043547(positive regulation of GTPase activity);GO:0045087(innate immune response);GO:0048010(vascular endothelial growth factor receptor signaling pathway)","04810(Regulation of actin cytoskeleton);04510(Focal adhesion);05131(Shigellosis);05100(Bacterial invasion of epithelial cells)","mRNA","agilent G3 V3"]
["A_24_P373844",3.02,3.11,2.85,6.29,{"v":5.8,"d":"5.80"},6.08,{"v":0.494221243808475,"d":"0.49"},{"v":-1.01677106949297,"d":"-1.02"},"down",{"v":4.2533999999983e-05,"d":"0.00"},1,"yes","AAGCATTTTTACACTTCCTGGAATGAGTATATTATCAGCAATCTTTTGTCAAATGCCAGC","FALSE","NM_024076","ref|NM_024076|ref|NM_001129994|ref|NM_001129995|ens|ENST00000284006","KCTD15","potassium channel tetramerization domain containing 15","ref|Homo sapiens potassium channel tetramerization domain containing 15 (KCTD15), transcript variant 1, mRNA [NM_024076]","chr19",34289292,34305148,"GO:0007275(multicellular organismal development);GO:0051260(protein homooligomerization)",null,"mRNA","agilent G3 V3"]
["A_23_P98580",11.95,11.91,11.92,11.66,11.64,11.63,{"v":1.02433438305182,"d":"1.02"},{"v":0.0346867446570435,"d":"0.03"},"up",{"v":4.2570000000075e-05,"d":"0.00"},1,"yes","CTGATCGTAATGTTTATCATGTTACTTCCCCACCCCTACATTTTTTGAAATAAAATAAGG","FALSE","NM_004265","ref|NM_004265|ref|NM_001281502|ref|NM_001281501|ens|ENST00000523235","FADS2","fatty acid desaturase 2","ref|Homo sapiens fatty acid desaturase 2 (FADS2), transcript variant 1, mRNA [NM_004265]","chr11",61621660,61634819,"GO:0004768(stearoyl-CoA 9-desaturase activity);GO:0005506(iron ion binding);GO:0005789(endoplasmic reticulum membrane);GO:0005887(integral to plasma membrane);GO:0006636(unsaturated fatty acid biosynthetic process);GO:0016020(membrane);GO:0020037(heme binding);GO:0033559(unsaturated fatty acid metabolic process);GO:0036109(alpha-linolenic acid metabolic process);GO:0043651(linoleic acid metabolic process);GO:0044281(small molecule metabolic process);GO:0055114(oxidation-reduction process)","01212(Fatty acid metabolism);00592(alpha-Linolenic acid metabolism);01040(Biosynthesis of unsaturated fatty acids);03320(PPAR signaling pathway)","mRNA","agilent G3 V3"]
["A_33_P3297599",{"v":10.2,"d":"10.20"},10.19,{"v":10,"d":"10.00"},{"v":11.4,"d":"11.40"},11.45,11.48,{"v":0.885231575881154,"d":"0.89"},{"v":-0.175873182434962,"d":"-0.18"},"down",{"v":4.2599000000032e-05,"d":"0.00"},1,"yes","TGGACAACATGGCGAAACCCCATCTCCACAAAAAATTAGCCAGGCAATGTGGTGCATGCC","FALSE","AF416714","gb|AF416714|gb|AF130056",null,null,"gb|Homo sapiens clone 3 unknown mRNA. [AF416714]","chrX",73806120,73807340,null,null,"mRNA","agilent G3 V3"]
["A_23_P201432",2.16,2.24,2.13,4.11,{"v":4.1,"d":"4.10"},4.41,{"v":0.51743264659271,"d":"0.52"},{"v":-0.950557013436118,"d":"-0.95"},"down",{"v":4.2627999999989e-05,"d":"0.00"},1,"yes","TGGATGCCTACTGTGGAGATTAACTTTGGCATATTCCAGTGTCAGCTTTCTTTAGCTGGA","FALSE","NM_001126","ref|NM_001126|ens|ENST00000366535|gb|BC012356|gb|AK025514","ADSS","adenylosuccinate synthase","ref|Homo sapiens adenylosuccinate synthase (ADSS), mRNA [NM_001126]","chr1",244571792,244615436,"GO:0000287(magnesium ion binding);GO:0002376(immune system process);GO:0004019(adenylosuccinate synthase activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006144(purine base metabolic process);GO:0006167(AMP biosynthetic process);GO:0006184(GTP catabolic process);GO:0006531(aspartate metabolic process);GO:0009168(purine ribonucleoside monophosphate biosynthetic process);GO:0014074(response to purine-containing compound);GO:0042301(phosphate ion binding);GO:0044208('de novo' AMP biosynthetic process);GO:0044281(small molecule metabolic process);GO:0046040(IMP metabolic process);GO:0055086(nucleobase-containing small molecule metabolic process);GO:0060359(response to ammonium ion);GO:0070062(extracellular vesicular exosome);GO:0071257(cellular response to electrical stimulus)","00230(Purine metabolism);00250(Alanine, aspartate and glutamate metabolism)","mRNA","agilent G3 V3"]
["A_33_P3232193",2.05,2.19,2.08,4.78,5.12,5.29,{"v":0.416063199473338,"d":"0.42"},{"v":-1.26512540632498,"d":"-1.27"},"down",{"v":4.27370000000149e-05,"d":"0.00"},1,"yes","GGTCTTTATAAAACTTCCTTTCCTCTATGTGGTGGCTACAGAGAGTCCAACCACACTTAC","FALSE","ENST00000394156","ens|ENST00000394156|ref|XM_005255764|gb|D21255|gb|E07383","CDH11","cadherin 11, type 2, OB-cadherin (osteoblast)","ens|cadherin 11, type 2, OB-cadherin (osteoblast) [Source:HGNC Symbol;Acc:HGNC:1750] [ENST00000394156]","chr16",64977656,65155939,"GO:0001501(skeletal system development);GO:0001503(ossification);GO:0005509(calcium ion binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion);GO:0016021(integral to membrane);GO:0021957(corticospinal tract morphogenesis);GO:0034329(cell junction assembly);GO:0034332(adherens junction organization);GO:0045216(cell-cell junction organization);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3365601",10.24,10.24,10.32,9.29,9.28,9.41,{"v":1.10078627591137,"d":"1.10"},{"v":0.138534388417511,"d":"0.14"},"up",{"v":4.27459999999824e-05,"d":"0.00"},1,"yes","CTCTGGGGAGAAGAGCAGCGCGGAGGCAGCGAGGCCAGGACGTCACCCCCACGGAGACTG","FALSE","NM_001278559","ref|NM_001278559|ens|ENST00000382252|ref|XM_006715629|ref|XM_006715630","ZNF316","zinc finger protein 316","ref|Homo sapiens zinc finger protein 316 (ZNF316), mRNA [NM_001278559]","chr7",{"v":6682041,"d":"6682041.00"},6694242,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3283669",13.99,14.06,13.95,13.09,{"v":13.2,"d":"13.20"},13.14,{"v":1.06517879786964,"d":"1.07"},{"v":0.0910956174456684,"d":"0.09"},"up",{"v":4.285599999998e-05,"d":"0.00"},1,"yes","CCCCTTCAGCCCCCCGGCTGATGCCATCTCTGGTTCTGGACAATTATCAAATATATCAGT","FALSE","NM_001256214","ref|NM_001256214|ref|NM_152296|ref|NM_001256213|ens|ENST00000545399","ATP1A3","ATPase, Na+/K+ transporting, alpha 3 polypeptide","ref|Homo sapiens ATPase, Na+/K+ transporting, alpha 3 polypeptide (ATP1A3), transcript variant 3, mRNA [NM_001256214]","chr19",42470772,42497619,"GO:0005391(sodium:potassium-exchanging ATPase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005890(sodium:potassium-exchanging ATPase complex);GO:0006883(cellular sodium ion homeostasis);GO:0007613(memory);GO:0008152(metabolic process);GO:0008344(adult locomotory behavior);GO:0008542(visual learning);GO:0010107(potassium ion import);GO:0016021(integral to membrane);GO:0030007(cellular potassium ion homeostasis);GO:0030424(axon);GO:0031748(D1 dopamine receptor binding);GO:0031982(vesicle);GO:0034220(ion transmembrane transport);GO:0035235(ionotropic glutamate receptor signaling pathway);GO:0042493(response to drug);GO:0043209(myelin sheath);GO:0044326(dendritic spine neck);GO:0044327(dendritic spine head);GO:0045202(synapse);GO:0046872(metal ion binding);GO:0051087(chaperone binding);GO:0055085(transmembrane transport);GO:0071383(cellular response to steroid hormone stimulus);GO:0086064(cell communication by electrical coupling involved in cardiac conduction)","04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04911(Insulin secretion);04918(Thyroid hormone synthesis);04919(Thyroid hormone signaling pathway);04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);04970(Salivary secretion);04971(Gastric acid secretion);04972(Pancreatic secretion);04976(Bile secretion);04973(Carbohydrate digestion and absorption);04974(Protein digestion and absorption);04978(Mineral absorption);04960(Aldosterone-regulated sodium reabsorption);04961(Endocrine and other factor-regulated calcium reabsorption);04964(Proximal tubule bicarbonate reclamation)","mRNA","agilent G3 V3"]
["A_32_P41065",1.89,2.12,1.86,4.32,4.08,4.37,{"v":0.459671104150352,"d":"0.46"},{"v":-1.12132611659267,"d":"-1.12"},"down",{"v":4.29130000000333e-05,"d":"0.00"},1,"yes","GTATGTCGTGTATGCTAGGTGATATCCTCAGTAGGGATTGACTACTAGACTGTGTGTTTT","FALSE","NM_001017395","ref|NM_001017395|ref|NM_001128224|ref|NR_033361|ens|ENST00000426664","TMCC1","transmembrane and coiled-coil domain family 1","ref|Homo sapiens transmembrane and coiled-coil domain family 1 (TMCC1), transcript variant 1, mRNA [NM_001017395]","chr3",129366640,129612419,"GO:0005789(endoplasmic reticulum membrane);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_24_P357100",11.11,11.22,11.22,9.64,9.83,9.84,{"v":1.14466052541795,"d":"1.14"},{"v":0.194919798398004,"d":"0.19"},"up",{"v":4.29630000000625e-05,"d":"0.00"},1,"yes","AGCAAGCTAGCGCTGGGCATTCAGTACATACCACGATGTGCTCCCTCTCTTGATGCTTGG","FALSE","NM_014310","ref|NM_014310|ens|ENST00000216127|ref|XM_005261441|ref|XM_005261442","RASD2","RASD family, member 2","ref|Homo sapiens RASD family, member 2 (RASD2), mRNA [NM_014310]","chr22",35936916,35950048,"GO:0001963(synaptic transmission, dopaminergic);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005886(plasma membrane);GO:0006184(GTP catabolic process);GO:0007264(small GTPase mediated signal transduction);GO:0007626(locomotory behavior);GO:0031397(negative regulation of protein ubiquitination);GO:0031624(ubiquitin conjugating enzyme binding);GO:0031681(G-protein beta-subunit binding);GO:0033235(positive regulation of protein sumoylation);GO:0043949(regulation of cAMP-mediated signaling);GO:0051897(positive regulation of protein kinase B signaling cascade)",null,"mRNA","agilent G3 V3"]
["A_33_P3337044",6.18,5.87,6.06,7.77,7.75,7.81,{"v":0.776253750535791,"d":"0.78"},{"v":-0.365399761034031,"d":"-0.37"},"down",{"v":4.29699999999755e-05,"d":"0.00"},1,"yes","TACTAAAAAATACAAAAAAGCTGGGTGTGGTGGCACACACCCGTAGTTCCAGCTACTTGG","FALSE","NM_017585","ref|NM_017585|ref|NM_001145099|ens|ENST00000371897|ens|ENST00000485978","SLC2A6","solute carrier family 2 (facilitated glucose transporter), member 6","ref|Homo sapiens solute carrier family 2 (facilitated glucose transporter), member 6 (SLC2A6), transcript variant 1, mRNA [NM_017585]","chr9",136336224,136344259,"GO:0005355(glucose transmembrane transporter activity);GO:0005886(plasma membrane);GO:0015758(glucose transport);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0055085(transmembrane transport)",null,"mRNA","agilent G3 V3"]
["A_24_P10657",2.27,2.42,2.36,5.58,5.97,6.21,{"v":0.396959459459459,"d":"0.40"},{"v":-1.33293641906395,"d":"-1.33"},"down",{"v":4.29779999999713e-05,"d":"0.00"},1,"yes","TGGACATGCATTAAAGGGTCTATTAGCTTTCTTTCCGTCTGTCTCAACAGCTGAGATGGG","FALSE","NM_020428","ref|NM_020428|ref|NM_001145056|ens|ENST00000407327|ens|ENST00000589561","SLC44A2","solute carrier family 44 (choline transporter), member 2","ref|Homo sapiens solute carrier family 44 (choline transporter), member 2 (SLC44A2), transcript variant 1, mRNA [NM_020428]","chr19",10753012,10754074,"GO:0004871(signal transducer activity);GO:0005765(lysosomal membrane);GO:0005886(plasma membrane);GO:0006644(phospholipid metabolic process);GO:0006656(phosphatidylcholine biosynthetic process);GO:0007165(signal transduction);GO:0015220(choline transmembrane transporter activity);GO:0015871(choline transport);GO:0016021(integral to membrane);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB cascade);GO:0044281(small molecule metabolic process);GO:0046474(glycerophospholipid biosynthetic process);GO:0055085(transmembrane transport);GO:0070062(extracellular vesicular exosome)","05231(Choline metabolism in cancer)","mRNA","agilent G3 V3"]
["A_23_P10374",2.37,2.83,2.74,5.55,{"v":5.7,"d":"5.70"},5.48,{"v":0.474596533173939,"d":"0.47"},{"v":-1.07522653289539,"d":"-1.08"},"down",{"v":4.30580000000402e-05,"d":"0.00"},1,"yes","TGTTTGTTTGAGGTTCGTGCCGCAGTAACAGACACAGTATTTAATTGCACATACAGATGT","FALSE","NM_014925","ref|NM_014925|ens|ENST00000441731|ens|ENST00000358907|ens|ENST00000347140","R3HDM2","R3H domain containing 2","ref|Homo sapiens R3H domain containing 2 (R3HDM2), mRNA [NM_014925]","chr12",57647548,57704246,"GO:0005634(nucleus)",null,"mRNA","agilent G3 V3"]
["A_32_P108889",8.65,8.52,8.54,7.69,7.62,{"v":7.7,"d":"7.70"},{"v":1.11734028683181,"d":"1.12"},{"v":0.160068626609566,"d":"0.16"},"up",{"v":4.30599999999837e-05,"d":"0.00"},1,"yes","TTCAAACAATTTGTGTCCTTAATTAAAGGTGGAATGAGATCCAATTTTTCCCCCTAATCC","FALSE","NM_004734","ref|NM_004734|ref|NM_001195415|ref|NM_001195416|ens|ENST00000360631","DCLK1","doublecortin-like kinase 1","ref|Homo sapiens doublecortin-like kinase 1 (DCLK1), transcript variant 1, mRNA [NM_004734]","chr13",36345480,36705443,"GO:0001764(neuron migration);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005057(receptor signaling protein activity);GO:0005524(ATP binding);GO:0005887(integral to plasma membrane);GO:0006468(protein phosphorylation);GO:0007399(nervous system development);GO:0007417(central nervous system development);GO:0009615(response to virus);GO:0016197(endosomal transport);GO:0021952(central nervous system projection neuron axonogenesis);GO:0030900(forebrain development);GO:0035556(intracellular signal transduction);GO:0048675(axon extension);GO:0048813(dendrite morphogenesis)",null,"mRNA","agilent G3 V3"]
["A_23_P40354",2.28,2.44,{"v":2.3,"d":"2.30"},4.78,4.41,4.67,{"v":0.506493506493506,"d":"0.51"},{"v":-0.981384321832653,"d":"-0.98"},"down",{"v":4.31220000000065e-05,"d":"0.00"},1,"yes","TTCATAAGCAAAAAGTACCTCTTCTTAAAGTGCACTTTGCAGACGTTTCACTCCTTTTCC","FALSE","NM_012325","ref|NM_012325|ens|ENST00000375571|gb|AK297273|gb|BC109281","MAPRE1","microtubule-associated protein, RP/EB family, member 1","ref|Homo sapiens microtubule-associated protein, RP/EB family, member 1 (MAPRE1), mRNA [NM_012325]","chr20",31407700,31438211,"GO:0000086(G2/M transition of mitotic cell cycle);GO:0000278(mitotic cell cycle);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005819(spindle);GO:0005829(cytosol);GO:0005874(microtubule);GO:0005881(cytoplasmic microtubule);GO:0006996(organelle organization);GO:0007067(mitosis);GO:0008022(protein C-terminus binding);GO:0008283(cell proliferation);GO:0030981(cortical microtubule cytoskeleton);GO:0031115(negative regulation of microtubule polymerization);GO:0031253(cell projection membrane);GO:0035371(microtubule plus end);GO:0035372(protein localization to microtubule);GO:0051010(microtubule plus-end binding);GO:0051301(cell division)",null,"mRNA","agilent G3 V3"]
["A_33_P3349597",13.41,13.42,13.39,14.35,14.35,14.21,{"v":0.937310650198089,"d":"0.94"},{"v":-0.0934008194430336,"d":"-0.09"},"down",{"v":4.31750000000619e-05,"d":"0.00"},1,"yes","ATCCATCCACCGATCCATCCGTCCACCCACCCATCCATCCATCCATCCATCCACCGATCC","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_24_P350622",8.36,8.25,8.49,6.91,6.86,6.77,{"v":1.22200584225901,"d":"1.22"},{"v":0.289251182519939,"d":"0.29"},"up",{"v":4.32270000000345e-05,"d":"0.00"},1,"yes","TTTCTGTCACAGGAAACCCTTCTAGTAGTTGGCCTTCACCCACTGAACCAAGCTTCAAAA","FALSE","NM_002255","ref|NM_002255|ref|NM_001080770|ref|NM_001080772|ref|NM_012313","KIR2DL4","killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4","ref|Homo sapiens killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4 (KIR2DL4), transcript variant 1, mRNA [NM_002255]","chrHSCHR19LRC_PGF2_CTG1",54979404,55007752,"GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0006968(cellular defense response);GO:0007165(signal transduction);GO:0016020(membrane);GO:0050776(regulation of immune response)","04650(Natural killer cell mediated cytotoxicity);04612(Antigen processing and presentation)","mRNA","agilent G3 V3"]
["A_23_P16562",1.94,2.06,2.05,{"v":4.8,"d":"4.80"},4.43,{"v":4.4,"d":"4.40"},{"v":0.443873807776963,"d":"0.44"},{"v":-1.17177851464325,"d":"-1.17"},"down",{"v":4.34649999999648e-05,"d":"0.00"},1,"yes","AAGCAGGATCGTTGAAGTTTTAAGTATGGGCAAAAATCTGGAAAACTTAGGATCCCTCTG","FALSE","NM_001017392","ref|NM_001017392|ens|ENST00000600239|ens|ENST00000601879|ens|ENST00000452918","SUGP2","SURP and G patch domain containing 2","ref|Homo sapiens SURP and G patch domain containing 2 (SUGP2), transcript variant 1, mRNA [NM_001017392]","chr19",19105408,19141839,"GO:0005654(nucleoplasm);GO:0006397(mRNA processing);GO:0008380(RNA splicing)",null,"mRNA","agilent G3 V3"]
["A_33_P3237344",8.26,8.21,8.34,7.49,7.44,{"v":7.5,"d":"7.50"},{"v":1.10610789121712,"d":"1.11"},{"v":0.145492114806158,"d":"0.15"},"up",{"v":4.34919999999783e-05,"d":"0.00"},1,"yes","TACCCTCGACCTCTTTGACAACATTGCGCTCACCCCAGAGTGTGCCTCAATGCCATGGGA","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_32_P170444",1.99,2.03,2.12,3.85,3.65,3.94,{"v":0.536713286713287,"d":"0.54"},{"v":-0.89777649140821,"d":"-0.90"},"down",{"v":4.35240000000725e-05,"d":"0.00"},1,"yes","TAGGTATCTCTCCTGAAATTCTTTGCAGTTCATTTTTTATGGCAGTTAATCCAGTGAAAC","FALSE","NM_006713","ref|NM_006713|ens|ENST00000265073|gb|BC071655|gb|BF793065","SUB1","SUB1 homolog (S. cerevisiae)","ref|Homo sapiens SUB1 homolog (S. cerevisiae) (SUB1), mRNA [NM_006713]","chr5",32585604,32604185,"GO:0001205(RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription);GO:0003697(single-stranded DNA binding);GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0005730(nucleolus);GO:0006351(transcription, DNA-dependent);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0060395(SMAD protein signal transduction);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_21_P0013971",9.79,9.74,9.82,9.24,{"v":9.2,"d":"9.20"},9.26,{"v":1.05956678700361,"d":"1.06"},{"v":0.0834745270608641,"d":"0.08"},"up",{"v":4.35520000000578e-05,"d":"0.00"},1,"yes","GCAATTTCCACAGATGCTTTGTTTGTGGAGAAAAGTAGGATGGCCCCTCTGCTTGTCTTA","FALSE","ENST00000497570","ens|ENST00000497570|gb|BX104753|tc|THC2699452","ZNF385D","zinc finger protein 385D","ens|zinc finger protein 385D [Source:HGNC Symbol;Acc:HGNC:26191] [ENST00000497570]","chr3",22175074,22210508,"GO:0003676(nucleic acid binding);GO:0005634(nucleus);GO:0008270(zinc ion binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3294654",6.48,6.42,{"v":6.4,"d":"6.40"},5.16,5.36,5.25,{"v":1.22384273937857,"d":"1.22"},{"v":0.291418187364933,"d":"0.29"},"up",{"v":4.3627000000046e-05,"d":"0.00"},1,"yes","CTTTGGCAGCACCGATGGAGGATGACTGGGAGAGGGGGTGCCTCTCAAGTTACTTCAATC","FALSE","NM_030907","ref|NM_030907|ens|ENST00000375599|gb|BC002946|gb|BC008702","RSG1","REM2 and RAB-like small GTPase 1","ref|Homo sapiens REM2 and RAB-like small GTPase 1 (RSG1), mRNA [NM_030907]","chr1",16558776,16563154,"GO:0005525(GTP binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006887(exocytosis);GO:0007264(small GTPase mediated signal transduction);GO:0015031(protein transport);GO:0017157(regulation of exocytosis);GO:0031338(regulation of vesicle fusion);GO:0034613(cellular protein localization);GO:0036064(cilium basal body);GO:0042384(cilium assembly)",null,"mRNA","agilent G3 V3"]
["A_23_P345460",2.46,2.64,2.56,6.82,6.53,{"v":7.3,"d":"7.30"},{"v":0.370944309927361,"d":"0.37"},{"v":-1.43072548438185,"d":"-1.43"},"down",{"v":4.36350000000418e-05,"d":"0.00"},1,"yes","GACTTGATGCCTTTTGAATAACTTTCAATAGAATTGTCTAAAATTATCTTACTGGTTGTT","FALSE","NM_001129728","ref|NM_001129728|ens|ENST00000379344|ens|ENST00000563969|ens|ENST00000360461","PLEKHG4","pleckstrin homology domain containing, family G (with RhoGef domain) member 4","ref|Homo sapiens pleckstrin homology domain containing, family G (with RhoGef domain) member 4 (PLEKHG4), transcript variant 3, mRNA [NM_001129728]","chr16",67321856,67322975,"GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0032321(positive regulation of Rho GTPase activity)",null,"mRNA","agilent G3 V3"]
["A_21_P0013477",5.51,5.35,5.36,6.75,6.83,6.66,{"v":0.801383399209486,"d":"0.80"},{"v":-0.319435470477037,"d":"-0.32"},"down",{"v":4.36480000000072e-05,"d":"0.00"},1,"yes","TGACAAAGATACAAATCTCTTAAGGAGGTGGACCCCAAGTTCCCGAGGAACATACGCTTT","FALSE","ENST00000425197","ens|ENST00000425197|linc|TCONS_l2_00027751|linc|TCONS_l2_00027748|linc|TCONS_l2_00027750",null,null,"ens|ribosomal protein L29 pseudogene 19 [Source:HGNC Symbol;Acc:HGNC:35508] [ENST00000425197]","chr8",49297152,49297609,null,null,"mRNA","agilent G3 V3"]
["A_23_P98282",11.25,11.21,11.15,10.62,10.63,10.65,{"v":1.05360501567398,"d":"1.05"},{"v":0.07533411865577,"d":"0.08"},"up",{"v":4.37199999999693e-05,"d":"0.00"},1,"yes","CCTTCTCTTCTGCTGTTTAATTCCAGACTGGTGGTGGGACCCAGGTAACCCCCTCTCCCA","FALSE","NM_006946","ref|NM_006946|ens|ENST00000529997|ens|ENST00000309996|ens|ENST00000617502","SPTBN2","spectrin, beta, non-erythrocytic 2","ref|Homo sapiens spectrin, beta, non-erythrocytic 2 (SPTBN2), mRNA [NM_006946]","chr11",66452720,66488870,"GO:0003779(actin binding);GO:0005200(structural constituent of cytoskeleton);GO:0005543(phospholipid binding);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007411(axon guidance);GO:0007416(synapse assembly);GO:0008091(spectrin);GO:0016192(vesicle-mediated transport);GO:0016324(apical plasma membrane);GO:0019886(antigen processing and presentation of exogenous peptide antigen via MHC class II);GO:0021692(cerebellar Purkinje cell layer morphogenesis);GO:0030054(cell junction);GO:0030534(adult behavior);GO:0035264(multicellular organism growth);GO:0043025(neuronal cell body);GO:0051693(actin filament capping)",null,"mRNA","agilent G3 V3"]
["A_21_P0014185",9.92,9.91,10.14,8.49,{"v":8.5,"d":"8.50"},{"v":8.4,"d":"8.40"},{"v":1.18038597873178,"d":"1.18"},{"v":0.239258688866069,"d":"0.24"},"up",{"v":4.39250000000557e-05,"d":"0.00"},1,"yes","AAGTTTTTAGCTCCTCCTGTAACTTTTTACTTCTTTGTGGCAGCTTTTCGTAGCAAAGAA","FALSE","AF090910","gb|AF090910|tc|THC2503940",null,null,"gb|Homo sapiens clone HQ0262. [AF090910]",{"$nulls":5},"mRNA","agilent G3 V3"]
["A_33_P3358824",{"v":1.9,"d":"1.90"},2.07,1.87,{"v":4.2,"d":"4.20"},3.99,4.34,{"v":0.466081404628891,"d":"0.47"},{"v":-1.10134614044184,"d":"-1.10"},"down",{"v":4.40769999999757e-05,"d":"0.00"},1,"yes","CCAGGACAGCGACAGCGATCAGCTGTTTTACACCAAGATCTTCTTGGACCCGGAGAAGAG","FALSE","NM_000302","ref|NM_000302|ens|ENST00000358133|ens|ENST00000485046|ens|ENST00000196061","PLOD1","procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1","ref|Homo sapiens procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 (PLOD1), mRNA [NM_000302]","chr1",11994792,12035150,"GO:0001666(response to hypoxia);GO:0005506(iron ion binding);GO:0005789(endoplasmic reticulum membrane);GO:0006464(cellular protein modification process);GO:0008475(procollagen-lysine 5-dioxygenase activity);GO:0008544(epidermis development);GO:0030198(extracellular matrix organization);GO:0030867(rough endoplasmic reticulum membrane);GO:0031418(L-ascorbic acid binding);GO:0042803(protein homodimerization activity);GO:0046947(hydroxylysine biosynthetic process);GO:0055114(oxidation-reduction process);GO:0070062(extracellular vesicular exosome)","00310(Lysine degradation)","mRNA","agilent G3 V3"]
["A_21_P0008580",14.71,{"v":14.8,"d":"14.80"},{"v":14.7,"d":"14.70"},{"v":14.1,"d":"14.10"},14.05,14.05,{"v":1.04763033175355,"d":"1.05"},{"v":0.0671297353595187,"d":"0.07"},"up",{"v":4.42649999999878e-05,"d":"0.00"},1,"yes","AACTCTCTGGCCCCCCATTGGATCTAGCAAAGATAACTTGGATGCTAGATATTTGCATAC","FALSE","XR_243177","ref|XR_243177|ref|XR_248103|ref|XR_253403|linc|lnc-UACA-2:1","LOC101929151","uncharacterized LOC101929151","ref|PREDICTED: Homo sapiens uncharacterized LOC101929151 (LOC101929151), ncRNA [XR_243177]","chr15",70863296,70878945,null,null,"mRNA","agilent G3 V3"]
["A_33_P3412716",4.48,4.29,{"v":4.2,"d":"4.20"},6.48,6.51,6.76,{"v":0.656708860759494,"d":"0.66"},{"v":-0.606674173700128,"d":"-0.61"},"down",{"v":4.4343999999974e-05,"d":"0.00"},1,"yes","TGAAATGCCCAGGCCATCAGGGTAGGCATATATGAAAAGCCACAAAGTATCTGAAAGATG","FALSE","ENST00000467688","ens|ENST00000467688",null,null,"ens|ribosomal protein L17 pseudogene 22 [Source:HGNC Symbol;Acc:HGNC:35761] [ENST00000467688]","chr5",55432808,55433358,null,null,"mRNA","agilent G3 V3"]
["A_24_P349274",5.64,5.49,5.74,7.07,7.02,{"v":7,"d":"7.00"},{"v":0.799905168326221,"d":"0.80"},{"v":-0.322099121506126,"d":"-0.32"},"down",{"v":4.45180000000489e-05,"d":"0.00"},1,"yes","GGAGGCTTCATGCATTCCTTTGCACAAATCCTTCTCATCTTCCACCTGCTCTTCTGTGGC","FALSE","NM_001004727","ref|NM_001004727|ens|ENST00000623137|ens|ENST00000302329|ens|ENST00000624868","OR4X2","olfactory receptor, family 4, subfamily X, member 2 (gene/pseudogene)","ref|Homo sapiens olfactory receptor, family 4, subfamily X, member 2 (gene/pseudogene) (OR4X2), mRNA [NM_001004727]","chr11",48266608,48267622,"GO:0004888(transmembrane signaling receptor activity);GO:0004930(G-protein coupled receptor activity);GO:0004984(olfactory receptor activity);GO:0005886(plasma membrane);GO:0007186(G-protein coupled receptor signaling pathway);GO:0016021(integral to membrane);GO:0050907(detection of chemical stimulus involved in sensory perception);GO:0050911(detection of chemical stimulus involved in sensory perception of smell)","04740(Olfactory transduction)","mRNA","agilent G3 V3"]
["A_22_P00012254",13.06,13.04,13.32,14.91,14.98,14.87,{"v":0.880697050938338,"d":"0.88"},{"v":-0.183282259932908,"d":"-0.18"},"down",{"v":4.46339999999879e-05,"d":"0.00"},1,"yes","CTCCAGCCCGCTCCGCCTGCGCCTCGGCCTTGCGCGCGGGGGCCCGGGTTACCTGCGCAG","FALSE","XR_424592","ref|XR_424592|linc|lnc-PPP1R14D-1:3|linc|lnc-PPP1R14D-1:1|linc|lnc-PPP1R14D-1:2","LOC102724362","uncharacterized LOC102724362","ref|PREDICTED: Homo sapiens uncharacterized LOC102724362 (LOC102724362), ncRNA [XR_424592]","chr15",41128188,41136482,null,null,"mRNA","agilent G3 V3"]
["A_33_P3413945",5.68,5.92,5.65,4.14,4.09,4.15,{"v":1.39337641357027,"d":"1.39"},{"v":0.478585047338629,"d":"0.48"},"up",{"v":4.47650000000577e-05,"d":"0.00"},1,"yes","GACCAAGACTCTGGATCCAATTCTATTTCCCAGAGAAGGAACCAAATCTATGCCCCACTT","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_22_P00011159",13.93,13.85,13.85,13.35,13.31,13.31,{"v":1.04153114836127,"d":"1.04"},{"v":0.0587059857197714,"d":"0.06"},"up",{"v":4.48029999999822e-05,"d":"0.00"},1,"yes","AAGTACCTGCTGCGCCACAAACCCACCAAGGTGCTCTCCCCCGAGTACTTGTGGGACCAG","FALSE","NM_020469","ref|NM_020469|ens|ENST00000538324|ens|ENST00000611156|linc|lnc-OBP2B-2:1","ABO","ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)","ref|Homo sapiens ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase) (ABO), mRNA [NM_020469]","chr9",136130560,136150630,"GO:0004380(glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity);GO:0004381(fucosylgalactoside 3-alpha-galactosyltransferase activity);GO:0005576(extracellular region);GO:0006486(protein glycosylation);GO:0016021(integral to membrane);GO:0032580(Golgi cisterna membrane);GO:0046872(metal ion binding)","00601(Glycosphingolipid biosynthesis - lacto and neolacto series)","mRNA","agilent G3 V3"]
["A_22_P00005912",{"v":13.5,"d":"13.50"},13.55,13.48,12.46,12.44,{"v":12.6,"d":"12.60"},{"v":1.0808,"d":"1.08"},{"v":0.112099579776235,"d":"0.11"},"up",{"v":4.48889999999924e-05,"d":"0.00"},1,"yes","CATTTGTTATGGCAAAGTTCTCTTTCTGTGCCCCTTCCCTAATAAAGAAATCCTCAGTCA","FALSE","ENST00000518886","ens|ENST00000518886|linc|lnc-EVX1-1:1",{"$nulls":3},"chr7",27286988,27290112,null,null,"mRNA","agilent G3 V3"]
["A_24_P235783",2.01,2.02,2.21,4.95,5.41,4.97,{"v":0.407045009784736,"d":"0.41"},{"v":-1.29673976279653,"d":"-1.30"},"down",{"v":5.50120000000209e-05,"d":"0.00"},1,"yes","GAGATTGTAGTTATCTTTTTTGAGATGAGATACTTTCACGACTTTGGTATCATCTGTCAG","FALSE","ENST00000463343","ens|ENST00000463343|ens|ENST00000472725|gb|D26121|tc|THC2588580","SF1","splicing factor 1","ens|splicing factor 1 [Source:HGNC Symbol;Acc:HGNC:12950] [ENST00000463343]","chr11",64543520,64546235,"GO:0000245(spliceosomal complex assembly);GO:0000389(nuclear mRNA 3'-splice site recognition);GO:0000398(nuclear mRNA splicing, via spliceosome);GO:0003714(transcription corepressor activity);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005681(spliceosomal complex);GO:0005840(ribosome);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0008270(zinc ion binding);GO:0030238(male sex determination);GO:0033327(Leydig cell differentiation);GO:0048662(negative regulation of smooth muscle cell proliferation);GO:0050810(regulation of steroid biosynthetic process)",null,"mRNA","agilent G3 V3"]
["A_32_P220696",2.14,2.33,2.29,3.67,3.85,{"v":3.7,"d":"3.70"},{"v":0.602495543672014,"d":"0.60"},{"v":-0.730977524326608,"d":"-0.73"},"down",{"v":5.50169999999905e-05,"d":"0.00"},1,"yes","CTTCATTTAATATATCAATATTGGGCCTAAAACAGTATTCTGTAAAGCTTAAATTGGTAT","FALSE","NM_017489","ref|NM_017489|ref|NM_003218|ens|ENST00000276602|ref|XR_254158","TERF1","telomeric repeat binding factor (NIMA-interacting) 1","ref|Homo sapiens telomeric repeat binding factor (NIMA-interacting) 1 (TERF1), transcript variant 1, mRNA [NM_017489]","chr8",73942192,73959210,"GO:0000086(G2/M transition of mitotic cell cycle);GO:0000723(telomere maintenance);GO:0000781(chromosome, telomeric region);GO:0000783(nuclear telomere cap complex);GO:0000784(nuclear chromosome, telomeric region);GO:0001309(age-dependent telomere shortening);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003691(double-stranded telomeric DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005819(spindle);GO:0007004(telomere maintenance via telomerase);GO:0007067(mitosis);GO:0007094(mitotic cell cycle spindle assembly checkpoint);GO:0008017(microtubule binding);GO:0008156(negative regulation of DNA replication);GO:0008301(DNA binding, bending);GO:0031116(positive regulation of microtubule polymerization);GO:0031627(telomeric loop formation);GO:0032211(negative regulation of telomere maintenance via telomerase);GO:0032214(negative regulation of telomere maintenance via semi-conservative replication);GO:0042162(telomeric DNA binding);GO:0042493(response to drug);GO:0042803(protein homodimerization activity);GO:0043065(positive regulation of apoptotic process);GO:0045840(positive regulation of mitosis);GO:0045931(positive regulation of mitotic cell cycle);GO:0046982(protein heterodimerization activity);GO:0051260(protein homooligomerization);GO:0051301(cell division);GO:0051974(negative regulation of telomerase activity)",null,"mRNA","agilent G3 V3"]
["A_33_P3379456",4.28,4.47,4.08,6.84,6.73,{"v":6.6,"d":"6.60"},{"v":0.636093207734259,"d":"0.64"},{"v":-0.652689913523279,"d":"-0.65"},"down",{"v":5.51149999999945e-05,"d":"0.00"},1,"yes","CATTTCCAGCAGTAGCATAAACTTACGGTGACATGGTAGACTTGTCTCTAAATAAAATTT","FALSE","NM_001282687","ref|NM_001282687|ref|NM_001282682|ref|NM_015677|ref|NM_001159597","SH3YL1","SH3 and SYLF domain containing 1","ref|Homo sapiens SH3 and SYLF domain containing 1 (SH3YL1), transcript variant 4, mRNA [NM_001282687]","chr2",{"v":218138,"d":"218138.00"},242800,"GO:0006661(phosphatidylinositol biosynthetic process);GO:0019902(phosphatase binding);GO:0032587(ruffle membrane);GO:0035091(phosphatidylinositol binding);GO:1900027(regulation of ruffle assembly)",null,"mRNA","agilent G3 V3"]
["A_23_P412409",2.21,2.26,2.61,5.21,5.19,5.49,{"v":0.445563247325362,"d":"0.45"},{"v":-1.16629785926552,"d":"-1.17"},"down",{"v":5.51460000000059e-05,"d":"0.00"},1,"yes","AGGACAGTACTGTATCATACCTCTGTGAATGTAAAATATCTTGTACCTGCTTTATGATAC","FALSE","NM_015172","ref|NM_015172|ens|ENST00000338920|ens|ENST00000426496|ref|XM_005245020","PRRC2C","proline-rich coiled-coil 2C","ref|Homo sapiens proline-rich coiled-coil 2C (PRRC2C), mRNA [NM_015172]","chr1",171556208,171561362,"GO:0002244(hemopoietic progenitor cell differentiation);GO:0008022(protein C-terminus binding);GO:0016020(membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P350234",7.88,7.75,7.85,6.78,6.67,6.62,{"v":1.16990533134031,"d":"1.17"},{"v":0.226391791747435,"d":"0.23"},"up",{"v":5.51559999999451e-05,"d":"0.00"},1,"yes","TTATTTTCATGTGGTCATTGCTGGGGAATCAAAGGATTCCCCCTTTGAGGGAGGGACTTT","FALSE","NM_001012989","ref|NM_001012989|ref|NR_121210|ens|ENST00000616924|ens|ENST00000618570","UBE2NL","ubiquitin-conjugating enzyme E2N-like (gene/pseudogene)","ref|Homo sapiens ubiquitin-conjugating enzyme E2N-like (gene/pseudogene) (UBE2NL), transcript variant coding, mRNA [NM_001012989]","chrX",142967168,142968355,"GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006301(postreplication repair);GO:0019787(small conjugating protein ligase activity);GO:0031625(ubiquitin protein ligase binding);GO:0070062(extracellular vesicular exosome);GO:0070534(protein K63-linked ubiquitination)","04120(Ubiquitin mediated proteolysis)","mRNA","agilent G3 V3"]
["A_24_P103025",6.19,6.29,5.88,8.55,8.46,8.61,{"v":0.716627634660421,"d":"0.72"},{"v":-0.480704416927839,"d":"-0.48"},"down",{"v":5.51839999999304e-05,"d":"0.00"},1,"yes","AAGGCTATTGGGCAAGTTTGGATGCATCTACTCAAACCACCCATGAACTCACCATTCCAA","FALSE","NM_006196","ref|NM_006196|ens|ENST00000303577|gb|AK314225|gb|AB464656","PCBP1","poly(rC) binding protein 1","ref|Homo sapiens poly(rC) binding protein 1 (PCBP1), mRNA [NM_006196]","chr2",70314584,70316332,"GO:0000398(nuclear mRNA splicing, via spliceosome);GO:0003697(single-stranded DNA binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0008380(RNA splicing);GO:0010467(gene expression);GO:0016020(membrane);GO:0030529(ribonucleoprotein complex);GO:0043231(intracellular membrane-bounded organelle);GO:0070062(extracellular vesicular exosome)","03040(Spliceosome)","mRNA","agilent G3 V3"]
["A_23_P143143",6.02,6.07,6.15,7.72,8.01,7.79,{"v":0.775510204081633,"d":"0.78"},{"v":-0.366782330671623,"d":"-0.37"},"down",{"v":5.52080000000288e-05,"d":"0.00"},1,"yes","AGGCTTCTGAATTCCCTTCTGAGTTAATGTCAAATGACAGCAAAGCACTGTGTGGCTGAA","FALSE","NM_002166","ref|NM_002166|ens|ENST00000331129|ens|ENST00000472142|ens|ENST00000396290","ID2","inhibitor of DNA binding 2, dominant negative helix-loop-helix protein","ref|Homo sapiens inhibitor of DNA binding 2, dominant negative helix-loop-helix protein (ID2), mRNA [NM_002166]","chr2",{"v":8822910,"d":"8822910.00"},8824161,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000785(chromatin);GO:0001656(metanephros development);GO:0001779(natural killer cell differentiation);GO:0003149(membranous septum morphogenesis);GO:0003166(bundle of His development);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006351(transcription, DNA-dependent);GO:0007275(multicellular organismal development);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0014003(oligodendrocyte development);GO:0015630(microtubule cytoskeleton);GO:0019216(regulation of lipid metabolic process);GO:0021772(olfactory bulb development);GO:0032922(circadian regulation of gene expression);GO:0033598(mammary gland epithelial cell proliferation);GO:0042752(regulation of circadian rhythm);GO:0043153(entrainment of circadian clock by photoperiod);GO:0043234(protein complex);GO:0043353(enucleate erythrocyte differentiation);GO:0043392(negative regulation of DNA binding);GO:0043433(negative regulation of sequence-specific DNA binding transcription factor activity);GO:0044325(ion channel binding);GO:0045475(locomotor rhythm);GO:0045578(negative regulation of B cell differentiation);GO:0045600(positive regulation of fat cell differentiation);GO:0045648(positive regulation of erythrocyte differentiation);GO:0045651(positive regulation of macrophage differentiation);GO:0045665(negative regulation of neuron differentiation);GO:0045668(negative regulation of osteoblast differentiation);GO:0045777(positive regulation of blood pressure);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0046983(protein dimerization activity);GO:0048469(cell maturation);GO:0048541(Peyer's patch development);GO:0048557(embryonic digestive tract morphogenesis);GO:0048661(positive regulation of smooth muscle cell proliferation);GO:0048663(neuron fate commitment);GO:0048711(positive regulation of astrocyte differentiation);GO:0048715(negative regulation of oligodendrocyte differentiation);GO:0060612(adipose tissue development);GO:0060749(mammary gland alveolus development);GO:0061030(epithelial cell differentiation involved in mammary gland alveolus development);GO:0061031(endodermal digestive tract morphogenesis);GO:0071158(positive regulation of cell cycle arrest);GO:0071285(cellular response to lithium ion);GO:0071931(positive regulation of transcription involved in G1/S phase of mitotic cell cycle);GO:0090398(cellular senescence);GO:2000045(regulation of G1/S transition of mitotic cell cycle);GO:2000178(negative regulation of neural precursor cell proliferation)","04350(TGF-beta signaling pathway);04390(Hippo signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);05202(Transcriptional misregulation in cancers)","mRNA","agilent G3 V3"]
["A_23_P250347",10.28,10.28,{"v":10.4,"d":"10.40"},9.24,9.31,9.37,{"v":1.10888252148997,"d":"1.11"},{"v":0.149106529934758,"d":"0.15"},"up",{"v":5.52999999999804e-05,"d":"0.00"},1,"yes","AGGTGCAAGCCTTAGAGAAAGTTAAAGGTGCAGATATAAATGCTGAAGAGGCCCCCAAAA","FALSE","NM_001744","ref|NM_001744|ens|ENST00000512453|ens|ENST00000510858|ens|ENST00000512890","CAMK4","calcium/calmodulin-dependent protein kinase IV","ref|Homo sapiens calcium/calmodulin-dependent protein kinase IV (CAMK4), mRNA [NM_001744]","chr5",110818184,110825410,"GO:0002372(myeloid dendritic cell cytokine production);GO:0004683(calmodulin-dependent protein kinase activity);GO:0005516(calmodulin binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0006913(nucleocytoplasmic transport);GO:0006954(inflammatory response);GO:0006996(organelle organization);GO:0007005(mitochondrion organization);GO:0007165(signal transduction);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007202(activation of phospholipase C activity);GO:0007268(synaptic transmission);GO:0007270(neuron-neuron synaptic transmission);GO:0007616(long-term memory);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0033081(regulation of T cell differentiation in thymus);GO:0043011(myeloid dendritic cell differentiation);GO:0045087(innate immune response);GO:0045670(regulation of osteoclast differentiation);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0046827(positive regulation of protein export from nucleus);GO:0048011(nerve growth factor receptor signaling pathway);GO:0070062(extracellular vesicular exosome)","04020(Calcium signaling pathway);04024(cAMP signaling pathway);04921(Oxytocin signaling pathway);04725(Cholinergic synapse);04720(Long-term potentiation);04722(Neurotrophin signaling pathway);04380(Osteoclast differentiation);05031(Amphetamine addiction);05034(Alcoholism)","mRNA","agilent G3 V3"]
["A_24_P244442",2.27,2.67,2.27,4.93,4.97,4.87,{"v":0.488151658767772,"d":"0.49"},{"v":-1.03459866152397,"d":"-1.03"},"down",{"v":5.53009999999521e-05,"d":"0.00"},1,"yes","CCTGTGAATCAAGATTTGGGCATGTTCTTGGTCACCATTTCCTGCTACACCAGAGGTGGC","FALSE","NM_032667","ref|NM_032667|ref|NM_001130702|ref|NM_001122955|ref|NR_037946","BSCL2","Berardinelli-Seip congenital lipodystrophy 2 (seipin)","ref|Homo sapiens Berardinelli-Seip congenital lipodystrophy 2 (seipin) (BSCL2), transcript variant 2, mRNA [NM_032667]","chr11",62457748,62477046,"GO:0003674(molecular_function);GO:0016042(lipid catabolic process);GO:0019915(lipid storage);GO:0030176(integral to endoplasmic reticulum membrane);GO:0034389(lipid particle organization);GO:0045444(fat cell differentiation);GO:0050995(negative regulation of lipid catabolic process)",null,"mRNA","agilent G3 V3"]
["A_24_P116351",4.87,4.73,{"v":4.4,"d":"4.40"},7.28,7.43,7.38,{"v":0.6337709370756,"d":"0.63"},{"v":-0.657966591522946,"d":"-0.66"},"down",{"v":5.53730000000252e-05,"d":"0.00"},1,"yes","TGGCCTCGTGGACTGCAGTGACATGTACGAGAAAGTGCTGTGCACCAGCTGTGCCATGTT","FALSE","NM_006427","ref|NM_006427|ref|NM_021709|ens|ENST00000329967|ens|ENST00000347067","SIVA1","SIVA1, apoptosis-inducing factor","ref|Homo sapiens SIVA1, apoptosis-inducing factor (SIVA1), transcript variant 1, mRNA [NM_006427]","chr14",105219440,105225994,"GO:0001618(viral receptor activity);GO:0005175(CD27 receptor binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0006924(activation-induced cell death of T cells);GO:0008270(zinc ion binding);GO:0009615(response to virus);GO:0016032(viral reproduction);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0046872(metal ion binding);GO:0097191(extrinsic apoptotic signaling pathway);GO:0097193(intrinsic apoptotic signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_23_P4353",3.81,3.97,3.22,7.94,7.88,8.03,{"v":0.461215932914046,"d":"0.46"},{"v":-1.11648574248085,"d":"-1.12"},"down",{"v":5.54029999999539e-05,"d":"0.00"},1,"yes","ATGGACCCTTTTGCTTTTCTGATTTTTAGTTCTGACATGTATATATTGCTTCAGTAGAGC","FALSE","NM_015626","ref|NM_015626|ref|NM_134265|ens|ENST00000348811|ens|ENST00000467843","WSB1","WD repeat and SOCS box containing 1","ref|Homo sapiens WD repeat and SOCS box containing 1 (WSB1), transcript variant 1, mRNA [NM_015626]","chr17",25621156,25639913,"GO:0005515(protein binding);GO:0005622(intracellular);GO:0008150(biological_process);GO:0016567(protein ubiquitination);GO:0035556(intracellular signal transduction)",null,"mRNA","agilent G3 V3"]
["A_33_P3358243",9.87,{"v":9.6,"d":"9.60"},9.78,11.22,11.27,11.23,{"v":0.867437722419929,"d":"0.87"},{"v":-0.205167911583953,"d":"-0.21"},"down",{"v":5.54779999999422e-05,"d":"0.00"},1,"yes","TATAAGAGGTTTCCCCTTTTGCTTAGTTCTCATTCTCTCTTGCCTGCCGCCATGTAAGAC","FALSE","NM_020702","ref|NM_020702|ens|ENST00000297625|ref|XM_006716808|gb|BC070098","KIAA1161","KIAA1161","ref|Homo sapiens KIAA1161 (KIAA1161), mRNA [NM_020702]","chr9",34366668,34376851,"GO:0004553(hydrolase activity, hydrolyzing O-glycosyl compounds);GO:0005975(carbohydrate metabolic process);GO:0016021(integral to membrane);GO:0031965(nuclear membrane);GO:0043568(positive regulation of insulin-like growth factor receptor signaling pathway);GO:0048741(skeletal muscle fiber development);GO:0051897(positive regulation of protein kinase B signaling cascade)",null,"mRNA","agilent G3 V3"]
["A_21_P0005461",14.67,14.77,14.63,13.27,13.29,13.46,{"v":1.10119940029985,"d":"1.10"},{"v":0.139075729371695,"d":"0.14"},"up",{"v":5.55099999999253e-05,"d":"0.00"},1,"yes","AATTTCAAATTCCCTTATCCAAACCAGTGTTACAAAAGGACTCCAGTTTGCCCCCCAAAT","FALSE","XR_426123","ref|XR_426123|ref|XR_430675|ref|XR_432109|ref|XR_428089","LOC102723672","uncharacterized LOC102723672","ref|PREDICTED: Homo sapiens uncharacterized LOC102723672 (LOC102723672), ncRNA [XR_426123]","chr7",{"v":144899,"d":"144899.00"},145683,null,null,"mRNA","agilent G3 V3"]
["A_24_P220485",6.22,6.19,6.34,9.02,8.86,8.57,{"v":0.708884688090737,"d":"0.71"},{"v":-0.496377126730783,"d":"-0.50"},"down",{"v":5.56290000000015e-05,"d":"0.00"},1,"yes","TCTAGCTTTCTGCTTTTACCTTTACCCTAATCTTTTTATTTTTATGCTATTGTACTTTAT","FALSE","NM_182487","ref|NM_182487|ref|NM_001282715|ens|ENST00000373580|ens|ENST00000288815","OLFML2A","olfactomedin-like 2A","ref|Homo sapiens olfactomedin-like 2A (OLFML2A), transcript variant 1, mRNA [NM_182487]","chr9",127563152,127577164,"GO:0005576(extracellular region);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix);GO:0042803(protein homodimerization activity);GO:0050840(extracellular matrix binding)",null,"mRNA","agilent G3 V3"]
["A_21_P0012971",2.07,1.92,{"v":2.2,"d":"2.20"},3.89,3.72,3.84,{"v":0.54061135371179,"d":"0.54"},{"v":-0.887336283770042,"d":"-0.89"},"down",{"v":5.5713999999929e-05,"d":"0.00"},1,"yes","ATACTGCTTCATGGTGGAGATGCTTCTGGTTTATTTTGTGGCTACCGCTGTTACTGCTTG","FALSE","ENST00000507290","ens|ENST00000507290|ens|ENST00000343123|ens|ENST00000522848|ens|ENST00000515587",null,null,"ens|programmed cell death 6 [Source:HGNC Symbol;Acc:HGNC:8765] [ENST00000515587]","chr5",{"v":1599035,"d":"1599035.00"},1634096,null,null,"mRNA","agilent G3 V3"]
["A_33_P3222761",{"v":10.2,"d":"10.20"},10.29,10.43,9.02,8.92,8.96,{"v":1.14944237918216,"d":"1.15"},{"v":0.200934146480861,"d":"0.20"},"up",{"v":5.58440000000271e-05,"d":"0.00"},1,"yes","CCAGACAGAAGGCCAAGTGCTCCCCTCTGAAGGGGATTCCCTGATTGTGAACTGCTCCTA","FALSE","ENST00000390431","ens|ENST00000390431",null,null,"ens|T cell receptor alpha variable 9-1 [Source:HGNC Symbol;Acc:HGNC:12153] [ENST00000390431]","chr14",22279674,22280149,null,null,"mRNA","agilent G3 V3"]
["A_24_P468810",2.38,2.55,2.74,4.86,5.15,5.03,{"v":0.509973404255319,"d":"0.51"},{"v":-0.971506084174704,"d":"-0.97"},"down",{"v":5.58449999999988e-05,"d":"0.00"},1,"yes","CAGTGGCATTAAGGATGGTCTCTTAATCCTGTGTTAACCACTAGATTAACTTTACAATCA","FALSE","NM_005610","ref|NM_005610|ref|NM_001135255|ref|NM_001135256|ens|ENST00000373493","RBBP4","retinoblastoma binding protein 4","ref|Homo sapiens retinoblastoma binding protein 4 (RBBP4), transcript variant 1, mRNA [NM_005610]","chr1",33116748,33151812,"GO:0000086(G2/M transition of mitotic cell cycle);GO:0000278(mitotic cell cycle);GO:0000790(nuclear chromatin);GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0000980(RNA polymerase II distal enhancer sequence-specific DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006260(DNA replication);GO:0006325(chromatin organization);GO:0006334(nucleosome assembly);GO:0006335(DNA replication-dependent nucleosome assembly);GO:0006336(DNA replication-independent nucleosome assembly);GO:0006338(chromatin remodeling);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0008094(DNA-dependent ATPase activity);GO:0008285(negative regulation of cell proliferation);GO:0010467(gene expression);GO:0016580(Sin3 complex);GO:0016581(NuRD complex);GO:0016589(NURF complex);GO:0031492(nucleosomal DNA binding);GO:0031497(chromatin assembly);GO:0033186(CAF-1 complex);GO:0034080(CenH3-containing nucleosome assembly at centromere);GO:0035098(ESC/E(Z) complex);GO:0040029(regulation of gene expression, epigenetic);GO:0042393(histone binding);GO:0042826(histone deacetylase binding);GO:0043044(ATP-dependent chromatin remodeling);GO:0043234(protein complex);GO:0045814(negative regulation of gene expression, epigenetic);GO:0051726(regulation of cell cycle)",null,"mRNA","agilent G3 V3"]
["A_23_P251293",13.33,13.37,13.42,12.19,12.23,12.37,{"v":1.09051372655613,"d":"1.09"},{"v":0.125007929639206,"d":"0.13"},"up",{"v":5.58939999999453e-05,"d":"0.00"},1,"yes","TGCGCAAGGAGGACTTGAGGCCATCTGCCCCCCAACAGGAGGGTGTGGCATCCAAAGAGA","FALSE","NM_003087","ref|NM_003087|ens|ENST00000465679|ens|ENST00000348795|ens|ENST00000483064","SNCG","synuclein, gamma (breast cancer-specific protein 1)","ref|Homo sapiens synuclein, gamma (breast cancer-specific protein 1) (SNCG), mRNA [NM_003087]","chr10",88718376,88722630,"GO:0002118(aggressive behavior);GO:0005737(cytoplasm);GO:0005815(microtubule organizing center);GO:0005819(spindle);GO:0005886(plasma membrane);GO:0007268(synaptic transmission);GO:0008344(adult locomotory behavior);GO:0009306(protein secretion);GO:0014059(regulation of dopamine secretion);GO:0042220(response to cocaine);GO:0042493(response to drug);GO:0043014(alpha-tubulin binding);GO:0043025(neuronal cell body);GO:0043679(axon terminus);GO:0046928(regulation of neurotransmitter secretion);GO:0048471(perinuclear region of cytoplasm);GO:0048487(beta-tubulin binding);GO:0050808(synapse organization);GO:0070062(extracellular vesicular exosome);GO:0071464(cellular response to hydrostatic pressure)",null,"mRNA","agilent G3 V3"]
["A_24_P99216",2.05,{"v":1.9,"d":"1.90"},2.17,5.42,{"v":5.4,"d":"5.40"},5.94,{"v":0.365155131264916,"d":"0.37"},{"v":-1.4534185910067,"d":"-1.45"},"down",{"v":5.59270000000112e-05,"d":"0.00"},1,"yes","CATCCCACCTGTAGAAGACTTTCCTACAGAGAATCCTAATGATAACTCAGTGCTGGGCAA","FALSE","NM_014045","ref|NM_014045|ens|ENST00000546834|ens|ENST00000470660|gb|CR457151","LRP10","low density lipoprotein receptor-related protein 10","ref|Homo sapiens low density lipoprotein receptor-related protein 10 (LRP10), mRNA [NM_014045]","chr14",23340822,23350789,"GO:0005905(coated pit);GO:0006897(endocytosis);GO:0016020(membrane);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P304543",11.98,11.98,{"v":12.1,"d":"12.10"},11.12,11.05,11.15,{"v":1.08223289315726,"d":"1.08"},{"v":0.114010996066794,"d":"0.11"},"up",{"v":5.59519999999702e-05,"d":"0.00"},1,"yes","TATCATTCTTGTCATAGTGAGGAGAAGTGTCCCCCTTGCACTTTCCTAACTCAGAAGTGG","FALSE","NM_147133","ref|NM_147133|ref|NM_147134|ens|ENST00000466971|ens|ENST00000318524","NFX1","nuclear transcription factor, X-box binding 1","ref|Homo sapiens nuclear transcription factor, X-box binding 1 (NFX1), transcript variant 2, mRNA [NM_147133]","chr9",33342810,33351880,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001078(RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006366(transcription from RNA polymerase II promoter);GO:0006954(inflammatory response);GO:0008270(zinc ion binding);GO:0016032(viral reproduction);GO:0016874(ligase activity);GO:0045347(negative regulation of MHC class II biosynthetic process)",null,"mRNA","agilent G3 V3"]
["A_23_P58763",2.23,2.45,2.33,5.36,{"v":5.9,"d":"5.90"},5.47,{"v":0.419007770472206,"d":"0.42"},{"v":-1.25495109602773,"d":"-1.25"},"down",{"v":5.59649999999356e-05,"d":"0.00"},1,"yes","TGGTGGACAGTGTGAAAGAGAATGCAGGCACCGTTAGGATATTCTCTAGTCTTCACGTTT","FALSE","NM_015946","ref|NM_015946|ens|ENST00000506949|gb|AK312633|gb|DQ892950","PELO","pelota homolog (Drosophila)","ref|Homo sapiens pelota homolog (Drosophila) (PELO), mRNA [NM_015946]","chr5",52083788,52097668,"GO:0004519(endonuclease activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0007049(cell cycle);GO:0008283(cell proliferation);GO:0046872(metal ion binding);GO:0051276(chromosome organization);GO:0051301(cell division);GO:0070481(nuclear-transcribed mRNA catabolic process, non-stop decay);GO:0070966(nuclear-transcribed mRNA catabolic process, no-go decay);GO:0071025(RNA surveillance);GO:0090305(nucleic acid phosphodiester bond hydrolysis)","03015(mRNA surveillance pathway)","mRNA","agilent G3 V3"]
["A_24_P690811",9.87,10.06,10.01,7.84,7.57,7.92,{"v":1.28332618945564,"d":"1.28"},{"v":0.359887914074217,"d":"0.36"},"up",{"v":5.60399999999239e-05,"d":"0.00"},1,"yes","GCCCATCCCAAAATAATCCATGAATCTGGGGCACAAATCCTGCGCCATGCCAATCTCCTG","FALSE","NM_001024656","ref|NM_001024656|ref|NM_001114598|ens|ENST00000593569|ens|ENST00000376916","ASPDH","aspartate dehydrogenase domain containing","ref|Homo sapiens aspartate dehydrogenase domain containing (ASPDH), transcript variant 2, mRNA [NM_001024656]","chr19",51016032,51017921,"GO:0006742(NADP catabolic process);GO:0009435(NAD biosynthetic process);GO:0033735(aspartate dehydrogenase activity);GO:0050661(NADP binding);GO:0055114(oxidation-reduction process)",null,"mRNA","agilent G3 V3"]
["A_23_P16096",10.98,11.02,{"v":11.1,"d":"11.10"},10.11,10.16,10.22,{"v":1.08560183666776,"d":"1.09"},{"v":0.118495066684832,"d":"0.12"},"up",{"v":5.61199999999928e-05,"d":"0.00"},1,"yes","TGGTATGCATGTGAAGCTCATGGCCACCATGTTCCAGAACCTGTTCCCCTCCATCAACGT","FALSE","NM_020230","ref|NM_020230|ens|ENST00000466025|ens|ENST00000253107|gb|CU679511","PPAN","peter pan homolog (Drosophila)","ref|Homo sapiens peter pan homolog (Drosophila) (PPAN), mRNA [NM_020230]","chr19",10218327,10218411,"GO:0005634(nucleus);GO:0005730(nucleolus);GO:0008380(RNA splicing)",null,"mRNA","agilent G3 V3"]
["A_33_P3408898",1.97,2.16,1.95,4.05,4.19,4.39,{"v":0.481393507521774,"d":"0.48"},{"v":-1.05471141034397,"d":"-1.05"},"down",{"v":5.6140999999954e-05,"d":"0.00"},1,"yes","GGTTTTGCATTTACATTTGTGGACCATGTTACAGTTAAGAAAAATCCTGTTTCAGTCCTT","FALSE","NM_001008739","ref|NM_001008739|gb|BC060325|gb|BC051007|gb|BC073804","C6orf226","chromosome 6 open reading frame 226","ref|Homo sapiens chromosome 6 open reading frame 226 (C6orf226), mRNA [NM_001008739]","chr6",42858004,42858554,null,null,"mRNA","agilent G3 V3"]
["A_23_P216501",8.02,7.99,7.49,11.02,11.07,10.97,{"v":0.710828796128252,"d":"0.71"},{"v":-0.492425967839952,"d":"-0.49"},"down",{"v":5.63190000000269e-05,"d":"0.00"},1,"yes","TGCCAAGGAGGAGAACGTCGAGATTCACCAGACCTTGGACCAGACCCTGCTGGAACTCAA","FALSE","NM_213674","ref|NM_213674|ref|NM_001301226|ens|ENST00000378292|ref|XM_005251566","TPM2","tropomyosin 2 (beta)","ref|Homo sapiens tropomyosin 2 (beta) (TPM2), transcript variant Tpm2.1, mRNA [NM_213674]","chr9",35682012,35689910,"GO:0003779(actin binding);GO:0005829(cytosol);GO:0005862(muscle thin filament tropomyosin);GO:0006936(muscle contraction);GO:0008307(structural constituent of muscle);GO:0030049(muscle filament sliding);GO:0043462(regulation of ATPase activity)","04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);05410(Hypertrophic cardiomyopathy (HCM));05414(Dilated cardiomyopathy (DCM))","mRNA","agilent G3 V3"]
["A_23_P74526",2.97,{"v":3.1,"d":"3.10"},3.03,4.87,4.58,4.78,{"v":0.639494026704146,"d":"0.64"},{"v":-0.644997211440424,"d":"-0.64"},"down",{"v":5.63679999999733e-05,"d":"0.00"},1,"yes","CATCCAGATGCTCCTGCGTTCTGATGTCGTGCCCATGACAGCAGAGAATTTCCGCTGCCT","FALSE","NM_203456","ref|NM_203456|ref|NM_001195007|ens|ENST00000474804|ens|ENST00000356511","PPIE","peptidylprolyl isomerase E (cyclophilin E)","ref|Homo sapiens peptidylprolyl isomerase E (cyclophilin E) (PPIE), transcript variant 2, mRNA [NM_203456]","chr1",40204552,40219379,"GO:0000166(nucleotide binding);GO:0000398(nuclear mRNA splicing, via spliceosome);GO:0000413(protein peptidyl-prolyl isomerization);GO:0003723(RNA binding);GO:0003755(peptidyl-prolyl cis-trans isomerase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-dependent);GO:0006457(protein folding);GO:0016018(cyclosporin A binding);GO:0045070(positive regulation of viral genome replication);GO:0071013(catalytic step 2 spliceosome)","03040(Spliceosome)","mRNA","agilent G3 V3"]
["A_33_P3373750",3.16,3.34,2.93,{"v":5.4,"d":"5.40"},5.56,5.46,{"v":0.574299634591961,"d":"0.57"},{"v":-0.800124451102708,"d":"-0.80"},"down",{"v":5.63679999999733e-05,"d":"0.00"},1,"yes","TTGAGTTGAAGATTGTCATGGAATAAAGATCACACCGTACTTGAGGCCATCTTCATGTAA","FALSE","NM_014299","ref|NM_014299|tc|THC2605886","BRD4","bromodomain containing 4","ref|Homo sapiens bromodomain containing 4 (BRD4), transcript variant short, mRNA [NM_014299]","chr19",15357868,15391262,"GO:0000083(regulation of transcription involved in G1/S phase of mitotic cell cycle);GO:0000790(nuclear chromatin);GO:0000794(condensed nuclear chromosome);GO:0001833(inner cell mass cell proliferation);GO:0002039(p53 binding);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0005737(cytoplasm);GO:0006338(chromatin remodeling);GO:0006351(transcription, DNA-dependent);GO:0006468(protein phosphorylation);GO:0006974(response to DNA damage stimulus);GO:0007059(chromosome segregation);GO:0008024(positive transcription elongation factor complex b);GO:0010971(positive regulation of G2/M transition of mitotic cell cycle);GO:0016032(viral reproduction);GO:0032968(positive regulation of transcription elongation from RNA polymerase II promoter);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB cascade);GO:0043388(positive regulation of DNA binding);GO:0043983(histone H4-K12 acetylation);GO:0044154(histone H3-K14 acetylation);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0050727(regulation of inflammatory response);GO:0070577(histone acetyl-lysine binding);GO:2000002(negative regulation of DNA damage checkpoint)",null,"mRNA","agilent G3 V3"]
["A_23_P109821",6.82,6.88,6.53,8.73,8.81,8.75,{"v":0.769494104222138,"d":"0.77"},{"v":-0.378017822059763,"d":"-0.38"},"down",{"v":5.65299999999436e-05,"d":"0.00"},1,"yes","TCCCCTTCAAGGACTTCTCCCTTGTGGTTTTGTAAAGTGCAAACTTAAGAATAAAGTGAC","FALSE","NM_006354","ref|NM_006354|ref|NM_001278270|ref|NR_103488|ens|ENST00000492103","TADA3","transcriptional adaptor 3","ref|Homo sapiens transcriptional adaptor 3 (TADA3), transcript variant 1, mRNA [NM_006354]","chr3",{"v":9821651,"d":"9821651.00"},9829767,"GO:0001932(regulation of protein phosphorylation);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0003713(transcription coactivator activity);GO:0004402(histone acetyltransferase activity);GO:0005515(protein binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005671(Ada2/Gcn5/Ada3 transcription activator complex);GO:0006325(chromatin organization);GO:0006351(transcription, DNA-dependent);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0007067(mitosis);GO:0010628(positive regulation of gene expression);GO:0016922(ligand-dependent nuclear receptor binding);GO:0019904(protein domain specific binding);GO:0030374(ligand-dependent nuclear receptor transcription coactivator activity);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0030914(STAGA complex);GO:0031063(regulation of histone deacetylation);GO:0031647(regulation of protein stability);GO:0033276(transcription factor TFTC complex);GO:0043966(histone H3 acetylation);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0072686(mitotic spindle);GO:0090043(regulation of tubulin deacetylation)",null,"mRNA","agilent G3 V3"]
["A_23_P112412",3.51,3.17,3.35,5.18,5.19,5.13,{"v":0.647096774193548,"d":"0.65"},{"v":-0.627946609549419,"d":"-0.63"},"down",{"v":5.65489999999613e-05,"d":"0.00"},1,"yes","GTGTTCAGGAACAGTGGCTCACAGACTTACATTACTGCTTTAACGTGTATATCACTGGGC","FALSE","NM_017746","ref|NM_017746|ref|NM_001161584|ens|ENST00000477648|ens|ENST00000374902","TEX10","testis expressed 10","ref|Homo sapiens testis expressed 10 (TEX10), transcript variant 1, mRNA [NM_017746]","chr9",103064360,103114853,"GO:0005515(protein binding);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0016021(integral to membrane);GO:0031965(nuclear membrane);GO:0071339(MLL1 complex)",null,"mRNA","agilent G3 V3"]
["A_21_P0011466",1.98,1.98,2.12,5.65,5.38,5.04,{"v":0.378344741754823,"d":"0.38"},{"v":-1.40222670023151,"d":"-1.40"},"down",{"v":5.65559999999854e-05,"d":"0.00"},1,"yes","ATCAGATCTTAGCTGTGCATTTGTTGCAAGCAGTCCTTCGGTCATGGGACAAGACCAAAA","FALSE","ENST00000570151","ens|ENST00000570151|ens|ENST00000562687|linc|TCONS_l2_00010107|linc|TCONS_l2_00010106",null,null,"ens|hect domain and RLD 2 pseudogene 4 [Source:HGNC Symbol;Acc:HGNC:4872] [ENST00000570151]","chr16",32163436,32164315,null,null,"mRNA","agilent G3 V3"]
["A_23_P142322",5.84,5.16,5.35,9.24,9.39,9.49,{"v":0.581436699857752,"d":"0.58"},{"v":-0.78230595868709,"d":"-0.78"},"down",{"v":5.66199999999517e-05,"d":"0.00"},1,"yes","TCAAGATCGTCCTTCCAATGGCTGTGTGTTTAAAGATTGTGGGAGCTTCGCTGAACGTTA","FALSE","NM_001280","ref|NM_001280|ref|NM_001300829|ens|ENST00000593128|ens|ENST00000585630","CIRBP","cold inducible RNA binding protein","ref|Homo sapiens cold inducible RNA binding protein (CIRBP), transcript variant 1, mRNA [NM_001280]","chr19",{"v":1269334,"d":"1269334.00"},1274806,"GO:0000166(nucleotide binding);GO:0003730(mRNA 3'-UTR binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0009409(response to cold);GO:0009411(response to UV);GO:0010494(cytoplasmic stress granule);GO:0017148(negative regulation of translation);GO:0030371(translation repressor activity);GO:0034063(stress granule assembly);GO:0045727(positive regulation of translation);GO:0048255(mRNA stabilization);GO:0070181(SSU rRNA binding)",null,"mRNA","agilent G3 V3"]
["A_23_P131050",10.23,10.09,10.17,9.18,9.16,9.27,{"v":1.10431003259689,"d":"1.10"},{"v":0.143145262421679,"d":"0.14"},"up",{"v":5.69269999999289e-05,"d":"0.00"},1,"yes","CAGACATTAGAAAGAAAAAGCCTCACAGATTTGAAGAACTGGACCCCCAAATCAACTCAC","FALSE","NM_030924","ref|NM_030924|ref|NM_001289177|ref|NM_001289178|ref|NM_001289179","ACSBG2","acyl-CoA synthetase bubblegum family member 2","ref|Homo sapiens acyl-CoA synthetase bubblegum family member 2 (ACSBG2), transcript variant 2, mRNA [NM_030924]","chr19",{"v":6135710,"d":"6135710.00"},6193112,"GO:0001676(long-chain fatty acid metabolic process);GO:0004467(long-chain fatty acid-CoA ligase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006631(fatty acid metabolic process);GO:0007275(multicellular organismal development);GO:0007283(spermatogenesis);GO:0016020(membrane);GO:0030154(cell differentiation);GO:0047617(acyl-CoA hydrolase activity)","01212(Fatty acid metabolism);00061(Fatty acid biosynthesis);00071(Fatty acid degradation);04920(Adipocytokine signaling pathway);03320(PPAR signaling pathway)","mRNA","agilent G3 V3"]
["A_33_P3288189",2.76,2.94,2.81,5.18,4.95,4.82,{"v":0.569230769230769,"d":"0.57"},{"v":-0.812914447399505,"d":"-0.81"},"down",{"v":5.69670000000189e-05,"d":"0.00"},1,"yes","CAGAAGTCTGAACAATTGGATAAATTTGACTTCCAAGACAGCTAAACTTTTCAACTGCAA","FALSE","NM_014899","ref|NM_014899|ens|ENST00000379982|tc|THC2550943|tc|THC2531617","RHOBTB3","Rho-related BTB domain containing 3","ref|Homo sapiens Rho-related BTB domain containing 3 (RHOBTB3), mRNA [NM_014899]","chr5",95066880,95132071,"GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005525(GTP binding);GO:0005794(Golgi apparatus);GO:0007264(small GTPase mediated signal transduction);GO:0008152(metabolic process);GO:0016887(ATPase activity);GO:0017137(Rab GTPase binding);GO:0042147(retrograde transport, endosome to Golgi);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3258146",7.58,7.68,{"v":7.7,"d":"7.70"},6.13,6.15,6.35,{"v":1.23242082662373,"d":"1.23"},{"v":0.30149496773405,"d":"0.30"},"up",{"v":5.69859999999256e-05,"d":"0.00"},1,"yes","ATGTAAGTAGGCCTTTCCCTGAGCTCTGTGAGCTGCTCTAGCGAATTATTCAAGTGTTAG","FALSE","NM_001258000","ref|NM_001258000|ens|ENST00000619243|ens|ENST00000624008|gb|AK295550","LOC100130539","uncharacterized LOC100130539","ref|Homo sapiens uncharacterized LOC100130539 (LOC100130539), mRNA [NM_001258000]","chr10",44788196,44790097,null,null,"mRNA","agilent G3 V3"]
["A_33_P3249081",{"v":10.2,"d":"10.20"},10.14,10.08,{"v":9.1,"d":"9.10"},9.22,9.22,{"v":1.10457516339869,"d":"1.10"},{"v":0.143491593589533,"d":"0.14"},"up",{"v":5.71400000000111e-05,"d":"0.00"},1,"yes","GAAGTACTGACTTTACCAAAAGAATCATCAAGAAAGCTATTTATATAAACCCCCTCAGTC","FALSE","NM_015082","ref|NM_015082|ens|ENST00000265342|gb|AB028984|tc|THC2666328","FSTL4","follistatin-like 4","ref|Homo sapiens follistatin-like 4 (FSTL4), mRNA [NM_015082]","chr5",132532144,132948255,"GO:0005509(calcium ion binding);GO:0005576(extracellular region)",null,"mRNA","agilent G3 V3"]
["A_23_P115356",4.65,4.63,4.83,7.85,8.29,7.74,{"v":0.590871021775544,"d":"0.59"},{"v":-0.759084848667541,"d":"-0.76"},"down",{"v":5.72319999999626e-05,"d":"0.00"},1,"yes","CTTGGCCTTAAGCTGACTTAGAAGGGTTTTTCTGAATTGTCTAGATCCATGCATTATTTT","FALSE","NM_003689","ref|NM_003689|ens|ENST00000235835|gb|Y16675|gb|AF026947","AKR7A2","aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)","ref|Homo sapiens aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) (AKR7A2), mRNA [NM_003689]","chr1",19630780,19634999,"GO:0004032(alditol:NADP+ 1-oxidoreductase activity);GO:0005739(mitochondrion);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005975(carbohydrate metabolic process);GO:0006081(cellular aldehyde metabolic process);GO:0006805(xenobiotic metabolic process);GO:0009055(electron carrier activity);GO:0019119(phenanthrene-9,10-epoxide hydrolase activity);GO:0044281(small molecule metabolic process);GO:0044597(daunorubicin metabolic process);GO:0044598(doxorubicin metabolic process);GO:0055114(oxidation-reduction process);GO:0070062(extracellular vesicular exosome)","00980(Metabolism of xenobiotics by cytochrome P450)","mRNA","agilent G3 V3"]
["A_33_P3230037",14.52,14.58,14.47,13.33,13.42,13.51,{"v":1.08221559860904,"d":"1.08"},{"v":0.113987940993828,"d":"0.11"},"up",{"v":5.73229999999425e-05,"d":"0.00"},1,"yes","TGACCCCCCCACCTCCCTCCTGGACGAGGCAGCTGGCCGGGCGGGGGGCTGACCCCCCCC","FALSE","AF336885","gb|AF336885|tc|NP316843",null,null,"gb|Homo sapiens FKSG58 (FKSG58) mRNA, complete cds. [AF336885]",{"$nulls":5},"mRNA","agilent G3 V3"]
["A_23_P16157",8.34,8.64,8.48,10.98,10.83,10.65,{"v":0.784349969192853,"d":"0.78"},{"v":-0.350430580646614,"d":"-0.35"},"down",{"v":5.73669999999193e-05,"d":"0.00"},1,"yes","TCAAAATTGGGATCCTTCCATGTTGAGCCAGCCAGAGAAGATAGCGAGATCTAAATCTCT","FALSE","NM_003685","ref|NM_003685|ens|ENST00000398148|ref|XM_005259668|gb|U69126","KHSRP","KH-type splicing regulatory protein","ref|Homo sapiens KH-type splicing regulatory protein (KHSRP), mRNA [NM_003685]","chr19",{"v":6413976,"d":"6413976.00"},6416823,"GO:0000375(RNA splicing, via transesterification reactions);GO:0003677(DNA binding);GO:0003729(mRNA binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0006397(mRNA processing);GO:0006402(mRNA catabolic process);GO:0008380(RNA splicing);GO:0010467(gene expression);GO:0010494(cytoplasmic stress granule);GO:0016020(membrane);GO:0051028(mRNA transport);GO:2000628(regulation of miRNA metabolic process)",null,"mRNA","agilent G3 V3"]
["A_23_P21618",{"v":1.9,"d":"1.90"},2.02,1.98,4.24,4.51,4.09,{"v":0.459501557632399,"d":"0.46"},{"v":-1.1218583428731,"d":"-1.12"},"down",{"v":5.74230000000009e-05,"d":"0.00"},1,"yes","TTTTAATGGAACCCTATTTTATAATGGTACGTTACTGAATGTGTTTCATATGCGTGACCG","FALSE","NM_015009","ref|NM_015009|ref|NM_001303139|ref|NM_001303142|ref|NM_001303140","PDZRN3","PDZ domain containing ring finger 3","ref|Homo sapiens PDZ domain containing ring finger 3 (PDZRN3), transcript variant 1, mRNA [NM_015009]","chr3",73432048,73523783,"GO:0004842(ubiquitin-protein ligase activity);GO:0007528(neuromuscular junction development);GO:0008270(zinc ion binding);GO:0016567(protein ubiquitination);GO:0016874(ligase activity);GO:0031594(neuromuscular junction)",null,"mRNA","agilent G3 V3"]
["A_33_P3373119",8.79,8.79,8.66,7.49,7.37,7.56,{"v":1.17038358608385,"d":"1.17"},{"v":0.226981441812657,"d":"0.23"},"up",{"v":5.74620000000081e-05,"d":"0.00"},1,"yes","ACCCATGGTACAAGGAAACCTTTGGGTCAGACCCAAACTGCCTCAGTGGCTCCCTTCCCA","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_23_P353056",9.52,9.71,9.52,8.06,{"v":7.9,"d":"7.90"},7.84,{"v":1.20798319327731,"d":"1.21"},{"v":0.272600382523794,"d":"0.27"},"up",{"v":5.74700000000039e-05,"d":"0.00"},1,"yes","AGCCTTCCCCAGAGAGATGGCTTTAGGGGCTTTATTTAAAGACTGTGATGATGGAGCCAC","FALSE","NM_014807","ref|NM_014807|ref|NM_001290474|ens|ENST00000525598|ref|XM_005271740","C2CD2L","C2CD2-like","ref|Homo sapiens C2CD2-like (C2CD2L), transcript variant 1, mRNA [NM_014807]","chr11",118981768,118987831,"GO:0003674(molecular_function);GO:0005575(cellular_component);GO:0008150(biological_process);GO:0016021(integral to membrane);GO:0035774(positive regulation of insulin secretion involved in cellular response to glucose stimulus);GO:0043559(insulin binding)",null,"mRNA","agilent G3 V3"]
["A_32_P528311",8.69,8.61,8.53,9.64,9.75,9.77,{"v":0.885802469135802,"d":"0.89"},{"v":-0.174943076208937,"d":"-0.17"},"down",{"v":5.74749999999735e-05,"d":"0.00"},1,"yes","TCCAACCTGCTCACCCTGTGGCTCTTCTCCAACAACCTCTCCACCATCTACCCGGGCACT","FALSE","NM_178570","ref|NM_178570|ens|ENST00000335099|gb|DQ864979|gb|AF532858","RTN4RL2","reticulon 4 receptor-like 2","ref|Homo sapiens reticulon 4 receptor-like 2 (RTN4RL2), mRNA [NM_178570]","chr11",57228340,57236103,"GO:0004872(receptor activity);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0031103(axon regeneration);GO:0045121(membrane raft);GO:0046658(anchored to plasma membrane);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3854217",7.63,7.57,7.59,7.24,7.21,7.24,{"v":1.05071461502997,"d":"1.05"},{"v":0.0713708715930232,"d":"0.07"},"up",{"v":5.74890000000217e-05,"d":"0.00"},1,"yes","AGGTTTCCTCTTTAAACCTGTCTGGTGGGCCCCCAGATATCCTCACCTCAGGGCCTCCTT","FALSE","NM_024874","ref|NM_024874|ens|ENST00000325722|ref|XR_246296|ref|XM_006710909","KIAA0319L","KIAA0319-like","ref|Homo sapiens KIAA0319-like (KIAA0319L), mRNA [NM_024874]","chr1",35900904,35909831,"GO:0005515(protein binding);GO:0016021(integral to membrane);GO:0031410(cytoplasmic vesicle);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P217958",3.07,3.15,3.22,5.92,6.02,6.44,{"v":0.513601741022851,"d":"0.51"},{"v":-0.961278001927193,"d":"-0.96"},"down",{"v":5.76909999999708e-05,"d":"0.00"},1,"yes","GTGGCATCCATTTCTAATGTATGCATTCATCCAACAGAGTTATTTATTGGCTGGAGATGG","FALSE","NM_033500","ref|NM_033500|ref|NM_033498|ref|NM_033497|ref|NM_000188","HK1","hexokinase 1","ref|Homo sapiens hexokinase 1 (HK1), transcript variant 5, mRNA [NM_033500]","chr10",71075608,71161635,"GO:0001678(cellular glucose homeostasis);GO:0004340(glucokinase activity);GO:0004396(hexokinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005829(cytosol);GO:0005975(carbohydrate metabolic process);GO:0006096(glycolysis);GO:0008645(hexose transport);GO:0008865(fructokinase activity);GO:0009405(pathogenesis);GO:0015758(glucose transport);GO:0019158(mannokinase activity);GO:0019318(hexose metabolic process);GO:0044281(small molecule metabolic process);GO:0045121(membrane raft);GO:0046835(carbohydrate phosphorylation);GO:0051156(glucose 6-phosphate metabolic process);GO:0055085(transmembrane transport);GO:0097228(sperm principal piece)","01200(Carbon metabolism);00010(Glycolysis / Gluconeogenesis);00051(Fructose and mannose metabolism);00052(Galactose metabolism);00500(Starch and sucrose metabolism);00520(Amino sugar and nucleotide sugar metabolism);00524(Butirosin and neomycin biosynthesis);04066(HIF-1 signaling pathway);04910(Insulin signaling pathway);04973(Carbohydrate digestion and absorption);05230(Central carbon metabolism in cancer);04930(Type II diabetes mellitus)","mRNA","agilent G3 V3"]
["A_23_P393607",3.47,3.24,2.96,6.56,6.25,6.55,{"v":0.49948347107438,"d":"0.50"},{"v":-1.00149115779775,"d":"-1.00"},"down",{"v":5.78079999999925e-05,"d":"0.00"},1,"yes","TTTGAGGGCATCCTATAAACACCCAACTGTTCTTTTATCGTCTCGGTTTTAGCCAAAAGT","FALSE","NM_053052","ref|NM_053052|ens|ENST00000366759|ens|ENST00000617596|ens|ENST00000366760","SNAP47","synaptosomal-associated protein, 47kDa","ref|Homo sapiens synaptosomal-associated protein, 47kDa (SNAP47), mRNA [NM_053052]","chr1",227922704,227968927,"GO:0005484(SNAP receptor activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0012505(endomembrane system);GO:0016082(synaptic vesicle priming);GO:0019905(syntaxin binding);GO:0030425(dendrite);GO:0031083(BLOC-1 complex);GO:0031201(SNARE complex);GO:0031629(synaptic vesicle fusion to presynaptic membrane);GO:0043025(neuronal cell body);GO:0048471(perinuclear region of cytoplasm);GO:0060291(long-term synaptic potentiation)",null,"mRNA","agilent G3 V3"]
["A_23_P502930",8.94,{"v":9,"d":"9.00"},8.98,10.35,10.15,10.15,{"v":0.878303425774878,"d":"0.88"},{"v":-0.187208663967827,"d":"-0.19"},"down",{"v":5.78179999999318e-05,"d":"0.00"},1,"yes","ATGGGGGGTGGATGATTTGCACTTTGGTTCCCTGTGTTTTGATTTCTCATTAAAGTTCCT","FALSE","NM_006712","ref|NM_006712|ref|NM_001258461|ref|NM_033015|ens|ENST00000460980","FASTK","Fas-activated serine/threonine kinase","ref|Homo sapiens Fas-activated serine/threonine kinase (FASTK), transcript variant 1, mRNA [NM_006712]","chr7",150773712,150777880,"GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0006468(protein phosphorylation);GO:0033867(Fas-activated serine/threonine kinase activity);GO:0043484(regulation of RNA splicing);GO:0097190(apoptotic signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_23_P334709",8.07,7.84,7.73,10.49,10.17,10.36,{"v":0.762088974854932,"d":"0.76"},{"v":-0.391968650858558,"d":"-0.39"},"down",{"v":5.79659999999649e-05,"d":"0.00"},1,"yes","TACTGATGTAGCCCTGAGGTAGTTCATGAAAATGCTGTGCACTCATTCCATGGAATAAAT","FALSE","NM_007270","ref|NM_007270|ref|NM_001284341|ref|NM_001284343|ref|NR_027339","FKBP9","FK506 binding protein 9, 63 kDa","ref|Homo sapiens FK506 binding protein 9, 63 kDa (FKBP9), transcript variant 1, mRNA [NM_007270]","chr7",32997086,33046456,"GO:0000413(protein peptidyl-prolyl isomerization);GO:0003755(peptidyl-prolyl cis-trans isomerase activity);GO:0005509(calcium ion binding);GO:0005528(FK506 binding);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006457(protein folding);GO:0061077(chaperone-mediated protein folding)",null,"mRNA","agilent G3 V3"]
["A_23_P117363",10.65,10.76,10.76,11.41,11.43,11.46,{"v":0.937900874635569,"d":"0.94"},{"v":-0.092492640407436,"d":"-0.09"},"down",{"v":5.79880000000088e-05,"d":"0.00"},1,"yes","TTGGAGAGCGGGAGGTTTCCCCCAATCTCCTCCAAGTTCTTCTCCCTCCAACCAGAGTTG","FALSE","NM_001756","ref|NM_001756|ens|ENST00000341584|ens|ENST00000621384|ens|ENST00000555056","SERPINA6","serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6","ref|Homo sapiens serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 (SERPINA6), mRNA [NM_001756]","chr14",94770584,94789731,"GO:0004867(serine-type endopeptidase inhibitor activity);GO:0005496(steroid binding);GO:0005615(extracellular space);GO:0006810(transport);GO:0008211(glucocorticoid metabolic process);GO:0010951(negative regulation of endopeptidase activity);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3275959",8.38,8.37,{"v":8.1,"d":"8.10"},10.44,10.25,10.49,{"v":0.796985246953175,"d":"0.80"},{"v":-0.327375076248136,"d":"-0.33"},"down",{"v":5.80580000000275e-05,"d":"0.00"},1,"yes","CAGTAACAATCTGATCTCTCTTGCTTTTCCCCACAGGTTGTCATTACTTAATTATTTAAG","FALSE","BC001407","gb|BC001407|tc|THC2482567","SLC25A16","solute carrier family 25 (mitochondrial carrier), member 16","gb|Homo sapiens solute carrier family 25 (mitochondrial carrier; Graves disease autoantigen), member 16, mRNA (cDNA clone IMAGE:3139311), with apparent retained intron. [BC001407]",{"$nulls":3},"GO:0005743(mitochondrial inner membrane);GO:0006766(vitamin metabolic process);GO:0006767(water-soluble vitamin metabolic process);GO:0006810(transport);GO:0009108(coenzyme biosynthetic process);GO:0015297(antiporter activity);GO:0015939(pantothenate metabolic process);GO:0016021(integral to membrane);GO:0044281(small molecule metabolic process);GO:0055085(transmembrane transport)",null,"mRNA","agilent G3 V3"]
["A_24_P13230",3.17,3.26,2.95,5.33,5.16,5.43,{"v":0.589195979899497,"d":"0.59"},{"v":-0.763180508028272,"d":"-0.76"},"down",{"v":5.80789999999887e-05,"d":"0.00"},1,"yes","CATTTGTAAATACATTGTTTGCAGGACGAAAACTTCTGAGTTACAGCTCAGGAAAAGCCT","FALSE","NM_002869","ref|NM_002869|ref|NM_001243718|ref|NM_001243719|ref|NM_198896","RAB6A","RAB6A, member RAS oncogene family","ref|Homo sapiens RAB6A, member RAS oncogene family (RAB6A), transcript variant 1, mRNA [NM_002869]","chr11",73386944,73472136,"GO:0000042(protein targeting to Golgi);GO:0000139(Golgi membrane);GO:0003924(GTPase activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0005829(cytosol);GO:0006890(retrograde vesicle-mediated transport, Golgi to ER);GO:0016020(membrane);GO:0018125(peptidyl-cysteine methylation);GO:0019003(GDP binding);GO:0019882(antigen processing and presentation);GO:0019904(protein domain specific binding);GO:0031410(cytoplasmic vesicle);GO:0031489(myosin V binding);GO:0032482(Rab protein signal transduction);GO:0034067(protein localization in Golgi apparatus);GO:0034498(early endosome to Golgi transport);GO:0042147(retrograde transport, endosome to Golgi);GO:0070062(extracellular vesicular exosome);GO:0072385(minus-end-directed organelle transport along microtubule)",null,"mRNA","agilent G3 V3"]
["A_23_P131816",8.75,8.78,8.85,7.93,7.87,{"v":8,"d":"8.00"},{"v":1.10840336134454,"d":"1.11"},{"v":0.148482991056239,"d":"0.15"},"up",{"v":5.81490000000073e-05,"d":"0.00"},1,"yes","ATCTGAAGCTAGAGGAATTGAAATCCTTTGTCCTACCCTCCTGGATGGTGGAGAAGATGA","FALSE","NM_052951","ref|NM_052951|ens|ENST00000372622|gb|AK314003|gb|HQ447713","DNTTIP1","deoxynucleotidyltransferase, terminal, interacting protein 1","ref|Homo sapiens deoxynucleotidyltransferase, terminal, interacting protein 1 (DNTTIP1), mRNA [NM_052951]","chr20",44422604,44440066,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent)",null,"mRNA","agilent G3 V3"]
["A_33_P3384260",2.58,3.02,2.73,5.82,5.49,5.68,{"v":0.490288404944085,"d":"0.49"},{"v":-1.02829745181867,"d":"-1.03"},"down",{"v":5.82230000000239e-05,"d":"0.00"},1,"yes","GCCATGCAGTTTACATGAGCTGTTCTGCAGCTCAAATTCCATTTTGTGAATGGGTTTTTT","FALSE","ENST00000546500","ens|ENST00000546500|ens|ENST00000551803|ens|ENST00000547566|ref|XR_245923","HNRNPA1","heterogeneous nuclear ribonucleoprotein A1","ens|heterogeneous nuclear ribonucleoprotein A1 [Source:HGNC Symbol;Acc:HGNC:5031] [ENST00000546500]","chr12",54679732,54680871,"GO:0000166(nucleotide binding);GO:0000398(nuclear mRNA splicing, via spliceosome);GO:0003697(single-stranded DNA binding);GO:0003723(RNA binding);GO:0003727(single-stranded RNA binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005681(spliceosomal complex);GO:0005737(cytoplasm);GO:0006397(mRNA processing);GO:0006405(RNA export from nucleus);GO:0008380(RNA splicing);GO:0010467(gene expression);GO:0016020(membrane);GO:0016032(viral reproduction);GO:0030529(ribonucleoprotein complex);GO:0045111(intermediate filament cytoskeleton);GO:0051028(mRNA transport);GO:0051168(nuclear export);GO:0051170(nuclear import);GO:0070062(extracellular vesicular exosome);GO:0071013(catalytic step 2 spliceosome)","03040(Spliceosome)","mRNA","agilent G3 V3"]
["A_23_P111487",2.59,3.02,2.72,5.12,{"v":5.2,"d":"5.20"},5.09,{"v":0.54055807916937,"d":"0.54"},{"v":-0.887478461149238,"d":"-0.89"},"down",{"v":5.83189999999734e-05,"d":"0.00"},1,"yes","GAGGAAGTGAAAAAGGAAGTCGCGTTTTTTAACAACTTCCTCACTGATGCTAAGCGCCCA","FALSE","NM_001128853","ref|NM_001128853|ref|NM_001128854|ref|NM_015908|ref|NM_001128852","SRRT","serrate, RNA effector molecule","ref|Homo sapiens serrate, RNA effector molecule (SRRT), transcript variant 4, mRNA [NM_001128853]","chr7",100485328,100486281,"GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0008283(cell proliferation);GO:0031053(primary miRNA processing);GO:0046685(response to arsenic-containing substance);GO:0097150(neuronal stem cell maintenance)",null,"mRNA","agilent G3 V3"]
["A_24_P292470",{"v":13.4,"d":"13.40"},{"v":13.4,"d":"13.40"},13.44,12.69,12.55,12.65,{"v":1.06202164159409,"d":"1.06"},{"v":0.0868131652968187,"d":"0.09"},"up",{"v":5.85060000000137e-05,"d":"0.00"},1,"yes","AACTCACCTCCAGGCCAGTACTTCAGCCCCCTCGACTGTATGATAAAGATGGTGGCCCAG","FALSE","NM_022803","ref|NM_022803|ens|ENST00000426995|gb|AB529052|gb|AK290630","UCP3","uncoupling protein 3 (mitochondrial, proton carrier)","ref|Homo sapiens uncoupling protein 3 (mitochondrial, proton carrier) (UCP3), transcript variant short, mRNA [NM_022803]","chr11",73711336,73720282,"GO:0000303(response to superoxide);GO:0001666(response to hypoxia);GO:0005215(transporter activity);GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0006629(lipid metabolic process);GO:0006631(fatty acid metabolic process);GO:0006839(mitochondrial transport);GO:0007568(aging);GO:0007584(response to nutrient);GO:0007585(respiratory gaseous exchange);GO:0009409(response to cold);GO:0014823(response to activity);GO:0015992(proton transport);GO:0016021(integral to membrane);GO:0017077(oxidative phosphorylation uncoupler activity);GO:0022904(respiratory electron transport chain);GO:0032868(response to insulin stimulus);GO:0032870(cellular response to hormone stimulus);GO:0044237(cellular metabolic process);GO:0044281(small molecule metabolic process);GO:0051384(response to glucocorticoid stimulus)",null,"mRNA","agilent G3 V3"]
["A_33_P3397743",9.81,9.77,9.87,8.73,8.69,8.86,{"v":1.12062404870624,"d":"1.12"},{"v":0.164302358395493,"d":"0.16"},"up",{"v":5.85109999999833e-05,"d":"0.00"},1,"yes","CAGTCCGTGGATGCAGGTTATCCCAAAATCATTGATGACCTCCCCGGAATTAGTAAAAAA","FALSE","ENST00000540293","ens|ENST00000540293",{"$nulls":3},"chr11",102622856,102624183,null,null,"mRNA","agilent G3 V3"]
["A_23_P147900",10.05,10.16,10.04,8.51,8.43,8.69,{"v":1.18025751072961,"d":"1.18"},{"v":0.239101663757742,"d":"0.24"},"up",{"v":5.85249999999204e-05,"d":"0.00"},1,"yes","CTTAACAGACTCTCTGGAAGAAAACTCCTAAAGAGATGCCCACCCATAATCAGAAGCAAA","FALSE","NM_007252","ref|NM_007252|ref|NM_001166018|ens|ENST00000403058|gb|U91935","POU6F2","POU class 6 homeobox 2","ref|Homo sapiens POU class 6 homeobox 2 (POU6F2), transcript variant 1, mRNA [NM_007252]","chr7",39446216,39504309,"GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-dependent);GO:0006366(transcription from RNA polymerase II promoter);GO:0007402(ganglion mother cell fate determination);GO:0007417(central nervous system development);GO:0007601(visual perception)",null,"mRNA","agilent G3 V3"]
["A_23_P311010",11.95,{"v":11.9,"d":"11.90"},11.87,10.91,11.06,10.93,{"v":1.08571428571429,"d":"1.09"},{"v":0.118644496498619,"d":"0.12"},"up",{"v":5.85789999999475e-05,"d":"0.00"},1,"yes","CAGAGAGGGCCACTTCTACCCCCCTAGGAGTCATACATCTGGCTACTTATTTGTTAAAAA","FALSE","NM_005840","ref|NM_005840|ens|ENST00000302805|tc|THC2615136","SPRY3","sprouty homolog 3 (Drosophila)","ref|Homo sapiens sprouty homolog 3 (Drosophila) (SPRY3), mRNA [NM_005840]","chrX",154997472,155012121,"GO:0003674(molecular_function);GO:0005737(cytoplasm);GO:0007275(multicellular organismal development);GO:0009966(regulation of signal transduction);GO:0016020(membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P29318",{"v":2.6,"d":"2.60"},3.13,2.67,5.93,{"v":6.1,"d":"6.10"},6.19,{"v":0.461031833150384,"d":"0.46"},{"v":-1.11706172613593,"d":"-1.12"},"down",{"v":5.86299999999484e-05,"d":"0.00"},1,"yes","CTTTGGAGAACTTTTCCGAACACACTTCTTTCTCAACGCAGGAAACCTCTGCAACCTCAA","FALSE","NM_015380","ref|NM_015380|ens|ENST00000494795|ens|ENST00000474323|ens|ENST00000350028","SAMM50","SAMM50 sorting and assembly machinery component","ref|Homo sapiens SAMM50 sorting and assembly machinery component (SAMM50), mRNA [NM_015380]","chr22",44351424,44392405,"GO:0001401(mitochondrial sorting and assembly machinery complex);GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005743(mitochondrial inner membrane);GO:0006626(protein targeting to mitochondrion);GO:0016021(integral to membrane);GO:0044267(cellular protein metabolic process);GO:0045040(protein import into mitochondrial outer membrane);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P414895",10.62,10.74,10.65,9.46,9.26,9.43,{"v":1.13712255772647,"d":"1.14"},{"v":0.185387754577989,"d":"0.19"},"up",{"v":5.8743999999944e-05,"d":"0.00"},1,"yes","TCTTCAAAAAACATTGACATCACAGAACACATAGATTTTGCCACCCCTATACAGCAGCCA","FALSE","NM_018259","ref|NM_018259|ens|ENST00000525135|ens|ENST00000039989|ref|XM_005253016","TTC17","tetratricopeptide repeat domain 17","ref|Homo sapiens tetratricopeptide repeat domain 17 (TTC17), mRNA [NM_018259]","chr11",43380492,43516483,"GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0015629(actin cytoskeleton);GO:0030041(actin filament polymerization)",null,"mRNA","agilent G3 V3"]
["A_33_P3225230",6.91,7.01,6.64,9.34,{"v":9.1,"d":"9.10"},9.17,{"v":0.744657732705541,"d":"0.74"},{"v":-0.425350623394191,"d":"-0.43"},"down",{"v":5.87989999999428e-05,"d":"0.00"},1,"yes","GGGGCTTGTCCTTCCTTTGCAGCTGTTTTGAATGTAGTTTTCCTTTTCTATTTATTTGCA","FALSE","NM_015260","ref|NM_015260|ref|NM_001297595|ref|NM_001297597|ens|ENST00000248054","SIN3B","SIN3 transcription regulator family member B","ref|Homo sapiens SIN3 transcription regulator family member B (SIN3B), transcript variant 1, mRNA [NM_015260]","chr19",16940218,16991164,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000805(X chromosome);GO:0000806(Y chromosome);GO:0001106(RNA polymerase II transcription corepressor activity);GO:0001741(XY body);GO:0003682(chromatin binding);GO:0004407(histone deacetylase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-dependent);GO:0007519(skeletal muscle tissue development);GO:0016575(histone deacetylation);GO:0016580(Sin3 complex);GO:0030849(autosome);GO:0044255(cellular lipid metabolic process);GO:0044281(small molecule metabolic process);GO:0048738(cardiac muscle tissue development)",null,"mRNA","agilent G3 V3"]
["A_23_P128706",5.99,6.32,{"v":5.8,"d":"5.80"},8.92,8.93,9.12,{"v":0.671486837226548,"d":"0.67"},{"v":-0.574568975285436,"d":"-0.57"},"down",{"v":5.88099999999647e-05,"d":"0.00"},1,"yes","AGGCCAGTGTGGTAACCTTACCTGTCTACCTGAACTTCACCCGTGCAGACCTCATCTTCA","FALSE","NM_001376","ref|NM_001376|ens|ENST00000360184|ens|ENST00000555062|gb|AB527134","DYNC1H1","dynein, cytoplasmic 1, heavy chain 1","ref|Homo sapiens dynein, cytoplasmic 1, heavy chain 1 (DYNC1H1), mRNA [NM_001376]","chr14",102430864,102517128,"GO:0000086(G2/M transition of mitotic cell cycle);GO:0000278(mitotic cell cycle);GO:0003777(microtubule motor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005868(cytoplasmic dynein complex);GO:0005874(microtubule);GO:0006810(transport);GO:0006996(organelle organization);GO:0007018(microtubule-based movement);GO:0007052(mitotic spindle organization);GO:0008152(metabolic process);GO:0016020(membrane);GO:0016887(ATPase activity);GO:0019886(antigen processing and presentation of exogenous peptide antigen via MHC class II);GO:0030175(filopodium);GO:0033962(cytoplasmic mRNA processing body assembly);GO:0034063(stress granule assembly);GO:0051959(dynein light intermediate chain binding);GO:0070062(extracellular vesicular exosome)","04145(Phagosome);04962(Vasopressin-regulated water reabsorption);05132(Salmonella infection)","mRNA","agilent G3 V3"]
["A_23_P109907",9.63,{"v":9.6,"d":"9.60"},9.42,11.11,11.21,11.34,{"v":0.851158645276292,"d":"0.85"},{"v":-0.232500037685682,"d":"-0.23"},"down",{"v":5.88139999999626e-05,"d":"0.00"},1,"yes","CACCTGTAATCACAGCACTTTGGGAGGCTAAGAATCACTTGAGACTAGGAGTTCAAGATC","FALSE","NM_175924","ref|NM_175924|ref|NM_001199799|ref|NM_001199800|ens|ENST00000344209","ILDR1","immunoglobulin-like domain containing receptor 1","ref|Homo sapiens immunoglobulin-like domain containing receptor 1 (ILDR1), transcript variant 2, mRNA [NM_175924]","chr3",121706752,121741051,"GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006898(receptor-mediated endocytosis);GO:0016021(integral to membrane);GO:0070506(high-density lipoprotein particle receptor activity);GO:0090277(positive regulation of peptide hormone secretion)",null,"mRNA","agilent G3 V3"]
["A_23_P214587",1.91,2.31,1.87,5.48,5.13,5.52,{"v":0.377557346559207,"d":"0.38"},{"v":-1.40523230524931,"d":"-1.41"},"down",{"v":5.88219999999584e-05,"d":"0.00"},1,"yes","ATTATCTCTAGATTGGTCCTTGTGAGGGGAGTTTTAAGAATCCAGAACATCTTGCTCTTG","FALSE","NM_003449","ref|NM_003449|ref|NM_001242783|ens|ENST00000327357|ens|ENST00000415923","TRIM26","tripartite motif containing 26","ref|Homo sapiens tripartite motif containing 26 (TRIM26), transcript variant 1, mRNA [NM_003449]","chr6",30152232,30181204,"GO:0003677(DNA binding);GO:0005575(cellular_component);GO:0005829(cytosol);GO:0008270(zinc ion binding);GO:0019221(cytokine-mediated signaling pathway);GO:0045087(innate immune response);GO:0046597(negative regulation of viral entry into host cell);GO:0046872(metal ion binding);GO:0051091(positive regulation of sequence-specific DNA binding transcription factor activity);GO:0060333(interferon-gamma-mediated signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_33_P3240182",7.47,7.44,7.49,7.11,7.06,{"v":7.1,"d":"7.10"},{"v":1.05312646920545,"d":"1.05"},{"v":0.0746786989842941,"d":"0.07"},"up",{"v":5.88339999999521e-05,"d":"0.00"},1,"yes","ATCCTGGTGACTCTGATACCAGATACAGCCCGTCCTTCCAAGGCCAGGTCACCATCTCAG","FALSE","ENST00000390626","ens|ENST00000390626|ens|ENST00000620764|gb|KJ424130|gb|L04331",null,null,"ens|immunoglobulin heavy variable 5-51 [Source:HGNC Symbol;Acc:HGNC:5659] [ENST00000390626]","chr14",107034728,107035221,null,null,"mRNA","agilent G3 V3"]
["A_23_P89931",9.12,9.05,8.98,9.88,9.87,9.95,{"v":0.914141414141414,"d":"0.91"},{"v":-0.129510732996404,"d":"-0.13"},"down",{"v":5.89199999999623e-05,"d":"0.00"},1,"yes","CAGATCAGTGGCTGACTCTGCCCGACTTCCTCTTTGGCACCTCCATTCCCTGTTGCTGAA","FALSE","NM_022752","ref|NM_022752|ens|ENST00000359044|ens|ENST00000222339|ens|ENST00000600245","ZNF574","zinc finger protein 574","ref|Homo sapiens zinc finger protein 574 (ZNF574), mRNA [NM_022752]","chr19",42580320,42585557,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3320393",10.82,10.96,10.74,12.02,11.99,12.04,{"v":0.902080443828017,"d":"0.90"},{"v":-0.148672002053157,"d":"-0.15"},"down",{"v":5.89300000000126e-05,"d":"0.00"},1,"yes","GCAGTGAACTGTGATTGTTCCACTACAGTCCAGCCTGGGTGACAGAGAAAAGAAAAAGAA","FALSE","NM_016065","ref|NM_016065|ens|ENST00000372940|ens|ENST00000372945|ens|ENST00000479005","MRPS16","mitochondrial ribosomal protein S16","ref|Homo sapiens mitochondrial ribosomal protein S16 (MRPS16), mRNA [NM_016065]","chr10",75008696,75012451,"GO:0003735(structural constituent of ribosome);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0005763(mitochondrial small ribosomal subunit);GO:0006412(translation);GO:0006996(organelle organization);GO:0032543(mitochondrial translation);GO:0070124(mitochondrial translational initiation);GO:0070125(mitochondrial translational elongation);GO:0070126(mitochondrial translational termination)","03010(Ribosome)","mRNA","agilent G3 V3"]
["A_24_P313334",9.08,8.97,8.97,8.19,8.25,8.16,{"v":1.09837398373984,"d":"1.10"},{"v":0.135369359099083,"d":"0.14"},"up",{"v":5.90040000000291e-05,"d":"0.00"},1,"yes","GGTTTTGGAATGGTCTTAAAAGATGTGAGGGTGTTAATCTAGGAAACTTCCCCCGTGAAA","FALSE","NM_001199877","ref|NM_001199877|ref|NM_001018108|ref|NM_001199875|ref|NM_001199876","SERF2","small EDRK-rich factor 2","ref|Homo sapiens small EDRK-rich factor 2 (SERF2), transcript variant 4, mRNA [NM_001199877]","chr15",44088340,44094280,"GO:0003674(molecular_function);GO:0005634(nucleus);GO:0005829(cytosol);GO:0008150(biological_process)",null,"mRNA","agilent G3 V3"]
["A_24_P396994",7.65,7.62,7.71,8.32,{"v":8.3,"d":"8.30"},8.39,{"v":0.918832467013195,"d":"0.92"},{"v":-0.122126259534857,"d":"-0.12"},"down",{"v":5.92379999999615e-05,"d":"0.00"},1,"yes","TATGCTCAGATATTCATCGTAAGTCTCCCTTCACCTGTTACAGAGTTTCAGATCGGTCAC","FALSE","NM_001690","ref|NM_001690|ens|ENST00000273398|gb|BC012169|gb|AF113129","ATP6V1A","ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A","ref|Homo sapiens ATPase, H+ transporting, lysosomal 70kDa, V1 subunit A (ATP6V1A), mRNA [NM_001690]","chr3",113465864,113530903,"GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0005765(lysosomal membrane);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0005902(microvillus);GO:0006810(transport);GO:0006879(cellular iron ion homeostasis);GO:0008286(insulin receptor signaling pathway);GO:0015991(ATP hydrolysis coupled proton transport);GO:0016324(apical plasma membrane);GO:0016469(proton-transporting two-sector ATPase complex);GO:0033180(proton-transporting V-type ATPase, V1 domain);GO:0033572(transferrin transport);GO:0046034(ATP metabolic process);GO:0046961(proton-transporting ATPase activity, rotational mechanism);GO:0051701(interaction with host);GO:0055085(transmembrane transport);GO:0070062(extracellular vesicular exosome);GO:0090382(phagosome maturation)","00190(Oxidative phosphorylation);04145(Phagosome);04966(Collecting duct acid secretion);04721(Synaptic vesicle cycle);05323(Rheumatoid arthritis);05110(Vibrio cholerae infection);05120(Epithelial cell signaling in Helicobacter pylori infection)","mRNA","agilent G3 V3"]
["A_23_P130064",6.08,5.96,5.86,7.62,7.44,7.45,{"v":0.795202132385606,"d":"0.80"},{"v":-0.330606469302537,"d":"-0.33"},"down",{"v":5.9287000000019e-05,"d":"0.00"},1,"yes","CCACTACTGGCTGCCAGCTCTCTTCACTGACCTCTACTCCCAGGAGATTACAGCTGAGGA","FALSE","NM_007241","ref|NM_007241|ens|ENST00000428788|ens|ENST00000573795|ens|ENST00000509989","SNF8","SNF8, ESCRT-II complex subunit","ref|Homo sapiens SNF8, ESCRT-II complex subunit (SNF8), mRNA [NM_007241]","chr2",229216832,229217931,"GO:0000814(ESCRT II complex);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006351(transcription, DNA-dependent);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0008134(transcription factor binding);GO:0016197(endosomal transport);GO:0031902(late endosome membrane);GO:0042803(protein homodimerization activity);GO:0043328(protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway);GO:0061024(membrane organization);GO:0070062(extracellular vesicular exosome)","04144(Endocytosis)","mRNA","agilent G3 V3"]
["A_24_P399500",11.76,11.81,11.75,11.17,11.15,11.24,{"v":1.05244338498212,"d":"1.05"},{"v":0.0737426272086427,"d":"0.07"},"up",{"v":5.94050000000124e-05,"d":"0.00"},1,"yes","CCCCTGAGGGCCTGAGGCATCCTGGGTCTCACTCGGCCCCCAAAAACTGATAAAAGAATA","FALSE","NM_174895","ref|NM_174895|ref|NM_001271830|ens|ENST00000311069|ref|XM_006722639","PCP2","Purkinje cell protein 2","ref|Homo sapiens Purkinje cell protein 2 (PCP2), transcript variant 1, mRNA [NM_174895]","chr19",{"v":7696501,"d":"7696501.00"},7698634,"GO:0005085(guanyl-nucleotide exchange factor activity);GO:0016056(rhodopsin mediated signaling pathway);GO:0030695(GTPase regulator activity);GO:0043025(neuronal cell body);GO:0043547(positive regulation of GTPase activity)",null,"mRNA","agilent G3 V3"]
["A_32_P41405",12.19,12.09,12.08,{"v":11.1,"d":"11.10"},10.96,11.11,{"v":1.09617123907145,"d":"1.10"},{"v":0.132473187406085,"d":"0.13"},"up",{"v":5.94149999999516e-05,"d":"0.00"},1,"yes","ATTTCGTTCTTTTGCTTTGTCTGTGTATTAGCTCTTTCCATTCTTTGCCCCCAGCATGAG","FALSE","NM_032361","ref|NM_032361|ref|NR_003615|ens|ENST00000506672|ens|ENST00000265097","THOC3","THO complex 3","ref|Homo sapiens THO complex 3 (THOC3), mRNA [NM_032361]","chr5",175387216,175395283,"GO:0000346(transcription export complex);GO:0000445(THO complex part of transcription export complex);GO:0003723(RNA binding);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0006397(mRNA processing);GO:0006406(mRNA export from nucleus);GO:0008380(RNA splicing);GO:0016607(nuclear speck);GO:0043231(intracellular membrane-bounded organelle);GO:0046784(intronless viral mRNA export from host nucleus)","03040(Spliceosome);03013(RNA transport)","mRNA","agilent G3 V3"]
["A_32_P172864",10.78,10.78,10.72,{"v":10.4,"d":"10.40"},10.38,10.39,{"v":1.03561116458133,"d":"1.04"},{"v":0.0504824236524124,"d":"0.05"},"up",{"v":5.94339999999693e-05,"d":"0.00"},1,"yes","GTTGACCAAATCCCATGGAGAAAAGACATCTCATTTGAGGTTCCCCTTCCTCTCATGTGT","FALSE","NM_001010883","ref|NM_001010883|ens|ENST00000483371|ens|ENST00000370035|gb|AK094905","FAM102B","family with sequence similarity 102, member B","ref|Homo sapiens family with sequence similarity 102, member B (FAM102B), mRNA [NM_001010883]","chr1",109167288,109181944,null,null,"mRNA","agilent G3 V3"]
["A_23_P55948",4.94,4.44,4.34,7.95,7.87,{"v":8,"d":"8.00"},{"v":0.575986565910999,"d":"0.58"},{"v":-0.795892931691302,"d":"-0.80"},"down",{"v":5.94349999999411e-05,"d":"0.00"},1,"yes","TGTCTCTTGCTCTTTCTTGGGCTTCTGTACAACTCAACTTGTATACACTGTGTACACACA","FALSE","NM_020719","ref|NM_020719|ens|ENST00000615927|gb|AB033031|ens|ENST00000418929","PRR12","proline rich 12","ref|Homo sapiens proline rich 12 (PRR12), mRNA [NM_020719]","chr19",50094900,50129696,"GO:0003677(DNA binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3229256",6.08,6.02,6.08,8.38,8.01,8.06,{"v":0.743558282208589,"d":"0.74"},{"v":-0.427482265645489,"d":"-0.43"},"down",{"v":5.94629999999263e-05,"d":"0.00"},1,"yes","TGGCATGGAAATACAGTGGGAAAACCAGTCGGGACCTTTAATAAAAGACCTTGGCTTTCT","FALSE","NM_014595","ref|NM_014595|ref|NM_001252377|ref|NR_045513|ens|ENST00000583655","NT5C","5', 3'-nucleotidase, cytosolic","ref|Homo sapiens 5', 3'-nucleotidase, cytosolic (NT5C), transcript variant 1, mRNA [NM_014595]","chr17",73126880,73127809,"GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006144(purine base metabolic process);GO:0006195(purine nucleotide catabolic process);GO:0006206(pyrimidine base metabolic process);GO:0008252(nucleotidase activity);GO:0008253(5'-nucleotidase activity);GO:0009223(pyrimidine deoxyribonucleotide catabolic process);GO:0016311(dephosphorylation);GO:0019103(pyrimidine nucleotide binding);GO:0044281(small molecule metabolic process);GO:0046135(pyrimidine nucleoside catabolic process);GO:0046872(metal ion binding);GO:0055086(nucleobase-containing small molecule metabolic process);GO:0070062(extracellular vesicular exosome)","00230(Purine metabolism);00240(Pyrimidine metabolism);00760(Nicotinate and nicotinamide metabolism)","mRNA","agilent G3 V3"]
["A_33_P3405957",2.67,2.85,2.87,4.03,{"v":4,"d":"4.00"},{"v":4.1,"d":"4.10"},{"v":0.691673536685903,"d":"0.69"},{"v":-0.531836834680687,"d":"-0.53"},"down",{"v":5.94659999999525e-05,"d":"0.00"},1,"yes","CTCCCTGCAGGCGGCTGGCCAGGTGGGCAGGTGCCAGCCGGAGCTGTAAATAGAGCGCTG","FALSE","NM_182557","ref|NM_182557|ref|XM_005271511|ref|XM_006718815|ref|XM_005271512","BCL9L","B-cell CLL/lymphoma 9-like","ref|Homo sapiens B-cell CLL/lymphoma 9-like (BCL9L), mRNA [NM_182557]","chr11",118768456,118796317,"GO:0003713(transcription coactivator activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006351(transcription, DNA-dependent);GO:0008013(beta-catenin binding);GO:0010718(positive regulation of epithelial to mesenchymal transition);GO:0022604(regulation of cell morphogenesis);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0035019(somatic stem cell maintenance);GO:0035914(skeletal muscle cell differentiation);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0060070(canonical Wnt receptor signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_33_P3274069",13.91,{"v":14,"d":"14.00"},{"v":13.9,"d":"13.90"},13.02,13.05,12.91,{"v":1.07260133401744,"d":"1.07"},{"v":0.101113952786247,"d":"0.10"},"up",{"v":5.95469999999931e-05,"d":"0.00"},1,"yes","CAGGAGAGGCCCCCCAGCATGCTGCCCTAGTACGTGTTTAGAATAAAAACCAGTTTGTTT","FALSE","NM_012265","ref|NM_012265|ens|ENST00000216085|ref|XM_006724224|ref|XM_005261504","RHBDD3","rhomboid domain containing 3","ref|Homo sapiens rhomboid domain containing 3 (RHBDD3), mRNA [NM_012265]","chr22",29656488,29660390,"GO:0000165(MAPK cascade);GO:0001889(liver development);GO:0002673(regulation of acute inflammatory response);GO:0004252(serine-type endopeptidase activity);GO:0006508(proteolysis);GO:0009410(response to xenobiotic stimulus);GO:0016021(integral to membrane);GO:0032815(negative regulation of natural killer cell activation);GO:0045732(positive regulation of protein catabolic process);GO:0050708(regulation of protein secretion)",null,"mRNA","agilent G3 V3"]
["A_33_P3329991",1.92,2.02,{"v":1.9,"d":"1.90"},5.05,5.65,5.16,{"v":0.368221941992434,"d":"0.37"},{"v":-1.44135249682396,"d":"-1.44"},"down",{"v":5.9562000000013e-05,"d":"0.00"},1,"yes","GAGTTACTCCGTTATAAAGTTGATGAAGCTGTAGCTATACTACAAGTCCATCAAGTTAAA","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_23_P164797",5.76,5.25,{"v":5.6,"d":"5.60"},8.48,8.65,{"v":8.4,"d":"8.40"},{"v":0.650607128867998,"d":"0.65"},{"v":-0.620141464444743,"d":"-0.62"},"down",{"v":5.96999999999959e-05,"d":"0.00"},1,"yes","TGAACCGGTGGTTGTCTGCGGGGAAGAGATGATAAAGAGCACGGGCACGGTCTGGTTCAT","FALSE","NM_016202","ref|NM_016202|ref|NM_207115|ref|NM_001163423|ens|ENST00000543039","ZNF580","zinc finger protein 580","ref|Homo sapiens zinc finger protein 580 (ZNF580), transcript variant 1, mRNA [NM_016202]","chr19",56154912,56156988,"GO:0001938(positive regulation of endothelial cell proliferation);GO:0002690(positive regulation of leukocyte chemotaxis);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0006935(chemotaxis);GO:0006954(inflammatory response);GO:0010595(positive regulation of endothelial cell migration);GO:0010628(positive regulation of gene expression);GO:0032757(positive regulation of interleukin-8 production);GO:0046872(metal ion binding);GO:0070301(cellular response to hydrogen peroxide)",null,"mRNA","agilent G3 V3"]
["A_22_P00013430",5.95,5.74,5.98,8.72,9.14,8.67,{"v":0.666038447041086,"d":"0.67"},{"v":-0.586322635677079,"d":"-0.59"},"down",{"v":6.007600000002e-05,"d":"0.00"},1,"yes","AAGGGATCGGGTTACCGTTGTATTCGCATCAACCATAAAATGGATCCTCTGATTGGACAG","FALSE","NM_001731","ref|NM_001731|ens|ENST00000256015|linc|lnc-RP11-24B21.1.1-1:1|gb|CR541782","BTG1","B-cell translocation gene 1, anti-proliferative","ref|Homo sapiens B-cell translocation gene 1, anti-proliferative (BTG1), mRNA [NM_001731]","chr12",92534056,92539673,"GO:0003712(transcription cofactor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-dependent);GO:0008285(negative regulation of cell proliferation);GO:0016477(cell migration);GO:0019899(enzyme binding);GO:0019900(kinase binding);GO:0030308(negative regulation of cell growth);GO:0045603(positive regulation of endothelial cell differentiation);GO:0045663(positive regulation of myoblast differentiation);GO:0045766(positive regulation of angiogenesis);GO:2000271(positive regulation of fibroblast apoptotic process)","03018(RNA degradation)","mRNA","agilent G3 V3"]
["A_23_P15357",{"v":14.1,"d":"14.10"},14.07,14.13,13.02,12.97,13.16,{"v":1.08045977011494,"d":"1.08"},{"v":0.111645355828909,"d":"0.11"},"up",{"v":6.01660000000281e-05,"d":"0.00"},1,"yes","GGGCCTTTGGTCAAATATTCTTCTGATTACTTCCAAGCCCCCTCTGACTACAGATACTAC","FALSE","NM_005567","ref|NM_005567|ens|ENST00000587251|ens|ENST00000586720|ens|ENST00000587311","LGALS3BP","lectin, galactoside-binding, soluble, 3 binding protein","ref|Homo sapiens lectin, galactoside-binding, soluble, 3 binding protein (LGALS3BP), mRNA [NM_005567]","chr17",76968848,76970878,"GO:0005044(scavenger receptor activity);GO:0005578(proteinaceous extracellular matrix);GO:0005615(extracellular space);GO:0006898(receptor-mediated endocytosis);GO:0006968(cellular defense response);GO:0007155(cell adhesion);GO:0007165(signal transduction);GO:0016020(membrane);GO:0031012(extracellular matrix);GO:0070062(extracellular vesicular exosome);GO:0072562(blood microparticle)",null,"mRNA","agilent G3 V3"]
["A_23_P73239",2.79,2.85,3.06,{"v":4.5,"d":"4.50"},4.51,4.64,{"v":0.637362637362638,"d":"0.64"},{"v":-0.649813645071124,"d":"-0.65"},"down",{"v":6.02210000000269e-05,"d":"0.00"},1,"yes","ATAGCATTCATCTGTGTGTAGATTATTTCATATAGGGAAGAGTTCTGATCTGTACCTATG","FALSE","NM_205842","ref|NM_205842|ref|NM_013436|ens|ENST00000360982|ref|XM_006712201","NCKAP1","NCK-associated protein 1","ref|Homo sapiens NCK-associated protein 1 (NCKAP1), transcript variant 2, mRNA [NM_205842]","chr2",183789584,183903586,"GO:0001701(in utero embryonic development);GO:0001756(somitogenesis);GO:0001843(neural tube closure);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005925(focal adhesion);GO:0006915(apoptotic process);GO:0007354(zygotic determination of anterior/posterior axis, embryo);GO:0007417(central nervous system development);GO:0007492(endoderm development);GO:0008078(mesodermal cell migration);GO:0010172(embryonic body morphogenesis);GO:0010592(positive regulation of lamellipodium assembly);GO:0016021(integral to membrane);GO:0016601(Rac protein signal transduction);GO:0030032(lamellipodium assembly);GO:0030950(establishment or maintenance of actin cytoskeleton polarity);GO:0031209(SCAR complex);GO:0031258(lamellipodium membrane);GO:0032403(protein complex binding);GO:0032880(regulation of protein localization);GO:0035050(embryonic heart tube development);GO:0038096(Fc-gamma receptor signaling pathway involved in phagocytosis);GO:0042074(cell migration involved in gastrulation);GO:0045087(innate immune response);GO:0045175(basal protein localization);GO:0045176(apical protein localization);GO:0048010(vascular endothelial growth factor receptor signaling pathway);GO:0048340(paraxial mesoderm morphogenesis);GO:0048365(Rac GTPase binding);GO:0048570(notochord morphogenesis);GO:0048617(embryonic foregut morphogenesis);GO:0050821(protein stabilization);GO:0070062(extracellular vesicular exosome);GO:2000601(positive regulation of Arp2/3 complex-mediated actin nucleation)","04810(Regulation of actin cytoskeleton)","mRNA","agilent G3 V3"]
["A_23_P326319",5.21,4.84,4.67,7.76,7.81,7.91,{"v":0.626916524701874,"d":"0.63"},{"v":-0.673654737053039,"d":"-0.67"},"down",{"v":6.02309999999662e-05,"d":"0.00"},1,"yes","TGTCCCGTCATTGGGTGGCATATGTTAACTAGCTGCCAAACAACTTCAACCCGTGTAATT","FALSE","NM_033201","ref|NM_033201|ref|NM_001142469|ens|ENST00000452191|ens|ENST00000300006","C16orf45","chromosome 16 open reading frame 45","ref|Homo sapiens chromosome 16 open reading frame 45 (C16orf45), transcript variant 1, mRNA [NM_033201]","chr16",15670991,15681214,"GO:0007026(negative regulation of microtubule depolymerization);GO:0015630(microtubule cytoskeleton);GO:0021822(negative regulation of cell motility involved in cerebral cortex radial glia guided migration)",null,"mRNA","agilent G3 V3"]
["A_24_P218074",15.22,15.26,15.17,15.87,15.91,15.82,{"v":0.959033613445378,"d":"0.96"},{"v":-0.0603467133237216,"d":"-0.06"},"down",{"v":6.02319999999379e-05,"d":"0.00"},1,"yes","GGATGCCCCCGCCGCCAAGCCCCTGGCCAGCGCGCCTGGCGGACCGGGCTGCGGCCCAGG","FALSE","NM_207336","ref|NM_207336|ens|ENST00000302017|ref|XM_006715864|ref|XM_006715865","ZNF467","zinc finger protein 467","ref|Homo sapiens zinc finger protein 467 (ZNF467), mRNA [NM_207336]","chr7",149461456,149470568,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P122852",6.92,6.68,6.69,9.19,9.04,8.84,{"v":0.74953823420761,"d":"0.75"},{"v":-0.415926022458305,"d":"-0.42"},"down",{"v":6.03599999999815e-05,"d":"0.00"},1,"yes","GGGCTCCAGCATCACTCCTCTGCCACCTTGGGGTGTGGGGCTGGATTAAAAGTCATTCAT","FALSE","NM_003078","ref|NM_003078|ref|NM_001003801|ref|NM_001003802|ens|ENST00000356800","SMARCD3","SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3","ref|Homo sapiens SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 (SMARCD3), transcript variant 2, mRNA [NM_003078]","chr7",150936064,150973820,"GO:0000790(nuclear chromatin);GO:0002052(positive regulation of neuroblast proliferation);GO:0003139(secondary heart field specification);GO:0003219(cardiac right ventricle formation);GO:0003407(neural retina development);GO:0003713(transcription coactivator activity);GO:0005102(receptor binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006337(nucleosome disassembly);GO:0006338(chromatin remodeling);GO:0006351(transcription, DNA-dependent);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0008134(transcription factor binding);GO:0016514(SWI/SNF complex);GO:0016922(ligand-dependent nuclear receptor binding);GO:0030374(ligand-dependent nuclear receptor transcription coactivator activity);GO:0035257(nuclear hormone receptor binding);GO:0042692(muscle cell differentiation);GO:0043393(regulation of protein binding);GO:0044255(cellular lipid metabolic process);GO:0044281(small molecule metabolic process);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0071564(npBAF complex);GO:0071565(nBAF complex)",null,"mRNA","agilent G3 V3"]
["A_23_P139795",13.78,13.84,13.81,12.38,12.33,12.58,{"v":1.11102172164119,"d":"1.11"},{"v":0.151887023205566,"d":"0.15"},"up",{"v":6.04599999999289e-05,"d":"0.00"},1,"yes","GAACCATCCCGTCCTGTATCATATGTAAATACTGTGAGGTGATGTGCCCACCCCTCTCTA","FALSE","NM_002442","ref|NM_002442|ens|ENST00000257552|ref|XM_006719404|gb|AB012851","MSI1","musashi RNA-binding protein 1","ref|Homo sapiens musashi RNA-binding protein 1 (MSI1), mRNA [NM_002442]","chr12",120779136,120806983,"GO:0000166(nucleotide binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005844(polysome);GO:0007399(nervous system development);GO:0008266(poly(U) RNA binding);GO:0009725(response to hormone stimulus);GO:0030855(epithelial cell differentiation)","03015(mRNA surveillance pathway)","mRNA","agilent G3 V3"]
["A_23_P95764",5.67,5.82,{"v":5.6,"d":"5.60"},7.19,{"v":7.1,"d":"7.10"},7.29,{"v":0.791936978683967,"d":"0.79"},{"v":-0.336542467811877,"d":"-0.34"},"down",{"v":6.05269999999214e-05,"d":"0.00"},1,"yes","ACCATCTGCTTGACTATGTAGCTTGGATTCTCCTTTGTACCTATCCCTTTCGATTTGGCT","FALSE","NM_002764","ref|NM_002764|ref|NM_001204402|ens|ENST00000372435|ens|ENST00000372428","PRPS1","phosphoribosyl pyrophosphate synthetase 1","ref|Homo sapiens phosphoribosyl pyrophosphate synthetase 1 (PRPS1), transcript variant 1, mRNA [NM_002764]","chrX",106871736,106894256,"GO:0000287(magnesium ion binding);GO:0004749(ribose phosphate diphosphokinase activity);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0005975(carbohydrate metabolic process);GO:0006015(5-phosphoribose 1-diphosphate biosynthetic process);GO:0006144(purine base metabolic process);GO:0006164(purine nucleotide biosynthetic process);GO:0006221(pyrimidine nucleotide biosynthetic process);GO:0007399(nervous system development);GO:0009156(ribonucleoside monophosphate biosynthetic process);GO:0009405(pathogenesis);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0034418(urate biosynthetic process);GO:0042803(protein homodimerization activity);GO:0044281(small molecule metabolic process);GO:0046101(hypoxanthine biosynthetic process)","01200(Carbon metabolism);01230(Biosynthesis of amino acids);00030(Pentose phosphate pathway);00230(Purine metabolism)","mRNA","agilent G3 V3"]
["A_24_P216313",2.97,3.01,3.49,6.59,6.74,{"v":7,"d":"7.00"},{"v":0.46581406787998,"d":"0.47"},{"v":-1.10217388437635,"d":"-1.10"},"down",{"v":6.05329999999737e-05,"d":"0.00"},1,"yes","CTGTAACACCTGTGAAGATGTGCGGGAGGCATATCGCCGTAGAGGCTGGGCCTTCAAGAA","FALSE","NM_015966","ref|NM_015966|ref|NM_198398|ens|ENST00000461043|ens|ENST00000489071","ERGIC3","ERGIC and golgi 3","ref|Homo sapiens ERGIC and golgi 3 (ERGIC3), transcript variant 2, mRNA [NM_015966]","chr20",34129832,34145404,"GO:0005789(endoplasmic reticulum membrane);GO:0005794(Golgi apparatus);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0016192(vesicle-mediated transport);GO:0033116(endoplasmic reticulum-Golgi intermediate compartment membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3243429",9.46,9.27,9.46,10.95,10.77,10.83,{"v":0.86605222734255,"d":"0.87"},{"v":-0.207474065482576,"d":"-0.21"},"down",{"v":6.05359999999999e-05,"d":"0.00"},1,"yes","TCCAGACCCCTGCACCTGCTGCCAGTTCTGTGCCCAGTCCCTGTGATGAAGCTTCCCCAA","FALSE","NM_206997","ref|NM_206997|ens|ENST00000312457|gb|BC119779|gb|AY569571","GPR152","G protein-coupled receptor 152","ref|Homo sapiens G protein-coupled receptor 152 (GPR152), mRNA [NM_206997]","chr11",67218768,67220200,"GO:0004930(G-protein coupled receptor activity);GO:0005886(plasma membrane);GO:0007186(G-protein coupled receptor signaling pathway);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P32847",12.37,12.44,12.42,11.33,11.23,11.43,{"v":1.09532215357458,"d":"1.10"},{"v":0.131355254309841,"d":"0.13"},"up",{"v":6.06229999999819e-05,"d":"0.00"},1,"yes","ACCTCCATAGACGTGTAAATAGCTTGTGCACAGATGACGACAGCCCCCATAAACAGTTTT","FALSE","NM_001510","ref|NM_001510|ref|NM_001286838|ens|ENST00000611049|ens|ENST00000282020","GRID2","glutamate receptor, ionotropic, delta 2","ref|Homo sapiens glutamate receptor, ionotropic, delta 2 (GRID2), transcript variant 1, mRNA [NM_001510]","chr4",93225808,94693649,"GO:0004970(ionotropic glutamate receptor activity);GO:0005234(extracellular-glutamate-gated ion channel activity);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0006810(transport);GO:0007157(heterophilic cell-cell adhesion);GO:0007215(glutamate receptor signaling pathway);GO:0008066(glutamate receptor activity);GO:0008328(ionotropic glutamate receptor complex);GO:0010975(regulation of neuron projection development);GO:0021707(cerebellar granule cell differentiation);GO:0030054(cell junction);GO:0030165(PDZ domain binding);GO:0030425(dendrite);GO:0034220(ion transmembrane transport);GO:0034613(cellular protein localization);GO:0035235(ionotropic glutamate receptor signaling pathway);GO:0035249(synaptic transmission, glutamatergic);GO:0043197(dendritic spine);GO:0043523(regulation of neuron apoptotic process);GO:0045202(synapse);GO:0045211(postsynaptic membrane);GO:0060079(regulation of excitatory postsynaptic membrane potential);GO:0060134(prepulse inhibition);GO:0097110(scaffold protein binding)","04080(Neuroactive ligand-receptor interaction);04730(Long-term depression)","mRNA","agilent G3 V3"]
["A_23_P112652",3.32,3.18,3.41,4.76,4.85,4.68,{"v":0.693491952414276,"d":"0.69"},{"v":-0.528048953909328,"d":"-0.53"},"down",{"v":6.06699999999849e-05,"d":"0.00"},1,"yes","ATTTACTGGCCATTTTAGTTGTATCACAGCAGAATGAATAAAAGATGGTGAAGGCTGTTA","FALSE","NM_015442","ref|NM_015442|ref|NM_001256742|ref|NM_001256741|ref|NR_046352","CNOT10","CCR4-NOT transcription complex, subunit 10","ref|Homo sapiens CCR4-NOT transcription complex, subunit 10 (CNOT10), transcript variant 1, mRNA [NM_015442]","chr3",32737040,32815204,"GO:0000288(nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay);GO:0000289(nuclear-transcribed mRNA poly(A) tail shortening);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0006417(regulation of translation);GO:0010467(gene expression);GO:0016020(membrane);GO:0030014(CCR4-NOT complex);GO:0031047(gene silencing by RNA)","03018(RNA degradation)","mRNA","agilent G3 V3"]
["A_23_P35399",4.74,4.66,5.06,8.07,7.96,8.44,{"v":0.590927666530445,"d":"0.59"},{"v":-0.758946549128272,"d":"-0.76"},"down",{"v":6.07209999999858e-05,"d":"0.00"},1,"yes","CGCTGTACCACGACATCTCGGGAGATACTTCAGGGGATTACCGGAAGATTCTGCTGAAGA","FALSE","NM_145869","ref|NM_145869|ref|NM_001278408|ref|NM_001278409|ref|NM_145868","ANXA11","annexin A11","ref|Homo sapiens annexin A11 (ANXA11), transcript variant c, mRNA [NM_145869]","chr10",81910648,81965328,"GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005544(calcium-dependent phospholipid binding);GO:0005635(nuclear envelope);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005819(spindle);GO:0006909(phagocytosis);GO:0007109(cytokinesis, completion of separation);GO:0008429(phosphatidylethanolamine binding);GO:0016020(membrane);GO:0023026(MHC class II protein complex binding);GO:0030496(midbody);GO:0042470(melanosome);GO:0042581(specific granule);GO:0042582(azurophil granule);GO:0044548(S100 protein binding);GO:0045335(phagocytic vesicle);GO:0048306(calcium-dependent protein binding);GO:0051592(response to calcium ion);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_21_P0000305",2.33,2.42,2.75,4.86,4.79,4.94,{"v":0.514050719671008,"d":"0.51"},{"v":-0.960017382534648,"d":"-0.96"},"down",{"v":6.10979999999817e-05,"d":"0.00"},1,"yes","GCTATCACATGCCGAACTTTCTTGTGACAAATGTCTGGATTTTTTAAAAAAGGAAAAAGC","FALSE","NM_024065","ref|NM_024065|ref|NR_002941|ens|ENST00000264254|gb|AK022267","PDCL3","phosducin-like 3","ref|Homo sapiens phosducin-like 3 (PDCL3), mRNA [NM_024065]","chr2",101179416,101193201,"GO:0001525(angiogenesis);GO:0001938(positive regulation of endothelial cell proliferation);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006457(protein folding);GO:0006915(apoptotic process);GO:0016032(viral reproduction);GO:0043184(vascular endothelial growth factor receptor 2 binding);GO:0044183(protein binding involved in protein folding);GO:0045766(positive regulation of angiogenesis);GO:0050730(regulation of peptidyl-tyrosine phosphorylation);GO:2000059(negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process)",null,"mRNA","agilent G3 V3"]
["A_33_P3383205",8.25,8.43,8.58,6.72,6.74,6.67,{"v":1.2548435171386,"d":"1.25"},{"v":0.327507466866212,"d":"0.33"},"up",{"v":6.12070000000076e-05,"d":"0.00"},1,"yes","AAAGGTCCTGGGGTATTCCTGGATCTTCAGGACATCTGCCTACCCTCAGGTTTCCCAGGC","FALSE","AB064667","gb|AB064667|tc|THC2487439","OK/SW-CL.58","OK/SW-CL.58","gb|Homo sapiens mRNA for OK/SW-CL.58, complete cds. [AB064667]","chr13",30162644,30167089,null,null,"mRNA","agilent G3 V3"]
["A_23_P113005",7.24,7.07,7.23,8.29,8.35,8.24,{"v":0.865755627009646,"d":"0.87"},{"v":-0.207968235586395,"d":"-0.21"},"down",{"v":6.12569999999257e-05,"d":"0.00"},1,"yes","ATGGAGAAAGAAGTGGAGACAGTCCTTTCCCACCATTCCTGCCTTTAAGCCAAAGAAACA","FALSE","NM_004428","ref|NM_004428|ref|NM_182685|ens|ENST00000469878|ens|ENST00000368407","EFNA1","ephrin-A1","ref|Homo sapiens ephrin-A1 (EFNA1), transcript variant 1, mRNA [NM_004428]","chr1",155103680,155106601,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000187(activation of MAPK activity);GO:0001525(angiogenesis);GO:0003180(aortic valve morphogenesis);GO:0003183(mitral valve morphogenesis);GO:0003199(endocardial cushion to mesenchymal transition involved in heart valve formation);GO:0005102(receptor binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0007267(cell-cell signaling);GO:0007411(axon guidance);GO:0010719(negative regulation of epithelial to mesenchymal transition);GO:0014028(notochord formation);GO:0016477(cell migration);GO:0033628(regulation of cell adhesion mediated by integrin);GO:0034446(substrate adhesion-dependent cell spreading);GO:0043535(regulation of blood vessel endothelial cell migration);GO:0045765(regulation of angiogenesis);GO:0046658(anchored to plasma membrane);GO:0046875(ephrin receptor binding);GO:0048013(ephrin receptor signaling pathway);GO:0050730(regulation of peptidyl-tyrosine phosphorylation);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0050770(regulation of axonogenesis);GO:0061002(negative regulation of dendritic spine morphogenesis);GO:0070062(extracellular vesicular exosome)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04151(PI3K-Akt signaling pathway);04360(Axon guidance)","mRNA","agilent G3 V3"]
["A_33_P3242039",7.85,7.96,7.78,8.84,8.89,8.82,{"v":0.888512241054614,"d":"0.89"},{"v":-0.170536442452053,"d":"-0.17"},"down",{"v":6.12819999999958e-05,"d":"0.00"},1,"yes","AACCTTTGCCTTCATGTCATTGATCTCCTTCTGGCTCCTCTTCTGGACTTCTGTGAAGAT","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_33_P3521643",7.75,7.46,7.54,9.41,9.24,9.32,{"v":0.813371469431534,"d":"0.81"},{"v":-0.298013708502771,"d":"-0.30"},"down",{"v":6.13199999999203e-05,"d":"0.00"},1,"yes","GGGGGAGAAGGTATTTTCGAGATAAAGCACAGGCACCACAAATAAAAGTCGTGAAGTTGC","FALSE","NM_001271618","ref|NM_001271618|ref|NM_017607|ens|ENST00000591938|ens|ENST00000263433","PPP1R12C","protein phosphatase 1, regulatory subunit 12C","ref|Homo sapiens protein phosphatase 1, regulatory subunit 12C (PPP1R12C), transcript variant 2, mRNA [NM_001271618]","chr19",55602284,55628927,"GO:0005515(protein binding);GO:0005737(cytoplasm)","04810(Regulation of actin cytoskeleton);04510(Focal adhesion);04921(Oxytocin signaling pathway);04270(Vascular smooth muscle contraction);05205(Proteoglycans in cancer)","mRNA","agilent G3 V3"]
["A_33_P3410251",4.38,4.49,3.97,7.23,7.12,7.09,{"v":0.598880597014925,"d":"0.60"},{"v":-0.739659703335469,"d":"-0.74"},"down",{"v":6.13269999999444e-05,"d":"0.00"},1,"yes","ATTGTATCTAGGAAGTAACTAACTTGCTTTTGATTTTACAGGCTCATAAGCGCAGGGACT","FALSE","ENST00000478701","ens|ENST00000478701|gb|AK090815|gb|AX746629|tc|THC2481240","UNC80","unc-80 homolog (C. elegans)","ens|unc-80 homolog (C. elegans) [Source:HGNC Symbol;Acc:HGNC:26582] [ENST00000478701]","chr2",210636720,210661271,"GO:0005886(plasma membrane);GO:0016021(integral to membrane);GO:0034220(ion transmembrane transport);GO:0055085(transmembrane transport)",null,"mRNA","agilent G3 V3"]
["A_33_P7278111",2.02,1.91,2.27,5.36,5.25,4.89,{"v":0.4,"d":"0.40"},{"v":-1.32192809488736,"d":"-1.32"},"down",{"v":6.15179999999826e-05,"d":"0.00"},1,"yes","TTGGTGGTAAAGGATTTTCTCCATGGCCTGAATTAAGACCATTAGAAAGCACCAGGCCGT","FALSE","NM_018407","ref|NM_018407|ens|ENST00000619747|ens|ENST00000445593|gb|AK311377","LAPTM4B","lysosomal protein transmembrane 4 beta","ref|Homo sapiens lysosomal protein transmembrane 4 beta (LAPTM4B), mRNA [NM_018407]","chr8",98787808,98864830,"GO:0005515(protein binding);GO:0006810(transport);GO:0012505(endomembrane system);GO:0016021(integral to membrane)","04142(Lysosome)","mRNA","agilent G3 V3"]
["A_32_P192545",5.53,{"v":5.2,"d":"5.20"},5.04,8.13,7.93,8.16,{"v":0.651114781172585,"d":"0.65"},{"v":-0.619016204903819,"d":"-0.62"},"down",{"v":6.15809999999772e-05,"d":"0.00"},1,"yes","ATTTGCCAGGCCCAATGCTTTAACCTTAAGCTGATATTTTTGCTTTAGATGTCAATCTCG","FALSE","NM_001006938","ref|NM_001006938|ref|NM_001006933|ref|NM_032926|ens|ENST00000622517","TCEAL6","transcription elongation factor A (SII)-like 6","ref|Homo sapiens transcription elongation factor A (SII)-like 6 (TCEAL6), mRNA [NM_001006938]","chrX",101395448,101397477,"GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent)",null,"mRNA","agilent G3 V3"]
["A_33_P3379157",7.07,6.84,6.98,8.27,8.36,8.24,{"v":0.839967832730197,"d":"0.84"},{"v":-0.251594015149798,"d":"-0.25"},"down",{"v":6.16339999999216e-05,"d":"0.00"},1,"yes","TGAGGCCTGACCACCTTGGGACACCTGCAAGACGACTCCAACCCAACAACAACCAGATGT","FALSE","NM_001271641","ref|NM_001271641|ref|NM_014341|ens|ENST00000471737|ens|ENST00000373627","MTCH1","mitochondrial carrier 1","ref|Homo sapiens mitochondrial carrier 1 (MTCH1), transcript variant 2, mRNA [NM_001271641]","chr6",36936688,36945449,"GO:0005515(protein binding);GO:0005622(intracellular);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0006810(transport);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0009966(regulation of signal transduction);GO:0016021(integral to membrane);GO:0043065(positive regulation of apoptotic process);GO:0045161(neuronal ion channel clustering)",null,"mRNA","agilent G3 V3"]
["A_33_P3239854",13.27,{"v":13.4,"d":"13.40"},13.34,12.43,12.29,12.38,{"v":1.07843665768194,"d":"1.08"},{"v":0.108941441837436,"d":"0.11"},"up",{"v":6.16369999999478e-05,"d":"0.00"},1,"yes","AGTTGCCCCTCCTTTTGTTTTGAGGGTTTTGTTTTTGTTCATTGGGGGGTTTTTGTTTTT","FALSE","NM_017758","ref|NM_017758|ens|ENST00000399138|ens|ENST00000490106|gb|AK311511","ALKBH5","AlkB family member 5, RNA demethylase","ref|Homo sapiens AlkB family member 5, RNA demethylase (ALKBH5), mRNA [NM_017758]","chr17",18109876,18113268,"GO:0001666(response to hypoxia);GO:0005634(nucleus);GO:0006397(mRNA processing);GO:0006406(mRNA export from nucleus);GO:0007283(spermatogenesis);GO:0016607(nuclear speck);GO:0016706(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors);GO:0030154(cell differentiation);GO:0035515(oxidative RNA demethylase activity);GO:0035553(oxidative single-stranded RNA demethylation);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3420035",6.48,6.17,6.18,8.49,8.27,8.45,{"v":0.746925823086077,"d":"0.75"},{"v":-0.420963118244312,"d":"-0.42"},"down",{"v":6.19519999999207e-05,"d":"0.00"},1,"yes","CCAAGATGGCAATGAAAGTGACCTCTGGTTGTCCTCACTGCTGTAATTATACTGTAATTA","FALSE","NM_181489","ref|NM_181489|ens|ENST00000396077|ens|ENST00000425708|gb|AY295873","ZNF445","zinc finger protein 445","ref|Homo sapiens zinc finger protein 445 (ZNF445), mRNA [NM_181489]","chr3",44481264,44519162,"GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P158775",12.06,12.08,12.03,11.45,11.33,11.36,{"v":1.05946104276509,"d":"1.06"},{"v":0.0833305396280362,"d":"0.08"},"up",{"v":6.19680000000233e-05,"d":"0.00"},1,"yes","GTGTACCTGAGGCCCCCATCTCCTTAAAGAGTGTGGCAAAATAATGATTTTTAAATCTCA","FALSE","NM_003361","ref|NM_003361|ref|NM_001278614|ref|NM_001008389|ens|ENST00000302509","UMOD","uromodulin","ref|Homo sapiens uromodulin (UMOD), transcript variant 1, mRNA [NM_003361]","chr16",20344374,20362164,"GO:0000922(spindle pole);GO:0005509(calcium ion binding);GO:0005615(extracellular space);GO:0005794(Golgi apparatus);GO:0006968(cellular defense response);GO:0007157(heterophilic cell-cell adhesion);GO:0007159(leukocyte cell-cell adhesion);GO:0007588(excretion);GO:0008285(negative regulation of cell proliferation);GO:0010033(response to organic substance);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0019864(IgG binding);GO:0019898(extrinsic to membrane);GO:0031225(anchored to membrane);GO:0031410(cytoplasmic vesicle);GO:0045121(membrane raft);GO:0048878(chemical homeostasis);GO:0060170(cilium membrane);GO:0070062(extracellular vesicular exosome);GO:0072218(metanephric ascending thin limb development);GO:0072221(metanephric distal convoluted tubule development);GO:0072233(metanephric thick ascending limb development);GO:0072372(primary cilium);GO:2000021(regulation of ion homeostasis)",null,"mRNA","agilent G3 V3"]
["A_33_P3372566",2.17,{"v":2.3,"d":"2.30"},2.48,4.99,4.73,5.15,{"v":0.46738399462004,"d":"0.47"},{"v":-1.09731976444155,"d":"-1.10"},"down",{"v":6.21170000000282e-05,"d":"0.00"},1,"yes","TATCTTCATCACCTATGTCCTCATGGGGCACCAGCTCACTGCCACCAAGGTGAGGACCAG","FALSE","ENST00000443426","ens|ENST00000443426|tc|THC2530428","ABCC10","ATP-binding cassette, sub-family C (CFTR/MRP), member 10","ens|ATP-binding cassette, sub-family C (CFTR/MRP), member 10 [Source:HGNC Symbol;Acc:HGNC:52] [ENST00000443426]","chr6",43395592,43402894,"GO:0005524(ATP binding);GO:0005765(lysosomal membrane);GO:0005886(plasma membrane);GO:0008152(metabolic process);GO:0016021(integral to membrane);GO:0042626(ATPase activity, coupled to transmembrane movement of substances);GO:0055085(transmembrane transport)","02010(ABC transporters)","mRNA","agilent G3 V3"]
["A_23_P151267",3.94,3.57,3.37,7.15,6.96,7.36,{"v":0.506753609687937,"d":"0.51"},{"v":-0.980643634608434,"d":"-0.98"},"down",{"v":6.21189999999716e-05,"d":"0.00"},1,"yes","TCAGGGTGAAATTAAACCAACTATAGGCCTTTTTCTTGGGATGATTTTCTAGTCTTAAGG","FALSE","NM_016357","ref|NM_016357|ref|NM_001113546|ref|NM_001113547|ref|NM_001243775","LIMA1","LIM domain and actin binding 1","ref|Homo sapiens LIM domain and actin binding 1 (LIMA1), transcript variant 2, mRNA [NM_016357]","chr12",50570788,50677239,"GO:0001725(stress fiber);GO:0003785(actin monomer binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0008270(zinc ion binding);GO:0015629(actin cytoskeleton);GO:0030835(negative regulation of actin filament depolymerization);GO:0031529(ruffle organization);GO:0032154(cleavage furrow);GO:0051015(actin filament binding);GO:0051017(actin filament bundle assembly)",null,"mRNA","agilent G3 V3"]
["A_23_P50081",1.96,2.47,{"v":1.9,"d":"1.90"},5.42,5.58,5.36,{"v":0.386919315403423,"d":"0.39"},{"v":-1.36989534351341,"d":"-1.37"},"down",{"v":6.21769999999966e-05,"d":"0.00"},1,"yes","TAGCTGTTTCTCTCTTTAATCTCACGTAGCCTTTTTCAGGTTAGTACGTGTTCTTCTGTC","FALSE","NM_014214","ref|NM_014214|ens|ENST00000590107|ens|ENST00000589374|ens|ENST00000269159","IMPA2","inositol(myo)-1(or 4)-monophosphatase 2","ref|Homo sapiens inositol(myo)-1(or 4)-monophosphatase 2 (IMPA2), mRNA [NM_014214]","chr18",12028607,12030874,"GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006021(inositol biosynthetic process);GO:0006796(phosphate-containing compound metabolic process);GO:0007165(signal transduction);GO:0008934(inositol monophosphate 1-phosphatase activity);GO:0042803(protein homodimerization activity);GO:0043647(inositol phosphate metabolic process);GO:0044281(small molecule metabolic process);GO:0046854(phosphatidylinositol phosphorylation);GO:0046855(inositol phosphate dephosphorylation);GO:0046872(metal ion binding);GO:0052832(inositol monophosphate 3-phosphatase activity);GO:0052833(inositol monophosphate 4-phosphatase activity)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system)","mRNA","agilent G3 V3"]
["A_24_P940310",6.91,7.03,7.12,5.91,5.96,5.93,{"v":1.18314606741573,"d":"1.18"},{"v":0.242628195171957,"d":"0.24"},"up",{"v":6.21960000000144e-05,"d":"0.00"},1,"yes","AGGTTGACCTCCCATCCAGCGCTGTATCTGAGTGTAGTTCATTTTATATCCATAGCCCAA","FALSE","NM_014825","ref|NM_014825|ens|ENST00000382751|gb|AF231919|tc|THC2491233","URB1","URB1 ribosome biogenesis 1 homolog (S. cerevisiae)","ref|Homo sapiens URB1 ribosome biogenesis 1 homolog (S. cerevisiae) (URB1), mRNA [NM_014825]","chr21",33683328,33765335,"GO:0005730(nucleolus);GO:0008150(biological_process)",null,"mRNA","agilent G3 V3"]
["A_23_P404821",2.19,2.03,2.14,3.76,3.94,4.08,{"v":0.539898132427844,"d":"0.54"},{"v":-0.889240868546106,"d":"-0.89"},"down",{"v":6.21969999999861e-05,"d":"0.00"},1,"yes","TTGTTGACTGAATTTTTGTATAGGTCCGGGAAAATAAGCCTAAACAAATAGTTGTAGCCT","FALSE","NM_001080392","ref|NM_001080392|ens|ENST00000536163|ens|ENST00000575464|gb|BC012493","KIAA1147","KIAA1147","ref|Homo sapiens KIAA1147 (KIAA1147), mRNA [NM_001080392]","chr7",141356528,141401953,null,null,"mRNA","agilent G3 V3"]
["A_23_P126752",3.58,4.03,3.65,7.01,6.69,7.07,{"v":0.542128069330766,"d":"0.54"},{"v":-0.883294388764418,"d":"-0.88"},"down",{"v":6.25269999999789e-05,"d":"0.00"},1,"yes","GCTGAACGAGATCTACTTTGGAAAAACAAAGGATATCGTCAATGGGCTGAGGTCTGTGCA","FALSE","NM_004930","ref|NM_004930|ref|NM_001282162|ens|ENST00000264202|ens|ENST00000375144","CAPZB","capping protein (actin filament) muscle Z-line, beta","ref|Homo sapiens capping protein (actin filament) muscle Z-line, beta (CAPZB), transcript variant 1, mRNA [NM_004930]","chr1",19665272,19746245,"GO:0003779(actin binding);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005884(actin filament);GO:0006928(cellular component movement);GO:0007010(cytoskeleton organization);GO:0007596(blood coagulation);GO:0008290(F-actin capping protein complex);GO:0010591(regulation of lamellipodium assembly);GO:0015629(actin cytoskeleton);GO:0022604(regulation of cell morphogenesis);GO:0030017(sarcomere);GO:0030036(actin cytoskeleton organization);GO:0030479(actin cortical patch);GO:0051015(actin filament binding);GO:0051016(barbed-end actin filament capping);GO:0051490(negative regulation of filopodium assembly);GO:0070062(extracellular vesicular exosome);GO:0071203(WASH complex)",null,"mRNA","agilent G3 V3"]
["A_33_P3226202",1.93,2.02,2.04,4.27,4.72,4.36,{"v":0.448689138576779,"d":"0.45"},{"v":-1.15621183378613,"d":"-1.16"},"down",{"v":6.25459999999967e-05,"d":"0.00"},1,"yes","CAGGTCTTCTATAGCTTTTTTCAGAATTCATGGGCTTACAAGTACTGTATGCATCTTTAA","FALSE","NM_015091","ref|NM_015091|ens|ENST00000361577|ens|ENST00000557423|ref|XM_005267451","FAM179B","family with sequence similarity 179, member B","ref|Homo sapiens family with sequence similarity 179, member B (FAM179B), mRNA [NM_015091]","chr14",45431440,45543632,null,null,"mRNA","agilent G3 V3"]
["A_23_P204079",14.84,{"v":14.9,"d":"14.90"},14.86,{"v":13.5,"d":"13.50"},13.58,13.74,{"v":1.09260166585007,"d":"1.09"},{"v":0.127767527774948,"d":"0.13"},"up",{"v":6.25669999999579e-05,"d":"0.00"},1,"yes","CTTGATATGTCTGCATGCAAGGTCCACACCCAAAAGTGTCAATGTTTGCCCCCCAAATAA","FALSE","NM_003717","ref|NM_003717|ens|ENST00000267017|ens|ENST00000448979|ref|XM_005269206","NPFF","neuropeptide FF-amide peptide precursor","ref|Homo sapiens neuropeptide FF-amide peptide precursor (NPFF), mRNA [NM_003717]","chr12",53900472,53901372,"GO:0001664(G-protein coupled receptor binding);GO:0002438(acute inflammatory response to antigenic stimulus);GO:0003254(regulation of membrane depolarization);GO:0005102(receptor binding);GO:0005184(neuropeptide hormone activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0007204(elevation of cytosolic calcium ion concentration);GO:0007218(neuropeptide signaling pathway);GO:0007268(synaptic transmission);GO:0010459(negative regulation of heart rate);GO:0021510(spinal cord development);GO:0030103(vasopressin secretion);GO:0030425(dendrite);GO:0031982(vesicle);GO:0032099(negative regulation of appetite);GO:0042493(response to drug);GO:0043204(perikaryon);GO:0043278(response to morphine);GO:0043679(axon terminus);GO:0045777(positive regulation of blood pressure);GO:0046676(negative regulation of insulin secretion);GO:0051930(regulation of sensory perception of pain);GO:0060079(regulation of excitatory postsynaptic membrane potential);GO:0060135(maternal process involved in female pregnancy);GO:0070253(somatostatin secretion)","04080(Neuroactive ligand-receptor interaction)","mRNA","agilent G3 V3"]
["A_23_P69586",5.58,5.45,{"v":5.5,"d":"5.50"},7.41,7.23,7.09,{"v":0.760699493787391,"d":"0.76"},{"v":-0.394601449888969,"d":"-0.39"},"down",{"v":6.25819999999777e-05,"d":"0.00"},1,"yes","AACTACTGTCATCGTGAGGTTTTCATCGGCTGTGCCATTTCCCAACGTCTTTTGGGATTT","FALSE","NM_005245","ref|NM_005245|ens|ENST00000500085|ens|ENST00000614102|ens|ENST00000441802","FAT1","FAT atypical cadherin 1","ref|Homo sapiens FAT atypical cadherin 1 (FAT1), mRNA [NM_005245]","chr4",187510224,187516954,"GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0005911(cell-cell junction);GO:0005925(focal adhesion);GO:0007015(actin filament organization);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion);GO:0007163(establishment or maintenance of cell polarity);GO:0007267(cell-cell signaling);GO:0009653(anatomical structure morphogenesis);GO:0016337(cell-cell adhesion);GO:0016477(cell migration);GO:0030027(lamellipodium);GO:0030175(filopodium);GO:0048471(perinuclear region of cytoplasm);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_24_P156113",8.22,8.11,8.29,9.74,9.64,9.52,{"v":0.851903114186851,"d":"0.85"},{"v":-0.231238730903584,"d":"-0.23"},"down",{"v":6.2645999999944e-05,"d":"0.00"},1,"yes","GGACCCCATGGAAAAGATGGGGAAGAGCAAAATACATGGAGACGACGCACCCTCCAGGAT","FALSE","NM_014601","ref|NM_014601|ens|ENST00000263277|gb|AK097126|gb|AK097228","EHD2","EH-domain containing 2","ref|Homo sapiens EH-domain containing 2 (EHD2), mRNA [NM_014601]","chr19",48216600,48246391,"GO:0003676(nucleic acid binding);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005525(GTP binding);GO:0005634(nucleus);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0006897(endocytosis);GO:0007596(blood coagulation);GO:0008152(metabolic process);GO:0010008(endosome membrane);GO:0016787(hydrolase activity);GO:0019904(protein domain specific binding);GO:0030866(cortical actin cytoskeleton organization);GO:0032456(endocytic recycling);GO:0048471(perinuclear region of cytoplasm);GO:0055038(recycling endosome membrane);GO:0070062(extracellular vesicular exosome);GO:0072659(protein localization in plasma membrane);GO:2001137(positive regulation of endocytic recycling)","04144(Endocytosis)","mRNA","agilent G3 V3"]
["A_33_P3244998",10.89,10.72,10.51,12.72,12.63,12.65,{"v":0.845263157894737,"d":"0.85"},{"v":-0.242527525700996,"d":"-0.24"},"down",{"v":6.26899999999209e-05,"d":"0.00"},1,"yes","CTGAAACTGGATCCCTTCCTTACACCTTATACAAAAATCAATTCAAGATGGATTAAAGAC","FALSE","NM_001007022","ref|NM_001007022|ref|NM_020729|ref|NM_001164436|ref|NR_125368","ODF2L","outer dense fiber of sperm tails 2-like","ref|Homo sapiens outer dense fiber of sperm tails 2-like (ODF2L), transcript variant 2, mRNA [NM_001007022]","chr1",86815776,86862025,"GO:0005813(centrosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3416350",10.24,10.42,10.22,{"v":9,"d":"9.00"},9.11,9.07,{"v":1.13612950699043,"d":"1.14"},{"v":0.184127296500689,"d":"0.18"},"up",{"v":6.26999999999711e-05,"d":"0.00"},1,"yes","ATCAAACTGAAGCTTCAAGGCCAACAGTTGCCTGTGGTTCTCCCTCCTATTATGAAGCAA","FALSE","NM_147152","ref|NM_147152|ref|NM_019595|ref|NM_006277|ens|ENST00000407704","ITSN2","intersectin 2","ref|Homo sapiens intersectin 2 (ITSN2), transcript variant 2, mRNA [NM_147152]","chr2",24534488,24583341,"GO:0005070(SH3/SH2 adaptor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006897(endocytosis);GO:0009967(positive regulation of signal transduction);GO:0032321(positive regulation of Rho GTPase activity);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3379463",13.79,13.74,13.73,12.65,12.83,12.79,{"v":1.07812908283251,"d":"1.08"},{"v":0.108529920217989,"d":"0.11"},"up",{"v":6.28209999999907e-05,"d":"0.00"},1,"yes","CTGTAGGGCTGGACTGAGGTTCAGGTCTCCCCCCAGCTGTCTCACCCCCACTTTGTCCCC","FALSE","NM_007260","ref|NM_007260|ens|ENST00000374514|ref|XM_005245728|gb|BC017034","LYPLA2","lysophospholipase II","ref|Homo sapiens lysophospholipase II (LYPLA2), mRNA [NM_007260]","chr1",24117646,24122027,"GO:0005737(cytoplasm);GO:0006631(fatty acid metabolic process);GO:0016787(hydrolase activity);GO:0070062(extracellular vesicular exosome)","00564(Glycerophospholipid metabolism)","mRNA","agilent G3 V3"]
["A_33_P3233055",10.54,10.51,{"v":10.5,"d":"10.50"},9.66,9.71,9.81,{"v":1.08122001370802,"d":"1.08"},{"v":0.11266012195202,"d":"0.11"},"up",{"v":6.28710000000199e-05,"d":"0.00"},1,"yes","TTTGCGCAGTTGGGCTTGCCTGGAAACTTGGCAAACTTTGGTCGGATCCTCCCCTGCAGA","FALSE","BF515046","gb|BF515046",null,null,"gb|UI-H-BW1-anr-f-12-0-UI.s1 NCI_CGAP_Sub7 Homo sapiens cDNA clone IMAGE:3083302 3', mRNA sequence [BF515046]","chr4",38664480,38665043,null,null,"mRNA","agilent G3 V3"]
["A_22_P00010118",9.24,9.14,9.14,7.92,8.07,7.86,{"v":1.1538784067086,"d":"1.15"},{"v":0.206491203809224,"d":"0.21"},"up",{"v":6.28990000000051e-05,"d":"0.00"},1,"yes","AATTTCACTATTCAAGTACAGTCAACCCCTCCAGATTCGGGCATCTGTAGAGTCAACCAA","FALSE","ENST00000424756","ens|ENST00000424756|linc|lnc-MRP63-5:1|linc|TCONS_l2_00007360|linc|TCONS_l2_00006720",null,null,"ens|mitochondrial intermediate peptidase pseudogene 3 [Source:HGNC Symbol;Acc:HGNC:39458] [ENST00000424756]","chr13",21872278,21878694,null,null,"mRNA","agilent G3 V3"]
["A_23_P355455",{"v":2,"d":"2.00"},2.24,2.14,5.01,4.72,5.24,{"v":0.426185704742819,"d":"0.43"},{"v":-1.23044589229355,"d":"-1.23"},"down",{"v":6.29580000000018e-05,"d":"0.00"},1,"yes","CCTCAAATTCCCACAGGCTCATACTCAGACAATTGTATTACTGCCTTATGTTTTTTAAGT","FALSE","NM_014744","ref|NM_014744|ref|NM_001134381|ens|ENST00000253692|ref|XM_006713429","TBC1D5","TBC1 domain family, member 5","ref|Homo sapiens TBC1 domain family, member 5 (TBC1D5), transcript variant 2, mRNA [NM_014744]","chr3",17198654,17782399,"GO:0002092(positive regulation of receptor internalization);GO:0005097(Rab GTPase activator activity);GO:0005515(protein binding);GO:0005776(autophagic vacuole);GO:0006914(autophagy);GO:0010008(endosome membrane);GO:0010508(positive regulation of autophagy);GO:0015031(protein transport);GO:0030122(AP-2 adaptor complex);GO:0030904(retromer complex);GO:0032851(positive regulation of Rab GTPase activity);GO:0035612(AP-2 adaptor complex binding);GO:0042147(retrograde transport, endosome to Golgi);GO:0042594(response to starvation);GO:0070969(ULK1-ATG13-FIP200 complex)",null,"mRNA","agilent G3 V3"]
["A_33_P3310588",8.87,8.84,8.95,7.59,{"v":7.8,"d":"7.80"},{"v":7.7,"d":"7.70"},{"v":1.15461238631442,"d":"1.15"},{"v":0.207408607314858,"d":"0.21"},"up",{"v":6.30879999999889e-05,"d":"0.00"},1,"yes","TGCTGTGTATGAACTGCATGTACAAAGCACCTGACCACTGGTACCCCCAGGACCTGCAGG","FALSE","ENST00000620637","ens|ENST00000620637",{"$nulls":3},"chr22",24366752,24370882,null,null,"mRNA","agilent G3 V3"]
["A_23_P216052",7.72,7.65,7.94,5.84,5.59,5.58,{"v":1.37037037037037,"d":"1.37"},{"v":0.454565863465482,"d":"0.45"},"up",{"v":6.3340999999939e-05,"d":"0.00"},1,"yes","GAATGGTCCACTCCCAAGAAATTCAGGAAAGAAAGACTGAGGAGAAGGTGTGGGAACATT","FALSE","NM_032899","ref|NM_032899|gb|AK098407|gb|DQ280323|gb|BC052300","FAM83A","family with sequence similarity 83, member A","ref|Homo sapiens family with sequence similarity 83, member A (FAM83A), transcript variant 1, mRNA [NM_032899]","chr8",124194752,124221203,null,null,"mRNA","agilent G3 V3"]
["A_22_P00007150",8.46,{"v":8.2,"d":"8.20"},8.65,11.39,11.68,11.29,{"v":0.736612339930151,"d":"0.74"},{"v":-0.441022529027779,"d":"-0.44"},"down",{"v":6.33639999999547e-05,"d":"0.00"},1,"yes","GAGCAGAGCGAACCGCACCGGCCCGAGCGGAGCGCCGCACGTTCCCAACCGCGAGGCCAG","FALSE","NM_006841","ref|NM_006841|ens|ENST00000610458|ens|ENST00000620404|ens|ENST00000621714","SLC38A3","solute carrier family 38, member 3","ref|Homo sapiens solute carrier family 38, member 3 (SLC38A3), mRNA [NM_006841]","chr3",50242680,50258411,"GO:0005290(L-histidine transmembrane transporter activity);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0006811(ion transport);GO:0006814(sodium ion transport);GO:0006865(amino acid transport);GO:0006867(asparagine transport);GO:0006868(glutamine transport);GO:0015180(L-alanine transmembrane transporter activity);GO:0015182(L-asparagine transmembrane transporter activity);GO:0015186(L-glutamine transmembrane transporter activity);GO:0015293(symporter activity);GO:0015297(antiporter activity);GO:0015808(L-alanine transport);GO:0015817(histidine transport);GO:0055085(transmembrane transport)","04964(Proximal tubule bicarbonate reclamation);04724(Glutamatergic synapse);04727(GABAergic synapse)","mRNA","agilent G3 V3"]
["A_33_P3423700",1.94,2.02,2.05,4.76,4.36,4.85,{"v":0.430207587687903,"d":"0.43"},{"v":-1.21689512469828,"d":"-1.22"},"down",{"v":6.34019999999902e-05,"d":"0.00"},1,"yes","CTCCATTTTAGGAGGCAGAGTTAAAACATTTTCCTCCTGTGGATGTCTGATTAGAAAAAA","FALSE","AK124002","gb|AK124002|tc|THC2478857","LOC100131829","uncharacterized LOC100131829","gb|Homo sapiens cDNA FLJ42008 fis, clone SPLEN2031724. [AK124002]","chr4",102225392,102228236,null,null,"mRNA","agilent G3 V3"]
["A_24_P404487",2.45,2.62,2.48,5.48,5.21,5.78,{"v":0.458409228901032,"d":"0.46"},{"v":-1.12529200551391,"d":"-1.13"},"down",{"v":6.34320000000299e-05,"d":"0.00"},1,"yes","ACCTTGCCTGTAAAACAAAACCTATCTAGTGTCTGCATAGGTTTCCACTTCTTGTCCCCA","FALSE","ENST00000443905","ens|ENST00000443905|ens|ENST00000591639|gb|AL136548|gb|BC034920","ZNF506","zinc finger protein 506","ens|zinc finger protein 506 [Source:HGNC Symbol;Acc:HGNC:23780] [ENST00000443905]","chr19",19897372,19932541,"GO:0003677(DNA binding);GO:0005730(nucleolus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P150741",{"v":8,"d":"8.00"},8.12,{"v":8.1,"d":"8.10"},6.97,7.02,7.13,{"v":1.1467803030303,"d":"1.15"},{"v":0.197589030335876,"d":"0.20"},"up",{"v":6.35519999999667e-05,"d":"0.00"},1,"yes","ACATGTAGATTGTGTGCATTGTGCATAGTCAAGGAAATCCTAGGGCCACCTCCAGTTCAT","FALSE","NM_001286577","ref|NM_001286577|ens|ENST00000442398|ens|ENST00000334126|ref|XM_005273893","C2CD3","C2 calcium-dependent domain containing 3","ref|Homo sapiens C2 calcium-dependent domain containing 3 (C2CD3), transcript variant 1, mRNA [NM_001286577]","chr11",73724432,73882064,"GO:0001701(in utero embryonic development);GO:0001947(heart looping);GO:0005515(protein binding);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0006996(organelle organization);GO:0007420(brain development);GO:0008589(regulation of smoothened signaling pathway);GO:0016485(protein processing);GO:0021915(neural tube development);GO:0021997(neural plate axis specification);GO:0030162(regulation of proteolysis);GO:0034451(centriolar satellite);GO:0035058(nonmotile primary cilium assembly);GO:0036064(cilium basal body);GO:0042733(embryonic digit morphogenesis);GO:0071539(protein localization to centrosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3310226",13.04,{"v":13.1,"d":"13.10"},13.03,12.09,{"v":12.1,"d":"12.10"},12.24,{"v":1.07521273675542,"d":"1.08"},{"v":0.104622133207964,"d":"0.10"},"up",{"v":6.35780000000086e-05,"d":"0.00"},1,"yes","ACTTTGTTGATTCTCCAAGGAATGTTATGGACTCTGGCACCGAGCCCCCGCCAGGCTCCA","FALSE","AK095213","gb|AK095213|tc|THC2484758","LOC100129115","uncharacterized LOC100129115","gb|Homo sapiens cDNA FLJ37894 fis, clone BRTHA2004639. [AK095213]","chr17",43204040,43205960,null,null,"mRNA","agilent G3 V3"]
["A_23_P111452",3.91,4.51,4.01,7.36,7.39,{"v":7.5,"d":"7.50"},{"v":0.558651685393258,"d":"0.56"},{"v":-0.839979039688638,"d":"-0.84"},"down",{"v":6.35869999999761e-05,"d":"0.00"},1,"yes","GTAAACTTTGTACATTGGAATATTTATGTTTGTGTACATATTTGATGTGTGTGTGTATGA","FALSE","NM_031946","ref|NM_031946|ref|NM_001281300|ens|ENST00000473633|ens|ENST00000397238","AGAP3","ArfGAP with GTPase domain, ankyrin repeat and PH domain 3","ref|Homo sapiens ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 (AGAP3), transcript variant 1, mRNA [NM_031946]","chr7",150836656,150841519,"GO:0000060(protein import into nucleus, translocation);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006184(GTP catabolic process);GO:0007264(small GTPase mediated signal transduction);GO:0008060(ARF GTPase activator activity);GO:0008270(zinc ion binding);GO:0016020(membrane);GO:0031593(polyubiquitin binding);GO:0032312(regulation of ARF GTPase activity);GO:0034614(cellular response to reactive oxygen species);GO:0043161(proteasomal ubiquitin-dependent protein catabolic process);GO:0043547(positive regulation of GTPase activity);GO:0071944(cell periphery)","04144(Endocytosis)","mRNA","agilent G3 V3"]
["A_23_P99967",2.53,2.71,2.56,4.68,4.85,4.48,{"v":0.556745182012848,"d":"0.56"},{"v":-0.844910926681207,"d":"-0.84"},"down",{"v":6.37449999999484e-05,"d":"0.00"},1,"yes","AGCTGAGTCAGCAAGGTACATGATGCTGTCTGCTTTCAAAAGGACTTTTCTCTCCTAGCT","FALSE","NM_033028","ref|NM_033028|ref|NM_001252678|ref|NR_045566|ref|NR_045565","BBS4","Bardet-Biedl syndrome 4","ref|Homo sapiens Bardet-Biedl syndrome 4 (BBS4), transcript variant 1, mRNA [NM_033028]","chr15",72978528,73030347,"GO:0000226(microtubule cytoskeleton organization);GO:0000242(pericentriolar material);GO:0000281(cytokinesis after mitosis);GO:0001103(RNA polymerase II repressing transcription factor binding);GO:0001843(neural tube closure);GO:0001895(retina homeostasis);GO:0001947(heart looping);GO:0003085(negative regulation of systemic arterial blood pressure);GO:0003777(microtubule motor activity);GO:0005515(protein binding);GO:0005813(centrosome);GO:0005814(centriole);GO:0005829(cytosol);GO:0005929(cilium);GO:0006996(organelle organization);GO:0007286(spermatid development);GO:0007601(visual perception);GO:0007608(sensory perception of smell);GO:0008152(metabolic process);GO:0010629(negative regulation of gene expression);GO:0015031(protein transport);GO:0016358(dendrite development);GO:0019216(regulation of lipid metabolic process);GO:0021756(striatum development);GO:0021766(hippocampus development);GO:0021987(cerebral cortex development);GO:0030534(adult behavior);GO:0031513(nonmotile primary cilium);GO:0031514(motile cilium);GO:0032402(melanosome transport);GO:0032465(regulation of cytokinesis);GO:0033365(protein localization to organelle);GO:0034451(centriolar satellite);GO:0034452(dynactin binding);GO:0034454(microtubule anchoring at centrosome);GO:0034464(BBSome);GO:0035058(nonmotile primary cilium assembly);GO:0036064(cilium basal body);GO:0038108(negative regulation of appetite by leptin-mediated signaling pathway);GO:0040018(positive regulation of multicellular organism growth);GO:0042384(cilium assembly);GO:0043014(alpha-tubulin binding);GO:0045444(fat cell differentiation);GO:0045494(photoreceptor cell maintenance);GO:0045724(positive regulation of flagellum assembly);GO:0046548(retinal rod cell development);GO:0046907(intracellular transport);GO:0048487(beta-tubulin binding);GO:0048854(brain morphogenesis);GO:0050893(sensory processing);GO:0051297(centrosome organization);GO:0051457(maintenance of protein location in nucleus);GO:0060170(cilium membrane);GO:0060271(cilium morphogenesis);GO:0060296(regulation of cilium beat frequency involved in ciliary motility);GO:0071539(protein localization to centrosome)",null,"mRNA","agilent G3 V3"]
["A_23_P27627",5.87,5.85,5.83,6.78,{"v":6.8,"d":"6.80"},6.96,{"v":0.854430379746835,"d":"0.85"},{"v":-0.226965151126272,"d":"-0.23"},"down",{"v":6.39159999999972e-05,"d":"0.00"},1,"yes","CTGCGTATGCATTGCTGAGTTCCTGTCCCTGTATGAGACAGAGAGGCTGATCCAGGAGCT","FALSE","NM_004317","ref|NM_004317|ens|ENST00000611688|ens|ENST00000591090|ens|ENST00000357332","ASNA1","arsA arsenite transporter, ATP-binding, homolog 1 (bacterial)","ref|Homo sapiens arsA arsenite transporter, ATP-binding, homolog 1 (bacterial) (ASNA1), mRNA [NM_004317]","chr19",12848306,12859137,"GO:0005215(transporter activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0006810(transport);GO:0008152(metabolic process);GO:0015105(arsenite transmembrane transporter activity);GO:0015698(inorganic anion transport);GO:0016887(ATPase activity);GO:0045048(protein insertion into ER membrane);GO:0046872(metal ion binding);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P357860",10.16,10.02,10.19,8.61,8.79,8.57,{"v":1.16942626107047,"d":"1.17"},{"v":0.225800894489052,"d":"0.23"},"up",{"v":6.39849999999331e-05,"d":"0.00"},1,"yes","AGCATGACAGAAAGAGGGAAAGATAAGTTAAATTTCAAGGGGGTCATATCATCACACTTT","FALSE","NM_003262","ref|NM_003262|ens|ENST00000337002|gb|AK057365|gb|BC089399","SEC62","SEC62 homolog (S. cerevisiae)","ref|Homo sapiens SEC62 homolog (S. cerevisiae) (SEC62), mRNA [NM_003262]","chr3",169684560,169716161,"GO:0004872(receptor activity);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005791(rough endoplasmic reticulum);GO:0006613(cotranslational protein targeting to membrane);GO:0006620(posttranslational protein targeting to membrane);GO:0008565(protein transporter activity);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0016235(aggresome);GO:0045111(intermediate filament cytoskeleton)","03060(Protein export);04141(Protein processing in endoplasmic reticulum)","mRNA","agilent G3 V3"]
["A_33_P3271651",4.16,4.47,4.36,7.82,7.71,7.27,{"v":0.569736842105263,"d":"0.57"},{"v":-0.811632393604223,"d":"-0.81"},"down",{"v":6.41120000000051e-05,"d":"0.00"},1,"yes","TGCTTGTCTGCCACGTGACGGATTTCTACCCAGGCAGCATTCAAGTCCGATGGTTCCTGA","FALSE","NM_002121","ref|NM_002121|ens|ENST00000471170|ens|ENST00000471485|ens|ENST00000475215","HLA-DPB1","major histocompatibility complex, class II, DP beta 1","ref|Homo sapiens major histocompatibility complex, class II, DP beta 1 (HLA-DPB1), mRNA [NM_002121]","chr6",33048448,33054978,"GO:0000139(Golgi membrane);GO:0005765(lysosomal membrane);GO:0005886(plasma membrane);GO:0009986(cell surface);GO:0010008(endosome membrane);GO:0012507(ER to Golgi transport vesicle membrane);GO:0016020(membrane);GO:0019221(cytokine-mediated signaling pathway);GO:0019886(antigen processing and presentation of exogenous peptide antigen via MHC class II);GO:0030658(transport vesicle membrane);GO:0030666(endocytic vesicle membrane);GO:0030669(clathrin-coated endocytic vesicle membrane);GO:0031295(T cell costimulation);GO:0032588(trans-Golgi network membrane);GO:0032729(positive regulation of interferon-gamma production);GO:0042102(positive regulation of T cell proliferation);GO:0042605(peptide antigen binding);GO:0042613(MHC class II protein complex);GO:0050852(T cell receptor signaling pathway);GO:0050870(positive regulation of T cell activation);GO:0060333(interferon-gamma-mediated signaling pathway);GO:0071556(integral to lumenal side of endoplasmic reticulum membrane)","04514(Cell adhesion molecules (CAMs));04145(Phagosome);04612(Antigen processing and presentation);04672(Intestinal immune network for IgA production);05310(Asthma);05322(Systemic lupus erythematosus);05323(Rheumatoid arthritis);05320(Autoimmune thyroid disease);05321(Inflammatiory bowel disease (IBD));05330(Allograft rejection);05332(Graft-versus-host disease);05416(Viral myocarditis);04940(Type I diabetes mellitus);05150(Staphylococcus aureus infection);05152(Tuberculosis);05166(HTLV-I infection);05164(Influenza A);05168(Herpes simplex infection);05169(Epstein-Barr virus infection);05145(Toxoplasmosis);05140(Leishmaniasis)","mRNA","agilent G3 V3"]
["A_23_P89056",2.01,1.92,2.22,3.89,4.12,3.94,{"v":0.514644351464435,"d":"0.51"},{"v":-0.958352302641509,"d":"-0.96"},"down",{"v":6.4274999999947e-05,"d":"0.00"},1,"yes","CATGTTTCTGCGCTGTGTGAGTGAGCTTGTGATTGAAAGCCGAGAGTTCGATATGATTCT","FALSE","NM_014669","ref|NM_014669|ref|NM_001242795|ref|NM_001242796|ens|ENST00000564887","NUP93","nucleoporin 93kDa","ref|Homo sapiens nucleoporin 93kDa (NUP93), transcript variant 1, mRNA [NM_014669]","chr16",56764016,56878681,"GO:0000278(mitotic cell cycle);GO:0005635(nuclear envelope);GO:0005643(nuclear pore);GO:0005975(carbohydrate metabolic process);GO:0006606(protein import into nucleus);GO:0007077(mitotic nuclear envelope disassembly);GO:0008645(hexose transport);GO:0009405(pathogenesis);GO:0010467(gene expression);GO:0010827(regulation of glucose transport);GO:0015758(glucose transport);GO:0016020(membrane);GO:0016032(viral reproduction);GO:0016973(poly(A)+ mRNA export from nucleus);GO:0017056(structural constituent of nuclear pore);GO:0019058(viral infectious cycle);GO:0019083(viral transcription);GO:0019221(cytokine-mediated signaling pathway);GO:0031965(nuclear membrane);GO:0034399(nuclear periphery);GO:0044281(small molecule metabolic process);GO:0051292(nuclear pore complex assembly);GO:0055085(transmembrane transport)","03013(RNA transport)","mRNA","agilent G3 V3"]
["A_21_P0011446",12.22,12.33,12.26,11.69,11.67,11.64,{"v":1.05171428571429,"d":"1.05"},{"v":0.0727428276643702,"d":"0.07"},"up",{"v":6.42770000000015e-05,"d":"0.00"},1,"yes","AGCAACCGGTTTGTGCTCCCCAACTCTGTCACACCCCCTTACTGACATTTGCACGGGTGA","FALSE","ENST00000565194","ens|ENST00000565194|linc|TCONS_l2_00009838",{"$nulls":3},"chr16",74876488,74877781,null,null,"mRNA","agilent G3 V3"]
["A_24_P338187",3.14,3.26,{"v":3.2,"d":"3.20"},4.83,4.77,4.56,{"v":0.677966101694915,"d":"0.68"},{"v":-0.560714954474479,"d":"-0.56"},"down",{"v":6.42899999999669e-05,"d":"0.00"},1,"yes","GCAGTAGCTGCCATGTCTAAAGATAAAAATAACATGCAACATCGATATATTGAACTCTTC","FALSE","NM_012207","ref|NM_012207|ref|NM_021644|ens|ENST00000481819|ens|ENST00000354695","HNRNPH3","heterogeneous nuclear ribonucleoprotein H3 (2H9)","ref|Homo sapiens heterogeneous nuclear ribonucleoprotein H3 (2H9) (HNRNPH3), transcript variant 2H9, mRNA [NM_012207]","chr10",70090928,70102030,"GO:0000166(nucleotide binding);GO:0000398(nuclear mRNA splicing, via spliceosome);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005681(spliceosomal complex);GO:0006396(RNA processing);GO:0008380(RNA splicing);GO:0030855(epithelial cell differentiation)",null,"mRNA","agilent G3 V3"]
["A_23_P252641",8.15,8.07,7.58,11.12,11.09,10.98,{"v":0.717083458873155,"d":"0.72"},{"v":-0.479787055882994,"d":"-0.48"},"down",{"v":6.44049999999341e-05,"d":"0.00"},1,"yes","AGAAGTAGACATGGGAGACTTTTCATTTTGTTCTGTACTAAGAAAAATTCTTCTGCCTTG","FALSE","NM_001007024","ref|NM_001007024|ref|NM_004871|ref|NM_001007025|ref|NR_125409","GOSR1","golgi SNAP receptor complex member 1","ref|Homo sapiens golgi SNAP receptor complex member 1 (GOSR1), transcript variant 3, mRNA [NM_001007024]","chr17",28804424,28853832,"GO:0000139(Golgi membrane);GO:0005484(SNAP receptor activity);GO:0005794(Golgi apparatus);GO:0005801(cis-Golgi network);GO:0006888(ER to Golgi vesicle-mediated transport);GO:0006891(intra-Golgi vesicle-mediated transport);GO:0015031(protein transport);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0031201(SNARE complex);GO:0042147(retrograde transport, endosome to Golgi)","04130(SNARE interactions in vesicular transport)","mRNA","agilent G3 V3"]
["A_33_P3284518",13.05,13.09,13.08,11.95,11.86,12.08,{"v":1.09278350515464,"d":"1.09"},{"v":0.128007612376071,"d":"0.13"},"up",{"v":6.44389999999717e-05,"d":"0.00"},1,"yes","CATTGTCTGTTATTGCATAATCATAGTATTCCAGCCATGCCCCCATAATTGTTTTTCTTA","FALSE","NM_001006947","ref|NM_001006947|ens|ENST00000356828|gb|BC014891|gb|BC026286","UHRF1BP1L","UHRF1 binding protein 1-like","ref|Homo sapiens UHRF1 binding protein 1-like (UHRF1BP1L), transcript variant 2, mRNA [NM_001006947]","chr12",100463688,100536625,null,null,"mRNA","agilent G3 V3"]
["A_23_P393080",{"v":8.4,"d":"8.40"},8.57,8.56,7.09,7.18,7.28,{"v":1.184686774942,"d":"1.18"},{"v":0.244505668430658,"d":"0.24"},"up",{"v":6.45870000000048e-05,"d":"0.00"},1,"yes","ACAGAATTCAAGGAGGCCTTCTCCCTGTTTGACAAGGATGGGGACGGCTGCATCACCACC","FALSE","NM_005185","ref|NM_005185|gb|AK313934|gb|AB590316|gb|DQ891776","CALML3","calmodulin-like 3","ref|Homo sapiens calmodulin-like 3 (CALML3), mRNA [NM_005185]","chr10",{"v":5566924,"d":"5566924.00"},5568225,"GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0070062(extracellular vesicular exosome)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04020(Calcium signaling pathway);04070(Phosphatidylinositol signaling system);04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04114(Oocyte meiosis);04910(Insulin signaling pathway);04922(Glucagon signaling pathway);04912(GnRH signaling pathway);04915(Estrogen signaling pathway);04921(Oxytocin signaling pathway);04916(Melanogenesis);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);04970(Salivary secretion);04971(Gastric acid secretion);04728(Dopaminergic synapse);04720(Long-term potentiation);04722(Neurotrophin signaling pathway);04744(Phototransduction);04740(Olfactory transduction);04750(Inflammatory mediator regulation of TRP channels);04713(Circadian entrainment);05214(Glioma);05010(Alzheimer's disease);05031(Amphetamine addiction);05034(Alcoholism);05133(Pertussis);05152(Tuberculosis)","mRNA","agilent G3 V3"]
["A_33_P3209351",{"v":2,"d":"2.00"},{"v":2.4,"d":"2.40"},1.94,4.96,4.77,4.75,{"v":0.437845303867403,"d":"0.44"},{"v":-1.1915068569438,"d":"-1.19"},"down",{"v":6.46909999999501e-05,"d":"0.00"},1,"yes","TTGTCACTAGCATTTTTGGTGTGAAAAATACAGAGCTGGCTGTCTTCCATGATGAAACAG","FALSE","NM_013417","ref|NM_013417|ref|NM_002161|ref|NR_073446|ens|ENST00000375627","IARS","isoleucyl-tRNA synthetase","ref|Homo sapiens isoleucyl-tRNA synthetase (IARS), transcript variant 2, mRNA [NM_013417]","chr9",94972624,95055965,"GO:0001649(osteoblast differentiation);GO:0002161(aminoacyl-tRNA editing activity);GO:0004822(isoleucine-tRNA ligase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006418(tRNA aminoacylation for protein translation);GO:0006428(isoleucyl-tRNA aminoacylation);GO:0006450(regulation of translational fidelity);GO:0010467(gene expression);GO:0016020(membrane);GO:0070062(extracellular vesicular exosome)","00970(Aminoacyl-tRNA biosynthesis)","mRNA","agilent G3 V3"]
["A_21_P0000115",3.59,3.95,3.48,7.06,6.89,6.64,{"v":0.535211267605634,"d":"0.54"},{"v":-0.901819606061097,"d":"-0.90"},"down",{"v":6.47329999999835e-05,"d":"0.00"},1,"yes","GCACTGTGGTATACATGCAAACATCCGTTCAAAATCTGAGTCGGAGCTAAAAATAAAAAA","FALSE","NM_001190991","ref|NM_001190991|ens|ENST00000553164|ens|ENST00000548013|ens|ENST00000547570","CNPY2","canopy FGF signaling regulator 2","ref|Homo sapiens canopy FGF signaling regulator 2 (CNPY2), transcript variant 2, mRNA [NM_001190991]","chr12",56708256,56710132,"GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005887(integral to plasma membrane);GO:0010629(negative regulation of gene expression);GO:0010988(regulation of low-density lipoprotein particle clearance);GO:0045716(positive regulation of low-density lipoprotein particle receptor biosynthetic process)",null,"mRNA","agilent G3 V3"]
["A_33_P3289207",12.69,12.59,12.84,11.38,11.35,11.44,{"v":1.11559847819725,"d":"1.12"},{"v":0.157817871480674,"d":"0.16"},"up",{"v":6.48639999999423e-05,"d":"0.00"},1,"yes","AAGCGTTTCCCCAGGATGATGGCTTTTGCTCCCCCTAGGACTCAGCGGTTGAATTTTTAA","FALSE","BC090950","gb|BC090950|tc|THC2536194","AAK1","AP2 associated kinase 1","gb|Homo sapiens cDNA clone IMAGE:5226225. [BC090950]","chr2",69685128,69870977,"GO:0004674(protein serine/threonine kinase activity);GO:0005112(Notch binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005905(coated pit);GO:0006468(protein phosphorylation);GO:0006897(endocytosis);GO:0019897(extrinsic to plasma membrane);GO:0030136(clathrin-coated vesicle);GO:0031252(cell leading edge);GO:0032880(regulation of protein localization);GO:0035612(AP-2 adaptor complex binding);GO:0043195(terminal button);GO:0045747(positive regulation of Notch signaling pathway);GO:0046777(protein autophosphorylation);GO:0050821(protein stabilization);GO:2000369(regulation of clathrin-mediated endocytosis)",null,"mRNA","agilent G3 V3"]
["A_33_P3360665",2.04,1.89,2.13,4.17,4.58,4.45,{"v":0.459090909090909,"d":"0.46"},{"v":-1.12314823077286,"d":"-1.12"},"down",{"v":6.48699999999947e-05,"d":"0.00"},1,"yes","ATAGTGTCAAGAAGGAAGATTTGACGTTGTTGTCATTGTCCAGCTGGGACCTAATGCTGG","FALSE","NM_001105","ref|NM_001105|ref|NM_001111067|ens|ENST00000410057|ens|ENST00000409283","ACVR1","activin A receptor, type I","ref|Homo sapiens activin A receptor, type I (ACVR1), transcript variant 1, mRNA [NM_001105]","chr2",158592960,158732374,"GO:0000082(G1/S transition of mitotic cell cycle);GO:0001569(patterning of blood vessels);GO:0001655(urogenital system development);GO:0001701(in utero embryonic development);GO:0001702(gastrulation with mouth forming second);GO:0001707(mesoderm formation);GO:0001755(neural crest cell migration);GO:0002526(acute inflammatory response);GO:0003143(embryonic heart tube morphogenesis);GO:0003183(mitral valve morphogenesis);GO:0003289(atrial septum primum morphogenesis);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004675(transmembrane receptor protein serine/threonine kinase activity);GO:0004702(receptor signaling protein serine/threonine kinase activity);GO:0005025(transforming growth factor beta receptor activity, type I);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005887(integral to plasma membrane);GO:0006468(protein phosphorylation);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007281(germ cell development);GO:0007368(determination of left/right symmetry);GO:0009968(negative regulation of signal transduction);GO:0010862(positive regulation of pathway-restricted SMAD protein phosphorylation);GO:0016361(activin receptor activity, type I);GO:0017046(peptide hormone binding);GO:0018107(peptidyl-threonine phosphorylation);GO:0023014(signal transduction by phosphorylation);GO:0030278(regulation of ossification);GO:0030501(positive regulation of bone mineralization);GO:0030509(BMP signaling pathway);GO:0032924(activin receptor signaling pathway);GO:0032926(negative regulation of activin receptor signaling pathway);GO:0042803(protein homodimerization activity);GO:0045177(apical part of cell);GO:0045669(positive regulation of osteoblast differentiation);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046332(SMAD binding);GO:0046872(metal ion binding);GO:0048179(activin receptor complex);GO:0048185(activin binding);GO:0048641(regulation of skeletal muscle tissue development);GO:0050431(transforming growth factor beta binding);GO:0051145(smooth muscle cell differentiation);GO:0060037(pharyngeal system development);GO:0060389(pathway-restricted SMAD protein phosphorylation);GO:0060923(cardiac muscle cell fate commitment);GO:0061445(endocardial cushion cell fate commitment);GO:0071385(cellular response to glucocorticoid stimulus);GO:2000017(positive regulation of determination of dorsal identity);GO:2001237(negative regulation of extrinsic apoptotic signaling pathway)","04350(TGF-beta signaling pathway);04060(Cytokine-cytokine receptor interaction);04550(Signaling pathways regulating pluripotency of stem cells)","mRNA","agilent G3 V3"]
["A_23_P111092",14.14,13.92,14.03,15.18,15.17,15.12,{"v":0.925665273806906,"d":"0.93"},{"v":-0.111437494403484,"d":"-0.11"},"down",{"v":6.4875999999936e-05,"d":"0.00"},1,"yes","CATCCACCCTCCACTTGCCCTTCTGTCCCCACCAGCAGATAGATGACTTTTTATGTGAGG","FALSE","NM_030883","ref|NM_030883|ens|ENST00000461453|ens|ENST00000473369|ens|ENST00000487930","OR2H1","olfactory receptor, family 2, subfamily H, member 1","ref|Homo sapiens olfactory receptor, family 2, subfamily H, member 1 (OR2H1), mRNA [NM_030883]","chr6",29426230,29432097,"GO:0004930(G-protein coupled receptor activity);GO:0004984(olfactory receptor activity);GO:0005886(plasma membrane);GO:0007186(G-protein coupled receptor signaling pathway);GO:0016021(integral to membrane);GO:0050911(detection of chemical stimulus involved in sensory perception of smell)","04740(Olfactory transduction)","mRNA","agilent G3 V3"]
["A_23_P83159",4.41,4.05,4.09,6.95,6.89,6.61,{"v":0.613691931540342,"d":"0.61"},{"v":-0.704413478990977,"d":"-0.70"},"down",{"v":6.49919999999859e-05,"d":"0.00"},1,"yes","TGAATATTTGTGTGCTATCGGTAGCTGTGTTTCTTTGATCAAATGTTCCTGTCCTTTTGC","FALSE","NM_018847","ref|NM_018847|gb|AL713669|gb|AK025468|gb|AB037775","KLHL9","kelch-like family member 9","ref|Homo sapiens kelch-like family member 9 (KLHL9), mRNA [NM_018847]","chr9",21331544,21335240,"GO:0000910(cytokinesis);GO:0004842(ubiquitin-protein ligase activity);GO:0007067(mitosis);GO:0016567(protein ubiquitination);GO:0030496(midbody);GO:0031463(Cul3-RING ubiquitin ligase complex)","04120(Ubiquitin mediated proteolysis)","mRNA","agilent G3 V3"]
["A_23_P14184",2.07,1.96,2.45,4.92,5.21,5.14,{"v":0.424361493123772,"d":"0.42"},{"v":-1.23663434391223,"d":"-1.24"},"down",{"v":7.50150000000671e-05,"d":"0.00"},1,"yes","TAGACTTTTGTGTAACTATTTGTACCGTAGGACAGAATGTGAGGAGGAAGTAACACACAG","FALSE","NM_018676","ref|NM_018676|ref|NM_199263|ref|NR_002816|ref|NR_051963","THSD1","thrombospondin, type I, domain containing 1","ref|Homo sapiens thrombospondin, type I, domain containing 1 (THSD1), transcript variant 1, mRNA [NM_018676]","chr13",52951304,52980278,"GO:0002244(hemopoietic progenitor cell differentiation);GO:0005576(extracellular region);GO:0005737(cytoplasm);GO:0009986(cell surface);GO:0016021(integral to membrane);GO:0071944(cell periphery)",null,"mRNA","agilent G3 V3"]
["A_23_P124122",2.41,{"v":2.6,"d":"2.60"},2.54,4.39,4.51,4.75,{"v":0.553113553113553,"d":"0.55"},{"v":-0.854352401594774,"d":"-0.85"},"down",{"v":7.52920000000046e-05,"d":"0.00"},1,"yes","AGAAACAGAAATCTCTGAATGTCAGAAACCCTGTCTTTTAAAAAGGCAGTCACTGCCTTC","FALSE","NM_018663","ref|NM_018663|ens|ENST00000539093|ens|ENST00000317479|gb|BC073997","PXMP2","peroxisomal membrane protein 2, 22kDa","ref|Homo sapiens peroxisomal membrane protein 2, 22kDa (PXMP2), mRNA [NM_018663]","chr12",133264192,133281577,"GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005778(peroxisomal membrane);GO:0008150(biological_process);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0043234(protein complex)","04146(Peroxisome)","mRNA","agilent G3 V3"]
["A_23_P211207",4.59,4.51,4.33,5.82,{"v":5.9,"d":"5.90"},5.83,{"v":0.765242165242165,"d":"0.77"},{"v":-0.386011725764481,"d":"-0.39"},"down",{"v":7.53010000000831e-05,"d":"0.00"},1,"yes","GGAACCGATGGGCCATTAAACATGAACTGAACGGTTAAAAGCACAGTCTATGGAACGCTA","FALSE","NM_001112","ref|NM_001112|ref|NM_015833|ref|NM_015834|ref|NM_001160230","ADARB1","adenosine deaminase, RNA-specific, B1","ref|Homo sapiens adenosine deaminase, RNA-specific, B1 (ADARB1), transcript variant 1, mRNA [NM_001112]","chr21",46494516,46646474,"GO:0003723(RNA binding);GO:0003725(double-stranded RNA binding);GO:0003726(double-stranded RNA adenosine deaminase activity);GO:0003729(mRNA binding);GO:0004000(adenosine deaminase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006382(adenosine to inosine editing);GO:0006396(RNA processing);GO:0006397(mRNA processing);GO:0008285(negative regulation of cell proliferation);GO:0010467(gene expression);GO:0016553(base conversion or substitution editing);GO:0016556(mRNA modification);GO:0030336(negative regulation of cell migration);GO:0044387(negative regulation of protein kinase activity by regulation of protein phosphorylation);GO:0045070(positive regulation of viral genome replication);GO:0045087(innate immune response);GO:0046872(metal ion binding);GO:0051607(defense response to virus);GO:0051726(regulation of cell cycle)",null,"mRNA","agilent G3 V3"]
["A_33_P3241771",9.74,9.64,9.85,11.03,11.01,{"v":10.9,"d":"10.90"},{"v":0.887370977534912,"d":"0.89"},{"v":-0.172390725920302,"d":"-0.17"},"down",{"v":7.53580000000253e-05,"d":"0.00"},1,"yes","TTTGGGGAATCTCTAACCTTCCAGAACTCCCTCTGCCCATATGGAGCCCCGATCTGGGCA","FALSE","ENST00000623469","ens|ENST00000623469|ref|XR_109230|ref|XR_111559|ref|XR_172101",null,null,"ref|PREDICTED: Homo sapiens uncharacterized LOC440313 (LOC440313), misc_RNA [XR_109230]","chr15",101322552,101326394,null,null,"mRNA","agilent G3 V3"]
["A_32_P152437",11.21,11.25,11.41,10.14,10.07,10.01,{"v":1.12078093977498,"d":"1.12"},{"v":0.164504326329328,"d":"0.16"},"up",{"v":7.54090000000263e-05,"d":"0.00"},1,"yes","TCAAATGTTCCCCCTCAGGTTATTTTGCTTATGGTACCCATGAGTTGCCTCTCTCTGTAC","FALSE","NM_005100","ref|NM_005100|ref|NM_144497|ens|ENST00000402676|ref|XM_005267234","AKAP12","A kinase (PRKA) anchor protein 12","ref|Homo sapiens A kinase (PRKA) anchor protein 12 (AKAP12), transcript variant 1, mRNA [NM_005100]","chr6",151561136,151679692,"GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0005938(cell cortex);GO:0006605(protein targeting);GO:0007186(G-protein coupled receptor signaling pathway);GO:0008179(adenylate cyclase binding);GO:0010739(positive regulation of protein kinase A signaling cascade);GO:0030819(positive regulation of cAMP biosynthetic process);GO:0051018(protein kinase A binding);GO:0090036(regulation of protein kinase C signaling cascade)",null,"mRNA","agilent G3 V3"]
["A_23_P38457",{"v":3.1,"d":"3.10"},3.19,{"v":2.9,"d":"2.90"},5.36,{"v":5.2,"d":"5.20"},5.04,{"v":0.589102564102564,"d":"0.59"},{"v":-0.763409262460576,"d":"-0.76"},"down",{"v":7.54609999999989e-05,"d":"0.00"},1,"yes","TTTACCAGCTGCTGACTAATCTTCATCACCACTGTAGATTTTGCTGCATGTGCAGGTCCT","FALSE","NM_020791","ref|NM_020791|ref|NM_025142|ens|ENST00000536202|ens|ENST00000261716","TAOK1","TAO kinase 1","ref|Homo sapiens TAO kinase 1 (TAOK1), transcript variant 1, mRNA [NM_020791]","chr17",27717948,27871358,"GO:0000165(MAPK cascade);GO:0000186(activation of MAPKK activity);GO:0000278(mitotic cell cycle);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004709(MAP kinase kinase kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0006281(DNA repair);GO:0006468(protein phosphorylation);GO:0006974(response to DNA damage stimulus);GO:0016301(kinase activity);GO:0016740(transferase activity);GO:0031572(G2/M transition DNA damage checkpoint);GO:0031577(spindle checkpoint);GO:0032874(positive regulation of stress-activated MAPK cascade);GO:0046330(positive regulation of JNK cascade);GO:0051493(regulation of cytoskeleton organization);GO:0070062(extracellular vesicular exosome);GO:0097194(execution phase of apoptosis)","04010(MAPK signaling pathway)","mRNA","agilent G3 V3"]
["A_33_P3288725",7.78,7.89,7.78,6.41,{"v":6.5,"d":"6.50"},6.24,{"v":1.22454308093995,"d":"1.22"},{"v":0.292243530590419,"d":"0.29"},"up",{"v":7.55630000000007e-05,"d":"0.00"},1,"yes","ATTTCTTGTAGTGATTGGGGGCGTCGGCAAAAGCAAACTTGAGGCGGTAGGCCTCGGCCA","FALSE","CU678159","gb|CU678159",null,null,"gb|Synthetic construct Homo sapiens gateway clone IMAGE:100017271 3' read TBC1D22A mRNA. [CU678159]",{"$nulls":5},"mRNA","agilent G3 V3"]
["A_33_P3359012",15.42,15.44,15.42,14.81,14.69,{"v":14.8,"d":"14.80"},{"v":1.04469525959368,"d":"1.04"},{"v":0.0630821656651094,"d":"0.06"},"up",{"v":7.57970000000441e-05,"d":"0.00"},1,"yes","CGGCCCCTCCCTTTGTATTTGGAGACAATGTGTTGTAATAAAGCTTAAAGTGGATGTTTT","FALSE","NM_004420","ref|NM_004420|ens|ENST00000331588|ens|ENST00000610856|ens|ENST00000617829","DUSP8","dual specificity phosphatase 8","ref|Homo sapiens dual specificity phosphatase 8 (DUSP8), mRNA [NM_004420]","chr11",{"v":1575281,"d":"1575281.00"},1587166,"GO:0000188(inactivation of MAPK activity);GO:0004725(protein tyrosine phosphatase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006470(protein dephosphorylation);GO:0008138(protein tyrosine/serine/threonine phosphatase activity);GO:0017017(MAP kinase tyrosine/serine/threonine phosphatase activity);GO:0035335(peptidyl-tyrosine dephosphorylation)","04010(MAPK signaling pathway)","mRNA","agilent G3 V3"]
["A_32_P147078",7.78,7.85,7.86,6.86,6.92,7.02,{"v":1.12932692307692,"d":"1.13"},{"v":0.175463184983742,"d":"0.18"},"up",{"v":7.58339999999968e-05,"d":"0.00"},1,"yes","GGGGGGCGGGAAATGCACTAATTGTGCTCTTCCTTATAAATGGTACATATTACTGACACA","FALSE","NM_021097","ref|NM_021097|ref|NM_001112800|ref|NM_001112802|ref|NM_001252624","SLC8A1","solute carrier family 8 (sodium/calcium exchanger), member 1","ref|Homo sapiens solute carrier family 8 (sodium/calcium exchanger), member 1 (SLC8A1), transcript variant A, mRNA [NM_021097]","chr2",40339288,40657444,"GO:0001892(embryonic placenta development);GO:0002026(regulation of the force of heart contraction);GO:0002027(regulation of heart rate);GO:0003007(heart morphogenesis);GO:0005432(calcium:sodium antiporter activity);GO:0005516(calmodulin binding);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0006811(ion transport);GO:0006883(cellular sodium ion homeostasis);GO:0006936(muscle contraction);GO:0007596(blood coagulation);GO:0008092(cytoskeletal protein binding);GO:0009791(post-embryonic development);GO:0010649(regulation of cell communication by electrical coupling);GO:0010881(regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion);GO:0010882(regulation of cardiac muscle contraction by calcium ion signaling);GO:0014704(intercalated disc);GO:0014829(vascular smooth muscle contraction);GO:0016323(basolateral plasma membrane);GO:0030018(Z disc);GO:0030315(T-tubule);GO:0030506(ankyrin binding);GO:0034614(cellular response to reactive oxygen species);GO:0035050(embryonic heart tube development);GO:0035994(response to muscle stretch);GO:0042383(sarcolemma);GO:0044325(ion channel binding);GO:0044557(relaxation of smooth muscle);GO:0046872(metal ion binding);GO:0048747(muscle fiber development);GO:0051481(reduction of cytosolic calcium ion concentration);GO:0055013(cardiac muscle cell development);GO:0055074(calcium ion homeostasis);GO:0055085(transmembrane transport);GO:0055119(relaxation of cardiac muscle);GO:0060048(cardiac muscle contraction);GO:0060401(cytosolic calcium ion transport);GO:0060402(calcium ion transport into cytosol);GO:0070509(calcium ion import);GO:0071313(cellular response to caffeine);GO:0071436(sodium ion export);GO:0086012(membrane depolarization involved in regulation of cardiac muscle cell action potential);GO:0086064(cell communication by electrical coupling involved in cardiac conduction)","04020(Calcium signaling pathway);04022(cGMP - PKG signaling pathway);04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);04974(Protein digestion and absorption);04978(Mineral absorption);04961(Endocrine and other factor-regulated calcium reabsorption);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM))","mRNA","agilent G3 V3"]
["A_32_P834166",12.34,12.53,12.43,11.28,11.32,{"v":11.4,"d":"11.40"},{"v":1.09705882352941,"d":"1.10"},{"v":0.133640884117536,"d":"0.13"},"up",{"v":7.62530000000261e-05,"d":"0.00"},1,"yes","AGCACCTGTCACTATCGGAAAGGAAACATCTGTTTACCGTTTGTCTCCCCCTCTCAAAAA","FALSE","ENST00000266880","ens|ENST00000266880|gb|AF128541|tc|THC2641609",null,null,"ens|checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase [Source:HGNC Symbol;Acc:HGNC:20455] [ENST00000266880]","chr12",133416936,133464184,null,null,"mRNA","agilent G3 V3"]
["A_23_P400147",12.76,12.78,12.73,11.55,11.77,11.64,{"v":1.09467963386728,"d":"1.09"},{"v":0.130508716167897,"d":"0.13"},"up",{"v":7.63790000000153e-05,"d":"0.00"},1,"yes","CTGGAGTGGGTCCAATATGAAGTCTCCCCCCGTGGAACGCAGCCACCATCAGAAATCTCT","FALSE","NM_001267723","ref|NM_001267723|ens|ENST00000536603|ref|XM_005259191|ref|XM_005259192","CCDC61","coiled-coil domain containing 61","ref|Homo sapiens coiled-coil domain containing 61 (CCDC61), mRNA [NM_001267723]","chr19",46498724,46521874,"GO:0005813(centrosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3480395",11.43,11.58,11.59,10.07,{"v":10.2,"d":"10.20"},10.28,{"v":1.13256955810147,"d":"1.13"},{"v":0.179599657817995,"d":"0.18"},"up",{"v":7.63930000000634e-05,"d":"0.00"},1,"yes","GCCACAAATATTCAGTTTTGTTTTATCCATCATGTCCCCCATATGCATGTAATGAAACAT","FALSE","ENST00000360835","ens|ENST00000360835|gb|AK055463|gb|AK056490|tc|THC2615816","SCUBE1","signal peptide, CUB domain, EGF-like 1","ens|signal peptide, CUB domain, EGF-like 1 [Source:HGNC Symbol;Acc:HGNC:13441] [ENST00000360835]","chr22",43593288,43739394,"GO:0005509(calcium ion binding);GO:0005615(extracellular space);GO:0006954(inflammatory response);GO:0007512(adult heart development);GO:0007596(blood coagulation);GO:0009791(post-embryonic development);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0019897(extrinsic to plasma membrane);GO:0042802(identical protein binding);GO:0045446(endothelial cell differentiation);GO:0046982(protein heterodimerization activity);GO:0051260(protein homooligomerization)",null,"mRNA","agilent G3 V3"]
["A_23_P13425",7.41,7.66,7.45,9.96,10.12,10.43,{"v":0.738118649623074,"d":"0.74"},{"v":-0.438075352498427,"d":"-0.44"},"down",{"v":7.65329999999897e-05,"d":"0.00"},1,"yes","TAACGTTTCCGGTATTACTCTGCTACACGTAGCCTTTTTACTTTTGGGGTTTTGTTTTTG","FALSE","NM_004356","ref|NM_004356|ref|NM_001297649|ens|ENST00000468153|ens|ENST00000481386","CD81","CD81 molecule","ref|Homo sapiens CD81 molecule (CD81), transcript variant 1, mRNA [NM_004356]","chr11",{"v":2417543,"d":"2417543.00"},2418529,"GO:0000187(activation of MAPK activity);GO:0001772(immunological synapse);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0005925(focal adhesion);GO:0006661(phosphatidylinositol biosynthetic process);GO:0008104(protein localization);GO:0008283(cell proliferation);GO:0008284(positive regulation of cell proliferation);GO:0016020(membrane);GO:0023026(MHC class II protein complex binding);GO:0030890(positive regulation of B cell proliferation);GO:0031982(vesicle);GO:0043128(positive regulation of 1-phosphatidylinositol 4-kinase activity);GO:0046488(phosphatidylinositol metabolic process);GO:0046718(viral entry into host cell);GO:0046813(virion attachment, binding of host cell surface receptor);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0050776(regulation of immune response);GO:0070062(extracellular vesicular exosome);GO:2000145(regulation of cell motility)","04662(B cell receptor signaling pathway);05160(Hepatitis C);05144(Malaria)","mRNA","agilent G3 V3"]
["A_23_P382045",2.16,2.25,{"v":2.5,"d":"2.50"},4.47,4.76,4.52,{"v":0.502545454545455,"d":"0.50"},{"v":-0.992674002911126,"d":"-0.99"},"down",{"v":7.65390000000421e-05,"d":"0.00"},1,"yes","CTTACGTATTTTGTGTATTAGATTGTGCAGGAGATATTCTAGAAGGCATTAATGGTTTGC","FALSE","NM_020245","ref|NM_020245|ref|NM_001007466|ens|ENST00000367097|ref|XM_005267057","TULP4","tubby like protein 4","ref|Homo sapiens tubby like protein 4 (TULP4), transcript variant 1, mRNA [NM_020245]","chr6",158733696,158932860,"GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-dependent);GO:0007584(response to nutrient);GO:0016567(protein ubiquitination);GO:0035556(intracellular signal transduction)",null,"mRNA","agilent G3 V3"]
["A_23_P46396",1.99,1.86,2.08,5.12,4.97,4.58,{"v":0.404226312201772,"d":"0.40"},{"v":-1.30676486112739,"d":"-1.31"},"down",{"v":7.65600000000033e-05,"d":"0.00"},1,"yes","AACCAGGTGGGACCAAAGTTTATGTGCCTTTAGTCTTAATTTACCTTGCATTGTAATATT","FALSE","NM_021190","ref|NM_021190|ref|NM_001300987|ref|NM_001300986|ref|NM_001300985","PTBP2","polypyrimidine tract binding protein 2","ref|Homo sapiens polypyrimidine tract binding protein 2 (PTBP2), transcript variant 6, mRNA [NM_021190]","chr1",97187376,97280349,"GO:0000166(nucleotide binding);GO:0003729(mRNA binding);GO:0005681(spliceosomal complex);GO:0006376(mRNA splice site selection);GO:0033119(negative regulation of RNA splicing);GO:2000177(regulation of neural precursor cell proliferation)",null,"mRNA","agilent G3 V3"]
["A_33_P3290888",{"v":7.5,"d":"7.50"},7.51,7.38,9.07,9.38,9.35,{"v":0.805395683453237,"d":"0.81"},{"v":-0.312230354758272,"d":"-0.31"},"down",{"v":7.65770000000776e-05,"d":"0.00"},1,"yes","TTCATGCTGTTGCTGCTGACTGATGGTGCTGTGACGGATGTGGAAGCCACACGTGAGGCT","FALSE","NM_003915","ref|NM_003915|ref|NM_152927|ref|NM_152928|ref|NM_152925","CPNE1","copine I","ref|Homo sapiens copine I (CPNE1), transcript variant 3, mRNA [NM_003915]","chr20",34213968,34252848,"GO:0001786(phosphatidylserine binding);GO:0005215(transporter activity);GO:0005544(calcium-dependent phospholipid binding);GO:0006629(lipid metabolic process);GO:0016192(vesicle-mediated transport);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P164196",2.98,3.22,2.97,6.22,6.23,6.77,{"v":0.477107180020812,"d":"0.48"},{"v":-1.0676146971787,"d":"-1.07"},"down",{"v":7.66530000000376e-05,"d":"0.00"},1,"yes","TACCTACTTACCATACTGGGAGGTAGAAGAGATGCAGAGAAATGTGGAATTTGTGGACCT","FALSE","NM_138281","ref|NM_138281|ref|NM_001934|ens|ENST00000411890|ens|ENST00000240306","DLX4","distal-less homeobox 4","ref|Homo sapiens distal-less homeobox 4 (DLX4), transcript variant 1, mRNA [NM_138281]","chr17",48050128,48051959,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0001078(RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-dependent);GO:0007275(multicellular organismal development);GO:0043565(sequence-specific DNA binding)",null,"mRNA","agilent G3 V3"]
["A_23_P102117",{"v":9.8,"d":"9.80"},9.61,9.85,7.94,8.06,8.18,{"v":1.21009098428453,"d":"1.21"},{"v":0.275115524889363,"d":"0.28"},"up",{"v":7.66800000000512e-05,"d":"0.00"},1,"yes","AAGAAATAGACATAACTGAGCTGAAGTAATTCCATAAAGGGCCCAGACAGCCTCCTCCAC","FALSE","NM_025216","ref|NM_025216|ens|ENST00000258411|gb|AK024363|gb|BC052234","WNT10A","wingless-type MMTV integration site family, member 10A","ref|Homo sapiens wingless-type MMTV integration site family, member 10A (WNT10A), mRNA [NM_025216]","chr2",219746880,219757868,"GO:0001942(hair follicle development);GO:0005109(frizzled binding);GO:0005576(extracellular region);GO:0005578(proteinaceous extracellular matrix);GO:0005615(extracellular space);GO:0010628(positive regulation of gene expression);GO:0014033(neural crest cell differentiation);GO:0016055(Wnt receptor signaling pathway);GO:0030182(neuron differentiation);GO:0031069(hair follicle morphogenesis);GO:0042476(odontogenesis);GO:0042487(regulation of odontogenesis of dentin-containing tooth);GO:0043586(tongue development);GO:0043588(skin development);GO:0045165(cell fate commitment);GO:0048730(epidermis morphogenesis);GO:0048733(sebaceous gland development);GO:0071560(cellular response to transforming growth factor beta stimulus)","04310(Wnt signaling pathway);04340(Hedgehog signaling pathway);04390(Hippo signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04916(Melanogenesis);05200(Pathways in cancer);05205(Proteoglycans in cancer);05217(Basal cell carcinoma);05166(HTLV-I infection)","mRNA","agilent G3 V3"]
["A_33_P3219286",7.48,7.32,7.45,6.01,6.15,6.21,{"v":1.21121393576483,"d":"1.21"},{"v":0.276453709629773,"d":"0.28"},"up",{"v":7.67340000000782e-05,"d":"0.00"},1,"yes","CTCGCGGGCACTGCGCGCAGCGGTGGGGTGGGGCAGCAGGGTCAGAGGTTGTCCCCAAGG","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_33_P3375613",6.75,6.86,6.51,8.52,8.58,8.67,{"v":0.780752813348855,"d":"0.78"},{"v":-0.357062232054093,"d":"-0.36"},"down",{"v":7.68490000000455e-05,"d":"0.00"},1,"yes","ATTGGAATAACTTTATTCTGCAGATCATTTAAGAAGTAACAGGCCGGGCGCGGTGGCTCA","FALSE","NM_001204173","ref|NM_001204173|ref|NM_001033578|ref|NM_013257|ref|NM_170709","C8orf44-SGK3","C8orf44-SGK3 readthrough","ref|Homo sapiens C8orf44-SGK3 readthrough (C8orf44-SGK3), mRNA [NM_001204173]","chr8",67687464,67774246,"GO:0001558(regulation of cell growth);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005246(calcium channel regulator activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005769(early endosome);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0006950(response to stress);GO:0015459(potassium channel regulator activity);GO:0016023(cytoplasmic membrane-bounded vesicle);GO:0017080(sodium channel regulator activity);GO:0017081(chloride channel regulator activity);GO:0030334(regulation of cell migration);GO:0034220(ion transmembrane transport);GO:0035091(phosphatidylinositol binding);GO:0042127(regulation of cell proliferation);GO:0051090(regulation of sequence-specific DNA binding transcription factor activity);GO:0055037(recycling endosome);GO:0055085(transmembrane transport)","04068(FoxO signaling pathway);04151(PI3K-Akt signaling pathway)","mRNA","agilent G3 V3"]
["A_33_P3420665",7.31,7.22,7.27,6.58,6.61,{"v":6.5,"d":"6.50"},{"v":1.10716099542915,"d":"1.11"},{"v":0.146865023762735,"d":"0.15"},"up",{"v":7.69059999999877e-05,"d":"0.00"},1,"yes","ACAGCTGTGCCATGCCCACCTATTGACAATGATAAAGGGAGGTCTCTCTTCTCAGCAGCA","FALSE","ENST00000394237","ens|ENST00000394237|ref|XM_006715292|ref|XM_006715293|gb|AK125780",null,null,"ens|guanylate cyclase activator 1A (retina) [Source:HGNC Symbol;Acc:HGNC:4678] [ENST00000394237]","chr6",42123280,42131156,null,null,"mRNA","agilent G3 V3"]
["A_24_P24142",4.92,4.94,5.25,7.47,{"v":7.3,"d":"7.30"},7.64,{"v":0.674252565818831,"d":"0.67"},{"v":-0.568638988345564,"d":"-0.57"},"down",{"v":7.70140000000419e-05,"d":"0.00"},1,"yes","TCCTCTCTCAAGGACGAGGTTTTGAAAATTATGCTGGTGCAGAAGCAGACCCATACCAGC","FALSE","ENST00000433054","ens|ENST00000433054",{"$nulls":3},"chr2",174162352,174163240,null,null,"mRNA","agilent G3 V3"]
["A_33_P3213463",{"v":6.3,"d":"6.30"},6.25,6.02,7.79,7.83,{"v":7.7,"d":"7.70"},{"v":0.79631217838765,"d":"0.80"},{"v":-0.328593973265076,"d":"-0.33"},"down",{"v":7.70230000000094e-05,"d":"0.00"},1,"yes","ACCCATGAGGAGCTGCTGTACAACAAGGAGAAGTTGCTCAACAACGGGGACAAGTGGGAG","FALSE","NM_002496","ref|NM_002496|ens|ENST00000313468|ens|ENST00000524810|ens|ENST00000531282","NDUFS8","NADH dehydrogenase (ubiquinone) Fe-S protein 8, 23kDa (NADH-coenzyme Q reductase)","ref|Homo sapiens NADH dehydrogenase (ubiquinone) Fe-S protein 8, 23kDa (NADH-coenzyme Q reductase) (NDUFS8), mRNA [NM_002496]","chr11",67803496,67804111,"GO:0003954(NADH dehydrogenase activity);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0005747(mitochondrial respiratory chain complex I);GO:0006120(mitochondrial electron transport, NADH to ubiquinone);GO:0006979(response to oxidative stress);GO:0008137(NADH dehydrogenase (ubiquinone) activity);GO:0022904(respiratory electron transport chain);GO:0032981(mitochondrial respiratory chain complex I assembly);GO:0044237(cellular metabolic process);GO:0044281(small molecule metabolic process);GO:0046872(metal ion binding);GO:0051539(4 iron, 4 sulfur cluster binding)","00190(Oxidative phosphorylation);05010(Alzheimer's disease);05012(Parkinson's disease);05016(Huntington's disease);04932(Non-alcoholic fatty liver disease (NAFLD))","mRNA","agilent G3 V3"]
["A_23_P49338",9.76,9.69,9.87,8.89,8.85,8.84,{"v":1.10308502633559,"d":"1.10"},{"v":0.141543998857637,"d":"0.14"},"up",{"v":7.73360000000389e-05,"d":"0.00"},1,"yes","TCACTCAGATGTCCTGAAATTCCACCACGGGGGTCACCCTGGGGGGTTAGGGACCTATTT","FALSE","NM_016639","ref|NM_016639|ens|ENST00000571351|ens|ENST00000326577|ens|ENST00000341627","TNFRSF12A","tumor necrosis factor receptor superfamily, member 12A","ref|Homo sapiens tumor necrosis factor receptor superfamily, member 12A (TNFRSF12A), mRNA [NM_016639]","chr16",{"v":3070391,"d":"3070391.00"},3072384,"GO:0001525(angiogenesis);GO:0001726(ruffle);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0006931(substrate-dependent cell migration, cell attachment to substrate);GO:0009986(cell surface);GO:0016021(integral to membrane);GO:0043065(positive regulation of apoptotic process);GO:0045765(regulation of angiogenesis);GO:0045773(positive regulation of axon extension);GO:0061041(regulation of wound healing);GO:0097191(extrinsic apoptotic signaling pathway);GO:2001238(positive regulation of extrinsic apoptotic signaling pathway)","04060(Cytokine-cytokine receptor interaction)","mRNA","agilent G3 V3"]
["A_22_P00014741",{"v":10,"d":"10.00"},10.08,10.09,8.91,8.91,8.71,{"v":1.13720316622691,"d":"1.14"},{"v":0.185490020918006,"d":"0.19"},"up",{"v":7.73400000000368e-05,"d":"0.00"},1,"yes","GGCCTCCCTATAATCAATGGTGTTAGTCAACTTTCAGATTTCCTTTAAATTACGTTTCTA","FALSE","XR_246237","ref|XR_246237|linc|lnc-SLC30A7-1:1|tc|THC2529560","SLC30A7","solute carrier family 30 (zinc transporter), member 7","ref|PREDICTED: Homo sapiens solute carrier family 30 (zinc transporter), member 7 (SLC30A7), transcript variant X3, misc_RNA [XR_246237]",{"$nulls":3},"GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0006829(zinc ion transport);GO:0008324(cation transmembrane transporter activity);GO:0016021(integral to membrane);GO:0016023(cytoplasmic membrane-bounded vesicle);GO:0031982(vesicle);GO:0032119(sequestering of zinc ion);GO:0044267(cellular protein metabolic process);GO:0048471(perinuclear region of cytoplasm);GO:0055085(transmembrane transport);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3252444",10.23,10.08,10.12,9.15,9.23,9.26,{"v":1.10094066570188,"d":"1.10"},{"v":0.138736718126337,"d":"0.14"},"up",{"v":7.73700000000765e-05,"d":"0.00"},1,"yes","TGTTTCTCTGTGTGGATACTGTGGGGCATATTATTTCCACCCCCAACACCGGCTGTGTAA","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_33_P3358908",7.66,{"v":7.6,"d":"7.60"},7.85,9.25,9.46,9.31,{"v":0.824768022840828,"d":"0.82"},{"v":-0.277939695963187,"d":"-0.28"},"down",{"v":7.74570000000585e-05,"d":"0.00"},1,"yes","CAGCCCTGCTACTGCCCAGCCTGCTGTGTGTCCAGCTGCTGCCAGCATTCTTGTTGCTGA","FALSE","NM_001277331","ref|NM_001277331|ens|ENST00000391355|ens|ENST00000576511","KRTAP9-6","keratin associated protein 9-6","ref|Homo sapiens keratin associated protein 9-6 (KRTAP9-6), mRNA [NM_001277331]","chr17",39421592,39422893,"GO:0045095(keratin filament)",null,"mRNA","agilent G3 V3"]
["A_23_P48740",8.96,8.83,9.05,7.66,7.78,7.74,{"v":1.15789473684211,"d":"1.16"},{"v":0.211504105193712,"d":"0.21"},"up",{"v":7.74620000000281e-05,"d":"0.00"},1,"yes","GCCCATGTCACTGGTCAGCGTGGTTTTTATGTGTATTAGGATTGGGGGATGTGAAGAAAT","FALSE","NM_013989","ref|NM_013989|ref|NM_000793|ref|NM_001242502|ref|NM_001242503","DIO2","deiodinase, iodothyronine, type II","ref|Homo sapiens deiodinase, iodothyronine, type II (DIO2), transcript variant 1, mRNA [NM_013989]","chr14",80663872,80697397,"GO:0001514(selenocysteine incorporation);GO:0004800(thyroxine 5'-deiodinase activity);GO:0005886(plasma membrane);GO:0006590(thyroid hormone generation);GO:0008430(selenium binding);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0031625(ubiquitin protein ligase binding);GO:0034641(cellular nitrogen compound metabolic process);GO:0042403(thyroid hormone metabolic process);GO:0042446(hormone biosynthetic process);GO:0044281(small molecule metabolic process);GO:0055114(oxidation-reduction process)","04919(Thyroid hormone signaling pathway)","mRNA","agilent G3 V3"]
["A_33_P3351934",8.38,8.19,8.14,{"v":9.6,"d":"9.60"},9.57,{"v":9.7,"d":"9.70"},{"v":0.855905784551438,"d":"0.86"},{"v":-0.224476096907197,"d":"-0.22"},"down",{"v":7.76040000000089e-05,"d":"0.00"},1,"yes","GCACTCCAGCCTAGGCGACAAGTGAAACTGCGTCTAAAATACATAAATAAATAAAAATTT","FALSE","BC070067","gb|BC070067|gb|BC099909|tc|THC2498772|tc|THC2551905","MSTO1","misato 1, mitochondrial distribution and morphology regulator","gb|Homo sapiens misato homolog 1 (Drosophila), mRNA (cDNA clone IMAGE:4828998). [BC070067]","chr1",155715584,155721376,"GO:0003674(molecular_function);GO:0005737(cytoplasm);GO:0005741(mitochondrial outer membrane);GO:0007005(mitochondrion organization);GO:0048311(mitochondrion distribution)",null,"mRNA","agilent G3 V3"]
["A_33_P3253239",13.45,13.73,13.51,11.95,11.77,11.91,{"v":1.14201515576761,"d":"1.14"},{"v":0.191581796940411,"d":"0.19"},"up",{"v":7.78240000000041e-05,"d":"0.00"},1,"yes","TGTCTAACTTATGTCCCTCCCGCAGTTCACAGAAGGCCCCTGACACTGGGACTACACGGA","FALSE","THC2497493","tc|THC2497493",{"$nulls":3},"chr1",180882320,180920750,null,null,"mRNA","agilent G3 V3"]
["A_33_P3281373",9.47,9.66,9.64,7.55,7.84,7.82,{"v":1.23955191727704,"d":"1.24"},{"v":0.309818698394805,"d":"0.31"},"up",{"v":7.80390000000297e-05,"d":"0.00"},1,"yes","GAACAAACTTGTGTTTGGGTGAAACAGGCTTCCCCATTGCAGTTACTATAACACCTGTGT","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_33_P3319925",{"v":8,"d":"8.00"},7.95,7.97,6.99,6.87,7.07,{"v":1.14285714285714,"d":"1.14"},{"v":0.192645077942396,"d":"0.19"},"up",{"v":7.82340000000659e-05,"d":"0.00"},1,"yes","AGAAGACCTAGAAGACTGTTCTGTGTTAACTACACTTCTCAAAGGACCCTCTCCACCAGA","FALSE","NM_001258406","ref|NM_001258406|ens|ENST00000449753|ens|ENST00000377462|tc|THC2656352","IRG1","immunoresponsive 1 homolog (mouse)","ref|Homo sapiens immunoresponsive 1 homolog (mouse) (IRG1), mRNA [NM_001258406]","chr13",77526608,77532120,"GO:0002760(positive regulation of antimicrobial humoral response);GO:0005739(mitochondrion);GO:0006952(defense response);GO:0006954(inflammatory response);GO:0007566(embryo implantation);GO:0008152(metabolic process);GO:0019543(propionate catabolic process);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0032480(negative regulation of type I interferon production);GO:0034136(negative regulation of toll-like receptor 2 signaling pathway);GO:0034144(negative regulation of toll-like receptor 4 signaling pathway);GO:0035458(cellular response to interferon-beta);GO:0045824(negative regulation of innate immune response);GO:0047547(2-methylcitrate dehydratase activity);GO:0047613(aconitate decarboxylase activity);GO:0050728(negative regulation of inflammatory response);GO:0071219(cellular response to molecule of bacterial origin);GO:0071222(cellular response to lipopolysaccharide);GO:0071346(cellular response to interferon-gamma);GO:0071347(cellular response to interleukin-1);GO:0071356(cellular response to tumor necrosis factor);GO:0071393(cellular response to progesterone stimulus);GO:0072573(tolerance induction to lipopolysaccharide);GO:2000379(positive regulation of reactive oxygen species metabolic process)","00650(Butanoate metabolism)","mRNA","agilent G3 V3"]
["A_24_P79153",2.65,1.89,2.13,6.53,6.57,{"v":6.2,"d":"6.20"},{"v":0.34559585492228,"d":"0.35"},{"v":-1.53284218097086,"d":"-1.53"},"down",{"v":7.82570000000815e-05,"d":"0.00"},1,"yes","TTGGGCCAAAAAGAAACTTTTCCTTCATCATTTCCTGCACTCGCTGACCACAACTTTGGA","FALSE","NM_079834","ref|NM_079834|ens|ENST00000472442|ens|ENST00000316097|ens|ENST00000409472","SCAMP4","secretory carrier membrane protein 4","ref|Homo sapiens secretory carrier membrane protein 4 (SCAMP4), mRNA [NM_079834]","chr19",{"v":1922132,"d":"1922132.00"},1926005,"GO:0015031(protein transport);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3406281",13.57,13.65,13.54,12.91,12.83,12.91,{"v":1.05459249676585,"d":"1.05"},{"v":0.0766856373536037,"d":"0.08"},"up",{"v":7.83040000000845e-05,"d":"0.00"},1,"yes","TGACAAACATGGCTAAAAACAAAACATCAAATCCTGCCCCCGTGAAGAGTTCCCTGTCAC","FALSE","NM_015474","ref|NM_015474|gb|AB208944|gb|AK311150","SAMHD1","SAM domain and HD domain 1","ref|Homo sapiens SAM domain and HD domain 1 (SAMHD1), mRNA [NM_015474]","chr20",35518632,35580246,"GO:0003676(nucleic acid binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005886(plasma membrane);GO:0006203(dGTP catabolic process);GO:0006955(immune response);GO:0008270(zinc ion binding);GO:0008832(dGTPase activity);GO:0019221(cytokine-mediated signaling pathway);GO:0032567(dGTP binding);GO:0045088(regulation of innate immune response);GO:0046061(dATP catabolic process);GO:0051289(protein homotetramerization);GO:0051607(defense response to virus);GO:0060337(type I interferon-mediated signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_23_P141032",4.97,4.47,4.45,{"v":7.6,"d":"7.60"},7.71,7.86,{"v":0.599482088908071,"d":"0.60"},{"v":-0.738211444883429,"d":"-0.74"},"down",{"v":7.83220000000195e-05,"d":"0.00"},1,"yes","CAATTTCCACCTCTGTGTGTGTACGAGCTCATGAAAGTGTTGTGAAGAGCGAAGACTTTT","FALSE","NM_001861","ref|NM_001861|ens|ENST00000565078|ens|ENST00000570123|ens|ENST00000566617","COX4I1","cytochrome c oxidase subunit IV isoform 1","ref|Homo sapiens cytochrome c oxidase subunit IV isoform 1 (COX4I1), mRNA [NM_001861]","chr16",85832240,85838598,"GO:0004129(cytochrome-c oxidase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0006091(generation of precursor metabolites and energy);GO:0007584(response to nutrient);GO:0016020(membrane);GO:0022904(respiratory electron transport chain);GO:0044237(cellular metabolic process);GO:0044281(small molecule metabolic process);GO:0055085(transmembrane transport);GO:0070062(extracellular vesicular exosome)","00190(Oxidative phosphorylation);04260(Cardiac muscle contraction);05010(Alzheimer's disease);05012(Parkinson's disease);05016(Huntington's disease);04932(Non-alcoholic fatty liver disease (NAFLD))","mRNA","agilent G3 V3"]
["A_23_P26325",8.89,8.83,8.89,8.24,8.26,8.15,{"v":1.07951318458418,"d":"1.08"},{"v":0.110380863756946,"d":"0.11"},"up",{"v":7.83460000000069e-05,"d":"0.00"},1,"yes","AAGAAGAGCCACAGTGAGGGAGATCCCATCCCCTTGTCTGAACTGGAGCCATGGGCACAA","FALSE","NM_002987","ref|NM_002987|ens|ENST00000219244|ens|ENST00000616880|gb|BC069107","CCL17","chemokine (C-C motif) ligand 17","ref|Homo sapiens chemokine (C-C motif) ligand 17 (CCL17), mRNA [NM_002987]","chr16",57438680,57449974,"GO:0005102(receptor binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006935(chemotaxis);GO:0006954(inflammatory response);GO:0006955(immune response);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007267(cell-cell signaling);GO:0007275(multicellular organismal development);GO:0008009(chemokine activity);GO:0031729(CCR4 chemokine receptor binding);GO:0045662(negative regulation of myoblast differentiation);GO:0060326(cell chemotaxis)","04060(Cytokine-cytokine receptor interaction);04062(Chemokine signaling pathway)","mRNA","agilent G3 V3"]
["A_23_P114185",4.25,4.61,4.33,6.68,6.51,6.79,{"v":0.66016016016016,"d":"0.66"},{"v":-0.599112018540874,"d":"-0.60"},"down",{"v":7.83840000000424e-05,"d":"0.00"},1,"yes","TGTCCCGGTTCATCACGGCCAATCAGTATGAGATGGTGTAAGGAGAAGTCTTTCAAGAAT","FALSE","NM_004615","ref|NM_004615|ens|ENST00000471410|ens|ENST00000475216|ens|ENST00000378482","TSPAN7","tetraspanin 7","ref|Homo sapiens tetraspanin 7 (TSPAN7), mRNA [NM_004615]","chrX",38420624,38548167,"GO:0005887(integral to plasma membrane);GO:0016032(viral reproduction)","05202(Transcriptional misregulation in cancers)","mRNA","agilent G3 V3"]
["A_23_P133629",2.22,2.26,2.64,4.78,4.64,4.79,{"v":0.501055594651654,"d":"0.50"},{"v":-0.996957408276382,"d":"-1.00"},"down",{"v":7.85200000000819e-05,"d":"0.00"},1,"yes","ATGAGGTAAAGGGAATCATTCTTATGGTGCTCTTGGAGAGTTTCAGGCCTGTGCATGTGT","FALSE","NM_004661","ref|NM_004661|ens|ENST00000394886|gb|BC017713|gb|AF053977","CDC23","cell division cycle 23","ref|Homo sapiens cell division cycle 23 (CDC23), mRNA [NM_004661]","chr5",137523344,137549032,"GO:0000278(mitotic cell cycle);GO:0004842(ubiquitin-protein ligase activity);GO:0005622(intracellular);GO:0005654(nucleoplasm);GO:0005680(anaphase-promoting complex);GO:0005829(cytosol);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007067(mitosis);GO:0007080(mitotic metaphase plate congression);GO:0007091(mitotic metaphase/anaphase transition);GO:0007094(mitotic cell cycle spindle assembly checkpoint);GO:0007096(regulation of exit from mitosis);GO:0030071(regulation of mitotic metaphase/anaphase transition);GO:0031145(anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process);GO:0051301(cell division);GO:0051436(negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle);GO:0051437(positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle);GO:0051439(regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle);GO:0070979(protein K11-linked ubiquitination)","04120(Ubiquitin mediated proteolysis);04110(Cell cycle);04114(Oocyte meiosis);04914(Progesterone-mediated oocyte maturation);05166(HTLV-I infection)","mRNA","agilent G3 V3"]
["A_33_P3218178",{"v":2,"d":"2.00"},2.02,2.18,3.82,4.12,4.14,{"v":0.513245033112583,"d":"0.51"},{"v":-0.962280334050841,"d":"-0.96"},"down",{"v":7.86500000000689e-05,"d":"0.00"},1,"yes","CAGCTCAAACATTTATCATTTCTTTGCATTGGGAACATTCCAAATCTTCTCTTCTAGCTA","FALSE","NM_001012755","ref|NM_001012755|ens|ENST00000594199|gb|AL833609|tc|THC2493401","SLC25A53","solute carrier family 25, member 53","ref|Homo sapiens solute carrier family 25, member 53 (SLC25A53), mRNA [NM_001012755]","chrX",103343896,103401708,"GO:0005743(mitochondrial inner membrane);GO:0006810(transport);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3412687",{"v":8.9,"d":"8.90"},8.95,8.97,9.58,{"v":9.7,"d":"9.70"},9.61,{"v":0.928348909657321,"d":"0.93"},{"v":-0.107260966660142,"d":"-0.11"},"down",{"v":7.88170000000088e-05,"d":"0.00"},1,"yes","CCCTGTCTGCATATGGCCTCTCCAGCGTGACCCTGTCTGCCTGTTGCCTCTCCAGTGTGA","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_33_P3257460",14.08,14.07,14.08,14.32,14.35,{"v":14.3,"d":"14.30"},{"v":0.982778682801955,"d":"0.98"},{"v":-0.0250615299726366,"d":"-0.03"},"down",{"v":7.90620000000741e-05,"d":"0.00"},1,"yes","CCCATTCCTGTGCGGACAGCCCTTCCTCCCATTTCCCATTAAAGAGCCAGTTTATTTTCT","FALSE","NM_018973","ref|NM_018973|ref|NM_153741|ens|ENST00000341298|ens|ENST00000368400","DPM3","dolichyl-phosphate mannosyltransferase polypeptide 3","ref|Homo sapiens dolichyl-phosphate mannosyltransferase polypeptide 3 (DPM3), transcript variant 1, mRNA [NM_018973]","chr1",155112368,155113071,"GO:0004582(dolichyl-phosphate beta-D-mannosyltransferase activity);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005975(carbohydrate metabolic process);GO:0006488(dolichol-linked oligosaccharide biosynthetic process);GO:0006501(C-terminal protein lipidation);GO:0006506(GPI anchor biosynthetic process);GO:0016020(membrane);GO:0018279(protein N-linked glycosylation via asparagine);GO:0018406(protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan);GO:0030176(integral to endoplasmic reticulum membrane);GO:0031501(mannosyltransferase complex);GO:0031647(regulation of protein stability);GO:0033185(dolichol-phosphate-mannose synthase complex);GO:0035268(protein mannosylation);GO:0035269(protein O-linked mannosylation);GO:0043687(post-translational protein modification);GO:0044267(cellular protein metabolic process)","00510(N-Glycan biosynthesis)","mRNA","agilent G3 V3"]
["A_23_P111005",5.59,5.69,5.81,{"v":7.8,"d":"7.80"},7.46,7.67,{"v":0.745311818578282,"d":"0.75"},{"v":-0.424083957904654,"d":"-0.42"},"down",{"v":7.91460000000299e-05,"d":"0.00"},1,"yes","TTAAAGGACAGTCCTGATGACATGTTTCGTAGATGGGGTTTGCAGCTGCCACTGAGCTGT","FALSE","NM_015388","ref|NM_015388|ens|ENST00000510102|ens|ENST00000372422|ref|XM_005248990","YIPF3","Yip1 domain family, member 3","ref|Homo sapiens Yip1 domain family, member 3 (YIPF3), mRNA [NM_015388]","chr6",43480568,43481459,"GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0016021(integral to membrane);GO:0030133(transport vesicle);GO:0030154(cell differentiation);GO:0043231(intracellular membrane-bounded organelle)",null,"mRNA","agilent G3 V3"]
["A_23_P102571",6.58,6.78,6.99,9.14,9.07,8.91,{"v":0.750368731563422,"d":"0.75"},{"v":-0.414328383982734,"d":"-0.41"},"down",{"v":7.92490000000035e-05,"d":"0.00"},1,"yes","CATGTTTGTTTTTGAAGCTCAGGTGTCTCACGTCTGGGCTGCACCAGGCGAAGAGAGAAA","FALSE","NM_020062","ref|NM_020062|ens|ENST00000619497|ens|ENST00000266077|ens|ENST00000493772","SLC2A4RG","SLC2A4 regulator","ref|Homo sapiens SLC2A4 regulator (SLC2A4RG), mRNA [NM_020062]","chr20",62373880,62374470,"GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P114445",9.67,9.68,9.72,8.47,8.68,8.64,{"v":1.12718107793718,"d":"1.13"},{"v":0.172719298347023,"d":"0.17"},"up",{"v":7.92729999999908e-05,"d":"0.00"},1,"yes","TTTGAGCCTCAGTTCTCATGTATTGGGGGGTGGGGGTGGGTACATATTGTATTTGGTATT","FALSE","NM_020932","ref|NM_020932|ens|ENST00000361470|gb|AK291270|gb|AB046807","MAGEE1","melanoma antigen family E, 1","ref|Homo sapiens melanoma antigen family E, 1 (MAGEE1), mRNA [NM_020932]","chrX",75648048,75651744,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0005886(plasma membrane);GO:0008150(biological_process);GO:0016010(dystrophin-associated glycoprotein complex);GO:0030425(dendrite);GO:0045211(postsynaptic membrane);GO:0048471(perinuclear region of cytoplasm)",null,"mRNA","agilent G3 V3"]
["A_23_P258944",2.22,2.28,2.53,5.16,5.44,5.72,{"v":0.430759803921569,"d":"0.43"},{"v":-1.21504446289896,"d":"-1.22"},"down",{"v":7.93300000000441e-05,"d":"0.00"},1,"yes","ATTTCTTTCTTAGTTGTTGGCACTCTTAGGTCTTAGTATGGATTTATGTGTTTGTGTGTG","FALSE","NM_012328","ref|NM_012328|ens|ENST00000249356|gb|AY359045|gb|AF083247","DNAJB9","DnaJ (Hsp40) homolog, subfamily B, member 9","ref|Homo sapiens DnaJ (Hsp40) homolog, subfamily B, member 9 (DNAJB9), mRNA [NM_012328]","chr7",108210016,108215294,"GO:0005515(protein binding);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005788(endoplasmic reticulum lumen);GO:0005789(endoplasmic reticulum membrane);GO:0006987(activation of signaling protein activity involved in unfolded protein response);GO:0030433(ER-associated protein catabolic process);GO:0030968(endoplasmic reticulum unfolded protein response);GO:0044267(cellular protein metabolic process);GO:0051787(misfolded protein binding);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3364964",7.31,{"v":7.1,"d":"7.10"},7.41,9.13,9.03,8.94,{"v":0.805166051660517,"d":"0.81"},{"v":-0.312641749917627,"d":"-0.31"},"down",{"v":7.93500000000336e-05,"d":"0.00"},1,"yes","GGCCTGTCAGGGCAACCTCCTCGGCTCCTGCAGCACAATCTTTCTGGTTCACTGCAGTAA","FALSE","AK130913","gb|AK130913|tc|THC2489577","LOC100129596","uncharacterized LOC100129596","gb|Homo sapiens cDNA FLJ27403 fis, clone WMC03327. [AK130913]","chr8",146044448,146046151,null,null,"mRNA","agilent G3 V3"]
["A_32_P155091",6.65,6.28,6.45,9.06,8.93,8.71,{"v":0.725842696629213,"d":"0.73"},{"v":-0.462271171159835,"d":"-0.46"},"down",{"v":7.9497000000095e-05,"d":"0.00"},1,"yes","GAGTGACCTGTGTGAGAGACAGACAGATGCCCCATGAGGATGGCTGGACAAGAACTTTTA","FALSE","NM_145714","ref|NM_145714|ref|NM_007245|ref|NM_148414|ref|NM_017492","ATXN2L","ataxin 2-like","ref|Homo sapiens ataxin 2-like (ATXN2L), transcript variant B, mRNA [NM_145714]","chr7",16623407,16626382,"GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0010494(cytoplasmic stress granule);GO:0010603(regulation of cytoplasmic mRNA processing body assembly);GO:0016020(membrane);GO:0016607(nuclear speck);GO:0034063(stress granule assembly)",null,"mRNA","agilent G3 V3"]
["A_23_P144827",5.79,5.33,5.66,8.66,8.35,8.74,{"v":0.651650485436893,"d":"0.65"},{"v":-0.61782971651812,"d":"-0.62"},"down",{"v":7.96240000000559e-05,"d":"0.00"},1,"yes","ACAAAGCTGACTGTTCACACTGATTGCCCAGCACATACCGTCTTGCCAGTTTCTTCTTTT","FALSE","NM_012304","ref|NM_012304|ref|NM_001278317|ens|ENST00000504595|ens|ENST00000329673","FBXL7","F-box and leucine-rich repeat protein 7","ref|Homo sapiens F-box and leucine-rich repeat protein 7 (FBXL7), transcript variant 1, mRNA [NM_012304]","chr5",15500305,15939900,"GO:0000086(G2/M transition of mitotic cell cycle);GO:0000151(ubiquitin ligase complex);GO:0004842(ubiquitin-protein ligase activity);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007067(mitosis);GO:0008283(cell proliferation);GO:0016567(protein ubiquitination);GO:0019005(SCF ubiquitin ligase complex);GO:0031146(SCF-dependent proteasomal ubiquitin-dependent protein catabolic process);GO:0051301(cell division)",null,"mRNA","agilent G3 V3"]
["A_23_P5389",{"v":3.4,"d":"3.40"},3.05,2.94,5.91,5.94,6.25,{"v":0.51878453038674,"d":"0.52"},{"v":-0.946792634316794,"d":"-0.95"},"down",{"v":7.97110000000378e-05,"d":"0.00"},1,"yes","TACCTGGATCAGACAGTTGTGCCTATCTTATTACAGGGACTTGCTGTGCTTGCAAAGGAA","FALSE","NM_032574","ref|NM_032574|ens|ENST00000540596|ens|ENST00000295066|ens|ENST00000414013","DPY30","dpy-30 homolog (C. elegans)","ref|Homo sapiens dpy-30 homolog (C. elegans) (DPY30), mRNA [NM_032574]","chr2",32249172,32264874,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0016197(endosomal transport);GO:0035097(histone methyltransferase complex);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0048188(Set1C/COMPASS complex);GO:0051568(histone H3-K4 methylation)",null,"mRNA","agilent G3 V3"]
["A_33_P3353692",5.52,5.18,5.45,7.51,7.57,{"v":7.8,"d":"7.80"},{"v":0.705856643356643,"d":"0.71"},{"v":-0.502552887197102,"d":"-0.50"},"down",{"v":7.9801000000046e-05,"d":"0.00"},1,"yes","CAAGAAGGTCATCCAGTATCTGGCGTACGTGGCGTCCTCGCACAAGAGCAAGAAGGACCA","FALSE","NM_002473","ref|NM_002473|ens|ENST00000463027|ens|ENST00000216181|gb|L29141","MYH9","myosin, heavy chain 9, non-muscle","ref|Homo sapiens myosin, heavy chain 9, non-muscle (MYH9), mRNA [NM_002473]","chr22",36721080,36761157,"GO:0000146(microfilament motor activity);GO:0000212(meiotic spindle organization);GO:0000910(cytokinesis);GO:0001525(angiogenesis);GO:0001701(in utero embryonic development);GO:0001725(stress fiber);GO:0001726(ruffle);GO:0001768(establishment of T cell polarity);GO:0001772(immunological synapse);GO:0001931(uropod);GO:0003774(motor activity);GO:0003779(actin binding);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005819(spindle);GO:0005826(actomyosin contractile ring);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005913(cell-cell adherens junction);GO:0006200(ATP catabolic process);GO:0006509(membrane protein ectodomain proteolysis);GO:0007229(integrin-mediated signaling pathway);GO:0007411(axon guidance);GO:0007520(myoblast fusion);GO:0008180(signalosome);GO:0008305(integrin complex);GO:0008360(regulation of cell shape);GO:0015031(protein transport);GO:0015629(actin cytoskeleton);GO:0016020(membrane);GO:0016460(myosin II complex);GO:0016887(ATPase activity);GO:0030048(actin filament-based movement);GO:0030220(platelet formation);GO:0030224(monocyte differentiation);GO:0030863(cortical cytoskeleton);GO:0030898(actin-dependent ATPase activity);GO:0031032(actomyosin structure organization);GO:0031252(cell leading edge);GO:0031532(actin cytoskeleton reorganization);GO:0031594(neuromuscular junction);GO:0032154(cleavage furrow);GO:0032796(uropod organization);GO:0038032(termination of G-protein coupled receptor signaling pathway);GO:0042641(actomyosin);GO:0042803(protein homodimerization activity);GO:0043234(protein complex);GO:0043495(protein anchor);GO:0043531(ADP binding);GO:0043534(blood vessel endothelial cell migration);GO:0048013(ephrin receptor signaling pathway);GO:0050900(leukocyte migration);GO:0051015(actin filament binding);GO:0051295(establishment of meiotic spindle localization);GO:0070062(extracellular vesicular exosome);GO:0070527(platelet aggregation)","04810(Regulation of actin cytoskeleton);04530(Tight junction);05132(Salmonella infection)","mRNA","agilent G3 V3"]
["A_33_P3213997",4.01,4.05,4.39,6.32,6.52,6.55,{"v":0.642083548220732,"d":"0.64"},{"v":-0.639167061151349,"d":"-0.64"},"down",{"v":7.98520000000469e-05,"d":"0.00"},1,"yes","ATTAACAACTTGCAAATGAGGTGCAAATAAAATGCAGATGATTGCGCGGCTTTGAATCCA","FALSE","NM_001193636","ref|NM_001193636|ref|NM_001193637|ref|NM_198083|ref|NM_001193635","DHRS4L2","dehydrogenase/reductase (SDR family) member 4 like 2","ref|Homo sapiens dehydrogenase/reductase (SDR family) member 4 like 2 (DHRS4L2), transcript variant 3, mRNA [NM_001193636]","chr14",24521206,24538916,"GO:0005576(extracellular region);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)","00830(Retinol metabolism)","mRNA","agilent G3 V3"]
["A_33_P3423859",12.14,12.29,12.16,11.32,11.21,11.25,{"v":1.08318531675548,"d":"1.08"},{"v":0.115280087537701,"d":"0.12"},"up",{"v":8.00340000000066e-05,"d":"0.00"},1,"yes","GCTGGGTTGTCCCCCCAAACATATTTTAATATGTTATTTAAAATGATTTTACCCAAGCCT","FALSE","NM_006242","ref|NM_006242|ens|ENST00000370996|gb|BC047502|gb|BX647298","PPP1R3D","protein phosphatase 1, regulatory subunit 3D","ref|Homo sapiens protein phosphatase 1, regulatory subunit 3D (PPP1R3D), mRNA [NM_006242]","chr20",58511896,58515352,"GO:0004722(protein serine/threonine phosphatase activity);GO:0005977(glycogen metabolic process);GO:0005979(regulation of glycogen biosynthetic process);GO:0005981(regulation of glycogen catabolic process);GO:0016311(dephosphorylation);GO:0019899(enzyme binding);GO:0042587(glycogen granule);GO:0043231(intracellular membrane-bounded organelle)","04910(Insulin signaling pathway)","mRNA","agilent G3 V3"]
["A_33_P3788618",12.58,12.66,12.72,11.81,11.75,11.86,{"v":1.07171089779785,"d":"1.07"},{"v":0.099915780269195,"d":"0.10"},"up",{"v":8.01730000000722e-05,"d":"0.00"},1,"yes","AATTTTTAAATACTGAGCACAATTTTTAAATACTGACATCACTTCCGCTTCCCCCTCCCA","FALSE","NM_001010887","ref|NM_001010887|ens|ENST00000340967|ref|XM_005251448|ref|XM_005251447","ACER2","alkaline ceramidase 2","ref|Homo sapiens alkaline ceramidase 2 (ACER2), mRNA [NM_001010887]","chr9",19409056,19452018,"GO:0000139(Golgi membrane);GO:0001953(negative regulation of cell-matrix adhesion);GO:0005794(Golgi apparatus);GO:0006665(sphingolipid metabolic process);GO:0006672(ceramide metabolic process);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0008284(positive regulation of cell proliferation);GO:0010942(positive regulation of cell death);GO:0017040(ceramidase activity);GO:0030148(sphingolipid biosynthetic process);GO:0030173(integral to Golgi membrane);GO:0032526(response to retinoic acid);GO:0033629(negative regulation of cell adhesion mediated by integrin);GO:0035690(cellular response to drug);GO:0044281(small molecule metabolic process);GO:0046512(sphingosine biosynthetic process);GO:0071633(dihydroceramidase activity);GO:0090285(negative regulation of protein glycosylation in Golgi)","00600(Sphingolipid metabolism);04071(Sphingolipid signaling pathway)","mRNA","agilent G3 V3"]
["A_33_P3225298",13.34,13.37,13.27,11.73,12.01,11.92,{"v":1.12114413909142,"d":"1.12"},{"v":0.164971769119633,"d":"0.16"},"up",{"v":8.02470000000888e-05,"d":"0.00"},1,"yes","GGGTTTGCCCCCTCACTATTTTTAATCCAGACTATTTTATACCTATCAGTATAACTATAG","FALSE","NM_001287258","ref|NM_001287258|ref|NM_001287259|ref|NM_001011720|ref|NM_001287260","XKR9","XK, Kell blood group complex subunit-related family, member 9","ref|Homo sapiens XK, Kell blood group complex subunit-related family, member 9 (XKR9), transcript variant 2, mRNA [NM_001287258]","chr8",71581632,71646725,"GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P416711",9.53,9.48,9.48,8.67,8.77,8.61,{"v":1.0936660268714,"d":"1.09"},{"v":0.129172249157981,"d":"0.13"},"up",{"v":8.03340000000707e-05,"d":"0.00"},1,"yes","AATAAACAGAGACAAATGTTAAAATTGCCATACAGACTGTTTTTCCCCCTGTTGTTTCAC","FALSE","NM_152996","ref|NM_152996|gb|AK091215|gb|AX746855|gb|BC059363","ST6GALNAC3","ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3","ref|Homo sapiens ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 (ST6GALNAC3), transcript variant 1, mRNA [NM_152996]","chr1",76540400,77100286,"GO:0000139(Golgi membrane);GO:0006488(dolichol-linked oligosaccharide biosynthetic process);GO:0006677(glycosylceramide metabolic process);GO:0006687(glycosphingolipid metabolic process);GO:0008373(sialyltransferase activity);GO:0009100(glycoprotein metabolic process);GO:0016021(integral to membrane);GO:0018279(protein N-linked glycosylation via asparagine);GO:0043687(post-translational protein modification);GO:0044267(cellular protein metabolic process)","00604(Glycosphingolipid biosynthesis - ganglio series)","mRNA","agilent G3 V3"]
["A_23_P148410",6.81,6.72,6.88,8.11,8.11,8.32,{"v":0.831703341483293,"d":"0.83"},{"v":-0.265859066630186,"d":"-0.27"},"down",{"v":8.04400000000705e-05,"d":"0.00"},1,"yes","GCTGGAGCTCTACACCTCCTACCTGTACCTGTCTATGGCCTTCTACTTCAACCGGGACGA","FALSE","NM_031894","ref|NM_031894|ens|ENST00000359202|gb|BC069538|gb|BC100768","FTHL17","ferritin, heavy polypeptide-like 17","ref|Homo sapiens ferritin, heavy polypeptide-like 17 (FTHL17), mRNA [NM_031894]","chrX",31089360,31090170,"GO:0006826(iron ion transport);GO:0006879(cellular iron ion homeostasis);GO:0008199(ferric iron binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3240518",3.53,4.15,3.86,7.21,6.93,7.06,{"v":0.544339622641509,"d":"0.54"},{"v":-0.877421040805079,"d":"-0.88"},"down",{"v":8.06130000000627e-05,"d":"0.00"},1,"yes","TGCTGAAGATCCGCCGGCGGAAGATGAACCACCACAAGTACCGGAAGCTGGTGAAGAAGA","FALSE","NM_001127230","ref|NM_001127230|ref|NM_017900|ref|NM_001127229|ens|ENST00000378853","AURKAIP1","aurora kinase A interacting protein 1","ref|Homo sapiens aurora kinase A interacting protein 1 (AURKAIP1), transcript variant 3, mRNA [NM_001127230]","chr1",{"v":1309818,"d":"1309818.00"},1310539,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0006996(organelle organization);GO:0032543(mitochondrial translation);GO:0043231(intracellular membrane-bounded organelle);GO:0045839(negative regulation of mitosis);GO:0045862(positive regulation of proteolysis);GO:0070124(mitochondrial translational initiation);GO:0070125(mitochondrial translational elongation);GO:0070126(mitochondrial translational termination)",null,"mRNA","agilent G3 V3"]
["A_33_P3336462",6.26,6.37,6.64,4.27,4.42,4.44,{"v":1.46763137852247,"d":"1.47"},{"v":0.553489655402834,"d":"0.55"},"up",{"v":8.07100000000949e-05,"d":"0.00"},1,"yes","CATCAGAAAACACAAGATATAGGGACTGGAGGCCTCTCCACAAATGAAATGGATATGGGA","FALSE","AK123300","gb|AK123300|tc|THC2513440",null,null,"gb|Homo sapiens cDNA FLJ41306 fis, clone BRAMY2042549. [AK123300]","chr7",{"v":6714599,"d":"6714599.00"},6715967,null,null,"mRNA","agilent G3 V3"]
["A_24_P206776",7.42,7.53,7.69,9.21,9.19,9.41,{"v":0.814095649047105,"d":"0.81"},{"v":-0.296729786514805,"d":"-0.30"},"down",{"v":8.07220000000886e-05,"d":"0.00"},1,"yes","TGTAGACCCTCTCACCATTACTTCATCCCTGTCATCTGATGGGGTCCTCACTGTGAATGG","FALSE","NM_001885","ref|NM_001885|ref|NM_001289808|ref|NM_001289807|ens|ENST00000527899","CRYAB","crystallin, alpha B","ref|Homo sapiens crystallin, alpha B (CRYAB), transcript variant 1, mRNA [NM_001885]","chr11",111779624,111784303,"GO:0001666(response to hypoxia);GO:0002088(lens development in camera-type eye);GO:0005212(structural constituent of eye lens);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006457(protein folding);GO:0006936(muscle contraction);GO:0007021(tubulin complex assembly);GO:0007517(muscle organ development);GO:0007568(aging);GO:0008017(microtubule binding);GO:0009986(cell surface);GO:0010941(regulation of cell death);GO:0015630(microtubule cytoskeleton);GO:0030018(Z disc);GO:0030308(negative regulation of cell growth);GO:0031109(microtubule polymerization or depolymerization);GO:0032355(response to estradiol stimulus);GO:0032387(negative regulation of intracellular transport);GO:0032432(actin filament bundle);GO:0042542(response to hydrogen peroxide);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043066(negative regulation of apoptotic process);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0046872(metal ion binding);GO:0051082(unfolded protein binding);GO:0051260(protein homooligomerization);GO:0051403(stress-activated MAPK cascade);GO:0060561(apoptotic process involved in morphogenesis);GO:0070062(extracellular vesicular exosome);GO:0071480(cellular response to gamma radiation);GO:2000378(negative regulation of reactive oxygen species metabolic process)","04141(Protein processing in endoplasmic reticulum)","mRNA","agilent G3 V3"]
["A_24_P376422",5.95,5.69,5.65,7.51,7.58,7.72,{"v":0.758000876808417,"d":"0.76"},{"v":-0.399728577669856,"d":"-0.40"},"down",{"v":8.08950000000808e-05,"d":"0.00"},1,"yes","GAGCCAAGTTTGCATTTTCACACGCATCTCACACTCCTCTGCACTCTCAACTTGGAGAGC","FALSE","ENST00000538869","ens|ENST00000538869|ref|XM_006716222|gb|BC035371|gb|DQ892414",null,null,"ens|RAS p21 protein activator 4 [Source:HGNC Symbol;Acc:HGNC:23181] [ENST00000538869]","chr7",102220096,102257204,null,null,"mRNA","agilent G3 V3"]
["A_24_P791829",2.76,3.05,2.66,4.73,4.81,4.78,{"v":0.591480446927374,"d":"0.59"},{"v":-0.757597617932058,"d":"-0.76"},"down",{"v":8.09420000000838e-05,"d":"0.00"},1,"yes","TTTTCCCTTTTGCTAAATGCTTAGGTATTTGCTATAGCTGTTTCTGATGTCATGGATTCT","FALSE","NM_020772","ref|NM_020772|ens|ENST00000225388|tc|THC2543120","NUFIP2","nuclear fragile X mental retardation protein interacting protein 2","ref|Homo sapiens nuclear fragile X mental retardation protein interacting protein 2 (NUFIP2), mRNA [NM_020772]","chr17",27582854,27621136,"GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0016020(membrane);GO:0042788(polysomal ribosome)",null,"mRNA","agilent G3 V3"]
["A_19_P00316185",8.19,{"v":8.2,"d":"8.20"},7.92,9.62,9.64,{"v":9.7,"d":"9.70"},{"v":0.839433701657459,"d":"0.84"},{"v":-0.252511709054476,"d":"-0.25"},"down",{"v":8.09689999999863e-05,"d":"0.00"},1,"yes","GTCTCTGCTGTACTTTCCCTGCCTCTACCTCACTTAGTAAAGAAATCATCTTTGCTTGAT","FALSE","XR_426095","ref|XR_426095|ref|XR_428011|ref|XR_432057|ref|XR_245573","LOC101927686","uncharacterized LOC101927686","ref|PREDICTED: Homo sapiens uncharacterized LOC101927686 (LOC101927686), transcript variant X8, ncRNA [XR_426095]","chr6",113944984,113953716,null,null,"mRNA","agilent G3 V3"]
["A_23_P107073",4.78,4.87,4.58,7.17,6.96,7.38,{"v":0.661552766155277,"d":"0.66"},{"v":-0.596071862896578,"d":"-0.60"},"down",{"v":8.10130000000742e-05,"d":"0.00"},1,"yes","GGCTACAAAGCGTTTCTTTACTTTTCACTTCAATTAATGCTGCGCTTCGCTTGGTGAGTG","FALSE","NM_002945","ref|NM_002945|ens|ENST00000254719|gb|BC018126|tc|THC2467849","RPA1","replication protein A1, 70kDa","ref|Homo sapiens replication protein A1, 70kDa (RPA1), mRNA [NM_002945]","chr17",{"v":1794944,"d":"1794944.00"},1800830,"GO:0000082(G1/S transition of mitotic cell cycle);GO:0000278(mitotic cell cycle);GO:0000718(nucleotide-excision repair, DNA damage removal);GO:0000722(telomere maintenance via recombination);GO:0000723(telomere maintenance);GO:0000724(double-strand break repair via homologous recombination);GO:0000730(DNA recombinase assembly);GO:0000800(lateral element);GO:0001673(male germ cell nucleus);GO:0001701(in utero embryonic development);GO:0003682(chromatin binding);GO:0003684(damaged DNA binding);GO:0003697(single-stranded DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005662(DNA replication factor A complex);GO:0006260(DNA replication);GO:0006261(DNA-dependent DNA replication);GO:0006271(DNA strand elongation involved in DNA replication);GO:0006281(DNA repair);GO:0006283(transcription-coupled nucleotide-excision repair);GO:0006284(base-excision repair);GO:0006289(nucleotide-excision repair);GO:0006297(nucleotide-excision repair, DNA gap filling);GO:0006298(mismatch repair);GO:0006302(double-strand break repair);GO:0006310(DNA recombination);GO:0007126(meiosis);GO:0008284(positive regulation of cell proliferation);GO:0016605(PML body);GO:0030097(hemopoiesis);GO:0032201(telomere maintenance via semi-conservative replication);GO:0034605(cellular response to heat);GO:0046872(metal ion binding);GO:0048873(homeostasis of number of cells within a tissue);GO:1900034(regulation of cellular response to heat)","03030(DNA replication);03420(Nucleotide excision repair);03430(Mismatch repair);03440(Homologous recombination);03460(Fanconi anemia pathway)","mRNA","agilent G3 V3"]
["A_23_P157147",6.27,6.56,6.36,7.92,8.05,7.92,{"v":0.80326496442026,"d":"0.80"},{"v":-0.316052142260952,"d":"-0.32"},"down",{"v":8.13130000000273e-05,"d":"0.00"},1,"yes","CTTCGGAGCAACCTTCAAGAGATCTTTCTACCTGCCTTTCCATGTCATGAGAGGAAGAAA","FALSE","NM_018106","ref|NM_018106|ref|NM_001134387|ref|NM_001134388|ref|NM_001134389","ZDHHC4","zinc finger, DHHC-type containing 4","ref|Homo sapiens zinc finger, DHHC-type containing 4 (ZDHHC4), transcript variant 3, mRNA [NM_018106]","chr7",{"v":6617065,"d":"6617065.00"},6628609,"GO:0005794(Golgi apparatus);GO:0008152(metabolic process);GO:0008270(zinc ion binding);GO:0016021(integral to membrane);GO:0019706(protein-cysteine S-palmitoleyltransferase activity)",null,"mRNA","agilent G3 V3"]
["A_23_P77048",2.75,2.93,{"v":2.8,"d":"2.80"},5.27,5.82,5.58,{"v":0.50869826034793,"d":"0.51"},{"v":-0.975117934423218,"d":"-0.98"},"down",{"v":8.19530000000235e-05,"d":"0.00"},1,"yes","GGGAATGTGCTCAGTGAAGACGACACTGGGCTTTGCACAGCCTGGTGTCGCTGTACAGAA","FALSE","NM_001039355","ref|NM_001039355|ref|NM_001291813|ref|NM_001291814|ref|NM_152333","SLC25A29","solute carrier family 25 (mitochondrial carnitine/acylcarnitine carrier), member 29","ref|Homo sapiens solute carrier family 25 (mitochondrial carnitine/acylcarnitine carrier), member 29 (SLC25A29), transcript variant 1, mRNA [NM_001039355]","chr14",100757456,100772778,"GO:0005743(mitochondrial inner membrane);GO:0015227(acyl carnitine transporter activity);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3228366",{"v":13.1,"d":"13.10"},13.22,13.16,11.76,11.82,{"v":12,"d":"12.00"},{"v":1.10961214165261,"d":"1.11"},{"v":0.150055479189238,"d":"0.15"},"up",{"v":8.19590000000758e-05,"d":"0.00"},1,"yes","GTTTGCTGTGTTTCAAAGAAGGGTGCTGACCACAGTAGTGCTCCCCCAGCAGATGGAGAC","FALSE","NM_020750","ref|NM_020750|ens|ENST00000486936|ens|ENST00000488195|ens|ENST00000265351","XPO5","exportin 5","ref|Homo sapiens exportin 5 (XPO5), mRNA [NM_020750]","chr6",43494924,43496605,"GO:0000049(tRNA binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006611(protein export from nucleus);GO:0008536(Ran GTPase binding);GO:0008565(protein transporter activity);GO:0010467(gene expression);GO:0031047(gene silencing by RNA)","03013(RNA transport)","mRNA","agilent G3 V3"]
["A_23_P373568",10.02,9.94,10.02,9.09,9.17,9.24,{"v":1.09018181818182,"d":"1.09"},{"v":0.124568764648475,"d":"0.12"},"up",{"v":8.19890000000045e-05,"d":"0.00"},1,"yes","TCTCTCTGTTTATTCGCTCACAATAATACACAGCCCCTGGATGGGGAGGGGGTAGGAGGG","FALSE","NM_025129","ref|NM_025129|ref|NM_001171937|ref|NR_033269|ens|ENST00000377092","FUZ","fuzzy planar cell polarity protein","ref|Homo sapiens fuzzy planar cell polarity protein (FUZ), transcript variant 1, mRNA [NM_025129]","chr19",50310336,50316567,"GO:0001736(establishment of planar polarity);GO:0001843(neural tube closure);GO:0001942(hair follicle development);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0008285(negative regulation of cell proliferation);GO:0008589(regulation of smoothened signaling pathway);GO:0010172(embryonic body morphogenesis);GO:0015031(protein transport);GO:0021513(spinal cord dorsal/ventral patterning);GO:0030336(negative regulation of cell migration);GO:0035058(nonmotile primary cilium assembly);GO:0042384(cilium assembly);GO:0045724(positive regulation of flagellum assembly);GO:0048704(embryonic skeletal system morphogenesis);GO:0070062(extracellular vesicular exosome);GO:0090090(negative regulation of canonical Wnt receptor signaling pathway);GO:0090301(negative regulation of neural crest formation);GO:2000314(negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation)",null,"mRNA","agilent G3 V3"]
["A_23_P432005",10.18,10.35,10.31,8.89,8.74,8.98,{"v":1.15896279594138,"d":"1.16"},{"v":0.212834254892814,"d":"0.21"},"up",{"v":8.20080000000223e-05,"d":"0.00"},1,"yes","AGGCAAAGCTCGATGCTCAACTCCGGGACAAAGAGTTTTACAGGCCCATCCCTAACCCCA","FALSE","NM_152670","ref|NM_152670|ens|ENST00000303254|ref|XM_005264188|ref|XM_006711964","TEX37","testis expressed 37","ref|Homo sapiens testis expressed 37 (TEX37), mRNA [NM_152670]","chr2",88824168,88829102,"GO:0005634(nucleus)",null,"mRNA","agilent G3 V3"]
["A_33_P3396270",{"v":7.8,"d":"7.80"},7.54,7.58,9.01,8.95,{"v":9,"d":"9.00"},{"v":0.850148367952522,"d":"0.85"},{"v":-0.234213452424954,"d":"-0.23"},"down",{"v":8.20800000000954e-05,"d":"0.00"},1,"yes","CTGAGAATGATGATTTTCAATTTCATCCATGTCCCTACAAAGGACATGAACTCATCATTT","FALSE","NM_001011552","ref|NM_001011552|ref|NM_001287258|ref|NM_001287259|ref|NM_001011720","SLC9A4","solute carrier family 9, subfamily A (NHE4, cation proton antiporter 4), member 4","ref|Homo sapiens solute carrier family 9, subfamily A (NHE4, cation proton antiporter 4), member 4 (SLC9A4), mRNA [NM_001011552]","chr2",103089760,103150431,"GO:0001696(gastric acid secretion);GO:0002064(epithelial cell development);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0006885(regulation of pH);GO:0015385(sodium:hydrogen antiporter activity);GO:0016021(integral to membrane);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0035725(sodium ion transmembrane transport);GO:0055085(transmembrane transport)","04971(Gastric acid secretion)","mRNA","agilent G3 V3"]
["A_33_P3257755",9.36,9.17,9.64,11.67,11.78,11.65,{"v":0.802564102564103,"d":"0.80"},{"v":-0.317311466816992,"d":"-0.32"},"down",{"v":8.2201000000004e-05,"d":"0.00"},1,"yes","ATCCTGGTCCTGGTTCTGCCCTGACCCTGGCCTTGCTCTGGATCCTCTCTGGTTCTGCTT","FALSE",{"$nulls":5},"chr9",70348576,70349113,null,null,"mRNA","agilent G3 V3"]
["A_23_P58862",1.97,1.91,1.97,3.78,4.08,{"v":3.7,"d":"3.70"},{"v":0.506055363321799,"d":"0.51"},{"v":-0.982632868029912,"d":"-0.98"},"down",{"v":8.23140000000278e-05,"d":"0.00"},1,"yes","AGCACCATACTTTGAGGGTACGCAGATTTTCTGAGGCATTCTTTTGTTTTGAGCATCCAA","FALSE","NM_020819","ref|NM_020819|ref|NM_001105531|ref|NM_001162529|ens|ENST00000515323","FAM135A","family with sequence similarity 135, member A","ref|Homo sapiens family with sequence similarity 135, member A (FAM135A), transcript variant 2, mRNA [NM_020819]","chr6",71123008,71270877,null,null,"mRNA","agilent G3 V3"]
["A_33_P3267640",8.15,8.24,8.11,9.02,8.93,9.04,{"v":0.907743608743979,"d":"0.91"},{"v":-0.139643227576919,"d":"-0.14"},"down",{"v":8.23840000000464e-05,"d":"0.00"},1,"yes","GCGGGACACCCTGGTTCCCACCATTCCCTGCCTTGCTGACAATAAAGATATTTCCAAGAA","FALSE","NM_001297439","ref|NM_001297439|ref|NM_001528|ens|ENST00000382774|gb|BC112192","HGFAC","HGF activator","ref|Homo sapiens HGF activator (HGFAC), transcript variant 1, mRNA [NM_001297439]","chr4",{"v":3446076,"d":"3446076.00"},3451162,"GO:0004252(serine-type endopeptidase activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006508(proteolysis);GO:0008236(serine-type peptidase activity)",null,"mRNA","agilent G3 V3"]
["A_24_P113686",2.07,2.21,2.07,4.14,3.78,3.99,{"v":0.533165407220823,"d":"0.53"},{"v":-0.907344916204586,"d":"-0.91"},"down",{"v":8.24060000000904e-05,"d":"0.00"},1,"yes","AACTTACCCTTGTGAGACAAGTTTTCTACTTGAGAAACTCCTAGTACAATGTCTTATACT","FALSE","NM_017953","ref|NM_017953|ref|NM_001170670|ens|ENST00000370574|ens|ENST00000431532","ZNHIT6","zinc finger, HIT-type containing 6","ref|Homo sapiens zinc finger, HIT-type containing 6 (ZNHIT6), transcript variant 1, mRNA [NM_017953]","chr1",86115104,86174116,"GO:0000492(box C/D snoRNP assembly);GO:0005515(protein binding);GO:0019899(enzyme binding);GO:0042254(ribosome biogenesis);GO:0042802(identical protein binding);GO:0046872(metal ion binding);GO:0070062(extracellular vesicular exosome);GO:0070761(pre-snoRNP complex)",null,"mRNA","agilent G3 V3"]
["A_33_P3383283",8.32,7.94,8.04,10.06,10.11,10.24,{"v":0.799079250246629,"d":"0.80"},{"v":-0.323589502537655,"d":"-0.32"},"down",{"v":8.25020000000398e-05,"d":"0.00"},1,"yes","GAGAACAATCCCCTTTGACTGTAATTTCCCACTACCTACCCAAATCCTATAAAACGGCCC","FALSE","NM_032977","ref|NM_032977|ref|NM_032976|ref|NM_001230|ref|NM_001206524","CASP10","caspase 10, apoptosis-related cysteine peptidase","ref|Homo sapiens caspase 10, apoptosis-related cysteine peptidase (CASP10), transcript variant 1, mRNA [NM_032977]","chr1",113362912,113392399,"GO:0004197(cysteine-type endopeptidase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006508(proteolysis);GO:0006915(apoptotic process);GO:0031265(CD95 death-inducing signaling complex);GO:0031625(ubiquitin protein ligase binding);GO:0035877(death effector domain binding);GO:0042981(regulation of apoptotic process);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB cascade);GO:0045087(innate immune response);GO:0097190(apoptotic signaling pathway);GO:0097199(cysteine-type endopeptidase activity involved in apoptotic signaling pathway)","04668(TNF signaling pathway);04210(Apoptosis);04622(RIG-I-like receptor signaling pathway);05152(Tuberculosis);05161(Hepatitis B)","mRNA","agilent G3 V3"]
["A_33_P3414058",10.16,10.44,10.26,8.52,{"v":8.5,"d":"8.50"},8.27,{"v":1.22024515618822,"d":"1.22"},{"v":0.287171024907496,"d":"0.29"},"up",{"v":8.25309999999968e-05,"d":"0.00"},1,"yes","AAGTGTCCACCCCTAGTGACTACACTCTGTCTTTCCTCAAGCGGCAGCGCAAAGGCCTCT","FALSE","NM_130803","ref|NM_130803|ref|NM_130802|ref|NM_130804|ref|NM_000244","MEN1","multiple endocrine neoplasia I","ref|Homo sapiens multiple endocrine neoplasia I (MEN1), transcript variant e1E, mRNA [NM_130803]","chr11",64570996,64578188,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000165(MAPK cascade);GO:0000400(four-way junction DNA binding);GO:0000403(Y-form DNA binding);GO:0000785(chromatin);GO:0001776(leukocyte homeostasis);GO:0001933(negative regulation of protein phosphorylation);GO:0002051(osteoblast fate commitment);GO:0002076(osteoblast development);GO:0003682(chromatin binding);GO:0003690(double-stranded DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006281(DNA repair);GO:0006338(chromatin remodeling);GO:0006351(transcription, DNA-dependent);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0006974(response to DNA damage stimulus);GO:0007050(cell cycle arrest);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007420(brain development);GO:0008285(negative regulation of cell proliferation);GO:0009411(response to UV);GO:0010332(response to gamma radiation);GO:0010467(gene expression);GO:0016363(nuclear matrix);GO:0018024(histone-lysine N-methyltransferase activity);GO:0030097(hemopoiesis);GO:0030511(positive regulation of transforming growth factor beta receptor signaling pathway);GO:0030674(protein binding, bridging);GO:0031062(positive regulation of histone methylation);GO:0032092(positive regulation of protein binding);GO:0032154(cleavage furrow);GO:0032925(regulation of activin receptor signaling pathway);GO:0034968(histone lysine methylation);GO:0035097(histone methyltransferase complex);GO:0043234(protein complex);GO:0043280(positive regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043433(negative regulation of sequence-specific DNA binding transcription factor activity);GO:0043565(sequence-specific DNA binding);GO:0044212(transcription regulatory region DNA binding);GO:0045668(negative regulation of osteoblast differentiation);GO:0045669(positive regulation of osteoblast differentiation);GO:0045736(negative regulation of cyclin-dependent protein kinase activity);GO:0045786(negative regulation of cell cycle);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046329(negative regulation of JNK cascade);GO:0046621(negative regulation of organ growth);GO:0047485(protein N-terminus binding);GO:0048704(embryonic skeletal system morphogenesis);GO:0051781(positive regulation of cell division);GO:0051974(negative regulation of telomerase activity);GO:0060021(palate development);GO:0060135(maternal process involved in female pregnancy);GO:0070412(R-SMAD binding)","05202(Transcriptional misregulation in cancers)","mRNA","agilent G3 V3"]
["A_23_P2884",1.92,2.03,2.03,3.86,3.96,4.26,{"v":0.495033112582781,"d":"0.50"},{"v":-1.01440306512697,"d":"-1.01"},"down",{"v":8.26590000000405e-05,"d":"0.00"},1,"yes","AGTCCTAGGAACCATTATGGATGTAGTGCATCTTAGAGCCATAGAGCAGGTGACTGGAAA","FALSE","NM_004569","ref|NM_004569|ens|ENST00000559118|ens|ENST00000216452|ref|XM_006720172","PIGH","phosphatidylinositol glycan anchor biosynthesis, class H","ref|Homo sapiens phosphatidylinositol glycan anchor biosynthesis, class H (PIGH), mRNA [NM_004569]","chr14",68056848,68066999,"GO:0000506(glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex);GO:0003824(catalytic activity);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006464(cellular protein modification process);GO:0006501(C-terminal protein lipidation);GO:0006506(GPI anchor biosynthetic process);GO:0016254(preassembly of GPI anchor in ER membrane);GO:0017176(phosphatidylinositol N-acetylglucosaminyltransferase activity);GO:0043687(post-translational protein modification);GO:0044267(cellular protein metabolic process)","00563(Glycosylphosphatidylinositol(GPI)-anchor biosynthesis)","mRNA","agilent G3 V3"]
["A_21_P0014773",12.84,12.77,12.87,11.61,{"v":11.6,"d":"11.60"},{"v":11.8,"d":"11.80"},{"v":1.09911453870323,"d":"1.10"},{"v":0.136341737341537,"d":"0.14"},"up",{"v":8.26910000000236e-05,"d":"0.00"},1,"yes","AACTTGAGAATTTATATTCCTCCCTTTTCTTTTACTGCTGCTTCATAGGCCTCCCCCGGG","FALSE","THC2668279","tc|THC2668279",null,null,"tc|TRX2_MOUSE (O08550) Trithorax homolog 2 (WW domain-binding protein 7) (Fragment), partial (7%) [THC2668279]",{"$nulls":5},"mRNA","agilent G3 V3"]
["A_33_P3406861",7.59,7.42,7.36,6.13,6.25,6.22,{"v":1.20268817204301,"d":"1.20"},{"v":0.266262635063725,"d":"0.27"},"up",{"v":8.28500000000787e-05,"d":"0.00"},1,"yes","AAGTCAAGTCGGAAAGCATGGGCTCCCTGTTATGTGAGGAGGACTCCAAGGAGAGCTGCC","FALSE","NM_001270771","ref|NM_001270771|ref|NM_021069|ref|NM_001145674|ens|ENST00000284776","SORBS2","sorbin and SH3 domain containing 2","ref|Homo sapiens sorbin and SH3 domain containing 2 (SORBS2), transcript variant 9, mRNA [NM_001270771]","chr4",186506592,186578123,"GO:0005200(structural constituent of cytoskeleton);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005886(plasma membrane);GO:0007015(actin filament organization);GO:0007155(cell adhesion);GO:0008093(cytoskeletal adaptor activity);GO:0008150(biological_process);GO:0008307(structural constituent of muscle);GO:0015629(actin cytoskeleton);GO:0016477(cell migration);GO:0019904(protein domain specific binding);GO:0030018(Z disc);GO:0046872(metal ion binding);GO:0048471(perinuclear region of cytoplasm)",null,"mRNA","agilent G3 V3"]
["A_33_P3306442",5.35,5.44,5.33,4.04,4.06,3.81,{"v":1.35348446683459,"d":"1.35"},{"v":0.436678330663853,"d":"0.44"},"up",{"v":8.33010000000911e-05,"d":"0.00"},1,"yes","GATGGCCACATTTACAAGGGACGGATGGACACAAGGCTGCCAGGCATCCTCCGAAAAGAC","FALSE","ENST00000524722","ens|ENST00000524722|ens|ENST00000262765|ref|XM_005257728|ref|XM_006722136","QRICH2","glutamine rich 2","ens|glutamine rich 2 [Source:HGNC Symbol;Acc:HGNC:25326] [ENST00000524722]","chr17",74270264,74276438,null,null,"mRNA","agilent G3 V3"]
["A_33_P3268564",8.45,8.51,8.58,7.63,7.69,7.75,{"v":1.10706545296922,"d":"1.11"},{"v":0.146740521019741,"d":"0.15"},"up",{"v":8.33909999999882e-05,"d":"0.00"},1,"yes","GTGGAGCGGAAGAACAGCCTGAAGAAGGGCTCCCTCGTGAAGAACCTGAAGGACACACTA","FALSE","NM_001004722","ref|NM_001004722|ens|ENST00000393348|ens|ENST00000425756|ens|ENST00000522586","NCK2","NCK adaptor protein 2","ref|Homo sapiens NCK adaptor protein 2 (NCK2), transcript variant 3, mRNA [NM_001004722]","chr2",106361520,106510730,"GO:0005070(SH3/SH2 adaptor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0006417(regulation of translation);GO:0007015(actin filament organization);GO:0007165(signal transduction);GO:0007172(signal complex assembly);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007176(regulation of epidermal growth factor-activated receptor activity);GO:0007411(axon guidance);GO:0008093(cytoskeletal adaptor activity);GO:0008285(negative regulation of cell proliferation);GO:0009967(positive regulation of signal transduction);GO:0012506(vesicle membrane);GO:0016477(cell migration);GO:0030032(lamellipodium assembly);GO:0030159(receptor signaling complex scaffold activity);GO:0030838(positive regulation of actin filament polymerization);GO:0033137(negative regulation of peptidyl-serine phosphorylation);GO:0042102(positive regulation of T cell proliferation);GO:0042110(T cell activation);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048010(vascular endothelial growth factor receptor signaling pathway);GO:0048013(ephrin receptor signaling pathway);GO:0060734(regulation of eIF2 alpha phosphorylation by endoplasmic reticulum stress)","04012(ErbB signaling pathway);04660(T cell receptor signaling pathway);04360(Axon guidance);05130(Pathogenic Escherichia coli infection)","mRNA","agilent G3 V3"]
["A_33_P3329078",7.94,8.01,7.82,8.98,9.07,9.13,{"v":0.874540103016924,"d":"0.87"},{"v":-0.193403552824957,"d":"-0.19"},"down",{"v":8.3410000000006e-05,"d":"0.00"},1,"yes","TGCCCTGTCCTCCAGATACCACTGAGCTCACTGCCCATGATTCAGAGCTTTCAAGGATAG","FALSE","NM_000559","ref|NM_000559|ref|NM_000184|ens|ENST00000620888|ens|ENST00000330597","HBG1","hemoglobin, gamma A","ref|Homo sapiens hemoglobin, gamma A (HBG1), mRNA [NM_000559]","chr11",{"v":5274432,"d":"5274432.00"},5276041,"GO:0005344(oxygen transporter activity);GO:0005506(iron ion binding);GO:0005829(cytosol);GO:0005833(hemoglobin complex);GO:0007596(blood coagulation);GO:0015671(oxygen transport);GO:0019825(oxygen binding);GO:0020037(heme binding)",null,"mRNA","agilent G3 V3"]
["A_23_P417148",7.44,{"v":7.4,"d":"7.40"},7.44,6.92,6.92,{"v":7,"d":"7.00"},{"v":1.06909788867562,"d":"1.07"},{"v":0.0963939550615237,"d":"0.10"},"up",{"v":8.35270000000277e-05,"d":"0.00"},1,"yes","AGCGCTAGATTTCGTGTACAAAACCTGTGTACCCCTCTATATATATGTTACATAGAATGT","FALSE","NM_030665","ref|NM_030665|ens|ENST00000353383|gb|AB058723|gb|AY172136","RAI1","retinoic acid induced 1","ref|Homo sapiens retinoic acid induced 1 (RAI1), mRNA [NM_030665]","chr17",17696264,17714194,"GO:0001501(skeletal system development);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0008270(zinc ion binding);GO:0032922(circadian regulation of gene expression);GO:0035326(enhancer binding);GO:0040015(negative regulation of multicellular organism growth);GO:0045893(positive regulation of transcription, DNA-dependent)",null,"mRNA","agilent G3 V3"]
["A_33_P3424507",12.88,12.95,12.99,11.61,11.56,{"v":11.8,"d":"11.80"},{"v":1.11009436659994,"d":"1.11"},{"v":0.150682322015947,"d":"0.15"},"up",{"v":8.38499999999964e-05,"d":"0.00"},1,"yes","TAATTATTCACTCTGTCCTCAGAATTGCCTCCCCTGAAGAATGGCACAAGGTCTTCAGCA","FALSE","NM_001004752","ref|NM_001004752|ens|ENST00000380383|ens|ENST00000343430|ens|ENST00000624103","OR51F1","olfactory receptor, family 51, subfamily F, member 1 (gene/pseudogene)","ref|Homo sapiens olfactory receptor, family 51, subfamily F, member 1 (gene/pseudogene) (OR51F1), mRNA [NM_001004752]","chr11",{"v":4790209,"d":"4790209.00"},4791168,"GO:0004930(G-protein coupled receptor activity);GO:0004984(olfactory receptor activity);GO:0005886(plasma membrane);GO:0007186(G-protein coupled receptor signaling pathway);GO:0016021(integral to membrane);GO:0050911(detection of chemical stimulus involved in sensory perception of smell)","04740(Olfactory transduction)","mRNA","agilent G3 V3"]
["A_24_P83808",2.18,2.38,2.22,4.45,4.93,{"v":4.7,"d":"4.70"},{"v":0.481534090909091,"d":"0.48"},{"v":-1.05429015550095,"d":"-1.05"},"down",{"v":8.39070000000497e-05,"d":"0.00"},1,"yes","GTAATAACTGGAAGTGAAAGTCCAATTGTGTTGCTCAGTGGCAGCATGGAACCTGCATTT","FALSE","ENST00000518383","ens|ENST00000518383",null,null,"ens|SEC11 homolog B, pseudogene (S. cerevisiae) [Source:HGNC Symbol;Acc:HGNC:31884] [ENST00000518383]","chr8",55435340,55435875,null,null,"mRNA","agilent G3 V3"]
["A_33_P3360525",2.89,{"v":3.1,"d":"3.10"},{"v":2.9,"d":"2.90"},5.21,5.54,5.12,{"v":0.560176433522369,"d":"0.56"},{"v":-0.836046804005412,"d":"-0.84"},"down",{"v":8.39100000000759e-05,"d":"0.00"},1,"yes","TCCATCTTATTTCATTTCTCTAACAGTCAATATCTGGCTGTCCTTTCTATAATGCAGAGT","FALSE","BU535024","gb|BU535024|tc|THC2575041|tc|THC2486872",null,null,"gb|AGENCOURT_10185273 NIH_MGC_126 Homo sapiens cDNA clone IMAGE:6562423 5', mRNA sequence [BU535024]","chr10",97949120,97949975,null,null,"mRNA","agilent G3 V3"]
["A_33_P3214884",2.07,1.95,2.43,5.17,4.93,4.83,{"v":0.432016075016745,"d":"0.43"},{"v":-1.21084309982393,"d":"-1.21"},"down",{"v":8.39519999999983e-05,"d":"0.00"},1,"yes","CGTTCTTTCAAAAGAGGCATCTAAATGTGTTCCTAATTTTGTATATGGGCTTAGGTTTTG","FALSE","NM_002267","ref|NM_002267|ens|ENST00000261667|gb|BC035090|tc|THC2469151","KPNA3","karyopherin alpha 3 (importin alpha 4)","ref|Homo sapiens karyopherin alpha 3 (importin alpha 4) (KPNA3), mRNA [NM_002267]","chr13",50273448,50367057,"GO:0005515(protein binding);GO:0005643(nuclear pore);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006461(protein complex assembly);GO:0006607(NLS-bearing substrate import into nucleus);GO:0008022(protein C-terminus binding);GO:0008139(nuclear localization sequence binding);GO:0008565(protein transporter activity);GO:0019221(cytokine-mediated signaling pathway);GO:0046718(viral entry into host cell)",null,"mRNA","agilent G3 V3"]
["A_23_P165130",{"v":4.9,"d":"4.90"},5.09,{"v":5,"d":"5.00"},6.21,6.11,6.06,{"v":0.815560391730141,"d":"0.82"},{"v":-0.294136383341175,"d":"-0.29"},"down",{"v":8.40390000000912e-05,"d":"0.00"},1,"yes","CAGCCTCTGTGTTTCTTTCCCTGGTCCTGAACTGTGGAAATGCCATTAAACTCTCTCTAT","FALSE","NM_032683","ref|NM_032683|ens|ENST00000532896|ens|ENST00000599612|ens|ENST00000533807","MPV17L2","MPV17 mitochondrial membrane protein-like 2","ref|Homo sapiens MPV17 mitochondrial membrane protein-like 2 (MPV17L2), mRNA [NM_032683]","chr19",18304060,18307758,"GO:0005743(mitochondrial inner membrane);GO:0005762(mitochondrial large ribosomal subunit);GO:0016021(integral to membrane);GO:0070131(positive regulation of mitochondrial translation)","04146(Peroxisome)","mRNA","agilent G3 V3"]
["A_23_P118462",4.34,4.79,4.63,7.07,6.95,6.84,{"v":0.659635666347076,"d":"0.66"},{"v":-0.600258687817668,"d":"-0.60"},"down",{"v":8.41110000000533e-05,"d":"0.00"},1,"yes","ATTGACTTGTGAAAACGCAAACATGAATATGGTTGGAGAGCCCTGGATTAGGAGGGTGAC","FALSE","NM_080822","ref|NM_080822|ref|NM_001383|ens|ENST00000572684|ens|ENST00000570867","OVCA2","ovarian tumor suppressor candidate 2","ref|Homo sapiens ovarian tumor suppressor candidate 2 (OVCA2), mRNA [NM_080822]","chr17",{"v":1945327,"d":"1945327.00"},1946724,"GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0008152(metabolic process);GO:0016787(hydrolase activity);GO:0032526(response to retinoic acid)",null,"mRNA","agilent G3 V3"]
["A_33_P3322430",8.89,8.73,8.68,9.83,{"v":9.8,"d":"9.80"},9.87,{"v":0.891525423728814,"d":"0.89"},{"v":-0.165652154956901,"d":"-0.17"},"down",{"v":8.41690000000783e-05,"d":"0.00"},1,"yes","CCCTCCAGCCTGAGTGTTGGAGCAAGACTCTGTCTCTAAAAAATTAAAAATAAAAATAAA","FALSE",{"$nulls":5},"chr17",{"v":3540398,"d":"3540398.00"},3553813,null,null,"mRNA","agilent G3 V3"]
["A_23_P146798",8.16,8.15,8.31,6.95,7.09,7.11,{"v":1.16406619385343,"d":"1.16"},{"v":0.219173098477146,"d":"0.22"},"up",{"v":8.43560000000076e-05,"d":"0.00"},1,"yes","TCCGAGGCCAGAGTAACATTTTGAACTTTGGGGGGATATTTGTTCATCACTTGGGTAGAA","FALSE","NM_012248","ref|NM_012248|ens|ENST00000478753|gb|AK303275|gb|AK093889","SEPHS2","selenophosphate synthetase 2","ref|Homo sapiens selenophosphate synthetase 2 (SEPHS2), mRNA [NM_012248]","chr16",30455702,30457048,"GO:0004756(selenide, water dikinase activity);GO:0005524(ATP binding);GO:0005575(cellular_component);GO:0016260(selenocysteine biosynthetic process);GO:0016310(phosphorylation)","00450(Selenocompound metabolism)","mRNA","agilent G3 V3"]
["A_23_P37949",6.71,6.63,6.73,5.98,5.86,5.87,{"v":1.13325804630152,"d":"1.13"},{"v":0.180476404610703,"d":"0.18"},"up",{"v":8.43810000000778e-05,"d":"0.00"},1,"yes","ACACTATGGACCTTGAAACTGGGACTTTCACGAGGGTCCTCCGGGGCCACACAGACTACA","FALSE","NM_024339","ref|NM_024339|ref|NM_001142350|ens|ENST00000573704|ens|ENST00000576143","THOC6","THO complex 6 homolog (Drosophila)","ref|Homo sapiens THO complex 6 homolog (Drosophila) (THOC6), transcript variant 1, mRNA [NM_024339]","chr16",{"v":3074028,"d":"3074028.00"},3076782,"GO:0000346(transcription export complex);GO:0000347(THO complex);GO:0000445(THO complex part of transcription export complex);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006397(mRNA processing);GO:0006406(mRNA export from nucleus);GO:0006915(apoptotic process);GO:0007417(central nervous system development);GO:0008380(RNA splicing);GO:0016607(nuclear speck);GO:0043066(negative regulation of apoptotic process);GO:0046784(intronless viral mRNA export from host nucleus)","03013(RNA transport)","mRNA","agilent G3 V3"]
["A_24_P191656",5.41,5.34,{"v":5.2,"d":"5.20"},6.97,6.85,7.14,{"v":0.760973282442748,"d":"0.76"},{"v":-0.394082292885219,"d":"-0.39"},"down",{"v":8.45660000000636e-05,"d":"0.00"},1,"yes","TTACTTGCAGAATCTCTTCAGCCTCTCTCAGCTGGACAAGTATGCTCCAGAAAACCTAGA","FALSE","NM_014049","ref|NM_014049|ref|NR_033426|ens|ENST00000511227|ens|ENST00000505867","ACAD9","acyl-CoA dehydrogenase family, member 9","ref|Homo sapiens acyl-CoA dehydrogenase family, member 9 (ACAD9), transcript variant 1, mRNA [NM_014049]","chr3",128598456,128631957,"GO:0003995(acyl-CoA dehydrogenase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005739(mitochondrion);GO:0030425(dendrite);GO:0032981(mitochondrial respiratory chain complex I assembly);GO:0050660(flavin adenine dinucleotide binding);GO:0055114(oxidation-reduction process)",null,"mRNA","agilent G3 V3"]
["A_23_P113184",7.58,7.79,7.61,9.03,8.91,8.88,{"v":0.856823266219239,"d":"0.86"},{"v":-0.222930439258361,"d":"-0.22"},"down",{"v":8.4607999999986e-05,"d":"0.00"},1,"yes","TTGGGGCATGACCCAGCCTATGGTTTGCCATACTCCCTCTTTTTCTCCGTTTTTTCATTA","FALSE","NM_001080432","ref|NM_001080432|ens|ENST00000463855|gb|BC003583|gb|AK096554","FTO","fat mass and obesity associated","ref|Homo sapiens fat mass and obesity associated (FTO), mRNA [NM_001080432]","chr16",53967944,54148375,"GO:0001659(temperature homeostasis);GO:0005634(nucleus);GO:0006307(DNA dealkylation involved in DNA repair);GO:0008198(ferrous iron binding);GO:0010883(regulation of lipid storage);GO:0016607(nuclear speck);GO:0035515(oxidative RNA demethylase activity);GO:0035516(oxidative DNA demethylase activity);GO:0035552(oxidative single-stranded DNA demethylation);GO:0035553(oxidative single-stranded RNA demethylation);GO:0040014(regulation of multicellular organism growth);GO:0042245(RNA repair);GO:0043734(DNA-N1-methyladenine dioxygenase activity);GO:0044065(regulation of respiratory system process);GO:0060612(adipose tissue development);GO:0070350(regulation of white fat cell proliferation);GO:0070989(oxidative demethylation);GO:0080111(DNA demethylation)",null,"mRNA","agilent G3 V3"]
["A_33_P3400578",1.98,2.16,1.96,{"v":5.8,"d":"5.80"},5.62,{"v":6.4,"d":"6.40"},{"v":0.342312008978676,"d":"0.34"},{"v":-1.54661618907167,"d":"-1.55"},"down",{"v":8.4648000000076e-05,"d":"0.00"},1,"yes","CACCATGATATTGGTGGTATTTATGCTGTTAAGTCCAAACCTTTATCTGTCTGTTATTCT","FALSE","NM_002126","ref|NM_002126|ens|ENST00000226067|ref|XM_005257269|tc|THC2604609","HLF","hepatic leukemia factor","ref|Homo sapiens hepatic leukemia factor (HLF), mRNA [NM_002126]","chr17",53344952,53400896,"GO:0003677(DNA binding);GO:0003690(double-stranded DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-dependent);GO:0006366(transcription from RNA polymerase II promoter);GO:0007275(multicellular organismal development);GO:0035914(skeletal muscle cell differentiation);GO:0043565(sequence-specific DNA binding);GO:0048511(rhythmic process)",null,"mRNA","agilent G3 V3"]
["A_33_P3231542",2.26,2.37,2.26,4.39,4.86,4.77,{"v":0.491440798858773,"d":"0.49"},{"v":-1.02491046130633,"d":"-1.02"},"down",{"v":8.47050000000182e-05,"d":"0.00"},1,"yes","CTGTACCAAAATACATGGAGACTAACAAACAGAACCACATGGAACTTTCAAACTGAAAAA","FALSE","NM_006885","ref|NM_006885|ref|NM_001164766|ens|ENST00000268489|ens|ENST00000397992","ZFHX3","zinc finger homeobox 3","ref|Homo sapiens zinc finger homeobox 3 (ZFHX3), transcript variant A, mRNA [NM_006885]","chr16",72816784,73093597,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0003705(RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005730(nucleolus);GO:0005739(mitochondrion);GO:0006355(regulation of transcription, DNA-dependent);GO:0006366(transcription from RNA polymerase II promoter);GO:0007050(cell cycle arrest);GO:0007420(brain development);GO:0007517(muscle organ development);GO:0008270(zinc ion binding);GO:0019899(enzyme binding);GO:0043231(intracellular membrane-bounded organelle);GO:0043565(sequence-specific DNA binding);GO:0044212(transcription regulatory region DNA binding);GO:0045662(negative regulation of myoblast differentiation);GO:0045663(positive regulation of myoblast differentiation);GO:0045664(regulation of neuron differentiation);GO:0045892(negative regulation of transcription, DNA-dependent)","04550(Signaling pathways regulating pluripotency of stem cells)","mRNA","agilent G3 V3"]
["A_23_P250122",8.28,8.35,{"v":8.1,"d":"8.10"},9.46,9.55,{"v":9.5,"d":"9.50"},{"v":0.86741494212557,"d":"0.87"},{"v":-0.205205799548015,"d":"-0.21"},"down",{"v":8.49019999999978e-05,"d":"0.00"},1,"yes","GACCTAATTCAAGTAAAAACCCTTTCTCCTTCCTGGGGCCTCGGCTCCTGGAGGGCTGGA","FALSE","NM_020223","ref|NM_020223|ens|ENST00000313766|ens|ENST00000515795|ref|XR_242097","FAM20C","family with sequence similarity 20, member C","ref|Homo sapiens family with sequence similarity 20, member C (FAM20C), mRNA [NM_020223]","chr7",{"v":285861,"d":"285861.00"},300711,"GO:0004674(protein serine/threonine kinase activity);GO:0005509(calcium ion binding);GO:0005615(extracellular space);GO:0005794(Golgi apparatus);GO:0006468(protein phosphorylation);GO:0030501(positive regulation of bone mineralization);GO:0036179(osteoclast maturation);GO:0040036(regulation of fibroblast growth factor receptor signaling pathway);GO:0045669(positive regulation of osteoblast differentiation);GO:0051174(regulation of phosphorus metabolic process);GO:0070062(extracellular vesicular exosome);GO:0070166(enamel mineralization);GO:0071895(odontoblast differentiation);GO:0097187(dentinogenesis)",null,"mRNA","agilent G3 V3"]
["A_23_P207842",11.79,11.65,11.59,12.89,12.83,12.75,{"v":0.910579672472056,"d":"0.91"},{"v":-0.135142841494552,"d":"-0.14"},"down",{"v":8.49420000000878e-05,"d":"0.00"},1,"yes","AGTTCTCCTCCTCAGCCTTTTCCTCCTCAGTTTTCTCTTTAAAACTGTGAAGTACTAACT","FALSE","NM_001024809","ref|NM_001024809|ref|NM_001145301|ref|NM_000964|ref|NM_001145302","RARA","retinoic acid receptor, alpha","ref|Homo sapiens retinoic acid receptor, alpha (RARA), transcript variant 2, mRNA [NM_001024809]","chr17",38507640,38512465,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000790(nuclear chromatin);GO:0000900(translation repressor activity, nucleic acid binding);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001657(ureteric bud development);GO:0001843(neural tube closure);GO:0001889(liver development);GO:0001972(retinoic acid binding);GO:0002068(glandular epithelial cell development);GO:0003148(outflow tract septum morphogenesis);GO:0003417(growth plate cartilage development);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0003707(steroid hormone receptor activity);GO:0003708(retinoic acid receptor activity);GO:0003713(transcription coactivator activity);GO:0003714(transcription corepressor activity);GO:0005102(receptor binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0006468(protein phosphorylation);GO:0007165(signal transduction);GO:0007281(germ cell development);GO:0007283(spermatogenesis);GO:0007565(female pregnancy);GO:0008134(transcription factor binding);GO:0008144(drug binding);GO:0008270(zinc ion binding);GO:0008284(positive regulation of cell proliferation);GO:0008285(negative regulation of cell proliferation);GO:0009986(cell surface);GO:0010467(gene expression);GO:0014068(positive regulation of phosphatidylinositol 3-kinase cascade);GO:0015629(actin cytoskeleton);GO:0019899(enzyme binding);GO:0019904(protein domain specific binding);GO:0030425(dendrite);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0030850(prostate gland development);GO:0030853(negative regulation of granulocyte differentiation);GO:0031076(embryonic camera-type eye development);GO:0031490(chromatin DNA binding);GO:0031641(regulation of myelination);GO:0032355(response to estradiol stimulus);GO:0032526(response to retinoic acid);GO:0032689(negative regulation of interferon-gamma production);GO:0032720(negative regulation of tumor necrosis factor production);GO:0032736(positive regulation of interleukin-13 production);GO:0032753(positive regulation of interleukin-4 production);GO:0032754(positive regulation of interleukin-5 production);GO:0033189(response to vitamin A);GO:0034097(response to cytokine stimulus);GO:0035014(phosphatidylinositol 3-kinase regulator activity);GO:0035264(multicellular organism growth);GO:0043025(neuronal cell body);GO:0043066(negative regulation of apoptotic process);GO:0043277(apoptotic cell clearance);GO:0043401(steroid hormone mediated signaling pathway);GO:0043422(protein kinase B binding);GO:0043551(regulation of phosphatidylinositol 3-kinase activity);GO:0044323(retinoic acid-responsive element binding);GO:0045471(response to ethanol);GO:0045630(positive regulation of T-helper 2 cell differentiation);GO:0045666(positive regulation of neuron differentiation);GO:0045787(positive regulation of cell cycle);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0045893(positive regulation of transcription, DNA-dependent)","05200(Pathways in cancer);05202(Transcriptional misregulation in cancers);05221(Acute myeloid leukemia)","mRNA","agilent G3 V3"]
["A_33_P3273854",11.02,{"v":11,"d":"11.00"},10.99,10.11,10.24,10.27,{"v":1.07805355976486,"d":"1.08"},{"v":0.108428855722748,"d":"0.11"},"up",{"v":8.49529999999987e-05,"d":"0.00"},1,"yes","TTCTATAGTGTGATTACCTGAGGGTGCCTCCAAATGTATATCATTTCACTCCCCTCCCCT","FALSE","NM_207015","ref|NM_207015|ens|ENST00000454872|ens|ENST00000614002|ref|XM_006713560","NAALADL2","N-acetylated alpha-linked acidic dipeptidase-like 2","ref|Homo sapiens N-acetylated alpha-linked acidic dipeptidase-like 2 (NAALADL2), mRNA [NM_207015]","chr3",174577072,175523428,"GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3381948",{"v":4.6,"d":"4.60"},4.87,4.69,6.56,6.37,6.33,{"v":0.735202492211838,"d":"0.74"},{"v":-0.443786437760462,"d":"-0.44"},"down",{"v":8.49540000000815e-05,"d":"0.00"},1,"yes","GCTCCACGACAAAAGGACAAGATTTGACTTAAATTAAGTTTTTCCCTTGAGGATATTTTC","FALSE","NM_001080436","ref|NM_001080436|ref|XM_005258518|gb|AK130059|gb|BC030216","WTIP","Wilms tumor 1 interacting protein","ref|Homo sapiens Wilms tumor 1 interacting protein (WTIP), mRNA [NM_001080436]","chr19",34971872,34992085,"GO:0000932(cytoplasmic mRNA processing body);GO:0001666(response to hypoxia);GO:0003714(transcription corepressor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005912(adherens junction);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0007010(cytoskeleton organization);GO:0008270(zinc ion binding);GO:0022604(regulation of cell morphogenesis);GO:0035195(gene silencing by miRNA);GO:0035331(negative regulation of hippo signaling cascade);GO:2000637(positive regulation of gene silencing by miRNA)","04390(Hippo signaling pathway)","mRNA","agilent G3 V3"]
["A_22_P00019155",6.92,6.82,6.95,5.23,5.53,5.35,{"v":1.28429546865301,"d":"1.28"},{"v":0.360977151153441,"d":"0.36"},"up",{"v":8.49970000000866e-05,"d":"0.00"},1,"yes","CGGACTTGAAATTGAGAATTATTACAAGCCATTAATCATTATAGATCTCCCCGGAAATGA","FALSE","ENST00000473959","ens|ENST00000473959|linc|lnc-CCDC80-1:1|linc|TCONS_00006616|gb|DA558726","CCDC80","coiled-coil domain containing 80","ens|coiled-coil domain containing 80 [Source:HGNC Symbol;Acc:HGNC:30649] [ENST00000473959]","chr3",112359568,112368294,"GO:0001968(fibronectin binding);GO:0005604(basement membrane);GO:0005614(interstitial matrix);GO:0008201(heparin binding);GO:0010811(positive regulation of cell-substrate adhesion);GO:0030198(extracellular matrix organization)",null,"mRNA","agilent G3 V3"]
["A_23_P2317",10.65,{"v":10.7,"d":"10.70"},10.87,9.46,{"v":9.4,"d":"9.40"},9.55,{"v":1.13410770855333,"d":"1.13"},{"v":0.181557662517027,"d":"0.18"},"up",{"v":9.50699999999749e-05,"d":"0.00"},1,"yes","GGAGGGAAGGACACCAATGAATCAGCTTGGGACCTCTTTAGGCCTTCCCCTTTTCCTCCA","FALSE","NM_015086","ref|NM_015086|ens|ENST00000421952|gb|AB018292|gb|BC039264","DDN","dendrin","ref|Homo sapiens dendrin (DDN), mRNA [NM_015086]","chr12",49388932,49393092,"GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0000982(RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005789(endoplasmic reticulum membrane);GO:0006366(transcription from RNA polymerase II promoter);GO:0032591(dendritic spine membrane);GO:0042995(cell projection);GO:0043204(perikaryon);GO:0045944(positive regulation of transcription from RNA polymerase II promoter)",null,"mRNA","agilent G3 V3"]
["A_33_P3294961",8.07,8.08,7.82,9.51,9.65,{"v":9.7,"d":"9.70"},{"v":0.830561330561331,"d":"0.83"},{"v":-0.267841390842065,"d":"-0.27"},"down",{"v":9.53590000000171e-05,"d":"0.00"},1,"yes","TAAAAACATTTAAAATTAGCCAGGCATGGTGGTGGATGCCCTAGAGTCCCACTGACTTGG","FALSE","ENST00000398475","ens|ENST00000398475|ref|XM_005250562|gb|BC006080|tc|NP335821","LAT2","linker for activation of T cells family, member 2","ens|linker for activation of T cells family, member 2 [Source:HGNC Symbol;Acc:HGNC:12749] [ENST00000398475]","chr7",73624312,73640838,"GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0016021(integral to membrane);GO:0019722(calcium-mediated signaling);GO:0035556(intracellular signal transduction);GO:0038095(Fc-epsilon receptor signaling pathway);GO:0042113(B cell activation);GO:0042169(SH2 domain binding);GO:0042629(mast cell granule);GO:0043303(mast cell degranulation);GO:0045087(innate immune response);GO:0045121(membrane raft);GO:0050853(B cell receptor signaling pathway);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_24_P128727",11.88,11.93,{"v":12.1,"d":"12.10"},10.34,{"v":10.2,"d":"10.20"},10.47,{"v":1.15801354401806,"d":"1.16"},{"v":0.211652127052036,"d":"0.21"},"up",{"v":9.53729999999542e-05,"d":"0.00"},1,"yes","CTTTTGTCTTACTCTAACATTGTCCCCTCCATTCTAAGAATTTCATCATCAGATGGGAAG","FALSE","ENST00000456741","ens|ENST00000456741|ens|ENST00000509527|ens|ENST00000448855|ens|ENST00000489105",null,null,"ens|olfactory receptor, family 7, subfamily E, member 62 pseudogene [Source:HGNC Symbol;Acc:HGNC:8438] [ENST00000456741]","chr2",71282656,71283133,null,null,"mRNA","agilent G3 V3"]
["A_33_P3316671",8.63,8.24,7.99,11.31,11.48,11.33,{"v":0.728604923798359,"d":"0.73"},{"v":-0.456791350265805,"d":"-0.46"},"down",{"v":9.54130000000442e-05,"d":"0.00"},1,"yes","AGAGTCATTCTTCCGGAGTTATCAGTCCATCCATCCATCACTGGAGAAGAGCTTTGATTG","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_22_P00014164",15.63,15.62,15.53,14.38,14.33,14.55,{"v":1.08136846971798,"d":"1.08"},{"v":0.112858196390449,"d":"0.11"},"up",{"v":9.57069999999449e-05,"d":"0.00"},1,"yes","AGAAAATCAGCAGAGCTAGGCAATAAGTCAATCTAAAGTCTACATGCCCCTCCCTCTTCC","FALSE","ENST00000442865","ens|ENST00000442865|linc|lnc-SCRN1-1:1|linc|TCONS_l2_00027302|linc|TCONS_l2_00026455","LOC646762","uncharacterized LOC646762","ens|zinc and ring finger 2 pseudogene 2 [Source:HGNC Symbol;Acc:HGNC:42793] [ENST00000442865]","chr7",29638412,29724871,null,null,"mRNA","agilent G3 V3"]
["A_24_P139094",7.03,{"v":6.9,"d":"6.90"},7.21,8.68,8.63,8.54,{"v":0.81779497098646,"d":"0.82"},{"v":-0.290188903819614,"d":"-0.29"},"down",{"v":9.57780000000463e-05,"d":"0.00"},1,"yes","CCCGACATCTGCTTCCTCTATCGCCCAATGCAAAATCGATGAAATGGGGAGTTCTCTGGG","FALSE","NM_003025","ref|NM_003025|ref|NM_001199943|ref|NM_001199944|ens|ENST00000598564","SH3GL1","SH3-domain GRB2-like 1","ref|Homo sapiens SH3-domain GRB2-like 1 (SH3GL1), transcript variant 1, mRNA [NM_003025]","chr19",{"v":4360368,"d":"4360368.00"},4400415,"GO:0002102(podosome);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006897(endocytosis);GO:0007165(signal transduction);GO:0007417(central nervous system development);GO:0008289(lipid binding);GO:0019902(phosphatase binding);GO:0030054(cell junction);GO:0031901(early endosome membrane);GO:0042802(identical protein binding);GO:0042995(cell projection);GO:0051020(GTPase binding)","04144(Endocytosis)","mRNA","agilent G3 V3"]
["A_33_P3304707",11.86,11.89,11.91,10.82,10.74,10.96,{"v":1.09655596555966,"d":"1.10"},{"v":0.132979445549967,"d":"0.13"},"up",{"v":9.59579999999516e-05,"d":"0.00"},1,"yes","GGTGGTTATAACTATGTCTCCTGGTACCAACAGCACCCAGGCAAAGCCCCCAAACTCATG","FALSE","ENST00000620395","ens|ENST00000620395|ens|ENST00000390314|ens|ENST00000390312|ens|ENST00000621800",null,null,"ens|immunoglobulin lambda variable 2-8 [Source:HGNC Symbol;Acc:HGNC:5895] [ENST00000620395]","chr22",23165152,23165787,null,null,"mRNA","agilent G3 V3"]
["A_23_P91891",5.68,5.62,5.83,7.92,7.56,7.64,{"v":0.740916955017301,"d":"0.74"},{"v":-0.43261624641668,"d":"-0.43"},"down",{"v":9.59649999999757e-05,"d":"0.00"},1,"yes","TTGATTGCTACCCTGACCACAGTGCTTTGGACTATGAGAAACTTCTTAGATTTTTATATG","FALSE","NM_004766","ref|NM_004766|ref|NR_023350|ens|ENST00000333188|gb|AK302943","COPB2","coatomer protein complex, subunit beta 2 (beta prime)","ref|Homo sapiens coatomer protein complex, subunit beta 2 (beta prime) (COPB2), transcript variant 1, mRNA [NM_004766]","chr3",139076672,139077585,"GO:0005198(structural molecule activity);GO:0005829(cytosol);GO:0006886(intracellular protein transport);GO:0006890(retrograde vesicle-mediated transport, Golgi to ER);GO:0006891(intra-Golgi vesicle-mediated transport);GO:0030126(COPI vesicle coat);GO:0048205(COPI coating of Golgi vesicle);GO:0061024(membrane organization)",null,"mRNA","agilent G3 V3"]
["A_24_P403734",13.61,{"v":13.7,"d":"13.70"},13.58,12.97,13.01,12.94,{"v":1.05061664953751,"d":"1.05"},{"v":0.0712363527452542,"d":"0.07"},"up",{"v":9.60150000000048e-05,"d":"0.00"},1,"yes","GGGGTCTGGCCTACACTGGTCTTCCCCTTCCCATCAACTCTTTCTGCTTGACAATGTAGC","FALSE","NM_015481","ref|NM_015481|ref|NM_001290002|ref|NM_001290004|ref|NM_001130967","ZNF385A","zinc finger protein 385A","ref|Homo sapiens zinc finger protein 385A (ZNF385A), transcript variant 3, mRNA [NM_015481]","chr12",54763664,54772973,"GO:0000790(nuclear chromatin);GO:0002039(p53 binding);GO:0003677(DNA binding);GO:0003730(mRNA 3'-UTR binding);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0006915(apoptotic process);GO:0006974(response to DNA damage stimulus);GO:0007599(hemostasis);GO:0007611(learning or memory);GO:0007626(locomotory behavior);GO:0008270(zinc ion binding);GO:0010609(posttranscriptional regulation of gene expression by mRNA localization);GO:0030220(platelet formation);GO:0030425(dendrite);GO:0035855(megakaryocyte development);GO:0043025(neuronal cell body);GO:0045600(positive regulation of fat cell differentiation);GO:0070889(platelet alpha granule organization);GO:2000765(regulation of cytoplasmic translation)",null,"mRNA","agilent G3 V3"]
["A_32_P51905",5.56,5.87,5.78,7.63,7.44,7.67,{"v":0.756816182937555,"d":"0.76"},{"v":-0.401985156852044,"d":"-0.40"},"down",{"v":9.62020000000452e-05,"d":"0.00"},1,"yes","GGAAGCCACCTTTTTATTTCTCTTCACTGTGTACAAGTTCACTTGTTGTCTTGAACACTG","FALSE","NM_020444","ref|NM_020444|ref|NM_001079684|ref|NM_001079685|ref|NM_001287336","KIAA1191","KIAA1191","ref|Homo sapiens KIAA1191 (KIAA1191), transcript variant 1, mRNA [NM_020444]","chr5",175773072,175788768,"GO:0003674(molecular_function);GO:0005575(cellular_component);GO:0005737(cytoplasm);GO:0008150(biological_process);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)",null,"mRNA","agilent G3 V3"]
["A_33_P3259736",6.22,6.08,6.24,4.67,4.87,4.89,{"v":1.28482328482328,"d":"1.28"},{"v":0.361569944134333,"d":"0.36"},"up",{"v":9.62449999999393e-05,"d":"0.00"},1,"yes","GTGGCTTAGGCCAAAAGAAATATCTAACCATTCAATTTATAAATAATTAGGTCCCCAACG","FALSE","NM_014324","ref|NM_014324|ref|NM_203382|ref|NM_001167595|ref|NR_037951","AMACR","alpha-methylacyl-CoA racemase","ref|Homo sapiens alpha-methylacyl-CoA racemase (AMACR), transcript variant 1, mRNA [NM_014324]","chr5",33987280,34124633,"GO:0005102(receptor binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005777(peroxisome);GO:0005782(peroxisomal matrix);GO:0006699(bile acid biosynthetic process);GO:0008111(alpha-methylacyl-CoA racemase activity);GO:0008206(bile acid metabolic process);GO:0033540(fatty acid beta-oxidation using acyl-CoA oxidase);GO:0044255(cellular lipid metabolic process);GO:0044281(small molecule metabolic process)","00120(Primary bile acid biosynthesis);04146(Peroxisome)","mRNA","agilent G3 V3"]
["A_24_P239731",1.94,2.03,1.93,4.55,{"v":5.1,"d":"5.10"},{"v":5.1,"d":"5.10"},{"v":0.4,"d":"0.40"},{"v":-1.32192809488736,"d":"-1.32"},"down",{"v":9.62500000000199e-05,"d":"0.00"},1,"yes","TTGTCAGGCGATCTTGTTTGAAGCTCTATGTTGCCATAATTACCATCAAGTACACACTGT","FALSE","NM_004776","ref|NM_004776|ens|ENST00000371711|gb|AK056333|gb|AF289556","B4GALT5","UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5","ref|Homo sapiens UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5 (B4GALT5), mRNA [NM_004776]","chr20",48249480,48330415,"GO:0000139(Golgi membrane);GO:0005975(carbohydrate metabolic process);GO:0006493(protein O-linked glycosylation);GO:0008378(galactosyltransferase activity);GO:0009405(pathogenesis);GO:0016021(integral to membrane);GO:0016266(O-glycan processing);GO:0018146(keratan sulfate biosynthetic process);GO:0018279(protein N-linked glycosylation via asparagine);GO:0030203(glycosaminoglycan metabolic process);GO:0032580(Golgi cisterna membrane);GO:0042339(keratan sulfate metabolic process);GO:0043687(post-translational protein modification);GO:0044267(cellular protein metabolic process);GO:0044281(small molecule metabolic process);GO:0046872(metal ion binding);GO:0070062(extracellular vesicular exosome)","00512(Mucin type O-glycan biosynthesis)","mRNA","agilent G3 V3"]
["A_23_P45324",7.28,7.03,7.25,{"v":5.9,"d":"5.90"},5.86,5.93,{"v":1.21876766534765,"d":"1.22"},{"v":0.285423130062047,"d":"0.29"},"up",{"v":9.62740000000073e-05,"d":"0.00"},1,"yes","GGGGGGTTGTGTGGGAAGAGTACTTATTATTGTGTTTTCTTCAGTGTAATTGTTCTTGGT","FALSE","NM_021637","ref|NM_021637|ens|ENST00000372930|gb|AK024146|gb|BC078658","TMEM35","transmembrane protein 35","ref|Homo sapiens transmembrane protein 35 (TMEM35), mRNA [NM_021637]","chrX",100333712,100351353,"GO:0003674(molecular_function);GO:0005575(cellular_component);GO:0005778(peroxisomal membrane);GO:0008150(biological_process);GO:0016021(integral to membrane);GO:0016023(cytoplasmic membrane-bounded vesicle)",null,"mRNA","agilent G3 V3"]
["A_33_P3225690",3.82,3.81,4.03,5.22,5.21,{"v":5.1,"d":"5.10"},{"v":0.750804893754024,"d":"0.75"},{"v":-0.413490041186805,"d":"-0.41"},"down",{"v":9.62740000000073e-05,"d":"0.00"},1,"yes","GTGACCCAGTCCTGTTTCTCTGTGTTTTAGTTATTAAAAAGAAATTCTGTACCCAAAGTG","FALSE","NM_014643","ref|NM_014643|ens|ENST00000443185|gb|D86975|tc|THC2606882","ZNF516","zinc finger protein 516","ref|Homo sapiens zinc finger protein 516 (ZNF516), mRNA [NM_014643]","chr18",74069648,74207146,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_24_P100517",9.93,10.17,10.11,8.25,8.52,8.39,{"v":1.20071542130366,"d":"1.20"},{"v":0.263894261848652,"d":"0.26"},"up",{"v":9.6286000000001e-05,"d":"0.00"},1,"yes","TTCCGTGCAAGGTGAAAAGAAATAGGTCCTCCCAGTTTACAGCTTGAAATCAGGCTAGTG","FALSE","NM_178448","ref|NM_178448|ens|ENST00000409687|ref|XM_006717315|gb|BC048267","SAPCD2","suppressor APC domain containing 2","ref|Homo sapiens suppressor APC domain containing 2 (SAPCD2), mRNA [NM_178448]","chr9",139956576,139965040,"GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm)",null,"mRNA","agilent G3 V3"]
["A_23_P104318",3.46,2.92,2.98,7.23,6.82,6.67,{"v":0.451737451737452,"d":"0.45"},{"v":-1.14644356810315,"d":"-1.15"},"down",{"v":9.65149999999637e-05,"d":"0.00"},1,"yes","TCGTGGAGGTGGTTTGTGTATCTTACTGGTCTGAAGGGACCAAGTGTGTTTGTTGTTTGT","FALSE","NM_019058","ref|NM_019058|ens|ENST00000307365|gb|AY090097|gb|HV708905","DDIT4","DNA-damage-inducible transcript 4","ref|Homo sapiens DNA-damage-inducible transcript 4 (DDIT4), mRNA [NM_019058]","chr10",74033680,74034708,"GO:0001666(response to hypoxia);GO:0001764(neuron migration);GO:0005622(intracellular);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0007420(brain development);GO:0008283(cell proliferation);GO:0010801(negative regulation of peptidyl-threonine phosphorylation);GO:0030182(neuron differentiation);GO:0032007(negative regulation of TOR signaling cascade);GO:0033137(negative regulation of peptidyl-serine phosphorylation);GO:0042771(DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis);GO:0043241(protein complex disassembly);GO:0045820(negative regulation of glycolysis);GO:0048011(nerve growth factor receptor signaling pathway);GO:0051607(defense response to virus);GO:0071889(14-3-3 protein binding);GO:0072593(reactive oxygen species metabolic process)","04151(PI3K-Akt signaling pathway);04150(mTOR signaling pathway);05206(MicroRNAs in cancer)","mRNA","agilent G3 V3"]
["A_23_P215088",2.15,2.33,2.17,4.05,4.45,4.28,{"v":0.520344287949922,"d":"0.52"},{"v":-0.942461590558443,"d":"-0.94"},"down",{"v":9.661900000002e-05,"d":"0.00"},1,"yes","AATTAAGGCTGAGTTCCTTTCGGTCAGCTGACACTAAGTTTTTCCTGTTCTGGGTTAATC","FALSE","NM_016478","ref|NM_016478|ref|NM_001282190|ref|NM_001282191|ens|ENST00000467642","ZC3HC1","zinc finger, C3HC-type containing 1","ref|Homo sapiens zinc finger, C3HC-type containing 1 (ZC3HC1), transcript variant 1, mRNA [NM_016478]","chr7",129658136,129691214,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0007067(mitosis);GO:0008270(zinc ion binding);GO:0016567(protein ubiquitination);GO:0019901(protein kinase binding);GO:0031965(nuclear membrane);GO:0051301(cell division);GO:2001240(negative regulation of extrinsic apoptotic signaling pathway in absence of ligand)",null,"mRNA","agilent G3 V3"]
["A_23_P141345",3.07,3.14,3.21,5.68,5.26,5.72,{"v":0.565426170468187,"d":"0.57"},{"v":-0.822589435752765,"d":"-0.82"},"down",{"v":9.66709999999926e-05,"d":"0.00"},1,"yes","TAAGTGGGAAGTCTTGTTTGTTGTTGGTTTTTGTCTGTTGTTTTTCACTGCACCTCTTTG","FALSE","NM_001932","ref|NM_001932|ref|NR_003562|ens|ENST00000398389|ens|ENST00000496503","MPP3","membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3)","ref|Homo sapiens membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3) (MPP3), transcript variant 1, mRNA [NM_001932]","chr17",41878812,41910538,"GO:0004385(guanylate kinase activity);GO:0005887(integral to plasma membrane);GO:0007165(signal transduction);GO:0030165(PDZ domain binding);GO:0046939(nucleotide phosphorylation)",null,"mRNA","agilent G3 V3"]
["A_23_P166807",6.85,{"v":7.4,"d":"7.40"},7.04,9.81,9.74,9.66,{"v":0.728859979459089,"d":"0.73"},{"v":-0.456286408376885,"d":"-0.46"},"down",{"v":9.67809999999902e-05,"d":"0.00"},1,"yes","AGGGGCCCAGTTCTCAGCAGCAGACACTCTGTACAGTTTTTTCAATCCCTGTTTTTGAAT","FALSE","NM_033010","ref|NM_033010|ref|NM_001174100|ref|NM_033008|ref|NM_020418","PCBP4","poly(rC) binding protein 4","ref|Homo sapiens poly(rC) binding protein 4 (PCBP4), transcript variant 4, mRNA [NM_033010]","chr3",51991476,52001464,"GO:0003677(DNA binding);GO:0003723(RNA binding);GO:0005737(cytoplasm);GO:0030529(ribonucleoprotein complex)",null,"mRNA","agilent G3 V3"]
["A_33_P3277298",7.89,7.79,{"v":8,"d":"8.00"},6.51,6.68,{"v":6.5,"d":"6.50"},{"v":1.20264093448451,"d":"1.20"},{"v":0.266205969727396,"d":"0.27"},"up",{"v":9.69199999999448e-05,"d":"0.00"},1,"yes","ATCCTGTCTACAATGAGGCCATCATCTTTGACATTCCCCCGGAAAACATGGATCAAGTCA","FALSE","NM_001270805","ref|NM_001270805|ref|NM_205848|ens|ENST00000610222|ens|ENST00000610096","SYT6","synaptotagmin VI","ref|Homo sapiens synaptotagmin VI (SYT6), transcript variant 3, mRNA [NM_001270805]","chr1",114631912,114696472,"GO:0005215(transporter activity);GO:0005544(calcium-dependent phospholipid binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0016021(integral to membrane);GO:0019898(extrinsic to membrane);GO:0019905(syntaxin binding);GO:0030054(cell junction);GO:0030276(clathrin binding);GO:0030672(synaptic vesicle membrane);GO:0042803(protein homodimerization activity);GO:0046872(metal ion binding);GO:0046982(protein heterodimerization activity);GO:0048306(calcium-dependent protein binding);GO:0060478(acrosomal vesicle exocytosis);GO:0097038(perinuclear endoplasmic reticulum)",null,"mRNA","agilent G3 V3"]
["A_24_P264664",2.19,2.22,2.59,5.21,5.61,5.72,{"v":0.423216444981862,"d":"0.42"},{"v":-1.24053240733895,"d":"-1.24"},"down",{"v":9.69880000000201e-05,"d":"0.00"},1,"yes","ACAGTTGATTTAGGAAGTCACACAATGACACTGAAATCCTACAGACCAAAATCCACTTGT","FALSE","NM_001271","ref|NM_001271|ens|ENST00000394196|gb|AL831836|gb|AK095933","CHD2","chromodomain helicase DNA binding protein 2","ref|Homo sapiens chromodomain helicase DNA binding protein 2 (CHD2), transcript variant 1, mRNA [NM_001271]","chr15",93443056,93571237,"GO:0001046(core promoter sequence-specific DNA binding);GO:0003677(DNA binding);GO:0004003(ATP-dependent DNA helicase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006351(transcription, DNA-dependent);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0006974(response to DNA damage stimulus);GO:0007517(muscle organ development);GO:0016568(chromatin modification);GO:0032508(DNA duplex unwinding);GO:0042393(histone binding);GO:0043231(intracellular membrane-bounded organelle);GO:0060218(hemopoietic stem cell differentiation);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_32_P158786",10.02,10.02,10.08,8.34,8.62,{"v":8.3,"d":"8.30"},{"v":1.19239904988123,"d":"1.19"},{"v":0.253867130884376,"d":"0.25"},"up",{"v":9.70609999999539e-05,"d":"0.00"},1,"yes","TGTCCTCCCATCATTACTTTTGTGGCCAGTATTGTGAAACAAGTGGTGAGGGGTCTTTCA","FALSE","NM_001170633","ref|NM_001170633|ref|NM_001099676|ens|ENST00000536975|ens|ENST00000542397","C12orf56","chromosome 12 open reading frame 56","ref|Homo sapiens chromosome 12 open reading frame 56 (C12orf56), transcript variant 1, mRNA [NM_001170633]","chr12",64660216,64784972,null,null,"mRNA","agilent G3 V3"]
["A_23_P256682",7.45,7.49,7.42,8.06,8.19,8.13,{"v":0.917145200984413,"d":"0.92"},{"v":-0.124777937777022,"d":"-0.12"},"down",{"v":9.7190999999941e-05,"d":"0.00"},1,"yes","TTACACCACTTTCCACCTTCCTGTCCGAAGTACACGGACACTAGCTGCCCCAGGAAGTTG","FALSE","NM_014481","ref|NM_014481|ref|NM_001271748|gb|AB021260|gb|AJ011311","APEX2","APEX nuclease (apurinic/apyrimidinic endonuclease) 2","ref|Homo sapiens APEX nuclease (apurinic/apyrimidinic endonuclease) 2 (APEX2), transcript variant 1, mRNA [NM_014481]","chrX",55026792,55035490,"GO:0000737(DNA catabolic process, endonucleolytic);GO:0000738(DNA catabolic process, exonucleolytic);GO:0003677(DNA binding);GO:0003906(DNA-(apurinic or apyrimidinic site) lyase activity);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005743(mitochondrial inner membrane);GO:0006284(base-excision repair);GO:0006310(DNA recombination);GO:0007049(cell cycle);GO:0008270(zinc ion binding);GO:0008311(double-stranded DNA specific 3'-5' exodeoxyribonuclease activity);GO:0043231(intracellular membrane-bounded organelle)","03410(Base excision repair)","mRNA","agilent G3 V3"]
["A_24_P161036",5.43,5.22,5.01,7.75,7.46,7.74,{"v":0.68235294117647,"d":"0.68"},{"v":-0.55140994101013,"d":"-0.55"},"down",{"v":9.71920000000237e-05,"d":"0.00"},1,"yes","CTGTTGCTAATCTCTCCTGGAAACATCTGCCACATTTAGTGTGTGTATGTGTATTCATTC","FALSE","NM_001037161","ref|NM_001037161|ref|NM_006821|ref|NR_046028|ens|ENST00000311148","ACOT1","acyl-CoA thioesterase 1","ref|Homo sapiens acyl-CoA thioesterase 1 (ACOT1), mRNA [NM_001037161]","chr14",74041008,74041905,"GO:0000038(very long-chain fatty acid metabolic process);GO:0001676(long-chain fatty acid metabolic process);GO:0005829(cytosol);GO:0006637(acyl-CoA metabolic process);GO:0016290(palmitoyl-CoA hydrolase activity);GO:0047617(acyl-CoA hydrolase activity);GO:0052689(carboxylic ester hydrolase activity)","00062(Fatty acid elongation);01040(Biosynthesis of unsaturated fatty acids)","mRNA","agilent G3 V3"]
["A_33_P3266350",2.23,2.34,2.21,{"v":3.5,"d":"3.50"},3.76,{"v":3.7,"d":"3.70"},{"v":0.618613138686131,"d":"0.62"},{"v":-0.692890619824183,"d":"-0.69"},"down",{"v":9.72900000000276e-05,"d":"0.00"},1,"yes","AATTCTGACATGTGCTGGATCAGAGTGTTCTCATTTCCAATAGGCCAGTCTGCCATCCAT","FALSE","THC2517090","tc|THC2517090",null,null,"tc|Q5VYZ1_HUMAN (Q5VYZ1) YY1 associated protein, partial (64%) [THC2517090]","chr1",155630512,155658266,null,null,"mRNA","agilent G3 V3"]
["A_33_P3311653",9.59,9.41,9.45,8.51,8.59,8.53,{"v":1.11002731174405,"d":"1.11"},{"v":0.150595173902367,"d":"0.15"},"up",{"v":9.72999999999669e-05,"d":"0.00"},1,"yes","ATTTGAGTTTCTTCTAGGGAAGAGTCCCAGATTTGATCAGCTCAGGATACCCCCACTATC","FALSE","ENST00000507766","ens|ENST00000507766|gb|AK124569|tc|THC2499653","PDS5A","PDS5 cohesin associated factor A","ens|PDS5, regulator of cohesion maintenance, homolog A (S. cerevisiae) [Source:HGNC Symbol;Acc:HGNC:29088] [ENST00000507766]","chr4",39838632,39850181,"GO:0000278(mitotic cell cycle);GO:0000775(chromosome, centromeric region);GO:0000785(chromatin);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007064(mitotic sister chromatid cohesion);GO:0008156(negative regulation of DNA replication);GO:0051301(cell division)",null,"mRNA","agilent G3 V3"]
["A_33_P3361817",2.19,2.16,2.62,5.02,5.21,5.39,{"v":0.446222791293214,"d":"0.45"},{"v":-1.16416389227356,"d":"-1.16"},"down",{"v":9.73989999999425e-05,"d":"0.00"},1,"yes","AGACACCTTCTACATGGCCAGTGCTGTTCTGGACGGCAGCAACCTCAGCTACTTTGGGCA","FALSE","ENST00000412176","ens|ENST00000412176",{"$nulls":3},"chr1",24227960,24229227,null,null,"mRNA","agilent G3 V3"]
["A_32_P215938",6.96,6.83,{"v":6.7,"d":"6.70"},{"v":9.3,"d":"9.30"},8.95,8.93,{"v":0.753863134657837,"d":"0.75"},{"v":-0.407625471756145,"d":"-0.41"},"down",{"v":9.75619999999955e-05,"d":"0.00"},1,"yes","GTCTGTGCCATGTTGTCAATGGGTCCTTTCCAACCCAAGAGGTACATTTGTTTTTCTGTT","FALSE","NM_001145638","ref|NM_001145638|ref|NM_001200003|ref|NM_001145639|ens|ENST00000291775","GPSM1","G-protein signaling modulator 1","ref|Homo sapiens G-protein signaling modulator 1 (GPSM1), transcript variant 1, mRNA [NM_001145638]","chr9",139247504,139254057,"GO:0000139(Golgi membrane);GO:0005092(GDP-dissociation inhibitor activity);GO:0005654(nucleoplasm);GO:0005789(endoplasmic reticulum membrane);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007399(nervous system development);GO:0008277(regulation of G-protein coupled receptor protein signaling pathway);GO:0030154(cell differentiation);GO:0050790(regulation of catalytic activity)","05030(Cocaine addiction)","mRNA","agilent G3 V3"]
["A_33_P3535175",{"v":2.9,"d":"2.90"},2.96,3.07,5.15,4.96,5.41,{"v":0.575386597938144,"d":"0.58"},{"v":-0.797396477065905,"d":"-0.80"},"down",{"v":9.7647000000034e-05,"d":"0.00"},1,"yes","CTTTTTAGTTAAACAAATCCTCAGAATCGAATTAAGAAGGATGTCCACAGCTCGATCAAA","FALSE","BX095413","gb|BX095413",null,null,"gb|BX095413 NCI_CGAP_Kid3 Homo sapiens cDNA clone IMAGp998P233802, mRNA sequence [BX095413]","chr20",{"v":5177880,"d":"5177880.00"},5178535,null,null,"mRNA","agilent G3 V3"]
["A_33_P3308158",8.17,7.91,8.06,9.65,9.49,9.71,{"v":0.836741767764298,"d":"0.84"},{"v":-0.257145642777823,"d":"-0.26"},"down",{"v":9.79639999999504e-05,"d":"0.00"},1,"yes","ACTGCTGTTTCTTCACCTGCTGAGCCTCAGTTTCCCCATCTGTCATTGGGGATACCAGCC","FALSE","ENST00000519878","ens|ENST00000519878|tc|THC2595300",null,null,"ens|RAS p21 protein activator 4 [Source:HGNC Symbol;Acc:HGNC:23181] [ENST00000519878]","chr7",102240304,102246624,null,null,"mRNA","agilent G3 V3"]
["A_24_P17722",5.56,5.66,5.07,8.44,8.51,8.32,{"v":0.644637910565888,"d":"0.64"},{"v":-0.633439060419257,"d":"-0.63"},"down",{"v":9.79660000000049e-05,"d":"0.00"},1,"yes","CAGGTCCTGATATATTTCCTTGGATTCATTTCACTTGGCTAGAAATTACACTGTGCTCAA","FALSE","NM_198868","ref|NM_198868|ref|NM_015043|ens|ENST00000520794|ens|ENST00000521469","TBC1D9B","TBC1 domain family, member 9B (with GRAM domain)","ref|Homo sapiens TBC1 domain family, member 9B (with GRAM domain) (TBC1D9B), transcript variant 1, mRNA [NM_198868]","chr5",179289072,179298805,"GO:0005097(Rab GTPase activator activity);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0016021(integral to membrane);GO:0032851(positive regulation of Rab GTPase activity)",null,"mRNA","agilent G3 V3"]
["A_33_P3276153",10.83,10.64,10.79,9.72,9.66,9.77,{"v":1.10668953687822,"d":"1.11"},{"v":0.146250555067784,"d":"0.15"},"up",{"v":9.79740000000007e-05,"d":"0.00"},1,"yes","TTCATTAGCTCAATATGTGGTTTGCCCCCAAGTGTGCACTTTTTATTACTTTGTAATATG","FALSE","NM_001282472","ref|NM_001282472|ref|NM_001282490|ref|NR_027024|ens|ENST00000611771","GOLGA8J","golgin A8 family, member J","ref|Homo sapiens golgin A8 family, member J (GOLGA8J), mRNA [NM_001282472]","chr15",102311960,102322192,"GO:0005794(Golgi apparatus)",null,"mRNA","agilent G3 V3"]
["A_33_P3384694",12.39,12.48,12.51,11.69,11.58,11.69,{"v":1.06922196796339,"d":"1.07"},{"v":0.0965613842445597,"d":"0.10"},"up",{"v":9.82320000000314e-05,"d":"0.00"},1,"yes","TCACCTTTTGAGCAGCGTGCCTCCCCGTACTACTTCCGTAAAGGAATCCCCAACGTGCTG","FALSE","ENST00000510773","ens|ENST00000510773",{"$nulls":3},"chr4",135865424,135865678,null,null,"mRNA","agilent G3 V3"]
["A_23_P210829",2.09,2.22,2.05,3.97,{"v":4.3,"d":"4.30"},3.95,{"v":0.520458265139116,"d":"0.52"},{"v":-0.942145614534374,"d":"-0.94"},"down",{"v":9.82640000000146e-05,"d":"0.00"},1,"yes","TCCTGCGCACCTTATACCAGAATTCAGTATAATACACTACTTTCTGTTTTCAAACAGATA","FALSE","NM_018257","ref|NM_018257|ref|NM_001104925|ens|ENST00000308824|gb|AK126700","PCMTD2","protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2","ref|Homo sapiens protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2 (PCMTD2), transcript variant 1, mRNA [NM_018257]","chr20",62902836,62906195,"GO:0004719(protein-L-isoaspartate (D-aspartate) O-methyltransferase activity);GO:0005737(cytoplasm);GO:0006479(protein methylation)",null,"mRNA","agilent G3 V3"]
["A_23_P95640",9.63,9.67,9.84,8.38,8.48,8.54,{"v":1.14724409448819,"d":"1.15"},{"v":0.198172380404984,"d":"0.20"},"up",{"v":9.83249999999547e-05,"d":"0.00"},1,"yes","TGAGAACTATGGAGTCCATCAGCAGAGATAGTAGTGAAGTCTCTCCCCAGGGAAAATTTT","FALSE","NM_001007544","ref|NM_001007544|ens|ENST00000582070|ens|ENST00000331555|ref|XM_005272738","C1orf186","chromosome 1 open reading frame 186","ref|Homo sapiens chromosome 1 open reading frame 186 (C1orf186), mRNA [NM_001007544]","chr1",206238880,206288647,"GO:0005886(plasma membrane);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P99661",5.67,5.36,5.28,7.66,7.68,7.46,{"v":0.715350877192983,"d":"0.72"},{"v":-0.48327704234022,"d":"-0.48"},"down",{"v":9.85260000000432e-05,"d":"0.00"},1,"yes","AACAATAGGAGGGTGTGACAGGGGAACCGTAGACTTTATATATGTAATTACTGTTATTAT","FALSE","NM_018071","ref|NM_018071|ref|NM_001278529|ref|NM_001278530|ens|ENST00000553709","ARHGEF40","Rho guanine nucleotide exchange factor (GEF) 40","ref|Homo sapiens Rho guanine nucleotide exchange factor (GEF) 40 (ARHGEF40), transcript variant 1, mRNA [NM_018071]","chr14",21538528,21558036,"GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005737(cytoplasm);GO:0032321(positive regulation of Rho GTPase activity)",null,"mRNA","agilent G3 V3"]
["A_33_P3403773",1.94,2.04,2.05,3.52,3.76,3.87,{"v":0.540807174887892,"d":"0.54"},{"v":-0.886813802907582,"d":"-0.89"},"down",{"v":9.88299999999942e-05,"d":"0.00"},1,"yes","CCTTTTGGGATGTGGGAAAGGTTTGGTGGGAGTTGTTATATTTATCTGTAATATTTCTTT","FALSE","NM_152484","ref|NM_152484|ens|ENST00000316950|ens|ENST00000392149|ref|XM_006723046","ZNF569","zinc finger protein 569","ref|Homo sapiens zinc finger protein 569 (ZNF569), mRNA [NM_152484]","chr19",37902056,37958339,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3411925",{"v":14.5,"d":"14.50"},14.57,14.56,13.72,13.71,13.85,{"v":1.05692829457364,"d":"1.06"},{"v":0.0798775029532456,"d":"0.08"},"up",{"v":9.89000000000129e-05,"d":"0.00"},1,"yes","CGTCACAGTGGTGCTAGTCTGTTTTTAACAAAAGAGGATGAAAAGCCCCTCCTCTCCGGC","FALSE","NM_024100","ref|NM_024100|ens|ENST00000585809|gb|AK131009|tc|THC2468321","WDR18","WD repeat domain 18","ref|Homo sapiens WD repeat domain 18 (WDR18), mRNA [NM_024100]","chr19",{"v":994013,"d":"994013.00"},994553,"GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0007275(multicellular organismal development)",null,"mRNA","agilent G3 V3"]
["A_22_P00016518",9.74,9.47,9.51,11.25,11.06,11.13,{"v":0.858851674641148,"d":"0.86"},{"v":-0.219519098257832,"d":"-0.22"},"down",{"v":9.91430000000237e-05,"d":"0.00"},1,"yes","GACACCTCACTCTGCACCCTGGACACCCTCACTCACCCTGGACACGTTCACTCACCCTGA","FALSE","NM_182832","ref|NM_182832|linc|lnc-TMPRSS2-4:3|gb|L13197|gb|AF269287","PLAC4","placenta-specific 4","ref|Homo sapiens placenta-specific 4 (PLAC4), mRNA [NM_182832]","chr21",42547156,42557166,null,null,"mRNA","agilent G3 V3"]
["A_23_P28969",1.94,2.46,1.89,5.46,5.19,5.55,{"v":0.388271604938272,"d":"0.39"},{"v":-1.3648618908927,"d":"-1.36"},"down",{"v":9.94530000000271e-05,"d":"0.00"},1,"yes","CAAGAACTTGCAGAGGAGATTTCAACAGCAATTTCGAAACCTGTAGGGTTTGGAGAAGAG","FALSE","NM_176812","ref|NM_176812|ens|ENST00000217402|gb|AY329085|gb|AY726594","CHMP4B","charged multivesicular body protein 4B","ref|Homo sapiens charged multivesicular body protein 4B (CHMP4B), mRNA [NM_176812]","chr20",32399110,32442172,"GO:0000815(ESCRT III complex);GO:0000920(cytokinetic cell separation);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005829(cytosol);GO:0006620(posttranslational protein targeting to membrane);GO:0006997(nucleus organization);GO:0007034(vacuolar transport);GO:0007080(mitotic metaphase plate congression);GO:0009898(internal side of plasma membrane);GO:0010824(regulation of centrosome duplication);GO:0016032(viral reproduction);GO:0016197(endosomal transport);GO:0019058(viral infectious cycle);GO:0030496(midbody);GO:0031902(late endosome membrane);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0046755(non-lytic virus budding);GO:0050792(regulation of viral reproduction);GO:0051260(protein homooligomerization);GO:0060548(negative regulation of cell death);GO:0061024(membrane organization);GO:0070062(extracellular vesicular exosome)","04144(Endocytosis)","mRNA","agilent G3 V3"]
["A_23_P156809",8.83,8.62,8.38,10.68,10.66,10.77,{"v":0.804422298349424,"d":"0.80"},{"v":-0.31397502160777,"d":"-0.31"},"down",{"v":9.95019999999736e-05,"d":"0.00"},1,"yes","TCAACAGGATCCCAAGGCAGAAGAATTTTTCTTAGTACAGAACAAAATGAAAAGTCTCCC","FALSE","NM_001127395","ref|NM_001127395|ref|NM_145280|ens|ENST00000625001|ens|ENST00000557832","METTL21A","methyltransferase like 21A","ref|Homo sapiens methyltransferase like 21A (METTL21A), transcript variant 2, mRNA [NM_001127395]","chr2",208477456,208490102,"GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006479(protein methylation);GO:0016279(protein-lysine N-methyltransferase activity);GO:0018022(peptidyl-lysine methylation);GO:0030544(Hsp70 protein binding);GO:0043462(regulation of ATPase activity);GO:0051117(ATPase binding)",null,"mRNA","agilent G3 V3"]
["A_23_P111621",3.44,{"v":2.6,"d":"2.60"},2.97,6.92,{"v":6.9,"d":"6.90"},7.15,{"v":0.42966142107773,"d":"0.43"},{"v":-1.21872785028305,"d":"-1.22"},"down",{"v":9.95990000000058e-05,"d":"0.00"},1,"yes","TCGGATATGTATCGATGCCTTTTAGTTTTTCCAATGATTTTTACACTATATTCCTGCCAC","FALSE","NM_005685","ref|NM_005685|ref|NM_001199207|ref|NM_016328|ens|ENST00000486086","GTF2IRD1","GTF2I repeat domain containing 1","ref|Homo sapiens GTF2I repeat domain containing 1 (GTF2IRD1), transcript variant 2, mRNA [NM_005685]","chr7",74015288,74016910,"GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0003705(RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-dependent);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0006366(transcription from RNA polymerase II promoter);GO:0007275(multicellular organismal development);GO:0014886(transition between slow and fast fiber)","03022(Basal transcription factors);04022(cGMP - PKG signaling pathway);05168(Herpes simplex infection)","mRNA","agilent G3 V3"]
["A_23_P94053",1.89,2.21,1.94,4.34,4.64,4.79,{"v":0.438634713144517,"d":"0.44"},{"v":-1.18890810480989,"d":"-1.19"},"down",{"v":9.96410000000392e-05,"d":"0.00"},1,"yes","CTTTCGGAAATAACACCTCACAGCAGCTTCGTGCTTTTGTACAGACCTTTGTAACAAGTG","FALSE","NM_003496","ref|NM_003496|ref|NM_001244580|ens|ENST00000359863|ens|ENST00000355540","TRRAP","transformation/transcription domain-associated protein","ref|Homo sapiens transformation/transcription domain-associated protein (TRRAP), transcript variant 2, mRNA [NM_003496]","chr7",98498304,98610866,"GO:0000125(PCAF complex);GO:0000812(Swr1 complex);GO:0003712(transcription cofactor activity);GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0006281(DNA repair);GO:0006325(chromatin organization);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0007093(mitotic cell cycle checkpoint);GO:0016301(kinase activity);GO:0016310(phosphorylation);GO:0016573(histone acetylation);GO:0016578(histone deubiquitination);GO:0016773(phosphotransferase activity, alcohol group as acceptor);GO:0030914(STAGA complex);GO:0033276(transcription factor TFTC complex);GO:0035267(NuA4 histone acetyltransferase complex);GO:0043967(histone H4 acetylation);GO:0043968(histone H2A acetylation)","05166(HTLV-I infection)","mRNA","agilent G3 V3"]
["A_33_P3334515",12.43,12.38,12.41,12.76,12.75,12.81,{"v":0.971294363256785,"d":"0.97"},{"v":-0.0420195056770287,"d":"-0.04"},"down",{"v":9.98450000000428e-05,"d":"0.00"},1,"yes","GGAGGGTGCCCTCCCGTCTCCCACAACTTCTGCTATAACAATAAACTGTAGAGGAATCTG","FALSE","NM_001282213","ref|NM_001282213|ref|NM_001282214|ref|NM_001282212|ref|NM_201535","NDRG2","NDRG family member 2","ref|Homo sapiens NDRG family member 2 (NDRG2), transcript variant 11, mRNA [NM_001282213]","chr14",21484932,21493219,"GO:0001818(negative regulation of cytokine production);GO:0003674(molecular_function);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005829(cytosol);GO:0010574(regulation of vascular endothelial growth factor production);GO:0016055(Wnt receptor signaling pathway);GO:0021762(substantia nigra development);GO:0030154(cell differentiation);GO:0030426(growth cone);GO:0048471(perinuclear region of cytoplasm);GO:0048662(negative regulation of smooth muscle cell proliferation);GO:0070062(extracellular vesicular exosome);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:0090361(regulation of platelet-derived growth factor production)",null,"mRNA","agilent G3 V3"]
["A_21_P0014753",4.12,4.76,{"v":4.4,"d":"4.40"},7.99,7.67,8.09,{"v":0.559157894736842,"d":"0.56"},{"v":-0.838672366758748,"d":"-0.84"},"down",{"v":9.98930000000176e-05,"d":"0.00"},1,"yes","TGTTTGTTCTCTGATGGTATCTCTGAGAATACTGGTTGTAGGACTGGCCAGTAGTGCCTT","FALSE","THC2507047","tc|THC2507047|tc|THC2598969|tc|THC2590205",null,null,"tc|HUMFNC fibronectin {Homo sapiens} (exp=-1; wgp=0; cg=0), partial (21%) [THC2507047]",{"$nulls":5},"mRNA","agilent G3 V3"]
["A_23_P10870",{"v":2.6,"d":"2.60"},2.77,2.46,4.85,4.51,4.67,{"v":0.558089807555239,"d":"0.56"},{"v":-0.841430796328858,"d":"-0.84"},"down",{"v":0.000100003999999987,"d":"0.00"},1,"yes","CTTTTGAGGGGACCATGACATCTATATTTGCGCAGATCATTTCTGTAGCTCTGATCTTAA","FALSE","NM_014908","ref|NM_014908|ens|ENST00000372586|gb|AK300180|gb|AB384111","DOLK","dolichol kinase","ref|Homo sapiens dolichol kinase (DOLK), mRNA [NM_014908]","chr9",131707808,131709898,"GO:0004168(dolichol kinase activity);GO:0005789(endoplasmic reticulum membrane);GO:0006488(dolichol-linked oligosaccharide biosynthetic process);GO:0006489(dolichyl diphosphate biosynthetic process);GO:0016310(phosphorylation);GO:0018279(protein N-linked glycosylation via asparagine);GO:0030176(integral to endoplasmic reticulum membrane);GO:0043048(dolichyl monophosphate biosynthetic process);GO:0043687(post-translational protein modification);GO:0044267(cellular protein metabolic process)","00510(N-Glycan biosynthesis)","mRNA","agilent G3 V3"]
["A_23_P51217",8.99,8.77,8.96,7.31,7.53,7.34,{"v":1.20468890892696,"d":"1.20"},{"v":0.268660642312342,"d":"0.27"},"up",{"v":0.000100109000000015,"d":"0.00"},1,"yes","GTAGGGGGCGATATACTAAATGTATATAGTACATTTATACTAAATGTATTCCTGTAGGGG","FALSE","NM_001285","ref|NM_001285|ens|ENST00000234701|ens|ENST00000394711|gb|AF039400","CLCA1","chloride channel accessory 1","ref|Homo sapiens chloride channel accessory 1 (CLCA1), mRNA [NM_001285]","chr1",86934528,86965972,"GO:0005254(chloride channel activity);GO:0005615(extracellular space);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0005902(microvillus);GO:0006508(proteolysis);GO:0006810(transport);GO:0006816(calcium ion transport);GO:0006821(chloride transport);GO:0008237(metallopeptidase activity);GO:0034220(ion transmembrane transport);GO:0042589(zymogen granule membrane);GO:0046872(metal ion binding);GO:0055085(transmembrane transport);GO:0071456(cellular response to hypoxia)","04972(Pancreatic secretion);04740(Olfactory transduction)","mRNA","agilent G3 V3"]
["A_33_P3871347",10.96,10.77,10.84,11.97,11.89,11.84,{"v":0.912324929971989,"d":"0.91"},{"v":-0.132380354520559,"d":"-0.13"},"down",{"v":0.000100129000000004,"d":"0.00"},1,"yes","CAAAGAGGGCCTCCTTCCTTTCCTCTTTCATAAAAATGTTTTTTGAAGAGTTAGAGTATA","FALSE","NM_001080437","ref|NM_001080437|gb|AK074062|gb|AF439717|tc|THC2471466","SNED1","sushi, nidogen and EGF-like domains 1","ref|Homo sapiens sushi, nidogen and EGF-like domains 1 (SNED1), mRNA [NM_001080437]","chr2",241938256,242032483,"GO:0005509(calcium ion binding);GO:0007160(cell-matrix adhesion);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_24_P322771",13.26,13.19,{"v":13.3,"d":"13.30"},12.49,12.52,{"v":12.6,"d":"12.60"},{"v":1.05689976070194,"d":"1.06"},{"v":0.0798385540187738,"d":"0.08"},"up",{"v":0.000100240999999945,"d":"0.00"},1,"yes","CCCCGTGAAAGACAGAATTGTGGTTTTCCTGGTGTCACGCCCTCCCAGTGTGCAAATAAG","FALSE","NM_003225","ref|NM_003225|ens|ENST00000291527|gb|E02904|gb|X52003","TFF1","trefoil factor 1","ref|Homo sapiens trefoil factor 1 (TFF1), mRNA [NM_003225]","chr21",43782392,43786703,"GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005975(carbohydrate metabolic process);GO:0007586(digestion);GO:0008083(growth factor activity);GO:0008285(negative regulation of cell proliferation);GO:0010039(response to iron ion);GO:0030154(cell differentiation);GO:0030277(maintenance of gastrointestinal epithelium);GO:0032355(response to estradiol stimulus);GO:0035902(response to immobilization stress);GO:0043434(response to peptide hormone stimulus)",null,"mRNA","agilent G3 V3"]
["A_33_P3377229",12.42,12.46,12.45,11.44,11.33,11.55,{"v":1.08770396270396,"d":"1.09"},{"v":0.121285955803524,"d":"0.12"},"up",{"v":0.000100270000000013,"d":"0.00"},1,"yes","GATGGGTGAGTAAACAGACGTATGTGGCAGCCAGCAGAGCCCCCACATTTGTTCCCTGAC","FALSE","NM_001142946","ref|NM_001142946|ref|NR_024621|ens|ENST00000381153|gb|AB029488","C11orf21","chromosome 11 open reading frame 21","ref|Homo sapiens chromosome 11 open reading frame 21 (C11orf21), transcript variant 1, mRNA [NM_001142946]","chr11",{"v":2316875,"d":"2316875.00"},2323290,"GO:0005737(cytoplasm)",null,"mRNA","agilent G3 V3"]
["A_23_P57819",1.96,2.51,1.91,5.27,5.28,5.11,{"v":0.407407407407407,"d":"0.41"},{"v":-1.29545588352617,"d":"-1.30"},"down",{"v":0.000100938999999967,"d":"0.00"},1,"yes","TACTTTTCTCTCTAGGATTTAGATTATCATTTATGTGCTGTTGCACAGTGAAACCTCACC","FALSE","NM_014760","ref|NM_014760|ens|ENST00000287652|ens|ENST00000448281|gb|D86972","TATDN2","TatD DNase domain containing 2","ref|Homo sapiens TatD DNase domain containing 2 (TATDN2), mRNA [NM_014760]","chr3",10290596,10322902,"GO:0000737(DNA catabolic process, endonucleolytic);GO:0004536(deoxyribonuclease activity);GO:0005654(nucleoplasm);GO:0006308(DNA catabolic process);GO:0006987(activation of signaling protein activity involved in unfolded protein response);GO:0016888(endodeoxyribonuclease activity, producing 5'-phosphomonoesters);GO:0030968(endoplasmic reticulum unfolded protein response);GO:0043229(intracellular organelle);GO:0044267(cellular protein metabolic process);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3268174",{"v":2.3,"d":"2.30"},2.51,2.51,4.04,4.23,4.35,{"v":0.580031695721078,"d":"0.58"},{"v":-0.785796356698507,"d":"-0.79"},"down",{"v":0.000100973999999976,"d":"0.00"},1,"yes","GCTTATCTCAAACAGATTACCCATCTGCAGAACTAAGGAAAGCAATTTATGTATGAAAGA","FALSE","NM_152903","ref|NM_152903|ens|ENST00000379485|gb|AK023475|gb|CR749688","KBTBD6","kelch repeat and BTB (POZ) domain containing 6","ref|Homo sapiens kelch repeat and BTB (POZ) domain containing 6 (KBTBD6), mRNA [NM_152903]","chr13",41701704,41706882,"GO:0003674(molecular_function);GO:0005515(protein binding);GO:0005575(cellular_component);GO:0008150(biological_process)",null,"mRNA","agilent G3 V3"]
["A_32_P14850",13.21,12.95,13.04,14.71,{"v":14.6,"d":"14.60"},14.49,{"v":0.894977168949772,"d":"0.89"},{"v":-0.160077215485965,"d":"-0.16"},"down",{"v":0.000101160000000045,"d":"0.00"},1,"yes","AAGACACCTCCCGAATGTCTCCTTCATCCCCTTCCACCCTCAGTGGATGATAATATCAAG","FALSE","ENST00000429990","ens|ENST00000429990|ens|ENST00000547442|ens|ENST00000588786|ref|XM_005256273","NPIPB15","nuclear pore complex interacting protein family, member B15","ens|nuclear pore complex interacting protein family, member B15 [Source:HGNC Symbol;Acc:HGNC:34409] [ENST00000429990]","chr18",11619714,11639460,"GO:0005576(extracellular region)",null,"mRNA","agilent G3 V3"]
["A_23_P6464",{"v":13.1,"d":"13.10"},13.13,13.03,12.47,12.37,12.45,{"v":1.05282917672298,"d":"1.05"},{"v":0.0742713756925299,"d":"0.07"},"up",{"v":0.000101471999999991,"d":"0.00"},1,"yes","TTTGGCCCCTTTCCCTGACTGTCAAGGACAACTGACTCCCCCATCAGCTCAAACATTAAG","FALSE","NM_003560","ref|NM_003560|ref|NM_001004426|ref|NM_001199562|ens|ENST00000402064","PLA2G6","phospholipase A2, group VI (cytosolic, calcium-independent)","ref|Homo sapiens phospholipase A2, group VI (cytosolic, calcium-independent) (PLA2G6), transcript variant 1, mRNA [NM_003560]","chr22",38507504,38577761,"GO:0001934(positive regulation of protein phosphorylation);GO:0004623(phospholipase A2 activity);GO:0005516(calmodulin binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005815(microtubule organizing center);GO:0005829(cytosol);GO:0006644(phospholipid metabolic process);GO:0006935(chemotaxis);GO:0007204(elevation of cytosolic calcium ion concentration);GO:0007613(memory);GO:0014832(urinary bladder smooth muscle contraction);GO:0016020(membrane);GO:0016042(lipid catabolic process);GO:0032049(cardiolipin biosynthetic process);GO:0034976(response to endoplasmic reticulum stress);GO:0035774(positive regulation of insulin secretion involved in cellular response to glucose stimulus);GO:0035965(cardiolipin acyl-chain remodeling);GO:0036151(phosphatidylcholine acyl-chain remodeling);GO:0036152(phosphatidylethanolamine acyl-chain remodeling);GO:0038096(Fc-gamma receptor signaling pathway involved in phagocytosis);GO:0043008(ATP-dependent protein binding);GO:0044281(small molecule metabolic process);GO:0045087(innate immune response);GO:0045909(positive regulation of vasodilation);GO:0045921(positive regulation of exocytosis);GO:0046474(glycerophospholipid biosynthetic process);GO:0047499(calcium-independent phospholipase A2 activity);GO:0051967(negative regulation of synaptic transmission, glutamatergic);GO:0060135(maternal process involved in female pregnancy);GO:0090037(positive regulation of protein kinase C signaling cascade);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:0090238(positive regulation of arachidonic acid secretion);GO:2000304(positive regulation of ceramide biosynthetic process)","00564(Glycerophospholipid metabolism);00565(Ether lipid metabolism);00590(Arachidonic acid metabolism);00591(Linoleic acid metabolism);00592(alpha-Linolenic acid metabolism);04014(Ras signaling pathway);04666(Fc gamma R-mediated phagocytosis);04270(Vascular smooth muscle contraction);04750(Inflammatory mediator regulation of TRP channels)","mRNA","agilent G3 V3"]
["A_33_P3225091",2.03,1.93,2.33,4.75,4.53,4.39,{"v":0.46013167520117,"d":"0.46"},{"v":-1.11988132072677,"d":"-1.12"},"down",{"v":0.000101491999999981,"d":"0.00"},1,"yes","GATGTGGCAACGTTTTACAGTCTTGCTATTGTTTCTTGAGTCCTTTAATCTATAAGATGT","FALSE","NM_004756","ref|NM_004756|ref|NM_001289979|ref|NM_001289980|ens|ENST00000252891","NUMBL","numb homolog (Drosophila)-like","ref|Homo sapiens numb homolog (Drosophila)-like (NUMBL), transcript variant 1, mRNA [NM_004756]","chr19",41172596,41196556,"GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0007399(nervous system development);GO:0007409(axonogenesis);GO:0019221(cytokine-mediated signaling pathway);GO:0019538(protein metabolic process);GO:0021670(lateral ventricle development);GO:0021849(neuroblast division in subventricular zone);GO:0034332(adherens junction organization);GO:0050769(positive regulation of neurogenesis);GO:0050775(positive regulation of dendrite morphogenesis)","04330(Notch signaling pathway)","mRNA","agilent G3 V3"]
["A_23_P114221",5.92,5.81,5.51,7.75,7.64,7.74,{"v":0.745352356247298,"d":"0.75"},{"v":-0.424005491547092,"d":"-0.42"},"down",{"v":0.000101813999999978,"d":"0.00"},1,"yes","AATGTAAGTGGGGTGGCTTATGGCTTCTTTATCCTCTGATTCTAGCACTTTCAAGTGAGC","FALSE","NM_002893","ref|NM_002893|ref|NM_001198719|ens|ENST00000465244|ens|ENST00000330735","RBBP7","retinoblastoma binding protein 7","ref|Homo sapiens retinoblastoma binding protein 7 (RBBP7), transcript variant 2, mRNA [NM_002893]","chrX",16862812,16888484,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006260(DNA replication);GO:0006325(chromatin organization);GO:0006334(nucleosome assembly);GO:0006351(transcription, DNA-dependent);GO:0007275(multicellular organismal development);GO:0008283(cell proliferation);GO:0010467(gene expression);GO:0016581(NuRD complex);GO:0030308(negative regulation of cell growth);GO:0034080(CenH3-containing nucleosome assembly at centromere);GO:0035098(ESC/E(Z) complex);GO:0040029(regulation of gene expression, epigenetic);GO:0045814(negative regulation of gene expression, epigenetic);GO:0070370(cellular heat acclimation)",null,"mRNA","agilent G3 V3"]
["A_23_P216845",7.74,7.83,7.66,6.18,6.26,6.45,{"v":1.22975119110641,"d":"1.23"},{"v":0.298366452420438,"d":"0.30"},"up",{"v":0.000101844000000018,"d":"0.00"},1,"yes","CTGGGTCTTTCTCAGCAGAAGTTGTTTCCAGGTGTGCTCAAGTGCCTTCCTCTAGCAGAG","FALSE","NM_004188","ref|NM_004188|ref|NM_001135031|ens|ENST00000339463|ens|ENST00000372122","GFI1B","growth factor independent 1B transcription repressor","ref|Homo sapiens growth factor independent 1B transcription repressor (GFI1B), transcript variant 1, mRNA [NM_004188]","chr9",135854096,135867083,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0001085(RNA polymerase II transcription factor binding);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0006366(transcription from RNA polymerase II promoter);GO:0008283(cell proliferation);GO:0016363(nuclear matrix);GO:0016568(chromatin modification);GO:0030097(hemopoiesis);GO:0046872(metal ion binding);GO:0051569(regulation of histone H3-K4 methylation)",null,"mRNA","agilent G3 V3"]
["A_33_P3317431",5.51,5.15,5.08,7.47,7.39,7.59,{"v":0.701113585746102,"d":"0.70"},{"v":-0.512279904121023,"d":"-0.51"},"down",{"v":0.000102008000000042,"d":"0.00"},1,"yes","GGAACCTGTGTGAAGATCAACAAGGCTTCAATTTACATGCTGAGGATTGTAGAGCCATAG","FALSE","ENST00000447700","ens|ENST00000447700",null,null,"ens|ribosomal protein L7 pseudogene 59 [Source:HGNC Symbol;Acc:HGNC:49215] [ENST00000447700]","chr7",144737088,144738034,null,null,"mRNA","agilent G3 V3"]
["A_33_P3274756",9.38,9.35,9.58,8.11,7.95,8.11,{"v":1.17128671907323,"d":"1.17"},{"v":0.228094276140165,"d":"0.23"},"up",{"v":0.000102197000000026,"d":"0.00"},1,"yes","TTACTTTTAAGAATGTCTCCCCAACATCTTACCTCACTCTGGCCTACCATGATTACAGAA","FALSE","NM_015018","ref|NM_015018|ref|NM_001199942|ens|ENST00000237163|ref|XM_006715401","DOPEY1","dopey family member 1","ref|Homo sapiens dopey family member 1 (DOPEY1), transcript variant 1, mRNA [NM_015018]","chr6",83847392,83881069,"GO:0015031(protein transport)",null,"mRNA","agilent G3 V3"]
["A_32_P141724",8.79,8.95,{"v":9,"d":"9.00"},7.87,7.91,7.93,{"v":1.12779417967102,"d":"1.13"},{"v":0.173503802611345,"d":"0.17"},"up",{"v":0.000102370000000018,"d":"0.00"},1,"yes","TCAGCTCTCTGAATTTGCCACCACCAATCAGATCAGTCTTGGCTCCCTCAGAAGCATCGT","FALSE","NM_053041","ref|NM_053041|ref|NM_001099339|ens|ENST00000446419|ens|ENST00000278980","COMMD7","COMM domain containing 7","ref|Homo sapiens COMM domain containing 7 (COMMD7), transcript variant 1, mRNA [NM_053041]","chr20",31292276,31331212,"GO:0005515(protein binding);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0033209(tumor necrosis factor-mediated signaling pathway);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0051059(NF-kappaB binding);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P396062",2.79,{"v":3,"d":"3.00"},2.84,4.67,5.06,4.93,{"v":0.588676671214188,"d":"0.59"},{"v":-0.764452638954857,"d":"-0.76"},"down",{"v":0.000102595999999955,"d":"0.00"},1,"yes","GCTGTGATGTGACACCTTCGGGGACATTGACCACTCAAAACTCAGATCATCTCGCCCACC","FALSE","NM_021168","ref|NM_021168|ref|NM_001172663|ref|NM_001172664|ref|NM_001172665","RAB40C","RAB40C, member RAS oncogene family","ref|Homo sapiens RAB40C, member RAS oncogene family (RAB40C), transcript variant 2, mRNA [NM_021168]","chr16",{"v":640077,"d":"640077.00"},679271,"GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0005886(plasma membrane);GO:0006184(GTP catabolic process);GO:0006886(intracellular protein transport);GO:0006904(vesicle docking involved in exocytosis);GO:0009306(protein secretion);GO:0010008(endosome membrane);GO:0016567(protein ubiquitination);GO:0017157(regulation of exocytosis);GO:0019003(GDP binding);GO:0032482(Rab protein signal transduction);GO:0048471(perinuclear region of cytoplasm);GO:0072659(protein localization in plasma membrane)",null,"mRNA","agilent G3 V3"]
["A_22_P00012693",8.28,8.08,8.31,6.85,6.79,6.64,{"v":1.21646942800789,"d":"1.22"},{"v":0.282700063296783,"d":"0.28"},"up",{"v":0.000102805000000039,"d":"0.00"},1,"yes","CATTTCAGCAGAATTAAGTATAGCGGGGGCTCATCTAATAAAGGAAGCCACTTCTCCCAA","FALSE","ENST00000452252","ens|ENST00000452252|linc|lnc-RAB11FIP2-3:1|tc|THC2776540","FAM204A","family with sequence similarity 204, member A","ens|family with sequence similarity 204, member A [Source:HGNC Symbol;Acc:HGNC:25794] [ENST00000452252]","chr10",120068120,120069092,null,null,"mRNA","agilent G3 V3"]
["A_33_P3230290",15.38,15.42,15.47,14.59,14.61,14.73,{"v":1.05326656043706,"d":"1.05"},{"v":0.0748705994725343,"d":"0.07"},"up",{"v":0.000102814000000007,"d":"0.00"},1,"yes","ACCCTGAAGAACAGAATTGATTCTTGCCCCTCTCCCTGTGTGAGCTTGGCCCCGCCTCTT","FALSE","NM_030649","ref|NM_030649|ens|ENST00000492936|ref|XM_006710329|ref|XM_005244716","ACAP3","ArfGAP with coiled-coil, ankyrin repeat and PH domains 3","ref|Homo sapiens ArfGAP with coiled-coil, ankyrin repeat and PH domains 3 (ACAP3), mRNA [NM_030649]","chr1",{"v":1227764,"d":"1227764.00"},1243269,"GO:0008060(ARF GTPase activator activity);GO:0008270(zinc ion binding);GO:0032312(regulation of ARF GTPase activity);GO:0043547(positive regulation of GTPase activity)","04144(Endocytosis)","mRNA","agilent G3 V3"]
["A_33_P3344451",13.01,{"v":13,"d":"13.00"},13.07,12.02,11.99,12.18,{"v":1.07985631389887,"d":"1.08"},{"v":0.110839359595846,"d":"0.11"},"up",{"v":0.000102988999999942,"d":"0.00"},1,"yes","TGGACATGCCAGCCAACAACAAATGCCTGATCTTCCGGAAAAACTAAGCCCCTCCTTCAC","FALSE","NM_032366","ref|NM_032366|ref|NM_001288710|ref|NM_001040160|ref|NM_001040165","C16orf13","chromosome 16 open reading frame 13","ref|Homo sapiens chromosome 16 open reading frame 13 (C16orf13), transcript variant 1, mRNA [NM_032366]","chr16",{"v":685281,"d":"685281.00"},686267,null,null,"mRNA","agilent G3 V3"]
["A_23_P94860",2.29,2.49,2.34,4.62,4.65,5.07,{"v":0.496513249651325,"d":"0.50"},{"v":-1.01009587773551,"d":"-1.01"},"down",{"v":0.000103086999999946,"d":"0.00"},1,"yes","AACAATTTGCATTTAGAGTGTTTCGCATCAGAATAACATGAGTAAGATGAACTGGAACAC","FALSE","NM_024047","ref|NM_024047|ref|NM_001248011|ref|NM_198038|ens|ENST00000302174","NUDT9","nudix (nucleoside diphosphate linked moiety X)-type motif 9","ref|Homo sapiens nudix (nucleoside diphosphate linked moiety X)-type motif 9 (NUDT9), transcript variant 1, mRNA [NM_024047]","chr4",88343960,88379070,"GO:0005622(intracellular);GO:0005759(mitochondrial matrix);GO:0019144(ADP-sugar diphosphatase activity);GO:0034656(nucleobase-containing small molecule catabolic process);GO:0043262(adenosine-diphosphatase activity);GO:0044281(small molecule metabolic process);GO:0046032(ADP catabolic process);GO:0046709(IDP catabolic process);GO:0047631(ADP-ribose diphosphatase activity);GO:0055086(nucleobase-containing small molecule metabolic process);GO:0070062(extracellular vesicular exosome)","00230(Purine metabolism)","mRNA","agilent G3 V3"]
["A_33_P3267948",10.67,10.47,10.62,9.47,{"v":9.3,"d":"9.30"},9.33,{"v":1.13024911032028,"d":"1.13"},{"v":0.176640782034669,"d":"0.18"},"up",{"v":0.000103176999999954,"d":"0.00"},1,"yes","TGGTATTAATGTACTCAAGATTGCCCCCGAGTCAGCTATCAAGTTCATGGCCTATGAACA","FALSE","NM_024103","ref|NM_024103|ens|ENST00000264088|ens|ENST00000334510|ens|ENST00000301454","SLC25A23","solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23","ref|Homo sapiens solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23 (SLC25A23), mRNA [NM_024103]","chr19",{"v":6441485,"d":"6441485.00"},6454681,"GO:0002082(regulation of oxidative phosphorylation);GO:0005509(calcium ion binding);GO:0005743(mitochondrial inner membrane);GO:0016021(integral to membrane);GO:0043457(regulation of cellular respiration);GO:0051282(regulation of sequestering of calcium ion);GO:0051503(adenine nucleotide transport);GO:0055085(transmembrane transport);GO:0071277(cellular response to calcium ion);GO:0097274(urea homeostasis)",null,"mRNA","agilent G3 V3"]
["A_32_P117170",2.03,1.98,2.29,{"v":4.5,"d":"4.50"},4.97,4.63,{"v":0.446808510638298,"d":"0.45"},{"v":-1.16227142889888,"d":"-1.16"},"down",{"v":0.000103180999999952,"d":"0.00"},1,"yes","GCCTTTTGGGGAATGAATACTTTTGTTCATGTCTAGCCCACTGGGAATTTTGTTTTCACC","FALSE","NM_001122838","ref|NM_001122838|ref|NM_198990|ens|ENST00000341533|ens|ENST00000422589","NAPEPLD","N-acyl phosphatidylethanolamine phospholipase D","ref|Homo sapiens N-acyl phosphatidylethanolamine phospholipase D (NAPEPLD), transcript variant 1, mRNA [NM_001122838]","chr7",102740344,102789335,"GO:0001523(retinoid metabolic process);GO:0005737(cytoplasm);GO:0007603(phototransduction, visible light);GO:0008270(zinc ion binding);GO:0009395(phospholipid catabolic process);GO:0042622(photoreceptor outer segment membrane);GO:0070062(extracellular vesicular exosome);GO:0070290(NAPE-specific phospholipase D activity)","04723(Retrograde endocannabinoid signaling)","mRNA","agilent G3 V3"]
["A_33_P3325661",10.04,9.99,{"v":10.2,"d":"10.20"},{"v":8.9,"d":"8.90"},8.73,8.86,{"v":1.14118535296338,"d":"1.14"},{"v":0.190533135258085,"d":"0.19"},"up",{"v":0.000103304000000026,"d":"0.00"},1,"yes","TCCCTAGAGTCTGCCATCCCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTG","FALSE","ENST00000390397","ens|ENST00000390397|gb|X51791|gb|X86139|gb|AF009790",null,null,"ens|T cell receptor beta variable 24-1 [Source:HGNC Symbol;Acc:HGNC:12203] [ENST00000390397]","chr7",142364192,142364710,null,null,"mRNA","agilent G3 V3"]
["A_33_P3351791",2.31,2.43,2.38,3.95,4.28,3.98,{"v":0.583128583128583,"d":"0.58"},{"v":-0.778114054021006,"d":"-0.78"},"down",{"v":0.000103339000000036,"d":"0.00"},1,"yes","AACAAAGCCTTCACGATTTGTCCTGTCCTTGGAAGCTAAATCTGAGCCTGCTCAGCAATT","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_33_P3258546",10.51,10.55,10.43,9.83,9.78,9.87,{"v":1.06818181818182,"d":"1.07"},{"v":0.0951572330403403,"d":"0.10"},"up",{"v":0.000103473000000021,"d":"0.00"},1,"yes","CTCTACAGACAACGTGAGTTTTCTAATATTAACATCCATCTTTCCCTCCCAATTTTCAAA","FALSE","NM_031501","ref|NM_031501|gb|AF152483","PCDHA5","protocadherin alpha 5","ref|Homo sapiens protocadherin alpha 5 (PCDHA5), transcript variant 2, mRNA [NM_031501]","chr5",140201360,140203811,"GO:0005509(calcium ion binding);GO:0005887(integral to plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion);GO:0007399(nervous system development)",null,"mRNA","agilent G3 V3"]
["A_33_P3234103",6.19,{"v":5.9,"d":"5.90"},{"v":5.8,"d":"5.80"},7.84,{"v":7.8,"d":"7.80"},7.94,{"v":0.758693808312129,"d":"0.76"},{"v":-0.398410330927854,"d":"-0.40"},"down",{"v":0.000103520999999995,"d":"0.00"},1,"yes","GACTGTACATATGTTAATAGCGCAAACCCGACGCCACATTTTTATAATTGTGATTAAACT","FALSE","ENST00000262519","ens|ENST00000262519|ref|XM_005255723|ref|XM_006721106|ref|XM_006721107","SETD1A","SET domain containing 1A","ens|SET domain containing 1A [Source:HGNC Symbol;Acc:HGNC:29010] [ENST00000262519]","chr16",30968616,30996437,"GO:0000166(nucleotide binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0006325(chromatin organization);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0016607(nuclear speck);GO:0019827(stem cell maintenance);GO:0035097(histone methyltransferase complex);GO:0042800(histone methyltransferase activity (H3-K4 specific));GO:0048188(Set1C/COMPASS complex);GO:0051568(histone H3-K4 methylation);GO:2000179(positive regulation of neural precursor cell proliferation);GO:2000648(positive regulation of stem cell proliferation)","00310(Lysine degradation)","mRNA","agilent G3 V3"]
["A_24_P281439",8.53,8.34,8.64,6.96,{"v":7,"d":"7.00"},6.82,{"v":1.22762271414822,"d":"1.23"},{"v":0.29586724469826,"d":"0.30"},"up",{"v":0.000103579999999992,"d":"0.00"},1,"yes","TCTATAGTCTTAGGAATAAGGATGTCATGGGGGCTCTGAAGAAAATGTTAACTGTGAGAT","FALSE","NM_001004697","ref|NM_001004697|ref|NM_001004694|ens|ENST00000328570|ens|ENST00000366473","OR2T5","olfactory receptor, family 2, subfamily T, member 5","ref|Homo sapiens olfactory receptor, family 2, subfamily T, member 5 (OR2T5), mRNA [NM_001004697]","chr1",248721792,248722797,"GO:0004930(G-protein coupled receptor activity);GO:0004984(olfactory receptor activity);GO:0005886(plasma membrane);GO:0007186(G-protein coupled receptor signaling pathway);GO:0016021(integral to membrane);GO:0050911(detection of chemical stimulus involved in sensory perception of smell)","04740(Olfactory transduction)","mRNA","agilent G3 V3"]
["A_33_P3377994",12.11,{"v":12,"d":"12.00"},12.19,13.21,13.11,13.08,{"v":0.921319796954315,"d":"0.92"},{"v":-0.118226081460626,"d":"-0.12"},"down",{"v":0.00010359900000001,"d":"0.00"},1,"yes","TGGAGCACAGGAGCTGGACAGCCTTCTCCACCTCCTCATCTTCTCCTGGAACTCCTTTGT","FALSE","NM_032387","ref|NM_032387|ens|ENST00000246914|ens|ENST00000591448|ref|XM_005257597","WNK4","WNK lysine deficient protein kinase 4","ref|Homo sapiens WNK lysine deficient protein kinase 4 (WNK4), mRNA [NM_032387]","chr17",40937344,40946507,"GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005923(tight junction);GO:0006468(protein phosphorylation);GO:0006811(ion transport);GO:0006821(chloride transport);GO:0008104(protein localization);GO:0019869(chloride channel inhibitor activity);GO:0035556(intracellular signal transduction);GO:0050794(regulation of cellular process);GO:0050801(ion homeostasis);GO:0070294(renal sodium ion absorption);GO:0072156(distal tubule morphogenesis);GO:0090188(negative regulation of pancreatic juice secretion)",null,"mRNA","agilent G3 V3"]
["A_23_P112113",3.42,3.04,3.29,5.23,5.08,5.29,{"v":0.625,"d":"0.63"},{"v":-0.678071905112638,"d":"-0.68"},"down",{"v":0.000103802000000042,"d":"0.00"},1,"yes","GTGCTGTAACTGTTTTTCCTACTTCTTCAATGGAAGGATTGTCCTTAGATCTTCCCACCA","FALSE","NM_014846","ref|NM_014846|ens|ENST00000318410|ens|ENST00000519042|ref|XM_005251120","KIAA0196","KIAA0196","ref|Homo sapiens KIAA0196 (KIAA0196), mRNA [NM_014846]","chr8",126036512,126104025,"GO:0005515(protein binding);GO:0005769(early endosome);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0016197(endosomal transport);GO:0071203(WASH complex)",null,"mRNA","agilent G3 V3"]
["A_33_P3308132",{"v":9,"d":"9.00"},8.93,9.04,10.14,10.28,10.41,{"v":0.874797275381122,"d":"0.87"},{"v":-0.192979367871572,"d":"-0.19"},"down",{"v":0.000103802000000042,"d":"0.00"},1,"yes","TAAAATGCATCCTTCCTCTGGCTGGTGTCTCCCTTCTGCCAAGCTGTGCCTCCTGCAGAG","FALSE","XR_433669","ref|XR_433669|linc|TCONS_l2_00007970|gb|XR_110291","LOC102725127","uncharacterized LOC102725127","ref|PREDICTED: Homo sapiens uncharacterized LOC102725127 (LOC102725127), ncRNA [XR_433669]","chr14",19887178,19894794,null,null,"mRNA","agilent G3 V3"]
["A_32_P216426",5.62,5.17,5.22,7.79,7.94,8.12,{"v":0.671278825995807,"d":"0.67"},{"v":-0.575015958376617,"d":"-0.58"},"down",{"v":0.000103953999999962,"d":"0.00"},1,"yes","ATTACAACAATCAGTCTTCAAATTTTGGACCCATGAAGGGAGGAAACTTTGGAGGCAGAA","FALSE","NM_001011724","ref|NM_001011724|ref|NM_001011725|ref|NM_031157|ref|NM_002136","HNRNPA1L2","heterogeneous nuclear ribonucleoprotein A1-like 2","ref|Homo sapiens heterogeneous nuclear ribonucleoprotein A1-like 2 (HNRNPA1L2), transcript variant 1, mRNA [NM_001011724]","chr13",21522432,21523738,"GO:0000166(nucleotide binding);GO:0000380(alternative nuclear mRNA splicing, via spliceosome);GO:0003723(RNA binding);GO:0005681(spliceosomal complex);GO:0005737(cytoplasm);GO:0051028(mRNA transport)","03040(Spliceosome)","mRNA","agilent G3 V3"]
["A_23_P109470",6.73,6.66,6.96,5.35,5.41,5.36,{"v":1.26240694789082,"d":"1.26"},{"v":0.336177050625642,"d":"0.34"},"up",{"v":0.000103999000000021,"d":"0.00"},1,"yes","TGAGCGACTATGTACTTGAGCTAGGTCACCCCTATTTGTGGGTGCAGAAGCTGGGTGGCC","FALSE","NM_001002878","ref|NM_001002878|ref|NM_001002879|ref|NM_001002877|ref|NM_003678","THOC5","THO complex 5","ref|Homo sapiens THO complex 5 (THOC5), transcript variant 1, mRNA [NM_001002878]","chr22",29904156,29949644,"GO:0000346(transcription export complex);GO:0000347(THO complex);GO:0000445(THO complex part of transcription export complex);GO:0000902(cell morphogenesis);GO:0001824(blastocyst development);GO:0003729(mRNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006397(mRNA processing);GO:0006406(mRNA export from nucleus);GO:0008380(RNA splicing);GO:0010793(regulation of mRNA export from nucleus);GO:0016607(nuclear speck);GO:0017145(stem cell division);GO:0030224(monocyte differentiation);GO:0032786(positive regulation of transcription elongation, DNA-dependent);GO:0045650(negative regulation of macrophage differentiation);GO:0046784(intronless viral mRNA export from host nucleus);GO:0060215(primitive hemopoiesis);GO:2000002(negative regulation of DNA damage checkpoint);GO:2000035(regulation of stem cell division)","03013(RNA transport)","mRNA","agilent G3 V3"]
["A_33_P3322192",14.67,14.55,{"v":14.7,"d":"14.70"},13.25,13.28,13.48,{"v":1.09772556860785,"d":"1.10"},{"v":0.134517425659597,"d":"0.13"},"up",{"v":0.000104014000000041,"d":"0.00"},1,"yes","ATCATGAGGTCCAGATTACATCGATCTCCATGTCTGTGTCCCGATCGGTGCCCCCCTGCA","FALSE","ENST00000548294","ens|ENST00000548294",{"$nulls":3},"chr12",94533856,94535113,null,null,"mRNA","agilent G3 V3"]
["A_33_P3303031",16.15,16.15,16.08,15.39,15.45,15.52,{"v":1.04357204486626,"d":"1.04"},{"v":0.0615302029734531,"d":"0.06"},"up",{"v":0.000104243999999976,"d":"0.00"},1,"yes","GCTTGCTTTCGGCCCCCTCCCCTTCTTCCCATCCGTCCCTGCTGTTCCTTGTGGCGCTGA","FALSE","BC133006","gb|BC133006|gb|BC133008","LOC643549","uncharacterized LOC643549","gb|Homo sapiens hypothetical protein LOC643549, mRNA (cDNA clone IMAGE:40147028). [BC133006]","chr20",44563336,44576657,null,null,"mRNA","agilent G3 V3"]
["A_23_P90804",{"v":2.1,"d":"2.10"},2.07,2.48,4.72,4.55,4.89,{"v":0.469632768361582,"d":"0.47"},{"v":-1.09039501969445,"d":"-1.09"},"down",{"v":0.000104301000000029,"d":"0.00"},1,"yes","CTAGGTTTAGTCAGAGCTTTCACAAGTAATAACCTTTCTGTATTAAAATCAGAGTAACCC","FALSE","NM_145686","ref|NM_145686|ref|NM_001242560|ref|NM_004834|ref|NM_001242559","MAP4K4","mitogen-activated protein kinase kinase kinase kinase 4","ref|Homo sapiens mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4), transcript variant 2, mRNA [NM_145686]","chr2",102508952,102511150,"GO:0004674(protein serine/threonine kinase activity);GO:0004702(receptor signaling protein serine/threonine kinase activity);GO:0005083(small GTPase regulator activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0023014(signal transduction by phosphorylation);GO:0030033(microvillus assembly);GO:0035556(intracellular signal transduction);GO:0046328(regulation of JNK cascade);GO:0050790(regulation of catalytic activity)","04010(MAPK signaling pathway)","mRNA","agilent G3 V3"]
["A_23_P334123",2.32,2.02,1.92,5.06,4.97,{"v":5.5,"d":"5.50"},{"v":0.403090792015454,"d":"0.40"},{"v":-1.31082326745468,"d":"-1.31"},"down",{"v":0.000104431000000016,"d":"0.00"},1,"yes","AACTGTATCTTACACCAAGTAATATTGTTCTGCTTACTGCTATAGCTCTCATCGGTGTCT","FALSE","NM_030790","ref|NM_030790|ens|ENST00000567957|ens|ENST00000542691|ens|ENST00000537184","ITFG1","integrin alpha FG-GAP repeat containing 1","ref|Homo sapiens integrin alpha FG-GAP repeat containing 1 (ITFG1), mRNA [NM_030790]","chr16",47189584,47292633,"GO:0016021(integral to membrane);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_32_P59302",2.28,2.55,2.34,3.98,4.24,{"v":4.2,"d":"4.20"},{"v":0.577294685990338,"d":"0.58"},{"v":-0.792620149518577,"d":"-0.79"},"down",{"v":0.00010443800000004,"d":"0.00"},1,"yes","GTGAATCCAGTCTGCTTTCCATTAGAAAACCGCTTCGGCACTTATGGTCACTTTAATAAA","FALSE","NM_024503","ref|NM_024503|ref|NM_001127714|ens|ENST00000372583|ens|ENST00000247584","HIVEP3","human immunodeficiency virus type I enhancer binding protein 3","ref|Homo sapiens human immunodeficiency virus type I enhancer binding protein 3 (HIVEP3), transcript variant 1, mRNA [NM_024503]","chr1",41972036,42384378,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-dependent);GO:0035914(skeletal muscle cell differentiation);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_24_P113221",1.97,2.38,1.91,4.74,5.13,4.89,{"v":0.424119241192412,"d":"0.42"},{"v":-1.23745815912778,"d":"-1.24"},"down",{"v":0.000104506999999976,"d":"0.00"},1,"yes","GGTTTCTCTCCGTCGACGAAAACGGGAAGTACTAGTAGAAGACATGGTATCTCAAGAAGA","FALSE","NM_006965","ref|NM_006965|ens|ENST00000399061|ens|ENST00000261332|ens|ENST00000589881","ZNF24","zinc finger protein 24","ref|Homo sapiens zinc finger protein 24 (ZNF24), mRNA [NM_006965]","chr18",32920328,32922639,"GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-dependent);GO:0008270(zinc ion binding);GO:0042552(myelination);GO:0043565(sequence-specific DNA binding);GO:0045892(negative regulation of transcription, DNA-dependent)",null,"mRNA","agilent G3 V3"]
["A_22_P00015195",15.05,15.03,14.98,{"v":13.8,"d":"13.80"},13.89,14.04,{"v":1.07979870596693,"d":"1.08"},{"v":0.110762392972033,"d":"0.11"},"up",{"v":0.000104625999999941,"d":"0.00"},1,"yes","TCAGCCCTTTGGCGGCCCCCCTCCAAAGTCTACAAGGTCACACGGATGTCTGCAGGCAGA","FALSE","XR_433332","ref|XR_433332|ref|XR_433330|ref|XR_433329|ref|XR_433328","LOC100996842","uncharacterized LOC100996842","ref|PREDICTED: Homo sapiens uncharacterized LOC100996842 (LOC100996842), transcript variant X9, misc_RNA [XR_433332]","chr17",{"v":7486086,"d":"7486086.00"},7487013,null,null,"mRNA","agilent G3 V3"]
["A_33_P3278303",10.48,10.42,9.95,12.84,{"v":13,"d":"13.00"},12.94,{"v":0.795513151108819,"d":"0.80"},{"v":-0.330042314070012,"d":"-0.33"},"down",{"v":0.000104663000000005,"d":"0.00"},1,"yes","TCCATCTACCTATGCATCCATCCATCCATCCATCCTTCATTTTTTAGTTTTATTAAATGA","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_23_P12680",10.09,9.88,10.03,11.21,11.08,11.22,{"v":0.895255147717099,"d":"0.90"},{"v":-0.159629185821228,"d":"-0.16"},"down",{"v":0.000104768000000033,"d":"0.00"},1,"yes","CCCTAGCCCCTGGCAGACATAGCTGCTTCAGTGCCCCTTTTCTCTCTGCTAGATGGATGT","FALSE","NM_001042465","ref|NM_001042465|ref|NM_001042466|ref|NM_002778|ens|ENST00000394934","PSAP","prosaposin","ref|Homo sapiens prosaposin (PSAP), transcript variant 2, mRNA [NM_001042465]","chr10",73576056,73611082,"GO:0002576(platelet degranulation);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005739(mitochondrion);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0006665(sphingolipid metabolic process);GO:0006687(glycosphingolipid metabolic process);GO:0006869(lipid transport);GO:0007596(blood coagulation);GO:0008047(enzyme activator activity);GO:0008289(lipid binding);GO:0016021(integral to membrane);GO:0019216(regulation of lipid metabolic process);GO:0030168(platelet activation);GO:0043085(positive regulation of catalytic activity);GO:0043202(lysosomal lumen);GO:0043231(intracellular membrane-bounded organelle);GO:0043408(regulation of MAPK cascade);GO:0044281(small molecule metabolic process);GO:0060736(prostate gland growth);GO:0060742(epithelial cell differentiation involved in prostate gland development);GO:0070062(extracellular vesicular exosome);GO:0071310(cellular response to organic substance)","04142(Lysosome)","mRNA","agilent G3 V3"]
["A_23_P113523",6.91,7.21,6.94,8.55,8.51,8.47,{"v":0.824911868390129,"d":"0.82"},{"v":-0.277688101381402,"d":"-0.28"},"down",{"v":0.000104886999999998,"d":"0.00"},1,"yes","ATCCACACAATTCCAGTGGGCCCTCGGTGCCTGCTGTGAACTGCTTTCCCTCGGAATGTT","FALSE","NM_012227","ref|NM_012227|ens|ENST00000326153|ens|ENST00000485332|ref|XM_006724447","GTPBP6","GTP binding protein 6 (putative)","ref|Homo sapiens GTP binding protein 6 (putative) (GTPBP6), mRNA [NM_012227]","chrX",{"v":220025,"d":"220025.00"},230886,"GO:0005525(GTP binding);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P37623",2.24,2.32,2.66,4.76,4.57,4.54,{"v":0.520547945205479,"d":"0.52"},{"v":-0.941897045436432,"d":"-0.94"},"down",{"v":0.000104894000000022,"d":"0.00"},1,"yes","ACTGTGGTGCAATCTACTGTTTGTGAATGTCTGTATTATCAGGAAACATGTCTATACGAT","FALSE","NM_181077","ref|NM_181077|ref|NM_001023567|ref|NR_027409|ref|NR_027410","GOLGA8A","golgin A8 family, member A","ref|Homo sapiens golgin A8 family, member A (GOLGA8A), transcript variant 1, mRNA [NM_181077]","chr15",34671272,34880704,"GO:0032580(Golgi cisterna membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3299766",2.03,2.03,2.27,4.06,4.16,4.44,{"v":0.5,"d":"0.50"},-1,"down",{"v":0.000104970999999954,"d":"0.00"},1,"yes","AGTTCCTGATCCACACCATGTTCTTGGGCATTAGTACATGCATTAATGTCTTACGAATAA","FALSE","ENST00000369246","ens|ENST00000369246","FAM160B1","family with sequence similarity 160, member B1","ens|family with sequence similarity 160, member B1 [Source:HGNC Symbol;Acc:HGNC:29320] [ENST00000369246]","chr10",116581528,116593224,null,null,"mRNA","agilent G3 V3"]
["A_33_P3217103",{"v":2.3,"d":"2.30"},{"v":2.5,"d":"2.50"},{"v":2.5,"d":"2.50"},{"v":4.1,"d":"4.10"},4.39,4.43,{"v":0.565015479876161,"d":"0.57"},{"v":-0.823637700926545,"d":"-0.82"},"down",{"v":0.000115084999999904,"d":"0.00"},1,"yes","TATGTTCTTTGAATATGTATTTTTCCTTTAAATTTCTGCCTTTAATTCTTTTGTTCCAAA","FALSE","NM_001031695","ref|NM_001031695|ref|NM_001082576|ref|NM_001082577|ref|NM_001082578","RBFOX2","RNA binding protein, fox-1 homolog (C. elegans) 2","ref|Homo sapiens RNA binding protein, fox-1 homolog (C. elegans) 2 (RBFOX2), transcript variant 1, mRNA [NM_001031695]","chr22",36140252,36424473,"GO:0000166(nucleotide binding);GO:0000381(regulation of alternative nuclear mRNA splicing, via spliceosome);GO:0003714(transcription corepressor activity);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006397(mRNA processing);GO:0008134(transcription factor binding);GO:0008380(RNA splicing);GO:0010724(regulation of definitive erythrocyte differentiation);GO:0016070(RNA metabolic process);GO:0021942(radial glia guided migration of Purkinje cell);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0042127(regulation of cell proliferation);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0048813(dendrite morphogenesis);GO:0050885(neuromuscular process controlling balance)",null,"mRNA","agilent G3 V3"]
["A_33_P3364308",8.91,8.88,8.74,9.77,9.78,9.69,{"v":0.907318741450069,"d":"0.91"},{"v":-0.140318635723741,"d":"-0.14"},"down",{"v":0.000115338999999937,"d":"0.00"},1,"yes","ATGCAGAAACTAGGGTATCTCCTTCCCTTCGCACCGATTTTAATTCTCATGGATGGCAGT","FALSE","ENST00000563871","ens|ENST00000563871|gb|BC040551|tc|THC2608175","OTOA","otoancorin","ens|otoancorin [Source:HGNC Symbol;Acc:HGNC:16378] [ENST00000563871]","chr16",21716290,21772047,"GO:0005578(proteinaceous extracellular matrix);GO:0007160(cell-matrix adhesion);GO:0007605(sensory perception of sound);GO:0016324(apical plasma membrane);GO:0019226(transmission of nerve impulse);GO:0031225(anchored to membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3407364",7.38,7.28,7.14,5.79,5.91,5.99,{"v":1.23233465234596,"d":"1.23"},{"v":0.301394086973831,"d":"0.30"},"up",{"v":0.000115928999999904,"d":"0.00"},1,"yes","ATCCTGAATCGAAGAAACTGCATGGCTGCCACCCTGAAGATCACTGAAAGAAATTTCCCT","FALSE","NM_032946","ref|NM_032946|ens|ENST00000473265|ens|ENST00000493509|ens|ENST00000372803","NXF5","nuclear RNA export factor 5","ref|Homo sapiens nuclear RNA export factor 5 (NXF5), transcript variant 1, mRNA [NM_032946]","chrX",101615320,101726732,"GO:0000166(nucleotide binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006406(mRNA export from nucleus);GO:0007275(multicellular organismal development);GO:0050658(RNA transport)","03013(RNA transport);03015(mRNA surveillance pathway);03008(Ribosome biogenesis in eukaryotes);05164(Influenza A);05168(Herpes simplex infection)","mRNA","agilent G3 V3"]
["A_23_P1431",2.84,3.01,2.86,4.47,4.58,4.81,{"v":0.628427128427128,"d":"0.63"},{"v":-0.670182633538349,"d":"-0.67"},"down",{"v":0.000115939999999926,"d":"0.00"},1,"yes","CGTTTGTATTCTACCTTTGTAAAACAGCCTATAGATGATGATGTGTTTGGGATACTGCTT","FALSE","NM_004329","ref|NM_004329|gb|Z22535|gb|BC028383|tc|THC2462414","BMPR1A","bone morphogenetic protein receptor, type IA","ref|Homo sapiens bone morphogenetic protein receptor, type IA (BMPR1A), mRNA [NM_004329]","chr10",88516408,88692595,"GO:0000981(sequence-specific DNA binding RNA polymerase II transcription factor activity);GO:0001701(in utero embryonic development);GO:0001707(mesoderm formation);GO:0001756(somitogenesis);GO:0001880(Mullerian duct regression);GO:0002053(positive regulation of mesenchymal cell proliferation);GO:0003272(endocardial cushion formation);GO:0004674(protein serine/threonine kinase activity);GO:0004675(transmembrane receptor protein serine/threonine kinase activity);GO:0004702(receptor signaling protein serine/threonine kinase activity);GO:0005024(transforming growth factor beta-activated receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0006366(transcription from RNA polymerase II promoter);GO:0006468(protein phosphorylation);GO:0006955(immune response);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007398(ectoderm development);GO:0009950(dorsal/ventral axis specification);GO:0010862(positive regulation of pathway-restricted SMAD protein phosphorylation);GO:0014032(neural crest cell development);GO:0016021(integral to membrane);GO:0019827(stem cell maintenance);GO:0021983(pituitary gland development);GO:0021998(neural plate mediolateral regionalization);GO:0023014(signal transduction by phosphorylation);GO:0030324(lung development);GO:0030425(dendrite);GO:0030501(positive regulation of bone mineralization);GO:0030509(BMP signaling pathway);GO:0035137(hindlimb morphogenesis);GO:0042475(odontogenesis of dentin-containing tooth);GO:0042733(embryonic digit morphogenesis);GO:0042803(protein homodimerization activity);GO:0043025(neuronal cell body);GO:0045669(positive regulation of osteoblast differentiation);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0046332(SMAD binding);GO:0046872(metal ion binding);GO:0048352(paraxial mesoderm structural organization);GO:0048368(lateral mesoderm development);GO:0048378(regulation of lateral mesodermal cell fate specification);GO:0048382(mesendoderm development);GO:0048568(embryonic organ development);GO:0048589(developmental growth);GO:0050679(positive regulation of epithelial cell proliferation);GO:0050768(negative regulation of neurogenesis);GO:0051216(cartilage development);GO:0060021(palate development);GO:0060391(positive regulation of SMAD protein import into nucleus);GO:0060914(heart formation);GO:2000772(regulation of cellular senescence)","04350(TGF-beta signaling pathway);04390(Hippo signaling pathway);04060(Cytokine-cytokine receptor interaction);04550(Signaling pathways regulating pluripotency of stem cells)","mRNA","agilent G3 V3"]
["A_24_P278192",9.77,9.67,9.78,9.11,9.06,9.14,{"v":1.06993775173929,"d":"1.07"},{"v":0.0975268640382117,"d":"0.10"},"up",{"v":0.000116057999999919,"d":"0.00"},1,"yes","CCTGTGTGGCCCTGGACACAGCCCACCCTCTGTGAGCCGTTTCCAATTCTAAAACAGACT","FALSE","NM_000476","ref|NM_000476|ens|ENST00000373176|gb|EU794628|tc|THC2468589","AK1","adenylate kinase 1","ref|Homo sapiens adenylate kinase 1 (AK1), mRNA [NM_000476]","chr9",130628760,130640022,"GO:0001520(outer dense fiber);GO:0004017(adenylate kinase activity);GO:0004550(nucleoside diphosphate kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006165(nucleoside diphosphate phosphorylation);GO:0006172(ADP biosynthetic process);GO:0007050(cell cycle arrest);GO:0009142(nucleoside triphosphate biosynthetic process);GO:0015949(nucleobase-containing small molecule interconversion);GO:0036126(sperm flagellum);GO:0044281(small molecule metabolic process);GO:0046033(AMP metabolic process);GO:0046034(ATP metabolic process);GO:0055086(nucleobase-containing small molecule metabolic process);GO:0070062(extracellular vesicular exosome)","00230(Purine metabolism)","mRNA","agilent G3 V3"]
["A_33_P3315074",9.79,9.63,9.21,12.16,12.32,12.25,{"v":0.779471821399401,"d":"0.78"},{"v":-0.359431225732305,"d":"-0.36"},"down",{"v":0.000116343999999935,"d":"0.00"},1,"yes","TGGGAACTGCTGCTTGTCTGACTTCCATCCATTCATCCATCCACCCACATGCATATCCAT","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_21_P0014948",2.31,2.44,2.64,4.23,4.12,4.04,{"v":0.596448748991122,"d":"0.60"},{"v":-0.745529917994451,"d":"-0.75"},"down",{"v":0.000116616999999986,"d":"0.00"},1,"yes","TAAGTATGTTCATGGTATTGCTGTACATTGGTACCTGGACTTTCTGGCTCCAGCCAAAGC","FALSE","ENST00000575568","ens|ENST00000575568|ens|ENST00000566701|ens|ENST00000486197|ens|ENST00000459805",null,null,"ens|glucosidase, beta, acid pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:4178] [ENST00000566701]","chrHSCHR1_2_CTG31",155199568,155204076,null,null,"mRNA","agilent G3 V3"]
["A_33_P7325293",{"v":10.4,"d":"10.40"},10.49,10.07,12.36,12.25,12.37,{"v":0.837209302325581,"d":"0.84"},{"v":-0.256339753259785,"d":"-0.26"},"down",{"v":0.000116793999999976,"d":"0.00"},1,"yes","AACATGGTGAAACCTCATCTCTACTAAAAAACAAAAAATTAGCCAGGCGTGGTGGCAGGC","FALSE","NM_001160223","ref|NM_001160223|ref|NM_030954|ref|NM_001160225|ref|NR_027668","RNF170","ring finger protein 170","ref|Homo sapiens ring finger protein 170 (RNF170), transcript variant 1, mRNA [NM_001160223]","chr8",42708436,42751866,"GO:0005789(endoplasmic reticulum membrane);GO:0008270(zinc ion binding);GO:0016021(integral to membrane);GO:0016567(protein ubiquitination);GO:0016874(ligase activity)",null,"mRNA","agilent G3 V3"]
["A_32_P129894",2.24,2.33,2.24,3.91,4.05,4.31,{"v":0.555012224938875,"d":"0.56"},{"v":-0.849408545650834,"d":"-0.85"},"down",{"v":0.000116863999999994,"d":"0.00"},1,"yes","TTTAGACAACATTTGTAGACACCTCAAATTATATCACTGTTCTCTAGCGCCAATATTCCC","FALSE","NM_001080497","ref|NM_001080497|ens|ENST00000373930|gb|BC016989|gb|AJ420444","MEGF9","multiple EGF-like-domains 9","ref|Homo sapiens multiple EGF-like-domains 9 (MEGF9), mRNA [NM_001080497]","chr9",123363088,123476612,"GO:0005575(cellular_component);GO:0008150(biological_process);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P403424",5.47,5.04,4.99,8.21,8.67,8.73,{"v":0.605232331120656,"d":"0.61"},{"v":-0.724439037435869,"d":"-0.72"},"down",{"v":0.000116901999999919,"d":"0.00"},1,"yes","CTGTTTTCCCTTCTGCGCTACCTTGAGTAGTTGGAGCACTTGATACATCACAGACTCATA","FALSE","NM_005090","ref|NM_005090|ref|NM_001198588|ref|NM_001114633|ens|ENST00000483748","JMJD7-PLA2G4B","JMJD7-PLA2G4B readthrough","ref|Homo sapiens JMJD7-PLA2G4B readthrough (JMJD7-PLA2G4B), transcript variant 1, mRNA [NM_005090]","chr15",42128984,42140341,null,"00564(Glycerophospholipid metabolism);00565(Ether lipid metabolism);00590(Arachidonic acid metabolism);00591(Linoleic acid metabolism);00592(alpha-Linolenic acid metabolism);04014(Ras signaling pathway);04010(MAPK signaling pathway);04370(VEGF signaling pathway);04611(Platelet activation);04664(Fc epsilon RI signaling pathway);04912(GnRH signaling pathway);04913(Ovarian Steroidogenesis);04921(Oxytocin signaling pathway);04270(Vascular smooth muscle contraction);04724(Glutamatergic synapse);04726(Serotonergic synapse);04730(Long-term depression);04750(Inflammatory mediator regulation of TRP channels);05231(Choline metabolism in cancer)","mRNA","agilent G3 V3"]
["A_23_P211212",7.64,{"v":7.7,"d":"7.70"},7.33,9.99,9.85,9.65,{"v":0.76873516446253,"d":"0.77"},{"v":-0.379441431320951,"d":"-0.38"},"down",{"v":0.000117093999999929,"d":"0.00"},1,"yes","CGGTGGGGCTGGTTCTGTAATTGTGTGTGATGTGAAGCCAATTCAGACAGGCAAATAAAA","FALSE","NM_030582","ref|NM_030582|ref|NM_130444|ref|NM_130445|ens|ENST00000359759","COL18A1","collagen, type XVIII, alpha 1","ref|Homo sapiens collagen, type XVIII, alpha 1 (COL18A1), transcript variant 1, mRNA [NM_030582]","chr21",46875424,46933633,"GO:0001525(angiogenesis);GO:0001886(endothelial cell morphogenesis);GO:0005198(structural molecule activity);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005581(collagen);GO:0005604(basement membrane);GO:0005615(extracellular space);GO:0005788(endoplasmic reticulum lumen);GO:0007155(cell adhesion);GO:0007601(visual perception);GO:0008284(positive regulation of cell proliferation);GO:0008285(negative regulation of cell proliferation);GO:0009887(organ morphogenesis);GO:0022617(extracellular matrix disassembly);GO:0030198(extracellular matrix organization);GO:0030335(positive regulation of cell migration);GO:0030574(collagen catabolic process);GO:0031012(extracellular matrix);GO:0042493(response to drug);GO:0042802(identical protein binding);GO:0046872(metal ion binding);GO:0051599(response to hydrostatic pressure);GO:0070062(extracellular vesicular exosome);GO:2000353(positive regulation of endothelial cell apoptotic process)","04974(Protein digestion and absorption)","mRNA","agilent G3 V3"]
["A_21_P0013567",4.88,{"v":4.5,"d":"4.50"},4.58,6.44,6.48,6.58,{"v":0.715897435897436,"d":"0.72"},{"v":-0.482175182427321,"d":"-0.48"},"down",{"v":0.000117205999999981,"d":"0.00"},1,"yes","AAATGATGGAATCATATATTCCACCAGCCTTACCTTTACCTACACACCAGAAGCAGGGCC","FALSE","NM_203284","ref|NM_203284|ref|NM_005349|ref|NM_015874|ref|NM_203283","RBPJ","recombination signal binding protein for immunoglobulin kappa J region","ref|Homo sapiens recombination signal binding protein for immunoglobulin kappa J region (RBPJ), transcript variant 4, mRNA [NM_203284]","chr4",26322428,26436752,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000150(recombinase activity);GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0000979(RNA polymerase II core promoter sequence-specific DNA binding);GO:0001077(RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription);GO:0001103(RNA polymerase II repressing transcription factor binding);GO:0001525(angiogenesis);GO:0001837(epithelial to mesenchymal transition);GO:0001974(blood vessel remodeling);GO:0002193(MAML1-RBP-Jkappa- ICN1 complex);GO:0002437(inflammatory response to antigenic stimulus);GO:0003139(secondary heart field specification);GO:0003151(outflow tract morphogenesis);GO:0003160(endocardium morphogenesis);GO:0003198(epithelial to mesenchymal transition involved in endocardial cushion formation);GO:0003214(cardiac left ventricle morphogenesis);GO:0003222(ventricular trabecula myocardium morphogenesis);GO:0003256(regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006310(DNA recombination);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0006959(humoral immune response);GO:0007219(Notch signaling pathway);GO:0007221(positive regulation of transcription of Notch receptor target);GO:0008285(negative regulation of cell proliferation);GO:0009912(auditory receptor cell fate commitment);GO:0009957(epidermal cell fate specification);GO:0010467(gene expression);GO:0021983(pituitary gland development);GO:0030183(B cell differentiation);GO:0030216(keratinocyte differentiation);GO:0030279(negative regulation of ossification);GO:0030513(positive regulation of BMP signaling pathway);GO:0035019(somatic stem cell maintenance);GO:0035912(dorsal aorta morphogenesis);GO:0042742(defense response to bacterium);GO:0043011(myeloid dendritic cell differentiation);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0047485(protein N-terminus binding);GO:0048505(regulation of timing of cell differentiation);GO:0048733(sebaceous gland development);GO:0048820(hair follicle maturation);GO:0060045(positive regulation of cardiac muscle cell proliferation);GO:0060486(Clara cell differentiation);GO:0060716(labyrinthine layer blood vessel development);GO:0060844(arterial endothelial cell fate commitment);GO:0061314(Notch signaling involved in heart development);GO:0072554(blood vessel lumenization);GO:0072602(interleukin-4 secretion);GO:0097101(blood vessel endothelial cell fate specification);GO:2000138(positive regulation of cell proliferation involved in heart morphogenesis)","04330(Notch signaling pathway);05203(Viral carcinogenesis);05169(Epstein-Barr virus infection)","mRNA","agilent G3 V3"]
["A_33_P3601802",11.84,11.74,11.88,10.79,10.91,10.73,{"v":1.09343200740056,"d":"1.09"},{"v":0.128863512442882,"d":"0.13"},"up",{"v":0.000117531999999976,"d":"0.00"},1,"yes","AACACAAGGCCTTTTACAGGGCGTATAAGATTGTAAACCCCCCGCGGAAGACGGGGGACG","FALSE","CD049182","gb|CD049182","RPS17","ribosomal protein S17","gb|AGENCOURT_13978263 NIH_MGC_172 Homo sapiens cDNA 5', mRNA sequence [CD049182]","chr15",83205512,83209203,"GO:0000028(ribosomal small subunit assembly);GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay);GO:0003735(structural constituent of ribosome);GO:0005829(cytosol);GO:0005840(ribosome);GO:0005925(focal adhesion);GO:0006364(rRNA processing);GO:0006412(translation);GO:0006413(translational initiation);GO:0006414(translational elongation);GO:0006415(translational termination);GO:0006614(SRP-dependent cotranslational protein targeting to membrane);GO:0010467(gene expression);GO:0016020(membrane);GO:0016032(viral reproduction);GO:0019058(viral infectious cycle);GO:0019083(viral transcription);GO:0022627(cytosolic small ribosomal subunit);GO:0034101(erythrocyte homeostasis);GO:0042274(ribosomal small subunit biogenesis);GO:0044267(cellular protein metabolic process);GO:0070062(extracellular vesicular exosome)","03010(Ribosome)","mRNA","agilent G3 V3"]
["A_24_P212539",7.51,7.58,{"v":7.8,"d":"7.80"},5.74,5.87,5.55,{"v":1.33391608391608,"d":"1.33"},{"v":0.415667910056141,"d":"0.42"},"up",{"v":0.000117913999999941,"d":"0.00"},1,"yes","TCCAGTTCTCGCGCATCAGTCCAGATGGTGAAGAAGGCTACCCCGGAGAGTTAAAAGTCT","FALSE","NM_138801","ref|NM_138801|ens|ENST00000444351|ens|ENST00000272252|ref|XR_244925","GALM","galactose mutarotase (aldose 1-epimerase)","ref|Homo sapiens galactose mutarotase (aldose 1-epimerase) (GALM), mRNA [NM_138801]","chr2",38908436,38968379,"GO:0004034(aldose 1-epimerase activity);GO:0005737(cytoplasm);GO:0006006(glucose metabolic process);GO:0006012(galactose metabolic process);GO:0030246(carbohydrate binding);GO:0070062(extracellular vesicular exosome)","00010(Glycolysis / Gluconeogenesis);00052(Galactose metabolism)","mRNA","agilent G3 V3"]
["A_23_P500501",5.45,5.17,5.99,9.82,9.64,9.38,{"v":0.575936199722607,"d":"0.58"},{"v":-0.796019091278447,"d":"-0.80"},"down",{"v":0.000118095999999901,"d":"0.00"},1,"yes","TGCTACCTTTCAAAGCTTGGAGGGAAGCCGTGAATTCAGTTGGTTCGTTCTGTACTGTTA","FALSE","NM_000142","ref|NM_000142|ref|NM_001163213|ref|NM_022965|ens|ENST00000260795","FGFR3","fibroblast growth factor receptor 3","ref|Homo sapiens fibroblast growth factor receptor 3 (FGFR3), transcript variant 1, mRNA [NM_000142]","chr4",{"v":1795039,"d":"1795039.00"},1810599,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000165(MAPK cascade);GO:0001501(skeletal system development);GO:0001938(positive regulation of endothelial cell proliferation);GO:0001958(endochondral ossification);GO:0002009(morphogenesis of an epithelium);GO:0002062(chondrocyte differentiation);GO:0002089(lens morphogenesis in camera-type eye);GO:0003416(endochondral bone growth);GO:0004713(protein tyrosine kinase activity);GO:0005007(fibroblast growth factor-activated receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005576(extracellular region);GO:0005634(nucleus);GO:0005764(lysosome);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0005925(focal adhesion);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007259(JAK-STAT cascade);GO:0007267(cell-cell signaling);GO:0008284(positive regulation of cell proliferation);GO:0008286(insulin receptor signaling pathway);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0009898(internal side of plasma membrane);GO:0009986(cell surface);GO:0010518(positive regulation of phospholipase activity);GO:0017134(fibroblast growth factor binding);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0021762(substantia nigra development);GO:0022010(central nervous system myelination);GO:0030133(transport vesicle);GO:0030282(bone mineralization);GO:0030900(forebrain development);GO:0031398(positive regulation of protein ubiquitination);GO:0035019(somatic stem cell maintenance);GO:0035988(chondrocyte proliferation);GO:0038095(Fc-epsilon receptor signaling pathway);GO:0042511(positive regulation of tyrosine phosphorylation of Stat1 protein);GO:0042517(positive regulation of tyrosine phosphorylation of Stat3 protein);GO:0043410(positive regulation of MAPK cascade);GO:0043525(positive regulation of neuron apoptotic process);GO:0043552(positive regulation of phosphatidylinositol 3-kinase activity);GO:0045087(innate immune response);GO:0045597(positive regulation of cell differentiation);GO:0045839(negative regulation of mitosis);GO:0045879(negative regulation of smoothened signaling pathway);GO:0046777(protein autophosphorylation);GO:0048011(nerve growth factor receptor signaling pathway);GO:0048015(phosphatidylinositol-mediated signaling);GO:0048471(perinuclear region of cytoplasm);GO:0048546(digestive tract morphogenesis);GO:0048640(negative regulation of developmental growth);GO:0048678(response to axon injury);GO:0048712(negative regulation of astrocyte differentiation);GO:0050680(negative regulation of epithelial cell proliferation);GO:0060113(inner ear receptor cell differentiation);GO:0060349(bone morphogenesis);GO:0060385(axonogenesis involved in innervation);GO:0061144(alveolar secondary septum development);GO:0070307(lens fiber cell development);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0070977(bone maturation);GO:0072148(epithelial cell fate commitment);GO:0090080(positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04151(PI3K-Akt signaling pathway);04144(Endocytosis);04810(Regulation of actin cytoskeleton);04550(Signaling pathways regulating pluripotency of stem cells);05200(Pathways in cancer);05230(Central carbon metabolism in cancer);05206(MicroRNAs in cancer);05219(Bladder cancer)","mRNA","agilent G3 V3"]
["A_22_P00000148",14.69,14.52,14.73,15.82,15.88,15.73,{"v":0.926417878979549,"d":"0.93"},{"v":-0.110264998656251,"d":"-0.11"},"down",{"v":0.000118102999999925,"d":"0.00"},1,"yes","ACTGCCCGCCCTGTGACTGTGCATGCATCCCTCCCGACCCTGCAGTTACAGACACAGCAA","FALSE","XR_245260","ref|XR_245260|ref|XR_249597|ref|XR_251583|linc|lnc-AASDH-1:1","LOC101928760","uncharacterized LOC101928760","ref|PREDICTED: Homo sapiens uncharacterized LOC101928760 (LOC101928760), ncRNA [XR_245260]","chr4",57095800,57112587,null,null,"mRNA","agilent G3 V3"]
["A_24_P6083",5.21,5.16,5.58,7.64,{"v":7.8,"d":"7.80"},7.99,{"v":0.68075117370892,"d":"0.68"},{"v":-0.554800530210904,"d":"-0.55"},"down",{"v":0.000118151999999982,"d":"0.00"},1,"yes","CCTATGAGATCAGGCAGTTCCTGGACTGTTCCACCACTCAGAGTGACCTGTCCCTGTGTG","FALSE","NM_213720","ref|NM_213720|ref|NM_001301339|ref|NR_125755|ref|NR_125756","CHCHD10","coiled-coil-helix-coiled-coil-helix domain containing 10","ref|Homo sapiens coiled-coil-helix-coiled-coil-helix domain containing 10 (CHCHD10), transcript variant 2, mRNA [NM_213720]","chr22",24108122,24110107,"GO:0003674(molecular_function);GO:0005739(mitochondrion);GO:0005758(mitochondrial intermembrane space);GO:0006119(oxidative phosphorylation);GO:0006754(ATP biosynthetic process);GO:0007005(mitochondrion organization);GO:2000984(negative regulation of ATP citrate synthase activity)",null,"mRNA","agilent G3 V3"]
["A_33_P3379669",9.07,9.16,9.15,8.59,8.52,{"v":8.5,"d":"8.50"},{"v":1.06911362748926,"d":"1.07"},{"v":0.0964151936604312,"d":"0.10"},"up",{"v":0.000118163999999976,"d":"0.00"},1,"yes","TGAGCAGTGCCTGCAGATTCTCTACGAGTCCTGCCCCAAGTACAAGTTCATCTCCTGCCC","FALSE","NM_031297","ref|NM_031297|ens|ENST00000392827|ens|ENST00000391553|gb|AM393547","RNF208","ring finger protein 208","ref|Homo sapiens ring finger protein 208 (RNF208), mRNA [NM_031297]","chr9",140114704,140115775,"GO:0004842(ubiquitin-protein ligase activity);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0051865(protein autoubiquitination)",null,"mRNA","agilent G3 V3"]
["A_33_P3413216",13.15,13.22,13.09,12.14,12.29,12.28,{"v":1.07491146826478,"d":"1.07"},{"v":0.104217841624011,"d":"0.10"},"up",{"v":0.000118182999999994,"d":"0.00"},1,"yes","CAGGTGGCTTCAGGGCCTCCGGACCCCCCCTGGGAGGGGTGGCCACGTGCTGGCTGCGGA","FALSE","NM_001025237","ref|NM_001025237|ref|NM_001025236|ref|NM_001025234|ref|NM_001025235","TSPAN4","tetraspanin 4","ref|Homo sapiens tetraspanin 4 (TSPAN4), transcript variant 1, mRNA [NM_001025237]","chr11",{"v":842824,"d":"842824.00"},867116,"GO:0003823(antigen binding);GO:0005178(integrin binding);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0006461(protein complex assembly);GO:0016021(integral to membrane);GO:0031982(vesicle)",null,"mRNA","agilent G3 V3"]
["A_21_P0014876",{"v":8.7,"d":"8.70"},8.66,{"v":8.6,"d":"8.60"},9.87,9.65,9.85,{"v":0.883895131086142,"d":"0.88"},{"v":-0.178052882325712,"d":"-0.18"},"down",{"v":0.00011824699999996,"d":"0.00"},1,"yes","AGAATTTCTGCTGGCCCTCGGTAGTCCTCTGCCCACGTCGGTGATCCGGTCTCGCTTCTC","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_33_P3416221",9.89,9.87,9.81,10.58,10.49,10.63,{"v":0.932807570977918,"d":"0.93"},{"v":-0.100348596906446,"d":"-0.10"},"down",{"v":0.000118310999999927,"d":"0.00"},1,"yes","ATGACTCTAGCTGATGTTGGGACCCTTTGCTGTCACCCCGCAGTCCCCACAGTGCCCGGT","FALSE","ENST00000485344","ens|ENST00000485344|gb|AK091719|gb|AB209440","NDUFA10","NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa","ens|NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa [Source:HGNC Symbol;Acc:HGNC:7684] [ENST00000485344]","chr2",240912928,240951071,"GO:0005524(ATP binding);GO:0005743(mitochondrial inner membrane);GO:0005747(mitochondrial respiratory chain complex I);GO:0005759(mitochondrial matrix);GO:0006120(mitochondrial electron transport, NADH to ubiquinone);GO:0008137(NADH dehydrogenase (ubiquinone) activity);GO:0009165(nucleotide biosynthetic process);GO:0019206(nucleoside kinase activity);GO:0022904(respiratory electron transport chain);GO:0042493(response to drug);GO:0044237(cellular metabolic process);GO:0044281(small molecule metabolic process)","00190(Oxidative phosphorylation);05010(Alzheimer's disease);05012(Parkinson's disease);05016(Huntington's disease);04932(Non-alcoholic fatty liver disease (NAFLD))","mRNA","agilent G3 V3"]
["A_33_P3240931",8.52,8.54,8.63,9.24,9.34,9.24,{"v":0.923436376707405,"d":"0.92"},{"v":-0.114915529641422,"d":"-0.11"},"down",{"v":0.000118310999999927,"d":"0.00"},1,"yes","GCTGTCCCCTGGCTGCCTCTAACAAACATTTTATCAAAAATCAGCAAATAAATAAAAGTT","FALSE","NM_001048249","ref|NM_001048249|ens|ENST00000339020|gb|BX538015|tc|THC2466851","SMIM15","small integral membrane protein 15","ref|Homo sapiens small integral membrane protein 15 (SMIM15), mRNA [NM_001048249]","chr5",60453536,60458301,"GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P105625",2.46,2.52,2.92,{"v":5.2,"d":"5.20"},5.22,4.96,{"v":0.513654096228869,"d":"0.51"},{"v":-0.961130944897361,"d":"-0.96"},"down",{"v":0.000118335999999997,"d":"0.00"},1,"yes","AGGCATTTGGTCTGTATCTTTGCTCAACTGCTAATTTCTCTTGGCTGTAGGGTGTGTGGT","FALSE","NM_032314","ref|NM_032314|ens|ENST00000288532|ref|XM_006719639|gb|AK225242","COQ5","coenzyme Q5 homolog, methyltransferase (S. cerevisiae)","ref|Homo sapiens coenzyme Q5 homolog, methyltransferase (S. cerevisiae) (COQ5), mRNA [NM_032314]","chr12",120941776,120966943,"GO:0005739(mitochondrion);GO:0006744(ubiquinone biosynthetic process);GO:0008757(S-adenosylmethionine-dependent methyltransferase activity);GO:0032259(methylation);GO:0044281(small molecule metabolic process)","00130(Ubiquinone and other terpenoid-quinone biosynthesis)","mRNA","agilent G3 V3"]
["A_33_P3417222",16.63,16.47,16.54,{"v":15.8,"d":"15.80"},15.84,15.78,{"v":1.04681568958245,"d":"1.05"},{"v":0.0660074526483486,"d":"0.07"},"up",{"v":0.000118562999999905,"d":"0.00"},1,"yes","CACCGCCCCCCTGCGGATGGTCCCAATTCACCTACCTGCCCCCCTTCCCCTCTCTCCGTC","FALSE","ENST00000378430","ens|ENST00000378430|ens|ENST00000482121|ens|ENST00000470387|gb|AK309268","CD72","CD72 molecule","ens|CD72 molecule [Source:HGNC Symbol;Acc:HGNC:1696] [ENST00000378430]","chr9",35616936,35618386,"GO:0004888(transmembrane signaling receptor activity);GO:0005102(receptor binding);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0007155(cell adhesion);GO:0007165(signal transduction);GO:0007411(axon guidance);GO:0030246(carbohydrate binding)","04662(B cell receptor signaling pathway)","mRNA","agilent G3 V3"]
["A_23_P355980",8.93,8.76,9.02,7.69,7.64,7.74,{"v":1.15778066753359,"d":"1.16"},{"v":0.211361971952127,"d":"0.21"},"up",{"v":0.000119314999999953,"d":"0.00"},1,"yes","GGCATGACTGGAAAGTTGGGGGGCATCTATGGTAGACATGGCACAGCCATGAAGAGACCA","FALSE","ENST00000413302","ens|ENST00000413302|gb|AB002058|tc|THC2476360","P2RX6","purinergic receptor P2X, ligand gated ion channel, 6","ens|purinergic receptor P2X, ligand-gated ion channel, 6 [Source:HGNC Symbol;Acc:HGNC:8538] [ENST00000413302]","chr22",21369476,21382296,"GO:0001614(purinergic nucleotide receptor activity);GO:0004888(transmembrane signaling receptor activity);GO:0004931(extracellular ATP-gated cation channel activity);GO:0005524(ATP binding);GO:0005639(integral to nuclear inner membrane);GO:0005737(cytoplasm);GO:0005887(integral to plasma membrane);GO:0006810(transport);GO:0006812(cation transport);GO:0006936(muscle contraction);GO:0007165(signal transduction);GO:0014069(postsynaptic density);GO:0015267(channel activity);GO:0030054(cell junction);GO:0035590(purinergic nucleotide receptor signaling pathway);GO:0042802(identical protein binding);GO:0043025(neuronal cell body);GO:0043197(dendritic spine);GO:0051260(protein homooligomerization);GO:0051291(protein heterooligomerization);GO:0055085(transmembrane transport)","04020(Calcium signaling pathway);04080(Neuroactive ligand-receptor interaction)","mRNA","agilent G3 V3"]
["A_23_P202138",11.26,11.18,11.21,{"v":10.7,"d":"10.70"},10.65,10.74,{"v":1.0486132751636,"d":"1.05"},{"v":0.0684827152158717,"d":"0.07"},"up",{"v":0.000119488999999917,"d":"0.00"},1,"yes","ACTGACATTTCTTAGACATTCAGCAAAACCCCCACCTTAACCTCTTTTCTTTCTTGAGGG","FALSE","NM_030971","ref|NM_030971|ens|ENST00000224807|ens|ENST00000470252|ens|ENST00000393459","SFXN3","sideroflexin 3","ref|Homo sapiens sideroflexin 3 (SFXN3), mRNA [NM_030971]","chr10",102790992,102800997,"GO:0005739(mitochondrion);GO:0015075(ion transmembrane transporter activity);GO:0016021(integral to membrane);GO:0031966(mitochondrial membrane);GO:0034220(ion transmembrane transport);GO:0055072(iron ion homeostasis)",null,"mRNA","agilent G3 V3"]
["A_23_P67785",1.87,2.04,1.86,3.97,4.43,4.08,{"v":0.462339743589744,"d":"0.46"},{"v":-1.11297471021677,"d":"-1.11"},"down",{"v":0.000119654999999996,"d":"0.00"},1,"yes","TCTGCAATTTCTTGATCAAAATGGGAATGACCAGAACTCTTGATTGCTTTCAGTCTGAAT","FALSE","NM_001025436","ref|NM_001025436|ens|ENST00000414961|ens|ENST00000272898|ens|ENST00000432529","SPAG16","sperm associated antigen 16","ref|Homo sapiens sperm associated antigen 16 (SPAG16), transcript variant 2, mRNA [NM_001025436]","chr2",214149200,214261416,"GO:0005634(nucleus);GO:0005930(axoneme);GO:0007283(spermatogenesis);GO:0015630(microtubule cytoskeleton);GO:0019901(protein kinase binding);GO:0031514(motile cilium);GO:0042384(cilium assembly)",null,"mRNA","agilent G3 V3"]
["A_23_P136413",15.47,15.55,15.43,14.31,14.45,14.52,{"v":1.07324399260628,"d":"1.07"},{"v":0.1019780974432,"d":"0.10"},"up",{"v":0.000119690999999977,"d":"0.00"},1,"yes","GAGCCCCCCACATGGTGCCGCGGCACGTCCCCCCTGTGACGCGTTCCAGACCAACATGCA","FALSE","NM_016155","ref|NM_016155|ens|ENST00000360564|ens|ENST00000535291|gb|BC040507","MMP17","matrix metallopeptidase 17 (membrane-inserted)","ref|Homo sapiens matrix metallopeptidase 17 (membrane-inserted) (MMP17), mRNA [NM_016155]","chr12",132312936,132336316,"GO:0004222(metalloendopeptidase activity);GO:0005509(calcium ion binding);GO:0005578(proteinaceous extracellular matrix);GO:0005887(integral to plasma membrane);GO:0006508(proteolysis);GO:0008047(enzyme activator activity);GO:0008270(zinc ion binding);GO:0031225(anchored to membrane);GO:0043085(positive regulation of catalytic activity)",null,"mRNA","agilent G3 V3"]
["A_21_P0002294",8.08,8.14,8.21,7.56,7.54,7.58,{"v":1.07716049382716,"d":"1.08"},{"v":0.107233223325027,"d":"0.11"},"up",{"v":0.000119974999999939,"d":"0.00"},1,"yes","TTTCGTTTAGCCTGGCGGTGGCCCTCCTTGTCTTCAAGAAGAGCATCCGTGGCTAGCAGT","FALSE","ENST00000590687","ens|ENST00000590687|linc|lnc-GPR39-2:1|linc|lnc-GPR39-2:2|linc|TCONS_00003878","ZNF112","zinc finger protein 112","ens|zinc finger protein 112 [Source:HGNC Symbol;Acc:HGNC:12892] [ENST00000590687]","chr19",44833860,44871365,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_24_P209113",12.63,12.51,12.62,11.47,11.47,11.65,{"v":1.09164498409945,"d":"1.09"},{"v":0.126503750988913,"d":"0.13"},"up",{"v":0.000120208999999982,"d":"0.00"},1,"yes","AGCGCAGCATATTTTGACTACAAGGATGAGTCTGGGTTTCCAAAGCCCCCATCTTACAAT","FALSE","NM_030571","ref|NM_030571|ens|ENST00000253814|gb|AK315481|gb|HQ447371","NDFIP1","Nedd4 family interacting protein 1","ref|Homo sapiens Nedd4 family interacting protein 1 (NDFIP1), mRNA [NM_030571]","chr5",141488064,141534005,"GO:0000139(Golgi membrane);GO:0002761(regulation of myeloid leukocyte differentiation);GO:0002829(negative regulation of type 2 immune response);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005938(cell cortex);GO:0006879(cellular iron ion homeostasis);GO:0007165(signal transduction);GO:0010008(endosome membrane);GO:0010629(negative regulation of gene expression);GO:0016021(integral to membrane);GO:0031398(positive regulation of protein ubiquitination);GO:0032410(negative regulation of transporter activity);GO:0032713(negative regulation of interleukin-4 production);GO:0042130(negative regulation of T cell proliferation);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB cascade);GO:0043162(ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway);GO:0045619(regulation of lymphocyte differentiation);GO:0045732(positive regulation of protein catabolic process);GO:0048294(negative regulation of isotype switching to IgE isotypes);GO:0048302(regulation of isotype switching to IgG isotypes);GO:0048471(perinuclear region of cytoplasm);GO:0050699(WW domain binding);GO:0050728(negative regulation of inflammatory response);GO:0051224(negative regulation of protein transport)",null,"mRNA","agilent G3 V3"]
["A_23_P215331",{"v":2,"d":"2.00"},1.96,2.18,5.03,5.61,4.98,{"v":0.393085787451985,"d":"0.39"},{"v":-1.3470838927718,"d":"-1.35"},"down",{"v":0.000120322999999978,"d":"0.00"},1,"yes","TATTTCAACTCCTTCCTGCAGTCGTTCCAGGGTTTCTTCGTGTCTGTCTTCTACTGCTTC","FALSE","NM_001883","ref|NM_001883|ref|NM_001202481|ref|NM_001202482|ref|NM_001202475","CRHR2","corticotropin releasing hormone receptor 2","ref|Homo sapiens corticotropin releasing hormone receptor 2 (CRHR2), transcript variant 1, mRNA [NM_001883]","chr7",30692200,30722314,"GO:0005179(hormone activity);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0007188(adenylate cyclase-modulating G-protein coupled receptor signaling pathway);GO:0009986(cell surface);GO:0015056(corticotrophin-releasing factor receptor activity);GO:0016525(negative regulation of angiogenesis);GO:0043950(positive regulation of cAMP-mediated signaling);GO:0043951(negative regulation of cAMP-mediated signaling);GO:0071376(cellular response to corticotropin-releasing hormone stimulus)","04080(Neuroactive ligand-receptor interaction)","mRNA","agilent G3 V3"]
["A_23_P215525",2.26,2.24,2.69,4.94,5.04,4.75,{"v":0.488119484046164,"d":"0.49"},{"v":-1.03469375459655,"d":"-1.03"},"down",{"v":0.000120416999999984,"d":"0.00"},1,"yes","TTTTTCAGGAAATCCGACGATGACTCTTGGGTGAGCAACGGCACCTATTTGGAACTTAGA","FALSE","NM_015550","ref|NM_015550|ref|NM_145320|ref|NM_145321|ref|NM_145322","OSBPL3","oxysterol binding protein-like 3","ref|Homo sapiens oxysterol binding protein-like 3 (OSBPL3), transcript variant 1, mRNA [NM_015550]","chr7",24836158,25019807,"GO:0005515(protein binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006869(lipid transport);GO:0015485(cholesterol binding);GO:0016020(membrane);GO:0031965(nuclear membrane);GO:0097038(perinuclear endoplasmic reticulum)",null,"mRNA","agilent G3 V3"]
["A_23_P24345",6.23,5.89,{"v":6.2,"d":"6.20"},9.04,{"v":8.8,"d":"8.80"},9.38,{"v":0.673034533431301,"d":"0.67"},{"v":-0.571247563407051,"d":"-0.57"},"down",{"v":0.000120496999999942,"d":"0.00"},1,"yes","AAGTGGCCATCGAGAGGTCTGGATGGTTTTATAGCAACTTTGCTGTGATTCCGTTTGTAT","FALSE","NM_152264","ref|NM_152264|ref|NM_001128225|ens|ENST00000354884|ens|ENST00000362021","SLC39A13","solute carrier family 39 (zinc transporter), member 13","ref|Homo sapiens solute carrier family 39 (zinc transporter), member 13 (SLC39A13), transcript variant 2, mRNA [NM_152264]","chr11",47431636,47438045,"GO:0005385(zinc ion transmembrane transporter activity);GO:0005794(Golgi apparatus);GO:0006882(cellular zinc ion homeostasis);GO:0016021(integral to membrane);GO:0030173(integral to Golgi membrane);GO:0042803(protein homodimerization activity);GO:0048471(perinuclear region of cytoplasm);GO:0061448(connective tissue development);GO:0071577(zinc ion transmembrane transport)",null,"mRNA","agilent G3 V3"]
["A_33_P3228072",2.53,2.71,2.55,5.98,5.76,6.53,{"v":0.426382047071702,"d":"0.43"},{"v":-1.22978140056582,"d":"-1.23"},"down",{"v":0.000120593999999974,"d":"0.00"},1,"yes","GATGGCCTAAATCTGTCTCTTCATTTACCTCAAACTCAAATTAGTATGCCATTTTCATAC","FALSE","NM_153240","ref|NM_153240|ens|ENST00000474871|gb|AL832863|gb|AL832877","NPHP3","nephronophthisis 3 (adolescent)","ref|Homo sapiens nephronophthisis 3 (adolescent) (NPHP3), mRNA [NM_153240]","chr3",132399456,132441276,"GO:0001822(kidney development);GO:0001947(heart looping);GO:0003283(atrial septum development);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005929(cilium);GO:0006996(organelle organization);GO:0007368(determination of left/right symmetry);GO:0016055(Wnt receptor signaling pathway);GO:0030324(lung development);GO:0035469(determination of pancreatic left/right asymmetry);GO:0045494(photoreceptor cell maintenance);GO:0048496(maintenance of organ identity);GO:0060027(convergent extension involved in gastrulation);GO:0060271(cilium morphogenesis);GO:0060287(epithelial cilium movement involved in determination of left/right asymmetry);GO:0060993(kidney morphogenesis);GO:0071908(determination of intestine left/right asymmetry);GO:0071909(determination of stomach left/right asymmetry);GO:0071910(determination of liver left/right asymmetry);GO:0072189(ureter development);GO:0072372(primary cilium);GO:0090090(negative regulation of canonical Wnt receptor signaling pathway);GO:2000095(regulation of Wnt receptor signaling pathway, planar cell polarity pathway);GO:2000167(regulation of planar cell polarity pathway involved in neural tube closure)",null,"mRNA","agilent G3 V3"]
["A_33_P3220437",8.42,8.14,8.13,9.65,9.74,9.75,{"v":0.847288949897049,"d":"0.85"},{"v":-0.239074040921731,"d":"-0.24"},"down",{"v":0.000120661999999938,"d":"0.00"},1,"yes","TAATCCCAGCTACTTGAGAGATGACGAGGGAAGATCACTTGAGCCCAGGAGTTAAGAGGC","FALSE","NM_001167942","ref|NM_001167942|ref|NM_152362|ens|ENST00000536716|ens|ENST00000327473","TNFAIP8L1","tumor necrosis factor, alpha-induced protein 8-like 1","ref|Homo sapiens tumor necrosis factor, alpha-induced protein 8-like 1 (TNFAIP8L1), transcript variant 1, mRNA [NM_001167942]","chr19",{"v":4640029,"d":"4640029.00"},4655580,"GO:0005737(cytoplasm);GO:0032007(negative regulation of TOR signaling cascade)",null,"mRNA","agilent G3 V3"]
["A_33_P3219578",11.78,11.74,11.82,10.82,10.66,10.87,{"v":1.09242658423493,"d":"1.09"},{"v":0.127536327671747,"d":"0.13"},"up",{"v":0.000120918999999997,"d":"0.00"},1,"yes","GGGCCGCGCGTCAAGGCTGCCCGGGGAAAGGCATGGAGCATCTCAGCCCCCTAAAAAAAA","FALSE","U79264","gb|U79264|tc|NP1167104","ZIC1","Zic family member 1","gb|Human clone 23814 mRNA sequence. [U79264]","chr3",147127408,147128875,"GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-dependent);GO:0007389(pattern specification process);GO:0007420(brain development);GO:0007628(adult walking behavior);GO:0008589(regulation of smoothened signaling pathway);GO:0021510(spinal cord development);GO:0030154(cell differentiation);GO:0042307(positive regulation of protein import into nucleus);GO:0042472(inner ear morphogenesis);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P103837",11.02,10.95,10.97,{"v":10,"d":"10.00"},10.16,10.17,{"v":1.08605341246291,"d":"1.09"},{"v":0.119095057102184,"d":"0.12"},"up",{"v":0.000121054999999926,"d":"0.00"},1,"yes","TGGATATGGGTCTCATGGATACAACACTGGAAGAAAATATCCACCCCCTTACAAGCATTT","FALSE","NM_001287815","ref|NM_001287815|ref|NM_001127320|ens|ENST00000475373|ens|ENST00000613315","UBAP2L","ubiquitin associated protein 2-like","ref|Homo sapiens ubiquitin associated protein 2-like (UBAP2L), transcript variant 3, mRNA [NM_001287815]","chr1",154192656,154235981,"GO:0005515(protein binding);GO:0005671(Ada2/Gcn5/Ada3 transcription activator complex);GO:0007339(binding of sperm to zona pellucida)",null,"mRNA","agilent G3 V3"]
["A_33_P3372332",5.71,5.87,5.75,7.75,7.88,7.47,{"v":0.75021645021645,"d":"0.75"},{"v":-0.41462119714325,"d":"-0.41"},"down",{"v":0.000121068000000002,"d":"0.00"},1,"yes","TGGTGAAGCTGTTCGGGCCCTTTACCAGGAATTACTATGTTCGGGCCGTCCTGCATCTCC","FALSE","NM_000101","ref|NM_000101|ens|ENST00000562209|ens|ENST00000261623|ens|ENST00000566534","CYBA","cytochrome b-245, alpha polypeptide","ref|Homo sapiens cytochrome b-245, alpha polypeptide (CYBA), mRNA [NM_000101]","chr16",88712552,88717439,"GO:0001938(positive regulation of endothelial cell proliferation);GO:0002474(antigen processing and presentation of peptide antigen via MHC class I);GO:0002479(antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent);GO:0003106(negative regulation of glomerular filtration by angiotensin);GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005768(endosome);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0006801(superoxide metabolic process);GO:0006954(inflammatory response);GO:0009055(electron carrier activity);GO:0014895(smooth muscle hypertrophy);GO:0016020(membrane);GO:0016175(superoxide-generating NADPH oxidase activity);GO:0016324(apical plasma membrane);GO:0017004(cytochrome complex assembly);GO:0017124(SH3 domain binding);GO:0020037(heme binding);GO:0030141(secretory granule);GO:0030307(positive regulation of cell growth);GO:0030425(dendrite);GO:0030670(phagocytic vesicle membrane);GO:0031667(response to nutrient levels);GO:0042493(response to drug);GO:0042554(superoxide anion generation);GO:0042590(antigen processing and presentation of exogenous peptide antigen via MHC class I);GO:0043020(NADPH oxidase complex);GO:0043025(neuronal cell body);GO:0045087(innate immune response);GO:0045730(respiratory burst);GO:0046872(metal ion binding);GO:0046982(protein heterodimerization activity);GO:0048010(vascular endothelial growth factor receptor signaling pathway);GO:0050665(hydrogen peroxide biosynthetic process);GO:0051279(regulation of release of sequestered calcium ion into cytosol);GO:0051701(interaction with host);GO:0055114(oxidation-reduction process);GO:0070257(positive regulation of mucus secretion);GO:0070555(response to interleukin-1);GO:0071230(cellular response to amino acid stimulus);GO:0071260(cellular response to mechanical stimulus);GO:0071333(cellular response to glucose stimulus);GO:0071356(cellular response to tumor necrosis factor);GO:0071407(cellular response to organic cyclic compound);GO:0071480(cellular response to gamma radiation);GO:0090382(phagosome maturation);GO:0097038(perinuclear endoplasmic reticulum)","04145(Phagosome);04670(Leukocyte transendothelial migration);04380(Osteoclast differentiation);05140(Leishmaniasis)","mRNA","agilent G3 V3"]
["A_33_P3268686",10.19,10.13,10.05,8.96,9.16,{"v":9,"d":"9.00"},{"v":1.11983775811209,"d":"1.12"},{"v":0.163289730031116,"d":"0.16"},"up",{"v":0.000121111999999979,"d":"0.00"},1,"yes","TTCTCAAATCTGGTAACCCTCCCTCAGATGCATCTCGCCATCACTATGGATCGGAAAAAA","FALSE","NM_207102","ref|NM_207102|ref|NM_001159929|ens|ENST00000296438|ens|ENST00000477542","FBXW12","F-box and WD repeat domain containing 12","ref|Homo sapiens F-box and WD repeat domain containing 12 (FBXW12), transcript variant 1, mRNA [NM_207102]","chr3",48413764,48436152,null,null,"mRNA","agilent G3 V3"]
["A_23_P22433",2.05,{"v":1.9,"d":"1.90"},2.19,3.69,3.94,3.98,{"v":0.52885443583118,"d":"0.53"},{"v":-0.919057411495387,"d":"-0.92"},"down",{"v":0.000121194999999963,"d":"0.00"},1,"yes","TTATTTCTCTTGCATTAATAGTACTGCTGTTTTTGTTTTGCTTCTTTATATTTATGTCTA","FALSE","NM_006915","ref|NM_006915|ens|ENST00000218340|gb|AJ007590|gb|AL049366","RP2","retinitis pigmentosa 2 (X-linked recessive)","ref|Homo sapiens retinitis pigmentosa 2 (X-linked recessive) (RP2), mRNA [NM_006915]","chrX",46696376,46741793,"GO:0000902(cell morphogenesis);GO:0003779(actin binding);GO:0004550(nucleoside diphosphate kinase activity);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005814(centriole);GO:0005886(plasma membrane);GO:0006165(nucleoside diphosphate phosphorylation);GO:0006183(GTP biosynthetic process);GO:0006228(UTP biosynthetic process);GO:0006241(CTP biosynthetic process);GO:0006457(protein folding);GO:0006892(post-Golgi vesicle-mediated transport);GO:0006996(organelle organization);GO:0007010(cytoskeleton organization);GO:0007023(post-chaperonin tubulin folding pathway);GO:0007601(visual perception);GO:0015031(protein transport);GO:0031410(cytoplasmic vesicle);GO:0036064(cilium basal body);GO:0043547(positive regulation of GTPase activity);GO:0051082(unfolded protein binding);GO:0070062(extracellular vesicular exosome);GO:0072372(primary cilium)",null,"mRNA","agilent G3 V3"]
["A_33_P3305117",8.48,8.29,7.97,10.43,10.52,10.48,{"v":0.787146038816417,"d":"0.79"},{"v":-0.345296771822381,"d":"-0.35"},"down",{"v":0.000121297999999936,"d":"0.00"},1,"yes","AGACCTGGAACCAACCCAAATGCCCATCAATGATTGATAGACTGGATTAAGAAAACGTGG","FALSE","AK092835","gb|AK092835|gb|AX747756|tc|THC2564085",null,null,"gb|Homo sapiens cDNA FLJ35516 fis, clone SPLEN2000695. [AK092835]",{"$nulls":5},"mRNA","agilent G3 V3"]
["A_23_P20876",8.86,{"v":8.9,"d":"8.90"},9.01,{"v":6.9,"d":"6.90"},6.95,7.28,{"v":1.2669190724089,"d":"1.27"},{"v":0.341324371705837,"d":"0.34"},"up",{"v":0.000121310999999902,"d":"0.00"},1,"yes","TTTTCTTGGGAAATTGAGTCCAGTGGATGTTAATGGAGTGGGTTGCCCATCCCTGAAATG","FALSE","NM_177995","ref|NM_177995|ref|NM_001253830|ref|NM_001253829|ref|NM_152422","PTPDC1","protein tyrosine phosphatase domain containing 1","ref|Homo sapiens protein tyrosine phosphatase domain containing 1 (PTPDC1), transcript variant 2, mRNA [NM_177995]","chr9",96846744,96872136,"GO:0004725(protein tyrosine phosphatase activity);GO:0005654(nucleoplasm);GO:0008138(protein tyrosine/serine/threonine phosphatase activity);GO:0030030(cell projection organization);GO:0035335(peptidyl-tyrosine dephosphorylation)",null,"mRNA","agilent G3 V3"]
["A_23_P152727",3.87,3.25,3.92,{"v":7.1,"d":"7.10"},6.88,7.06,{"v":0.524714828897338,"d":"0.52"},{"v":-0.930394532514134,"d":"-0.93"},"down",{"v":0.000121341999999913,"d":"0.00"},1,"yes","TCTGGCCCTGAGGAGTCTTTGCAATGTATTGAAGGAATTGCTGCCGTGTGAGTTTTGAAT","FALSE","NM_014798","ref|NM_014798|ref|NR_027774|ref|NR_027782|ens|ENST00000579197","PLEKHM1","pleckstrin homology domain containing, family M (with RUN domain) member 1","ref|Homo sapiens pleckstrin homology domain containing, family M (with RUN domain) member 1 (PLEKHM1), transcript variant 1, mRNA [NM_014798]","chr17",43513272,43568094,"GO:0005737(cytoplasm);GO:0035556(intracellular signal transduction);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P119573",7.32,{"v":7.3,"d":"7.30"},7.83,4.02,4.45,4.02,{"v":1.79743795036029,"d":"1.80"},{"v":0.845941968020552,"d":"0.85"},"up",{"v":0.000121386000000001,"d":"0.00"},1,"yes","AAACGCCGCTGCTAACGTTCTCAGGGAGACGTGGCTCATCTACAAACATACCAGGCTGGT","FALSE","NM_002248","ref|NM_002248|ens|ENST00000615435|ref|XR_244072|ref|XM_005259905","KCNN1","potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 1","ref|Homo sapiens potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 1 (KCNN1), mRNA [NM_002248]","chr19",18062102,18110889,"GO:0005516(calmodulin binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006813(potassium ion transport);GO:0007268(synaptic transmission);GO:0008076(voltage-gated potassium channel complex);GO:0015269(calcium-activated potassium channel activity);GO:0016286(small conductance calcium-activated potassium channel activity);GO:0043025(neuronal cell body);GO:0046982(protein heterodimerization activity);GO:0071805(potassium ion transmembrane transport)","04911(Insulin secretion)","mRNA","agilent G3 V3"]
["A_24_P312692",1.92,2.03,2.04,3.84,4.18,{"v":4.3,"d":"4.30"},{"v":0.486201298701299,"d":"0.49"},{"v":-1.04037434790612,"d":"-1.04"},"down",{"v":0.000121437000000002,"d":"0.00"},1,"yes","TTGCTATTCAAATCAACTGCCTGAATGACATTTCTAGTAGTCTGATGTATTTTTCTGAGG","FALSE","NM_006595","ref|NM_006595|ref|NM_001243747|ref|NM_001142930|ref|NM_001142931","API5","apoptosis inhibitor 5","ref|Homo sapiens apoptosis inhibitor 5 (API5), transcript variant 2, mRNA [NM_006595]","chr11",43333552,43366079,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005681(spliceosomal complex);GO:0005737(cytoplasm);GO:0006915(apoptotic process);GO:0016020(membrane);GO:0017134(fibroblast growth factor binding);GO:0043066(negative regulation of apoptotic process);GO:2000270(negative regulation of fibroblast apoptotic process)",null,"mRNA","agilent G3 V3"]
["A_24_P56330",8.09,8.21,8.41,6.16,6.41,6.44,{"v":1.29984218832194,"d":"1.30"},{"v":0.378336478680232,"d":"0.38"},"up",{"v":0.000121453999999965,"d":"0.00"},1,"yes","CCATCATCTACAGAGTCATTCAGGAGAGCAGGAAAGAAAAGGCCATCCCTGTGGATGTCG","FALSE","NM_152324","ref|NM_152324|ref|NM_001303133|ens|ENST00000283547|ens|ENST00000497241","TEX29","testis expressed 29","ref|Homo sapiens testis expressed 29 (TEX29), transcript variant 2, mRNA [NM_152324]","chr13",111968528,111996596,"GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3229472",12.23,11.99,12.17,13.43,13.34,13.29,{"v":0.908387418871692,"d":"0.91"},{"v":-0.138620369971041,"d":"-0.14"},"down",{"v":0.000121467999999902,"d":"0.00"},1,"yes","AAGCATTTGTTATGATTTCCCTGAATTAATTCATCCCACGCATCCTCCCTGAGGCACCTG","FALSE","NM_001012710","ref|NM_001012710|ens|ENST00000619191|ens|ENST00000398531|gb|BC137550","KRTAP5-10","keratin associated protein 5-10","ref|Homo sapiens keratin associated protein 5-10 (KRTAP5-10), mRNA [NM_001012710]","chr11",71276608,71277666,"GO:0045095(keratin filament)",null,"mRNA","agilent G3 V3"]
["A_23_P101655",5.21,5.24,5.71,7.84,7.81,7.75,{"v":0.690598290598291,"d":"0.69"},{"v":-0.534081331718972,"d":"-0.53"},"down",{"v":0.000122122999999918,"d":"0.00"},1,"yes","TAAATATGTATGATGTGTTGTGCTTTTTTAACCAAGGAGGGGCCAGTGGATTCCCACAGC","FALSE","NM_004924","ref|NM_004924|ref|XM_006723406|ref|XM_005259281|ref|XM_005259282","ACTN4","actinin, alpha 4","ref|Homo sapiens actinin, alpha 4 (ACTN4), mRNA [NM_004924]","chr19",39138328,39220072,"GO:0001666(response to hypoxia);GO:0001725(stress fiber);GO:0001882(nucleoside binding);GO:0002576(platelet degranulation);GO:0003779(actin binding);GO:0005178(integrin binding);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005911(cell-cell junction);GO:0005925(focal adhesion);GO:0007596(blood coagulation);GO:0015031(protein transport);GO:0030018(Z disc);GO:0030168(platelet activation);GO:0030374(ligand-dependent nuclear receptor transcription coactivator activity);GO:0030529(ribonucleoprotein complex);GO:0030863(cortical cytoskeleton);GO:0031093(platelet alpha granule lumen);GO:0031143(pseudopodium);GO:0032417(positive regulation of sodium:hydrogen antiporter activity);GO:0035257(nuclear hormone receptor binding);GO:0035357(peroxisome proliferator activated receptor signaling pathway);GO:0042803(protein homodimerization activity);GO:0042974(retinoic acid receptor binding);GO:0042981(regulation of apoptotic process);GO:0043005(neuron projection);GO:0043234(protein complex);GO:0047485(protein N-terminus binding);GO:0048384(retinoic acid receptor signaling pathway);GO:0048471(perinuclear region of cytoplasm);GO:0048549(positive regulation of pinocytosis);GO:0051015(actin filament binding);GO:0051017(actin filament bundle assembly);GO:0051271(negative regulation of cellular component movement);GO:0051272(positive regulation of cellular component movement);GO:0070062(extracellular vesicular exosome);GO:0070830(tight junction assembly)","04810(Regulation of actin cytoskeleton);04510(Focal adhesion);04520(Adherens junction);04530(Tight junction);04670(Leukocyte transendothelial migration);05203(Viral carcinogenesis);05322(Systemic lupus erythematosus);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05146(Amoebiasis)","mRNA","agilent G3 V3"]
["A_22_P00024641",10.89,10.87,{"v":11,"d":"11.00"},13.82,13.91,13.32,{"v":0.798051157125457,"d":"0.80"},{"v":-0.325446865024159,"d":"-0.33"},"down",{"v":0.000122220999999922,"d":"0.00"},1,"yes","GGCCACGCCCCCGGGAACCAAGCTTTTTGAGCCGGAGGGAGGTAGAAAACTTTTATTAGC","FALSE","ENST00000419060","ens|ENST00000419060|linc|lnc-TOR2A-1:1|gb|AK090922|gb|AX746684",null,null,"ens|peptidyl-tRNA hydrolase 1 homolog (S. cerevisiae) [Source:HGNC Symbol;Acc:HGNC:27039] [ENST00000419060]","chr9",130475792,130487152,null,null,"mRNA","agilent G3 V3"]
["A_23_P120629",{"v":2.8,"d":"2.80"},2.85,{"v":3.1,"d":"3.10"},4.62,4.91,4.74,{"v":0.613174491941135,"d":"0.61"},{"v":-0.705630412756073,"d":"-0.71"},"down",{"v":0.000122478999999953,"d":"0.00"},1,"yes","TACTGGATGTCCCTTCTGTCTCTATTGTGGCGCTGAACAAGAAATCCAAACCGATCGGCA","FALSE","NM_001672","ref|NM_001672|ens|ENST00000568305|ens|ENST00000374954|ref|XM_005260412","ASIP","agouti signaling protein","ref|Homo sapiens agouti signaling protein (ASIP), mRNA [NM_001672]","chr20",32782376,32856982,"GO:0005102(receptor binding);GO:0005615(extracellular space);GO:0006091(generation of precursor metabolites and energy);GO:0007165(signal transduction);GO:0007267(cell-cell signaling);GO:0008343(adult feeding behavior);GO:0009755(hormone-mediated signaling pathway);GO:0031781(type 3 melanocortin receptor binding);GO:0031782(type 4 melanocortin receptor binding);GO:0032402(melanosome transport);GO:0032438(melanosome organization);GO:0040030(regulation of molecular function, epigenetic);GO:0042438(melanin biosynthetic process);GO:0071514(genetic imprinting)","04916(Melanogenesis)","mRNA","agilent G3 V3"]
["A_32_P95462",{"v":9.5,"d":"9.50"},{"v":9.6,"d":"9.60"},9.57,8.12,8.18,{"v":8.4,"d":"8.40"},{"v":1.16072874493927,"d":"1.16"},{"v":0.215030862768484,"d":"0.22"},"up",{"v":0.000122586999999896,"d":"0.00"},1,"yes","TCTGCTGTTGGCCCACCCTTCTTGACTGCAAAGCCAGAAAATAAACTAGATGGTGGTTTT","FALSE","NM_014980","ref|NM_014980|ens|ENST00000273666|ref|XM_006713825|ref|XM_005247907","STXBP5L","syntaxin binding protein 5-like","ref|Homo sapiens syntaxin binding protein 5-like (STXBP5L), mRNA [NM_014980]","chr3",120626920,121143608,"GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006887(exocytosis);GO:0015031(protein transport);GO:0016021(integral to membrane);GO:0017157(regulation of exocytosis);GO:0019905(syntaxin binding);GO:0042593(glucose homeostasis);GO:0046676(negative regulation of insulin secretion);GO:0050714(positive regulation of protein secretion)",null,"mRNA","agilent G3 V3"]
["A_23_P80382",5.94,5.97,6.02,{"v":7,"d":"7.00"},7.16,7.26,{"v":0.837068160597572,"d":"0.84"},{"v":-0.256582991881881,"d":"-0.26"},"down",{"v":0.000122603999999971,"d":"0.00"},1,"yes","TGTATTTCTGTCTTGGTTGGAAATACCATCAGCCTTCCTTGCTCGGCCCAGGTCTGTTTC","FALSE","NM_015366","ref|NM_015366|ref|NM_001017530|ref|NM_181333|ref|NM_001017528","PRR5","proline rich 5 (renal)","ref|Homo sapiens proline rich 5 (renal) (PRR5), transcript variant 2, mRNA [NM_015366]","chr22",45129988,45133561,"GO:0001934(positive regulation of protein phosphorylation);GO:0007049(cell cycle);GO:0014068(positive regulation of phosphatidylinositol 3-kinase cascade);GO:0031932(TORC2 complex)",null,"mRNA","agilent G3 V3"]
["A_23_P91019",2.42,2.61,2.52,4.68,4.75,4.33,{"v":0.548691860465116,"d":"0.55"},{"v":-0.865931920489657,"d":"-0.87"},"down",{"v":0.000122681999999985,"d":"0.00"},1,"yes","TGTTACGATGGGATTCTGCTGCATTTTATTAAAAAGCTGCTGACTTGACTGTCATCCTGT","FALSE","NM_003690","ref|NM_003690|ref|NM_001139517|ref|NM_001139518|ens|ENST00000490501","PRKRA","protein kinase, interferon-inducible double stranded RNA dependent activator","ref|Homo sapiens protein kinase, interferon-inducible double stranded RNA dependent activator (PRKRA), transcript variant 1, mRNA [NM_003690]","chr2",179296144,179315958,"GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0006955(immune response);GO:0008047(enzyme activator activity);GO:0008285(negative regulation of cell proliferation);GO:0009615(response to virus);GO:0010467(gene expression);GO:0016020(membrane);GO:0030422(production of siRNA involved in RNA interference);GO:0034599(cellular response to oxidative stress);GO:0042473(outer ear morphogenesis);GO:0042474(middle ear morphogenesis);GO:0042803(protein homodimerization activity);GO:0043085(positive regulation of catalytic activity);GO:0048471(perinuclear region of cytoplasm);GO:0048705(skeletal system morphogenesis);GO:2001244(positive regulation of intrinsic apoptotic signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_23_P84952",10.67,10.56,10.68,9.64,{"v":9.8,"d":"9.80"},9.76,{"v":1.09280821917808,"d":"1.09"},{"v":0.128040239511932,"d":"0.13"},"up",{"v":0.000122722999999936,"d":"0.00"},1,"yes","GAAGCTTGGAGGAGGGTTGTAAAAGCATATTGTACCCCCTCATTTGTTTATCTGATTTTT","FALSE","NM_006521","ref|NM_006521|ref|NM_001282142|ens|ENST00000315869|ens|ENST00000493583","TFE3","transcription factor binding to IGHM enhancer 3","ref|Homo sapiens transcription factor binding to IGHM enhancer 3 (TFE3), transcript variant 1, mRNA [NM_006521]","chrX",48886240,48901012,"GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-dependent);GO:0006959(humoral immune response);GO:0044212(transcription regulatory region DNA binding);GO:0045670(regulation of osteoclast differentiation);GO:0045785(positive regulation of cell adhesion);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046983(protein dimerization activity)","05202(Transcriptional misregulation in cancers)","mRNA","agilent G3 V3"]
["A_24_P189458",2.57,2.77,2.67,4.59,4.88,4.47,{"v":0.574605451936872,"d":"0.57"},{"v":-0.799356413459713,"d":"-0.80"},"down",{"v":0.000122739999999899,"d":"0.00"},1,"yes","AGCAGAAAACACCTTTAATAAAACCCATACATTCCACTTTCTGTTGGGTTCAATATACGG","FALSE","NM_017615","ref|NM_017615|ref|NM_001167865|ens|ENST00000464321|ens|ENST00000468209","NSMCE4A","non-SMC element 4 homolog A (S. cerevisiae)","ref|Homo sapiens non-SMC element 4 homolog A (S. cerevisiae) (NSMCE4A), transcript variant 1, mRNA [NM_017615]","chr10",123716600,123734732,"GO:0000781(chromosome, telomeric region);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0006281(DNA repair);GO:0006310(DNA recombination);GO:0030915(Smc5-Smc6 complex);GO:2001022(positive regulation of response to DNA damage stimulus)",null,"mRNA","agilent G3 V3"]
["A_33_P3335682",15.67,{"v":15.8,"d":"15.80"},{"v":15.7,"d":"15.70"},14.98,14.88,14.99,{"v":1.05172798216276,"d":"1.05"},{"v":0.0727616157229733,"d":"0.07"},"up",{"v":0.000122764999999969,"d":"0.00"},1,"yes","AGCCCCCTCCAGGACCGGGCCCGGACTGCTCACCCCTGACCCTCTTGCACTCTCCCTGCC","FALSE","NM_033256","ref|NM_033256|ref|NM_001243947|ens|ENST00000301242|gb|AB056508","PPP1R14A","protein phosphatase 1, regulatory (inhibitor) subunit 14A","ref|Homo sapiens protein phosphatase 1, regulatory (inhibitor) subunit 14A (PPP1R14A), transcript variant 1, mRNA [NM_033256]","chr19",38741876,38747231,"GO:0004864(protein phosphatase inhibitor activity);GO:0005737(cytoplasm);GO:0042325(regulation of phosphorylation);GO:0043086(negative regulation of catalytic activity)","04270(Vascular smooth muscle contraction)","mRNA","agilent G3 V3"]
["A_33_P3212167",10.09,10.05,10.14,8.95,8.99,8.74,{"v":1.13493253373313,"d":"1.13"},{"v":0.182606538801147,"d":"0.18"},"up",{"v":0.000122772999999965,"d":"0.00"},1,"yes","TATAATTCCCCCCTGTTTTTCCATCTTGTTGACAGCTTGTAGAGAATAAAGCAGGAATTC","FALSE","NM_001278344","ref|NM_001278344|ref|NM_001103|ref|NM_001278343|ens|ENST00000546208","ACTN2","actinin, alpha 2","ref|Homo sapiens actinin, alpha 2 (ACTN2), transcript variant 3, mRNA [NM_001278344]","chr1",236849808,236927931,"GO:0002576(platelet degranulation);GO:0005178(integrin binding);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005884(actin filament);GO:0005925(focal adhesion);GO:0007155(cell adhesion);GO:0007268(synaptic transmission);GO:0007596(blood coagulation);GO:0008092(cytoskeletal protein binding);GO:0008307(structural constituent of muscle);GO:0030018(Z disc);GO:0030035(microspike assembly);GO:0030049(muscle filament sliding);GO:0030168(platelet activation);GO:0030175(filopodium);GO:0030274(LIM domain binding);GO:0030375(thyroid hormone receptor coactivator activity);GO:0030864(cortical actin cytoskeleton);GO:0031093(platelet alpha granule lumen);GO:0031143(pseudopodium);GO:0031432(titin binding);GO:0042391(regulation of membrane potential);GO:0042802(identical protein binding);GO:0042981(regulation of apoptotic process);GO:0043197(dendritic spine);GO:0043267(negative regulation of potassium ion transport);GO:0043268(positive regulation of potassium ion transport);GO:0044325(ion channel binding);GO:0046983(protein dimerization activity);GO:0048041(focal adhesion assembly);GO:0051015(actin filament binding);GO:0051289(protein homotetramerization);GO:0051373(FATZ binding);GO:0070062(extracellular vesicular exosome);GO:0070080(titin Z domain binding);GO:2000009(negative regulation of protein localization at cell surface);GO:2000273(positive regulation of receptor activity)","04810(Regulation of actin cytoskeleton);04510(Focal adhesion);04520(Adherens junction);04530(Tight junction);04670(Leukocyte transendothelial migration);05203(Viral carcinogenesis);05322(Systemic lupus erythematosus);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05146(Amoebiasis)","mRNA","agilent G3 V3"]
["A_24_P194508",2.06,{"v":1.9,"d":"1.90"},{"v":2.4,"d":"2.40"},4.74,4.46,{"v":4.7,"d":"4.70"},{"v":0.457553956834532,"d":"0.46"},{"v":-1.12798621232651,"d":"-1.13"},"down",{"v":0.000122922999999941,"d":"0.00"},1,"yes","AACCCTCTGTGTATTTCATCAAGTTTGATGATGATTTCCATATCTATGTCTACGATTTGG","FALSE","NM_001006683","ref|NM_001006683|ref|NM_001282461|ref|NM_001282462|ref|NM_001006682","SPIN2B","spindlin family, member 2B","ref|Homo sapiens spindlin family, member 2B (SPIN2B), transcript variant 3, mRNA [NM_001006683]","chrX",57162084,57164058,"GO:0005634(nucleus);GO:0006915(apoptotic process);GO:0007049(cell cycle);GO:0007276(gamete generation);GO:0051726(regulation of cell cycle)",null,"mRNA","agilent G3 V3"]
["A_32_P155416",2.08,2.04,2.23,4.18,4.61,4.65,{"v":0.472470238095238,"d":"0.47"},{"v":-1.08170464111923,"d":"-1.08"},"down",{"v":0.000122932999999992,"d":"0.00"},1,"yes","TAGATCCAAACGTCAAGTCAATTTTTGTCACCTGTGGAGACTGGGACTTAAAAGTCATGC","FALSE","NM_024066","ref|NM_024066|ref|NM_001301700|ref|NM_001301698|ref|NM_001301699","ERI3","ERI1 exoribonuclease family member 3","ref|Homo sapiens ERI1 exoribonuclease family member 3 (ERI3), transcript variant 1, mRNA [NM_024066]","chr1",44773984,44820921,"GO:0000175(3'-5'-exoribonuclease activity);GO:0000467(exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3381305",10.35,10.11,9.77,12.64,{"v":12.9,"d":"12.90"},12.81,{"v":0.788265971316819,"d":"0.79"},{"v":-0.343245598762589,"d":"-0.34"},"down",{"v":0.000123108999999899,"d":"0.00"},1,"yes","TCCATCCATCCATCCATCCATACATACATACATGCATACATCCACCTATCTCTTCATCCA","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_23_P141180",5.19,5.48,5.44,7.62,7.99,8.11,{"v":0.679173693086004,"d":"0.68"},{"v":-0.558147515839435,"d":"-0.56"},"down",{"v":0.000123138999999939,"d":"0.00"},1,"yes","GCTACTGAAAAGAGGAATGTGTTGAATGTCGCGTTTGCTGTCCACTCGTCCTAGAAGTTT","FALSE","NM_001082968","ref|NM_001082968|ref|NM_001288786|ref|NM_001288787|ref|NM_001033551","TOM1L2","target of myb1-like 2 (chicken)","ref|Homo sapiens target of myb1-like 2 (chicken) (TOM1L2), transcript variant 3, mRNA [NM_001082968]","chr17",17746828,17875724,"GO:0005515(protein binding);GO:0005622(intracellular);GO:0006886(intracellular protein transport);GO:0007165(signal transduction);GO:0019901(protein kinase binding);GO:0030276(clathrin binding);GO:0045839(negative regulation of mitosis);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3248794",5.63,5.56,5.23,7.82,7.67,8.03,{"v":0.69812925170068,"d":"0.70"},{"v":-0.518433933058559,"d":"-0.52"},"down",{"v":0.000123218999999897,"d":"0.00"},1,"yes","CACCTATCTGAGCAGTTAGAGCGTCTTTCTTTTCAGATTGTGTACAGTAGATTATTTATT","FALSE","NM_005967","ref|NM_005967|ens|ENST00000342556|ens|ENST00000300131|ref|XM_005268894","NAB2","NGFI-A binding protein 2 (EGR1 binding protein 2)","ref|Homo sapiens NGFI-A binding protein 2 (EGR1 binding protein 2) (NAB2), mRNA [NM_005967]","chr12",57482888,57489258,"GO:0001958(endochondral ossification);GO:0003714(transcription corepressor activity);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0007399(nervous system development);GO:0008134(transcription factor binding);GO:0008283(cell proliferation);GO:0014037(Schwann cell differentiation);GO:0016480(negative regulation of transcription from RNA polymerase III promoter);GO:0042552(myelination);GO:0045682(regulation of epidermis development)",null,"mRNA","agilent G3 V3"]
["A_33_P3371785",11.12,11.03,11.22,12.55,12.49,12.31,{"v":0.893440428380187,"d":"0.89"},{"v":-0.16255655649428,"d":"-0.16"},"down",{"v":0.000123312999999903,"d":"0.00"},1,"yes","TGAACGACACCCTGTTCTCCCACTCTGTTCCCTCCTCAGGAAGTCCTTTTATTACCAGGA","FALSE","NM_001128175","ref|NM_001128175|ref|NM_001392|ens|ENST00000315456|ens|ENST00000554864","DTNA","dystrobrevin, alpha","ref|Homo sapiens dystrobrevin, alpha (DTNA), transcript variant 9, mRNA [NM_001128175]","chr18",32173328,32471362,"GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006941(striated muscle contraction);GO:0007165(signal transduction);GO:0007268(synaptic transmission);GO:0007274(neuromuscular synaptic transmission);GO:0008270(zinc ion binding);GO:0030054(cell junction);GO:0030165(PDZ domain binding);GO:0030424(axon);GO:0031234(extrinsic to internal side of plasma membrane);GO:0042383(sarcolemma);GO:0043234(protein complex);GO:0045202(synapse)",null,"mRNA","agilent G3 V3"]
["A_23_P258018",1.86,2.11,1.89,3.72,4.08,4.01,{"v":0.49618966977138,"d":"0.50"},{"v":-1.01103639497491,"d":"-1.01"},"down",{"v":0.000123340999999999,"d":"0.00"},1,"yes","ACCATGTTTCTGAACCTGTTTGGGGAGAAGCTGAGCGGTACCGACGCCGAGGAGACCATT","FALSE","NM_002477","ref|NM_002477|ens|ENST00000513662|ens|ENST00000505477|ens|ENST00000506838","MYL5","myosin, light chain 5, regulatory","ref|Homo sapiens myosin, light chain 5, regulatory (MYL5), mRNA [NM_002477]","chr4",{"v":667369,"d":"667369.00"},675816,"GO:0005509(calcium ion binding);GO:0005859(muscle myosin complex);GO:0006937(regulation of muscle contraction);GO:0008307(structural constituent of muscle)","04810(Regulation of actin cytoskeleton);04510(Focal adhesion);04530(Tight junction);04670(Leukocyte transendothelial migration)","mRNA","agilent G3 V3"]
["A_23_P63897",6.04,5.88,5.59,7.84,7.93,7.79,{"v":0.74320882852292,"d":"0.74"},{"v":-0.428160455396903,"d":"-0.43"},"down",{"v":0.000123632999999956,"d":"0.00"},1,"yes","ATCTGAACTGCATACTGAGCGGGCAAGTCGGTTGTAAGTTCAGTAAAACCCTCTGATGAT","FALSE","NM_022802","ref|NM_022802|ref|NM_001083914|ref|NM_001329|ref|NM_001290214","CTBP2","C-terminal binding protein 2","ref|Homo sapiens C-terminal binding protein 2 (CTBP2), transcript variant 2, mRNA [NM_022802]","chr10",126677704,126694582,"GO:0003682(chromatin binding);GO:0003713(transcription coactivator activity);GO:0003714(transcription corepressor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0008285(negative regulation of cell proliferation);GO:0016616(oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor);GO:0017053(transcriptional repressor complex);GO:0019079(viral genome replication);GO:0030054(cell junction);GO:0035563(positive regulation of chromatin binding);GO:0042974(retinoic acid receptor binding);GO:0045202(synapse);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048386(positive regulation of retinoic acid receptor signaling pathway);GO:0050872(white fat cell differentiation);GO:0051287(NAD binding);GO:0055114(oxidation-reduction process)","04310(Wnt signaling pathway);04330(Notch signaling pathway);05200(Pathways in cancer);05220(Chronic myeloid leukemia)","mRNA","agilent G3 V3"]
["A_33_P3416563",2.09,2.09,2.44,5.99,5.31,5.88,{"v":0.385331781140861,"d":"0.39"},{"v":-1.37582691433125,"d":"-1.38"},"down",{"v":0.000123781999999961,"d":"0.00"},1,"yes","ATGAACTTCCTGTACCTGCTGGGAGAAGTTCTGAACAACTATATCTGGGATACACAGAAA","FALSE","NM_016108","ref|NM_016108|ref|NM_001286587|ens|ENST00000275235|ens|ENST00000357847","AIG1","androgen-induced 1","ref|Homo sapiens androgen-induced 1 (AIG1), transcript variant 1, mRNA [NM_016108]","chr6",143382016,143661441,"GO:0005515(protein binding);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_21_P0013888",14.01,13.99,14.06,{"v":12.8,"d":"12.80"},12.84,13.04,{"v":1.08738366080662,"d":"1.09"},{"v":0.120861055254938,"d":"0.12"},"up",{"v":0.000123785999999959,"d":"0.00"},1,"yes","AGAAATGACTTCCAATGACATTGTAGCTGGATCCGATTAAGTATAGCTCCCCCTTCCCCT","FALSE","NM_199254","ref|NM_199254|ref|NM_001141968|ref|NM_130785|ref|NM_001271850","TPTE2","transmembrane phosphoinositide 3-phosphatase and tensin homolog 2","ref|Homo sapiens transmembrane phosphoinositide 3-phosphatase and tensin homolog 2 (TPTE2), transcript variant 3, mRNA [NM_199254]","chr13",19997018,20110903,"GO:0000139(Golgi membrane);GO:0004725(protein tyrosine phosphatase activity);GO:0005216(ion channel activity);GO:0005789(endoplasmic reticulum membrane);GO:0006644(phospholipid metabolic process);GO:0006661(phosphatidylinositol biosynthetic process);GO:0008138(protein tyrosine/serine/threonine phosphatase activity);GO:0016021(integral to membrane);GO:0016314(phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity);GO:0034220(ion transmembrane transport);GO:0035335(peptidyl-tyrosine dephosphorylation);GO:0044281(small molecule metabolic process)",null,"mRNA","agilent G3 V3"]
["A_33_P3278033",11.34,11.12,11.55,13.88,13.86,13.54,{"v":0.823885658914729,"d":"0.82"},{"v":-0.279483964715412,"d":"-0.28"},"down",{"v":0.000123984999999993,"d":"0.00"},1,"yes","CAGGAACCCGACTCCGGCCTCCGCTCCCGGGACTCGGAGCCCTCTGGGCCCTGGCTGTAG","FALSE","NM_001004125","ref|NM_001004125|ens|ENST00000358022|gb|BC046919|gb|BC028316","TUSC1","tumor suppressor candidate 1","ref|Homo sapiens tumor suppressor candidate 1 (TUSC1), mRNA [NM_001004125]","chr9",25676396,25678856,null,null,"mRNA","agilent G3 V3"]
["A_33_P3495234",10.99,10.83,10.94,9.72,{"v":9.5,"d":"9.50"},9.72,{"v":1.13199723565999,"d":"1.13"},{"v":0.178870435109284,"d":"0.18"},"up",{"v":0.000124087999999967,"d":"0.00"},1,"yes","GCTTTCTTTGTTCTACTAGGAAGTATATGCCCCCAAATTATGAAATTCCATTTCAAACAG","FALSE","AJ276510","gb|AJ276510|tc|THC2754584","ORF1","uncharacterized protein, clone pT-Adv JuaX22","gb|Homo sapiens partial mRNA for hypothetical protein (ORF1), clone pT-Adv JuaX22. [AJ276510]","chr18",77275808,77276057,null,null,"mRNA","agilent G3 V3"]
["A_23_P29985",7.13,6.99,7.23,8.67,8.55,8.43,{"v":0.832358674463938,"d":"0.83"},{"v":-0.264722755986563,"d":"-0.26"},"down",{"v":0.000124093999999908,"d":"0.00"},1,"yes","TGCTCCGACCTTTGAGTTGTCCCGCCTTTCTGGACCAAACCAATGTATTTCTCAAATGTA","FALSE","AK022953","gb|AK022953|tc|THC2483039","TRMT44","tRNA methyltransferase 44 homolog (S. cerevisiae)","gb|Homo sapiens cDNA FLJ12891 fis, clone NT2RP2004142. [AK022953]",{"$nulls":3},"GO:0005737(cytoplasm);GO:0008033(tRNA processing);GO:0008168(methyltransferase activity);GO:0032259(methylation);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_24_P363802",6.27,6.31,6.03,7.97,7.78,8.05,{"v":0.781932773109244,"d":"0.78"},{"v":-0.354883518136154,"d":"-0.35"},"down",{"v":0.000124143999999937,"d":"0.00"},1,"yes","AGGATAATCTTTCTTTTCATTGACAACACCTACACCCACCTGTTTTCCAGTGTTCTTCTC","FALSE","NM_005047","ref|NM_005047|ref|NM_001270427|ens|ENST00000210313|gb|AK026925","PSMD5","proteasome (prosome, macropain) 26S subunit, non-ATPase, 5","ref|Homo sapiens proteasome (prosome, macropain) 26S subunit, non-ATPase, 5 (PSMD5), transcript variant 1, mRNA [NM_005047]","chr9",123578328,123605262,"GO:0000082(G1/S transition of mitotic cell cycle);GO:0000209(protein polyubiquitination);GO:0000278(mitotic cell cycle);GO:0000502(proteasome complex);GO:0002474(antigen processing and presentation of peptide antigen via MHC class I);GO:0002479(antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006521(regulation of cellular amino acid metabolic process);GO:0006915(apoptotic process);GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest);GO:0008540(proteasome regulatory particle, base subcomplex);GO:0010467(gene expression);GO:0016032(viral reproduction);GO:0022624(proteasome accessory complex);GO:0031145(anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process);GO:0034641(cellular nitrogen compound metabolic process);GO:0042590(antigen processing and presentation of exogenous peptide antigen via MHC class I);GO:0042981(regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0044281(small molecule metabolic process);GO:0051436(negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle);GO:0051437(positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle);GO:0051439(regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle);GO:0070682(proteasome regulatory particle assembly);GO:0090090(negative regulation of canonical Wnt receptor signaling pathway);GO:0090263(positive regulation of canonical Wnt receptor signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_23_P255916",1.86,2.02,1.87,3.93,4.41,4.34,{"v":0.453470031545741,"d":"0.45"},{"v":-1.14092088430767,"d":"-1.14"},"down",{"v":0.000124289999999916,"d":"0.00"},1,"yes","TGTCAAGAAGACTCTCAGTCACTTTCGTGTGGTAGCCACAGGCTCTGGCTGTGCCCTGGT","FALSE","NM_173659","ref|NM_173659|ref|NM_001142547|ens|ENST00000484134|ens|ENST00000475470","RPUSD3","RNA pseudouridylate synthase domain containing 3","ref|Homo sapiens RNA pseudouridylate synthase domain containing 3 (RPUSD3), transcript variant 1, mRNA [NM_173659]","chr3",{"v":9882366,"d":"9882366.00"},9885702,"GO:0001522(pseudouridine synthesis);GO:0009982(pseudouridine synthase activity)",null,"mRNA","agilent G3 V3"]
["A_21_P0000319",12.06,11.95,11.89,11.01,10.89,11.04,{"v":1.08986035215543,"d":"1.09"},{"v":0.124143288984059,"d":"0.12"},"up",{"v":0.00012430699999999,"d":"0.00"},1,"yes","TCTGAAGAGGGAGGGTTTTTTCATGTCCTCCTCCTATATGAAATGGCTGAACGGATATTA","FALSE","NR_002965","ref|NR_002965|ens|ENST00000467544|gb|AJ609472","SNORA29","small nucleolar RNA, H/ACA box 29","ref|Homo sapiens small nucleolar RNA, H/ACA box 29 (SNORA29), small nucleolar RNA [NR_002965]","chr6",160206624,160206765,null,null,"mRNA","agilent G3 V3"]
["A_23_P92196",10.18,{"v":10.3,"d":"10.30"},10.33,9.07,8.92,9.16,{"v":1.13480662983425,"d":"1.13"},{"v":0.182446484347627,"d":"0.18"},"up",{"v":0.000124324999999925,"d":"0.00"},1,"yes","AAGAAGATCAAGGATGTTCTCAACAGTCTAGAGTACAGTCCCTCTCCTATAAGCAAGAAG","FALSE","NM_032579","ref|NM_032579|ens|ENST00000295755|gb|HQ258043|gb|BC113502","RETNLB","resistin like beta","ref|Homo sapiens resistin like beta (RETNLB), mRNA [NM_032579]","chr3",108474480,108476231,"GO:0003674(molecular_function);GO:0005179(hormone activity);GO:0005575(cellular_component);GO:0005576(extracellular region);GO:0008283(cell proliferation)",null,"mRNA","agilent G3 V3"]
["A_23_P74668",{"v":13.6,"d":"13.60"},13.66,13.49,12.78,12.82,12.84,{"v":1.06009365244537,"d":"1.06"},{"v":0.0841917232320519,"d":"0.08"},"up",{"v":0.000124345999999997,"d":"0.00"},1,"yes","GGTACCTGTCCCCCCTCAAAACCCACAGGTTCCTTTCTTTTCCATCCAACAATTAAAGAT","FALSE","NM_152290","ref|NM_152290|gb|BC029894|gb|AK026705|ens|ENST00000376210","C1orf158","chromosome 1 open reading frame 158","ref|Homo sapiens chromosome 1 open reading frame 158 (C1orf158), mRNA [NM_152290]","chr1",12806373,12821102,null,null,"mRNA","agilent G3 V3"]
["A_23_P360240",12.51,{"v":12.5,"d":"12.50"},12.61,11.83,11.69,11.74,{"v":1.06693136698809,"d":"1.07"},{"v":0.0934673742030134,"d":"0.09"},"up",{"v":0.000124353999999993,"d":"0.00"},1,"yes","TGTGTTGCATGGCCCTCCCAACCAATTCAGTATTTTTCTCCCCATTTTCCAGGGAGAAAT","FALSE","NM_138768","ref|NM_138768|ref|NM_001293294|ref|NM_001293291|ref|NM_001293296","MYEOV","myeloma overexpressed","ref|Homo sapiens myeloma overexpressed (MYEOV), transcript variant 2, mRNA [NM_138768]","chr11",69063056,69063638,null,null,"mRNA","agilent G3 V3"]
["A_32_P36046",1.97,2.29,2.03,{"v":4.2,"d":"4.20"},4.35,4.62,{"v":0.477600607441154,"d":"0.48"},{"v":-1.06612342337723,"d":"-1.07"},"down",{"v":0.000124373999999983,"d":"0.00"},1,"yes","ATTATTTTCCTACCACTAGATTTTTGGGGAGAGTCACCATGGAATGTTGACAATTACTTA","FALSE","NM_001013649","ref|NM_001013649|tc|THC2772589|tc|THC2665933","C2orf68","chromosome 2 open reading frame 68","ref|Homo sapiens chromosome 2 open reading frame 68 (C2orf68), mRNA [NM_001013649]","chr2",85833776,85839152,null,null,"mRNA","agilent G3 V3"]
["A_23_P213199",2.26,2.27,2.68,4.76,4.59,4.87,{"v":0.507032348804501,"d":"0.51"},{"v":-0.979850300378593,"d":"-0.98"},"down",{"v":0.000124814999999945,"d":"0.00"},1,"yes","TGATACTGAAAACTAAACTGAATAGTTGGTTCCTGAAATCTTGGACTGTTTATGACCTAC","FALSE","NM_001031723","ref|NM_001031723|ref|NM_001278310|ens|ENST00000455208|ens|ENST00000471101","DNAJB14","DnaJ (Hsp40) homolog, subfamily B, member 14","ref|Homo sapiens DnaJ (Hsp40) homolog, subfamily B, member 14 (DNAJB14), transcript variant 1, mRNA [NM_001031723]","chr4",100821792,100827754,"GO:0005789(endoplasmic reticulum membrane);GO:0016020(membrane);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3319905",9.91,9.92,{"v":10,"d":"10.00"},8.26,8.57,8.25,{"v":1.18939393939394,"d":"1.19"},{"v":0.250226629533174,"d":"0.25"},"up",{"v":0.000124908999999951,"d":"0.00"},1,"yes","AATACAGACAGCTCAATGCTTTTCACCGTAATTCTCTTGTGGGGGCTGTGACATGCAGAA","FALSE","NM_018643","ref|NM_018643|ref|NM_001242590|ens|ENST00000334475|ens|ENST00000244709","TREM1","triggering receptor expressed on myeloid cells 1","ref|Homo sapiens triggering receptor expressed on myeloid cells 1 (TREM1), transcript variant 1, mRNA [NM_018643]","chr6",41243724,41248972,"GO:0002374(cytokine secretion involved in immune response);GO:0004872(receptor activity);GO:0005576(extracellular region);GO:0005886(plasma membrane);GO:0006959(humoral immune response);GO:0007596(blood coagulation);GO:0016021(integral to membrane);GO:0030593(neutrophil chemotaxis);GO:0035556(intracellular signal transduction);GO:0045087(innate immune response);GO:0050755(chemokine metabolic process);GO:0050900(leukocyte migration);GO:0070945(neutrophil mediated killing of gram-negative bacterium);GO:0072672(neutrophil extravasation);GO:0097110(scaffold protein binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3249872",9.69,9.59,9.29,11.91,11.71,11.59,{"v":0.811417211019597,"d":"0.81"},{"v":-0.301484190926759,"d":"-0.30"},"down",{"v":0.000124964999999921,"d":"0.00"},1,"yes","CCTCCTGTTGCTTTCCTAACCCTGCCCTCCGGGGCGTTAATAAAGTCTTAGCAAGCGTCC","FALSE","NM_001996","ref|NM_001996|ens|ENST00000262722|gb|AK300806|gb|AK075460","FBLN1","fibulin 1","ref|Homo sapiens fibulin 1 (FBLN1), transcript variant C, mRNA [NM_001996]","chr22",45898764,45959242,"GO:0005201(extracellular matrix structural constituent);GO:0005509(calcium ion binding);GO:0005576(extracellular region);GO:0005578(proteinaceous extracellular matrix);GO:0005604(basement membrane);GO:0005615(extracellular space);GO:0007566(embryo implantation);GO:0010952(positive regulation of peptidase activity);GO:0016032(viral reproduction);GO:0016504(peptidase activator activity);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_24_P177353",2.08,1.91,2.45,4.82,5.22,5.13,{"v":0.424522083058669,"d":"0.42"},{"v":-1.23608849213242,"d":"-1.24"},"down",{"v":0.000135164999999993,"d":"0.00"},1,"yes","GGAGCTTTGTATTGCTGAACTTTCATCTGGAAAAGTTTCACAGTGACATTTTTAAAAGAG","FALSE","NM_001081550","ref|NM_001081550|ens|ENST00000245838|ens|ENST00000448128|ref|XM_006724768","THOC2","THO complex 2","ref|Homo sapiens THO complex 2 (THOC2), mRNA [NM_001081550]","chrX",122734416,122866904,"GO:0000346(transcription export complex);GO:0000347(THO complex);GO:0000445(THO complex part of transcription export complex);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0006397(mRNA processing);GO:0006406(mRNA export from nucleus);GO:0008380(RNA splicing);GO:0016607(nuclear speck);GO:0016973(poly(A)+ mRNA export from nucleus);GO:0046784(intronless viral mRNA export from host nucleus)","03040(Spliceosome);03013(RNA transport)","mRNA","agilent G3 V3"]
["A_33_P3408047",9.79,9.95,10.03,7.86,7.88,8.21,{"v":1.24300626304802,"d":"1.24"},{"v":0.313833565614493,"d":"0.31"},"up",{"v":0.000135441000000069,"d":"0.00"},1,"yes","AAAGTCTACTTTCAGGGAGTTACATGGCCCATCCCAAATCTCCTGGTATGGTGGTATGAA","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_33_P3702055",10.41,10.35,10.43,11.34,11.16,11.22,{"v":0.92497034400949,"d":"0.92"},{"v":-0.11252098356793,"d":"-0.11"},"down",{"v":0.00013557799999997,"d":"0.00"},1,"yes","TTTCTGGCCCACAGCTCCCACCACCACTTCCTGTATGGGCTCCTTGAAGAGGACCAGAAA","FALSE","NM_000578","ref|NM_000578|ens|ENST00000354352|ens|ENST00000465984|ens|ENST00000468221","SLC11A1","solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1","ref|Homo sapiens solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1 (SLC11A1), mRNA [NM_000578]","chr2",219247040,219260014,"GO:0000060(protein import into nucleus, translocation);GO:0001818(negative regulation of cytokine production);GO:0001819(positive regulation of cytokine production);GO:0002309(T cell proliferation involved in immune response);GO:0002369(T cell cytokine production);GO:0002606(positive regulation of dendritic cell antigen processing and presentation);GO:0002827(positive regulation of T-helper 1 type immune response);GO:0005384(manganese ion transmembrane transporter activity);GO:0005764(lysosome);GO:0005770(late endosome);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0006826(iron ion transport);GO:0006828(manganese ion transport);GO:0006876(cellular cadmium ion homeostasis);GO:0006879(cellular iron ion homeostasis);GO:0006909(phagocytosis);GO:0006954(inflammatory response);GO:0007035(vacuolar acidification);GO:0009279(cell outer membrane);GO:0009617(response to bacterium);GO:0010628(positive regulation of gene expression);GO:0015707(nitrite transport);GO:0030670(phagocytic vesicle membrane);GO:0031902(late endosome membrane);GO:0032147(activation of protein kinase activity);GO:0032496(response to lipopolysaccharide);GO:0032623(interleukin-2 production);GO:0032632(interleukin-3 production);GO:0032729(positive regulation of interferon-gamma production);GO:0034341(response to interferon-gamma);GO:0042060(wound healing);GO:0042116(macrophage activation);GO:0042742(defense response to bacterium);GO:0042803(protein homodimerization activity);GO:0042832(defense response to protozoan);GO:0043091(L-arginine import);GO:0045342(MHC class II biosynthetic process);GO:0045730(respiratory burst);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046915(transition metal ion transmembrane transporter activity);GO:0048002(antigen processing and presentation of peptide antigen);GO:0048255(mRNA stabilization);GO:0050766(positive regulation of phagocytosis);GO:0050829(defense response to Gram-negative bacterium);GO:0051139(metal ion:hydrogen antiporter activity);GO:0051701(interaction with host);GO:0055072(iron ion homeostasis);GO:0055085(transmembrane transport);GO:0060586(multicellular organismal iron ion homeostasis);GO:0070574(cadmium ion transmembrane transport);GO:0070821(tertiary granule membrane);GO:0070839(divalent metal ion export);GO:0071421(manganese ion transmembrane transport);GO:0090382(phagosome maturation)","04142(Lysosome);04978(Mineral absorption)","mRNA","agilent G3 V3"]
["A_23_P79545",3.18,3.33,2.98,5.18,{"v":4.9,"d":"4.90"},5.07,{"v":0.626402640264026,"d":"0.63"},{"v":-0.674837801339204,"d":"-0.67"},"down",{"v":0.000135623000000029,"d":"0.00"},1,"yes","TCCTTTTAATGGAACAGATTTTATTGACTGCCTCGAAATCTTTTTGAACGATTCTGCCAC","FALSE","NM_003849","ref|NM_003849|ens|ENST00000487809|ens|ENST00000491123|ens|ENST00000393868","SUCLG1","succinate-CoA ligase, alpha subunit","ref|Homo sapiens succinate-CoA ligase, alpha subunit (SUCLG1), mRNA [NM_003849]","chr2",84652536,84660895,"GO:0003878(ATP citrate synthase activity);GO:0004775(succinate-CoA ligase (ADP-forming) activity);GO:0004776(succinate-CoA ligase (GDP-forming) activity);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0005759(mitochondrial matrix);GO:0005886(plasma membrane);GO:0006099(tricarboxylic acid cycle);GO:0006104(succinyl-CoA metabolic process);GO:0006105(succinate metabolic process);GO:0019003(GDP binding);GO:0044237(cellular metabolic process);GO:0044281(small molecule metabolic process);GO:0045244(succinate-CoA ligase complex (GDP-forming));GO:0046982(protein heterodimerization activity);GO:0048037(cofactor binding);GO:0070062(extracellular vesicular exosome)","01200(Carbon metabolism);00020(Citrate cycle (TCA cycle));00640(Propanoate metabolism)","mRNA","agilent G3 V3"]
["A_23_P122915",9.88,10.02,9.82,10.91,10.96,10.84,{"v":0.908590645062672,"d":"0.91"},{"v":-0.138297643544182,"d":"-0.14"},"down",{"v":0.000135701000000044,"d":"0.00"},1,"yes","GAGAGGCAGTGCTGCTGCTCCCGCCCGAGGCTCATGACAACTCAATAAAGCACTGCTTTT","FALSE","NM_015379","ref|NM_015379|ens|ENST00000297290|ens|ENST00000456357|ens|ENST00000473967","BRI3","brain protein I3","ref|Homo sapiens brain protein I3 (BRI3), transcript variant 1, mRNA [NM_015379]","chr7",97911152,97920857,"GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3321689",8.53,8.41,8.49,9.16,9.29,9.25,{"v":0.918050541516246,"d":"0.92"},{"v":-0.123354514246444,"d":"-0.12"},"down",{"v":0.000135722000000005,"d":"0.00"},1,"yes","CAGGGCTTCCAGCTCCCTGCTTCCTGTCTAAGTCCAGGTACTTACCCCACCTATAGGTGA","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_32_P104000",8.65,8.71,8.56,7.28,7.41,7.12,{"v":1.18844566712517,"d":"1.19"},{"v":0.249075948243874,"d":"0.25"},"up",{"v":0.000135858000000044,"d":"0.00"},1,"yes","GGTTTCAGTTAGAGGGTCCTCCTGTTATTTTTCCATTTAAAAAGTATGTCCTCATAAAAC","FALSE","NM_173475","ref|NM_173475|gb|BX648998|gb|BC040442|gb|BI093161","DCUN1D3","DCN1, defective in cullin neddylation 1, domain containing 3","ref|Homo sapiens DCN1, defective in cullin neddylation 1, domain containing 3 (DCUN1D3), mRNA [NM_173475]","chr16",20870318,20880302,"GO:0003674(molecular_function);GO:0010225(response to UV-C);GO:0010332(response to gamma radiation);GO:0030308(negative regulation of cell growth);GO:0043065(positive regulation of apoptotic process);GO:0048471(perinuclear region of cytoplasm)",null,"mRNA","agilent G3 V3"]
["A_32_P45009",{"v":2.1,"d":"2.10"},1.96,2.51,5.21,4.88,4.93,{"v":0.437416777629827,"d":"0.44"},{"v":-1.19291953719194,"d":"-1.19"},"down",{"v":0.000135916000000069,"d":"0.00"},1,"yes","GTTCTGGTGTCATAGATGTCCCATTTTGTGAGGTAGAGCTGTGCATTAAACTTGCACATG","FALSE","NM_005896","ref|NM_005896|ref|NM_001282387|ref|NM_001282386|ens|ENST00000415913","IDH1","isocitrate dehydrogenase 1 (NADP+), soluble","ref|Homo sapiens isocitrate dehydrogenase 1 (NADP+), soluble (IDH1), transcript variant 1, mRNA [NM_005896]","chr2",209100944,209119867,"GO:0000287(magnesium ion binding);GO:0004450(isocitrate dehydrogenase (NADP+) activity);GO:0005102(receptor binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005777(peroxisome);GO:0005782(peroxisomal matrix);GO:0005829(cytosol);GO:0006097(glyoxylate cycle);GO:0006099(tricarboxylic acid cycle);GO:0006102(isocitrate metabolic process);GO:0006103(2-oxoglutarate metabolic process);GO:0006740(NADPH regeneration);GO:0006749(glutathione metabolic process);GO:0006979(response to oxidative stress);GO:0008585(female gonad development);GO:0042803(protein homodimerization activity);GO:0044255(cellular lipid metabolic process);GO:0044281(small molecule metabolic process);GO:0048545(response to steroid hormone stimulus);GO:0050661(NADP binding);GO:0051287(NAD binding);GO:0070062(extracellular vesicular exosome)","01200(Carbon metabolism);01210(2-Oxocarboxylic acid metabolism);01230(Biosynthesis of amino acids);00020(Citrate cycle (TCA cycle));00480(Glutathione metabolism);04146(Peroxisome);05230(Central carbon metabolism in cancer)","mRNA","agilent G3 V3"]
["A_33_P3323486",12.05,{"v":12.2,"d":"12.20"},12.19,10.36,10.22,{"v":10.6,"d":"10.60"},{"v":1.1686978832585,"d":"1.17"},{"v":0.224902031104266,"d":"0.22"},"up",{"v":0.000136067999999989,"d":"0.00"},1,"yes","AAACACCTGTTGTGTAAGAAGCTAACTATAGTTAGAATAAGAGTGTCCCTCCTCATGTAG","FALSE","AB529256","gb|AB529256|tc|NP511198",null,null,"gb|Synthetic construct DNA, clone: pF1KE0827, Homo sapiens OR4A13P gene for Putative olfactory receptor, family 4, subfamily A, member 13, without stop codon, in Flexi system. [AB529256]","chr11",55234248,55235188,null,null,"mRNA","agilent G3 V3"]
["A_24_P278747",5.96,5.76,6.02,7.92,{"v":7.7,"d":"7.70"},8.09,{"v":0.748207507380852,"d":"0.75"},{"v":-0.418489653180944,"d":"-0.42"},"down",{"v":0.000136365999999999,"d":"0.00"},1,"yes","ATCGGGCCATTGGATTTTTTCCATTATGTTCATCACCCTTATATCATGTACCTCAGATCT","FALSE","NM_001759","ref|NM_001759|ens|ENST00000261254|gb|D13639|gb|BX647508","CCND2","cyclin D2","ref|Homo sapiens cyclin D2 (CCND2), mRNA [NM_001759]","chr12",{"v":4382938,"d":"4382938.00"},4414516,"GO:0000307(cyclin-dependent protein kinase holoenzyme complex);GO:0000785(chromatin);GO:0001934(positive regulation of protein phosphorylation);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0007049(cell cycle);GO:0019901(protein kinase binding);GO:0031965(nuclear membrane);GO:0045737(positive regulation of cyclin-dependent protein kinase activity);GO:0051301(cell division)","04310(Wnt signaling pathway);04390(Hippo signaling pathway);04630(Jak-STAT signaling pathway);04068(FoxO signaling pathway);04151(PI3K-Akt signaling pathway);04110(Cell cycle);04115(p53 signaling pathway);04510(Focal adhesion);04917(Prolactin signaling pathway);05202(Transcriptional misregulation in cancers);05206(MicroRNAs in cancer);05203(Viral carcinogenesis);05166(HTLV-I infection);05162(Measles)","mRNA","agilent G3 V3"]
["A_33_P3642217",9.59,9.55,9.78,8.05,{"v":8.3,"d":"8.30"},8.18,{"v":1.17896453322462,"d":"1.18"},{"v":0.237520318393516,"d":"0.24"},"up",{"v":0.000136526999999997,"d":"0.00"},1,"yes","TAACAAAAACAGAGAGGGGGCGTTAAATTACTGGGGGGCAGATTCGTACCGTTTTTGCAA","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_23_P369983",4.52,4.08,3.91,6.86,{"v":7.1,"d":"7.10"},6.98,{"v":0.597421203438395,"d":"0.60"},{"v":-0.743179652764989,"d":"-0.74"},"down",{"v":0.000136727000000003,"d":"0.00"},1,"yes","AGATGCTAATGCTATCGGTAATCTCTGGGGAGTCCGTTTAAGGCTTTCCTTGGTATTTGG","FALSE","NM_174905","ref|NM_174905|ens|ENST00000586372|ens|ENST00000252530|ens|ENST00000343358","FAM98C","family with sequence similarity 98, member C","ref|Homo sapiens family with sequence similarity 98, member C (FAM98C), mRNA [NM_174905]","chr19",38897384,38899726,null,null,"mRNA","agilent G3 V3"]
["A_23_P352358",5.68,5.59,5.75,7.31,7.71,7.62,{"v":0.751766784452297,"d":"0.75"},{"v":-0.41164292114592,"d":"-0.41"},"down",{"v":0.000136784000000056,"d":"0.00"},1,"yes","TGCTTTCAGCCACCATTTGCACAAGACACCCAGCACTGAAAGTCCCGCTGCCAGGAGCAA","FALSE","NM_138346","ref|NM_138346|ens|ENST00000616327|ens|ENST00000376572|ref|XM_006725222","KIAA2013","KIAA2013","ref|Homo sapiens KIAA2013 (KIAA2013), mRNA [NM_138346]","chr1",11979648,11986480,"GO:0016020(membrane);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_32_P91902",2.32,2.52,2.37,4.04,4.42,4.32,{"v":0.564162754303599,"d":"0.56"},{"v":-0.825816671706172,"d":"-0.83"},"down",{"v":0.000136945000000055,"d":"0.00"},1,"yes","AAGGAGGACGTGAGTATTCCTTACAAGGCTCCGAAACAATTCTTTCTTCACTTAGTTTTC","FALSE","NM_030927","ref|NM_030927|ref|NM_001128309|ens|ENST00000372164|ref|XM_005270192","TSPAN14","tetraspanin 14","ref|Homo sapiens tetraspanin 14 (TSPAN14), transcript variant 1, mRNA [NM_030927]","chr10",82214088,82282387,"GO:0005886(plasma membrane);GO:0009986(cell surface);GO:0016021(integral to membrane);GO:0019899(enzyme binding);GO:0045747(positive regulation of Notch signaling pathway);GO:0051604(protein maturation);GO:0090002(establishment of protein localization in plasma membrane);GO:0097197(tetraspanin-enriched microdomain)",null,"mRNA","agilent G3 V3"]
["A_33_P3209706",9.68,9.67,9.65,10.06,10.11,10.02,{"v":0.960582974494866,"d":"0.96"},{"v":-0.0580178566113283,"d":"-0.06"},"down",{"v":0.000137014999999963,"d":"0.00"},1,"yes","AGTGGGTTCCTGATAAAAGGATGAGTTCGGCCTTCTTCTTCCCCAAAATCTTTATCCCCA","FALSE","NM_001012659","ref|NM_001012659|ref|XM_005247505","ARGFX","arginine-fifty homeobox","ref|Homo sapiens arginine-fifty homeobox (ARGFX), mRNA [NM_001012659]","chr3",121286776,121309469,"GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0043565(sequence-specific DNA binding)",null,"mRNA","agilent G3 V3"]
["A_24_P941625",{"v":2.1,"d":"2.10"},2.34,2.05,4.28,3.94,4.06,{"v":0.528501628664495,"d":"0.53"},{"v":-0.920020177371041,"d":"-0.92"},"down",{"v":0.000137277999999963,"d":"0.00"},1,"yes","TGGGCTAACATGAACTCATCATGGTAACACTGGGTATTTCAGCTGATCAGAAGCTCAGCA","FALSE","NM_021916","ref|NM_021916|ens|ENST00000341976|gb|AK122721|gb|BC040161","ZNF70","zinc finger protein 70","ref|Homo sapiens zinc finger protein 70 (ZNF70), mRNA [NM_021916]","chr22",24083768,24093279,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P393099",6.79,6.84,6.85,{"v":7.7,"d":"7.70"},7.54,7.56,{"v":0.898245614035088,"d":"0.90"},{"v":-0.154818109052104,"d":"-0.15"},"down",{"v":0.000137292000000011,"d":"0.00"},1,"yes","TGTCCCTTTGCTCCCGGCAAGCTTTCTGCTGAAAGTTCATATCTGGAGCCTGATGTCTTA","FALSE","NM_003226","ref|NM_003226|ens|ENST00000291525|ens|ENST00000518498|gb|L08044","TFF3","trefoil factor 3 (intestinal)","ref|Homo sapiens trefoil factor 3 (intestinal) (TFF3), mRNA [NM_003226]","chr21",43731776,43735706,"GO:0003674(molecular_function);GO:0005576(extracellular region);GO:0005578(proteinaceous extracellular matrix);GO:0006952(defense response);GO:0007586(digestion);GO:0030141(secretory granule);GO:0043434(response to peptide hormone stimulus);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P205900",8.14,8.29,{"v":8.3,"d":"8.30"},6.95,6.95,6.71,{"v":1.19990295972829,"d":"1.20"},{"v":0.262917734850682,"d":"0.26"},"up",{"v":0.000137323999999994,"d":"0.00"},1,"yes","GTTGAACATCAAGGAGATCTACAAAATCCTCCATGCTTTGGGGAAGGCCACCCCAATCTA","FALSE","NM_001012338","ref|NM_001012338|ref|NM_002530|ref|NM_001243101|ens|ENST00000360948","NTRK3","neurotrophic tyrosine kinase, receptor, type 3","ref|Homo sapiens neurotrophic tyrosine kinase, receptor, type 3 (NTRK3), transcript variant 1, mRNA [NM_001012338]","chr15",88420024,88799661,"GO:0000187(activation of MAPK activity);GO:0001764(neuron migration);GO:0001933(negative regulation of protein phosphorylation);GO:0002039(p53 binding);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0005030(neurotrophin receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005887(integral to plasma membrane);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007623(circadian rhythm);GO:0008284(positive regulation of cell proliferation);GO:0010628(positive regulation of gene expression);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0019056(modulation by virus of host transcription);GO:0030335(positive regulation of cell migration);GO:0032148(activation of protein kinase B activity);GO:0032856(activation of Ras GTPase activity);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0042490(mechanoreceptor differentiation);GO:0043121(neurotrophin binding);GO:0043235(receptor complex);GO:0045471(response to ethanol);GO:0046777(protein autophosphorylation);GO:0046875(ephrin receptor binding);GO:0048665(neuron fate specification);GO:0048678(response to axon injury);GO:0048691(positive regulation of axon extension involved in regeneration);GO:0048712(negative regulation of astrocyte differentiation);GO:0050927(positive regulation of positive chemotaxis);GO:0051412(response to corticosterone stimulus);GO:0060548(negative regulation of cell death);GO:0070306(lens fiber cell differentiation);GO:0071300(cellular response to retinoic acid);GO:0090102(cochlea development);GO:2000251(positive regulation of actin cytoskeleton reorganization)","04722(Neurotrophin signaling pathway);05230(Central carbon metabolism in cancer)","mRNA","agilent G3 V3"]
["A_23_P258164",{"v":12.1,"d":"12.10"},12.06,11.92,12.83,12.85,12.81,{"v":0.937386334112757,"d":"0.94"},{"v":-0.0932843325554578,"d":"-0.09"},"down",{"v":0.000137536999999965,"d":"0.00"},1,"yes","CAGACCTGAATAAAATGTATTAAGCAGCAGTGATCTTTCCTCTCCTCCTTCCCAAGTCAT","FALSE","NM_001302","ref|NM_001302|ref|NM_001270517|ref|NM_001243768|ref|NM_198544","CORT","cortistatin","ref|Homo sapiens cortistatin (CORT), mRNA [NM_001302]","chr1",10509971,10511955,"GO:0001664(G-protein coupled receptor binding);GO:0005184(neuropeptide hormone activity);GO:0005615(extracellular space);GO:0007193(adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway);GO:0007268(synaptic transmission)","04080(Neuroactive ligand-receptor interaction)","mRNA","agilent G3 V3"]
["A_23_P55936",11.33,11.51,11.25,12.54,12.52,12.47,{"v":0.90833999467093,"d":"0.91"},{"v":-0.13869569074703,"d":"-0.14"},"down",{"v":0.000137657999999985,"d":"0.00"},1,"yes","CTGTGGTCTGCCTCAGTTTCCCCTCCTAATACATATGGCTGTTTTCCACCTCGATAATAT","FALSE","NM_004107","ref|NM_004107|ref|NM_001136019|ens|ENST00000595881|ens|ENST00000221466","FCGRT","Fc fragment of IgG, receptor, transporter, alpha","ref|Homo sapiens Fc fragment of IgG, receptor, transporter, alpha (FCGRT), transcript variant 2, mRNA [NM_004107]","chr19",50017316,50029590,"GO:0002416(IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor);GO:0003823(antigen binding);GO:0005886(plasma membrane);GO:0006955(immune response);GO:0016021(integral to membrane);GO:0019770(IgG receptor activity);GO:0019864(IgG binding);GO:0019882(antigen processing and presentation);GO:0030881(beta-2-microglobulin binding);GO:0038094(Fc-gamma receptor signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_33_P3812815",13.39,{"v":13.5,"d":"13.50"},13.53,12.52,12.56,12.67,{"v":1.07072847682119,"d":"1.07"},{"v":0.0985926772799316,"d":"0.10"},"up",{"v":0.000137663000000066,"d":"0.00"},1,"yes","CTATGCGCTATGGAGAGAGTTCCTCTTCTCCGTTCCCGCGGGGCCCCCCGCGCAGTACTC","FALSE","NM_000296","ref|NM_000296|ref|NM_001009944|ref|NR_036447|ens|ENST00000537889","PKD1","polycystic kidney disease 1 (autosomal dominant)","ref|Homo sapiens polycystic kidney disease 1 (autosomal dominant) (PKD1), transcript variant 2, mRNA [NM_000296]","chr16",18411806,18441131,"GO:0000139(Golgi membrane);GO:0001502(cartilage condensation);GO:0001701(in utero embryonic development);GO:0001822(kidney development);GO:0001889(liver development);GO:0001892(embryonic placenta development);GO:0002133(polycystin complex);GO:0005262(calcium channel activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0005929(cilium);GO:0006611(protein export from nucleus);GO:0006807(nitrogen compound metabolic process);GO:0006996(organelle organization);GO:0007050(cell cycle arrest);GO:0007156(homophilic cell adhesion);GO:0007160(cell-matrix adhesion);GO:0007161(calcium-independent cell-matrix adhesion);GO:0007204(elevation of cytosolic calcium ion concentration);GO:0007259(JAK-STAT cascade);GO:0007507(heart development);GO:0009653(anatomical structure morphogenesis);GO:0016021(integral to membrane);GO:0016323(basolateral plasma membrane);GO:0016328(lateral plasma membrane);GO:0016337(cell-cell adhesion);GO:0018105(peptidyl-serine phosphorylation);GO:0019901(protein kinase binding);GO:0019904(protein domain specific binding);GO:0021510(spinal cord development);GO:0021915(neural tube development);GO:0030246(carbohydrate binding);GO:0030660(Golgi-associated vesicle membrane);GO:0031512(motile primary cilium);GO:0031659(positive regulation of cyclin-dependent protein kinase activity involved in G1/S);GO:0032092(positive regulation of protein binding);GO:0034405(response to fluid shear stress);GO:0042994(cytoplasmic sequestering of transcription factor);GO:0043588(skin development);GO:0044325(ion channel binding);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048565(digestive tract development);GO:0048754(branching morphogenesis of a tube);GO:0048806(genitalia development);GO:0050982(detection of mechanical stimulus);GO:0051216(cartilage development);GO:0060170(cilium membrane);GO:0060236(regulation of mitotic spindle organization);GO:0060428(lung epithelium development);GO:0060674(placenta blood vessel development);GO:0061136(regulation of proteasomal protein catabolic process);GO:0070062(extracellular vesicular exosome);GO:0070588(calcium ion transmembrane transport);GO:0072164(mesonephric tubule development);GO:0072177(mesonephric duct development);GO:0072205(metanephric collecting duct development);GO:0072218(metanephric ascending thin limb development);GO:0072237(metanephric proximal tubule development);GO:0072287(metanephric distal tubule morphogenesis);GO:0072372(primary cilium)",null,"mRNA","agilent G3 V3"]
["A_23_P314070",7.29,7.64,7.24,10.09,9.78,9.71,{"v":0.749492900608519,"d":"0.75"},{"v":-0.41601328223176,"d":"-0.42"},"down",{"v":0.000137786000000029,"d":"0.00"},1,"yes","CCAGTGTTCACATTCACACTTAATGACTTCCTTGGCACCAATCATGTATTTCACCGTTTG","FALSE","NM_004308","ref|NM_004308|ens|ENST00000311956|gb|U02570|gb|BX640781","ARHGAP1","Rho GTPase activating protein 1","ref|Homo sapiens Rho GTPase activating protein 1 (ARHGAP1), mRNA [NM_004308]","chr11",46698632,46722149,"GO:0001726(ruffle);GO:0005070(SH3/SH2 adaptor activity);GO:0005100(Rho GTPase activator activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007264(small GTPase mediated signal transduction);GO:0007266(Rho protein signal transduction);GO:0009967(positive regulation of signal transduction);GO:0017124(SH3 domain binding);GO:0030675(Rac GTPase activator activity);GO:0032855(positive regulation of Rac GTPase activity);GO:0051056(regulation of small GTPase mediated signal transduction);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_24_P411186",2.11,2.21,2.42,3.89,4.18,4.02,{"v":0.557485525227461,"d":"0.56"},{"v":-0.842993748067265,"d":"-0.84"},"down",{"v":0.000137936999999977,"d":"0.00"},1,"yes","GATGACCAAAGGTCATTACAACCTGGCTTTTTATTGTATTTGTTTCTGGTCTTTGTTAAG","FALSE","NM_022893","ref|NM_022893|ens|ENST00000335712|gb|AJ404611|tc|THC2666533","BCL11A","B-cell CLL/lymphoma 11A (zinc finger protein)","ref|Homo sapiens B-cell CLL/lymphoma 11A (zinc finger protein) (BCL11A), transcript variant 1, mRNA [NM_022893]","chr2",60684332,60780633,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0001078(RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription);GO:0003714(transcription corepressor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-dependent);GO:0010976(positive regulation of neuron projection development);GO:0010977(negative regulation of neuron projection development);GO:0016925(protein sumoylation);GO:0030183(B cell differentiation);GO:0030217(T cell differentiation);GO:0030517(negative regulation of axon extension);GO:0032463(negative regulation of protein homooligomerization);GO:0042803(protein homodimerization activity);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046872(metal ion binding);GO:0046982(protein heterodimerization activity);GO:0048671(negative regulation of collateral sprouting);GO:0048672(positive regulation of collateral sprouting);GO:0050773(regulation of dendrite development);GO:2000171(negative regulation of dendrite development)",null,"mRNA","agilent G3 V3"]
["A_23_P106463",4.19,4.56,4.04,6.77,6.71,6.55,{"v":0.63854218671992,"d":"0.64"},{"v":-0.647146156931071,"d":"-0.65"},"down",{"v":0.000138065000000021,"d":"0.00"},1,"yes","CCAAGGTCTCCTTCTTGGGGTCACAAACAGCAGTAAGGAAGAGGAATATATAGCAACTCA","FALSE","NM_002537","ref|NM_002537|ref|NM_001301302|ens|ENST00000558194|ens|ENST00000326005","OAZ2","ornithine decarboxylase antizyme 2","ref|Homo sapiens ornithine decarboxylase antizyme 2 (OAZ2), transcript variant 1, mRNA [NM_002537]","chr15",64979804,64995407,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0006521(regulation of cellular amino acid metabolic process);GO:0006595(polyamine metabolic process);GO:0006596(polyamine biosynthetic process);GO:0008073(ornithine decarboxylase inhibitor activity);GO:0034641(cellular nitrogen compound metabolic process);GO:0043086(negative regulation of catalytic activity);GO:0044281(small molecule metabolic process);GO:0045732(positive regulation of protein catabolic process);GO:0090316(positive regulation of intracellular protein transport)",null,"mRNA","agilent G3 V3"]
["A_24_P57898",11.31,11.29,11.46,{"v":13.9,"d":"13.90"},14.06,13.51,{"v":0.821316614420063,"d":"0.82"},{"v":-0.283989612227419,"d":"-0.28"},"down",{"v":0.000138189000000066,"d":"0.00"},1,"yes","GCCTGGCCGCGCCCGTAAACGCCGCGCCCTTGACGCCCTTCGGCCAGGCCACTGTGTGCC","FALSE","NM_080606","ref|NM_080606|ens|ENST00000370346|ens|ENST00000612929|gb|AB464464","BHLHE23","basic helix-loop-helix family, member e23","ref|Homo sapiens basic helix-loop-helix family, member e23 (BHLHE23), mRNA [NM_080606]","chr20",61637332,61638387,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046983(protein dimerization activity)",null,"mRNA","agilent G3 V3"]
["A_23_P339053",7.16,6.65,6.61,9.39,9.59,9.47,{"v":0.717750439367311,"d":"0.72"},{"v":-0.478445786316143,"d":"-0.48"},"down",{"v":0.000138242999999982,"d":"0.00"},1,"yes","TCTGCTGTCTTGAAGCCATCCATCCATTTGATAGGTTTTGCAAAGACTTGGTCCTGCCAA","FALSE","ENST00000569656","ens|ENST00000569656|ens|ENST00000331057|ens|ENST00000568049|ref|XR_429679",null,null,"ens|chromosome 16 open reading frame 52 [Source:HGNC Symbol;Acc:HGNC:27087] [ENST00000569656]","chr16",22019530,22098854,null,null,"mRNA","agilent G3 V3"]
["A_23_P81158",9.43,9.49,9.49,8.21,7.88,7.96,{"v":1.18128898128898,"d":"1.18"},{"v":0.240361937532137,"d":"0.24"},"up",{"v":0.000138786000000057,"d":"0.00"},1,"yes","GAAAGAGTATCCGTACCGTCCTGACGTTTTGAAACAATACAGATGCCTTCCCTTGTAGCA","FALSE","NM_000669","ref|NM_000669|ens|ENST00000515683|gb|BC066228|gb|BC067420","ADH1C","alcohol dehydrogenase 1C (class I), gamma polypeptide","ref|Homo sapiens alcohol dehydrogenase 1C (class I), gamma polypeptide (ADH1C), mRNA [NM_000669]","chr4",100257648,100274184,"GO:0004022(alcohol dehydrogenase (NAD) activity);GO:0005829(cytosol);GO:0006069(ethanol oxidation);GO:0006805(xenobiotic metabolic process);GO:0008270(zinc ion binding);GO:0044281(small molecule metabolic process)","00010(Glycolysis / Gluconeogenesis);00071(Fatty acid degradation);00350(Tyrosine metabolism);00830(Retinol metabolism);00980(Metabolism of xenobiotics by cytochrome P450);00982(Drug metabolism - cytochrome P450);05204(Chemical carcinogenesis)","mRNA","agilent G3 V3"]
["A_23_P34496",6.17,5.95,5.67,7.99,8.09,8.06,{"v":0.736951118475559,"d":"0.74"},{"v":-0.440359165487862,"d":"-0.44"},"down",{"v":0.000138850000000024,"d":"0.00"},1,"yes","CCTCATCCTCTTCAGCAACTACTATGCCTTCTTCAAGCTGCTCCGGGACCGCTTGGTATT","FALSE","NM_018056","ref|NM_018056|ens|ENST00000336294|ens|ENST00000487305|ens|ENST00000476968","TMEM39B","transmembrane protein 39B","ref|Homo sapiens transmembrane protein 39B (TMEM39B), mRNA [NM_018056]","chr1",32538592,32568465,"GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P39364",7.54,7.68,7.71,8.92,8.75,8.98,{"v":0.860412757973734,"d":"0.86"},{"v":-0.216899178065745,"d":"-0.22"},"down",{"v":0.000138912000000047,"d":"0.00"},1,"yes","TGGCAGCTTTGGGGCTGTTTTTGAGCTTCTCATTGTGTAGAATTTCTAGATCCCCCGATT","FALSE","NM_004838","ref|NM_004838|ref|NM_001145722|ref|NM_001145721|ref|NM_001145724","HOMER3","homer homolog 3 (Drosophila)","ref|Homo sapiens homer homolog 3 (Drosophila) (HOMER3), transcript variant 2, mRNA [NM_004838]","chr19",19040252,19051999,"GO:0005515(protein binding);GO:0005575(cellular_component);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006605(protein targeting);GO:0007216(G-protein coupled glutamate receptor signaling pathway);GO:0008022(protein C-terminus binding);GO:0019904(protein domain specific binding);GO:0030054(cell junction);GO:0035256(G-protein coupled glutamate receptor binding);GO:0045178(basal part of cell);GO:0045211(postsynaptic membrane);GO:2001256(regulation of store-operated calcium entry)","04068(FoxO signaling pathway);04724(Glutamatergic synapse)","mRNA","agilent G3 V3"]
["A_33_P3289391",{"v":8.9,"d":"8.90"},8.91,9.05,11.47,{"v":11.5,"d":"11.50"},11.01,{"v":0.790464979399647,"d":"0.79"},{"v":-0.339226547756778,"d":"-0.34"},"down",{"v":0.000139183000000043,"d":"0.00"},1,"yes","CCGGCGCCCCGGCTCCATCGCGCCCGGCGAAAGGAAGGAAGGAAGGGACGAAGGAAGGGA","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_23_P386450",2.27,2.24,2.56,4.34,4.61,4.73,{"v":0.516812865497076,"d":"0.52"},{"v":-0.952286110076499,"d":"-0.95"},"down",{"v":0.000139294000000012,"d":"0.00"},1,"yes","TGTGAAAGAAGACAGCTTAATAGTAGTTAGCTTAAGTAGTTTCTCCAAGTACTTTTGTGC","FALSE","NM_016218","ref|NM_016218|ens|ENST00000506928|ens|ENST00000514141|gb|AF194973","POLK","polymerase (DNA directed) kappa","ref|Homo sapiens polymerase (DNA directed) kappa (POLK), mRNA [NM_016218]","chr5",74842848,74893843,"GO:0003684(damaged DNA binding);GO:0003887(DNA-directed DNA polymerase activity);GO:0005654(nucleoplasm);GO:0006260(DNA replication);GO:0006281(DNA repair);GO:0006297(nucleotide-excision repair, DNA gap filling);GO:0046872(metal ion binding);GO:0071897(DNA biosynthetic process)","03460(Fanconi anemia pathway)","mRNA","agilent G3 V3"]
["A_33_P3276638",{"v":10.3,"d":"10.30"},10.18,10.11,11.16,11.32,11.22,{"v":0.907715133531157,"d":"0.91"},{"v":-0.139688484511018,"d":"-0.14"},"down",{"v":0.000139466000000033,"d":"0.00"},1,"yes","TCTTGTAACACTAGTCTGTACTCCCTTTTCCTTCCCCAAGACTGATAGGATGCAAGCTGA","FALSE","NM_024567","ref|NM_024567|ref|NM_001135726|ens|ENST00000521516|ens|ENST00000287701","HMBOX1","homeobox containing 1","ref|Homo sapiens homeobox containing 1 (HMBOX1), transcript variant 1, mRNA [NM_024567]","chr8",28747912,28910242,"GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-dependent);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0045893(positive regulation of transcription, DNA-dependent)",null,"mRNA","agilent G3 V3"]
["A_23_P141636",5.49,5.89,5.46,7.59,7.68,7.62,{"v":0.73569244211446,"d":"0.74"},{"v":-0.442825324489291,"d":"-0.44"},"down",{"v":0.000139620000000007,"d":"0.00"},1,"yes","CCAGATTCTACTTAATGGGGTTTATATGGACTTTCTTCTCATAAATGGCCTGCCGTCTCC","FALSE","NM_014740","ref|NM_014740|ens|ENST00000576573|ens|ENST00000570625|ens|ENST00000575978","EIF4A3","eukaryotic translation initiation factor 4A3","ref|Homo sapiens eukaryotic translation initiation factor 4A3 (EIF4A3), mRNA [NM_014740]","chr17",78109064,78111402,"GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay);GO:0000288(nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay);GO:0000289(nuclear-transcribed mRNA poly(A) tail shortening);GO:0000398(nuclear mRNA splicing, via spliceosome);GO:0003729(mRNA binding);GO:0004004(ATP-dependent RNA helicase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006364(rRNA processing);GO:0008143(poly(A) RNA binding);GO:0010467(gene expression);GO:0016020(membrane);GO:0016607(nuclear speck);GO:0017148(negative regulation of translation);GO:0019221(cytokine-mediated signaling pathway);GO:0035145(exon-exon junction complex);GO:0045727(positive regulation of translation);GO:0048701(embryonic cranial skeleton morphogenesis);GO:0051028(mRNA transport);GO:0071013(catalytic step 2 spliceosome)","03040(Spliceosome);03013(RNA transport);03015(mRNA surveillance pathway)","mRNA","agilent G3 V3"]
["A_23_P49539",9.51,9.35,9.58,8.34,8.33,8.19,{"v":1.14400643604183,"d":"1.14"},{"v":0.19409516856693,"d":"0.19"},"up",{"v":0.000139734999999974,"d":"0.00"},1,"yes","TCGGGGATCAGAACGATGTCAAGTGAAGAAAAATGCACGGGGGCATGCTGAGCCACTGGA","FALSE","NM_001291324","ref|NM_001291324|ens|ENST00000307745|ref|XM_006721989|ref|XM_006721990","BAHCC1","BAH domain and coiled-coil containing 1","ref|Homo sapiens BAH domain and coiled-coil containing 1 (BAHCC1), mRNA [NM_001291324]","chr17",79373536,79433357,"GO:0003682(chromatin binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3386765",6.59,6.33,6.62,8.26,8.28,8.05,{"v":0.794631964213095,"d":"0.79"},{"v":-0.331641267627697,"d":"-0.33"},"down",{"v":0.000139777999999979,"d":"0.00"},1,"yes","GCCAGGACTCCTCATTTCATCTCACAGACACAATAAAAAAGCATATTTGTCCTGCCTGGG","FALSE","NM_015407","ref|NM_015407|ens|ENST00000273596|ens|ENST00000458031|gb|BC002571","ABHD14A","abhydrolase domain containing 14A","ref|Homo sapiens abhydrolase domain containing 14A (ABHD14A), mRNA [NM_015407]","chr3",52009120,52015211,"GO:0005737(cytoplasm);GO:0008152(metabolic process);GO:0016021(integral to membrane);GO:0016787(hydrolase activity);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3221748",5.77,5.24,5.82,8.47,8.64,8.83,{"v":0.648804934464148,"d":"0.65"},{"v":-0.624143302921751,"d":"-0.62"},"down",{"v":0.000139918000000017,"d":"0.00"},1,"yes","GGCACACACCTGTCTGTAACCTGTTTTGTGCTCTGAAAGCAAATAGTCCTGAGCAAAAAA","FALSE","NM_001031680","ref|NM_001031680|ref|NM_004350|ens|ENST00000338888|ens|ENST00000308873","RUNX3","runt-related transcription factor 3","ref|Homo sapiens runt-related transcription factor 3 (RUNX3), transcript variant 1, mRNA [NM_001031680]","chr1",25226002,25291501,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000790(nuclear chromatin);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0000981(sequence-specific DNA binding RNA polymerase II transcription factor activity);GO:0002062(chondrocyte differentiation);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0006355(regulation of transcription, DNA-dependent);GO:0006366(transcription from RNA polymerase II promoter);GO:0006468(protein phosphorylation);GO:0007411(axon guidance);GO:0031069(hair follicle morphogenesis);GO:0032609(interferon-gamma production);GO:0043231(intracellular membrane-bounded organelle);GO:0045786(negative regulation of cell cycle);GO:0048469(cell maturation);GO:0048935(peripheral nervous system neuron development);GO:0050680(negative regulation of epithelial cell proliferation);GO:2001238(positive regulation of extrinsic apoptotic signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_33_P3404759",2.08,2.14,2.06,3.87,4.35,4.19,{"v":0.506043513295729,"d":"0.51"},{"v":-0.982666651238729,"d":"-0.98"},"down",{"v":0.000139940000000061,"d":"0.00"},1,"yes","GTCAAAAGTATGACCTCAGCTCATGGCTCTGCTTCAGGTAAATTGGATCCAGATTTCTAA","FALSE",{"$nulls":5},"chr1",243328224,243329874,null,null,"mRNA","agilent G3 V3"]
["A_33_P3327158",8.71,8.62,8.43,9.77,9.85,9.81,{"v":0.875297315664288,"d":"0.88"},{"v":-0.192154948825778,"d":"-0.19"},"down",{"v":0.000139949000000028,"d":"0.00"},1,"yes","TTGTTTGAGAATCCTTCCCTCTCTTGTCGTCCCTGTGGACAATTGTTTGAATGGGAAGCA","FALSE","AK127761","gb|AK127761|tc|THC2657439","LOC100131432","uncharacterized LOC100131432","gb|Homo sapiens cDNA FLJ45862 fis, clone OCBBF3000830. [AK127761]","chr11",45069440,45073418,null,null,"mRNA","agilent G3 V3"]
["A_33_P3413514",11.94,12.01,11.95,11.03,{"v":11.1,"d":"11.10"},11.22,{"v":1.07646176911544,"d":"1.08"},{"v":0.106297082638466,"d":"0.11"},"up",{"v":0.000140330999999994,"d":"0.00"},1,"yes","TGTGACCTTCACGTCATCTTTCCACATGGTCCAGGCCCCCATCTGCAGAGGCCAACAGTT","FALSE",{"$nulls":5},"chr2",132534144,132534601,null,null,"mRNA","agilent G3 V3"]
["A_23_P317796",11.37,11.27,11.33,10.32,10.22,10.44,{"v":1.09651387992253,"d":"1.10"},{"v":0.132924074089632,"d":"0.13"},"up",{"v":0.00014034400000007,"d":"0.00"},1,"yes","GATTATTATCCTGTCAAGCTGGTGAAAACAGCAGAGCTGCCCCCGGATCGGAACTACGTG","FALSE","NM_178176","ref|NM_178176|ref|NM_001287147|ens|ENST00000379423|ens|ENST00000440203","MOGAT3","monoacylglycerol O-acyltransferase 3","ref|Homo sapiens monoacylglycerol O-acyltransferase 3 (MOGAT3), transcript variant 1, mRNA [NM_178176]","chr7",100838288,100844302,"GO:0003846(2-acylglycerol O-acyltransferase activity);GO:0004144(diacylglycerol O-acyltransferase activity);GO:0005789(endoplasmic reticulum membrane);GO:0006071(glycerol metabolic process);GO:0016021(integral to membrane);GO:0019432(triglyceride biosynthetic process)","00561(Glycerolipid metabolism);04975(Fat digestion and absorption)","mRNA","agilent G3 V3"]
["A_33_P3361442",8.07,7.98,8.15,6.42,6.73,6.48,{"v":1.23280692817117,"d":"1.23"},{"v":0.301946874695786,"d":"0.30"},"up",{"v":0.000140360000000062,"d":"0.00"},1,"yes","TAAAGGTTGGATTTCAAGGCGGGGGCTGCTTCCGGAAAGACGCGCTGTGTTTGGAAGGTG","FALSE","NM_018111","ref|NM_018111|ens|ENST00000408991|gb|HQ448398|gb|BC069669","C19orf73","chromosome 19 open reading frame 73","ref|Homo sapiens chromosome 19 open reading frame 73 (C19orf73), mRNA [NM_018111]","chr19",49621656,49622397,null,null,"mRNA","agilent G3 V3"]
["A_23_P41166",10.07,9.99,10.07,10.88,10.74,10.75,{"v":0.930800123571208,"d":"0.93"},{"v":-0.10345669261471,"d":"-0.10"},"down",{"v":0.000140373000000027,"d":"0.00"},1,"yes","AAAGGGGAGCACTCCTTGCCCCCTGTTCCTGGGTTTATGCAGTTTTCTTTTTAGAGTTTA","FALSE","NM_001038628","ref|NM_001038628|ref|NM_033167|ref|NM_003781|ref|NM_033169","B3GALNT1","beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)","ref|Homo sapiens beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group) (B3GALNT1), transcript variant 5, mRNA [NM_001038628]","chr3",160801664,160823160,"GO:0000139(Golgi membrane);GO:0006486(protein glycosylation);GO:0008499(UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity);GO:0009312(oligosaccharide biosynthetic process);GO:0016021(integral to membrane);GO:0047273(galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity)","00603(Glycosphingolipid biosynthesis - globo series)","mRNA","agilent G3 V3"]
["A_23_P37870",4.84,5.43,4.65,8.42,8.48,{"v":8.7,"d":"8.70"},{"v":0.5828125,"d":"0.58"},{"v":-0.778896274632125,"d":"-0.78"},"down",{"v":0.00014037499999997,"d":"0.00"},1,"yes","TCCCCAACTTGGCTATGAAGGAGGTTATTGACGCATTCATCTCTGAGAATGGCTGGGTGG","FALSE","NM_005861","ref|NM_005861|ref|NM_001293197|ens|ENST00000564370|ens|ENST00000569248","STUB1","STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase","ref|Homo sapiens STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase (STUB1), transcript variant 1, mRNA [NM_005861]","chr16",{"v":732416,"d":"732416.00"},732870,"GO:0000151(ubiquitin ligase complex);GO:0000209(protein polyubiquitination);GO:0001664(G-protein coupled receptor binding);GO:0004842(ubiquitin-protein ligase activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006281(DNA repair);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0006515(misfolded or incompletely synthesized protein catabolic process);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0016874(ligase activity);GO:0019899(enzyme binding);GO:0019900(kinase binding);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0030544(Hsp70 protein binding);GO:0030579(ubiquitin-dependent SMAD protein catabolic process);GO:0030674(protein binding, bridging);GO:0030911(TPR domain binding);GO:0030968(endoplasmic reticulum unfolded protein response);GO:0031371(ubiquitin conjugating enzyme complex);GO:0031398(positive regulation of protein ubiquitination);GO:0031625(ubiquitin protein ligase binding);GO:0031943(regulation of glucocorticoid metabolic process);GO:0032091(negative regulation of protein binding);GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0034450(ubiquitin-ubiquitin ligase activity);GO:0042405(nuclear inclusion body);GO:0042803(protein homodimerization activity);GO:0043161(proteasomal ubiquitin-dependent protein catabolic process);GO:0045111(intermediate filament cytoskeleton);GO:0046332(SMAD binding);GO:0051443(positive regulation of ubiquitin-protein ligase activity);GO:0051604(protein maturation);GO:0051787(misfolded protein binding);GO:0051865(protein autoubiquitination);GO:0051879(Hsp90 protein binding);GO:0070062(extracellular vesicular exosome);GO:0070534(protein K63-linked ubiquitination);GO:0071218(cellular response to misfolded protein);GO:0090035(positive regulation of chaperone-mediated protein complex assembly)","04141(Protein processing in endoplasmic reticulum);04120(Ubiquitin mediated proteolysis)","mRNA","agilent G3 V3"]
["A_33_P3414017",14.71,14.61,14.74,15.87,15.81,15.65,{"v":0.93091062750898,"d":"0.93"},{"v":-0.10328542703748,"d":"-0.10"},"down",{"v":0.000140537000000052,"d":"0.00"},1,"yes","AGGCTCCCCGGCCACCAACCCCACACCCAAAGCAGCTGGGATTCCAGCCAGTAAAATGTG","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_24_P320033",{"v":7.7,"d":"7.70"},7.66,{"v":7.9,"d":"7.90"},6.11,6.26,6.37,{"v":1.24119530416222,"d":"1.24"},{"v":0.311730143814031,"d":"0.31"},"up",{"v":0.000140549000000045,"d":"0.00"},1,"yes","CTATCTTCAAATGTCTAAGGTAGTAACTTTCCATAGGGCCTCCTTAGATCCCTAAGATGG","FALSE","NM_005191","ref|NM_005191|ens|ENST00000264246|gb|BC042665|tc|THC2477754","CD80","CD80 molecule","ref|Homo sapiens CD80 molecule (CD80), mRNA [NM_005191]","chr3",119243136,119278449,"GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007267(cell-cell signaling);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0009897(external side of plasma membrane);GO:0009967(positive regulation of signal transduction);GO:0009986(cell surface);GO:0015026(coreceptor activity);GO:0016021(integral to membrane);GO:0016032(viral reproduction);GO:0031295(T cell costimulation);GO:0035556(intracellular signal transduction);GO:0038095(Fc-epsilon receptor signaling pathway);GO:0042110(T cell activation);GO:0045086(positive regulation of interleukin-2 biosynthetic process);GO:0045087(innate immune response);GO:0045425(positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process);GO:0045627(positive regulation of T-helper 1 cell differentiation);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0046641(positive regulation of alpha-beta T cell proliferation);GO:0048011(nerve growth factor receptor signaling pathway);GO:0048015(phosphatidylinositol-mediated signaling);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation)","04514(Cell adhesion molecules (CAMs));04620(Toll-like receptor signaling pathway);04672(Intestinal immune network for IgA production);05322(Systemic lupus erythematosus);05323(Rheumatoid arthritis);05320(Autoimmune thyroid disease);05330(Allograft rejection);05332(Graft-versus-host disease);05416(Viral myocarditis);04940(Type I diabetes mellitus)","mRNA","agilent G3 V3"]
["A_33_P3277514",6.99,6.79,6.86,5.35,5.59,5.57,{"v":1.25015142337977,"d":"1.25"},{"v":0.322102850509996,"d":"0.32"},"up",{"v":0.000140593999999994,"d":"0.00"},1,"yes","CGAATTTGGCAAGAATGAAATGGTGTCATAAAGATGGGAGGGGAGGGTGTTTTGATAAAA","FALSE","NM_001287344","ref|NM_001287344|ref|NM_000061|ref|NM_001287345|ens|ENST00000308731","BTK","Bruton agammaglobulinemia tyrosine kinase","ref|Homo sapiens Bruton agammaglobulinemia tyrosine kinase (BTK), transcript variant 3, mRNA [NM_001287344]","chrX",100604432,100641167,"GO:0002224(toll-like receptor signaling pathway);GO:0002250(adaptive immune response);GO:0002553(histamine secretion by mast cell);GO:0002721(regulation of B cell cytokine production);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0002902(regulation of B cell apoptotic process);GO:0004713(protein tyrosine kinase activity);GO:0004715(non-membrane spanning protein tyrosine kinase activity);GO:0005102(receptor binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005547(phosphatidylinositol-3,4,5-trisphosphate binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006351(transcription, DNA-dependent);GO:0006468(protein phosphorylation);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007249(I-kappaB kinase/NF-kappaB cascade);GO:0007498(mesoderm development);GO:0019722(calcium-mediated signaling);GO:0030154(cell differentiation);GO:0031234(extrinsic to internal side of plasma membrane);GO:0031410(cytoplasmic vesicle);GO:0034134(toll-like receptor 2 signaling pathway);GO:0034142(toll-like receptor 4 signaling pathway);GO:0034614(cellular response to reactive oxygen species);GO:0035556(intracellular signal transduction);GO:0038083(peptidyl-tyrosine autophosphorylation);GO:0038095(Fc-epsilon receptor signaling pathway);GO:0038123(toll-like receptor TLR1:TLR2 signaling pathway);GO:0038124(toll-like receptor TLR6:TLR2 signaling pathway);GO:0042113(B cell activation);GO:0042127(regulation of cell proliferation);GO:0042629(mast cell granule);GO:0042802(identical protein binding);GO:0043231(intracellular membrane-bounded organelle);GO:0045087(innate immune response);GO:0045121(membrane raft);GO:0045579(positive regulation of B cell differentiation);GO:0046872(metal ion binding);GO:0048469(cell maturation);GO:0048471(perinuclear region of cytoplasm);GO:0050852(T cell receptor signaling pathway);GO:0050853(B cell receptor signaling pathway);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0071226(cellular response to molecule of fungal origin);GO:0097190(apoptotic signaling pathway)","04064(NF-kappa B signaling pathway);04611(Platelet activation);04662(B cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04380(Osteoclast differentiation);05340(Primary immunodeficiency)","mRNA","agilent G3 V3"]
["A_33_P3348574",6.98,7.07,7.42,4.73,5.03,{"v":4.8,"d":"4.80"},{"v":1.47458791208791,"d":"1.47"},{"v":0.560311835660077,"d":"0.56"},"up",{"v":0.000140934000000037,"d":"0.00"},1,"yes","TTTGATATGGACAAAATAGTTTCTACATTTTATACTGAGGTACTCCCCATGTTGAATCCC","FALSE","NM_001013358","ref|NM_001013358|ens|ENST00000571130","OR9G9","olfactory receptor, family 9, subfamily G, member 9","ref|Homo sapiens olfactory receptor, family 9, subfamily G, member 9 (OR9G9), mRNA [NM_001013358]","chr11",56467864,56468781,"GO:0004930(G-protein coupled receptor activity);GO:0004984(olfactory receptor activity);GO:0005886(plasma membrane);GO:0007186(G-protein coupled receptor signaling pathway);GO:0016021(integral to membrane);GO:0050911(detection of chemical stimulus involved in sensory perception of smell)","04740(Olfactory transduction)","mRNA","agilent G3 V3"]
["A_33_P3287119",9.78,9.98,9.58,11.48,11.49,11.41,{"v":0.853403141361257,"d":"0.85"},{"v":-0.228700673804671,"d":"-0.23"},"down",{"v":0.000141100999999977,"d":"0.00"},1,"yes","ATCTCCTCTTCCCTAAGGCCTCTGTCTCCATAGCTCTGGTTTCCCTGGGCCTCAGTCCTC","FALSE","NM_001122646","ref|NM_001122646|ref|NM_016490|ref|NM_001172667|ens|ENST00000490605","FAM178B","family with sequence similarity 178, member B","ref|Homo sapiens family with sequence similarity 178, member B (FAM178B), transcript variant A, mRNA [NM_001122646]","chr2",97541616,97652301,null,null,"mRNA","agilent G3 V3"]
["A_33_P3289848",13.23,13.04,13.26,14.56,{"v":14.4,"d":"14.40"},14.38,{"v":0.912090447623442,"d":"0.91"},{"v":-0.13275119827406,"d":"-0.13"},"down",{"v":0.000141232000000047,"d":"0.00"},1,"yes","AACACCAGCCTCCTGGCCACCTCCTCTCCAATGCCTGTGAAAGAGGAGTTTCTGCCATAG","FALSE","NM_001804","ref|NM_001804|ens|ENST00000231656|ens|ENST00000616154|gb|AF239666","CDX1","caudal type homeobox 1","ref|Homo sapiens caudal type homeobox 1 (CDX1), mRNA [NM_001804]","chr5",149546352,149564120,"GO:0000980(RNA polymerase II distal enhancer sequence-specific DNA binding);GO:0001205(RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription);GO:0005515(protein binding);GO:0005634(nucleus);GO:0009887(organ morphogenesis);GO:0009952(anterior/posterior pattern specification);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0060349(bone morphogenesis)",null,"mRNA","agilent G3 V3"]
["A_21_P0012869",8.67,8.35,7.98,11.25,11.44,11.24,{"v":0.736811081638668,"d":"0.74"},{"v":-0.440633335161527,"d":"-0.44"},"down",{"v":0.000141520999999978,"d":"0.00"},1,"yes","AGTGTTTTACCTCGTTCCTGGAGACCCTCAGGTTCCATCCATCCATCCAATTGGTTTTTA","FALSE","ENST00000507037",null,"LOC728554","THO complex 3 pseudogene","gb|Homo sapiens cDNA, FLJ17316. [AK310274]","chr5",177303264,177377733,null,null,"mRNA","agilent G3 V3"]
["A_23_P130531",5.27,5.02,4.99,{"v":7,"d":"7.00"},6.86,{"v":6.7,"d":"6.70"},{"v":0.743190661478599,"d":"0.74"},{"v":-0.428195721158129,"d":"-0.43"},"down",{"v":0.000141653000000019,"d":"0.00"},1,"yes","GTGTGCGAGGAGACAGCCAATTACCTGGTCATTTGGTGCATTGACCTAGAGGTGGAGGAG","FALSE","NM_007065","ref|NM_007065|ens|ENST00000588869|ens|ENST00000588498|ens|ENST00000589755","CDC37","cell division cycle 37","ref|Homo sapiens cell division cycle 37 (CDC37), mRNA [NM_007065]","chr19",10505699,10514187,"GO:0000079(regulation of cyclin-dependent protein kinase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006457(protein folding);GO:0006605(protein targeting);GO:0019900(kinase binding);GO:0031072(heat shock protein binding);GO:0031435(mitogen-activated protein kinase kinase kinase binding);GO:0032587(ruffle membrane);GO:0043234(protein complex);GO:0043422(protein kinase B binding);GO:0050821(protein stabilization);GO:0051082(unfolded protein binding);GO:0051087(chaperone binding);GO:0051879(Hsp90 protein binding);GO:0060334(regulation of interferon-gamma-mediated signaling pathway);GO:0060338(regulation of type I interferon-mediated signaling pathway);GO:0070062(extracellular vesicular exosome)","04151(PI3K-Akt signaling pathway)","mRNA","agilent G3 V3"]
["A_33_P3360555",6.11,5.68,5.78,7.87,7.72,7.84,{"v":0.749893299189074,"d":"0.75"},{"v":-0.415242762854759,"d":"-0.42"},"down",{"v":0.000141818999999987,"d":"0.00"},1,"yes","GTTGGGGAGGGCAGTTCACCAGCATCCATAGAGTAATAAAGTCACTGTGTGTAGACCCGG","FALSE","NM_001253792","ref|NM_001253792|ref|NM_018337|ens|ENST00000337080|ens|ENST00000592949","ZNF444","zinc finger protein 444","ref|Homo sapiens zinc finger protein 444 (ZNF444), transcript variant 2, mRNA [NM_001253792]","chr19",56668680,56671336,"GO:0000981(sequence-specific DNA binding RNA polymerase II transcription factor activity);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0006366(transcription from RNA polymerase II promoter);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_24_P178065",7.54,7.25,7.26,8.85,9.04,8.89,{"v":0.823375653472741,"d":"0.82"},{"v":-0.280377304879428,"d":"-0.28"},"down",{"v":0.00014197199999999,"d":"0.00"},1,"yes","CTCCTGCTATCCTTCTTCTTCCCATATCACTATTAATAGGCTTGTTTGGCTATCTTGAAG","FALSE","BC038806","gb|BC038806|tc|THC2486140","PHLDB2","pleckstrin homology-like domain, family B, member 2","gb|Homo sapiens pleckstrin homology-like domain, family B, member 2, mRNA (cDNA clone IMAGE:5169755), complete cds. [BC038806]","chr3",111578600,111604642,"GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0045111(intermediate filament cytoskeleton)",null,"mRNA","agilent G3 V3"]
["A_23_P87982",6.43,6.34,6.71,4.34,4.64,4.42,{"v":1.45373134328358,"d":"1.45"},{"v":0.539760676737207,"d":"0.54"},"up",{"v":0.000141999999999975,"d":"0.00"},1,"yes","CGGAAGCTCTTCATCAGGCTCTACCCTGGAAGCTGGTGGGATAAGAACATGTATTATTAA","FALSE","NM_001676","ref|NM_001676|ref|NM_001185085|ens|ENST00000218548|ens|ENST00000381946","ATP12A","ATPase, H+/K+ transporting, nongastric, alpha polypeptide","ref|Homo sapiens ATPase, H+/K+ transporting, nongastric, alpha polypeptide (ATP12A), transcript variant 2, mRNA [NM_001676]","chr13",25254716,25285911,"GO:0005391(sodium:potassium-exchanging ATPase activity);GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0005889(hydrogen:potassium-exchanging ATPase complex);GO:0006813(potassium ion transport);GO:0006885(regulation of pH);GO:0008152(metabolic process);GO:0008900(hydrogen:potassium-exchanging ATPase activity);GO:0016323(basolateral plasma membrane);GO:0034220(ion transmembrane transport);GO:0035725(sodium ion transmembrane transport);GO:0046872(metal ion binding);GO:0055075(potassium ion homeostasis);GO:0055085(transmembrane transport)","00190(Oxidative phosphorylation)","mRNA","agilent G3 V3"]
["A_21_P0011654",9.48,{"v":9.7,"d":"9.70"},9.33,{"v":11.9,"d":"11.90"},11.54,11.61,{"v":0.813409415121255,"d":"0.81"},{"v":-0.297946404960033,"d":"-0.30"},"down",{"v":0.000142124999999993,"d":"0.00"},1,"yes","ATTCTTCAGGATTGCCCTACTGGCCCTACCTCACAGCTGAAACTTTAAAAAACAGGATGG","FALSE","NM_001277324","ref|NM_001277324|ref|NM_001277325|ref|NM_001277323|ref|NM_006985","NPIPA2","nuclear pore complex interacting protein family, member A2","ref|Homo sapiens nuclear pore complex interacting protein family, member A2 (NPIPA2), mRNA [NM_001277324]","chr16",14844669,14859305,null,null,"mRNA","agilent G3 V3"]
["A_24_P251688",3.62,4.16,4.26,6.98,7.22,6.97,{"v":0.568729333963155,"d":"0.57"},{"v":-0.814185877247887,"d":"-0.81"},"down",{"v":0.000142193000000068,"d":"0.00"},1,"yes","TTGGGGACAGCCTTATTCCCAAATGTCTCTATCCTTTTGACTGGAGCATCTTCTGCACAA","FALSE","NM_018358","ref|NM_018358|ens|ENST00000468892|ens|ENST00000292808|ens|ENST00000466742","ABCF3","ATP-binding cassette, sub-family F (GCN20), member 3","ref|Homo sapiens ATP-binding cassette, sub-family F (GCN20), member 3 (ABCF3), mRNA [NM_018358]","chr3",183910944,183911557,"GO:0005524(ATP binding);GO:0008152(metabolic process);GO:0016020(membrane);GO:0016887(ATPase activity);GO:0051607(defense response to virus)",null,"mRNA","agilent G3 V3"]
["A_33_P3209703",8.37,8.54,8.43,7.09,6.85,7.13,{"v":1.20265780730897,"d":"1.20"},{"v":0.266226210323503,"d":"0.27"},"up",{"v":0.000142462999999982,"d":"0.00"},1,"yes","AAGGGTCCCTTCCCAGGGAAGACGCCTGCAAAACCCAGATAGTACTATCCTGGAGTCACG","FALSE",{"$nulls":5},"chr3",33099580,33138638,null,null,"mRNA","agilent G3 V3"]
["A_32_P212802",12.52,12.57,12.55,11.58,11.37,11.59,{"v":1.08975101331789,"d":"1.09"},{"v":0.123998545199612,"d":"0.12"},"up",{"v":0.000143010000000054,"d":"0.00"},1,"yes","TAAAAAGAGGAAACTTCCAATAACCACACTTTTCCAATGGGAAAGATACGCCCCCAGTGG","FALSE","XM_005276001","ref|XM_005276001","LOC101930277","putative speedy protein-like protein LOC442572-like","ref|PREDICTED: Homo sapiens putative speedy protein-like protein LOC442572-like (LOC101930277), mRNA [XM_005276001]",{"$nulls":5},"mRNA","agilent G3 V3"]
["A_33_P3263756",8.96,8.67,8.77,10.24,10.21,10.08,{"v":0.864723223059286,"d":"0.86"},{"v":-0.209689659960964,"d":"-0.21"},"down",{"v":0.000155122000000008,"d":"0.00"},1,"yes","TTGGCTTCCGTTTCTCCTGCTCCCTGTGTGTGTTAGAATTTTAACATAAATTCCACTTTC","FALSE","NM_017908","ref|NM_017908|ens|ENST00000622379|ens|ENST00000622313|ens|ENST00000610298","ZNF446","zinc finger protein 446","ref|Homo sapiens zinc finger protein 446 (ZNF446), mRNA [NM_017908]","chr19",58987816,58992597,"GO:0000981(sequence-specific DNA binding RNA polymerase II transcription factor activity);GO:0003677(DNA binding);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0006366(transcription from RNA polymerase II promoter);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P59388",{"v":7.6,"d":"7.60"},7.56,7.61,6.91,7.04,7.02,{"v":1.08583690987124,"d":"1.09"},{"v":0.11880743004003,"d":"0.12"},"up",{"v":0.000157944000000021,"d":"0.00"},1,"yes","ATAAACTTGATGAACTCCAAGTTCACAGTGTCATTTCTTCAGAACTCCCCTTCATTGAAT","FALSE","NM_001723","ref|NM_001723|ens|ENST00000370765|ref|XM_005249326|gb|L11690","DST","dystonin","ref|Homo sapiens dystonin (DST), transcript variant 1e, mRNA [NM_001723]","chr6",56479376,56507694,"GO:0000226(microtubule cytoskeleton organization);GO:0003779(actin binding);GO:0005178(integrin binding);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005604(basement membrane);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005737(cytoplasm);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0005882(intermediate filament);GO:0005925(focal adhesion);GO:0005938(cell cortex);GO:0007010(cytoskeleton organization);GO:0007050(cell cycle arrest);GO:0007155(cell adhesion);GO:0007229(integrin-mediated signaling pathway);GO:0008022(protein C-terminus binding);GO:0009611(response to wounding);GO:0009925(basal plasma membrane);GO:0015629(actin cytoskeleton);GO:0015630(microtubule cytoskeleton);GO:0016021(integral to membrane);GO:0016023(cytoplasmic membrane-bounded vesicle);GO:0030011(maintenance of cell polarity);GO:0030018(Z disc);GO:0030056(hemidesmosome);GO:0030198(extracellular matrix organization);GO:0030424(axon);GO:0031252(cell leading edge);GO:0031581(hemidesmosome assembly);GO:0031673(H zone);GO:0035371(microtubule plus end);GO:0042803(protein homodimerization activity);GO:0045104(intermediate filament cytoskeleton organization);GO:0045111(intermediate filament cytoskeleton);GO:0048870(cell motility);GO:0051010(microtubule plus-end binding);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_32_P45168",15.21,15.31,15.21,13.98,13.94,{"v":14.2,"d":"14.20"},{"v":1.08570750237417,"d":"1.09"},{"v":0.118635482781246,"d":"0.12"},"up",{"v":0.00016074899999996,"d":"0.00"},1,"yes","TTTGCATGTTGAAGCCTGTATAAAACATGGTACAGTGAGTGAATGCCCCCATCCCCAAGA","FALSE","NM_002184","ref|NM_002184|ref|NM_175767|ref|NM_001190981|ref|NR_002211","IL6ST","interleukin 6 signal transducer","ref|Homo sapiens interleukin 6 signal transducer (IL6ST), transcript variant 1, mRNA [NM_002184]","chr5",55230924,55290821,"GO:0002675(positive regulation of acute inflammatory response);GO:0002821(positive regulation of adaptive immune response);GO:0004897(ciliary neurotrophic factor receptor activity);GO:0004915(interleukin-6 receptor activity);GO:0004921(interleukin-11 receptor activity);GO:0004923(leukemia inhibitory factor receptor activity);GO:0004924(oncostatin-M receptor activity);GO:0005127(ciliary neurotrophic factor receptor binding);GO:0005138(interleukin-6 receptor binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005886(plasma membrane);GO:0005896(interleukin-6 receptor complex);GO:0005900(oncostatin-M receptor complex);GO:0005977(glycogen metabolic process);GO:0008284(positive regulation of cell proliferation);GO:0008593(regulation of Notch signaling pathway);GO:0009897(external side of plasma membrane);GO:0010575(positive regulation vascular endothelial growth factor production);GO:0010613(positive regulation of cardiac muscle hypertrophy);GO:0016020(membrane);GO:0016032(viral reproduction);GO:0019221(cytokine-mediated signaling pathway);GO:0019838(growth factor binding);GO:0019970(interleukin-11 binding);GO:0019981(interleukin-6 binding);GO:0030425(dendrite);GO:0034097(response to cytokine stimulus);GO:0038154(interleukin-11-mediated signaling pathway);GO:0038165(oncostatin-M-mediated signaling pathway);GO:0042102(positive regulation of T cell proliferation);GO:0042511(positive regulation of tyrosine phosphorylation of Stat1 protein);GO:0042517(positive regulation of tyrosine phosphorylation of Stat3 protein);GO:0042803(protein homodimerization activity);GO:0043025(neuronal cell body);GO:0043066(negative regulation of apoptotic process);GO:0045509(interleukin-27 receptor activity);GO:0045669(positive regulation of osteoblast differentiation);GO:0048711(positive regulation of astrocyte differentiation);GO:0048861(leukemia inhibitory factor signaling pathway);GO:0070062(extracellular vesicular exosome);GO:0070102(interleukin-6-mediated signaling pathway);GO:0070104(negative regulation of interleukin-6-mediated signaling pathway);GO:0070106(interleukin-27-mediated signaling pathway);GO:0070110(ciliary neurotrophic factor receptor complex);GO:0070120(ciliary neurotrophic factor-mediated signaling pathway)","04630(Jak-STAT signaling pathway);04060(Cytokine-cytokine receptor interaction);04550(Signaling pathways regulating pluripotency of stem cells);05203(Viral carcinogenesis)","mRNA","agilent G3 V3"]
["A_21_P0011142",13.76,13.64,13.78,12.49,{"v":12.3,"d":"12.30"},12.58,{"v":1.1019534385871,"d":"1.10"},{"v":0.14006326625151,"d":"0.14"},"up",{"v":0.000164657000000012,"d":"0.00"},1,"yes","TAAAACAGTTTCCAATGACTCTTTCTTTAAATTTTTTGCCCCTCCTGAAGTTTCTGAGAG","FALSE","NM_139207","ref|NM_139207|ref|NM_004537|ens|ENST00000432820|ens|ENST00000547993","NAP1L1","nucleosome assembly protein 1-like 1","ref|Homo sapiens nucleosome assembly protein 1-like 1 (NAP1L1), transcript variant 1, mRNA [NM_139207]","chr12",76438528,76478813,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0006260(DNA replication);GO:0006334(nucleosome assembly);GO:0008284(positive regulation of cell proliferation);GO:0016020(membrane);GO:0042470(melanosome)",null,"mRNA","agilent G3 V3"]
["A_23_P40194",5.81,5.53,5.34,{"v":7.9,"d":"7.90"},7.61,7.87,{"v":0.713430282292558,"d":"0.71"},{"v":-0.487155641086993,"d":"-0.49"},"down",{"v":0.000175511999999989,"d":"0.00"},1,"yes","CATGTCTGTCAATCTCCCTTCTTGCTGATTAGCTTTCATATGACTATATTAAATGGAAGT","FALSE","NM_017895","ref|NM_017895|ens|ENST00000622530|ens|ENST00000484427|ens|ENST00000471144","DDX27","DEAD (Asp-Glu-Ala-Asp) box polypeptide 27","ref|Homo sapiens DEAD (Asp-Glu-Ala-Asp) box polypeptide 27 (DDX27), mRNA [NM_017895]","chr20",47850376,47860614,"GO:0004386(helicase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0008152(metabolic process)",null,"mRNA","agilent G3 V3"]
["A_33_P3357322",2.28,{"v":2.4,"d":"2.40"},2.28,4.07,4.01,4.43,{"v":0.556354916067146,"d":"0.56"},{"v":-0.845922578317092,"d":"-0.85"},"down",{"v":0.000177299000000075,"d":"0.00"},1,"yes","CCAGAACCTAAGATATACTACGTCACTGACAGCTTGAACATTTGTATTTATTGTACAGAA","FALSE","NM_001042550","ref|NM_001042550|ref|NM_001265602|ref|NM_001042551|ref|NM_006444","SMC2","structural maintenance of chromosomes 2","ref|Homo sapiens structural maintenance of chromosomes 2 (SMC2), transcript variant 1, mRNA [NM_001042550]","chr9",106856544,106903690,"GO:0000228(nuclear chromosome);GO:0000278(mitotic cell cycle);GO:0000793(condensed chromosome);GO:0000796(condensin complex);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007076(mitotic chromosome condensation);GO:0010032(meiotic chromosome condensation);GO:0045132(meiotic chromosome segregation);GO:0046982(protein heterodimerization activity);GO:0051301(cell division);GO:0051383(kinetochore organization);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P90790",2.18,2.25,2.13,3.75,3.94,4.19,{"v":0.552188552188552,"d":"0.55"},{"v":-0.856767116182682,"d":"-0.86"},"down",{"v":0.000178997999999986,"d":"0.00"},1,"yes","GACAGTTACAATGATCTTTGTATCTGAACTTTGCACGTCTGCCGAAAAATCCGAACCTGT","FALSE","NM_199227","ref|NM_199227|gb|BC143913|gb|BC113644|gb|BC029123","METAP1D","methionyl aminopeptidase type 1D (mitochondrial)","ref|Homo sapiens methionyl aminopeptidase type 1D (mitochondrial) (METAP1D), mRNA [NM_199227]","chr2",172935392,172945207,"GO:0004177(aminopeptidase activity);GO:0005739(mitochondrion);GO:0006508(proteolysis);GO:0008235(metalloexopeptidase activity);GO:0018206(peptidyl-methionine modification);GO:0031365(N-terminal protein amino acid modification);GO:0046872(metal ion binding);GO:0070006(metalloaminopeptidase activity);GO:0070084(protein initiator methionine removal)",null,"mRNA","agilent G3 V3"]
["A_32_P12639",3.34,3.17,3.32,{"v":4.6,"d":"4.60"},4.81,4.94,{"v":0.685017421602787,"d":"0.69"},{"v":-0.54578741522247,"d":"-0.55"},"down",{"v":0.000180341000000084,"d":"0.00"},1,"yes","TGGATCTATCTGTTGATGAGTCCGAAGCCTTTCTCTCAAATCTAGTAGTTAACAAGACCA","FALSE","NM_002816","ref|NM_002816|ref|NM_174871|ens|ENST00000577724|ens|ENST00000490962","PSMD12","proteasome (prosome, macropain) 26S subunit, non-ATPase, 12","ref|Homo sapiens proteasome (prosome, macropain) 26S subunit, non-ATPase, 12 (PSMD12), transcript variant 1, mRNA [NM_002816]","chr17",65334032,65362743,"GO:0000082(G1/S transition of mitotic cell cycle);GO:0000209(protein polyubiquitination);GO:0000278(mitotic cell cycle);GO:0000502(proteasome complex);GO:0002474(antigen processing and presentation of peptide antigen via MHC class I);GO:0002479(antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005838(proteasome regulatory particle);GO:0006521(regulation of cellular amino acid metabolic process);GO:0006915(apoptotic process);GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest);GO:0010467(gene expression);GO:0016020(membrane);GO:0016032(viral reproduction);GO:0022624(proteasome accessory complex);GO:0031145(anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process);GO:0034641(cellular nitrogen compound metabolic process);GO:0042590(antigen processing and presentation of exogenous peptide antigen via MHC class I);GO:0042981(regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0044281(small molecule metabolic process);GO:0051436(negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle);GO:0051437(positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle);GO:0051439(regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle);GO:0070062(extracellular vesicular exosome);GO:0090090(negative regulation of canonical Wnt receptor signaling pathway);GO:0090263(positive regulation of canonical Wnt receptor signaling pathway)","03050(Proteasome);05169(Epstein-Barr virus infection)","mRNA","agilent G3 V3"]
["A_23_P205746",2.02,{"v":2.3,"d":"2.30"},1.98,5.25,5.09,4.61,{"v":0.421404682274248,"d":"0.42"},{"v":-1.24672175069819,"d":"-1.25"},"down",{"v":0.000182801999999982,"d":"0.00"},1,"yes","GTTCTGATGCGTTAAACGGAGGTGGCAGAAATTTGTCAAGAAGGCCTTATCCATTTCGAT","FALSE","NM_001008707","ref|NM_001008707|ref|NM_004434|ens|ENST00000334192|ens|ENST00000262233","EML1","echinoderm microtubule associated protein like 1","ref|Homo sapiens echinoderm microtubule associated protein like 1 (EML1), transcript variant 1, mRNA [NM_001008707]","chr14",100259680,100407874,"GO:0000226(microtubule cytoskeleton organization);GO:0002244(hemopoietic progenitor cell differentiation);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005874(microtubule);GO:0005875(microtubule associated complex);GO:0007052(mitotic spindle organization);GO:0007405(neuroblast proliferation);GO:0007420(brain development);GO:0008017(microtubule binding);GO:0015631(tubulin binding);GO:0048471(perinuclear region of cytoplasm)",null,"mRNA","agilent G3 V3"]
["A_24_P272917",11.83,11.85,11.76,13.42,13.31,13.06,{"v":0.890676049258608,"d":"0.89"},{"v":-0.167027295138719,"d":"-0.17"},"down",{"v":0.000195488999999993,"d":"0.00"},1,"yes","TACCCTGCCTCCCGACGTACTTGTGATTCATCAATCAAAATACAAGTGTGGGATGAAGAA","FALSE","NM_001242326","ref|NM_001242326|ref|NM_001242327|ref|NM_001242328|ref|NM_001242329","USP17L25","ubiquitin specific peptidase 17-like family member 25","ref|Homo sapiens ubiquitin specific peptidase 17-like family member 25 (USP17L25), mRNA [NM_001242326]","chr4",{"v":9364855,"d":"9364855.00"},9366447,null,null,"mRNA","agilent G3 V3"]
["A_23_P138514",5.97,5.75,5.58,8.07,8.03,7.69,{"v":0.727196300966793,"d":"0.73"},{"v":-0.459583233901048,"d":"-0.46"},"down",{"v":0.000198073999999937,"d":"0.00"},1,"yes","TTGCCTTCAGCTGAACCACCGTTTGTGCGAGCTGGATGTCCTTTTCAGTAGAAAAGAATT","FALSE","NM_012071","ref|NM_012071|ens|ENST00000479958|ens|ENST00000602574|ens|ENST00000463688","COMMD3","COMM domain containing 3","ref|Homo sapiens COMM domain containing 3 (COMMD3), mRNA [NM_012071]","chr10",22606812,22609235,"GO:0005515(protein binding)",null,"mRNA","agilent G3 V3"]
["A_23_P256391",1.98,2.36,1.93,4.11,4.11,4.38,{"v":0.497619047619048,"d":"0.50"},{"v":-1.00688638558524,"d":"-1.01"},"down",{"v":0.000202449999999965,"d":"0.00"},1,"yes","TAGATTTTATCAGTGGAGAAATGGTGATAGTTTTTTCTTCAGTTTTCTCTTGGGAAGGAG","FALSE","NM_002078","ref|NM_002078|ref|NM_001172713|ens|ENST00000361924|ref|XM_005265069","GOLGA4","golgin A4","ref|Homo sapiens golgin A4 (GOLGA4), transcript variant 2, mRNA [NM_002078]","chr3",37284680,37408370,"GO:0000042(protein targeting to Golgi);GO:0000139(Golgi membrane);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0016192(vesicle-mediated transport);GO:0043001(Golgi to plasma membrane protein transport);GO:0043231(intracellular membrane-bounded organelle);GO:0045773(positive regulation of axon extension);GO:0051020(GTPase binding);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P84344",12.82,12.84,{"v":12.9,"d":"12.90"},11.96,11.87,12.09,{"v":1.07349665924276,"d":"1.07"},{"v":0.102317701488815,"d":"0.10"},"up",{"v":0.000204210000000038,"d":"0.00"},1,"yes","CGCACAGACTTCTACTGCCTGGTGTCCAAGGATGATATGTAGCTCCCACCCCAGAGTGCA","FALSE","NM_021805","ref|NM_021805|ref|NM_001135054|ref|NM_001135053|ens|ENST00000531205","SIGIRR","single immunoglobulin and toll-interleukin 1 receptor (TIR) domain","ref|Homo sapiens single immunoglobulin and toll-interleukin 1 receptor (TIR) domain (SIGIRR), transcript variant 3, mRNA [NM_021805]","chr11",{"v":405903,"d":"405903.00"},417325,"GO:0001960(negative regulation of cytokine-mediated signaling pathway);GO:0005515(protein binding);GO:0006953(acute-phase response);GO:0007165(signal transduction);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0031665(negative regulation of lipopolysaccharide-mediated signaling pathway);GO:0043433(negative regulation of sequence-specific DNA binding transcription factor activity);GO:0045079(negative regulation of chemokine biosynthetic process)",null,"mRNA","agilent G3 V3"]
["A_23_P62967",1.96,1.86,2.09,4.88,4.44,5.17,{"v":0.407867494824017,"d":"0.41"},{"v":-1.2938275593794,"d":"-1.29"},"down",{"v":0.000215430000000016,"d":"0.00"},1,"yes","TCTGTGTTGTGGAGAAAAGCAACCATGCATTTACTGGTCAATGCCTTCTTGTATATGTAA","FALSE","NM_018662","ref|NM_018662|ref|NM_001164537|ref|NM_001012957|ref|NM_001164540","DISC1","disrupted in schizophrenia 1","ref|Homo sapiens disrupted in schizophrenia 1 (DISC1), transcript variant L, mRNA [NM_018662]","chr1",231762560,232177018,"GO:0000226(microtubule cytoskeleton organization);GO:0001764(neuron migration);GO:0002052(positive regulation of neuroblast proliferation);GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005813(centrosome);GO:0005874(microtubule);GO:0010975(regulation of neuron projection development);GO:0014069(postsynaptic density);GO:0021799(cerebral cortex radially oriented cell migration);GO:0021846(cell proliferation in forebrain);GO:0030054(cell junction);GO:0030177(positive regulation of Wnt receptor signaling pathway);GO:0031929(TOR signaling cascade);GO:0034613(cellular protein localization);GO:0036064(cilium basal body);GO:0045211(postsynaptic membrane);GO:0051560(mitochondrial calcium ion homeostasis);GO:0060070(canonical Wnt receptor signaling pathway);GO:0090128(regulation of synapse maturation);GO:2000060(positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process)",null,"mRNA","agilent G3 V3"]
["A_33_P3407529",{"v":7.1,"d":"7.10"},6.97,7.16,5.61,5.87,5.86,{"v":1.22433679354095,"d":"1.22"},{"v":0.292000472683543,"d":"0.29"},"up",{"v":0.000219740000000024,"d":"0.00"},1,"yes","CAGGGGTCCATGACCCATCTAGGAGACTTTATAGCAGTTGGGTGGGAGGGGAATGCTCTT","FALSE","NM_001174164","ref|NM_001174164|ref|NM_001114726|ens|ENST00000446477|ref|XM_006715984","PRRT4","proline-rich transmembrane protein 4","ref|Homo sapiens proline-rich transmembrane protein 4 (PRRT4), transcript variant 1, mRNA [NM_001174164]","chr7",127990912,128001739,"GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3291454",6.92,6.98,6.95,8.07,8.33,8.41,{"v":0.840386940749698,"d":"0.84"},{"v":-0.250874351560405,"d":"-0.25"},"down",{"v":0.00022132000000008,"d":"0.00"},1,"yes","TTGTTTACTAGTGTATAGCACTTCTCCACTTTGCTCCTGCTGCCACCGTATGAGATGTCT","FALSE","NM_198515","ref|NM_198515|ens|ENST00000333254|gb|BC044830|tc|THC2481266","CCDC172","coiled-coil domain containing 172","ref|Homo sapiens coiled-coil domain containing 172 (CCDC172), mRNA [NM_198515]","chr10",118083936,118139541,null,null,"mRNA","agilent G3 V3"]
["A_33_P3348288",3.92,4.04,3.94,5.55,5.31,{"v":5.2,"d":"5.20"},{"v":0.740971357409714,"d":"0.74"},{"v":-0.432510319322009,"d":"-0.43"},"down",{"v":0.000223150000000061,"d":"0.00"},1,"yes","CTGATTATGGCCTTTAACCATGGTGGTTTGTTGTGTGTTTTTTATTTCACAAAAAGCCAA","FALSE","NM_001242359","ref|NM_001242359|ref|NM_014836|ref|NR_024554|ref|NR_024555","RHOBTB1","Rho-related BTB domain containing 1","ref|Homo sapiens Rho-related BTB domain containing 1 (RHOBTB1), transcript variant 4, mRNA [NM_001242359]","chr10",62629196,62761198,"GO:0005525(GTP binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007264(small GTPase mediated signal transduction);GO:0051056(regulation of small GTPase mediated signal transduction)","04120(Ubiquitin mediated proteolysis)","mRNA","agilent G3 V3"]
["A_23_P63379",{"v":8.9,"d":"8.90"},9.14,9.07,8.08,8.06,8.14,{"v":1.1165568369028,"d":"1.12"},{"v":0.159056691582029,"d":"0.16"},"up",{"v":0.000236209999999959,"d":"0.00"},1,"yes","ATGGCCCTTTCCCTAGATATACTGCGGGATCTCTCCTTAGGATAAAGAGTTGCTGTTGAA","FALSE","NM_012113","ref|NM_012113|ens|ENST00000369111|ref|XM_005245059|ref|XM_005245060","CA14","carbonic anhydrase XIV","ref|Homo sapiens carbonic anhydrase XIV (CA14), mRNA [NM_012113]","chr1",150235440,150237291,"GO:0004089(carbonate dehydratase activity);GO:0005886(plasma membrane);GO:0015701(bicarbonate transport);GO:0016021(integral to membrane);GO:0044281(small molecule metabolic process);GO:0046872(metal ion binding)","00910(Nitrogen metabolism)","mRNA","agilent G3 V3"]
["A_33_P3373707",2.53,2.68,2.78,4.09,3.83,3.97,{"v":0.671993271656855,"d":"0.67"},{"v":-0.573481306817679,"d":"-0.57"},"down",{"v":0.000240079999999976,"d":"0.00"},1,"yes","AATTACAGAGGATGACCTCCGTCTTATTCATGAGAGAGAATCTTCTATCAGGCAACTTGA","FALSE","NM_003569","ref|NM_003569|ens|ENST00000367937|ens|ENST00000367941|gb|AK294911","STX7","syntaxin 7","ref|Homo sapiens syntaxin 7 (STX7), mRNA [NM_003569]","chr6",132791136,132834274,"GO:0000149(SNARE binding);GO:0001772(immunological synapse);GO:0001916(positive regulation of T cell mediated cytotoxicity);GO:0005484(SNAP receptor activity);GO:0005764(lysosome);GO:0005765(lysosomal membrane);GO:0005768(endosome);GO:0005769(early endosome);GO:0005770(late endosome);GO:0005886(plasma membrane);GO:0006886(intracellular protein transport);GO:0006906(vesicle fusion);GO:0012505(endomembrane system);GO:0016021(integral to membrane);GO:0019869(chloride channel inhibitor activity);GO:0019905(syntaxin binding);GO:0030139(endocytic vesicle);GO:0031201(SNARE complex);GO:0031901(early endosome membrane);GO:0031982(vesicle);GO:0042582(azurophil granule);GO:0043231(intracellular membrane-bounded organelle);GO:0048278(vesicle docking);GO:0048471(perinuclear region of cytoplasm);GO:0051640(organelle localization);GO:0055037(recycling endosome);GO:0070062(extracellular vesicular exosome);GO:0070820(tertiary granule);GO:0070925(organelle assembly)","04130(SNARE interactions in vesicular transport);04145(Phagosome)","mRNA","agilent G3 V3"]
["A_32_P148726",14.36,14.48,14.39,{"v":13.4,"d":"13.40"},13.32,13.56,{"v":1.07323733862959,"d":"1.07"},{"v":0.101969152889119,"d":"0.10"},"up",{"v":0.000241159999999963,"d":"0.00"},1,"yes","GTTACCCATATTGCATGTTGTGGTAGTAGATGCAGCCCCCCAAAATAAAAGTCAAAAGAT","FALSE","AK127789","gb|AK127789|tc|THC2476245","LOC728673","uncharacterized LOC728673","gb|Homo sapiens cDNA FLJ45890 fis, clone OCBBF3022576. [AK127789]",{"$nulls":5},"mRNA","agilent G3 V3"]
["A_19_P00325336",7.81,7.51,{"v":7.4,"d":"7.40"},9.15,{"v":9.3,"d":"9.30"},9.16,{"v":0.822890257153205,"d":"0.82"},{"v":-0.281228053083387,"d":"-0.28"},"down",{"v":0.000242619999999971,"d":"0.00"},1,"yes","AATTTCTCCTCTTTATCCTTCTCTCCTGGTTTGGATTTCAAGGTATACCACCGCATCTTC","FALSE","AK125301","gb|AK125301|tc|THC2477614",null,null,"gb|Homo sapiens cDNA FLJ43311 fis, clone NT2RI2009855. [AK125301]","chrX",73420064,73461983,null,null,"mRNA","agilent G3 V3"]
["A_24_P320545",7.96,7.65,7.65,9.03,9.15,{"v":9.1,"d":"9.10"},{"v":0.852639296187683,"d":"0.85"},{"v":-0.229992547550954,"d":"-0.23"},"down",{"v":0.000255909999999915,"d":"0.00"},1,"yes","CCACCTCTTCCTCTATCAGGGACAGTGTGGGTGCCACAGGTAACCCCAATTTCTGGCCTT","FALSE","NM_002821","ref|NM_002821|ref|NM_152880|ref|NM_001270398|ref|NM_152882","PTK7","protein tyrosine kinase 7 (inactive)","ref|Homo sapiens protein tyrosine kinase 7 (PTK7), transcript variant PTK7-1, mRNA [NM_002821]","chr6",43112040,43128774,"GO:0001736(establishment of planar polarity);GO:0001843(neural tube closure);GO:0003401(axis elongation);GO:0004713(protein tyrosine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005887(integral to plasma membrane);GO:0005911(cell-cell junction);GO:0005925(focal adhesion);GO:0007155(cell adhesion);GO:0007165(signal transduction);GO:0010976(positive regulation of neuron projection development);GO:0016477(cell migration);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0031532(actin cytoskeleton reorganization);GO:0042060(wound healing);GO:0045198(establishment of epithelial cell apical/basal polarity);GO:0060026(convergent extension);GO:0060070(canonical Wnt receptor signaling pathway);GO:0060484(lung-associated mesenchyme development);GO:0071300(cellular response to retinoic acid);GO:0090103(cochlea morphogenesis);GO:0090179(planar cell polarity pathway involved in neural tube closure)",null,"mRNA","agilent G3 V3"]
["A_33_P3264835",2.22,2.17,2.67,5.31,4.87,4.86,{"v":0.469414893617021,"d":"0.47"},{"v":-1.09106447840646,"d":"-1.09"},"down",{"v":0.000258229999999915,"d":"0.00"},1,"yes","GTGCCAGATACTTTCCCAAGGTTCTCTCATTTAATCCTCACAATAACCCTGTGAAGTCCA","FALSE","ENST00000374757","ens|ENST00000374757|tc|THC2629778","RAP1GAP","RAP1 GTPase activating protein","ens|RAP1 GTPase activating protein [Source:HGNC Symbol;Acc:HGNC:9858] [ENST00000374757]","chr1",21939528,21978396,"GO:0000139(Golgi membrane);GO:0003924(GTPase activity);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0007165(signal transduction);GO:0008152(metabolic process);GO:0016020(membrane);GO:0017016(Ras GTPase binding);GO:0032318(regulation of Ras GTPase activity);GO:0032854(positive regulation of Rap GTPase activity);GO:0042803(protein homodimerization activity);GO:0046582(Rap GTPase activator activity)","04015(Rap1 signaling pathway)","mRNA","agilent G3 V3"]
["A_24_P283324",8.58,8.43,{"v":8.7,"d":"8.70"},7.09,7.27,7.35,{"v":1.18424689083372,"d":"1.18"},{"v":0.243969884218511,"d":"0.24"},"up",{"v":0.000260979999999966,"d":"0.00"},1,"yes","ATCAGGGAGCTGAACCTTCCTTTCGGGGGGATGAAGAGTTCTGGAATAGGTAGAGAGGGA","FALSE","NM_022568","ref|NM_022568|ref|NM_001193480|ref|NM_170771|ens|ENST00000349305","ALDH8A1","aldehyde dehydrogenase 8 family, member A1","ref|Homo sapiens aldehyde dehydrogenase 8 family, member A1 (ALDH8A1), transcript variant 1, mRNA [NM_022568]","chr6",135239664,135250299,"GO:0001758(retinal dehydrogenase activity);GO:0004029(aldehyde dehydrogenase (NAD) activity);GO:0005622(intracellular);GO:0005737(cytoplasm);GO:0042573(retinoic acid metabolic process);GO:0042574(retinal metabolic process);GO:0042904(9-cis-retinoic acid biosynthetic process);GO:0055114(oxidation-reduction process);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_24_P87490",3.17,3.35,2.99,{"v":4.8,"d":"4.80"},5.15,5.12,{"v":0.631055076310551,"d":"0.63"},{"v":-0.664162170737261,"d":"-0.66"},"down",{"v":0.000262509999999994,"d":"0.00"},1,"yes","AAGAATCTTTTGGTTGGGACTTATTGCCTGTTCAGTACTGTGGGTGATATTTGCCTTTAG","FALSE","NM_145301","ref|NM_145301|ens|ENST00000518506|ens|ENST00000481756|ens|ENST00000521179","TVP23C","trans-golgi network vesicle protein 23 homolog C (S. cerevisiae)","ref|Homo sapiens trans-golgi network vesicle protein 23 homolog C (S. cerevisiae) (TVP23C), transcript variant 1, mRNA [NM_145301]","chr17",15341205,15466873,"GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3695548",7.78,7.61,7.72,6.56,{"v":6.8,"d":"6.80"},6.65,{"v":1.15492253873063,"d":"1.15"},{"v":0.20779609256189,"d":"0.21"},"up",{"v":0.000276860000000045,"d":"0.00"},1,"yes","CGAGATGACGCTGGTGGAAGTTCTACAGAAGAAGCTGATGGCCTTCACCCTGCAGGACCT","FALSE","NM_006231","ref|NM_006231|ens|ENST00000538196|ens|ENST00000544692|ens|ENST00000537064","POLE","polymerase (DNA directed), epsilon, catalytic subunit","ref|Homo sapiens polymerase (DNA directed), epsilon, catalytic subunit (POLE), mRNA [NM_006231]","chr12",133202856,133212586,"GO:0000082(G1/S transition of mitotic cell cycle);GO:0000166(nucleotide binding);GO:0000278(mitotic cell cycle);GO:0000722(telomere maintenance via recombination);GO:0000723(telomere maintenance);GO:0000731(DNA synthesis involved in DNA repair);GO:0001701(in utero embryonic development);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003887(DNA-directed DNA polymerase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006260(DNA replication);GO:0006270(DNA-dependent DNA replication initiation);GO:0006281(DNA repair);GO:0006283(transcription-coupled nucleotide-excision repair);GO:0006287(base-excision repair, gap-filling);GO:0006289(nucleotide-excision repair);GO:0006297(nucleotide-excision repair, DNA gap filling);GO:0008270(zinc ion binding);GO:0008622(epsilon DNA polymerase complex);GO:0032201(telomere maintenance via semi-conservative replication);GO:0051539(4 iron, 4 sulfur cluster binding)","00230(Purine metabolism);00240(Pyrimidine metabolism);03030(DNA replication);03410(Base excision repair);03420(Nucleotide excision repair);05166(HTLV-I infection)","mRNA","agilent G3 V3"]
["A_23_P410600",7.17,7.48,7.39,6.26,6.21,6.22,{"v":1.17924023542001,"d":"1.18"},{"v":0.237857654826,"d":"0.24"},"up",{"v":0.000279829999999981,"d":"0.00"},1,"yes","ACACGAAAGTCACGTTTCCTGGGTATTTTACCGACTCCTGTAGTAGCCACCCATTATACA","FALSE","NM_033261","ref|NM_033261|ens|ENST00000277517|gb|HQ447793|gb|CU676058","IDI2","isopentenyl-diphosphate delta isomerase 2","ref|Homo sapiens isopentenyl-diphosphate delta isomerase 2 (IDI2), mRNA [NM_033261]","chr10",{"v":1064847,"d":"1064847.00"},1071799,"GO:0004452(isopentenyl-diphosphate delta-isomerase activity);GO:0005777(peroxisome);GO:0005829(cytosol);GO:0006695(cholesterol biosynthetic process);GO:0008299(isoprenoid biosynthetic process);GO:0016787(hydrolase activity);GO:0044281(small molecule metabolic process);GO:0046490(isopentenyl diphosphate metabolic process);GO:0046872(metal ion binding);GO:0050992(dimethylallyl diphosphate biosynthetic process)","00900(Terpenoid backbone biosynthesis)","mRNA","agilent G3 V3"]
["A_23_P133245",4.18,4.77,4.24,6.74,6.84,7.05,{"v":0.639360155113912,"d":"0.64"},{"v":-0.64529925663494,"d":"-0.65"},"down",{"v":0.00028318000000005,"d":"0.00"},1,"yes","ATTCCAGTATGGTATCAAAATGTCTGAAGGGCGGAAAACCAGGCGCTTCAAGGAAACCAA","FALSE","NM_006083","ref|NM_006083|ens|ENST00000610522|ens|ENST00000417647|ens|ENST00000613660","IK","IK cytokine, down-regulator of HLA II","ref|Homo sapiens IK cytokine, down-regulator of HLA II (IK), mRNA [NM_006083]","chr5",140039744,140042064,"GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006955(immune response);GO:0007267(cell-cell signaling);GO:0042802(identical protein binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3309662",4.94,4.64,4.02,8.32,8.15,7.86,{"v":0.558980682285245,"d":"0.56"},{"v":-0.839129668800727,"d":"-0.84"},"down",{"v":0.00029614999999994,"d":"0.00"},1,"yes","AAGAGATCAAAGAGTTCGCCGCGGGCTACAACGTCAAATTCGATATGTTCAGCAAGATCT","FALSE","NM_001039848","ref|NM_001039848|ref|NM_002085|ref|NM_001039847|ens|ENST00000585480","GPX4","glutathione peroxidase 4","ref|Homo sapiens glutathione peroxidase 4 (GPX4), transcript variant 3, mRNA [NM_001039848]","chr19",{"v":1105584,"d":"1105584.00"},1105847,"GO:0004602(glutathione peroxidase activity);GO:0005634(nucleus);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006644(phospholipid metabolic process);GO:0006749(glutathione metabolic process);GO:0006979(response to oxidative stress);GO:0007275(multicellular organismal development);GO:0007568(aging);GO:0008430(selenium binding);GO:0019369(arachidonic acid metabolic process);GO:0019372(lipoxygenase pathway);GO:0032355(response to estradiol stimulus);GO:0042744(hydrogen peroxide catabolic process);GO:0043295(glutathione binding);GO:0044281(small molecule metabolic process);GO:0047066(phospholipid-hydroperoxide glutathione peroxidase activity);GO:0050727(regulation of inflammatory response);GO:0055114(oxidation-reduction process);GO:0070062(extracellular vesicular exosome)","00480(Glutathione metabolism)","mRNA","agilent G3 V3"]
["A_33_P3328619",11.04,11.18,10.64,12.85,{"v":13,"d":"13.00"},13.01,{"v":0.845599588265569,"d":"0.85"},{"v":-0.24195342063527,"d":"-0.24"},"down",{"v":0.000298889999999941,"d":"0.00"},1,"yes","TACAAAAATTAGCCAGGCATGGTGGCACATACCTGTAATCCTAGCTACTCAGGAGTCTGA","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_33_P3629131",13.04,13.15,13.04,12.62,12.56,12.61,{"v":1.03810531886743,"d":"1.04"},{"v":0.0539528168171339,"d":"0.05"},"up",{"v":0.00030361000000001,"d":"0.00"},1,"yes","TCTTCATAGTGTCCTTTAGCAAGCACCTCTGCCCCCTATAAAGCAGCTGTCATATCTAGA","FALSE","BX484257","gb|BX484257","CDRT3","CMT1A duplicated region transcript 3","gb|DKFZp686P15240_r1 686 (synonym: hlcc3) Homo sapiens cDNA clone DKFZp686P15240 5', mRNA sequence [BX484257]","chr17",15373624,15374150,null,null,"mRNA","agilent G3 V3"]
["A_33_P3229288",13.02,12.94,13.04,12.39,12.34,12.48,{"v":1.04810534802472,"d":"1.05"},{"v":0.0677837335112004,"d":"0.07"},"up",{"v":0.000303779999999976,"d":"0.00"},1,"yes","TGCCTGACACTGAGCCCCACCTCTCCAAGTCTCTCTGTGAATACAATTAAAGGTCCTGCC","FALSE","NM_000789","ref|NM_000789|ref|NM_152830|ref|NM_001178057|ens|ENST00000579314","ACE","angiotensin I converting enzyme","ref|Homo sapiens angiotensin I converting enzyme (ACE), transcript variant 1, mRNA [NM_000789]","chr17",61554432,61574921,"GO:0001822(kidney development);GO:0001974(blood vessel remodeling);GO:0002003(angiotensin maturation);GO:0002005(angiotensin catabolic process in blood);GO:0002019(regulation of renal output by angiotensin);GO:0002446(neutrophil mediated immunity);GO:0002474(antigen processing and presentation of peptide antigen via MHC class I);GO:0003081(regulation of systemic arterial blood pressure by renin-angiotensin);GO:0003779(actin binding);GO:0004175(endopeptidase activity);GO:0004180(carboxypeptidase activity);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005764(lysosome);GO:0005768(endosome);GO:0005886(plasma membrane);GO:0006508(proteolysis);GO:0007283(spermatogenesis);GO:0008144(drug binding);GO:0008217(regulation of blood pressure);GO:0008237(metallopeptidase activity);GO:0008238(exopeptidase activity);GO:0008240(tripeptidyl-peptidase activity);GO:0008241(peptidyl-dipeptidase activity);GO:0008270(zinc ion binding);GO:0009897(external side of plasma membrane);GO:0014910(regulation of smooth muscle cell migration);GO:0016021(integral to membrane);GO:0019229(regulation of vasoconstriction);GO:0031404(chloride ion binding);GO:0031434(mitogen-activated protein kinase kinase binding);GO:0031711(bradykinin receptor binding);GO:0032943(mononuclear cell proliferation);GO:0042312(regulation of vasodilation);GO:0042447(hormone catabolic process);GO:0043171(peptide catabolic process);GO:0044267(cellular protein metabolic process);GO:0050435(beta-amyloid metabolic process);GO:0050482(arachidonic acid secretion);GO:0051019(mitogen-activated protein kinase binding);GO:0060047(heart contraction);GO:0060177(regulation of angiotensin metabolic process);GO:0060218(hemopoietic stem cell differentiation);GO:0061098(positive regulation of protein tyrosine kinase activity);GO:0070062(extracellular vesicular exosome);GO:0071838(cell proliferation in bone marrow);GO:1900086(positive regulation of peptidyl-tyrosine autophosphorylation);GO:2000170(positive regulation of peptidyl-cysteine S-nitrosylation)","04614(Renin-angiotensin system);05410(Hypertrophic cardiomyopathy (HCM));05142(Chagas disease (American trypanosomiasis))","mRNA","agilent G3 V3"]
["A_33_P3260062",6.73,7.01,6.95,{"v":5.7,"d":"5.70"},5.74,5.86,{"v":1.19595375722543,"d":"1.20"},{"v":0.258161607335923,"d":"0.26"},"up",{"v":0.000319940000000019,"d":"0.00"},1,"yes","GAAAAATGAAACAAAAAAGTCAAACTCTTAAAAACAAGGCCGGCCACCCACACAGCCGCC","FALSE","ENST00000262971","ens|ENST00000262971|gb|AK022481|tc|THC2497298","PIAS4","protein inhibitor of activated STAT, 4","ens|protein inhibitor of activated STAT, 4 [Source:HGNC Symbol;Acc:HGNC:17002] [ENST00000262971]","chr19",{"v":4007644,"d":"4007644.00"},4039384,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-dependent);GO:0008270(zinc ion binding);GO:0016055(Wnt receptor signaling pathway);GO:0016363(nuclear matrix);GO:0016605(PML body);GO:0016874(ligase activity);GO:0016925(protein sumoylation);GO:0019789(SUMO ligase activity);GO:0031625(ubiquitin protein ligase binding);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0033235(positive regulation of protein sumoylation);GO:0045892(negative regulation of transcription, DNA-dependent)","04120(Ubiquitin mediated proteolysis);04630(Jak-STAT signaling pathway);04064(NF-kappa B signaling pathway)","mRNA","agilent G3 V3"]
["A_33_P3280461",13.87,13.92,13.74,{"v":12.8,"d":"12.80"},12.81,{"v":13,"d":"13.00"},{"v":1.07562807562808,"d":"1.08"},{"v":0.105179317482937,"d":"0.11"},"up",{"v":0.000320890000000018,"d":"0.00"},1,"yes","GACTAATTTGATGATTTTCGATCTCTTTTCCCCTGTCCTGATTTTAAAAGCCCCCTCCTT","FALSE","NM_005119","ref|NM_005119|ens|ENST00000354618|ref|XM_005271371|gb|AF117756","THRAP3","thyroid hormone receptor associated protein 3","ref|Homo sapiens thyroid hormone receptor associated protein 3 (THRAP3), mRNA [NM_005119]","chr1",36690016,36770958,"GO:0000381(regulation of alternative nuclear mRNA splicing, via spliceosome);GO:0000956(nuclear-transcribed mRNA catabolic process);GO:0001046(core promoter sequence-specific DNA binding);GO:0001104(RNA polymerase II transcription cofactor activity);GO:0003712(transcription cofactor activity);GO:0003713(transcription coactivator activity);GO:0004872(receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0006397(mRNA processing);GO:0008380(RNA splicing);GO:0016592(mediator complex);GO:0030374(ligand-dependent nuclear receptor transcription coactivator activity);GO:0030518(intracellular steroid hormone receptor signaling pathway);GO:0030521(androgen receptor signaling pathway);GO:0035145(exon-exon junction complex);GO:0042753(positive regulation of circadian rhythm);GO:0042809(vitamin D receptor binding);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046966(thyroid hormone receptor binding);GO:0048026(positive regulation of nuclear mRNA splicing, via spliceosome);GO:0048255(mRNA stabilization);GO:0051219(phosphoprotein binding);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P74843",{"v":2.4,"d":"2.40"},{"v":3.1,"d":"3.10"},2.24,5.58,5.75,5.77,{"v":0.452631578947368,"d":"0.45"},{"v":-1.14359085362885,"d":"-1.14"},"down",{"v":0.000322180000000061,"d":"0.00"},1,"yes","TTGTTGGAAGTATACAGCGGAGTCTTCAGATACACTGTGTCCTCGATGTGCAGAAGTTGT","FALSE","NM_018060","ref|NM_018060|ens|ENST00000366922|gb|BC137438|gb|AK291432","IARS2","isoleucyl-tRNA synthetase 2, mitochondrial","ref|Homo sapiens isoleucyl-tRNA synthetase 2, mitochondrial (IARS2), mRNA [NM_018060]","chr1",220267456,220321376,"GO:0002161(aminoacyl-tRNA editing activity);GO:0004822(isoleucine-tRNA ligase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0005829(cytosol);GO:0006418(tRNA aminoacylation for protein translation);GO:0006428(isoleucyl-tRNA aminoacylation);GO:0006450(regulation of translational fidelity);GO:0010467(gene expression);GO:0032543(mitochondrial translation)","00970(Aminoacyl-tRNA biosynthesis)","mRNA","agilent G3 V3"]
["A_33_P3405491",9.97,9.77,10.02,{"v":8.6,"d":"8.60"},8.83,8.59,{"v":1.14373558800922,"d":"1.14"},{"v":0.193753564390236,"d":"0.19"},"up",{"v":0.00033939000000005,"d":"0.00"},1,"yes","TCTGACTGTGTAGCTGGTTCAGGAAACCAAAGGCAAGCGGGGGTCACTCATCCCTCCAGA","FALSE","AY465895","gb|AY465895|gb|AK025343","HCRP1","hepatocellular carcinoma-related HCRP1","gb|Homo sapiens hepatocellular carcinoma-related HCRP1 mRNA, complete cds. [AY465895]","chr6",42326528,42328540,null,null,"mRNA","agilent G3 V3"]
["A_33_P3219260",4.93,{"v":5.3,"d":"5.30"},4.93,6.61,6.52,6.47,{"v":0.773469387755102,"d":"0.77"},{"v":-0.370583900831479,"d":"-0.37"},"down",{"v":0.000339540000000027,"d":"0.00"},1,"yes","TGCATTACCCAAACCATATTGCACTTTTAGTTCCCTAGTTTTCTAGGTGAGCTTCATTCC","FALSE","NM_016484","ref|NM_016484|ens|ENST00000374454|ens|ENST00000239666|ref|XM_006724660","PDZD11","PDZ domain containing 11","ref|Homo sapiens PDZ domain containing 11 (PDZD11), mRNA [NM_016484]","chrX",69507616,69510364,"GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005829(cytosol);GO:0005911(cell-cell junction);GO:0006766(vitamin metabolic process);GO:0006767(water-soluble vitamin metabolic process);GO:0006768(biotin metabolic process);GO:0006887(exocytosis);GO:0007269(neurotransmitter secretion);GO:0008022(protein C-terminus binding);GO:0008105(asymmetric protein localization);GO:0015939(pantothenate metabolic process);GO:0016323(basolateral plasma membrane);GO:0034220(ion transmembrane transport);GO:0044281(small molecule metabolic process);GO:0045199(maintenance of epithelial cell apical/basal polarity);GO:0045202(synapse);GO:0055085(transmembrane transport)",null,"mRNA","agilent G3 V3"]
["A_24_P48539",{"v":10.1,"d":"10.10"},9.99,10.43,8.53,8.64,8.66,{"v":1.18157181571816,"d":"1.18"},{"v":0.24070731871653,"d":"0.24"},"up",{"v":0.000344250000000046,"d":"0.00"},1,"yes","GAAGAACAAAAGGAGCTCCATTATGCCTCCCTTAGTTTTTCTGAGATGAAGTCGAGGGAG","FALSE","NM_003830","ref|NM_003830|ens|ENST00000570106|gb|DQ892433|gb|U71383","SIGLEC5","sialic acid binding Ig-like lectin 5","ref|Homo sapiens sialic acid binding Ig-like lectin 5 (SIGLEC5), mRNA [NM_003830]","chr19",52115344,52150142,"GO:0007155(cell adhesion);GO:0016021(integral to membrane);GO:0030246(carbohydrate binding)",null,"mRNA","agilent G3 V3"]
["A_23_P157795",5.12,4.91,4.64,7.36,7.31,6.89,{"v":0.680426716141002,"d":"0.68"},{"v":-0.555488307079115,"d":"-0.56"},"down",{"v":0.000356440000000013,"d":"0.00"},1,"yes","GGATAGTAAAACTTGAGAAGCTTTTGGGGTCAGATCTCTGGAACATCATGTGATGAAGCT","FALSE","NM_003798","ref|NM_003798|ref|NM_001286974|ens|ENST00000374594|ens|ENST00000325551","CTNNAL1","catenin (cadherin-associated protein), alpha-like 1","ref|Homo sapiens catenin (cadherin-associated protein), alpha-like 1 (CTNNAL1), transcript variant 1, mRNA [NM_003798]","chr9",111704856,111775779,"GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007266(Rho protein signal transduction);GO:0045296(cadherin binding);GO:0051015(actin filament binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3410206",16.05,16.06,16.09,16.59,16.57,16.46,{"v":0.971382507053608,"d":"0.97"},{"v":-0.0418885887751068,"d":"-0.04"},"down",{"v":0.000359299999999951,"d":"0.00"},1,"yes","GCCCGAGCCCAGCGCAGCCCCGCGGCCCCAGGACAGTCCCCCCACGCCCCCACTCCAACC","FALSE","NM_004913","ref|NM_004913|ens|ENST00000614968|ens|ENST00000389386|ref|XM_006721350","VPS9D1","VPS9 domain containing 1","ref|Homo sapiens VPS9 domain containing 1 (VPS9D1), mRNA [NM_004913]","chr16",89777768,89779448,"GO:0005096(GTPase activator activity);GO:0005215(transporter activity);GO:0015986(ATP synthesis coupled proton transport);GO:0043547(positive regulation of GTPase activity)",null,"mRNA","agilent G3 V3"]
["A_33_P3318861",13.39,{"v":13.5,"d":"13.50"},13.37,12.37,12.53,12.24,{"v":1.08400646203554,"d":"1.08"},{"v":0.116373356985919,"d":"0.12"},"up",{"v":0.000362739999999917,"d":"0.00"},1,"yes","TGATCTCCCTCCCTACTTATGTATCTTAGTTCTGCAGTTCAGAGTGAAGGTTGGGGGTTA","FALSE","NM_001093730","ref|NM_001093730|ens|ENST00000452335|gb|DQ516347","DYTN","dystrotelin","ref|Homo sapiens dystrotelin (DYTN), mRNA [NM_001093730]","chr2",207516352,207583120,"GO:0005886(plasma membrane);GO:0008270(zinc ion binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3215412",14.92,15.04,{"v":14.8,"d":"14.80"},13.82,14.02,{"v":13.9,"d":"13.90"},{"v":1.0723526593196,"d":"1.07"},{"v":0.100779435816559,"d":"0.10"},"up",{"v":0.000375279999999978,"d":"0.00"},1,"yes","TAGCCCCCCTGCACTCTTTGATATCTTAGTGTCTGAGGTTGACTGTGGGTAAATCTTTAA","FALSE","NM_001136263","ref|NM_001136263|ens|ENST00000332235|ref|XM_006722649|gb|AB075837","C2CD4C","C2 calcium-dependent domain containing 4C","ref|Homo sapiens C2 calcium-dependent domain containing 4C (C2CD4C), mRNA [NM_001136263]","chr19",{"v":405438,"d":"405438.00"},409139,null,null,"mRNA","agilent G3 V3"]
["A_23_P503182",6.19,5.84,5.49,8.72,8.51,{"v":9.1,"d":"9.10"},{"v":0.665400683630839,"d":"0.67"},{"v":-0.587704746444889,"d":"-0.59"},"down",{"v":0.00038077000000003,"d":"0.00"},1,"yes","GCTGCCAGTTTCTGCTGATACACAGGTAGGATGGGACCCTTCATGAATATCTGACTTTAA","FALSE","NM_021962","ref|NM_021962|ref|NM_001159746|ref|NM_001092|ref|NM_001282149","ABR","active BCR-related","ref|Homo sapiens active BCR-related (ABR), transcript variant 1, mRNA [NM_021962]","chr17",{"v":906767,"d":"906767.00"},1090616,"GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005096(GTPase activator activity);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007264(small GTPase mediated signal transduction);GO:0007420(brain development);GO:0016020(membrane);GO:0030036(actin cytoskeleton organization);GO:0030336(negative regulation of cell migration);GO:0030675(Rac GTPase activator activity);GO:0032496(response to lipopolysaccharide);GO:0032855(positive regulation of Rac GTPase activity);GO:0042472(inner ear morphogenesis);GO:0043065(positive regulation of apoptotic process);GO:0043314(negative regulation of neutrophil degranulation);GO:0048011(nerve growth factor receptor signaling pathway);GO:0050728(negative regulation of inflammatory response);GO:0050766(positive regulation of phagocytosis);GO:0050885(neuromuscular process controlling balance);GO:0051056(regulation of small GTPase mediated signal transduction);GO:0097190(apoptotic signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_21_P0011841",8.34,8.47,{"v":8.5,"d":"8.50"},7.07,7.24,6.84,{"v":1.19669030732861,"d":"1.20"},{"v":0.259049844103372,"d":"0.26"},"up",{"v":0.000382969999999982,"d":"0.00"},1,"yes","GCTACCCCACTGAGCTCTGTTTAAATAAATATTGTCCTTTCATGTAAATTATTCTGGATG","FALSE","NM_000430","ref|NM_000430|ens|ENST00000397193|ens|ENST00000571495|ens|ENST00000397195","PAFAH1B1","platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa)","ref|Homo sapiens platelet-activating factor acetylhydrolase 1b, regulatory subunit 1 (45kDa) (PAFAH1B1), mRNA [NM_000430]","chr17",{"v":2496922,"d":"2496922.00"},2588909,"GO:0000086(G2/M transition of mitotic cell cycle);GO:0000132(establishment of mitotic spindle orientation);GO:0000226(microtubule cytoskeleton organization);GO:0000235(astral microtubule);GO:0000278(mitotic cell cycle);GO:0000776(kinetochore);GO:0001667(ameboidal cell migration);GO:0001675(acrosome assembly);GO:0001764(neuron migration);GO:0001961(positive regulation of cytokine-mediated signaling pathway);GO:0005515(protein binding);GO:0005635(nuclear envelope);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005871(kinesin complex);GO:0005875(microtubule associated complex);GO:0005938(cell cortex);GO:0006996(organelle organization);GO:0007017(microtubule-based process);GO:0007067(mitosis);GO:0007097(nuclear migration);GO:0007268(synaptic transmission);GO:0007405(neuroblast proliferation);GO:0007611(learning or memory);GO:0008017(microtubule binding);GO:0008090(retrograde axon cargo transport);GO:0008201(heparin binding);GO:0008344(adult locomotory behavior);GO:0009306(protein secretion);GO:0010977(negative regulation of neuron projection development);GO:0016042(lipid catabolic process);GO:0017145(stem cell division);GO:0019226(transmission of nerve impulse);GO:0021540(corpus callosum morphogenesis);GO:0021766(hippocampus development);GO:0021819(layer formation in cerebral cortex);GO:0021895(cerebral cortex neuron differentiation);GO:0021987(cerebral cortex development);GO:0030036(actin cytoskeleton organization);GO:0030424(axon);GO:0030426(growth cone);GO:0031023(microtubule organizing center organization);GO:0031252(cell leading edge);GO:0031512(motile primary cilium);GO:0031965(nuclear membrane);GO:0032319(regulation of Rho GTPase activity);GO:0034452(dynactin binding);GO:0036035(osteoclast development);GO:0042803(protein homodimerization activity);GO:0043025(neuronal cell body);GO:0043274(phospholipase binding);GO:0045502(dynein binding);GO:0045505(dynein intermediate chain binding);GO:0045773(positive regulation of axon extension);GO:0045931(positive regulation of mitotic cell cycle);GO:0046329(negative regulation of JNK cascade);GO:0046469(platelet activating factor metabolic process);GO:0047496(vesicle transport along microtubule);GO:0048471(perinuclear region of cytoplasm);GO:0048854(brain morphogenesis);GO:0050885(neuromuscular process controlling balance);GO:0051081(nuclear envelope disassembly);GO:0051219(phosphoprotein binding);GO:0051660(establishment of centrosome localization);GO:0070062(extracellular vesicular exosome)","00565(Ether lipid metabolism)","mRNA","agilent G3 V3"]
["A_23_P204395",8.61,8.57,{"v":8.5,"d":"8.50"},7.72,7.51,7.75,{"v":1.11749347258486,"d":"1.12"},{"v":0.16026640447619,"d":"0.16"},"up",{"v":0.000396300000000016,"d":"0.00"},1,"yes","CCAGCTTCCCTCCAAGGAATGAGTGGATTTCATACAGGATCTCTTTATTGCACAGACTGA","FALSE","NM_023928","ref|NM_023928|ens|ENST00000316543|ens|ENST00000543665|ens|ENST00000316519","AACS","acetoacetyl-CoA synthetase","ref|Homo sapiens acetoacetyl-CoA synthetase (AACS), mRNA [NM_023928]","chr12",125549984,125627861,"GO:0001889(liver development);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0006631(fatty acid metabolic process);GO:0007584(response to nutrient);GO:0014074(response to purine-containing compound);GO:0030729(acetoacetate-CoA ligase activity);GO:0032024(positive regulation of insulin secretion);GO:0034201(response to oleic acid);GO:0042493(response to drug);GO:0042594(response to starvation);GO:0045471(response to ethanol);GO:0047760(butyrate-CoA ligase activity);GO:0050872(white fat cell differentiation);GO:0060612(adipose tissue development);GO:0071333(cellular response to glucose stimulus);GO:0071394(cellular response to testosterone stimulus);GO:0071397(cellular response to cholesterol)","00650(Butanoate metabolism);00280(Valine, leucine and isoleucine degradation)","mRNA","agilent G3 V3"]
["A_33_P3360886",13.62,13.35,13.42,15.13,14.91,14.76,{"v":0.9015625,"d":"0.90"},{"v":-0.14950058624188,"d":"-0.15"},"down",{"v":0.000398979999999938,"d":"0.00"},1,"yes","GGAAACTTTCCTCCCCGCCTAGTCTGCGCTGGGTACTGTTGTTATTCGTGACTGTCCCCT","FALSE","THC2642603","tc|THC2642603|tc|THC2633776",null,null,"tc|GRP33_ARTSA (P13230) Glycine-rich protein GRP33, partial (8%) [THC2642603]",{"$nulls":5},"mRNA","agilent G3 V3"]
["A_24_P63563",4.13,3.88,4.54,6.27,6.28,{"v":6.4,"d":"6.40"},{"v":0.662269129287599,"d":"0.66"},{"v":-0.59451048422032,"d":"-0.59"},"down",{"v":0.000415730000000059,"d":"0.00"},1,"yes","AGAGTTCTTGTCCATCAGTTCATACTGCAATTTTATGTGAAAGCATTATGACTGTCCTAC","FALSE","NM_014773","ref|NM_014773|ref|NM_001142603|ens|ENST00000194118|ens|ENST00000507481","KIAA0141","KIAA0141","ref|Homo sapiens KIAA0141 (KIAA0141), transcript variant 1, mRNA [NM_014773]","chr5",141312960,141319711,"GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0008625(induction of apoptosis via death domain receptors);GO:0043281(regulation of cysteine-type endopeptidase activity involved in apoptotic process)",null,"mRNA","agilent G3 V3"]
["A_23_P214037",6.44,6.89,6.44,8.31,8.23,{"v":8.2,"d":"8.20"},{"v":0.799110751818917,"d":"0.80"},{"v":-0.323532629247162,"d":"-0.32"},"down",{"v":0.000419270000000083,"d":"0.00"},1,"yes","GCAAAAATGCAAGCAAGTATAGAAAAAGGTGGTTCTCTTCCCAAAGTGGAAGCCAAATTC","FALSE","NM_002520","ref|NM_002520|ref|NM_199185|ens|ENST00000502784|ens|ENST00000517671","NPM1","nucleophosmin (nucleolar phosphoprotein B23, numatrin)","ref|Homo sapiens nucleophosmin (nucleolar phosphoprotein B23, numatrin) (NPM1), transcript variant 1, mRNA [NM_002520]","chr5",170814112,170837887,"GO:0003713(transcription coactivator activity);GO:0003723(RNA binding);GO:0004860(protein kinase inhibitor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005925(focal adhesion);GO:0006281(DNA repair);GO:0006334(nucleosome assembly);GO:0006886(intracellular protein transport);GO:0006913(nucleocytoplasmic transport);GO:0006950(response to stress);GO:0007098(centrosome cycle);GO:0007165(signal transduction);GO:0007569(cell aging);GO:0008104(protein localization);GO:0008285(negative regulation of cell proliferation);GO:0010826(negative regulation of centrosome duplication);GO:0016020(membrane);GO:0016032(viral reproduction);GO:0019901(protein kinase binding);GO:0030529(ribonucleoprotein complex);GO:0030957(Tat protein binding);GO:0031616(spindle pole centrosome);GO:0032071(regulation of endodeoxyribonuclease activity);GO:0034080(CenH3-containing nucleosome assembly at centromere);GO:0042255(ribosome assembly);GO:0042393(histone binding);GO:0042803(protein homodimerization activity);GO:0043023(ribosomal large subunit binding);GO:0043024(ribosomal small subunit binding);GO:0043066(negative regulation of apoptotic process);GO:0044387(negative regulation of protein kinase activity by regulation of protein phosphorylation);GO:0045727(positive regulation of translation);GO:0046599(regulation of centriole replication);GO:0046982(protein heterodimerization activity);GO:0051059(NF-kappaB binding);GO:0051082(unfolded protein binding);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051259(protein oligomerization);GO:0060699(regulation of endoribonuclease activity);GO:0060735(regulation of eIF2 alpha phosphorylation by dsRNA)",null,"mRNA","agilent G3 V3"]
["A_33_P3258593",13.05,{"v":13.1,"d":"13.10"},12.98,12.48,12.54,12.59,{"v":1.04041478330231,"d":"1.04"},{"v":0.0571588038604878,"d":"0.06"},"up",{"v":0.000422400000000045,"d":"0.00"},1,"yes","ACAAACCTCAAGGTCCCCCACCTCCAGGAAAGCCACAAGGACCACCCGCACAAGGAGGCA","FALSE","NM_005039","ref|NM_005039|ref|NM_199353|ref|NM_006248|ens|ENST00000612352","PRB1","proline-rich protein BstNI subfamily 1","ref|Homo sapiens proline-rich protein BstNI subfamily 1 (PRB1), transcript variant 1, mRNA [NM_005039]","chr12",11546906,11653975,"GO:0003674(molecular_function);GO:0005576(extracellular region);GO:0008150(biological_process)","04970(Salivary secretion)","mRNA","agilent G3 V3"]
["A_24_P194714",4.79,5.12,4.91,{"v":6.3,"d":"6.30"},6.41,6.65,{"v":0.765495867768595,"d":"0.77"},{"v":-0.385533504968761,"d":"-0.39"},"down",{"v":0.000435590000000041,"d":"0.00"},1,"yes","CCGAATCAGAATCCCATCTCACCAGGGCGAAATTTTAATTTAAAAACTTAAAAAGAGACT","FALSE","NM_182565","ref|NM_182565|ens|ENST00000327490|gb|BC035511|gb|AF109186","UBALD2","UBA-like domain containing 2","ref|Homo sapiens UBA-like domain containing 2 (UBALD2), mRNA [NM_182565]","chr17",74261456,74266464,null,null,"mRNA","agilent G3 V3"]
["A_33_P3284404",7.96,7.88,8.09,7.21,7.28,{"v":7.3,"d":"7.30"},{"v":1.09821018815971,"d":"1.10"},{"v":0.135154200422592,"d":"0.14"},"up",{"v":0.000440349999999978,"d":"0.00"},1,"yes","TCCCGCAGATCAGCAGCGTCAAGGACCGCAAGAAAGCCGTCCTGTCCGACATCGGTGTCT","FALSE","NM_145731","ref|NM_145731|ref|NM_145738|ens|ENST00000415332|ens|ENST00000381535","SYNGR1","synaptogyrin 1","ref|Homo sapiens synaptogyrin 1 (SYNGR1), transcript variant 1b, mRNA [NM_145731]","chr22",39760176,39774386,"GO:0006605(protein targeting);GO:0016021(integral to membrane);GO:0030054(cell junction);GO:0030672(synaptic vesicle membrane);GO:0031594(neuromuscular junction);GO:0042470(melanosome);GO:0048169(regulation of long-term neuronal synaptic plasticity);GO:0048172(regulation of short-term neuronal synaptic plasticity)",null,"mRNA","agilent G3 V3"]
["A_33_P3331326",12.98,12.91,12.87,13.43,13.48,13.36,{"v":0.962503104047678,"d":"0.96"},{"v":-0.0551369015306729,"d":"-0.06"},"down",{"v":0.000442170000000019,"d":"0.00"},1,"yes","CAAAAAGCAAACTCCGGCCAAGACTTCACTTCTCAACCGCCCCTGCTGCCTTCCCGGGGG","FALSE",{"$nulls":5},"chr13",28194904,28197589,null,null,"mRNA","agilent G3 V3"]
["A_33_P3361217",7.77,7.71,7.57,6.23,6.59,6.43,{"v":1.1974025974026,"d":"1.20"},{"v":0.259908304847074,"d":"0.26"},"up",{"v":0.000456489999999921,"d":"0.00"},1,"yes","AAATGCCTAGCGGCCTCCTCATTTGCAAGCAAGCAGCGTTTTGCTGATAAAATGTTTCCA","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_21_P0014657",4.84,4.97,5.15,6.03,5.99,6.15,{"v":0.823335167859108,"d":"0.82"},{"v":-0.280448244346479,"d":"-0.28"},"down",{"v":0.000462749999999956,"d":"0.00"},1,"yes","CCACATCTTCTCCCTGCATGTCCTTGGGTTGGAAGGAACAGCTTATTTTTTGTCCTACAT","FALSE","THC2657673","tc|THC2657673",{"$nulls":8},"mRNA","agilent G3 V3"]
["A_33_P3355608",8.83,8.93,8.75,9.47,9.46,9.39,{"v":0.936087570621469,"d":"0.94"},{"v":-0.0952845952157387,"d":"-0.10"},"down",{"v":0.000478450000000019,"d":"0.00"},1,"yes","GCCTTCAGTCCCAGCCTTCCTCAGGGTCCATCCTCTACAGACAATGTGAGTCATAAATAA","FALSE","NM_031852","ref|NM_031852|ens|ENST00000356878|gb|AF152485|tc|THC2709681","PCDHA7","protocadherin alpha 7","ref|Homo sapiens protocadherin alpha 7 (PCDHA7), transcript variant 2, mRNA [NM_031852]","chr5",140213968,140216338,"GO:0005509(calcium ion binding);GO:0005887(integral to plasma membrane);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion);GO:0007399(nervous system development)",null,"mRNA","agilent G3 V3"]
["A_23_P104323",5.11,4.71,5.11,6.62,6.48,6.41,{"v":0.765248590466427,"d":"0.77"},{"v":-0.385999612474485,"d":"-0.39"},"down",{"v":0.000482239999999967,"d":"0.00"},1,"yes","TCTTCACCATCCCGTTTTCCAGCAAGAGTCGTTCACCAGACAGGTGTTATGGAAGCTGCT","FALSE","NM_002412","ref|NM_002412|ref|XM_005252682|ref|XM_006717863|gb|BT006714","MGMT","O-6-methylguanine-DNA methyltransferase","ref|Homo sapiens O-6-methylguanine-DNA methyltransferase (MGMT), mRNA [NM_002412]","chr10",131265448,131566271,"GO:0003677(DNA binding);GO:0003684(damaged DNA binding);GO:0003908(methylated-DNA-[protein]-cysteine S-methyltransferase activity);GO:0005509(calcium ion binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006266(DNA ligation);GO:0006281(DNA repair);GO:0006306(DNA methylation);GO:0006307(DNA dealkylation involved in DNA repair);GO:0008168(methyltransferase activity);GO:0009008(DNA-methyltransferase activity);GO:0009636(response to toxin);GO:0016020(membrane);GO:0034599(cellular response to oxidative stress);GO:0042493(response to drug);GO:0043281(regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0045471(response to ethanol);GO:0045739(positive regulation of DNA repair);GO:0051593(response to folic acid);GO:0060548(negative regulation of cell death);GO:0060644(mammary gland epithelial cell differentiation);GO:0071407(cellular response to organic cyclic compound);GO:0071479(cellular response to ionizing radiation)",null,"mRNA","agilent G3 V3"]
["A_33_P3255647",3.93,4.15,3.45,6.09,5.95,6.03,{"v":0.638074156059768,"d":"0.64"},{"v":-0.648203993212828,"d":"-0.65"},"down",{"v":0.000495829999999975,"d":"0.00"},1,"yes","GAAGTATTCAAGTCTAACAGTGTTGAAATGGATTGGGTGTTGAAGCATACAGGTCCGAAT","FALSE","NM_001199973","ref|NM_001199973|ref|NM_001199974|ref|NM_019597|ref|NM_001032393","RPL36A-HNRNPH2","RPL36A-HNRNPH2 readthrough","ref|Homo sapiens RPL36A-HNRNPH2 readthrough (RPL36A-HNRNPH2), transcript variant 1, mRNA [NM_001199973]","chrX",100663280,100669121,null,"03010(Ribosome)","mRNA","agilent G3 V3"]
["A_23_P74229",4.24,5.07,4.36,7.51,{"v":7.4,"d":"7.40"},7.21,{"v":0.617992766726944,"d":"0.62"},{"v":-0.694338142628647,"d":"-0.69"},"down",{"v":0.000500419999999946,"d":"0.00"},1,"yes","TCAGCCCTCACTGGGTGTCACACACTGAGAGAAGTCCTATTGTAAAGAAACGGAAAAAGT","FALSE","NM_032017","ref|NM_032017|ref|NM_001282546|ref|NM_001282547|ens|ENST00000359297","STK40","serine/threonine kinase 40","ref|Homo sapiens serine/threonine kinase 40 (STK40), transcript variant 3, mRNA [NM_032017]","chr1",36805224,36851497,"GO:0003016(respiratory system process);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005977(glycogen metabolic process);GO:0006468(protein phosphorylation);GO:0010468(regulation of gene expression);GO:0035264(multicellular organism growth);GO:0043066(negative regulation of apoptotic process);GO:0043408(regulation of MAPK cascade);GO:0048286(lung alveolus development);GO:0060425(lung morphogenesis)",null,"mRNA","agilent G3 V3"]
["A_33_P3233891",1.94,2.09,1.91,4.41,4.82,4.02,{"v":0.448301886792453,"d":"0.45"},{"v":-1.15745752353716,"d":"-1.16"},"down",{"v":0.000504769999999932,"d":"0.00"},1,"yes","GATGTGTATGTGTACATTTATAAGAACCAGTATGGATACATCCATTCACTGTGGTACATT","FALSE","NM_006947","ref|NM_006947|ref|NM_001267722|ens|ENST00000507126|gb|AK023480","SRP72","signal recognition particle 72kDa","ref|Homo sapiens signal recognition particle 72kDa (SRP72), transcript variant 1, mRNA [NM_006947]","chr4",57366680,57369839,"GO:0005047(signal recognition particle binding);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005786(signal recognition particle, endoplasmic reticulum targeting);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006412(translation);GO:0006614(SRP-dependent cotranslational protein targeting to membrane);GO:0008312(7S RNA binding);GO:0010467(gene expression);GO:0042493(response to drug);GO:0044267(cellular protein metabolic process)","03060(Protein export)","mRNA","agilent G3 V3"]
["A_23_P201459",8.77,8.69,8.59,10.41,10.11,9.95,{"v":0.854939284542173,"d":"0.85"},{"v":-0.226106127520615,"d":"-0.23"},"down",{"v":0.000520850000000017,"d":"0.00"},1,"yes","AGTAGCCAGCAGCTCCCAGAACCTCTTCTTCCTTCTTGGCCTAACTCTTCCAGTTAGGAT","FALSE","NM_022873","ref|NM_022873|ref|NM_022872|ref|NM_002038|ens|ENST00000362020","IFI6","interferon, alpha-inducible protein 6","ref|Homo sapiens interferon, alpha-inducible protein 6 (IFI6), transcript variant 3, mRNA [NM_022873]","chr1",27992576,27998709,"GO:0001836(release of cytochrome c from mitochondria);GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005886(plasma membrane);GO:0006955(immune response);GO:0016021(integral to membrane);GO:0019221(cytokine-mediated signaling pathway);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0051902(negative regulation of mitochondrial depolarization);GO:0060337(type I interferon-mediated signaling pathway);GO:2001240(negative regulation of extrinsic apoptotic signaling pathway in absence of ligand)",null,"mRNA","agilent G3 V3"]
["A_23_P330419",8.95,8.74,{"v":8.7,"d":"8.70"},9.63,9.78,9.69,{"v":0.906872852233677,"d":"0.91"},{"v":-0.141027802469378,"d":"-0.14"},"down",{"v":0.000524630000000026,"d":"0.00"},1,"yes","CGCCAAAGATGGAGGGAATGTCACCGTCTCCCTCTTCTACCGCAATGACTCCGCCCACCT","FALSE","NM_033068","ref|NM_033068|gb|AB463389|gb|BC140294|gb|BC146506","ACPT","acid phosphatase, testicular","ref|Homo sapiens acid phosphatase, testicular (ACPT), mRNA [NM_033068]","chr19",51293672,51298481,"GO:0003993(acid phosphatase activity);GO:0016021(integral to membrane);GO:0016311(dephosphorylation)",null,"mRNA","agilent G3 V3"]
["A_23_P83266",7.04,6.88,6.88,7.51,{"v":7.5,"d":"7.50"},7.58,{"v":0.920761398849048,"d":"0.92"},{"v":-0.11910074236463,"d":"-0.12"},"down",{"v":0.000538550000000027,"d":"0.00"},1,"yes","AGCTACCAAAACGTCTATGTCTGCACAGGGCCACTCTTCCTGCCCAGGACAGAGGCTGAT","FALSE","NM_004435","ref|NM_004435|ens|ENST00000372642|gb|AB590755|gb|AK130973","ENDOG","endonuclease G","ref|Homo sapiens endonuclease G (ENDOG), mRNA [NM_004435]","chr9",131580752,131584956,"GO:0001701(in utero embryonic development);GO:0003676(nucleic acid binding);GO:0004518(nuclease activity);GO:0004519(endonuclease activity);GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0006309(apoptotic DNA fragmentation);GO:0006310(DNA recombination);GO:0034612(response to tumor necrosis factor);GO:0043065(positive regulation of apoptotic process);GO:0046677(response to antibiotic);GO:0046872(metal ion binding)","04210(Apoptosis)","mRNA","agilent G3 V3"]
["A_33_P3252612",13.53,{"v":13.8,"d":"13.80"},13.32,14.97,14.99,15.12,{"v":0.901730257320319,"d":"0.90"},{"v":-0.149232163209831,"d":"-0.15"},"down",{"v":0.000543700000000036,"d":"0.00"},1,"yes","CAAAAATGGAAACACTGACCCGGTGCGGTGGCTCATGCCTGTAATCCCAGCACTTTGGGA","FALSE","NM_017781","ref|NM_017781|ens|ENST00000308919|ref|XM_005249792|gb|AK024104","CYP2W1","cytochrome P450, family 2, subfamily W, polypeptide 1","ref|Homo sapiens cytochrome P450, family 2, subfamily W, polypeptide 1 (CYP2W1), mRNA [NM_017781]","chr7",{"v":1022994,"d":"1022994.00"},1029276,"GO:0005506(iron ion binding);GO:0005737(cytoplasm);GO:0005788(endoplasmic reticulum lumen);GO:0005789(endoplasmic reticulum membrane);GO:0006082(organic acid metabolic process);GO:0006805(xenobiotic metabolic process);GO:0008395(steroid hydroxylase activity);GO:0009986(cell surface);GO:0016712(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen);GO:0019825(oxygen binding);GO:0020037(heme binding);GO:0042738(exogenous drug catabolic process);GO:0043231(intracellular membrane-bounded organelle);GO:0043390(aflatoxin B1 metabolic process);GO:0044281(small molecule metabolic process);GO:0055114(oxidation-reduction process)",null,"mRNA","agilent G3 V3"]
["A_24_P187119",8.87,8.76,9.03,7.39,7.71,7.34,{"v":1.18805704099822,"d":"1.19"},{"v":0.24860410448018,"d":"0.25"},"up",{"v":0.000555269999999997,"d":"0.00"},1,"yes","GGAATGCTCTAGTTCCACTAGACCTTTGGTTTTCACTTAAGGGGGAATCAAGGACCATTG","FALSE","AK098491","gb|AK098491|tc|THC2477995","RPAIN","RPA interacting protein","gb|Homo sapiens cDNA FLJ25625 fis, clone STM02974. [AK098491]","chr17",{"v":5323505,"d":"5323505.00"},5334804,"GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006261(DNA-dependent DNA replication);GO:0006281(DNA repair);GO:0006310(DNA recombination);GO:0006606(protein import into nucleus);GO:0009411(response to UV);GO:0016605(PML body);GO:0032403(protein complex binding);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3413989",7.01,7.15,7.48,9.03,9.18,9.53,{"v":0.780100937274694,"d":"0.78"},{"v":-0.358267288496788,"d":"-0.36"},"down",{"v":0.000561149999999899,"d":"0.00"},1,"yes","AGCTTGCCGACAACCAACTCAACAACCAATTCAGCCACCAAAATAACAGCTAATACCACT","FALSE","NM_000062","ref|NM_000062|ref|NM_001032295|ens|ENST00000405496|ens|ENST00000619430","SERPING1","serpin peptidase inhibitor, clade G (C1 inhibitor), member 1","ref|Homo sapiens serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 (SERPING1), transcript variant 1, mRNA [NM_000062]","chr11",57365276,57382287,"GO:0001869(negative regulation of complement activation, lectin pathway);GO:0002576(platelet degranulation);GO:0004867(serine-type endopeptidase inhibitor activity);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006958(complement activation, classical pathway);GO:0007568(aging);GO:0007596(blood coagulation);GO:0007597(blood coagulation, intrinsic pathway);GO:0008015(blood circulation);GO:0010951(negative regulation of endopeptidase activity);GO:0030168(platelet activation);GO:0031093(platelet alpha granule lumen);GO:0042730(fibrinolysis);GO:0045087(innate immune response);GO:0070062(extracellular vesicular exosome);GO:0072562(blood microparticle)","04610(Complement and coagulation cascades);05133(Pertussis)","mRNA","agilent G3 V3"]
["A_33_P3242783",5.12,4.73,5.25,6.79,7.21,7.11,{"v":0.715300805305543,"d":"0.72"},{"v":-0.483378029134714,"d":"-0.48"},"down",{"v":0.000575380000000014,"d":"0.00"},1,"yes","ATGTAAGACTCCTGCTCCAGCTTTGCCTTTTGCCACAAGTAAAAGCTCCTTAAGGTTTCC","FALSE","AK131474","gb|AK131474","LOC440082","uncharacterized LOC440082","gb|Homo sapiens cDNA FLJ16642 fis, clone TESTI4029348. [AK131474]","chr12",11005925,11009863,null,null,"mRNA","agilent G3 V3"]
["A_24_P44931",1.95,1.95,1.94,3.87,3.86,3.73,{"v":0.509598603839441,"d":"0.51"},{"v":-0.972566769876888,"d":"-0.97"},"down",{"v":0.000581029999999982,"d":"0.00"},1,"yes","ATCCTTTGCAGCCATCAACAAGTTCCAGCCGTTCAACGTGGCTGTTTCTAGCAACGTGCT","FALSE","NM_032868","ref|NM_032868|ref|NM_001159846|ref|NM_001300862|ens|ENST00000359935","MPND","MPN domain containing","ref|Homo sapiens MPN domain containing (MPND), transcript variant 1, mRNA [NM_032868]","chr19",{"v":4352987,"d":"4352987.00"},4354574,"GO:0006508(proteolysis);GO:0008233(peptidase activity)",null,"mRNA","agilent G3 V3"]
["A_33_P3329607",8.62,8.85,8.95,7.57,7.67,7.78,{"v":1.14769765421373,"d":"1.15"},{"v":0.198742633114597,"d":"0.20"},"up",{"v":0.000597210000000015,"d":"0.00"},1,"yes","TTTGCAGACTCTCTGGGCATCCCCTTCTTGGAGACGAGCGCCAAGAATGCCACCAATGTC","FALSE","NM_030981","ref|NM_030981|ens|ENST00000311481|ens|ENST00000615245|ens|ENST00000409159","RAB1B","RAB1B, member RAS oncogene family","ref|Homo sapiens RAB1B, member RAS oncogene family (RAB1B), mRNA [NM_030981]","chr11",66036060,66044100,"GO:0000139(Golgi membrane);GO:0003924(GTPase activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005739(mitochondrion);GO:0005789(endoplasmic reticulum membrane);GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005794(Golgi apparatus);GO:0006184(GTP catabolic process);GO:0006886(intracellular protein transport);GO:0006888(ER to Golgi vesicle-mediated transport);GO:0006914(autophagy);GO:0019003(GDP binding);GO:0019068(virion assembly);GO:0032482(Rab protein signal transduction);GO:0034045(pre-autophagosomal structure membrane);GO:0070062(extracellular vesicular exosome);GO:2000785(regulation of autophagic vacuole assembly)","05134(Legionellosis)","mRNA","agilent G3 V3"]
["A_32_P49508",7.43,{"v":7.3,"d":"7.30"},7.57,6.14,5.85,5.67,{"v":1.26274065685164,"d":"1.26"},{"v":0.336558367159201,"d":"0.34"},"up",{"v":0.000601819999999975,"d":"0.00"},1,"yes","ACGACCTCCCATGTTTGTTACATGCATCCAGTTTACCACACTTTACCTGTCATCAGTTAT","FALSE","NM_019036","ref|NM_019036|ref|NM_001287746|ref|NM_001042406|ref|NM_001287741","HMGCLL1","3-hydroxymethyl-3-methylglutaryl-CoA lyase-like 1","ref|Homo sapiens 3-hydroxymethyl-3-methylglutaryl-CoA lyase-like 1 (HMGCLL1), transcript variant 1, mRNA [NM_019036]","chr6",55300216,55304526,"GO:0004419(hydroxymethylglutaryl-CoA lyase activity);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0016020(membrane);GO:0046872(metal ion binding);GO:0046951(ketone body biosynthetic process);GO:0048471(perinuclear region of cytoplasm)","00650(Butanoate metabolism);00072(Synthesis and degradation of ketone bodies);00280(Valine, leucine and isoleucine degradation);04146(Peroxisome)","mRNA","agilent G3 V3"]
["A_23_P152055",{"v":2.8,"d":"2.80"},3.18,2.87,4.33,4.68,4.43,{"v":0.658482142857143,"d":"0.66"},{"v":-0.6027837778084,"d":"-0.60"},"down",{"v":0.000616080000000019,"d":"0.00"},1,"yes","GTAGCTACCTACTACTGGTGGATTCTTTTCCTTATAGTGAATTTAAAAGTATCATCAAGG","FALSE","NM_024580","ref|NM_024580|ref|NM_001040610|ens|ENST00000359445|ens|ENST00000268206","EFTUD1","elongation factor Tu GTP binding domain containing 1","ref|Homo sapiens elongation factor Tu GTP binding domain containing 1 (EFTUD1), transcript variant 1, mRNA [NM_024580]","chr15",82422576,82555055,"GO:0003746(translation elongation factor activity);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0006184(GTP catabolic process);GO:0006414(translational elongation);GO:0042256(mature ribosome assembly);GO:0043022(ribosome binding)","03008(Ribosome biogenesis in eukaryotes)","mRNA","agilent G3 V3"]
["A_33_P3346871",7.33,6.96,7.23,5.84,{"v":5.5,"d":"5.50"},5.47,{"v":1.28019036287924,"d":"1.28"},{"v":0.356358353320457,"d":"0.36"},"up",{"v":0.000638269999999941,"d":"0.00"},1,"yes","GGTGTCCACAAGTTCTGTTCATTGGCACTGTGGAACCCCCATAAAATCAAAGAAAAATCA","FALSE","AW593215","gb|AW593215",null,null,"gb|hg11b12.x1 Soares_NFL_T_GBC_S1 Homo sapiens cDNA clone IMAGE:2945279 3' similar to gb:X62048_cds1 WEE1-LIKE PROTEIN KINASE (HUMAN);, mRNA sequence [AW593215]","chr17",22192652,22194158,null,null,"mRNA","agilent G3 V3"]
["A_32_P360193",8.12,8.03,8.34,7.17,7.09,7.25,{"v":1.13854021385402,"d":"1.14"},{"v":0.187185249140917,"d":"0.19"},"up",{"v":0.000643410000000011,"d":"0.00"},1,"yes","GTTCTGGCCCATCTTTGATACCTTCATAAGGGATTCTATTAGTCGCCTCTCCAACTACCC","FALSE","NM_144666","ref|NM_144666|ens|ENST00000532027|ens|ENST00000533649|ens|ENST00000254579","DNHD1","dynein heavy chain domain 1","ref|Homo sapiens dynein heavy chain domain 1 (DNHD1), transcript variant 1, mRNA [NM_144666]","chr11",{"v":6518526,"d":"6518526.00"},6593252,"GO:0003777(microtubule motor activity);GO:0007018(microtubule-based movement);GO:0008152(metabolic process);GO:0030286(dynein complex);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P252335",4.05,3.49,3.94,6.64,6.27,5.98,{"v":0.607728957120169,"d":"0.61"},{"v":-0.718500059712682,"d":"-0.72"},"down",{"v":0.000655440000000063,"d":"0.00"},1,"yes","GCCGAATCCAAATTGTCCTTTGCCACTTGTAAAAGCTGAACTCTAGTCTGTGTCCTCCAT","FALSE","NM_018944","ref|NM_018944|ens|ENST00000290130|gb|AF231921|gb|AF387845","MIS18A","MIS18 kinetochore protein A","ref|Homo sapiens MIS18 kinetochore protein A (MIS18A), mRNA [NM_018944]","chr21",33641920,33642889,"GO:0000775(chromosome, centromeric region);GO:0003674(molecular_function);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006334(nucleosome assembly);GO:0007059(chromosome segregation);GO:0007067(mitosis);GO:0008150(biological_process);GO:0034080(CenH3-containing nucleosome assembly at centromere);GO:0044030(regulation of DNA methylation);GO:0051301(cell division)",null,"mRNA","agilent G3 V3"]
["A_33_P3322654",5.97,{"v":5.9,"d":"5.90"},5.17,8.24,8.07,8.24,{"v":0.694093686354379,"d":"0.69"},{"v":-0.526797688976218,"d":"-0.53"},"down",{"v":0.000675109999999979,"d":"0.00"},1,"yes","CAGCCTGGGACTGCTGTGATGGGGTATCACGGTGATGGTCCCATTAAACTTCCACTCTGC","FALSE","NM_018226","ref|NM_018226|ens|ENST00000481757|ens|ENST00000486058|ref|XM_005247036","RNPEPL1","arginyl aminopeptidase (aminopeptidase B)-like 1","ref|Homo sapiens arginyl aminopeptidase (aminopeptidase B)-like 1 (RNPEPL1), mRNA [NM_018226]","chr2",241514912,241518141,"GO:0004177(aminopeptidase activity);GO:0006508(proteolysis);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0019370(leukotriene biosynthetic process)",null,"mRNA","agilent G3 V3"]
["A_23_P376599",4.93,5.11,4.29,7.14,7.14,7.28,{"v":0.664656771799629,"d":"0.66"},{"v":-0.58931856849036,"d":"-0.59"},"down",{"v":0.000679879999999966,"d":"0.00"},1,"yes","TGTCCTGTCGGTCTCAGTACGTTCACTTTATAGCTGCTGGCAATATCGAAGGTTCCTTTT","FALSE","NM_006788","ref|NM_006788|ens|ENST00000019317|ens|ENST00000383432|ref|XM_006722295","RALBP1","ralA binding protein 1","ref|Homo sapiens ralA binding protein 1 (RALBP1), mRNA [NM_006788]","chr18",{"v":9475668,"d":"9475668.00"},9538114,"GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0006810(transport);GO:0006935(chemotaxis);GO:0007165(signal transduction);GO:0007264(small GTPase mediated signal transduction);GO:0008152(metabolic process);GO:0016020(membrane);GO:0016887(ATPase activity);GO:0017160(Ral GTPase binding);GO:0030675(Rac GTPase activator activity);GO:0032855(positive regulation of Rac GTPase activity);GO:0043087(regulation of GTPase activity);GO:0043089(positive regulation of Cdc42 GTPase activity);GO:0043492(ATPase activity, coupled to movement of substances);GO:0048365(Rac GTPase binding);GO:0051056(regulation of small GTPase mediated signal transduction)","04014(Ras signaling pathway);05200(Pathways in cancer);05212(Pancreatic cancer)","mRNA","agilent G3 V3"]
["A_33_P3263603",11.81,11.73,11.83,11.11,10.97,{"v":11.2,"d":"11.20"},{"v":1.06280048076923,"d":"1.06"},{"v":0.0878707855598265,"d":"0.09"},"up",{"v":0.000696719999999984,"d":"0.00"},1,"yes","ATGAGAAGATGCTCCAGCTGCAGTCCAAAGCCCAACACCCCCAAGTGTGCCACGTGTGAT","FALSE","ENST00000592994","ens|ENST00000592994|ens|ENST00000457191|ens|ENST00000440782|ens|ENST00000422015",null,null,"ens|capicua transcriptional repressor pseudogene 19 [Source:HGNC Symbol;Acc:HGNC:48829] [ENST00000592994]","chr11",{"v":123312,"d":"123312.00"},126123,null,null,"mRNA","agilent G3 V3"]
["A_33_P3415923",10.51,10.46,10.24,11.19,11.31,11.26,{"v":0.92446682464455,"d":"0.92"},{"v":-0.113306546787975,"d":"-0.11"},"down",{"v":0.000699530000000004,"d":"0.00"},1,"yes","ATGTGGGGGCCCACTTTTTTGTACATGTACCACCTCCCTTTCCTCTTACTGTACATAAAC","FALSE","NM_175736","ref|NM_175736|ref|NM_198900|ens|ENST00000352151|ens|ENST00000549137","FMNL3","formin-like 3","ref|Homo sapiens formin-like 3 (FMNL3), transcript variant 1, mRNA [NM_175736]","chr12",50038736,50101176,"GO:0003779(actin binding);GO:0005737(cytoplasm);GO:0007010(cytoskeleton organization);GO:0008360(regulation of cell shape);GO:0016477(cell migration);GO:0017048(Rho GTPase binding);GO:0030036(actin cytoskeleton organization);GO:0032794(GTPase activating protein binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3282018",8.91,8.59,8.93,7.34,7.56,7.19,{"v":1.19646899049344,"d":"1.20"},{"v":0.258783006286295,"d":"0.26"},"up",{"v":0.000716669999999975,"d":"0.00"},1,"yes","AATGCTGAAATACAGCAGGAACTGCGAGGGGGCTGAGGACCTGCAGGAGGCGCTGAGCTC","FALSE","NM_024979","ref|NM_024979|ref|NM_001112732|ens|ENST00000375597|ens|ENST00000375608","MCF2L","MCF.2 cell line derived transforming sequence-like","ref|Homo sapiens MCF.2 cell line derived transforming sequence-like (MCF2L), transcript variant 2, mRNA [NM_024979]","chr13",113656032,113751224,"GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005545(1-phosphatidylinositol binding);GO:0005615(extracellular space);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007264(small GTPase mediated signal transduction);GO:0007266(Rho protein signal transduction);GO:0030027(lamellipodium);GO:0032321(positive regulation of Rho GTPase activity);GO:0043065(positive regulation of apoptotic process);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048011(nerve growth factor receptor signaling pathway);GO:0051056(regulation of small GTPase mediated signal transduction);GO:0097190(apoptotic signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_23_P139740",7.32,{"v":7.3,"d":"7.30"},7.31,5.62,{"v":5.5,"d":"5.50"},5.65,{"v":1.30769230769231,"d":"1.31"},{"v":0.387023123109247,"d":"0.39"},"up",{"v":0.00072017000000002,"d":"0.00"},1,"yes","GTGCCGTCCCAAAGAATACCGTTTGCAGGACTACACACTTGAAAACCAGAGTTTTCAACT","FALSE","NM_019854","ref|NM_019854|ref|NM_001256536|ens|ENST00000543701|ens|ENST00000261252","PRMT8","protein arginine methyltransferase 8","ref|Homo sapiens protein arginine methyltransferase 8 (PRMT8), transcript variant 1, mRNA [NM_019854]","chr12",{"v":3647380,"d":"3647380.00"},3703139,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006355(regulation of transcription, DNA-dependent);GO:0008469(histone-arginine N-methyltransferase activity);GO:0008757(S-adenosylmethionine-dependent methyltransferase activity);GO:0016571(histone methylation);GO:0018216(peptidyl-arginine methylation);GO:0019919(peptidyl-arginine methylation, to asymmetrical-dimethyl arginine);GO:0034969(histone arginine methylation);GO:0035241(protein-arginine omega-N monomethyltransferase activity);GO:0035242(protein-arginine omega-N asymmetric methyltransferase activity);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043393(regulation of protein binding);GO:0043985(histone H4-R3 methylation);GO:0044020(histone methyltransferase activity (H4-R3 specific));GO:0046982(protein heterodimerization activity)",null,"mRNA","agilent G3 V3"]
["A_23_P75500",3.72,3.31,3.52,5.45,4.98,5.19,{"v":0.675416133162612,"d":"0.68"},{"v":-0.566151454547432,"d":"-0.57"},"down",{"v":0.000720420000000055,"d":"0.00"},1,"yes","GAGAAGACAGCCGAAGTCAAAGCCACATCCTCTTGCTGATGTTGGATGCAGGCTGTCCGG","FALSE","NM_001024957","ref|NM_001024957|ref|NM_015399|ens|ENST00000530238|ens|ENST00000359957","BRMS1","breast cancer metastasis suppressor 1","ref|Homo sapiens breast cancer metastasis suppressor 1 (BRMS1), transcript variant 2, mRNA [NM_001024957]","chr11",66105712,66112283,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0004407(histone deacetylase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006325(chromatin organization);GO:0006351(transcription, DNA-dependent);GO:0006915(apoptotic process);GO:0016575(histone deacetylation);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0042826(histone deacetylase binding);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0051059(NF-kappaB binding);GO:0070822(Sin3-type complex);GO:0090312(positive regulation of protein deacetylation);GO:2000210(positive regulation of anoikis)",null,"mRNA","agilent G3 V3"]
["A_23_P71752",6.01,6.34,5.66,7.95,7.89,{"v":7.8,"d":"7.80"},{"v":0.761844331641286,"d":"0.76"},{"v":-0.392431854271257,"d":"-0.39"},"down",{"v":0.000737070000000006,"d":"0.00"},1,"yes","TGTAGGACTCTAGTGTTCTTGGGTGTATTGCATGGGCTGCATTATCTACAGCATTGTACA","FALSE","NM_006007","ref|NM_006007|ref|NM_001102420|ref|NM_001102421|ref|NM_001278243","ZFAND5","zinc finger, AN1-type domain 5","ref|Homo sapiens zinc finger, AN1-type domain 5 (ZFAND5), transcript variant c, mRNA [NM_006007]","chr9",74966344,74980163,"GO:0001701(in utero embryonic development);GO:0001944(vasculature development);GO:0003016(respiratory system process);GO:0003674(molecular_function);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005575(cellular_component);GO:0005737(cytoplasm);GO:0008150(biological_process);GO:0008270(zinc ion binding);GO:0010761(fibroblast migration);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0048705(skeletal system morphogenesis);GO:0048745(smooth muscle tissue development);GO:0060324(face development)",null,"mRNA","agilent G3 V3"]
["A_23_P99063",8.24,7.54,7.95,11.07,{"v":10.5,"d":"10.50"},10.38,{"v":0.742723004694836,"d":"0.74"},{"v":-0.429103830640409,"d":"-0.43"},"down",{"v":0.00073968000000002,"d":"0.00"},1,"yes","TTTTTATTTCTACTGTCAAATGATGTGCAAAACCTTTTACTGGTTGCATGGAAATCAGCC","FALSE","NM_002345","ref|NM_002345|ens|ENST00000548071|gb|AK223177|gb|U21128","LUM","lumican","ref|Homo sapiens lumican (LUM), mRNA [NM_002345]","chr12",91497920,91505216,"GO:0005201(extracellular matrix structural constituent);GO:0005515(protein binding);GO:0005518(collagen binding);GO:0005576(extracellular region);GO:0005578(proteinaceous extracellular matrix);GO:0005583(fibrillar collagen);GO:0005615(extracellular space);GO:0005796(Golgi lumen);GO:0005975(carbohydrate metabolic process);GO:0007601(visual perception);GO:0009405(pathogenesis);GO:0014070(response to organic cyclic compound);GO:0018146(keratan sulfate biosynthetic process);GO:0030198(extracellular matrix organization);GO:0030199(collagen fibril organization);GO:0030203(glycosaminoglycan metabolic process);GO:0031012(extracellular matrix);GO:0042339(keratan sulfate metabolic process);GO:0042340(keratan sulfate catabolic process);GO:0043202(lysosomal lumen);GO:0044281(small molecule metabolic process);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0051216(cartilage development);GO:0070062(extracellular vesicular exosome);GO:0070848(response to growth factor stimulus)","05205(Proteoglycans in cancer)","mRNA","agilent G3 V3"]
["A_23_P25974",3.72,{"v":3.1,"d":"3.10"},2.76,5.88,5.74,5.94,{"v":0.545558086560364,"d":"0.55"},{"v":-0.874195283799178,"d":"-0.87"},"down",{"v":0.000757890000000039,"d":"0.00"},1,"yes","AGCTTCAAATGGAATATTTACCGACATTCCTTATACATGACAGACACTTGGCTACATGGG","FALSE","NM_001010854","ref|NM_001010854|ens|ENST00000555005|ref|XM_006720059|ref|XM_006720058","TTC7B","tetratricopeptide repeat domain 7B","ref|Homo sapiens tetratricopeptide repeat domain 7B (TTC7B), mRNA [NM_001010854]","chr14",91006936,91282761,null,null,"mRNA","agilent G3 V3"]
["A_33_P3396612",7.75,7.85,7.29,9.27,9.19,{"v":9.3,"d":"9.30"},{"v":0.824567723342939,"d":"0.82"},{"v":-0.278290105022574,"d":"-0.28"},"down",{"v":0.000760000000000094,"d":"0.00"},1,"yes","GGATTCTCTTACTTTCCTCTGCCTGCCTCAGTTTAATTATTTTGTCCTGCAAAAATACCA","FALSE","ENST00000567036","ens|ENST00000567036|linc|TCONS_l2_00010128|tc|THC2721303","BMS1P20","BMS1 pseudogene 20","ens|BMS1 pseudogene 8 [Source:HGNC Symbol;Acc:HGNC:49152] [ENST00000567036]","chr16",33489796,33500971,null,null,"mRNA","agilent G3 V3"]
["A_33_P3227904",5.25,5.15,5.09,6.98,7.23,6.59,{"v":0.744711538461538,"d":"0.74"},{"v":-0.425246384238886,"d":"-0.43"},"down",{"v":0.000764520000000046,"d":"0.00"},1,"yes","CTCCCAGGAACACCTGCTACTGCACACTCCAAACCAATAAAGTTTTATATTTTGTTTACT","FALSE","NM_207348","ref|NM_207348|ens|ENST00000294454|ref|XM_005245856|gb|AK024244","SLC25A34","solute carrier family 25, member 34","ref|Homo sapiens solute carrier family 25, member 34 (SLC25A34), mRNA [NM_207348]","chr1",16062900,16067891,"GO:0005743(mitochondrial inner membrane);GO:0006810(transport);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P313223",10.13,10.05,10.06,8.89,9.14,8.71,{"v":1.13089005235602,"d":"1.13"},{"v":0.17745867412772,"d":"0.18"},"up",{"v":0.000782210000000005,"d":"0.00"},1,"yes","GCCTTACACAAGAGTGGTCATAAGGGGGTTTGAACTGAGTCCCACTACCTCGGGGGACAC","FALSE","NM_138471","ref|NM_138471|ens|ENST00000294244|ref|XM_006718437|gb|AK091493","C11orf84","chromosome 11 open reading frame 84","ref|Homo sapiens chromosome 11 open reading frame 84 (C11orf84), mRNA [NM_138471]","chr11",63580860,63595190,null,null,"mRNA","agilent G3 V3"]
["A_23_P44295",9.62,9.61,9.59,9.19,9.28,9.13,{"v":1.04420289855072,"d":"1.04"},{"v":0.062402068509216,"d":"0.06"},"up",{"v":0.000796889999999939,"d":"0.00"},1,"yes","GAGTACTGAATGGATGATTTGTCATAGGCTTTCCCCTTTCTTTCTGTTCTAGCAGCAGGA","FALSE","NM_015097","ref|NM_015097|ref|NM_001207044|ens|ENST00000480013|ens|ENST00000359576","CLASP2","cytoplasmic linker associated protein 2","ref|Homo sapiens cytoplasmic linker associated protein 2 (CLASP2), transcript variant 1, mRNA [NM_015097]","chr3",33537740,33686807,"GO:0000278(mitotic cell cycle);GO:0000777(condensed chromosome kinetochore);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005802(trans-Golgi network);GO:0005815(microtubule organizing center);GO:0005828(kinetochore microtubule);GO:0005829(cytosol);GO:0005874(microtubule);GO:0005881(cytoplasmic microtubule);GO:0005886(plasma membrane);GO:0005938(cell cortex);GO:0007020(microtubule nucleation);GO:0007026(negative regulation of microtubule depolymerization);GO:0007067(mitosis);GO:0007163(establishment or maintenance of cell polarity);GO:0007411(axon guidance);GO:0008107(galactoside 2-alpha-L-fucosyltransferase activity);GO:0016020(membrane);GO:0031023(microtubule organizing center organization);GO:0031110(regulation of microtubule polymerization or depolymerization);GO:0032587(ruffle membrane);GO:0032886(regulation of microtubule-based process);GO:0034453(microtubule anchoring);GO:0036065(fucosylation);GO:0051010(microtubule plus-end binding);GO:0051301(cell division)",null,"mRNA","agilent G3 V3"]
["A_23_P47709",6.98,7.13,6.86,8.49,8.13,8.16,{"v":0.846246973365617,"d":"0.85"},{"v":-0.240849326044009,"d":"-0.24"},"down",{"v":0.000801289999999955,"d":"0.00"},1,"yes","CCTTAAGCATGCTTCTATTAGTCACCTAACCCTCTGTCACCCAGTCTGTTGCTGCTCCAT","FALSE","NM_000803","ref|NM_000803|ref|NM_001113534|ref|NM_001113535|ref|NM_001113536","FOLR2","folate receptor 2 (fetal)","ref|Homo sapiens folate receptor 2 (fetal) (FOLR2), transcript variant 1, mRNA [NM_000803]","chr11",71929584,71932610,"GO:0005542(folic acid binding);GO:0005576(extracellular region);GO:0008517(folic acid transporter activity);GO:0015884(folic acid transport);GO:0016020(membrane);GO:0031362(anchored to external side of plasma membrane)","04144(Endocytosis)","mRNA","agilent G3 V3"]
["A_22_P00023644",9.76,9.72,9.91,8.99,{"v":8.8,"d":"8.80"},8.68,{"v":1.11031356252361,"d":"1.11"},{"v":0.150967164155934,"d":"0.15"},"up",{"v":0.000817669999999993,"d":"0.00"},1,"yes","AGGTCACCTTTACTCTCAGAAGGAAACTGACCCCCTGACCTATTAAATAGCTGAAATCAA","FALSE","XR_243157","ref|XR_243157|ref|XR_248123|ref|XR_253381|linc|lnc-FAM63B-2:2","LOC101928668","uncharacterized LOC101928668","ref|PREDICTED: Homo sapiens uncharacterized LOC101928668 (LOC101928668), ncRNA [XR_243157]","chr15",58813508,58815570,null,null,"mRNA","agilent G3 V3"]
["A_23_P301521",5.78,4.82,{"v":4.8,"d":"4.80"},8.15,8.66,8.28,{"v":0.613790354722997,"d":"0.61"},{"v":-0.704182119826909,"d":"-0.70"},"down",{"v":0.00083681999999996,"d":"0.00"},1,"yes","CAAGAAGCTCTTGTATTTCTCTGCACAGTGTAAATATCCTTGCTATTTCAGGATGGCGGC","FALSE","NM_020848","ref|NM_020848|ens|ENST00000375377|ens|ENST00000464386|ref|XM_005252549","KIAA1462","KIAA1462","ref|Homo sapiens KIAA1462 (KIAA1462), mRNA [NM_020848]","chr10",30301732,30302847,"GO:0005911(cell-cell junction);GO:0005912(adherens junction);GO:0007155(cell adhesion)",null,"mRNA","agilent G3 V3"]
["A_33_P3384721",10.08,10.08,10.04,9.66,9.78,9.74,{"v":1.03495544893763,"d":"1.03"},{"v":0.0495686662945503,"d":"0.05"},"up",{"v":0.000839119999999971,"d":"0.00"},1,"yes","GCACTGGCACCTAGACATGTACAACAGGAACCGTGTGGATACATCCCCCACACCTGTTTC","FALSE","NM_005004","ref|NM_005004|ref|NM_001284368|ref|NM_001284367|ens|ENST00000533549","NDUFB8","NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, 19kDa","ref|Homo sapiens NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, 19kDa (NDUFB8), transcript variant 1, mRNA [NM_005004]","chr10",102267200,102289638,"GO:0005743(mitochondrial inner membrane);GO:0005747(mitochondrial respiratory chain complex I);GO:0005783(endoplasmic reticulum);GO:0006120(mitochondrial electron transport, NADH to ubiquinone);GO:0008137(NADH dehydrogenase (ubiquinone) activity);GO:0016021(integral to membrane);GO:0022904(respiratory electron transport chain);GO:0044237(cellular metabolic process);GO:0044281(small molecule metabolic process)","00190(Oxidative phosphorylation);05010(Alzheimer's disease);05012(Parkinson's disease);05016(Huntington's disease);04932(Non-alcoholic fatty liver disease (NAFLD))","mRNA","agilent G3 V3"]
["A_23_P334608",5.06,4.58,4.08,7.07,7.24,7.36,{"v":0.633133364097831,"d":"0.63"},{"v":-0.659418671920861,"d":"-0.66"},"down",{"v":0.000855900000000021,"d":"0.00"},1,"yes","TGTGGTCATCTATTCTAGCAGGGAACACTAAAGGTGGAAATAAAAGATTTTCTATTATGG","FALSE","NM_000181","ref|NM_000181|ref|NM_001293104|ref|NM_001293105|ref|NM_001284290","GUSB","glucuronidase, beta","ref|Homo sapiens glucuronidase, beta (GUSB), transcript variant 1, mRNA [NM_000181]","chr7",65425688,65447198,"GO:0004566(beta-glucuronidase activity);GO:0005102(receptor binding);GO:0005975(carbohydrate metabolic process);GO:0006027(glycosaminoglycan catabolic process);GO:0009405(pathogenesis);GO:0016020(membrane);GO:0019904(protein domain specific binding);GO:0030203(glycosaminoglycan metabolic process);GO:0030212(hyaluronan metabolic process);GO:0030214(hyaluronan catabolic process);GO:0043202(lysosomal lumen);GO:0043231(intracellular membrane-bounded organelle);GO:0044281(small molecule metabolic process);GO:0070062(extracellular vesicular exosome)","00040(Pentose and glucuronate interconversions);00500(Starch and sucrose metabolism);00531(Glycosaminoglycan degradation);00860(Porphyrin and chlorophyll metabolism);00983(Drug metabolism - other enzymes);04142(Lysosome)","mRNA","agilent G3 V3"]
["A_33_P3237674",10.99,10.86,10.83,10.34,10.23,10.37,{"v":1.05623787976729,"d":"1.06"},{"v":0.0789347866966478,"d":"0.08"},"up",{"v":0.000875509999999968,"d":"0.00"},1,"yes","ACGAACCTAAACTTTCAAAACCTGTCAGTGATTGGGTTCCGAATCCTCCTCCTGAAAGTG","FALSE","ENST00000613353","ens|ENST00000613353|ens|ENST00000618259|ens|ENST00000616778|ens|ENST00000611116",null,null,"ens|T cell receptor alpha constant [Source:HGNC Symbol;Acc:HGNC:12029] [ENST00000613353]","chr14",23016448,23021097,null,null,"mRNA","agilent G3 V3"]
["A_23_P411953",5.66,4.89,5.08,7.23,{"v":7.5,"d":"7.50"},7.43,{"v":0.705324909747292,"d":"0.71"},{"v":-0.503640103049524,"d":"-0.50"},"down",{"v":0.000895569999999957,"d":"0.00"},1,"yes","GCTGCTCAACTCTTGTGTTTGTTGTTCTGTTTGCCCCATTTATCTGTTGCTGTTTTTGTG","FALSE","NM_138300","ref|NM_138300|ens|ENST00000368457|gb|AK092389|gb|AX747515","PYGO2","pygopus family PHD finger 2","ref|Homo sapiens pygopus family PHD finger 2 (PYGO2), mRNA [NM_138300]","chr1",154929504,154934224,"GO:0001701(in utero embryonic development);GO:0001822(kidney development);GO:0002088(lens development in camera-type eye);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0007289(spermatid nucleus differentiation);GO:0007420(brain development);GO:0008270(zinc ion binding);GO:0009791(post-embryonic development);GO:0030879(mammary gland development);GO:0033599(regulation of mammary gland epithelial cell proliferation);GO:0035034(histone acetyltransferase regulator activity);GO:0035065(regulation of histone acetylation);GO:0035563(positive regulation of chromatin binding);GO:0042393(histone binding);GO:0048589(developmental growth);GO:0051569(regulation of histone H3-K4 methylation);GO:0060021(palate development);GO:0060070(canonical Wnt receptor signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_33_P3293265",5.89,5.71,5.76,4.39,4.69,4.79,{"v":1.25162220620043,"d":"1.25"},{"v":0.323799160120877,"d":"0.32"},"up",{"v":0.000902199999999964,"d":"0.00"},1,"yes","AGATGAAGAAGTATTCCTCAATATTCCTTGTGTCCTGGGAAAGCTGACCCCTGAAGAGGA","FALSE","ENST00000405916","ens|ENST00000405916",null,null,"ens|lactate dehydrogenase A-like 6F, pseudogene [Source:HGNC Symbol;Acc:HGNC:44240] [ENST00000405916]","chr6",157720080,157721158,null,null,"mRNA","agilent G3 V3"]
["A_23_P97932",{"v":5,"d":"5.00"},5.52,4.72,7.24,7.45,7.16,{"v":0.697482837528604,"d":"0.70"},{"v":-0.519770376894639,"d":"-0.52"},"down",{"v":0.000916030000000068,"d":"0.00"},1,"yes","CACGTGTTTCCTGATGGACCTGGGCCCAATGGTCAGAGGTTTTGCATCAACAGTGTGGCT","FALSE","NM_012228","ref|NM_012228|ens|ENST00000468633|ens|ENST00000472663|ens|ENST00000376510","MSRB2","methionine sulfoxide reductase B2","ref|Homo sapiens methionine sulfoxide reductase B2 (MSRB2), mRNA [NM_012228]","chr10",23408072,23409822,"GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0003779(actin binding);GO:0005739(mitochondrion);GO:0006355(regulation of transcription, DNA-dependent);GO:0006979(response to oxidative stress);GO:0008270(zinc ion binding);GO:0030041(actin filament polymerization);GO:0030091(protein repair);GO:0033743(peptide-methionine (R)-S-oxide reductase activity);GO:0055114(oxidation-reduction process)",null,"mRNA","agilent G3 V3"]
["A_33_P3410459",7.93,7.79,7.16,9.72,10.12,{"v":10,"d":"10.00"},{"v":0.766756032171582,"d":"0.77"},{"v":-0.383160483476848,"d":"-0.38"},"down",{"v":0.000937809999999928,"d":"0.00"},1,"yes","GTTCACTTCATGCGGTTCTTGACATGTTTATTTCTACCCTTAATGCAATGAAATGTTTCA","FALSE","NM_001204255","ref|NM_001204255|ref|NM_005506|ens|ENST00000264896|gb|AK056001","SCARB2","scavenger receptor class B, member 2","ref|Homo sapiens scavenger receptor class B, member 2 (SCARB2), transcript variant 2, mRNA [NM_001204255]","chr4",77079888,77135046,"GO:0004872(receptor activity);GO:0005515(protein binding);GO:0005765(lysosomal membrane);GO:0005925(focal adhesion);GO:0006622(protein targeting to lysosome);GO:0007155(cell adhesion);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0019899(enzyme binding);GO:0043202(lysosomal lumen);GO:0070062(extracellular vesicular exosome)","04142(Lysosome)","mRNA","agilent G3 V3"]
["A_23_P6624",2.76,2.82,3.08,4.82,4.96,4.35,{"v":0.612880396319887,"d":"0.61"},{"v":-0.706322535607214,"d":"-0.71"},"down",{"v":0.00095540999999999,"d":"0.00"},1,"yes","TTTGAGTAGACTTGGTGTTTGAGTGCTTCAGATACATTTTTCAGATACAATGTGAAGACA","FALSE","NM_000373","ref|NM_000373|ref|NR_033437|ref|NR_033434|ens|ENST00000479719","UMPS","uridine monophosphate synthetase","ref|Homo sapiens uridine monophosphate synthetase (UMPS), transcript variant 1, mRNA [NM_000373]","chr3",124449296,124463604,"GO:0004588(orotate phosphoribosyltransferase activity);GO:0004590(orotidine-5'-phosphate decarboxylase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006206(pyrimidine base metabolic process);GO:0006207('de novo' pyrimidine base biosynthetic process);GO:0006222(UMP biosynthetic process);GO:0007565(female pregnancy);GO:0007595(lactation);GO:0035690(cellular response to drug);GO:0044205('de novo' UMP biosynthetic process);GO:0044281(small molecule metabolic process);GO:0046134(pyrimidine nucleoside biosynthetic process);GO:0055086(nucleobase-containing small molecule metabolic process)","00240(Pyrimidine metabolism);00983(Drug metabolism - other enzymes)","mRNA","agilent G3 V3"]
["A_33_P3252414",8.04,7.77,7.88,{"v":8.8,"d":"8.80"},8.81,8.63,{"v":0.902820121951219,"d":"0.90"},{"v":-0.147489521377853,"d":"-0.15"},"down",{"v":0.000961509999999999,"d":"0.00"},1,"yes","CTTCCCTGACACTGTCTGCTGCCCCAATCACCGTCACAATAAAAGAAACTGTGGTCTCTA","FALSE","NM_199292","ref|NM_199292|ref|NM_199293|ref|NM_000360|ens|ENST00000381178","TH","tyrosine hydroxylase","ref|Homo sapiens tyrosine hydroxylase (TH), transcript variant 1, mRNA [NM_199292]","chr11",{"v":2185160,"d":"2185160.00"},2193025,"GO:0001666(response to hypoxia);GO:0001963(synaptic transmission, dopaminergic);GO:0001975(response to amphetamine);GO:0003007(heart morphogenesis);GO:0004511(tyrosine 3-monooxygenase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005790(smooth endoplasmic reticulum);GO:0005829(cytosol);GO:0006585(dopamine biosynthetic process from tyrosine);GO:0006631(fatty acid metabolic process);GO:0006665(sphingolipid metabolic process);GO:0007507(heart development);GO:0007601(visual perception);GO:0007605(sensory perception of sound);GO:0007612(learning);GO:0007613(memory);GO:0007617(mating behavior);GO:0007626(locomotory behavior);GO:0008016(regulation of heart contraction);GO:0008021(synaptic vesicle);GO:0008198(ferrous iron binding);GO:0008199(ferric iron binding);GO:0009414(response to water deprivation);GO:0009416(response to light stimulus);GO:0009635(response to herbicide);GO:0009651(response to salt stress);GO:0009653(anatomical structure morphogenesis);GO:0009887(organ morphogenesis);GO:0009898(internal side of plasma membrane);GO:0010043(response to zinc ion);GO:0010259(multicellular organismal aging);GO:0014823(response to activity);GO:0015842(synaptic vesicle amine transport);GO:0016137(glycoside metabolic process);GO:0016597(amino acid binding);GO:0018963(phthalate metabolic process);GO:0019825(oxygen binding);GO:0019899(enzyme binding);GO:0019904(protein domain specific binding);GO:0021987(cerebral cortex development);GO:0030425(dendrite);GO:0031410(cytoplasmic vesicle);GO:0031667(response to nutrient levels);GO:0032355(response to estradiol stimulus);GO:0032496(response to lipopolysaccharide);GO:0033076(isoquinoline alkaloid metabolic process);GO:0033162(melanosome membrane);GO:0034617(tetrahydrobiopterin binding);GO:0034641(cellular nitrogen compound metabolic process);GO:0035176(social behavior);GO:0035240(dopamine binding);GO:0035690(cellular response to drug);GO:0035902(response to immobilization stress);GO:0042136(neurotransmitter biosynthetic process);GO:0042214(terpene metabolic process);GO:0042416(dopamine biosynthetic process);GO:0042418(epinephrine biosynthetic process);GO:0042421(norepinephrine biosynthetic process);GO:0042423(catecholamine biosynthetic process);GO:0042462(eye photoreceptor cell development);GO:0042745(circadian sleep/wake cycle);GO:0042755(eating behavior);GO:0043005(neuron projection);GO:0043195(terminal button);GO:0043204(perikaryon);GO:0043434(response to peptide hormone stimulus);GO:0043473(pigmentation);GO:0044281(small molecule metabolic process);GO:0045471(response to ethanol);GO:0045472(response to ether);GO:0046684(response to pyrethroid);GO:0048596(embryonic camera-type eye morphogenesis);GO:0051412(response to corticosterone stimulus);GO:0051602(response to electrical stimulus);GO:0052314(phytoalexin metabolic process);GO:0055114(oxidation-reduction process);GO:0071287(cellular response to manganese ion);GO:0071316(cellular response to nicotine);GO:0071333(cellular response to glucose stimulus);GO:0071363(cellular response to growth factor stimulus)","00350(Tyrosine metabolism);04917(Prolactin signaling pathway);04728(Dopaminergic synapse);05012(Parkinson's disease);05030(Cocaine addiction);05031(Amphetamine addiction);05034(Alcoholism)","mRNA","agilent G3 V3"]
["A_23_P102864",8.62,8.41,8.69,6.99,7.38,6.89,{"v":1.20978363123236,"d":"1.21"},{"v":0.274749045796843,"d":"0.27"},"up",{"v":0.000977560000000044,"d":"0.00"},1,"yes","TGCAGGCTATGAAGAAGGAGGAATAGATTCTTGTCAGGGGGATTCAGGAGGACCATTAAT","FALSE","NM_002772","ref|NM_002772|ens|ENST00000284885|gb|KF688184|gb|BC111749","TMPRSS15","transmembrane protease, serine 15","ref|Homo sapiens transmembrane protease, serine 15 (TMPRSS15), mRNA [NM_002772]","chr21",19641432,19775973,"GO:0004252(serine-type endopeptidase activity);GO:0005044(scavenger receptor activity);GO:0005903(brush border);GO:0006508(proteolysis);GO:0006898(receptor-mediated endocytosis);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_24_P62615",5.18,5.19,4.79,6.45,6.65,6.91,{"v":0.757621189405297,"d":"0.76"},{"v":-0.40045141373465,"d":"-0.40"},"down",{"v":0.000995229999999903,"d":"0.00"},1,"yes","CCTGGTATTCGATGACGTGGTGGGCATTGTGGAGATAATCAACAGTAAGGATGTCAAAGT","FALSE","NM_006367","ref|NM_006367|ref|NM_001105530|ens|ENST00000372792|ens|ENST00000479759","CAP1","CAP, adenylate cyclase-associated protein 1 (yeast)","ref|Homo sapiens CAP, adenylate cyclase-associated protein 1 (yeast) (CAP1), transcript variant 1, mRNA [NM_006367]","chr1",40536144,40537355,"GO:0001667(ameboidal cell migration);GO:0002576(platelet degranulation);GO:0003779(actin binding);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0006898(receptor-mediated endocytosis);GO:0007163(establishment or maintenance of cell polarity);GO:0007165(signal transduction);GO:0007190(activation of adenylate cyclase activity);GO:0007411(axon guidance);GO:0007596(blood coagulation);GO:0030036(actin cytoskeleton organization);GO:0030168(platelet activation);GO:0030864(cortical actin cytoskeleton);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3324839",8.05,{"v":7.9,"d":"7.90"},8.08,7.47,7.53,7.44,{"v":1.07085561497326,"d":"1.07"},{"v":0.0987639725210734,"d":"0.10"},"up",{"v":0.00100279999999997,"d":"0.00"},1,"yes","TTGGTCTCTACTCCCAGGGGGAGGGGGGAACTTACTCTAGGAAAAGCCATGTCTCTCTCC","FALSE","NM_006772","ref|NM_006772|ens|ENST00000418600|ens|ENST00000455687|gb|AL713634","SYNGAP1","synaptic Ras GTPase activating protein 1","ref|Homo sapiens synaptic Ras GTPase activating protein 1 (SYNGAP1), mRNA [NM_006772]","chr6",33388088,33420172,"GO:0005097(Rab GTPase activator activity);GO:0005099(Ras GTPase activator activity);GO:0005737(cytoplasm);GO:0007265(Ras protein signal transduction);GO:0007389(pattern specification process);GO:0008542(visual learning);GO:0016358(dendrite development);GO:0017124(SH3 domain binding);GO:0031235(intrinsic to internal side of plasma membrane);GO:0032320(positive regulation of Ras GTPase activity);GO:0032851(positive regulation of Rab GTPase activity);GO:0043113(receptor clustering);GO:0043198(dendritic shaft);GO:0043408(regulation of MAPK cascade);GO:0043524(negative regulation of neuron apoptotic process);GO:0046580(negative regulation of Ras protein signal transduction);GO:0048167(regulation of synaptic plasticity);GO:0048169(regulation of long-term neuronal synaptic plasticity);GO:0050771(negative regulation of axonogenesis);GO:0050803(regulation of synapse structure and activity)","04014(Ras signaling pathway)","mRNA","agilent G3 V3"]
["A_33_P3410659",6.52,6.08,6.46,5.05,5.18,5.15,{"v":1.23927178153446,"d":"1.24"},{"v":0.309492615948115,"d":"0.31"},"up",{"v":0.00102071000000004,"d":"0.00"},1,"yes","GAAATTTTTTGGATTTGCGAGAAGACAGCTGCCCCAGTGAAGACTGAGGATTTGGATTAG","FALSE","NM_001129998","ref|NM_001129998|ens|ENST00000544853|ens|ENST00000338896|ref|XR_242889","CLEC12B","C-type lectin domain family 12, member B","ref|Homo sapiens C-type lectin domain family 12, member B (CLEC12B), transcript variant 1, mRNA [NM_001129998]","chr12",10163358,10170551,"GO:0005886(plasma membrane);GO:0016021(integral to membrane);GO:0030246(carbohydrate binding)",null,"mRNA","agilent G3 V3"]
["A_23_P203949",11.24,11.35,{"v":11.3,"d":"11.30"},10.68,10.61,10.82,{"v":1.05543444409841,"d":"1.06"},{"v":0.0778369717582246,"d":"0.08"},"up",{"v":0.00102495000000002,"d":"0.00"},1,"yes","CCGTGTCATCACGGAGACCTTTGTTCCTGTGGGAAAATATCCCTCCCACCTGCAACAGCT","FALSE","NM_030653","ref|NM_030653|ref|NM_001257145|ref|NM_152438|ref|NM_004399","DDX11","DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11","ref|Homo sapiens DEAD/H (Asp-Glu-Ala-Asp/His) box helicase 11 (DDX11), transcript variant 1, mRNA [NM_030653]","chr12",31226780,31257725,"GO:0000790(nuclear chromatin);GO:0000922(spindle pole);GO:0003690(double-stranded DNA binding);GO:0003697(single-stranded DNA binding);GO:0003723(RNA binding);GO:0004003(ATP-dependent DNA helicase activity);GO:0004386(helicase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006987(activation of signaling protein activity involved in unfolded protein response);GO:0007062(sister chromatid cohesion);GO:0008094(DNA-dependent ATPase activity);GO:0016032(viral reproduction);GO:0030496(midbody);GO:0030968(endoplasmic reticulum unfolded protein response);GO:0032508(DNA duplex unwinding);GO:0044267(cellular protein metabolic process);GO:0046872(metal ion binding);GO:0051539(4 iron, 4 sulfur cluster binding);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3287922",11.82,{"v":11.6,"d":"11.60"},11.77,12.56,12.57,12.38,{"v":0.938149826712876,"d":"0.94"},{"v":-0.0921097489118054,"d":"-0.09"},"down",{"v":0.00104128999999997,"d":"0.00"},1,"yes","AGGTCAGTTCCCCTCCATCTGCATACACCTCCCTGTCTTCAAATAATGAGATGGAACTAA","FALSE","ENST00000449821","ens|ENST00000449821|ens|ENST00000373448|ens|ENST00000373447|ref|XR_244159","TTI1","TELO2 interacting protein 1","ens|TELO2 interacting protein 1 [Source:HGNC Symbol;Acc:HGNC:29029] [ENST00000449821]","chr20",36611424,36642305,"GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0031931(TORC1 complex);GO:0031932(TORC2 complex);GO:0032006(regulation of TOR signaling cascade)",null,"mRNA","agilent G3 V3"]
["A_24_P687594",2.01,{"v":2.3,"d":"2.30"},1.97,3.86,4.26,4.67,{"v":0.491008600469116,"d":"0.49"},{"v":-1.02617979999001,"d":"-1.03"},"down",{"v":0.00106013999999999,"d":"0.00"},1,"yes","TATTATTGTCCCATGTACTTTCTAAACTGAGCTTGGAACATTTAGTATTCCTGCAATTGG","FALSE","NM_153713","ref|NM_153713|ens|ENST00000604000|gb|AK123675|gb|AK128733","LIX1L","Lix1 homolog (chicken) like","ref|Homo sapiens Lix1 homolog (chicken) like (LIX1L), mRNA [NM_153713]","chr1",145477088,145501669,"GO:0003674(molecular_function);GO:0005575(cellular_component);GO:0005737(cytoplasm);GO:0006914(autophagy);GO:0008150(biological_process)",null,"mRNA","agilent G3 V3"]
["A_23_P40049",4.64,{"v":4.6,"d":"4.60"},4.35,5.92,{"v":6,"d":"6.00"},5.59,{"v":0.776127926898915,"d":"0.78"},{"v":-0.365633627666167,"d":"-0.37"},"down",{"v":0.00108010000000003,"d":"0.00"},1,"yes","CCTGACACTGATGTGCTCTACATGACTCGAATCCAGAAGGAACGATTTGGCTCTACCCAG","FALSE","NM_004341","ref|NM_004341|ens|ENST00000264705|ref|XM_005264555|ref|XM_005264556","CAD","carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase","ref|Homo sapiens carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase (CAD), mRNA [NM_004341]","chr2",27464788,27466458,"GO:0000050(urea cycle);GO:0001889(liver development);GO:0004070(aspartate carbamoyltransferase activity);GO:0004087(carbamoyl-phosphate synthase (ammonia) activity);GO:0004088(carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity);GO:0004151(dihydroorotase activity);GO:0004672(protein kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006206(pyrimidine base metabolic process);GO:0006207('de novo' pyrimidine base biosynthetic process);GO:0006228(UTP biosynthetic process);GO:0006526(arginine biosynthetic process);GO:0006541(glutamine metabolic process);GO:0006543(glutamine catabolic process);GO:0007507(heart development);GO:0007565(female pregnancy);GO:0007595(lactation);GO:0008270(zinc ion binding);GO:0014075(response to amine stimulus);GO:0016020(membrane);GO:0016363(nuclear matrix);GO:0017144(drug metabolic process);GO:0018107(peptidyl-threonine phosphorylation);GO:0019899(enzyme binding);GO:0031000(response to caffeine);GO:0031100(organ regeneration);GO:0033574(response to testosterone stimulus);GO:0035690(cellular response to drug);GO:0042802(identical protein binding);GO:0042995(cell projection);GO:0043025(neuronal cell body);GO:0043195(terminal button);GO:0043234(protein complex);GO:0044205('de novo' UMP biosynthetic process);GO:0044281(small molecule metabolic process);GO:0046134(pyrimidine nucleoside biosynthetic process);GO:0046777(protein autophosphorylation);GO:0051414(response to cortisol stimulus);GO:0055086(nucleobase-containing small molecule metabolic process);GO:0070062(extracellular vesicular exosome);GO:0070335(aspartate binding);GO:0070409(carbamoyl phosphate biosynthetic process);GO:0071364(cellular response to epidermal growth factor stimulus)","00240(Pyrimidine metabolism);00250(Alanine, aspartate and glutamate metabolism)","mRNA","agilent G3 V3"]
["A_23_P310",5.25,{"v":6.4,"d":"6.40"},5.66,9.69,9.61,8.85,{"v":0.614920071047957,"d":"0.61"},{"v":-0.701529197600953,"d":"-0.70"},"down",{"v":0.00109870000000001,"d":"0.00"},1,"yes","TTCTCCTCTTAAGGCCAGTTGAAGATGGTCCCTTACAGCTTCCCAAGTTAGGTTAGTGAT","FALSE","NM_023009","ref|NM_023009|ref|NR_052852|ens|ENST00000329421|gb|X70326","MARCKSL1","MARCKS-like 1","ref|Homo sapiens MARCKS-like 1 (MARCKSL1), transcript variant 1, mRNA [NM_023009]","chr1",32799432,32801980,"GO:0003779(actin binding);GO:0005516(calmodulin binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0008284(positive regulation of cell proliferation);GO:0070062(extracellular vesicular exosome)","04666(Fc gamma R-mediated phagocytosis);05140(Leishmaniasis)","mRNA","agilent G3 V3"]
["A_23_P104054",2.36,3.15,2.96,{"v":4.8,"d":"4.80"},4.99,5.13,{"v":0.56769436997319,"d":"0.57"},{"v":-0.816813660923039,"d":"-0.82"},"down",{"v":0.00110459000000007,"d":"0.00"},1,"yes","TAAATTTCTTTCCTGTCTGCACAATTAGCTATTCAGAGCAAGAGGGCCTGATTTTATAGA","FALSE","NM_016227","ref|NM_016227|ref|NM_014283|ref|NM_001282751|ref|NM_001282750","SUCO","SUN domain containing ossification factor","ref|Homo sapiens SUN domain containing ossification factor (SUCO), transcript variant 2, mRNA [NM_016227]","chr1",172501616,172580971,"GO:0001503(ossification);GO:0005791(rough endoplasmic reticulum);GO:0007275(multicellular organismal development);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0030867(rough endoplasmic reticulum membrane);GO:0032967(positive regulation of collagen biosynthetic process);GO:0045669(positive regulation of osteoblast differentiation);GO:0046850(regulation of bone remodeling)",null,"mRNA","agilent G3 V3"]
["A_23_P87082",7.93,8.13,8.26,7.25,7.16,{"v":7.3,"d":"7.30"},{"v":1.120221096269,"d":"1.12"},{"v":0.163783502828441,"d":"0.16"},"up",{"v":0.00113553999999993,"d":"0.00"},1,"yes","AGCGGGTGCTCCACCCAGATGAAGAGGCCTGGCTCCCATACAGCAGACCAAGCTTCCTGT","FALSE","NM_022370","ref|NM_022370|ens|ENST00000524971|ens|ENST00000525304|ens|ENST00000543966","ROBO3","roundabout, axon guidance receptor, homolog 3 (Drosophila)","ref|Homo sapiens roundabout, axon guidance receptor, homolog 3 (Drosophila) (ROBO3), mRNA [NM_022370]","chr11",124735280,124751362,"GO:0001764(neuron migration);GO:0007411(axon guidance);GO:0016021(integral to membrane);GO:0016199(axon midline choice point recognition);GO:0030424(axon);GO:0071679(commissural neuron axon guidance)","04360(Axon guidance)","mRNA","agilent G3 V3"]
["A_32_P95823",2.08,2.22,2.31,3.63,{"v":3.3,"d":"3.30"},3.82,{"v":0.614883720930233,"d":"0.61"},{"v":-0.701614482969131,"d":"-0.70"},"down",{"v":0.00114180999999991,"d":"0.00"},1,"yes","AGTGGACATACGGAAAGACTGTGACTTTATTTTGTAATGGGAGGAAGAAATTTTCTCAGA","FALSE","NM_014607","ref|NM_014607|ens|ENST00000272638|ens|ENST00000490163|gb|EF199840","UBXN4","UBX domain protein 4","ref|Homo sapiens UBX domain protein 4 (UBXN4), mRNA [NM_014607]","chr2",136511728,136542625,"GO:0005515(protein binding);GO:0005635(nuclear envelope);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006986(response to unfolded protein)",null,"mRNA","agilent G3 V3"]
["A_23_P148463",1.99,2.01,2.12,3.76,3.37,4.06,{"v":0.546916890080429,"d":"0.55"},{"v":-0.870606478283742,"d":"-0.87"},"down",{"v":0.00115728999999998,"d":"0.00"},1,"yes","TGGCCAGGTATTTTAAAAAGTCGTCTATTTCTTTCTAGTTGCATCAACTTGCACACTGGT","FALSE","NM_003588","ref|NM_003588|ref|NM_001079872|ens|ENST00000371322|ref|XM_005262481","CUL4B","cullin 4B","ref|Homo sapiens cullin 4B (CUL4B), transcript variant 1, mRNA [NM_003588]","chrX",119658464,119694555,"GO:0003684(damaged DNA binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007049(cell cycle);GO:0031465(Cul4B-RING ubiquitin ligase complex);GO:0031625(ubiquitin protein ligase binding);GO:0035518(histone H2A monoubiquitination);GO:0045732(positive regulation of protein catabolic process);GO:0070062(extracellular vesicular exosome);GO:0070914(UV-damage excision repair);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle)","04120(Ubiquitin mediated proteolysis);03420(Nucleotide excision repair)","mRNA","agilent G3 V3"]
["A_22_P00019819",7.43,6.96,7.51,5.77,5.92,5.81,{"v":1.25142857142857,"d":"1.25"},{"v":0.323575947768845,"d":"0.32"},"up",{"v":0.00116305000000005,"d":"0.00"},1,"yes","ACAGCTTGACATTTTTTGTTTGCCTTGGAGGGGGTACTTTTAAAAATTCCTCTTTTGAAA","FALSE","ENST00000508366","ens|ENST00000508366|ref|XR_108587|ref|XR_112744|ref|XR_171513",null,null,"ens|ATPase, H+ transporting, lysosomal accessory protein 1-like [Source:HGNC Symbol;Acc:HGNC:28091] [ENST00000508366]","chr5",81604680,81682796,null,null,"mRNA","agilent G3 V3"]
["A_33_P3393708",11.43,{"v":11.4,"d":"11.40"},11.27,{"v":10.2,"d":"10.20"},10.53,{"v":10.5,"d":"10.50"},{"v":1.09189881524175,"d":"1.09"},{"v":0.126839169890961,"d":"0.13"},"up",{"v":0.00118412999999995,"d":"0.00"},1,"yes","TGTGTGGAACTCAGCACCTGTGTTTTGCCAGAAAACCCCCCAGAGCTCATGCGGTTGTGA","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_33_P3390217",{"v":7.7,"d":"7.70"},7.79,7.63,8.28,8.44,8.53,{"v":0.915643564356436,"d":"0.92"},{"v":-0.127141990025841,"d":"-0.13"},"down",{"v":0.00120130000000007,"d":"0.00"},1,"yes","TAGACCTTCTGCCTTCAGAGCATGAGGACTTCTCCCACTCATCCCTGTACCTGAGGCACA","FALSE","ENST00000375922","ens|ENST00000375922|ens|ENST00000310998|ens|ENST00000375921|ens|ENST00000375938","TTLL9","tubulin tyrosine ligase-like family member 9","ens|tubulin tyrosine ligase-like family, member 9 [Source:HGNC Symbol;Acc:HGNC:16118] [ENST00000375922]","chr20",30458504,30532764,"GO:0005737(cytoplasm);GO:0005874(microtubule);GO:0005929(cilium);GO:0006464(cellular protein modification process);GO:0016874(ligase activity)",null,"mRNA","agilent G3 V3"]
["A_23_P400945",{"v":10.4,"d":"10.40"},{"v":10.4,"d":"10.40"},10.59,9.94,9.83,9.84,{"v":1.06011482607227,"d":"1.06"},{"v":0.0842205384045615,"d":"0.08"},"up",{"v":0.00120448000000006,"d":"0.00"},1,"yes","TCTTGACTTTCCTGGTTATAGCTTTCCATCACAGCTCCCCACATTCTCTCTTGATGTTGA","FALSE","NM_005240","ref|NM_005240|ens|ENST00000326786|gb|BC022868|gb|AF218540","ETV3","ets variant 3","ref|Homo sapiens ets variant 3 (ETV3), transcript variant 2, mRNA [NM_005240]","chr1",157102944,157108266,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000981(sequence-specific DNA binding RNA polymerase II transcription factor activity);GO:0003674(molecular_function);GO:0005634(nucleus);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0006366(transcription from RNA polymerase II promoter);GO:0008150(biological_process);GO:0017053(transcriptional repressor complex);GO:0030154(cell differentiation);GO:0043565(sequence-specific DNA binding)",null,"mRNA","agilent G3 V3"]
["A_23_P156284",4.33,5.23,4.74,8.01,7.65,{"v":7.2,"d":"7.20"},{"v":0.625546806649169,"d":"0.63"},{"v":-0.676810256548726,"d":"-0.68"},"down",{"v":0.00123680999999998,"d":"0.00"},1,"yes","TTGGGAAAATATCACTTTGTATTCTCTGTCCAGGGCTTCAGATATTTTGCACGAATTTTA","FALSE","NM_080881","ref|NM_080881|ref|NM_004395|ens|ENST00000472831|ens|ENST00000292385","DBN1","drebrin 1","ref|Homo sapiens drebrin 1 (DBN1), transcript variant 2, mRNA [NM_080881]","chr5",176884368,176889414,"GO:0003779(actin binding);GO:0005515(protein binding);GO:0005522(profilin binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005921(gap junction);GO:0005938(cell cortex);GO:0007015(actin filament organization);GO:0010643(cell communication by chemical coupling);GO:0010644(cell communication by electrical coupling);GO:0015629(actin cytoskeleton);GO:0030425(dendrite);GO:0032507(maintenance of protein location in cell);GO:0042641(actomyosin);GO:0048168(regulation of neuronal synaptic plasticity);GO:0050773(regulation of dendrite development);GO:0061351(neural precursor cell proliferation)",null,"mRNA","agilent G3 V3"]
["A_23_P76622",8.86,{"v":8.8,"d":"8.80"},8.52,9.57,9.59,9.66,{"v":0.908396946564885,"d":"0.91"},{"v":-0.138605238229507,"d":"-0.14"},"down",{"v":0.00124316999999996,"d":"0.00"},1,"yes","CCCTATTGGTCACAATCGGATGTACAACATGGTTCCTTTCTTCCCTCCAGTGACTAATGA","FALSE","NM_001922","ref|NM_001922|ref|NM_001129889|ens|ENST00000446125|ens|ENST00000483392","DCT","dopachrome tautomerase","ref|Homo sapiens dopachrome tautomerase (DCT), transcript variant 1, mRNA [NM_001922]","chr13",95091840,95131936,"GO:0002052(positive regulation of neuroblast proliferation);GO:0004167(dopachrome isomerase activity);GO:0005507(copper ion binding);GO:0005829(cytosol);GO:0006583(melanin biosynthetic process from tyrosine);GO:0008544(epidermis development);GO:0016021(integral to membrane);GO:0016491(oxidoreductase activity);GO:0021847(ventricular zone neuroblast division);GO:0033162(melanosome membrane);GO:0042470(melanosome);GO:0048066(developmental pigmentation);GO:0048468(cell development);GO:0055114(oxidation-reduction process)","00350(Tyrosine metabolism);04916(Melanogenesis)","mRNA","agilent G3 V3"]
["A_23_P148057",3.64,2.62,2.33,6.73,6.35,6.11,{"v":0.447628973423658,"d":"0.45"},{"v":-1.15962467505692,"d":"-1.16"},"down",{"v":0.00126205000000001,"d":"0.00"},1,"yes","CACTTTGGTCATTTCTTTTCCTCAGAGGAAGCCTGAGTGCTCACTTAAACACTATCCCCT","FALSE","NM_016032","ref|NM_016032|ref|NM_001008222|ens|ENST00000371064|ens|ENST00000357166","ZDHHC9","zinc finger, DHHC-type containing 9","ref|Homo sapiens zinc finger, DHHC-type containing 9 (ZDHHC9), transcript variant 1, mRNA [NM_016032]","chrX",128939304,128977436,"GO:0002178(palmitoyltransferase complex);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005794(Golgi apparatus);GO:0008270(zinc ion binding);GO:0016021(integral to membrane);GO:0016409(palmitoyltransferase activity);GO:0018230(peptidyl-L-cysteine S-palmitoylation);GO:0018345(protein palmitoylation);GO:0019706(protein-cysteine S-palmitoleyltransferase activity);GO:0031228(intrinsic to Golgi membrane);GO:0043849(Ras palmitoyltransferase activity)",null,"mRNA","agilent G3 V3"]
["A_23_P58353",7.02,7.13,6.53,8.74,8.44,{"v":8.5,"d":"8.50"},{"v":0.805295950155763,"d":"0.81"},{"v":-0.312409016807368,"d":"-0.31"},"down",{"v":0.00126347000000004,"d":"0.00"},1,"yes","TTCAAACTAAATTTTTTGTATCAAGTCCCTGAATGGAAGTATGACGTTGGGTCCCTCTGA","FALSE","NM_031370","ref|NM_031370|ref|NM_031369|ref|NM_002138|ref|NM_001003810","HNRNPD","heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)","ref|Homo sapiens heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa) (HNRNPD), transcript variant 1, mRNA [NM_031370]","chr4",83274984,83294831,"GO:0000166(nucleotide binding);GO:0000398(nuclear mRNA splicing, via spliceosome);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0006396(RNA processing);GO:0006401(RNA catabolic process);GO:0008380(RNA splicing);GO:0010467(gene expression);GO:0030529(ribonucleoprotein complex);GO:0042162(telomeric DNA binding);GO:0042752(regulation of circadian rhythm);GO:0043488(regulation of mRNA stability);GO:0045727(positive regulation of translation);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0070062(extracellular vesicular exosome);GO:0097167(circadian regulation of translation)",null,"mRNA","agilent G3 V3"]
["A_23_P150009",{"v":4.6,"d":"4.60"},4.67,4.83,5.63,5.38,5.49,{"v":0.854545454545454,"d":"0.85"},{"v":-0.226770861847022,"d":"-0.23"},"down",{"v":0.00129526000000002,"d":"0.00"},1,"yes","ACCACTGCAGAAGAAAGACACAATGTGGAGAAATCTTAGGACTGACATCCCTTTACTCAG","FALSE","NM_198046","ref|NM_198046|ref|NM_001287803|ref|NM_032327|ref|NM_198043","ZDHHC16","zinc finger, DHHC-type containing 16","ref|Homo sapiens zinc finger, DHHC-type containing 16 (ZDHHC16), transcript variant 5, mRNA [NM_198046]","chr10",99205944,99217124,"GO:0005789(endoplasmic reticulum membrane);GO:0006915(apoptotic process);GO:0008270(zinc ion binding);GO:0016021(integral to membrane);GO:0016409(palmitoyltransferase activity);GO:0018345(protein palmitoylation);GO:0019706(protein-cysteine S-palmitoleyltransferase activity)",null,"mRNA","agilent G3 V3"]
["A_24_P331655",3.03,4.03,2.72,7.16,7.08,6.46,{"v":0.472463768115942,"d":"0.47"},{"v":-1.08172439743445,"d":"-1.08"},"down",{"v":0.00130068999999999,"d":"0.00"},1,"yes","TAGTTTTCCCATCTGTAAAACTCAGAAACGCAGTTGGAAAGTCCTTATTCATTTAGTAAG","FALSE","NM_001040715","ref|NM_001040715|ens|ENST00000290881|ens|ENST00000561621|ens|ENST00000561679","KIAA0895L","KIAA0895-like","ref|Homo sapiens KIAA0895-like (KIAA0895L), mRNA [NM_001040715]","chr16",67209504,67217943,null,null,"mRNA","agilent G3 V3"]
["A_23_P14886",9.11,9.18,9.21,8.89,8.93,8.88,{"v":1.02996254681648,"d":"1.03"},{"v":0.0425918767244678,"d":"0.04"},"up",{"v":0.00132195000000002,"d":"0.00"},1,"yes","AAAGGCTGAAAGGTTTGCTCACCCAGCACGGCATCCCCTACACGAGGCCCACAGAAACTT","FALSE","NM_032520","ref|NM_032520|ens|ENST00000527168|ens|ENST00000527076|ens|ENST00000204679","GNPTG","N-acetylglucosamine-1-phosphate transferase, gamma subunit","ref|Homo sapiens N-acetylglucosamine-1-phosphate transferase, gamma subunit (GNPTG), mRNA [NM_032520]","chr16",{"v":1401924,"d":"1401924.00"},1413352,"GO:0000139(Golgi membrane);GO:0003976(UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity);GO:0005794(Golgi apparatus);GO:0016256(N-glycan processing to lysosome);GO:0042803(protein homodimerization activity);GO:0046835(carbohydrate phosphorylation);GO:0070062(extracellular vesicular exosome)","04142(Lysosome)","mRNA","agilent G3 V3"]
["A_23_P381351",5.97,5.92,6.06,6.51,6.46,6.37,{"v":0.928128231644261,"d":"0.93"},{"v":-0.107603950766427,"d":"-0.11"},"down",{"v":0.00132239999999995,"d":"0.00"},1,"yes","CTCCTTCTGCTTCTCAGACTCTATTCCGACACCCTCCAACATGGAGGAAACGCAACAGAA","FALSE","NM_001317","ref|NM_001317|ref|NM_020991|ref|NM_022644|ref|NM_022579","CSH1","chorionic somatomammotropin hormone 1 (placental lactogen)","ref|Homo sapiens chorionic somatomammotropin hormone 1 (placental lactogen) (CSH1), mRNA [NM_001317]","chr17",61973192,61974021,"GO:0005179(hormone activity);GO:0005576(extracellular region);GO:0046872(metal ion binding);GO:0060397(JAK-STAT cascade involved in growth hormone signaling pathway)","04630(Jak-STAT signaling pathway);04151(PI3K-Akt signaling pathway);04080(Neuroactive ligand-receptor interaction);04060(Cytokine-cytokine receptor interaction)","mRNA","agilent G3 V3"]
["A_32_P51894",2.25,2.27,2.74,{"v":3.9,"d":"3.90"},4.05,4.37,{"v":0.589285714285714,"d":"0.59"},{"v":-0.762960802699151,"d":"-0.76"},"down",{"v":0.00134313999999991,"d":"0.00"},1,"yes","GGACCATGTGAATAATGGGTTCCATTGCACAAATACAAATATTTTAATAGCTTCTTAGGC","FALSE","NM_031844","ref|NM_031844|ref|NM_004501|ens|ENST00000444376|gb|AK095525","HNRNPU","heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A)","ref|Homo sapiens heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A) (HNRNPU), transcript variant 1, mRNA [NM_031844]","chr1",245014464,245027844,"GO:0000398(nuclear mRNA splicing, via spliceosome);GO:0001047(core promoter binding);GO:0001649(osteoblast differentiation);GO:0003677(DNA binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006396(RNA processing);GO:0008380(RNA splicing);GO:0009986(cell surface);GO:0010467(gene expression);GO:0016020(membrane);GO:0030529(ribonucleoprotein complex);GO:0032922(circadian regulation of gene expression);GO:0070934(CRD-mediated mRNA stabilization);GO:0070937(CRD-mediated mRNA stability complex);GO:0071013(catalytic step 2 spliceosome)","03040(Spliceosome)","mRNA","agilent G3 V3"]
["A_33_P3289860",{"v":14.2,"d":"14.20"},14.07,13.98,14.79,14.86,14.66,{"v":0.953509365831641,"d":"0.95"},{"v":-0.0686809854290364,"d":"-0.07"},"down",{"v":0.00137670999999995,"d":"0.00"},1,"yes","GGATCGCAGTCCCGATTATCCTCCCCTCCAGCCTCTCCCTTTCTCGTTGAAGGGTTAATA","FALSE","BX648603","gb|BX648603|tc|THC2652919",null,null,"gb|Homo sapiens mRNA; cDNA DKFZp686G10213 (from clone DKFZp686G10213). [BX648603]","chr18",48087012,48232509,null,null,"mRNA","agilent G3 V3"]
["A_33_P3312044",11.63,11.54,11.66,10.48,10.81,10.39,{"v":1.09943181818182,"d":"1.10"},{"v":0.136758137507113,"d":"0.14"},"up",{"v":0.00137948999999993,"d":"0.00"},1,"yes","AGCCTTCGACCAATAAGAGAGGATCGTTCGATTGTCTAGCCAATCGCCTGGGGGCTGCTC","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_24_P216253",2.97,4.01,2.62,6.48,6.49,6.76,{"v":0.486568677141409,"d":"0.49"},{"v":-1.03928464511504,"d":"-1.04"},"down",{"v":0.00138401999999993,"d":"0.00"},1,"yes","GAACGGAACAGAGTTTTCTCAACCTTTGCTATGGTTATTCTGTCTAGAGACCCTGAGCCA","FALSE","NM_014902","ref|NM_014902|ref|NM_183006|ref|NM_001042486|ens|ENST00000373907","DLGAP4","discs, large (Drosophila) homolog-associated protein 4","ref|Homo sapiens discs, large (Drosophila) homolog-associated protein 4 (DLGAP4), transcript variant 1, mRNA [NM_014902]","chrHG144_PATCH",35019640,35116557,"GO:0005515(protein binding);GO:0007267(cell-cell signaling);GO:0016020(membrane);GO:0045202(synapse)",null,"mRNA","agilent G3 V3"]
["A_23_P36865",3.34,1.91,2.19,6.14,6.56,5.94,{"v":0.399141630901288,"d":"0.40"},{"v":-1.32502733354625,"d":"-1.33"},"down",{"v":0.00140316000000007,"d":"0.00"},1,"yes","TAAGCAGTTCTCCGAACTGTAGTATTTCCTTCTCACTACCTTGTACCTTTATACTTAGAT","FALSE","NM_025114","ref|NM_025114|ens|ENST00000552810|ens|ENST00000547691|ens|ENST00000309041","CEP290","centrosomal protein 290kDa","ref|Homo sapiens centrosomal protein 290kDa (CEP290), mRNA [NM_025114]","chr12",88442960,88523488,"GO:0000086(G2/M transition of mitotic cell cycle);GO:0000278(mitotic cell cycle);GO:0000930(gamma-tubulin complex);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006996(organelle organization);GO:0007163(establishment or maintenance of cell polarity);GO:0015031(protein transport);GO:0016020(membrane);GO:0030814(regulation of cAMP metabolic process);GO:0030902(hindbrain development);GO:0030916(otic vesicle formation);GO:0032391(photoreceptor connecting cilium);GO:0034451(centriolar satellite);GO:0036038(TCTN-B9D complex);GO:0036064(cilium basal body);GO:0042384(cilium assembly);GO:0042462(eye photoreceptor cell development);GO:0043234(protein complex);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0048793(pronephros development);GO:0051011(microtubule minus-end binding);GO:0060041(retina development in camera-type eye);GO:0060271(cilium morphogenesis);GO:0070201(regulation of establishment of protein localization);GO:0090316(positive regulation of intracellular protein transport)",null,"mRNA","agilent G3 V3"]
["A_32_P226186",3.84,3.02,3.67,5.54,5.63,5.42,{"v":0.634719710669078,"d":"0.63"},{"v":-0.655808449930146,"d":"-0.66"},"down",{"v":0.00141963000000001,"d":"0.00"},1,"yes","TTGCTGGTCCTCAAACAGGCACTGAAATCTCAGTATGGGTATACGATTTAATAATCGGCC","FALSE","NM_001164665","ref|NM_001164665|ref|NM_020910|ens|ENST00000440172|tc|THC2623121","KIAA1549","KIAA1549","ref|Homo sapiens KIAA1549 (KIAA1549), transcript variant 2, mRNA [NM_001164665]","chr7",138516128,138604221,"GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_24_P391853",3.04,3.47,3.62,{"v":4.8,"d":"4.80"},{"v":5.2,"d":"5.20"},5.12,{"v":0.669973544973545,"d":"0.67"},{"v":-0.577823965419935,"d":"-0.58"},"down",{"v":0.00143876000000009,"d":"0.00"},1,"yes","AACAAGCACATCATGGTTGTCTTGGGGACTGGCAACAACAAGATTAACTGGGCCATGGAG","FALSE","ENST00000392417","ens|ENST00000392417",{"$nulls":3},"chr2",180678976,180679402,null,null,"mRNA","agilent G3 V3"]
["A_21_P0014256",2.52,2.85,2.48,4.68,4.19,4.97,{"v":0.567196531791908,"d":"0.57"},{"v":-0.818079383857735,"d":"-0.82"},"down",{"v":0.00145936999999996,"d":"0.00"},1,"yes","CAGCACGATGCTATTTCTAACAAGTTTCAGCATTCCAGTATCTCTTTTCACAAATAAAAC","FALSE","ENST00000456004","ens|ENST00000456004|ref|XR_424192|ref|XR_428830|ref|XR_432665","STK32C","serine/threonine kinase 32C","ens|serine/threonine kinase 32C [Source:HGNC Symbol;Acc:HGNC:21332] [ENST00000456004]","chr10",134143784,134145341,"GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P129413",14.71,{"v":14.8,"d":"14.80"},14.75,13.72,13.88,14.09,{"v":1.06164547853202,"d":"1.06"},{"v":0.0863020789926228,"d":"0.09"},"up",{"v":0.00147947999999998,"d":"0.00"},1,"yes","TGGCAAAGCCTCACAAAGCCCCCTCTCCTAGTTCATTCACAAGCATATGCTGAGAATAAA","FALSE","NM_022357","ref|NM_022357|ref|NM_001129758|ens|ENST00000268793|gb|AK057401","DPEP3","dipeptidase 3","ref|Homo sapiens dipeptidase 3 (DPEP3), transcript variant 1, mRNA [NM_022357]","chr16",68009568,68014732,"GO:0006508(proteolysis);GO:0007140(male meiosis);GO:0008235(metalloexopeptidase activity);GO:0008239(dipeptidyl-peptidase activity);GO:0016805(dipeptidase activity);GO:0031225(anchored to membrane);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_24_P282762",3.61,3.22,3.67,4.63,4.67,4.56,{"v":0.757575757575757,"d":"0.76"},{"v":-0.400537929583729,"d":"-0.40"},"down",{"v":0.00150004999999998,"d":"0.00"},1,"yes","CGGTCTATTGTAATGCAGATTGTAAATGCACTAAGATATCTCAATGAGATCAAACCCCCT","FALSE","NM_012290","ref|NM_012290|ref|NM_001136554|ref|NM_001136555|ens|ENST00000409443","TLK1","tousled-like kinase 1","ref|Homo sapiens tousled-like kinase 1 (TLK1), transcript variant 1, mRNA [NM_012290]","chr2",171847328,172017410,"GO:0001672(regulation of chromatin assembly or disassembly);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0006468(protein phosphorylation);GO:0006886(intracellular protein transport);GO:0006974(response to DNA damage stimulus);GO:0007049(cell cycle);GO:0016568(chromatin modification);GO:0035556(intracellular signal transduction)",null,"mRNA","agilent G3 V3"]
["A_23_P433676",2.51,3.04,2.39,4.57,4.51,5.08,{"v":0.560734463276836,"d":"0.56"},{"v":-0.83461035294004,"d":"-0.83"},"down",{"v":0.0015368,"d":"0.00"},1,"yes","ATTGGTTGTTGTTTCATGTCCTACACAGTAAGAACAAGAGTATGTTAACCTTTTTGTCAG","FALSE","NM_020951","ref|NM_020951|ref|NM_001145649|ref|NM_001145650|ens|ENST00000591340","ZNF529","zinc finger protein 529","ref|Homo sapiens zinc finger protein 529 (ZNF529), transcript variant 2, mRNA [NM_020951]","chr19",37035288,37064154,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P304304",11.75,11.84,{"v":11.7,"d":"11.70"},10.95,11.09,11.22,{"v":1.06103427540589,"d":"1.06"},{"v":0.0854712614924552,"d":"0.09"},"up",{"v":0.00154149000000003,"d":"0.00"},1,"yes","TGTCACCTCATTATGCAGATGTTTCGGAGAACAGGTTACCTACCACAACCCCCCTCTGCT","FALSE","NM_004042","ref|NM_004042|ref|NM_001201539|ref|NM_001201538|ens|ENST00000359361","ARSF","arylsulfatase F","ref|Homo sapiens arylsulfatase F (ARSF), transcript variant 1, mRNA [NM_004042]","chrX",{"v":2976652,"d":"2976652.00"},3030747,"GO:0004065(arylsulfatase activity);GO:0005788(endoplasmic reticulum lumen);GO:0006665(sphingolipid metabolic process);GO:0006687(glycosphingolipid metabolic process);GO:0043687(post-translational protein modification);GO:0044267(cellular protein metabolic process);GO:0044281(small molecule metabolic process);GO:0046872(metal ion binding);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3310377",8.66,8.38,8.48,7.26,7.52,7.04,{"v":1.16956920256645,"d":"1.17"},{"v":0.225977227441262,"d":"0.23"},"up",{"v":0.00156235000000005,"d":"0.00"},1,"yes","AAAGATATGAAGGGGGCTCTGAGGAGACTTCTGGCCAGGATCTGGAGGCTCTGTGGATGA","FALSE","NM_001004492","ref|NM_001004492|ens|ENST00000318749|gb|BC137181|gb|BC137205","OR2B11","olfactory receptor, family 2, subfamily B, member 11","ref|Homo sapiens olfactory receptor, family 2, subfamily B, member 11 (OR2B11), mRNA [NM_001004492]","chr1",247614256,247615308,"GO:0004930(G-protein coupled receptor activity);GO:0004984(olfactory receptor activity);GO:0005886(plasma membrane);GO:0007186(G-protein coupled receptor signaling pathway);GO:0016021(integral to membrane);GO:0050911(detection of chemical stimulus involved in sensory perception of smell)","04740(Olfactory transduction)","mRNA","agilent G3 V3"]
["A_33_P3256550",5.65,5.38,5.55,{"v":6.3,"d":"6.30"},{"v":6.5,"d":"6.50"},6.26,{"v":0.869884575026233,"d":"0.87"},{"v":-0.201104112414191,"d":"-0.20"},"down",{"v":0.00158016999999999,"d":"0.00"},1,"yes","TGGATGATTTCCCTTCATCATGACCATTTCTTCCCTGGCTCTGCCTTTACCTATGAATCT","FALSE","AF190155","gb|AF190155|tc|THC2482006|tc|THC2689737","MST152","MSTP152","gb|Homo sapiens MSTP152 (MST152) mRNA, complete cds. [AF190155]",{"$nulls":5},"mRNA","agilent G3 V3"]
["A_33_P3377060",{"v":7.4,"d":"7.40"},7.56,6.98,9.25,8.82,8.88,{"v":0.814100185528757,"d":"0.81"},{"v":-0.296721747236675,"d":"-0.30"},"down",{"v":0.00158485999999991,"d":"0.00"},1,"yes","TGTGTATCAAACCTATCCCCGGATGTGTGAGAATAATGTGTTCATAAAGCATGGATCTCG","FALSE","NM_003144","ref|NM_003144|ref|NM_001292008|ref|NR_120448|ens|ENST00000244763","SSR1","signal sequence receptor, alpha","ref|Homo sapiens signal sequence receptor, alpha (SSR1), transcript variant 1, mRNA [NM_003144]","chr6",{"v":7287804,"d":"7287804.00"},7313435,"GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006412(translation);GO:0006613(cotranslational protein targeting to membrane);GO:0006614(SRP-dependent cotranslational protein targeting to membrane);GO:0006987(activation of signaling protein activity involved in unfolded protein response);GO:0008284(positive regulation of cell proliferation);GO:0010467(gene expression);GO:0016021(integral to membrane);GO:0030968(endoplasmic reticulum unfolded protein response);GO:0044267(cellular protein metabolic process)","04141(Protein processing in endoplasmic reticulum)","mRNA","agilent G3 V3"]
["A_23_P83634",{"v":7,"d":"7.00"},6.63,7.16,5.62,5.77,5.69,{"v":1.2172131147541,"d":"1.22"},{"v":0.28358178323788,"d":"0.28"},"up",{"v":0.00161606999999997,"d":"0.00"},1,"yes","CGGAATTGCAGTCTTGGGTGCAGGAAATATTTAAAGAGTGCCTCCTGGGGCGGGAGAGCT","FALSE","NM_001139","ref|NM_001139|ens|ENST00000319144|gb|AB590845|gb|BC041058","ALOX12B","arachidonate 12-lipoxygenase, 12R type","ref|Homo sapiens arachidonate 12-lipoxygenase, 12R type (ALOX12B), mRNA [NM_001139]","chr17",{"v":7979613,"d":"7979613.00"},7983413,"GO:0004052(arachidonate 12-lipoxygenase activity);GO:0005506(iron ion binding);GO:0005515(protein binding);GO:0005829(cytosol);GO:0006497(protein lipidation);GO:0006665(sphingolipid metabolic process);GO:0010628(positive regulation of gene expression);GO:0016702(oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen);GO:0019369(arachidonic acid metabolic process);GO:0019372(lipoxygenase pathway);GO:0043410(positive regulation of MAPK cascade);GO:0043651(linoleic acid metabolic process);GO:0044281(small molecule metabolic process);GO:0046513(ceramide biosynthetic process);GO:0051122(hepoxilin biosynthetic process);GO:0055114(oxidation-reduction process);GO:0061436(establishment of skin barrier);GO:0070257(positive regulation of mucus secretion)","00590(Arachidonic acid metabolism);04726(Serotonergic synapse)","mRNA","agilent G3 V3"]
["A_33_P3408711",7.09,6.71,7.17,8.19,8.18,8.03,{"v":0.859426229508197,"d":"0.86"},{"v":-0.218554286353656,"d":"-0.22"},"down",{"v":0.00163624000000007,"d":"0.00"},1,"yes","AAATCAAAGGGTGCTGGTGGTCAAGGCAAAGTGGCATCCAAGATTGTGGGCCCCTCGGGT","FALSE","NM_001456","ref|NM_001456|ref|NM_001110556|ens|ENST00000610817|ens|ENST00000369850","FLNA","filamin A, alpha","ref|Homo sapiens filamin A, alpha (FLNA), transcript variant 1, mRNA [NM_001456]","chrX",153576896,153603006,"GO:0001837(epithelial to mesenchymal transition);GO:0001948(glycoprotein binding);GO:0002576(platelet degranulation);GO:0004871(signal transducer activity);GO:0005080(protein kinase C binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005802(trans-Golgi network);GO:0005829(cytosol);GO:0005884(actin filament);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0007195(adenylate cyclase-inhibiting dopamine receptor signaling pathway);GO:0007596(blood coagulation);GO:0008134(transcription factor binding);GO:0015629(actin cytoskeleton);GO:0016020(membrane);GO:0017048(Rho GTPase binding);GO:0017160(Ral GTPase binding);GO:0030168(platelet activation);GO:0030863(cortical cytoskeleton);GO:0031267(small GTPase binding);GO:0031523(Myb complex);GO:0031532(actin cytoskeleton reorganization);GO:0031852(mu-type opioid receptor binding);GO:0034329(cell junction assembly);GO:0034394(protein localization at cell surface);GO:0034988(Fc-gamma receptor I complex binding);GO:0042177(negative regulation of protein catabolic process);GO:0042384(cilium assembly);GO:0042789(mRNA transcription from RNA polymerase II promoter);GO:0042803(protein homodimerization activity);GO:0042993(positive regulation of transcription factor import into nucleus);GO:0043025(neuronal cell body);GO:0043113(receptor clustering);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB cascade);GO:0043198(dendritic shaft);GO:0043433(negative regulation of sequence-specific DNA binding transcription factor activity);GO:0045022(early endosome to late endosome transport);GO:0045184(establishment of protein localization);GO:0046332(SMAD binding);GO:0048365(Rac GTPase binding);GO:0048471(perinuclear region of cytoplasm);GO:0050821(protein stabilization);GO:0051015(actin filament binding);GO:0051220(cytoplasmic sequestering of protein);GO:0051764(actin crosslink formation);GO:0070062(extracellular vesicular exosome);GO:0070527(platelet aggregation);GO:0090307(spindle assembly involved in mitosis)","04010(MAPK signaling pathway);04510(Focal adhesion);05205(Proteoglycans in cancer);05132(Salmonella infection)","mRNA","agilent G3 V3"]
["A_33_P3292179",9.75,9.78,9.13,11.34,11.39,11.11,{"v":0.846926713947991,"d":"0.85"},{"v":-0.239690958857804,"d":"-0.24"},"down",{"v":0.00164472000000004,"d":"0.00"},1,"yes","GAAATACCTGATGTAGATGATGGGTTGATGGGTGCAGCAAAGTACCATGGCACATGTATA","FALSE","NM_080283","ref|NM_080283|ens|ENST00000340001|ref|XM_005256935|ref|XM_006721633","ABCA9","ATP-binding cassette, sub-family A (ABC1), member 9","ref|Homo sapiens ATP-binding cassette, sub-family A (ABC1), member 9 (ABCA9), mRNA [NM_080283]","chr17",66970772,67057136,"GO:0005215(transporter activity);GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0006810(transport);GO:0008152(metabolic process);GO:0016021(integral to membrane);GO:0016887(ATPase activity)","02010(ABC transporters)","mRNA","agilent G3 V3"]
["A_33_P3382849",13.34,{"v":13.5,"d":"13.50"},13.38,12.75,12.63,12.88,{"v":1.05122843700993,"d":"1.05"},{"v":0.0720762079592393,"d":"0.07"},"up",{"v":0.00166157,"d":"0.00"},1,"yes","ATCGCCTCCAAGATTGGTTCTAACGCTTTGCGTATGATTCAATCGGCCACCCCTCCACCT","FALSE","NM_001097","ref|NM_001097|ens|ENST00000527761|ens|ENST00000419351|ens|ENST00000216139","ACR","acrosin","ref|Homo sapiens acrosin (ACR), mRNA [NM_001097]","chr22",51182572,51183338,"GO:0002077(acrosome matrix dispersal);GO:0003677(DNA binding);GO:0004040(amidase activity);GO:0004252(serine-type endopeptidase activity);GO:0005507(copper ion binding);GO:0005515(protein binding);GO:0005537(mannose binding);GO:0005576(extracellular region);GO:0005634(nucleus);GO:0005798(Golgi-associated vesicle);GO:0007190(activation of adenylate cyclase activity);GO:0007338(single fertilization);GO:0007339(binding of sperm to zona pellucida);GO:0007340(acrosome reaction);GO:0007341(penetration of zona pellucida);GO:0008144(drug binding);GO:0008270(zinc ion binding);GO:0032504(multicellular organism reproduction);GO:0042806(fucose binding);GO:0043159(acrosomal matrix);GO:0043234(protein complex);GO:0048545(response to steroid hormone stimulus)",null,"mRNA","agilent G3 V3"]
["A_23_P11390",10.32,10.03,9.99,11.31,11.13,{"v":11,"d":"11.00"},{"v":0.907296650717703,"d":"0.91"},{"v":-0.140353761833849,"d":"-0.14"},"down",{"v":0.00167755999999997,"d":"0.00"},1,"yes","ATCTACTCCCCTATCTCCCTGAGCAGCAACTAAGTTTAGGCCCAGCTGCCAGACCTCAGA","FALSE","NM_004679","ref|NM_004679|ref|NM_181880|ens|ENST00000250823|ens|ENST00000250825","VCY","variable charge, Y-linked","ref|Homo sapiens variable charge, Y-linked (VCY), mRNA [NM_004679]","chrY",16168097,16168838,null,null,"mRNA","agilent G3 V3"]
["A_24_P355876",7.75,8.17,7.31,9.61,9.89,9.65,{"v":0.796912521440823,"d":"0.80"},{"v":-0.327506729279051,"d":"-0.33"},"down",{"v":0.00169684999999997,"d":"0.00"},1,"yes","AACTCCACCTTCTGTGCTTTTTGCTTGGGATAATGGAGTTTTTCTTTAGAAACAGTGCCA","FALSE","NM_003217","ref|NM_003217|ref|NM_001098576|ens|ENST00000549385|ens|ENST00000552699","TMBIM6","transmembrane BAX inhibitor motif containing 6","ref|Homo sapiens transmembrane BAX inhibitor motif containing 6 (TMBIM6), transcript variant 1, mRNA [NM_003217]","chr12",50135592,50158717,"GO:0005634(nucleus);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005887(integral to plasma membrane);GO:0006986(response to unfolded protein);GO:0016020(membrane);GO:0032469(endoplasmic reticulum calcium ion homeostasis);GO:0070059(intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress)",null,"mRNA","agilent G3 V3"]
["A_24_P142095",5.91,6.04,4.91,8.46,8.39,{"v":8.2,"d":"8.20"},{"v":0.673053892215569,"d":"0.67"},{"v":-0.571206067140489,"d":"-0.57"},"down",{"v":0.00171716999999993,"d":"0.00"},1,"yes","TGCCACAACATACTGGCTTCGTATTTTATTTATCTTTCTTTCTAGTTACCAGCTTCAGAC","FALSE","NM_006738","ref|NM_006738|ref|NM_007200|ref|NM_001270546|ens|ENST00000394518","AKAP13","A kinase (PRKA) anchor protein 13","ref|Homo sapiens A kinase (PRKA) anchor protein 13 (AKAP13), transcript variant 1, mRNA [NM_006738]","chr15",86220272,86292586,"GO:0004691(cAMP-dependent protein kinase activity);GO:0004871(signal transducer activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0007264(small GTPase mediated signal transduction);GO:0010611(regulation of cardiac muscle hypertrophy);GO:0016020(membrane);GO:0017048(Rho GTPase binding);GO:0032321(positive regulation of Rho GTPase activity);GO:0032947(protein complex scaffold);GO:0043065(positive regulation of apoptotic process);GO:0045859(regulation of protein kinase activity);GO:0046872(metal ion binding);GO:0048011(nerve growth factor receptor signaling pathway);GO:0048471(perinuclear region of cytoplasm);GO:0051018(protein kinase A binding);GO:0051056(regulation of small GTPase mediated signal transduction);GO:0051168(nuclear export);GO:0097190(apoptotic signaling pathway);GO:1900169(regulation of glucocorticoid mediated signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_23_P35414",7.14,6.57,6.89,8.94,8.58,8.36,{"v":0.795981452859351,"d":"0.80"},{"v":-0.329193279921927,"d":"-0.33"},"down",{"v":0.00173644000000006,"d":"0.00"},1,"yes","AGCATCCATACTTTTCTACTGTAAATATTTCACTCTCCTCTAGCTATCCTTGATGAGCTT","FALSE","NM_005398","ref|NM_005398|ens|ENST00000238994|gb|BC012625|gb|BX537399","PPP1R3C","protein phosphatase 1, regulatory subunit 3C","ref|Homo sapiens protein phosphatase 1, regulatory subunit 3C (PPP1R3C), mRNA [NM_005398]","chr10",93388200,93392811,"GO:0004722(protein serine/threonine phosphatase activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005975(carbohydrate metabolic process);GO:0005978(glycogen biosynthetic process);GO:0006006(glucose metabolic process);GO:0009405(pathogenesis);GO:0016311(dephosphorylation);GO:0019903(protein phosphatase binding);GO:0044281(small molecule metabolic process)","04910(Insulin signaling pathway)","mRNA","agilent G3 V3"]
["A_33_P3396129",11.21,11.18,11.09,10.45,10.69,10.59,{"v":1.05515285219036,"d":"1.06"},{"v":0.0774520066327061,"d":"0.08"},"up",{"v":0.00174070000000004,"d":"0.00"},1,"yes","TGTCTGTGGCCCTTGGTCCATCTGTGACTTCATCCATCTCCCCCTAAAGCTACGTCCAGA","FALSE","ENST00000566611","ens|ENST00000566611|gb|AB209250|tc|THC2603047","KATNB1","katanin p80 (WD repeat containing) subunit B 1","ens|katanin p80 (WD repeat containing) subunit B 1 [Source:HGNC Symbol;Acc:HGNC:6217] [ENST00000566611]","chr16",57769776,57790797,"GO:0000922(spindle pole);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005874(microtubule);GO:0005886(plasma membrane);GO:0006605(protein targeting);GO:0007026(negative regulation of microtubule depolymerization);GO:0007079(mitotic chromosome movement towards spindle pole);GO:0008017(microtubule binding);GO:0008152(metabolic process);GO:0008352(katanin complex);GO:0008568(microtubule-severing ATPase activity);GO:0010942(positive regulation of cell death);GO:0010976(positive regulation of neuron projection development);GO:0015630(microtubule cytoskeleton);GO:0016020(membrane);GO:0030424(axon);GO:0030426(growth cone);GO:0030496(midbody);GO:0031117(positive regulation of microtubule depolymerization);GO:0043025(neuronal cell body);GO:0045502(dynein binding);GO:0046982(protein heterodimerization activity);GO:0051013(microtubule severing);GO:0051301(cell division)",null,"mRNA","agilent G3 V3"]
["A_21_P0000147",2.02,1.89,2.26,4.42,3.61,3.92,{"v":0.516317991631799,"d":"0.52"},{"v":-0.953668223718693,"d":"-0.95"},"down",{"v":0.00176036000000002,"d":"0.00"},1,"yes","AGACTCACAAGAAAGTGCAGATCACCTTGCACATGAAGTGAGCTTGGCAGTATTTCAGCT","FALSE","NM_001199919","ref|NM_001199919|ens|ENST00000504780|gb|AK314512|gb|AK301867","PGM3","phosphoglucomutase 3","ref|Homo sapiens phosphoglucomutase 3 (PGM3), transcript variant 4, mRNA [NM_001199919]","chr6",83875848,83903012,"GO:0000287(magnesium ion binding);GO:0004610(phosphoacetylglucosamine mutase activity);GO:0004614(phosphoglucomutase activity);GO:0005575(cellular_component);GO:0005829(cytosol);GO:0006041(glucosamine metabolic process);GO:0006048(UDP-N-acetylglucosamine biosynthetic process);GO:0006487(protein N-linked glycosylation);GO:0006488(dolichol-linked oligosaccharide biosynthetic process);GO:0006493(protein O-linked glycosylation);GO:0007283(spermatogenesis);GO:0018279(protein N-linked glycosylation via asparagine);GO:0019255(glucose 1-phosphate metabolic process);GO:0030097(hemopoiesis);GO:0043687(post-translational protein modification);GO:0044267(cellular protein metabolic process)","00520(Amino sugar and nucleotide sugar metabolism)","mRNA","agilent G3 V3"]
["A_33_P3350547",{"v":6.9,"d":"6.90"},7.17,6.74,5.87,6.02,5.97,{"v":1.16517357222844,"d":"1.17"},{"v":0.220544884614112,"d":"0.22"},"up",{"v":0.00178232999999994,"d":"0.00"},1,"yes","TGGAGGAGAAGTTCATGGCAGCCAACCCATCCAAGATCTCCTACGAGCCCATCACCACCA","FALSE","NM_001099404","ref|NM_001099404|ref|NM_198056|ref|NM_000335|ref|NM_001099405","SCN5A","sodium channel, voltage gated, type V alpha subunit","ref|Homo sapiens sodium channel, voltage-gated, type V, alpha subunit (SCN5A), transcript variant 3, mRNA [NM_001099404]","chr3",38589552,38691163,"GO:0001518(voltage-gated sodium channel complex);GO:0002027(regulation of heart rate);GO:0003231(cardiac ventricle development);GO:0003360(brainstem development);GO:0005248(voltage-gated sodium channel activity);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0006814(sodium ion transport);GO:0007411(axon guidance);GO:0009986(cell surface);GO:0010765(positive regulation of sodium ion transport);GO:0014704(intercalated disc);GO:0014894(response to denervation involved in regulation of muscle adaptation);GO:0016021(integral to membrane);GO:0016328(lateral plasma membrane);GO:0017134(fibroblast growth factor binding);GO:0019228(regulation of action potential in neuron);GO:0019899(enzyme binding);GO:0019901(protein kinase binding);GO:0021537(telencephalon development);GO:0021549(cerebellum development);GO:0030315(T-tubule);GO:0030506(ankyrin binding);GO:0031625(ubiquitin protein ligase binding);GO:0035725(sodium ion transmembrane transport);GO:0042383(sarcolemma);GO:0042475(odontogenesis of dentin-containing tooth);GO:0044325(ion channel binding);GO:0045760(positive regulation of action potential);GO:0050679(positive regulation of epithelial cell proliferation);GO:0050998(nitric-oxide synthase binding);GO:0051899(membrane depolarization);GO:0060048(cardiac muscle contraction);GO:0060307(regulation of ventricular cardiomyocyte membrane repolarization);GO:0060371(regulation of atrial cardiomyocyte membrane depolarization);GO:0060372(regulation of atrial cardiomyocyte membrane repolarization);GO:0060373(regulation of ventricular cardiomyocyte membrane depolarization);GO:0071277(cellular response to calcium ion);GO:0086002(regulation of cardiac muscle cell action potential involved in contraction);GO:0086004(regulation of cardiac muscle cell contraction);GO:0086005(regulation of ventricular cardiac muscle cell action potential);GO:0086006(voltage-gated sodium channel activity involved in regulation of cardiac muscle cell action potential);GO:0086010(membrane depolarization involved in regulation of action potential);GO:0086012(membrane depolarization involved in regulation of cardiac muscle cell action potential);GO:0086046(membrane depolarization involved in regulation of SA node cardiac muscle cell action potential);GO:0086067(AV node cell to bundle of His cell communication);GO:0086069(bundle of His cardiac muscle cell to Purkinje myocyte communication);GO:0086070(SA node cardiomyocyte to atrial cardiomyocyte communication);GO:0086091(regulation of heart rate by cardiac conduction);GO:0097110(scaffold protein binding)","04261(Adrenergic signaling in cardiomyocytes)","mRNA","agilent G3 V3"]
["A_33_P3671506",8.28,7.99,{"v":8,"d":"8.00"},8.91,9.19,8.98,{"v":0.896233382570162,"d":"0.90"},{"v":-0.158053630423863,"d":"-0.16"},"down",{"v":0.00179877000000006,"d":"0.00"},1,"yes","GTCACCTGCACTCATCTTGGGTTTTCCTTCCTTTTCCACCCTAAGCTGAAGGTATTTTTT","FALSE","AK021734","gb|AK021734","LOC153811","uncharacterized LOC153811","gb|Homo sapiens cDNA FLJ11672 fis, clone HEMBA1004733. [AK021734]","chr5",179338656,179498721,null,null,"mRNA","agilent G3 V3"]
["A_33_P3369956",13.36,13.23,13.29,12.91,12.99,12.98,{"v":1.02572016460905,"d":"1.03"},{"v":0.036637190792415,"d":"0.04"},"up",{"v":0.00180215000000006,"d":"0.00"},1,"yes","GGGTGCCTGCACTCTCAGCTTCCACACCCTCACCCTACCCCTACATCGGACACCCCCAAG","FALSE","NM_148416","ref|NM_148416|ref|NM_148415|ref|NM_145714|ref|NM_017492","ATXN2L","ataxin 2-like","ref|Homo sapiens ataxin 2-like (ATXN2L), transcript variant E, mRNA [NM_148416]","chr16",28846990,28848558,"GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0010494(cytoplasmic stress granule);GO:0010603(regulation of cytoplasmic mRNA processing body assembly);GO:0016020(membrane);GO:0016607(nuclear speck);GO:0034063(stress granule assembly)",null,"mRNA","agilent G3 V3"]
["A_23_P13364",4.51,3.74,3.54,6.17,6.12,6.49,{"v":0.627795527156549,"d":"0.63"},{"v":-0.671633344674012,"d":"-0.67"},"down",{"v":0.00183881000000008,"d":"0.00"},1,"yes","GATGAGCTTCAGAAACAAAAAGAAGAGCTACAACGTCAGCATGATCAACTGGAGGCTCAG","FALSE","NM_005013","ref|NM_005013|ens|ENST00000531242|ens|ENST00000622082|ens|ENST00000458064","NUCB2","nucleobindin 2","ref|Homo sapiens nucleobindin 2 (NUCB2), mRNA [NM_005013]","chr11",17316872,17352997,"GO:0003677(DNA binding);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005635(nuclear envelope);GO:0005783(endoplasmic reticulum);GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3221563",5.93,5.64,6.25,7.18,7.34,7.33,{"v":0.815560640732265,"d":"0.82"},{"v":-0.294135942866039,"d":"-0.29"},"down",{"v":0.00185831000000003,"d":"0.00"},1,"yes","GCCCCAGGTGCCTGGCCTGGCCTAGACCTCTGGAATTGAGATTAAACAATTTGGAGTTGG","FALSE","NM_024742","ref|NM_024742|ref|NM_001301820|ref|NM_001105247|ref|NM_001288767","ARMC5","armadillo repeat containing 5","ref|Homo sapiens armadillo repeat containing 5 (ARMC5), transcript variant 2, mRNA [NM_024742]","chr16",31471282,31478486,"GO:0005737(cytoplasm)",null,"mRNA","agilent G3 V3"]
["A_22_P00004279",{"v":11.1,"d":"11.10"},10.94,10.94,11.61,11.45,11.49,{"v":0.954558610709117,"d":"0.95"},{"v":-0.0670943118381539,"d":"-0.07"},"down",{"v":0.00188174000000008,"d":"0.00"},1,"yes","ACCACCTTGCACTCCATGTGGCTCTCCTTTCCCCTAATTCACAGGGTGAAGCCAGATTTG","FALSE","NM_144988","ref|NM_144988|ens|ENST00000507727|linc|lnc-CNN3-2:1|ref|XM_005270582","ALG14","ALG14, UDP-N-acetylglucosaminyltransferase subunit","ref|Homo sapiens ALG14, UDP-N-acetylglucosaminyltransferase subunit (ALG14), mRNA [NM_144988]","chr1",95448280,95538507,"GO:0005789(endoplasmic reticulum membrane);GO:0006488(dolichol-linked oligosaccharide biosynthetic process);GO:0016021(integral to membrane);GO:0018279(protein N-linked glycosylation via asparagine);GO:0043687(post-translational protein modification);GO:0044267(cellular protein metabolic process)","00510(N-Glycan biosynthesis)","mRNA","agilent G3 V3"]
["A_23_P30363",7.29,{"v":6.8,"d":"6.80"},6.95,8.66,{"v":8.4,"d":"8.40"},9.02,{"v":0.806748466257669,"d":"0.81"},{"v":-0.309809164938775,"d":"-0.31"},"down",{"v":0.00189817999999997,"d":"0.00"},1,"yes","TTTATGGCATTTCTATCTATTGTGGCTTTACCAAAAAATAAAATGTCCCTACCAGAAGCC","FALSE","NM_004199","ref|NM_004199|ref|NM_001017973|ref|NM_001142599|ref|NM_001142598","P4HA2","prolyl 4-hydroxylase, alpha polypeptide II","ref|Homo sapiens prolyl 4-hydroxylase, alpha polypeptide II (P4HA2), transcript variant 1, mRNA [NM_004199]","chr5",131528304,131562935,"GO:0004656(procollagen-proline 4-dioxygenase activity);GO:0005506(iron ion binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005788(endoplasmic reticulum lumen);GO:0009055(electron carrier activity);GO:0016222(procollagen-proline 4-dioxygenase complex);GO:0016702(oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen);GO:0018401(peptidyl-proline hydroxylation to 4-hydroxy-L-proline);GO:0031418(L-ascorbic acid binding);GO:0043231(intracellular membrane-bounded organelle);GO:0055114(oxidation-reduction process)","00330(Arginine and proline metabolism)","mRNA","agilent G3 V3"]
["A_33_P3404525",6.42,6.23,6.56,4.89,5.06,{"v":5.4,"d":"5.40"},{"v":1.2514657980456,"d":"1.25"},{"v":0.323618863407986,"d":"0.32"},"up",{"v":0.00193798000000001,"d":"0.00"},1,"yes","TTCCTCCTAGACTACTAGGGCCGCCTTAGCTTGCTACCCTTTTAGGACCCTGGAGCTGTG","FALSE","ENST00000573596","ens|ENST00000573596|gb|AK308677|gb|AK124286|tc|THC2653358","ASGR1","asialoglycoprotein receptor 1","ens|asialoglycoprotein receptor 1 [Source:HGNC Symbol;Acc:HGNC:742] [ENST00000573596]","chr17",{"v":7079933,"d":"7079933.00"},7082695,"GO:0004873(asialoglycoprotein receptor activity);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005887(integral to plasma membrane);GO:0006898(receptor-mediated endocytosis);GO:0030246(carbohydrate binding);GO:0031668(cellular response to extracellular stimulus);GO:0042803(protein homodimerization activity);GO:0046872(metal ion binding)","04918(Thyroid hormone synthesis)","mRNA","agilent G3 V3"]
["A_23_P68942",8.23,9.47,8.02,11.72,11.98,12.04,{"v":0.719641857862339,"d":"0.72"},{"v":-0.474648991713543,"d":"-0.47"},"down",{"v":0.00195857999999993,"d":"0.00"},1,"yes","GCTACCATCACCGCACTGAGATCAACAAGAAGATTTATAAGATTGGCCAGGGCTACCTTA","FALSE","NM_000967","ref|NM_000967|ref|NM_001033853|ens|ENST00000481985|ens|ENST00000465618","RPL3","ribosomal protein L3","ref|Homo sapiens ribosomal protein L3 (RPL3), transcript variant 1, mRNA [NM_000967]","chr22",39708888,39714619,"GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay);GO:0003723(RNA binding);GO:0003735(structural constituent of ribosome);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005925(focal adhesion);GO:0006412(translation);GO:0006413(translational initiation);GO:0006414(translational elongation);GO:0006415(translational termination);GO:0006614(SRP-dependent cotranslational protein targeting to membrane);GO:0010467(gene expression);GO:0016032(viral reproduction);GO:0019058(viral infectious cycle);GO:0019083(viral transcription);GO:0022625(cytosolic large ribosomal subunit);GO:0044267(cellular protein metabolic process);GO:0070062(extracellular vesicular exosome);GO:0071353(cellular response to interleukin-4)","03010(Ribosome)","mRNA","agilent G3 V3"]
["A_33_P3249185",2.07,2.04,3.31,5.71,{"v":5.4,"d":"5.40"},5.54,{"v":0.445645645645646,"d":"0.45"},{"v":-1.16603108533782,"d":"-1.17"},"down",{"v":0.00198128000000009,"d":"0.00"},1,"yes","CGCCTCGTGGAATCCAAAGTTGAGCTTAATGTATGTTTTGTCCTTTAATGTGTATTTTAA","FALSE","ENST00000373236","ens|ENST00000373236|tc|THC2557427","SAR1A","secretion associated, Ras related GTPase 1A","ens|secretion associated, Ras related GTPase 1A [Source:HGNC Symbol;Acc:HGNC:10534] [ENST00000373236]","chr10",71917432,71921671,"GO:0005525(GTP binding);GO:0005794(Golgi apparatus);GO:0006886(intracellular protein transport);GO:0016192(vesicle-mediated transport);GO:0016529(sarcoplasmic reticulum);GO:0070062(extracellular vesicular exosome)","04141(Protein processing in endoplasmic reticulum);05134(Legionellosis)","mRNA","agilent G3 V3"]
["A_23_P49849",10.27,10.38,10.18,8.31,8.78,9.03,{"v":1.18032159264931,"d":"1.18"},{"v":0.239179992560744,"d":"0.24"},"up",{"v":0.00199939000000005,"d":"0.00"},1,"yes","CTTTCCTCCGATGTTTATTTAGCTGTTGCAAACATCTTCACCCTAATAGTCCCTCCTCCA","FALSE","NM_178860","ref|NM_178860|ref|NM_001290202|ref|NM_001098635|ens|ENST00000335960","SEZ6","seizure related 6 homolog (mouse)","ref|Homo sapiens seizure related 6 homolog (mouse) (SEZ6), transcript variant 1, mRNA [NM_178860]","chr17",27282148,27332931,"GO:0005615(extracellular space);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0008344(adult locomotory behavior);GO:0016021(integral to membrane);GO:0021680(cerebellar Purkinje cell layer development);GO:0043025(neuronal cell body);GO:0043197(dendritic spine);GO:0043198(dendritic shaft);GO:0048471(perinuclear region of cytoplasm);GO:0060074(synapse maturation);GO:0060079(regulation of excitatory postsynaptic membrane potential);GO:0090036(regulation of protein kinase C signaling cascade);GO:1900006(positive regulation of dendrite development);GO:2000171(negative regulation of dendrite development)",null,"mRNA","agilent G3 V3"]
["A_24_P38347",3.36,3.44,2.83,5.58,4.93,{"v":5.7,"d":"5.70"},{"v":0.594077729796422,"d":"0.59"},{"v":-0.751276387674083,"d":"-0.75"},"down",{"v":0.00201699999999994,"d":"0.00"},1,"yes","CAATTTTTGTTTCAATTCTAAGAAACACTTGCAGCTCTAGTATTCACTTGAGTCTTCCTG","FALSE","NM_001386","ref|NM_001386|ref|NM_001197293|ref|NM_001244604|ens|ENST00000521913","DPYSL2","dihydropyrimidinase-like 2","ref|Homo sapiens dihydropyrimidinase-like 2 (DPYSL2), transcript variant 2, mRNA [NM_001386]","chr8",26435360,26515694,"GO:0001975(response to amphetamine);GO:0004157(dihydropyrimidinase activity);GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0005874(microtubule);GO:0006139(nucleobase-containing compound metabolic process);GO:0006208(pyrimidine base catabolic process);GO:0006897(endocytosis);GO:0007010(cytoskeleton organization);GO:0007165(signal transduction);GO:0007399(nervous system development);GO:0007411(axon guidance);GO:0010975(regulation of neuron projection development);GO:0014049(positive regulation of glutamate secretion);GO:0016020(membrane);GO:0019901(protein kinase binding);GO:0021510(spinal cord development);GO:0021772(olfactory bulb development);GO:0030425(dendrite);GO:0030426(growth cone);GO:0042220(response to cocaine);GO:0042493(response to drug);GO:0043025(neuronal cell body);GO:0043195(terminal button);GO:0048489(synaptic vesicle transport);GO:0070062(extracellular vesicular exosome)","04360(Axon guidance)","mRNA","agilent G3 V3"]
["A_33_P3302657",10.65,10.46,10.75,9.22,9.57,8.98,{"v":1.14728123874685,"d":"1.15"},{"v":0.198219089706464,"d":"0.20"},"up",{"v":0.00204380000000004,"d":"0.00"},1,"yes","CTATTAGTTTGGAATACCAAAAACAAGAATATGTTTAAATTGCTGGGGGCTGCAAGATAG","FALSE","ENST00000376525","ens|ENST00000376525","TLE4","transducin-like enhancer of split 4","ens|transducin-like enhancer of split 4 [Source:HGNC Symbol;Acc:HGNC:11840] [ENST00000376525]","chr9",82187624,82189944,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0003674(molecular_function);GO:0003682(chromatin binding);GO:0003705(RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity);GO:0003714(transcription corepressor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006366(transcription from RNA polymerase II promoter);GO:0007219(Notch signaling pathway);GO:0008150(biological_process);GO:0016055(Wnt receptor signaling pathway);GO:0070491(repressing transcription factor binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3307103",7.19,7.19,7.37,5.44,5.88,5.03,{"v":1.3302752293578,"d":"1.33"},{"v":0.411724765238008,"d":"0.41"},"up",{"v":0.00205599999999995,"d":"0.00"},1,"yes","TTTGGGATTCATCAATTTCCTGGAGGTTCATGTGGAACATCTATGGCACAGGGGAGTACT","FALSE","ENST00000556639","ens|ENST00000556639|gb|BX247991|tc|THC2481677",null,null,"ens|EF-hand calcium binding domain 11 [Source:HGNC Symbol;Acc:HGNC:20357] [ENST00000556639]","chr14",90302904,90421028,null,null,"mRNA","agilent G3 V3"]
["A_23_P85164",6.56,6.44,6.14,7.25,7.41,7.46,{"v":0.865280289330922,"d":"0.87"},{"v":-0.208760555748681,"d":"-0.21"},"down",{"v":0.00208300000000006,"d":"0.00"},1,"yes","TCAAACTCCTTCCCTGAAACCAGCAAACACCGGGAAACATTTTGGCTCATTATAATCCGG","FALSE","ENST00000309585","ens|ENST00000309585|ens|ENST00000369808|ens|ENST00000014935|ens|ENST00000369807","DNASE1L1","deoxyribonuclease I-like 1","ens|deoxyribonuclease I-like 1 [Source:HGNC Symbol;Acc:HGNC:2957] [ENST00000309585]","chrX",153629584,153640427,"GO:0000737(DNA catabolic process, endonucleolytic);GO:0003677(DNA binding);GO:0004520(endodeoxyribonuclease activity);GO:0004536(deoxyribonuclease activity);GO:0005634(nucleus);GO:0005783(endoplasmic reticulum);GO:0006259(DNA metabolic process);GO:0016888(endodeoxyribonuclease activity, producing 5'-phosphomonoesters);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3325851",6.55,6.52,{"v":6.4,"d":"6.40"},4.64,5.02,5.35,{"v":1.29713524317122,"d":"1.30"},{"v":0.375328907099606,"d":"0.38"},"up",{"v":0.0021042,"d":"0.00"},1,"yes","AACCACGTTGCTTTCTCTTCCTATGGGTCTTCCACATATCCATTAGTGACAGCTTCTTAG","FALSE","ENST00000425215","ens|ENST00000425215",null,null,"ens|vomeronasal 1 receptor 20 pseudogene [Source:HGNC Symbol;Acc:HGNC:37335] [ENST00000425215]","chr3",13968310,13969275,null,null,"mRNA","agilent G3 V3"]
["A_23_P19576",5.91,6.85,6.28,8.19,8.41,8.41,{"v":0.761295481807277,"d":"0.76"},{"v":-0.393471578873027,"d":"-0.39"},"down",{"v":0.0021584,"d":"0.00"},1,"yes","TGACCTGCCTTCATGTGGACCCTTAGAACAGCACTGGGAGACCAGCAGGACTCCTGAGAA","FALSE","NM_031287","ref|NM_031287|ens|ENST00000367569|gb|BC000198|gb|AK074417","SF3B5","splicing factor 3b, subunit 5, 10kDa","ref|Homo sapiens splicing factor 3b, subunit 5, 10kDa (SF3B5), mRNA [NM_031287]","chr6",144416016,144416754,"GO:0000398(nuclear mRNA splicing, via spliceosome);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005689(U12-type spliceosomal complex);GO:0008380(RNA splicing);GO:0010467(gene expression)","03040(Spliceosome)","mRNA","agilent G3 V3"]
["A_24_P272061",8.96,9.78,9.03,11.04,11.18,11.31,{"v":0.828213540113331,"d":"0.83"},{"v":-0.271925305974938,"d":"-0.27"},"down",{"v":0.00217850000000008,"d":"0.00"},1,"yes","CTCTGGACCGCCTCAAGGTGTTTGACTGCATCCCACCGCCTTACGACAAGAAAAAGCGGA","FALSE","NM_012423","ref|NM_012423|ref|NM_001270491|ref|NR_026715|ref|NR_026712","RPL13A","ribosomal protein L13a","ref|Homo sapiens ribosomal protein L13a (RPL13A), transcript variant 1, mRNA [NM_012423]","chr19",49990812,49995565,"GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay);GO:0003735(structural constituent of ribosome);GO:0005634(nucleus);GO:0005829(cytosol);GO:0005925(focal adhesion);GO:0006412(translation);GO:0006413(translational initiation);GO:0006414(translational elongation);GO:0006415(translational termination);GO:0006614(SRP-dependent cotranslational protein targeting to membrane);GO:0010467(gene expression);GO:0015934(large ribosomal subunit);GO:0016020(membrane);GO:0016032(viral reproduction);GO:0017148(negative regulation of translation);GO:0019058(viral infectious cycle);GO:0019083(viral transcription);GO:0022625(cytosolic large ribosomal subunit);GO:0030529(ribonucleoprotein complex);GO:0044267(cellular protein metabolic process);GO:0071346(cellular response to interferon-gamma)","03010(Ribosome)","mRNA","agilent G3 V3"]
["A_33_P3392077",4.82,3.54,4.02,6.81,6.88,6.66,{"v":0.608353808353808,"d":"0.61"},{"v":-0.717017479939345,"d":"-0.72"},"down",{"v":0.00217970000000001,"d":"0.00"},1,"yes","ACGTCTGCTGCCGGTTCTGGACAGAATCTACCCAGTGACCGAAATCCAGGAGGCCCATAA","FALSE","NM_004881","ref|NM_004881|ref|NM_147184|ref|NM_001206802|ens|ENST00000238721","TP53I3","tumor protein p53 inducible protein 3","ref|Homo sapiens tumor protein p53 inducible protein 3 (TP53I3), transcript variant 1, mRNA [NM_004881]","chr2",24300306,24307655,"GO:0003960(NADPH:quinone reductase activity);GO:0006739(NADP metabolic process);GO:0008270(zinc ion binding);GO:0042803(protein homodimerization activity);GO:0048038(quinone binding);GO:0055114(oxidation-reduction process);GO:0070062(extracellular vesicular exosome);GO:0070402(NADPH binding)","04115(p53 signaling pathway)","mRNA","agilent G3 V3"]
["A_33_P3258801",8.74,8.46,8.78,9.87,9.52,9.62,{"v":0.895553257497415,"d":"0.90"},{"v":-0.159148864750116,"d":"-0.16"},"down",{"v":0.00222070000000008,"d":"0.00"},1,"yes","AGGGGCGCCCTCTGCCTTCCATACCCCACGCTTATAAAACATAACTAAGCCAAGAGTGGA","FALSE","NM_020427","ref|NM_020427|ens|ENST00000246515|tc|THC2479548","SLURP1","secreted LY6/PLAUR domain containing 1","ref|Homo sapiens secreted LY6/PLAUR domain containing 1 (SLURP1), mRNA [NM_020427]","chr8",143822368,143823829,"GO:0001775(cell activation);GO:0005125(cytokine activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0007155(cell adhesion);GO:0007626(locomotory behavior);GO:0010839(negative regulation of keratinocyte proliferation);GO:0050884(neuromuscular process controlling posture);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_32_P76627",3.53,2.01,3.64,6.69,7.42,7.68,{"v":0.421294171638366,"d":"0.42"},{"v":-1.2471001377021,"d":"-1.25"},"down",{"v":0.00223819999999997,"d":"0.00"},1,"yes","CTCTGGCACACCATGCAGAACCTGGAGATTGAGCTGCAGTCCCAGCTCAGCATGTTAGGA","FALSE","ENST00000417510","ens|ENST00000417510|linc|TCONS_l2_00011623|tc|THC2531223|tc|THC2495115",null,null,"ens|keratin 16 pseudogene 6 [Source:HGNC Symbol;Acc:HGNC:50719] [ENST00000417510]","chr17",16722827,16725442,null,null,"mRNA","agilent G3 V3"]
["A_33_P3216442",5.08,4.66,4.44,{"v":6.2,"d":"6.20"},6.27,6.67,{"v":0.74085684430512,"d":"0.74"},{"v":-0.43273329724651,"d":"-0.43"},"down",{"v":0.00225909999999996,"d":"0.00"},1,"yes","AGAAACGGAATAGTGTGGGGTGTGTGCAGGGCTGCATCCCGCAGATGGCTGGAATATTAA","FALSE","NM_080680","ref|NM_080680|ref|NM_080681|ref|NM_080679|ens|ENST00000433947","COL11A2","collagen, type XI, alpha 2","ref|Homo sapiens collagen, type XI, alpha 2 (COL11A2), transcript variant 1, mRNA [NM_080680]","chr6",33130468,33160245,"GO:0001501(skeletal system development);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005592(collagen type XI);GO:0005788(endoplasmic reticulum lumen);GO:0007605(sensory perception of sound);GO:0022617(extracellular matrix disassembly);GO:0030020(extracellular matrix structural constituent conferring tensile strength);GO:0030198(extracellular matrix organization);GO:0030199(collagen fibril organization);GO:0030574(collagen catabolic process);GO:0030674(protein binding, bridging);GO:0046872(metal ion binding);GO:0051216(cartilage development);GO:0060021(palate development);GO:0060023(soft palate development)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04611(Platelet activation);04974(Protein digestion and absorption);05146(Amoebiasis)","mRNA","agilent G3 V3"]
["A_33_P3237734",9.12,9.07,9.46,8.25,8.29,{"v":8.4,"d":"8.40"},{"v":1.10866078588613,"d":"1.11"},{"v":0.148818015292399,"d":"0.15"},"up",{"v":0.00228200000000001,"d":"0.00"},1,"yes","TAAACTAAAACAGCACTTTAATAATGCGCTCCCCAAACAGAACAGCACTACCACCGGGGT","FALSE","NM_001040261","ref|NM_001040261|ref|NM_001040260|ref|NR_036614|ens|ENST00000506325","DCLK2","doublecortin-like kinase 2","ref|Homo sapiens doublecortin-like kinase 2 (DCLK2), transcript variant 2, mRNA [NM_001040261]","chr4",151000176,151178590,"GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0006468(protein phosphorylation);GO:0035556(intracellular signal transduction)",null,"mRNA","agilent G3 V3"]
["A_33_P3371142",6.02,5.39,6.01,4.04,4.36,4.27,{"v":1.37490134175217,"d":"1.37"},{"v":0.459328099458055,"d":"0.46"},"up",{"v":0.00229990000000002,"d":"0.00"},1,"yes","TACTGAAGAAAATCTGGGGTTCTGCCCAAGGGTTGGACTCCATGTGAAAGGACTTAGAAA","FALSE","ENST00000416620","ens|ENST00000416620",{"$nulls":3},"chrX",{"v":9370791,"d":"9370791.00"},9382606,null,null,"mRNA","agilent G3 V3"]
["A_21_P0014885",12.97,12.97,12.91,11.84,12.16,12.25,{"v":1.07172413793103,"d":"1.07"},{"v":0.0999336035054133,"d":"0.10"},"up",{"v":0.00234069999999997,"d":"0.00"},1,"yes","TGAGATTCCTAGGAAGACCCCTCCCCAACTCTCAGAGGTCCCTGAGGATGGAGAGTCCAT","FALSE","AK295076","gb|AK295076|gb|XR_132801|tc|THC2717460","LOC100506257","uncharacterized LOC100506257","gb|Homo sapiens cDNA FLJ61763 complete cds. [AK295076]","chr1",110772584,110774042,null,null,"mRNA","agilent G3 V3"]
["A_33_P3386716",3.12,3.72,{"v":3.1,"d":"3.10"},4.87,4.71,5.07,{"v":0.678498293515358,"d":"0.68"},{"v":-0.559582907747324,"d":"-0.56"},"down",{"v":0.00235560000000001,"d":"0.00"},1,"yes","GGGACTAGAAGACTCTAAATTGGCTTCTACAGATCAATAATTTAAATGTAACTAGTTGGG","FALSE","NM_032833","ref|NM_032833|ens|ENST00000367188|gb|AK023680|gb|AL833746","PPP1R15B","protein phosphatase 1, regulatory subunit 15B","ref|Homo sapiens protein phosphatase 1, regulatory subunit 15B (PPP1R15B), mRNA [NM_032833]","chr1",204372512,204380919,"GO:0000164(protein phosphatase type 1 complex);GO:0004722(protein serine/threonine phosphatase activity);GO:0005515(protein binding);GO:0006417(regulation of translation);GO:0006983(ER overload response);GO:0016311(dephosphorylation);GO:0042542(response to hydrogen peroxide)",null,"mRNA","agilent G3 V3"]
["A_23_P142878",3.14,3.27,3.19,3.99,4.34,4.51,{"v":0.747663551401869,"d":"0.75"},{"v":-0.419538891513785,"d":"-0.42"},"down",{"v":0.00237940000000003,"d":"0.00"},1,"yes","GGGCAGGCCCTGCCATGGACAGAAAAAGAGTTTTTCTCTTGTTCAGCCTGCACGTGGCCT","FALSE","NM_032827","ref|NM_032827|ens|ENST00000306279|ens|ENST00000469442|ref|XM_006712123","ATOH8","atonal homolog 8 (Drosophila)","ref|Homo sapiens atonal homolog 8 (Drosophila) (ATOH8), mRNA [NM_032827]","chr2",86008160,86015162,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0007399(nervous system development);GO:0030154(cell differentiation);GO:0046983(protein dimerization activity)",null,"mRNA","agilent G3 V3"]
["A_33_P3287537",6.99,6.53,6.83,5.74,5.57,5.84,{"v":1.1865889212828,"d":"1.19"},{"v":0.246820218093435,"d":"0.25"},"up",{"v":0.0024016,"d":"0.00"},1,"yes","GGGGAGGGTGCCTCCGTGATGTTGTCCTTGCAGGTTATGGATATATACAGAACATTTTTT","FALSE","ENST00000371720","ens|ENST00000371720|ens|ENST00000622209|ens|ENST00000612553|gb|AK307206","PMPCA","peptidase (mitochondrial processing) alpha","ens|peptidase (mitochondrial processing) alpha [Source:HGNC Symbol;Acc:HGNC:18667] [ENST00000371720]","chr9",139310512,139315385,"GO:0004222(metalloendopeptidase activity);GO:0005615(extracellular space);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0005759(mitochondrial matrix);GO:0006508(proteolysis);GO:0006626(protein targeting to mitochondrion);GO:0044267(cellular protein metabolic process);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3320804",15.96,16.07,16.02,16.47,{"v":16.5,"d":"16.50"},16.33,{"v":0.974645030425964,"d":"0.97"},{"v":-0.0370512156041611,"d":"-0.04"},"down",{"v":0.00244219999999995,"d":"0.00"},1,"yes","GCTGCCCGCCCCGCTTGTGTCTGAGGTCGTGTATGTCAAAAATAAAGCCGCTAGAAACGG","FALSE","NM_001242829","ref|NM_001242829|ref|NM_153273|ref|NM_001006115|ens|ENST00000613416","IP6K1","inositol hexakisphosphate kinase 1","ref|Homo sapiens inositol hexakisphosphate kinase 1 (IP6K1), transcript variant 3, mRNA [NM_001242829]","chr3",49761728,49823973,"GO:0000832(inositol hexakisphosphate 5-kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0008440(inositol-1,4,5-trisphosphate 3-kinase activity);GO:0043647(inositol phosphate metabolic process);GO:0044281(small molecule metabolic process);GO:0046854(phosphatidylinositol phosphorylation);GO:0052723(inositol hexakisphosphate 1-kinase activity);GO:0052724(inositol hexakisphosphate 3-kinase activity)",null,"mRNA","agilent G3 V3"]
["A_24_P270144",7.59,8.53,7.36,10.52,10.23,10.83,{"v":0.743508549715009,"d":"0.74"},{"v":-0.427578762750185,"d":"-0.43"},"down",{"v":0.0024578999999999,"d":"0.00"},1,"yes","TGTGGGCTGTGGGATTAATTTCAACGAGAAGGCGATCCATAAGGAGGGCTGTGTGGAGAA","FALSE","NM_001257389","ref|NM_001257389|ref|NM_001780|ref|NM_001267698|ref|NM_001257390","CD63","CD63 molecule","ref|Homo sapiens CD63 molecule (CD63), transcript variant 3, mRNA [NM_001257389]","chr12",56119108,56120892,"GO:0002092(positive regulation of receptor internalization);GO:0002576(platelet degranulation);GO:0005515(protein binding);GO:0005765(lysosomal membrane);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0007160(cell-matrix adhesion);GO:0007596(blood coagulation);GO:0009986(cell surface);GO:0010008(endosome membrane);GO:0015031(protein transport);GO:0016477(cell migration);GO:0030168(platelet activation);GO:0031088(platelet dense granule membrane);GO:0031226(intrinsic to plasma membrane);GO:0031902(late endosome membrane);GO:0031904(endosome lumen);GO:0034613(cellular protein localization);GO:0035646(endosome to melanosome transport);GO:0042470(melanosome);GO:0048757(pigment granule maturation);GO:0070062(extracellular vesicular exosome);GO:1900746(regulation of vascular endothelial growth factor signaling pathway);GO:2000680(regulation of rubidium ion transport);GO:2001046(positive regulation of integrin-mediated signaling pathway)","04142(Lysosome);05205(Proteoglycans in cancer)","mRNA","agilent G3 V3"]
["A_33_P3253365",5.54,5.41,5.78,6.43,6.42,6.68,{"v":0.85663082437276,"d":"0.86"},{"v":-0.223254503848439,"d":"-0.22"},"down",{"v":0.00247850000000005,"d":"0.00"},1,"yes","GAATACAGTTTTATTTCTCTCTCAAGCCCTGCTTTGCCTGTTGCTTCCATCCTTTTTGAC","FALSE","ENST00000618777","ens|ENST00000618777|ens|ENST00000358144|gb|AB051501|tc|THC2500835",null,null,"ens|contactin associated protein-like 3B [Source:HGNC Symbol;Acc:HGNC:32035] [ENST00000618777]","chr9",47310640,47314322,null,null,"mRNA","agilent G3 V3"]
["A_23_P22382",15.34,15.41,15.36,{"v":14.8,"d":"14.80"},14.72,14.98,{"v":1.0361797752809,"d":"1.04"},{"v":0.0512743296708049,"d":"0.05"},"up",{"v":0.00252430000000003,"d":"0.00"},1,"yes","CATTCTCTTCTGTCTCTGCCCCCACCCCATGCAGCGCTTTGAGGAATTGGAAAAGAACCT","FALSE","NM_015527","ref|NM_015527|ens|ENST00000478158|ens|ENST00000409939|ens|ENST00000475650","TBC1D10B","TBC1 domain family, member 10B","ref|Homo sapiens TBC1 domain family, member 10B (TBC1D10B), mRNA [NM_015527]","chr16",30368428,30379328,"GO:0005097(Rab GTPase activator activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0032313(regulation of Rab GTPase activity);GO:0032851(positive regulation of Rab GTPase activity);GO:0042147(retrograde transport, endosome to Golgi)",null,"mRNA","agilent G3 V3"]
["A_23_P13438",8.28,7.99,{"v":8.4,"d":"8.40"},6.79,7.14,6.56,{"v":1.20400195217179,"d":"1.20"},{"v":0.267837731288876,"d":"0.27"},"up",{"v":0.00258080000000005,"d":"0.00"},1,"yes","TGTTTACCAGTAGGTTTGTGAAATTGGTTCTTTGTATGGGGGATGGTCCTTTTTCACACA","FALSE","NM_032320","ref|NM_032320|ref|NM_001297742|ref|NM_001297741|ens|ENST00000527102","BTBD10","BTB (POZ) domain containing 10","ref|Homo sapiens BTB (POZ) domain containing 10 (BTBD10), transcript variant 2, mRNA [NM_032320]","chr11",13410230,13461826,"GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0042327(positive regulation of phosphorylation);GO:0044342(type B pancreatic cell proliferation)",null,"mRNA","agilent G3 V3"]
["A_33_P3277728",9.74,10.26,9.87,8.89,8.77,8.93,{"v":1.12335464460323,"d":"1.12"},{"v":0.167813460453123,"d":"0.17"},"up",{"v":0.00259939999999992,"d":"0.00"},1,"yes","CCCTGACTGGTGGAAAGGAGAAGTCAATGGACAAGTGGGGCTCTTCCCATCCAATTATGT","FALSE","NM_001001132","ref|NM_001001132|ens|ENST00000379960|ens|ENST00000462212|ens|ENST00000479424","ITSN1","intersectin 1 (SH3 domain protein)","ref|Homo sapiens intersectin 1 (SH3 domain protein) (ITSN1), transcript variant 2, mRNA [NM_001001132]","chr5",10664607,10665225,"GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005905(coated pit);GO:0007264(small GTPase mediated signal transduction);GO:0007411(axon guidance);GO:0019209(kinase activator activity);GO:0030027(lamellipodium);GO:0030054(cell junction);GO:0030139(endocytic vesicle);GO:0032321(positive regulation of Rho GTPase activity);GO:0032947(protein complex scaffold);GO:0042327(positive regulation of phosphorylation);GO:0043005(neuron projection);GO:0043065(positive regulation of apoptotic process);GO:0043524(negative regulation of neuron apoptotic process);GO:0043547(positive regulation of GTPase activity);GO:0045202(synapse);GO:0048011(nerve growth factor receptor signaling pathway);GO:0048013(ephrin receptor signaling pathway);GO:0048488(synaptic vesicle endocytosis);GO:0051056(regulation of small GTPase mediated signal transduction);GO:0051897(positive regulation of protein kinase B signaling cascade);GO:0070064(proline-rich region binding);GO:0097190(apoptotic signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_23_P13885",6.04,5.85,5.46,9.16,9.13,{"v":9.1,"d":"9.10"},{"v":0.633442862358525,"d":"0.63"},{"v":-0.658713603239755,"d":"-0.66"},"down",{"v":0.00261929999999999,"d":"0.00"},1,"yes","CTGCCCCGTTGGTGTGATTATTTCATCTGTTAGATGTGGCTGTTTTGCGTAGCATCGTGT","FALSE","NM_001007026","ref|NM_001007026|ref|NM_001940|ens|ENST00000396684|ens|ENST00000356654","ATN1","atrophin 1","ref|Homo sapiens atrophin 1 (ATN1), transcript variant 1, mRNA [NM_001007026]","chr12",{"v":7048270,"d":"7048270.00"},7051220,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0003714(transcription corepressor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-dependent);GO:0007417(central nervous system development);GO:0009404(toxin metabolic process);GO:0016363(nuclear matrix);GO:0016477(cell migration);GO:0019904(protein domain specific binding);GO:0030011(maintenance of cell polarity);GO:0030054(cell junction);GO:0048471(perinuclear region of cytoplasm);GO:0050827(toxin receptor binding);GO:0051402(neuron apoptotic process)",null,"mRNA","agilent G3 V3"]
["A_33_P3409274",9.26,{"v":9,"d":"9.00"},9.24,7.68,8.18,7.58,{"v":1.17320819112628,"d":"1.17"},{"v":0.230459048877137,"d":"0.23"},"up",{"v":0.0026579000000001,"d":"0.00"},1,"yes","GACTGGAATATGTTTCAGCTATTAGTAGTAATGGGGGTAGCACATATTATGCAGACTCTG","FALSE","ENST00000454421","ens|ENST00000454421|ens|ENST00000618085|gb|FJ385288|gb|AY452138",null,null,"ens|immunoglobulin heavy variable 3-64 [Source:HGNC Symbol;Acc:HGNC:5617] [ENST00000454421]","chr14",107113744,107114274,null,null,"mRNA","agilent G3 V3"]
["A_23_P117037",4.84,4.93,4.28,5.97,6.16,{"v":6.2,"d":"6.20"},{"v":0.766503000545554,"d":"0.77"},{"v":-0.383636655431597,"d":"-0.38"},"down",{"v":0.00269649999999999,"d":"0.00"},1,"yes","CTTCACTGGCATGGGCTAACCACTTCTTTTTCAAACCCTCTGAACACCTTTTTCTGATGG","FALSE","NM_015416","ref|NM_015416|ref|NM_001243689|ref|NM_001300765|ref|NR_045018","LETMD1","LETM1 domain containing 1","ref|Homo sapiens LETM1 domain containing 1 (LETMD1), transcript variant 1, mRNA [NM_015416]","chr12",51442112,51454201,"GO:0005515(protein binding);GO:0005741(mitochondrial outer membrane);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3243878",6.68,5.29,6.12,8.65,8.92,{"v":8.7,"d":"8.70"},{"v":0.688618195660449,"d":"0.69"},{"v":-0.538223792512391,"d":"-0.54"},"down",{"v":0.00270399999999993,"d":"0.00"},1,"yes","TCGGGCTGCCGAGAACAGGGAGCTAAACATCACCATCATCTAAGAGCGGGTCAAGGAATT","FALSE","NM_001267536","ref|NM_001267536|ref|NM_198181|ref|NM_001291420|ref|NM_001164465","GOLGA6L4","golgin A6 family-like 4","ref|Homo sapiens golgin A6 family-like 4 (GOLGA6L4), mRNA [NM_001267536]","chr15",84908672,84911353,null,null,"mRNA","agilent G3 V3"]
["A_24_P392060",8.68,8.66,9.13,{"v":7.3,"d":"7.30"},7.74,7.36,{"v":1.18169642857143,"d":"1.18"},{"v":0.240859462550432,"d":"0.24"},"up",{"v":0.00276150000000008,"d":"0.00"},1,"yes","TATATTGCCTGTTAATTTGACTGTAATGAATAGGGGGTAGAAACAAAAGGATCAAGTGTG","FALSE","NM_198567","ref|NM_198567|ens|ENST00000341199|ens|ENST00000430704|ens|ENST00000332772","SIMC1","SUMO-interacting motifs containing 1","ref|Homo sapiens SUMO-interacting motifs containing 1 (SIMC1), mRNA [NM_198567]","chr5",175665360,175772988,"GO:0032184(SUMO polymer binding)",null,"mRNA","agilent G3 V3"]
["A_23_P31109",6.13,6.66,5.91,7.77,7.66,7.95,{"v":0.799828913601369,"d":"0.80"},{"v":-0.322236659756657,"d":"-0.32"},"down",{"v":0.00280289999999994,"d":"0.00"},1,"yes","CCATCTCATATCATGGACTCCGAAGTAGCCTGTTGCCTCCAAATTTGCCACTTGAATATA","FALSE","NM_138785","ref|NM_138785|ens|ENST00000367419|gb|AY358952|gb|BC014320","GINM1","glycoprotein integral membrane 1","ref|Homo sapiens glycoprotein integral membrane 1 (GINM1), mRNA [NM_138785]","chr6",149887424,149912884,"GO:0016021(integral to membrane);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P115519",9.26,9.24,9.34,7.84,8.38,8.29,{"v":1.1358629130967,"d":"1.14"},{"v":0.183788726981889,"d":"0.18"},"up",{"v":0.00282490000000002,"d":"0.00"},1,"yes","GAGCTAGGGGTTTTCCTGTGGAAGGTCTGAGCTCTCCCCAGAAGGCACTTCCTGTCTGAT","FALSE","NM_032563","ref|NM_032563|ens|ENST00000368787|gb|AB048288|tc|THC2481277","LCE3D","late cornified envelope 3D","ref|Homo sapiens late cornified envelope 3D (LCE3D), mRNA [NM_032563]","chr1",152551856,152552980,"GO:0031424(keratinization)",null,"mRNA","agilent G3 V3"]
["A_23_P94736",10.84,10.96,11.08,{"v":10.4,"d":"10.40"},10.12,10.14,{"v":1.07240704500978,"d":"1.07"},{"v":0.100852602022906,"d":"0.10"},"up",{"v":0.00287930000000003,"d":"0.00"},1,"yes","GAGAAGAGCCACCCCTCAGTGCCTTACCACTACTTTGAGAAGGGCCGGCTAGATGAGTGT","FALSE","NM_175039","ref|NM_175039|ref|NM_175040|ens|ENST00000467674|ens|ENST00000474282","ST6GALNAC4","ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 4","ref|Homo sapiens ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 4 (ST6GALNAC4), transcript variant 1, mRNA [NM_175039]","chr9",130670168,130679305,"GO:0000139(Golgi membrane);GO:0006488(dolichol-linked oligosaccharide biosynthetic process);GO:0006493(protein O-linked glycosylation);GO:0006664(glycolipid metabolic process);GO:0008373(sialyltransferase activity);GO:0016021(integral to membrane);GO:0016266(O-glycan processing);GO:0018279(protein N-linked glycosylation via asparagine);GO:0043687(post-translational protein modification);GO:0044267(cellular protein metabolic process);GO:0047290((alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity)","00604(Glycosphingolipid biosynthesis - ganglio series)","mRNA","agilent G3 V3"]
["A_33_P3372580",8.86,8.99,8.68,9.51,9.56,9.76,{"v":0.920221990981616,"d":"0.92"},{"v":-0.119946161266211,"d":"-0.12"},"down",{"v":0.00288489999999997,"d":"0.00"},1,"yes","CTAAGTAACATGGCAACACATCTGTCTCTCCCTAAATAAATACTACCACATTATTTCTTC","FALSE","NM_018714","ref|NM_018714|ens|ENST00000618996|ens|ENST00000299886|ens|ENST00000582973","COG1","component of oligomeric golgi complex 1","ref|Homo sapiens component of oligomeric golgi complex 1 (COG1), mRNA [NM_018714]","chr17",71202880,71204646,"GO:0000139(Golgi membrane);GO:0005515(protein binding);GO:0005794(Golgi apparatus);GO:0006891(intra-Golgi vesicle-mediated transport);GO:0007030(Golgi organization);GO:0015031(protein transport);GO:0017119(Golgi transport complex)",null,"mRNA","agilent G3 V3"]
["A_24_P281975",3.34,1.96,2.17,5.42,5.15,5.48,{"v":0.465420560747664,"d":"0.47"},{"v":-1.10339314922043,"d":"-1.10"},"down",{"v":0.00291890000000006,"d":"0.00"},1,"yes","AGATCATGATCTCAACAATATTCTTCCAAAATGGCATACATCTTTTGTACAAAGAACTTG","FALSE","NM_024312","ref|NM_024312|ens|ENST00000299314|gb|AB033034|gb|AK001821","GNPTAB","N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits","ref|Homo sapiens N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits (GNPTAB), mRNA [NM_024312]","chr12",102139272,102224716,"GO:0000139(Golgi membrane);GO:0003976(UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity);GO:0005509(calcium ion binding);GO:0005634(nucleus);GO:0005794(Golgi apparatus);GO:0007040(lysosome organization);GO:0008134(transcription factor binding);GO:0009306(protein secretion);GO:0016021(integral to membrane);GO:0030154(cell differentiation);GO:0046835(carbohydrate phosphorylation)","04142(Lysosome)","mRNA","agilent G3 V3"]
["A_23_P159255",3.92,2.99,3.97,5.81,5.69,6.17,{"v":0.615732880588568,"d":"0.62"},{"v":-0.699623483301278,"d":"-0.70"},"down",{"v":0.00293939999999993,"d":"0.00"},1,"yes","ACCGGCTTCCTAGAGCAGCGTAGACAGCTGGTAAACTGAAGAGCACAACTATATTCTTAT","FALSE","NM_002845","ref|NM_002845|ref|NM_001105244|ens|ENST00000580949|ens|ENST00000577827","PTPRM","protein tyrosine phosphatase, receptor type, M","ref|Homo sapiens protein tyrosine phosphatase, receptor type, M (PTPRM), transcript variant 2, mRNA [NM_002845]","chr18",{"v":7946952,"d":"7946952.00"},8406854,"GO:0001937(negative regulation of endothelial cell proliferation);GO:0004725(protein tyrosine phosphatase activity);GO:0005001(transmembrane receptor protein tyrosine phosphatase activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005887(integral to plasma membrane);GO:0005911(cell-cell junction);GO:0005913(cell-cell adherens junction);GO:0006470(protein dephosphorylation);GO:0007156(homophilic cell adhesion);GO:0007165(signal transduction);GO:0010596(negative regulation of endothelial cell migration);GO:0010842(retina layer formation);GO:0016525(negative regulation of angiogenesis);GO:0030027(lamellipodium);GO:0031175(neuron projection development);GO:0031290(retinal ganglion cell axon guidance);GO:0035335(peptidyl-tyrosine dephosphorylation);GO:0042493(response to drug);GO:0042802(identical protein binding);GO:0045296(cadherin binding);GO:0045909(positive regulation of vasodilation);GO:0048471(perinuclear region of cytoplasm)","04514(Cell adhesion molecules (CAMs));04520(Adherens junction)","mRNA","agilent G3 V3"]
["A_23_P11664",5.32,3.48,{"v":4.7,"d":"4.70"},8.16,7.86,8.12,{"v":0.55923777961889,"d":"0.56"},{"v":-0.838466268816828,"d":"-0.84"},"down",{"v":0.00294439999999996,"d":"0.00"},1,"yes","GCCTCTGAGGGAGTCCAACTGTATACCTGCATCAGTGTCATTCCTTTGTGTGATTTCTTA","FALSE","NM_004768","ref|NM_004768|ref|NM_001190987|ens|ENST00000489188|ens|ENST00000463859","SRSF11","serine/arginine-rich splicing factor 11","ref|Homo sapiens serine/arginine-rich splicing factor 11 (SRSF11), transcript variant 1, mRNA [NM_004768]","chr1",70671408,70716488,"GO:0000166(nucleotide binding);GO:0000398(nuclear mRNA splicing, via spliceosome);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006366(transcription from RNA polymerase II promoter);GO:0006369(termination of RNA polymerase II transcription);GO:0006397(mRNA processing);GO:0006406(mRNA export from nucleus);GO:0008380(RNA splicing);GO:0010467(gene expression);GO:0031124(mRNA 3'-end processing)",null,"mRNA","agilent G3 V3"]
["A_24_P58337",7.36,8.47,7.51,10.01,10.11,10.48,{"v":0.762745098039216,"d":"0.76"},{"v":-0.390727091872666,"d":"-0.39"},"down",{"v":0.00299799999999995,"d":"0.00"},1,"yes","TGAATAAGCAGGTGAAAGCCATCAAAGAATTGGGTGAGCACGTGACCAACTTGTGCAAGA","FALSE","NM_002032","ref|NM_002032|ens|ENST00000466086|ens|ENST00000534719|ens|ENST00000492727","FTH1","ferritin, heavy polypeptide 1","ref|Homo sapiens ferritin, heavy polypeptide 1 (FTH1), mRNA [NM_002032]","chr1",228823168,228823574,"GO:0004322(ferroxidase activity);GO:0005506(iron ion binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006826(iron ion transport);GO:0006879(cellular iron ion homeostasis);GO:0006880(intracellular sequestering of iron ion);GO:0006892(post-Golgi vesicle-mediated transport);GO:0006898(receptor-mediated endocytosis);GO:0006955(immune response);GO:0008043(intracellular ferritin complex);GO:0008199(ferric iron binding);GO:0008285(negative regulation of cell proliferation);GO:0048147(negative regulation of fibroblast proliferation);GO:0055085(transmembrane transport);GO:0055114(oxidation-reduction process);GO:0061024(membrane organization);GO:0070062(extracellular vesicular exosome)","04978(Mineral absorption)","mRNA","agilent G3 V3"]
["A_23_P210538",3.34,2.38,3.35,{"v":5,"d":"5.00"},5.44,5.33,{"v":0.575142675967026,"d":"0.58"},{"v":-0.798008204261988,"d":"-0.80"},"down",{"v":0.00302150000000001,"d":"0.00"},1,"yes","GTATGACCCTGATGAGACCTTAAACTTCATCGCACCTAATAAATATGAGTACTGCATCTG","FALSE","NM_182764","ref|NM_182764|ref|NM_133171|ens|ENST00000352077|ens|ENST00000396391","ELMO2","engulfment and cell motility 2","ref|Homo sapiens engulfment and cell motility 2 (ELMO2), transcript variant 2, mRNA [NM_182764]","chr20",44994688,45035256,"GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0006915(apoptotic process);GO:0016020(membrane);GO:0017124(SH3 domain binding);GO:0030971(receptor tyrosine kinase binding);GO:0038096(Fc-gamma receptor signaling pathway involved in phagocytosis);GO:0045087(innate immune response);GO:0048010(vascular endothelial growth factor receptor signaling pathway);GO:0060326(cell chemotaxis)","05131(Shigellosis);05100(Bacterial invasion of epithelial cells)","mRNA","agilent G3 V3"]
["A_23_P164436",{"v":2.5,"d":"2.50"},2.61,2.88,4.38,3.74,4.03,{"v":0.65761316872428,"d":"0.66"},{"v":-0.604688905565167,"d":"-0.60"},"down",{"v":0.00306250000000008,"d":"0.00"},1,"yes","TTGTGCCTTATTCAACTGCATACATAGCTCCTAGCACAGTGCCTTATTCGGTAGGCATCT","FALSE","NM_000049","ref|NM_000049|ref|NM_001128085|ref|XM_006721527|gb|S67156","ASPA","aspartoacylase","ref|Homo sapiens aspartoacylase (ASPA), transcript variant 1, mRNA [NM_000049]","chr17",{"v":3379296,"d":"3379296.00"},3406713,"GO:0004046(aminoacylase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006533(aspartate catabolic process);GO:0016788(hydrolase activity, acting on ester bonds);GO:0019807(aspartoacylase activity);GO:0022010(central nervous system myelination);GO:0046872(metal ion binding);GO:0048714(positive regulation of oligodendrocyte differentiation);GO:0070062(extracellular vesicular exosome)","00250(Alanine, aspartate and glutamate metabolism);00340(Histidine metabolism)","mRNA","agilent G3 V3"]
["A_23_P138776",11.57,11.55,11.57,10.65,10.51,10.68,{"v":1.08951005025126,"d":"1.09"},{"v":0.123679504742733,"d":"0.12"},"up",{"v":0.00307800000000003,"d":"0.00"},1,"yes","AATTTCTCAGTGGAGATGTACTTTCGGAACGAGAGTGACAAGGCCCCCTGGCCGCTCAGC","FALSE","NM_001610","ref|NM_001610|ref|NM_001302489|ref|NM_001302492|ref|NM_001302490","ACP2","acid phosphatase 2, lysosomal","ref|Homo sapiens acid phosphatase 2, lysosomal (ACP2), transcript variant 1, mRNA [NM_001610]","chr11",47261436,47270365,"GO:0001501(skeletal system development);GO:0003993(acid phosphatase activity);GO:0005764(lysosome);GO:0005765(lysosomal membrane);GO:0007040(lysosome organization);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0016311(dephosphorylation);GO:0043202(lysosomal lumen);GO:0070062(extracellular vesicular exosome)","04142(Lysosome)","mRNA","agilent G3 V3"]
["A_32_P31182",5.36,5.35,4.96,6.34,6.09,6.44,{"v":0.830418653948066,"d":"0.83"},{"v":-0.268089243127865,"d":"-0.27"},"down",{"v":0.00314149999999991,"d":"0.00"},1,"yes","GTAGAAGAGAAGAAGAAGGTTCCTGCTGTGCCAGAAACCCTTAAGAAAAAGCGAAGGAAT","FALSE","NM_000971","ref|NM_000971|ens|ENST00000457119|ens|ENST00000333817|ens|ENST00000468161","RPL7","ribosomal protein L7","ref|Homo sapiens ribosomal protein L7 (RPL7), mRNA [NM_000971]","chr7",108150680,108151420,"GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay);GO:0003677(DNA binding);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0003735(structural constituent of ribosome);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0005925(focal adhesion);GO:0006364(rRNA processing);GO:0006412(translation);GO:0006413(translational initiation);GO:0006414(translational elongation);GO:0006415(translational termination);GO:0006614(SRP-dependent cotranslational protein targeting to membrane);GO:0010467(gene expression);GO:0016020(membrane);GO:0016032(viral reproduction);GO:0019058(viral infectious cycle);GO:0019083(viral transcription);GO:0022625(cytosolic large ribosomal subunit);GO:0030529(ribonucleoprotein complex);GO:0042273(ribosomal large subunit biogenesis);GO:0042803(protein homodimerization activity);GO:0044267(cellular protein metabolic process);GO:0070062(extracellular vesicular exosome)","03010(Ribosome)","mRNA","agilent G3 V3"]
["A_23_P74799",2.31,2.33,{"v":2.9,"d":"2.90"},4.51,4.82,4.01,{"v":0.565217391304348,"d":"0.57"},{"v":-0.823122237915921,"d":"-0.82"},"down",{"v":0.00317789999999996,"d":"0.00"},1,"yes","GATTCTGTATCTTTTGGAAAAAAGCCGAGAGTTGAAGATAGTATATTTCTGGTAGTACTG","FALSE","NM_213651","ref|NM_213651|ref|NM_013386|ens|ENST00000370041|ens|ENST00000264128","SLC25A24","solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 24","ref|Homo sapiens solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 24 (SLC25A24), transcript variant 2, mRNA [NM_213651]","chr1",108677448,108735440,"GO:0005347(ATP transmembrane transporter activity);GO:0005509(calcium ion binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0006839(mitochondrial transport);GO:0010941(regulation of cell death);GO:0015867(ATP transport);GO:0016021(integral to membrane);GO:0034599(cellular response to oxidative stress);GO:0055085(transmembrane transport);GO:0071277(cellular response to calcium ion)",null,"mRNA","agilent G3 V3"]
["A_23_P76969",8.15,8.03,8.41,{"v":9.1,"d":"9.10"},8.89,9.09,{"v":0.908050221565731,"d":"0.91"},{"v":-0.139156003978914,"d":"-0.14"},"down",{"v":0.00320480000000001,"d":"0.00"},1,"yes","AGTGAGTGTCCTGCAGCCCTTATTCCCTCCATAGAAAGCATCCTCAGAGCACCTTCCCTG","FALSE","NM_015556","ref|NM_015556|ref|NM_001284246|ref|NM_001284247|ref|NM_001284245","SIPA1L1","signal-induced proliferation-associated 1 like 1","ref|Homo sapiens signal-induced proliferation-associated 1 like 1 (SIPA1L1), transcript variant 1, mRNA [NM_015556]","chr14",72169032,72206084,"GO:0003674(molecular_function);GO:0005096(GTPase activator activity);GO:0005575(cellular_component);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0008150(biological_process);GO:0014069(postsynaptic density);GO:0030054(cell junction);GO:0031532(actin cytoskeleton reorganization);GO:0032317(regulation of Rap GTPase activity);GO:0032861(activation of Rap GTPase activity);GO:0043197(dendritic spine);GO:0045211(postsynaptic membrane);GO:0046875(ephrin receptor binding);GO:0048013(ephrin receptor signaling pathway);GO:0048167(regulation of synaptic plasticity);GO:0050770(regulation of axonogenesis);GO:0061001(regulation of dendritic spine morphogenesis)","04015(Rap1 signaling pathway)","mRNA","agilent G3 V3"]
["A_33_P3401571",11.11,10.94,{"v":11.1,"d":"11.10"},11.46,11.44,11.58,{"v":0.961426914153132,"d":"0.96"},{"v":-0.056750904089148,"d":"-0.06"},"down",{"v":0.00323770000000001,"d":"0.00"},1,"yes","GTCAATTGTTGCTGGCCCATGGATAAGTGTATCACCACTCCCAGCCCTCCAACTACCACT","FALSE","NM_002457","ref|NM_002457|ens|ENST00000622511|gb|M94131|gb|L21998","MUC2","mucin 2, oligomeric mucus/gel-forming","ref|Homo sapiens mucin 2, oligomeric mucus/gel-forming (MUC2), mRNA [NM_002457]","chr11",{"v":1074902,"d":"1074902.00"},1093653,"GO:0005515(protein binding);GO:0005796(Golgi lumen);GO:0006493(protein O-linked glycosylation);GO:0016266(O-glycan processing);GO:0030277(maintenance of gastrointestinal epithelium);GO:0043687(post-translational protein modification);GO:0044267(cellular protein metabolic process);GO:0070702(inner mucus layer);GO:0070703(outer mucus layer)","05110(Vibrio cholerae infection);05146(Amoebiasis)","mRNA","agilent G3 V3"]
["A_24_P89872",1.94,1.97,1.93,4.25,4.42,4.74,{"v":0.435495898583147,"d":"0.44"},{"v":-1.19926896302446,"d":"-1.20"},"down",{"v":0.00324369999999996,"d":"0.00"},1,"yes","GCCAAGTATTGGAAATGAAAAGACCTGGAGTCTATGCTAGGAAGCTGAGATATTTTGGTA","FALSE","NM_197977","ref|NM_197977|ref|NM_001278240|ref|NM_003452|ref|NM_001278231","ZNF189","zinc finger protein 189","ref|Homo sapiens zinc finger protein 189 (ZNF189), transcript variant 2, mRNA [NM_197977]","chr9",104161312,104172942,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_24_P59111",7.11,6.56,6.99,5.76,5.74,5.43,{"v":1.22031896042528,"d":"1.22"},{"v":0.287258280969418,"d":"0.29"},"up",{"v":0.00329850000000009,"d":"0.00"},1,"yes","CCAGCTTGCCATGTACAAGGGGGACCTGTTTCAGATATTCCATGGAGACCCTGGCTGGAG","FALSE","NM_001290253","ref|NM_001290253|ens|ENST00000619756|gb|BC035912|tc|THC2483531","DPP6","dipeptidyl-peptidase 6","ref|Homo sapiens dipeptidyl-peptidase 6 (DPP6), transcript variant 5, mRNA [NM_001290253]","chr7",154002304,154379111,"GO:0006508(proteolysis);GO:0008236(serine-type peptidase activity);GO:0008239(dipeptidyl-peptidase activity);GO:0016021(integral to membrane);GO:0019228(regulation of action potential in neuron);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P214211",8.22,8.11,8.02,8.46,8.52,8.53,{"v":0.95452763622109,"d":"0.95"},{"v":-0.0671411266327678,"d":"-0.07"},"down",{"v":0.00333639999999991,"d":"0.00"},1,"yes","GGCCAGACTTCATCTTTTCAAAGCTGTCCGTTCTGTCCTAGCCAATGGAATGAAACTTCT","FALSE","NM_020320","ref|NM_020320|ens|ENST00000493269|ens|ENST00000369536|ref|XR_241848","RARS2","arginyl-tRNA synthetase 2, mitochondrial","ref|Homo sapiens arginyl-tRNA synthetase 2, mitochondrial (RARS2), mRNA [NM_020320]","chr6",88224128,88226598,"GO:0004814(arginine-tRNA ligase activity);GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0006418(tRNA aminoacylation for protein translation);GO:0006420(arginyl-tRNA aminoacylation);GO:0010467(gene expression);GO:0032543(mitochondrial translation)","00970(Aminoacyl-tRNA biosynthesis)","mRNA","agilent G3 V3"]
["A_32_P44316",9.03,9.62,8.73,10.72,10.88,11.11,{"v":0.837052889024763,"d":"0.84"},{"v":-0.256609312824879,"d":"-0.26"},"down",{"v":0.00336400000000003,"d":"0.00"},1,"yes","TGAGTGTGAACATGGTATCACCATTGATACCTCCTTGTGGAAATTTGAGACCAGCAAGTA","FALSE","NM_001402","ref|NM_001402|ens|ENST00000443590|ens|ENST00000455918|ens|ENST00000356303","EEF1A1","eukaryotic translation elongation factor 1 alpha 1","ref|Homo sapiens eukaryotic translation elongation factor 1 alpha 1 (EEF1A1), mRNA [NM_001402]","chr2",107313784,107315132,"GO:0003746(translation elongation factor activity);GO:0003924(GTPase activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005853(eukaryotic translation elongation factor 1 complex);GO:0005886(plasma membrane);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0006412(translation);GO:0006414(translational elongation);GO:0010467(gene expression);GO:0016020(membrane);GO:0019901(protein kinase binding);GO:0044267(cellular protein metabolic process);GO:0070062(extracellular vesicular exosome);GO:0071364(cellular response to epidermal growth factor stimulus)","03013(RNA transport);05134(Legionellosis)","mRNA","agilent G3 V3"]
["A_33_P3373459",6.86,6.57,6.21,7.93,7.71,{"v":8.1,"d":"8.10"},{"v":0.827295703454086,"d":"0.83"},{"v":-0.273525005327214,"d":"-0.27"},"down",{"v":0.0033784,"d":"0.00"},1,"yes","CTTGTTCACTCCACTGCCTCTATCCATTGAGTACTGTATCGATATTGTTTTTTAAGATTA","FALSE","NM_018641","ref|NM_018641|ref|NM_001243795|ref|NM_001243794|ens|ENST00000618655","CHST12","carbohydrate (chondroitin 4) sulfotransferase 12","ref|Homo sapiens carbohydrate (chondroitin 4) sulfotransferase 12 (CHST12), transcript variant 3, mRNA [NM_018641]","chr7",{"v":2443734,"d":"2443734.00"},2473010,"GO:0000139(Golgi membrane);GO:0005975(carbohydrate metabolic process);GO:0009405(pathogenesis);GO:0016020(membrane);GO:0016051(carbohydrate biosynthetic process);GO:0030173(integral to Golgi membrane);GO:0030203(glycosaminoglycan metabolic process);GO:0030204(chondroitin sulfate metabolic process);GO:0030206(chondroitin sulfate biosynthetic process);GO:0030208(dermatan sulfate biosynthetic process);GO:0044281(small molecule metabolic process);GO:0047756(chondroitin 4-sulfotransferase activity);GO:0050656(3'-phosphoadenosine 5'-phosphosulfate binding)","00532(Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate)","mRNA","agilent G3 V3"]
["A_33_P3318911",6.08,5.58,5.87,6.95,6.87,7.28,{"v":0.830805687203791,"d":"0.83"},{"v":-0.267417002835009,"d":"-0.27"},"down",{"v":0.00342370000000003,"d":"0.00"},1,"yes","TATGAAGAATTGTCCCCTGGCTTCCAGCAGGCCATGGCTGGCTGTTTTGTGACTGTTACA","FALSE","NM_001135642","ref|NM_001135642|ref|NM_130766|ref|NM_016532|ens|ENST00000406424","INPP5K","inositol polyphosphate-5-phosphatase K","ref|Homo sapiens inositol polyphosphate-5-phosphatase K (INPP5K), transcript variant 3, mRNA [NM_001135642]","chr17",{"v":1398861,"d":"1398861.00"},1419912,"GO:0001701(in utero embryonic development);GO:0001726(ruffle);GO:0001933(negative regulation of protein phosphorylation);GO:0004445(inositol-polyphosphate 5-phosphatase activity);GO:0005000(vasopressin receptor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005802(trans-Golgi network);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005979(regulation of glycogen biosynthetic process);GO:0006469(negative regulation of protein kinase activity);GO:0006644(phospholipid metabolic process);GO:0006661(phosphatidylinositol biosynthetic process);GO:0007186(G-protein coupled receptor signaling pathway);GO:0010801(negative regulation of peptidyl-threonine phosphorylation);GO:0010829(negative regulation of glucose transport);GO:0016020(membrane);GO:0016311(dephosphorylation);GO:0016312(inositol bisphosphate phosphatase activity);GO:0030036(actin cytoskeleton organization);GO:0032587(ruffle membrane);GO:0032869(cellular response to insulin stimulus);GO:0032870(cellular response to hormone stimulus);GO:0033137(negative regulation of peptidyl-serine phosphorylation);GO:0034485(phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity);GO:0034594(phosphatidylinositol trisphosphate phosphatase activity);GO:0034595(phosphatidylinositol phosphate 5-phosphatase activity);GO:0035305(negative regulation of dephosphorylation);GO:0035810(positive regulation of urine volume);GO:0042577(lipid phosphatase activity);GO:0042593(glucose homeostasis);GO:0043005(neuron projection);GO:0043407(negative regulation of MAP kinase activity);GO:0043922(negative regulation by host of viral transcription);GO:0044281(small molecule metabolic process);GO:0045719(negative regulation of glycogen biosynthetic process);GO:0045869(negative regulation of retroviral genome replication);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0046030(inositol trisphosphate phosphatase activity);GO:0046627(negative regulation of insulin receptor signaling pathway);GO:0046855(inositol phosphate dephosphorylation);GO:0046856(phosphatidylinositol dephosphorylation);GO:0048471(perinuclear region of cytoplasm);GO:0051497(negative regulation of stress fiber assembly);GO:0051898(negative regulation of protein kinase B signaling cascade);GO:0051926(negative regulation of calcium ion transport);GO:0052658(inositol-1,4,5-trisphosphate 5-phosphatase activity);GO:0052659(inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity);GO:0071320(cellular response to cAMP);GO:0071356(cellular response to tumor necrosis factor);GO:0071364(cellular response to epidermal growth factor stimulus);GO:0072661(protein targeting to plasma membrane);GO:0090315(negative regulation of protein targeting to membrane);GO:0097178(ruffle assembly);GO:2000466(negative regulation of glycogen (starch) synthase activity);GO:2001153(positive regulation of renal water transport)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system);04910(Insulin signaling pathway)","mRNA","agilent G3 V3"]
["A_33_P3220422",9.15,{"v":9.1,"d":"9.10"},9.11,9.35,9.39,{"v":9.5,"d":"9.50"},{"v":0.968838526912181,"d":"0.97"},{"v":-0.0456718583852826,"d":"-0.05"},"down",{"v":0.0034594,"d":"0.00"},1,"yes","TGCAGTAGGGTCTCCTTCGCCCTCGAGGTCACCCAGTCTGCTGGCCCCTTTGGCTCCTAA","FALSE","NM_182595","ref|NM_182595|ens|ENST00000408890|gb|AK097768|gb|AL833888","POM121L12","POM121 transmembrane nucleoporin-like 12","ref|Homo sapiens POM121 transmembrane nucleoporin-like 12 (POM121L12), mRNA [NM_182595]","chr7",53103348,53104617,null,null,"mRNA","agilent G3 V3"]
["A_21_P0000346",5.29,5.23,5.53,{"v":4.5,"d":"4.50"},3.95,{"v":4.2,"d":"4.20"},{"v":1.26877470355731,"d":"1.27"},{"v":0.343435912427993,"d":"0.34"},"up",{"v":0.00349600000000005,"d":"0.00"},1,"yes","GGCTAGGGAAAATGATTGGATAGAAACTATTATTCTATTCATTTATCCCCAGCCTACAAA","FALSE","NR_002994","ref|NR_002994|ref|NR_031705","SNORA36B","small nucleolar RNA, H/ACA box 36B","ref|Homo sapiens small nucleolar RNA, H/ACA box 36B (SNORA36B), small nucleolar RNA [NR_002994]","chr1",220373888,220374018,null,null,"mRNA","agilent G3 V3"]
["A_23_P163455",6.73,6.35,6.63,7.65,7.66,8.16,{"v":0.83979548359608,"d":"0.84"},{"v":-0.251890065479684,"d":"-0.25"},"down",{"v":0.00350300000000003,"d":"0.00"},1,"yes","AATGCCAGAATTCTTCCAAACTCCCTGACTCTTTGAAGTTTTTACTCACCCCATTTCAAT","FALSE","NM_002373","ref|NM_002373|ens|ENST00000300231|ref|XM_005254385|ens|ENST00000382031","MAP1A","microtubule-associated protein 1A","ref|Homo sapiens microtubule-associated protein 1A (MAP1A), mRNA [NM_002373]","chr15",43809808,43823818,"GO:0000226(microtubule cytoskeleton organization);GO:0005198(structural molecule activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005874(microtubule);GO:0005875(microtubule associated complex);GO:0007605(sensory perception of sound);GO:0008017(microtubule binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3232871",7.08,7.32,7.38,6.52,{"v":6.5,"d":"6.50"},{"v":6.7,"d":"6.70"},{"v":1.10446247464503,"d":"1.10"},{"v":0.143344402338995,"d":"0.14"},"up",{"v":0.00353720000000002,"d":"0.00"},1,"yes","TCCATGACTCACCCAGGCGACACTCAGGATTTGGATCAATAGAAGGGCAACCCCATCCCA","FALSE","NM_001167670","ref|NM_001167670|ens|ENST00000380585|gb|AK129653|tc|THC2479377","TMEM239","transmembrane protein 239","ref|Homo sapiens transmembrane protein 239 (TMEM239), mRNA [NM_001167670]","chr20",{"v":2795614,"d":"2795614.00"},2798712,"GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P319005",6.33,6.52,6.22,5.73,{"v":5.6,"d":"5.60"},{"v":5.8,"d":"5.80"},{"v":1.11325160537069,"d":"1.11"},{"v":0.154779692228757,"d":"0.15"},"up",{"v":0.0035792,"d":"0.00"},1,"yes","GAGAATTGGTTATTTGAGATGTGGTACTGCTTCCTCACAAGTCTCCCACAGGCCATGTAA","FALSE","NM_015980","ref|NM_015980|ens|ENST00000303177|gb|AK098398|gb|AF133422","HMP19","HMP19 protein","ref|Homo sapiens HMP19 protein (HMP19), mRNA [NM_015980]","chr5",173518208,173535349,"GO:0007212(dopamine receptor signaling pathway);GO:0016021(integral to membrane);GO:0030659(cytoplasmic vesicle membrane);GO:0032051(clathrin light chain binding);GO:0032580(Golgi cisterna membrane);GO:0032585(multivesicular body membrane);GO:0048268(clathrin coat assembly)",null,"mRNA","agilent G3 V3"]
["A_23_P213592",8.57,8.35,8.85,7.62,7.72,7.71,{"v":1.11800433839479,"d":"1.12"},{"v":0.160925786542919,"d":"0.16"},"up",{"v":0.00360460000000007,"d":"0.00"},1,"yes","ACCTTGCTATAGATGCCATGTTACCAATGATTTCCTGTGGTGGGGGCTTGCCATTGTTTA","FALSE","NM_014901","ref|NM_014901|ens|ENST00000274811|ref|XM_005265842|ref|XM_005265844","RNF44","ring finger protein 44","ref|Homo sapiens ring finger protein 44 (RNF44), mRNA [NM_014901]","chr5",175953696,175964421,"GO:0008270(zinc ion binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3255056",6.58,{"v":5.7,"d":"5.70"},6.83,4.06,4.38,4.17,{"v":1.51546391752577,"d":"1.52"},{"v":0.599759502649237,"d":"0.60"},"up",{"v":0.00365919999999997,"d":"0.00"},1,"yes","TTGATCTGCGGCATGCTCAGGGCCTGGGTATTAAAGGGGCTGGATCACCCTCAGGCTTTT","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_33_P3301970",{"v":7.1,"d":"7.10"},6.25,6.45,8.32,8.49,{"v":8.1,"d":"8.10"},{"v":0.794861501405058,"d":"0.79"},{"v":-0.331224591273865,"d":"-0.33"},"down",{"v":0.00370320000000002,"d":"0.00"},1,"yes","CTTTCTCTCCTGCCTTCTTTAGCTTGGTACAGCTCTGTTTGCAACAAGATCCTGAGAAAA","FALSE","NM_018571","ref|NM_018571|ref|NM_001206864|ens|ENST00000392249|ens|ENST00000412769","STRADB","STE20-related kinase adaptor beta","ref|Homo sapiens STE20-related kinase adaptor beta (STRADB), transcript variant 1, mRNA [NM_018571]","chr2",202340400,202343290,"GO:0000278(mitotic cell cycle);GO:0000902(cell morphogenesis);GO:0004672(protein kinase activity);GO:0004702(receptor signaling protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0006611(protein export from nucleus);GO:0007050(cell cycle arrest);GO:0007254(JNK cascade);GO:0008286(insulin receptor signaling pathway);GO:0032147(activation of protein kinase activity);GO:0035556(intracellular signal transduction);GO:2001240(negative regulation of extrinsic apoptotic signaling pathway in absence of ligand)","04152(AMPK signaling pathway)","mRNA","agilent G3 V3"]
["A_23_P155830",4.22,4.94,5.23,6.85,6.54,7.01,{"v":0.705392156862745,"d":"0.71"},{"v":-0.50350256011856,"d":"-0.50"},"down",{"v":0.00373830000000008,"d":"0.00"},1,"yes","CTCCAGAGGTCTGCACACTCCACTTCACATGCCGTTGACTCTCACAGTCTAAGACTTCAG","FALSE","NM_020773","ref|NM_020773|ref|NM_001113361|ref|NM_001113363|ref|NM_001286805","TBC1D14","TBC1 domain family, member 14","ref|Homo sapiens TBC1 domain family, member 14 (TBC1D14), transcript variant 1, mRNA [NM_020773]","chr4",{"v":6911171,"d":"6911171.00"},7034845,"GO:0005097(Rab GTPase activator activity);GO:0005515(protein binding);GO:0005776(autophagic vacuole);GO:0005794(Golgi apparatus);GO:0010507(negative regulation of autophagy);GO:0019901(protein kinase binding);GO:0032851(positive regulation of Rab GTPase activity);GO:0055037(recycling endosome);GO:0071955(recycling endosome to Golgi transport);GO:2000785(regulation of autophagic vacuole assembly)",null,"mRNA","agilent G3 V3"]
["A_23_P219013",8.44,8.77,8.41,7.74,7.73,7.88,{"v":1.09721627408994,"d":"1.10"},{"v":0.133847925744622,"d":"0.13"},"up",{"v":0.00376359999999998,"d":"0.00"},1,"yes","AGCTGTTGTGTTTGGCCAGGGCTCTCCTCACAGATGCCAAGATCCTGTGTATCGATGAGG","FALSE","NM_033450","ref|NM_033450|ref|NM_001198934|ens|ENST00000244533|ens|ENST00000463024","ABCC10","ATP-binding cassette, sub-family C (CFTR/MRP), member 10","ref|Homo sapiens ATP-binding cassette, sub-family C (CFTR/MRP), member 10 (ABCC10), transcript variant MRP7A, mRNA [NM_033450]","chr6",43395292,43418168,"GO:0005524(ATP binding);GO:0005765(lysosomal membrane);GO:0005886(plasma membrane);GO:0008152(metabolic process);GO:0016021(integral to membrane);GO:0042626(ATPase activity, coupled to transmembrane movement of substances);GO:0055085(transmembrane transport)","02010(ABC transporters)","mRNA","agilent G3 V3"]
["A_24_P23445",10.34,10.91,11.17,9.27,8.68,9.05,{"v":1.20074074074074,"d":"1.20"},{"v":0.263924683579348,"d":"0.26"},"up",{"v":0.00380389999999997,"d":"0.00"},1,"yes","ATCCTCACTGCTAATGTGAGACGAATTTTTGAGCTGGTAAAGGTCGCCCCTAAGGTGACC","FALSE","NR_029422","ref|NR_029422|ens|ENST00000602478|gb|J04119|gb|AV763774","RNU12","RNA, U12 small nuclear","ref|Homo sapiens RNA, U12 small nuclear (RNU12), small nuclear RNA [NR_029422]","chrX",46992072,46992225,null,null,"mRNA","agilent G3 V3"]
["A_24_P119685",6.35,6.48,6.36,6.05,6.03,6.14,{"v":1.05323819978046,"d":"1.05"},{"v":0.0748317523933297,"d":"0.07"},"up",{"v":0.00384280000000004,"d":"0.00"},1,"yes","ACGGGCCCTTCTTACCTCACTCAACTTCAGCCAGGAGGACTGGGTGGTGCTTGCAATGTT","FALSE","NM_052843","ref|NM_052843|ens|ENST00000284548|ref|XM_005273309|ref|XM_005273310","OBSCN","obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF","ref|Homo sapiens obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF (OBSCN), transcript variant 1, mRNA [NM_052843]","chr1",228395856,228548456,"GO:0004674(protein serine/threonine kinase activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0007264(small GTPase mediated signal transduction);GO:0007275(multicellular organismal development);GO:0008307(structural constituent of muscle);GO:0030016(myofibril);GO:0030018(Z disc);GO:0030506(ankyrin binding);GO:0031430(M band);GO:0031432(titin binding);GO:0032321(positive regulation of Rho GTPase activity);GO:0043065(positive regulation of apoptotic process);GO:0045214(sarcomere organization);GO:0046872(metal ion binding);GO:0048011(nerve growth factor receptor signaling pathway);GO:0051056(regulation of small GTPase mediated signal transduction);GO:0097190(apoptotic signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_23_P141779",4.89,4.62,5.34,6.18,6.24,6.41,{"v":0.788635156664896,"d":"0.79"},{"v":-0.3425700689261,"d":"-0.34"},"down",{"v":0.0038779000000001,"d":"0.00"},1,"yes","CTGCTACGCCAAGTATGAGAGCCAGACGTCCTTTGGGTCCATGTACCCCACACGCATTGA","FALSE","NM_014593","ref|NM_014593|ref|NM_001101654|ens|ENST00000590901|ens|ENST00000285106","CXXC1","CXXC finger protein 1","ref|Homo sapiens CXXC finger protein 1 (CXXC1), transcript variant 2, mRNA [NM_014593]","chr18",47808712,47814006,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0006987(activation of signaling protein activity involved in unfolded protein response);GO:0008270(zinc ion binding);GO:0016363(nuclear matrix);GO:0016607(nuclear speck);GO:0030968(endoplasmic reticulum unfolded protein response);GO:0035097(histone methyltransferase complex);GO:0042800(histone methyltransferase activity (H3-K4 specific));GO:0044267(cellular protein metabolic process);GO:0045322(unmethylated CpG binding);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0048188(Set1C/COMPASS complex);GO:0051568(histone H3-K4 methylation)",null,"mRNA","agilent G3 V3"]
["A_23_P82674",2.14,2.22,2.48,3.65,3.37,4.11,{"v":0.61455525606469,"d":"0.61"},{"v":-0.702385362456062,"d":"-0.70"},"down",{"v":0.00391779999999997,"d":"0.00"},1,"yes","TTACAAGTGTACCCAATAACTGAAAATGTTTTAACTCACTCTCATTTGTAAGCAGTCCAC","FALSE","NM_001483","ref|NM_001483|ref|NM_001202469|ens|ENST00000497279|ens|ENST00000322090","GBAS","glioblastoma amplified sequence","ref|Homo sapiens glioblastoma amplified sequence (GBAS), transcript variant 1, mRNA [NM_001483]","chr7",56049168,56066997,"GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005887(integral to plasma membrane);GO:0006119(oxidative phosphorylation);GO:0006754(ATP biosynthetic process);GO:0016020(membrane);GO:2000984(negative regulation of ATP citrate synthase activity)",null,"mRNA","agilent G3 V3"]
["A_23_P90062",2.88,3.38,2.76,4.25,4.45,4.81,{"v":0.667653589933383,"d":"0.67"},{"v":-0.582828336070304,"d":"-0.58"},"down",{"v":0.0039595,"d":"0.00"},1,"yes","AGCACTGTGGAACGTCTGTAAATATGTTTTTATAATTCCATGTATAGTTGGTGTACACTC","FALSE","NM_006145","ref|NM_006145|ref|NM_001300914|ens|ENST00000254322|ref|XM_006722733","DNAJB1","DnaJ (Hsp40) homolog, subfamily B, member 1","ref|Homo sapiens DnaJ (Hsp40) homolog, subfamily B, member 1 (DNAJB1), transcript variant 1, mRNA [NM_006145]","chr19",14625582,14629232,"GO:0001671(ATPase activator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006986(response to unfolded protein);GO:0030544(Hsp70 protein binding);GO:0032781(positive regulation of ATPase activity);GO:0034605(cellular response to heat);GO:0051082(unfolded protein binding);GO:0051085(chaperone mediated protein folding requiring cofactor);GO:0051087(chaperone binding);GO:0051117(ATPase binding);GO:0070062(extracellular vesicular exosome);GO:0070389(chaperone cofactor-dependent protein refolding);GO:0090084(negative regulation of inclusion body assembly);GO:1900034(regulation of cellular response to heat)","04141(Protein processing in endoplasmic reticulum);05164(Influenza A)","mRNA","agilent G3 V3"]
["A_21_P0014031",5.96,6.34,5.66,4.07,4.49,4.67,{"v":1.35752078609221,"d":"1.36"},{"v":0.44097428846247,"d":"0.44"},"up",{"v":0.00401659999999993,"d":"0.00"},1,"yes","TCAAAATCAGTGATGGGAGTAAGAGCAAATTTCATCTTTCCAAATTGATGGGTGGGCTAG","FALSE","NM_001123066","ref|NM_001123066|ref|NM_016835|ref|NM_005910|ref|NM_001123067","MAPT","microtubule-associated protein tau","ref|Homo sapiens microtubule-associated protein tau (MAPT), transcript variant 6, mRNA [NM_001123066]","chr17",43971748,44105699,"GO:0000226(microtubule cytoskeleton organization);GO:0001764(neuron migration);GO:0005200(structural constituent of cytoskeleton);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005874(microtubule);GO:0005875(microtubule associated complex);GO:0005886(plasma membrane);GO:0005930(axoneme);GO:0006915(apoptotic process);GO:0006921(cellular component disassembly involved in apoptotic process);GO:0007628(adult walking behavior);GO:0008017(microtubule binding);GO:0008088(axon cargo transport);GO:0010506(regulation of autophagy);GO:0017124(SH3 domain binding);GO:0019899(enzyme binding);GO:0019901(protein kinase binding);GO:0030424(axon);GO:0030426(growth cone);GO:0031113(regulation of microtubule polymerization);GO:0031116(positive regulation of microtubule polymerization);GO:0032387(negative regulation of intracellular transport);GO:0034185(apolipoprotein binding);GO:0034399(nuclear periphery);GO:0045298(tubulin complex);GO:0045773(positive regulation of axon extension);GO:0047497(mitochondrion transport along microtubule);GO:0048675(axon extension);GO:0048699(generation of neurons);GO:0060632(regulation of microtubule-based movement);GO:0071813(lipoprotein particle binding)","04010(MAPK signaling pathway);05010(Alzheimer's disease)","mRNA","agilent G3 V3"]
["A_23_P156156",2.35,2.39,2.85,3.85,3.78,4.38,{"v":0.631973355537052,"d":"0.63"},{"v":-0.662064360290168,"d":"-0.66"},"down",{"v":0.00403940000000003,"d":"0.00"},1,"yes","CCCTGTAGCCAGGACTATGCTGTAGATATCAGTATGATCTGGGTGTGGCCAAAAACAATT","FALSE","NM_032280","ref|NM_032280|ref|NM_001131035|ref|NM_001131036|ens|ENST00000507402","ZCCHC9","zinc finger, CCHC domain containing 9","ref|Homo sapiens zinc finger, CCHC domain containing 9 (ZCCHC9), transcript variant 1, mRNA [NM_032280]","chr5",80604488,80608792,"GO:0008270(zinc ion binding);GO:0010923(negative regulation of phosphatase activity)",null,"mRNA","agilent G3 V3"]
["A_22_P00006598",7.42,7.51,7.14,8.24,8.82,8.66,{"v":0.858087091757387,"d":"0.86"},{"v":-0.220804013048333,"d":"-0.22"},"down",{"v":0.00409649999999995,"d":"0.00"},1,"yes","ATCAATATTGGAAACCTGTGCTTTAGTTCTTCCACCTCTGCTGCTGCTATGCTGTGTGAC","FALSE","XR_427815","ref|XR_427815|ref|XR_431942|linc|lnc-FNDC9-1:1|linc|lnc-FNDC9-1:2","LOC101927675","uncharacterized LOC101927675","ref|PREDICTED: Homo sapiens uncharacterized LOC101927675 (LOC101927675), ncRNA [XR_427815]","chr5",156790384,156792509,null,null,"mRNA","agilent G3 V3"]
["A_33_P3301689",8.89,8.58,8.99,7.52,7.99,7.68,{"v":1.14100905562743,"d":"1.14"},{"v":0.190310241632673,"d":"0.19"},"up",{"v":0.00415949999999998,"d":"0.00"},1,"yes","TACCTAAACCAGTCATATGGCATGGACAATCACAGTGGTGGTGGTGGGGGTAGCAGGTAA","FALSE","NM_182975","ref|NM_182975|ens|ENST00000361911|gb|BC053888|gb|AK000410","ZNF326","zinc finger protein 326","ref|Homo sapiens zinc finger protein 326 (ZNF326), transcript variant 3, mRNA [NM_182975]","chr1",90460696,90501090,"GO:0000993(RNA polymerase II core binding);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005681(spliceosomal complex);GO:0006351(transcription, DNA-dependent);GO:0006397(mRNA processing);GO:0008270(zinc ion binding);GO:0008380(RNA splicing);GO:0016363(nuclear matrix);GO:0032784(regulation of transcription elongation, DNA-dependent);GO:0043231(intracellular membrane-bounded organelle);GO:0044609(DBIRD complex);GO:0045893(positive regulation of transcription, DNA-dependent)",null,"mRNA","agilent G3 V3"]
["A_23_P24004",2.84,3.39,2.59,5.17,4.83,4.43,{"v":0.611226611226611,"d":"0.61"},{"v":-0.710220738933677,"d":"-0.71"},"down",{"v":0.00421629999999995,"d":"0.00"},1,"yes","AGCTGACCCAGCATCAGCCACACTCTGGGTTGGAAAATGTTTGCCTGTTGGAATTAATTT","FALSE","NM_001547","ref|NM_001547|ens|ENST00000611722|ens|ENST00000371826|gb|BC032839","IFIT2","interferon-induced protein with tetratricopeptide repeats 2","ref|Homo sapiens interferon-induced protein with tetratricopeptide repeats 2 (IFIT2), mRNA [NM_001547]","chr10",91061712,91069033,"GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0008637(apoptotic mitochondrial changes);GO:0009615(response to virus);GO:0019221(cytokine-mediated signaling pathway);GO:0032091(negative regulation of protein binding);GO:0035457(cellular response to interferon-alpha);GO:0043065(positive regulation of apoptotic process);GO:0051607(defense response to virus);GO:0060337(type I interferon-mediated signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_33_P3336273",9.39,9.66,9.68,8.98,8.76,8.66,{"v":1.08825757575758,"d":"1.09"},{"v":0.122020063286708,"d":"0.12"},"up",{"v":0.00428099999999998,"d":"0.00"},1,"yes","AGTTTACAATGCAGACCATTTTTTGTCCCTTCCTTTTGTTTCCTCTGAGGGGCTGTTCGC","FALSE","NM_001024383","ref|NM_001024383|ref|NM_014903|ens|ENST00000397909|ref|XM_005269215","NAV3","neuron navigator 3","ref|Homo sapiens neuron navigator 3 (NAV3), transcript variant 1, mRNA [NM_001024383]","chr12",78592856,78604763,"GO:0005640(nuclear outer membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P129476",11.36,11.08,11.11,11.92,11.87,{"v":11.7,"d":"11.70"},{"v":0.945336714567484,"d":"0.95"},{"v":-0.0810998079733987,"d":"-0.08"},"down",{"v":0.00431890000000001,"d":"0.00"},1,"yes","GCAGTCCAGTTTCTCTCCCCTCTGACCCCTAGAAGGGGAGTTGTAGCCCCATGAACTAGT","FALSE","NM_004913","ref|NM_004913|ens|ENST00000614968|ens|ENST00000389386|ref|XM_005256329","VPS9D1","VPS9 domain containing 1","ref|Homo sapiens VPS9 domain containing 1 (VPS9D1), mRNA [NM_004913]","chr16",89773544,89787394,"GO:0005096(GTPase activator activity);GO:0005215(transporter activity);GO:0015986(ATP synthesis coupled proton transport);GO:0043547(positive regulation of GTPase activity)",null,"mRNA","agilent G3 V3"]
["A_23_P76136",5.46,6.53,5.54,8.11,7.76,7.92,{"v":0.736864228667507,"d":"0.74"},{"v":-0.440529275665596,"d":"-0.44"},"down",{"v":0.00434290000000004,"d":"0.00"},1,"yes","AGAGGTCTTAACCTAATGCGCATAGAGAAATTGTTCTCATTGTAAACATACCCCTGTCCT","FALSE","NM_001080509","ref|NM_001080509|ens|ENST00000261177|gb|AK024399|gb|AY358804","TSPAN11","tetraspanin 11","ref|Homo sapiens tetraspanin 11 (TSPAN11), mRNA [NM_001080509]","chr12",31079892,31149534,"GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P104892",4.76,5.81,4.04,8.08,7.73,7.92,{"v":0.615676359039191,"d":"0.62"},{"v":-0.69975592239045,"d":"-0.70"},"down",{"v":0.00438170000000004,"d":"0.00"},1,"yes","AAGCAGAGGCAGTCTATTGCAAGGGACCTTCTTTGCTGCCAGTTATCATAGGCTGTTTTA","FALSE","NM_001418","ref|NM_001418|ref|NM_001172705|ref|NM_001042559|ens|ENST00000396525","EIF4G2","eukaryotic translation initiation factor 4 gamma, 2","ref|Homo sapiens eukaryotic translation initiation factor 4 gamma, 2 (EIF4G2), transcript variant 1, mRNA [NM_001418]","chr11",10818592,10830582,"GO:0003743(translation initiation factor activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0006413(translational initiation);GO:0006446(regulation of translational initiation);GO:0007050(cell cycle arrest);GO:0008135(translation factor activity, nucleic acid binding);GO:0008219(cell death);GO:0016020(membrane);GO:0016281(eukaryotic translation initiation factor 4F complex);GO:0019221(cytokine-mediated signaling pathway)","03013(RNA transport);05416(Viral myocarditis)","mRNA","agilent G3 V3"]
["A_23_P123866",9.34,8.87,9.25,8.25,8.24,8.37,{"v":1.10458567980692,"d":"1.10"},{"v":0.143505329094616,"d":"0.14"},"up",{"v":0.00445629999999997,"d":"0.00"},1,"yes","TGAAAGATTCTTCCAGGGTTTTATTTTTTCCCCTCCTAACAAAGTCTCATAGTGTTAACA","FALSE","NM_016525","ref|NM_016525|ref|NM_001171203|ref|NM_001171204|ref|NM_001171201","UBAP1","ubiquitin associated protein 1","ref|Homo sapiens ubiquitin associated protein 1 (UBAP1), transcript variant 1, mRNA [NM_016525]","chr9",34179004,34252521,"GO:0000813(ESCRT I complex);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0015031(protein transport);GO:0043130(ubiquitin binding);GO:0043162(ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway)",null,"mRNA","agilent G3 V3"]
["A_24_P273666",12.39,12.28,12.34,12.69,12.58,12.58,{"v":0.9778071334214,"d":"0.98"},{"v":-0.0323781645728734,"d":"-0.03"},"down",{"v":0.00448040000000005,"d":"0.00"},1,"yes","CCCCGAGTGATTTTGCGAAACCCCCTTTTCCCTTCAGCTTGCTTAGATGTTCCAAATTTA","FALSE","NM_001077489","ref|NM_001077489|ref|NM_001077490|ref|NM_080425|ref|NM_016592","GNAS","GNAS complex locus","ref|Homo sapiens GNAS complex locus (GNAS), transcript variant 7, mRNA [NM_001077489]","chr20",57466464,57486241,"GO:0001726(ruffle);GO:0001894(tissue homeostasis);GO:0001958(endochondral ossification);GO:0003091(renal water homeostasis);GO:0003674(molecular_function);GO:0003924(GTPase activity);GO:0004016(adenylate cyclase activity);GO:0004871(signal transducer activity);GO:0005159(insulin-like growth factor receptor binding);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005576(extracellular region);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005834(heterotrimeric G-protein complex);GO:0005886(plasma membrane);GO:0006112(energy reserve metabolic process);GO:0006171(cAMP biosynthetic process);GO:0006184(GTP catabolic process);GO:0006306(DNA methylation);GO:0006833(water transport);GO:0007189(adenylate cyclase-activating G-protein coupled receptor signaling pathway);GO:0007190(activation of adenylate cyclase activity);GO:0007191(adenylate cyclase-activating dopamine receptor signaling pathway);GO:0007565(female pregnancy);GO:0007596(blood coagulation);GO:0007606(sensory perception of chemical stimulus);GO:0007608(sensory perception of smell);GO:0009306(protein secretion);GO:0016020(membrane);GO:0030133(transport vesicle);GO:0030425(dendrite);GO:0030819(positive regulation of cAMP biosynthetic process);GO:0031224(intrinsic to membrane);GO:0031683(G-protein beta/gamma-subunit complex binding);GO:0031698(beta-2 adrenergic receptor binding);GO:0031748(D1 dopamine receptor binding);GO:0031852(mu-type opioid receptor binding);GO:0032320(positive regulation of Ras GTPase activity);GO:0032588(trans-Golgi network membrane);GO:0035116(embryonic hindlimb morphogenesis);GO:0035255(ionotropic glutamate receptor binding);GO:0035264(multicellular organism growth);GO:0040015(negative regulation of multicellular organism growth);GO:0040032(post-embryonic body morphogenesis);GO:0042493(response to drug);GO:0043950(positive regulation of cAMP-mediated signaling);GO:0044281(small molecule metabolic process);GO:0045669(positive regulation of osteoblast differentiation);GO:0045672(positive regulation of osteoclast differentiation);GO:0046872(metal ion binding);GO:0046907(intracellular transport);GO:0048471(perinuclear region of cytoplasm);GO:0048589(developmental growth);GO:0048701(embryonic cranial skeleton morphogenesis);GO:0050796(regulation of insulin secretion);GO:0050890(cognition);GO:0051216(cartilage development);GO:0051430(corticotropin-releasing hormone receptor 1 binding);GO:0055085(transmembrane transport);GO:0060348(bone development);GO:0060789(hair follicle placode formation);GO:0070062(extracellular vesicular exosome);GO:0070527(platelet aggregation);GO:0071107(response to parathyroid hormone stimulus);GO:0071377(cellular response to glucagon stimulus);GO:0071380(cellular response to prostaglandin E stimulus);GO:0071514(genetic imprinting);GO:0071870(cellular response to catecholamine stimulus);GO:0071880(adenylate cyclase-activating adrenergic receptor signaling pathway)","04015(Rap1 signaling pathway);04020(Calcium signaling pathway);04024(cAMP signaling pathway);04540(Gap junction);04611(Platelet activation);04911(Insulin secretion);04922(Glucagon signaling pathway);04923(Regulation of lipolysis in adipocyte);04912(GnRH signaling pathway);04913(Ovarian Steroidogenesis);04915(Estrogen signaling pathway);04921(Oxytocin signaling pathway);04918(Thyroid hormone synthesis);04916(Melanogenesis);04261(Adrenergic signaling in cardiomyocytes);04270(Vascular smooth muscle contraction);04970(Salivary secretion);04971(Gastric acid secretion);04972(Pancreatic secretion);04976(Bile secretion);04962(Vasopressin-regulated water reabsorption);04961(Endocrine and other factor-regulated calcium reabsorption);04724(Glutamatergic synapse);04728(Dopaminergic synapse);04726(Serotonergic synapse);04730(Long-term depression);04742(Taste transduction);04750(Inflammatory mediator regulation of TRP channels);04713(Circadian entrainment);05200(Pathways in cancer);05030(Cocaine addiction);05031(Amphetamine addiction);05032(Morphine addiction);05034(Alcoholism);05414(Dilated cardiomyopathy (DCM));05110(Vibrio cholerae infection);05146(Amoebiasis);05142(Chagas disease (American trypanosomiasis))","mRNA","agilent G3 V3"]
["A_33_P3224027",{"v":8.9,"d":"8.90"},8.64,8.93,{"v":7.8,"d":"7.80"},8.06,7.53,{"v":1.1316802052159,"d":"1.13"},{"v":0.178466333142971,"d":"0.18"},"up",{"v":0.00453879999999995,"d":"0.00"},1,"yes","ACCCACCATTGGCAGCATAATGGGGAGCTGGCTGAAGGGGGTGCTGAGCCCAAGGATCCA","FALSE","NM_052897","ref|NM_052897|ens|ENST00000547545|ens|ENST00000355673|ref|XR_429078","MBD6","methyl-CpG binding domain protein 6","ref|Homo sapiens methyl-CpG binding domain protein 6 (MBD6), mRNA [NM_052897]","chr12",57916624,57923931,"GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0010369(chromocenter)",null,"mRNA","agilent G3 V3"]
["A_33_P3379326",6.94,6.53,6.78,5.55,5.87,5.29,{"v":1.21184919210054,"d":"1.21"},{"v":0.277210174598161,"d":"0.28"},"up",{"v":0.00458250000000004,"d":"0.00"},1,"yes","CAATGGGGGACAAGAGCCTGTTCACATTCTGAAGATGCTGGAGTCACTTGCACTTTATAA","FALSE","NM_138715","ref|NM_138715|ref|NM_138716|ens|ENST00000355282|ens|ENST00000262101","MSR1","macrophage scavenger receptor 1","ref|Homo sapiens macrophage scavenger receptor 1 (MSR1), transcript variant SR-AI, mRNA [NM_138715]","chr8",15965387,16050300,"GO:0005044(scavenger receptor activity);GO:0005515(protein binding);GO:0005581(collagen);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0006898(receptor-mediated endocytosis);GO:0010744(positive regulation of macrophage derived foam cell differentiation);GO:0010886(positive regulation of cholesterol storage);GO:0030169(low-density lipoprotein particle binding);GO:0030301(cholesterol transport);GO:0030666(endocytic vesicle membrane);GO:0034362(low-density lipoprotein particle);GO:0034381(plasma lipoprotein particle clearance);GO:0042953(lipoprotein transport);GO:0071407(cellular response to organic cyclic compound)","04145(Phagosome)","mRNA","agilent G3 V3"]
["A_23_P203255",{"v":6.3,"d":"6.30"},6.07,6.06,6.79,7.17,7.25,{"v":0.868929750117869,"d":"0.87"},{"v":-0.202688549899842,"d":"-0.20"},"down",{"v":0.00463639999999998,"d":"0.00"},1,"yes","AAGGATCTCTTCCACATTCCTCCTTCTTATAAGAGCACAGTAACACTATCCTGGAAACCT","FALSE","NM_006595","ref|NM_006595|ref|NM_001243747|ref|NM_001142931|ref|NM_001142930","API5","apoptosis inhibitor 5","ref|Homo sapiens apoptosis inhibitor 5 (API5), transcript variant 2, mRNA [NM_006595]","chr11",43356828,43360923,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005681(spliceosomal complex);GO:0005737(cytoplasm);GO:0006915(apoptotic process);GO:0016020(membrane);GO:0017134(fibroblast growth factor binding);GO:0043066(negative regulation of apoptotic process);GO:2000270(negative regulation of fibroblast apoptotic process)",null,"mRNA","agilent G3 V3"]
["A_24_P394368",6.47,6.06,6.26,4.99,5.47,5.21,{"v":1.19910657306956,"d":"1.20"},{"v":0.261959886947475,"d":"0.26"},"up",{"v":0.00467640000000002,"d":"0.00"},1,"yes","GTAAAGATTCATGTTAAAAATGGAGATCACATGAAAGGGGCTCGCATGCTCATTCGGGTG","FALSE","NM_025132","ref|NM_025132|ens|ENST00000512095|ens|ENST00000506869|ens|ENST00000399820","WDR19","WD repeat domain 19","ref|Homo sapiens WD repeat domain 19 (WDR19), mRNA [NM_025132]","chr4",39184024,39287430,"GO:0001701(in utero embryonic development);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005929(cilium);GO:0006996(organelle organization);GO:0030326(embryonic limb morphogenesis);GO:0030991(intraflagellar transport particle A);GO:0031076(embryonic camera-type eye development);GO:0031513(nonmotile primary cilium);GO:0031514(motile cilium);GO:0032391(photoreceptor connecting cilium);GO:0035721(intraflagellar retrograde transport);GO:0042384(cilium assembly);GO:0042471(ear morphogenesis);GO:0048701(embryonic cranial skeleton morphogenesis);GO:0050877(neurological system process);GO:0055123(digestive system development);GO:0060830(ciliary receptor clustering involved in smoothened signaling pathway);GO:0060831(smoothened signaling pathway involved in dorsal/ventral neural tube patterning);GO:0061055(myotome development);GO:0072372(primary cilium)",null,"mRNA","agilent G3 V3"]
["A_23_P76109",4.31,{"v":5.1,"d":"5.10"},3.92,6.65,6.54,7.29,{"v":0.65087890625,"d":"0.65"},{"v":-0.619538934911027,"d":"-0.62"},"down",{"v":0.0046988,"d":"0.00"},1,"yes","GAAAGCAGGAAAATGTGCTATTGAGATTCCAGTGGTGACTTCACTGATATTTAGTGAATA","FALSE","ENST00000280571","ens|ENST00000280571|gb|AK056934|gb|BC013042|gb|AB085763","RILPL2","Rab interacting lysosomal protein-like 2","ens|Rab interacting lysosomal protein-like 2 [Source:HGNC Symbol;Acc:HGNC:28787] [ENST00000280571]","chr12",123899936,123921264,"GO:0003382(epithelial cell morphogenesis);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006886(intracellular protein transport);GO:0042802(identical protein binding);GO:0070062(extracellular vesicular exosome);GO:0072372(primary cilium)",null,"mRNA","agilent G3 V3"]
["A_23_P114774",3.86,2.59,4.37,6.83,6.83,6.44,{"v":0.538308457711443,"d":"0.54"},{"v":-0.893495002239476,"d":"-0.89"},"down",{"v":0.0047566,"d":"0.00"},1,"yes","CAGGAAACCTCTGGAGACCTCATTTTCTCCATGGGGAAGACAGCCATGCTCTTCAGGAGG","FALSE","NM_006556","ref|NM_006556|ens|ENST00000368467|gb|AK130234|gb|L77213","PMVK","phosphomevalonate kinase","ref|Homo sapiens phosphomevalonate kinase (PMVK), mRNA [NM_006556]","chr1",154897216,154909467,"GO:0004631(phosphomevalonate kinase activity);GO:0005524(ATP binding);GO:0005777(peroxisome);GO:0005829(cytosol);GO:0006695(cholesterol biosynthetic process);GO:0016020(membrane);GO:0016126(sterol biosynthetic process);GO:0016310(phosphorylation);GO:0019287(isopentenyl diphosphate biosynthetic process, mevalonate pathway);GO:0044281(small molecule metabolic process);GO:0070062(extracellular vesicular exosome);GO:0070723(response to cholesterol)","00900(Terpenoid backbone biosynthesis);04146(Peroxisome)","mRNA","agilent G3 V3"]
["A_23_P97632",3.53,4.42,2.77,6.56,{"v":6.3,"d":"6.30"},6.18,{"v":0.563025210084034,"d":"0.56"},{"v":-0.828728572850171,"d":"-0.83"},"down",{"v":0.00479849999999993,"d":"0.00"},1,"yes","TTGTTCAGATTCCATTCTGTGGGGAAATTGACTGTGAGGACTGGATCAAAAAGACCACTG","FALSE","NM_004446","ref|NM_004446|ens|ENST00000468487|ens|ENST00000366923|gb|BC126275","EPRS","glutamyl-prolyl-tRNA synthetase","ref|Homo sapiens glutamyl-prolyl-tRNA synthetase (EPRS), mRNA [NM_004446]","chr1",220142032,220142589,"GO:0004818(glutamate-tRNA ligase activity);GO:0004827(proline-tRNA ligase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006418(tRNA aminoacylation for protein translation);GO:0006424(glutamyl-tRNA aminoacylation);GO:0006433(prolyl-tRNA aminoacylation);GO:0006461(protein complex assembly);GO:0010467(gene expression);GO:0016020(membrane);GO:0017101(aminoacyl-tRNA synthetase multienzyme complex);GO:0017148(negative regulation of translation);GO:0030529(ribonucleoprotein complex);GO:0035613(RNA stem-loop binding);GO:0071346(cellular response to interferon-gamma)","00860(Porphyrin and chlorophyll metabolism);00970(Aminoacyl-tRNA biosynthesis)","mRNA","agilent G3 V3"]
["A_23_P130194",5.82,4.34,6.18,9.24,{"v":8.8,"d":"8.80"},8.51,{"v":0.615442561205273,"d":"0.62"},{"v":-0.700303877545833,"d":"-0.70"},"down",{"v":0.00481700000000007,"d":"0.00"},1,"yes","CCCTGCCTGTGTGGGAGGGTGGTTACTGTGGGTGGAATAGTGGAGGCCTTCAACTGATTA","FALSE","NM_006907","ref|NM_006907|ref|NM_001282280|ref|NM_001282281|ref|NM_153824","PYCR1","pyrroline-5-carboxylate reductase 1","ref|Homo sapiens pyrroline-5-carboxylate reductase 1 (PYCR1), transcript variant 1, mRNA [NM_006907]","chr17",79891232,79900288,"GO:0004735(pyrroline-5-carboxylate reductase activity);GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0006561(proline biosynthetic process);GO:0008652(cellular amino acid biosynthetic process);GO:0034599(cellular response to oxidative stress);GO:0034641(cellular nitrogen compound metabolic process);GO:0042802(identical protein binding);GO:0044281(small molecule metabolic process);GO:0051881(regulation of mitochondrial membrane potential);GO:0055114(oxidation-reduction process);GO:0055129(L-proline biosynthetic process)","01230(Biosynthesis of amino acids);00330(Arginine and proline metabolism)","mRNA","agilent G3 V3"]
["A_23_P14915",{"v":2.3,"d":"2.30"},{"v":2.3,"d":"2.30"},{"v":2.8,"d":"2.80"},3.68,3.95,4.43,{"v":0.613598673300166,"d":"0.61"},{"v":-0.704632731383773,"d":"-0.70"},"down",{"v":0.00486400000000009,"d":"0.00"},1,"yes","ACTTTTCCATAAGCAGAACAAGAACCAAATCAAACGTCTTAACGCGTATAGAGAGATCAC","FALSE","NM_001896","ref|NM_001896|ens|ENST00000262506|ens|ENST00000566813|ref|XM_005255801","CSNK2A2","casein kinase 2, alpha prime polypeptide","ref|Homo sapiens casein kinase 2, alpha prime polypeptide (CSNK2A2), mRNA [NM_001896]","chr16",58193456,58201617,"GO:0000278(mitotic cell cycle);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0006468(protein phosphorylation);GO:0006915(apoptotic process);GO:0007411(axon guidance);GO:0016055(Wnt receptor signaling pathway);GO:0031519(PcG protein complex);GO:0047485(protein N-terminus binding);GO:0071174(mitotic cell cycle spindle checkpoint)","03008(Ribosome biogenesis in eukaryotes);04310(Wnt signaling pathway);04064(NF-kappa B signaling pathway);04520(Adherens junction);04530(Tight junction);05162(Measles);05168(Herpes simplex infection);05169(Epstein-Barr virus infection)","mRNA","agilent G3 V3"]
["A_33_P3210969",8.73,8.58,8.86,9.17,9.36,9.31,{"v":0.940014367816092,"d":"0.94"},{"v":-0.0892452868006935,"d":"-0.09"},"down",{"v":0.00489889999999993,"d":"0.00"},1,"yes","AGGTGAAGTCCACCCTCTATGCCTCCAGGACATCCACCCACTCTTCTGAAGAAGCTACTG","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_23_P420361",12.31,12.04,11.93,10.77,11.22,11.19,{"v":1.09342977697408,"d":"1.09"},{"v":0.128860569572659,"d":"0.13"},"up",{"v":0.00493900000000003,"d":"0.00"},1,"yes","CCCCCACTTGGCTTGAAGGGACATTTTCAGACTTTTCTTTCTGTCACTTGGAGTGTCTAT","FALSE","NM_018462","ref|NM_018462|ens|ENST00000530758|gb|AK127083|gb|BC001067","BRK1","BRICK1, SCAR/WAVE actin-nucleating complex subunit","ref|Homo sapiens BRICK1, SCAR/WAVE actin-nucleating complex subunit (BRK1), mRNA [NM_018462]","chr3",10157376,10168601,"GO:0001701(in utero embryonic development);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0008284(positive regulation of cell proliferation);GO:0010592(positive regulation of lamellipodium assembly);GO:0016601(Rac protein signal transduction);GO:0030027(lamellipodium);GO:0030036(actin cytoskeleton organization);GO:0031209(SCAR complex);GO:0032403(protein complex binding);GO:0038096(Fc-gamma receptor signaling pathway involved in phagocytosis);GO:0045087(innate immune response);GO:0048010(vascular endothelial growth factor receptor signaling pathway);GO:0048365(Rac GTPase binding);GO:0048870(cell motility);GO:0070062(extracellular vesicular exosome);GO:0070207(protein homotrimerization);GO:2000601(positive regulation of Arp2/3 complex-mediated actin nucleation)","04810(Regulation of actin cytoskeleton)","mRNA","agilent G3 V3"]
["A_23_P164528",4.27,3.65,3.63,4.97,5.11,5.24,{"v":0.753916449086162,"d":"0.75"},{"v":-0.407523445621537,"d":"-0.41"},"down",{"v":0.00496289999999999,"d":"0.00"},1,"yes","AAGATGACATGACGTGACACCTGTATGAAAATGTGATGATTGAACTCCCTGTGTACAGCG","FALSE","NM_015285","ref|NM_015285|ref|NM_052834|ens|ENST00000615645|ens|ENST00000357574","WDR7","WD repeat domain 7","ref|Homo sapiens WD repeat domain 7 (WDR7), transcript variant 1, mRNA [NM_015285]","chr18",54318616,54698828,"GO:0002244(hemopoietic progenitor cell differentiation)",null,"mRNA","agilent G3 V3"]
["A_23_P48166",3.09,3.79,3.06,{"v":4.8,"d":"4.80"},4.82,4.56,{"v":0.70098730606488,"d":"0.70"},{"v":-0.51253977567723,"d":"-0.51"},"down",{"v":0.00501740000000006,"d":"0.01"},1,"yes","TGGAGCAGACCATAGCTGAAGCTGTTATTTTCAGTCAGGAAGACTACCTGTCATGAAGGT","FALSE","NM_002822","ref|NM_002822|ref|NM_001242397|ref|NR_073472|ref|NR_073473","TWF1","twinfilin actin-binding protein 1","ref|Homo sapiens twinfilin actin-binding protein 1 (TWF1), transcript variant 2, mRNA [NM_002822]","chr12",44187528,44200178,"GO:0003785(actin monomer binding);GO:0004713(protein tyrosine kinase activity);GO:0005524(ATP binding);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0005737(cytoplasm);GO:0005911(cell-cell junction);GO:0005925(focal adhesion);GO:0015629(actin cytoskeleton);GO:0030016(myofibril);GO:0030175(filopodium);GO:0030837(negative regulation of actin filament polymerization);GO:0032587(ruffle membrane);GO:0042989(sequestering of actin monomers);GO:0043538(regulation of actin phosphorylation);GO:0048471(perinuclear region of cytoplasm)",null,"mRNA","agilent G3 V3"]
["A_24_P407930",2.74,3.24,{"v":2.7,"d":"2.70"},4.54,4.34,3.94,{"v":0.677067082683307,"d":"0.68"},{"v":-0.562629314174262,"d":"-0.56"},"down",{"v":0.00507800000000003,"d":"0.01"},1,"yes","TATGTCCAAGTAACGTTAACTGTGAAGTTACACACAGTAGCTGACTTCAAAGTGCCTGTT","FALSE","NM_031216","ref|NM_031216|ref|NM_001013437|ens|ENST00000590843|ens|ENST00000262124","SEH1L","SEH1-like (S. cerevisiae)","ref|Homo sapiens SEH1-like (S. cerevisiae) (SEH1L), transcript variant 2, mRNA [NM_031216]","chr18",12976287,12987530,"GO:0000278(mitotic cell cycle);GO:0000776(kinetochore);GO:0000777(condensed chromosome kinetochore);GO:0002534(cytokine production involved in inflammatory response);GO:0005635(nuclear envelope);GO:0005829(cytosol);GO:0005975(carbohydrate metabolic process);GO:0006999(nuclear pore organization);GO:0007077(mitotic nuclear envelope disassembly);GO:0007080(mitotic metaphase plate congression);GO:0008645(hexose transport);GO:0009405(pathogenesis);GO:0010467(gene expression);GO:0010827(regulation of glucose transport);GO:0015031(protein transport);GO:0015758(glucose transport);GO:0016032(viral reproduction);GO:0019058(viral infectious cycle);GO:0019083(viral transcription);GO:0019221(cytokine-mediated signaling pathway);GO:0031080(Nup107-160 complex);GO:0044281(small molecule metabolic process);GO:0050830(defense response to Gram-positive bacterium);GO:0051028(mRNA transport);GO:0051301(cell division);GO:0051315(attachment of spindle microtubules to kinetochore involved in mitotic sister chromatid segregation);GO:0055085(transmembrane transport)","03013(RNA transport)","mRNA","agilent G3 V3"]
["A_21_P0013895",7.59,7.17,7.36,5.97,6.36,6.49,{"v":1.17534537725824,"d":"1.18"},{"v":0.23308475750617,"d":"0.23"},"up",{"v":0.00512330000000005,"d":"0.01"},1,"yes","ATTACTTTTTCTTGGCGCATTCTTCCTTTAGGACCTATAGTGAGGACCCACCCAACAGTG","FALSE","ENST00000505047","ens|ENST00000505047|ens|ENST00000510613|linc|lnc-HSFY1-1:1|linc|lnc-HSFY2-1:1",null,null,"ens|heat shock transcription factor, Y linked 2 [Source:HGNC Symbol;Acc:HGNC:23950] [ENST00000505047]","chrY",20934594,20990548,null,null,"mRNA","agilent G3 V3"]
["A_33_P3344816",6.01,5.87,5.56,4.51,4.69,3.96,{"v":1.32522796352584,"d":"1.33"},{"v":0.406240551041685,"d":"0.41"},"up",{"v":0.005135,"d":"0.01"},1,"yes","ACAGTCCTTTTTACATCCTCTTGAATACAGCTTTTTAGTACAAGGGGTCTTCAAGAAGTT","FALSE","NM_001004301","ref|NM_001004301|gb|AK131422|tc|THC2478070","ZNF813","zinc finger protein 813","ref|Homo sapiens zinc finger protein 813 (ZNF813), mRNA [NM_001004301]","chr19",53970988,53999509,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P144807",1.99,1.97,2.17,3.15,4.15,{"v":3.8,"d":"3.80"},{"v":0.552252252252252,"d":"0.55"},{"v":-0.856600697546687,"d":"-0.86"},"down",{"v":0.00523909999999994,"d":"0.01"},1,"yes","TGGAACTGTGTTGGATTTAAGATACCTTTTCACTCTTCCGTATGTCATGAGCCTTGTGCG","FALSE","NM_001098811","ref|NM_001098811|ens|ENST00000378719|ref|XM_005271931|ref|XM_005271927","entg|SEPT8","septin 8","ref|Homo sapiens septin 8 (SEPT8), transcript variant 1, mRNA [NM_001098811]","chr5",132087152,132096563,"GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0007049(cell cycle)","05100(Bacterial invasion of epithelial cells)","mRNA","agilent G3 V3"]
["A_23_P416034",8.28,7.92,8.21,7.37,7.23,7.52,{"v":1.10352622061483,"d":"1.10"},{"v":0.142120909546447,"d":"0.14"},"up",{"v":0.00527749999999994,"d":"0.01"},1,"yes","GGGTCTGTATATCACAGAGCCAAAGACAATTCAGGAACTGCTGTGCAGCCCCTCAGAGTA","FALSE","NM_017518","ref|NM_017518|ens|ENST00000490453|ens|ENST00000490165|ens|ENST00000464993","HAUS7","HAUS augmin-like complex, subunit 7","ref|Homo sapiens HAUS augmin-like complex, subunit 7 (HAUS7), transcript variant 1, mRNA [NM_017518]","chrX",152713120,152760978,"GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005819(spindle);GO:0005874(microtubule);GO:0005886(plasma membrane);GO:0007067(mitosis);GO:0031996(thioesterase binding);GO:0051225(spindle assembly);GO:0051297(centrosome organization);GO:0051301(cell division);GO:0070652(HAUS complex)",null,"mRNA","agilent G3 V3"]
["A_32_P722809",{"v":6.8,"d":"6.80"},7.37,6.73,5.07,5.65,4.77,{"v":1.34925758553906,"d":"1.35"},{"v":0.432165798178677,"d":"0.43"},"up",{"v":0.00535680000000005,"d":"0.01"},1,"yes","GATTTTACACTGAAAATCAGCAGAGTGGAGGCTGAGGATGTTGGGGTTTATTACTGCATG","FALSE","ENST00000453166","ens|ENST00000453166|ens|ENST00000482769|ens|ENST00000558026|ens|ENST00000610638",null,null,"ens|immunoglobulin kappa variable 2D-28 [Source:HGNC Symbol;Acc:HGNC:5799] [ENST00000453166]","chr2",89999256,89999564,null,null,"mRNA","agilent G3 V3"]
["A_33_P3360773",10.93,10.91,{"v":11,"d":"11.00"},10.28,10.57,10.25,{"v":1.05594855305466,"d":"1.06"},{"v":0.0785395467598399,"d":"0.08"},"up",{"v":0.00535920000000001,"d":"0.01"},1,"yes","TGACCCCACTGGCCACTGCCATCCTGCTGCCTTCCCAGTGGGGCTGGTCAGGGGGCAGCC","FALSE","NM_001297658","ref|NM_001297658|ref|NM_001297659|ref|NM_001297660|ref|NM_005706","TSSC4","tumor suppressing subtransferable candidate 4","ref|Homo sapiens tumor suppressing subtransferable candidate 4 (TSSC4), transcript variant 1, mRNA [NM_001297658]","chr11",{"v":2423523,"d":"2423523.00"},2425105,null,null,"mRNA","agilent G3 V3"]
["A_22_P00018346",15.61,15.24,{"v":15.6,"d":"15.60"},14.65,14.77,14.84,{"v":1.04948034342521,"d":"1.05"},{"v":0.0696751454690037,"d":"0.07"},"up",{"v":0.00547880000000001,"d":"0.01"},1,"yes","AGTGGAGAAGACAGCCCCTCCCTCCTGCTCTGACCTGACAGTGTTCATCCATCGCCCTGT","FALSE","XR_243341","ref|XR_243341|ref|XR_248273|ref|XR_253486|linc|lnc-ZSCAN10-3:2","ZNF213-AS1","ZNF213 antisense RNA 1 (head to head)","ref|PREDICTED: Homo sapiens uncharacterized LOC100507458 (RP11-473M20.14), transcript variant X2, ncRNA [XR_243341]","chr16",{"v":3178820,"d":"3178820.00"},3184883,null,null,"mRNA","agilent G3 V3"]
["A_24_P347624",{"v":5.3,"d":"5.30"},4.68,4.83,6.55,6.14,6.06,{"v":0.789866666666667,"d":"0.79"},{"v":-0.340318954981758,"d":"-0.34"},"down",{"v":0.00547959999999992,"d":"0.01"},1,"yes","GCTTACACCTGAGACGAACTACAGAACAGCACGTACCAGAGGTGGAAGTCCAAGTCAAAC","FALSE","NM_022804","ref|NM_022804|ref|NM_022807|ref|NM_022808|ref|NM_022806","SNURF","SNRPN upstream reading frame","ref|Homo sapiens SNRPN upstream reading frame (SNURF), transcript variant 2, mRNA [NM_022804]","chr15",25200180,25245423,"GO:0003674(molecular_function);GO:0005634(nucleus);GO:0008150(biological_process)",null,"mRNA","agilent G3 V3"]
["A_32_P89352",7.21,7.77,7.15,6.19,{"v":5.7,"d":"5.70"},6.14,{"v":1.22739877981143,"d":"1.23"},{"v":0.29560405436867,"d":"0.30"},"up",{"v":0.00555919999999999,"d":"0.01"},1,"yes","TTGCTGTAGGAGAGACAAAGGGGCTTTTCCTCTAGCTGGTAACTATTCAGATGATGGACA","FALSE","NM_080676","ref|NM_080676|ref|NM_001033087|ens|ENST00000217246|ens|ENST00000378058","MACROD2","MACRO domain containing 2","ref|Homo sapiens MACRO domain containing 2 (MACROD2), transcript variant 1, mRNA [NM_080676]","chr20",15177504,16033842,"GO:0005634(nucleus);GO:0006974(response to DNA damage stimulus);GO:0007420(brain development);GO:0016798(hydrolase activity, acting on glycosyl bonds);GO:0019213(deacetylase activity);GO:0042278(purine nucleoside metabolic process);GO:0051725(protein de-ADP-ribosylation)",null,"mRNA","agilent G3 V3"]
["A_23_P205567",7.81,7.92,8.21,7.21,7.33,7.34,{"v":1.09414990859232,"d":"1.09"},{"v":0.129810414150946,"d":"0.13"},"up",{"v":0.00557560000000001,"d":"0.01"},1,"yes","TGAATGGTGTTTGCATTCTGTGAAATGCCTCTCCACGTTGCATATGTCACACTTTTGTCT","FALSE","NM_006255","ref|NM_006255|ens|ENST00000556245|ens|ENST00000332981|gb|AK093241","PRKCH","protein kinase C, eta","ref|Homo sapiens protein kinase C, eta (PRKCH), mRNA [NM_006255]","chr14",62010080,62017690,"GO:0004697(protein kinase C activity);GO:0004699(calcium-independent protein kinase C activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0006468(protein phosphorylation);GO:0007165(signal transduction);GO:0007596(blood coagulation);GO:0010744(positive regulation of macrophage derived foam cell differentiation);GO:0017160(Ral GTPase binding);GO:0019899(enzyme binding);GO:0030168(platelet activation);GO:0034351(negative regulation of glial cell apoptotic process);GO:0045618(positive regulation of keratinocyte differentiation);GO:0046872(metal ion binding);GO:0050861(positive regulation of B cell receptor signaling pathway);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0060252(positive regulation of glial cell proliferation);GO:0070062(extracellular vesicular exosome);GO:0070528(protein kinase C signaling cascade);GO:2000810(regulation of tight junction assembly)","04530(Tight junction);04270(Vascular smooth muscle contraction);04750(Inflammatory mediator regulation of TRP channels)","mRNA","agilent G3 V3"]
["A_23_P38041",6.59,6.08,6.41,7.24,7.16,7.15,{"v":0.88538283062645,"d":"0.89"},{"v":-0.175626697970949,"d":"-0.18"},"down",{"v":0.00563630000000004,"d":"0.01"},1,"yes","CTGCCTTCCTGGCTGTGACACGGGACCCCTTTTCTACAGACCTCATCACTGGATTTGCCA","FALSE","NM_016256","ref|NM_016256|ens|ENST00000568202|ens|ENST00000564397|ens|ENST00000562746","NAGPA","N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase","ref|Homo sapiens N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase (NAGPA), mRNA [NM_016256]","chr16",{"v":5074931,"d":"5074931.00"},5083633,"GO:0003944(N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity);GO:0005975(carbohydrate metabolic process);GO:0006464(cellular protein modification process);GO:0006486(protein glycosylation);GO:0006622(protein targeting to lysosome);GO:0007040(lysosome organization);GO:0016021(integral to membrane);GO:0032580(Golgi cisterna membrane)","04142(Lysosome)","mRNA","agilent G3 V3"]
["A_23_P54929",6.47,5.82,6.16,{"v":5.1,"d":"5.10"},4.59,4.53,{"v":1.29746835443038,"d":"1.30"},{"v":0.375699351328343,"d":"0.38"},"up",{"v":0.00565769999999999,"d":"0.01"},1,"yes","CCCCTGTGATGTAAACTTAGATATCCCTAGAGTTTCTCAGCATCTTTCTTCCTGAGTGGA","FALSE","NM_020424","ref|NM_020424|ref|NM_001302835|ref|NM_001302836|ref|NM_001128301","LYRM1","LYR motif containing 1","ref|Homo sapiens LYR motif containing 1 (LYRM1), transcript variant 1, mRNA [NM_020424]","chr16",20912076,20936326,"GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0045171(intercellular bridge)",null,"mRNA","agilent G3 V3"]
["A_23_P339480",3.72,2.01,{"v":3.3,"d":"3.30"},5.93,5.87,5.65,{"v":0.517478510028653,"d":"0.52"},{"v":-0.950429143616157,"d":"-0.95"},"down",{"v":0.00576029999999994,"d":"0.01"},1,"yes","AACATGAACAGCTGGAAGAGAGTTTTCAGGAACTAGTGGAAGATTACCGGCGTGTTATTG","FALSE","NM_003642","ref|NM_003642|ref|NR_027862|ens|ENST00000494601|ens|ENST00000264108","HAT1","histone acetyltransferase 1","ref|Homo sapiens histone acetyltransferase 1 (HAT1), transcript variant 1, mRNA [NM_003642]","chr2",172778960,172848599,"GO:0000790(nuclear chromatin);GO:0004402(histone acetyltransferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006323(DNA packaging);GO:0006325(chromatin organization);GO:0006335(DNA replication-dependent nucleosome assembly);GO:0006336(DNA replication-independent nucleosome assembly);GO:0006348(chromatin silencing at telomere);GO:0006475(internal protein amino acid acetylation);GO:0007584(response to nutrient);GO:0010485(H4 histone acetyltransferase activity);GO:0016363(nuclear matrix);GO:0043231(intracellular membrane-bounded organelle);GO:0043234(protein complex);GO:0043967(histone H4 acetylation)","05034(Alcoholism)","mRNA","agilent G3 V3"]
["A_24_P118591",7.77,8.63,7.68,9.69,9.59,9.89,{"v":0.8255056564964,"d":"0.83"},{"v":-0.276649994138476,"d":"-0.28"},"down",{"v":0.00576429999999994,"d":"0.01"},1,"yes","CAAAACTGGGGTCTACGATGTTCCCCAGCATGCTGTTGGCATTGTTGTAAACAAACAAGT","FALSE","ENST00000404609","ens|ENST00000404609",{"$nulls":3},"chr6",159947088,159947559,null,null,"mRNA","agilent G3 V3"]
["A_33_P3398809",2.64,3.48,2.75,4.53,4.56,4.27,{"v":0.663922155688623,"d":"0.66"},{"v":-0.590913998172988,"d":"-0.59"},"down",{"v":0.00584230000000008,"d":"0.01"},1,"yes","AATACTTGCTGCTGGCAAAAGGCCTGTACTCAGGCATTTGCTTTGACTTGATGTTGCCAA","FALSE","NM_138777","ref|NM_138777|ref|NM_001173512|ref|NM_199177|ens|ENST00000489572","MRRF","mitochondrial ribosome recycling factor","ref|Homo sapiens mitochondrial ribosome recycling factor (MRRF), transcript variant 1, mRNA [NM_138777]","chr9",125033144,125085740,"GO:0005759(mitochondrial matrix);GO:0006996(organelle organization);GO:0032543(mitochondrial translation);GO:0032790(ribosome disassembly);GO:0070126(mitochondrial translational termination)",null,"mRNA","agilent G3 V3"]
["A_23_P26117",2.14,2.34,3.71,5.24,5.45,5.56,{"v":0.504,"d":"0.50"},{"v":-0.98850436116217,"d":"-0.99"},"down",{"v":0.00588410000000006,"d":"0.01"},1,"yes","TACCCACTACAATACCTCTTGGGACTGGGCTCGATTTGAGGTGTGGGCCCATCGCTGGAT","FALSE","NM_006715","ref|NM_006715|ref|NM_001256495|ref|NM_001256494|ref|NM_001256496","MAN2C1","mannosidase, alpha, class 2C, member 1","ref|Homo sapiens mannosidase, alpha, class 2C, member 1 (MAN2C1), transcript variant 1, mRNA [NM_006715]","chr15",75648136,75660933,"GO:0004559(alpha-mannosidase activity);GO:0006013(mannose metabolic process);GO:0008270(zinc ion binding);GO:0030246(carbohydrate binding)","00511(Other glycan degradation)","mRNA","agilent G3 V3"]
["A_33_P3381127",7.06,7.35,6.91,6.01,6.36,6.28,{"v":1.14316353887399,"d":"1.14"},{"v":0.193031807616576,"d":"0.19"},"up",{"v":0.00596390000000002,"d":"0.01"},1,"yes","TGAATGTAATCAGTGTATGTTAGTACAAATGTCTATCCACAGGCTAACCCCACTCTATGA","FALSE","NM_000043","ref|NM_000043|ref|NM_152872|ref|NM_152871|ref|NR_028036","FAS","Fas cell surface death receptor","ref|Homo sapiens Fas cell surface death receptor (FAS), transcript variant 1, mRNA [NM_000043]","chr10",90751200,90773973,"GO:0002377(immunoglobulin production);GO:0003014(renal system process);GO:0004871(signal transducer activity);GO:0004872(receptor activity);GO:0004888(transmembrane signaling receptor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006461(protein complex assembly);GO:0006915(apoptotic process);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0006924(activation-induced cell death of T cells);GO:0006925(inflammatory cell apoptotic process);GO:0006927(transformed cell apoptotic process);GO:0007165(signal transduction);GO:0007623(circadian rhythm);GO:0008625(induction of apoptosis via death domain receptors);GO:0009636(response to toxin);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0016021(integral to membrane);GO:0019724(B cell mediated immunity);GO:0019900(kinase binding);GO:0031264(death-inducing signaling complex);GO:0031265(CD95 death-inducing signaling complex);GO:0032464(positive regulation of protein homooligomerization);GO:0042802(identical protein binding);GO:0042981(regulation of apoptotic process);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0045060(negative thymic T cell selection);GO:0045121(membrane raft);GO:0045619(regulation of lymphocyte differentiation);GO:0045637(regulation of myeloid cell differentiation);GO:0048536(spleen development);GO:0050869(negative regulation of B cell activation);GO:0051260(protein homooligomerization);GO:0051384(response to glucocorticoid stimulus);GO:0070062(extracellular vesicular exosome);GO:0071260(cellular response to mechanical stimulus);GO:0071285(cellular response to lithium ion);GO:0071455(cellular response to hyperoxia);GO:0097049(motor neuron apoptotic process);GO:0097190(apoptotic signaling pathway);GO:0097191(extrinsic apoptotic signaling pathway);GO:0097192(extrinsic apoptotic signaling pathway in absence of ligand);GO:0097284(hepatocyte apoptotic process);GO:2001239(regulation of extrinsic apoptotic signaling pathway in absence of ligand);GO:2001241(positive regulation of extrinsic apoptotic signaling pathway in absence of ligand)","04010(MAPK signaling pathway);04668(TNF signaling pathway);04060(Cytokine-cytokine receptor interaction);04210(Apoptosis);04115(p53 signaling pathway);04650(Natural killer cell mediated cytotoxicity);05200(Pathways in cancer);05205(Proteoglycans in cancer);05320(Autoimmune thyroid disease);05330(Allograft rejection);05332(Graft-versus-host disease);05010(Alzheimer's disease);04940(Type I diabetes mellitus);04932(Non-alcoholic fatty liver disease (NAFLD));05162(Measles);05164(Influenza A);05161(Hepatitis B);05168(Herpes simplex infection);05142(Chagas disease (American trypanosomiasis));05143(African trypanosomiasis)","mRNA","agilent G3 V3"]
["A_23_P94365",3.34,2.26,{"v":2.5,"d":"2.50"},4.95,4.82,4.34,{"v":0.574060949681077,"d":"0.57"},{"v":-0.800724174825277,"d":"-0.80"},"down",{"v":0.00599550000000004,"d":"0.01"},1,"yes","TGCGCCACGCCAAGGTCGTCTGGGAGATGCTCAAGTTTGAAGTGGCGCTCAGGCTGGAGA","FALSE","NM_174922","ref|NM_174922|ens|ENST00000308860|ens|ENST00000529654|ref|XM_006716527","ADCK5","aarF domain containing kinase 5","ref|Homo sapiens aarF domain containing kinase 5 (ADCK5), mRNA [NM_174922]","chr8",145597728,145618457,"GO:0004674(protein serine/threonine kinase activity);GO:0005739(mitochondrion);GO:0006468(protein phosphorylation);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3370515",{"v":15.7,"d":"15.70"},15.74,15.55,16.09,16.18,15.99,{"v":0.973684210526316,"d":"0.97"},{"v":-0.0384741478146358,"d":"-0.04"},"down",{"v":0.00604280000000001,"d":"0.01"},1,"yes","CGTTCCCCCGCCCCCGCGACAGTCTCCCGTTCCCCCGCCCCCGCGACAGTCACCCGTTCC","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_33_P3296479",6.27,4.97,6.38,8.24,{"v":8.7,"d":"8.70"},8.26,{"v":0.699206349206349,"d":"0.70"},{"v":-0.516209809466865,"d":"-0.52"},"down",{"v":0.00610010000000005,"d":"0.01"},1,"yes","AAGAAAGTGACAATGTGGATTCTGCTGATGCGGAGGAGGATGACTCGGATGTCTGGTGGG","FALSE","NM_001204303","ref|NM_001204303|ref|NM_201414|ref|NM_001136131|ref|NM_001136129","APP","amyloid beta (A4) precursor protein","ref|Homo sapiens amyloid beta (A4) precursor protein (APP), transcript variant 10, mRNA [NM_001204303]","chr21",27253638,27543446,"GO:0001967(suckling behavior);GO:0002576(platelet degranulation);GO:0003677(DNA binding);GO:0004867(serine-type endopeptidase inhibitor activity);GO:0005102(receptor binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005641(nuclear envelope lumen);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0005905(coated pit);GO:0005911(cell-cell junction);GO:0006378(mRNA polyadenylation);GO:0006417(regulation of translation);GO:0006468(protein phosphorylation);GO:0006878(cellular copper ion homeostasis);GO:0006897(endocytosis);GO:0006979(response to oxidative stress);GO:0007155(cell adhesion);GO:0007176(regulation of epidermal growth factor-activated receptor activity);GO:0007219(Notch signaling pathway);GO:0007409(axonogenesis);GO:0007596(blood coagulation);GO:0007617(mating behavior);GO:0007626(locomotory behavior);GO:0008088(axon cargo transport);GO:0008201(heparin binding);GO:0008203(cholesterol metabolic process);GO:0008344(adult locomotory behavior);GO:0008542(visual learning);GO:0009986(cell surface);GO:0010951(negative regulation of endopeptidase activity);GO:0010952(positive regulation of peptidase activity);GO:0010971(positive regulation of G2/M transition of mitotic cell cycle);GO:0016021(integral to membrane);GO:0016199(axon midline choice point recognition);GO:0016322(neuron remodeling);GO:0016358(dendrite development);GO:0016504(peptidase activator activity);GO:0019899(enzyme binding);GO:0030134(ER to Golgi transport vesicle);GO:0030168(platelet activation);GO:0030198(extracellular matrix organization);GO:0030424(axon);GO:0030900(forebrain development);GO:0031093(platelet alpha granule lumen);GO:0031175(neuron projection development);GO:0031594(neuromuscular junction);GO:0033130(acetylcholine receptor binding);GO:0035235(ionotropic glutamate receptor signaling pathway);GO:0035253(ciliary rootlet);GO:0035872(nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway);GO:0040014(regulation of multicellular organism growth);GO:0042802(identical protein binding);GO:0043197(dendritic spine);GO:0043198(dendritic shaft);GO:0043231(intracellular membrane-bounded organelle);GO:0043235(receptor complex);GO:0043393(regulation of protein binding);GO:0045087(innate immune response);GO:0045121(membrane raft);GO:0045177(apical part of cell);GO:0045202(synapse);GO:0045665(negative regulation of neuron differentiation);GO:0045931(positive regulation of mitotic cell cycle);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046914(transition metal ion binding);GO:0048471(perinuclear region of cytoplasm);GO:0048669(collateral sprouting in absence of injury);GO:0050803(regulation of synapse structure and activity);GO:0050885(neuromuscular process controlling balance);GO:0051124(synaptic growth at neuromuscular junction);GO:0051233(spindle midzone);GO:0051402(neuron apoptotic process);GO:0051425(PTB domain binding);GO:0051563(smooth endoplasmic reticulum calcium ion homeostasis)","04726(Serotonergic synapse);05010(Alzheimer's disease)","mRNA","agilent G3 V3"]
["A_21_P0013573",{"v":12.2,"d":"12.20"},{"v":12.1,"d":"12.10"},{"v":11.8,"d":"11.80"},10.97,11.37,11.08,{"v":1.08019150209455,"d":"1.08"},{"v":0.111287103713345,"d":"0.11"},"up",{"v":0.00619510000000001,"d":"0.01"},1,"yes","TTCTCCCCCCATTTTTCGTTTGGATTCATAGCATAAATTGACAACAAAGATACATCTCAA","FALSE","XR_252557","ref|XR_252557|ref|XR_252558|ref|XR_252559|ref|XR_432413","LOC101928195","monofunctional C1-tetrahydrofolate synthase, mitochondrial-like","ref|PREDICTED: Homo sapiens monofunctional C1-tetrahydrofolate synthase, mitochondrial-like (LOC101928195), transcript variant X6, misc_RNA [XR_252557]",{"$nulls":5},"mRNA","agilent G3 V3"]
["A_21_P0000120",1.95,1.95,1.94,{"v":3.3,"d":"3.30"},3.46,3.72,{"v":0.557251908396946,"d":"0.56"},{"v":-0.843598442657433,"d":"-0.84"},"down",{"v":0.00620379999999998,"d":"0.01"},1,"yes","GGAGAAACACCGGGTTTCAGCTTTCTCGACCTTAGCTTGGGTGAGACTGTTTACAAAAAA","FALSE","NM_001194958","ref|NM_001194958|ens|ENST00000567955|ens|ENST00000331718|gb|FJ434338","KCNJ18","potassium channel, inwardly rectifying subfamily J, member 18","ref|Homo sapiens potassium channel, inwardly rectifying subfamily J, member 18 (KCNJ18), mRNA [NM_001194958]","chr17",21308448,21320482,"GO:0005242(inward rectifier potassium channel activity);GO:0005886(plasma membrane);GO:0016021(integral to membrane);GO:0034765(regulation of ion transmembrane transport);GO:0071805(potassium ion transmembrane transport)",null,"mRNA","agilent G3 V3"]
["A_33_P3257993",3.08,3.16,3.22,3.63,4.05,4.03,{"v":0.807856532877882,"d":"0.81"},{"v":-0.30782898716182,"d":"-0.31"},"down",{"v":0.00626409999999999,"d":"0.01"},1,"yes","GTGCCAAGTGTCTTTCATTTGGAAGTGAACTTACTCCAGTTATTGAATGTTTATCATATC","FALSE","NM_017831","ref|NM_017831|ens|ENST00000217740|tc|THC2720395|tc|THC2764874","RNF125","ring finger protein 125, E3 ubiquitin protein ligase","ref|Homo sapiens ring finger protein 125, E3 ubiquitin protein ligase (RNF125), mRNA [NM_017831]","chr18",29598336,29653176,"GO:0004842(ubiquitin-protein ligase activity);GO:0008270(zinc ion binding);GO:0016567(protein ubiquitination);GO:0016874(ligase activity);GO:0032480(negative regulation of type I interferon production);GO:0045087(innate immune response)","04622(RIG-I-like receptor signaling pathway)","mRNA","agilent G3 V3"]
["A_33_P3281303",7.57,{"v":6.9,"d":"6.90"},7.87,5.97,5.71,5.96,{"v":1.26643990929705,"d":"1.27"},{"v":0.340778624925794,"d":"0.34"},"up",{"v":0.0063436,"d":"0.01"},1,"yes","AAATGGGTCGAGGATCTGGTGCGGCGTGTTCACTTCATTGCGGACTGGTACGCACATGGA","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_23_P159839",3.44,3.74,3.14,4.47,4.52,4.28,{"v":0.777694046721929,"d":"0.78"},{"v":-0.362725399946939,"d":"-0.36"},"down",{"v":0.00638080000000008,"d":"0.01"},1,"yes","TCCAAATCAGATGCATGTGATGATGTATGGGGTATACCGCCTTAGGGCATTTGGGCATAT","FALSE","NM_152692","ref|NM_152692|ref|NM_001011551|ens|ENST00000371313|ens|ENST00000304661","C1GALT1C1","C1GALT1-specific chaperone 1","ref|Homo sapiens C1GALT1-specific chaperone 1 (C1GALT1C1), transcript variant 1, mRNA [NM_152692]","chrX",119759784,119763850,"GO:0000139(Golgi membrane);GO:0004653(polypeptide N-acetylgalactosaminyltransferase activity);GO:0005515(protein binding);GO:0006493(protein O-linked glycosylation);GO:0016021(integral to membrane);GO:0016266(O-glycan processing);GO:0030168(platelet activation);GO:0043687(post-translational protein modification);GO:0044267(cellular protein metabolic process);GO:0051347(positive regulation of transferase activity);GO:0070062(extracellular vesicular exosome)","00512(Mucin type O-glycan biosynthesis)","mRNA","agilent G3 V3"]
["A_23_P383679",6.12,5.88,6.34,5.15,4.46,4.38,{"v":1.31093638313081,"d":"1.31"},{"v":0.390597676430301,"d":"0.39"},"up",{"v":0.00646069999999999,"d":"0.01"},1,"yes","CGGGTACAGCATAATCATCCCCTTCAAGAATGTCTTCTATCACATGGTGACCTTCTCCAT","FALSE","NM_001270974","ref|NM_001270974|ens|ENST00000378856|ref|XM_006721206|gb|BC043273","HYDIN","HYDIN, axonemal central pair apparatus protein","ref|Homo sapiens HYDIN, axonemal central pair apparatus protein (HYDIN), transcript variant 1, mRNA [NM_001270974]","chr16",70841400,70900200,"GO:0002064(epithelial cell development);GO:0003341(cilium movement);GO:0005929(cilium);GO:0021591(ventricular system development);GO:0042384(cilium assembly);GO:0060438(trachea development)",null,"mRNA","agilent G3 V3"]
["A_33_P3314231",8.92,8.74,8.88,9.98,9.61,9.47,{"v":0.913282863041982,"d":"0.91"},{"v":-0.130866332262648,"d":"-0.13"},"down",{"v":0.00652420000000009,"d":"0.01"},1,"yes","TAGGCTCCACGGCCCCAGACACCTTCCCTGAGGACACTCAATAAAGGTTCCTGAATCTTC","FALSE","NM_057093","ref|NM_057093|ref|NM_057094|ens|ENST00000295728|ens|ENST00000496566","CRYBA2","crystallin, beta A2","ref|Homo sapiens crystallin, beta A2 (CRYBA2), transcript variant 2, mRNA [NM_057093]","chr2",219855632,219858123,"GO:0002088(lens development in camera-type eye);GO:0003674(molecular_function);GO:0005212(structural constituent of eye lens);GO:0005575(cellular_component);GO:0008150(biological_process);GO:0042803(protein homodimerization activity)",null,"mRNA","agilent G3 V3"]
["A_33_P3273148",6.62,6.55,5.66,7.76,8.03,8.06,{"v":0.789517819706499,"d":"0.79"},{"v":-0.340956266278646,"d":"-0.34"},"down",{"v":0.00663579999999997,"d":"0.01"},1,"yes","AGTGCATGGCCAAGATGCCACAGATGATTGTGAACTGGCAGCAGCAGCAGCGGGAGAACT","FALSE","NM_052850","ref|NM_052850|gb|AJ429498|gb|HQ447517|gb|AF479749","GADD45GIP1","growth arrest and DNA-damage-inducible, gamma interacting protein 1","ref|Homo sapiens growth arrest and DNA-damage-inducible, gamma interacting protein 1 (GADD45GIP1), mRNA [NM_052850]","chr19",13064972,13068050,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0006996(organelle organization);GO:0007049(cell cycle);GO:0016032(viral reproduction);GO:0032543(mitochondrial translation);GO:0070124(mitochondrial translational initiation);GO:0070125(mitochondrial translational elongation);GO:0070126(mitochondrial translational termination)",null,"mRNA","agilent G3 V3"]
["A_23_P165676",{"v":7.4,"d":"7.40"},7.33,7.16,6.04,6.13,5.25,{"v":1.25660160734788,"d":"1.26"},{"v":0.329527330582081,"d":"0.33"},"up",{"v":0.00667760000000006,"d":"0.01"},1,"yes","TGGAGTAGGGGTGTATGCACTGCAGGCTGAGATGAGCAATTGAGGGGCAAGTGTCCAGCA","FALSE","ENST00000491265","ens|ENST00000491265|ref|XM_005263792|gb|BC017694|gb|AK024408",null,null,"ens|mitotic spindle organizing protein 2A [Source:HGNC Symbol;Acc:HGNC:33187] [ENST00000491265]","chr2",132246944,132249949,null,null,"mRNA","agilent G3 V3"]
["A_33_P3380086",5.56,5.38,5.65,4.72,5.06,4.79,{"v":1.13864104323953,"d":"1.14"},{"v":0.187313008891351,"d":"0.19"},"up",{"v":0.00670479999999996,"d":"0.01"},1,"yes","AAGAAGTAACAGAGCCAGCTGTAGTGGCAGTGGACCGGCAGGCCATCTTCCCAGATACCT","FALSE","ENST00000323871","ens|ENST00000323871|ref|XR_243019|ref|XM_005253912|ref|XM_006719537","PXN","paxillin","ens|paxillin [Source:HGNC Symbol;Acc:HGNC:9718] [ENST00000323871]","chr12",120648248,120657181,"GO:0000187(activation of MAPK activity);GO:0001725(stress fiber);GO:0005178(integrin binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005875(microtubule associated complex);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0005938(cell cortex);GO:0006928(cellular component movement);GO:0006936(muscle contraction);GO:0007010(cytoskeleton organization);GO:0007155(cell adhesion);GO:0007165(signal transduction);GO:0007172(signal complex assembly);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007229(integrin-mediated signaling pathway);GO:0008013(beta-catenin binding);GO:0008270(zinc ion binding);GO:0008360(regulation of cell shape);GO:0017166(vinculin binding);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0019901(protein kinase binding);GO:0030027(lamellipodium);GO:0030032(lamellipodium assembly);GO:0034329(cell junction assembly);GO:0034446(substrate adhesion-dependent cell spreading);GO:0034614(cellular response to reactive oxygen species);GO:0048010(vascular endothelial growth factor receptor signaling pathway);GO:0048041(focal adhesion assembly);GO:0048754(branching morphogenesis of a tube);GO:0051435(BH4 domain binding);GO:0060396(growth hormone receptor signaling pathway)","04370(VEGF signaling pathway);04810(Regulation of actin cytoskeleton);04510(Focal adhesion);04670(Leukocyte transendothelial migration);04062(Chemokine signaling pathway);05205(Proteoglycans in cancer);05203(Viral carcinogenesis);05100(Bacterial invasion of epithelial cells)","mRNA","agilent G3 V3"]
["A_23_P154108",{"v":5,"d":"5.00"},5.08,3.86,6.81,6.54,6.98,{"v":0.685686178061977,"d":"0.69"},{"v":-0.54437965397631,"d":"-0.54"},"down",{"v":0.00678319999999999,"d":"0.01"},1,"yes","TAACTAGTGGATTTGGGAAAGGTTCTTAAGTAGATCCTGAGACTATTTGCATGCTTCTGT","FALSE","NM_001378","ref|NM_001378|ref|NM_001271785|ref|NM_001271786|ref|NM_001271787","DYNC1I2","dynein, cytoplasmic 1, intermediate chain 2","ref|Homo sapiens dynein, cytoplasmic 1, intermediate chain 2 (DYNC1I2), transcript variant 1, mRNA [NM_001378]","chr10",52024736,52026575,"GO:0000086(G2/M transition of mitotic cell cycle);GO:0000278(mitotic cell cycle);GO:0003777(microtubule motor activity);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005868(cytoplasmic dynein complex);GO:0005874(microtubule);GO:0006810(transport);GO:0006996(organelle organization);GO:0007018(microtubule-based movement);GO:0008152(metabolic process);GO:0016032(viral reproduction);GO:0019886(antigen processing and presentation of exogenous peptide antigen via MHC class II);GO:0031982(vesicle)","04145(Phagosome);04962(Vasopressin-regulated water reabsorption);05132(Salmonella infection)","mRNA","agilent G3 V3"]
["A_23_P101111",7.38,7.09,7.47,6.34,6.63,6.13,{"v":1.14869109947644,"d":"1.15"},{"v":0.199990887480082,"d":"0.20"},"up",{"v":0.00687749999999998,"d":"0.01"},1,"yes","TTGTGTACCAGAGCACATTCCTTAGGGGACGGCTTTGGGGGTCCCACGAGACATGGACTA","FALSE","NM_004715","ref|NM_004715|ref|NM_048368|ref|NM_001202504|ens|ENST00000590599","CTDP1","CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1","ref|Homo sapiens CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1 (CTDP1), transcript variant 1, mRNA [NM_004715]","chr18",77495608,77514501,"GO:0000922(spindle pole);GO:0003899(DNA-directed RNA polymerase activity);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005819(spindle);GO:0006366(transcription from RNA polymerase II promoter);GO:0006368(transcription elongation from RNA polymerase II promoter);GO:0006470(protein dephosphorylation);GO:0008420(CTD phosphatase activity);GO:0010458(exit from mitosis);GO:0010467(gene expression);GO:0015629(actin cytoskeleton);GO:0016032(viral reproduction);GO:0030496(midbody);GO:0050434(positive regulation of viral transcription);GO:0051233(spindle midzone);GO:0051301(cell division)",null,"mRNA","agilent G3 V3"]
["A_23_P19852",4.05,4.66,4.59,5.74,5.94,5.41,{"v":0.778232884727911,"d":"0.78"},{"v":-0.361726151287587,"d":"-0.36"},"down",{"v":0.00691710000000001,"d":"0.01"},1,"yes","GGCCGATCTTTTGGAAGGGATAAGGTTTTCATTCTTGTGCAACTCATTATTCTCATTATT","FALSE","NM_152558","ref|NM_152558|ref|NM_001287501|ens|ENST00000623361|ens|ENST00000402050","IQCE","IQ motif containing E","ref|Homo sapiens IQ motif containing E (IQCE), transcript variant 1, mRNA [NM_152558]","chr7",{"v":2598632,"d":"2598632.00"},2654367,"GO:0072372(primary cilium)",null,"mRNA","agilent G3 V3"]
["A_23_P165078",9.18,9.18,9.17,7.95,8.11,8.26,{"v":1.13199013157895,"d":"1.13"},{"v":0.178861381151976,"d":"0.18"},"up",{"v":0.00693709999999992,"d":"0.01"},1,"yes","GTGCCGCGGTGGTGCTGCACTCGCCGCTCACCTCGGGCATGCGCGTCGCCTTCCCCGACA","FALSE","NM_031213","ref|NM_031213|ref|NM_001130111|ens|ENST00000411545|ens|ENST00000592757","ABHD17A","abhydrolase domain containing 17A","ref|Homo sapiens abhydrolase domain containing 17A (ABHD17A), transcript variant 1, mRNA [NM_031213]","chr19",{"v":1877203,"d":"1877203.00"},1880016,"GO:0005515(protein binding);GO:0005576(extracellular region);GO:0008150(biological_process);GO:0008152(metabolic process);GO:0016020(membrane);GO:0016787(hydrolase activity)",null,"mRNA","agilent G3 V3"]
["A_33_P3228988",11.75,11.93,11.41,13.51,{"v":13.5,"d":"13.50"},13.57,{"v":0.864711680630853,"d":"0.86"},{"v":-0.209708917354492,"d":"-0.21"},"down",{"v":0.00700459999999992,"d":"0.01"},1,"yes","ATTGGAAATAAACTCTATGGCTTGGGCACGGTGGCTCATGCCTGTAATCCCTAACACTTT","FALSE","ENST00000435033","ens|ENST00000435033|gb|BC057831|tc|THC2481380",null,null,"ens|Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000394047}  [Source:UniProtKB/TrEMBL;Acc:F2Z351] [ENST00000435033]","chr19",12490003,12512088,null,null,"mRNA","agilent G3 V3"]
["A_23_P33407",1.92,1.95,1.89,4.69,4.38,{"v":5.2,"d":"5.20"},{"v":0.40364400840925,"d":"0.40"},{"v":-1.30884461803345,"d":"-1.31"},"down",{"v":0.00706170000000006,"d":"0.01"},1,"yes","AGCGACGATTCAGATAACGAGGATGTCGACTCCTTTGCTTCGGACTCTACACAAGATTAT","FALSE","NM_004667","ref|NM_004667|ens|ENST00000562136|ens|ENST00000566635|ens|ENST00000261609","HERC2","HECT and RLD domain containing E3 ubiquitin protein ligase 2","ref|Homo sapiens HECT and RLD domain containing E3 ubiquitin protein ligase 2 (HERC2), mRNA [NM_004667]","chrHSCHR15_1_CTG4",28356424,28362697,"GO:0004842(ubiquitin-protein ligase activity);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005743(mitochondrial inner membrane);GO:0005814(centriole);GO:0006281(DNA repair);GO:0006886(intracellular protein transport);GO:0006974(response to DNA damage stimulus);GO:0007283(spermatogenesis);GO:0008270(zinc ion binding);GO:0016020(membrane);GO:0016567(protein ubiquitination);GO:0016874(ligase activity);GO:0020037(heme binding);GO:0031625(ubiquitin protein ligase binding);GO:0032183(SUMO binding);GO:0042787(protein ubiquitination involved in ubiquitin-dependent protein catabolic process);GO:0043547(positive regulation of GTPase activity)","04120(Ubiquitin mediated proteolysis)","mRNA","agilent G3 V3"]
["A_21_P0012039",8.57,8.44,8.78,7.15,7.48,6.49,{"v":1.22111742424242,"d":"1.22"},{"v":0.28820193843076,"d":"0.29"},"up",{"v":0.00716139999999998,"d":"0.01"},1,"yes","ACTGTATTTCTGCTGTCCAACAATAGTTAGCCTTACTCCACACTTCAATGGGGTCGAAGA","FALSE","ENST00000467633","ens|ENST00000467633|linc|TCONS_l2_00015573",null,null,"ens|aldehyde oxidase 3, pseudogene [Source:HGNC Symbol;Acc:HGNC:19049] [ENST00000467633]","chr2",201560464,201565095,null,null,"mRNA","agilent G3 V3"]
["A_23_P62881",5.65,{"v":5.4,"d":"5.40"},5.88,4.99,4.78,4.72,{"v":1.16839199447895,"d":"1.17"},{"v":0.224524378338713,"d":"0.22"},"up",{"v":0.00721859999999996,"d":"0.01"},1,"yes","GGAGTCTCAGTTGTAAAACCTTCCCTCATTAATATCTGAAAATGTTAGTCTTCCTTTAAG","FALSE","NM_032291","ref|NM_032291|ens|ENST00000435165|ens|ENST00000371039|gb|AK125044","SGIP1","SH3-domain GRB2-like (endophilin) interacting protein 1","ref|Homo sapiens SH3-domain GRB2-like (endophilin) interacting protein 1 (SGIP1), mRNA [NM_032291]","chr1",66999868,67213982,"GO:0002021(response to dietary excess);GO:0005515(protein binding);GO:0005543(phospholipid binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005905(coated pit);GO:0006897(endocytosis);GO:0008017(microtubule binding);GO:0017124(SH3 domain binding);GO:0030122(AP-2 adaptor complex);GO:0030136(clathrin-coated vesicle);GO:0048260(positive regulation of receptor-mediated endocytosis);GO:0097320(membrane tubulation);GO:2000253(positive regulation of feeding behavior);GO:2000507(positive regulation of energy homeostasis)",null,"mRNA","agilent G3 V3"]
["A_23_P126844",8.32,8.11,8.35,7.79,7.69,7.47,{"v":1.0797385620915,"d":"1.08"},{"v":0.110682033839431,"d":"0.11"},"up",{"v":0.0072643,"d":"0.01"},1,"yes","CGAGAGGGGGTGAAGACATTTCTCAACTTCTCGGCCGGAGTTTGGCTGAGATCGCGGTAT","FALSE","NM_148965","ref|NM_148965|ref|NM_003790|ref|NM_148966|ref|NM_148967","TNFRSF25","tumor necrosis factor receptor superfamily, member 25","ref|Homo sapiens tumor necrosis factor receptor superfamily, member 25 (TNFRSF25), transcript variant 1, mRNA [NM_148965]","chr1",{"v":6522054,"d":"6522054.00"},6525332,"GO:0004872(receptor activity);GO:0005031(tumor necrosis factor-activated receptor activity);GO:0005576(extracellular region);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0006915(apoptotic process);GO:0007165(signal transduction);GO:0007166(cell surface receptor signaling pathway);GO:0033209(tumor necrosis factor-mediated signaling pathway);GO:0042981(regulation of apoptotic process);GO:0097190(apoptotic signaling pathway)","04060(Cytokine-cytokine receptor interaction)","mRNA","agilent G3 V3"]
["A_23_P73780",8.54,8.27,8.58,7.92,7.93,8.01,{"v":1.06412405699916,"d":"1.06"},{"v":0.0896663519522778,"d":"0.09"},"up",{"v":0.00734219999999997,"d":"0.01"},1,"yes","TGCACAATGGGGCCGACGAGGCCTAGGGCCCTCCTACCTGCTTACAATTTGGAAAAGTGT","FALSE","NM_001569","ref|NM_001569|ref|NM_001025242|ref|NM_001025243|ens|ENST00000369980","IRAK1","interleukin-1 receptor-associated kinase 1","ref|Homo sapiens interleukin-1 receptor-associated kinase 1 (IRAK1), transcript variant 1, mRNA [NM_001569]","chrX",153275968,153285263,"GO:0000187(activation of MAPK activity);GO:0001959(regulation of cytokine-mediated signaling pathway);GO:0002224(toll-like receptor signaling pathway);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0002756(MyD88-independent toll-like receptor signaling pathway);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004704(NF-kappaB-inducing kinase activity);GO:0004842(ubiquitin-protein ligase activity);GO:0005149(interleukin-1 receptor binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005811(lipid particle);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0007165(signal transduction);GO:0007178(transmembrane receptor protein serine/threonine kinase signaling pathway);GO:0007250(activation of NF-kappaB-inducing kinase activity);GO:0007254(JNK cascade);GO:0007568(aging);GO:0010008(endosome membrane);GO:0016301(kinase activity);GO:0016567(protein ubiquitination);GO:0031072(heat shock protein binding);GO:0031663(lipopolysaccharide-mediated signaling pathway);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0032494(response to peptidoglycan);GO:0032496(response to lipopolysaccharide);GO:0034134(toll-like receptor 2 signaling pathway);GO:0034138(toll-like receptor 3 signaling pathway);GO:0034142(toll-like receptor 4 signaling pathway);GO:0034146(toll-like receptor 5 signaling pathway);GO:0034162(toll-like receptor 9 signaling pathway);GO:0034166(toll-like receptor 10 signaling pathway);GO:0034605(cellular response to heat);GO:0035666(TRIF-dependent toll-like receptor signaling pathway);GO:0035872(nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway);GO:0038123(toll-like receptor TLR1:TLR2 signaling pathway);GO:0038124(toll-like receptor TLR6:TLR2 signaling pathway);GO:0042803(protein homodimerization activity);GO:0043066(negative regulation of apoptotic process);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB cascade);GO:0043406(positive regulation of MAP kinase activity);GO:0045087(innate immune response);GO:0045323(interleukin-1 receptor complex);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0046777(protein autophosphorylation);GO:0046982(protein heterodimerization activity);GO:0048011(nerve growth factor receptor signaling pathway);GO:0048661(positive regulation of smooth muscle cell proliferation);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051259(protein oligomerization);GO:0051403(stress-activated MAPK cascade);GO:0070423(nucleotide-binding oligomerization domain containing signaling pathway);GO:0070498(interleukin-1-mediated signaling pathway);GO:0070555(response to interleukin-1);GO:0071456(cellular response to hypoxia)","04064(NF-kappa B signaling pathway);04210(Apoptosis);04620(Toll-like receptor signaling pathway);04722(Neurotrophin signaling pathway);05133(Pertussis);05152(Tuberculosis);05162(Measles);05169(Epstein-Barr virus infection);05145(Toxoplasmosis);05140(Leishmaniasis);05142(Chagas disease (American trypanosomiasis))","mRNA","agilent G3 V3"]
["A_24_P419120",3.79,1.97,2.25,5.61,5.34,5.86,{"v":0.476502082093992,"d":"0.48"},{"v":-1.06944557682746,"d":"-1.07"},"down",{"v":0.0074363999999999,"d":"0.01"},1,"yes","GAATAAGCATTTCTTATTCCTAGTTGTAGGGACTCCTATTTTTACCTTCCGTTACAGTGT","FALSE","NM_015250","ref|NM_015250|ref|NM_001003800|ens|ENST00000356884|ens|ENST00000375512","BICD2","bicaudal D homolog 2 (Drosophila)","ref|Homo sapiens bicaudal D homolog 2 (Drosophila) (BICD2), transcript variant 2, mRNA [NM_015250]","chr9",95473648,95527094,"GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0017137(Rab GTPase binding);GO:0031410(cytoplasmic vesicle);GO:0072385(minus-end-directed organelle transport along microtubule);GO:0072393(microtubule anchoring at microtubule organizing center)",null,"mRNA","agilent G3 V3"]
["A_23_P42514",6.71,6.23,5.97,7.75,7.35,{"v":7.5,"d":"7.50"},{"v":0.836725663716814,"d":"0.84"},{"v":-0.257173409352789,"d":"-0.26"},"down",{"v":0.00750320000000004,"d":"0.01"},1,"yes","TCCTTTGGAGTAAAACTAGTGCTTACCAGTTTCCAATTGTATTTAGCTTCTGGTTGGAAT","FALSE","NM_030939","ref|NM_030939|ens|ENST00000378119|gb|AB075502|gb|BC047866","C6orf62","chromosome 6 open reading frame 62","ref|Homo sapiens chromosome 6 open reading frame 62 (C6orf62), mRNA [NM_030939]","chr6",24705088,24721064,"GO:0003674(molecular_function);GO:0005622(intracellular);GO:0008150(biological_process)",null,"mRNA","agilent G3 V3"]
["A_33_P3258392",7.37,7.04,7.62,6.01,6.37,6.44,{"v":1.17056323060574,"d":"1.17"},{"v":0.227202866972346,"d":"0.23"},"up",{"v":0.0075383,"d":"0.01"},1,"yes","TCAAATCATCTTTTCATGATCCCAAGCTGAAAGGCAAGCCCTCCAGAGAGCGTTATGTGA","FALSE","NM_001955","ref|NM_001955|ref|NM_001168319|ens|ENST00000379375|gb|CR541903","EDN1","endothelin 1","ref|Homo sapiens endothelin 1 (EDN1), transcript variant 1, mRNA [NM_001955]","chr6",12290596,12297427,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0001516(prostaglandin biosynthetic process);GO:0001569(patterning of blood vessels);GO:0001701(in utero embryonic development);GO:0001821(histamine secretion);GO:0003100(regulation of systemic arterial blood pressure by endothelin);GO:0005125(cytokine activity);GO:0005179(hormone activity);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0006885(regulation of pH);GO:0007166(cell surface receptor signaling pathway);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007204(elevation of cytosolic calcium ion concentration);GO:0007205(protein kinase C-activating G-protein coupled receptor signaling pathway);GO:0007267(cell-cell signaling);GO:0007507(heart development);GO:0007585(respiratory gaseous exchange);GO:0007589(body fluid secretion);GO:0008284(positive regulation of cell proliferation);GO:0009953(dorsal/ventral pattern formation);GO:0010193(response to ozone);GO:0010259(multicellular organismal aging);GO:0010460(positive regulation of heart rate);GO:0010595(positive regulation of endothelial cell migration);GO:0010613(positive regulation of cardiac muscle hypertrophy);GO:0010870(positive regulation of receptor biosynthetic process);GO:0014032(neural crest cell development);GO:0014065(phosphatidylinositol 3-kinase cascade);GO:0014823(response to activity);GO:0014824(artery smooth muscle contraction);GO:0014826(vein smooth muscle contraction);GO:0015758(glucose transport);GO:0016049(cell growth);GO:0019229(regulation of vasoconstriction);GO:0019233(sensory perception of pain);GO:0019722(calcium-mediated signaling);GO:0030072(peptide hormone secretion);GO:0030185(nitric oxide transport);GO:0030195(negative regulation of blood coagulation);GO:0030335(positive regulation of cell migration);GO:0030593(neutrophil chemotaxis);GO:0030818(negative regulation of cAMP biosynthetic process);GO:0031583(phospholipase D-activating G-protein coupled receptor signaling pathway);GO:0031707(endothelin A receptor binding);GO:0031708(endothelin B receptor binding);GO:0032269(negative regulation of cellular protein metabolic process);GO:0032308(positive regulation of prostaglandin secretion);GO:0032496(response to lipopolysaccharide);GO:0033093(Weibel-Palade body);GO:0033574(response to testosterone stimulus);GO:0034392(negative regulation of smooth muscle cell apoptotic process);GO:0034696(response to prostaglandin F stimulus);GO:0035094(response to nicotine);GO:0035690(cellular response to drug);GO:0035810(positive regulation of urine volume);GO:0035815(positive regulation of renal sodium excretion);GO:0035994(response to muscle stretch);GO:0042045(epithelial fluid transport);GO:0042310(vasoconstriction);GO:0042313(protein kinase C deactivation);GO:0042474(middle ear morphogenesis);GO:0042482(positive regulation of odontogenesis);GO:0042554(superoxide anion generation);GO:0043179(rhythmic excitation);GO:0043200(response to amino acid stimulus);GO:0043406(positive regulation of MAP kinase activity);GO:0043507(positive regulation of JUN kinase activity);GO:0044321(response to leptin stimulus)","04668(TNF signaling pathway);04066(HIF-1 signaling pathway);04080(Neuroactive ligand-receptor interaction);04916(Melanogenesis);04270(Vascular smooth muscle contraction);05410(Hypertrophic cardiomyopathy (HCM))","mRNA","agilent G3 V3"]
["A_33_P3378697",2.66,2.76,2.48,5.42,3.98,{"v":5,"d":"5.00"},{"v":0.548611111111111,"d":"0.55"},{"v":-0.866144253265209,"d":"-0.87"},"down",{"v":0.00761650000000003,"d":"0.01"},1,"yes","TTGCAAACCTGGTCTTTCTTCAGTGCTGCAAGGCCTATGCCAAGGAGAAAGGAAAAGTAT","FALSE","XR_171111","gb|XR_171111",null,null,"gb|PREDICTED: Homo sapiens carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2-like (LOC101060081), misc_RNA [XR_171111]",{"$nulls":5},"mRNA","agilent G3 V3"]
["A_21_P0011681",5.42,5.22,{"v":5.4,"d":"5.40"},5.95,5.74,6.07,{"v":0.903153153153153,"d":"0.90"},{"v":-0.146957439895186,"d":"-0.15"},"down",{"v":0.00768439999999992,"d":"0.01"},1,"yes","CTTTCTTGGTATTGTTGTCTCAAAGCCAGACCTCATCACCCATCTGGAGCAAGGAAAAAA","FALSE","ENST00000344519","ens|ENST00000344519|linc|TCONS_l2_00012388|linc|TCONS_l2_00012390|linc|TCONS_l2_00013303",null,null,"ens|zinc finger protein 66 [Source:HGNC Symbol;Acc:HGNC:13135] [ENST00000344519]","chr19",20959232,20990128,null,null,"mRNA","agilent G3 V3"]
["A_33_P3415778",5.85,{"v":5.4,"d":"5.40"},5.81,4.48,{"v":4.9,"d":"4.90"},4.31,{"v":1.24616508400292,"d":"1.25"},{"v":0.317495200060391,"d":"0.32"},"up",{"v":0.00774030000000003,"d":"0.01"},1,"yes","TCAGCCAGAACTTGGGAGGACTTGGTGCTTAATGCCCCATCTTTGGTTCGCCCTAGGTAA","FALSE","AK126643","gb|AK126643|tc|THC2626336","LOC100129721","uncharacterized LOC100129721","gb|Homo sapiens cDNA FLJ44685 fis, clone BRACE3011447. [AK126643]","chr10",61463496,61469323,null,null,"mRNA","agilent G3 V3"]
["A_24_P250650",{"v":10.3,"d":"10.30"},10.02,9.97,9.55,9.49,9.27,{"v":1.06993995054751,"d":"1.07"},{"v":0.0975298288896254,"d":"0.10"},"up",{"v":0.00776489999999996,"d":"0.01"},1,"yes","CACCCCTCTCTGGTACTTGTGGCTTGCTAGTATGTTTTTATGATAATCTCGGGCATTGTT","FALSE","NM_013412","ref|NM_013412|ref|NM_001130921|ref|NM_001130923|ref|NM_001130920","RABL2A","RAB, member of RAS oncogene family-like 2A","ref|Homo sapiens RAB, member of RAS oncogene family-like 2A (RABL2A), transcript variant 1, mRNA [NM_013412]","chr22",51205928,51222090,"GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0006886(intracellular protein transport);GO:0008152(metabolic process);GO:0012505(endomembrane system);GO:0019003(GDP binding);GO:0032482(Rab protein signal transduction)",null,"mRNA","agilent G3 V3"]
["A_23_P89460",3.28,3.84,4.42,5.59,5.41,5.95,{"v":0.680825958702065,"d":"0.68"},{"v":-0.554642049378224,"d":"-0.55"},"down",{"v":0.0078414,"d":"0.01"},1,"yes","AGGAAACTTCGGTTTCATGTCCTTAGCAAGCTACTGAGTTTCATGGCACCTATTGACCAT","FALSE","NM_012138","ref|NM_012138|ens|ENST00000620004|ens|ENST00000619387|gb|AB385572","AATF","apoptosis antagonizing transcription factor","ref|Homo sapiens apoptosis antagonizing transcription factor (AATF), mRNA [NM_012138]","chr17",35306176,35414171,"GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005925(focal adhesion);GO:0006974(response to DNA damage stimulus);GO:0007155(cell adhesion);GO:0007346(regulation of mitotic cell cycle);GO:0032929(negative regulation of superoxide anion generation);GO:0040016(embryonic cleavage);GO:0042254(ribosome biogenesis);GO:0042985(negative regulation of amyloid precursor protein biosynthetic process);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043522(leucine zipper domain binding);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048011(nerve growth factor receptor signaling pathway);GO:0048156(tau protein binding);GO:0097190(apoptotic signaling pathway);GO:2000378(negative regulation of reactive oxygen species metabolic process)",null,"mRNA","agilent G3 V3"]
["A_33_P3385988",10.83,10.29,{"v":11.1,"d":"11.10"},11.98,12.21,11.86,{"v":0.89375866851595,"d":"0.89"},{"v":-0.162042765421616,"d":"-0.16"},"down",{"v":0.00791559999999991,"d":"0.01"},1,"yes","CGCGGGCTGCTGCCACCCGCCGGGCCCTGCAAGCGCTGCCGCTCGTTCTGCGCCGCGGTC","FALSE","ENST00000266182","ens|ENST00000266182",null,null,"ens|tubulin tyrosine ligase-like family, member 8 [Source:HGNC Symbol;Acc:HGNC:34000] [ENST00000266182]","chr22",50453552,50493055,null,null,"mRNA","agilent G3 V3"]
["A_33_P3384462",5.82,5.02,4.96,6.53,6.72,6.79,{"v":0.788423153692615,"d":"0.79"},{"v":-0.342957950130743,"d":"-0.34"},"down",{"v":0.00799499999999997,"d":"0.01"},1,"yes","TTCTCCTGCAAATAGCGCCCTCTAAAAAGAAGAGTCAGACAATAAACTGGTTGAAATATC","FALSE","NM_024817","ref|NM_024817|ref|NM_001286429|ens|ENST00000355327","THSD4","thrombospondin, type I, domain containing 4","ref|Homo sapiens thrombospondin, type I, domain containing 4 (THSD4), transcript variant 1, mRNA [NM_024817]","chr15",71433792,72075722,"GO:0001527(microfibril);GO:0004222(metalloendopeptidase activity);GO:0006508(proteolysis);GO:0048251(elastic fiber assembly);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_21_P0000309",12.83,12.66,{"v":13.3,"d":"13.30"},11.43,11.41,11.99,{"v":1.11369509043928,"d":"1.11"},{"v":0.155354302944688,"d":"0.16"},"up",{"v":0.00808120000000001,"d":"0.01"},1,"yes","TCATTGTGATGAGGGCGTCAAACTTGTGGCTTCCCTATGAACAAACGTCCCCCAACACCT","FALSE","NR_002953","ref|NR_002953|gb|AM055729|gb|BG739944|tc|THC2547106","SNORA11","small nucleolar RNA, H/ACA box 11","ref|Homo sapiens small nucleolar RNA, H/ACA box 11 (SNORA11), small nucleolar RNA [NR_002953]","chrX",54840800,54840933,null,null,"mRNA","agilent G3 V3"]
["A_23_P6066",5.66,4.84,5.73,7.38,6.92,6.82,{"v":0.768465909090909,"d":"0.77"},{"v":-0.379946834810482,"d":"-0.38"},"down",{"v":0.00813740000000007,"d":"0.01"},1,"yes","TCACGCCCACACCAGATGATGCTGTGTTTCGCTGGCTCAGCACTGTCTATGCTGGCAGTA","FALSE","NM_019609","ref|NM_019609|ens|ENST00000380605|gb|AK027661|gb|AK303142","CPXM1","carboxypeptidase X (M14 family), member 1","ref|Homo sapiens carboxypeptidase X (M14 family), member 1 (CPXM1), transcript variant 1, mRNA [NM_019609]","chr20",{"v":2774715,"d":"2774715.00"},2781283,"GO:0004181(metallocarboxypeptidase activity);GO:0005615(extracellular space);GO:0006508(proteolysis);GO:0008270(zinc ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P12989",6.34,7.26,6.38,{"v":10,"d":"10.00"},10.01,9.92,{"v":0.667557634480454,"d":"0.67"},{"v":-0.583035695705682,"d":"-0.58"},"down",{"v":0.00816319999999993,"d":"0.01"},1,"yes","ATCTTTGGGAATCGACGTCTCAAGAGGTTCTCCATGGTGGTACAGGATGGCATAGTGAAG","FALSE","NM_012094","ref|NM_012094|ref|NM_181651|ref|NM_181652|ens|ENST00000352435","PRDX5","peroxiredoxin 5","ref|Homo sapiens peroxiredoxin 5 (PRDX5), transcript variant 1, mRNA [NM_012094]","chr11",64085560,64089283,"GO:0000302(response to reactive oxygen species);GO:0001016(RNA polymerase III regulatory region DNA binding);GO:0004601(peroxidase activity);GO:0005102(receptor binding);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0005777(peroxisome);GO:0005782(peroxisomal matrix);GO:0005829(cytosol);GO:0006954(inflammatory response);GO:0006979(response to oxidative stress);GO:0016209(antioxidant activity);GO:0016480(negative regulation of transcription from RNA polymerase III promoter);GO:0031410(cytoplasmic vesicle);GO:0032967(positive regulation of collagen biosynthetic process);GO:0034614(cellular response to reactive oxygen species);GO:0042744(hydrogen peroxide catabolic process);GO:0043027(cysteine-type endopeptidase inhibitor activity involved in apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043231(intracellular membrane-bounded organelle);GO:0046983(protein dimerization activity);GO:0048471(perinuclear region of cytoplasm);GO:0051354(negative regulation of oxidoreductase activity);GO:0051920(peroxiredoxin activity);GO:0055114(oxidation-reduction process);GO:0060785(regulation of apoptosis involved in tissue homeostasis);GO:0070062(extracellular vesicular exosome);GO:0070995(NADPH oxidation);GO:0072541(peroxynitrite reductase activity);GO:2001057(reactive nitrogen species metabolic process)","04146(Peroxisome)","mRNA","agilent G3 V3"]
["A_24_P56894",6.71,6.43,6.64,{"v":6.1,"d":"6.10"},6.22,{"v":6.1,"d":"6.10"},{"v":1.07383279044517,"d":"1.07"},{"v":0.102769364667775,"d":"0.10"},"up",{"v":0.00824040000000004,"d":"0.01"},1,"yes","AGGTATTTGTAAGCAGTGTTGACTTTTATCCCCTCTTCAGTAATCTTTAAGTCCCCAAAA","FALSE","NM_015986","ref|NM_015986|ref|NR_073118|ens|ENST00000324238|ref|XM_006721941","CRLF3","cytokine receptor-like factor 3","ref|Homo sapiens cytokine receptor-like factor 3 (CRLF3), transcript variant 1, mRNA [NM_015986]","chr17",29110954,29151689,"GO:0000082(G1/S transition of mitotic cell cycle);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0030308(negative regulation of cell growth);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046427(positive regulation of JAK-STAT cascade);GO:0071158(positive regulation of cell cycle arrest)",null,"mRNA","agilent G3 V3"]
["A_33_P3306153",6.29,6.11,6.44,5.37,5.29,4.67,{"v":1.22896281800391,"d":"1.23"},{"v":0.297441267954006,"d":"0.30"},"up",{"v":0.00829930000000001,"d":"0.01"},1,"yes","GCACCTAATAAAAATGAGATTGGGGGATCTGGACCGAGTCAAGTCAAAGGAAGCAAAAGA","FALSE","NM_032506","ref|NM_032506|ens|ENST00000356719|ens|ENST00000488322|ens|ENST00000295031","KIAA1841","KIAA1841","ref|Homo sapiens KIAA1841 (KIAA1841), transcript variant 2, mRNA [NM_032506]","chr2",61297460,61351409,null,null,"mRNA","agilent G3 V3"]
["A_32_P478023",6.49,6.29,6.56,{"v":5.3,"d":"5.30"},4.74,4.09,{"v":1.36871903750885,"d":"1.37"},{"v":0.452826329142902,"d":"0.45"},"up",{"v":0.00840169999999996,"d":"0.01"},1,"yes","TCAGCATTCCCCTATGATGGGTTTACTGATGAGTTGCATCAACTCCAGAGCCAAGTTCAA","FALSE","NM_178864","ref|NM_178864|ens|ENST00000525148|ens|ENST00000311034|gb|EU446888","NPAS4","neuronal PAS domain protein 4","ref|Homo sapiens neuronal PAS domain protein 4 (NPAS4), mRNA [NM_178864]","chr11",66188560,66193526,"GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0001077(RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription);GO:0004871(signal transducer activity);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0006351(transcription, DNA-dependent);GO:0007165(signal transduction);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046982(protein heterodimerization activity)",null,"mRNA","agilent G3 V3"]
["A_33_P3383189",1.96,1.96,1.95,4.36,4.34,5.08,{"v":0.425979680696662,"d":"0.43"},{"v":-1.23114347959424,"d":"-1.23"},"down",{"v":0.00841800000000004,"d":"0.01"},1,"yes","TGCAACAAGCGCTTCATGCGCAGCGACCACCTGAGCAAACACATTAAGACGCACAACGGG","FALSE","NM_001145250","ref|NM_001145250|ens|ENST00000394967","SP9","Sp9 transcription factor","ref|Homo sapiens Sp9 transcription factor (SP9), mRNA [NM_001145250]","chr2",175199680,175203220,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0030326(embryonic limb morphogenesis);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P331928",6.02,{"v":5.6,"d":"5.60"},4.17,8.07,7.83,8.56,{"v":0.645543744889616,"d":"0.65"},{"v":-0.63141323266715,"d":"-0.63"},"down",{"v":0.00853539999999997,"d":"0.01"},1,"yes","ATTTCATTCACGAATCTCTTATTTTGGGAAGCTGTTTTGCATATGAGAAGAACACTGTTG","FALSE","NM_133493","ref|NM_133493|ref|NM_001159587|ref|NM_001159588|ens|ENST00000287097","CD109","CD109 molecule","ref|Homo sapiens CD109 molecule (CD109), transcript variant 1, mRNA [NM_133493]","chr6",74405504,74538040,"GO:0001933(negative regulation of protein phosphorylation);GO:0001942(hair follicle development);GO:0004867(serine-type endopeptidase inhibitor activity);GO:0005615(extracellular space);GO:0005886(plasma membrane);GO:0009986(cell surface);GO:0010839(negative regulation of keratinocyte proliferation);GO:0010951(negative regulation of endopeptidase activity);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0031225(anchored to membrane);GO:0045616(regulation of keratinocyte differentiation);GO:0050431(transforming growth factor beta binding);GO:0061045(negative regulation of wound healing);GO:0072675(osteoclast fusion)",null,"mRNA","agilent G3 V3"]
["A_23_P258964",{"v":3.9,"d":"3.90"},{"v":4.9,"d":"4.90"},2.81,7.09,6.69,6.73,{"v":0.566065333983423,"d":"0.57"},{"v":-0.820959519614285,"d":"-0.82"},"down",{"v":0.0085828,"d":"0.01"},1,"yes","TCAAGTAACTTGAGACCTCACAGTAATCTTCACACTTAACCTTAGACACCTATGCAGTCA","FALSE","NM_013417","ref|NM_013417|ref|NM_002161|ref|NR_073446|ens|ENST00000443024","IARS","isoleucyl-tRNA synthetase","ref|Homo sapiens isoleucyl-tRNA synthetase (IARS), transcript variant 2, mRNA [NM_013417]","chr9",94972624,95055965,"GO:0001649(osteoblast differentiation);GO:0002161(aminoacyl-tRNA editing activity);GO:0004822(isoleucine-tRNA ligase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006418(tRNA aminoacylation for protein translation);GO:0006428(isoleucyl-tRNA aminoacylation);GO:0006450(regulation of translational fidelity);GO:0010467(gene expression);GO:0016020(membrane);GO:0070062(extracellular vesicular exosome)","00970(Aminoacyl-tRNA biosynthesis)","mRNA","agilent G3 V3"]
["A_23_P143935",{"v":3.5,"d":"3.50"},2.05,1.92,{"v":4.7,"d":"4.70"},5.29,5.44,{"v":0.484121840570318,"d":"0.48"},{"v":-1.0465579137815,"d":"-1.05"},"down",{"v":0.00874079999999999,"d":"0.01"},1,"yes","GTTGTACTTCATGGCACTCTGATGCCTGCTGTCTCAGTGTTTGGTTATTATGCAAACAAG","FALSE","NM_025163","ref|NM_025163|ens|ENST00000412723|ref|XM_006713758|gb|AK022830","PIGZ","phosphatidylinositol glycan anchor biosynthesis, class Z","ref|Homo sapiens phosphatidylinositol glycan anchor biosynthesis, class Z (PIGZ), mRNA [NM_025163]","chr3",196673600,196678801,"GO:0000026(alpha-1,2-mannosyltransferase activity);GO:0000030(mannosyltransferase activity);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006506(GPI anchor biosynthetic process);GO:0016021(integral to membrane)","00563(Glycosylphosphatidylinositol(GPI)-anchor biosynthesis)","mRNA","agilent G3 V3"]
["A_24_P128163",5.22,4.84,5.42,4.05,4.33,3.79,{"v":1.27198027937551,"d":"1.27"},{"v":0.347076303430682,"d":"0.35"},"up",{"v":0.00876280000000007,"d":"0.01"},1,"yes","TTCACTGCTGCTCATGAACTGGGTAAAGTAGGGGTGGATGAGAAAGGTATTAGGGAGGAG","FALSE","ENST00000367995","ens|ENST00000367995|gb|BC030812|tc|NP482437","ADAMTS4","ADAM metallopeptidase with thrombospondin type 1 motif, 4","ens|ADAM metallopeptidase with thrombospondin type 1 motif, 4 [Source:HGNC Symbol;Acc:HGNC:220] [ENST00000367995]","chr1",161165776,161168843,"GO:0001501(skeletal system development);GO:0002020(protease binding);GO:0004222(metalloendopeptidase activity);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005578(proteinaceous extracellular matrix);GO:0005615(extracellular space);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0022617(extracellular matrix disassembly);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix);GO:0042742(defense response to bacterium)",null,"mRNA","agilent G3 V3"]
["A_23_P87973",2.93,3.83,2.61,{"v":4.9,"d":"4.90"},4.97,5.59,{"v":0.60608020698577,"d":"0.61"},{"v":-0.722419366265661,"d":"-0.72"},"down",{"v":0.0088646,"d":"0.01"},1,"yes","TGGAGCTTTTATAAGTTATTTTTGCTAATCCTTCTGCTTGGCCTTGTCATTGTCTTTGGT","FALSE","NM_213590","ref|NM_213590|ref|NM_001007278|ref|NM_052811|ref|NM_005798","TRIM13","tripartite motif containing 13","ref|Homo sapiens tripartite motif containing 13 (TRIM13), transcript variant 3, mRNA [NM_213590]","chr13",50575240,50587305,"GO:0004842(ubiquitin-protein ligase activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005789(endoplasmic reticulum membrane);GO:0007165(signal transduction);GO:0008270(zinc ion binding);GO:0009653(anatomical structure morphogenesis);GO:0010332(response to gamma radiation);GO:0010942(positive regulation of cell death);GO:0016021(integral to membrane);GO:0016239(positive regulation of macroautophagy);GO:0016874(ligase activity);GO:0030433(ER-associated protein catabolic process);GO:0032897(negative regulation of viral transcription);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB cascade);GO:0043161(proteasomal ubiquitin-dependent protein catabolic process);GO:0045087(innate immune response);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051865(protein autoubiquitination);GO:0097038(perinuclear endoplasmic reticulum)",null,"mRNA","agilent G3 V3"]
["A_33_P3318993",7.74,7.65,7.64,7.91,7.89,8.04,{"v":0.966023489932886,"d":"0.97"},{"v":-0.0498698246693158,"d":"-0.05"},"down",{"v":0.00892409999999999,"d":"0.01"},1,"yes","TTTGCAAGGCCCAACTCCACCTTTCCCATTGATAAATCCATGACTGTGGTTTTAACTTGT","FALSE","ENST00000532759","ens|ENST00000532759",null,null,"ens|olfactory receptor, family 4, subfamily A, member 21 pseudogene [Source:HGNC Symbol;Acc:HGNC:15158] [ENST00000532759]","chr11",55258628,55259618,null,null,"mRNA","agilent G3 V3"]
["A_33_P3301851",7.85,{"v":8.8,"d":"8.80"},7.99,9.77,9.72,9.51,{"v":0.849655172413793,"d":"0.85"},{"v":-0.235050644207395,"d":"-0.24"},"down",{"v":0.00903959999999993,"d":"0.01"},1,"yes","TCTTAGCCTCGGGATCCAGTGAAGCCAGAAGCCAAATAAACTCAAAAGCTGTCTCCCCAC","FALSE","NM_002419","ref|NM_002419|ens|ENST00000309100|ens|ENST00000524848|ref|XR_428915","MAP3K11","mitogen-activated protein kinase kinase kinase 11","ref|Homo sapiens mitogen-activated protein kinase kinase kinase 11 (MAP3K11), mRNA [NM_002419]","chr11",65365228,65375893,"GO:0000187(activation of MAPK activity);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004706(JUN kinase kinase kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005874(microtubule);GO:0006468(protein phosphorylation);GO:0007017(microtubule-based process);GO:0007254(JNK cascade);GO:0007256(activation of JNKK activity);GO:0007257(activation of JUN kinase activity);GO:0008219(cell death);GO:0008283(cell proliferation);GO:0016020(membrane);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0031434(mitogen-activated protein kinase kinase binding);GO:0031435(mitogen-activated protein kinase kinase kinase binding);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043507(positive regulation of JUN kinase activity);GO:0043525(positive regulation of neuron apoptotic process);GO:0046330(positive regulation of JNK cascade);GO:0046777(protein autophosphorylation);GO:0048365(Rac GTPase binding)","04010(MAPK signaling pathway);04932(Non-alcoholic fatty liver disease (NAFLD))","mRNA","agilent G3 V3"]
["A_21_P0013513",7.38,7.54,7.01,6.18,6.14,6.59,{"v":1.15970386039133,"d":"1.16"},{"v":0.213756448723832,"d":"0.21"},"up",{"v":0.00910490000000008,"d":"0.01"},1,"yes","CAAAAGCAAAACTCATGGTGCTTTTGTTTGTGAAATGGGCTCCTTCTGAAAAAGCCAAGG","FALSE","ENST00000518311","ens|ENST00000518311|linc|TCONS_l2_00028187",null,null,"ens|asparagine synthetase pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:754] [ENST00000518311]","chr8",47490836,47526145,null,null,"mRNA","agilent G3 V3"]
["A_33_P3211260",4.06,2.73,3.53,5.58,5.13,5.38,{"v":0.641392169049099,"d":"0.64"},{"v":-0.640721355300192,"d":"-0.64"},"down",{"v":0.00920180000000004,"d":"0.01"},1,"yes","AAATGACAGACGCACTCGGGACAACAACTTGGCTCTTATGAAATAAACATATACTTACCA","FALSE","AB209486","gb|AB209486|tc|THC2714483","DBNL","drebrin-like","gb|Homo sapiens mRNA for Drebrin-like protein variant protein. [AB209486]","chr7",44089844,44109055,"GO:0000139(Golgi membrane);GO:0001726(ruffle);GO:0002102(podosome);GO:0002376(immune system process);GO:0003779(actin binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005938(cell cortex);GO:0006898(receptor-mediated endocytosis);GO:0006915(apoptotic process);GO:0006921(cellular component disassembly involved in apoptotic process);GO:0007257(activation of JUN kinase activity);GO:0007416(synapse assembly);GO:0008022(protein C-terminus binding);GO:0008047(enzyme activator activity);GO:0014069(postsynaptic density);GO:0016601(Rac protein signal transduction);GO:0019904(protein domain specific binding);GO:0030027(lamellipodium);GO:0030054(cell junction);GO:0030425(dendrite);GO:0030665(clathrin coated vesicle membrane);GO:0048812(neuron projection morphogenesis);GO:0051015(actin filament binding);GO:0070062(extracellular vesicular exosome);GO:0071800(podosome assembly);GO:0097178(ruffle assembly)",null,"mRNA","agilent G3 V3"]
["A_33_P3304097",9.39,9.35,9.29,9.76,{"v":10,"d":"10.00"},10.23,{"v":0.934644881627209,"d":"0.93"},{"v":-0.0975097778362462,"d":"-0.10"},"down",{"v":0.00925589999999998,"d":"0.01"},1,"yes","ATGCACACATACACATATAAACATACACACACACACATATACACTAATAGATTATATTGA","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_33_P3332871",7.13,7.01,7.08,6.27,6.68,6.26,{"v":1.10463300364394,"d":"1.10"},{"v":0.143567137249238,"d":"0.14"},"up",{"v":0.00933779999999995,"d":"0.01"},1,"yes","TTTGTTCCTCCTCTGCAAAGCAAAGGTGCCACAGGGCGCGGCTTTCCGAGAAAGCGTACT","FALSE","BE616696","gb|BE616696|tc|THC2505887",null,null,"gb|601279876F1 NIH_MGC_39 Homo sapiens cDNA clone IMAGE:3621930 5', mRNA sequence [BE616696]","chr7",65196532,65199347,null,null,"mRNA","agilent G3 V3"]
["A_23_P203475",8.59,9.51,8.02,10.62,10.83,10.84,{"v":0.808919170021679,"d":"0.81"},{"v":-0.30593254406755,"d":"-0.31"},"down",{"v":0.0094822,"d":"0.01"},1,"yes","TCCCTTCCTTAAGCCCAGTCCTGTGTCCTCTGAAAGAGGTGCAGTCACTCACACCTGCTT","FALSE","NM_145040","ref|NM_145040|ens|ENST00000303927|ens|ENST00000532354|gb|AF339881","PRKCDBP","protein kinase C, delta binding protein","ref|Homo sapiens protein kinase C, delta binding protein (PRKCDBP), mRNA [NM_145040]","chr11",{"v":6340360,"d":"6340360.00"},6341385,"GO:0005080(protein kinase C binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005901(caveola);GO:0030866(cortical actin cytoskeleton organization);GO:0032922(circadian regulation of gene expression);GO:0043234(protein complex);GO:0051898(negative regulation of protein kinase B signaling cascade);GO:0070374(positive regulation of ERK1 and ERK2 cascade)",null,"mRNA","agilent G3 V3"]
["A_24_P823684",4.47,4.87,3.92,{"v":5.7,"d":"5.70"},5.73,6.11,{"v":0.755986316989738,"d":"0.76"},{"v":-0.403567972332145,"d":"-0.40"},"down",{"v":0.0095018,"d":"0.01"},1,"yes","ATGCTCCAGCAGAGCAAAATCTTGAAAGTCATTCGCAAAAACATTGGTAAGAAGTGCCTT","FALSE","NM_007355","ref|NM_007355|ref|NM_001271969|ref|NM_001271972|ref|NM_001271970","HSP90AB1","heat shock protein 90kDa alpha (cytosolic), class B member 1","ref|Homo sapiens heat shock protein 90kDa alpha (cytosolic), class B member 1 (HSP90AB1), transcript variant 2, mRNA [NM_007355]","chr4",88812992,88815167,"GO:0001890(placenta development);GO:0002134(UTP binding);GO:0002135(CTP binding);GO:0003725(double-stranded RNA binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005525(GTP binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006457(protein folding);GO:0006986(response to unfolded protein);GO:0007411(axon guidance);GO:0008180(signalosome);GO:0009651(response to salt stress);GO:0009986(cell surface);GO:0016020(membrane);GO:0016234(inclusion body);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0017098(sulfonylurea receptor binding);GO:0019900(kinase binding);GO:0019901(protein kinase binding);GO:0023026(MHC class II protein complex binding);GO:0030235(nitric-oxide synthase regulator activity);GO:0030911(TPR domain binding);GO:0031526(brush border membrane);GO:0032092(positive regulation of protein binding);GO:0032435(negative regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0032564(dATP binding);GO:0033160(positive regulation of protein import into nucleus, translocation);GO:0034605(cellular response to heat);GO:0035872(nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway);GO:0038096(Fc-gamma receptor signaling pathway involved in phagocytosis);GO:0042470(melanosome);GO:0043524(negative regulation of neuron apoptotic process);GO:0044325(ion channel binding);GO:0045087(innate immune response);GO:0045429(positive regulation of nitric oxide biosynthetic process);GO:0045793(positive regulation of cell size);GO:0051082(unfolded protein binding);GO:0060334(regulation of interferon-gamma-mediated signaling pathway);GO:0060338(regulation of type I interferon-mediated signaling pathway);GO:0070062(extracellular vesicular exosome);GO:0071353(cellular response to interleukin-4);GO:0071407(cellular response to organic cyclic compound);GO:0071902(positive regulation of protein serine/threonine kinase activity);GO:1900034(regulation of cellular response to heat)","04141(Protein processing in endoplasmic reticulum);04151(PI3K-Akt signaling pathway);04621(NOD-like receptor signaling pathway);04612(Antigen processing and presentation);04915(Estrogen signaling pathway);04914(Progesterone-mediated oocyte maturation);05200(Pathways in cancer);05215(Prostate cancer)","mRNA","agilent G3 V3"]
["A_33_P3559060",5.31,5.45,4.95,4.29,4.53,4.05,{"v":1.22066822066822,"d":"1.22"},{"v":0.287671127073495,"d":"0.29"},"up",{"v":0.0096368,"d":"0.01"},1,"yes","TCATTCCTGCAGAAGGTTTGTGACGTAGCTGTGCCTGTACCTGGGGCAGAGAGGATGCCA","FALSE","NM_138814","ref|NM_138814|ref|NM_001177675|ens|ENST00000381198|ens|ENST00000216177","PNPLA5","patatin-like phospholipase domain containing 5","ref|Homo sapiens patatin-like phospholipase domain containing 5 (PNPLA5), transcript variant 1, mRNA [NM_138814]","chr22",44275560,44287893,"GO:0016042(lipid catabolic process);GO:0016787(hydrolase activity)",null,"mRNA","agilent G3 V3"]
["A_23_P35000",11.89,11.81,11.61,11.29,11.42,11.31,{"v":1.0379188712522,"d":"1.04"},{"v":0.0536936800962153,"d":"0.05"},"up",{"v":0.00969580000000003,"d":"0.01"},1,"yes","CTCCACACCCCCCAGACCCAGCTGGTTCTGGAGTTCTAGGACATTGGGTGTTTCAAGGTT","FALSE","NM_005281","ref|NM_005281|ens|ENST00000374024|gb|AK291185|gb|BC032702","GPR3","G protein-coupled receptor 3","ref|Homo sapiens G protein-coupled receptor 3 (GPR3), mRNA [NM_005281]","chr1",27719148,27722318,"GO:0004930(G-protein coupled receptor activity);GO:0005515(protein binding);GO:0005887(integral to plasma membrane);GO:0007189(adenylate cyclase-activating G-protein coupled receptor signaling pathway);GO:0007204(elevation of cytosolic calcium ion concentration);GO:0030816(positive regulation of cAMP metabolic process);GO:0040020(regulation of meiosis)",null,"mRNA","agilent G3 V3"]
["A_23_P32414",1.98,2.55,1.93,4.11,4.03,{"v":5.5,"d":"5.50"},{"v":0.473607038123167,"d":"0.47"},{"v":-1.07823757433025,"d":"-1.08"},"down",{"v":0.0098163,"d":"0.01"},1,"yes","TGTATTGCTTATTCATTATAGCTATTCGTCCTGTAATCTGTTTCTAGGTGAAGCATACTC","FALSE","NM_016542","ref|NM_016542|ref|NM_001042453|ref|NM_001042452|ens|ENST00000394334","STK26","serine/threonine protein kinase 26","ref|Homo sapiens serine/threonine protein kinase 26 (STK26), transcript variant 1, mRNA [NM_016542]","chrX",131157336,131209971,"GO:0000139(Golgi membrane);GO:0000287(magnesium ion binding);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005798(Golgi-associated vesicle);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006468(protein phosphorylation);GO:0006915(apoptotic process);GO:0006921(cellular component disassembly involved in apoptotic process);GO:0016324(apical plasma membrane);GO:0030033(microvillus assembly);GO:0042542(response to hydrogen peroxide);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0042981(regulation of apoptotic process);GO:0046777(protein autophosphorylation);GO:0048471(perinuclear region of cytoplasm);GO:0070062(extracellular vesicular exosome);GO:0071944(cell periphery)",null,"mRNA","agilent G3 V3"]
["A_24_P341504",3.44,1.97,2.15,4.56,4.67,{"v":4.9,"d":"4.90"},{"v":0.535031847133758,"d":"0.54"},{"v":-0.902303326112867,"d":"-0.90"},"down",{"v":0.00985649999999993,"d":"0.01"},1,"yes","TAATGGATATGTGCTTTTTGGAAAACCCATGGTGGTTCAGTTTGCTCGATCTGCTAGACC","FALSE","NM_017619","ref|NM_017619|ens|ENST00000423855|ens|ENST00000533834|ens|ENST00000605810","RNPC3","RNA-binding region (RNP1, RRM) containing 3","ref|Homo sapiens RNA-binding region (RNP1, RRM) containing 3 (RNPC3), mRNA [NM_017619]","chr1",104068312,104095965,"GO:0000166(nucleotide binding);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005689(U12-type spliceosomal complex);GO:0006397(mRNA processing);GO:0008380(RNA splicing)",null,"mRNA","agilent G3 V3"]
["A_33_P3671378",8.29,8.02,8.03,7.65,7.71,7.72,{"v":1.05459272097054,"d":"1.05"},{"v":0.0766859440682459,"d":"0.08"},"up",{"v":0.0099359,"d":"0.01"},1,"yes","AACTTCAGGGGGCGGCTGGAGCGGCTGATGGAGGATGTGGAGGCAGAGAAACTGTCTTGG","FALSE","NM_016174","ref|NM_016174|ref|NM_001286760|ens|ENST00000463535|ens|ENST00000612334","CERCAM","cerebral endothelial cell adhesion molecule","ref|Homo sapiens cerebral endothelial cell adhesion molecule (CERCAM), transcript variant 1, mRNA [NM_016174]","chr9",131193024,131196473,"GO:0005788(endoplasmic reticulum lumen);GO:0005886(plasma membrane);GO:0006928(cellular component movement);GO:0007155(cell adhesion);GO:0007159(leukocyte cell-cell adhesion)",null,"mRNA","agilent G3 V3"]
["A_23_P148969",1.94,1.93,1.94,3.94,4.25,3.56,{"v":0.494468085106383,"d":"0.49"},{"v":-1.01605068804783,"d":"-1.02"},"down",{"v":0.0100027,"d":"0.01"},1,"yes","GCATGTATATCAATTTATATAGATAGGTAGATAGCTTTTGGATGATTGAGGCATGCTTAT","FALSE","NM_017768","ref|NM_017768|ens|ENST00000370952|ref|XM_005271013|ref|XM_006710757","LRRC40","leucine rich repeat containing 40","ref|Homo sapiens leucine rich repeat containing 40 (LRRC40), mRNA [NM_017768]","chr1",70610488,70671303,"GO:0016020(membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3390441",4.36,5.61,3.07,8.01,7.76,7.54,{"v":0.559416559416559,"d":"0.56"},{"v":-0.838005134897789,"d":"-0.84"},"down",{"v":0.0101012,"d":"0.01"},1,"yes","GTAAACACATACACACAAAACAGCAAACTTCAGGTAACTATTTTGGATTGCAAACAGGAT","FALSE","NM_002265","ref|NM_002265|ref|NM_001276453|gb|L38951|tc|THC2465238","KPNB1","karyopherin (importin) beta 1","ref|Homo sapiens karyopherin (importin) beta 1 (KPNB1), transcript variant 1, mRNA [NM_002265]","chr17",45727204,45762871,"GO:0000060(protein import into nucleus, translocation);GO:0005515(protein binding);GO:0005635(nuclear envelope);GO:0005643(nuclear pore);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006309(apoptotic DNA fragmentation);GO:0006606(protein import into nucleus);GO:0006607(NLS-bearing substrate import into nucleus);GO:0006610(ribosomal protein import into nucleus);GO:0006915(apoptotic process);GO:0006921(cellular component disassembly involved in apoptotic process);GO:0008139(nuclear localization sequence binding);GO:0008270(zinc ion binding);GO:0008536(Ran GTPase binding);GO:0008565(protein transporter activity);GO:0016020(membrane);GO:0016032(viral reproduction);GO:0019058(viral infectious cycle);GO:0019221(cytokine-mediated signaling pathway);GO:0019899(enzyme binding);GO:0019904(protein domain specific binding);GO:0031965(nuclear membrane);GO:0044281(small molecule metabolic process);GO:0070062(extracellular vesicular exosome);GO:0071782(endoplasmic reticulum tubular network)","03013(RNA transport)","mRNA","agilent G3 V3"]
["A_23_P129014",7.29,{"v":7,"d":"7.00"},{"v":7.4,"d":"7.40"},6.04,6.31,5.44,{"v":1.21922428330523,"d":"1.22"},{"v":0.285963542405114,"d":"0.29"},"up",{"v":0.0101362,"d":"0.01"},1,"yes","GAACTATGGACAGAAGGAAGCCTAACTATTGTGAACTACTTTTGGTAACTCTGGGGAGAT","FALSE","NM_145231","ref|NM_145231|ref|NM_001284269|ref|NM_001284267|ens|ENST00000553871","EFCAB11","EF-hand calcium binding domain 11","ref|Homo sapiens EF-hand calcium binding domain 11 (EFCAB11), transcript variant 1, mRNA [NM_145231]","chr14",90263504,90418949,"GO:0005509(calcium ion binding)",null,"mRNA","agilent G3 V3"]
["A_24_P196499",{"v":5.7,"d":"5.70"},5.22,6.32,{"v":3.5,"d":"3.50"},4.26,4.09,{"v":1.45485232067511,"d":"1.45"},{"v":0.540872715303477,"d":"0.54"},"up",{"v":0.0102417,"d":"0.01"},1,"yes","AAGTGGAAATTCAAATCGGTACCTTCCCAAAGTATTAGTGCCTTTCGATGGTGCCATAGC","FALSE","ENST00000471257","ens|ENST00000471257|gb|AB030181","ARID4B","AT rich interactive domain 4B (RBP1-like)","ens|AT rich interactive domain 4B (RBP1-like) [Source:HGNC Symbol;Acc:HGNC:15550] [ENST00000471257]","chr1",235343456,235397807,"GO:0003674(molecular_function);GO:0005515(protein binding);GO:0005575(cellular_component);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006325(chromatin organization);GO:0006349(regulation of gene expression by genetic imprinting);GO:0006351(transcription, DNA-dependent);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0007283(spermatogenesis);GO:0008150(biological_process);GO:0010467(gene expression);GO:0034773(histone H4-K20 trimethylation);GO:0036124(histone H3-K9 trimethylation);GO:0040029(regulation of gene expression, epigenetic);GO:0044212(transcription regulatory region DNA binding);GO:0045814(negative regulation of gene expression, epigenetic);GO:0045944(positive regulation of transcription from RNA polymerase II promoter)",null,"mRNA","agilent G3 V3"]
["A_32_P24585",{"v":4.4,"d":"4.40"},2.04,4.28,7.47,7.13,6.88,{"v":0.499068901303538,"d":"0.50"},{"v":-1.00268908752764,"d":"-1.00"},"down",{"v":0.0103229,"d":"0.01"},1,"yes","ACCTTGATTACAACCCACATTTCCTGCTTTGGGGAGCTTCCAAGTAACAGGCCATTTCTT","FALSE","NM_001017995","ref|NM_001017995|ens|ENST00000311601|gb|AB037716|gb|AK095834","SH3PXD2B","SH3 and PX domains 2B","ref|Homo sapiens SH3 and PX domains 2B (SH3PXD2B), mRNA [NM_001017995]","chr5",171760496,171881527,"GO:0001501(skeletal system development);GO:0001654(eye development);GO:0002102(podosome);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006801(superoxide metabolic process);GO:0007507(heart development);GO:0010314(phosphatidylinositol-5-phosphate binding);GO:0022617(extracellular matrix disassembly);GO:0030054(cell junction);GO:0030154(cell differentiation);GO:0032266(phosphatidylinositol-3-phosphate binding);GO:0042169(SH2 domain binding);GO:0042995(cell projection);GO:0045600(positive regulation of fat cell differentiation);GO:0060348(bone development);GO:0060612(adipose tissue development);GO:0070273(phosphatidylinositol-4-phosphate binding);GO:0071800(podosome assembly);GO:0072657(protein localization in membrane);GO:0080025(phosphatidylinositol-3,5-bisphosphate binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3310409",11.05,10.62,11.13,10.02,9.62,9.17,{"v":1.13849357861854,"d":"1.14"},{"v":0.187126154345576,"d":"0.19"},"up",{"v":0.0103995,"d":"0.01"},1,"yes","AAACCCCTGGAACCCCCAACAGAGGACAGATTCTGAACTCCTCAAGGAGGATCAGGGCTG","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_24_P346762",7.32,7.57,7.39,8.04,7.83,7.82,{"v":0.940481215702828,"d":"0.94"},{"v":-0.0885289659001992,"d":"-0.09"},"down",{"v":0.0104446,"d":"0.01"},1,"yes","AAGAGACCCTTCAGGCTTGAATTAAAGCCCTCACCATGCTCACGCCCAAATGGATTATTT","FALSE","NM_025182","ref|NM_025182|ens|ENST00000378557|ens|ENST00000378561|ens|ENST00000603301","FAM214B","family with sequence similarity 214, member B","ref|Homo sapiens family with sequence similarity 214, member B (FAM214B), mRNA [NM_025182]","chr9",35104140,35111420,"GO:0005634(nucleus)",null,"mRNA","agilent G3 V3"]
["A_23_P169838",3.93,2.79,3.74,4.99,5.92,{"v":5.9,"d":"5.90"},{"v":0.622248661511005,"d":"0.62"},{"v":-0.684436872989226,"d":"-0.68"},"down",{"v":0.0105826,"d":"0.01"},1,"yes","TTTCACTCTCCTTAGAATTGGAACTATGCAGTTAAGGCAGATAAAATGTACAGATGTTTC","FALSE","NM_025154","ref|NM_025154|ref|NM_001130965|ref|NM_001171944|ens|ENST00000413171","SUN1","Sad1 and UNC84 domain containing 1","ref|Homo sapiens Sad1 and UNC84 domain containing 1 (SUN1), transcript variant 2, mRNA [NM_025154]","chr7",{"v":872142,"d":"872142.00"},914557,"GO:0002080(acrosomal membrane);GO:0005515(protein binding);GO:0005521(lamin binding);GO:0005635(nuclear envelope);GO:0005639(integral to nuclear inner membrane);GO:0006998(nuclear envelope organization);GO:0031965(nuclear membrane);GO:0034993(SUN-KASH complex);GO:0043231(intracellular membrane-bounded organelle);GO:0090286(cytoskeletal anchoring at nuclear membrane);GO:0090292(nuclear matrix anchoring at nuclear membrane)",null,"mRNA","agilent G3 V3"]
["A_24_P227091",2.04,1.97,2.02,3.13,3.52,{"v":3.6,"d":"3.60"},{"v":0.588292682926829,"d":"0.59"},{"v":-0.765394002492724,"d":"-0.77"},"down",{"v":0.0106986,"d":"0.01"},1,"yes","ACACTCCAAGACCTGTGCCTTTTAGAGAAGCTCACAATGATTTAAGGACTGTTTGAAACT","FALSE","NM_004523","ref|NM_004523|ens|ENST00000260731|gb|U37426|gb|BC050421","KIF11","kinesin family member 11","ref|Homo sapiens kinesin family member 11 (KIF11), mRNA [NM_004523]","chr10",94353040,94415150,"GO:0000922(spindle pole);GO:0003777(microtubule motor activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005819(spindle);GO:0005829(cytosol);GO:0005871(kinesin complex);GO:0005874(microtubule);GO:0005876(spindle microtubule);GO:0007018(microtubule-based movement);GO:0007051(spindle organization);GO:0007052(mitotic spindle organization);GO:0007059(chromosome segregation);GO:0007067(mitosis);GO:0007100(mitotic centrosome separation);GO:0007596(blood coagulation);GO:0008017(microtubule binding);GO:0008152(metabolic process);GO:0008574(plus-end-directed microtubule motor activity);GO:0016020(membrane);GO:0016887(ATPase activity);GO:0019886(antigen processing and presentation of exogenous peptide antigen via MHC class II);GO:0019901(protein kinase binding);GO:0032403(protein complex binding);GO:0046602(regulation of mitotic centrosome separation);GO:0051301(cell division);GO:0090307(spindle assembly involved in mitosis)",null,"mRNA","agilent G3 V3"]
["A_21_P0014126",6.64,6.27,6.88,7.44,7.43,7.35,{"v":0.890639063906391,"d":"0.89"},{"v":-0.16708720434158,"d":"-0.17"},"down",{"v":0.0107593,"d":"0.01"},1,"yes","GAAGAATACTGGCTACAAAACAGCCTGCACCCACACTGAGGTAATAAACACCTACTCTCA","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_24_P82106",7.07,5.95,7.08,8.44,8.29,8.74,{"v":0.789163722025913,"d":"0.79"},{"v":-0.341603458207904,"d":"-0.34"},"down",{"v":0.0108157,"d":"0.01"},1,"yes","GGACTGCCAAGCCACCCTAAGACCTTGGGAGGAAAACTCAGAGAGGGTCTTCGTTGCTCA","FALSE","NM_004995","ref|NM_004995|ens|ENST00000311852|gb|BC064803|gb|BC039581","MMP14","matrix metallopeptidase 14 (membrane-inserted)","ref|Homo sapiens matrix metallopeptidase 14 (membrane-inserted) (MMP14), mRNA [NM_004995]","chr14",23305766,23316970,"GO:0001525(angiogenesis);GO:0001541(ovarian follicle development);GO:0001666(response to hypoxia);GO:0001935(endothelial cell proliferation);GO:0001958(endochondral ossification);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0004222(metalloendopeptidase activity);GO:0005178(integrin binding);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005796(Golgi lumen);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0005925(focal adhesion);GO:0006355(regulation of transcription, DNA-dependent);GO:0006508(proteolysis);GO:0006979(response to oxidative stress);GO:0008270(zinc ion binding);GO:0008584(male gonad development);GO:0009612(response to mechanical stimulus);GO:0010952(positive regulation of peptidase activity);GO:0016504(peptidase activator activity);GO:0022617(extracellular matrix disassembly);GO:0030198(extracellular matrix organization);GO:0030307(positive regulation of cell growth);GO:0030324(lung development);GO:0030335(positive regulation of cell migration);GO:0030574(collagen catabolic process);GO:0031012(extracellular matrix);GO:0031638(zymogen activation);GO:0035987(endodermal cell differentiation);GO:0035988(chondrocyte proliferation);GO:0042470(melanosome);GO:0043615(astrocyte cell migration);GO:0043627(response to estrogen stimulus);GO:0048701(embryonic cranial skeleton morphogenesis);GO:0048754(branching morphogenesis of a tube);GO:0048771(tissue remodeling);GO:0051895(negative regulation of focal adhesion assembly);GO:0097094(craniofacial suture morphogenesis)","04668(TNF signaling pathway);04912(GnRH signaling pathway)","mRNA","agilent G3 V3"]
["A_33_P3242323",2.14,2.19,2.52,3.07,3.89,3.88,{"v":0.631918819188192,"d":"0.63"},{"v":-0.662188863505983,"d":"-0.66"},"down",{"v":0.0109629,"d":"0.01"},1,"yes","AACCTCAGTGAGCTACGTTAAGTGAATGATGTTGGCCTCAGAGACCCTGTCTGTCATTTA","FALSE","ENST00000366674","ens|ENST00000366674","TAF5L","TAF5-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa","ens|TAF5-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa [Source:HGNC Symbol;Acc:HGNC:17304] [ENST00000366674]","chr1",229749904,229761794,"GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0003713(transcription coactivator activity);GO:0004402(histone acetyltransferase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006325(chromatin organization);GO:0006355(regulation of transcription, DNA-dependent);GO:0006366(transcription from RNA polymerase II promoter);GO:0030914(STAGA complex);GO:0033276(transcription factor TFTC complex);GO:0043966(histone H3 acetylation)","03022(Basal transcription factors);05168(Herpes simplex infection)","mRNA","agilent G3 V3"]
["A_33_P3242483",3.69,3.35,3.46,4.13,4.53,4.81,{"v":0.779510022271715,"d":"0.78"},{"v":-0.359360522908818,"d":"-0.36"},"down",{"v":0.0110408,"d":"0.01"},1,"yes","AAGTTCTTGAACTATTTTACCAGCTTTAACTTTGGGGCTCTTAGTTTCTTTTCTCCAGAT","FALSE","NM_001030055","ref|NM_001030055|ref|NM_001173|ens|ENST00000345122|ens|ENST00000396582","ARHGAP5","Rho GTPase activating protein 5","ref|Homo sapiens Rho GTPase activating protein 5 (ARHGAP5), transcript variant 1, mRNA [NM_001030055]","chr14",32546496,32628934,"GO:0002053(positive regulation of mesenchymal cell proliferation);GO:0003924(GTPase activity);GO:0005100(Rho GTPase activator activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007155(cell adhesion);GO:0007264(small GTPase mediated signal transduction);GO:0007266(Rho protein signal transduction);GO:0008152(metabolic process);GO:0008361(regulation of cell size);GO:0016020(membrane);GO:0030335(positive regulation of cell migration);GO:0030879(mammary gland development);GO:0032321(positive regulation of Rho GTPase activity);GO:0042169(SH2 domain binding);GO:0051056(regulation of small GTPase mediated signal transduction)","04510(Focal adhesion);04670(Leukocyte transendothelial migration)","mRNA","agilent G3 V3"]
["A_23_P66110",4.46,3.18,3.93,5.34,5.94,5.87,{"v":0.67463556851312,"d":"0.67"},{"v":-0.567819711952685,"d":"-0.57"},"down",{"v":0.0111409,"d":"0.01"},1,"yes","ACAAGCACCGCTGCGACAAGAAGCGCCACCTGGGCAACGACTTTGTGTCCATTGTCTACA","FALSE","NM_000548","ref|NM_000548|ref|NM_001114382|ref|NM_001077183|ens|ENST00000569930","TSC2","tuberous sclerosis 2","ref|Homo sapiens tuberous sclerosis 2 (TSC2), transcript variant 1, mRNA [NM_000548]","chr16",{"v":2097990,"d":"2097990.00"},2138712,"GO:0001666(response to hypoxia);GO:0001843(neural tube closure);GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005901(caveola);GO:0006469(negative regulation of protein kinase activity);GO:0006606(protein import into nucleus);GO:0006897(endocytosis);GO:0006953(acute-phase response);GO:0007050(cell cycle arrest);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007507(heart development);GO:0008104(protein localization);GO:0008285(negative regulation of cell proliferation);GO:0008286(insulin receptor signaling pathway);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0014065(phosphatidylinositol 3-kinase cascade);GO:0014067(negative regulation of phosphatidylinositol 3-kinase cascade);GO:0016020(membrane);GO:0016192(vesicle-mediated transport);GO:0019902(phosphatase binding);GO:0030030(cell projection organization);GO:0030100(regulation of endocytosis);GO:0030178(negative regulation of Wnt receptor signaling pathway);GO:0030425(dendrite);GO:0030426(growth cone);GO:0032007(negative regulation of TOR signaling cascade);GO:0032320(positive regulation of Ras GTPase activity);GO:0033596(TSC1-TSC2 complex);GO:0038095(Fc-epsilon receptor signaling pathway);GO:0042803(protein homodimerization activity);GO:0043025(neuronal cell body);GO:0043407(negative regulation of MAP kinase activity);GO:0043491(protein kinase B signaling cascade);GO:0045087(innate immune response);GO:0045792(negative regulation of cell size);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046323(glucose import);GO:0046626(regulation of insulin receptor signaling pathway);GO:0046627(negative regulation of insulin receptor signaling pathway);GO:0046982(protein heterodimerization activity);GO:0048009(insulin-like growth factor receptor signaling pathway);GO:0048011(nerve growth factor receptor signaling pathway);GO:0048015(phosphatidylinositol-mediated signaling);GO:0048471(perinuclear region of cytoplasm);GO:0050680(negative regulation of epithelial cell proliferation);GO:0050918(positive chemotaxis);GO:0051260(protein homooligomerization);GO:0051291(protein heterooligomerization);GO:0051726(regulation of cell cycle);GO:0051898(negative regulation of protein kinase B signaling cascade);GO:0071889(14-3-3 protein binding)","04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04150(mTOR signaling pathway);04115(p53 signaling pathway);04910(Insulin signaling pathway);04919(Thyroid hormone signaling pathway);05231(Choline metabolism in cancer)","mRNA","agilent G3 V3"]
["A_21_P0000394",11.71,11.77,{"v":11.8,"d":"11.80"},11.48,11.62,11.52,{"v":1.01906412478336,"d":"1.02"},{"v":0.0272448361908817,"d":"0.03"},"up",{"v":0.0111607,"d":"0.01"},1,"yes","ACTTGCGAATCAAATCTGTCAATCCCCTGAGTGCAATCACTGATGTCTCCATGTCTCTGA","FALSE","NR_003078","ref|NR_003078|ens|ENST00000494697|tc|THC2552075|tc|THC2513815","SNORD110","small nucleolar RNA, C/D box 110","ref|Homo sapiens small nucleolar RNA, C/D box 110 (SNORD110), small nucleolar RNA [NR_003078]","chr20",{"v":2634857,"d":"2634857.00"},2634932,null,null,"mRNA","agilent G3 V3"]
["A_24_P371194",5.89,{"v":5.9,"d":"5.90"},6.18,5.54,5.37,5.56,{"v":1.09107468123862,"d":"1.09"},{"v":0.125749853783587,"d":"0.13"},"up",{"v":0.0113155,"d":"0.01"},1,"yes","ACGGTGAGCAGTGAGAAGGTCCGCTCCACTAATCTCAACTGCTCAGTGATTGCGGACGTG","FALSE","NM_053050","ref|NM_053050|ens|ENST00000467349|ens|ENST00000454193|ens|ENST00000258105","MRPL53","mitochondrial ribosomal protein L53","ref|Homo sapiens mitochondrial ribosomal protein L53 (MRPL53), mRNA [NM_053050]","chr2",74699112,74709669,"GO:0005743(mitochondrial inner membrane);GO:0005840(ribosome);GO:0006996(organelle organization);GO:0032543(mitochondrial translation);GO:0070124(mitochondrial translational initiation);GO:0070125(mitochondrial translational elongation);GO:0070126(mitochondrial translational termination)",null,"mRNA","agilent G3 V3"]
["A_33_P3330716",{"v":2.5,"d":"2.50"},3.78,2.44,4.66,5.08,5.09,{"v":0.587997302764666,"d":"0.59"},{"v":-0.766118557677704,"d":"-0.77"},"down",{"v":0.0113967,"d":"0.01"},1,"yes","CGATTGACTTTTGGTTTGTAATTTCCCTTTAAACAAGAAGAGATGGCTCACATTTTCCAT","FALSE","NM_017759","ref|NM_017759|ens|ENST00000403263|gb|DJ031155|gb|CR933609","INO80D","INO80 complex subunit D","ref|Homo sapiens INO80 complex subunit D (INO80D), mRNA [NM_017759]","chr2",206858448,206950906,"GO:0005634(nucleus);GO:0006281(DNA repair);GO:0006310(DNA recombination);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent)",null,"mRNA","agilent G3 V3"]
["A_24_P3249",1.95,2.23,1.91,3.45,4.84,{"v":5.3,"d":"5.30"},{"v":0.448123620309051,"d":"0.45"},{"v":-1.15803132286106,"d":"-1.16"},"down",{"v":0.0114784999999999,"d":"0.01"},1,"yes","GGACTATTGACAGGACTATTGTACAGTATGACAAGATAAGGCTGAAGATATTCTACTTTA","FALSE","NM_000965","ref|NM_000965|ref|NM_001290276|ref|NM_001290277|ref|NM_001290266","RARB","retinoic acid receptor, beta","ref|Homo sapiens retinoic acid receptor, beta (RARB), transcript variant 1, mRNA [NM_000965]","chr3",25215888,25638107,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001657(ureteric bud development);GO:0002068(glandular epithelial cell development);GO:0003148(outflow tract septum morphogenesis);GO:0003406(retinal pigment epithelium development);GO:0003417(growth plate cartilage development);GO:0003677(DNA binding);GO:0003707(steroid hormone receptor activity);GO:0003708(retinoic acid receptor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0007165(signal transduction);GO:0008144(drug binding);GO:0008270(zinc ion binding);GO:0008284(positive regulation of cell proliferation);GO:0008285(negative regulation of cell proliferation);GO:0010467(gene expression);GO:0021756(striatum development);GO:0031641(regulation of myelination);GO:0032331(negative regulation of chondrocyte differentiation);GO:0032403(protein complex binding);GO:0035116(embryonic hindlimb morphogenesis);GO:0035264(multicellular organism growth);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043401(steroid hormone mediated signaling pathway);GO:0045666(positive regulation of neuron differentiation);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046965(retinoid X receptor binding);GO:0048048(embryonic eye morphogenesis);GO:0048384(retinoic acid receptor signaling pathway);GO:0048566(embryonic digestive tract development);GO:0055012(ventricular cardiac muscle cell differentiation);GO:0055085(transmembrane transport)","05200(Pathways in cancer);05222(Small cell lung cancer);05223(Non-small cell lung cancer)","mRNA","agilent G3 V3"]
["A_23_P89812",4.29,3.72,4.38,{"v":6,"d":"6.00"},6.07,6.06,{"v":0.683397683397683,"d":"0.68"},{"v":-0.549202737603556,"d":"-0.55"},"down",{"v":0.0115849,"d":"0.01"},1,"yes","AGACTCTGTCTCTACAAAAAGTTTAAGAAATGAGCCAGACATGGTGGTGTATGCCTGTAG","FALSE","NM_018235","ref|NM_018235|ref|NM_001168499|ens|ENST00000584581|ens|ENST00000324301","CNDP2","CNDP dipeptidase 2 (metallopeptidase M20 family)","ref|Homo sapiens CNDP dipeptidase 2 (metallopeptidase M20 family) (CNDP2), transcript variant 1, mRNA [NM_018235]","chr18",72178112,72188339,"GO:0000096(sulfur amino acid metabolic process);GO:0004180(carboxypeptidase activity);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0006750(glutathione biosynthetic process);GO:0006805(xenobiotic metabolic process);GO:0008237(metallopeptidase activity);GO:0016805(dipeptidase activity);GO:0034641(cellular nitrogen compound metabolic process);GO:0034701(tripeptidase activity);GO:0044281(small molecule metabolic process);GO:0046872(metal ion binding);GO:0070062(extracellular vesicular exosome)","00330(Arginine and proline metabolism);00340(Histidine metabolism);00410(beta-Alanine metabolism)","mRNA","agilent G3 V3"]
["A_23_P208847",4.14,4.49,4.45,5.25,6.27,5.72,{"v":0.758700696055684,"d":"0.76"},{"v":-0.398397233591016,"d":"-0.40"},"down",{"v":0.0116445000000001,"d":"0.01"},1,"yes","TGTGGATTCTTTTTCTCTCGTGGTCTCACTTTGTTACTTGTTTCTGTCCCCGGGAGCCTC","FALSE","NM_016539","ref|NM_016539|ref|NM_001193285|ens|ENST00000600938|ens|ENST00000337491","SIRT6","sirtuin 6","ref|Homo sapiens sirtuin 6 (SIRT6), transcript variant 1, mRNA [NM_016539]","chr19",{"v":4174107,"d":"4174107.00"},4182562,"GO:0003682(chromatin binding);GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0003956(NAD(P)+-protein-arginine ADP-ribosyltransferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005724(nuclear telomeric heterochromatin);GO:0005730(nucleolus);GO:0006471(protein ADP-ribosylation);GO:0008270(zinc ion binding);GO:0010569(regulation of double-strand break repair via homologous recombination);GO:0016575(histone deacetylation);GO:0017136(NAD-dependent histone deacetylase activity);GO:0043231(intracellular membrane-bounded organelle);GO:0046969(NAD-dependent histone deacetylase activity (H3-K9 specific));GO:0070403(NAD+ binding);GO:0070932(histone H3 deacetylation)","05230(Central carbon metabolism in cancer)","mRNA","agilent G3 V3"]
["A_24_P158065",4.93,5.57,4.24,6.67,6.73,6.49,{"v":0.741075917546506,"d":"0.74"},{"v":-0.432306751738674,"d":"-0.43"},"down",{"v":0.0117558,"d":"0.01"},1,"yes","TTTGTATGAATTTTGTTTAGGCTGCAATGTTTAGCTTTTGTTAACTCCTCACTCTTGCTG","FALSE","NM_001040057","ref|NM_001040057|ref|NM_001288584|ref|NM_152789|ref|NR_034169","FAM133B","family with sequence similarity 133, member B","ref|Homo sapiens family with sequence similarity 133, member B (FAM133B), transcript variant 2, mRNA [NM_001040057]","chr7",92190528,92219704,null,null,"mRNA","agilent G3 V3"]
["A_22_P00007978",6.04,{"v":4.9,"d":"4.90"},5.55,6.87,7.32,7.72,{"v":0.752624372432679,"d":"0.75"},{"v":-0.409998085552755,"d":"-0.41"},"down",{"v":0.0117767,"d":"0.01"},1,"yes","AACTTGTGTCTCTTTTTCCCACGCTGGCTGGACTTGCAGGACTGCAGGTTCCACCTCGCT","FALSE","NM_000202","ref|NM_000202|ref|NM_001166550|ens|ENST00000441880|ens|ENST00000340855","IDS","iduronate 2-sulfatase","ref|Homo sapiens iduronate 2-sulfatase (IDS), transcript variant 1, mRNA [NM_000202]","chrX",148558528,148586884,"GO:0004423(iduronate-2-sulfatase activity);GO:0005975(carbohydrate metabolic process);GO:0006027(glycosaminoglycan catabolic process);GO:0009405(pathogenesis);GO:0030203(glycosaminoglycan metabolic process);GO:0030204(chondroitin sulfate metabolic process);GO:0030207(chondroitin sulfate catabolic process);GO:0043202(lysosomal lumen);GO:0044281(small molecule metabolic process);GO:0046872(metal ion binding)","00531(Glycosaminoglycan degradation);04142(Lysosome)","mRNA","agilent G3 V3"]
["A_33_P3370787",{"v":9.3,"d":"9.30"},9.24,{"v":9.3,"d":"9.30"},9.53,9.76,9.86,{"v":0.955060034305317,"d":"0.96"},{"v":-0.0663366722391304,"d":"-0.07"},"down",{"v":0.0118828,"d":"0.01"},1,"yes","AGATTCAGTCTGTGGAGGTTTGACATTCACCTGCCTCGGCTCACCTCTTCCTCCAAGCCC","FALSE","NM_004442","ref|NM_004442|ref|NM_017449|ens|ENST00000374630|ens|ENST00000374632","EPHB2","EPH receptor B2","ref|Homo sapiens EPH receptor B2 (EPHB2), transcript variant 2, mRNA [NM_004442]","chr1",23101672,23240245,"GO:0001525(angiogenesis);GO:0001655(urogenital system development);GO:0004713(protein tyrosine kinase activity);GO:0005005(transmembrane-ephrin receptor activity);GO:0005102(receptor binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005576(extracellular region);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0007399(nervous system development);GO:0007411(axon guidance);GO:0007413(axonal fasciculation);GO:0007612(learning);GO:0008046(axon guidance receptor activity);GO:0016310(phosphorylation);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0021631(optic nerve morphogenesis);GO:0021952(central nervous system projection neuron axonogenesis);GO:0022038(corpus callosum development);GO:0030424(axon);GO:0030425(dendrite);GO:0031290(retinal ganglion cell axon guidance);GO:0042472(inner ear morphogenesis);GO:0043025(neuronal cell body);GO:0048013(ephrin receptor signaling pathway);GO:0048170(positive regulation of long-term neuronal synaptic plasticity);GO:0048593(camera-type eye morphogenesis);GO:0050771(negative regulation of axonogenesis);GO:0050878(regulation of body fluid levels);GO:0051965(positive regulation of synapse assembly);GO:0060021(palate development);GO:0060996(dendritic spine development);GO:0060997(dendritic spine morphogenesis);GO:0071679(commissural neuron axon guidance)","04360(Axon guidance)","mRNA","agilent G3 V3"]
["A_21_P0013916",6.39,5.51,6.23,{"v":4.2,"d":"4.20"},4.94,4.44,{"v":1.33505154639175,"d":"1.34"},{"v":0.416895445499426,"d":"0.42"},"up",{"v":0.0120197999999999,"d":"0.01"},1,"yes","CAAATATTGGACCTTTATAATAATCTGAATATTGCCAAGGGATTGTACATGGGGATCCAT","FALSE","BX648696","gb|BX648696|tc|THC2664678","ANKRD62","ankyrin repeat domain 62","gb|Homo sapiens mRNA; cDNA DKFZp686E2239 (from clone DKFZp686E2239). [BX648696]","chr18",12102704,12129763,null,null,"mRNA","agilent G3 V3"]
["A_33_P3271455",4.82,5.11,3.77,{"v":6.8,"d":"6.80"},6.18,6.54,{"v":0.701844262295082,"d":"0.70"},{"v":-0.510777159714997,"d":"-0.51"},"down",{"v":0.0120612999999999,"d":"0.01"},1,"yes","GACCATTGTATTCAGTTCATTACCAAAGAAATGTTTGCACTTTGTAATGATGCCTTTCAG","FALSE","NM_012293","ref|NM_012293|ens|ENST00000252804|ref|XM_005264707|ref|XM_006711896","PXDN","peroxidasin","ref|Homo sapiens peroxidasin (PXDN), mRNA [NM_012293]","chr2",{"v":1635659,"d":"1635659.00"},1748278,"GO:0001960(negative regulation of cytokine-mediated signaling pathway);GO:0004601(peroxidase activity);GO:0005152(interleukin-1 receptor antagonist activity);GO:0005201(extracellular matrix structural constituent);GO:0005578(proteinaceous extracellular matrix);GO:0005615(extracellular space);GO:0005783(endoplasmic reticulum);GO:0006955(immune response);GO:0006979(response to oxidative stress);GO:0020037(heme binding);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix);GO:0042744(hydrogen peroxide catabolic process);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3221177",10.88,10.73,11.04,9.12,9.78,10.03,{"v":1.12858624265468,"d":"1.13"},{"v":0.174516668504194,"d":"0.17"},"up",{"v":0.0122637,"d":"0.01"},1,"yes","TTTTTCCACAGAGTTTTGCTCTGTCTCCCAGGCAGGAGTGCAGTGGCGGGATCTTGGCTC","FALSE","NM_153251","ref|NM_153251|ref|NM_001286638|ref|NR_104486|ref|NR_104487","ZDHHC20","zinc finger, DHHC-type containing 20","ref|Homo sapiens zinc finger, DHHC-type containing 20 (ZDHHC20), transcript variant 1, mRNA [NM_153251]","chr13",21946708,22033508,"GO:0005886(plasma membrane);GO:0008270(zinc ion binding);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0016409(palmitoyltransferase activity);GO:0018345(protein palmitoylation);GO:0019706(protein-cysteine S-palmitoleyltransferase activity)",null,"mRNA","agilent G3 V3"]
["A_23_P311150",3.31,4.12,3.13,5.05,4.77,5.44,{"v":0.692005242463958,"d":"0.69"},{"v":-0.531145127476077,"d":"-0.53"},"down",{"v":0.0122774,"d":"0.01"},1,"yes","TTAGTTTAATGATTGTAATGGGTGCTGCATTTGCACATTGCATTAAGTTATGATGAGACG","FALSE","NM_138288","ref|NM_138288|ens|ENST00000298130|gb|AK001993|gb|AL080066","SPTSSA","serine palmitoyltransferase, small subunit A","ref|Homo sapiens serine palmitoyltransferase, small subunit A (SPTSSA), mRNA [NM_138288]","chr14",34901996,34931562,"GO:0004758(serine C-palmitoyltransferase activity);GO:0005515(protein binding);GO:0005789(endoplasmic reticulum membrane);GO:0016021(integral to membrane);GO:0017059(serine C-palmitoyltransferase complex);GO:0030148(sphingolipid biosynthetic process)",null,"mRNA","agilent G3 V3"]
["A_24_P23258",2.88,3.06,2.89,4.18,3.58,4.43,{"v":0.724364232977851,"d":"0.72"},{"v":-0.465212782971746,"d":"-0.47"},"down",{"v":0.0123833,"d":"0.01"},1,"yes","TCTGGGCAGATGTTTAATTTCTGTGACTAATCACTGAACTAGACGAATGTTAAATTTTTT","FALSE","NM_015124","ref|NM_015124|ens|ENST00000406902|ens|ENST00000361034|ref|XM_005261398","GRAMD4","GRAM domain containing 4","ref|Homo sapiens GRAM domain containing 4 (GRAMD4), mRNA [NM_015124]","chr22",47022656,47075688,"GO:0006915(apoptotic process);GO:0016021(integral to membrane);GO:0031966(mitochondrial membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P218608",3.79,{"v":2.9,"d":"2.90"},{"v":3.6,"d":"3.60"},5.27,{"v":4.8,"d":"4.80"},4.59,{"v":0.701909959072306,"d":"0.70"},{"v":-0.510642121239843,"d":"-0.51"},"down",{"v":0.0124387,"d":"0.01"},1,"yes","GGACACTGATGGACTTAAGTATGGAAGGAAGAAAAATAGGTGTATAAAATGTTTTCCATG","FALSE","NM_015904","ref|NM_015904|ens|ENST00000470023|ens|ENST00000617677|ref|XM_005264075","EIF5B","eukaryotic translation initiation factor 5B","ref|Homo sapiens eukaryotic translation initiation factor 5B (EIF5B), mRNA [NM_015904]","chr2",100013512,100016237,"GO:0003743(translation initiation factor activity);GO:0003924(GTPase activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005829(cytosol);GO:0006412(translation);GO:0006413(translational initiation);GO:0006446(regulation of translational initiation);GO:0010467(gene expression);GO:0044267(cellular protein metabolic process)","03013(RNA transport)","mRNA","agilent G3 V3"]
["A_33_P3420224",7.89,7.47,7.47,6.74,6.64,6.02,{"v":1.17680412371134,"d":"1.18"},{"v":0.234874207150212,"d":"0.23"},"up",{"v":0.0125240000000001,"d":"0.01"},1,"yes","CACTTGGAGGGTGAGACTGCAGTGGGGGTTGTTTTTATTAAAAGCATCATGGACACAGCA","FALSE","NM_001033113","ref|NM_001033113|ref|NM_198585|ens|ENST00000461823|ens|ENST00000371506","ENTPD8","ectonucleoside triphosphate diphosphohydrolase 8","ref|Homo sapiens ectonucleoside triphosphate diphosphohydrolase 8 (ENTPD8), transcript variant 1, mRNA [NM_001033113]","chr9",140328816,140335901,"GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0009124(nucleoside monophosphate biosynthetic process);GO:0009133(nucleoside diphosphate biosynthetic process);GO:0016021(integral to membrane);GO:0017110(nucleoside-diphosphatase activity);GO:0017111(nucleoside-triphosphatase activity);GO:0046872(metal ion binding)","00230(Purine metabolism);00240(Pyrimidine metabolism);05169(Epstein-Barr virus infection)","mRNA","agilent G3 V3"]
["A_33_P3213392",9.43,9.59,9.86,9.13,9.01,9.06,{"v":1.06176470588235,"d":"1.06"},{"v":0.0864640907494689,"d":"0.09"},"up",{"v":0.0126397,"d":"0.01"},1,"yes","AAATTTGAAACGCCTCCCGTGCCTAGAGCCTCTGGTGGATTCTGGGGAAGGAAGAGGACG","FALSE","ENST00000375713","ens|ENST00000375713|tc|THC2752485",null,null,"tc|Q5T400_HUMAN (Q5T400) OTTHUMP00000018721, partial (95%) [THC2752485]","chr13",112240640,112324955,null,null,"mRNA","agilent G3 V3"]
["A_23_P8095",4.96,3.46,5.22,{"v":6.8,"d":"6.80"},6.89,7.12,{"v":0.655454108601634,"d":"0.66"},{"v":-0.609433320711162,"d":"-0.61"},"down",{"v":0.0127174,"d":"0.01"},1,"yes","GGAGGAGGAGTGAAGTCTGTGCATAGATGGGAGAGCCTTCTGCTCAGAGGCTCACTCAGT","FALSE","NM_006913","ref|NM_006913|ref|NR_003129|ens|ENST00000375094|ens|ENST00000413786","RNF5","ring finger protein 5, E3 ubiquitin protein ligase","ref|Homo sapiens ring finger protein 5, E3 ubiquitin protein ligase (RNF5), mRNA [NM_006913]","chr6",32146214,32147550,"GO:0004842(ubiquitin-protein ligase activity);GO:0005515(protein binding);GO:0005789(endoplasmic reticulum membrane);GO:0008270(zinc ion binding);GO:0009617(response to bacterium);GO:0010507(negative regulation of autophagy);GO:0016021(integral to membrane);GO:0016874(ligase activity);GO:0031648(protein destabilization);GO:0031966(mitochondrial membrane);GO:0044257(cellular protein catabolic process);GO:0070534(protein K63-linked ubiquitination);GO:0070936(protein K48-linked ubiquitination);GO:0071712(ER-associated misfolded protein catabolic process);GO:2000785(regulation of autophagic vacuole assembly)","04141(Protein processing in endoplasmic reticulum)","mRNA","agilent G3 V3"]
["A_23_P397055",4.72,5.04,5.34,6.35,5.78,{"v":6.1,"d":"6.10"},{"v":0.828304991771805,"d":"0.83"},{"v":-0.271766011826693,"d":"-0.27"},"down",{"v":0.012783,"d":"0.01"},1,"yes","CCTTTGCAGCCAATGTCCTGGAGCCACGAGAACATGCATTGCTCACCCTGTTGCTGGTCT","FALSE","NM_019015","ref|NM_019015|ref|NM_001284295|ens|ENST00000035307|gb|AB384599","CHPF2","chondroitin polymerizing factor 2","ref|Homo sapiens chondroitin polymerizing factor 2 (CHPF2), transcript variant 1, mRNA [NM_019015]","chr7",150932544,150934679,"GO:0000139(Golgi membrane);GO:0005975(carbohydrate metabolic process);GO:0008376(acetylgalactosaminyltransferase activity);GO:0009405(pathogenesis);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0030203(glycosaminoglycan metabolic process);GO:0030204(chondroitin sulfate metabolic process);GO:0030206(chondroitin sulfate biosynthetic process);GO:0032580(Golgi cisterna membrane);GO:0044281(small molecule metabolic process);GO:0050510(N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity)","00532(Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate)","mRNA","agilent G3 V3"]
["A_24_P124973",{"v":1.9,"d":"1.90"},2.03,3.32,4.17,4.54,{"v":4.6,"d":"4.60"},{"v":0.544703230653644,"d":"0.54"},{"v":-0.876457671009595,"d":"-0.88"},"down",{"v":0.0129201,"d":"0.01"},1,"yes","GGAGATCCAAAGAAACTCATTACTGAGGACTTTGTGCGACAGCGTTACCTGGAATACCGG","FALSE","NM_138704","ref|NM_138704|ens|ENST00000332303|gb|AK056957|gb|BC035458","NDNL2","necdin-like 2","ref|Homo sapiens necdin-like 2 (NDNL2), mRNA [NM_138704]","chr15",29560352,29562033,"GO:0000781(chromosome, telomeric region);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006281(DNA repair);GO:0006310(DNA recombination);GO:0030915(Smc5-Smc6 complex);GO:0031398(positive regulation of protein ubiquitination);GO:0040008(regulation of growth)",null,"mRNA","agilent G3 V3"]
["A_33_P3256168",3.52,3.11,3.17,4.73,4.07,5.06,{"v":0.707070707070707,"d":"0.71"},{"v":-0.500073603134643,"d":"-0.50"},"down",{"v":0.0130801,"d":"0.01"},1,"yes","GCAGGACTTCCGGCAGCTACTCATGGGGATGGCTGACAAGAACATCCAGTATTATGAGAA","FALSE","NM_001012994","ref|NM_001012994|ens|ENST00000604751|ens|ENST00000374232|ref|XM_005251986","SNX30","sorting nexin family member 30","ref|Homo sapiens sorting nexin family member 30 (SNX30), mRNA [NM_001012994]","chr9",115618992,115643951,"GO:0005515(protein binding);GO:0005768(endosome);GO:0006897(endocytosis);GO:0015031(protein transport);GO:0016050(vesicle organization);GO:0019898(extrinsic to membrane);GO:0035091(phosphatidylinositol binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3395237",3.22,3.39,2.35,{"v":4.2,"d":"4.20"},4.63,{"v":4.6,"d":"4.60"},{"v":0.667163067758749,"d":"0.67"},{"v":-0.583888667369838,"d":"-0.58"},"down",{"v":0.013163,"d":"0.01"},1,"yes","AGAAAATACACCTGGAGGGCTGATGAGTCCCAGCAGATCTTCATCTGTAGCCAGGAAGAG","FALSE","ENST00000513279","ens|ENST00000513279",null,null,"ens|eukaryotic translation initiation factor 3, subunit K pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:44016] [ENST00000513279]","chr5",102201432,102366809,null,null,"mRNA","agilent G3 V3"]
["A_23_P370142",3.96,2.56,1.99,5.08,5.54,5.82,{"v":0.517639902676399,"d":"0.52"},{"v":-0.949979261995721,"d":"-0.95"},"down",{"v":0.0132838,"d":"0.01"},1,"yes","GACATCCTAGTTTGCGTCAGTGACAGAACTTACTGCTTAGTCTTTGTACTTTTTAAAAAA","FALSE","NM_002572","ref|NM_002572|ref|NR_110282|ens|ENST00000527958|gb|BC010009","PAFAH1B2","platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (30kDa)","ref|Homo sapiens platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (30kDa) (PAFAH1B2), transcript variant 1, mRNA [NM_002572]","chr11",117014984,117041761,"GO:0003847(1-alkyl-2-acetylglycerophosphocholine esterase activity);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006629(lipid metabolic process);GO:0007283(spermatogenesis);GO:0007420(brain development);GO:0016042(lipid catabolic process);GO:0016239(positive regulation of macroautophagy);GO:0042803(protein homodimerization activity);GO:0046982(protein heterodimerization activity);GO:0047179(platelet-activating factor acetyltransferase activity);GO:0070062(extracellular vesicular exosome)","00565(Ether lipid metabolism)","mRNA","agilent G3 V3"]
["A_33_P3268181",4.47,2.01,1.99,6.02,6.63,6.54,{"v":0.44137571651902,"d":"0.44"},{"v":-1.17992083686318,"d":"-1.18"},"down",{"v":0.013382,"d":"0.01"},1,"yes","TAAGAGGTGCTACGAGAAGTTCCCGCTGGAGCTGAAGAAGCGGCTGAAGAAGCTGTCGGA","FALSE","NM_001161404","ref|NM_001161404|ref|NM_017980|ref|NM_001136037|ref|NM_001161403","LIMS2","LIM and senescent cell antigen-like domains 2","ref|Homo sapiens LIM and senescent cell antigen-like domains 2 (LIMS2), transcript variant 5, mRNA [NM_001161404]","chr2",128396768,128408113,"GO:0005634(nucleus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0008270(zinc ion binding);GO:0016337(cell-cell adhesion);GO:0034329(cell junction assembly);GO:0043066(negative regulation of apoptotic process);GO:0045216(cell-cell junction organization);GO:2000178(negative regulation of neural precursor cell proliferation);GO:2000346(negative regulation of hepatocyte proliferation);GO:2001046(positive regulation of integrin-mediated signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_33_P3278801",4.29,4.34,3.13,{"v":5.5,"d":"5.50"},5.59,5.83,{"v":0.695035460992908,"d":"0.70"},{"v":-0.524841508283586,"d":"-0.52"},"down",{"v":0.0134557,"d":"0.01"},1,"yes","TCAGAGTTTGGTTCCTGTTCCTGTAGCTTCCATGACAGTGATTCTCTTTACCCAACTCAC","FALSE","AK128758","gb|AK128758|tc|THC2632246","LRCH3","leucine-rich repeats and calponin homology (CH) domain containing 3","gb|Homo sapiens cDNA FLJ44976 fis, clone BRAWH3001833. [AK128758]","chr3",197598288,197603211,"GO:0005576(extracellular region);GO:0005737(cytoplasm)",null,"mRNA","agilent G3 V3"]
["A_33_P3242080",3.86,3.21,4.52,5.94,5.67,{"v":5.3,"d":"5.30"},{"v":0.685393258426966,"d":"0.69"},{"v":-0.544996093403512,"d":"-0.54"},"down",{"v":0.0135829,"d":"0.01"},1,"yes","CCCGACTCAATAAATAAATAAGGATGGATAAATTGTAGCGTATGCACCATTCATTATGCT","FALSE","NM_018332","ref|NM_018332|ens|ENST00000566574|ens|ENST00000569771|ens|ENST00000302243","DDX19A","DEAD (Asp-Glu-Ala-Asp) box polypeptide 19A","ref|Homo sapiens DEAD (Asp-Glu-Ala-Asp) box polypeptide 19A (DDX19A), mRNA [NM_018332]","chr16",70398448,70406973,"GO:0003674(molecular_function);GO:0003723(RNA binding);GO:0004386(helicase activity);GO:0005524(ATP binding);GO:0005643(nuclear pore);GO:0005737(cytoplasm);GO:0008150(biological_process);GO:0008152(metabolic process);GO:0010043(response to zinc ion);GO:0015031(protein transport);GO:0016020(membrane);GO:0031965(nuclear membrane);GO:0043065(positive regulation of apoptotic process);GO:0051028(mRNA transport)",null,"mRNA","agilent G3 V3"]
["A_23_P2998",4.62,5.86,4.17,7.15,6.82,7.24,{"v":0.690711928335691,"d":"0.69"},{"v":-0.533843956220945,"d":"-0.53"},"down",{"v":0.0137428000000001,"d":"0.01"},1,"yes","TAGGTGCTGAGACAGGTGTGCAAAGTTCTGACCTTCAGTGGATGAGAAATGTCATCAGAA","FALSE","NM_005015","ref|NM_005015|ens|ENST00000358043|ens|ENST00000495424|ens|ENST00000481218","OXA1L","oxidase (cytochrome c) assembly 1-like","ref|Homo sapiens oxidase (cytochrome c) assembly 1-like (OXA1L), mRNA [NM_005015]","chr14",23236492,23240970,"GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005746(mitochondrial respiratory chain);GO:0006461(protein complex assembly);GO:0009060(aerobic respiration);GO:0031966(mitochondrial membrane);GO:0032592(integral to mitochondrial membrane);GO:0032780(negative regulation of ATPase activity);GO:0032981(mitochondrial respiratory chain complex I assembly);GO:0033615(mitochondrial proton-transporting ATP synthase complex assembly);GO:0042803(protein homodimerization activity);GO:0043234(protein complex);GO:0051205(protein insertion into membrane);GO:0051262(protein tetramerization);GO:0051354(negative regulation of oxidoreductase activity);GO:0055114(oxidation-reduction process);GO:0097031(mitochondrial respiratory chain complex I biogenesis);GO:0097177(mitochondrial ribosome binding)","03060(Protein export)","mRNA","agilent G3 V3"]
["A_24_P358305",{"v":4.2,"d":"4.20"},2.93,2.85,5.58,5.18,5.06,{"v":0.630847029077118,"d":"0.63"},{"v":-0.664637879135531,"d":"-0.66"},"down",{"v":0.0138171,"d":"0.01"},1,"yes","GGAGGTGTCCGAACTAAAATGTGGTGACGTGAAAGAACTCAAGAATGTTACTAACAATCT","FALSE","ENST00000520239","ens|ENST00000520239|linc|TCONS_l2_00027831|linc|TCONS_l2_00027830",{"$nulls":3},"chr8",70041832,70042580,null,null,"mRNA","agilent G3 V3"]
["A_33_P3531204",6.76,5.99,6.47,7.25,7.49,7.44,{"v":0.866546438232642,"d":"0.87"},{"v":-0.20665102938796,"d":"-0.21"},"down",{"v":0.0139373,"d":"0.01"},1,"yes","TGAAAGCACTTTTTGGCAAGACTAGAGTCTCACCGATTTTCCCTTTCTCTCCTCGATCTC","FALSE","NM_001135816","ref|NM_001135816|ref|NM_001014442|linc|lnc-TNFRSF19-6:2|linc|lnc-TNFRSF19-6:1","C1QTNF9B-AS1","C1QTNF9B antisense RNA 1","ref|Homo sapiens C1QTNF9B antisense RNA 1 (C1QTNF9B-AS1), transcript variant 2, mRNA [NM_001135816]","chr13",24895264,24895566,"GO:0005737(cytoplasm)",null,"mRNA","agilent G3 V3"]
["A_33_P3400224",10.57,10.16,10.79,8.25,9.48,8.77,{"v":1.18943396226415,"d":"1.19"},{"v":0.250275175118452,"d":"0.25"},"up",{"v":0.0140551999999999,"d":"0.01"},1,"yes","AAGCTTTTCTACAAAGTCACATTCAACGCCGCCACACTGAAGAAAATTCTCATTTTGGTG","FALSE","NM_014934","ref|NM_014934|ref|NM_198968|ens|ENST00000466569|ens|ENST00000376829","DZIP1","DAZ interacting zinc finger protein 1","ref|Homo sapiens DAZ interacting zinc finger protein 1 (DZIP1), transcript variant 1, mRNA [NM_014934]","chr13",96251608,96294283,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005814(centriole);GO:0007275(multicellular organismal development);GO:0007281(germ cell development);GO:0007283(spermatogenesis);GO:0036064(cilium basal body);GO:0042384(cilium assembly);GO:0043231(intracellular membrane-bounded organelle);GO:0043234(protein complex);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P29495",6.59,7.53,6.39,8.74,8.67,8.12,{"v":0.803368585977282,"d":"0.80"},{"v":-0.315866045927267,"d":"-0.32"},"down",{"v":0.0141631999999999,"d":"0.01"},1,"yes","TGATCAAAAACTATTTGGGATATGTATGGGTAGGGTAAATCAGTAAGAGGTGTTATTTGG","FALSE","NM_001904","ref|NM_001904|ref|NM_001098209|ref|NM_001098210|ens|ENST00000396185","CTNNB1","catenin (cadherin-associated protein), beta 1, 88kDa","ref|Homo sapiens catenin (cadherin-associated protein), beta 1, 88kDa (CTNNB1), transcript variant 1, mRNA [NM_001904]","chr3",41240996,41281934,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000578(embryonic axis specification);GO:0000922(spindle pole);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0001569(patterning of blood vessels);GO:0001658(branching involved in ureteric bud morphogenesis);GO:0001701(in utero embryonic development);GO:0001702(gastrulation with mouth forming second);GO:0001708(cell fate specification);GO:0001711(endodermal cell fate commitment);GO:0001764(neuron migration);GO:0001837(epithelial to mesenchymal transition);GO:0001840(neural plate development);GO:0001889(liver development);GO:0002052(positive regulation of neuroblast proliferation);GO:0002053(positive regulation of mesenchymal cell proliferation);GO:0002089(lens morphogenesis in camera-type eye);GO:0003266(regulation of secondary heart field cardioblast proliferation);GO:0003337(mesenchymal to epithelial transition involved in metanephros morphogenesis);GO:0003690(double-stranded DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0003713(transcription coactivator activity);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005719(nuclear euchromatin);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0005912(adherens junction);GO:0005913(cell-cell adherens junction);GO:0005916(fascia adherens);GO:0005923(tight junction);GO:0005925(focal adhesion);GO:0005938(cell cortex);GO:0006351(transcription, DNA-dependent);GO:0006915(apoptotic process);GO:0006921(cellular component disassembly involved in apoptotic process);GO:0007155(cell adhesion);GO:0007160(cell-matrix adhesion);GO:0007398(ectoderm development);GO:0007403(glial cell fate determination);GO:0007494(midgut development);GO:0008022(protein C-terminus binding);GO:0008134(transcription factor binding);GO:0008285(negative regulation of cell proliferation);GO:0009948(anterior/posterior axis specification);GO:0009950(dorsal/ventral axis specification);GO:0009954(proximal/distal pattern formation);GO:0010718(positive regulation of epithelial to mesenchymal transition);GO:0010909(positive regulation of heparan sulfate proteoglycan biosynthetic process);GO:0014010(Schwann cell proliferation);GO:0016020(membrane);GO:0016055(Wnt receptor signaling pathway);GO:0016323(basolateral plasma membrane);GO:0016328(lateral plasma membrane);GO:0016337(cell-cell adhesion);GO:0016342(catenin complex);GO:0019827(stem cell maintenance);GO:0019899(enzyme binding);GO:0019900(kinase binding);GO:0019903(protein phosphatase binding);GO:0021819(layer formation in cerebral cortex);GO:0022009(central nervous system vasculogenesis);GO:0030018(Z disc);GO:0030027(lamellipodium);GO:0030054(cell junction);GO:0030316(osteoclast differentiation);GO:0030331(estrogen receptor binding);GO:0030521(androgen receptor signaling pathway);GO:0030539(male genitalia development);GO:0030877(beta-catenin destruction complex)","04015(Rap1 signaling pathway);04310(Wnt signaling pathway);04390(Hippo signaling pathway);04510(Focal adhesion);04520(Adherens junction);04530(Tight junction);04550(Signaling pathways regulating pluripotency of stem cells);04670(Leukocyte transendothelial migration);04919(Thyroid hormone signaling pathway);04916(Melanogenesis);05200(Pathways in cancer);05205(Proteoglycans in cancer);05210(Colorectal cancer);05216(Thyroid cancer);05217(Basal cell carcinoma);05215(Prostate cancer);05213(Endometrial cancer);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05130(Pathogenic Escherichia coli infection);05100(Bacterial invasion of epithelial cells);05166(HTLV-I infection)","mRNA","agilent G3 V3"]
["A_23_P412603",7.92,7.58,7.32,5.43,6.12,6.58,{"v":1.25868725868726,"d":"1.26"},{"v":0.331919866544524,"d":"0.33"},"up",{"v":0.0142557,"d":"0.01"},1,"yes","CTTCCTGATCGCCTTGGTCTGGATGGTGTCCATTCTCATTGCCATCCCATCGGCTTACTT","FALSE","NM_144773","ref|NM_144773|ens|ENST00000217270|gb|AB084081|gb|AF506288","PROKR2","prokineticin receptor 2","ref|Homo sapiens prokineticin receptor 2 (PROKR2), mRNA [NM_144773]","chr20",{"v":5282317,"d":"5282317.00"},5297378,"GO:0004983(neuropeptide Y receptor activity);GO:0005886(plasma membrane);GO:0007218(neuropeptide signaling pathway);GO:0007623(circadian rhythm);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P214876",{"v":7.5,"d":"7.50"},7.89,7.44,7.06,7.02,6.91,{"v":1.08766079085279,"d":"1.09"},{"v":0.121228692932547,"d":"0.12"},"up",{"v":0.014338,"d":"0.01"},1,"yes","TTGCCCTTCTCCGGTTGTGTGTACAGTATGTGTGGAATAAAAAAGGGAAACTGTTTTCAC","FALSE","NM_004973","ref|NM_004973|ref|NM_001267040|ens|ENST00000341776|ens|ENST00000397311","JARID2","jumonji, AT rich interactive domain 2","ref|Homo sapiens jumonji, AT rich interactive domain 2 (JARID2), transcript variant 1, mRNA [NM_004973]","chr6",15246527,15522252,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0001889(liver development);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-dependent);GO:0007417(central nervous system development);GO:0008285(negative regulation of cell proliferation);GO:0010467(gene expression);GO:0016568(chromatin modification);GO:0031061(negative regulation of histone methylation);GO:0032452(histone demethylase activity);GO:0035097(histone methyltransferase complex);GO:0035098(ESC/E(Z) complex);GO:0040029(regulation of gene expression, epigenetic);GO:0045814(negative regulation of gene expression, epigenetic);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0048536(spleen development);GO:0048538(thymus development);GO:0048863(stem cell differentiation);GO:0051574(positive regulation of histone H3-K9 methylation)","04550(Signaling pathways regulating pluripotency of stem cells)","mRNA","agilent G3 V3"]
["A_33_P3225522",8.78,8.77,8.68,8.25,{"v":8.5,"d":"8.50"},8.16,{"v":1.05299076676034,"d":"1.05"},{"v":0.0744927860241475,"d":"0.07"},"up",{"v":0.0145026,"d":"0.01"},1,"yes","TTCTGAGGATGCCCTACCCTGTAACAAAGTCGTTTCTAATAAATTTGCTTCTTTCACCAT","FALSE","NM_001032731","ref|NM_001032731|ens|ENST00000449768|gb|BC053870|gb|BC023637","OAS2","2'-5'-oligoadenylate synthetase 2, 69/71kDa","ref|Homo sapiens 2'-5'-oligoadenylate synthetase 2, 69/71kDa (OAS2), transcript variant 3, mRNA [NM_001032731]","chr12",113416288,113426610,"GO:0001730(2'-5'-oligoadenylate synthetase activity);GO:0003725(double-stranded RNA binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0006139(nucleobase-containing compound metabolic process);GO:0006164(purine nucleotide biosynthetic process);GO:0006401(RNA catabolic process);GO:0006486(protein glycosylation);GO:0008270(zinc ion binding);GO:0009615(response to virus);GO:0016020(membrane);GO:0018377(protein myristoylation);GO:0019221(cytokine-mediated signaling pathway);GO:0043231(intracellular membrane-bounded organelle);GO:0046872(metal ion binding);GO:0048471(perinuclear region of cytoplasm);GO:0051607(defense response to virus);GO:0060333(interferon-gamma-mediated signaling pathway);GO:0060337(type I interferon-mediated signaling pathway)","05162(Measles);05164(Influenza A);05160(Hepatitis C);05168(Herpes simplex infection)","mRNA","agilent G3 V3"]
["A_24_P196592",12.39,12.32,12.41,12.93,12.77,12.61,{"v":0.968937614199948,"d":"0.97"},{"v":-0.0455243152963078,"d":"-0.05"},"down",{"v":0.0146372,"d":"0.01"},1,"yes","AATGAACAGGTCCCCAAAGCTCCCACCTCCACTCGATTCAGCGATGCCATCAGAGCGTTT","FALSE","NM_001032278","ref|NM_001032278|ens|ENST00000612672|ens|ENST00000616383|gb|BC011774","MMP28","matrix metallopeptidase 28","ref|Homo sapiens matrix metallopeptidase 28 (MMP28), transcript variant 3, mRNA [NM_001032278]","chrHG385_PATCH",34092876,34122655,"GO:0004222(metalloendopeptidase activity);GO:0005509(calcium ion binding);GO:0005578(proteinaceous extracellular matrix);GO:0005737(cytoplasm);GO:0006508(proteolysis);GO:0008270(zinc ion binding);GO:0010760(negative regulation of macrophage chemotaxis)",null,"mRNA","agilent G3 V3"]
["A_33_P3347639",5.78,6.04,5.31,4.88,4.61,4.82,{"v":1.19706498951782,"d":"1.20"},{"v":0.259501479357331,"d":"0.26"},"up",{"v":0.0147419,"d":"0.01"},1,"yes","AGGATCTGTCCACATTTGGGGCCTATCCTTACTTGTTTGAAAAAATATGTTTGCTTTTTT","FALSE","NM_017638","ref|NM_017638|ref|NM_001127350|ens|ENST00000373842|ens|ENST00000398997","MED18","mediator complex subunit 18","ref|Homo sapiens mediator complex subunit 18 (MED18), transcript variant 1, mRNA [NM_017638]","chr1",28655566,28662475,"GO:0001104(RNA polymerase II transcription cofactor activity);GO:0005515(protein binding);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0006366(transcription from RNA polymerase II promoter);GO:0016592(mediator complex)",null,"mRNA","agilent G3 V3"]
["A_23_P143029",{"v":5.1,"d":"5.10"},4.62,{"v":5.6,"d":"5.60"},3.99,{"v":3.4,"d":"3.40"},3.83,{"v":1.36541889483066,"d":"1.37"},{"v":0.449343621316164,"d":"0.45"},"up",{"v":0.0148427999999999,"d":"0.01"},1,"yes","AAAGAAAAGAAACTGAACAGAGACCGTCTGCAGTATTTCACTGGAAACCCCTTATTTTGA","FALSE","NM_021192","ref|NM_021192|ens|ENST00000619244|ens|ENST00000249504|ens|ENST00000498438","HOXD11","homeobox D11","ref|Homo sapiens homeobox D11 (HOXD11), mRNA [NM_021192]","chr2",176973600,176983971,"GO:0001656(metanephros development);GO:0001658(branching involved in ureteric bud morphogenesis);GO:0001759(organ induction);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0007338(single fertilization);GO:0009952(anterior/posterior pattern specification);GO:0009953(dorsal/ventral pattern formation);GO:0009954(proximal/distal pattern formation);GO:0010720(positive regulation of cell development);GO:0032332(positive regulation of chondrocyte differentiation);GO:0035115(embryonic forelimb morphogenesis);GO:0042733(embryonic digit morphogenesis);GO:0043565(sequence-specific DNA binding);GO:0048589(developmental growth);GO:0060272(embryonic skeletal joint morphogenesis);GO:0060351(cartilage development involved in endochondral bone morphogenesis)",null,"mRNA","agilent G3 V3"]
["A_23_P120227",10.45,10.46,10.51,9.35,9.67,9.24,{"v":1.11181882519462,"d":"1.11"},{"v":0.152921714960257,"d":"0.15"},"up",{"v":0.0149598000000001,"d":"0.01"},1,"yes","CTTGTAAACTGCGTAACAAATCTACTTTGTGTATGTGTCTGTTTATGGGGGTGGTTTATT","FALSE","NM_030915","ref|NM_030915|ens|ENST00000395323|gb|AK023425|gb|BC012373","LBH","limb bud and heart development","ref|Homo sapiens limb bud and heart development (LBH), mRNA [NM_030915]","chr2",30481192,30482893,"GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-dependent);GO:0007275(multicellular organismal development);GO:0010468(regulation of gene expression);GO:0030193(regulation of blood coagulation);GO:0045893(positive regulation of transcription, DNA-dependent)",null,"mRNA","agilent G3 V3"]
["A_23_P103897",6.12,5.13,{"v":5.4,"d":"5.40"},6.72,6.99,6.72,{"v":0.814977973568282,"d":"0.81"},{"v":-0.295167026774603,"d":"-0.30"},"down",{"v":0.0151028999999999,"d":"0.02"},1,"yes","CTACCAGATCACCCTTCACTTCCTTGTCAACCTGTTCTTTCTTCAGGAATAACTGATATA","FALSE","ENST00000431031","ens|ENST00000431031|ens|ENST00000490879|ens|ENST00000554297|ens|ENST00000460286","SPATA1","spermatogenesis associated 1","ens|spermatogenesis associated 1 [Source:HGNC Symbol;Acc:HGNC:14682] [ENST00000431031]","chr1",84971976,85031875,null,null,"mRNA","agilent G3 V3"]
["A_33_P3306264",7.79,7.41,7.62,7.19,7.08,7.15,{"v":1.06535947712418,"d":"1.07"},{"v":0.0913403115384258,"d":"0.09"},"up",{"v":0.0151568000000001,"d":"0.02"},1,"yes","AATTCAGGGCAGTATCCTGCAAAAGGGGGGCCCCAGCAGCCCCATAATAAAGGCTGTGTG","FALSE","NM_014400","ref|NM_014400|ens|ENST00000244333|gb|AK314773|gb|HQ447474","LYPD3","LY6/PLAUR domain containing 3","ref|Homo sapiens LY6/PLAUR domain containing 3 (LYPD3), mRNA [NM_014400]","chr19",43965952,43968115,"GO:0005615(extracellular space);GO:0006928(cellular component movement);GO:0007160(cell-matrix adhesion);GO:0016021(integral to membrane);GO:0043236(laminin binding);GO:0046658(anchored to plasma membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3511265",8.14,6.29,6.81,11.57,11.37,11.61,{"v":0.614761215629523,"d":"0.61"},{"v":-0.701901944471467,"d":"-0.70"},"down",{"v":0.0153375,"d":"0.02"},1,"yes","TAACCTGACCTTAGAAAATTGTGAGAGCCAAGTTGACTTCAGGAACTGAAACATCAGCAC","FALSE","NM_006475","ref|NM_006475|ref|NM_001286665|ref|NM_001135935|ref|NM_001135934","POSTN","periostin, osteoblast specific factor","ref|Homo sapiens periostin, osteoblast specific factor (POSTN), transcript variant 1, mRNA [NM_006475]","chr13",38137472,38172863,"GO:0001501(skeletal system development);GO:0005515(protein binding);GO:0005578(proteinaceous extracellular matrix);GO:0005615(extracellular space);GO:0005802(trans-Golgi network);GO:0007155(cell adhesion);GO:0008201(heparin binding);GO:0008593(regulation of Notch signaling pathway);GO:0009888(tissue development);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix);GO:0050839(cell adhesion molecule binding)",null,"mRNA","agilent G3 V3"]
["A_23_P129556",2.81,5.32,2.47,7.61,7.65,6.79,{"v":0.480725623582766,"d":"0.48"},{"v":-1.05671439099432,"d":"-1.06"},"down",{"v":0.0154204999999999,"d":"0.02"},1,"yes","GTCTGTGTGTTTTAGTTTCATCACCTGTTATCTGTGTTTGCTGAGGAGAGTGGAACAGAA","FALSE","NM_000418","ref|NM_000418|ref|NM_001257407|ref|NM_001257406|ref|NM_001257997","IL4R","interleukin 4 receptor","ref|Homo sapiens interleukin 4 receptor (IL4R), transcript variant 1, mRNA [NM_000418]","chr16",27351504,27376098,"GO:0002532(production of molecular mediator involved in inflammatory response);GO:0004913(interleukin-4 receptor activity);GO:0005057(receptor signaling protein activity);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005887(integral to plasma membrane);GO:0006955(immune response);GO:0007165(signal transduction);GO:0030728(ovulation);GO:0035556(intracellular signal transduction);GO:0035771(interleukin-4-mediated signaling pathway);GO:0042127(regulation of cell proliferation);GO:0042832(defense response to protozoan);GO:0043032(positive regulation of macrophage activation);GO:0043235(receptor complex);GO:0043627(response to estrogen stimulus);GO:0045626(negative regulation of T-helper 1 cell differentiation);GO:0045630(positive regulation of T-helper 2 cell differentiation);GO:0090197(positive regulation of chemokine secretion)","04630(Jak-STAT signaling pathway);04151(PI3K-Akt signaling pathway);04060(Cytokine-cytokine receptor interaction);04640(Hematopoietic cell lineage);05321(Inflammatiory bowel disease (IBD))","mRNA","agilent G3 V3"]
["A_33_P3258712",{"v":6.6,"d":"6.60"},6.51,5.85,5.44,5.29,{"v":5.3,"d":"5.30"},{"v":1.18278228321896,"d":"1.18"},{"v":0.242184538743711,"d":"0.24"},"up",{"v":0.0155179,"d":"0.02"},1,"yes","TAGGGCTTTTCTCCACTATGAATTCTATGATGTCGAATAAAGTGTGAGCTCTGATTACAA","FALSE","XR_243583","ref|XR_243583|ref|XR_248316|ref|XR_253622|linc|lnc-USP6-1:3","LOC101928000","uncharacterized LOC101928000","ref|PREDICTED: Homo sapiens uncharacterized LOC101928000 (LOC101928000), ncRNA [XR_243583]","chr17",{"v":5017068,"d":"5017068.00"},5017671,null,null,"mRNA","agilent G3 V3"]
["A_33_P3324894",7.23,7.37,7.42,7.04,7.14,7.03,{"v":1.03818953323904,"d":"1.04"},{"v":0.0540698480338141,"d":"0.05"},"up",{"v":0.0156026,"d":"0.02"},1,"yes","ATCTGTCCTCTCCATGAGTCTTTCCATTCACCTTCTTGTCCCAACTATGACTAAAGGGGA","FALSE","AK130532","gb|AK130532|tc|THC2487969",null,null,"gb|Homo sapiens cDNA FLJ27022 fis, clone SLV06258. [AK130532]",{"$nulls":5},"mRNA","agilent G3 V3"]
["A_23_P28697",6.93,5.97,7.66,8.85,8.71,9.01,{"v":0.773805043281897,"d":"0.77"},{"v":-0.369957963296629,"d":"-0.37"},"down",{"v":0.0157202,"d":"0.02"},1,"yes","CTGATGACAGCCTCCTGGTGCTAGCTGGGACCTCGTATGCCTGGGAGCGAACACAAGGCT","FALSE","NM_012205","ref|NM_012205|ens|ENST00000402698|ens|ENST00000294973|ens|ENST00000406007","HAAO","3-hydroxyanthranilate 3,4-dioxygenase","ref|Homo sapiens 3-hydroxyanthranilate 3,4-dioxygenase (HAAO), mRNA [NM_012205]","chr2",42994228,42997033,"GO:0000334(3-hydroxyanthranilate 3,4-dioxygenase activity);GO:0005829(cytosol);GO:0006569(tryptophan catabolic process);GO:0008198(ferrous iron binding);GO:0009055(electron carrier activity);GO:0010043(response to zinc ion);GO:0019805(quinolinate biosynthetic process);GO:0019825(oxygen binding);GO:0031966(mitochondrial membrane);GO:0034354(de novo NAD biosynthetic process from tryptophan);GO:0034641(cellular nitrogen compound metabolic process);GO:0043420(anthranilate metabolic process);GO:0044281(small molecule metabolic process);GO:0046686(response to cadmium ion);GO:0055114(oxidation-reduction process);GO:0070050(neuron homeostasis);GO:0070062(extracellular vesicular exosome)","00380(Tryptophan metabolism)","mRNA","agilent G3 V3"]
["A_23_P146233",3.71,3.63,3.63,5.36,{"v":5.3,"d":"5.30"},4.77,{"v":0.710952689565781,"d":"0.71"},{"v":-0.492174536167542,"d":"-0.49"},"down",{"v":0.0158393,"d":"0.02"},1,"yes","AACAGTCGATCAAGGGATGTATTGGAACATGTCGGAGTAGAAATTGTTCCTGATGTGCCA","FALSE","NM_000237","ref|NM_000237|ens|ENST00000311322|gb|M15856|tc|THC2465480","LPL","lipoprotein lipase","ref|Homo sapiens lipoprotein lipase (LPL), mRNA [NM_000237]","chr8",19796482,19824769,"GO:0001523(retinoid metabolic process);GO:0004465(lipoprotein lipase activity);GO:0004620(phospholipase activity);GO:0004806(triglyceride lipase activity);GO:0005102(receptor binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005886(plasma membrane);GO:0006633(fatty acid biosynthetic process);GO:0006641(triglyceride metabolic process);GO:0006644(phospholipid metabolic process);GO:0007603(phototransduction, visible light);GO:0008201(heparin binding);GO:0009409(response to cold);GO:0009986(cell surface);GO:0010744(positive regulation of macrophage derived foam cell differentiation);GO:0010886(positive regulation of cholesterol storage);GO:0010890(positive regulation of sequestering of triglyceride);GO:0017129(triglyceride binding);GO:0019432(triglyceride biosynthetic process);GO:0019433(triglyceride catabolic process);GO:0031012(extracellular matrix);GO:0031225(anchored to membrane);GO:0034185(apolipoprotein binding);GO:0034361(very-low-density lipoprotein particle);GO:0034371(chylomicron remodeling);GO:0034372(very-low-density lipoprotein particle remodeling);GO:0042157(lipoprotein metabolic process);GO:0042493(response to drug);GO:0042627(chylomicron);GO:0044281(small molecule metabolic process);GO:0070062(extracellular vesicular exosome);GO:0070328(triglyceride homeostasis)","00561(Glycerolipid metabolism);03320(PPAR signaling pathway);05010(Alzheimer's disease)","mRNA","agilent G3 V3"]
["A_33_P3231352",5.25,6.49,5.82,{"v":4.5,"d":"4.50"},{"v":4.4,"d":"4.40"},4.28,{"v":1.33232169954477,"d":"1.33"},{"v":0.413942474527307,"d":"0.41"},"up",{"v":0.0159777000000001,"d":"0.02"},1,"yes","ACAAAGGGCATCATTCTAAAATATATACAGAACCATAAAAGCCCCAAATAGCCAAAGCAA","FALSE","AK022088","gb|AK022088|gb|CX784106|tc|THC2503428|tc|THC2525942",null,null,"gb|Homo sapiens cDNA FLJ12026 fis, clone HEMBB1001816. [AK022088]","chr4",140334976,140375188,null,null,"mRNA","agilent G3 V3"]
["A_33_P3271634",7.21,{"v":7.3,"d":"7.30"},7.38,6.74,7.01,6.97,{"v":1.05646718146718,"d":"1.06"},{"v":0.0792479514943923,"d":"0.08"},"up",{"v":0.0160806,"d":"0.02"},1,"yes","ACTCAGTGCCCCTGAGCTCATTCTTTTCAGTAAATTCTCTCTCTGCGTGGTGAGAAAACA","FALSE","ENST00000466949","ens|ENST00000466949|ens|ENST00000487157|ens|ENST00000487685|ens|ENST00000488575","HLA-DPB1","major histocompatibility complex, class II, DP beta 1","ens|major histocompatibility complex, class II, DP beta 1 [Source:HGNC Symbol;Acc:HGNC:4940] [ENST00000466949]","chr6",33048264,33053666,"GO:0000139(Golgi membrane);GO:0005765(lysosomal membrane);GO:0005886(plasma membrane);GO:0009986(cell surface);GO:0010008(endosome membrane);GO:0012507(ER to Golgi transport vesicle membrane);GO:0016020(membrane);GO:0019221(cytokine-mediated signaling pathway);GO:0019886(antigen processing and presentation of exogenous peptide antigen via MHC class II);GO:0030658(transport vesicle membrane);GO:0030666(endocytic vesicle membrane);GO:0030669(clathrin-coated endocytic vesicle membrane);GO:0031295(T cell costimulation);GO:0032588(trans-Golgi network membrane);GO:0032729(positive regulation of interferon-gamma production);GO:0042102(positive regulation of T cell proliferation);GO:0042605(peptide antigen binding);GO:0042613(MHC class II protein complex);GO:0050852(T cell receptor signaling pathway);GO:0050870(positive regulation of T cell activation);GO:0060333(interferon-gamma-mediated signaling pathway);GO:0071556(integral to lumenal side of endoplasmic reticulum membrane)","04514(Cell adhesion molecules (CAMs));04145(Phagosome);04612(Antigen processing and presentation);04672(Intestinal immune network for IgA production);05310(Asthma);05322(Systemic lupus erythematosus);05323(Rheumatoid arthritis);05320(Autoimmune thyroid disease);05321(Inflammatiory bowel disease (IBD));05330(Allograft rejection);05332(Graft-versus-host disease);05416(Viral myocarditis);04940(Type I diabetes mellitus);05150(Staphylococcus aureus infection);05152(Tuberculosis);05166(HTLV-I infection);05164(Influenza A);05168(Herpes simplex infection);05169(Epstein-Barr virus infection);05145(Toxoplasmosis);05140(Leishmaniasis)","mRNA","agilent G3 V3"]
["A_33_P3224867",8.76,8.71,8.58,8.15,8.33,8.42,{"v":1.04618473895582,"d":"1.05"},{"v":0.0651376302104272,"d":"0.07"},"up",{"v":0.0161159,"d":"0.02"},1,"yes","ACAGAACAGAAGATAAACTGAAACTTCTCTGCCTTCCCGCTGCAAGAGTGAATGAGCGAT","FALSE","NM_001206842","ref|NM_001206842|ref|NM_001080555|ref|NM_001080554|ens|ENST00000432710","GSG1","germ cell associated 1","ref|Homo sapiens germ cell associated 1 (GSG1), transcript variant 5, mRNA [NM_001206842]","chr12",13237042,13256619,"GO:0005789(endoplasmic reticulum membrane);GO:0016021(integral to membrane);GO:0070063(RNA polymerase binding)",null,"mRNA","agilent G3 V3"]
["A_23_P97700",7.44,7.19,6.37,{"v":8.2,"d":"8.20"},8.93,8.49,{"v":0.819672131147541,"d":"0.82"},{"v":-0.286881147788161,"d":"-0.29"},"down",{"v":0.0163576999999999,"d":"0.02"},1,"yes","TCCACCCTTTTCTGAGAGTTATTACAGCCAGAAAGTGTGGGCTGAAGATGGTTGGTTTCA","FALSE","NM_006472","ref|NM_006472|ens|ENST00000582401|gb|S73591|gb|BX537824","TXNIP","thioredoxin interacting protein","ref|Homo sapiens thioredoxin interacting protein (TXNIP), mRNA [NM_006472]","chr1",145438512,145442592,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0004857(enzyme inhibitor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005758(mitochondrial intermembrane space);GO:0005829(cytosol);GO:0006351(transcription, DNA-dependent);GO:0006606(protein import into nucleus);GO:0007049(cell cycle);GO:0009612(response to mechanical stimulus);GO:0009749(response to glucose stimulus);GO:0030216(keratinocyte differentiation);GO:0031625(ubiquitin protein ligase binding);GO:0032355(response to estradiol stimulus);GO:0032570(response to progesterone stimulus);GO:0035872(nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway);GO:0042127(regulation of cell proliferation);GO:0042493(response to drug);GO:0042542(response to hydrogen peroxide);GO:0043065(positive regulation of apoptotic process);GO:0043086(negative regulation of catalytic activity);GO:0045087(innate immune response);GO:0048008(platelet-derived growth factor receptor signaling pathway);GO:0051592(response to calcium ion);GO:0051782(negative regulation of cell division);GO:0071228(cellular response to tumor cell)",null,"mRNA","agilent G3 V3"]
["A_23_P122662",5.33,5.53,4.73,7.04,7.06,7.04,{"v":0.737464522232734,"d":"0.74"},{"v":-0.439354448684898,"d":"-0.44"},"down",{"v":0.0164791,"d":"0.02"},1,"yes","CATCCAGCTTTGTGGATTTAGAAAGGAAGCCTTCAGTTCCAATCAGAATCCTCTTTCCTT","FALSE","NM_018988","ref|NM_018988|ref|NM_001242630|ref|NM_001242628|ens|ENST00000612338","GFOD1","glucose-fructose oxidoreductase domain containing 1","ref|Homo sapiens glucose-fructose oxidoreductase domain containing 1 (GFOD1), transcript variant 1, mRNA [NM_018988]","chr6",13358062,13487787,"GO:0005576(extracellular region);GO:0016491(oxidoreductase activity);GO:0055114(oxidation-reduction process)",null,"mRNA","agilent G3 V3"]
["A_33_P3414594",6.24,5.43,6.12,{"v":4.7,"d":"4.70"},4.74,3.89,{"v":1.33458364591148,"d":"1.33"},{"v":0.416389730178187,"d":"0.42"},"up",{"v":0.0165635999999999,"d":"0.02"},1,"yes","AGCAAACACCTGTGCAACTGAGTAAGGAGCAAGAAGAGCTGATCCGGACACTCCTGGGGG","FALSE","NM_001077474","ref|NM_001077474|ref|NM_001077475|ref|NM_001077477|ref|NM_001077478","NR1I3","nuclear receptor subfamily 1, group I, member 3","ref|Homo sapiens nuclear receptor subfamily 1, group I, member 3 (NR1I3), transcript variant 8, mRNA [NM_001077474]","chr1",161199456,161208000,"GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001228(RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription);GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0003713(transcription coactivator activity);GO:0004879(ligand-activated sequence-specific DNA binding RNA polymerase II transcription factor activity);GO:0004882(androgen receptor activity);GO:0004887(thyroid hormone receptor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0007165(signal transduction);GO:0008270(zinc ion binding);GO:0010467(gene expression);GO:0030521(androgen receptor signaling pathway);GO:0030522(intracellular receptor mediated signaling pathway);GO:0043401(steroid hormone mediated signaling pathway);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0045944(positive regulation of transcription from RNA polymerase II promoter)",null,"mRNA","agilent G3 V3"]
["A_23_P206733",9.24,9.22,9.14,9.89,9.47,9.76,{"v":0.947802197802198,"d":"0.95"},{"v":-0.0773420885331646,"d":"-0.08"},"down",{"v":0.0166371,"d":"0.02"},1,"yes","ACCTGAAGAGCTTCAAGCTGAAAGGAATTTCCACACTGTCCCCTACATGGTCGGAATTAA","FALSE","NM_001266","ref|NM_001266|ref|NM_001025195|ref|NM_001025194|ens|ENST00000569260","CES1","carboxylesterase 1","ref|Homo sapiens carboxylesterase 1 (CES1), transcript variant 3, mRNA [NM_001266]","chr16",55844484,55853492,"GO:0005615(extracellular space);GO:0005788(endoplasmic reticulum lumen);GO:0008152(metabolic process);GO:0009636(response to toxin);GO:0030855(epithelial cell differentiation);GO:0047374(methylumbelliferyl-acetate deacetylase activity);GO:0052689(carboxylic ester hydrolase activity)","00983(Drug metabolism - other enzymes)","mRNA","agilent G3 V3"]
["A_23_P112825",3.67,2.64,3.71,6.02,5.99,6.05,{"v":0.554817275747508,"d":"0.55"},{"v":-0.84991538428565,"d":"-0.85"},"down",{"v":0.0166843,"d":"0.02"},1,"yes","GACATGATGGAGTTGTACAACAGGTTACCTCGAGCTGAAGTGAGCAGGATAGAATCACTT","FALSE","NM_016309","ref|NM_016309|ref|NM_001032391|ens|ENST00000380966|ens|ENST00000564011","LCMT1","leucine carboxyl methyltransferase 1","ref|Homo sapiens leucine carboxyl methyltransferase 1 (LCMT1), transcript variant 1, mRNA [NM_016309]","chr16",25123050,25189552,"GO:0003880(protein C-terminal carboxyl O-methyltransferase activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0006464(cellular protein modification process);GO:0006479(protein methylation);GO:0006481(C-terminal protein methylation);GO:0008757(S-adenosylmethionine-dependent methyltransferase activity);GO:0010906(regulation of glucose metabolic process);GO:0031333(negative regulation of protein complex assembly);GO:0042981(regulation of apoptotic process);GO:0090266(regulation of mitotic cell cycle spindle assembly checkpoint)",null,"mRNA","agilent G3 V3"]
["A_23_P218937",3.74,2.83,4.38,5.43,5.31,5.74,{"v":0.664441747572816,"d":"0.66"},{"v":-0.589785372694682,"d":"-0.59"},"down",{"v":0.0169245,"d":"0.02"},1,"yes","AGTGTTCGGAGTAATCATATTCAAAGTTTACAAGTGGAAGCAGTCTAGAGACCTATACCG","FALSE","NM_032402","ref|NM_032402|ens|ENST00000611950|gb|AF152524|gb|DQ893469","PCDHGC3","protocadherin gamma subfamily C, 3","ref|Homo sapiens protocadherin gamma subfamily C, 3 (PCDHGC3), transcript variant 2, mRNA [NM_032402]","chr5",140855584,140892542,"GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0007156(homophilic cell adhesion);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0016339(calcium-dependent cell-cell adhesion);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P152963",3.91,2.14,3.44,5.02,5.45,5.65,{"v":0.588709677419355,"d":"0.59"},{"v":-0.764371751506858,"d":"-0.76"},"down",{"v":0.0169758,"d":"0.02"},1,"yes","GAAGGGATGTTGCTCTGCTTGTATTCAGTTGGCCATCTGTAGCTACCCTGTTCTTCCCAA","FALSE","NM_017622","ref|NM_017622|ens|ENST00000389017|gb|BC009261|gb|BC018880","C17orf59","chromosome 17 open reading frame 59","ref|Homo sapiens chromosome 17 open reading frame 59 (C17orf59), mRNA [NM_017622]","chr17",{"v":8091652,"d":"8091652.00"},8093564,null,null,"mRNA","agilent G3 V3"]
["A_33_P3311056",5.65,4.67,4.37,7.86,7.79,7.79,{"v":0.626706484641638,"d":"0.63"},{"v":-0.674138173865968,"d":"-0.67"},"down",{"v":0.0171755,"d":"0.02"},1,"yes","CTTTGTCCCTTGCTTCATTTTTGTGACAAGATAAAACTGGGCACAGCTCTTAAATAAAAT","FALSE","NM_004168","ref|NM_004168|ref|NM_001294332|ref|NR_003263|ens|ENST00000354559","SDHA","succinate dehydrogenase complex, subunit A, flavoprotein (Fp)","ref|Homo sapiens succinate dehydrogenase complex, subunit A, flavoprotein (Fp) (SDHA), transcript variant 1, mRNA [NM_004168]","chr3",195690208,195717129,"GO:0000104(succinate dehydrogenase activity);GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0005749(mitochondrial respiratory chain complex II);GO:0006099(tricarboxylic acid cycle);GO:0006105(succinate metabolic process);GO:0007399(nervous system development);GO:0008177(succinate dehydrogenase (ubiquinone) activity);GO:0022904(respiratory electron transport chain);GO:0044237(cellular metabolic process);GO:0044281(small molecule metabolic process);GO:0050660(flavin adenine dinucleotide binding);GO:0055114(oxidation-reduction process)","01200(Carbon metabolism);00020(Citrate cycle (TCA cycle));00190(Oxidative phosphorylation);05010(Alzheimer's disease);05012(Parkinson's disease);05016(Huntington's disease);04932(Non-alcoholic fatty liver disease (NAFLD))","mRNA","agilent G3 V3"]
["A_33_P3359268",{"v":8.1,"d":"8.10"},8.55,7.95,9.18,9.12,8.81,{"v":0.907414238288454,"d":"0.91"},{"v":-0.14016679761111,"d":"-0.14"},"down",{"v":0.0173019000000001,"d":"0.02"},1,"yes","GGCTCCTTCTCACTGCTGGATCCGGACTTTTTAAATAAAAACAAGTAAAATTTGTGTTTT","FALSE","NM_006339","ref|NM_006339|ens|ENST00000619543|ens|ENST00000488973|ens|ENST00000333651","HMG20B","high mobility group 20B","ref|Homo sapiens high mobility group 20B (HMG20B), mRNA [NM_006339]","chr19",{"v":3576883,"d":"3576883.00"},3578442,"GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0006325(chromatin organization);GO:0006338(chromatin remodeling);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0007049(cell cycle);GO:0007596(blood coagulation);GO:0033234(negative regulation of protein sumoylation);GO:0035914(skeletal muscle cell differentiation);GO:0045666(positive regulation of neuron differentiation);GO:0046982(protein heterodimerization activity)",null,"mRNA","agilent G3 V3"]
["A_24_P359441",5.94,5.35,5.83,4.89,4.92,4.39,{"v":1.2056338028169,"d":"1.21"},{"v":0.269791772009102,"d":"0.27"},"up",{"v":0.0175767999999999,"d":"0.02"},1,"yes","AAGAGCCATGGAGACCTTGGGGGCAGCTACAAGGTGATCTTGTACGAACTAGAGAACTTC","FALSE","NM_004076","ref|NM_004076|ens|ENST00000215855|gb|U71216|gb|AB528115","CRYBB3","crystallin, beta B3","ref|Homo sapiens crystallin, beta B3 (CRYBB3), mRNA [NM_004076]","chr22",25595816,25603330,"GO:0005212(structural constituent of eye lens);GO:0007601(visual perception)",null,"mRNA","agilent G3 V3"]
["A_33_P3319261",7.17,7.02,{"v":7.1,"d":"7.10"},6.45,6.31,6.79,{"v":1.08900255754476,"d":"1.09"},{"v":0.123007342257579,"d":"0.12"},"up",{"v":0.0176378,"d":"0.02"},1,"yes","GCTGCCTCTGGAGAGGAGCGGCTGGGGCTGGCAGGAGCACAGCCCTCTTCTCCCGAGTGA","FALSE","NM_001286823","ref|NM_001286823|ref|NR_104598|ens|ENST00000460390|gb|BC037355","EXD3","exonuclease 3'-5' domain containing 3","ref|Homo sapiens exonuclease 3'-5' domain containing 3 (EXD3), transcript variant 2, mRNA [NM_001286823]","chr9",140260592,140317663,"GO:0003676(nucleic acid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0008408(3'-5' exonuclease activity);GO:0046872(metal ion binding);GO:0090305(nucleic acid phosphodiester bond hydrolysis)",null,"mRNA","agilent G3 V3"]
["A_32_P234935",5.96,6.64,{"v":5,"d":"5.00"},7.96,7.67,7.64,{"v":0.756338633433606,"d":"0.76"},{"v":-0.402895781880689,"d":"-0.40"},"down",{"v":0.0177761999999999,"d":"0.02"},1,"yes","GTCCTGTGCTTGGATGCTTTTTATAAGAGTTGTCATTGTTGGAAATTCTTAAATAAAACT","FALSE","NM_007375","ref|NM_007375|ref|NR_026923|ens|ENST00000620632|ens|ENST00000480464","TARDBP","TAR DNA binding protein","ref|Homo sapiens TAR DNA binding protein (TARDBP), mRNA [NM_007375]","chr1",11073773,11084240,"GO:0000166(nucleotide binding);GO:0001205(RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription);GO:0003690(double-stranded DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0003723(RNA binding);GO:0003730(mRNA 3'-UTR binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005726(perichromatin fibrils);GO:0005737(cytoplasm);GO:0006366(transcription from RNA polymerase II promoter);GO:0006397(mRNA processing);GO:0008380(RNA splicing);GO:0016607(nuclear speck);GO:0032024(positive regulation of insulin secretion);GO:0034976(response to endoplasmic reticulum stress);GO:0035061(interchromatin granule);GO:0042802(identical protein binding);GO:0043922(negative regulation by host of viral transcription);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0070935(3'-UTR-mediated mRNA stabilization)",null,"mRNA","agilent G3 V3"]
["A_23_P432545",4.75,{"v":4.8,"d":"4.80"},5.02,5.68,5.42,5.24,{"v":0.891676866585067,"d":"0.89"},{"v":-0.165407106081171,"d":"-0.17"},"down",{"v":0.0179226,"d":"0.02"},1,"yes","AGACGTGGTCGCCGTCTCCAGGAACATGCAGAAAGAGAAAGTCAACCTGCTACGGCAACT","FALSE","NM_173584","ref|NM_173584|ref|NM_001286606|ens|ENST00000526531|ens|ENST00000528694","CRACR2B","calcium release activated channel regulator 2B","ref|Homo sapiens calcium release activated channel regulator 2B (CRACR2B), transcript variant 2, mRNA [NM_173584]","chr11",{"v":827585,"d":"827585.00"},831991,"GO:0002115(store-operated calcium entry);GO:0005509(calcium ion binding);GO:0005737(cytoplasm);GO:0034613(cellular protein localization);GO:2001256(regulation of store-operated calcium entry)",null,"mRNA","agilent G3 V3"]
["A_32_P214665",{"v":6.9,"d":"6.90"},7.09,7.08,{"v":7.4,"d":"7.40"},7.48,7.25,{"v":0.952101220063262,"d":"0.95"},{"v":-0.0708131369837055,"d":"-0.07"},"down",{"v":0.0180618,"d":"0.02"},1,"yes","TGTACTACATGAAGGATGCTTGGGGCTTTGCTAACCTGCTCACCGCTAACCCTCCAAGTC","FALSE","NM_001102566","ref|NM_001102566|ens|ENST00000504449|gb|BC147003|gb|BC147004","PCP4L1","Purkinje cell protein 4 like 1","ref|Homo sapiens Purkinje cell protein 4 like 1 (PCP4L1), mRNA [NM_001102566]","chr1",161228512,161255240,null,null,"mRNA","agilent G3 V3"]
["A_24_P911288",8.25,8.06,8.33,7.57,{"v":7.9,"d":"7.90"},7.73,{"v":1.06206896551724,"d":"1.06"},{"v":0.0868774506799668,"d":"0.09"},"up",{"v":0.0181981,"d":"0.02"},1,"yes","CCCGAACCTACCTGCTCCTCCGAGCATTTGAGAAGGATCGCTTTACAGGCATTGCCACCA","FALSE","X74861","gb|X74861|tc|NP093843","HPX-2","homeobox HPX-2","gb|H.sapiens HPX-2 mRNA. [X74861]",{"$nulls":5},"mRNA","agilent G3 V3"]
["A_33_P3249746",5.46,5.81,6.05,5.13,4.65,4.42,{"v":1.21971830985915,"d":"1.22"},{"v":0.28654800033468,"d":"0.29"},"up",{"v":0.0183557999999999,"d":"0.02"},1,"yes","AGGAAGACTCACAGAACACAGTTGAAGAAGGAAAGTGGCGATGGACCTCATCCCAAATTT","FALSE","NM_001190484","ref|NM_001190484|ens|ENST00000469622|ens|ENST00000456417|ens|ENST00000489231","CYP3A5","cytochrome P450, family 3, subfamily A, polypeptide 5","ref|Homo sapiens cytochrome P450, family 3, subfamily A, polypeptide 5 (CYP3A5), transcript variant 2, mRNA [NM_001190484]","chr7",99245824,99277621,"GO:0004497(monooxygenase activity);GO:0005506(iron ion binding);GO:0005789(endoplasmic reticulum membrane);GO:0006805(xenobiotic metabolic process);GO:0008202(steroid metabolic process);GO:0009822(alkaloid catabolic process);GO:0016491(oxidoreductase activity);GO:0019825(oxygen binding);GO:0020037(heme binding);GO:0042737(drug catabolic process);GO:0043231(intracellular membrane-bounded organelle);GO:0044281(small molecule metabolic process);GO:0070330(aromatase activity);GO:0070989(oxidative demethylation)","00140(Steroid hormone biosynthesis);00830(Retinol metabolism);00980(Metabolism of xenobiotics by cytochrome P450);00982(Drug metabolism - cytochrome P450);05204(Chemical carcinogenesis)","mRNA","agilent G3 V3"]
["A_23_P165494",{"v":2.8,"d":"2.80"},5.53,3.94,7.14,{"v":7,"d":"7.00"},8.17,{"v":0.549977588525325,"d":"0.55"},{"v":-0.862555264581236,"d":"-0.86"},"down",{"v":0.018584,"d":"0.02"},1,"yes","ACTCACACGCAACATTTCTTGTACTTTGTAAGTCGTTTGCGAGAATGCAGACCACCTCAC","FALSE","NM_015530","ref|NM_015530|ref|NM_001201428|ens|ENST00000486498|ens|ENST00000442798","GORASP2","golgi reassembly stacking protein 2, 55kDa","ref|Homo sapiens golgi reassembly stacking protein 2, 55kDa (GORASP2), transcript variant 1, mRNA [NM_015530]","chr2",171785824,171823133,"GO:0000139(Golgi membrane);GO:0000278(mitotic cell cycle);GO:0005515(protein binding);GO:0005794(Golgi apparatus);GO:0006996(organelle organization);GO:0016020(membrane)",null,"mRNA","agilent G3 V3"]
["A_24_P45005",5.68,6.32,5.07,7.14,6.94,7.31,{"v":0.798036465638149,"d":"0.80"},{"v":-0.325473424137306,"d":"-0.33"},"down",{"v":0.0186821,"d":"0.02"},1,"yes","ACGGGGATCTTTTACCTCACTTTGCACTGATTAATTTTAAGCAATTGAAAGATTGCCCTT","FALSE","NM_024663","ref|NM_024663|ref|NM_001204872|ref|NM_001204873|ref|NR_037945","NPEPL1","aminopeptidase-like 1","ref|Homo sapiens aminopeptidase-like 1 (NPEPL1), transcript variant 1, mRNA [NM_024663]","chr20",57288788,57290020,"GO:0004177(aminopeptidase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006508(proteolysis);GO:0008235(metalloexopeptidase activity);GO:0030145(manganese ion binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3295523",7.46,7.14,7.46,8.56,8.38,7.85,{"v":0.889874949576442,"d":"0.89"},{"v":-0.16832548049534,"d":"-0.17"},"down",{"v":0.0187999999999999,"d":"0.02"},1,"yes","TCCTTGTGCCCCGAGGTGGGGCAGCCCCTTCTCATTTTATACAATAAACATTCTCCACCT","FALSE","NM_005052","ref|NM_005052|ens|ENST00000306897|ens|ENST00000585014|gb|BC009605","RAC3","ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)","ref|Homo sapiens ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) (RAC3), mRNA [NM_005052]","chr17",79990752,79992080,"GO:0003924(GTPase activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007264(small GTPase mediated signal transduction);GO:0008152(metabolic process);GO:0012505(endomembrane system);GO:0030027(lamellipodium);GO:0030031(cell projection assembly);GO:0030036(actin cytoskeleton organization);GO:0030426(growth cone);GO:0031175(neuron projection development);GO:0031941(filamentous actin);GO:0033630(positive regulation of cell adhesion mediated by integrin);GO:0035556(intracellular signal transduction);GO:0043005(neuron projection);GO:0043025(neuronal cell body);GO:0048306(calcium-dependent protein binding);GO:0048471(perinuclear region of cytoplasm);GO:0050885(neuromuscular process controlling balance);GO:0051056(regulation of small GTPase mediated signal transduction);GO:0070062(extracellular vesicular exosome);GO:0071944(cell periphery);GO:1900026(positive regulation of substrate adhesion-dependent cell spreading)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04310(Wnt signaling pathway);04370(VEGF signaling pathway);04071(Sphingolipid signaling pathway);04024(cAMP signaling pathway);04810(Regulation of actin cytoskeleton);04510(Focal adhesion);04520(Adherens junction);04650(Natural killer cell mediated cytotoxicity);04662(B cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04360(Axon guidance);05200(Pathways in cancer);05231(Choline metabolism in cancer);05210(Colorectal cancer);05212(Pancreatic cancer);05416(Viral myocarditis)","mRNA","agilent G3 V3"]
["A_23_P102060",3.68,4.52,3.45,4.98,5.38,5.24,{"v":0.746794871794872,"d":"0.75"},{"v":-0.421216074207968,"d":"-0.42"},"down",{"v":0.0189567,"d":"0.02"},1,"yes","GTATCATCCAAATAATGGGGCCTATGACTTGAATGAATAGAAATGAATAAGCTGGTGTTT","FALSE","NM_006751","ref|NM_006751|ref|NM_001130445|ref|NM_001287503|ref|NM_001287504","SSFA2","sperm specific antigen 2","ref|Homo sapiens sperm specific antigen 2 (SSFA2), transcript variant 2, mRNA [NM_006751]","chr2",182783584,182794404,"GO:0003779(actin binding);GO:0005102(receptor binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005886(plasma membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3259203",5.91,6.57,5.72,7.38,7.21,6.92,{"v":0.846118084611808,"d":"0.85"},{"v":-0.241069074337002,"d":"-0.24"},"down",{"v":0.0191355999999999,"d":"0.02"},1,"yes","CCTCCTCTGAGAGCAATTGTTCTGGTGTTTTCACATCCCTTAATTAATTAGCTATTATTA","FALSE","ENST00000375353","ens|ENST00000375353|ref|XM_006719983|ref|XM_006719982|ref|XM_006719984","TMEM255B","transmembrane protein 255B","ens|transmembrane protein 255B [Source:HGNC Symbol;Acc:HGNC:28297] [ENST00000375353]","chr13",114506024,114514926,"GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3243093",4.82,3.73,4.14,6.37,6.06,5.32,{"v":0.714929577464789,"d":"0.71"},{"v":-0.484126955438301,"d":"-0.48"},"down",{"v":0.0192638000000001,"d":"0.02"},1,"yes","GCCATGTATGAGGGTAATCGAGATGAGGATATTAACTCAAAAGAAATAGGGTGATTTTTA","FALSE","NM_003617","ref|NM_003617|ref|NM_001254749|ref|NM_001254748|ref|NM_001195303","RGS5","regulator of G-protein signaling 5","ref|Homo sapiens regulator of G-protein signaling 5 (RGS5), transcript variant 1, mRNA [NM_003617]","chr1",163112096,163172903,"GO:0005096(GTPase activator activity);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0008277(regulation of G-protein coupled receptor protein signaling pathway);GO:0038032(termination of G-protein coupled receptor signaling pathway);GO:0043547(positive regulation of GTPase activity)",null,"mRNA","agilent G3 V3"]
["A_23_P200560",7.06,8.06,6.87,8.84,8.84,{"v":8.6,"d":"8.60"},{"v":0.83675799086758,"d":"0.84"},{"v":-0.257117671467361,"d":"-0.26"},"down",{"v":0.0193245,"d":"0.02"},1,"yes","GCTTATTTTGGTTGCAGTTTCCAATTTTTAAAAATGTTGAGGTAATCTTTCCCACCTTCC","FALSE","NM_001039802","ref|NM_001039802|ref|NM_001791|ens|ENST00000400259|ens|ENST00000344548","CDC42","cell division cycle 42","ref|Homo sapiens cell division cycle 42 (CDC42), transcript variant 3, mRNA [NM_001039802]","chr1",22379120,22419416,"GO:0000139(Golgi membrane);GO:0002040(sprouting angiogenesis);GO:0003161(cardiac conduction system development);GO:0003334(keratinocyte development);GO:0003924(GTPase activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005815(microtubule organizing center);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0005925(focal adhesion);GO:0007030(Golgi organization);GO:0007088(regulation of mitosis);GO:0007097(nuclear migration);GO:0007163(establishment or maintenance of cell polarity);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007264(small GTPase mediated signal transduction);GO:0007411(axon guidance);GO:0007596(blood coagulation);GO:0008152(metabolic process);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0016020(membrane);GO:0019901(protein kinase binding);GO:0021762(substantia nigra development);GO:0030036(actin cytoskeleton organization);GO:0030141(secretory granule);GO:0030175(filopodium);GO:0030225(macrophage differentiation);GO:0030496(midbody);GO:0030742(GTP-dependent protein binding);GO:0031069(hair follicle morphogenesis);GO:0031256(leading edge membrane);GO:0031274(positive regulation of pseudopodium assembly);GO:0031295(T cell costimulation);GO:0031333(negative regulation of protein complex assembly);GO:0031424(keratinization);GO:0031435(mitogen-activated protein kinase kinase kinase binding);GO:0031647(regulation of protein stability);GO:0031996(thioesterase binding);GO:0032467(positive regulation of cytokinesis);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0034191(apolipoprotein A-I receptor binding);GO:0034332(adherens junction organization);GO:0034613(cellular protein localization);GO:0035088(establishment or maintenance of apical/basal cell polarity);GO:0035264(multicellular organism growth);GO:0038096(Fc-gamma receptor signaling pathway involved in phagocytosis);GO:0042059(negative regulation of epidermal growth factor receptor signaling pathway);GO:0042176(regulation of protein catabolic process);GO:0042692(muscle cell differentiation);GO:0042802(identical protein binding);GO:0043005(neuron projection);GO:0043025(neuronal cell body);GO:0043497(regulation of protein heterodimerization activity);GO:0043525(positive regulation of neuron apoptotic process);GO:0043552(positive regulation of phosphatidylinositol 3-kinase activity);GO:0045087(innate immune response);GO:0045177(apical part of cell);GO:0045740(positive regulation of DNA replication);GO:0045859(regulation of protein kinase activity);GO:0046330(positive regulation of JNK cascade);GO:0046847(filopodium assembly);GO:0048010(vascular endothelial growth factor receptor signaling pathway);GO:0048013(ephrin receptor signaling pathway);GO:0048554(positive regulation of metalloenzyme activity);GO:0048664(neuron fate determination);GO:0051017(actin filament bundle assembly);GO:0051056(regulation of small GTPase mediated signal transduction);GO:0051149(positive regulation of muscle cell differentiation);GO:0051233(spindle midzone);GO:0051489(regulation of filopodium assembly)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04370(VEGF signaling pathway);04144(Endocytosis);04810(Regulation of actin cytoskeleton);04510(Focal adhesion);04520(Adherens junction);04530(Tight junction);04660(T cell receptor signaling pathway);04666(Fc gamma R-mediated phagocytosis);04670(Leukocyte transendothelial migration);04062(Chemokine signaling pathway);04912(GnRH signaling pathway);04722(Neurotrophin signaling pathway);04360(Axon guidance);05200(Pathways in cancer);05205(Proteoglycans in cancer);05203(Viral carcinogenesis);05212(Pancreatic cancer);05211(Renal cell carcinoma);04932(Non-alcoholic fatty liver disease (NAFLD));05120(Epithelial cell signaling in Helicobacter pylori infection);05130(Pathogenic Escherichia coli infection);05132(Salmonella infection);05131(Shigellosis);05100(Bacterial invasion of epithelial cells)","mRNA","agilent G3 V3"]
["A_23_P66798",5.01,2.24,5.01,7.13,8.33,8.01,{"v":0.522368981678739,"d":"0.52"},{"v":-0.936858862832389,"d":"-0.94"},"down",{"v":0.0195637,"d":"0.02"},1,"yes","CTTCTGCTGTCCTTTGGAGGGTGTCTTCTGGGTAGAGGGATGGGAAGGAAGGGACCCTTA","FALSE","NM_002276","ref|NM_002276|ens|ENST00000361566|gb|AK293479|gb|Y00503","KRT19","keratin 19, type I","ref|Homo sapiens keratin 19, type I (KRT19), mRNA [NM_002276]","chr17",39680772,39684551,"GO:0005200(structural constituent of cytoskeleton);GO:0005515(protein binding);GO:0005882(intermediate filament);GO:0008307(structural constituent of muscle);GO:0016010(dystrophin-associated glycoprotein complex);GO:0016032(viral reproduction);GO:0030018(Z disc);GO:0032403(protein complex binding);GO:0042383(sarcolemma);GO:0043034(costamere);GO:0043627(response to estrogen stimulus);GO:0045214(sarcomere organization);GO:0060706(cell differentiation involved in embryonic placenta development);GO:0070062(extracellular vesicular exosome);GO:0071944(cell periphery)",null,"mRNA","agilent G3 V3"]
["A_33_P3318946",8.12,8.64,{"v":8.3,"d":"8.30"},9.11,8.87,8.97,{"v":0.92987012987013,"d":"0.93"},{"v":-0.104898858318007,"d":"-0.10"},"down",{"v":0.0197959,"d":"0.02"},1,"yes","GAGGCGGCCGGGGGCATTAACTGACCTCTGAGTACAGCAATAAAATAACCTGGGGATCTT","FALSE","NM_021817","ref|NM_021817|ens|ENST00000255039|ref|XM_005245415|gb|AK294131","HAPLN2","hyaluronan and proteoglycan link protein 2","ref|Homo sapiens hyaluronan and proteoglycan link protein 2 (HAPLN2), mRNA [NM_021817]","chr1",156593856,156595327,"GO:0001501(skeletal system development);GO:0005201(extracellular matrix structural constituent);GO:0005540(hyaluronic acid binding);GO:0005578(proteinaceous extracellular matrix);GO:0007155(cell adhesion);GO:0007417(central nervous system development);GO:0008065(establishment of blood-nerve barrier);GO:0085029(extracellular matrix assembly)",null,"mRNA","agilent G3 V3"]
["A_23_P403588",1.94,2.06,1.92,4.04,4.19,5.17,{"v":0.441791044776119,"d":"0.44"},{"v":-1.17856391971619,"d":"-1.18"},"down",{"v":0.0198962,"d":"0.02"},1,"yes","CCCTCACACTAGAGTGTTTGGTCATCTCTTATAATGTAAGGGAAGGTACTTTAAAATTCT","FALSE","NM_017944","ref|NM_017944|ref|NM_001282659|ens|ENST00000305481|ens|ENST00000339865","USP47","ubiquitin specific peptidase 47","ref|Homo sapiens ubiquitin specific peptidase 47 (USP47), transcript variant 2, mRNA [NM_017944]","chr11",11971990,11980701,"GO:0004197(cysteine-type endopeptidase activity);GO:0004843(ubiquitin-specific protease activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006284(base-excision repair);GO:0006974(response to DNA damage stimulus);GO:0010972(negative regulation of G2/M transition of mitotic cell cycle);GO:0019005(SCF ubiquitin ligase complex);GO:0030307(positive regulation of cell growth);GO:0034644(cellular response to UV);GO:0035520(monoubiquitinated protein deubiquitination);GO:0042493(response to drug);GO:0043066(negative regulation of apoptotic process);GO:0043154(negative regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043161(proteasomal ubiquitin-dependent protein catabolic process);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0061136(regulation of proteasomal protein catabolic process);GO:0071987(WD40-repeat domain binding)",null,"mRNA","agilent G3 V3"]
["A_32_P156892",4.59,3.38,4.37,5.34,5.66,5.91,{"v":0.729745712596097,"d":"0.73"},{"v":-0.454534265260565,"d":"-0.45"},"down",{"v":0.0200800000000001,"d":"0.02"},1,"yes","AGTTCAACATAGGGCACAGAAAATTGCAGAACATCGGAGAAAGTATGAGCGAAAATGTGA","FALSE","NM_003932","ref|NM_003932|ref|NM_001278589|ref|NR_002183|ens|ENST00000421179","ST13","suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein)","ref|Homo sapiens suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) (ST13), transcript variant 1, mRNA [NM_003932]","chr22",41220540,41253026,"GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006457(protein folding);GO:0019904(protein domain specific binding);GO:0030544(Hsp70 protein binding);GO:0030674(protein binding, bridging);GO:0032403(protein complex binding);GO:0032564(dATP binding);GO:0042802(identical protein binding);GO:0043234(protein complex);GO:0051082(unfolded protein binding);GO:0051087(chaperone binding);GO:0051260(protein homooligomerization);GO:0061084(negative regulation of protein refolding);GO:0070062(extracellular vesicular exosome);GO:0070389(chaperone cofactor-dependent protein refolding)",null,"mRNA","agilent G3 V3"]
["A_23_P30745",7.01,7.79,6.74,9.41,9.33,9.36,{"v":0.766548042704626,"d":"0.77"},{"v":-0.383551880564081,"d":"-0.38"},"down",{"v":0.020205,"d":"0.02"},1,"yes","CCAGAACCAGCACAGGACTGAACACATCCCTGGTTGTAATGTCCATTTCCATCTTCCCCG","FALSE","NM_014623","ref|NM_014623|ens|ENST00000244711|ref|XM_005249121|ref|XM_005249122","MEA1","male-enhanced antigen 1","ref|Homo sapiens male-enhanced antigen 1 (MEA1), mRNA [NM_014623]","chr6",42979832,42981706,"GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0007283(spermatogenesis);GO:0008584(male gonad development);GO:0030154(cell differentiation)",null,"mRNA","agilent G3 V3"]
["A_23_P52207",7.65,5.52,6.84,9.02,8.96,10.09,{"v":0.712860705379408,"d":"0.71"},{"v":-0.488307896606783,"d":"-0.49"},"down",{"v":0.020378,"d":"0.02"},1,"yes","AAGACTTTGTACACACTGTCACCAGGGTTATTTGCATCCAAGGGAGCTGGAATTGAGTAC","FALSE","NM_012342","ref|NM_012342|ens|ENST00000375533|ens|ENST00000622753|gb|AK290639","BAMBI","BMP and activin membrane-bound inhibitor","ref|Homo sapiens BMP and activin membrane-bound inhibitor (BAMBI), mRNA [NM_012342]","chr10",28966440,28971606,"GO:0005109(frizzled binding);GO:0005114(type II transforming growth factor beta receptor binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0008284(positive regulation of cell proliferation);GO:0008360(regulation of cell shape);GO:0010718(positive regulation of epithelial to mesenchymal transition);GO:0016021(integral to membrane);GO:0016477(cell migration);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0032092(positive regulation of protein binding);GO:0035413(positive regulation of catenin import into nucleus);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0090263(positive regulation of canonical Wnt receptor signaling pathway)","04310(Wnt signaling pathway);04350(TGF-beta signaling pathway)","mRNA","agilent G3 V3"]
["A_23_P218706",8.63,8.03,8.48,7.57,6.89,{"v":6.4,"d":"6.40"},{"v":1.20517737296261,"d":"1.21"},{"v":0.269245491900742,"d":"0.27"},"up",{"v":0.020583,"d":"0.02"},1,"yes","CCCCAGTAAGCCCCAGAGTATATTGAATAGAAATTCTGCATGTGTGGGGAGAATGGACAA","FALSE","NM_024325","ref|NM_024325|ref|NM_001282497|ref|NM_001282496|ref|NM_001282495","ZNF343","zinc finger protein 343","ref|Homo sapiens zinc finger protein 343 (ZNF343), transcript variant 1, mRNA [NM_024325]","chr20",{"v":2462463,"d":"2462463.00"},2489778,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3356821",{"v":7.1,"d":"7.10"},6.63,6.07,5.24,4.45,3.44,{"v":1.50799695354151,"d":"1.51"},{"v":0.592633514074085,"d":"0.59"},"up",{"v":0.020736,"d":"0.02"},1,"yes","CCCCTAGCTTACTCAATGTCATTTGCAGCGTGCATCTGCTGATTAAAGGACTAAAACAAG","FALSE","NM_178351","ref|NM_178351|ref|NM_001276331|ens|ENST00000607093|tc|THC2680271","LCE1C","late cornified envelope 1C","ref|Homo sapiens late cornified envelope 1C (LCE1C), transcript variant 1, mRNA [NM_178351]","chr1",152777312,152779107,"GO:0031424(keratinization)",null,"mRNA","agilent G3 V3"]
["A_33_P3330413",9.46,9.17,{"v":9.4,"d":"9.40"},9.04,{"v":8.9,"d":"8.90"},8.76,{"v":1.0498127340824,"d":"1.05"},{"v":0.070132002457578,"d":"0.07"},"up",{"v":0.020803,"d":"0.02"},1,"yes","ATTTACTTCCCCCATCCTGGTTTAAGTATAAAGCACTGTGAATGAAGGTAGTTGTCCGGT","FALSE",{"$nulls":5},"chr8",48504708,48505171,null,null,"mRNA","agilent G3 V3"]
["A_33_P3327519",5.46,5.48,5.18,3.91,3.63,4.74,{"v":1.31270358306189,"d":"1.31"},{"v":0.392541183157788,"d":"0.39"},"up",{"v":0.021057,"d":"0.02"},1,"yes","TGCACCTCTGAGAGTGGAATGACTCCTGTGGAGTTGATCCTAGTCTGGGTGCAAACAATT","FALSE","NR_002915","ref|NR_002915|gb|X94290|tc|NP1164007","SNORA74A","small nucleolar RNA, H/ACA box 74A","ref|Homo sapiens small nucleolar RNA, H/ACA box 74A (SNORA74A), small nucleolar RNA [NR_002915]","chr5",138614464,138614667,null,null,"mRNA","agilent G3 V3"]
["A_33_P3360301",4.78,3.34,4.22,{"v":6.9,"d":"6.90"},6.93,7.07,{"v":0.590430622009569,"d":"0.59"},{"v":-0.760160547818827,"d":"-0.76"},"down",{"v":0.021218,"d":"0.02"},1,"yes","CTGCGTGATTTGATTCTGTTGTACCTTCAATTCTTCTGACCCGCATTATAAACATTATAA","FALSE","NM_001199161","ref|NM_001199161|ref|NM_001199162|ref|XM_005264829|ref|XM_006712948","USP19","ubiquitin specific peptidase 19","ref|Homo sapiens ubiquitin specific peptidase 19 (USP19), transcript variant 2, mRNA [NM_001199161]","chr3",49145564,49158371,"GO:0004197(cysteine-type endopeptidase activity);GO:0004843(ubiquitin-specific protease activity);GO:0005515(protein binding);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0016021(integral to membrane);GO:0016579(protein deubiquitination);GO:0030433(ER-associated protein catabolic process);GO:0031647(regulation of protein stability);GO:0034976(response to endoplasmic reticulum stress);GO:0046872(metal ion binding);GO:0048642(negative regulation of skeletal muscle tissue development);GO:0061136(regulation of proteasomal protein catabolic process);GO:0090068(positive regulation of cell cycle process);GO:1900037(regulation of cellular response to hypoxia)",null,"mRNA","agilent G3 V3"]
["A_23_P3819",7.52,7.29,7.49,7.16,6.99,7.15,{"v":1.04694835680751,"d":"1.05"},{"v":0.0661902796944662,"d":"0.07"},"up",{"v":0.0213749999999999,"d":"0.02"},1,"yes","GCAAAAGCTGTTTCTCCTCCCAGAGATGCTAAGAGGATTGAGGTAGAGAAGAACCTTGTT","FALSE","NM_023931","ref|NM_023931|gb|AK292192|gb|AK054567|gb|BC001361","ZNF747","zinc finger protein 747","ref|Homo sapiens zinc finger protein 747 (ZNF747), mRNA [NM_023931]","chr16",30543628,30546325,"GO:0003676(nucleic acid binding);GO:0005622(intracellular);GO:0006355(regulation of transcription, DNA-dependent)",null,"mRNA","agilent G3 V3"]
["A_23_P255444",6.15,5.07,5.25,4.22,4.04,4.38,{"v":1.30300632911392,"d":"1.30"},{"v":0.381844091549252,"d":"0.38"},"up",{"v":0.021459,"d":"0.02"},1,"yes","AGAAGAATGAGATACTGATGTCCACAGTTCATTGGCAGAATCTAACCCCTTCTGTTATCT","FALSE","NM_014395","ref|NM_014395|ens|ENST00000514301|gb|BC012924|gb|AL713793","DAPP1","dual adaptor of phosphotyrosine and 3-phosphoinositides","ref|Homo sapiens dual adaptor of phosphotyrosine and 3-phosphoinositides (DAPP1), mRNA [NM_014395]","chr4",100786032,100790771,"GO:0005543(phospholipid binding);GO:0005547(phosphatidylinositol-3,4,5-trisphosphate binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006470(protein dephosphorylation);GO:0007165(signal transduction);GO:0043325(phosphatidylinositol-3,4-bisphosphate binding)","04662(B cell receptor signaling pathway)","mRNA","agilent G3 V3"]
["A_21_P0010986",3.52,1.88,2.16,6.09,5.89,5.84,{"v":0.424242424242424,"d":"0.42"},{"v":-1.23703919730085,"d":"-1.24"},"down",{"v":0.021702,"d":"0.02"},1,"yes","AGTCAGTATGAGATGGGAGAATGCACACAAGGCAGCTTCTGCAACTTCATGCATTTGAAG","FALSE","NM_001025204","ref|NM_001025204|ref|NM_001025203|ref|NM_006758|ens|ENST00000393668","U2AF1","U2 small nuclear RNA auxiliary factor 1","ref|Homo sapiens U2 small nuclear RNA auxiliary factor 1 (U2AF1), transcript variant c, mRNA [NM_001025204]","chr21",44513064,44527688,"GO:0000166(nucleotide binding);GO:0000398(nuclear mRNA splicing, via spliceosome);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005681(spliceosomal complex);GO:0006366(transcription from RNA polymerase II promoter);GO:0006369(termination of RNA polymerase II transcription);GO:0006397(mRNA processing);GO:0006406(mRNA export from nucleus);GO:0008380(RNA splicing);GO:0010467(gene expression);GO:0015030(Cajal body);GO:0016607(nuclear speck);GO:0031124(mRNA 3'-end processing);GO:0046872(metal ion binding);GO:0050733(RS domain binding);GO:0071013(catalytic step 2 spliceosome)","03040(Spliceosome);05131(Shigellosis)","mRNA","agilent G3 V3"]
["A_23_P82748",6.21,7.11,5.73,8.08,7.69,7.86,{"v":0.806178586542531,"d":"0.81"},{"v":-0.310828631593162,"d":"-0.31"},"down",{"v":0.022056,"d":"0.02"},1,"yes","CATTCCTTGCTCAGCATGCCAGCCTTTAAGATTGAATTAGATTGTGTTGTTGTGGTTTTA","FALSE","NM_020189","ref|NM_020189|ref|NM_001193557|ref|NR_036472|ref|NR_036471","ENY2","enhancer of yellow 2 homolog (Drosophila)","ref|Homo sapiens enhancer of yellow 2 homolog (Drosophila) (ENY2), transcript variant 1, mRNA [NM_020189]","chr8",110352592,110358181,"GO:0000124(SAGA complex);GO:0003713(transcription coactivator activity);GO:0005643(nuclear pore);GO:0006325(chromatin organization);GO:0006368(transcription elongation from RNA polymerase II promoter);GO:0006406(mRNA export from nucleus);GO:0015031(protein transport);GO:0016578(histone deubiquitination);GO:0030374(ligand-dependent nuclear receptor transcription coactivator activity);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0070390(transcription export complex 2);GO:0071819(DUBm complex)",null,"mRNA","agilent G3 V3"]
["A_24_P408047",5.18,7.03,5.91,8.41,7.72,8.29,{"v":0.742014742014742,"d":"0.74"},{"v":-0.430480244941168,"d":"-0.43"},"down",{"v":0.0221629999999999,"d":"0.02"},1,"yes","CTATGGCCAAAGTTTGGTTTTCTCAACACTGTCTAAATTTGGATTAAAACTTTGAACTTT","FALSE","NM_020904","ref|NM_020904|ref|NM_001161354|ens|ENST00000263265|ens|ENST00000355496","PLEKHA4","pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 4","ref|Homo sapiens pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 4 (PLEKHA4), transcript variant 1, mRNA [NM_020904]","chr19",49340440,49341571,"GO:0005545(1-phosphatidylinositol binding);GO:0005575(cellular_component);GO:0005737(cytoplasm);GO:0008150(biological_process);GO:0016020(membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3337272",4.44,5.14,{"v":3.7,"d":"3.70"},6.31,6.13,5.73,{"v":0.730875068794717,"d":"0.73"},{"v":-0.452303272887191,"d":"-0.45"},"down",{"v":0.022262,"d":"0.02"},1,"yes","CACATTCCTGAGTGTACGATATTGACCTGTAGCCCAGCGTGAAAAATTTATAAATAAATT","FALSE","NM_001004354","ref|NM_001004354|gb|AJ420434|tc|THC2667407","NRARP","NOTCH-regulated ankyrin repeat protein","ref|Homo sapiens NOTCH-regulated ankyrin repeat protein (NRARP), mRNA [NM_001004354]","chr9",140194080,140196703,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0001569(patterning of blood vessels);GO:0001938(positive regulation of endothelial cell proliferation);GO:0002043(blood vessel endothelial cell proliferation involved in sprouting angiogenesis);GO:0032525(somite rostral/caudal axis specification);GO:0045581(negative regulation of T cell differentiation);GO:0045746(negative regulation of Notch signaling pathway);GO:0090263(positive regulation of canonical Wnt receptor signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_33_P3334443",4.21,4.59,3.63,6.47,5.83,5.18,{"v":0.711098398169336,"d":"0.71"},{"v":-0.491878888448113,"d":"-0.49"},"down",{"v":0.022418,"d":"0.02"},1,"yes","CCTTCAACGCCATGGATTAGCACCAGTTTTGTTTACTTTAAGGTACTTTTCCCATTCATC","FALSE","NM_001252271","ref|NM_001252271|ref|NM_001006605|ref|NM_001252269|ref|NM_001252270","FAM69A","family with sequence similarity 69, member A","ref|Homo sapiens family with sequence similarity 69, member A (FAM69A), transcript variant 4, mRNA [NM_001252271]","chr1",93307728,93427057,"GO:0005789(endoplasmic reticulum membrane);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_24_P237389",2.99,3.56,3.79,4.23,4.43,4.33,{"v":0.795996920708237,"d":"0.80"},{"v":-0.329165245132946,"d":"-0.33"},"down",{"v":0.0225599999999999,"d":"0.02"},1,"yes","GCAGTCTTTGATTCGTACAATAGAAGGAACACGTAGAATGTATATTTGTACATTCATGTC","FALSE","NM_001412","ref|NM_001412|ens|ENST00000379607|gb|AL079283|gb|BC047573","EIF1AX","eukaryotic translation initiation factor 1A, X-linked","ref|Homo sapiens eukaryotic translation initiation factor 1A, X-linked (EIF1AX), mRNA [NM_001412]","chrX",20142636,20159962,"GO:0003743(translation initiation factor activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0006412(translation);GO:0006413(translational initiation);GO:0008135(translation factor activity, nucleic acid binding);GO:0010467(gene expression);GO:0044267(cellular protein metabolic process)","03013(RNA transport)","mRNA","agilent G3 V3"]
["A_23_P1492",3.99,2.34,4.08,5.62,{"v":5.3,"d":"5.30"},5.86,{"v":0.620381406436234,"d":"0.62"},{"v":-0.688772647140406,"d":"-0.69"},"down",{"v":0.022582,"d":"0.02"},1,"yes","TGGGAGCAAAGTGACAGGCACTTAGATGCAGCATTTCACCACTCATGCTACTAATCATCT","FALSE","NM_021732","ref|NM_021732|ens|ENST00000370626|gb|AF241786|gb|BC000877","AVPI1","arginine vasopressin-induced 1","ref|Homo sapiens arginine vasopressin-induced 1 (AVPI1), mRNA [NM_021732]","chr10",99437184,99447080,"GO:0000187(activation of MAPK activity);GO:0007049(cell cycle)",null,"mRNA","agilent G3 V3"]
["A_23_P128073",10.97,11.18,10.93,{"v":11.3,"d":"11.30"},11.29,11.35,{"v":0.974661166764879,"d":"0.97"},{"v":-0.0370273303713886,"d":"-0.04"},"down",{"v":0.022841,"d":"0.02"},1,"yes","CAAGGTTCTATTAACCACTTCTAAGGGTACACCTCCCTCCAAACTACTGCATTTTCTATG","FALSE","NM_139067","ref|NM_139067|ref|NM_003075|ref|NM_001130420|ens|ENST00000267064","SMARCC2","SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2","ref|Homo sapiens SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2 (SMARCC2), transcript variant 2, mRNA [NM_139067]","chr12",56557128,56583332,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000790(nuclear chromatin);GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0000980(RNA polymerase II distal enhancer sequence-specific DNA binding);GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0006325(chromatin organization);GO:0006337(nucleosome disassembly);GO:0006338(chromatin remodeling);GO:0006351(transcription, DNA-dependent);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0016514(SWI/SNF complex);GO:0017053(transcriptional repressor complex);GO:0021882(regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment);GO:0031492(nucleosomal DNA binding);GO:0043044(ATP-dependent chromatin remodeling);GO:0043234(protein complex);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0071564(npBAF complex);GO:0071565(nBAF complex)",null,"mRNA","agilent G3 V3"]
["A_23_P218079",3.47,{"v":4.5,"d":"4.50"},3.16,5.09,5.14,5.33,{"v":0.715295629820051,"d":"0.72"},{"v":-0.483388467644233,"d":"-0.48"},"down",{"v":0.0230009999999999,"d":"0.02"},1,"yes","ACAAAACCACGAGTCTCGGGTTAAGGGAAGTGACAATTTTATTCCATTCCAGAGAATGGA","FALSE","NM_018976","ref|NM_018976|ens|ENST00000549258|ens|ENST00000256689|ref|XM_005268983","SLC38A2","solute carrier family 38, member 2","ref|Homo sapiens solute carrier family 38, member 2 (SLC38A2), mRNA [NM_018976]","chr12",46754900,46756687,"GO:0003333(amino acid transmembrane transport);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0006811(ion transport);GO:0006814(sodium ion transport);GO:0006865(amino acid transport);GO:0007268(synaptic transmission);GO:0007269(neurotransmitter secretion);GO:0014047(glutamate secretion);GO:0015171(amino acid transmembrane transporter activity);GO:0015293(symporter activity);GO:0055085(transmembrane transport)","04974(Protein digestion and absorption);04724(Glutamatergic synapse);04727(GABAergic synapse)","mRNA","agilent G3 V3"]
["A_33_P3240497",7.57,7.54,7.42,7.89,7.83,7.67,{"v":0.963232150491663,"d":"0.96"},{"v":-0.0540445481169996,"d":"-0.05"},"down",{"v":0.023161,"d":"0.02"},1,"yes","TGGTCTCCCTTTCTTCAGTTTCCTTATTCCAGGCTTTCTTCCACATTGCTACCAGAATTA","FALSE","AK095730","gb|AK095730|tc|THC2487176",null,null,"gb|Homo sapiens cDNA FLJ38411 fis, clone FEBRA2009352. [AK095730]",{"$nulls":5},"mRNA","agilent G3 V3"]
["A_23_P137543",6.29,5.15,5.89,8.03,7.94,7.88,{"v":0.726624737945493,"d":"0.73"},{"v":-0.460717611732704,"d":"-0.46"},"down",{"v":0.02318,"d":"0.02"},1,"yes","ACTCCCTGTAAATACGCTGTTATACATACTGTTAACACCCCTTTGCTTTTTCTATGGGAC","FALSE","NM_152493","ref|NM_152493|ens|ENST00000539719|ens|ENST00000373428|ref|XM_005270508","ZNF362","zinc finger protein 362","ref|Homo sapiens zinc finger protein 362 (ZNF362), mRNA [NM_152493]","chr1",33736176,33766320,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_21_P0000285",{"v":8,"d":"8.00"},8.05,7.76,7.26,6.91,7.52,{"v":1.09774089442139,"d":"1.10"},{"v":0.134537567598061,"d":"0.13"},"up",{"v":0.0234369999999999,"d":"0.02"},1,"yes","AATCACTAATAGGAAGTGCCGTCAGAAGCGATAACTGACGAAGACTACTCCTGTCTGATT","FALSE","NR_002744","ref|NR_002744|linc|lnc-TRPV2-1:14|linc|lnc-TRPV2-1:6|gb|X96649","SNORD49A","small nucleolar RNA, C/D box 49A","ref|Homo sapiens small nucleolar RNA, C/D box 49A (SNORD49A), small nucleolar RNA [NR_002744]","chr17",16343349,16343420,null,null,"mRNA","agilent G3 V3"]
["A_23_P218784",6.86,5.63,6.08,8.53,8.44,8.49,{"v":0.729379418695994,"d":"0.73"},{"v":-0.455258603965937,"d":"-0.46"},"down",{"v":0.0237360000000001,"d":"0.02"},1,"yes","CATGGAGACAAGAGTCAACCAGAAAGAGATTGGGTACTTAATGAGTTCCGTTCTGGAAAG","FALSE","NM_006386","ref|NM_006386|ref|NM_001098504|ens|ENST00000432525|ens|ENST00000475004","DDX17","DEAD (Asp-Glu-Ala-Asp) box helicase 17","ref|Homo sapiens DEAD (Asp-Glu-Ala-Asp) box helicase 17 (DDX17), transcript variant 1, mRNA [NM_006386]","chr22",38879444,38902342,"GO:0003713(transcription coactivator activity);GO:0003723(RNA binding);GO:0003724(RNA helicase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006351(transcription, DNA-dependent);GO:0006396(RNA processing);GO:0008186(RNA-dependent ATPase activity);GO:0016020(membrane);GO:0030331(estrogen receptor binding);GO:0033148(positive regulation of intracellular estrogen receptor signaling pathway);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:2001014(regulation of skeletal muscle cell differentiation)",null,"mRNA","agilent G3 V3"]
["A_23_P125815",4.94,2.57,4.76,7.05,6.85,{"v":6.6,"d":"6.60"},{"v":0.598536585365854,"d":"0.60"},{"v":-0.740488660729903,"d":"-0.74"},"down",{"v":0.023802,"d":"0.02"},1,"yes","CAGCTCCTACGGGGTCACCTCAACCGAGTCCTACAAGGAGACACTGCACAAGACAATGGT","FALSE","NM_005676","ref|NM_005676|ref|NM_001204468|ref|NM_001204467|ref|NM_001204466","RBM10","RNA binding motif protein 10","ref|Homo sapiens RNA binding motif protein 10 (RBM10), transcript variant 1, mRNA [NM_005676]","chrX",47004632,47046211,"GO:0000166(nucleotide binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006397(mRNA processing);GO:0008150(biological_process);GO:0008270(zinc ion binding);GO:0008380(RNA splicing);GO:0032403(protein complex binding);GO:0042802(identical protein binding)",null,"mRNA","agilent G3 V3"]
["A_32_P226149",5.18,6.02,4.44,6.97,7.08,6.64,{"v":0.755920734654422,"d":"0.76"},{"v":-0.403693132552657,"d":"-0.40"},"down",{"v":0.023959,"d":"0.02"},1,"yes","CTCTAAATAATGATGGGGCTAAGTTATACCCAAAGCTCACTTTACAAAATATTTCGTCAG","FALSE","NM_145690","ref|NM_145690|ref|NM_001135702|ref|NM_001135701|ref|NM_001135699","YWHAZ","tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta","ref|Homo sapiens tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta (YWHAZ), transcript variant 2, mRNA [NM_145690]","chr8",101930808,101964357,"GO:0002553(histamine secretion by mast cell);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0005925(focal adhesion);GO:0006626(protein targeting to mitochondrion);GO:0006915(apoptotic process);GO:0007165(signal transduction);GO:0007596(blood coagulation);GO:0008134(transcription factor binding);GO:0010467(gene expression);GO:0014069(postsynaptic density);GO:0019901(protein kinase binding);GO:0019904(protein domain specific binding);GO:0030168(platelet activation);GO:0030659(cytoplasmic vesicle membrane);GO:0031252(cell leading edge);GO:0032403(protein complex binding);GO:0042470(melanosome);GO:0042493(response to drug);GO:0042629(mast cell granule);GO:0042802(identical protein binding);GO:0043066(negative regulation of apoptotic process);GO:0043234(protein complex);GO:0048471(perinuclear region of cytoplasm);GO:0051683(establishment of Golgi localization);GO:0061024(membrane organization);GO:0070062(extracellular vesicular exosome);GO:0072562(blood microparticle);GO:0090168(Golgi reassembly);GO:0097193(intrinsic apoptotic signaling pathway);GO:1900740(positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway)","04390(Hippo signaling pathway);04151(PI3K-Akt signaling pathway);04110(Cell cycle);04114(Oocyte meiosis);05203(Viral carcinogenesis);05130(Pathogenic Escherichia coli infection);05161(Hepatitis B);05169(Epstein-Barr virus infection)","mRNA","agilent G3 V3"]
["A_32_P96807",4.36,1.95,3.31,5.49,5.75,5.88,{"v":0.561915887850467,"d":"0.56"},{"v":-0.831573902631105,"d":"-0.83"},"down",{"v":0.024098,"d":"0.02"},1,"yes","CTGGGTCTAAATAAGTACATGTTCCCACTTGTTGCCGATTTTTGAGAGTACTAGGGCCAT","FALSE","NM_001300850","ref|NM_001300850|ref|NM_172071|ref|NM_001300851|ref|NM_001300852","RC3H1","ring finger and CCCH-type domains 1","ref|Homo sapiens ring finger and CCCH-type domains 1 (RC3H1), transcript variant 1, mRNA [NM_001300850]","chr1",173900352,173962202,"GO:0000932(cytoplasmic mRNA processing body);GO:0000956(nuclear-transcribed mRNA catabolic process);GO:0001782(B cell homeostasis);GO:0002634(regulation of germinal center formation);GO:0002635(negative regulation of germinal center formation);GO:0003730(mRNA 3'-UTR binding);GO:0008270(zinc ion binding);GO:0010494(cytoplasmic stress granule);GO:0010608(posttranscriptional regulation of gene expression);GO:0016567(protein ubiquitination);GO:0030889(negative regulation of B cell proliferation);GO:0033962(cytoplasmic mRNA processing body assembly);GO:0042098(T cell proliferation);GO:0043029(T cell homeostasis);GO:0043488(regulation of mRNA stability);GO:0045623(negative regulation of T-helper cell differentiation);GO:0046007(negative regulation of activated T cell proliferation);GO:0048535(lymph node development);GO:0048536(spleen development);GO:0050856(regulation of T cell receptor signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_33_P3328284",9.78,9.57,9.86,9.44,9.36,9.45,{"v":1.03398230088496,"d":"1.03"},{"v":0.0482114906392667,"d":"0.05"},"up",{"v":0.024562,"d":"0.02"},1,"yes","TTACAAGAATTTGAGAATGATGAAGACATCAGGCCCTCCTTCAGGACTCCACCACCTTTC","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_33_P3210647",7.25,6.26,7.21,{"v":8.6,"d":"8.60"},8.24,{"v":7.9,"d":"7.90"},{"v":0.837510105092967,"d":"0.84"},{"v":-0.255821497289816,"d":"-0.26"},"down",{"v":0.0246160000000001,"d":"0.02"},1,"yes","AGGGGTGAAAGGAGCCACCGGACCTGTGGGACCTCCTGGGGCCAGTGTCTCTGGGCCTCC","FALSE","NM_001856","ref|NM_001856|ens|ENST00000373672|ref|XM_005270481|gb|BC167814","COL16A1","collagen, type XVI, alpha 1","ref|Homo sapiens collagen, type XVI, alpha 1 (COL16A1), mRNA [NM_001856]","chr1",32117848,32169768,"GO:0005178(integrin binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005578(proteinaceous extracellular matrix);GO:0005597(collagen type XVI);GO:0005788(endoplasmic reticulum lumen);GO:0007155(cell adhesion);GO:0007229(integrin-mediated signaling pathway);GO:0007565(female pregnancy);GO:0022617(extracellular matrix disassembly);GO:0030198(extracellular matrix organization);GO:0030574(collagen catabolic process);GO:0071230(cellular response to amino acid stimulus)",null,"mRNA","agilent G3 V3"]
["A_33_P3343785",3.68,1.85,2.03,6.12,6.16,6.17,{"v":0.409756097560976,"d":"0.41"},{"v":-1.28716267672669,"d":"-1.29"},"down",{"v":0.024799,"d":"0.02"},1,"yes","GCCTTAAAATAGTAGCCTGCTACAATGACTTCTTTGGGTAGCCATTTTCATAAGAAATAA","FALSE","NM_052865","ref|NM_052865|ens|ENST00000377710|ens|ENST00000377709|ens|ENST00000377704","MGME1","mitochondrial genome maintenance exonuclease 1","ref|Homo sapiens mitochondrial genome maintenance exonuclease 1 (MGME1), mRNA [NM_052865]","chr20",17950700,17970874,"GO:0000738(DNA catabolic process, exonucleolytic);GO:0005739(mitochondrion);GO:0006264(mitochondrial DNA replication);GO:0008297(single-stranded DNA specific exodeoxyribonuclease activity);GO:0043504(mitochondrial DNA repair)",null,"mRNA","agilent G3 V3"]
["A_24_P349039",3.55,1.93,{"v":2.2,"d":"2.20"},{"v":4.6,"d":"4.60"},4.08,4.52,{"v":0.581818181818182,"d":"0.58"},{"v":-0.781359713524659,"d":"-0.78"},"down",{"v":0.025019,"d":"0.03"},1,"yes","ATGTCACCATAGATAAAAGCCTCATACAAAGGCAGAACTACACTCCAAATTTAATGTGTT","FALSE","NM_020754","ref|NM_020754|ens|ENST00000264245|ref|XM_006713714|ref|XM_005247671","ARHGAP31","Rho GTPase activating protein 31","ref|Homo sapiens Rho GTPase activating protein 31 (ARHGAP31), mRNA [NM_020754]","chr3",119013216,119139561,"GO:0005096(GTPase activator activity);GO:0005829(cytosol);GO:0005925(focal adhesion);GO:0007264(small GTPase mediated signal transduction);GO:0017124(SH3 domain binding);GO:0030027(lamellipodium);GO:0043547(positive regulation of GTPase activity);GO:0051056(regulation of small GTPase mediated signal transduction)",null,"mRNA","agilent G3 V3"]
["A_23_P40025",6.74,7.63,6.26,8.24,{"v":8.2,"d":"8.20"},8.53,{"v":0.826191429715659,"d":"0.83"},{"v":-0.275452000041727,"d":"-0.28"},"down",{"v":0.025139,"d":"0.03"},1,"yes","TGTGTTCTGTACATGTGATGTTTGACTGTACCATTGACTGTTATGGAAGTTCAGCGTTGT","FALSE","NM_014764","ref|NM_014764|ref|NM_001136264|ref|NM_001136266|ref|NM_001136267","DAZAP2","DAZ associated protein 2","ref|Homo sapiens DAZ associated protein 2 (DAZAP2), transcript variant 1, mRNA [NM_014764]","chr12",51632508,51637715,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0050699(WW domain binding)",null,"mRNA","agilent G3 V3"]
["A_24_P97001",3.84,2.09,3.54,4.96,4.96,5.31,{"v":0.621799080761655,"d":"0.62"},{"v":-0.685479611018907,"d":"-0.69"},"down",{"v":0.025502,"d":"0.03"},1,"yes","CTGGTCATAAGGTAAACATTCTATATATTCTATGCCTGCTCTAGAATTGAAAGACTTCAG","FALSE","NM_032864","ref|NM_032864|gb|AK092038|gb|AX747327|gb|AK027842","PRPF38A","pre-mRNA processing factor 38A","ref|Homo sapiens pre-mRNA processing factor 38A (PRPF38A), mRNA [NM_032864]","chr1",52870236,52886511,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0006397(mRNA processing);GO:0008380(RNA splicing);GO:0031965(nuclear membrane);GO:0071011(precatalytic spliceosome)","03040(Spliceosome)","mRNA","agilent G3 V3"]
["A_23_P19210",2.68,3.74,2.65,4.17,4.36,4.32,{"v":0.705836575875486,"d":"0.71"},{"v":-0.502593903552718,"d":"-0.50"},"down",{"v":0.025577,"d":"0.03"},1,"yes","AGTAAATGTCCTGAGGGAACAAAACCCATGCTGATATTTGCTGGCGATGATTTCGATGTA","FALSE","NM_032194","ref|NM_032194|ref|NM_001289111|ens|ENST00000368864|ens|ENST00000441448","RPF2","ribosome production factor 2 homolog (S. cerevisiae)","ref|Homo sapiens ribosome production factor 2 homolog (S. cerevisiae) (RPF2), transcript variant 1, mRNA [NM_032194]","chr6",111303520,111345530,"GO:0000027(ribosomal large subunit assembly);GO:0000463(maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0005634(nucleus);GO:0005730(nucleolus);GO:0019843(rRNA binding)",null,"mRNA","agilent G3 V3"]
["A_23_P83110",3.89,4.04,2.66,6.23,6.12,{"v":6.3,"d":"6.30"},{"v":0.567828418230563,"d":"0.57"},{"v":-0.816473041150264,"d":"-0.82"},"down",{"v":0.02582,"d":"0.03"},1,"yes","TTTTGCAGCTGAGCAAGCGCCAGGAAAAAGTCATCTTTGATCAATTGGTCGTAACCCACA","FALSE","NM_018249","ref|NM_018249|ref|NM_001011649|ref|NM_001272039|ref|NR_073556","CDK5RAP2","CDK5 regulatory subunit associated protein 2","ref|Homo sapiens CDK5 regulatory subunit associated protein 2 (CDK5RAP2), transcript variant 1, mRNA [NM_018249]","chr9",123151152,123342436,"GO:0000086(G2/M transition of mitotic cell cycle);GO:0000132(establishment of mitotic spindle orientation);GO:0000226(microtubule cytoskeleton organization);GO:0000242(pericentriolar material);GO:0000278(mitotic cell cycle);GO:0000922(spindle pole);GO:0001578(microtubule bundle formation);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0006996(organelle organization);GO:0007059(chromosome segregation);GO:0007420(brain development);GO:0008017(microtubule binding);GO:0015631(tubulin binding);GO:0019901(protein kinase binding);GO:0022008(neurogenesis);GO:0030054(cell junction);GO:0044212(transcription regulatory region DNA binding);GO:0045664(regulation of neuron differentiation);GO:0045665(negative regulation of neuron differentiation);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0046600(negative regulation of centriole replication);GO:0048471(perinuclear region of cytoplasm);GO:0051297(centrosome organization);GO:0070062(extracellular vesicular exosome);GO:0090231(regulation of spindle checkpoint)",null,"mRNA","agilent G3 V3"]
["A_23_P44674",6.25,7.17,5.31,7.78,8.54,8.72,{"v":0.748003194888179,"d":"0.75"},{"v":-0.418883662689573,"d":"-0.42"},"down",{"v":0.026015,"d":"0.03"},1,"yes","CTACGTAGCCATGTTTGGGCCTAAAGGCTTTGGGCGGGGCGGAGCCGAGAGCCACACTTT","FALSE","NM_001311","ref|NM_001311|ens|ENST00000496700|ens|ENST00000461556|ens|ENST00000330233","CRIP1","cysteine-rich protein 1 (intestinal)","ref|Homo sapiens cysteine-rich protein 1 (intestinal) (CRIP1), mRNA [NM_001311]","chrHG1592_PATCH",105953536,105958604,"GO:0003680(AT DNA binding);GO:0005737(cytoplasm);GO:0006955(immune response);GO:0007507(heart development);GO:0008270(zinc ion binding);GO:0008283(cell proliferation);GO:0008301(DNA binding, bending);GO:0008630(DNA damage response, signal transduction resulting in induction of apoptosis);GO:0010033(response to organic substance);GO:0010043(response to zinc ion);GO:0010468(regulation of gene expression);GO:0042277(peptide binding);GO:0060741(prostate gland stromal morphogenesis);GO:0071236(cellular response to antibiotic);GO:0071493(cellular response to UV-B)",null,"mRNA","agilent G3 V3"]
["A_33_P3272558",9.61,{"v":9.5,"d":"9.50"},9.66,9.79,9.73,9.77,{"v":0.98224650051212,"d":"0.98"},{"v":-0.0258429721400799,"d":"-0.03"},"down",{"v":0.026382,"d":"0.03"},1,"yes","TCTGCTCCTGGCTGGCCCGGCCTAATAAAGCAGTGTTGCCATCTCATCTTCCCCCTAAAA","FALSE","NM_001185011","ref|NM_001185011|ref|NM_152299","NCAPH2","non-SMC condensin II complex, subunit H2","ref|Homo sapiens non-SMC condensin II complex, subunit H2 (NCAPH2), transcript variant 3, mRNA [NM_001185011]","chr22",50960952,50961900,"GO:0000278(mitotic cell cycle);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0016020(membrane);GO:0030261(chromosome condensation)",null,"mRNA","agilent G3 V3"]
["A_24_P181672",6.98,6.74,7.34,{"v":6.4,"d":"6.40"},{"v":6,"d":"6.00"},{"v":6.4,"d":"6.40"},{"v":1.12021276595745,"d":"1.12"},{"v":0.163772774460717,"d":"0.16"},"up",{"v":0.026482,"d":"0.03"},1,"yes","AAGATCAGGAAAGGCTTCTATTGCCACGAGGACTCTCAGGAAAGACCCAAGCCCCGAATC","FALSE","NM_001009905","ref|NM_001009905|ens|ENST00000571394|ens|ENST00000621596|ens|ENST00000320865","B3GNTL1","UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1","ref|Homo sapiens UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1 (B3GNTL1), mRNA [NM_001009905]","chr17",80900032,80964864,"GO:0008152(metabolic process);GO:0016757(transferase activity, transferring glycosyl groups)",null,"mRNA","agilent G3 V3"]
["A_23_P71981",5.73,5.02,5.85,6.53,6.36,6.42,{"v":0.859658208182289,"d":"0.86"},{"v":-0.218164922716363,"d":"-0.22"},"down",{"v":0.0266569999999999,"d":"0.03"},1,"yes","CTACAAAGGTGTAGCTAAGAAGATGGCCCATTGGTGGGAGCAATGTCACCCTGCCTCCAG","FALSE","NM_005702","ref|NM_005702|ens|ENST00000471992|ens|ENST00000461894|ens|ENST00000254928","ERAL1","Era-like 12S mitochondrial rRNA chaperone 1","ref|Homo sapiens Era-like 12S mitochondrial rRNA chaperone 1 (ERAL1), mRNA [NM_005702]","chr17",27186004,27188079,"GO:0000028(ribosomal small subunit assembly);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0005759(mitochondrial matrix);GO:0015629(actin cytoskeleton);GO:0019843(rRNA binding);GO:0043024(ribosomal small subunit binding);GO:0045111(intermediate filament cytoskeleton)",null,"mRNA","agilent G3 V3"]
["A_33_P3253832",8.11,6.48,7.84,10.53,10.51,10.45,{"v":0.712289615751032,"d":"0.71"},{"v":-0.489464137049137,"d":"-0.49"},"down",{"v":0.0268389999999999,"d":"0.03"},1,"yes","CCAGCACACAGTAGGCCCTCAATAAAAGCCATTTGCACTTTAAATATATATATGTATGTA","FALSE",{"$nulls":5},"chr9",131182760,131199626,null,null,"mRNA","agilent G3 V3"]
["A_33_P3316323",9.73,{"v":9.8,"d":"9.80"},9.72,9.85,10.03,9.97,{"v":0.979899497487437,"d":"0.98"},{"v":-0.0292943067940383,"d":"-0.03"},"down",{"v":0.0269429999999999,"d":"0.03"},1,"yes","GCATAAAACCCTTAAATTCATCTAGTAGCTGTTCCCCCGAACAGGTTTATTTTAGTAAAA","FALSE","NM_016836","ref|NM_016836|ref|NM_002897|ens|ENST00000409972|ens|ENST00000490637","RBMS1","RNA binding motif, single stranded interacting protein 1","ref|Homo sapiens RNA binding motif, single stranded interacting protein 1 (RBMS1), transcript variant 1, mRNA [NM_016836]","chr2",161130992,161350029,"GO:0000166(nucleotide binding);GO:0003690(double-stranded DNA binding);GO:0003697(single-stranded DNA binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006260(DNA replication);GO:0006396(RNA processing)",null,"mRNA","agilent G3 V3"]
["A_23_P163567",4.53,1.89,3.68,6.31,5.64,6.62,{"v":0.543887991383953,"d":"0.54"},{"v":-0.878618522296264,"d":"-0.88"},"down",{"v":0.027241,"d":"0.03"},1,"yes","CGAAGAGAGGTGTTCTTTTTCCTTACTGGTGCTGAAAGGAAGGATGGATAACGAGGAGAA","FALSE","NM_018667","ref|NM_018667|ens|ENST00000219334|ref|XM_005256031|ref|XM_006721231","SMPD3","sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II)","ref|Homo sapiens sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) (SMPD3), mRNA [NM_018667]","chr16",68392232,68482591,"GO:0000137(Golgi cis cisterna);GO:0000139(Golgi membrane);GO:0002244(hemopoietic progenitor cell differentiation);GO:0004767(sphingomyelin phosphodiesterase activity);GO:0005886(plasma membrane);GO:0006665(sphingolipid metabolic process);GO:0006685(sphingomyelin catabolic process);GO:0006687(glycosphingolipid metabolic process);GO:0007049(cell cycle);GO:0030072(peptide hormone secretion);GO:0044281(small molecule metabolic process);GO:0046872(metal ion binding)","00600(Sphingolipid metabolism)","mRNA","agilent G3 V3"]
["A_23_P83736",7.34,7.76,7.28,6.48,{"v":6.9,"d":"6.90"},6.04,{"v":1.1524201853759,"d":"1.15"},{"v":0.204666835557202,"d":"0.20"},"up",{"v":0.027397,"d":"0.03"},1,"yes","TTGCAATAGATCCTAATGAACCTACATACTGCTTATGCAACCAAGTGTCTTATGGGGAGA","FALSE","NM_001564","ref|NM_001564|ref|NM_001291959|ens|ENST00000302327|gb|AJ006851","ING2","inhibitor of growth family, member 2","ref|Homo sapiens inhibitor of growth family, member 2 (ING2), transcript variant 1, mRNA [NM_001564]","chr4",184427360,184432105,"GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0007141(male meiosis I);GO:0007165(signal transduction);GO:0007283(spermatogenesis);GO:0007286(spermatid development);GO:0008270(zinc ion binding);GO:0008285(negative regulation of cell proliferation);GO:0016568(chromatin modification);GO:0016580(Sin3 complex);GO:0016602(CCAAT-binding factor complex);GO:0030317(sperm motility);GO:0030511(positive regulation of transforming growth factor beta receptor signaling pathway);GO:0032403(protein complex binding);GO:0035064(methylated histone residue binding);GO:0035091(phosphatidylinositol binding);GO:0040008(regulation of growth);GO:0043065(positive regulation of apoptotic process);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0048133(male germ-line stem cell division);GO:0072520(seminiferous tubule development);GO:2000772(regulation of cellular senescence);GO:2001020(regulation of response to DNA damage stimulus)",null,"mRNA","agilent G3 V3"]
["A_33_P3320112",3.42,{"v":2.8,"d":"2.80"},3.75,5.02,4.99,4.91,{"v":0.668230563002681,"d":"0.67"},{"v":-0.581582125857042,"d":"-0.58"},"down",{"v":0.027683,"d":"0.03"},1,"yes","ACGTTGGAAGTTAGCAAAGTGCTCCTACAGCCGCATCTGCAGTTAACATAGTATCCCTAT","FALSE","THC2471881","tc|THC2471881",null,null,"tc|Q9BXM8_HUMAN (Q9BXM8) Colon cancer-associated antigen AgSK1-2HT-ECS, complete [THC2471881]",{"$nulls":5},"mRNA","agilent G3 V3"]
["A_33_P3370575",3.57,1.95,1.93,{"v":5.6,"d":"5.60"},5.65,5.87,{"v":0.435163551401869,"d":"0.44"},{"v":-1.20037037105162,"d":"-1.20"},"down",{"v":0.027864,"d":"0.03"},1,"yes","ATTCTTCTCGTCCTAATCTCAATCTTACTGTACTGGAAACGTCACCGGAATCAGGACCGA","FALSE","NM_001004196","ref|NM_001004196|ref|NM_005944|ens|ENST00000498096|ens|ENST00000473539","CD200","CD200 molecule","ref|Homo sapiens CD200 molecule (CD200), transcript variant 2, mRNA [NM_001004196]","chr3",112052024,112081656,"GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0050776(regulation of immune response)",null,"mRNA","agilent G3 V3"]
["A_23_P59452",6.79,6.54,6.54,7.11,7.13,{"v":7.1,"d":"7.10"},{"v":0.931115276476101,"d":"0.93"},{"v":-0.102968303574755,"d":"-0.10"},"down",{"v":0.028022,"d":"0.03"},1,"yes","TGCACACCCACCTGATTGGCAACATACACACTCACTTGGTGCACTACCGCGTAGACCTGG","FALSE","NM_001091","ref|NM_001091|ref|NM_001272072|ens|ENST00000622116|ens|ENST00000416793","AOC1","amine oxidase, copper containing 1","ref|Homo sapiens amine oxidase, copper containing 1 (AOC1), transcript variant 2, mRNA [NM_001091]","chr7",150555024,150558307,"GO:0004872(receptor activity);GO:0005261(cation channel activity);GO:0005272(sodium channel activity);GO:0005507(copper ion binding);GO:0005509(calcium ion binding);GO:0005615(extracellular space);GO:0005777(peroxisome);GO:0005886(plasma membrane);GO:0005923(tight junction);GO:0008131(primary amine oxidase activity);GO:0008144(drug binding);GO:0008201(heparin binding);GO:0008270(zinc ion binding);GO:0009308(amine metabolic process);GO:0032403(protein complex binding);GO:0035725(sodium ion transmembrane transport);GO:0035874(cellular response to copper ion starvation);GO:0042493(response to drug);GO:0042803(protein homodimerization activity);GO:0046677(response to antibiotic);GO:0048038(quinone binding);GO:0052597(diamine oxidase activity);GO:0052598(histamine oxidase activity);GO:0052599(methylputrescine oxidase activity);GO:0052600(propane-1,3-diamine oxidase activity);GO:0055114(oxidation-reduction process);GO:0070062(extracellular vesicular exosome);GO:0071280(cellular response to copper ion);GO:0071420(cellular response to histamine);GO:0071504(cellular response to heparin);GO:0097185(cellular response to azide)","00330(Arginine and proline metabolism);00340(Histidine metabolism);00380(Tryptophan metabolism)","mRNA","agilent G3 V3"]
["A_24_P194881",6.18,6.66,5.27,8.42,8.35,8.48,{"v":0.717227722772277,"d":"0.72"},{"v":-0.479496841576352,"d":"-0.48"},"down",{"v":0.0283249999999999,"d":"0.03"},1,"yes","GTTTGGAGTCTGGACTAAGCTCCATCCACGTCACTCACAAGTTTCTGTTTATATTTCTAG","FALSE","NM_033517","ref|NM_033517|gb|AB051437|gb|AK074038|gb|BC018856","SHANK3","SH3 and multiple ankyrin repeat domains 3","ref|Homo sapiens SH3 and multiple ankyrin repeat domains 3 (SHANK3), mRNA [NM_033517]","chr22",51113072,51171641,"GO:0000165(MAPK cascade);GO:0003779(actin binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0007416(synapse assembly);GO:0007612(learning);GO:0007613(memory);GO:0008022(protein C-terminus binding);GO:0008270(zinc ion binding);GO:0017124(SH3 domain binding);GO:0021773(striatal medium spiny neuron differentiation);GO:0030054(cell junction);GO:0030160(GKAP/Homer scaffold activity);GO:0030534(adult behavior);GO:0032232(negative regulation of actin filament bundle assembly);GO:0035176(social behavior);GO:0035255(ionotropic glutamate receptor binding);GO:0042297(vocal learning);GO:0042802(identical protein binding);GO:0043005(neuron projection);GO:0043197(dendritic spine);GO:0044309(neuron spine);GO:0045211(postsynaptic membrane);GO:0045794(negative regulation of cell volume);GO:0048170(positive regulation of long-term neuronal synaptic plasticity);GO:0048854(brain morphogenesis);GO:0051835(positive regulation of synapse structural plasticity);GO:0051968(positive regulation of synaptic transmission, glutamatergic);GO:0060170(cilium membrane);GO:0060997(dendritic spine morphogenesis);GO:0060999(positive regulation of dendritic spine development);GO:0061001(regulation of dendritic spine morphogenesis);GO:0071625(vocalization behavior);GO:0097107(postsynaptic density assembly);GO:0097110(scaffold protein binding);GO:0097113(alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor clustering);GO:0097114(N-methyl-D-aspartate receptor clustering);GO:0097117(guanylate kinase-associated protein clustering);GO:1900271(regulation of long-term synaptic potentiation);GO:1900451(positive regulation of glutamate receptor signaling pathway);GO:1900452(regulation of long term synaptic depression);GO:2000463(positive regulation of excitatory postsynaptic membrane potential);GO:2000969(positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity)","04724(Glutamatergic synapse)","mRNA","agilent G3 V3"]
["A_23_P3956",4.11,2.83,4.69,5.81,5.53,6.44,{"v":0.654105736782902,"d":"0.65"},{"v":-0.612404227356552,"d":"-0.61"},"down",{"v":0.0285559999999999,"d":"0.03"},1,"yes","TGGGCTAAGCATCACCGCTTCCACGTGTGTTGTGTTGGTTGGCAGCAAGGCTGATCCAGA","FALSE","NM_198594","ref|NM_198594|ref|NM_030968|ref|NM_198593|ref|NM_153372","C1QTNF1","C1q and tumor necrosis factor related protein 1","ref|Homo sapiens C1q and tumor necrosis factor related protein 1 (C1QTNF1), transcript variant 4, mRNA [NM_198594]","chr17",77042984,77044398,"GO:0005515(protein binding);GO:0005518(collagen binding);GO:0005581(collagen);GO:0005615(extracellular space);GO:0005887(integral to plasma membrane);GO:0007204(elevation of cytosolic calcium ion concentration);GO:0010544(negative regulation of platelet activation);GO:0010628(positive regulation of gene expression);GO:0010906(regulation of glucose metabolic process);GO:0043410(positive regulation of MAPK cascade);GO:0051260(protein homooligomerization);GO:0051897(positive regulation of protein kinase B signaling cascade);GO:0070208(protein heterotrimerization);GO:0090331(negative regulation of platelet aggregation);GO:2000860(positive regulation of aldosterone secretion)",null,"mRNA","agilent G3 V3"]
["A_33_P3375646",11.39,11.16,11.22,11.47,11.49,11.51,{"v":0.979692486219901,"d":"0.98"},{"v":-0.0295991193597927,"d":"-0.03"},"down",{"v":0.0288160000000001,"d":"0.03"},1,"yes","GGTACAGCAGCCAAGGTGAGGATGTCATCTACCCCATCCTCCCATCCAGAGCTTTACCAC","FALSE","AK296003","gb|AK296003|gb|AK298260|tc|THC2551411","GTPBP6","GTP binding protein 6 (putative)","gb|Homo sapiens cDNA FLJ56662 complete cds, highly similar to Homo sapiens GTP binding protein 6 (GTPBP6), mRNA. [AK296003]","chrX",{"v":221196,"d":"221196.00"},229130,"GO:0005525(GTP binding);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P13137",6.45,5.33,6.48,4.45,4.94,4.81,{"v":1.28591549295775,"d":"1.29"},{"v":0.362795835592178,"d":"0.36"},"up",{"v":0.0289779999999999,"d":"0.03"},1,"yes","AAGATGACTGTTCAGTAGCTGATGTTCTGGAAAAGATCTGGGCCTTCACCATGAAATCTT","FALSE","AY358815","gb|AY358815|tc|THC2488105",null,null,"gb|Homo sapiens clone DNA108923 SFVP2550 (UNQ2550) mRNA, complete cds. [AY358815]",{"$nulls":5},"mRNA","agilent G3 V3"]
["A_33_P3394183",6.44,6.06,{"v":6.4,"d":"6.40"},6.88,6.62,6.89,{"v":0.926924963217263,"d":"0.93"},{"v":-0.109475540908162,"d":"-0.11"},"down",{"v":0.0293030000000001,"d":"0.03"},1,"yes","CCCATCCTTACCTGAGACCTCACCTCCAAGAAATTAATGGTCTTTTCAATGGAGAAAAAA","FALSE","NM_207395","ref|NM_207395|ens|ENST00000336614|gb|AK131452|gb|BX648711","ZNF324B","zinc finger protein 324B","ref|Homo sapiens zinc finger protein 324B (ZNF324B), mRNA [NM_207395]","chr19",58963016,58969179,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P819",8.46,6.93,8.74,11.32,11.17,11.25,{"v":0.715174866627149,"d":"0.72"},{"v":-0.483632058071814,"d":"-0.48"},"down",{"v":0.0296430000000001,"d":"0.03"},1,"yes","CACGGTCCTGCTGGTGGTGGACAAATGCGACGAACCTCTGAGCATCCTGGTGAGGAATAA","FALSE","NM_005101","ref|NM_005101|ens|ENST00000379389|gb|M13755|gb|AY168648","ISG15","ISG15 ubiquitin-like modifier","ref|Homo sapiens ISG15 ubiquitin-like modifier (ISG15), mRNA [NM_005101]","chr1",{"v":948803,"d":"948803.00"},949920,"GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005829(cytosol);GO:0016032(viral reproduction);GO:0019221(cytokine-mediated signaling pathway);GO:0019941(modification-dependent protein catabolic process);GO:0031386(protein tag);GO:0031397(negative regulation of protein ubiquitination);GO:0032020(ISG15-protein conjugation);GO:0032480(negative regulation of type I interferon production);GO:0032649(regulation of interferon-gamma production);GO:0034340(response to type I interferon);GO:0042742(defense response to bacterium);GO:0045071(negative regulation of viral genome replication);GO:0045087(innate immune response);GO:0045648(positive regulation of erythrocyte differentiation);GO:0051607(defense response to virus);GO:0060337(type I interferon-mediated signaling pathway)","04622(RIG-I-like receptor signaling pathway)","mRNA","agilent G3 V3"]
["A_23_P87902",4.15,3.29,4.12,4.91,{"v":4.7,"d":"4.70"},4.81,{"v":0.801664355062413,"d":"0.80"},{"v":-0.318929766740144,"d":"-0.32"},"down",{"v":0.029725,"d":"0.03"},1,"yes","ACAAGGTTCAAGGCTGTCATCACTCGAGCAGAAAAGCAGATGAGATCACCAAAGAGACTA","FALSE","NM_003845","ref|NM_003845|ref|NM_001282285|ref|NM_001282286|ens|ENST00000541024","DYRK4","dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4","ref|Homo sapiens dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4 (DYRK4), transcript variant 1, mRNA [NM_003845]","chr12",{"v":4699244,"d":"4699244.00"},4723217,"GO:0004674(protein serine/threonine kinase activity);GO:0004712(protein serine/threonine/tyrosine kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0043231(intracellular membrane-bounded organelle);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_21_P0000491",7.48,7.08,6.92,6.42,6.41,5.66,{"v":1.16170903190914,"d":"1.16"},{"v":0.216248768581216,"d":"0.22"},"up",{"v":0.0298620000000001,"d":"0.03"},1,"yes","TCAAGGCTAGGCGAGGGTGTGAGGGACTGGAGTTCGAGGTCAACCTGGGCCCCATTGGTA","FALSE","NR_004383","ref|NR_004383|tc|THC2776275","SNAR-G1","small ILF3/NF90-associated RNA G1","ref|Homo sapiens small ILF3/NF90-associated RNA G1 (SNAR-G1), small nuclear RNA [NR_004383]","chr19",49540276,49540404,null,null,"mRNA","agilent G3 V3"]
["A_33_P3220149",17.47,17.17,17.57,18.08,18.08,18.08,{"v":0.962573746312684,"d":"0.96"},{"v":-0.0550310197884159,"d":"-0.06"},"down",{"v":0.0301239999999999,"d":"0.03"},1,"yes","GGGCCTCCTCGCGCCACCTCCCCGCTGACCGCCGCCCGCAGGCTGGCACCGCTGTACGCG","FALSE","ENST00000503050","ens|ENST00000503050|gb|AB209135|tc|THC2776662|tc|THC2670310","MAML1","mastermind-like 1 (Drosophila)","ens|mastermind-like 1 (Drosophila) [Source:HGNC Symbol;Acc:HGNC:13632] [ENST00000503050]","chr5",179221040,179223160,"GO:0002193(MAML1-RBP-Jkappa- ICN1 complex);GO:0003162(atrioventricular node development);GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0006468(protein phosphorylation);GO:0007219(Notch signaling pathway);GO:0007221(positive regulation of transcription of Notch receptor target);GO:0010467(gene expression);GO:0010831(positive regulation of myotube differentiation);GO:0016607(nuclear speck);GO:0019901(protein kinase binding);GO:0042605(peptide antigen binding);GO:0043231(intracellular membrane-bounded organelle);GO:0045445(myoblast differentiation);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0060928(atrioventricular node cell development)","04330(Notch signaling pathway)","mRNA","agilent G3 V3"]
["A_24_P372932",4.36,2.65,{"v":3.5,"d":"3.50"},{"v":5,"d":"5.00"},{"v":5.3,"d":"5.30"},5.15,{"v":0.680258899676375,"d":"0.68"},{"v":-0.555844168829559,"d":"-0.56"},"down",{"v":0.03034,"d":"0.03"},1,"yes","CGGAGAACATCTGGAGCACCCTGCGTTTGGCATTGTCTATGTTAGGCCAGAGCGATGCCT","FALSE","NM_000319","ref|NM_000319|ref|NM_001131026|ref|NM_001131025|ref|NM_001300789","PEX5","peroxisomal biogenesis factor 5","ref|Homo sapiens peroxisomal biogenesis factor 5 (PEX5), transcript variant 2, mRNA [NM_000319]","chr12",{"v":7362726,"d":"7362726.00"},7371170,"GO:0000268(peroxisome targeting sequence binding);GO:0005052(peroxisome matrix targeting signal-1 binding);GO:0005515(protein binding);GO:0005622(intracellular);GO:0005737(cytoplasm);GO:0005777(peroxisome);GO:0005778(peroxisomal membrane);GO:0005782(peroxisomal matrix);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0006625(protein targeting to peroxisome);GO:0008022(protein C-terminus binding);GO:0016020(membrane);GO:0016558(protein import into peroxisome matrix);GO:0016560(protein import into peroxisome matrix, docking);GO:0016561(protein import into peroxisome matrix, translocation);GO:0019899(enzyme binding);GO:0031267(small GTPase binding);GO:0043234(protein complex);GO:0045046(protein import into peroxisome membrane);GO:0047485(protein N-terminus binding);GO:0051262(protein tetramerization)","04146(Peroxisome)","mRNA","agilent G3 V3"]
["A_33_P3405789",5.29,3.21,4.53,6.16,{"v":6.5,"d":"6.50"},6.43,{"v":0.682556312205343,"d":"0.68"},{"v":-0.550980018835803,"d":"-0.55"},"down",{"v":0.030585,"d":"0.03"},1,"yes","TACACGACAGCATGTGGGGAAGGACTTATGGTGGGCCAGGTGGACCTCATCCTGCTTCTT","FALSE","NM_003324","ref|NM_003324|ref|NM_001160408|ens|ENST00000448120|gb|BC032587","TULP3","tubby like protein 3","ref|Homo sapiens tubby like protein 3 (TULP3), transcript variant 1, mRNA [NM_003324]","chr12",{"v":3000073,"d":"3000073.00"},3050296,"GO:0001843(neural tube closure);GO:0005515(protein binding);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0005576(extracellular region);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005886(plasma membrane);GO:0005929(cilium);GO:0005930(axoneme);GO:0006355(regulation of transcription, DNA-dependent);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007420(brain development);GO:0008277(regulation of G-protein coupled receptor protein signaling pathway);GO:0009952(anterior/posterior pattern specification);GO:0019899(enzyme binding);GO:0021914(negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning);GO:0021953(central nervous system neuron differentiation);GO:0030991(intraflagellar transport particle A);GO:0031076(embryonic camera-type eye development);GO:0032403(protein complex binding);GO:0035091(phosphatidylinositol binding);GO:0042733(embryonic digit morphogenesis);GO:0045879(negative regulation of smoothened signaling pathway);GO:0048702(embryonic neurocranium morphogenesis);GO:0060348(bone development);GO:0060434(bronchus morphogenesis);GO:0060831(smoothened signaling pathway involved in dorsal/ventral neural tube patterning);GO:0072372(primary cilium)",null,"mRNA","agilent G3 V3"]
["A_22_P00008229",5.43,4.93,5.79,{"v":4.7,"d":"4.70"},4.44,4.27,{"v":1.20432513049963,"d":"1.20"},{"v":0.268224927676813,"d":"0.27"},"up",{"v":0.030663,"d":"0.03"},1,"yes","GTTTCTCAAGAAAATCACAGATATTCCCCTCTGTGATGTTCAGCTCAGCCTGGAAAGGAG","FALSE","XR_425875","ref|XR_425875|ref|XR_427772|ref|XR_431920|linc|lnc-IRF1-2:2","LOC102723741","uncharacterized LOC102723741","ref|PREDICTED: Homo sapiens uncharacterized LOC102723741 (LOC102723741), ncRNA [XR_425875]","chr5",131755104,131762402,null,null,"mRNA","agilent G3 V3"]
["A_23_P208493",2.45,3.64,2.65,4.33,4.23,3.95,{"v":0.698641087130296,"d":"0.70"},{"v":-0.517376604665222,"d":"-0.52"},"down",{"v":0.030979,"d":"0.03"},1,"yes","ACTTGATTCTGCAGTCGAAATAACTAATATCCCTACATTTTTTAATTAAAGCAACAGACT","FALSE","NM_005874","ref|NM_005874|ref|NM_001080978|ref|NM_001278403|ref|NM_001278404","LILRB2","leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2","ref|Homo sapiens leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 (LILRB2), transcript variant 1, mRNA [NM_005874]","chr19",54778320,54785011,"GO:0002578(negative regulation of antigen processing and presentation);GO:0002666(positive regulation of T cell tolerance induction);GO:0002767(immune response-inhibiting cell surface receptor signaling pathway);GO:0002774(Fc receptor mediated inhibitory signaling pathway);GO:0004872(receptor activity);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0006955(immune response);GO:0006968(cellular defense response);GO:0007165(signal transduction);GO:0007166(cell surface receptor signaling pathway);GO:0007267(cell-cell signaling);GO:0008157(protein phosphatase 1 binding);GO:0009986(cell surface);GO:0016020(membrane);GO:0023029(MHC class Ib protein binding);GO:0032396(inhibitory MHC class I receptor activity);GO:0032755(positive regulation of interleukin-6 production);GO:0034113(heterotypic cell-cell adhesion);GO:0042102(positive regulation of T cell proliferation);GO:0042130(negative regulation of T cell proliferation);GO:0042288(MHC class I protein binding);GO:0045591(positive regulation of regulatory T cell differentiation);GO:0050776(regulation of immune response);GO:0050839(cell adhesion molecule binding);GO:0051926(negative regulation of calcium ion transport);GO:0071222(cellular response to lipopolysaccharide);GO:2001198(regulation of dendritic cell differentiation)","04380(Osteoclast differentiation)","mRNA","agilent G3 V3"]
["A_33_P3411333",2.65,3.11,2.76,3.26,{"v":4,"d":"4.00"},3.92,{"v":0.762075134168157,"d":"0.76"},{"v":-0.391994852617352,"d":"-0.39"},"down",{"v":0.031237,"d":"0.03"},1,"yes","GGAGTTTTTAACTCTCAAGCAATTCATCACTGTCACCATTTAAGTATTTCTGCCAGTTTA","FALSE","ENST00000460619","ens|ENST00000460619","CHIT1","chitinase 1 (chitotriosidase)","ens|chitinase 1 (chitotriosidase) [Source:HGNC Symbol;Acc:HGNC:1936] [ENST00000460619]","chr1",203209456,203242769,"GO:0000272(polysaccharide catabolic process);GO:0004568(chitinase activity);GO:0005615(extracellular space);GO:0005764(lysosome);GO:0006032(chitin catabolic process);GO:0006955(immune response);GO:0008061(chitin binding);GO:0008843(endochitinase activity);GO:0009617(response to bacterium)","00520(Amino sugar and nucleotide sugar metabolism)","mRNA","agilent G3 V3"]
["A_23_P161338",4.02,5.33,3.46,6.36,5.99,5.99,{"v":0.698473282442748,"d":"0.70"},{"v":-0.517723163253408,"d":"-0.52"},"down",{"v":0.031459,"d":"0.03"},1,"yes","TTCCATCACCAGAAAAACTAATGAGATTTCTCTGGAATACAAGCTGATATTGCTACATCG","FALSE","NM_021129","ref|NM_021129|ens|ENST00000373232|gb|BC105034|gb|BC105036","PPA1","pyrophosphatase (inorganic) 1","ref|Homo sapiens pyrophosphatase (inorganic) 1 (PPA1), mRNA [NM_021129]","chr10",71963344,71970006,"GO:0000287(magnesium ion binding);GO:0004427(inorganic diphosphatase activity);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006418(tRNA aminoacylation for protein translation);GO:0006796(phosphate-containing compound metabolic process);GO:0010467(gene expression);GO:0070062(extracellular vesicular exosome);GO:0071344(diphosphate metabolic process)","00190(Oxidative phosphorylation)","mRNA","agilent G3 V3"]
["A_33_P3239587",9.99,10.42,9.64,11.09,10.61,10.94,{"v":0.920649509803922,"d":"0.92"},{"v":-0.119276066372948,"d":"-0.12"},"down",{"v":0.031659,"d":"0.03"},1,"yes","TGGCTTGGATCTCTGTATTCAGCCTTTGTTCAGTCCAATAAACTTTGAGTAGATGATCTC","FALSE","NM_001008529","ref|NM_001008529|ref|NM_198530|ens|ENST00000375036|ens|ENST00000449428","MXRA7","matrix-remodelling associated 7","ref|Homo sapiens matrix-remodelling associated 7 (MXRA7), transcript variant 2, mRNA [NM_001008529]","chr17",74675656,74686301,"GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_24_P254965",6.45,6.04,6.88,{"v":5.7,"d":"5.70"},5.69,{"v":5.3,"d":"5.30"},{"v":1.16057519472738,"d":"1.16"},{"v":0.214839999240655,"d":"0.21"},"up",{"v":0.03176,"d":"0.03"},1,"yes","AGGTTATGACTGCCCAGCCACTGAAGGGATATTTGACTATGCAGCAGCTATAGGAGGGGC","FALSE","NM_018486","ref|NM_018486|ref|NM_001166422|ref|NM_001166420|ref|NM_001166419","HDAC8","histone deacetylase 8","ref|Homo sapiens histone deacetylase 8 (HDAC8), transcript variant 1, mRNA [NM_018486]","chrHG1438_PATCH",71684520,71792620,"GO:0000118(histone deacetylase complex);GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000228(nuclear chromosome);GO:0000278(mitotic cell cycle);GO:0004407(histone deacetylase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006325(chromatin organization);GO:0006333(chromatin assembly or disassembly);GO:0006351(transcription, DNA-dependent);GO:0007062(sister chromatid cohesion);GO:0008134(transcription factor binding);GO:0016568(chromatin modification);GO:0032041(NAD-dependent histone deacetylase activity (H3-K14 specific));GO:0046872(metal ion binding);GO:0046969(NAD-dependent histone deacetylase activity (H3-K9 specific));GO:0046970(NAD-dependent histone deacetylase activity (H4-K16 specific));GO:0070932(histone H3 deacetylation);GO:0070933(histone H4 deacetylation);GO:0071922(regulation of cohesin localization to chromatin)","05203(Viral carcinogenesis);05034(Alcoholism)","mRNA","agilent G3 V3"]
["A_23_P210274",2.49,3.28,2.22,3.52,3.84,4.03,{"v":0.701492537313433,"d":"0.70"},{"v":-0.511500338780135,"d":"-0.51"},"down",{"v":0.032042,"d":"0.03"},1,"yes","GGATCAGTATGCCGTAGGATTTACAGAATATTTTCACATGCTTATTTTCATCATCGGCAG","FALSE","NM_015387","ref|NM_015387|ref|NM_001202485|ref|NM_199482|ref|NM_001204094","MOB4","MOB family member 4, phocein","ref|Homo sapiens MOB family member 4, phocein (MOB4), transcript variant 1, mRNA [NM_015387]","chr2",198380880,198416003,"GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0006810(transport);GO:0019900(kinase binding);GO:0032580(Golgi cisterna membrane);GO:0043025(neuronal cell body);GO:0043197(dendritic spine);GO:0046872(metal ion binding);GO:0048471(perinuclear region of cytoplasm)",null,"mRNA","agilent G3 V3"]
["A_23_P204736",{"v":7.8,"d":"7.80"},{"v":6.8,"d":"6.80"},7.42,{"v":6.4,"d":"6.40"},6.39,5.78,{"v":1.18578352180937,"d":"1.19"},{"v":0.245840653628948,"d":"0.25"},"up",{"v":0.032057,"d":"0.03"},1,"yes","AGGATGGGGTGGCAGCAGAGGAATGTCACAGGTCAGCAGCCTAGGCCTCCAGCTATAAAT","FALSE","NM_005276","ref|NM_005276|ref|NM_001257199|ens|ENST00000301149|gb|BC032234","GPD1","glycerol-3-phosphate dehydrogenase 1 (soluble)","ref|Homo sapiens glycerol-3-phosphate dehydrogenase 1 (soluble) (GPD1), transcript variant 1, mRNA [NM_005276]","chr12",50497600,50505102,"GO:0004367(glycerol-3-phosphate dehydrogenase [NAD+] activity);GO:0004368(glycerol-3-phosphate dehydrogenase activity);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006094(gluconeogenesis);GO:0006116(NADH oxidation);GO:0006127(glycerophosphate shuttle);GO:0006644(phospholipid metabolic process);GO:0006654(phosphatidic acid biosynthetic process);GO:0009331(glycerol-3-phosphate dehydrogenase complex);GO:0019432(triglyceride biosynthetic process);GO:0042803(protein homodimerization activity);GO:0044255(cellular lipid metabolic process);GO:0044281(small molecule metabolic process);GO:0045821(positive regulation of glycolysis);GO:0046168(glycerol-3-phosphate catabolic process);GO:0046474(glycerophospholipid biosynthetic process);GO:0051287(NAD binding);GO:0070062(extracellular vesicular exosome);GO:0071320(cellular response to cAMP);GO:0071356(cellular response to tumor necrosis factor)","00564(Glycerophospholipid metabolism)","mRNA","agilent G3 V3"]
["A_33_P3350179",5.26,4.72,4.76,3.15,3.46,4.33,{"v":1.3473491773309,"d":"1.35"},{"v":0.430123786302513,"d":"0.43"},"up",{"v":0.032339,"d":"0.03"},1,"yes","TTCGTTCTTCATTCAGCGTTTTTTAGTCAATCAAAAAGAACGTGGCAGGTGGAGGGCAGC","FALSE","N95477","gb|N95477",null,null,"gb|zb81h09.s1 Soares_senescent_fibroblasts_NbHSF Homo sapiens cDNA clone IMAGE:310049 3' similar to contains element MER22 repetitive element ;, mRNA sequence [N95477]","chr17",14207000,14207492,null,null,"mRNA","agilent G3 V3"]
["A_33_P3351836",10.02,9.95,10.09,{"v":9.9,"d":"9.90"},9.69,9.69,{"v":1.02663934426229,"d":"1.03"},{"v":0.037929455632322,"d":"0.04"},"up",{"v":0.032381,"d":"0.03"},1,"yes","AAGGCCTCCCACCAACAGCCAGCAAAGAACTGAGACCTTCTGCCTACAGTCATGAGTCCT","FALSE","ENST00000414747","ens|ENST00000414747|tc|THC2774850|tc|THC2753884","C2orf73","chromosome 2 open reading frame 73","ens|chromosome 2 open reading frame 73 [Source:HGNC Symbol;Acc:HGNC:26861] [ENST00000414747]","chr2",54558124,54610331,null,null,"mRNA","agilent G3 V3"]
["A_23_P416212",10.18,10.04,9.82,10.39,10.49,{"v":10.3,"d":"10.30"},{"v":0.963438101347017,"d":"0.96"},{"v":-0.0537361151835131,"d":"-0.05"},"down",{"v":0.0325,"d":"0.03"},1,"yes","AGTTACCGCATGTCACAGAAGGTGCACCGGAAAATGCTCCCGTCCAACCTGAGTCCTACC","FALSE","NM_033194","ref|NM_033194|ens|ENST00000565659|gb|AK093488|gb|AX748161","HSPB9","heat shock protein, alpha-crystallin-related, B9","ref|Homo sapiens heat shock protein, alpha-crystallin-related, B9 (HSPB9), mRNA [NM_033194]","chr17",40274756,40275371,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm)",null,"mRNA","agilent G3 V3"]
["A_23_P344421",{"v":5.7,"d":"5.70"},5.69,4.97,6.74,6.56,6.07,{"v":0.84460505937016,"d":"0.84"},{"v":-0.243651205661505,"d":"-0.24"},"down",{"v":0.0329959999999999,"d":"0.03"},1,"yes","AACCTCACCATGGAAAGAAAATAATTATGAATGCCACTGAGGCACTGAGGCCCTACCTCA","FALSE","NM_019055","ref|NM_019055|ref|NM_001301088|ens|ENST00000534407|ens|ENST00000306534","ROBO4","roundabout, axon guidance receptor, homolog 4 (Drosophila)","ref|Homo sapiens roundabout, axon guidance receptor, homolog 4 (Drosophila) (ROBO4), transcript variant 1, mRNA [NM_019055]","chr11",124754112,124762921,"GO:0001525(angiogenesis);GO:0004872(receptor activity);GO:0009897(external side of plasma membrane);GO:0016021(integral to membrane);GO:0030154(cell differentiation);GO:0030334(regulation of cell migration);GO:0030336(negative regulation of cell migration);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3290040",5.64,6.14,5.29,4.53,4.99,4.85,{"v":1.18789144050104,"d":"1.19"},{"v":0.248402996570402,"d":"0.25"},"up",{"v":0.033065,"d":"0.03"},1,"yes","TTCCAGCAGGCAGCTGGCCTCTCCAAGGAATAAGGGTGAAATTGCCACAGCTGGCTGACA","FALSE","NM_001199752","ref|NM_001199752|ref|NM_001199753|ref|NM_152359|ref|NM_001136052","CPT1C","carnitine palmitoyltransferase 1C","ref|Homo sapiens carnitine palmitoyltransferase 1C (CPT1C), transcript variant 3, mRNA [NM_001199752]","chr19",50194392,50216929,"GO:0004095(carnitine O-palmitoyltransferase activity);GO:0005741(mitochondrial outer membrane);GO:0005789(endoplasmic reticulum membrane);GO:0006635(fatty acid beta-oxidation);GO:0009437(carnitine metabolic process);GO:0030054(cell junction);GO:0032281(alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid selective glutamate receptor complex);GO:0045202(synapse)","01212(Fatty acid metabolism);00071(Fatty acid degradation);04152(AMPK signaling pathway);04922(Glucagon signaling pathway);04920(Adipocytokine signaling pathway);03320(PPAR signaling pathway)","mRNA","agilent G3 V3"]
["A_23_P4443",6.04,7.62,5.25,4.33,4.03,3.54,{"v":1.5890756302521,"d":"1.59"},{"v":0.668187789754456,"d":"0.67"},"up",{"v":0.0333960000000001,"d":"0.03"},1,"yes","GATGACGTTCGGAAAGGGTCATGGGCTAAATGTCACCTGAGGGGTATTTTTAAAGGGTTT","FALSE","NM_018488","ref|NM_018488|ens|ENST00000240335|ens|ENST00000393853|ref|XM_005257837","TBX4","T-box 4","ref|Homo sapiens T-box 4 (TBX4), mRNA [NM_018488]","chr17",59555712,59560731,"GO:0001525(angiogenesis);GO:0002009(morphogenesis of an epithelium);GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0007275(multicellular organismal development);GO:0030324(lung development);GO:0030326(embryonic limb morphogenesis);GO:0035108(limb morphogenesis);GO:0048705(skeletal system morphogenesis)",null,"mRNA","agilent G3 V3"]
["A_24_P38276",3.48,5.14,3.44,6.12,{"v":5.5,"d":"5.50"},6.63,{"v":0.660821917808219,"d":"0.66"},{"v":-0.597666556754657,"d":"-0.60"},"down",{"v":0.033476,"d":"0.03"},1,"yes","AAATGCCGGTACTTAGGACCTAAATTTATCTATGTCTGTCATACGCTAAAATGATATTGG","FALSE","NM_003505","ref|NM_003505|gb|BC017719|gb|AL049994|gb|AB017363","FZD1","frizzled class receptor 1","ref|Homo sapiens frizzled class receptor 1 (FZD1), mRNA [NM_003505]","chr7",90893784,90898123,"GO:0001934(positive regulation of protein phosphorylation);GO:0003149(membranous septum morphogenesis);GO:0003150(muscular septum morphogenesis);GO:0003151(outflow tract morphogenesis);GO:0004930(G-protein coupled receptor activity);GO:0005102(receptor binding);GO:0005109(frizzled binding);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007267(cell-cell signaling);GO:0009986(cell surface);GO:0016021(integral to membrane);GO:0017147(Wnt-protein binding);GO:0030165(PDZ domain binding);GO:0030182(neuron differentiation);GO:0030514(negative regulation of BMP signaling pathway);GO:0030855(epithelial cell differentiation);GO:0035414(negative regulation of catenin import into nucleus);GO:0035425(autocrine signaling);GO:0035567(non-canonical Wnt receptor signaling pathway);GO:0042493(response to drug);GO:0042813(Wnt-activated receptor activity);GO:0044338(canonical Wnt receptor signaling pathway involved in mesenchymal stem cell differentiation);GO:0044339(canonical Wnt receptor signaling pathway involved in osteoblast differentiation);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0051091(positive regulation of sequence-specific DNA binding transcription factor activity);GO:0060022(hard palate development);GO:0060070(canonical Wnt receptor signaling pathway);GO:0090090(negative regulation of canonical Wnt receptor signaling pathway);GO:0090179(planar cell polarity pathway involved in neural tube closure);GO:0090263(positive regulation of canonical Wnt receptor signaling pathway)","04310(Wnt signaling pathway);04390(Hippo signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04916(Melanogenesis);05200(Pathways in cancer);05205(Proteoglycans in cancer);05217(Basal cell carcinoma);05166(HTLV-I infection)","mRNA","agilent G3 V3"]
["A_33_P3238335",3.97,2.86,2.53,4.73,4.51,5.85,{"v":0.620278330019881,"d":"0.62"},{"v":-0.689012370943279,"d":"-0.69"},"down",{"v":0.0336839999999999,"d":"0.03"},1,"yes","CCTTGTCCTATCCTCATTCTAAGCTGATGACCTTACTTCCTATTTCACAAAAATAATAGA","FALSE","BC060765","gb|BC060765","MCOLN3","mucolipin 3","gb|Homo sapiens mucolipin 3, mRNA (cDNA clone MGC:71509 IMAGE:30340464), complete cds. [BC060765]","chr1",85490504,85495642,"GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0007626(locomotory behavior);GO:0016021(integral to membrane);GO:0034220(ion transmembrane transport);GO:0042491(auditory receptor cell differentiation);GO:0055085(transmembrane transport);GO:0070588(calcium ion transmembrane transport)",null,"mRNA","agilent G3 V3"]
["A_32_P161913",4.87,5.09,4.64,4.39,{"v":4.4,"d":"4.40"},3.96,{"v":1.14509803921569,"d":"1.15"},{"v":0.195471122021159,"d":"0.20"},"up",{"v":0.033955,"d":"0.03"},1,"yes","GCGAGGGGAGCACCCGCGTGTGCACAGCCACAGGGTGGGGTGCAGGTGGCTGGGCCCAGG","FALSE","NM_001114748","ref|NM_001114748","TMEM240","transmembrane protein 240","ref|Homo sapiens transmembrane protein 240 (TMEM240), mRNA [NM_001114748]","chr1",{"v":1470157,"d":"1470157.00"},1475740,"GO:0016021(integral to membrane);GO:0097060(synaptic membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P418485",10.99,11.01,11.04,{"v":9.8,"d":"9.80"},10.34,9.68,{"v":1.10798122065728,"d":"1.11"},{"v":0.147933429136003,"d":"0.15"},"up",{"v":0.034118,"d":"0.03"},1,"yes","TCTAGGACTAATTCACACTGCAACAAAGGGGCTGATTAGAGCTTTTGAAGATGGGGGGAT","FALSE","NM_152587","ref|NM_152587|ens|ENST00000393084|ens|ENST00000529391|ref|XM_005271415","C11orf65","chromosome 11 open reading frame 65","ref|Homo sapiens chromosome 11 open reading frame 65 (C11orf65), mRNA [NM_152587]","chr11",108253728,108338258,null,null,"mRNA","agilent G3 V3"]
["A_23_P215484",6.86,5.58,6.54,5.31,4.63,4.07,{"v":1.3547466095646,"d":"1.35"},{"v":0.438023036590291,"d":"0.44"},"up",{"v":0.034482,"d":"0.03"},1,"yes","AGCGGGCTGTGATATTCACTACCAAAAGAGGCAAGAAAGTCTGTACCCATCCAAGGAAAA","FALSE","NM_006072","ref|NM_006072|ens|ENST00000394905|ens|ENST00000005180|ref|XM_006715837","CCL26","chemokine (C-C motif) ligand 26","ref|Homo sapiens chemokine (C-C motif) ligand 26 (CCL26), mRNA [NM_006072]","chrHG1257_PATCH",75234488,75237214,"GO:0001938(positive regulation of endothelial cell proliferation);GO:0005615(extracellular space);GO:0006935(chemotaxis);GO:0006954(inflammatory response);GO:0006955(immune response);GO:0007165(signal transduction);GO:0007267(cell-cell signaling);GO:0008009(chemokine activity);GO:0030335(positive regulation of cell migration);GO:0030838(positive regulation of actin filament polymerization);GO:0032855(positive regulation of Rac GTPase activity);GO:0060326(cell chemotaxis)","04060(Cytokine-cytokine receptor interaction);04062(Chemokine signaling pathway)","mRNA","agilent G3 V3"]
["A_23_P13663",6.65,{"v":6.9,"d":"6.90"},6.36,5.77,6.25,5.87,{"v":1.11291224147568,"d":"1.11"},{"v":0.154339833668594,"d":"0.15"},"up",{"v":0.034544,"d":"0.03"},1,"yes","TCTGCCCATCTCCACTCAGGAGTGGTGACTGAGGTTTTTATGTAGAAGGGGAACAAAAAA","FALSE","NM_021238","ref|NM_021238|ref|NM_001135811|ref|NM_001135812|ens|ENST00000544921","FAM60A","family with sequence similarity 60, member A","ref|Homo sapiens family with sequence similarity 60, member A (FAM60A), transcript variant 2, mRNA [NM_021238]","chr12",31435232,31479070,"GO:0005515(protein binding);GO:0016580(Sin3 complex);GO:0030336(negative regulation of cell migration)",null,"mRNA","agilent G3 V3"]
["A_24_P234838",11.22,{"v":11.2,"d":"11.20"},11.27,9.84,10.52,9.89,{"v":1.11371900826446,"d":"1.11"},{"v":0.155385286072438,"d":"0.16"},"up",{"v":0.034837,"d":"0.03"},1,"yes","TCCCCATTTCTGCCTGATTTGCAACTTTTCTTGTTGATGTCGTGTTGTCTTGGGGGACCC","FALSE","NM_032420","ref|NM_032420|ens|ENST00000287008|ref|XM_005268452|ref|XM_005268453","PCDH1","protocadherin 1","ref|Homo sapiens protocadherin 1 (PCDH1), transcript variant 2, mRNA [NM_032420]","chr5",141232944,141257975,"GO:0005509(calcium ion binding);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0005911(cell-cell junction);GO:0007156(homophilic cell adhesion);GO:0007267(cell-cell signaling);GO:0007399(nervous system development)",null,"mRNA","agilent G3 V3"]
["A_33_P3307965",6.81,{"v":6.5,"d":"6.50"},{"v":6.5,"d":"6.50"},{"v":6.3,"d":"6.30"},6.22,6.29,{"v":1.05316321105795,"d":"1.05"},{"v":0.0747290313662916,"d":"0.07"},"up",{"v":0.035042,"d":"0.04"},1,"yes","TGGTTGCTGAAGGTGGGGGAGGCTGTGGCAATTTCTTAAAATAAAATAAGACAACAGTGG","FALSE","NM_001103170","ref|NM_001103170|ref|NR_111984|ens|ENST00000620146|gb|AK127828","AADACL3","arylacetamide deacetylase-like 3","ref|Homo sapiens arylacetamide deacetylase-like 3 (AADACL3), transcript variant 1, mRNA [NM_001103170]","chr1",12776118,12788726,"GO:0008152(metabolic process);GO:0016787(hydrolase activity)",null,"mRNA","agilent G3 V3"]
["A_23_P205228",{"v":6.9,"d":"6.90"},6.86,6.92,5.87,6.35,5.82,{"v":1.14634146341463,"d":"1.15"},{"v":0.197036847059554,"d":"0.20"},"up",{"v":0.0353000000000001,"d":"0.04"},1,"yes","ACATTTCCGCTGTCCGTCAGTAATTGTGTCCTCTCTTTATGCTTGCTTGGGGAATGTTGT","FALSE","NM_000053","ref|NM_000053|ref|NM_001243182|ref|NM_001005918|ens|ENST00000400366","ATP7B","ATPase, Cu++ transporting, beta polypeptide","ref|Homo sapiens ATPase, Cu++ transporting, beta polypeptide (ATP7B), transcript variant 1, mRNA [NM_000053]","chr13",52506808,52585630,"GO:0000139(Golgi membrane);GO:0004008(copper-exporting ATPase activity);GO:0005507(copper ion binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0005770(late endosome);GO:0005802(trans-Golgi network);GO:0005887(integral to plasma membrane);GO:0006825(copper ion transport);GO:0006878(cellular copper ion homeostasis);GO:0006882(cellular zinc ion homeostasis);GO:0007595(lactation);GO:0008152(metabolic process);GO:0015677(copper ion import);GO:0015680(intracellular copper ion transport);GO:0016020(membrane);GO:0016023(cytoplasmic membrane-bounded vesicle);GO:0016323(basolateral plasma membrane);GO:0034220(ion transmembrane transport);GO:0046688(response to copper ion);GO:0048471(perinuclear region of cytoplasm);GO:0051208(sequestering of calcium ion);GO:0055085(transmembrane transport);GO:0060003(copper ion export)",null,"mRNA","agilent G3 V3"]
["A_33_P3311907",11.97,12.42,12.02,11.66,11.65,11.74,{"v":1.03880171184023,"d":"1.04"},{"v":0.054920296546529,"d":"0.05"},"up",{"v":0.0354640000000001,"d":"0.04"},1,"yes","AGAAACTTTGTACTTTTAGTCAGAGGTTCCCTCTCCCGTCCATGTACCGTGCATTGGTAT","FALSE","NM_001258457","ref|NM_001258457|ref|NM_016495|ref|NM_001143964|ref|NM_001143965","TBC1D7","TBC1 domain family, member 7","ref|Homo sapiens TBC1 domain family, member 7 (TBC1D7), transcript variant 5, mRNA [NM_001258457]","chr6",13305309,13328737,"GO:0005097(Rab GTPase activator activity);GO:0005515(protein binding);GO:0016023(cytoplasmic membrane-bounded vesicle);GO:0017137(Rab GTPase binding);GO:0031398(positive regulation of protein ubiquitination);GO:0031410(cytoplasmic vesicle);GO:0032007(negative regulation of TOR signaling cascade);GO:0032851(positive regulation of Rab GTPase activity);GO:0032862(activation of Rho GTPase activity);GO:0033126(positive regulation of GTP catabolic process);GO:0036064(cilium basal body);GO:0070848(response to growth factor stimulus)",null,"mRNA","agilent G3 V3"]
["A_21_P0000302",9.73,9.92,9.68,8.55,8.37,9.39,{"v":1.11478525275561,"d":"1.11"},{"v":0.156765822591066,"d":"0.16"},"up",{"v":0.0355439999999999,"d":"0.04"},1,"yes","GGCATCGTTGGTTTTCTTGGCTTTGTGCTTGTTAAACCTGGTATTTCTACTGATACAGTA","FALSE","NR_002920","ref|NR_002920|ens|ENST00000534079|ens|ENST00000530769|gb|AJ609454","SNORA8","small nucleolar RNA, H/ACA box 8","ref|Homo sapiens small nucleolar RNA, H/ACA box 8 (SNORA8), small nucleolar RNA [NR_002920]","chr11",93465528,93465665,null,null,"mRNA","agilent G3 V3"]
["A_23_P163027",2.59,3.47,4.18,{"v":5.8,"d":"5.80"},5.69,5.91,{"v":0.588505747126437,"d":"0.59"},{"v":-0.764871590736091,"d":"-0.76"},"down",{"v":0.035817,"d":"0.04"},1,"yes","GGTCCGTATGCGGTACCTTTTAAAGGTTCAGTTTAATTTCCTTCAGCTGTGGTGAATGTT","FALSE","NM_005484","ref|NM_005484|ref|NM_001042618|ens|ENST00000250416|ens|ENST00000429687","PARP2","poly (ADP-ribose) polymerase 2","ref|Homo sapiens poly (ADP-ribose) polymerase 2 (PARP2), transcript variant 1, mRNA [NM_005484]","chr14",20823956,20825668,"GO:0003677(DNA binding);GO:0003950(NAD+ ADP-ribosyltransferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006281(DNA repair);GO:0006284(base-excision repair);GO:0006471(protein ADP-ribosylation);GO:0097191(extrinsic apoptotic signaling pathway)","03410(Base excision repair)","mRNA","agilent G3 V3"]
["A_33_P3407999",{"v":6.7,"d":"6.70"},6.81,6.77,5.87,5.08,4.98,{"v":1.27306967984934,"d":"1.27"},{"v":0.348311385478031,"d":"0.35"},"up",{"v":0.0361199999999999,"d":"0.04"},1,"yes","CCCTCTGGCGAGGATGGAAAATCCAAGAAAATAGTGTGGATCAATAAATCCTTCCCCTGA","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_24_P290163",{"v":9.4,"d":"9.40"},9.42,9.33,7.82,8.34,7.28,{"v":1.2009385665529,"d":"1.20"},{"v":0.264162352545344,"d":"0.26"},"up",{"v":0.036223,"d":"0.04"},1,"yes","ATTTTCAGCACTAATTTTAGGGTGAGTTCCTCATTCCGCTGTTCAGATCATGGGGTGAGG","FALSE","ENST00000337787","ens|ENST00000337787|ens|ENST00000517529|ens|ENST00000330588|gb|AL834164","SMG1P1","SMG1 pseudogene 1","ens|SMG1 pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:44186] [ENST00000337787]","chr16",22462888,22477939,null,null,"mRNA","agilent G3 V3"]
["A_24_P126741",{"v":5.6,"d":"5.60"},{"v":4.3,"d":"4.30"},5.52,6.53,6.32,6.53,{"v":0.795665634674922,"d":"0.80"},{"v":-0.329765805500047,"d":"-0.33"},"down",{"v":0.0363790000000001,"d":"0.04"},1,"yes","AGCCTCCAACCACACTAACAAGATTCAAGATTACTTGCAACAGCTCACAGGAGCGAGAAT","FALSE","ENST00000470810","ens|ENST00000470810",null,null,"ens|glutaredoxin (thioltransferase) pseudogene 3 [Source:HGNC Symbol;Acc:HGNC:34049] [ENST00000470810]","chr5",161178448,161178774,null,null,"mRNA","agilent G3 V3"]
["A_23_P115022",6.97,5.99,6.48,5.46,5.64,4.79,{"v":1.2234109502832,"d":"1.22"},{"v":0.290909094257262,"d":"0.29"},"up",{"v":0.036675,"d":"0.04"},1,"yes","TTGTGTATGGAAGGCGGGGCTCATGGCTGATTGGCAATAAAATGGCGGCTGCCGTTGTCA","FALSE","NM_144626","ref|NM_144626|ens|ENST00000432792|ens|ENST00000439858|ref|XM_005270467","TMEM125","transmembrane protein 125","ref|Homo sapiens transmembrane protein 125 (TMEM125), mRNA [NM_144626]","chr1",43735696,43739673,"GO:0003674(molecular_function);GO:0005575(cellular_component);GO:0008150(biological_process);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3216297",3.31,4.22,3.27,4.34,4.92,{"v":4.9,"d":"4.90"},{"v":0.76271186440678,"d":"0.76"},{"v":-0.390789953032167,"d":"-0.39"},"down",{"v":0.036984,"d":"0.04"},1,"yes","CGAATTGGCAGTAAATGTTAGCCATTTACAGCAATGCCAAATATGGAGAAACATCATAAT","FALSE","NM_001018077","ref|NM_001018077|ref|NM_001024094|ref|NM_000176|ref|NM_001018074","NR3C1","nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)","ref|Homo sapiens nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) (NR3C1), transcript variant 5, mRNA [NM_001018077]","chr5",142659136,142780417,"GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0001077(RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0004883(glucocorticoid receptor activity);GO:0005496(steroid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005759(mitochondrial matrix);GO:0005829(cytosol);GO:0006111(regulation of gluconeogenesis);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0006366(transcription from RNA polymerase II promoter);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0007165(signal transduction);GO:0008211(glucocorticoid metabolic process);GO:0008270(zinc ion binding);GO:0010467(gene expression);GO:0016020(membrane);GO:0016568(chromatin modification);GO:0030325(adrenal gland development);GO:0031946(regulation of glucocorticoid biosynthetic process);GO:0038051(glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity);GO:0042711(maternal behavior);GO:0042921(glucocorticoid receptor signaling pathway);GO:0043402(glucocorticoid mediated signaling pathway);GO:0043525(positive regulation of neuron apoptotic process);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046983(protein dimerization activity);GO:0060603(mammary gland duct morphogenesis);GO:0071383(cellular response to steroid hormone stimulus);GO:1900170(negative regulation of glucocorticoid mediated signaling pathway)","04080(Neuroactive ligand-receptor interaction)","mRNA","agilent G3 V3"]
["A_33_P3360565",8.16,7.34,8.08,7.11,6.14,{"v":5.6,"d":"5.60"},{"v":1.25092838196286,"d":"1.25"},{"v":0.322999194823736,"d":"0.32"},"up",{"v":0.037196,"d":"0.04"},1,"yes","TAGAATCTGTGTCAAAAACCCCCAATGACTTTAGCAACAATTAAACACTGAAGCACTTGC","FALSE","ENST00000296600","ens|ENST00000296600|gb|AY461732|tc|THC2477480","ZNF474","zinc finger protein 474","ens|zinc finger protein 474 [Source:HGNC Symbol;Acc:HGNC:23245] [ENST00000296600]","chr5",121465208,121489266,"GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3353259",7.82,8.98,7.66,10.14,10.31,10.32,{"v":0.794930126746831,"d":"0.79"},{"v":-0.331100039806158,"d":"-0.33"},"down",{"v":0.0376369999999999,"d":"0.04"},1,"yes","TTCTCCTGGGGTTCAGAGTGTTGTACTCGCAAAACAAGGATCACTGATGTTGTCTACGAT","FALSE","ENST00000454541","ens|ENST00000454541",{"$nulls":3},"chr10",121397968,121398594,null,null,"mRNA","agilent G3 V3"]
["A_23_P101950",6.36,7.18,5.91,8.34,8.46,8.27,{"v":0.775827682489031,"d":"0.78"},{"v":-0.366191840960385,"d":"-0.37"},"down",{"v":0.0379809999999999,"d":"0.04"},1,"yes","TTAAAGATTACGTGCTTCTTGGTACAGGTTTGTGAATGACAGTTTATCGTCATGCTGTTA","FALSE","NM_005917","ref|NM_005917|ref|NM_001199111|ref|NM_001199112|ens|ENST00000539945","MDH1","malate dehydrogenase 1, NAD (soluble)","ref|Homo sapiens malate dehydrogenase 1, NAD (soluble) (MDH1), transcript variant 2, mRNA [NM_005917]","chr2",63816460,63834328,"GO:0004470(malic enzyme activity);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005975(carbohydrate metabolic process);GO:0006006(glucose metabolic process);GO:0006094(gluconeogenesis);GO:0006099(tricarboxylic acid cycle);GO:0006107(oxaloacetate metabolic process);GO:0006108(malate metabolic process);GO:0006734(NADH metabolic process);GO:0009405(pathogenesis);GO:0030060(L-malate dehydrogenase activity);GO:0044262(cellular carbohydrate metabolic process);GO:0044281(small molecule metabolic process);GO:0047860(diiodophenylpyruvate reductase activity);GO:0051287(NAD binding);GO:0070062(extracellular vesicular exosome)","01200(Carbon metabolism);00020(Citrate cycle (TCA cycle));00620(Pyruvate metabolism);00630(Glyoxylate and dicarboxylate metabolism);00270(Cysteine and methionine metabolism);04964(Proximal tubule bicarbonate reclamation)","mRNA","agilent G3 V3"]
["A_21_P0010519",{"v":13,"d":"13.00"},13.01,13.04,12.61,12.28,12.58,{"v":1.04216706698692,"d":"1.04"},{"v":0.059586570700228,"d":"0.06"},"up",{"v":0.0382239999999999,"d":"0.04"},1,"yes","AGTCTGGGTTTCATCCAGCCCACCCCATCCTACAGACCAGGTGCAGTTTGAGAAGTGTGG","FALSE","ENST00000497359","ens|ENST00000497359|ens|ENST00000479115|linc|TCONS_l2_00000122|gb|AK311553","MST1","macrophage stimulating 1 (hepatocyte growth factor-like)","ens|macrophage stimulating 1 (hepatocyte growth factor-like) [Source:HGNC Symbol;Acc:HGNC:7380] [ENST00000497359]","chr3",49722296,49724299,"GO:0003674(molecular_function);GO:0004252(serine-type endopeptidase activity);GO:0006508(proteolysis);GO:0007283(spermatogenesis);GO:0007566(embryo implantation);GO:0008150(biological_process);GO:0030317(sperm motility);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P123916",3.96,2.96,4.34,{"v":4.9,"d":"4.90"},5.18,{"v":5,"d":"5.00"},{"v":0.746684350132626,"d":"0.75"},{"v":-0.421429601188435,"d":"-0.42"},"down",{"v":0.0386160000000001,"d":"0.04"},1,"yes","AGGTGCAGGCCTCAGAGTGTGTCGTGTGCCTGGAACGGGAGGCCCAGATGATCTTCCTCA","FALSE","NM_138361","ref|NM_138361|ref|NM_001005373|ref|NM_001190723|ref|NM_001005374","LRSAM1","leucine rich repeat and sterile alpha motif containing 1","ref|Homo sapiens leucine rich repeat and sterile alpha motif containing 1 (LRSAM1), transcript variant 1, mRNA [NM_138361]","chr9",130213784,130265778,"GO:0000209(protein polyubiquitination);GO:0004842(ubiquitin-protein ligase activity);GO:0005179(hormone activity);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0016020(membrane);GO:0016874(ligase activity);GO:0030163(protein catabolic process);GO:0045806(negative regulation of endocytosis);GO:0046755(non-lytic virus budding);GO:0051865(protein autoubiquitination);GO:0070086(ubiquitin-dependent endocytosis)",null,"mRNA","agilent G3 V3"]
["A_23_P41145",8.98,{"v":9.1,"d":"9.10"},9.15,7.43,8.05,6.94,{"v":1.21454058876004,"d":"1.21"},{"v":0.280410704238369,"d":"0.28"},"up",{"v":0.03874,"d":"0.04"},1,"yes","AAGACCAGCCTCAGAGGGTCCTTCTGGAACCAGCTGTCTGTGGAGAGAATGGGGTGCTTT","FALSE","NM_138805","ref|NM_138805|ens|ENST00000358781|ref|XM_005264863|ref|XM_005264864","FAM3D","family with sequence similarity 3, member D","ref|Homo sapiens family with sequence similarity 3, member D (FAM3D), mRNA [NM_138805]","chr3",58619672,58652575,"GO:0005125(cytokine activity);GO:0005576(extracellular region);GO:0046676(negative regulation of insulin secretion)",null,"mRNA","agilent G3 V3"]
["A_33_P3240158",3.85,{"v":2.7,"d":"2.70"},3.03,4.07,4.32,4.66,{"v":0.734099616858238,"d":"0.73"},{"v":-0.445952245721067,"d":"-0.45"},"down",{"v":0.038937,"d":"0.04"},1,"yes","GCAAATGCGATTCACCAGTGGAGATTTCTGCTCAGGATCCGAGTTTTCCCACTCGCCACC","FALSE",{"$nulls":5},"chr7",76132688,76135155,null,null,"mRNA","agilent G3 V3"]
["A_33_P3338186",5.02,2.52,3.83,7.15,7.48,7.45,{"v":0.514945652173913,"d":"0.51"},{"v":-0.957507917885921,"d":"-0.96"},"down",{"v":0.0393210000000001,"d":"0.04"},1,"yes","ACCCGCTTTGTGATCTGCATGTGTGACACTGATTCTTTGGAAATAAAGAGTGGAAGCTGC","FALSE","NM_173620","ref|NM_173620|ens|ENST00000337014|ens|ENST00000327949|ref|XM_005256347","HEXDC","hexosaminidase (glycosyl hydrolase family 20, catalytic domain) containing","ref|Homo sapiens hexosaminidase (glycosyl hydrolase family 20, catalytic domain) containing (HEXDC), mRNA [NM_173620]","chr17",80397992,80400228,"GO:0004563(beta-N-acetylhexosaminidase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005975(carbohydrate metabolic process)","00511(Other glycan degradation)","mRNA","agilent G3 V3"]
["A_33_P3281151",4.41,2.48,2.19,6.49,6.31,6.55,{"v":0.469250645994832,"d":"0.47"},{"v":-1.09156936374086,"d":"-1.09"},"down",{"v":0.0394030000000001,"d":"0.04"},1,"yes","TATAGTGCAGCCTGGGCTGAGTATTATAGACAACAAGCAGCCTATTATGCCCAGACAAGT","FALSE","NM_001303433","ref|NM_001303433|ref|NM_003902|ref|NR_130152|ens|ENST00000487684","FUBP1","far upstream element (FUSE) binding protein 1","ref|Homo sapiens far upstream element (FUSE) binding protein 1 (FUBP1), transcript variant 1, mRNA [NM_001303433]","chr1",78414368,78444745,"GO:0001205(RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription);GO:0003697(single-stranded DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006366(transcription from RNA polymerase II promoter);GO:0010628(positive regulation of gene expression);GO:0045944(positive regulation of transcription from RNA polymerase II promoter)",null,"mRNA","agilent G3 V3"]
["A_23_P161481",9.02,8.31,9.03,8.18,7.46,7.05,{"v":1.16174526223006,"d":"1.16"},{"v":0.216293761335714,"d":"0.22"},"up",{"v":0.039801,"d":"0.04"},1,"yes","TTGACCCCCTTGGCTGAATTCTTTTGCAGAACTACTGTGTGTCTGTTCACTACCTTTTCA","FALSE","NM_014431","ref|NM_014431|ens|ENST00000263563|ref|XM_006717765|ref|XM_006717766","PALD1","phosphatase domain containing, paladin 1","ref|Homo sapiens phosphatase domain containing, paladin 1 (PALD1), mRNA [NM_014431]","chr10",72238576,72328205,"GO:0005515(protein binding);GO:0005829(cytosol)",null,"mRNA","agilent G3 V3"]
["A_33_P3240951",5.26,6.47,5.21,3.53,4.61,4.15,{"v":1.37835638730675,"d":"1.38"},{"v":0.462948958959537,"d":"0.46"},"up",{"v":0.040082,"d":"0.04"},1,"yes","TTATGTTTCCAATAGCACTTCCTGAAATAAACCAAAGCAACACTGCTCAAGGCCCCTGGG","FALSE","NM_001280544","ref|NM_001280544|ref|NM_001280543|ref|NM_012074|ens|ENST00000366353","DPF3","D4, zinc and double PHD fingers, family 3","ref|Homo sapiens D4, zinc and double PHD fingers, family 3 (DPF3), transcript variant 4, mRNA [NM_001280544]","chr14",73136656,73360809,"GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0007399(nervous system development);GO:0008150(biological_process);GO:0008270(zinc ion binding);GO:0016568(chromatin modification);GO:0071565(nBAF complex)",null,"mRNA","agilent G3 V3"]
["A_24_P258846",{"v":7.5,"d":"7.50"},7.46,7.58,7.15,{"v":7.1,"d":"7.10"},{"v":7.4,"d":"7.40"},{"v":1.04110854503464,"d":"1.04"},{"v":0.0581204905581338,"d":"0.06"},"up",{"v":0.040402,"d":"0.04"},1,"yes","CTCTGGTGGTTGAGATCCCGCCATTTCGGAATCAGAGGATAACCAGCCCCGTTCACGTCA","FALSE","NM_172390","ref|NM_172390|ref|NM_001278675|ens|ENST00000592223|ens|ENST00000427363","NFATC1","nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1","ref|Homo sapiens nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (NFATC1), transcript variant 1, mRNA [NM_172390]","chr18",77160328,77287741,"GO:0000082(G1/S transition of mitotic cell cycle);GO:0000790(nuclear chromatin);GO:0000979(RNA polymerase II core promoter sequence-specific DNA binding);GO:0000980(RNA polymerase II distal enhancer sequence-specific DNA binding);GO:0001085(RNA polymerase II transcription factor binding);GO:0001205(RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription);GO:0001837(epithelial to mesenchymal transition);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0003705(RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity);GO:0005515(protein binding);GO:0005528(FK506 binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006366(transcription from RNA polymerase II promoter);GO:0006816(calcium ion transport);GO:0007507(heart development);GO:0030316(osteoclast differentiation);GO:0035556(intracellular signal transduction);GO:0038095(Fc-epsilon receptor signaling pathway);GO:0044212(transcription regulatory region DNA binding);GO:0045087(innate immune response);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048273(mitogen-activated protein kinase p38 binding)","04010(MAPK signaling pathway);04310(Wnt signaling pathway);04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04650(Natural killer cell mediated cytotoxicity);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);04921(Oxytocin signaling pathway);04380(Osteoclast differentiation);05321(Inflammatiory bowel disease (IBD));05166(HTLV-I infection);05161(Hepatitis B)","mRNA","agilent G3 V3"]
["A_23_P122387",4.02,3.18,3.01,4.85,4.94,4.94,{"v":0.693143245078072,"d":"0.69"},{"v":-0.528774564158048,"d":"-0.53"},"down",{"v":0.040705,"d":"0.04"},1,"yes","TTCTGAGGGACAATGTCTGCTACTCAAGAACACCTTGGAAGCTGTATCACTGACAGAGAG","FALSE","NM_018135","ref|NM_018135|ref|NM_001193343|ens|ENST00000372116|ens|ENST00000372133","MRPS18A","mitochondrial ribosomal protein S18A","ref|Homo sapiens mitochondrial ribosomal protein S18A (MRPS18A), transcript variant 1, mRNA [NM_018135]","chr6",43639520,43655528,"GO:0003735(structural constituent of ribosome);GO:0005743(mitochondrial inner membrane);GO:0005763(mitochondrial small ribosomal subunit);GO:0006412(translation);GO:0006996(organelle organization);GO:0032543(mitochondrial translation);GO:0070124(mitochondrial translational initiation);GO:0070125(mitochondrial translational elongation);GO:0070126(mitochondrial translational termination)","03010(Ribosome)","mRNA","agilent G3 V3"]
["A_33_P3418234",4.12,5.31,5.11,3.21,3.56,3.96,{"v":1.35507921714818,"d":"1.36"},{"v":0.438377193163072,"d":"0.44"},"up",{"v":0.0409590000000001,"d":"0.04"},1,"yes","TTCATGCTTATAAATTTCAAGTGGAGTCTCATCTGGGTTGCCTCAAGGTATCAAAAGTAG","FALSE","NM_001290693","ref|NM_001290693|gb|HM031116","BECN1P1","beclin 1, autophagy related, pseudogene 1","ref|Homo sapiens beclin 1, autophagy related, pseudogene 1 (BECN1P1), mRNA [NM_001290693]","chr1",242121040,242122364,"GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006914(autophagy);GO:0008333(endosome to lysosome transport)",null,"mRNA","agilent G3 V3"]
["A_24_P318593",5.02,4.07,{"v":5.1,"d":"5.10"},5.91,5.65,5.67,{"v":0.823563551944283,"d":"0.82"},{"v":-0.280048112164397,"d":"-0.28"},"down",{"v":0.041142,"d":"0.04"},1,"yes","GGTGATGATGGGCATCCTCAGAGACAAGGAGAGTGGTATCTGTATGGACTCGGGAGGCTT","FALSE","NM_138355","ref|NM_138355|ref|NM_001145023|ens|ENST00000579856|ens|ENST00000582459","SCRN2","secernin 2","ref|Homo sapiens secernin 2 (SCRN2), transcript variant 1, mRNA [NM_138355]","chr17",45916824,45918633,"GO:0003674(molecular_function);GO:0006508(proteolysis);GO:0006887(exocytosis);GO:0008150(biological_process);GO:0016805(dipeptidase activity);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_22_P00005099",7.36,6.65,5.75,{"v":7.7,"d":"7.70"},{"v":8.2,"d":"8.20"},8.35,{"v":0.814845360824742,"d":"0.81"},{"v":-0.295401800377175,"d":"-0.30"},"down",{"v":0.041542,"d":"0.04"},1,"yes","CCCACACACACCACTGGAGGCCGCAGCTGTGGAGGCAGACCCGGGCCTGCAGCAGAGCAG","FALSE","ENST00000445654","ens|ENST00000445654|linc|lnc-DHCR7-2:1","SHANK2","SH3 and multiple ankyrin repeat domains 2","ens|SH3 and multiple ankyrin repeat domains 2 [Source:HGNC Symbol;Acc:HGNC:14295] [ENST00000445654]","chr11",70412496,70506015,"GO:0001750(photoreceptor outer segment);GO:0001917(photoreceptor inner segment);GO:0005515(protein binding);GO:0005575(cellular_component);GO:0005883(neurofilament);GO:0005886(plasma membrane);GO:0007416(synapse assembly);GO:0007612(learning);GO:0007613(memory);GO:0008328(ionotropic glutamate receptor complex);GO:0014069(postsynaptic density);GO:0016324(apical plasma membrane);GO:0017124(SH3 domain binding);GO:0030054(cell junction);GO:0030160(GKAP/Homer scaffold activity);GO:0030426(growth cone);GO:0030534(adult behavior);GO:0031526(brush border membrane);GO:0035176(social behavior);GO:0035255(ionotropic glutamate receptor binding);GO:0035640(exploration behavior);GO:0043005(neuron projection);GO:0043025(neuronal cell body);GO:0043197(dendritic spine);GO:0045211(postsynaptic membrane);GO:0060170(cilium membrane);GO:0060291(long-term synaptic potentiation);GO:0060292(long term synaptic depression);GO:0071625(vocalization behavior)","04724(Glutamatergic synapse)","mRNA","agilent G3 V3"]
["A_23_P332789",{"v":5.8,"d":"5.80"},6.64,5.43,{"v":4.7,"d":"4.70"},3.45,1.92,{"v":1.77457795431976,"d":"1.77"},{"v":0.827475951034706,"d":"0.83"},"up",{"v":0.041778,"d":"0.04"},1,"yes","CCGGGCAATGGGGATAAAGATGACTTCGTAGCAGCACCTACTATGCTTCAGGCATGGTGC","FALSE","NM_000750","ref|NM_000750|ref|NM_001256567|ens|ENST00000261751|gb|U62439","CHRNB4","cholinergic receptor, nicotinic, beta 4 (neuronal)","ref|Homo sapiens cholinergic receptor, nicotinic, beta 4 (neuronal) (CHRNB4), transcript variant 1, mRNA [NM_000750]","chr15",78916752,78933587,"GO:0001508(regulation of action potential);GO:0004889(acetylcholine-activated cation-selective channel activity);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0005892(acetylcholine-gated channel complex);GO:0006811(ion transport);GO:0006812(cation transport);GO:0006939(smooth muscle contraction);GO:0006940(regulation of smooth muscle contraction);GO:0007165(signal transduction);GO:0007268(synaptic transmission);GO:0007271(synaptic transmission, cholinergic);GO:0007626(locomotory behavior);GO:0015276(ligand-gated ion channel activity);GO:0015464(acetylcholine receptor activity);GO:0016021(integral to membrane);GO:0030054(cell junction);GO:0034220(ion transmembrane transport);GO:0035095(behavioral response to nicotine);GO:0045211(postsynaptic membrane);GO:0046928(regulation of neurotransmitter secretion);GO:0060084(synaptic transmission involved in micturition)","04080(Neuroactive ligand-receptor interaction);04725(Cholinergic synapse)","mRNA","agilent G3 V3"]
["A_23_P201808",6.26,7.39,5.54,7.94,7.89,8.21,{"v":0.798252911813644,"d":"0.80"},{"v":-0.325082184515805,"d":"-0.33"},"down",{"v":0.041856,"d":"0.04"},1,"yes","TATGGATCAACCACATGCACATCCTTACTACAGAATCCGTCCTTTCATTTCAACTTATAG","FALSE","NM_003713","ref|NM_003713|ens|ENST00000371250|gb|AF480883|tc|THC2585233","PPAP2B","phosphatidic acid phosphatase type 2B","ref|Homo sapiens phosphatidic acid phosphatase type 2B (PPAP2B), mRNA [NM_003713]","chr1",56960420,57045241,"GO:0001568(blood vessel development);GO:0001702(gastrulation with mouth forming second);GO:0001933(negative regulation of protein phosphorylation);GO:0004721(phosphoprotein phosphatase activity);GO:0005178(integrin binding);GO:0005515(protein binding);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005912(adherens junction);GO:0006629(lipid metabolic process);GO:0006644(phospholipid metabolic process);GO:0006665(sphingolipid metabolic process);GO:0008195(phosphatidate phosphatase activity);GO:0008354(germ cell migration);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0016311(dephosphorylation);GO:0030111(regulation of Wnt receptor signaling pathway);GO:0030148(sphingolipid biosynthetic process);GO:0034109(homotypic cell-cell adhesion);GO:0042392(sphingosine-1-phosphate phosphatase activity);GO:0042577(lipid phosphatase activity);GO:0044281(small molecule metabolic process);GO:0044328(canonical Wnt receptor signaling pathway involved in positive regulation of endothelial cell migration);GO:0044329(canonical Wnt receptor signaling pathway involved in positive regulation of cell-cell adhesion);GO:0044330(canonical Wnt receptor signaling pathway involved in positive regulation of wound healing);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0050821(protein stabilization);GO:0051091(positive regulation of sequence-specific DNA binding transcription factor activity);GO:0060020(Bergmann glial cell differentiation);GO:0070062(extracellular vesicular exosome)","00561(Glycerolipid metabolism);00564(Glycerophospholipid metabolism);00565(Ether lipid metabolism);00600(Sphingolipid metabolism);04666(Fc gamma R-mediated phagocytosis);04975(Fat digestion and absorption);05231(Choline metabolism in cancer)","mRNA","agilent G3 V3"]
["A_33_P3283646",{"v":5.5,"d":"5.50"},5.84,5.54,5.22,4.98,4.44,{"v":1.15300546448087,"d":"1.15"},{"v":0.205399350423143,"d":"0.21"},"up",{"v":0.042596,"d":"0.04"},1,"yes","TCCAAGTGGCCCCACACAGCAAGGTGTTTTTGACATCCACGTGGTGGCAAAACCAACTAT","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_33_P3270346",5.76,5.27,5.67,4.41,4.64,{"v":5.2,"d":"5.20"},{"v":1.1719298245614,"d":"1.17"},{"v":0.228886183421948,"d":"0.23"},"up",{"v":0.042836,"d":"0.04"},1,"yes","CTCCATGACTCACCCTATGAGTGGTCAGACCCGAGTGACCCACTGCTTGTTTCTGTCACA","FALSE","NM_020535","ref|NM_020535|ref|NM_001018081|ens|ENST00000615969|ens|ENST00000612730","KIR2DL5A","killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A","ref|Homo sapiens killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A (KIR2DL5A), mRNA [NM_020535]","chrGL000209.1",{"v":86746,"d":"86746.00"},96246,"GO:0005886(plasma membrane);GO:0016021(integral to membrane)","04650(Natural killer cell mediated cytotoxicity);04612(Antigen processing and presentation);05332(Graft-versus-host disease)","mRNA","agilent G3 V3"]
["A_23_P90130",6.14,6.38,5.95,5.86,5.51,{"v":5.3,"d":"5.30"},{"v":1.10797840431914,"d":"1.11"},{"v":0.147929761996021,"d":"0.15"},"up",{"v":0.043142,"d":"0.04"},1,"yes","GGCCCATGATTACGTCATCCAGACTACTCGAAATGGCGTCCGCCTCTGCTTGTCCGGTTT","FALSE","NM_004851","ref|NM_004851|ens|ENST00000598044|ens|ENST00000253719|gb|AK314364","NAPSA","napsin A aspartic peptidase","ref|Homo sapiens napsin A aspartic peptidase (NAPSA), mRNA [NM_004851]","chr19",50861736,50869087,"GO:0004175(endopeptidase activity);GO:0004190(aspartic-type endopeptidase activity);GO:0005615(extracellular space);GO:0005764(lysosome);GO:0006508(proteolysis);GO:0008233(peptidase activity);GO:0033619(membrane protein proteolysis);GO:0043129(surfactant homeostasis);GO:0070062(extracellular vesicular exosome);GO:0097208(alveolar lamellar body)","04142(Lysosome)","mRNA","agilent G3 V3"]
["A_33_P3262575",2.32,2.33,2.82,3.04,3.24,3.91,{"v":0.733071638861629,"d":"0.73"},{"v":-0.447973903376577,"d":"-0.45"},"down",{"v":0.043262,"d":"0.04"},1,"yes","GACCAGCTCAGCCATTTAAAATATTTTCTTCCTATTCTGTTCAAGAAACAGTAAACTTGG","FALSE","NM_018842","ref|NM_018842|ens|ENST00000005260|gb|AK124269|gb|AK027109","BAIAP2L1","BAI1-associated protein 2-like 1","ref|Homo sapiens BAI1-associated protein 2-like 1 (BAIAP2L1), mRNA [NM_018842]","chr7",97920960,98030380,"GO:0003779(actin binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007009(plasma membrane organization);GO:0009617(response to bacterium);GO:0015629(actin cytoskeleton);GO:0030838(positive regulation of actin filament polymerization);GO:0046626(regulation of insulin receptor signaling pathway);GO:0070062(extracellular vesicular exosome);GO:0070064(proline-rich region binding);GO:2000251(positive regulation of actin cytoskeleton reorganization)",null,"mRNA","agilent G3 V3"]
["A_33_P3380982",7.47,7.75,6.71,8.69,8.75,8.83,{"v":0.834792539017891,"d":"0.83"},{"v":-0.260510388460038,"d":"-0.26"},"down",{"v":0.043844,"d":"0.04"},1,"yes","CCCATGCACCATTCAGTAAACATAAAAATCACAATTCTGCTAATGTCATTTGGAACTTCA","FALSE","NM_018247","ref|NM_018247|ref|NM_001143958|ens|ENST00000230461|gb|AL162046","TMEM30A","transmembrane protein 30A","ref|Homo sapiens transmembrane protein 30A (TMEM30A), transcript variant 1, mRNA [NM_018247]","chr6",75963328,75982616,"GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0006855(drug transmembrane transport);GO:0010976(positive regulation of neuron projection development);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0016324(apical plasma membrane);GO:0030658(transport vesicle membrane);GO:0036010(protein localization in endosome);GO:0045332(phospholipid translocation);GO:0070863(positive regulation of protein exit from endoplasmic reticulum)",null,"mRNA","agilent G3 V3"]
["A_23_P158925",4.65,3.01,4.56,6.48,6.72,6.46,{"v":0.621566632756867,"d":"0.62"},{"v":-0.686019036521851,"d":"-0.69"},"down",{"v":0.044102,"d":"0.04"},1,"yes","GTTGTCAAAGCACCAACAGGACATTTTGGGATGTGAAATGTAATTTCTTGGAATCTGTAA","FALSE","NM_145290","ref|NM_145290|ens|ENST00000499527|ens|ENST00000334304|gb|M37712","GPR125","G protein-coupled receptor 125","ref|Homo sapiens G protein-coupled receptor 125 (GPR125), mRNA [NM_145290]","chr4",22389332,22457457,"GO:0004930(G-protein coupled receptor activity);GO:0007186(G-protein coupled receptor signaling pathway);GO:0009897(external side of plasma membrane);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_24_P787947",2.02,1.96,3.52,4.02,3.79,4.34,{"v":0.617283950617284,"d":"0.62"},{"v":-0.6959938131099,"d":"-0.70"},"down",{"v":0.044157,"d":"0.04"},1,"yes","AAGGTAAAGCCTAGAAGAAACTATGAAAGCTATTCTCATGTTACCAAATTCTATCTGCGC","FALSE","NM_001005404","ref|NM_001005404|ens|ENST00000312655|gb|AB098736|tc|THC2608705","YPEL2","yippee-like 2 (Drosophila)","ref|Homo sapiens yippee-like 2 (Drosophila) (YPEL2), mRNA [NM_001005404]","chr17",57409064,57479090,"GO:0005730(nucleolus)",null,"mRNA","agilent G3 V3"]
["A_24_P154006",7.25,7.84,6.69,8.83,8.82,8.72,{"v":0.825938566552901,"d":"0.83"},{"v":-0.275893617147653,"d":"-0.28"},"down",{"v":0.0444629999999999,"d":"0.04"},1,"yes","ACTGTGGTGGTATATTGTGACCAGACCCCGGGAGCGGCCCATGTAGAAAGAGAGAGACCT","FALSE","NM_005005","ref|NM_005005|ref|NM_001278646|ref|NM_001278645|ens|ENST00000518657","NDUFB9","NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa","ref|Homo sapiens NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9, 22kDa (NDUFB9), transcript variant 1, mRNA [NM_005005]","chr8",125558920,125562219,"GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0005747(mitochondrial respiratory chain complex I);GO:0006120(mitochondrial electron transport, NADH to ubiquinone);GO:0007605(sensory perception of sound);GO:0008137(NADH dehydrogenase (ubiquinone) activity);GO:0022904(respiratory electron transport chain);GO:0044237(cellular metabolic process);GO:0044281(small molecule metabolic process);GO:0070062(extracellular vesicular exosome)","00190(Oxidative phosphorylation);05010(Alzheimer's disease);05012(Parkinson's disease);05016(Huntington's disease);04932(Non-alcoholic fatty liver disease (NAFLD))","mRNA","agilent G3 V3"]
["A_23_P13294",6.49,5.86,6.32,6.76,6.98,6.71,{"v":0.912958435207824,"d":"0.91"},{"v":-0.131378915602909,"d":"-0.13"},"down",{"v":0.044778,"d":"0.04"},1,"yes","GGACTCTCCAACCAGGCTGAACATCAAAACCTCCTCTTTGTGCTTTTCCTGAGTATGTAT","FALSE","NM_001004459","ref|NM_001004459|ens|ENST00000302592|tc|THC2603194","OR1S2","olfactory receptor, family 1, subfamily S, member 2","ref|Homo sapiens olfactory receptor, family 1, subfamily S, member 2 (OR1S2), mRNA [NM_001004459]","chr11",57970672,57971653,"GO:0004888(transmembrane signaling receptor activity);GO:0004930(G-protein coupled receptor activity);GO:0004984(olfactory receptor activity);GO:0005886(plasma membrane);GO:0007186(G-protein coupled receptor signaling pathway);GO:0016021(integral to membrane);GO:0050907(detection of chemical stimulus involved in sensory perception);GO:0050911(detection of chemical stimulus involved in sensory perception of smell)","04740(Olfactory transduction)","mRNA","agilent G3 V3"]
["A_24_P98251",4.26,1.92,1.95,6.29,6.11,6.38,{"v":0.432907348242811,"d":"0.43"},{"v":-1.20786980557875,"d":"-1.21"},"down",{"v":0.044941,"d":"0.04"},1,"yes","TACCTGGGTTTAATACAGCTCACATCACTGAATGTTACACATGAGTTTAAATGGGTAATA","FALSE","NM_017890","ref|NM_017890|ref|NM_152564|ens|ENST00000358544|ens|ENST00000357162","VPS13B","vacuolar protein sorting 13 homolog B (yeast)","ref|Homo sapiens vacuolar protein sorting 13 homolog B (yeast) (VPS13B), transcript variant 5, mRNA [NM_017890]","chr8",100025496,100889807,"GO:0015031(protein transport)",null,"mRNA","agilent G3 V3"]
["A_32_P167791",4.13,4.84,1.98,5.84,6.24,6.44,{"v":0.591252699784017,"d":"0.59"},{"v":-0.758153228771701,"d":"-0.76"},"down",{"v":0.045241,"d":"0.05"},1,"yes","AAGCATAATGCCCTTCTGATAAATAAAGCCCTGCTGAAGGAAAAGCAACCTAGATCACCT","FALSE","NM_003932","ref|NM_003932|ref|NM_001278589|ens|ENST00000620312|ens|ENST00000615506","ST13","suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein)","ref|Homo sapiens suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein) (ST13), transcript variant 1, mRNA [NM_003932]","chr11",18283528,18283896,"GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006457(protein folding);GO:0019904(protein domain specific binding);GO:0030544(Hsp70 protein binding);GO:0030674(protein binding, bridging);GO:0032403(protein complex binding);GO:0032564(dATP binding);GO:0042802(identical protein binding);GO:0043234(protein complex);GO:0051082(unfolded protein binding);GO:0051087(chaperone binding);GO:0051260(protein homooligomerization);GO:0061084(negative regulation of protein refolding);GO:0070062(extracellular vesicular exosome);GO:0070389(chaperone cofactor-dependent protein refolding)",null,"mRNA","agilent G3 V3"]
["A_23_P18413",6.08,6.77,5.22,8.15,7.98,8.05,{"v":0.747311827956989,"d":"0.75"},{"v":-0.420217738384524,"d":"-0.42"},"down",{"v":0.045705,"d":"0.05"},1,"yes","TGCTGACAAATTTAAGTGCTGGTACCTGTGGTGGCAGTGGCTTGCTCTTGTCTTTTTCTT","FALSE","NM_016589","ref|NM_016589|ens|ENST00000498399|ens|ENST00000264244|ens|ENST00000494664","TIMMDC1","translocase of inner mitochondrial membrane domain containing 1","ref|Homo sapiens translocase of inner mitochondrial membrane domain containing 1 (TIMMDC1), mRNA [NM_016589]","chr3",119217664,119242908,"GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0016021(integral to membrane);GO:0031966(mitochondrial membrane)",null,"mRNA","agilent G3 V3"]
["A_21_P0000301",8.46,8.71,8.21,7.26,6.93,8.06,{"v":1.14067415730337,"d":"1.14"},{"v":0.189886733099984,"d":"0.19"},"up",{"v":0.046079,"d":"0.05"},1,"yes","TGACTCATGGGCCCTGTTCCTGTGTCCCAGGCTCAGGGATAAATTTGGTTACAGACATCA","FALSE","NR_002919","ref|NR_002919|gb|JX629745|gb|AJ609453","SNORA5A","small nucleolar RNA, H/ACA box 5A","ref|Homo sapiens small nucleolar RNA, H/ACA box 5A (SNORA5A), small nucleolar RNA [NR_002919]","chr7",45143948,45144081,null,null,"mRNA","agilent G3 V3"]
["A_33_P3283350",5.32,{"v":6,"d":"6.00"},5.52,5.04,3.56,4.18,{"v":1.31768388106416,"d":"1.32"},{"v":0.398004302119402,"d":"0.40"},"up",{"v":0.046203,"d":"0.05"},1,"yes","GGGCCGATCAGCACAGCGGACCCACCTTATTTTCTCATTGCCTGTCACGGATGTGTTTAA","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_33_P3318671",4.86,5.56,3.61,7.21,7.29,{"v":7.2,"d":"7.20"},{"v":0.646543778801843,"d":"0.65"},{"v":-0.629180033711942,"d":"-0.63"},"down",{"v":0.04644,"d":"0.05"},1,"yes","CTCCATGTGGTTTTTGGGTGTTTTTCTTCTTGTGTCCTGGATTCTGATAAAATTAAAGAA","FALSE","NM_007260","ref|NM_007260|ref|NR_033250|ens|ENST00000374514|ref|XM_005245728","LYPLA2","lysophospholipase II","ref|Homo sapiens lysophospholipase II (LYPLA2), mRNA [NM_007260]","chr6",33333324,33334020,"GO:0005737(cytoplasm);GO:0006631(fatty acid metabolic process);GO:0016787(hydrolase activity);GO:0070062(extracellular vesicular exosome)","00564(Glycerophospholipid metabolism)","mRNA","agilent G3 V3"]
["A_23_P150768",3.82,4.98,2.44,6.46,5.87,5.56,{"v":0.628283957518167,"d":"0.63"},{"v":-0.670511351830982,"d":"-0.67"},"down",{"v":0.0468029999999999,"d":"0.05"},1,"yes","TGCTGGTTGGTATCTGTAAATGTTTAATAAATATCTGAGCATGTATCTATCAACGCCAAG","FALSE","NM_007256","ref|NM_007256|ref|NM_001145211|ref|NM_001145212|ens|ENST00000341411","SLCO2B1","solute carrier organic anion transporter family, member 2B1","ref|Homo sapiens solute carrier organic anion transporter family, member 2B1 (SLCO2B1), transcript variant 1, mRNA [NM_007256]","chr11",74862040,74917444,"GO:0005886(plasma membrane);GO:0008514(organic anion transmembrane transporter activity);GO:0015347(sodium-independent organic anion transmembrane transporter activity);GO:0016021(integral to membrane);GO:0043252(sodium-independent organic anion transport);GO:0055085(transmembrane transport)",null,"mRNA","agilent G3 V3"]
["A_21_P0013958",6.11,5.69,{"v":7.3,"d":"7.30"},4.89,5.16,4.88,{"v":1.27930341594106,"d":"1.28"},{"v":0.35535847278857,"d":"0.36"},"up",{"v":0.0472429999999999,"d":"0.05"},1,"yes","GTAACTGTTAGGAAGTTGGCCTCAGAAGCAAAAATTCTTCTTTTGTCTTGGCCCCTGTGA","FALSE","ENST00000512466","ens|ENST00000512466|gb|AK128087|tc|THC2628463","PDCD6","programmed cell death 6","ens|programmed cell death 6 [Source:HGNC Symbol;Acc:HGNC:8765] [ENST00000512466]","chr5",{"v":308312,"d":"308312.00"},315088,"GO:0001525(angiogenesis);GO:0001938(positive regulation of endothelial cell proliferation);GO:0004198(calcium-dependent cysteine-type endopeptidase activity);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006508(proteolysis);GO:0006886(intracellular protein transport);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0010595(positive regulation of endothelial cell migration);GO:0030948(negative regulation of vascular endothelial growth factor receptor signaling pathway);GO:0031410(cytoplasmic vesicle);GO:0031965(nuclear membrane);GO:0032007(negative regulation of TOR signaling cascade);GO:0034605(cellular response to heat);GO:0042803(protein homodimerization activity);GO:0043280(positive regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043495(protein anchor);GO:0045766(positive regulation of angiogenesis);GO:0046983(protein dimerization activity);GO:0048306(calcium-dependent protein binding);GO:0051592(response to calcium ion);GO:0051898(negative regulation of protein kinase B signaling cascade);GO:0060090(binding, bridging);GO:0070062(extracellular vesicular exosome);GO:0070971(endoplasmic reticulum exit site);GO:0097190(apoptotic signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_24_P8494",6.41,7.81,6.42,8.43,8.02,8.26,{"v":0.835289356535815,"d":"0.84"},{"v":-0.25965203990553,"d":"-0.26"},"down",{"v":0.047516,"d":"0.05"},1,"yes","TTATGTTGCACATTTGGGGCAAGTACACTCGTTCGTAGATTCAGTTACATCCATCTGTCA","FALSE","NM_006808","ref|NM_006808|ens|ENST00000223641|gb|L25085|gb|BC001734","SEC61B","Sec61 beta subunit","ref|Homo sapiens Sec61 beta subunit (SEC61B), mRNA [NM_006808]","chr9",101984584,101992897,"GO:0000060(protein import into nucleus, translocation);GO:0002474(antigen processing and presentation of peptide antigen via MHC class I);GO:0002479(antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0006412(translation);GO:0006614(SRP-dependent cotranslational protein targeting to membrane);GO:0010467(gene expression);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0030433(ER-associated protein catabolic process);GO:0030970(retrograde protein transport, ER to cytosol);GO:0031205(endoplasmic reticulum Sec complex);GO:0042590(antigen processing and presentation of exogenous peptide antigen via MHC class I);GO:0044267(cellular protein metabolic process);GO:0048408(epidermal growth factor binding)","03060(Protein export);04141(Protein processing in endoplasmic reticulum);04145(Phagosome);05110(Vibrio cholerae infection)","mRNA","agilent G3 V3"]
["A_23_P316960",5.86,3.71,4.58,7.54,7.39,{"v":7.5,"d":"7.50"},{"v":0.630851538118591,"d":"0.63"},{"v":-0.664627567367028,"d":"-0.66"},"down",{"v":0.0477839999999999,"d":"0.05"},1,"yes","CATCATCAACATCTTCCTGTACATCCTCACCATCATTGGCCGCGCCAAGGAGTAGCCGAG","FALSE","NM_000837","ref|NM_000837|ref|NM_001009184|ens|ENST00000533377|ens|ENST00000313269","GRINA","glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding)","ref|Homo sapiens glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding) (GRINA), transcript variant 1, mRNA [NM_000837]","chr8",145064224,145067583,"GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0016021(integral to membrane);GO:0032469(endoplasmic reticulum calcium ion homeostasis);GO:0044325(ion channel binding)",null,"mRNA","agilent G3 V3"]
["A_24_P75230",7.07,7.87,6.66,8.12,8.18,8.36,{"v":0.875912408759124,"d":"0.88"},{"v":-0.191141487352008,"d":"-0.19"},"down",{"v":0.048143,"d":"0.05"},1,"yes","GGGATCAGTTTACGGATGAGGAAGTGGATGAGCTGTACACAGAAGCACCTATTGACAAAA","FALSE","NM_033546","ref|NM_033546|ref|NM_001144944|ref|NM_001144945|ens|ENST00000503948","MYL12B","myosin, light chain 12B, regulatory","ref|Homo sapiens myosin, light chain 12B, regulatory (MYL12B), transcript variant 2, mRNA [NM_033546]","chr4",185220288,185220800,"GO:0001725(stress fiber);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005829(cytosol);GO:0006936(muscle contraction);GO:0007411(axon guidance);GO:0008360(regulation of cell shape);GO:0016460(myosin II complex);GO:0030018(Z disc);GO:0045177(apical part of cell);GO:0048013(ephrin receptor signaling pathway);GO:0070062(extracellular vesicular exosome)","04810(Regulation of actin cytoskeleton);04510(Focal adhesion);04530(Tight junction);04611(Platelet activation);04670(Leukocyte transendothelial migration)","mRNA","agilent G3 V3"]
["A_33_P3413962",3.29,4.33,{"v":3.2,"d":"3.20"},5.04,4.37,4.92,{"v":0.755059316120028,"d":"0.76"},{"v":-0.40533811043533,"d":"-0.41"},"down",{"v":0.0485800000000001,"d":"0.05"},1,"yes","TAAGCAAAAGAAACGTTATTTTTCAACCTGTGGCAGAGCTGAAGAAGCAAACGGATTTTG","FALSE","NM_001242339","ref|NM_001242339|ref|NM_002627|ens|ENST00000381075|ens|ENST00000381125","PFKP","phosphofructokinase, platelet","ref|Homo sapiens phosphofructokinase, platelet (PFKP), transcript variant 2, mRNA [NM_001242339]","chr10",{"v":3175427,"d":"3175427.00"},3179904,"GO:0003872(6-phosphofructokinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0005975(carbohydrate metabolic process);GO:0006002(fructose 6-phosphate metabolic process);GO:0006006(glucose metabolic process);GO:0006096(glycolysis);GO:0009405(pathogenesis);GO:0016020(membrane);GO:0032403(protein complex binding);GO:0044281(small molecule metabolic process);GO:0046835(carbohydrate phosphorylation);GO:0046872(metal ion binding);GO:0070062(extracellular vesicular exosome)","01200(Carbon metabolism);01230(Biosynthesis of amino acids);00010(Glycolysis / Gluconeogenesis);00030(Pentose phosphate pathway);00051(Fructose and mannose metabolism);00052(Galactose metabolism);03018(RNA degradation);04152(AMPK signaling pathway);04919(Thyroid hormone signaling pathway);05230(Central carbon metabolism in cancer)","mRNA","agilent G3 V3"]
["A_33_P3330428",5.86,{"v":5.7,"d":"5.70"},5.97,5.63,5.02,4.95,{"v":1.12371794871795,"d":"1.12"},{"v":0.168279967009928,"d":"0.17"},"up",{"v":0.048797,"d":"0.05"},1,"yes","TCAAGAAGGAGCAGGAACCCACTTCCCATCAGTCAGGGTGCAGCCAGGAAGAGGGAAACT","FALSE","ENST00000615516","ens|ENST00000615516|ref|XR_109635|ref|XR_112171|ref|XR_254004",null,null,"ens|oxysterol binding protein-like 2 [Source:HGNC Symbol;Acc:HGNC:15761] [ENST00000615516]","chr20",60807016,60811355,null,null,"mRNA","agilent G3 V3"]
["A_33_P3271166",{"v":10.3,"d":"10.30"},9.93,10.18,9.82,9.27,{"v":8.9,"d":"8.90"},{"v":1.0864594498035,"d":"1.09"},{"v":0.119634329457883,"d":"0.12"},"up",{"v":0.049077,"d":"0.05"},1,"yes","GTTGCCCCCATGTTGAATCCCTTTATTTATACACTGAGAAACAAACAAGTAAAAGATGTT","FALSE","NM_001005490","ref|NM_001005490|ens|ENST00000343870|gb|BC140754|tc|NP1472395","OR6C74","olfactory receptor, family 6, subfamily C, member 74","ref|Homo sapiens olfactory receptor, family 6, subfamily C, member 74 (OR6C74), mRNA [NM_001005490]","chr12",55640984,55642086,"GO:0004930(G-protein coupled receptor activity);GO:0004984(olfactory receptor activity);GO:0005886(plasma membrane);GO:0007186(G-protein coupled receptor signaling pathway);GO:0016021(integral to membrane);GO:0050911(detection of chemical stimulus involved in sensory perception of smell)","04740(Olfactory transduction)","mRNA","agilent G3 V3"]
["A_33_P3292854",9.58,10.86,9.53,11.42,11.34,{"v":11,"d":"11.00"},{"v":0.887736966824645,"d":"0.89"},{"v":-0.171795820193611,"d":"-0.17"},"down",{"v":0.049643,"d":"0.05"},1,"yes","GGGTCCCAGATTGGCTCACACTGAGAATGTAAGAACTACAAACAAAATTTCTATTAAATT","FALSE","NM_004343","ref|NM_004343|ens|ENST00000316448|ens|ENST00000586967|gb|FJ224311","CALR","calreticulin","ref|Homo sapiens calreticulin (CALR), mRNA [NM_004343]","chr19",13054687,13055303,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0001669(acrosomal vesicle);GO:0001849(complement component C1q binding);GO:0001948(glycoprotein binding);GO:0002474(antigen processing and presentation of peptide antigen via MHC class I);GO:0002479(antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent);GO:0002502(peptide antigen assembly with MHC class I protein complex);GO:0003677(DNA binding);GO:0003729(mRNA binding);GO:0005178(integrin binding);GO:0005506(iron ion binding);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005578(proteinaceous extracellular matrix);GO:0005615(extracellular space);GO:0005622(intracellular);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005788(endoplasmic reticulum lumen);GO:0005790(smooth endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005844(polysome);GO:0005925(focal adhesion);GO:0006355(regulation of transcription, DNA-dependent);GO:0006457(protein folding);GO:0006611(protein export from nucleus);GO:0006874(cellular calcium ion homeostasis);GO:0006898(receptor-mediated endocytosis);GO:0006987(activation of signaling protein activity involved in unfolded protein response);GO:0007050(cell cycle arrest);GO:0007283(spermatogenesis);GO:0008270(zinc ion binding);GO:0008284(positive regulation of cell proliferation);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0010628(positive regulation of gene expression);GO:0016020(membrane);GO:0017148(negative regulation of translation);GO:0018279(protein N-linked glycosylation via asparagine);GO:0022417(protein maturation by protein folding);GO:0030246(carbohydrate binding);GO:0030866(cortical actin cytoskeleton organization);GO:0030968(endoplasmic reticulum unfolded protein response);GO:0031625(ubiquitin protein ligase binding);GO:0032355(response to estradiol stimulus);GO:0033018(sarcoplasmic reticulum lumen);GO:0033144(negative regulation of intracellular steroid hormone receptor signaling pathway);GO:0033574(response to testosterone stimulus);GO:0034504(protein localization to nucleus);GO:0040020(regulation of meiosis);GO:0042277(peptide binding);GO:0042493(response to drug);GO:0042562(hormone binding);GO:0042590(antigen processing and presentation of exogenous peptide antigen via MHC class I);GO:0042824(MHC class I peptide loading complex);GO:0042921(glucocorticoid receptor signaling pathway);GO:0042981(regulation of apoptotic process);GO:0043687(post-translational protein modification);GO:0044183(protein binding involved in protein folding);GO:0044267(cellular protein metabolic process);GO:0045665(negative regulation of neuron differentiation);GO:0045740(positive regulation of DNA replication);GO:0045787(positive regulation of cell cycle);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0048387(negative regulation of retinoic acid receptor signaling pathway);GO:0048471(perinuclear region of cytoplasm);GO:0050681(androgen receptor binding);GO:0050766(positive regulation of phagocytosis);GO:0050821(protein stabilization);GO:0051082(unfolded protein binding)","04141(Protein processing in endoplasmic reticulum);04145(Phagosome);04612(Antigen processing and presentation);05166(HTLV-I infection);05142(Chagas disease (American trypanosomiasis))","mRNA","agilent G3 V3"]
["A_33_P3414695",5.61,3.73,5.12,7.24,7.24,7.25,{"v":0.665439484583525,"d":"0.67"},{"v":-0.587620622230165,"d":"-0.59"},"down",{"v":0.049978,"d":"0.05"},1,"yes","AATCTGTCTCCACTGTAGAAGAACAAGAGAATGAAACTCCACCTGCTACTTCGAGTGAGG","FALSE","NM_016287","ref|NM_016287|ens|ENST00000375000|ens|ENST00000417710|ens|ENST00000424732","HP1BP3","heterochromatin protein 1, binding protein 3","ref|Homo sapiens heterochromatin protein 1, binding protein 3 (HP1BP3), mRNA [NM_016287]","chr1",21103212,21113145,"GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0006334(nucleosome assembly);GO:0006355(regulation of transcription, DNA-dependent);GO:0031491(nucleosome binding);GO:0042127(regulation of cell proliferation);GO:0070828(heterochromatin organization);GO:0071456(cellular response to hypoxia);GO:0097298(regulation of nucleus size)",null,"mRNA","agilent G3 V3"]
["A_33_P3415491",9.66,8.73,10.13,11.25,11.21,{"v":11.4,"d":"11.40"},{"v":0.842291789722386,"d":"0.84"},{"v":-0.247607991451753,"d":"-0.25"},"down",{"v":0.050381,"d":"0.05"},1,"no","TCTGAGGACGGCTTCTTGCGGCTCTGGCCCCTGGACTTCTCCTCGGTGCTCCTGGAGGCA","FALSE","NM_145294","ref|NM_145294|ens|ENST00000615333|ens|ENST00000549648|ens|ENST00000420061","WDR90","WD repeat domain 90","ref|Homo sapiens WD repeat domain 90 (WDR90), mRNA [NM_145294]","chr16",{"v":705058,"d":"705058.00"},713433,null,null,"mRNA","agilent G3 V3"]
["A_23_P128993",6.03,5.08,6.34,5.02,{"v":4.5,"d":"4.50"},4.15,{"v":1.27651792245794,"d":"1.28"},{"v":0.352213793490955,"d":"0.35"},"up",{"v":0.050557,"d":"0.05"},1,"no","TCTGGGACAGAGGCAAGAATCCCCAAGGGGTGGGCAGTCAGGGTTGCAGGACTGTAATAA","FALSE","NM_033423","ref|NM_033423|ref|NM_001270780|ref|NM_001270781|ens|ENST00000216338","GZMH","granzyme H (cathepsin G-like 2, protein h-CCPX)","ref|Homo sapiens granzyme H (cathepsin G-like 2, protein h-CCPX) (GZMH), transcript variant 1, mRNA [NM_033423]","chr14",25075692,25078905,"GO:0004252(serine-type endopeptidase activity);GO:0005737(cytoplasm);GO:0006508(proteolysis);GO:0006915(apoptotic process);GO:0006955(immune response);GO:0016020(membrane);GO:0016485(protein processing);GO:0019835(cytolysis);GO:0043231(intracellular membrane-bounded organelle)",null,"mRNA","agilent G3 V3"]
["A_24_P302038",3.25,3.62,3.69,4.11,3.98,3.81,{"v":0.887394957983193,"d":"0.89"},{"v":-0.172351738836852,"d":"-0.17"},"down",{"v":0.050817,"d":"0.05"},1,"no","GGCTTCTCAACCAGATGAGTTGACCATTGAGGAACATGAGGTGTTAGAAGTGATTGAAGA","FALSE","NM_014824","ref|NM_014824|ens|ENST00000432043|ens|ENST00000409853|ens|ENST00000409418","FCHSD2","FCH and double SH3 domains 2","ref|Homo sapiens FCH and double SH3 domains 2 (FCHSD2), mRNA [NM_014824]","chr11",72554272,72598620,"GO:0005515(protein binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3272117",4.16,2.29,4.34,5.17,5.59,5.56,{"v":0.661151960784314,"d":"0.66"},{"v":-0.596946192483479,"d":"-0.60"},"down",{"v":0.0511389999999999,"d":"0.05"},1,"no","TGAGTTCTTTGAGCTGACGGTGGACGACGTGAGAAGACGCTTGGCCCAGCTCAAGAGTGA","FALSE","NM_024083","ref|NM_024083|ref|NM_001251888|ref|NR_045351|ens|ENST00000583503","ASPSCR1","alveolar soft part sarcoma chromosome region, candidate 1","ref|Homo sapiens alveolar soft part sarcoma chromosome region, candidate 1 (ASPSCR1), transcript variant 1, mRNA [NM_024083]","chr17",79965312,79975279,"GO:0003674(molecular_function);GO:0005515(protein binding);GO:0005575(cellular_component);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006886(intracellular protein transport);GO:0008150(biological_process);GO:0009898(internal side of plasma membrane);GO:0012505(endomembrane system);GO:0012506(vesicle membrane);GO:0019898(extrinsic to membrane);GO:0033116(endoplasmic reticulum-Golgi intermediate compartment membrane);GO:0042593(glucose homeostasis);GO:0043231(intracellular membrane-bounded organelle);GO:0046324(regulation of glucose import);GO:0048471(perinuclear region of cytoplasm);GO:0061024(membrane organization)","05202(Transcriptional misregulation in cancers)","mRNA","agilent G3 V3"]
["A_23_P101480",8.02,8.11,8.44,9.35,9.36,8.48,{"v":0.903641044501655,"d":"0.90"},{"v":-0.146178293662595,"d":"-0.15"},"down",{"v":0.051756,"d":"0.05"},1,"no","GGCCCCGCGCTGTACAGCCTCCGTATACATATGTACACATATAAATAAAGTGCGTCCGTG","FALSE","NM_014975","ref|NM_014975|ens|ENST00000251472|ref|XM_005259820|ref|XM_006722691","MAST1","microtubule associated serine/threonine kinase 1","ref|Homo sapiens microtubule associated serine/threonine kinase 1 (MAST1), mRNA [NM_014975]","chr19",12984068,12985163,"GO:0000287(magnesium ion binding);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0006468(protein phosphorylation);GO:0007010(cytoskeleton organization);GO:0035556(intracellular signal transduction)",null,"mRNA","agilent G3 V3"]
["A_33_P3422931",4.56,2.56,4.63,5.97,5.87,5.57,{"v":0.674899483055715,"d":"0.67"},{"v":-0.567255446198739,"d":"-0.57"},"down",{"v":0.0520400000000001,"d":"0.05"},1,"no","ACAAGCACCGAGGAGCCCATGCTGAATGTGCAGAGGATACGCATGGAACCCTGGGATTAC","FALSE","NM_001300900","ref|NM_001300900|ref|NM_023936|ens|ENST00000569585|ens|ENST00000397375","MRPS34","mitochondrial ribosomal protein S34","ref|Homo sapiens mitochondrial ribosomal protein S34 (MRPS34), transcript variant 1, mRNA [NM_001300900]","chr16",{"v":1821897,"d":"1821897.00"},1822699,"GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0005840(ribosome);GO:0006996(organelle organization);GO:0032543(mitochondrial translation);GO:0070124(mitochondrial translational initiation);GO:0070125(mitochondrial translational elongation);GO:0070126(mitochondrial translational termination)",null,"mRNA","agilent G3 V3"]
["A_33_P3645888",7.03,7.03,6.83,7.12,7.21,7.37,{"v":0.962672811059908,"d":"0.96"},{"v":-0.0548825502647334,"d":"-0.05"},"down",{"v":0.0525,"d":"0.05"},1,"no","TTGTGTTGCTCTTCTCCCTGGCCCAGGGCAGTTATTGTGAGACATGAGGGAAGGGTGTGG","FALSE","BG943532","gb|BG943532","SNORA71C","small nucleolar RNA, H/ACA box 71C","gb|ax39a01.x1 Proliferating Human Erythroid Cells (LCB:ax library) Homo sapiens cDNA clone ax39a01 random, mRNA sequence [BG943532]","chr20",37058312,37058446,null,null,"mRNA","agilent G3 V3"]
["A_24_P165205",7.79,{"v":7.6,"d":"7.60"},7.33,8.57,7.89,{"v":8.2,"d":"8.20"},{"v":0.921330089213301,"d":"0.92"},{"v":-0.118209964898157,"d":"-0.12"},"down",{"v":0.052882,"d":"0.05"},1,"no","GACAGAGACAACCAAGAGACACTCATCCAGACCCCATTTGGGTTCGAATGCATCCCTTAT","FALSE","NM_024848","ref|NM_024848|ref|NM_001301060|ens|ENST00000378531|ens|ENST00000606372","MORN1","MORN repeat containing 1","ref|Homo sapiens MORN repeat containing 1 (MORN1), transcript variant 1, mRNA [NM_024848]","chr1",{"v":2252692,"d":"2252692.00"},2323146,null,null,"mRNA","agilent G3 V3"]
["A_33_P3456341",6.51,5.39,5.75,5.05,5.05,4.64,{"v":1.19742198100407,"d":"1.20"},{"v":0.259931659063473,"d":"0.26"},"up",{"v":0.0532640000000001,"d":"0.05"},1,"no","AAACTTACCTTCAGAAGGAGACTTCCACTTTGCAGGTGGAACAGAATGGGGACTATGGTA","FALSE","NM_001170804","ref|NM_001170804|ref|NR_033200|ens|ENST00000616828|gb|BC063479","LARP4","La ribonucleoprotein domain family, member 4","ref|Homo sapiens La ribonucleoprotein domain family, member 4 (LARP4), transcript variant 5, mRNA [NM_001170804]","chr12",50834224,50870239,"GO:0007010(cytoskeleton organization);GO:0016020(membrane);GO:0022604(regulation of cell morphogenesis)",null,"mRNA","agilent G3 V3"]
["A_33_P3301410",5.48,5.66,5.47,6.18,5.81,5.78,{"v":0.934721440630276,"d":"0.93"},{"v":-0.097391608066302,"d":"-0.10"},"down",{"v":0.053524,"d":"0.05"},1,"no","AGATGTGCACACCCTCTTAGATCGAGTGGTCCGGCAGCATGTGCGTGAGGCCTCTATCTT","FALSE","NM_019037","ref|NM_019037|ens|ENST00000316052|gb|AB528720|gb|JF432617","EXOSC4","exosome component 4","ref|Homo sapiens exosome component 4 (EXOSC4), mRNA [NM_019037]","chr8",145134320,145135482,"GO:0000175(3'-5'-exoribonuclease activity);GO:0000178(exosome (RNase complex));GO:0000288(nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay);GO:0000460(maturation of 5.8S rRNA);GO:0000956(nuclear-transcribed mRNA catabolic process);GO:0004532(exoribonuclease activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006364(rRNA processing);GO:0010467(gene expression);GO:0017091(AU-rich element binding);GO:0030307(positive regulation of cell growth);GO:0035327(transcriptionally active chromatin);GO:0043928(exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay);GO:0045006(DNA deamination);GO:0051607(defense response to virus);GO:0071028(nuclear mRNA surveillance);GO:0071044(histone mRNA catabolic process)","03018(RNA degradation)","mRNA","agilent G3 V3"]
["A_23_P56228",4.13,3.11,4.05,5.63,4.95,4.49,{"v":0.749170537491705,"d":"0.75"},{"v":-0.416633930824823,"d":"-0.42"},"down",{"v":0.0537829999999999,"d":"0.05"},1,"no","GCCACTCGGGCTCAGAGGTCACTCAGGGTCAATACTCAGGGTCAGTGCAGGTTATGAGAT","FALSE","NM_016573","ref|NM_016573|ref|NM_001288999|ref|NM_001288998|ens|ENST00000203556","GMIP","GEM interacting protein","ref|Homo sapiens GEM interacting protein (GMIP), transcript variant 1, mRNA [NM_016573]","chr19",19740284,19754476,"GO:0005100(Rho GTPase activator activity);GO:0005515(protein binding);GO:0005622(intracellular);GO:0005829(cytosol);GO:0007264(small GTPase mediated signal transduction);GO:0032321(positive regulation of Rho GTPase activity);GO:0034259(negative regulation of Rho GTPase activity);GO:0035556(intracellular signal transduction);GO:0046872(metal ion binding);GO:0051056(regulation of small GTPase mediated signal transduction)",null,"mRNA","agilent G3 V3"]
["A_23_P161727",4.86,3.62,5.24,6.54,6.62,6.61,{"v":0.693980778958017,"d":"0.69"},{"v":-0.527032389556396,"d":"-0.53"},"down",{"v":0.054225,"d":"0.05"},1,"no","TATGGTTTGGTCCCATGGGACATGTCATAGCCTTGGTTTAGTTTTGGGTGGAGCTGAATA","FALSE","NM_001541","ref|NM_001541|ens|ENST00000304298|gb|AB096250|gb|D89617","HSPB2","heat shock 27kDa protein 2","ref|Homo sapiens heat shock 27kDa protein 2 (HSPB2), mRNA [NM_001541]","chr11",111782968,111784817,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006986(response to unfolded protein);GO:0008047(enzyme activator activity);GO:0043085(positive regulation of catalytic activity)","05205(Proteoglycans in cancer);05169(Epstein-Barr virus infection)","mRNA","agilent G3 V3"]
["A_23_P136936",3.72,2.99,2.77,4.37,4.31,4.34,{"v":0.728110599078341,"d":"0.73"},{"v":-0.457770484267376,"d":"-0.46"},"down",{"v":0.054599,"d":"0.05"},1,"no","CACTCCCGTGATGAAACAGCTAGGTTAATAGGAGGACAGAACCAACGGGTCTGTGGGACT","FALSE","NM_003179","ref|NM_003179|ens|ENST00000263233|gb|X06389|gb|BC064550","SYP","synaptophysin","ref|Homo sapiens synaptophysin (SYP), mRNA [NM_003179]","chrX",49044268,49056718,"GO:0005215(transporter activity);GO:0006897(endocytosis);GO:0008021(synaptic vesicle);GO:0015485(cholesterol binding);GO:0016188(synaptic vesicle maturation);GO:0017075(syntaxin-1 binding);GO:0030054(cell junction);GO:0030285(integral to synaptic vesicle membrane);GO:0030672(synaptic vesicle membrane);GO:0032403(protein complex binding);GO:0042169(SH2 domain binding);GO:0042734(presynaptic membrane);GO:0042802(identical protein binding);GO:0043005(neuron projection);GO:0043234(protein complex);GO:0043621(protein self-association);GO:0044306(neuron projection terminus);GO:0048168(regulation of neuronal synaptic plasticity);GO:0048169(regulation of long-term neuronal synaptic plasticity);GO:0048172(regulation of short-term neuronal synaptic plasticity);GO:0048499(synaptic vesicle membrane organization);GO:0048786(presynaptic active zone);GO:0060076(excitatory synapse);GO:0071310(cellular response to organic substance);GO:2000474(regulation of opioid receptor signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_23_P128991",5.88,7.24,6.14,7.81,7.65,7.34,{"v":0.844736842105263,"d":"0.84"},{"v":-0.243426121208645,"d":"-0.24"},"down",{"v":0.054797,"d":"0.05"},1,"no","CAGAAGAAGGACTTCGGAATGCACTACAACAGGAAAATCATATTATAGATGGAGTAAAGG","FALSE","NM_031210","ref|NM_031210|ref|NM_001267863|ref|NM_001267864|ref|NR_052025","SLIRP","SRA stem-loop interacting RNA binding protein","ref|Homo sapiens SRA stem-loop interacting RNA binding protein (SLIRP), transcript variant 1, mRNA [NM_031210]","chr14",78176984,78183927,"GO:0000166(nucleotide binding);GO:0000961(negative regulation of mitochondrial RNA catabolic process);GO:0001669(acrosomal vesicle);GO:0005634(nucleus);GO:0005739(mitochondrion);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0007286(spermatid development);GO:0007338(single fertilization);GO:0030317(sperm motility);GO:0030529(ribonucleoprotein complex);GO:0036126(sperm flagellum);GO:0048471(perinuclear region of cytoplasm);GO:0070584(mitochondrion morphogenesis)",null,"mRNA","agilent G3 V3"]
["A_33_P3390357",4.12,2.23,1.93,5.67,5.45,5.59,{"v":0.495511669658887,"d":"0.50"},{"v":-1.01300906056186,"d":"-1.01"},"down",{"v":0.055119,"d":"0.06"},1,"no","GCTGGCATTCAGGGTGACATGATGGTACTAAATGTTTTCCATTAAAGTCTTCTATTTTAA","FALSE","NM_001128626","ref|NM_001128626|ref|NM_020148|ref|NM_001128627|ens|ENST00000410092","SPIRE1","spire-type actin nucleation factor 1","ref|Homo sapiens spire-type actin nucleation factor 1 (SPIRE1), transcript variant 1, mRNA [NM_001128626]","chr18",12446512,12658044,"GO:0003779(actin binding);GO:0005794(Golgi apparatus);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0005938(cell cortex);GO:0015031(protein transport);GO:0016192(vesicle-mediated transport);GO:0030036(actin cytoskeleton organization);GO:0030659(cytoplasmic vesicle membrane);GO:0032154(cleavage furrow);GO:0036089(cleavage furrow formation);GO:0040038(polar body extrusion after meiotic divisions);GO:0045010(actin nucleation);GO:0046907(intracellular transport);GO:0048193(Golgi vesicle transport);GO:0048471(perinuclear region of cytoplasm);GO:0051295(establishment of meiotic spindle localization);GO:0070649(formin-nucleated actin cable assembly)","04320(Dorso-ventral axis formation)","mRNA","agilent G3 V3"]
["A_33_P3333554",7.13,6.85,7.14,6.76,6.62,6.83,{"v":1.04502721425037,"d":"1.05"},{"v":0.0635405129787182,"d":"0.06"},"up",{"v":0.0554359999999999,"d":"0.06"},1,"no","TCTCTGTAGGTTTGGGCAACTGCTCCTTCCATCCATATATTCAGGCTGAGTTGTGGAAAA","FALSE","ENST00000613959","ens|ENST00000613959|gb|BX640643|tc|THC2613875","ACTR3C","ARP3 actin-related protein 3 homolog C (yeast)","ens|ARP3 actin-related protein 3 homolog C (yeast) [Source:HGNC Symbol;Acc:HGNC:37282] [ENST00000613959]","chr7",149941008,150020662,"GO:0003674(molecular_function);GO:0003779(actin binding);GO:0005524(ATP binding);GO:0005885(Arp2/3 protein complex);GO:0008150(biological_process);GO:0034314(Arp2/3 complex-mediated actin nucleation);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3315314",9.83,9.54,9.49,{"v":9.4,"d":"9.40"},9.24,9.29,{"v":1.03329752953813,"d":"1.03"},{"v":0.0472557262112482,"d":"0.05"},"up",{"v":0.055724,"d":"0.06"},1,"no","AGTGCAAAAAGTGCAAATGCACCTCCTGCAAGAAGAGCTGCTGCTCCTGTTGCCCCCTGG","FALSE","NM_001276687","ref|NM_001276687|ref|NM_005951|ens|ENST00000464121|ens|ENST00000332374","MT1HL1","metallothionein 1H-like 1","ref|Homo sapiens metallothionein 1H-like 1 (MT1HL1), mRNA [NM_001276687]","chr16",56703728,56705041,"GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P18205",4.13,{"v":2,"d":"2.00"},3.61,5.92,5.73,5.92,{"v":0.554354012521343,"d":"0.55"},{"v":-0.851120513926034,"d":"-0.85"},"down",{"v":0.055878,"d":"0.06"},1,"no","GAGGTTGGGTTCAGCTCCAATGATGATGAGGATAAAGACGATGATGTGATAGAGGTCACT","FALSE","NM_015106","ref|NM_015106|ens|ENST00000461680|ens|ENST00000487093|gb|DQ892190","RAD54L2","RAD54-like 2 (S. cerevisiae)","ref|Homo sapiens RAD54-like 2 (S. cerevisiae) (RAD54L2), mRNA [NM_015106]","chr3",51663408,51697473,"GO:0003677(DNA binding);GO:0003712(transcription cofactor activity);GO:0004386(helicase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0008152(metabolic process);GO:0019901(protein kinase binding)",null,"mRNA","agilent G3 V3"]
["A_24_P313262",4.07,2.05,3.77,5.74,5.82,5.98,{"v":0.563854047890536,"d":"0.56"},{"v":-0.826606321685622,"d":"-0.83"},"down",{"v":0.056498,"d":"0.06"},1,"no","TTAGGGCTAATGAGTCATTGTTCCTTAATATCGTTTTCAATATGCCACAATTTAGGACAC","FALSE","NM_006628","ref|NM_006628|ens|ENST00000249822|ens|ENST00000566423|ref|XM_005254132","ARPP19","cAMP-regulated phosphoprotein, 19kDa","ref|Homo sapiens cAMP-regulated phosphoprotein, 19kDa (ARPP19), mRNA [NM_006628]","chr15",52841724,52861029,"GO:0000086(G2/M transition of mitotic cell cycle);GO:0000278(mitotic cell cycle);GO:0004864(protein phosphatase inhibitor activity);GO:0005102(receptor binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0007067(mitosis);GO:0008601(protein phosphatase type 2A regulator activity);GO:0015459(potassium channel regulator activity);GO:0019212(phosphatase inhibitor activity);GO:0043086(negative regulation of catalytic activity);GO:0045722(positive regulation of gluconeogenesis);GO:0046326(positive regulation of glucose import);GO:0050790(regulation of catalytic activity);GO:0051301(cell division);GO:0051721(protein phosphatase 2A binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3373850",6.45,5.82,6.04,6.74,{"v":6.9,"d":"6.90"},6.46,{"v":0.910945273631841,"d":"0.91"},{"v":-0.134563710268954,"d":"-0.13"},"down",{"v":0.056855,"d":"0.06"},1,"no","CTGCGGCCACCTCTGCGAGTACTCCTGACGGGGCATCTGCTGGGCTTGCCCGGGCGGCCG","FALSE","NM_032259","ref|NM_032259|ref|NM_001303027|ens|ENST00000293883|gb|AL136863","WDR24","WD repeat domain 24","ref|Homo sapiens WD repeat domain 24 (WDR24), mRNA [NM_032259]","chr16",{"v":734622,"d":"734622.00"},740444,null,null,"mRNA","agilent G3 V3"]
["A_33_P3376071",9.64,10.75,9.42,10.96,10.97,11.21,{"v":0.8995171997586,"d":"0.90"},{"v":-0.152777227230283,"d":"-0.15"},"down",{"v":0.0572640000000001,"d":"0.06"},1,"no","GATATTGACATGATCAAGGTCAACACCCTGATTCGGCCTGATGGAGAGAAGAAGGCATAT","FALSE","ENST00000467573","ens|ENST00000467573|ens|ENST00000453844",null,null,"ens|ribosomal protein L23a pseudogene 12 [Source:HGNC Symbol;Acc:HGNC:23840] [ENST00000467573]","chr21",40499496,40499966,null,null,"mRNA","agilent G3 V3"]
["A_21_P0000284",9.43,9.34,9.54,9.32,9.03,9.15,{"v":1.02945454545455,"d":"1.03"},{"v":0.0418801306063627,"d":"0.04"},"up",{"v":0.057298,"d":"0.06"},1,"no","ATGATGATTTCACAGACTAGAGTCTCCGATGCTGGTCATGATGTCAAAACTAAGTTCTGA","FALSE","NR_002742","ref|NR_002742|ens|ENST00000395788|ens|ENST00000400039|ens|ENST00000421039","SNORD52","small nucleolar RNA, C/D box 52","ref|Homo sapiens small nucleolar RNA, C/D box 52 (SNORD52), small nucleolar RNA [NR_002742]","chr6_qbl_hap6",{"v":3098508,"d":"3098508.00"},3098572,null,null,"mRNA","agilent G3 V3"]
["A_23_P130149",7.02,6.56,6.81,5.88,6.46,5.39,{"v":1.15002820078962,"d":"1.15"},{"v":0.201669239117908,"d":"0.20"},"up",{"v":0.0579400000000001,"d":"0.06"},1,"no","CTCGGAGCGTCTGGCCAAATACAACCAACTCATGAGGATCGAGGAGGCTCTTGGGGACAA","FALSE","NM_001976","ref|NM_001976|ref|NM_053013|ref|NM_001193503|ens|ENST00000518175","ENO3","enolase 3 (beta, muscle)","ref|Homo sapiens enolase 3 (beta, muscle) (ENO3), transcript variant 1, mRNA [NM_001976]","chr17",{"v":4854390,"d":"4854390.00"},4860426,"GO:0000015(phosphopyruvate hydratase complex);GO:0000287(magnesium ion binding);GO:0004634(phosphopyruvate hydratase activity);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005975(carbohydrate metabolic process);GO:0006006(glucose metabolic process);GO:0006094(gluconeogenesis);GO:0006096(glycolysis);GO:0007568(aging);GO:0009405(pathogenesis);GO:0042493(response to drug);GO:0042803(protein homodimerization activity);GO:0043403(skeletal muscle tissue regeneration);GO:0044281(small molecule metabolic process);GO:0046982(protein heterodimerization activity);GO:0070062(extracellular vesicular exosome)","01200(Carbon metabolism);01230(Biosynthesis of amino acids);00010(Glycolysis / Gluconeogenesis);03018(RNA degradation);04066(HIF-1 signaling pathway)","mRNA","agilent G3 V3"]
["A_23_P251043",4.39,5.14,4.82,{"v":4.3,"d":"4.30"},4.11,4.17,{"v":1.14069952305246,"d":"1.14"},{"v":0.189918814683761,"d":"0.19"},"up",{"v":0.058237,"d":"0.06"},1,"no","TGATCCTGGAAATGAGATGGGCCTTACTCTGTCGACTAAATGAATAGCTATTTTCTTGTC","FALSE","NM_024893","ref|NM_024893|ens|ENST00000376862|ref|XM_006723626|ref|XM_006723627","SYNDIG1","synapse differentiation inducing 1","ref|Homo sapiens synapse differentiation inducing 1 (SYNDIG1), mRNA [NM_024893]","chr20",24449836,24647252,"GO:0005887(integral to plasma membrane);GO:0006886(intracellular protein transport);GO:0009607(response to biotic stimulus);GO:0014069(postsynaptic density);GO:0030054(cell junction);GO:0031901(early endosome membrane);GO:0035254(glutamate receptor binding);GO:0042803(protein homodimerization activity);GO:0043197(dendritic spine);GO:0043198(dendritic shaft);GO:0044297(cell body);GO:0045211(postsynaptic membrane);GO:0051965(positive regulation of synapse assembly);GO:0060076(excitatory synapse);GO:0097091(synaptic vesicle clustering)",null,"mRNA","agilent G3 V3"]
["A_33_P3420367",6.35,5.17,{"v":5.5,"d":"5.50"},7.13,7.14,6.29,{"v":0.827821011673152,"d":"0.83"},{"v":-0.272609227507915,"d":"-0.27"},"down",{"v":0.0588190000000001,"d":"0.06"},1,"no","AACTGAGGTCCAGAGGGGCGTGACATACCTACCTACTCTGCATGAAGCTGTTGTCGCCAG","FALSE","ENST00000395703","ens|ENST00000395703|tc|THC2636376|tc|THC2770952","MIEF2","mitochondrial elongation factor 2","ens|mitochondrial elongation factor 2 [Source:HGNC Symbol;Acc:HGNC:17920] [ENST00000395703]","chr17",18163976,18166495,"GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005777(peroxisome);GO:0007005(mitochondrion organization);GO:0008053(mitochondrial fusion);GO:0016021(integral to membrane);GO:0032464(positive regulation of protein homooligomerization);GO:0090141(positive regulation of mitochondrial fission);GO:0090314(positive regulation of protein targeting to membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P70307",5.98,{"v":6.7,"d":"6.70"},7.35,8.71,8.18,7.42,{"v":0.823940765117236,"d":"0.82"},{"v":-0.279387472216021,"d":"-0.28"},"down",{"v":0.058844,"d":"0.06"},1,"no","TGTGCAAGGTAAAAATCAAGCCTTTGGAGCCACAGAACCAGCTCAAGTACATGCCAATGT","FALSE","NM_022138","ref|NM_022138|ref|NM_001166412|ens|ENST00000535039|ens|ENST00000354536","SMOC2","SPARC related modular calcium binding 2","ref|Homo sapiens SPARC related modular calcium binding 2 (SMOC2), transcript variant 1, mRNA [NM_022138]","chr6",168841824,169068674,"GO:0005509(calcium ion binding);GO:0005604(basement membrane);GO:0005614(interstitial matrix);GO:0007165(signal transduction);GO:0008201(heparin binding);GO:0010811(positive regulation of cell-substrate adhesion);GO:0030198(extracellular matrix organization)",null,"mRNA","agilent G3 V3"]
["A_23_P31671",6.45,7.37,5.78,{"v":8.3,"d":"8.30"},8.38,8.36,{"v":0.782747603833866,"d":"0.78"},{"v":-0.353380907930048,"d":"-0.35"},"down",{"v":0.0590959999999999,"d":"0.06"},1,"no","AAGCCATAAGAAGACTTCCTGAGAACCTTTATAATGACAGGATGTTTCGCATTAAGAGGG","FALSE","NM_006294","ref|NM_006294|ref|NM_001199975|ref|NM_001254752|ref|NR_045639","UQCRB","ubiquinol-cytochrome c reductase binding protein","ref|Homo sapiens ubiquinol-cytochrome c reductase binding protein (UQCRB), transcript variant 1, mRNA [NM_006294]","chr8",97243528,97247773,"GO:0005743(mitochondrial inner membrane);GO:0005746(mitochondrial respiratory chain);GO:0005750(mitochondrial respiratory chain complex III);GO:0006119(oxidative phosphorylation);GO:0006122(mitochondrial electron transport, ubiquinol to cytochrome c);GO:0009060(aerobic respiration);GO:0022904(respiratory electron transport chain);GO:0044237(cellular metabolic process);GO:0044281(small molecule metabolic process);GO:0055114(oxidation-reduction process)","00190(Oxidative phosphorylation);04260(Cardiac muscle contraction);05010(Alzheimer's disease);05012(Parkinson's disease);05016(Huntington's disease);04932(Non-alcoholic fatty liver disease (NAFLD))","mRNA","agilent G3 V3"]
["A_23_P210358",2.23,2.29,3.91,4.39,3.96,4.73,{"v":0.644495412844037,"d":"0.64"},{"v":-0.633758004556,"d":"-0.63"},"down",{"v":0.059361,"d":"0.06"},1,"no","TCTACCCATATTTAAAGCTATATCTCAAAGCAGTTGAGAGAAGAGGACCTATATGAATGG","FALSE","NM_004987","ref|NM_004987|ref|NM_001193485|ref|NM_001193483|ref|NM_001193484","LIMS1","LIM and senescent cell antigen-like domains 1","ref|Homo sapiens LIM and senescent cell antigen-like domains 1 (LIMS1), transcript variant 2, mRNA [NM_004987]","chr2",109271496,109300712,"GO:0001837(epithelial to mesenchymal transition);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0005925(focal adhesion);GO:0007160(cell-matrix adhesion);GO:0007163(establishment or maintenance of cell polarity);GO:0007569(cell aging);GO:0008270(zinc ion binding);GO:0010628(positive regulation of gene expression);GO:0010811(positive regulation of cell-substrate adhesion);GO:0016337(cell-cell adhesion);GO:0019901(protein kinase binding);GO:0034329(cell junction assembly);GO:0043009(chordate embryonic development);GO:0043066(negative regulation of apoptotic process);GO:0043234(protein complex);GO:0043547(positive regulation of GTPase activity);GO:0045184(establishment of protein localization);GO:0045216(cell-cell junction organization);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0048471(perinuclear region of cytoplasm);GO:0050678(regulation of epithelial cell proliferation);GO:0051291(protein heterooligomerization);GO:0051894(positive regulation of focal adhesion assembly);GO:0071560(cellular response to transforming growth factor beta stimulus);GO:1900026(positive regulation of substrate adhesion-dependent cell spreading);GO:2000178(negative regulation of neural precursor cell proliferation);GO:2001046(positive regulation of integrin-mediated signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_33_P3409513",5.91,4.87,3.94,7.18,7.19,7.03,{"v":0.68785046728972,"d":"0.69"},{"v":-0.539833125231497,"d":"-0.54"},"down",{"v":0.059978,"d":"0.06"},1,"no","TCTGTGGGTCAGTCCTCTTTCCTTGTCCCAGGATGGAGCTGATCCAGTAACCTCGGAGAC","FALSE","NM_002751","ref|NM_002751|ens|ENST00000417877|ens|ENST00000330651|gb|U53442","MAPK11","mitogen-activated protein kinase 11","ref|Homo sapiens mitogen-activated protein kinase 11 (MAPK11), transcript variant 1, mRNA [NM_002751]","chr22",50702168,50708822,"GO:0000187(activation of MAPK activity);GO:0002224(toll-like receptor signaling pathway);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0002756(MyD88-independent toll-like receptor signaling pathway);GO:0004674(protein serine/threonine kinase activity);GO:0004707(MAP kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006351(transcription, DNA-dependent);GO:0006468(protein phosphorylation);GO:0006950(response to stress);GO:0006996(organelle organization);GO:0007005(mitochondrion organization);GO:0007165(signal transduction);GO:0007265(Ras protein signal transduction);GO:0010467(gene expression);GO:0034134(toll-like receptor 2 signaling pathway);GO:0034138(toll-like receptor 3 signaling pathway);GO:0034142(toll-like receptor 4 signaling pathway);GO:0034146(toll-like receptor 5 signaling pathway);GO:0034162(toll-like receptor 9 signaling pathway);GO:0034166(toll-like receptor 10 signaling pathway);GO:0035556(intracellular signal transduction);GO:0035666(TRIF-dependent toll-like receptor signaling pathway);GO:0038123(toll-like receptor TLR1:TLR2 signaling pathway);GO:0038124(toll-like receptor TLR6:TLR2 signaling pathway);GO:0042692(muscle cell differentiation);GO:0045087(innate immune response);GO:0048010(vascular endothelial growth factor receptor signaling pathway);GO:0048011(nerve growth factor receptor signaling pathway);GO:0051090(regulation of sequence-specific DNA binding transcription factor activity);GO:0051149(positive regulation of muscle cell differentiation);GO:0051403(stress-activated MAPK cascade)","04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04370(VEGF signaling pathway);04668(TNF signaling pathway);04068(FoxO signaling pathway);04071(Sphingolipid signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04611(Platelet activation);04620(Toll-like receptor signaling pathway);04621(NOD-like receptor signaling pathway);04622(RIG-I-like receptor signaling pathway);04660(T cell receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04670(Leukocyte transendothelial migration);04912(GnRH signaling pathway);04914(Progesterone-mediated oocyte maturation);04917(Prolactin signaling pathway);04261(Adrenergic signaling in cardiomyocytes);04728(Dopaminergic synapse);04723(Retrograde endocannabinoid signaling);04722(Neurotrophin signaling pathway);04750(Inflammatory mediator regulation of TRP channels);04380(Osteoclast differentiation);05205(Proteoglycans in cancer);05014(Amyotrophic lateral sclerosis (ALS));05120(Epithelial cell signaling in Helicobacter pylori infection);05132(Salmonella infection);05131(Shigellosis);05133(Pertussis);05152(Tuberculosis);05164(Influenza A);05160(Hepatitis C);05169(Epstein-Barr virus infection);05145(Toxoplasmosis);05140(Leishmaniasis);05142(Chagas disease (American trypanosomiasis))","mRNA","agilent G3 V3"]
["A_33_P3376404",5.53,4.74,5.73,6.27,6.15,6.01,{"v":0.868149755832881,"d":"0.87"},{"v":-0.203984165855988,"d":"-0.20"},"down",{"v":0.059996,"d":"0.06"},1,"no","AAGGGACGGAACTAGATCCCTTCGCTCGGGACGCTCACATTCCAGGCCCTTGTCCTGCAG","FALSE","NM_017883","ref|NM_017883|ref|NR_029427|ens|ENST00000486125|ens|ENST00000218056","WDR13","WD repeat domain 13","ref|Homo sapiens WD repeat domain 13 (WDR13), transcript variant 1, mRNA [NM_017883]","chrX",48456196,48463581,"GO:0005654(nucleoplasm);GO:0005737(cytoplasm)",null,"mRNA","agilent G3 V3"]
["A_24_P93371",2.21,{"v":2.2,"d":"2.20"},{"v":4.2,"d":"4.20"},5.52,5.38,5.47,{"v":0.525962125839951,"d":"0.53"},{"v":-0.926969179077309,"d":"-0.93"},"down",{"v":0.060399,"d":"0.06"},1,"no","AGTTTCATCCTCTCCGGTGCGGCCAAGCACAGTGTCGATGGCAAATCCTTGGCCAGTGAA","FALSE","NM_017828","ref|NM_017828|ref|NM_001284378|ref|NM_001284377|ref|NM_001284379","COMMD4","COMM domain containing 4","ref|Homo sapiens COMM domain containing 4 (COMMD4), transcript variant 1, mRNA [NM_017828]","chr15",74387928,74390758,"GO:0005515(protein binding);GO:0005737(cytoplasm)",null,"mRNA","agilent G3 V3"]
["A_33_P3226565",9.71,9.37,9.27,{"v":9.9,"d":"9.90"},9.92,{"v":9.7,"d":"9.70"},{"v":0.960365853658537,"d":"0.96"},{"v":-0.0583439862308049,"d":"-0.06"},"down",{"v":0.060658,"d":"0.06"},1,"no","CTCCCTTCTCCAACCTGCAATAAACTATCTACAAAATCATTTCAGATGATTCCTTGGAAA","FALSE",{"$nulls":5},"chr10",93667888,93669105,null,null,"mRNA","agilent G3 V3"]
["A_32_P75299",{"v":5.1,"d":"5.10"},{"v":6.5,"d":"6.50"},4.68,7.04,6.78,6.77,{"v":0.790675084992715,"d":"0.79"},{"v":-0.338843130366007,"d":"-0.34"},"down",{"v":0.0614429999999999,"d":"0.06"},1,"no","AGGACATCACATATGAATGCACGATATGAAGAGCCTGGTTACAGTTTCGACTCCTCTCTG","FALSE","NM_001134484","ref|NM_001134484|ref|NM_001134485|ref|NM_001001790|ens|ENST00000544379","TOMM5","translocase of outer mitochondrial membrane 5 homolog (yeast)","ref|Homo sapiens translocase of outer mitochondrial membrane 5 homolog (yeast) (TOMM5), transcript variant 3, mRNA [NM_001134484]","chr9",37588408,38068684,"GO:0005739(mitochondrion);GO:0005742(mitochondrial outer membrane translocase complex);GO:0006626(protein targeting to mitochondrion);GO:0008565(protein transporter activity);GO:0016021(integral to membrane);GO:0044267(cellular protein metabolic process)",null,"mRNA","agilent G3 V3"]
["A_24_P233850",3.77,4.57,4.46,5.22,5.19,{"v":5.3,"d":"5.30"},{"v":0.814767663908339,"d":"0.81"},{"v":-0.295539370406834,"d":"-0.30"},"down",{"v":0.0615640000000001,"d":"0.06"},1,"no","CCTGTTACTCCCTGGGAACTTTGAGTCTTATTTGGAACTTGTGAAGTCCCTGTGTCTGGG","FALSE","NM_003001","ref|NM_003001|ref|NM_001035512|ref|NM_001035513|ref|NR_103459","SDHC","succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa","ref|Homo sapiens succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa (SDHC), transcript variant 1, mRNA [NM_003001]","chr1",161293408,161332447,"GO:0000104(succinate dehydrogenase activity);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0005749(mitochondrial respiratory chain complex II);GO:0006099(tricarboxylic acid cycle);GO:0009055(electron carrier activity);GO:0009060(aerobic respiration);GO:0016021(integral to membrane);GO:0020037(heme binding);GO:0022904(respiratory electron transport chain);GO:0044237(cellular metabolic process);GO:0044281(small molecule metabolic process);GO:0045273(respiratory chain complex II);GO:0046872(metal ion binding);GO:0055114(oxidation-reduction process)","01200(Carbon metabolism);00020(Citrate cycle (TCA cycle));00190(Oxidative phosphorylation);05010(Alzheimer's disease);05012(Parkinson's disease);05016(Huntington's disease);04932(Non-alcoholic fatty liver disease (NAFLD))","mRNA","agilent G3 V3"]
["A_33_P3259022",{"v":6.6,"d":"6.60"},5.77,6.35,7.07,{"v":6.8,"d":"6.80"},6.85,{"v":0.903474903474903,"d":"0.90"},{"v":-0.146443568103149,"d":"-0.15"},"down",{"v":0.062003,"d":"0.06"},1,"no","GGTCCTGGTGCCCATCTACGTCATCTATAAGTTCCTCAGCACGCAGGGCTCTCTTTGGGA","FALSE","NM_001172504","ref|NM_001172504|ens|ENST00000219833|ens|ENST00000568943|ens|ENST00000561820","SLC6A2","solute carrier family 6 (neurotransmitter transporter), member 2","ref|Homo sapiens solute carrier family 6 (neurotransmitter transporter), member 2 (SLC6A2), transcript variant 1, mRNA [NM_001172504]","chr16",55690556,55740104,"GO:0005334(norepinephrine:sodium symporter activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0006810(transport);GO:0006836(neurotransmitter transport);GO:0007268(synaptic transmission);GO:0008504(monoamine transmembrane transporter activity);GO:0009986(cell surface);GO:0015844(monoamine transport);GO:0015874(norepinephrine transport);GO:0016020(membrane);GO:0042493(response to drug);GO:0043005(neuron projection);GO:0043014(alpha-tubulin binding);GO:0045121(membrane raft);GO:0048265(response to pain);GO:0048487(beta-tubulin binding);GO:0055085(transmembrane transport)",null,"mRNA","agilent G3 V3"]
["A_23_P376686",8.44,8.15,8.64,8.98,8.72,8.78,{"v":0.952794561933535,"d":"0.95"},{"v":-0.0697629158309175,"d":"-0.07"},"down",{"v":0.062381,"d":"0.06"},1,"no","TGGTTCCCACAGCCCCACGTGCCATGGAGGGACATGGAAGGAAAGACGATACCATCATCT","FALSE","NM_019602","ref|NM_019602|ens|ENST00000374993|ens|ENST00000548835|ens|ENST00000550327","BTNL2","butyrophilin-like 2 (MHC class II associated)","ref|Homo sapiens butyrophilin-like 2 (MHC class II associated) (BTNL2), mRNA [NM_019602]","chr6",32362512,32374900,"GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P43095",{"v":3.5,"d":"3.50"},4.82,1.96,5.97,5.56,5.27,{"v":0.611904761904762,"d":"0.61"},{"v":-0.708620968472244,"d":"-0.71"},"down",{"v":0.063044,"d":"0.06"},1,"no","CAGAAGCTAGAAGACTTAGATAATTCTTTGGAAGTGAAGGCTAAGCCTGCTTCTGGCCTA","FALSE","NM_024721","ref|NM_024721|ens|ENST00000518282|ens|ENST00000521891|gb|AB083343","ZFHX4","zinc finger homeobox 4","ref|Homo sapiens zinc finger homeobox 4 (ZFHX4), mRNA [NM_024721]","chr8",77593512,77776801,"GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0008270(zinc ion binding);GO:0043565(sequence-specific DNA binding)",null,"mRNA","agilent G3 V3"]
["A_23_P125668",2.31,2.44,2.33,3.99,4.41,6.13,{"v":0.487267721954577,"d":"0.49"},{"v":-1.03721343754984,"d":"-1.04"},"down",{"v":0.063219,"d":"0.06"},1,"no","TGCTGACATCTGAGTGCACACACCACAGTGTAAATTATGCCTTATCAGAATCTAAATGAA","FALSE","NM_145305","ref|NM_145305|ens|ENST00000488158|ens|ENST00000217909|ref|XM_005262392","SLC25A43","solute carrier family 25, member 43","ref|Homo sapiens solute carrier family 25, member 43 (SLC25A43), mRNA [NM_145305]","chrX",118533376,118587145,"GO:0005743(mitochondrial inner membrane);GO:0016021(integral to membrane);GO:0055085(transmembrane transport)",null,"mRNA","agilent G3 V3"]
["A_23_P82286",7.34,6.95,7.15,{"v":6.9,"d":"6.90"},6.68,6.33,{"v":1.07684580612757,"d":"1.08"},{"v":0.10681168473727,"d":"0.11"},"up",{"v":0.063781,"d":"0.06"},1,"no","AAATGCAGTGATCTCCCTACCCAGCATGTACGAGGGGCTTGTGAGTGGCCTGTGCGGAAA","FALSE","NM_173059","ref|NM_173059|ref|NM_003386|ref|NR_111919|ref|NR_111918","ZAN","zonadhesin (gene/pseudogene)","ref|Homo sapiens zonadhesin (gene/pseudogene) (ZAN), transcript variant 6, mRNA [NM_173059]","chr7",100331248,100395419,"GO:0005886(plasma membrane);GO:0007339(binding of sperm to zona pellucida);GO:0016021(integral to membrane);GO:0016337(cell-cell adhesion)",null,"mRNA","agilent G3 V3"]
["A_33_P3414883",4.36,2.07,4.14,6.21,6.45,6.18,{"v":0.56104033970276,"d":"0.56"},{"v":-0.8338235882301,"d":"-0.83"},"down",{"v":0.064218,"d":"0.06"},1,"no","TTCAGCTGCACGACGCTCAATCTACAACATCAGCTCCTGTCTGGTTCTCCAGCTGCACGA","FALSE","AK302556","gb|AK302556|linc|TCONS_l2_00019097|linc|TCONS_l2_00019098|tc|THC2565290","ATMIN","ATM interactor","gb|Homo sapiens cDNA FLJ61620 complete cds. [AK302556]","chr3",195663616,195672579,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006974(response to DNA damage stimulus);GO:0044212(transcription regulatory region DNA binding);GO:0045502(dynein binding);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3371954",4.14,1.86,2.15,5.31,5.42,5.46,{"v":0.503397158739963,"d":"0.50"},{"v":-0.990231021184126,"d":"-0.99"},"down",{"v":0.064863,"d":"0.06"},1,"no","AAGCCATCGGCTGAGACTACACAGCTTGGGGCCCGAGGATGAAGGCGTGTACCACTGTGC","FALSE","NM_052868","ref|NM_052868|ref|NM_001206665|ens|ENST00000614243|ens|ENST00000314485","IGSF8","immunoglobulin superfamily, member 8","ref|Homo sapiens immunoglobulin superfamily, member 8 (IGSF8), transcript variant 1, mRNA [NM_052868]","chr1",160061136,160068479,"GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0006928(cellular component movement);GO:0007338(single fertilization);GO:0007399(nervous system development);GO:0007519(skeletal muscle tissue development);GO:0008283(cell proliferation);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0030424(axon);GO:0045202(synapse);GO:0070062(extracellular vesicular exosome);GO:2000145(regulation of cell motility)",null,"mRNA","agilent G3 V3"]
["A_23_P133338",5.64,3.93,5.78,7.25,7.29,7.53,{"v":0.695514272768464,"d":"0.70"},{"v":-0.523847974022072,"d":"-0.52"},"down",{"v":0.0650609999999999,"d":"0.07"},1,"no","GGATTGGGAGTGGCTTTGCTGCTGGTCCTTGTGATCATGACCATGGCCTTCGTGTGTGTG","FALSE","NM_017675","ref|NM_017675|ref|NM_001171976|ens|ENST00000416365|ens|ENST00000506348","CDHR2","cadherin-related family member 2","ref|Homo sapiens cadherin-related family member 2 (CDHR2), transcript variant 2, mRNA [NM_017675]","chr5",176017600,176018691,"GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005903(brush border);GO:0007155(cell adhesion);GO:0007156(homophilic cell adhesion);GO:0016021(integral to membrane);GO:0016324(apical plasma membrane);GO:0030054(cell junction);GO:0030308(negative regulation of cell growth);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P327777",5.19,6.77,5.33,4.86,3.91,4.14,{"v":1.33927188226181,"d":"1.34"},{"v":0.421448868335091,"d":"0.42"},"up",{"v":0.0656640000000001,"d":"0.07"},1,"no","GAGAAAGGGGAATGTTATACTGGAAAAGAACAGAGGGAACCAACTCCACAGACACCAGTA","FALSE","NM_178831","ref|NM_178831|ref|NR_028039|ref|NR_028040|ens|ENST00000328453","GATS","GATS, stromal antigen 3 opposite strand","ref|Homo sapiens GATS, stromal antigen 3 opposite strand (GATS), transcript variant 1, mRNA [NM_178831]","chr7",99798280,99869855,null,null,"mRNA","agilent G3 V3"]
["A_33_P3285354",9.04,8.86,9.01,8.67,8.73,8.88,{"v":1.02397260273973,"d":"1.02"},{"v":0.0341771153180875,"d":"0.03"},"up",{"v":0.066059,"d":"0.07"},1,"no","GAGGAAGAAGAGGAGGAGGAGGAGGGGGCCGGTGTCCCAGCTTGCCCGCCCAAGGGCCCA","FALSE","NM_001144936","ref|NM_001144936|ens|ENST00000433688|linc|lnc-ATL3-1:6|linc|lnc-ATL3-1:3","C11orf95","chromosome 11 open reading frame 95","ref|Homo sapiens chromosome 11 open reading frame 95 (C11orf95), mRNA [NM_001144936]","chr11",63527364,63536113,null,null,"mRNA","agilent G3 V3"]
["A_33_P3402010",9.51,9.62,9.73,9.46,9.01,8.74,{"v":1.0606394707828,"d":"1.06"},{"v":0.0849343432415195,"d":"0.08"},"up",{"v":0.0662779999999999,"d":"0.07"},1,"no","ATGGTAATGTCACTCAGTGGCACAGGGCTTGTTCCTCCCTTTTGTTCTCTTTTCTTTTTT","FALSE","AK024445","gb|AK024445|tc|THC2750828",null,null,"gb|Homo sapiens mRNA for FLJ00035 protein, partial cds. [AK024445]","chr14",71683032,71683462,null,null,"mRNA","agilent G3 V3"]
["A_33_P3343101",3.91,4.25,3.05,5.05,{"v":5,"d":"5.00"},5.12,{"v":0.738958470665788,"d":"0.74"},{"v":-0.436434807441607,"d":"-0.44"},"down",{"v":0.066581,"d":"0.07"},1,"no","GCGAAAGTTAATTTTTTAGCCTATTCAGAAGTGCTGACTGATAACTTAAAAGTTGGAAGC","FALSE","XR_243043","ref|XR_243043|gb|AK304751|gb|AK303575|gb|AK309941","ARGLU1","arginine and glutamate rich 1","ref|PREDICTED: Homo sapiens arginine and glutamate rich 1 (ARGLU1), transcript variant X1, misc_RNA [XR_243043]","chr13",107195672,107196037,"GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent)",null,"mRNA","agilent G3 V3"]
["A_33_P3225937",1.97,2.16,1.94,3.21,3.24,4.56,{"v":0.551316984559491,"d":"0.55"},{"v":-0.859046047308687,"d":"-0.86"},"down",{"v":0.06734,"d":"0.07"},1,"no","GCAGAAATGAAGATGAAAAAGGATTTATTTCCTGTTGGGAGAGAAATTGCTGGAATTGTA","FALSE","NM_145858","ref|NM_145858|ens|ENST00000431177|ens|ENST00000490714|ens|ENST00000381554","CRYZL1","crystallin, zeta (quinone reductase)-like 1","ref|Homo sapiens crystallin, zeta (quinone reductase)-like 1 (CRYZL1), mRNA [NM_145858]","chr21",34988592,35014028,"GO:0003960(NADPH:quinone reductase activity);GO:0005829(cytosol);GO:0008270(zinc ion binding);GO:0050661(NADP binding);GO:0055114(oxidation-reduction process)",null,"mRNA","agilent G3 V3"]
["A_33_P3312104",{"v":3.4,"d":"3.40"},1.86,2.04,{"v":3.3,"d":"3.30"},3.94,4.43,{"v":0.625535561268209,"d":"0.63"},{"v":-0.676836191939968,"d":"-0.68"},"down",{"v":0.067778,"d":"0.07"},1,"no","AAGTTTCTACCCGGAGCCAGTTGCCTTCTGGTAACAGAATTATATTGCACCTACTGCTTC","FALSE","NM_025099","ref|NM_025099|ref|NR_046431|ens|ENST00000449476|ref|XR_429823","CTC1","CTS telomere maintenance complex component 1","ref|Homo sapiens CTS telomere maintenance complex component 1 (CTC1), transcript variant 1, mRNA [NM_025099]","chr17",{"v":8130191,"d":"8130191.00"},8151360,"GO:0000723(telomere maintenance);GO:0000784(nuclear chromosome, telomeric region);GO:0003697(single-stranded DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006974(response to DNA damage stimulus);GO:0010389(regulation of G2/M transition of mitotic cell cycle);GO:0010833(telomere maintenance via telomere lengthening);GO:0035264(multicellular organism growth);GO:0045740(positive regulation of DNA replication);GO:0048146(positive regulation of fibroblast proliferation);GO:0048536(spleen development);GO:0048538(thymus development);GO:0048539(bone marrow development);GO:0070188(Stn1-Ten1 complex);GO:0071425(hemopoietic stem cell proliferation);GO:0090399(replicative senescence)",null,"mRNA","agilent G3 V3"]
["A_33_P3406811",3.52,3.95,4.42,4.98,4.89,4.39,{"v":0.833800841514726,"d":"0.83"},{"v":-0.262225266698232,"d":"-0.26"},"down",{"v":0.0679839999999999,"d":"0.07"},1,"no","ATTCTGCTGAAGGTTTGCAGTCTACCTCACTTTCATTCTTCTTCATTCCCTCTGTGTTAA","FALSE",{"$nulls":5},"chr17",39346288,39346891,null,null,"mRNA","agilent G3 V3"]
["A_19_P00316107",8.57,8.56,8.56,7.48,8.04,7.05,{"v":1.13823659725299,"d":"1.14"},{"v":0.186800471708981,"d":"0.19"},"up",{"v":0.068275,"d":"0.07"},1,"no","CAGAGTTTGCAAATGAAGCCTTTTTTGCACTTTCATTCACATGCACTTTGGTGGGGTTAC","FALSE","AB014581","gb|AB014581|tc|THC2682070|tc|THC2664170|tc|THC2626450","L3MBTL1","l(3)mbt-like 1 (Drosophila)","gb|Homo sapiens mRNA for KIAA0681 protein, partial cds. [AB014581]","chr20",42157348,42179590,"GO:0000785(chromatin);GO:0000793(condensed chromosome);GO:0003682(chromatin binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005886(plasma membrane);GO:0006351(transcription, DNA-dependent);GO:0007088(regulation of mitosis);GO:0008270(zinc ion binding);GO:0016568(chromatin modification);GO:0030097(hemopoiesis);GO:0031491(nucleosome binding);GO:0031493(nucleosomal histone binding);GO:0032093(SAM domain binding);GO:0035064(methylated histone residue binding);GO:0042393(histone binding);GO:0042802(identical protein binding);GO:0045652(regulation of megakaryocyte differentiation);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0051726(regulation of cell cycle)",null,"mRNA","agilent G3 V3"]
["A_33_P3413463",6.38,6.15,6.32,6.56,6.61,6.39,{"v":0.963701431492842,"d":"0.96"},{"v":-0.0533418467962072,"d":"-0.05"},"down",{"v":0.068918,"d":"0.07"},1,"no","TCTCGAGGGCTTGGGGGAAGAATAGATTTAGTAAAGCAGGAAGATCTGTTGTTACTTAAC","FALSE","NM_001519","ref|NM_001519|ref|NM_001242788|ref|NM_145685|ref|NM_001242786","BRF1","BRF1, RNA polymerase III transcription initiation factor 90 kDa subunit","ref|Homo sapiens BRF1, RNA polymerase III transcription initiation factor 90 kDa subunit (BRF1), transcript variant 1, mRNA [NM_001519]","chr14",105676416,105679765,"GO:0000126(transcription factor TFIIIB complex);GO:0005654(nucleoplasm);GO:0006355(regulation of transcription, DNA-dependent);GO:0006383(transcription from RNA polymerase III promoter);GO:0006384(transcription initiation from RNA polymerase III promoter);GO:0008270(zinc ion binding);GO:0009303(rRNA transcription);GO:0009304(tRNA transcription);GO:0010467(gene expression);GO:0017025(TBP-class protein binding);GO:0043488(regulation of mRNA stability)",null,"mRNA","agilent G3 V3"]
["A_23_P79441",3.95,3.16,3.12,4.69,4.18,3.94,{"v":0.798594847775176,"d":"0.80"},{"v":-0.324464330596318,"d":"-0.32"},"down",{"v":0.069479,"d":"0.07"},1,"no","GGCTAGAGTTTTAAAAGGAACAGAAAGAAAACCAGCTTATTTTCCTTCTTACGGACTCAT","FALSE","NM_017880","ref|NM_017880|ens|ENST00000420306|ens|ENST00000264434|ref|XM_005264389","C2orf42","chromosome 2 open reading frame 42","ref|Homo sapiens chromosome 2 open reading frame 42 (C2orf42), mRNA [NM_017880]","chr2",70377032,70409127,"GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0031965(nuclear membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3397755",8.83,8.82,8.93,8.79,8.74,8.77,{"v":1.0106463878327,"d":"1.01"},{"v":0.0152783050965095,"d":"0.02"},"up",{"v":0.070005,"d":"0.07"},1,"no","AAGAAGATCGATGTCTACCTCCCTCTGCACTCGAGCCAGGACAGACTGCTGCCAATGACC","FALSE","NM_001006618","ref|NM_001006618|ens|ENST00000448439|ens|ENST00000473837|gb|AY524430","MAPKAP1","mitogen-activated protein kinase associated protein 1","ref|Homo sapiens mitogen-activated protein kinase associated protein 1 (MAPKAP1), transcript variant 6, mRNA [NM_001006618]","chr9",128200816,128420011,"GO:0005515(protein binding);GO:0005546(phosphatidylinositol-4,5-bisphosphate binding);GO:0005547(phosphatidylinositol-3,4,5-trisphosphate binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0016023(cytoplasmic membrane-bounded vesicle);GO:0017016(Ras GTPase binding);GO:0019901(protein kinase binding);GO:0021762(substantia nigra development);GO:0031295(T cell costimulation);GO:0038095(Fc-epsilon receptor signaling pathway);GO:0043325(phosphatidylinositol-3,4-bisphosphate binding);GO:0045087(innate immune response);GO:0046580(negative regulation of Ras protein signal transduction);GO:0048010(vascular endothelial growth factor receptor signaling pathway);GO:0048011(nerve growth factor receptor signaling pathway);GO:0048015(phosphatidylinositol-mediated signaling);GO:0070300(phosphatidic acid binding);GO:0080025(phosphatidylinositol-3,5-bisphosphate binding)",null,"mRNA","agilent G3 V3"]
["A_23_P329924",6.16,4.66,5.73,4.75,4.13,3.89,{"v":1.29600626468285,"d":"1.30"},{"v":0.374072691991856,"d":"0.37"},"up",{"v":0.070458,"d":"0.07"},1,"no","ATTGTCAAGGTGTTGCCGCCGGTGTTGGGGCTGGAGTTTATCTTCGGGCTTCTGGGCAAT","FALSE","NM_177551","ref|NM_177551|ref|NM_006018|ens|ENST00000328880|ens|ENST00000528880","HCAR2","hydroxycarboxylic acid receptor 2","ref|Homo sapiens hydroxycarboxylic acid receptor 2 (HCAR2), mRNA [NM_177551]","chr12",123185840,123187890,"GO:0001781(neutrophil apoptotic process);GO:0005886(plasma membrane);GO:0007186(G-protein coupled receptor signaling pathway);GO:0016021(integral to membrane);GO:0033031(positive regulation of neutrophil apoptotic process);GO:0050995(negative regulation of lipid catabolic process);GO:0070165(positive regulation of adiponectin secretion);GO:0070553(nicotinic acid receptor activity)","04024(cAMP signaling pathway)","mRNA","agilent G3 V3"]
["A_23_P374559",6.14,5.76,5.85,4.97,5.35,5.69,{"v":1.10868207370394,"d":"1.11"},{"v":0.14884571676315,"d":"0.15"},"up",{"v":0.0710190000000001,"d":"0.07"},1,"no","TGTGCAAACAGTCGGTGGCCGCCACAGAAGACAGCTTTGACTCCACCACCTACAGCTTCA","FALSE","NM_181710","ref|NM_181710|ens|ENST00000222033|gb|AK292251|gb|AK098722","ZNRF4","zinc and ring finger 4","ref|Homo sapiens zinc and ring finger 4 (ZNRF4), mRNA [NM_181710]","chr19",{"v":5455426,"d":"5455426.00"},5456867,"GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3344733",4.69,2.69,4.78,5.86,{"v":6,"d":"6.00"},5.44,{"v":0.702890173410405,"d":"0.70"},{"v":-0.508628809080502,"d":"-0.51"},"down",{"v":0.0713200000000001,"d":"0.07"},1,"no","GGTGAAGGGCACATGGAATCTCTGTATTATTTCAACTGCATGTAAATCTACAATTATCTC","FALSE","NM_025152","ref|NM_025152|ref|NM_001201573|ref|NM_001201574|ref|NR_120408","NUBPL","nucleotide binding protein-like","ref|Homo sapiens nucleotide binding protein-like (NUBPL), transcript variant 1, mRNA [NM_025152]","chr14",32068444,32330399,"GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0032981(mitochondrial respiratory chain complex I assembly);GO:0046872(metal ion binding);GO:0051539(4 iron, 4 sulfur cluster binding);GO:0070584(mitochondrion morphogenesis)",null,"mRNA","agilent G3 V3"]
["A_23_P156683",6.87,5.49,6.54,5.64,4.86,4.68,{"v":1.24505928853755,"d":"1.25"},{"v":0.316214443692969,"d":"0.32"},"up",{"v":0.071801,"d":"0.07"},1,"no","TCCCCACCAGTGGCATCTACTTCGTCTACTCCCAGGTGGTCTTCTCTGGGAAAGCCTACT","FALSE","NM_000595","ref|NM_000595|ref|NM_001159740|ens|ENST00000383303|ens|ENST00000400272","LTA","lymphotoxin alpha","ref|Homo sapiens lymphotoxin alpha (LTA), transcript variant 2, mRNA [NM_000595]","chr6",31540072,31542101,"GO:0001666(response to hypoxia);GO:0002876(positive regulation of chronic inflammatory response to antigenic stimulus);GO:0002925(positive regulation of humoral immune response mediated by circulating immunoglobulin);GO:0005102(receptor binding);GO:0005125(cytokine activity);GO:0005164(tumor necrosis factor receptor binding);GO:0005615(extracellular space);GO:0006915(apoptotic process);GO:0006959(humoral immune response);GO:0007165(signal transduction);GO:0007267(cell-cell signaling);GO:0007584(response to nutrient);GO:0016020(membrane);GO:0032496(response to lipopolysaccharide);GO:0032729(positive regulation of interferon-gamma production);GO:0042493(response to drug);GO:0043065(positive regulation of apoptotic process);GO:0044130(negative regulation of growth of symbiont in host);GO:0048147(negative regulation of fibroblast proliferation);GO:0048535(lymph node development);GO:0050830(defense response to Gram-positive bacterium);GO:0060252(positive regulation of glial cell proliferation)","04064(NF-kappa B signaling pathway);04668(TNF signaling pathway);04060(Cytokine-cytokine receptor interaction);04940(Type I diabetes mellitus);05166(HTLV-I infection);05168(Herpes simplex infection)","mRNA","agilent G3 V3"]
["A_33_P3263497",7.17,7.15,7.33,6.97,6.61,7.03,{"v":1.05046094129064,"d":"1.05"},{"v":0.071022520074831,"d":"0.07"},"up",{"v":0.072404,"d":"0.07"},1,"no","AAGAGTTCCCAGACGCTCACGAGGCAGTTCCCCTTCGGGCAGCACCAATACATGTGTGTT","FALSE","ENST00000401884","ens|ENST00000401884|gb|AF439718|tc|NP1459507","SNED1","sushi, nidogen and EGF-like domains 1","ens|sushi, nidogen and EGF-like domains 1 [Source:HGNC Symbol;Acc:HGNC:24696] [ENST00000401884]","chr2",242010816,242015020,"GO:0005509(calcium ion binding);GO:0007160(cell-matrix adhesion);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_24_P244356",{"v":5.2,"d":"5.20"},6.51,5.53,7.22,7.09,7.09,{"v":0.805607476635514,"d":"0.81"},{"v":-0.311851022199411,"d":"-0.31"},"down",{"v":0.072682,"d":"0.07"},1,"no","TGGCTTGGTAGCCCCTCGAGGCAGATGCACCTGACTTGCTGCTATTAAAAAGCCGTGTGC","FALSE","NM_001282144","ref|NM_001282144|ref|NM_024618|ref|NM_001282143|ref|NM_001282358","NLRX1","NLR family member X1","ref|Homo sapiens NLR family member X1 (NLRX1), transcript variant 4, mRNA [NM_001282144]","chr11",119039440,119054723,"GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005741(mitochondrial outer membrane);GO:0016032(viral reproduction);GO:0032480(negative regulation of type I interferon production);GO:0032688(negative regulation of interferon-beta production);GO:0032715(negative regulation of interleukin-6 production);GO:0039536(negative regulation of RIG-I signaling pathway);GO:0043124(negative regulation of I-kappaB kinase/NF-kappaB cascade);GO:0045087(innate immune response);GO:0045824(negative regulation of innate immune response);GO:0050728(negative regulation of inflammatory response)","04622(RIG-I-like receptor signaling pathway);05164(Influenza A)","mRNA","agilent G3 V3"]
["A_23_P28733",6.23,{"v":5.5,"d":"5.50"},5.86,5.42,5.05,4.31,{"v":1.19012178619756,"d":"1.19"},{"v":0.25110921332581,"d":"0.25"},"up",{"v":0.073445,"d":"0.07"},1,"no","ATGCAGAATCCCCTGCCAAACGCGTCTGTCAAGAAAATGATGACGTTTTACTGAAACGAC","FALSE","NM_002895","ref|NM_002895|ens|ENST00000373664|ref|XM_006723842|gb|M74547","RBL1","retinoblastoma-like 1","ref|Homo sapiens retinoblastoma-like 1 (RBL1), transcript variant 1, mRNA [NM_002895]","chr20",35624752,35724398,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000278(mitotic cell cycle);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0006351(transcription, DNA-dependent);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0008134(transcription factor binding);GO:0010467(gene expression);GO:0016032(viral reproduction);GO:0016568(chromatin modification);GO:0043550(regulation of lipid kinase activity);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0051726(regulation of cell cycle)","04350(TGF-beta signaling pathway);04110(Cell cycle);05203(Viral carcinogenesis)","mRNA","agilent G3 V3"]
["A_33_P3220919",3.29,4.27,3.24,4.74,4.86,4.72,{"v":0.754189944134078,"d":"0.75"},{"v":-0.407000180213425,"d":"-0.41"},"down",{"v":0.07396,"d":"0.07"},1,"no","CAGTTACTTTGGAGCTGCTAGACTGGTTTTCTGTGTTGGTAAATTGCCTATATAAATCTG","FALSE","NM_005160","ref|NM_005160|ens|ENST00000324198|ref|XM_006724158|gb|AK123767","ADRBK2","adrenergic, beta, receptor kinase 2","ref|Homo sapiens adrenergic, beta, receptor kinase 2 (ADRBK2), mRNA [NM_005160]","chr22",25960816,26125261,"GO:0004672(protein kinase activity);GO:0004703(G-protein coupled receptor kinase activity);GO:0005524(ATP binding);GO:0006468(protein phosphorylation);GO:0007165(signal transduction);GO:0031623(receptor internalization);GO:0038032(termination of G-protein coupled receptor signaling pathway);GO:0047696(beta-adrenergic receptor kinase activity)","04144(Endocytosis);04062(Chemokine signaling pathway);04724(Glutamatergic synapse);04740(Olfactory transduction);05032(Morphine addiction)","mRNA","agilent G3 V3"]
["A_23_P30024",5.69,4.59,4.98,{"v":6.1,"d":"6.10"},6.12,5.63,{"v":0.854901960784314,"d":"0.85"},{"v":-0.226169112081931,"d":"-0.23"},"down",{"v":0.0742849999999999,"d":"0.07"},1,"no","CCCGCCTGAATCATTCTCGATTTAACTCGAGACCTTTTCAACTTGGCTTCCTTTCTTGGT","FALSE","NM_003998","ref|NM_003998|ref|NM_001165412|ens|ENST00000394820|ens|ENST00000505458","NFKB1","nuclear factor of kappa light polypeptide gene enhancer in B-cells 1","ref|Homo sapiens nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (NFKB1), transcript variant 1, mRNA [NM_003998]","chr4",103498872,103538255,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000975(regulatory region DNA binding);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000980(RNA polymerase II distal enhancer sequence-specific DNA binding);GO:0001205(RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription);GO:0001227(RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription);GO:0002224(toll-like receptor signaling pathway);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0002756(MyD88-independent toll-like receptor signaling pathway);GO:0003682(chromatin binding);GO:0003690(double-stranded DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006366(transcription from RNA polymerase II promoter);GO:0006915(apoptotic process);GO:0006954(inflammatory response);GO:0006979(response to oxidative stress);GO:0007249(I-kappaB kinase/NF-kappaB cascade);GO:0008134(transcription factor binding);GO:0010744(positive regulation of macrophage derived foam cell differentiation);GO:0010884(positive regulation of lipid storage);GO:0010956(negative regulation of calcidiol 1-monooxygenase activity);GO:0010957(negative regulation of vitamin D biosynthetic process);GO:0031072(heat shock protein binding);GO:0031293(membrane protein intracellular domain proteolysis);GO:0032269(negative regulation of cellular protein metabolic process);GO:0032375(negative regulation of cholesterol transport);GO:0032481(positive regulation of type I interferon production);GO:0033256(I-kappaB/NF-kappaB complex);GO:0034134(toll-like receptor 2 signaling pathway);GO:0034138(toll-like receptor 3 signaling pathway);GO:0034142(toll-like receptor 4 signaling pathway);GO:0034146(toll-like receptor 5 signaling pathway);GO:0034162(toll-like receptor 9 signaling pathway);GO:0034166(toll-like receptor 10 signaling pathway);GO:0035666(TRIF-dependent toll-like receptor signaling pathway);GO:0038061(NIK/NF-kappaB cascade);GO:0038095(Fc-epsilon receptor signaling pathway);GO:0038123(toll-like receptor TLR1:TLR2 signaling pathway);GO:0038124(toll-like receptor TLR6:TLR2 signaling pathway);GO:0042803(protein homodimerization activity);GO:0043066(negative regulation of apoptotic process);GO:0044212(transcription regulatory region DNA binding);GO:0045083(negative regulation of interleukin-12 biosynthetic process);GO:0045087(innate immune response);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046688(response to copper ion);GO:0048011(nerve growth factor receptor signaling pathway);GO:0050728(negative regulation of inflammatory response);GO:0050852(T cell receptor signaling pathway)","04014(Ras signaling pathway);04010(MAPK signaling pathway);04064(NF-kappa B signaling pathway);04668(TNF signaling pathway);04066(HIF-1 signaling pathway);04071(Sphingolipid signaling pathway);04024(cAMP signaling pathway);04151(PI3K-Akt signaling pathway);04210(Apoptosis);04620(Toll-like receptor signaling pathway);04621(NOD-like receptor signaling pathway);04622(RIG-I-like receptor signaling pathway);04623(Cytosolic DNA-sensing pathway);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);04062(Chemokine signaling pathway);04920(Adipocytokine signaling pathway);04917(Prolactin signaling pathway);04722(Neurotrophin signaling pathway);04380(Osteoclast differentiation);05200(Pathways in cancer);05202(Transcriptional misregulation in cancers);05206(MicroRNAs in cancer);05203(Viral carcinogenesis);05212(Pancreatic cancer);05221(Acute myeloid leukemia);05220(Chronic myeloid leukemia);05215(Prostate cancer);05222(Small cell lung cancer);05321(Inflammatiory bowel disease (IBD));05030(Cocaine addiction);04932(Non-alcoholic fatty liver disease (NAFLD));05120(Epithelial cell signaling in Helicobacter pylori infection);05132(Salmonella infection);05131(Shigellosis);05133(Pertussis);05134(Legionellosis);05152(Tuberculosis);05166(HTLV-I infection);05162(Measles);05164(Influenza A);05161(Hepatitis B);05160(Hepatitis C);05168(Herpes simplex infection);05169(Epstein-Barr virus infection);05146(Amoebiasis);05145(Toxoplasmosis);05140(Leishmaniasis);05142(Chagas disease (American trypanosomiasis))","mRNA","agilent G3 V3"]
["A_23_P157495",3.56,2.39,4.09,4.39,4.68,4.64,{"v":0.732312180889861,"d":"0.73"},{"v":-0.449469301828454,"d":"-0.45"},"down",{"v":0.074595,"d":"0.07"},1,"no","TGTCAACACATTTGTGAAGTCTTGTGCTATAAAGGGGAACTTCCCCTAATAAAAGGGCCT","FALSE","NM_005605","ref|NM_005605|ref|NM_001243974|ref|NM_001243975|ens|ENST00000240139","PPP3CC","protein phosphatase 3, catalytic subunit, gamma isozyme","ref|Homo sapiens protein phosphatase 3, catalytic subunit, gamma isozyme (PPP3CC), transcript variant 2, mRNA [NM_005605]","chr8",22298648,22398569,"GO:0004721(phosphoprotein phosphatase activity);GO:0005516(calmodulin binding);GO:0005829(cytosol);GO:0006915(apoptotic process);GO:0016311(dephosphorylation);GO:0046872(metal ion binding);GO:0070062(extracellular vesicular exosome);GO:0097193(intrinsic apoptotic signaling pathway);GO:1900740(positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway)","04010(MAPK signaling pathway);04310(Wnt signaling pathway);04370(VEGF signaling pathway);04020(Calcium signaling pathway);04022(cGMP - PKG signaling pathway);04114(Oocyte meiosis);04210(Apoptosis);04650(Natural killer cell mediated cytotoxicity);04660(T cell receptor signaling pathway);04662(B cell receptor signaling pathway);04922(Glucagon signaling pathway);04921(Oxytocin signaling pathway);04724(Glutamatergic synapse);04728(Dopaminergic synapse);04720(Long-term potentiation);04360(Axon guidance);04380(Osteoclast differentiation);05010(Alzheimer's disease);05014(Amyotrophic lateral sclerosis (ALS));05031(Amphetamine addiction);05152(Tuberculosis);05166(HTLV-I infection)","mRNA","agilent G3 V3"]
["A_23_P147845",5.28,2.91,3.59,6.45,6.26,6.36,{"v":0.617724174095438,"d":"0.62"},{"v":-0.694965304482295,"d":"-0.69"},"down",{"v":0.075163,"d":"0.08"},1,"no","GGGAAAATTCACACTGGGTTTCTGGACTGTAGTATTGGAAGCCTTAGTTATAGTATATTA","FALSE","NM_015027","ref|NM_015027|ref|NM_001285444|ref|NM_001285445|ref|NM_001285448","PDXDC1","pyridoxal-dependent decarboxylase domain containing 1","ref|Homo sapiens pyridoxal-dependent decarboxylase domain containing 1 (PDXDC1), transcript variant 1, mRNA [NM_015027]","chr16",15068980,15131544,"GO:0005794(Golgi apparatus);GO:0016831(carboxy-lyase activity);GO:0019752(carboxylic acid metabolic process);GO:0030170(pyridoxal phosphate binding);GO:0043231(intracellular membrane-bounded organelle)",null,"mRNA","agilent G3 V3"]
["A_23_P369899",2.79,{"v":4.4,"d":"4.40"},3.03,4.59,4.81,6.58,{"v":0.639549436795995,"d":"0.64"},{"v":-0.644872211990356,"d":"-0.64"},"down",{"v":0.0755999999999999,"d":"0.08"},1,"no","AAATTGCTATTGCTGTAGTAAGAGAAGCTCTTTGTATCTGAACATAGTTGTATTTGAAAT","FALSE","NM_015444","ref|NM_015444|ens|ENST00000503771|gb|AF438313|gb|AL080235","TMEM158","transmembrane protein 158 (gene/pseudogene)","ref|Homo sapiens transmembrane protein 158 (gene/pseudogene) (TMEM158), mRNA [NM_015444]","chr3",45265960,45267770,"GO:0016021(integral to membrane);GO:0042277(peptide binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3298587",2.79,5.77,{"v":2,"d":"2.00"},6.59,{"v":6.4,"d":"6.40"},5.89,{"v":0.559322033898305,"d":"0.56"},{"v":-0.838248930003388,"d":"-0.84"},"down",{"v":0.0762400000000001,"d":"0.08"},1,"no","CGCCTGCGGTTTCTATGTATTTATAGCAAGTTCTGATGTACATATGTAAAGGACTTTTTT","FALSE","NM_014963","ref|NM_014963|ref|NM_001100122|ens|ENST00000438103|ens|ENST00000361757","SBNO2","strawberry notch homolog 2 (Drosophila)","ref|Homo sapiens strawberry notch homolog 2 (Drosophila) (SBNO2), transcript variant 1, mRNA [NM_014963]","chr19",{"v":1108564,"d":"1108564.00"},1111677,"GO:0002281(macrophage activation involved in immune response);GO:0005575(cellular_component);GO:0006351(transcription, DNA-dependent);GO:0030282(bone mineralization);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0050727(regulation of inflammatory response);GO:0061430(bone trabecula morphogenesis);GO:0072675(osteoclast fusion)",null,"mRNA","agilent G3 V3"]
["A_24_P96234",6.11,5.41,6.17,5.06,5.51,5.11,{"v":1.1281887755102,"d":"1.13"},{"v":0.17400848857525,"d":"0.17"},"up",{"v":0.076659,"d":"0.08"},1,"no","TGCCGAAGGACAAGCCCCGATATCTGATGGGGGTTGGCTATGCCACTGATCTGGTAGTCT","FALSE","NM_031209","ref|NM_031209|ens|ENST00000250237|gb|AK314308|gb|AF302785","QTRT1","queuine tRNA-ribosyltransferase 1","ref|Homo sapiens queuine tRNA-ribosyltransferase 1 (QTRT1), mRNA [NM_031209]","chr19",10812127,10824041,"GO:0005634(nucleus);GO:0005739(mitochondrion);GO:0006400(tRNA modification);GO:0008479(queuine tRNA-ribosyltransferase activity);GO:0008616(queuosine biosynthetic process);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3227793",{"v":3,"d":"3.00"},4.61,3.06,4.76,5.37,4.62,{"v":0.723389830508475,"d":"0.72"},{"v":-0.467154778312141,"d":"-0.47"},"down",{"v":0.077241,"d":"0.08"},1,"no","AAGAACACCCAAAATGACTTTGAGGTGCACATTGTTCAAGTGGAGAATGATGAGATCTAG","FALSE","NM_006569","ref|NM_006569|ref|NM_001166239|ens|ENST00000312734|ens|ENST00000260595","CGREF1","cell growth regulator with EF-hand domain 1","ref|Homo sapiens cell growth regulator with EF-hand domain 1 (CGREF1), transcript variant 1, mRNA [NM_006569]","chr2",27324142,27341995,"GO:0005509(calcium ion binding);GO:0005576(extracellular region);GO:0006950(response to stress);GO:0007050(cell cycle arrest);GO:0007155(cell adhesion);GO:0008285(negative regulation of cell proliferation);GO:0030308(negative regulation of cell growth)",null,"mRNA","agilent G3 V3"]
["A_24_P68585",7.54,7.77,7.98,7.55,7.24,{"v":7.4,"d":"7.40"},{"v":1.04957187922488,"d":"1.05"},{"v":0.0698009720138547,"d":"0.07"},"up",{"v":0.0777359999999999,"d":"0.08"},1,"no","TGTCCAGGCAGAGAGCTTTTTGATGATCCCTCCTATGTCAACGTCCAGAACCTAGACAAG","FALSE","NM_183001","ref|NM_183001|ref|NM_001130041|ref|NM_001202859|ens|ENST00000444664","SHC1","SHC (Src homology 2 domain containing) transforming protein 1","ref|Homo sapiens SHC (Src homology 2 domain containing) transforming protein 1 (SHC1), transcript variant 1, mRNA [NM_183001]","chr1",154934768,154943217,"GO:0000165(MAPK cascade);GO:0000187(activation of MAPK activity);GO:0001525(angiogenesis);GO:0004713(protein tyrosine kinase activity);GO:0005068(transmembrane receptor protein tyrosine kinase adaptor activity);GO:0005154(epidermal growth factor receptor binding);GO:0005158(insulin receptor binding);GO:0005159(insulin-like growth factor receptor binding);GO:0005168(neurotrophin TRKA receptor binding);GO:0005515(protein binding);GO:0005543(phospholipid binding);GO:0005759(mitochondrial matrix);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006987(activation of signaling protein activity involved in unfolded protein response);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007176(regulation of epidermal growth factor-activated receptor activity);GO:0007265(Ras protein signal transduction);GO:0007507(heart development);GO:0007596(blood coagulation);GO:0008284(positive regulation of cell proliferation);GO:0008286(insulin receptor signaling pathway);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0016337(cell-cell adhesion);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0019901(protein kinase binding);GO:0030168(platelet activation);GO:0030968(endoplasmic reticulum unfolded protein response);GO:0031532(actin cytoskeleton reorganization);GO:0038095(Fc-epsilon receptor signaling pathway);GO:0040008(regulation of growth);GO:0044267(cellular protein metabolic process);GO:0045087(innate immune response);GO:0045740(positive regulation of DNA replication);GO:0046875(ephrin receptor binding);GO:0048011(nerve growth factor receptor signaling pathway);GO:0050900(leukocyte migration);GO:0070435(Shc-EGFR complex)","04014(Ras signaling pathway);04012(ErbB signaling pathway);04510(Focal adhesion);04650(Natural killer cell mediated cytotoxicity);04062(Chemokine signaling pathway);04910(Insulin signaling pathway);04915(Estrogen signaling pathway);04917(Prolactin signaling pathway);04722(Neurotrophin signaling pathway);05206(MicroRNAs in cancer);05214(Glioma);05220(Chronic myeloid leukemia);05034(Alcoholism);05100(Bacterial invasion of epithelial cells)","mRNA","agilent G3 V3"]
["A_33_P3367447",5.19,4.23,5.14,5.51,5.53,5.94,{"v":0.857479387514724,"d":"0.86"},{"v":-0.221826103354342,"d":"-0.22"},"down",{"v":0.077784,"d":"0.08"},1,"no","TTCTGTGGGAACGACGGCTTCATGCACATGACCCTGGCCAGCCTGCCTTTTGGAGGAGTG","FALSE","NM_001161473","ref|NM_001161473|ref|NM_000694|ref|NM_001290059|ref|NM_001030010","ALDH3B1","aldehyde dehydrogenase 3 family, member B1","ref|Homo sapiens aldehyde dehydrogenase 3 family, member B1 (ALDH3B1), transcript variant 3, mRNA [NM_001161473]","chr11",67777792,67796741,"GO:0004028(3-chloroallyl aldehyde dehydrogenase activity);GO:0004030(aldehyde dehydrogenase [NAD(P)+] activity);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006066(alcohol metabolic process);GO:0006068(ethanol catabolic process);GO:0006629(lipid metabolic process);GO:0031982(vesicle);GO:0034599(cellular response to oxidative stress);GO:0046185(aldehyde catabolic process);GO:0055114(oxidation-reduction process);GO:0070062(extracellular vesicular exosome)","00010(Glycolysis / Gluconeogenesis);00340(Histidine metabolism);00350(Tyrosine metabolism);00360(Phenylalanine metabolism);00410(beta-Alanine metabolism);00980(Metabolism of xenobiotics by cytochrome P450);00982(Drug metabolism - cytochrome P450);05204(Chemical carcinogenesis)","mRNA","agilent G3 V3"]
["A_23_P161439",8.58,9.72,8.13,9.59,10.32,11.19,{"v":0.84983922829582,"d":"0.85"},{"v":-0.234738155376395,"d":"-0.23"},"down",{"v":0.078282,"d":"0.08"},1,"no","GGATTGGGAAAAAATTCGGCCTCCTGAAATGACAGCAGGGAGACTTGGGTCGGCCTCCTG","FALSE","NM_006829","ref|NM_006829|ens|ENST00000372013|ens|ENST00000561504|linc|lnc-C10orf116-1:1","ADIRF","adipogenesis regulatory factor","ref|Homo sapiens adipogenesis regulatory factor (ADIRF), mRNA [NM_006829]","chr10",88730496,88769883,"GO:0003674(molecular_function);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-dependent);GO:0030154(cell differentiation);GO:0045600(positive regulation of fat cell differentiation);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0070062(extracellular vesicular exosome);GO:0071478(cellular response to radiation);GO:0072719(cellular response to cisplatin);GO:2001023(regulation of response to drug)",null,"mRNA","agilent G3 V3"]
["A_33_P3220570",5.43,5.74,3.88,6.59,6.22,6.35,{"v":0.785490605427975,"d":"0.79"},{"v":-0.348334074089116,"d":"-0.35"},"down",{"v":0.079376,"d":"0.08"},1,"no","CACAGCAGGTCCCTGTGGACAGACATATCTGCATATTTATCAATAAAGCCTTTTGCTCCT","FALSE","NM_024954","ref|NM_024954|ens|ENST00000370664|gb|AK021869|gb|BC007331","UBTD1","ubiquitin domain containing 1","ref|Homo sapiens ubiquitin domain containing 1 (UBTD1), mRNA [NM_024954]","chr10",99258624,99330966,null,null,"mRNA","agilent G3 V3"]
["A_32_P516342",10.34,10.74,10.32,{"v":10,"d":"10.00"},10.03,{"v":10,"d":"10.00"},{"v":1.04562104562105,"d":"1.05"},{"v":0.0643600842218395,"d":"0.06"},"up",{"v":0.079581,"d":"0.08"},1,"no","AGTCCTTCAGGACACCAAAGTCTGGCCCTTCCTCTCTGGCGATACCAGGAGCTCAGGATA","FALSE","NM_182608","ref|NM_182608|ref|NM_001130015|ens|ENST00000548383|ens|ENST00000549751","ANKRD33","ankyrin repeat domain 33","ref|Homo sapiens ankyrin repeat domain 33 (ANKRD33), transcript variant 2, mRNA [NM_182608]","chr12",52281792,52285138,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0005634(nucleus);GO:0005829(cytosol);GO:0035914(skeletal muscle cell differentiation);GO:2000678(negative regulation of transcription regulatory region DNA binding)",null,"mRNA","agilent G3 V3"]
["A_23_P79927",6.02,4.98,5.48,6.85,6.37,5.99,{"v":0.857886517438834,"d":"0.86"},{"v":-0.221141276482309,"d":"-0.22"},"down",{"v":0.079956,"d":"0.08"},1,"no","GCCACATACTGCCGTCTTGCCCAGTTTATTGGAAACCGAAGGGAACTGAATGAGGACAAG","FALSE","NM_006392","ref|NM_006392|ref|NR_027700|ens|ENST00000469588|ens|ENST00000494697","NOP56","NOP56 ribonucleoprotein","ref|Homo sapiens NOP56 ribonucleoprotein (NOP56), transcript variant 1, mRNA [NM_006392]","chr20",{"v":2636262,"d":"2636262.00"},2638296,"GO:0000154(rRNA modification);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005732(small nucleolar ribonucleoprotein complex);GO:0005737(cytoplasm);GO:0006364(rRNA processing);GO:0016020(membrane);GO:0030515(snoRNA binding);GO:0031428(box C/D snoRNP complex);GO:0070761(pre-snoRNP complex)","03008(Ribosome biogenesis in eukaryotes)","mRNA","agilent G3 V3"]
["A_24_P347704",{"v":5.2,"d":"5.20"},5.27,4.58,4.54,4.57,4.21,{"v":1.12987987987988,"d":"1.13"},{"v":0.176169404575802,"d":"0.18"},"up",{"v":0.0804589999999999,"d":"0.08"},1,"no","CCAGAGTTCTATGGTCTTCTTCCCAAGAGAGTTTTTAATTGTAAATGCATACTTGGGAAG","FALSE","NM_006565","ref|NM_006565|ref|NM_001191022|ens|ENST00000264010|ens|ENST00000401394","CTCF","CCCTC-binding factor (zinc finger protein)","ref|Homo sapiens CCCTC-binding factor (zinc finger protein) (CTCF), transcript variant 1, mRNA [NM_006565]","chr16",67596312,67673086,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000775(chromosome, centromeric region);GO:0000793(condensed chromosome);GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0001078(RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0003714(transcription corepressor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006306(DNA methylation);GO:0006349(regulation of gene expression by genetic imprinting);GO:0006351(transcription, DNA-dependent);GO:0007059(chromosome segregation);GO:0008270(zinc ion binding);GO:0010216(maintenance of DNA methylation);GO:0010628(positive regulation of gene expression);GO:0016568(chromatin modification);GO:0016584(nucleosome positioning);GO:0031060(regulation of histone methylation);GO:0035065(regulation of histone acetylation);GO:0040029(regulation of gene expression, epigenetic);GO:0040030(regulation of molecular function, epigenetic);GO:0043035(chromatin insulator sequence binding);GO:0043565(sequence-specific DNA binding);GO:0044212(transcription regulatory region DNA binding);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0070602(regulation of centromeric sister chromatid cohesion)",null,"mRNA","agilent G3 V3"]
["A_23_P131534",9.67,9.27,9.38,9.24,{"v":9,"d":"9.00"},8.68,{"v":1.0520059435364,"d":"1.05"},{"v":0.0731428554726804,"d":"0.07"},"up",{"v":0.081345,"d":"0.08"},1,"no","AGACCTTCCAAATCCTCCCCAAAGTGCCTGAGCGGATCCGAAGGAGAATCCAGCCAAGCA","FALSE","NM_007227","ref|NM_007227|ens|ENST00000258456|gb|EU883573|gb|BC066879","GPR45","G protein-coupled receptor 45","ref|Homo sapiens G protein-coupled receptor 45 (GPR45), mRNA [NM_007227]","chr2",105858200,105859924,"GO:0004930(G-protein coupled receptor activity);GO:0005886(plasma membrane);GO:0007186(G-protein coupled receptor signaling pathway);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3298535",7.54,8.78,7.61,8.97,8.77,9.04,{"v":0.893577296489918,"d":"0.89"},{"v":-0.162335563785812,"d":"-0.16"},"down",{"v":0.0815170000000001,"d":"0.08"},1,"no","AGAGTGGCGGCACCTTTGGCACATTCATGGCCATTGGGATGGGCATCCGATGCTAACCAT","FALSE","NM_080748","ref|NM_080748|ens|ENST00000397416|ens|ENST00000336695|ens|ENST00000374078","ROMO1","reactive oxygen species modulator 1","ref|Homo sapiens reactive oxygen species modulator 1 (ROMO1), mRNA [NM_080748]","chr20",34287372,34288902,"GO:0001302(replicative cell aging);GO:0003674(molecular_function);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0008284(positive regulation of cell proliferation);GO:0016021(integral to membrane);GO:0034614(cellular response to reactive oxygen species);GO:0042742(defense response to bacterium);GO:2000379(positive regulation of reactive oxygen species metabolic process)",null,"mRNA","agilent G3 V3"]
["A_23_P102582",3.83,5.17,3.61,5.83,5.88,5.71,{"v":0.723880597014925,"d":"0.72"},{"v":-0.466176348270645,"d":"-0.47"},"down",{"v":0.0820960000000001,"d":"0.08"},1,"no","TAAACTATCAATGGCATTTCAAGTCTTCTGAAACAGCATGGCTGTATGTGCGTGGTCCAT","FALSE","NM_018840","ref|NM_018840|ref|NM_001199535|ref|NM_001199534|ref|NM_199483","C20orf24","chromosome 20 open reading frame 24","ref|Homo sapiens chromosome 20 open reading frame 24 (C20orf24), transcript variant 1, mRNA [NM_018840]","chr20",35236208,35240960,"GO:0003674(molecular_function);GO:0005575(cellular_component);GO:0008150(biological_process)",null,"mRNA","agilent G3 V3"]
["A_23_P42282",4.92,4.81,5.41,6.03,5.47,5.46,{"v":0.892688679245283,"d":"0.89"},{"v":-0.163770964577467,"d":"-0.16"},"down",{"v":0.082816,"d":"0.08"},1,"no","GCTTTCCGCCTCTTTGAGACCAAGATCACCCAAGTCCTGCACTTCACCAAGGATGTCAAG","FALSE","NM_001002029","ref|NM_001002029|ref|NM_007293|ref|NM_001252204|ref|NM_001242823","C4B","complement component 4B (Chido blood group)","ref|Homo sapiens complement component 4B (Chido blood group) (C4B), mRNA [NM_001002029]","chrHSCHR6_MHC_MCF",32058986,32079643,"GO:0001848(complement binding);GO:0004866(endopeptidase inhibitor activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005886(plasma membrane);GO:0006954(inflammatory response);GO:0006956(complement activation);GO:0006958(complement activation, classical pathway);GO:0008228(opsonization);GO:0010951(negative regulation of endopeptidase activity);GO:0030246(carbohydrate binding);GO:0030449(regulation of complement activation);GO:0032490(detection of molecule of bacterial origin);GO:0044216(other organism cell);GO:0045087(innate immune response);GO:0070062(extracellular vesicular exosome);GO:0072562(blood microparticle);GO:2000427(positive regulation of apoptotic cell clearance)","04610(Complement and coagulation cascades);05322(Systemic lupus erythematosus);05133(Pertussis);05150(Staphylococcus aureus infection)","mRNA","agilent G3 V3"]
["A_23_P104705",2.72,3.62,2.67,3.49,3.87,4.14,{"v":0.783478260869565,"d":"0.78"},{"v":-0.352034850018199,"d":"-0.35"},"down",{"v":0.083419,"d":"0.08"},1,"no","CACAGGATGCCTACTTCATCACCTTCATGCTGCTCTTTGCCGTTTCTAATGGCTACCTGG","FALSE","NM_001532","ref|NM_001532|ref|NM_001300868|ref|NM_001300869|ref|NR_125343","SLC29A2","solute carrier family 29 (equilibrative nucleoside transporter), member 2","ref|Homo sapiens solute carrier family 29 (equilibrative nucleoside transporter), member 2 (SLC29A2), transcript variant 2, mRNA [NM_001532]","chr11",66129992,66139685,"GO:0005337(nucleoside transmembrane transporter activity);GO:0005730(nucleolus);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0006139(nucleobase-containing compound metabolic process);GO:0008283(cell proliferation);GO:0015858(nucleoside transport);GO:0016323(basolateral plasma membrane);GO:0031965(nuclear membrane);GO:0055085(transmembrane transport)",null,"mRNA","agilent G3 V3"]
["A_33_P3351290",5.19,4.59,4.71,5.23,{"v":5.6,"d":"5.60"},{"v":5.2,"d":"5.20"},{"v":0.903930131004367,"d":"0.90"},{"v":-0.145716830597619,"d":"-0.15"},"down",{"v":0.083638,"d":"0.08"},1,"no","GTGCTTCCTGCTCAAACGGCTCTCTTGCCACTTTATTTTCCCCAGAGACTCTGCTCCTAT","FALSE","ENST00000509591","ens|ENST00000509591|ens|ENST00000503120|ens|ENST00000511979|gb|AK057549","MZB1","marginal zone B and B1 cell-specific protein","ens|marginal zone B and B1 cell-specific protein [Source:HGNC Symbol;Acc:HGNC:30125] [ENST00000509591]","chr5",138724288,138725603,"GO:0002642(positive regulation of immunoglobulin biosynthetic process);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005737(cytoplasm);GO:0005788(endoplasmic reticulum lumen);GO:0006915(apoptotic process);GO:0008284(positive regulation of cell proliferation);GO:0030888(regulation of B cell proliferation);GO:0033622(integrin activation);GO:0034663(endoplasmic reticulum chaperone complex);GO:0042127(regulation of cell proliferation);GO:2001274(negative regulation of glucose import in response to insulin stimulus)",null,"mRNA","agilent G3 V3"]
["A_23_P86252",2.64,3.38,4.97,5.18,5.48,5.11,{"v":0.696892834495878,"d":"0.70"},{"v":-0.520991273841279,"d":"-0.52"},"down",{"v":0.084125,"d":"0.08"},1,"no","AAAGCAAGCTGATAGATTAGCCTCCTAACTAGTATAGAACTTAAAGACAGAGTTCCATTC","FALSE","NM_002642","ref|NM_002642|ref|NM_153747|ens|ENST00000367728|ens|ENST00000344529","PIGC","phosphatidylinositol glycan anchor biosynthesis, class C","ref|Homo sapiens phosphatidylinositol glycan anchor biosynthesis, class C (PIGC), transcript variant 2, mRNA [NM_002642]","chr1",172410592,172413230,"GO:0000506(glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex);GO:0003824(catalytic activity);GO:0005789(endoplasmic reticulum membrane);GO:0006501(C-terminal protein lipidation);GO:0006506(GPI anchor biosynthetic process);GO:0016021(integral to membrane);GO:0016254(preassembly of GPI anchor in ER membrane);GO:0017176(phosphatidylinositol N-acetylglucosaminyltransferase activity);GO:0043687(post-translational protein modification);GO:0044267(cellular protein metabolic process)","00563(Glycosylphosphatidylinositol(GPI)-anchor biosynthesis)","mRNA","agilent G3 V3"]
["A_23_P200138",5.47,5.36,5.47,5.86,5.96,5.49,{"v":0.941652224147891,"d":"0.94"},{"v":-0.0867337602481989,"d":"-0.09"},"down",{"v":0.08466,"d":"0.08"},1,"no","TGCACCAGGGCCTTGTTGAACAGATCCACACTGCTCTAATAAAGTTCCCATCCTTAATGA","FALSE","NM_020125","ref|NM_020125|ens|ENST00000289707|ens|ENST00000471286|ens|ENST00000497141","SLAMF8","SLAM family member 8","ref|Homo sapiens SLAM family member 8 (SLAMF8), mRNA [NM_020125]","chr1",159802800,159807039,"GO:0004872(receptor activity);GO:0016021(integral to membrane);GO:0033860(regulation of NAD(P)H oxidase activity);GO:0035690(cellular response to drug);GO:0042742(defense response to bacterium);GO:0043549(regulation of kinase activity);GO:0090383(phagosome acidification)",null,"mRNA","agilent G3 V3"]
["A_23_P78664",3.96,5.54,2.06,7.21,{"v":7,"d":"7.00"},7.03,{"v":0.544256120527307,"d":"0.54"},{"v":-0.877642368303475,"d":"-0.88"},"down",{"v":0.0853160000000001,"d":"0.09"},1,"no","TGTCTGACGAGAATGATGCCAAAATCCTCAATGACGTCCAGGACCGGTTTGAAGTTAATG","FALSE","NM_005804","ref|NM_005804|ref|NR_046366|ens|ENST00000242776|ens|ENST00000588692","DDX39A","DEAD (Asp-Glu-Ala-Asp) box polypeptide 39A","ref|Homo sapiens DEAD (Asp-Glu-Ala-Asp) box polypeptide 39A (DDX39A), transcript variant 1, mRNA [NM_005804]","chr19",14520722,14524032,"GO:0000398(nuclear mRNA splicing, via spliceosome);GO:0004386(helicase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006406(mRNA export from nucleus);GO:0016020(membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3318766",1.97,2.15,1.94,3.21,3.17,4.77,{"v":0.543497757847534,"d":"0.54"},{"v":-0.879654011334716,"d":"-0.88"},"down",{"v":0.085522,"d":"0.09"},1,"no","ACTCTCCGATGCTCACCTGTGGTTGTGGGTGATGCTCCAGACCATCAGATGCTCACCTGA","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_33_P3342295",14.95,14.83,15.08,15.07,15.35,15.18,{"v":0.983771929824561,"d":"0.98"},{"v":-0.0236042039658317,"d":"-0.02"},"down",{"v":0.0860610000000001,"d":"0.09"},1,"no","CCCAGCCGTCCGCCGCCTGCGCTCGGCCGCCAGAAGCGCAGCGACAGCGTCTCCACGTCC","FALSE","NM_199425","ref|NM_199425|ens|ENST00000376707|ens|ENST00000444511|ens|ENST00000409958","VSX1","visual system homeobox 1","ref|Homo sapiens visual system homeobox 1 (VSX1), transcript variant 2, mRNA [NM_199425]","chr20",25062076,25062996,"GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005575(cellular_component);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0007601(visual perception);GO:0042551(neuron maturation);GO:0043565(sequence-specific DNA binding);GO:0050896(response to stimulus);GO:0060040(retinal bipolar neuron differentiation)",null,"mRNA","agilent G3 V3"]
["A_33_P3236392",3.29,4.21,3.25,4.01,4.86,{"v":5.5,"d":"5.50"},{"v":0.748086290883786,"d":"0.75"},{"v":-0.418723401980514,"d":"-0.42"},"down",{"v":0.0864799999999999,"d":"0.09"},1,"no","CCTAGTAGCTGGGACTTTAAGTGTACACCACTGTGCCTGCTTTGAATCCTTTACGAAGAG","FALSE","NM_030916","ref|NM_030916|ens|ENST00000368012|ref|XM_005245508|gb|AK027753","PVRL4","poliovirus receptor-related 4","ref|Homo sapiens poliovirus receptor-related 4 (PVRL4), mRNA [NM_030916]","chr1",161041936,161044048,"GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005912(adherens junction);GO:0007155(cell adhesion);GO:0016021(integral to membrane);GO:0016032(viral reproduction);GO:0034329(cell junction assembly);GO:0034332(adherens junction organization);GO:0045216(cell-cell junction organization);GO:0070062(extracellular vesicular exosome)","04520(Adherens junction)","mRNA","agilent G3 V3"]
["A_33_P3314441",8.69,8.82,8.66,8.86,{"v":8.8,"d":"8.80"},8.88,{"v":0.986058779201206,"d":"0.99"},{"v":-0.0202544463221587,"d":"-0.02"},"down",{"v":0.087076,"d":"0.09"},1,"no","CACATTGAACTGTATCATTTTCATATCCACTTCCCCACCACTGAAATATCTTATTTCACA","FALSE","NM_001163315","ref|NM_001163315|ens|ENST00000619412|ens|ENST00000542267|ens|ENST00000359660","FBXL17","F-box and leucine-rich repeat protein 17","ref|Homo sapiens F-box and leucine-rich repeat protein 17 (FBXL17), mRNA [NM_001163315]","chr5",107194744,107717799,null,null,"mRNA","agilent G3 V3"]
["A_21_P0011433",2.04,5.45,2.03,{"v":6.6,"d":"6.60"},{"v":6.8,"d":"6.80"},{"v":6.9,"d":"6.90"},{"v":0.468965517241379,"d":"0.47"},{"v":-1.09244624876459,"d":"-1.09"},"down",{"v":0.087859,"d":"0.09"},1,"no","CAAGCACATTACAGGGTACCTGATTGCTACACGTTCAGAATGCATTTGCTGTTATCCTGC","FALSE","NM_001139457","ref|NM_001139457|ref|NM_001256447|ref|NM_005745|ref|NM_001139441","BCAP31","B-cell receptor-associated protein 31","ref|Homo sapiens B-cell receptor-associated protein 31 (BCAP31), transcript variant 1, mRNA [NM_001139457]","chrX",152965952,152989556,"GO:0002474(antigen processing and presentation of peptide antigen via MHC class I);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005811(lipid particle);GO:0005829(cytosol);GO:0005887(integral to plasma membrane);GO:0006886(intracellular protein transport);GO:0006888(ER to Golgi vesicle-mediated transport);GO:0006915(apoptotic process);GO:0006921(cellular component disassembly involved in apoptotic process);GO:0007204(elevation of cytosolic calcium ion concentration);GO:0007283(spermatogenesis);GO:0016020(membrane);GO:0030136(clathrin-coated vesicle);GO:0032403(protein complex binding);GO:0032471(reduction of endoplasmic reticulum calcium ion concentration);GO:0032580(Golgi cisterna membrane);GO:0033116(endoplasmic reticulum-Golgi intermediate compartment membrane);GO:0035584(calcium-mediated signaling using intracellular calcium source);GO:0042288(MHC class I protein binding);GO:0043280(positive regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0051561(elevation of mitochondrial calcium ion concentration);GO:0070973(protein localization to endoplasmic reticulum exit site);GO:0071556(integral to lumenal side of endoplasmic reticulum membrane);GO:2001244(positive regulation of intrinsic apoptotic signaling pathway)","04141(Protein processing in endoplasmic reticulum)","mRNA","agilent G3 V3"]
["A_22_P00005107",2.53,3.96,{"v":2.5,"d":"2.50"},3.69,4.46,4.61,{"v":0.704545454545454,"d":"0.70"},{"v":-0.505235308250422,"d":"-0.51"},"down",{"v":0.088118,"d":"0.09"},1,"no","TGTTAAACATTTCCCAGCACACACCTGGATCTGCATCTGCTGTGTCAATTGAACCACTCA","FALSE","XR_245766","ref|XR_245766|ref|XR_248001|ref|XR_253257|linc|lnc-DHRS7-1:5","LOC101927702","uncharacterized LOC101927702","ref|PREDICTED: Homo sapiens uncharacterized LOC101927702 (LOC101927702), ncRNA [XR_245766]","chr14",60706844,60712371,null,null,"mRNA","agilent G3 V3"]
["A_33_P3253264",8.22,8.01,8.13,7.41,7.16,6.16,{"v":1.17510853835022,"d":"1.18"},{"v":0.232794016796918,"d":"0.23"},"up",{"v":0.088744,"d":"0.09"},1,"no","ACGGCACAAGGGGGTGAGGAAGTTTGAGTGCACCGAGTGTGGCTACAAGTTTACCCGACA","FALSE","NM_005341","ref|NM_005341|ref|NM_001278648|ref|NM_001278647|ens|ENST00000466813","ZBTB48","zinc finger and BTB domain containing 48","ref|Homo sapiens zinc finger and BTB domain containing 48 (ZBTB48), transcript variant 1, mRNA [NM_005341]","chr1",{"v":6648747,"d":"6648747.00"},6649340,"GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_24_P287043",9.15,11.65,9.04,12.18,{"v":11.9,"d":"11.90"},11.58,{"v":0.836791923724061,"d":"0.84"},{"v":-0.257059167369757,"d":"-0.26"},"down",{"v":0.089544,"d":"0.09"},1,"no","TTCATGACCATTCTGCTCGTCATCATCCCAGTGTTGGTCGTCCAGGCCCAGCGATAGATC","FALSE","NM_006435","ref|NM_006435|ens|ENST00000616316|ens|ENST00000619184|ens|ENST00000527146","IFITM2","interferon induced transmembrane protein 2","ref|Homo sapiens interferon induced transmembrane protein 2 (IFITM2), mRNA [NM_006435]","chr11",{"v":308320,"d":"308320.00"},309392,"GO:0005886(plasma membrane);GO:0006955(immune response);GO:0009615(response to virus);GO:0016021(integral to membrane);GO:0019221(cytokine-mediated signaling pathway);GO:0034341(response to interferon-gamma);GO:0035455(response to interferon-alpha);GO:0035456(response to interferon-beta);GO:0045071(negative regulation of viral genome replication);GO:0046597(negative regulation of viral entry into host cell);GO:0051607(defense response to virus);GO:0060337(type I interferon-mediated signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_23_P61426",2.91,5.37,2.96,5.32,5.54,5.92,{"v":0.66984505363528,"d":"0.67"},{"v":-0.578100680218897,"d":"-0.58"},"down",{"v":0.090257,"d":"0.09"},1,"no","TCTCTGTGCAGAGAAAAGATGTGAGTCCGCTTGATGAATTCTAATGCTTTGCTTAGAGCT","FALSE","NM_012331","ref|NM_012331|ref|NM_001199729|ref|NM_001135671|ref|NM_001135670","MSRA","methionine sulfoxide reductase A","ref|Homo sapiens methionine sulfoxide reductase A (MSRA), transcript variant 1, mRNA [NM_012331]","chr8",{"v":9953237,"d":"9953237.00"},10286399,"GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0006464(cellular protein modification process);GO:0006555(methionine metabolic process);GO:0006979(response to oxidative stress);GO:0008113(peptide-methionine-(S)-S-oxide reductase activity);GO:0015629(actin cytoskeleton);GO:0016020(membrane);GO:0030091(protein repair);GO:0055114(oxidation-reduction process);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3285868",{"v":15.5,"d":"15.50"},15.45,15.93,{"v":16.1,"d":"16.10"},16.13,16.07,{"v":0.970600414078675,"d":"0.97"},{"v":-0.0430506193008878,"d":"-0.04"},"down",{"v":0.090862,"d":"0.09"},1,"no","GCAACCGCCCGTCCTCCTTTTCTAGTTTCTGATGTTTGTAACCAGACCCAGCTGTGTCAT","FALSE","NM_134268","ref|NM_134268|ens|ENST00000293230|gb|AK098057|gb|BC029798","CYGB","cytoglobin","ref|Homo sapiens cytoglobin (CYGB), mRNA [NM_134268]","chr17",74524136,74525075,"GO:0004601(peroxidase activity);GO:0005344(oxygen transporter activity);GO:0005506(iron ion binding);GO:0005737(cytoplasm);GO:0006979(response to oxidative stress);GO:0015671(oxygen transport);GO:0019825(oxygen binding);GO:0020037(heme binding);GO:0043005(neuron projection);GO:0043025(neuronal cell body);GO:0055114(oxidation-reduction process)",null,"mRNA","agilent G3 V3"]
["A_24_P358321",7.04,7.31,7.38,7.36,7.67,7.68,{"v":0.956847203874945,"d":"0.96"},{"v":-0.063639531525605,"d":"-0.06"},"down",{"v":0.0912599999999999,"d":"0.09"},1,"no","TTGTATTGGTACCTGCAGAAGCCAGGCCAGCCTCCACAGCTCCTGATCTATGAAGTTTCC","FALSE","ENST00000491977","ens|ENST00000491977|ens|ENST00000612356|ens|ENST00000521304|ens|ENST00000519999",null,null,"ens|immunoglobulin kappa variable 2D-29 [Source:HGNC Symbol;Acc:HGNC:5800] [ENST00000491977]","chr2",89986320,89987079,null,null,"mRNA","agilent G3 V3"]
["A_24_P324405",3.12,3.99,{"v":3.1,"d":"3.10"},4.16,4.16,3.91,{"v":0.83483237939493,"d":"0.83"},{"v":-0.260441537649585,"d":"-0.26"},"down",{"v":0.091861,"d":"0.09"},1,"no","ACAAAAGTGAGAAATCAATCCTGGAAAAATGTCAGAAGGACAAAGAATTTGATAAATGTT","FALSE","NM_013275","ref|NM_013275|ref|NM_001256182|ref|NM_001256183|ens|ENST00000330736","ANKRD11","ankyrin repeat domain 11","ref|Homo sapiens ankyrin repeat domain 11 (ANKRD11), transcript variant 2, mRNA [NM_013275]","chr16",89334752,89383550,"GO:0001701(in utero embryonic development);GO:0001894(tissue homeostasis);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0035264(multicellular organism growth);GO:0042475(odontogenesis of dentin-containing tooth);GO:0048705(skeletal system morphogenesis);GO:0060325(face morphogenesis);GO:0060348(bone development)",null,"mRNA","agilent G3 V3"]
["A_23_P85560",2.85,5.55,4.39,6.61,6.57,6.79,{"v":0.640460691036555,"d":"0.64"},{"v":-0.642818068562336,"d":"-0.64"},"down",{"v":0.092822,"d":"0.09"},1,"no","TATCCATTACTTCGACCCACAGTACTTCGAATTTGAGTTTGAGGCTTAAGAAGCTGGATC","FALSE","NM_003757","ref|NM_003757|ens|ENST00000373586|gb|AK289882|gb|U36764","EIF3I","eukaryotic translation initiation factor 3, subunit I","ref|Homo sapiens eukaryotic translation initiation factor 3, subunit I (EIF3I), mRNA [NM_003757]","chr1",32688146,32696655,"GO:0001731(formation of translation preinitiation complex);GO:0003743(translation initiation factor activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005852(eukaryotic translation initiation factor 3 complex);GO:0006412(translation);GO:0006413(translational initiation);GO:0006446(regulation of translational initiation);GO:0010467(gene expression);GO:0016282(eukaryotic 43S preinitiation complex);GO:0033290(eukaryotic 48S preinitiation complex);GO:0044267(cellular protein metabolic process);GO:0070062(extracellular vesicular exosome);GO:0071541(eukaryotic translation initiation factor 3 complex, eIF3m)","03013(RNA transport)","mRNA","agilent G3 V3"]
["A_24_P26073",4.41,1.89,2.26,5.17,5.37,5.21,{"v":0.543492063492063,"d":"0.54"},{"v":-0.879669126873494,"d":"-0.88"},"down",{"v":0.093236,"d":"0.09"},1,"no","AGAGAAAGATGTCACATCTGCTAAAGCACTGTATGAACATTTGACTGCAAAGAATACAAA","FALSE","NM_133259","ref|NM_133259|ens|ENST00000463456|ens|ENST00000260665|ref|XM_006711915","LRPPRC","leucine-rich pentatricopeptide repeat containing","ref|Homo sapiens leucine-rich pentatricopeptide repeat containing (LRPPRC), mRNA [NM_133259]","chr2",44115416,44131070,"GO:0000794(condensed nuclear chromosome);GO:0000961(negative regulation of mitochondrial RNA catabolic process);GO:0003697(single-stranded DNA binding);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005637(nuclear inner membrane);GO:0005640(nuclear outer membrane);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0005856(cytoskeleton);GO:0005874(microtubule);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0008017(microtubule binding);GO:0016020(membrane);GO:0030529(ribonucleoprotein complex);GO:0042645(mitochondrial nucleoid);GO:0047497(mitochondrion transport along microtubule);GO:0048471(perinuclear region of cytoplasm);GO:0048487(beta-tubulin binding);GO:0051015(actin filament binding);GO:0051028(mRNA transport);GO:0070129(regulation of mitochondrial translation)",null,"mRNA","agilent G3 V3"]
["A_23_P129513",7.43,7.58,7.33,8.02,7.63,7.65,{"v":0.958798283261803,"d":"0.96"},{"v":-0.0607007690583275,"d":"-0.06"},"down",{"v":0.093719,"d":"0.09"},1,"no","AGCAGAGACTTTTGGAGGAGAAGGACCCTGTACCCCTGTTCAAGATCTATGTGGCGGAGC","FALSE","NM_006428","ref|NM_006428|ens|ENST00000441883|ens|ENST00000389675|ens|ENST00000469744","MRPL28","mitochondrial ribosomal protein L28","ref|Homo sapiens mitochondrial ribosomal protein L28 (MRPL28), mRNA [NM_006428]","chr16",{"v":417384,"d":"417384.00"},420527,"GO:0003735(structural constituent of ribosome);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0005761(mitochondrial ribosome);GO:0006412(translation);GO:0006996(organelle organization);GO:0032543(mitochondrial translation);GO:0070124(mitochondrial translational initiation);GO:0070125(mitochondrial translational elongation);GO:0070126(mitochondrial translational termination)","03010(Ribosome)","mRNA","agilent G3 V3"]
["A_21_P0000396",5.19,4.95,5.99,3.91,4.88,4.56,{"v":1.20823970037453,"d":"1.21"},{"v":0.272906696580727,"d":"0.27"},"up",{"v":0.0944809999999999,"d":"0.09"},1,"no","AGTGTTTATGAACAAAAGATCATGATTAATCCAGTTCTGCACAAAACACTGAGGTCCATT","FALSE","NR_003080","ref|NR_003080|gb|BQ710871","SNORD112","small nucleolar RNA, C/D box 112","ref|Homo sapiens small nucleolar RNA, C/D box 112 (SNORD112), small nucleolar RNA [NR_003080]","chr14",101364144,101364939,null,null,"mRNA","agilent G3 V3"]
["A_33_P3340309",4.12,5.31,2.02,5.67,5.82,6.39,{"v":0.640380313199105,"d":"0.64"},{"v":-0.642999138199011,"d":"-0.64"},"down",{"v":0.095518,"d":"0.10"},1,"no","ACCTAATTAGAGTGGGTTAGCTTAGATTGGTAGCTGCTGAAACTCTCGTTGAGTCAGGAG","FALSE","NM_024671","ref|NM_024671|ens|ENST00000380412|gb|AK295274|gb|BC013760","ZNF768","zinc finger protein 768","ref|Homo sapiens zinc finger protein 768 (ZNF768), mRNA [NM_024671]","chr16",30535454,30538142,"GO:0003677(DNA binding);GO:0005665(DNA-directed RNA polymerase II, core complex);GO:0006355(regulation of transcription, DNA-dependent);GO:0006366(transcription from RNA polymerase II promoter);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P339687",5.26,3.19,5.37,6.84,6.77,{"v":6.6,"d":"6.60"},{"v":0.683819891142998,"d":"0.68"},{"v":-0.548311705991477,"d":"-0.55"},"down",{"v":0.0960759999999999,"d":"0.10"},1,"no","AGAAACCCTACAAATGTGAAGAATGCGGCAAAGCCTCTAACCAGTTCTCAAATCTTACTA","FALSE","NM_138330","ref|NM_138330|ens|ENST00000600299|gb|AY044432|gb|BC156533","ZNF675","zinc finger protein 675","ref|Homo sapiens zinc finger protein 675 (ZNF675), mRNA [NM_138330]","chr19",23835708,23870017,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0007249(I-kappaB kinase/NF-kappaB cascade);GO:0008270(zinc ion binding);GO:0010804(negative regulation of tumor necrosis factor-mediated signaling pathway);GO:0019221(cytokine-mediated signaling pathway);GO:0031625(ubiquitin protein ligase binding);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0043508(negative regulation of JUN kinase activity);GO:0045453(bone resorption);GO:0045671(negative regulation of osteoclast differentiation);GO:0046329(negative regulation of JNK cascade);GO:0048471(perinuclear region of cytoplasm);GO:2000660(negative regulation of interleukin-1-mediated signaling pathway);GO:2000678(negative regulation of transcription regulatory region DNA binding)",null,"mRNA","agilent G3 V3"]
["A_24_P319354",6.34,5.66,6.02,5.56,5.15,3.97,{"v":1.2275204359673,"d":"1.23"},{"v":0.295747042970326,"d":"0.30"},"up",{"v":0.096916,"d":"0.10"},1,"no","CAACTGAGGACTTGGGGGATAAGAAGGAAGGTGAATATATTAAACTCAAAGTCATTGGAC","FALSE","NM_001005781","ref|NM_001005781|ref|NR_002190|ens|ENST00000439961|ens|ENST00000469034","SUMO1","small ubiquitin-like modifier 1","ref|Homo sapiens small ubiquitin-like modifier 1 (SUMO1), transcript variant 2, mRNA [NM_001005781]","chr2",203070912,203103322,"GO:0001650(fibrillar center);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005643(nuclear pore);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006281(DNA repair);GO:0008134(transcription factor binding);GO:0016605(PML body);GO:0016607(nuclear speck);GO:0016925(protein sumoylation);GO:0019221(cytokine-mediated signaling pathway);GO:0019789(SUMO ligase activity);GO:0030425(dendrite);GO:0030578(PML body organization);GO:0031334(positive regulation of protein complex assembly);GO:0031625(ubiquitin protein ligase binding);GO:0031965(nuclear membrane);GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0032880(regulation of protein localization);GO:0043392(negative regulation of DNA binding);GO:0043433(negative regulation of sequence-specific DNA binding transcription factor activity);GO:0043687(post-translational protein modification);GO:0044267(cellular protein metabolic process);GO:0045202(synapse);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0060021(palate development);GO:0060333(interferon-gamma-mediated signaling pathway);GO:0060334(regulation of interferon-gamma-mediated signaling pathway);GO:0090204(protein localization to nuclear pore)","03013(RNA transport)","mRNA","agilent G3 V3"]
["A_33_P3243558",9.23,9.01,9.28,8.74,8.71,{"v":9.1,"d":"9.10"},{"v":1.03653483992467,"d":"1.04"},{"v":0.0517686090105818,"d":"0.05"},"up",{"v":0.09778,"d":"0.10"},1,"no","TACTGCTGCTGGGGCTGTGGCAGCCTCTGCTGCCCACCCCTAGGCAGCCCCGAGGTCTGA","FALSE","NM_001190228","ref|NM_001190228|ens|ENST00000445101","RNF224","ring finger protein 224","ref|Homo sapiens ring finger protein 224 (RNF224), mRNA [NM_001190228]","chr9",140122016,140124090,"GO:0008270(zinc ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P402787",6.29,5.95,6.64,6.66,6.69,{"v":6.9,"d":"6.90"},{"v":0.932345679012346,"d":"0.93"},{"v":-0.101063143297508,"d":"-0.10"},"down",{"v":0.098665,"d":"0.10"},1,"no","TTGCTGTTCCTTGCAGAGAAAAGGATTGTGGGAAACTCCAGGACTCTTCCCACCGCCTCC","FALSE","NM_145253","ref|NM_145253|ens|ENST00000588691|ens|ENST00000590891|ens|ENST00000283474","UBALD1","UBA-like domain containing 1","ref|Homo sapiens UBA-like domain containing 1 (UBALD1), mRNA [NM_145253]","chr16",{"v":4659832,"d":"4659832.00"},4664403,null,null,"mRNA","agilent G3 V3"]
["A_22_P00000261",6.32,{"v":6.3,"d":"6.30"},{"v":6.4,"d":"6.40"},5.99,6.27,6.19,{"v":1.03089430894309,"d":"1.03"},{"v":0.0438964299128052,"d":"0.04"},"up",{"v":0.098842,"d":"0.10"},1,"no","AAGAAGATGTCTTTGATTGTGCAGCTGATCTCTCCCATGCCTTTTAAGCAATTAGAACTA","FALSE","NM_001290031","ref|NM_001290031|ref|NR_110644|ens|ENST00000429172|ens|ENST00000426475","ERICH2","glutamate-rich 2","ref|Homo sapiens glutamate-rich 2 (ERICH2), transcript variant 3, mRNA [NM_001290031]","chr2",171627184,171634619,null,null,"mRNA","agilent G3 V3"]
["A_23_P214330",4.79,5.95,{"v":4.3,"d":"4.30"},6.02,5.86,6.69,{"v":0.8099084544965,"d":"0.81"},{"v":-0.304169248257784,"d":"-0.30"},"down",{"v":0.099739,"d":"0.10"},1,"no","TGCCGACCATCCATTCCTTTTCTTTATTCGGCATAATTCCTCAGGTAGCATCCTATTCTT","FALSE","NM_030666","ref|NM_030666|ref|NR_073111|ref|NR_073112|ens|ENST00000468511","SERPINB1","serpin peptidase inhibitor, clade B (ovalbumin), member 1","ref|Homo sapiens serpin peptidase inhibitor, clade B (ovalbumin), member 1 (SERPINB1), transcript variant 1, mRNA [NM_030666]","chr6",{"v":2833642,"d":"2833642.00"},2842094,"GO:0004867(serine-type endopeptidase inhibitor activity);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0010951(negative regulation of endopeptidase activity);GO:0016020(membrane);GO:0070062(extracellular vesicular exosome)","05146(Amoebiasis)","mRNA","agilent G3 V3"]
["A_19_P00805548",4.88,3.01,2.06,5.55,5.92,5.78,{"v":0.576811594202899,"d":"0.58"},{"v":-0.793827931121883,"d":"-0.79"},"down",{"v":0.100419,"d":"0.10"},1,"no","CAGGCAGAAATATTTAGTATCTAGTCAGTATCTGTAGCTACACTGTATAACTGTTCTTCA","FALSE","NM_004329","ref|NM_004329|gb|BC028383|gb|DQ786215|tc|THC2462414","BMPR1A","bone morphogenetic protein receptor, type IA","ref|Homo sapiens bone morphogenetic protein receptor, type IA (BMPR1A), mRNA [NM_004329]","chr10",88516408,88692595,"GO:0000981(sequence-specific DNA binding RNA polymerase II transcription factor activity);GO:0001701(in utero embryonic development);GO:0001707(mesoderm formation);GO:0001756(somitogenesis);GO:0001880(Mullerian duct regression);GO:0002053(positive regulation of mesenchymal cell proliferation);GO:0003272(endocardial cushion formation);GO:0004674(protein serine/threonine kinase activity);GO:0004675(transmembrane receptor protein serine/threonine kinase activity);GO:0004702(receptor signaling protein serine/threonine kinase activity);GO:0005024(transforming growth factor beta-activated receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0006366(transcription from RNA polymerase II promoter);GO:0006468(protein phosphorylation);GO:0006955(immune response);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007398(ectoderm development);GO:0009950(dorsal/ventral axis specification);GO:0010862(positive regulation of pathway-restricted SMAD protein phosphorylation);GO:0014032(neural crest cell development);GO:0016021(integral to membrane);GO:0019827(stem cell maintenance);GO:0021983(pituitary gland development);GO:0021998(neural plate mediolateral regionalization);GO:0023014(signal transduction by phosphorylation);GO:0030324(lung development);GO:0030425(dendrite);GO:0030501(positive regulation of bone mineralization);GO:0030509(BMP signaling pathway);GO:0035137(hindlimb morphogenesis);GO:0042475(odontogenesis of dentin-containing tooth);GO:0042733(embryonic digit morphogenesis);GO:0042803(protein homodimerization activity);GO:0043025(neuronal cell body);GO:0045669(positive regulation of osteoblast differentiation);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0046332(SMAD binding);GO:0046872(metal ion binding);GO:0048352(paraxial mesoderm structural organization);GO:0048368(lateral mesoderm development);GO:0048378(regulation of lateral mesodermal cell fate specification);GO:0048382(mesendoderm development);GO:0048568(embryonic organ development);GO:0048589(developmental growth);GO:0050679(positive regulation of epithelial cell proliferation);GO:0050768(negative regulation of neurogenesis);GO:0051216(cartilage development);GO:0060021(palate development);GO:0060391(positive regulation of SMAD protein import into nucleus);GO:0060914(heart formation);GO:2000772(regulation of cellular senescence)","04350(TGF-beta signaling pathway);04390(Hippo signaling pathway);04060(Cytokine-cytokine receptor interaction);04550(Signaling pathways regulating pluripotency of stem cells)","mRNA","agilent G3 V3"]
["A_23_P83298",5.96,{"v":7.9,"d":"7.90"},6.17,8.38,7.57,8.33,{"v":0.82495881383855,"d":"0.82"},{"v":-0.277606000442974,"d":"-0.28"},"down",{"v":0.101324,"d":"0.10"},1,"no","CAAGGACCTCATTTAGTTTGTGTATTAAAACCAAAAAGCTTTTGTCTTTAAGAAATAAAA","FALSE","NM_016307","ref|NM_016307|ens|ENST00000372469|ref|XM_006717142|gb|AF061970","PRRX2","paired related homeobox 2","ref|Homo sapiens paired related homeobox 2 (PRRX2), mRNA [NM_016307]","chr9",132427920,132484875,"GO:0002053(positive regulation of mesenchymal cell proliferation);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005634(nucleus);GO:0006355(regulation of transcription, DNA-dependent);GO:0030326(embryonic limb morphogenesis);GO:0042472(inner ear morphogenesis);GO:0042474(middle ear morphogenesis);GO:0043565(sequence-specific DNA binding);GO:0045880(positive regulation of smoothened signaling pathway);GO:0048701(embryonic cranial skeleton morphogenesis);GO:0048844(artery morphogenesis);GO:0051216(cartilage development)",null,"mRNA","agilent G3 V3"]
["A_23_P215956",3.06,4.64,3.73,5.21,5.14,5.07,{"v":0.74124513618677,"d":"0.74"},{"v":-0.431977361700556,"d":"-0.43"},"down",{"v":0.101562,"d":"0.10"},1,"no","TTCAAATGCATGATCAAATGCAACCTCACAACCTTGGCTGAGTCTTGAGACTGAAAGATT","FALSE","NM_002467","ref|NM_002467|ens|ENST00000613283|ens|ENST00000377970|ens|ENST00000621592","MYC","v-myc avian myelocytomatosis viral oncogene homolog","ref|Homo sapiens v-myc avian myelocytomatosis viral oncogene homolog (MYC), mRNA [NM_002467]","chr8",128748464,128753618,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000165(MAPK cascade);GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0001077(RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription);GO:0001658(branching involved in ureteric bud morphogenesis);GO:0002053(positive regulation of mesenchymal cell proliferation);GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006112(energy reserve metabolic process);GO:0006338(chromatin remodeling);GO:0006351(transcription, DNA-dependent);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0006879(cellular iron ion homeostasis);GO:0006974(response to DNA damage stimulus);GO:0007050(cell cycle arrest);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007219(Notch signaling pathway);GO:0008134(transcription factor binding);GO:0008284(positive regulation of cell proliferation);GO:0010332(response to gamma radiation);GO:0010467(gene expression);GO:0010468(regulation of gene expression);GO:0015671(oxygen transport);GO:0032204(regulation of telomere maintenance);GO:0032403(protein complex binding);GO:0032873(negative regulation of stress-activated MAPK cascade);GO:0034644(cellular response to UV);GO:0035690(cellular response to drug);GO:0042493(response to drug);GO:0043066(negative regulation of apoptotic process);GO:0043234(protein complex);GO:0043280(positive regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0044346(fibroblast apoptotic process);GO:0045656(negative regulation of monocyte differentiation);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046983(protein dimerization activity);GO:0048146(positive regulation of fibroblast proliferation);GO:0048147(negative regulation of fibroblast proliferation);GO:0050679(positive regulation of epithelial cell proliferation);GO:0051276(chromosome organization);GO:0051782(negative regulation of cell division);GO:0060070(canonical Wnt receptor signaling pathway);GO:0070491(repressing transcription factor binding);GO:0070848(response to growth factor stimulus);GO:0070888(E-box binding);GO:0090096(positive regulation of metanephric cap mesenchymal cell proliferation);GO:2000573(positive regulation of DNA biosynthetic process);GO:2001022(positive regulation of response to DNA damage stimulus)","04010(MAPK signaling pathway);04012(ErbB signaling pathway);04310(Wnt signaling pathway);04350(TGF-beta signaling pathway);04390(Hippo signaling pathway);04630(Jak-STAT signaling pathway);04151(PI3K-Akt signaling pathway);04110(Cell cycle);04550(Signaling pathways regulating pluripotency of stem cells);04919(Thyroid hormone signaling pathway);05200(Pathways in cancer);05230(Central carbon metabolism in cancer);05202(Transcriptional misregulation in cancers);05206(MicroRNAs in cancer);05205(Proteoglycans in cancer);05210(Colorectal cancer);05216(Thyroid cancer);05221(Acute myeloid leukemia);05220(Chronic myeloid leukemia);05219(Bladder cancer);05213(Endometrial cancer);05222(Small cell lung cancer);05166(HTLV-I infection);05161(Hepatitis B);05169(Epstein-Barr virus infection)","mRNA","agilent G3 V3"]
["A_33_P3727762",8.11,9.05,7.61,{"v":9.6,"d":"9.60"},9.44,9.41,{"v":0.870650263620387,"d":"0.87"},{"v":-0.199834783947581,"d":"-0.20"},"down",{"v":0.102499,"d":"0.10"},1,"no","GTGAATATGGACGGTTAGCATTTACCAACATGTGTCTGTCTACTTTCTCTTGTTTAAAAA","FALSE","NM_003011","ref|NM_003011|ref|NM_001122821|ref|NM_001248000|ref|NM_001248001","SET","SET nuclear proto-oncogene","ref|Homo sapiens SET nuclear proto-oncogene (SET), transcript variant 2, mRNA [NM_003011]","chrX",84010144,84011011,"GO:0000278(mitotic cell cycle);GO:0003677(DNA binding);GO:0004864(protein phosphatase inhibitor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0006260(DNA replication);GO:0006334(nucleosome assembly);GO:0006337(nucleosome disassembly);GO:0006913(nucleocytoplasmic transport);GO:0008601(protein phosphatase type 2A regulator activity);GO:0010467(gene expression);GO:0035067(negative regulation of histone acetylation);GO:0042393(histone binding);GO:0043086(negative regulation of catalytic activity);GO:0043234(protein complex);GO:0043524(negative regulation of neuron apoptotic process);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0048471(perinuclear region of cytoplasm);GO:0050790(regulation of catalytic activity)",null,"mRNA","agilent G3 V3"]
["A_23_P145153",3.43,2.68,{"v":2.5,"d":"2.50"},3.68,3.63,3.78,{"v":0.776375112714157,"d":"0.78"},{"v":-0.365174222764866,"d":"-0.37"},"down",{"v":0.103076,"d":"0.10"},1,"no","TTGTAATAGAAACAGAAGATGAGATTATGCCTGAGGTTGTGGAAAAGGAAGATTACTCAG","FALSE","NM_002598","ref|NM_002598|ref|NM_001199461|ref|NM_001199464|ref|NM_144781","PDCD2","programmed cell death 2","ref|Homo sapiens programmed cell death 2 (PDCD2), transcript variant 1, mRNA [NM_002598]","chr6",170891936,170893509,"GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006915(apoptotic process);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0019899(enzyme binding);GO:0043065(positive regulation of apoptotic process);GO:0046872(metal ion binding);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3803639",4.16,5.94,3.37,6.33,6.11,5.88,{"v":0.735262008733624,"d":"0.74"},{"v":-0.443669652634641,"d":"-0.44"},"down",{"v":0.104039,"d":"0.10"},1,"no","GGTAAAGTGTGAGAGCTTGCCATCCAGCTCACGAAGACAGAGTTATTAAACCATTCAAAT","FALSE","NM_021138","ref|NM_021138|ens|ENST00000247668|ref|XM_005266099|gb|AK054686","TRAF2","TNF receptor-associated factor 2","ref|Homo sapiens TNF receptor-associated factor 2 (TRAF2), mRNA [NM_021138]","chr9",139780976,139821059,"GO:0000151(ubiquitin ligase complex);GO:0002726(positive regulation of T cell cytokine production);GO:0004842(ubiquitin-protein ligase activity);GO:0004871(signal transducer activity);GO:0005164(tumor necrosis factor receptor binding);GO:0005174(CD40 receptor binding);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005938(cell cortex);GO:0006461(protein complex assembly);GO:0006915(apoptotic process);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0007165(signal transduction);GO:0007250(activation of NF-kappaB-inducing kinase activity);GO:0008270(zinc ion binding);GO:0009898(internal side of plasma membrane);GO:0012506(vesicle membrane);GO:0016874(ligase activity);GO:0019899(enzyme binding);GO:0019903(protein phosphatase binding);GO:0030163(protein catabolic process);GO:0031435(mitogen-activated protein kinase kinase kinase binding);GO:0031625(ubiquitin protein ligase binding);GO:0031996(thioesterase binding);GO:0032403(protein complex binding);GO:0032743(positive regulation of interleukin-2 production);GO:0033209(tumor necrosis factor-mediated signaling pathway);GO:0034351(negative regulation of glial cell apoptotic process);GO:0035631(CD40 receptor complex);GO:0042802(identical protein binding);GO:0042981(regulation of apoptotic process);GO:0043507(positive regulation of JUN kinase activity);GO:0043623(cellular protein complex assembly);GO:0045087(innate immune response);GO:0045121(membrane raft);GO:0046625(sphingolipid binding);GO:0050870(positive regulation of T cell activation);GO:0051023(regulation of immunoglobulin secretion);GO:0051091(positive regulation of sequence-specific DNA binding transcription factor activity);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0051291(protein heterooligomerization);GO:0051865(protein autoubiquitination);GO:0070207(protein homotrimerization);GO:0070534(protein K63-linked ubiquitination);GO:0071732(cellular response to nitric oxide);GO:0090073(positive regulation of protein homodimerization activity);GO:0097057(TRAF2-GSTP1 complex);GO:0097300(programmed necrotic cell death);GO:2001238(positive regulation of extrinsic apoptotic signaling pathway);GO:2001239(regulation of extrinsic apoptotic signaling pathway in absence of ligand)","04141(Protein processing in endoplasmic reticulum);04010(MAPK signaling pathway);04064(NF-kappa B signaling pathway);04668(TNF signaling pathway);04071(Sphingolipid signaling pathway);04210(Apoptosis);04622(RIG-I-like receptor signaling pathway);04920(Adipocytokine signaling pathway);04380(Osteoclast differentiation);05200(Pathways in cancer);05203(Viral carcinogenesis);05222(Small cell lung cancer);04932(Non-alcoholic fatty liver disease (NAFLD));05160(Hepatitis C);05168(Herpes simplex infection);05169(Epstein-Barr virus infection)","mRNA","agilent G3 V3"]
["A_32_P135348",{"v":5.8,"d":"5.80"},6.01,4.45,6.98,6.75,6.75,{"v":0.7939453125,"d":"0.79"},{"v":-0.332888457924972,"d":"-0.33"},"down",{"v":0.104643,"d":"0.10"},1,"no","AAATAGGAACCTCTGATGTCATTCTTCAACGTTTGTTCCTGTGTGTACAATTGTACTTTG","FALSE","NM_033394","ref|NM_033394|ref|NM_001145909|ens|ENST00000470074|ens|ENST00000454300","TANC1","tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1","ref|Homo sapiens tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 (TANC1), transcript variant 1, mRNA [NM_033394]","chr2",159825152,160089166,"GO:0007520(myoblast fusion);GO:0008542(visual learning);GO:0014069(postsynaptic density);GO:0030054(cell junction);GO:0030425(dendrite);GO:0043025(neuronal cell body);GO:0043679(axon terminus);GO:0045211(postsynaptic membrane);GO:0097062(dendritic spine maintenance)",null,"mRNA","agilent G3 V3"]
["A_23_P156061",4.06,2.04,2.01,4.37,4.47,8.15,{"v":0.477339611536198,"d":"0.48"},{"v":-1.06691203296695,"d":"-1.07"},"down",{"v":0.1049,"d":"0.10"},1,"no","GGGTCGACATTTTCCTGGACACTTACTGGCATGGGATTTTGTCAAAGAGAACTGGAATAA","FALSE","NM_005575","ref|NM_005575|ref|NM_175920|ens|ENST00000395770|gb|AK314226","LNPEP","leucyl/cystinyl aminopeptidase","ref|Homo sapiens leucyl/cystinyl aminopeptidase (LNPEP), transcript variant 1, mRNA [NM_005575]","chr5",96294152,96364740,"GO:0000209(protein polyubiquitination);GO:0002474(antigen processing and presentation of peptide antigen via MHC class I);GO:0002480(antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent);GO:0004177(aminopeptidase activity);GO:0005576(extracellular region);GO:0005622(intracellular);GO:0005765(lysosomal membrane);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0006508(proteolysis);GO:0007267(cell-cell signaling);GO:0007565(female pregnancy);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0016020(membrane);GO:0030163(protein catabolic process);GO:0030659(cytoplasmic vesicle membrane);GO:0031905(early endosome lumen);GO:0042590(antigen processing and presentation of exogenous peptide antigen via MHC class I);GO:0048471(perinuclear region of cytoplasm);GO:0060395(SMAD protein signal transduction);GO:0061024(membrane organization)","04614(Renin-angiotensin system)","mRNA","agilent G3 V3"]
["A_33_P3249595",4.73,5.45,5.46,{"v":4.4,"d":"4.40"},4.79,4.75,{"v":1.1219512195122,"d":"1.12"},{"v":0.166009951438929,"d":"0.17"},"up",{"v":0.10524,"d":"0.11"},1,"no","GATGACGATTGTTTATCAACGTCATCTAGAGGAATTTGCCCCAAACAGGAACACATAGCA","FALSE","NM_138559","ref|NM_138559|ens|ENST00000489516|ens|ENST00000359629|gb|AY692278","BCL11A","B-cell CLL/lymphoma 11A (zinc finger protein)","ref|Homo sapiens B-cell CLL/lymphoma 11A (zinc finger protein) (BCL11A), transcript variant 3, mRNA [NM_138559]","chr2",60679636,60780617,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0001078(RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription);GO:0003714(transcription corepressor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-dependent);GO:0010976(positive regulation of neuron projection development);GO:0010977(negative regulation of neuron projection development);GO:0016925(protein sumoylation);GO:0030183(B cell differentiation);GO:0030217(T cell differentiation);GO:0030517(negative regulation of axon extension);GO:0032463(negative regulation of protein homooligomerization);GO:0042803(protein homodimerization activity);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046872(metal ion binding);GO:0046982(protein heterodimerization activity);GO:0048671(negative regulation of collateral sprouting);GO:0048672(positive regulation of collateral sprouting);GO:0050773(regulation of dendrite development);GO:2000171(negative regulation of dendrite development)",null,"mRNA","agilent G3 V3"]
["A_24_P336113",7.35,7.64,7.64,7.79,7.68,7.82,{"v":0.971661657363675,"d":"0.97"},{"v":-0.0414740549439737,"d":"-0.04"},"down",{"v":0.105675,"d":"0.11"},1,"no","CATCCTTTTCTATGAAGTGTTGACTTTGTAAATCTGCCCACACCCAGCTGGCCATATCCA","FALSE","NM_012295","ref|NM_012295|ref|NM_001199281|ref|NM_001201429|ens|ENST00000620406","CABIN1","calcineurin binding protein 1","ref|Homo sapiens calcineurin binding protein 1 (CABIN1), transcript variant 2, mRNA [NM_012295]","chr22",24551806,24574595,"GO:0004864(protein phosphatase inhibitor activity);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006336(DNA replication-independent nucleosome assembly);GO:0007166(cell surface receptor signaling pathway);GO:0016235(aggresome);GO:0016568(chromatin modification);GO:0043086(negative regulation of catalytic activity)",null,"mRNA","agilent G3 V3"]
["A_24_P90881",7.56,7.28,7.57,7.41,6.53,6.67,{"v":1.08733624454148,"d":"1.09"},{"v":0.120798143971137,"d":"0.12"},"up",{"v":0.106559,"d":"0.11"},1,"no","GTCACAGAGAAAAGAAGAGACCCACCCACTCGGGCTGCAAAAGGTGAAAAGCACCAAGAG","FALSE","NM_024922","ref|NM_024922|ref|NM_001185177|ref|NM_001185176|ens|ENST00000303334","CES3","carboxylesterase 3","ref|Homo sapiens carboxylesterase 3 (CES3), transcript variant 1, mRNA [NM_024922]","chr16",67001376,67009051,"GO:0005615(extracellular space);GO:0005788(endoplasmic reticulum lumen);GO:0008152(metabolic process);GO:0052689(carboxylic ester hydrolase activity);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P337033",7.83,8.15,7.85,7.79,7.71,7.53,{"v":1.03473729917499,"d":"1.03"},{"v":0.0492645403974252,"d":"0.05"},"up",{"v":0.107435,"d":"0.11"},1,"no","CCTGCCCCTTAGCTACTGAGGCATAGGGAGAGGAAGTTAATTTCAGAGCCATACAAAAAT","FALSE","NM_012384","ref|NM_012384|ens|ENST00000266068|ens|ENST00000370077|ens|ENST00000370069","GMEB2","glucocorticoid modulatory element binding protein 2","ref|Homo sapiens glucocorticoid modulatory element binding protein 2 (GMEB2), mRNA [NM_012384]","chr20",62218956,62258394,"GO:0003677(DNA binding);GO:0003713(transcription coactivator activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-dependent);GO:0006366(transcription from RNA polymerase II promoter);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3364801",6.63,5.76,6.31,5.79,5.59,4.67,{"v":1.16510903426791,"d":"1.17"},{"v":0.220464972765334,"d":"0.22"},"up",{"v":0.108181,"d":"0.11"},1,"no","AGGGGGATGCGAAACTCAAAGGAGTTAGGATGTCAACCCTGCAAACCGCAGAAACTAAAC","FALSE","XM_379325","gb|XM_379325",null,null,"gb|PREDICTED: Homo sapiens uncharacterized LOC401180 (LOC401180), mRNA [XM_379325]","chr5",34656516,34657355,null,null,"mRNA","agilent G3 V3"]
["A_23_P204087",4.46,2.04,4.38,{"v":5.6,"d":"5.60"},5.24,5.03,{"v":0.685570258349086,"d":"0.69"},{"v":-0.544623571584843,"d":"-0.54"},"down",{"v":0.109544,"d":"0.11"},1,"no","TCTTCAAAGCAAAGCTCTTTACTTTCCCCTTGGTTCTCATAACTCTGTGATCTTGCTCTC","FALSE","NM_016817","ref|NM_016817|ens|ENST00000620097|ens|ENST00000392583|ens|ENST00000342315","OAS2","2'-5'-oligoadenylate synthetase 2, 69/71kDa","ref|Homo sapiens 2'-5'-oligoadenylate synthetase 2, 69/71kDa (OAS2), transcript variant 1, mRNA [NM_016817]","chr12",113416208,113449523,"GO:0001730(2'-5'-oligoadenylate synthetase activity);GO:0003725(double-stranded RNA binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005783(endoplasmic reticulum);GO:0005829(cytosol);GO:0006139(nucleobase-containing compound metabolic process);GO:0006164(purine nucleotide biosynthetic process);GO:0006401(RNA catabolic process);GO:0006486(protein glycosylation);GO:0008270(zinc ion binding);GO:0009615(response to virus);GO:0016020(membrane);GO:0018377(protein myristoylation);GO:0019221(cytokine-mediated signaling pathway);GO:0043231(intracellular membrane-bounded organelle);GO:0046872(metal ion binding);GO:0048471(perinuclear region of cytoplasm);GO:0051607(defense response to virus);GO:0060333(interferon-gamma-mediated signaling pathway);GO:0060337(type I interferon-mediated signaling pathway)","05162(Measles);05164(Influenza A);05160(Hepatitis C);05168(Herpes simplex infection)","mRNA","agilent G3 V3"]
["A_33_P3215953",4.27,2.01,{"v":4.4,"d":"4.40"},{"v":5.8,"d":"5.80"},5.51,5.87,{"v":0.621653084982538,"d":"0.62"},{"v":-0.68581838945091,"d":"-0.69"},"down",{"v":0.109718,"d":"0.11"},1,"no","TCATCAGCATGATTCTGGCTGTCCTCTATAGAAGGAAAAACTCTAAACGGGATTACACTG","FALSE","NM_024569","ref|NM_024569|ref|NM_003953|ens|ENST00000474859|ens|ENST00000474729","MPZL1","myelin protein zero-like 1","ref|Homo sapiens myelin protein zero-like 1 (MPZL1), transcript variant 2, mRNA [NM_024569]","chr1",167734800,167757410,"GO:0005198(structural molecule activity);GO:0005515(protein binding);GO:0005887(integral to plasma membrane);GO:0005925(focal adhesion);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007267(cell-cell signaling);GO:0009986(cell surface)","04514(Cell adhesion molecules (CAMs))","mRNA","agilent G3 V3"]
["A_33_P3321372",3.87,2.03,1.92,3.98,3.63,4.23,{"v":0.660472972972973,"d":"0.66"},{"v":-0.598428568321597,"d":"-0.60"},"down",{"v":0.110596,"d":"0.11"},1,"no","ATGGGTTGCAGGACCAAAACCTGAAAATATCTCTGACTGTGTGTCACCAGACCACACAAT","FALSE","ENST00000276974","ens|ENST00000276974|ens|ENST00000377653|gb|AK024257|tc|THC2481668",null,null,"ens|contactin associated protein-like 3B [Source:HGNC Symbol;Acc:HGNC:32035] [ENST00000276974]","chr9",43684912,43821362,null,null,"mRNA","agilent G3 V3"]
["A_33_P3248982",4.46,3.52,4.32,4.58,5.29,6.78,{"v":0.738738738738739,"d":"0.74"},{"v":-0.436863861732023,"d":"-0.44"},"down",{"v":0.111138,"d":"0.11"},1,"no","CTCACCTTCCTGGGGTCTGTGACTGACTGGAGATAAAAATAAAAGCAATTGTGACACCTG","FALSE","NM_012306","ref|NM_012306|ens|ENST00000320634|ref|XM_005268730|gb|AB023167","FAIM2","Fas apoptotic inhibitory molecule 2","ref|Homo sapiens Fas apoptotic inhibitory molecule 2 (FAIM2), mRNA [NM_012306]","chr12",50260680,50297670,"GO:0002931(response to ischemia);GO:0006915(apoptotic process);GO:0016021(integral to membrane);GO:0021549(cerebellum development);GO:0021680(cerebellar Purkinje cell layer development);GO:0021681(cerebellar granular layer development);GO:0021702(cerebellar Purkinje cell differentiation);GO:0030054(cell junction);GO:0043066(negative regulation of apoptotic process);GO:0043523(regulation of neuron apoptotic process);GO:0043524(negative regulation of neuron apoptotic process);GO:0045121(membrane raft);GO:0045211(postsynaptic membrane);GO:2001234(negative regulation of apoptotic signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_33_P3319041",3.39,4.76,3.83,{"v":4.6,"d":"4.60"},4.84,5.32,{"v":0.811653116531165,"d":"0.81"},{"v":-0.30106481327161,"d":"-0.30"},"down",{"v":0.1119,"d":"0.11"},1,"no","GTATTTGGGGACGTTGGATGCATTCATTTTCTGTAATAAAGTTTCTTAATCACTCTTCCC","FALSE","NM_001301228","ref|NM_001301228|ref|NM_001301231|ref|NM_005342|ref|NM_001301229","HMGB3","high mobility group box 3","ref|Homo sapiens high mobility group box 3 (HMGB3), transcript variant 1, mRNA [NM_001301228]","chrX",150151760,150159248,"GO:0003682(chromatin binding);GO:0003690(double-stranded DNA binding);GO:0005634(nucleus);GO:0005694(chromosome);GO:0006310(DNA recombination);GO:0006338(chromatin remodeling);GO:0006355(regulation of transcription, DNA-dependent);GO:0007275(multicellular organismal development);GO:0008301(DNA binding, bending);GO:0045578(negative regulation of B cell differentiation);GO:0045638(negative regulation of myeloid cell differentiation)",null,"mRNA","agilent G3 V3"]
["A_24_P337058",4.03,{"v":3.3,"d":"3.30"},2.75,4.25,4.36,6.55,{"v":0.66490765171504,"d":"0.66"},{"v":-0.588774114671175,"d":"-0.59"},"down",{"v":0.112701,"d":"0.11"},1,"no","GTCAAGAACACGATCACGTTCTAGATCACATACTCCAAGAAGACACTATAATAATAGGCG","FALSE","NM_020307","ref|NM_020307|ens|ENST00000468977|ens|ENST00000470121|ens|ENST00000476744","CCNL1","cyclin L1","ref|Homo sapiens cyclin L1 (CCNL1), mRNA [NM_020307]","chr3",156865344,156878002,"GO:0000079(regulation of cyclin-dependent protein kinase activity);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0006396(RNA processing);GO:0016607(nuclear speck);GO:0019901(protein kinase binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3289121",6.82,3.16,{"v":6.3,"d":"6.30"},7.32,7.56,9.21,{"v":0.675799086757991,"d":"0.68"},{"v":-0.565333693972224,"d":"-0.57"},"down",{"v":0.113417,"d":"0.11"},1,"no","CTGATTTGCTCTATTTCAGCAGATCTTTTCTACCTACTTTGTGTGATCAAAAAAGAAGAG","FALSE","NM_032411","ref|NM_032411|ens|ENST00000479337|ens|ENST00000238044|ref|XM_006712799","C2orf40","chromosome 2 open reading frame 40","ref|Homo sapiens chromosome 2 open reading frame 40 (C2orf40), mRNA [NM_032411]","chr2",106690272,106694611,"GO:0005615(extracellular space);GO:0008054(cyclin catabolic process);GO:0030133(transport vesicle);GO:0070314(G1 to G0 transition);GO:0090398(cellular senescence)",null,"mRNA","agilent G3 V3"]
["A_23_P357284",1.93,1.97,3.39,3.26,{"v":3.3,"d":"3.30"},3.87,{"v":0.698945349952061,"d":"0.70"},{"v":-0.516748438192828,"d":"-0.52"},"down",{"v":0.113919,"d":"0.11"},1,"no","GAGAATGTCAGAACTCAAGTGAAGGGCAATCAGGGCAGACTGCCTGGAGGAGTGATGCCA","FALSE","NM_005282","ref|NM_005282|ens|ENST00000323040|gb|BC038450|gb|BM999208","GPR4","G protein-coupled receptor 4","ref|Homo sapiens G protein-coupled receptor 4 (GPR4), mRNA [NM_005282]","chr19",46093024,46105466,"GO:0004930(G-protein coupled receptor activity);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0007186(G-protein coupled receptor signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_23_P502553",8.78,8.85,8.75,8.78,8.54,8.57,{"v":1.01892622634222,"d":"1.02"},{"v":0.0270495993514334,"d":"0.03"},"up",{"v":0.114296,"d":"0.11"},1,"no","TGACCCTCTCCTGTAAAGTATTTATCCCACCCATTAATATAATTTCTGTATAATAAACTT","FALSE","NM_171982","ref|NM_171982|ens|ENST00000305364|ref|XM_005273451|gb|BC069226","TRIM35","tripartite motif containing 35","ref|Homo sapiens tripartite motif containing 35 (TRIM35), mRNA [NM_171982]","chr8",27143326,27151652,"GO:0003674(molecular_function);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006915(apoptotic process);GO:0008270(zinc ion binding);GO:0008285(negative regulation of cell proliferation);GO:0043065(positive regulation of apoptotic process);GO:0045087(innate immune response);GO:0045930(negative regulation of mitotic cell cycle)",null,"mRNA","agilent G3 V3"]
["A_23_P154801",4.67,1.93,3.76,5.62,5.58,5.66,{"v":0.614472123368921,"d":"0.61"},{"v":-0.702580533255528,"d":"-0.70"},"down",{"v":0.115002,"d":"0.12"},1,"no","GCATCAGCTTCTCATACTGGAAGGAGACAGTGTCCATCCTGTTGAACCCGGACCGGCAGT","FALSE","NM_015638","ref|NM_015638|ref|NM_199368|ens|ENST00000252015|ens|ENST00000451813","TRPC4AP","transient receptor potential cation channel, subfamily C, member 4 associated protein","ref|Homo sapiens transient receptor potential cation channel, subfamily C, member 4 associated protein (TRPC4AP), transcript variant 1, mRNA [NM_015638]","chr20",33590548,33623094,"GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0016567(protein ubiquitination);GO:0019902(phosphatase binding);GO:0031464(Cul4A-RING ubiquitin ligase complex);GO:0034220(ion transmembrane transport);GO:0055085(transmembrane transport);GO:0070588(calcium ion transmembrane transport)",null,"mRNA","agilent G3 V3"]
["A_23_P75622",8.24,{"v":9.5,"d":"9.50"},8.39,9.86,9.84,9.66,{"v":0.889986376021798,"d":"0.89"},{"v":-0.168144843523192,"d":"-0.17"},"down",{"v":0.115915,"d":"0.12"},1,"no","CGGAGAGATTATAGGCAAGCGGGGCATCATTGGCTATGATGTTTGAAGACCAATCTTTAA","FALSE","NM_006476","ref|NM_006476|ref|NR_033759|ens|ENST00000529770|ens|ENST00000529460","ATP5L","ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G","ref|Homo sapiens ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G (ATP5L), transcript variant 1, mRNA [NM_006476]","chr11",118276840,118280325,"GO:0000276(mitochondrial proton-transporting ATP synthase complex, coupling factor F(o));GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0005753(mitochondrial proton-transporting ATP synthase complex);GO:0015078(hydrogen ion transmembrane transporter activity);GO:0016887(ATPase activity);GO:0022857(transmembrane transporter activity);GO:0022904(respiratory electron transport chain);GO:0042776(mitochondrial ATP synthesis coupled proton transport);GO:0044237(cellular metabolic process);GO:0044281(small molecule metabolic process);GO:0070062(extracellular vesicular exosome)","00190(Oxidative phosphorylation)","mRNA","agilent G3 V3"]
["A_23_P167194",4.44,2.38,2.03,4.83,4.55,4.13,{"v":0.655070318282754,"d":"0.66"},{"v":-0.610278314355325,"d":"-0.61"},"down",{"v":0.116862,"d":"0.12"},1,"no","AAGGAAGGCCATCAGGAGGATTCGTGATTAGTGGAGTACTATCTCCAGACACAATATCGT","FALSE","NM_001812","ref|NM_001812|ens|ENST00000506882|ens|ENST00000515140|ens|ENST00000513216","CENPC","centromere protein C","ref|Homo sapiens centromere protein C (CENPC), mRNA [NM_001812]","chr4",68337520,68411324,"GO:0000278(mitotic cell cycle);GO:0000776(kinetochore);GO:0000777(condensed chromosome kinetochore);GO:0000780(condensed nuclear chromosome, centromeric region);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005721(centromeric heterochromatin);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006334(nucleosome assembly);GO:0007059(chromosome segregation);GO:0007067(mitosis);GO:0019237(centromeric DNA binding);GO:0034080(CenH3-containing nucleosome assembly at centromere);GO:0051301(cell division);GO:0051382(kinetochore assembly)",null,"mRNA","agilent G3 V3"]
["A_23_P68087",3.44,2.18,4.36,4.65,4.87,4.34,{"v":0.72005772005772,"d":"0.72"},{"v":-0.473815536799953,"d":"-0.47"},"down",{"v":0.117602,"d":"0.12"},1,"no","GCAGAGAAGAAGGAATGGGTTGAGAAACTGACTGAAGTTTCTATCAGCTCTGATGCCTTC","FALSE","NM_004044","ref|NM_004044|ens|ENST00000479093|ens|ENST00000478734|ens|ENST00000236959","ATIC","5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase","ref|Homo sapiens 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase (ATIC), mRNA [NM_004044]","chr2",216176800,216214486,"GO:0003360(brainstem development);GO:0003937(IMP cyclohydrolase activity);GO:0004643(phosphoribosylaminoimidazolecarboxamide formyltransferase activity);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0006139(nucleobase-containing compound metabolic process);GO:0006144(purine base metabolic process);GO:0006189('de novo' IMP biosynthetic process);GO:0009116(nucleoside metabolic process);GO:0009168(purine ribonucleoside monophosphate biosynthetic process);GO:0010035(response to inorganic substance);GO:0016020(membrane);GO:0021549(cerebellum development);GO:0021987(cerebral cortex development);GO:0031100(organ regeneration);GO:0042803(protein homodimerization activity);GO:0044281(small molecule metabolic process);GO:0046452(dihydrofolate metabolic process);GO:0046654(tetrahydrofolate biosynthetic process);GO:0055086(nucleobase-containing small molecule metabolic process);GO:0070062(extracellular vesicular exosome)","00230(Purine metabolism);00670(One carbon pool by folate)","mRNA","agilent G3 V3"]
["A_33_P3241482",5.41,{"v":2,"d":"2.00"},4.64,6.68,6.84,6.73,{"v":0.595061728395062,"d":"0.60"},{"v":-0.748888761542025,"d":"-0.75"},"down",{"v":0.118181,"d":"0.12"},1,"no","ATGCTCTGTCTCTTGGTCACTGAAGCATCCAAATAAAGAATTTCCCTCATGGGCCAGACT","FALSE","NM_012279","ref|NM_012279|ens|ENST00000358149|ref|XR_427802|ref|XR_245272","ZNF346","zinc finger protein 346","ref|Homo sapiens zinc finger protein 346 (ZNF346), mRNA [NM_012279]","chr5",176449728,176492975,"GO:0003725(double-stranded RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0019899(enzyme binding);GO:0043065(positive regulation of apoptotic process)",null,"mRNA","agilent G3 V3"]
["A_23_P329112",5.08,5.71,4.95,{"v":5,"d":"5.00"},4.59,4.44,{"v":1.12188168210976,"d":"1.12"},{"v":0.165920531887587,"d":"0.17"},"up",{"v":0.119155,"d":"0.12"},1,"no","TCAGTGGGGCTCTCTGAGTCCTGGCCCAAAGAAGCAAGGAACCAAATTTAAGACTCTCGC","FALSE","NM_000215","ref|NM_000215|ens|ENST00000527670|ens|ENST00000458235|ref|XM_006722745","JAK3","Janus kinase 3","ref|Homo sapiens Janus kinase 3 (JAK3), mRNA [NM_000215]","chr19",17935596,17958841,"GO:0002731(negative regulation of dendritic cell cytokine production);GO:0004713(protein tyrosine kinase activity);GO:0004715(non-membrane spanning protein tyrosine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0006468(protein phosphorylation);GO:0006954(inflammatory response);GO:0007167(enzyme linked receptor protein signaling pathway);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007260(tyrosine phosphorylation of STAT protein);GO:0007262(STAT protein import into nucleus);GO:0012505(endomembrane system);GO:0016477(cell migration);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0019903(protein phosphatase binding);GO:0030183(B cell differentiation);GO:0030218(erythrocyte differentiation);GO:0031234(extrinsic to internal side of plasma membrane);GO:0032693(negative regulation of interleukin-10 production);GO:0032695(negative regulation of interleukin-12 production);GO:0035556(intracellular signal transduction);GO:0035771(interleukin-4-mediated signaling pathway);GO:0038083(peptidyl-tyrosine autophosphorylation);GO:0042102(positive regulation of T cell proliferation);GO:0042981(regulation of apoptotic process);GO:0043029(T cell homeostasis);GO:0045087(innate immune response);GO:0045221(negative regulation of FasL biosynthetic process);GO:0045626(negative regulation of T-helper 1 cell differentiation);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0050868(negative regulation of T cell activation);GO:0051427(hormone receptor binding);GO:0060397(JAK-STAT cascade involved in growth hormone signaling pathway);GO:0070232(regulation of T cell apoptotic process);GO:0070244(negative regulation of thymocyte apoptotic process);GO:0070669(response to interleukin-2);GO:0070670(response to interleukin-4);GO:0070672(response to interleukin-15);GO:0071104(response to interleukin-9);GO:2000670(positive regulation of dendritic cell apoptotic process);GO:2001241(positive regulation of extrinsic apoptotic signaling pathway in absence of ligand)","04630(Jak-STAT signaling pathway);04151(PI3K-Akt signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04062(Chemokine signaling pathway);05203(Viral carcinogenesis);05340(Primary immunodeficiency);05166(HTLV-I infection);05162(Measles);05169(Epstein-Barr virus infection)","mRNA","agilent G3 V3"]
["A_33_P3219469",5.27,5.07,2.36,6.86,6.65,6.59,{"v":0.6318407960199,"d":"0.63"},{"v":-0.662367004406763,"d":"-0.66"},"down",{"v":0.120122,"d":"0.12"},1,"no","GGTCCATGAGATATTGTTTGTATTATGAAGTTGGAGTGCTGTCTACTGAAATTATACTCT","FALSE","NM_004719","ref|NM_004719|ens|ENST00000369367|ens|ENST00000550629|ref|XM_006719692","SCAF11","SR-related CTD-associated factor 11","ref|Homo sapiens SR-related CTD-associated factor 11 (SCAF11), mRNA [NM_004719]","chr12",46312912,46318571,"GO:0000245(spliceosomal complex assembly);GO:0000375(RNA splicing, via transesterification reactions);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006397(mRNA processing);GO:0008270(zinc ion binding);GO:0008380(RNA splicing)",null,"mRNA","agilent G3 V3"]
["A_24_P204214",4.56,4.53,3.04,5.48,5.26,5.35,{"v":0.753884400248602,"d":"0.75"},{"v":-0.407584775602936,"d":"-0.41"},"down",{"v":0.120785,"d":"0.12"},1,"no","CCAATTTCGGGGCAACCATGTGGAGATGATCAAAATGCTTCACCTTCAAAACTCTCAAAG","FALSE","NM_006311","ref|NM_006311|ref|NM_001190438|ref|NM_001190440|ens|ENST00000579974","NCOR1","nuclear receptor corepressor 1","ref|Homo sapiens nuclear receptor corepressor 1 (NCOR1), transcript variant 1, mRNA [NM_006311]","chr17",16068220,16097925,"GO:0000118(histone deacetylase complex);GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000790(nuclear chromatin);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0002361(CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation);GO:0003682(chromatin binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0003714(transcription corepressor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0005876(spindle microtubule);GO:0006325(chromatin organization);GO:0006351(transcription, DNA-dependent);GO:0006366(transcription from RNA polymerase II promoter);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007219(Notch signaling pathway);GO:0007623(circadian rhythm);GO:0010467(gene expression);GO:0014067(negative regulation of phosphatidylinositol 3-kinase cascade);GO:0016020(membrane);GO:0016568(chromatin modification);GO:0016580(Sin3 complex);GO:0017053(transcriptional repressor complex);GO:0021794(thalamus development);GO:0031065(positive regulation of histone deacetylation);GO:0032922(circadian regulation of gene expression);GO:0035033(histone deacetylase regulator activity);GO:0035257(nuclear hormone receptor binding);GO:0040014(regulation of multicellular organism growth);GO:0042632(cholesterol homeostasis);GO:0042826(histone deacetylase binding);GO:0043565(sequence-specific DNA binding);GO:0044212(transcription regulatory region DNA binding);GO:0044255(cellular lipid metabolic process);GO:0044281(small molecule metabolic process);GO:0046329(negative regulation of JNK cascade);GO:0046965(retinoid X receptor binding);GO:0046966(thyroid hormone receptor binding);GO:0051225(spindle assembly);GO:0060318(definitive erythrocyte differentiation);GO:0072362(regulation of glycolysis by negative regulation of transcription from RNA polymerase II promoter);GO:0072368(regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter);GO:2000191(regulation of fatty acid transport)","04919(Thyroid hormone signaling pathway);05202(Transcriptional misregulation in cancers)","mRNA","agilent G3 V3"]
["A_23_P420831",4.31,4.61,3.84,3.28,3.89,3.84,{"v":1.15894641235241,"d":"1.16"},{"v":0.2128138602005,"d":"0.21"},"up",{"v":0.121355,"d":"0.12"},1,"no","TATGCTGCACTGCCTCATTCAGAGATAGATGCCTGCATGGGTCCTGGCGATTATTTTAAT","FALSE","NM_052828","ref|NM_052828|ref|NM_006778|ens|ENST00000448645|ens|ENST00000456988","TRIM10","tripartite motif containing 10","ref|Homo sapiens tripartite motif containing 10 (TRIM10), transcript variant 2, mRNA [NM_052828]","chr6",30119722,30128711,"GO:0003674(molecular_function);GO:0005737(cytoplasm);GO:0008150(biological_process);GO:0008270(zinc ion binding);GO:0030218(erythrocyte differentiation);GO:0045087(innate immune response);GO:0046597(negative regulation of viral entry into host cell)",null,"mRNA","agilent G3 V3"]
["A_23_P18579",{"v":5.1,"d":"5.10"},3.44,4.64,5.55,5.26,5.32,{"v":0.8171109733416,"d":"0.82"},{"v":-0.291396068147591,"d":"-0.29"},"down",{"v":0.122075,"d":"0.12"},1,"no","AGACTGTTAAAACAAAAAGTTCTGTTCCTGCCTCAGATGACGCCTATCCAGAAATAGAAA","FALSE","NM_006607","ref|NM_006607|ref|NM_001282382|ref|NM_001282383|ref|NM_004219","PTTG2","pituitary tumor-transforming 2","ref|Homo sapiens pituitary tumor-transforming 2 (PTTG2), mRNA [NM_006607]","chr4",37962056,37962665,"GO:0003674(molecular_function);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0017124(SH3 domain binding);GO:0051276(chromosome organization)","04110(Cell cycle);04114(Oocyte meiosis);05166(HTLV-I infection)","mRNA","agilent G3 V3"]
["A_23_P141315",4.37,2.03,4.09,5.47,5.41,5.33,{"v":0.647131400370142,"d":"0.65"},{"v":-0.627869412940274,"d":"-0.63"},"down",{"v":0.123061,"d":"0.12"},1,"no","AGCCAGAAATCGAAGGTCACAGGAAGTTGTCACTGAACTTGGCCCGTGTCTGCTACTCTG","FALSE","NM_001014445","ref|NM_001014445|ref|NM_018096|ens|ENST00000442241|ref|XM_005257992","NLE1","notchless homolog 1 (Drosophila)","ref|Homo sapiens notchless homolog 1 (Drosophila) (NLE1), transcript variant 2, mRNA [NM_001014445]","chr17",33459264,33464186,"GO:0001826(inner cell mass cell differentiation);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0007219(Notch signaling pathway);GO:0042273(ribosomal large subunit biogenesis);GO:0045930(negative regulation of mitotic cell cycle);GO:0090263(positive regulation of canonical Wnt receptor signaling pathway);GO:2001268(negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_33_P3272080",9.89,9.76,10.01,9.82,9.63,9.67,{"v":1.01854395604396,"d":"1.02"},{"v":0.0265082422559338,"d":"0.03"},"up",{"v":0.12352,"d":"0.12"},1,"no","TGTTTTTATCAACGCGGTCAGCACTGCCCCTCTTCAACAACAGCGTCCCCAATGGAATCC","FALSE","ENST00000623824","ens|ENST00000623824|gb|CV575364","QRFP","pyroglutamylated RFamide peptide","ens|pyroglutamylated RFamide peptide [Source:HGNC Symbol;Acc:HGNC:29982] [ENST00000623824]","chr9",133769136,133772199,"GO:0005184(neuropeptide hormone activity);GO:0005575(cellular_component);GO:0005576(extracellular region);GO:0007218(neuropeptide signaling pathway);GO:0007625(grooming behavior);GO:0007626(locomotory behavior);GO:0031854(orexigenic neuropeptide QRFP receptor binding);GO:0045777(positive regulation of blood pressure);GO:0060259(regulation of feeding behavior)",null,"mRNA","agilent G3 V3"]
["A_23_P80353",{"v":5.1,"d":"5.10"},4.15,4.49,{"v":5.2,"d":"5.20"},5.34,4.95,{"v":0.887023886378309,"d":"0.89"},{"v":-0.172955139971468,"d":"-0.17"},"down",{"v":0.12412,"d":"0.12"},1,"no","CCCGACAAGGCTTCAAGTCCAGAGCTGCCTGTCTCCGTCGAGAACATCAAGCAGGAAACA","FALSE","NM_031488","ref|NM_031488|ens|ENST00000466589|ens|ENST00000479978|ens|ENST00000216237","L3MBTL2","l(3)mbt-like 2 (Drosophila)","ref|Homo sapiens l(3)mbt-like 2 (Drosophila) (L3MBTL2), mRNA [NM_031488]","chr22",41601328,41627275,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0008270(zinc ion binding);GO:0016568(chromatin modification);GO:0035064(methylated histone residue binding);GO:0042393(histone binding)",null,"mRNA","agilent G3 V3"]
["A_23_P83917",3.78,2.65,4.24,4.85,4.38,4.34,{"v":0.786293294030951,"d":"0.79"},{"v":-0.346860544594429,"d":"-0.35"},"down",{"v":0.125305,"d":"0.13"},1,"no","AATCTGGGGTTGAAACTTTGAGGAAATGCCAGTGACTTATTCCAGAGTGCCTCAGTTAGG","FALSE","NM_012308","ref|NM_012308|ref|NM_001256405|ref|NR_027473|ens|ENST00000526258","KDM2A","lysine (K)-specific demethylase 2A","ref|Homo sapiens lysine (K)-specific demethylase 2A (KDM2A), transcript variant 1, mRNA [NM_012308]","chr11",67007520,67023822,"GO:0000790(nuclear chromatin);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006303(double-strand break repair via nonhomologous end joining);GO:0006325(chromatin organization);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0008270(zinc ion binding);GO:0045322(unmethylated CpG binding);GO:0051864(histone demethylase activity (H3-K36 specific));GO:0055114(oxidation-reduction process);GO:0070544(histone H3-K36 demethylation)",null,"mRNA","agilent G3 V3"]
["A_23_P256526",3.38,2.09,4.46,5.01,5.14,5.01,{"v":0.655013192612137,"d":"0.66"},{"v":-0.610404130642718,"d":"-0.61"},"down",{"v":0.126319,"d":"0.13"},1,"no","GAAAGCTGTGACCTGCAGCTCATCCTCACTTGGCATTGAAGAATTCCTTCCAGAGATAAA","FALSE","NM_007136","ref|NM_007136|ens|ENST00000619534|ens|ENST00000308095|ens|ENST00000482457","ZNF80","zinc finger protein 80","ref|Homo sapiens zinc finger protein 80 (ZNF80), mRNA [NM_007136]","chr3",113953488,113956425,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P19663",3.99,4.46,4.37,3.91,3.18,4.01,{"v":1.15495495495495,"d":"1.15"},{"v":0.207836585381273,"d":"0.21"},"up",{"v":0.127283,"d":"0.13"},1,"no","TGGAACTACATTAGTACACAGCACCAGAATGTATATTAAGGTGTGGCTTTAGGAGCAGTG","FALSE","NM_001901","ref|NM_001901|ens|ENST00000367976|gb|AY550024|gb|AY395801","CTGF","connective tissue growth factor","ref|Homo sapiens connective tissue growth factor (CTGF), mRNA [NM_001901]","chr6",132269312,132272513,"GO:0001502(cartilage condensation);GO:0001503(ossification);GO:0001525(angiogenesis);GO:0001558(regulation of cell growth);GO:0001894(tissue homeostasis);GO:0001934(positive regulation of protein phosphorylation);GO:0001968(fibronectin binding);GO:0005178(integrin binding);GO:0005515(protein binding);GO:0005520(insulin-like growth factor binding);GO:0005576(extracellular region);GO:0005578(proteinaceous extracellular matrix);GO:0005615(extracellular space);GO:0005794(Golgi apparatus);GO:0005801(cis-Golgi network);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005938(cell cortex);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0007155(cell adhesion);GO:0007160(cell-matrix adhesion);GO:0007229(integrin-mediated signaling pathway);GO:0007267(cell-cell signaling);GO:0008083(growth factor activity);GO:0008201(heparin binding);GO:0008284(positive regulation of cell proliferation);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0008544(epidermis development);GO:0009611(response to wounding);GO:0009749(response to glucose stimulus);GO:0010260(organ senescence);GO:0010467(gene expression);GO:0010628(positive regulation of gene expression);GO:0010629(negative regulation of gene expression);GO:0016477(cell migration);GO:0030154(cell differentiation);GO:0030324(lung development);GO:0032330(regulation of chondrocyte differentiation);GO:0032355(response to estradiol stimulus);GO:0032967(positive regulation of collagen biosynthetic process);GO:0034059(response to anoxia);GO:0035556(intracellular signal transduction);GO:0035988(chondrocyte proliferation);GO:0043200(response to amino acid stimulus);GO:0043231(intracellular membrane-bounded organelle);GO:0043280(positive regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043434(response to peptide hormone stimulus);GO:0044255(cellular lipid metabolic process);GO:0044281(small molecule metabolic process);GO:0045597(positive regulation of cell differentiation);GO:0046330(positive regulation of JNK cascade);GO:0048471(perinuclear region of cytoplasm);GO:0050867(positive regulation of cell activation);GO:0051385(response to mineralocorticoid stimulus);GO:0051496(positive regulation of stress fiber assembly);GO:0060401(cytosolic calcium ion transport);GO:0060452(positive regulation of cardiac muscle contraction);GO:0060548(negative regulation of cell death);GO:0070278(extracellular matrix constituent secretion);GO:0070318(positive regulation of G0 to G1 transition);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0070542(response to fatty acid);GO:0071897(DNA biosynthetic process);GO:0072593(reactive oxygen species metabolic process)","04390(Hippo signaling pathway)","mRNA","agilent G3 V3"]
["A_33_P3251896",4.71,5.68,4.47,5.64,6.03,{"v":5.5,"d":"5.50"},{"v":0.865463016889924,"d":"0.87"},{"v":-0.208455923463538,"d":"-0.21"},"down",{"v":0.128255,"d":"0.13"},1,"no","GTCCAAATTCCTTACGCAGTGGTATTCATGATGGTGCCCTATCTAAGTCCAGGACTGTTT","FALSE","NM_004307","ref|NM_004307|ref|NM_001166050|ref|NM_173075|ref|NM_001166051","APBB2","amyloid beta (A4) precursor protein-binding, family B, member 2","ref|Homo sapiens amyloid beta (A4) precursor protein-binding, family B, member 2 (APBB2), transcript variant 1, mRNA [NM_004307]","chr4",40812044,40859172,"GO:0001540(beta-amyloid binding);GO:0001764(neuron migration);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-dependent);GO:0007050(cell cycle arrest);GO:0007411(axon guidance);GO:0008134(transcription factor binding);GO:0016020(membrane);GO:0030027(lamellipodium);GO:0030198(extracellular matrix organization);GO:0030308(negative regulation of cell growth);GO:0030426(growth cone);GO:0035556(intracellular signal transduction);GO:0043065(positive regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0045202(synapse)",null,"mRNA","agilent G3 V3"]
["A_23_P66011",5.24,5.55,{"v":4.5,"d":"4.50"},5.54,5.76,5.85,{"v":0.891545189504373,"d":"0.89"},{"v":-0.16562016969937,"d":"-0.17"},"down",{"v":0.128903,"d":"0.13"},1,"no","TTTTTTCTAGACAGACACTTTGGTGCAGAAGCTTCTTTTCAATCCATCCTCCACAAGAAG","FALSE","NM_019065","ref|NM_019065|ens|ENST00000305202|ref|XM_006721200|gb|BC131615","NECAB2","N-terminal EF-hand calcium binding protein 2","ref|Homo sapiens N-terminal EF-hand calcium binding protein 2 (NECAB2), mRNA [NM_019065]","chr16",84031856,84036381,"GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005737(cytoplasm)",null,"mRNA","agilent G3 V3"]
["A_33_P3210303",{"v":5.4,"d":"5.40"},5.57,4.65,{"v":5,"d":"5.00"},{"v":4.1,"d":"4.10"},4.26,{"v":1.16916167664671,"d":"1.17"},{"v":0.225474445667927,"d":"0.23"},"up",{"v":0.1298,"d":"0.13"},1,"no","ACATAGAACCAGCAGAACAGCACGATGGCCGTGAGCCACACCAGGATGAGCTTGACCATG","FALSE","CU688821","gb|CU688821",null,null,"gb|Synthetic construct Homo sapiens gateway clone IMAGE:100021983 3' read WFS1 mRNA. [CU688821]",{"$nulls":5},"mRNA","agilent G3 V3"]
["A_33_P3323999",4.17,5.66,2.22,6.29,{"v":6.6,"d":"6.60"},6.66,{"v":0.616368286445013,"d":"0.62"},{"v":-0.698135461077391,"d":"-0.70"},"down",{"v":0.130158,"d":"0.13"},1,"no","AGCCAGCGGCTGCAGGCGAGTTTCTAGAACCAGAGTCTATATAAAGAGAGAACTAACGCC","FALSE","NM_002972","ref|NM_002972|ens|ENST00000380817|ref|XM_005261931|ref|XM_005261932","SBF1","SET binding factor 1","ref|Homo sapiens SET binding factor 1 (SBF1), mRNA [NM_002972]","chr22",50885572,50913454,"GO:0005634(nucleus);GO:0006470(protein dephosphorylation);GO:0007283(spermatogenesis);GO:0008138(protein tyrosine/serine/threonine phosphatase activity);GO:0016021(integral to membrane);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0032851(positive regulation of Rab GTPase activity)",null,"mRNA","agilent G3 V3"]
["A_21_P0011312",6.47,7.75,6.13,6.01,5.72,5.78,{"v":1.16219303255283,"d":"1.16"},{"v":0.216849710720051,"d":"0.22"},"up",{"v":0.131845,"d":"0.13"},1,"no","GGCTGTAGGGGCTGACGGTTCTCATGAATATTACTGCTCTTCTTTCCAACAGTTAAAAGA","FALSE","ENST00000624918","ens|ENST00000624918|linc|TCONS_l2_00008541",null,null,"ens|golgin A8 family, member R [Source:HGNC Symbol;Acc:HGNC:44407] [ENST00000624918]","chr15",30701762,30704823,null,null,"mRNA","agilent G3 V3"]
["A_33_P3226212",4.51,6.42,{"v":3.4,"d":"3.40"},6.95,{"v":7.1,"d":"7.10"},6.83,{"v":0.686302681992337,"d":"0.69"},{"v":-0.543083102307739,"d":"-0.54"},"down",{"v":0.132525,"d":"0.13"},1,"no","TTAGTGATTTCCGTTTGTGGCCTTGGTGTATGCTATGCTCAGAGGAAAGGCTACTTTTCA","FALSE","NM_001270408","ref|NM_001270408|ens|ENST00000460679|ens|ENST00000492962|ref|XM_006724037","JAM2","junctional adhesion molecule 2","ref|Homo sapiens junctional adhesion molecule 2 (JAM2), transcript variant 3, mRNA [NM_001270408]","chr21",27011910,27087648,"GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0005923(tight junction);GO:0007162(negative regulation of cell adhesion);GO:0007596(blood coagulation);GO:0016337(cell-cell adhesion);GO:0030198(extracellular matrix organization);GO:0046982(protein heterodimerization activity);GO:0050900(leukocyte migration)","04514(Cell adhesion molecules (CAMs));04530(Tight junction);04670(Leukocyte transendothelial migration);05120(Epithelial cell signaling in Helicobacter pylori infection)","mRNA","agilent G3 V3"]
["A_33_P3269578",3.76,1.95,1.99,3.91,3.37,3.94,{"v":0.686274509803922,"d":"0.69"},{"v":-0.543142325026529,"d":"-0.54"},"down",{"v":0.133623,"d":"0.13"},1,"no","CCTCAACATTCGCCAAGCATACAACCTAGAAAATGTTTAATCACATCATTACGTTTCTTT","FALSE","NM_018313","ref|NM_018313|ens|ENST00000296302|ens|ENST00000409057|ens|ENST00000337303","PBRM1","polybromo 1","ref|Homo sapiens polybromo 1 (PBRM1), mRNA [NM_018313]","chr3",52582028,52713730,"GO:0000228(nuclear chromosome);GO:0000776(kinetochore);GO:0001890(placenta development);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0006338(chromatin remodeling);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0007067(mitosis);GO:0007507(heart development);GO:0008285(negative regulation of cell proliferation)",null,"mRNA","agilent G3 V3"]
["A_21_P0003027",6.02,4.98,6.12,5.51,4.25,4.22,{"v":1.22460658082976,"d":"1.22"},{"v":0.292318341025711,"d":"0.29"},"up",{"v":0.134957,"d":"0.13"},1,"no","AAGACTTGCAAAAGACCCCTGAAAATAATGCCTGGAAGCTGCGAAACATCAGACTGACAC","FALSE","XR_171034","ref|XR_171034|ref|XR_171402|ref|XR_172464|linc|lnc-CCDC37-2:4","LOC644662","uncharacterized LOC644662","ref|PREDICTED: Homo sapiens uncharacterized LOC644662 (LOC644662), ncRNA [XR_171034]","chr3",126006608,126007514,null,null,"mRNA","agilent G3 V3"]
["A_33_P3350227",{"v":7,"d":"7.00"},6.28,6.54,{"v":7.1,"d":"7.10"},7.13,6.86,{"v":0.939781887150308,"d":"0.94"},{"v":-0.0896021326072033,"d":"-0.09"},"down",{"v":0.135861,"d":"0.14"},1,"no","GGGCAGTGCGTTCTGGGGCTGTGCTGCTCCTGTTACCTTCTGAATCCATATGTAGAGATT","FALSE","NM_181491","ref|NM_181491|ens|ENST00000471524|ens|ENST00000614493|ens|ENST00000610888","MED22","mediator complex subunit 22","ref|Homo sapiens mediator complex subunit 22 (MED22), transcript variant c, mRNA [NM_181491]","chr9",136211056,136214986,"GO:0001104(RNA polymerase II transcription cofactor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0006366(transcription from RNA polymerase II promoter);GO:0016592(mediator complex)",null,"mRNA","agilent G3 V3"]
["A_33_P3284939",1.96,4.55,{"v":1.9,"d":"1.90"},5.07,4.79,4.93,{"v":0.568627450980392,"d":"0.57"},{"v":-0.814444346843923,"d":"-0.81"},"down",{"v":0.136224,"d":"0.14"},1,"no","ATCCTGGTGGAGCTGACCTCCTGGGAAAAGAGTCAATAAACAAATAAATGCACATGGAAA","FALSE","NM_199129","ref|NM_199129|ref|NM_001162505|ref|NR_027889|ens|ENST00000371650","TMEM189","transmembrane protein 189","ref|Homo sapiens transmembrane protein 189 (TMEM189), transcript variant 1, mRNA [NM_199129]","chr20",48740580,48770271,"GO:0005737(cytoplasm);GO:0005789(endoplasmic reticulum membrane);GO:0016021(integral to membrane);GO:0016567(protein ubiquitination);GO:0019787(small conjugating protein ligase activity);GO:0031625(ubiquitin protein ligase binding)",null,"mRNA","agilent G3 V3"]
["A_21_P0011288",3.44,2.54,2.02,3.31,3.39,{"v":3.7,"d":"3.70"},{"v":0.769230769230769,"d":"0.77"},{"v":-0.37851162325373,"d":"-0.38"},"down",{"v":0.137345,"d":"0.14"},1,"no","TGAAGATGATGTTGTCTACAGACCAGGAGACTGTGTGTATATCGAGAGTTGGAGGCCAAA","FALSE","NM_012102","ref|NM_012102|ref|NM_001042681|ref|NR_033735|ens|ENST00000556034","RERE","arginine-glutamic acid dipeptide (RE) repeats","ref|Homo sapiens arginine-glutamic acid dipeptide (RE) repeats (RERE), transcript variant 1, mRNA [NM_012102]","chr1",{"v":8412463,"d":"8412463.00"},8877699,"GO:0000118(histone deacetylase complex);GO:0003682(chromatin binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006338(chromatin remodeling);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0006607(NLS-bearing substrate import into nucleus);GO:0007275(multicellular organismal development);GO:0008267(poly-glutamine tract binding);GO:0008270(zinc ion binding);GO:0043565(sequence-specific DNA binding)",null,"mRNA","agilent G3 V3"]
["A_23_P253412",4.63,1.93,2.21,4.82,4.53,4.26,{"v":0.644379132990448,"d":"0.64"},{"v":-0.634018319059262,"d":"-0.63"},"down",{"v":0.138058,"d":"0.14"},1,"no","GAAAAGTTTTGAGAGGGCACTGTCAACTTGGGTTTAAGACAGGAGGACATTGCAAGTTCA","FALSE","NM_019051","ref|NM_019051|gb|AK000500|gb|BC032008|gb|AK025643","MRPL50","mitochondrial ribosomal protein L50","ref|Homo sapiens mitochondrial ribosomal protein L50 (MRPL50), mRNA [NM_019051]","chr9",104149912,104160896,"GO:0005743(mitochondrial inner membrane);GO:0005840(ribosome);GO:0006996(organelle organization);GO:0032543(mitochondrial translation);GO:0070124(mitochondrial translational initiation);GO:0070125(mitochondrial translational elongation);GO:0070126(mitochondrial translational termination)",null,"mRNA","agilent G3 V3"]
["A_23_P317082",7.75,7.47,7.96,7.61,7.34,7.15,{"v":1.04886877828054,"d":"1.05"},{"v":0.0688341967276776,"d":"0.07"},"up",{"v":0.138338,"d":"0.14"},1,"no","AGAGTGTTAACCCTCAGTGGAATCATACATTCATGTTCAGTGGCATCCATCCCCAGGATA","FALSE","NM_138780","ref|NM_138780|ref|NM_001163335|ref|NM_001163334|ens|ENST00000297875","SYTL5","synaptotagmin-like 5","ref|Homo sapiens synaptotagmin-like 5 (SYTL5), transcript variant 1, mRNA [NM_138780]","chrX",37892788,37988072,"GO:0005515(protein binding);GO:0006886(intracellular protein transport);GO:0006887(exocytosis);GO:0016020(membrane);GO:0017137(Rab GTPase binding);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3393843",2.85,3.64,2.57,3.24,4.02,4.53,{"v":0.768447837150127,"d":"0.77"},{"v":-0.379980762933527,"d":"-0.38"},"down",{"v":0.138825,"d":"0.14"},1,"no","ATTGATTATGCCTGTGAGCAGAACATTCCCTTTGTGTTTGCTCTCAACCGCAAAGCTCTG","FALSE","NM_001282690","ref|NM_001282690|ref|NM_024077|ref|NM_001282688|ref|NM_001282689","SECISBP2","SECIS binding protein 2","ref|Homo sapiens SECIS binding protein 2 (SECISBP2), transcript variant 4, mRNA [NM_001282690]","chr9",91933768,91974078,"GO:0001514(selenocysteine incorporation);GO:0003730(mRNA 3'-UTR binding);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0030529(ribonucleoprotein complex);GO:0035368(selenocysteine insertion sequence binding);GO:0043021(ribonucleoprotein complex binding);GO:2000623(negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay)",null,"mRNA","agilent G3 V3"]
["A_23_P359540",4.62,5.69,4.95,5.78,5.93,5.83,{"v":0.870011402508552,"d":"0.87"},{"v":-0.200893785610203,"d":"-0.20"},"down",{"v":0.140378,"d":"0.14"},1,"no","CCGCGGTGTTCTTAAGGTGTTCCTGGAGAATGTGATACGGGACGCCGTAACCTACACGGA","FALSE","NM_003540","ref|NM_003540|ens|ENST00000244537|gb|BC093765|gb|BC093763","HIST1H4F","histone cluster 1, H4f","ref|Homo sapiens histone cluster 1, H4f (HIST1H4F), mRNA [NM_003540]","chr6",26240560,26240976,"GO:0000183(chromatin silencing at rDNA);GO:0000228(nuclear chromosome);GO:0000278(mitotic cell cycle);GO:0000723(telomere maintenance);GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006325(chromatin organization);GO:0006334(nucleosome assembly);GO:0006335(DNA replication-dependent nucleosome assembly);GO:0006336(DNA replication-independent nucleosome assembly);GO:0010467(gene expression);GO:0016020(membrane);GO:0032776(DNA methylation on cytosine);GO:0034080(CenH3-containing nucleosome assembly at centromere);GO:0035574(histone H4-K20 demethylation);GO:0035575(histone demethylase activity (H4-K20 specific));GO:0040029(regulation of gene expression, epigenetic);GO:0043234(protein complex);GO:0045653(negative regulation of megakaryocyte differentiation);GO:0045814(negative regulation of gene expression, epigenetic);GO:0046982(protein heterodimerization activity);GO:0070062(extracellular vesicular exosome)","05203(Viral carcinogenesis);05322(Systemic lupus erythematosus);05034(Alcoholism)","mRNA","agilent G3 V3"]
["A_33_P3423791",{"v":5,"d":"5.00"},5.64,5.26,4.82,4.51,5.14,{"v":1.09882515549413,"d":"1.10"},{"v":0.135961843639993,"d":"0.14"},"up",{"v":0.140703,"d":"0.14"},1,"no","TGGATATCACAGTTTTCAAACCCTTCATTGATCTCGATACTCAGCCTGTCCTCTTCATTC","FALSE","NM_198182","ref|NM_198182|ens|ENST00000464418|ens|ENST00000472167|ens|ENST00000405379","GRHL1","grainyhead-like 1 (Drosophila)","ref|Homo sapiens grainyhead-like 1 (Drosophila) (GRHL1), mRNA [NM_198182]","chr2",10091792,10142411,"GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0001077(RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0006351(transcription, DNA-dependent);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0007275(multicellular organismal development);GO:0043231(intracellular membrane-bounded organelle);GO:0043565(sequence-specific DNA binding);GO:0044255(cellular lipid metabolic process);GO:0044281(small molecule metabolic process);GO:0045944(positive regulation of transcription from RNA polymerase II promoter)",null,"mRNA","agilent G3 V3"]
["A_33_P3230219",5.93,{"v":6,"d":"6.00"},{"v":4.7,"d":"4.70"},6.42,6.61,6.63,{"v":0.84587995930824,"d":"0.85"},{"v":-0.241475153053312,"d":"-0.24"},"down",{"v":0.141936,"d":"0.14"},1,"no","CCAGCCCACTGCACTGAAATGAGACTTTATTCTGAAATTATTAAAAAGAACAGAGATGCT","FALSE","NM_033504","ref|NM_033504|ens|ENST00000373463|ens|ENST00000329151|ens|ENST00000482771","TMEM54","transmembrane protein 54","ref|Homo sapiens transmembrane protein 54 (TMEM54), mRNA [NM_033504]","chr1",33360906,33363357,"GO:0003674(molecular_function);GO:0005575(cellular_component);GO:0008150(biological_process);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3315856",3.53,3.66,4.65,4.22,5.64,4.94,{"v":0.8,"d":"0.80"},{"v":-0.321928094887362,"d":"-0.32"},"down",{"v":0.142479,"d":"0.14"},1,"no","GAGCACTGGTGTTCACGTGGGACCACAGGCTGCACCATAAGACCCACTCACAATAAAAAA","FALSE","NM_014681","ref|NM_014681|ens|ENST00000328771|ref|XR_243974|ref|XM_005259443","DHX34","DEAH (Asp-Glu-Ala-His) box polypeptide 34","ref|Homo sapiens DEAH (Asp-Glu-Ala-His) box polypeptide 34 (DHX34), mRNA [NM_014681]","chr19",47876056,47885536,"GO:0000956(nuclear-transcribed mRNA catabolic process);GO:0004004(ATP-dependent RNA helicase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006396(RNA processing);GO:0016020(membrane);GO:2000623(negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay)",null,"mRNA","agilent G3 V3"]
["A_23_P26771",5.24,4.48,6.04,4.74,4.32,3.96,{"v":1.21044546850998,"d":"1.21"},{"v":0.275538086290741,"d":"0.28"},"up",{"v":0.143961,"d":"0.14"},1,"no","ACCAAAGGGTCAGCAGGGAAAAGGAATGGCCGAGTGTCCATCAGGGACAGTCCTGCAAAC","FALSE","NM_006678","ref|NM_006678|ens|ENST00000330793|ens|ENST00000582319|ref|XM_005256991","CD300C","CD300c molecule","ref|Homo sapiens CD300c molecule (CD300C), mRNA [NM_006678]","chr17",72537248,72542282,"GO:0002376(immune system process);GO:0004888(transmembrane signaling receptor activity);GO:0005887(integral to plasma membrane);GO:0006968(cellular defense response);GO:0007165(signal transduction)",null,"mRNA","agilent G3 V3"]
["A_32_P2452",4.53,6.16,{"v":4.5,"d":"4.50"},5.85,6.52,{"v":6,"d":"6.00"},{"v":0.826891671203049,"d":"0.83"},{"v":-0.274229756609266,"d":"-0.27"},"down",{"v":0.144099,"d":"0.14"},1,"no","GTACATTTTTGTTACTTTGGCTGTGCCCGTTAGAATTTATCTTCCATAAAGTATTTCTCC","FALSE","NM_175861","ref|NM_175861|ref|NM_001193451|ens|ENST00000256062|ref|XM_005253498","TMTC1","transmembrane and tetratricopeptide repeat containing 1","ref|Homo sapiens transmembrane and tetratricopeptide repeat containing 1 (TMTC1), transcript variant 2, mRNA [NM_175861]","chr12",29653772,29937692,"GO:0005739(mitochondrion);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_32_P98975",5.08,4.51,5.37,4.61,4.42,4.53,{"v":1.10324483775811,"d":"1.10"},{"v":0.141752996751292,"d":"0.14"},"up",{"v":0.145396,"d":"0.15"},1,"no","GATCGGTTCCTCCAGGAGAAGTTAGCTTCAGAGTTCTTTGTGGATGGACTTGATTCTGAT","FALSE","NM_052849","ref|NM_052849|ref|NM_001289132|ref|NM_001080791|ref|NM_001080792","C15orf57","chromosome 15 open reading frame 57","ref|Homo sapiens chromosome 15 open reading frame 57 (C15orf57), transcript variant 2, mRNA [NM_052849]","chr15",40848820,40857241,null,null,"mRNA","agilent G3 V3"]
["A_33_P3420013",{"v":5.6,"d":"5.60"},5.45,6.04,5.27,5.42,5.41,{"v":1.06149068322981,"d":"1.06"},{"v":0.08609170867416,"d":"0.09"},"up",{"v":0.146596,"d":"0.15"},1,"no","TAAAGGAATTCTCCAGGAAGGTAGGCAGGCCTCCTACACCATCCCGCAGGGTATACAGGG","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_33_P3329949",{"v":4.3,"d":"4.30"},5.59,2.56,6.05,6.14,6.34,{"v":0.671883432271991,"d":"0.67"},{"v":-0.573717139071822,"d":"-0.57"},"down",{"v":0.148385,"d":"0.15"},1,"no","CCGTATCAGGGTAATGTGCTTGGTTTGCACATGTTGTTATTGCCTTAATTCTAATTTTAT","FALSE","NM_004034","ref|NM_004034|ref|NM_001156|ens|ENST00000463788|ens|ENST00000372919","ANXA7","annexin A7","ref|Homo sapiens annexin A7 (ANXA7), transcript variant 2, mRNA [NM_004034]","chr10",75135408,75138716,"GO:0005178(integrin binding);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005544(calcium-dependent phospholipid binding);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006874(cellular calcium ion homeostasis);GO:0006914(autophagy);GO:0007599(hemostasis);GO:0008283(cell proliferation);GO:0008360(regulation of cell shape);GO:0009651(response to salt stress);GO:0009992(cellular water homeostasis);GO:0010629(negative regulation of gene expression);GO:0014070(response to organic cyclic compound);GO:0016020(membrane);GO:0030855(epithelial cell differentiation);GO:0035176(social behavior);GO:0042584(chromaffin granule membrane);GO:0048306(calcium-dependent protein binding);GO:0051592(response to calcium ion);GO:0061025(membrane fusion);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P431330",4.35,4.73,2.05,5.59,5.68,5.63,{"v":0.658579881656805,"d":"0.66"},{"v":-0.602569653827587,"d":"-0.60"},"down",{"v":0.148538,"d":"0.15"},1,"no","GCTGTTACCGTACATTCTACTCATGGTGGCTTTTTAATACGTTTTTATGTCAAGGATCCC","FALSE","NM_175918","ref|NM_175918|ens|ENST00000324803|gb|BC131709|gb|AK091762","CRIPAK","cysteine-rich PAK1 inhibitor","ref|Homo sapiens cysteine-rich PAK1 inhibitor (CRIPAK), mRNA [NM_175918]","chr4",{"v":1385340,"d":"1385340.00"},1389780,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005886(plasma membrane);GO:0006469(negative regulation of protein kinase activity);GO:0033147(negative regulation of intracellular estrogen receptor signaling pathway);GO:0043627(response to estrogen stimulus);GO:0051493(regulation of cytoskeleton organization)",null,"mRNA","agilent G3 V3"]
["A_33_P3215059",3.35,2.49,3.47,3.45,4.13,3.69,{"v":0.826086956521739,"d":"0.83"},{"v":-0.275634442613428,"d":"-0.28"},"down",{"v":0.14988,"d":"0.15"},1,"no","ATATTGAACCTGGTTGATCAACTTAAAGGCAAGAAGATGAGGAAGAAGGAAGCGGAGCAG","FALSE","NM_145080","ref|NM_145080|ens|ENST00000566087|ens|ENST00000569236|ens|ENST00000361439","NSMCE1","non-SMC element 1 homolog (S. cerevisiae)","ref|Homo sapiens non-SMC element 1 homolog (S. cerevisiae) (NSMCE1), mRNA [NM_145080]","chr16",27244392,27269472,"GO:0000781(chromosome, telomeric region);GO:0004842(ubiquitin-protein ligase activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006281(DNA repair);GO:0006310(DNA recombination);GO:0008270(zinc ion binding);GO:0016567(protein ubiquitination);GO:0016874(ligase activity);GO:0030915(Smc5-Smc6 complex);GO:0035556(intracellular signal transduction);GO:0043231(intracellular membrane-bounded organelle);GO:2001022(positive regulation of response to DNA damage stimulus)",null,"mRNA","agilent G3 V3"]
["A_33_P3365432",7.61,7.14,7.64,7.38,6.94,6.66,{"v":1.06720686367969,"d":"1.07"},{"v":0.09383985027533,"d":"0.09"},"up",{"v":0.15058,"d":"0.15"},1,"no","AAGACTTCCCTGAGGAGGACGACCCCACCAACTGGCTGCGTTGCTACTACTACGAAGACA","FALSE","NM_000631","ref|NM_000631|ref|NM_013416|ens|ENST00000447071|ens|ENST00000614157","NCF4","neutrophil cytosolic factor 4, 40kDa","ref|Homo sapiens neutrophil cytosolic factor 4, 40kDa (NCF4), transcript variant 1, mRNA [NM_000631]","chr22",37268180,37273806,"GO:0002474(antigen processing and presentation of peptide antigen via MHC class I);GO:0002479(antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent);GO:0005515(protein binding);GO:0005829(cytosol);GO:0006955(immune response);GO:0010008(endosome membrane);GO:0016020(membrane);GO:0016176(superoxide-generating NADPH oxidase activator activity);GO:0032010(phagolysosome);GO:0032266(phosphatidylinositol-3-phosphate binding);GO:0042590(antigen processing and presentation of exogenous peptide antigen via MHC class I);GO:0043020(NADPH oxidase complex);GO:0043085(positive regulation of catalytic activity);GO:0046983(protein dimerization activity);GO:0048010(vascular endothelial growth factor receptor signaling pathway);GO:0051701(interaction with host);GO:0055114(oxidation-reduction process);GO:0090382(phagosome maturation)","04145(Phagosome);04670(Leukocyte transendothelial migration);04380(Osteoclast differentiation);05140(Leishmaniasis)","mRNA","agilent G3 V3"]
["A_23_P43273",4.43,4.57,2.04,{"v":5.6,"d":"5.60"},5.54,5.49,{"v":0.663860493084786,"d":"0.66"},{"v":-0.5910479965091,"d":"-0.59"},"down",{"v":0.15146,"d":"0.15"},1,"no","ACGACTACTCCATGGTGTTGACAGGAGCTGCTATTTACCACAAATATTATCACTACCTAT","FALSE","NM_000127","ref|NM_000127|ens|ENST00000437196|gb|AK313129|gb|AB528313","EXT1","exostosin glycosyltransferase 1","ref|Homo sapiens exostosin glycosyltransferase 1 (EXT1), mRNA [NM_000127]","chr8",118806728,119124092,"GO:0000139(Golgi membrane);GO:0001501(skeletal system development);GO:0001503(ossification);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0005794(Golgi apparatus);GO:0005975(carbohydrate metabolic process);GO:0006024(glycosaminoglycan biosynthetic process);GO:0006486(protein glycosylation);GO:0007165(signal transduction);GO:0007369(gastrulation);GO:0007411(axon guidance);GO:0007492(endoderm development);GO:0007498(mesoderm development);GO:0008375(acetylglucosaminyltransferase activity);GO:0009405(pathogenesis);GO:0015012(heparan sulfate proteoglycan biosynthetic process);GO:0015014(heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process);GO:0015020(glucuronosyltransferase activity);GO:0016021(integral to membrane);GO:0016757(transferase activity, transferring glycosyl groups);GO:0021772(olfactory bulb development);GO:0030176(integral to endoplasmic reticulum membrane);GO:0030203(glycosaminoglycan metabolic process);GO:0033692(cellular polysaccharide biosynthetic process);GO:0042328(heparan sulfate N-acetylglucosaminyltransferase activity);GO:0042803(protein homodimerization activity);GO:0044281(small molecule metabolic process);GO:0046872(metal ion binding);GO:0046982(protein heterodimerization activity);GO:0050508(glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity);GO:0050509(N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity);GO:0072498(embryonic skeletal joint development)","00534(Glycosaminoglycan biosynthesis - heparan sulfate / heparin)","mRNA","agilent G3 V3"]
["A_23_P209625",7.33,{"v":7.5,"d":"7.50"},6.16,8.88,8.36,{"v":7.2,"d":"7.20"},{"v":0.858837970540098,"d":"0.86"},{"v":-0.219542118526575,"d":"-0.22"},"down",{"v":0.152123,"d":"0.15"},1,"no","CTGTGTTTATATGGAAGAAAGTAAGGTGCTTGGAGTTTACCTGGCTTATTTAATATGCTT","FALSE","NM_000104","ref|NM_000104|ens|ENST00000610745|gb|FW340004|gb|U03688","CYP1B1","cytochrome P450, family 1, subfamily B, polypeptide 1","ref|Homo sapiens cytochrome P450, family 1, subfamily B, polypeptide 1 (CYP1B1), mRNA [NM_000104]","chr2",38294652,38303323,"GO:0001525(angiogenesis);GO:0002930(trabecular meshwork development);GO:0004497(monooxygenase activity);GO:0005506(iron ion binding);GO:0005739(mitochondrion);GO:0005789(endoplasmic reticulum membrane);GO:0006725(cellular aromatic compound metabolic process);GO:0006805(xenobiotic metabolic process);GO:0006809(nitric oxide biosynthetic process);GO:0007155(cell adhesion);GO:0007601(visual perception);GO:0008202(steroid metabolic process);GO:0008210(estrogen metabolic process);GO:0008285(negative regulation of cell proliferation);GO:0008631(induction of apoptosis by oxidative stress);GO:0009404(toxin metabolic process);GO:0009636(response to toxin);GO:0010575(positive regulation vascular endothelial growth factor production);GO:0016125(sterol metabolic process);GO:0016712(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen);GO:0019369(arachidonic acid metabolic process);GO:0019373(epoxygenase P450 pathway);GO:0019825(oxygen binding);GO:0020037(heme binding);GO:0030199(collagen fibril organization);GO:0030336(negative regulation of cell migration);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0033629(negative regulation of cell adhesion mediated by integrin);GO:0042572(retinol metabolic process);GO:0042574(retinal metabolic process);GO:0043065(positive regulation of apoptotic process);GO:0043542(endothelial cell migration);GO:0044281(small molecule metabolic process);GO:0045766(positive regulation of angiogenesis);GO:0046427(positive regulation of JAK-STAT cascade);GO:0046466(membrane lipid catabolic process);GO:0048514(blood vessel morphogenesis);GO:0055114(oxidation-reduction process);GO:0061304(retinal blood vessel morphogenesis);GO:0070301(cellular response to hydrogen peroxide);GO:0070330(aromatase activity);GO:0071407(cellular response to organic cyclic compound);GO:0071603(endothelial cell-cell adhesion);GO:0097267(omega-hydroxylase P450 pathway);GO:2000377(regulation of reactive oxygen species metabolic process)","00140(Steroid hormone biosynthesis);00380(Tryptophan metabolism);00980(Metabolism of xenobiotics by cytochrome P450);04913(Ovarian Steroidogenesis);05206(MicroRNAs in cancer);05204(Chemical carcinogenesis)","mRNA","agilent G3 V3"]
["A_24_P331373",4.23,{"v":2.4,"d":"2.40"},3.98,5.15,4.47,{"v":4.3,"d":"4.30"},{"v":0.762212643678161,"d":"0.76"},{"v":-0.391734554933964,"d":"-0.39"},"down",{"v":0.154278,"d":"0.15"},1,"no","CCAGCATCAGTAACTTTGAGGAGGCCAGAACCAGCTATGGCACAGATGAGGACATCCTCT","FALSE","NM_031444","ref|NM_031444|ref|NM_001284254|ref|NM_001284251|ref|NM_001284252","GUCD1","guanylyl cyclase domain containing 1","ref|Homo sapiens guanylyl cyclase domain containing 1 (GUCD1), transcript variant 4, mRNA [NM_031444]","chr22",24938798,24940051,null,null,"mRNA","agilent G3 V3"]
["A_23_P138849",2.24,{"v":4.4,"d":"4.40"},4.56,5.22,5.63,5.42,{"v":0.688383527965581,"d":"0.69"},{"v":-0.538715518727561,"d":"-0.54"},"down",{"v":0.15536,"d":"0.16"},1,"no","CAGCATCAAGAAGGAGGATGTCATCTCCACTCTGCAGTACCTCAATCTCATCAACTACTA","FALSE","NM_006388","ref|NM_006388|ref|NM_182710|ref|NM_001206833|ref|NM_182709","KAT5","K(lysine) acetyltransferase 5","ref|Homo sapiens K(lysine) acetyltransferase 5 (KAT5), transcript variant 2, mRNA [NM_006388]","chr11",65486176,65487074,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000812(Swr1 complex);GO:0003713(transcription coactivator activity);GO:0004402(histone acetyltransferase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005730(nucleolus);GO:0005829(cytosol);GO:0006302(double-strand break repair);GO:0006325(chromatin organization);GO:0006351(transcription, DNA-dependent);GO:0006978(DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator);GO:0010212(response to ionizing radiation);GO:0016032(viral reproduction);GO:0016573(histone acetylation);GO:0030521(androgen receptor signaling pathway);GO:0032403(protein complex binding);GO:0032703(negative regulation of interleukin-2 production);GO:0032777(Piccolo NuA4 histone acetyltransferase complex);GO:0035267(NuA4 histone acetyltransferase complex);GO:0040008(regulation of growth);GO:0043161(proteasomal ubiquitin-dependent protein catabolic process);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046872(metal ion binding);GO:0048471(perinuclear region of cytoplasm);GO:0050681(androgen receptor binding);GO:0070491(repressing transcription factor binding);GO:0071392(cellular response to estradiol stimulus)","05166(HTLV-I infection)","mRNA","agilent G3 V3"]
["A_33_P3393370",{"v":9.3,"d":"9.30"},8.91,9.35,9.61,9.32,9.48,{"v":0.970080957409363,"d":"0.97"},{"v":-0.0438229434852498,"d":"-0.04"},"down",{"v":0.156005,"d":"0.16"},1,"no","CGGGACCCAAGACTCTCCACGCGGCTCACCCACCAGGCCCAGGAGGCGACCCGAACCTGA","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_23_P45864",6.64,6.36,6.62,6.29,4.67,3.85,{"v":1.32478055367995,"d":"1.32"},{"v":0.405753400930391,"d":"0.41"},"up",{"v":0.156698,"d":"0.16"},1,"no","GGGAACGTGGAGGATGAGTTCTGGCTGGGGCTGGACAATATACACAGGATCACATCCCAG","FALSE","NM_003285","ref|NM_003285|ens|ENST00000263525|gb|BC129830|gb|X98085","TNR","tenascin R","ref|Homo sapiens tenascin R (TNR), mRNA [NM_003285]","chr1",175284336,175712906,"GO:0005576(extracellular region);GO:0005578(proteinaceous extracellular matrix);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0007155(cell adhesion);GO:0007158(neuron cell-cell adhesion);GO:0007411(axon guidance);GO:0008306(associative learning);GO:0009986(cell surface);GO:0022029(telencephalon cell migration);GO:0022408(negative regulation of cell-cell adhesion);GO:0030198(extracellular matrix organization);GO:0035641(locomotory exploration behavior);GO:0045121(membrane raft);GO:0048692(negative regulation of axon extension involved in regeneration);GO:0050805(negative regulation of synaptic transmission);GO:0050808(synapse organization);GO:0050885(neuromuscular process controlling balance);GO:0051968(positive regulation of synaptic transmission, glutamatergic);GO:0051971(positive regulation of transmission of nerve impulse);GO:0060291(long-term synaptic potentiation);GO:0072534(perineuronal net)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);05206(MicroRNAs in cancer)","mRNA","agilent G3 V3"]
["A_24_P71439",4.52,5.36,3.81,5.52,5.66,{"v":5.5,"d":"5.50"},{"v":0.820743405275779,"d":"0.82"},{"v":-0.284996842186764,"d":"-0.28"},"down",{"v":0.157596,"d":"0.16"},1,"no","GATTCGACCTCACATTACTACTTTGCGCAAATACACATACGGGAAGCATATACTGGCCAA","FALSE","NM_015317","ref|NM_015317|ref|NM_001282752|ref|NM_001282791|ref|NM_001282790","PUM2","pumilio RNA-binding family member 2","ref|Homo sapiens pumilio RNA-binding family member 2 (PUM2), transcript variant 1, mRNA [NM_015317]","chr2",20451072,20550382,"GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006417(regulation of translation);GO:0010494(cytoplasmic stress granule);GO:0031965(nuclear membrane);GO:0034063(stress granule assembly);GO:0048471(perinuclear region of cytoplasm)",null,"mRNA","agilent G3 V3"]
["A_33_P3331446",5.42,5.98,6.65,4.87,5.17,5.74,{"v":1.14385297845374,"d":"1.14"},{"v":0.193901631761075,"d":"0.19"},"up",{"v":0.158859,"d":"0.16"},1,"no","CAAAAATAAGAAACTAGTCTGAAGAAAGAGAGTCCCTCGCTTCTTCAGAACTCACCTGTC","FALSE","ENST00000479209","ens|ENST00000479209|gb|AK125413|tc|THC2538116|tc|THC2518233",null,null,"ens|stress-associated endoplasmic reticulum protein 1 [Source:HGNC Symbol;Acc:HGNC:10759] [ENST00000479209]","chr3",150259776,150264428,null,null,"mRNA","agilent G3 V3"]
["A_22_P00017703",6.13,5.63,6.38,5.56,5.64,5.76,{"v":1.06957547169811,"d":"1.07"},{"v":0.0970382859653232,"d":"0.10"},"up",{"v":0.159601,"d":"0.16"},1,"no","CAAAGACAGTGGACGTCTCCCTCTACAAGGAGGGCAATAGCTTTGGCTTTGTCCTTAGAG","FALSE","NM_001080423","ref|NM_001080423|ens|ENST00000422481|ens|ENST00000413414|ens|ENST00000619221","GRIP2","glutamate receptor interacting protein 2","ref|Homo sapiens glutamate receptor interacting protein 2 (GRIP2), mRNA [NM_001080423]","chr3",14530618,14581850,"GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007268(synaptic transmission);GO:0030159(receptor signaling complex scaffold activity)",null,"mRNA","agilent G3 V3"]
["A_33_P3263061",4.79,6.61,5.51,6.85,6.93,6.65,{"v":0.827704356338718,"d":"0.83"},{"v":-0.272812544323244,"d":"-0.27"},"down",{"v":0.159901,"d":"0.16"},1,"no","TGCTGCCTGATGTCTCAATGGCTTCTGAATGACTGTTCTAATAAATGATCTTAAAACAGT","FALSE","NM_016282","ref|NM_016282|ref|NM_001199852|ref|NM_001199856|ref|NM_001199855","AK3","adenylate kinase 3","ref|Homo sapiens adenylate kinase 3 (AK3), transcript variant 1, mRNA [NM_016282]","chr9",{"v":4712045,"d":"4712045.00"},4742043,"GO:0004017(adenylate kinase activity);GO:0005524(ATP binding);GO:0005525(GTP binding);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0006172(ADP biosynthetic process);GO:0007596(blood coagulation);GO:0016310(phosphorylation);GO:0046033(AMP metabolic process);GO:0046039(GTP metabolic process);GO:0046041(ITP metabolic process);GO:0046051(UTP metabolic process);GO:0046899(nucleoside triphosphate adenylate kinase activity)","00230(Purine metabolism)","mRNA","agilent G3 V3"]
["A_23_P203488",2.11,5.37,3.45,5.57,5.76,{"v":5.8,"d":"5.80"},{"v":0.638061879743141,"d":"0.64"},{"v":-0.648231750412094,"d":"-0.65"},"down",{"v":0.161242,"d":"0.16"},1,"no","GTGTACCAAATAGATGGAAACTACTCCGGGAGCTCTCACGTGGTCCTGGACCATGAGACC","FALSE","NM_000543","ref|NM_000543|ref|NM_001007593|ens|ENST00000531336|ens|ENST00000527275","SMPD1","sphingomyelin phosphodiesterase 1, acid lysosomal","ref|Homo sapiens sphingomyelin phosphodiesterase 1, acid lysosomal (SMPD1), transcript variant 1, mRNA [NM_000543]","chr11",{"v":6411655,"d":"6411655.00"},6416225,"GO:0004767(sphingomyelin phosphodiesterase activity);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005764(lysosome);GO:0005768(endosome);GO:0005886(plasma membrane);GO:0006665(sphingolipid metabolic process);GO:0006684(sphingomyelin metabolic process);GO:0006685(sphingomyelin catabolic process);GO:0006687(glycosphingolipid metabolic process);GO:0007165(signal transduction);GO:0007399(nervous system development);GO:0016798(hydrolase activity, acting on glycosyl bonds);GO:0023021(termination of signal transduction);GO:0035307(positive regulation of protein dephosphorylation);GO:0042220(response to cocaine);GO:0042493(response to drug);GO:0042599(lamellar body);GO:0043065(positive regulation of apoptotic process);GO:0043202(lysosomal lumen);GO:0043407(negative regulation of MAP kinase activity);GO:0044281(small molecule metabolic process);GO:0046513(ceramide biosynthetic process);GO:0070062(extracellular vesicular exosome)","00600(Sphingolipid metabolism);04071(Sphingolipid signaling pathway);04142(Lysosome)","mRNA","agilent G3 V3"]
["A_24_P185117",5.14,4.56,5.28,4.51,4.81,{"v":4,"d":"4.00"},{"v":1.12462462462462,"d":"1.12"},{"v":0.169443541387489,"d":"0.17"},"up",{"v":0.162081,"d":"0.16"},1,"no","GGAGTCCAAAATACAGAGTTTCTTTGGCCTATGGTATCGGGGTAAAGCTGAATCCTCTGA","FALSE","NM_031430","ref|NM_031430|ens|ENST00000570858|ens|ENST00000622136|ens|ENST00000301336","RILP","Rab interacting lysosomal protein","ref|Homo sapiens Rab interacting lysosomal protein (RILP), mRNA [NM_031430]","chr17",{"v":1549444,"d":"1549444.00"},1553371,"GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005764(lysosome);GO:0005765(lysosomal membrane);GO:0005770(late endosome);GO:0008333(endosome to lysosome transport);GO:0015031(protein transport);GO:0017137(Rab GTPase binding);GO:0019886(antigen processing and presentation of exogenous peptide antigen via MHC class II);GO:0030670(phagocytic vesicle membrane);GO:0031902(late endosome membrane);GO:0043234(protein complex)","04145(Phagosome);05132(Salmonella infection)","mRNA","agilent G3 V3"]
["A_23_P102925",3.84,2.28,{"v":3.3,"d":"3.30"},4.17,{"v":4.1,"d":"4.10"},4.12,{"v":0.760290556900726,"d":"0.76"},{"v":-0.395377222527818,"d":"-0.40"},"down",{"v":0.163104,"d":"0.16"},1,"no","TGACAGCCTGCATCTGCTTGGAGGAGGAGGCAGAGACTCAGAAGAAGAGATGCTGGCCTA","FALSE","NM_005049","ref|NM_005049|ens|ENST00000291576|ref|XM_006710096|ref|XM_006723910","PWP2","PWP2 periodic tryptophan protein homolog (yeast)","ref|Homo sapiens PWP2 periodic tryptophan protein homolog (yeast) (PWP2), mRNA [NM_005049]","chr21",45527172,45551063,"GO:0000028(ribosomal small subunit assembly);GO:0000462(maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0030515(snoRNA binding);GO:0032040(small-subunit processome);GO:0034388(Pwp2p-containing subcomplex of 90S preribosome)","03008(Ribosome biogenesis in eukaryotes)","mRNA","agilent G3 V3"]
["A_24_P41570",7.18,6.92,7.05,7.65,7.06,7.39,{"v":0.957013574660633,"d":"0.96"},{"v":-0.0633887062714821,"d":"-0.06"},"down",{"v":0.164735,"d":"0.16"},1,"no","CAGGAAATGCATCAAAAGACTTAAAGGTAAAGATTACCCCTCGTCACTTGCAACTTGCTA","FALSE","NM_002106","ref|NM_002106|ens|ENST00000527366|ens|ENST00000529158|ens|ENST00000511319","H2AFZ","H2A histone family, member Z","ref|Homo sapiens H2A histone family, member Z (H2AFZ), mRNA [NM_002106]","chr4",100869240,100871512,"GO:0000786(nucleosome);GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0000979(RNA polymerase II core promoter sequence-specific DNA binding);GO:0000980(RNA polymerase II distal enhancer sequence-specific DNA binding);GO:0001740(Barr body);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005719(nuclear euchromatin);GO:0005720(nuclear heterochromatin);GO:0031490(chromatin DNA binding);GO:0031492(nucleosomal DNA binding);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046982(protein heterodimerization activity);GO:0070062(extracellular vesicular exosome);GO:0071392(cellular response to estradiol stimulus)","05322(Systemic lupus erythematosus);05034(Alcoholism)","mRNA","agilent G3 V3"]
["A_33_P3362321",3.55,3.96,3.21,3.77,4.02,4.63,{"v":0.863123993558776,"d":"0.86"},{"v":-0.212360267762709,"d":"-0.21"},"down",{"v":0.16602,"d":"0.17"},1,"no","TACAGACTGCTATTCCAACGAGTACTCATCCAAGTGCCAGGAATGCAAGAAGACCATCAT","FALSE","NM_201555","ref|NM_201555|ref|NM_001450|ref|NM_201557|ref|NM_001039492","FHL2","four and a half LIM domains 2","ref|Homo sapiens four and a half LIM domains 2 (FHL2), transcript variant 2, mRNA [NM_201555]","chr2",105977288,106015681,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0001649(osteoblast differentiation);GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005925(focal adhesion);GO:0006351(transcription, DNA-dependent);GO:0008134(transcription factor binding);GO:0008270(zinc ion binding);GO:0009725(response to hormone stimulus);GO:0015629(actin cytoskeleton);GO:0030018(Z disc);GO:0030521(androgen receptor signaling pathway);GO:0031430(M band);GO:0042802(identical protein binding);GO:0043066(negative regulation of apoptotic process);GO:0044255(cellular lipid metabolic process);GO:0044281(small molecule metabolic process);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0050681(androgen receptor binding);GO:0055014(atrial cardiac muscle cell development);GO:0055015(ventricular cardiac muscle cell development);GO:0060347(heart trabecula formation)","04380(Osteoclast differentiation)","mRNA","agilent G3 V3"]
["A_23_P41009",{"v":6.1,"d":"6.10"},6.51,5.75,6.56,{"v":6.6,"d":"6.60"},{"v":6.6,"d":"6.60"},{"v":0.92914979757085,"d":"0.93"},{"v":-0.10601688817087,"d":"-0.11"},"down",{"v":0.167996,"d":"0.17"},1,"no","TGCCTTGGACACCTACATCAAGGAGCGGAAGCTGTGTGCCTATCCTCGGCTGGAGATCTA","FALSE","NM_015926","ref|NM_015926|ref|NM_001278195|ref|NM_001129884|ref|NM_001243725","TEX264","testis expressed 264","ref|Homo sapiens testis expressed 264 (TEX264), transcript variant 1, mRNA [NM_015926]","chr3",51705192,51738034,"GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_21_P0014476",{"v":3.5,"d":"3.50"},3.11,4.09,4.15,4.25,4.12,{"v":0.854632587859425,"d":"0.85"},{"v":-0.226623765644109,"d":"-0.23"},"down",{"v":0.169358,"d":"0.17"},1,"no","TGCTTTTTAATATGTCTAAGCCCAGGCCAATAAATGCACAGTTGAAAATTTGACTCCAAA","FALSE","BX647890","gb|BX647890|gb|XR_112461|tc|THC2532158",null,null,"gb|Homo sapiens mRNA; cDNA DKFZp686N05102 (from clone DKFZp686N05102). [BX647890]","chr3",48973892,48976373,null,null,"mRNA","agilent G3 V3"]
["A_33_P3406567",5.24,5.55,5.63,4.69,5.48,4.94,{"v":1.08669755129054,"d":"1.09"},{"v":0.119950466612975,"d":"0.12"},"up",{"v":0.170535,"d":"0.17"},1,"no","GCCAAGAAGTAGAAGATATATTCTCTAGCCTTAGTTTTTCCTCCCAATTTGCATTTTTGT","FALSE","NM_152866","ref|NM_152866|ref|NM_021950|ens|ENST00000389939|ens|ENST00000345732","MS4A1","membrane-spanning 4-domains, subfamily A, member 1","ref|Homo sapiens membrane-spanning 4-domains, subfamily A, member 1 (MS4A1), transcript variant 1, mRNA [NM_152866]","chr11",60229656,60238225,"GO:0005154(epidermal growth factor receptor binding);GO:0005615(extracellular space);GO:0005887(integral to plasma membrane);GO:0006959(humoral immune response);GO:0009897(external side of plasma membrane);GO:0023026(MHC class II protein complex binding);GO:0042100(B cell proliferation);GO:0070062(extracellular vesicular exosome)","04640(Hematopoietic cell lineage)","mRNA","agilent G3 V3"]
["A_23_P151280",6.53,7.78,6.67,7.91,7.86,7.72,{"v":0.893146019582801,"d":"0.89"},{"v":-0.163032035434929,"d":"-0.16"},"down",{"v":0.171239,"d":"0.17"},1,"no","GTGCCCATGGTTTCTCTGGTTCTGCCAGTTTGACAGTTTATGGAGGCTTTTGAATCGTAA","FALSE","NM_032901","ref|NM_032901|ref|NM_001257134|ref|NM_001257133|ens|ENST00000550487","COX14","COX14 cytochrome c oxidase assembly factor","ref|Homo sapiens COX14 cytochrome c oxidase assembly factor (COX14), transcript variant 1, mRNA [NM_032901]","chr12",50506020,50514234,"GO:0005739(mitochondrion);GO:0016021(integral to membrane);GO:0031966(mitochondrial membrane);GO:0033617(mitochondrial respiratory chain complex IV assembly)",null,"mRNA","agilent G3 V3"]
["A_23_P213857",6.72,5.45,5.25,4.69,{"v":5.1,"d":"5.10"},5.21,{"v":1.16133333333333,"d":"1.16"},{"v":0.215782123215622,"d":"0.22"},"up",{"v":0.1728,"d":"0.17"},1,"no","ACAGGCTGGCTGCGTGTTCTTGAAATAGGTGTTACCTTCTCTGGGCCTTGGTTTTTTAAA","FALSE","NM_000587","ref|NM_000587|ens|ENST00000313164|gb|J03507|gb|BC041807","C7","complement component 7","ref|Homo sapiens complement component 7 (C7), mRNA [NM_000587]","chr5",40976764,40981868,"GO:0005576(extracellular region);GO:0005579(membrane attack complex);GO:0006883(cellular sodium ion homeostasis);GO:0006956(complement activation);GO:0006957(complement activation, alternative pathway);GO:0006958(complement activation, classical pathway);GO:0019835(cytolysis);GO:0030449(regulation of complement activation);GO:0045087(innate immune response);GO:0070062(extracellular vesicular exosome)","04610(Complement and coagulation cascades);05322(Systemic lupus erythematosus);05020(Prion diseases)","mRNA","agilent G3 V3"]
["A_24_P200000",{"v":4,"d":"4.00"},2.89,4.19,3.92,4.98,4.74,{"v":0.812316715542522,"d":"0.81"},{"v":-0.299885762974984,"d":"-0.30"},"down",{"v":0.174198,"d":"0.17"},1,"no","CGTGACCTCACTGCCGTCCATTGCAAACTCGCTCAACTGGAGGGAGTTCAGCTTCGTTCA","FALSE","NM_182915","ref|NM_182915|ref|NM_018234|ref|NM_001008410|ens|ENST00000393107","STEAP3","STEAP family member 3, metalloreductase","ref|Homo sapiens STEAP family member 3, metalloreductase (STEAP3), transcript variant 1, mRNA [NM_182915]","chr2",119981384,120015221,"GO:0000293(ferric-chelate reductase activity);GO:0005515(protein binding);GO:0005771(multivesicular body);GO:0005886(plasma membrane);GO:0006879(cellular iron ion homeostasis);GO:0006915(apoptotic process);GO:0007049(cell cycle);GO:0008823(cupric reductase activity);GO:0009306(protein secretion);GO:0010008(endosome membrane);GO:0015677(copper ion import);GO:0016021(integral to membrane);GO:0033572(transferrin transport);GO:0046872(metal ion binding);GO:0052851(ferric-chelate reductase (NADPH) activity);GO:0055085(transmembrane transport);GO:0055114(oxidation-reduction process)","04115(p53 signaling pathway)","mRNA","agilent G3 V3"]
["A_23_P114061",5.42,4.75,5.76,5.71,5.98,5.76,{"v":0.912893982808023,"d":"0.91"},{"v":-0.131480769571705,"d":"-0.13"},"down",{"v":0.175397,"d":"0.18"},1,"no","AGTTCTACCTAACGTCCCACATCCTTCTCATGCCAACACTTCTGTAATTGATCATTATAA","FALSE","NM_001007471","ref|NM_001007471|ref|NM_206946|ref|NM_206947|ref|NM_024971","TRPM3","transient receptor potential cation channel, subfamily M, member 3","ref|Homo sapiens transient receptor potential cation channel, subfamily M, member 3 (TRPM3), transcript variant 9, mRNA [NM_001007471]","chr9",73149968,73483974,"GO:0005227(calcium activated cation channel activity);GO:0005261(cation channel activity);GO:0005262(calcium channel activity);GO:0005886(plasma membrane);GO:0006812(cation transport);GO:0016021(integral to membrane);GO:0016048(detection of temperature stimulus);GO:0034220(ion transmembrane transport);GO:0050951(sensory perception of temperature stimulus);GO:0055085(transmembrane transport);GO:0070588(calcium ion transmembrane transport)",null,"mRNA","agilent G3 V3"]
["A_23_P77455",9.21,9.15,9.21,9.18,8.91,9.08,{"v":1.01472211998528,"d":"1.01"},{"v":0.0210847017882157,"d":"0.02"},"up",{"v":0.176381,"d":"0.18"},1,"no","AGCATGGCCACCCTTATTGGTCTGTCCATCAAGGTCAAGCTTCTGCGCTCCCTTCCTCAG","FALSE","NM_016062","ref|NM_016062|ref|NR_024525|ref|NR_046109|ens|ENST00000569299","FAM96B","family with sequence similarity 96, member B","ref|Homo sapiens family with sequence similarity 96, member B (FAM96B), transcript variant 1, mRNA [NM_016062]","chr16",66967372,66968326,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005819(spindle);GO:0007059(chromosome segregation);GO:0016226(iron-sulfur cluster assembly);GO:0044281(small molecule metabolic process);GO:0071817(MMXD complex)",null,"mRNA","agilent G3 V3"]
["A_33_P3297321",5.69,5.48,{"v":5.2,"d":"5.20"},5.08,5.29,5.24,{"v":1.0486867392697,"d":"1.05"},{"v":0.0685837844962445,"d":"0.07"},"up",{"v":0.178439,"d":"0.18"},1,"no","ATGATGACACACACGAACAGAACTTAGAACTCTGGTAACCAGGCACCCATATCCTAGAGT","FALSE","CF272591","gb|CF272591|tc|THC2663262","CDRT15P2","CMT1A duplicated region transcript 15 pseudogene 2","gb|TFU00116 Transcript Finishing Unit (TFU) Homo sapiens cDNA, mRNA sequence [CF272591]","chr17",15668017,15668978,"GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P57199",6.83,5.92,6.49,6.11,5.92,4.69,{"v":1.15071770334928,"d":"1.15"},{"v":0.20253395168916,"d":"0.20"},"up",{"v":0.180356,"d":"0.18"},1,"no","GACGAGGAAGAGGACTTTGGGGGACAGGCTTCTCCTGTGAGCAGCAGAGCAGCACAATAA","FALSE","NM_178311","ref|NM_178311|ref|NM_178312|ens|ENST00000335694|ens|ENST00000278765","GGTLC1","gamma-glutamyltransferase light chain 1","ref|Homo sapiens gamma-glutamyltransferase light chain 1 (GGTLC1), transcript variant A, mRNA [NM_178311]","chr20",23965690,23969416,"GO:0003840(gamma-glutamyltransferase activity);GO:0006749(glutathione metabolic process);GO:0019370(leukotriene biosynthetic process);GO:0031362(anchored to external side of plasma membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3323939",9.66,10.12,9.04,9.13,8.77,9.25,{"v":1.06151012891344,"d":"1.06"},{"v":0.0861181374830237,"d":"0.09"},"up",{"v":0.181476,"d":"0.18"},1,"no","CTCGATGCCCCTCAACGGATGTACAGTGAAATCATAGCTTTAATGAAGGCATATTCCTAA","FALSE","NM_001102469","ref|NM_001102469|ens|ENST00000404459|ref|XM_005270049|gb|EF426483","LIPN","lipase, family member N","ref|Homo sapiens lipase, family member N (LIPN), mRNA [NM_001102469]","chr10",90521160,90537999,"GO:0005576(extracellular region);GO:0016042(lipid catabolic process);GO:0016788(hydrolase activity, acting on ester bonds)",null,"mRNA","agilent G3 V3"]
["A_23_P64617",6.25,6.86,4.44,7.31,7.36,7.26,{"v":0.800273597811218,"d":"0.80"},{"v":-0.32143478148167,"d":"-0.32"},"down",{"v":0.182476,"d":"0.18"},1,"no","AAATGGACCCTGCTTTTAAGGATGTACAAAAGTATGTCTGCATCGATGTCTGTACTGTAA","FALSE","NM_012193","ref|NM_012193|ens|ENST00000531380|gb|AB032417|gb|AK025516","FZD4","frizzled class receptor 4","ref|Homo sapiens frizzled class receptor 4 (FZD4), mRNA [NM_012193]","chr11",86656720,86666433,"GO:0001570(vasculogenesis);GO:0004930(G-protein coupled receptor activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0005911(cell-cell junction);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007223(Wnt receptor signaling pathway, calcium modulating pathway);GO:0007605(sensory perception of sound);GO:0009986(cell surface);GO:0010812(negative regulation of cell-substrate adhesion);GO:0016021(integral to membrane);GO:0016055(Wnt receptor signaling pathway);GO:0017147(Wnt-protein binding);GO:0019955(cytokine binding);GO:0030165(PDZ domain binding);GO:0030182(neuron differentiation);GO:0030669(clathrin-coated endocytic vesicle membrane);GO:0030947(regulation of vascular endothelial growth factor receptor signaling pathway);GO:0031625(ubiquitin protein ligase binding);GO:0031987(locomotion involved in locomotory behavior);GO:0034446(substrate adhesion-dependent cell spreading);GO:0035426(extracellular matrix-cell signaling);GO:0042701(progesterone secretion);GO:0042803(protein homodimerization activity);GO:0042813(Wnt-activated receptor activity);GO:0043507(positive regulation of JUN kinase activity);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0046982(protein heterodimerization activity);GO:0051091(positive regulation of sequence-specific DNA binding transcription factor activity);GO:0060070(canonical Wnt receptor signaling pathway);GO:0061299(retina vasculature morphogenesis in camera-type eye);GO:0061301(cerebellum vasculature morphogenesis);GO:0061304(retinal blood vessel morphogenesis);GO:0070062(extracellular vesicular exosome);GO:0071300(cellular response to retinoic acid)","04310(Wnt signaling pathway);04390(Hippo signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04916(Melanogenesis);05200(Pathways in cancer);05205(Proteoglycans in cancer);05217(Basal cell carcinoma);05166(HTLV-I infection)","mRNA","agilent G3 V3"]
["A_21_P0014370",12.03,12.17,11.72,11.81,11.67,11.77,{"v":1.01900709219858,"d":"1.02"},{"v":0.0271640925676288,"d":"0.03"},"up",{"v":0.184201,"d":"0.18"},1,"no","GGAGCTGACCCCACCCTTCTTGTGGCTTTATGAAGAAAAGTACAATCTGTTAGCTTGTCA","FALSE","BX103273","gb|BX103273|tc|THC2697455",null,null,"gb|BX103273 Soares_testis_NHT Homo sapiens cDNA clone IMAGp998D091862, mRNA sequence [BX103273]","chr19",49915372,49918987,null,null,"mRNA","agilent G3 V3"]
["A_32_P131367",3.04,4.06,2.73,4.01,3.65,4.29,{"v":0.822594142259414,"d":"0.82"},{"v":-0.28174729652753,"d":"-0.28"},"down",{"v":0.185436,"d":"0.19"},1,"no","CTGTCTCATCTTGATAGTCATTTTCATGATCACAAAATTTTTCCAGGATAGACATAGAGC","FALSE","NM_007282","ref|NM_007282|ref|NM_183381|ens|ENST00000467996|ens|ENST00000474348","RNF13","ring finger protein 13","ref|Homo sapiens ring finger protein 13 (RNF13), transcript variant 1, mRNA [NM_007282]","chr3",149530496,149679926,"GO:0000139(Golgi membrane);GO:0004842(ubiquitin-protein ligase activity);GO:0005515(protein binding);GO:0005637(nuclear inner membrane);GO:0005765(lysosomal membrane);GO:0005789(endoplasmic reticulum membrane);GO:0008270(zinc ion binding);GO:0016021(integral to membrane);GO:0016874(ligase activity);GO:0031902(late endosome membrane);GO:0051865(protein autoubiquitination)",null,"mRNA","agilent G3 V3"]
["A_23_P116890",13.04,13.14,12.95,12.88,12.89,13.02,{"v":1.0087651456561,"d":"1.01"},{"v":0.0125903343693833,"d":"0.01"},"up",{"v":0.185784,"d":"0.19"},1,"no","CAAGGTCCCCCACCTCGTCCAGGAAAGCCAGAAGGATCACCTTCACAAGGAGGCAACAAA","FALSE","NM_006249","ref|NM_006249|ens|ENST00000617030|ens|ENST00000381842|ens|ENST00000617491","PRB3","proline-rich protein BstNI subfamily 3","ref|Homo sapiens proline-rich protein BstNI subfamily 3 (PRB3), mRNA [NM_006249]","chr12",11418890,11422641,"GO:0005576(extracellular region);GO:0008150(biological_process);GO:0050829(defense response to Gram-negative bacterium)",null,"mRNA","agilent G3 V3"]
["A_21_P0000259",{"v":7.1,"d":"7.10"},7.41,7.33,7.07,6.82,7.23,{"v":1.03409090909091,"d":"1.03"},{"v":0.0483630215613988,"d":"0.05"},"up",{"v":0.187678,"d":"0.19"},1,"no","ATGATGAGGACCTTTTCACAGACCTGTACTGAGCTCCGTGAGGATAAATAACTCTGAGGA","FALSE","NR_002565","ref|NR_002565|ens|ENST00000537925|ens|ENST00000540725|linc|lnc-WDR74-1:6","SNORD25","small nucleolar RNA, C/D box 25","ref|Homo sapiens small nucleolar RNA, C/D box 25 (SNORD25), small nucleolar RNA [NR_002565]","chr11",62623036,62623103,null,null,"mRNA","agilent G3 V3"]
["A_33_P3415430",6.35,7.42,6.46,6.94,7.77,7.51,{"v":0.910441044104411,"d":"0.91"},{"v":-0.135362496830809,"d":"-0.14"},"down",{"v":0.188557,"d":"0.19"},1,"no","GTTTCGTTCCCTTTAAATGAATCAACACTGCCACCTTCTGTACGAGTTTGTTTGTTTTTT","FALSE","NM_005346","ref|NM_005346|ens|ENST00000545241|ens|ENST00000391548|ens|ENST00000375650","HSPA1B","heat shock 70kDa protein 1B","ref|Homo sapiens heat shock 70kDa protein 1B (HSPA1B), mRNA [NM_005346]","chr6",31795728,31797653,"GO:0000151(ubiquitin ligase complex);GO:0001618(viral receptor activity);GO:0001664(G-protein coupled receptor binding);GO:0003725(double-stranded RNA binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005783(endoplasmic reticulum);GO:0005814(centriole);GO:0005829(cytosol);GO:0005925(focal adhesion);GO:0006200(ATP catabolic process);GO:0006402(mRNA catabolic process);GO:0006986(response to unfolded protein);GO:0008180(signalosome);GO:0008285(negative regulation of cell proliferation);GO:0009615(response to virus);GO:0010467(gene expression);GO:0010941(regulation of cell death);GO:0016234(inclusion body);GO:0016235(aggresome);GO:0016607(nuclear speck);GO:0016887(ATPase activity);GO:0019899(enzyme binding);GO:0030308(negative regulation of cell growth);GO:0030529(ribonucleoprotein complex);GO:0031072(heat shock protein binding);GO:0031397(negative regulation of protein ubiquitination);GO:0031625(ubiquitin protein ligase binding);GO:0031982(vesicle);GO:0034599(cellular response to oxidative stress);GO:0034605(cellular response to heat);GO:0042026(protein refolding);GO:0042623(ATPase activity, coupled);GO:0043066(negative regulation of apoptotic process);GO:0044183(protein binding involved in protein folding);GO:0045648(positive regulation of erythrocyte differentiation);GO:0047485(protein N-terminus binding);GO:0048471(perinuclear region of cytoplasm);GO:0050821(protein stabilization);GO:0051082(unfolded protein binding);GO:0060548(negative regulation of cell death);GO:0070062(extracellular vesicular exosome);GO:0070370(cellular heat acclimation);GO:0072562(blood microparticle);GO:0090084(negative regulation of inclusion body assembly);GO:1900034(regulation of cellular response to heat);GO:2001240(negative regulation of extrinsic apoptotic signaling pathway in absence of ligand)","03040(Spliceosome);04141(Protein processing in endoplasmic reticulum);04010(MAPK signaling pathway);04144(Endocytosis);04612(Antigen processing and presentation);04915(Estrogen signaling pathway);05134(Legionellosis);05162(Measles);05164(Influenza A);05169(Epstein-Barr virus infection);05145(Toxoplasmosis)","mRNA","agilent G3 V3"]
["A_24_P107859",2.45,3.87,2.62,3.56,{"v":3.5,"d":"3.50"},{"v":4.5,"d":"4.50"},{"v":0.773356401384083,"d":"0.77"},{"v":-0.370794661317361,"d":"-0.37"},"down",{"v":0.189118,"d":"0.19"},1,"no","TACTGTTTATATATTTGAATGCTGCTACAACAGATGATCTTCATCCCTGAAGTTTTCAGC","FALSE","NM_152594","ref|NM_152594|ens|ENST00000299084|ref|XM_005254202|ref|XM_005254203","SPRED1","sprouty-related, EVH1 domain containing 1","ref|Homo sapiens sprouty-related, EVH1 domain containing 1 (SPRED1), mRNA [NM_152594]","chr15",38544528,38649450,"GO:0000188(inactivation of MAPK activity);GO:0005173(stem cell factor receptor binding);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005901(caveola);GO:0007275(multicellular organismal development);GO:0010801(negative regulation of peptidyl-threonine phosphorylation);GO:0010923(negative regulation of phosphatase activity);GO:0019901(protein kinase binding);GO:0019902(phosphatase binding);GO:0030291(protein serine/threonine kinase inhibitor activity);GO:0043517(positive regulation of DNA damage response, signal transduction by p53 class mediator);GO:0090311(regulation of protein deacetylation)","04630(Jak-STAT signaling pathway)","mRNA","agilent G3 V3"]
["A_23_P115316",3.31,4.28,3.24,{"v":4.3,"d":"4.30"},4.21,4.29,{"v":0.84609375,"d":"0.85"},{"v":-0.241110567279035,"d":"-0.24"},"down",{"v":0.190537,"d":"0.19"},1,"no","CTTATTATGACACTCCAGATGGTCTCCTTAGCATCTCAGCTCTTCTGCAAGGAAGAGCTT","FALSE","NM_022371","ref|NM_022371|ens|ENST00000367627|ref|XM_006711485|gb|AK130132","TOR3A","torsin family 3, member A","ref|Homo sapiens torsin family 3, member A (TOR3A), mRNA [NM_022371]","chr1",179050512,179065131,"GO:0005524(ATP binding);GO:0005783(endoplasmic reticulum);GO:0005788(endoplasmic reticulum lumen);GO:0006200(ATP catabolic process);GO:0016887(ATPase activity);GO:0051085(chaperone mediated protein folding requiring cofactor);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P153867",4.69,1.96,3.88,4.45,4.92,5.07,{"v":0.729224376731302,"d":"0.73"},{"v":-0.455565305861454,"d":"-0.46"},"down",{"v":0.191764,"d":"0.19"},1,"no","CAACAGGGGCCCCTTCTTCGGCTACTACTTCTTCAACGGGCTTCTGATGTTGCTGCAGCT","FALSE","NM_024552","ref|NM_024552|ens|ENST00000557925|ens|ENST00000595722|ens|ENST00000251363","CERS4","ceramide synthase 4","ref|Homo sapiens ceramide synthase 4 (CERS4), mRNA [NM_024552]","chr19",{"v":8326511,"d":"8326511.00"},8327305,"GO:0003677(DNA binding);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006665(sphingolipid metabolic process);GO:0016021(integral to membrane);GO:0030148(sphingolipid biosynthetic process);GO:0031965(nuclear membrane);GO:0044281(small molecule metabolic process);GO:0046513(ceramide biosynthetic process);GO:0050291(sphingosine N-acyltransferase activity)","00600(Sphingolipid metabolism);04071(Sphingolipid signaling pathway)","mRNA","agilent G3 V3"]
["A_21_P0010857",4.25,4.79,2.65,4.96,4.61,5.24,{"v":0.789331532748143,"d":"0.79"},{"v":-0.341296710757192,"d":"-0.34"},"down",{"v":0.19442,"d":"0.19"},1,"no","AATTGCAGACATACTGTCAACATCTGGGACTCGAGTTACTATTACAATCATGTCTTCTTT","FALSE","ENST00000440192","ens|ENST00000440192|linc|TCONS_l2_00003387",null,null,"ens|syndecan binding protein (syntenin) pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:44684] [ENST00000440192]","chr10",{"v":6335063,"d":"6335063.00"},6336647,null,null,"mRNA","agilent G3 V3"]
["A_33_P3419632",4.76,2.44,4.14,4.99,{"v":5.3,"d":"5.30"},5.08,{"v":0.737800910865322,"d":"0.74"},{"v":-0.438696524748542,"d":"-0.44"},"down",{"v":0.194805,"d":"0.19"},1,"no","CATTCCCTTCACCAGCTTGTGCACCCTATTCTGTAACTGATAATAAATGGTTGGTATTGC","FALSE","ENST00000389887","ens|ENST00000389887|gb|BC011001|tc|THC2488781","GLB1L3","galactosidase, beta 1-like 3","ens|galactosidase, beta 1-like 3 [Source:HGNC Symbol;Acc:HGNC:25147] [ENST00000389887]","chr11",134144136,134175202,"GO:0004565(beta-galactosidase activity);GO:0005773(vacuole);GO:0005975(carbohydrate metabolic process)",null,"mRNA","agilent G3 V3"]
["A_21_P0000296",4.79,4.54,4.54,3.36,{"v":3.3,"d":"3.30"},4.84,{"v":1.20608695652174,"d":"1.21"},{"v":0.270333926491865,"d":"0.27"},"up",{"v":0.196639,"d":"0.20"},1,"no","ATGTATTTTATTCAACACATCATTCTGAAAGAACGTGTGGAAAACTAATGACTGAGCACA","FALSE","NR_002913","ref|NR_002913|gb|U72852","SNORD63","small nucleolar RNA, C/D box 63","ref|Homo sapiens small nucleolar RNA, C/D box 63 (SNORD63), small nucleolar RNA [NR_002913]","chr5",137896736,137896799,null,null,"mRNA","agilent G3 V3"]
["A_32_P1173",4.51,4.79,5.23,{"v":4.6,"d":"4.60"},4.58,4.24,{"v":1.08271236959762,"d":"1.08"},{"v":0.114650031432658,"d":"0.11"},"up",{"v":0.197877,"d":"0.20"},1,"no","TGGCGGCTATCCTTCTCTCACATCGAAAAGGAAATTTTGAACAATCATGGAAAATCTAAA","FALSE","NM_138441","ref|NM_138441|ens|ENST00000370318|ref|XM_006715327|gb|KC294566","MB21D1","Mab-21 domain containing 1","ref|Homo sapiens Mab-21 domain containing 1 (MB21D1), mRNA [NM_138441]","chr6",74133432,74161999,"GO:0002218(activation of innate immune response);GO:0002230(positive regulation of defense response to virus by host);GO:0003677(DNA binding);GO:0005524(ATP binding);GO:0005525(GTP binding);GO:0005829(cytosol);GO:0009190(cyclic nucleotide biosynthetic process);GO:0032481(positive regulation of type I interferon production);GO:0045087(innate immune response);GO:0046872(metal ion binding);GO:0051607(defense response to virus);GO:0071360(cellular response to exogenous dsRNA)","04623(Cytosolic DNA-sensing pathway)","mRNA","agilent G3 V3"]
["A_32_P130577",2.42,4.53,2.33,4.04,4.46,4.14,{"v":0.734177215189873,"d":"0.73"},{"v":-0.445799753049531,"d":"-0.45"},"down",{"v":0.199697,"d":"0.20"},1,"no","TTTTGAAATTGACTTAAGAGAATGTTGGCTGTGTATGTCTGTATCTTGCATTTCTGTTGG","FALSE","BC066989","gb|BC066989|tc|THC2498673",null,null,"gb|Homo sapiens cDNA clone IMAGE:5267335. [BC066989]","chr2",190648816,190742355,null,null,"mRNA","agilent G3 V3"]
["A_33_P3310104",3.07,{"v":4.3,"d":"4.30"},3.16,3.59,5.08,4.57,{"v":0.795317220543807,"d":"0.80"},{"v":-0.330397685781501,"d":"-0.33"},"down",{"v":0.20038,"d":"0.20"},1,"no","CATCTCTTCCTTGACCTGCATTGTAAATAGGTTCTTCTTGTTCTGAGATTCAATATTGAA","FALSE","NM_002639","ref|NM_002639|ens|ENST00000382771|ref|XM_006722483|gb|U04313","SERPINB5","serpin peptidase inhibitor, clade B (ovalbumin), member 5","ref|Homo sapiens serpin peptidase inhibitor, clade B (ovalbumin), member 5 (SERPINB5), mRNA [NM_002639]","chr18",61143992,61172318,"GO:0002009(morphogenesis of an epithelium);GO:0004867(serine-type endopeptidase inhibitor activity);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0006928(cellular component movement);GO:0010951(negative regulation of endopeptidase activity);GO:0030198(extracellular matrix organization);GO:0050678(regulation of epithelial cell proliferation);GO:0060512(prostate gland morphogenesis);GO:0070062(extracellular vesicular exosome)","04115(p53 signaling pathway);05206(MicroRNAs in cancer)","mRNA","agilent G3 V3"]
["A_23_P215296",5.91,1.91,4.84,6.55,5.99,5.71,{"v":0.693698630136986,"d":"0.69"},{"v":-0.527619059226401,"d":"-0.53"},"down",{"v":0.20164,"d":"0.20"},1,"no","AGAGGCAGAGGCAGAGGGTTACCATACTGAGTATCTGTTTTTCCTCAGGCACATCATTTT","FALSE","NM_003718","ref|NM_003718|ref|NM_031267|ens|ENST00000465643|ens|ENST00000340829","CDK13","cyclin-dependent kinase 13","ref|Homo sapiens cyclin-dependent kinase 13 (CDK13), transcript variant 1, mRNA [NM_003718]","chr7",40131848,40135131,"GO:0000380(alternative nuclear mRNA splicing, via spliceosome);GO:0004672(protein kinase activity);GO:0004693(cyclin-dependent protein kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005615(extracellular space);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0007088(regulation of mitosis);GO:0007275(multicellular organismal development);GO:0008284(positive regulation of cell proliferation);GO:0008353(RNA polymerase II carboxy-terminal domain kinase activity);GO:0016032(viral reproduction);GO:0016607(nuclear speck);GO:0019908(nuclear cyclin-dependent protein kinase holoenzyme complex);GO:0030097(hemopoiesis);GO:0030332(cyclin binding);GO:0070816(phosphorylation of RNA polymerase II C-terminal domain)",null,"mRNA","agilent G3 V3"]
["A_23_P166196",5.64,2.21,4.77,6.23,6.21,5.97,{"v":0.68549701249321,"d":"0.69"},{"v":-0.544777716367358,"d":"-0.54"},"down",{"v":0.20262,"d":"0.20"},1,"no","TTCCTCTCTAGACAAGTACACAGGCCTGCCACCTGACATCAAACTGTTGTACTATGATCA","FALSE","NM_015511","ref|NM_015511|ref|NM_001271874|ens|ENST00000373932|ens|ENST00000320849","AAR2","AAR2 splicing factor homolog (S. cerevisiae)","ref|Homo sapiens AAR2 splicing factor homolog (S. cerevisiae) (AAR2), transcript variant 1, mRNA [NM_015511]","chr20",34824336,34844863,null,null,"mRNA","agilent G3 V3"]
["A_21_P0000024",4.48,3.11,3.45,4.47,4.58,4.02,{"v":0.844682478959449,"d":"0.84"},{"v":-0.243518969017264,"d":"-0.24"},"down",{"v":0.20388,"d":"0.20"},1,"no","TGACAGCAACATGGGAAACAGAATTGAGAGCATCACTCAGCGCATGGCAATAATAGAAGG","FALSE","NM_001160031","ref|NM_001160031|ref|NM_001160030|ens|ENST00000539099|ens|ENST00000541932","FLT1","fms-related tyrosine kinase 1","ref|Homo sapiens fms-related tyrosine kinase 1 (FLT1), transcript variant 4, mRNA [NM_001160031]","chr13",28973180,29069265,"GO:0001569(patterning of blood vessels);GO:0002040(sprouting angiogenesis);GO:0002548(monocyte chemotaxis);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0005021(vascular endothelial growth factor-activated receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005615(extracellular space);GO:0005768(endosome);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0005925(focal adhesion);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0008284(positive regulation of cell proliferation);GO:0010863(positive regulation of phospholipase C activity);GO:0014068(positive regulation of phosphatidylinositol 3-kinase cascade);GO:0016477(cell migration);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0019838(growth factor binding);GO:0030154(cell differentiation);GO:0030335(positive regulation of cell migration);GO:0030949(positive regulation of vascular endothelial growth factor receptor signaling pathway);GO:0035924(cellular response to vascular endothelial growth factor stimulus);GO:0038084(vascular endothelial growth factor signaling pathway);GO:0042802(identical protein binding);GO:0043235(receptor complex);GO:0043406(positive regulation of MAP kinase activity);GO:0043410(positive regulation of MAPK cascade);GO:0043552(positive regulation of phosphatidylinositol 3-kinase activity);GO:0045766(positive regulation of angiogenesis);GO:0046777(protein autophosphorylation);GO:0048010(vascular endothelial growth factor receptor signaling pathway);GO:0048514(blood vessel morphogenesis);GO:0048598(embryonic morphogenesis)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04066(HIF-1 signaling pathway);04151(PI3K-Akt signaling pathway);04060(Cytokine-cytokine receptor interaction);04144(Endocytosis);04510(Focal adhesion);05202(Transcriptional misregulation in cancers);05323(Rheumatoid arthritis)","mRNA","agilent G3 V3"]
["A_23_P218751",8.02,7.76,7.97,9.15,{"v":8.3,"d":"8.30"},7.95,{"v":0.93503937007874,"d":"0.94"},{"v":-0.0969009835538558,"d":"-0.10"},"down",{"v":0.20642,"d":"0.21"},1,"no","GGAGTCCCCGCTGTCTTCATGAGGTTGGTATTTCCTTTTGTGGAGTGCCTCATCACAGGA","FALSE","NM_053004","ref|NM_053004|ens|ENST00000460402|ens|ENST00000405009|ens|ENST00000403325","GNB1L","guanine nucleotide binding protein (G protein), beta polypeptide 1-like","ref|Homo sapiens guanine nucleotide binding protein (G protein), beta polypeptide 1-like (GNB1L), mRNA [NM_053004]","chr22",19775988,19842329,"GO:0003674(molecular_function);GO:0005737(cytoplasm);GO:0007186(G-protein coupled receptor signaling pathway);GO:0009898(internal side of plasma membrane);GO:0035176(social behavior);GO:0035556(intracellular signal transduction)",null,"mRNA","agilent G3 V3"]
["A_23_P13073",4.24,1.98,3.58,4.41,4.71,3.89,{"v":0.753266717909301,"d":"0.75"},{"v":-0.408767307715225,"d":"-0.41"},"down",{"v":0.20754,"d":"0.21"},1,"no","AATGACACACTAGAGGAAGAGAATACTAATTTGGAGACACCAACGAAGAGGGTCTGTGTT","FALSE","NM_031307","ref|NM_031307|ref|NM_001271985|ens|ENST00000227474|ens|ENST00000613398","PUS3","pseudouridylate synthase 3","ref|Homo sapiens pseudouridylate synthase 3 (PUS3), transcript variant 1, mRNA [NM_031307]","chr11",125763384,125773116,"GO:0003723(RNA binding);GO:0005634(nucleus);GO:0009982(pseudouridine synthase activity);GO:0031119(tRNA pseudouridine synthesis)",null,"mRNA","agilent G3 V3"]
["A_33_P3372924",4.29,5.51,{"v":4.1,"d":"4.10"},4.01,3.59,4.17,{"v":1.18096856414613,"d":"1.18"},{"v":0.239970562572426,"d":"0.24"},"up",{"v":0.20884,"d":"0.21"},1,"no","TTTCCATAAGTGGGTGGATGGGTTCCTGAGCTCTCTACTGTTAATAGAACTTGCTCTCTC","FALSE","ENST00000366779","ens|ENST00000366779|ref|XM_005273202|gb|AK123980|gb|AK126466","ADCK3","aarF domain containing kinase 3","ens|aarF domain containing kinase 3 [Source:HGNC Symbol;Acc:HGNC:16812] [ENST00000366779]","chr1",227087104,227091500,"GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0006468(protein phosphorylation);GO:0006744(ubiquinone biosynthetic process)",null,"mRNA","agilent G3 V3"]
["A_33_P3379916",4.02,1.96,4.16,4.86,4.49,4.72,{"v":0.720682302771855,"d":"0.72"},{"v":-0.472564676233192,"d":"-0.47"},"down",{"v":0.21016,"d":"0.21"},1,"no","TTAATTAAATGTGCCGTTATTTACCCCTGATGTTATTTATGACTATGTGCCGATTCCTGC","FALSE","NM_014905","ref|NM_014905|ens|ENST00000320717|ref|XM_006712435|gb|BC038507","GLS","glutaminase","ref|Homo sapiens glutaminase (GLS), transcript variant 1, mRNA [NM_014905]","chr2",191745552,191830278,"GO:0001967(suckling behavior);GO:0002087(regulation of respiratory gaseous exchange by neurological system process);GO:0004359(glutaminase activity);GO:0005515(protein binding);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0005829(cytosol);GO:0006537(glutamate biosynthetic process);GO:0006543(glutamine catabolic process);GO:0007268(synaptic transmission);GO:0007269(neurotransmitter secretion);GO:0008652(cellular amino acid biosynthetic process);GO:0014047(glutamate secretion);GO:0034641(cellular nitrogen compound metabolic process);GO:0044281(small molecule metabolic process);GO:0051289(protein homotetramerization)","00250(Alanine, aspartate and glutamate metabolism);00330(Arginine and proline metabolism);00471(D-Glutamine and D-glutamate metabolism);04964(Proximal tubule bicarbonate reclamation);04724(Glutamatergic synapse);04727(GABAergic synapse);05230(Central carbon metabolism in cancer);05206(MicroRNAs in cancer)","mRNA","agilent G3 V3"]
["A_23_P119789",3.05,4.41,3.85,4.59,4.07,4.56,{"v":0.855521936459909,"d":"0.86"},{"v":-0.225123247517871,"d":"-0.23"},"down",{"v":0.21206,"d":"0.21"},1,"no","ATGCTGAAGAAACATCAGTTCCAGAAGCTCCGAAAATTGCTCCAATATTTGGAAAGAAGG","FALSE","NM_024121","ref|NM_024121|ens|ENST00000426077|gb|AK024632|gb|BC080607","TMEM185B","transmembrane protein 185B","ref|Homo sapiens transmembrane protein 185B (TMEM185B), mRNA [NM_024121]","chr2",120978856,120980984,"GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3234571",2.49,2.56,4.71,4.61,4.44,4.68,{"v":0.710852148579752,"d":"0.71"},{"v":-0.492378572584214,"d":"-0.49"},"down",{"v":0.2124,"d":"0.21"},1,"no","ATGTGTGGATCTGCATGGAGCTCATGGACACATCCTTGGACAAGTTCTACCGGAAGGTGC","FALSE","NM_145109","ref|NM_145109|ref|NM_002756|ens|ENST00000526076|ens|ENST00000316920","MAP2K3","mitogen-activated protein kinase kinase 3","ref|Homo sapiens mitogen-activated protein kinase kinase 3 (MAP2K3), transcript variant B, mRNA [NM_145109]","chr17",21191348,21218525,"GO:0000187(activation of MAPK activity);GO:0002224(toll-like receptor signaling pathway);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0002756(MyD88-independent toll-like receptor signaling pathway);GO:0004702(receptor signaling protein serine/threonine kinase activity);GO:0004708(MAP kinase kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006954(inflammatory response);GO:0007165(signal transduction);GO:0009405(pathogenesis);GO:0016020(membrane);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0019901(protein kinase binding);GO:0034134(toll-like receptor 2 signaling pathway);GO:0034138(toll-like receptor 3 signaling pathway);GO:0034142(toll-like receptor 4 signaling pathway);GO:0034146(toll-like receptor 5 signaling pathway);GO:0034162(toll-like receptor 9 signaling pathway);GO:0034166(toll-like receptor 10 signaling pathway);GO:0035666(TRIF-dependent toll-like receptor signaling pathway);GO:0038123(toll-like receptor TLR1:TLR2 signaling pathway);GO:0038124(toll-like receptor TLR6:TLR2 signaling pathway);GO:0042035(regulation of cytokine biosynthetic process);GO:0045087(innate immune response);GO:0045860(positive regulation of protein kinase activity);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0051403(stress-activated MAPK cascade);GO:0060048(cardiac muscle contraction)","04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04668(TNF signaling pathway);04620(Toll-like receptor signaling pathway);04664(Fc epsilon RI signaling pathway);04912(GnRH signaling pathway);04750(Inflammatory mediator regulation of TRP channels);05014(Amyotrophic lateral sclerosis (ALS));05164(Influenza A);05169(Epstein-Barr virus infection);05145(Toxoplasmosis)","mRNA","agilent G3 V3"]
["A_24_P381604",6.99,7.19,5.65,7.38,7.48,{"v":7.6,"d":"7.60"},{"v":0.882902938557435,"d":"0.88"},{"v":-0.179673250171754,"d":"-0.18"},"down",{"v":0.21402,"d":"0.21"},1,"no","TAGAAAATGTTTGGAATTTAAGAAATAACTTGTGTTACTAATTTGTATAACCCATATCTG","FALSE","NM_021999","ref|NM_021999|gb|AK027411|gb|BC018053|gb|AK000503","ITM2B","integral membrane protein 2B","ref|Homo sapiens integral membrane protein 2B (ITM2B), mRNA [NM_021999]","chr13",48807296,48836460,"GO:0001540(beta-amyloid binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0007399(nervous system development);GO:0010008(endosome membrane);GO:0016020(membrane);GO:0030660(Golgi-associated vesicle membrane);GO:0031301(integral to organelle membrane);GO:0042985(negative regulation of amyloid precursor protein biosynthetic process);GO:0043231(intracellular membrane-bounded organelle);GO:0070062(extracellular vesicular exosome);GO:0097192(extrinsic apoptotic signaling pathway in absence of ligand)",null,"mRNA","agilent G3 V3"]
["A_23_P3532",3.47,5.22,4.47,4.95,5.29,{"v":5.2,"d":"5.20"},{"v":0.852331606217616,"d":"0.85"},{"v":-0.230513263532839,"d":"-0.23"},"down",{"v":0.2155,"d":"0.22"},1,"no","GACATATCCACAAGGTCGTAAATGCATGCTAGAAAAATAGGGCTGGATCTTATCACTGCC","FALSE","NM_004862","ref|NM_004862|ref|NM_001136473|ref|NM_001136472|ref|NR_024320","LITAF","lipopolysaccharide-induced TNF factor","ref|Homo sapiens lipopolysaccharide-induced TNF factor (LITAF), transcript variant 1, mRNA [NM_004862]","chr16",11642459,11680788,"GO:0001817(regulation of cytokine production);GO:0004871(signal transducer activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0006351(transcription, DNA-dependent);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0006915(apoptotic process);GO:0007165(signal transduction);GO:0007568(aging);GO:0042347(negative regulation of NF-kappaB import into nucleus);GO:0043123(positive regulation of I-kappaB kinase/NF-kappaB cascade);GO:0043231(intracellular membrane-bounded organelle);GO:0050699(WW domain binding);GO:0071222(cellular response to lipopolysaccharide)",null,"mRNA","agilent G3 V3"]
["A_33_P3315027",11.06,12.38,10.85,12.23,12.24,12.39,{"v":0.930276722734672,"d":"0.93"},{"v":-0.104268166695079,"d":"-0.10"},"down",{"v":0.21726,"d":"0.22"},1,"no","GTTCAACTGGCTCCTGATTACGATGCTTTGGATGTTGCCAACAAAATTGGGTTCATGTAA","FALSE","ENST00000482216","ens|ENST00000482216",{"$nulls":3},"chr5",120911544,120912015,null,null,"mRNA","agilent G3 V3"]
["A_33_P3405360",5.68,5.14,5.46,5.57,{"v":4.6,"d":"4.60"},{"v":4.1,"d":"4.10"},{"v":1.14085494043448,"d":"1.14"},{"v":0.190115364790484,"d":"0.19"},"up",{"v":0.21824,"d":"0.22"},1,"no","CCCATCTGGATGAAGAGGAGGAGCAACAGAAACAGAAAGACCTCCAGGAGAAGATCAGTG","FALSE","NM_005388","ref|NM_005388|ens|ENST00000394285|ens|ENST00000436632|ens|ENST00000259467","PDCL","phosducin-like","ref|Homo sapiens phosducin-like (PDCL), mRNA [NM_005388]","chr9",125582824,125589031,"GO:0005057(receptor signaling protein activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0006457(protein folding);GO:0007165(signal transduction);GO:0007601(visual perception);GO:0008277(regulation of G-protein coupled receptor protein signaling pathway);GO:0032403(protein complex binding);GO:0035556(intracellular signal transduction);GO:0061084(negative regulation of protein refolding)",null,"mRNA","agilent G3 V3"]
["A_33_P3266520",5.45,1.96,5.65,6.34,{"v":6.5,"d":"6.50"},6.58,{"v":0.672502574665294,"d":"0.67"},{"v":-0.572388303872762,"d":"-0.57"},"down",{"v":0.21936,"d":"0.22"},1,"no","GTGTTTGTGGTGATGTGCTGCTCCATGCTGGTGCTGCTCTACTATTTCTACGATCTCCTC","FALSE","NM_152988","ref|NM_152988|ref|NM_001077238|ens|ENST00000621568|ens|ENST00000621615","SPPL2B","signal peptide peptidase like 2B","ref|Homo sapiens signal peptide peptidase like 2B (SPPL2B), transcript variant 2, mRNA [NM_152988]","chr19",{"v":2328629,"d":"2328629.00"},2341016,"GO:0005515(protein binding);GO:0005765(lysosomal membrane);GO:0005886(plasma membrane);GO:0006509(membrane protein ectodomain proteolysis);GO:0010008(endosome membrane);GO:0030660(Golgi-associated vesicle membrane);GO:0031293(membrane protein intracellular domain proteolysis);GO:0042500(aspartic endopeptidase activity, intramembrane cleaving);GO:0042803(protein homodimerization activity);GO:0050776(regulation of immune response);GO:0071458(integral to cytosolic side of endoplasmic reticulum membrane);GO:0071556(integral to lumenal side of endoplasmic reticulum membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P502350",7.23,7.59,7.16,7.09,7.12,7.18,{"v":1.0275829827022,"d":"1.03"},{"v":0.039254903784187,"d":"0.04"},"up",{"v":0.22116,"d":"0.22"},1,"no","AAGCTCACAGTTAACGGATTGTAATGCCCGGCTTTTCCTCACTCCTGGTAACCAATACAA","FALSE","NM_000635","ref|NM_000635|ref|NM_134433|ens|ENST00000303657|gb|BC071571","RFX2","regulatory factor X, 2 (influences HLA class II expression)","ref|Homo sapiens regulatory factor X, 2 (influences HLA class II expression) (RFX2), transcript variant 1, mRNA [NM_000635]","chr19",{"v":5993528,"d":"5993528.00"},6049243,"GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006357(regulation of transcription from RNA polymerase II promoter)",null,"mRNA","agilent G3 V3"]
["A_23_P96285",6.68,6.42,6.88,5.75,5.98,6.78,{"v":1.07941653160454,"d":"1.08"},{"v":0.110251687921844,"d":"0.11"},"up",{"v":0.22226,"d":"0.22"},1,"no","ATGTGGACTTGTGCTTATAAACTGGAGAGTTTAGTCATAATCCCTCCTGGCTTTGTGTGA","FALSE","NM_022912","ref|NM_022912|ref|NM_001164731|ref|NM_001164730|ref|NM_001164732","REEP1","receptor accessory protein 1","ref|Homo sapiens receptor accessory protein 1 (REEP1), transcript variant 2, mRNA [NM_022912]","chr2",86441120,86564777,"GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0008017(microtubule binding);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0031849(olfactory receptor binding);GO:0031966(mitochondrial membrane);GO:0032386(regulation of intracellular transport);GO:0051205(protein insertion into membrane);GO:0071786(endoplasmic reticulum tubular network organization)",null,"mRNA","agilent G3 V3"]
["A_23_P151820",{"v":4.5,"d":"4.50"},3.29,{"v":4.4,"d":"4.40"},4.68,4.71,{"v":4.5,"d":"4.50"},{"v":0.877609791216703,"d":"0.88"},{"v":-0.18834847336118,"d":"-0.19"},"down",{"v":0.22302,"d":"0.22"},1,"no","AAGTCCTAATAGCCCTGAGACACCGAGACGGCATGTTCTTCATTAGACGGAAAGGGAAAC","FALSE","NM_024832","ref|NM_024832|ens|ENST00000620541|ens|ENST00000418924|ens|ENST00000216487","RIN3","Ras and Rab interactor 3","ref|Homo sapiens Ras and Rab interactor 3 (RIN3), mRNA [NM_024832]","chr14",93125728,93154394,"GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005769(early endosome);GO:0006897(endocytosis);GO:0007165(signal transduction);GO:0016023(cytoplasmic membrane-bounded vesicle);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0017137(Rab GTPase binding);GO:0031410(cytoplasmic vesicle);GO:0032851(positive regulation of Rab GTPase activity)",null,"mRNA","agilent G3 V3"]
["A_24_P126651",3.69,2.49,1.99,3.56,3.57,3.67,{"v":0.756481481481481,"d":"0.76"},{"v":-0.402623328905148,"d":"-0.40"},"down",{"v":0.2251,"d":"0.23"},1,"no","GCAACAGAAAGGATGAGACAAATGCTCGAGATACTTATGTTTCATCCTTTCCTCGGGCAC","FALSE","NM_006756","ref|NM_006756|ref|NM_201437|ref|NR_109901|ens|ENST00000522397","TCEA1","transcription elongation factor A (SII), 1","ref|Homo sapiens transcription elongation factor A (SII), 1 (TCEA1), transcript variant 1, mRNA [NM_006756]","chr8",54882824,54935008,"GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0006281(DNA repair);GO:0006283(transcription-coupled nucleotide-excision repair);GO:0006289(nucleotide-excision repair);GO:0006366(transcription from RNA polymerase II promoter);GO:0006368(transcription elongation from RNA polymerase II promoter);GO:0008270(zinc ion binding);GO:0010467(gene expression);GO:0016032(viral reproduction);GO:0030218(erythrocyte differentiation);GO:0032784(regulation of transcription elongation, DNA-dependent);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0050434(positive regulation of viral transcription)",null,"mRNA","agilent G3 V3"]
["A_23_P113793",3.73,{"v":2,"d":"2.00"},3.21,{"v":3.6,"d":"3.60"},3.41,5.06,{"v":0.740679370339685,"d":"0.74"},{"v":-0.433078939571704,"d":"-0.43"},"down",{"v":0.22666,"d":"0.23"},1,"no","AGACCACCAGTATGAATAAAAGCTTGTTCTGTGTGACCCAGCAAGTGGAAGGACAAAGAA","FALSE","NM_024508","ref|NM_024508|ens|ENST00000317012|gb|BC071956|gb|BC003536","ZBED2","zinc finger, BED-type containing 2","ref|Homo sapiens zinc finger, BED-type containing 2 (ZBED2), mRNA [NM_024508]","chr3",111311744,111314290,"GO:0003677(DNA binding);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P63459",2.31,4.73,3.34,{"v":4.7,"d":"4.70"},4.73,4.57,{"v":0.741428571428571,"d":"0.74"},{"v":-0.431620383474448,"d":"-0.43"},"down",{"v":0.22816,"d":"0.23"},1,"no","TTTCTGGACATTGAAAAAGCTCCACTGACTATGGAACAGTAATAGTTTGAATCATAGTGA","FALSE","NM_001012985","ref|NM_001012985|ref|NM_001301733|ref|NM_001206641|ens|ENST00000619305","COA6","cytochrome c oxidase assembly factor 6","ref|Homo sapiens cytochrome c oxidase assembly factor 6 (COA6), transcript variant 1, mRNA [NM_001012985]","chr1",234509440,234519792,"GO:0004129(cytochrome-c oxidase activity);GO:0005739(mitochondrion);GO:0008150(biological_process)",null,"mRNA","agilent G3 V3"]
["A_33_P3405213",5.46,6.99,5.88,{"v":6.9,"d":"6.90"},6.95,6.83,{"v":0.886363636363636,"d":"0.89"},{"v":-0.174029399775049,"d":"-0.17"},"down",{"v":0.22914,"d":"0.23"},1,"no","TTCAAAGGCTTGTAGTTTTGGCTAGTCCTTGTTCTTTGGAAATACACAGTGCTGACCAGA","FALSE","NM_000442","ref|NM_000442|ens|ENST00000563924|ref|XM_005276880|ref|XM_005276881","PECAM1","platelet/endothelial cell adhesion molecule 1","ref|Homo sapiens platelet/endothelial cell adhesion molecule 1 (PECAM1), mRNA [NM_000442]","chr17",62396776,62407083,"GO:0002576(platelet degranulation);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005886(plasma membrane);GO:0006909(phagocytosis);GO:0007155(cell adhesion);GO:0007165(signal transduction);GO:0007596(blood coagulation);GO:0008037(cell recognition);GO:0016021(integral to membrane);GO:0030054(cell junction);GO:0030168(platelet activation);GO:0030198(extracellular matrix organization);GO:0031092(platelet alpha granule membrane);GO:0050900(leukocyte migration);GO:0050904(diapedesis);GO:0070062(extracellular vesicular exosome);GO:0072011(glomerular endothelium development)","04514(Cell adhesion molecules (CAMs));04670(Leukocyte transendothelial migration);05144(Malaria)","mRNA","agilent G3 V3"]
["A_24_P218001",5.07,2.65,4.91,{"v":5.8,"d":"5.80"},{"v":5.1,"d":"5.10"},5.17,{"v":0.78593652769135,"d":"0.79"},{"v":-0.347515289887541,"d":"-0.35"},"down",{"v":0.23098,"d":"0.23"},1,"no","CTTGTCTGGAGCAAGGAAAAGAGCCCTGCAATATGAAGAGACATGCGATGGTAGCCAAAC","FALSE","NM_021148","ref|NM_021148|ref|NR_003099|ens|ENST00000489672|ens|ENST00000527278","ZNF273","zinc finger protein 273","ref|Homo sapiens zinc finger protein 273 (ZNF273), transcript variant 1, mRNA [NM_021148]","chr7",64363632,64389416,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_24_P314597",5.96,4.46,5.64,4.99,4.76,4.04,{"v":1.16461203770848,"d":"1.16"},{"v":0.219849436003334,"d":"0.22"},"up",{"v":0.23264,"d":"0.23"},1,"no","GGACAGGTTCACCTTCCCACAGAGTAAGGGGTGAGTGACCCAAGGCTCAATGGATGAGCA","FALSE","ENST00000485551","ens|ENST00000485551|gb|AB058740|gb|AK097107|tc|THC2479231","KIAA0319L","KIAA0319-like","ens|KIAA0319-like [Source:HGNC Symbol;Acc:HGNC:30071] [ENST00000485551]","chr1",35904144,35936507,"GO:0005515(protein binding);GO:0016021(integral to membrane);GO:0031410(cytoplasmic vesicle);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3259620",5.13,5.34,6.96,6.97,6.68,6.73,{"v":0.855250245338567,"d":"0.86"},{"v":-0.225581482040129,"d":"-0.23"},"down",{"v":0.23484,"d":"0.23"},1,"no","GCAAAGAAAAAGCTGTAAGAATGAAGCAATGAATCAAGACTTCTACCCAAAGCAACATTT","FALSE","NM_014639","ref|NM_014639|ens|ENST00000358746|gb|BC056893|gb|AB002370","TTC37","tetratricopeptide repeat domain 37","ref|Homo sapiens tetratricopeptide repeat domain 37 (TTC37), mRNA [NM_014639]","chr5",94799600,94890711,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0035327(transcriptionally active chromatin);GO:0055087(Ski complex)","03018(RNA degradation)","mRNA","agilent G3 V3"]
["A_23_P315836",2.93,{"v":3.9,"d":"3.90"},4.14,4.11,4.12,4.31,{"v":0.874800637958533,"d":"0.87"},{"v":-0.192973822398846,"d":"-0.19"},"down",{"v":0.23592,"d":"0.24"},1,"no","GGACTTTATCATCGGCAGACCTCAGAAGACAACACACAAAGGTTTCTTTTTTCTTAGCTT","FALSE","NM_017451","ref|NM_017451|ref|NM_006340|ref|NM_001144888|ens|ENST00000321300","BAIAP2","BAI1-associated protein 2","ref|Homo sapiens BAI1-associated protein 2 (BAIAP2), transcript variant 2, mRNA [NM_017451]","chr17",79008960,79091232,"GO:0001726(ruffle);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007009(plasma membrane organization);GO:0007409(axonogenesis);GO:0008022(protein C-terminus binding);GO:0008093(cytoskeletal adaptor activity);GO:0008286(insulin receptor signaling pathway);GO:0008360(regulation of cell shape);GO:0009617(response to bacterium);GO:0015629(actin cytoskeleton);GO:0016358(dendrite development);GO:0030175(filopodium);GO:0032956(regulation of actin cytoskeleton organization);GO:0038096(Fc-gamma receptor signaling pathway involved in phagocytosis);GO:0042802(identical protein binding);GO:0043005(neuron projection);GO:0045087(innate immune response);GO:0048010(vascular endothelial growth factor receptor signaling pathway);GO:0048167(regulation of synaptic plasticity);GO:0051017(actin filament bundle assembly);GO:0051764(actin crosslink formation);GO:0070062(extracellular vesicular exosome);GO:0070064(proline-rich region binding)","04810(Regulation of actin cytoskeleton);04520(Adherens junction)","mRNA","agilent G3 V3"]
["A_23_P307382",{"v":2.2,"d":"2.20"},2.82,4.78,4.12,4.59,4.37,{"v":0.749235474006116,"d":"0.75"},{"v":-0.416508886495512,"d":"-0.42"},"down",{"v":0.23824,"d":"0.24"},1,"no","CCAGCTTGCCTGCCGGTTTTCAGGAATCTAAACTCTCATCTTGTGCAATTTATCAGGTGT","FALSE","NM_080552","ref|NM_080552|ens|ENST00000217420|gb|AK091079|gb|AK055051","SLC32A1","solute carrier family 32 (GABA vesicular transporter), member 1","ref|Homo sapiens solute carrier family 32 (GABA vesicular transporter), member 1 (SLC32A1), mRNA [NM_080552]","chr20",37353104,37358015,"GO:0003333(amino acid transmembrane transport);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0007268(synaptic transmission);GO:0007269(neurotransmitter secretion);GO:0007568(aging);GO:0015171(amino acid transmembrane transporter activity);GO:0015187(glycine transmembrane transporter activity);GO:0015495(gamma-aminobutyric acid:hydrogen symporter activity);GO:0015812(gamma-aminobutyric acid transport);GO:0015816(glycine transport);GO:0016021(integral to membrane);GO:0030425(dendrite);GO:0030672(synaptic vesicle membrane);GO:0043005(neuron projection);GO:0044292(dendrite terminus);GO:0044306(neuron projection terminus);GO:0044316(cone cell pedicle);GO:0051286(cell tip);GO:0055085(transmembrane transport);GO:0060077(inhibitory synapse);GO:0061202(clathrin sculpted gamma-aminobutyric acid transport vesicle membrane)","04727(GABAergic synapse);04723(Retrograde endocannabinoid signaling);04721(Synaptic vesicle cycle);05032(Morphine addiction);05033(Nicotine addiction)","mRNA","agilent G3 V3"]
["A_24_P49597",4.01,6.04,6.87,6.71,6.42,7.61,{"v":0.815814850530376,"d":"0.82"},{"v":-0.293686325693276,"d":"-0.29"},"down",{"v":0.23938,"d":"0.24"},1,"no","TACATTACTTTTTGAGTTGTGCAGTTCACAGCAAAGTAGTCAGGAATCAATCTTGTGTAG","FALSE","ENST00000473094","ens|ENST00000473094",null,null,"ens|ribosomal protein S26 pseudogene 54 [Source:HGNC Symbol;Acc:HGNC:36868] [ENST00000473094]","chr18",57428792,57429137,null,null,"mRNA","agilent G3 V3"]
["A_23_P24244",{"v":3.6,"d":"3.60"},2.04,2.03,2.96,3.27,3.84,{"v":0.761668321747766,"d":"0.76"},{"v":-0.392765200503851,"d":"-0.39"},"down",{"v":0.24114,"d":"0.24"},1,"no","GAAAGGCATACGATGCTACTATTATGCTCTGTTTTAAAGGTTTTACCTACCCTTGTAAAA","FALSE","NM_017782","ref|NM_017782|ens|ENST00000328090|ens|ENST00000459693|gb|AK000367","FAM208B","family with sequence similarity 208, member B","ref|Homo sapiens family with sequence similarity 208, member B (FAM208B), mRNA [NM_017782]","chr10",{"v":5726800,"d":"5726800.00"},5805703,"GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm)",null,"mRNA","agilent G3 V3"]
["A_33_P3369761",5.49,2.64,4.03,5.53,5.44,5.27,{"v":0.748768472906404,"d":"0.75"},{"v":-0.417408403741591,"d":"-0.42"},"down",{"v":0.24154,"d":"0.24"},1,"no","AATGTACAGAATGGTTGGAGAAATGCCTATGGTGAATTAAAGCTTCATATCTGCTTTCTG","FALSE","NM_001161779","ref|NM_001161779|ref|NM_018444|ref|NM_001161780|ref|NM_001161781","PDP1","pyruvate dehyrogenase phosphatase catalytic subunit 1","ref|Homo sapiens pyruvate dehyrogenase phosphatase catalytic subunit 1 (PDP1), transcript variant 2, mRNA [NM_001161779]","chr8",94929176,94938294,"GO:0004722(protein serine/threonine phosphatase activity);GO:0004741([pyruvate dehydrogenase (lipoamide)] phosphatase activity);GO:0005759(mitochondrial matrix);GO:0006090(pyruvate metabolic process);GO:0010510(regulation of acetyl-CoA biosynthetic process from pyruvate);GO:0035970(peptidyl-threonine dephosphorylation);GO:0044237(cellular metabolic process);GO:0044281(small molecule metabolic process);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_21_P0000264",8.43,8.31,{"v":8.2,"d":"8.20"},8.19,7.98,{"v":8.3,"d":"8.30"},{"v":1.01920719248059,"d":"1.02"},{"v":0.0274473637502802,"d":"0.03"},"up",{"v":0.24472,"d":"0.24"},1,"no","AAGCCTGTGTTGGTAGGGACATCTGACAGTAATGATGAATGCCAACCGCTCTGATGGTGG","FALSE","NR_002579","ref|NR_002579|gb|DA438590|gb|BG944474|tc|THC2556111","SNORD74","small nucleolar RNA, C/D box 74","ref|Homo sapiens small nucleolar RNA, C/D box 74 (SNORD74), small nucleolar RNA [NR_002579]","chr1",173836816,173836883,null,null,"mRNA","agilent G3 V3"]
["A_24_P143574",5.96,5.43,5.44,5.26,5.58,5.01,{"v":1.06182965299685,"d":"1.06"},{"v":0.0865523363031797,"d":"0.09"},"up",{"v":0.24594,"d":"0.25"},1,"no","GTTCAAAAATGGGAATGAGCTCTCAGACTTCCAGACCAACGTGGACCCCGCAGGAGACAG","FALSE","NM_006065","ref|NM_006065|ref|NM_001135844|ens|ENST00000562014|ens|ENST00000279477","SIRPB1","signal-regulatory protein beta 1","ref|Homo sapiens signal-regulatory protein beta 1 (SIRPB1), transcript variant 1, mRNA [NM_006065]","chr20",{"v":1585621,"d":"1585621.00"},1600632,"GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0007165(signal transduction);GO:0007166(cell surface receptor signaling pathway);GO:0016021(integral to membrane);GO:0045087(innate immune response);GO:0070062(extracellular vesicular exosome)","04380(Osteoclast differentiation)","mRNA","agilent G3 V3"]
["A_33_P3329352",6.96,6.88,6.99,7.07,5.91,5.17,{"v":1.14765840220386,"d":"1.15"},{"v":0.198693291157534,"d":"0.20"},"up",{"v":0.24812,"d":"0.25"},1,"no","ACCCACCACAATCTCCGACACCATGCCCAAGAAGAAAGGCTAAAGGGGATGCTAAAGGAG","FALSE","ENST00000529541","ens|ENST00000529541",null,null,"ens|high mobility group nucleosomal binding domain 2 pseudogene 36 [Source:HGNC Symbol;Acc:HGNC:39407] [ENST00000529541]","chr11",13631910,13632318,null,null,"mRNA","agilent G3 V3"]
["A_23_P254816",5.25,{"v":4,"d":"4.00"},5.07,4.97,{"v":5.5,"d":"5.50"},5.62,{"v":0.889993784959602,"d":"0.89"},{"v":-0.16813283345919,"d":"-0.17"},"down",{"v":0.24948,"d":"0.25"},1,"no","AACAAAGACTGTTGGTGACAGGGTGTGTGTGTATCTGTGCGTGAGTGTGAGTGTGTGTGA","FALSE","NM_004609","ref|NM_004609|ens|ENST00000621005|ens|ENST00000246080|gb|U08336","TCF15","transcription factor 15 (basic helix-loop-helix)","ref|Homo sapiens transcription factor 15 (basic helix-loop-helix) (TCF15), mRNA [NM_004609]","chr20",{"v":584441,"d":"584441.00"},591042,"GO:0001756(somitogenesis);GO:0003016(respiratory system process);GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0007498(mesoderm development);GO:0016265(death);GO:0042755(eating behavior);GO:0043583(ear development);GO:0043588(skin development);GO:0045198(establishment of epithelial cell apical/basal polarity);GO:0046983(protein dimerization activity);GO:0048339(paraxial mesoderm development);GO:0048644(muscle organ morphogenesis);GO:0048705(skeletal system morphogenesis);GO:0050884(neuromuscular process controlling posture);GO:0060231(mesenchymal to epithelial transition)",null,"mRNA","agilent G3 V3"]
["A_33_P3287113",10.57,10.59,10.62,10.77,10.57,10.68,{"v":0.992504684572143,"d":"0.99"},{"v":-0.0108541831677376,"d":"-0.01"},"down",{"v":0.25082,"d":"0.25"},1,"no","TCCAGAGGAGGGACGGAGCCATCCCCACGTCCCTGTGGCTCTCAGGACGCCCTCCTCTGA","FALSE","ENST00000503548","ens|ENST00000503548|ref|XM_006713899|ref|XM_006713898|gb|AL390128","UVSSA","UV-stimulated scaffold protein A","ens|UV-stimulated scaffold protein A [Source:HGNC Symbol;Acc:HGNC:29304] [ENST00000503548]","chr4",{"v":1369822,"d":"1369822.00"},1381837,"GO:0000993(RNA polymerase II core binding);GO:0005515(protein binding);GO:0005694(chromosome);GO:0006283(transcription-coupled nucleotide-excision repair);GO:0009411(response to UV);GO:0016567(protein ubiquitination)",null,"mRNA","agilent G3 V3"]
["A_32_P90080",{"v":3.2,"d":"3.20"},4.23,3.17,3.67,4.19,4.36,{"v":0.867430441898527,"d":"0.87"},{"v":-0.205180020368168,"d":"-0.21"},"down",{"v":0.25386,"d":"0.25"},1,"no","TTGCCGTGGTTCTCAGATTTATTTTGGACTATTTTGATGCCAAGTGAGTATAAGAGCTTG","FALSE","NM_031905","ref|NM_031905|ref|NM_001161009|ref|NM_001161010|ref|NM_001161011","ARMC10","armadillo repeat containing 10","ref|Homo sapiens armadillo repeat containing 10 (ARMC10), transcript variant A, mRNA [NM_031905]","chr7",102715328,102740196,"GO:0005739(mitochondrion);GO:0005789(endoplasmic reticulum membrane);GO:0016021(integral to membrane);GO:0040008(regulation of growth)",null,"mRNA","agilent G3 V3"]
["A_23_P387031",{"v":7.8,"d":"7.80"},7.93,7.76,7.72,7.82,7.38,{"v":1.02486910994764,"d":"1.02"},{"v":0.0354396692552922,"d":"0.04"},"up",{"v":0.25388,"d":"0.25"},1,"no","CAAGTCTCCCACCCAGAACTCTGGCCAAAAATGGCTCTCTAGGTGGGCTGTGCAGGCAAA","FALSE","NM_173465","ref|NM_173465|ens|ENST00000407622|ens|ENST00000390654|ref|XM_006714933","COL23A1","collagen, type XXIII, alpha 1","ref|Homo sapiens collagen, type XXIII, alpha 1 (COL23A1), mRNA [NM_173465]","chr5",177664624,178017556,"GO:0005581(collagen);GO:0005788(endoplasmic reticulum lumen);GO:0005886(plasma membrane);GO:0016021(integral to membrane);GO:0022617(extracellular matrix disassembly);GO:0030198(extracellular matrix organization);GO:0030574(collagen catabolic process)",null,"mRNA","agilent G3 V3"]
["A_33_P3342160",3.39,4.74,1.87,4.14,4.65,4.56,{"v":0.749063670411985,"d":"0.75"},{"v":-0.416839741912829,"d":"-0.42"},"down",{"v":0.25626,"d":"0.26"},1,"no","CTCACCACAAGTAAAAGAACATGTGTATTGACTGTCTTTGCTAAGTTTCCTAATTTTTCC","FALSE","NM_018036","ref|NM_018036|ens|ENST00000359933|ref|XM_006720187|gb|AK123451","ATG2B","autophagy related 2B","ref|Homo sapiens autophagy related 2B (ATG2B), mRNA [NM_018036]","chr14",96747592,96830207,"GO:0000045(autophagic vacuole assembly);GO:0000407(pre-autophagosomal structure);GO:0000422(mitochondrion degradation);GO:0005811(lipid particle);GO:0006995(cellular response to nitrogen starvation);GO:0019898(extrinsic to membrane);GO:0034045(pre-autophagosomal structure membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3319580",6.56,5.85,6.74,6.14,6.01,5.89,{"v":1.06152993348115,"d":"1.06"},{"v":0.0861450535569385,"d":"0.09"},"up",{"v":0.25846,"d":"0.26"},1,"no","TGCTCCTGCATCCCCAATCAACGACAAAGAGAAGGACAAAGCTGGAGGCAGGCTCCCAAG","FALSE","AK097459","gb|AK097459|tc|THC2486001",null,null,"gb|Homo sapiens cDNA FLJ40140 fis, clone TESTI2012835. [AK097459]",{"$nulls":5},"mRNA","agilent G3 V3"]
["A_32_P153892",3.88,1.91,4.35,{"v":4.5,"d":"4.50"},{"v":4.7,"d":"4.70"},{"v":4,"d":"4.00"},{"v":0.768181818181818,"d":"0.77"},{"v":-0.380480277242475,"d":"-0.38"},"down",{"v":0.25894,"d":"0.26"},1,"no","AAAGAGGAAGAGGCAGATCCCTACAAGTTTAAAATCAAAGAATTTGAAGATGTTGATCCC","FALSE","NM_031923","ref|NM_031923|gb|BC024661|gb|AL117661|gb|BC062352","TAF3","TAF3 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 140kDa","ref|Homo sapiens TAF3 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 140kDa (TAF3), mRNA [NM_031923]","chr10",{"v":7860467,"d":"7860467.00"},8058590,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0002039(p53 binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005669(transcription factor TFIID complex);GO:0006366(transcription from RNA polymerase II promoter);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0006368(transcription elongation from RNA polymerase II promoter);GO:0008270(zinc ion binding);GO:0010467(gene expression);GO:0016032(viral reproduction);GO:0043433(negative regulation of sequence-specific DNA binding transcription factor activity);GO:0051457(maintenance of protein location in nucleus)","03022(Basal transcription factors);05168(Herpes simplex infection)","mRNA","agilent G3 V3"]
["A_24_P324814",4.46,{"v":4.4,"d":"4.40"},3.94,4.42,4.41,4.74,{"v":0.943257184966839,"d":"0.94"},{"v":-0.0842769105314919,"d":"-0.08"},"down",{"v":0.2621,"d":"0.26"},1,"no","TGGCCCAACACTAAGCAAAATGTGGAAACAGCAAATTGCACAGGTTGAACAGCTTAAGAA","FALSE","NM_138363","ref|NM_138363|ens|ENST00000582698|ens|ENST00000556440|ens|ENST00000553412","CEP95","centrosomal protein 95kDa","ref|Homo sapiens centrosomal protein 95kDa (CEP95), mRNA [NM_138363]","chr17",62503152,62534060,"GO:0000922(spindle pole);GO:0005737(cytoplasm);GO:0005813(centrosome)",null,"mRNA","agilent G3 V3"]
["A_23_P41976",1.91,4.99,2.02,4.45,4.46,{"v":4.7,"d":"4.70"},{"v":0.655400440852315,"d":"0.66"},{"v":-0.60955145158369,"d":"-0.61"},"down",{"v":0.26246,"d":"0.26"},1,"no","TTTAGGCTGCCAGTATTGTATTAAGCAGAACAGTATAACCTCGTATTTTAGCTCCAGGGT","FALSE","NM_145265","ref|NM_145265|ref|XM_005248246|gb|AK098567|gb|BC015349","CCDC127","coiled-coil domain containing 127","ref|Homo sapiens coiled-coil domain containing 127 (CCDC127), mRNA [NM_145265]","chr5",{"v":205988,"d":"205988.00"},217333,null,null,"mRNA","agilent G3 V3"]
["A_24_P346807",3.15,4.01,2.87,3.96,{"v":3.8,"d":"3.80"},3.86,{"v":0.863166953528399,"d":"0.86"},{"v":-0.212288462792348,"d":"-0.21"},"down",{"v":0.2654,"d":"0.27"},1,"no","AGGTGACAGAGGTACTATTATAATTCTTACTTGCAGAATGTTCAATCTACGAGTGTTCAT","FALSE","NM_022079","ref|NM_022079|ref|NM_015601|ref|NM_001278185|ref|NM_001278186","HERC4","HECT and RLD domain containing E3 ubiquitin protein ligase 4","ref|Homo sapiens HECT and RLD domain containing E3 ubiquitin protein ligase 4 (HERC4), transcript variant 1, mRNA [NM_022079]","chr10",69682752,69834983,"GO:0004842(ubiquitin-protein ligase activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0007283(spermatogenesis);GO:0016874(ligase activity);GO:0030154(cell differentiation);GO:0042787(protein ubiquitination involved in ubiquitin-dependent protein catabolic process)","04120(Ubiquitin mediated proteolysis)","mRNA","agilent G3 V3"]
["A_23_P397933",17.72,7.74,8.04,6.88,6.27,5.21,{"v":1.82461873638344,"d":"1.82"},{"v":0.867595036818689,"d":"0.87"},"up",{"v":0.26724,"d":"0.27"},1,"no","TTCCCCCTGATAAGATGAGGTAAAGCCAATGTAACCAAAAGGCAAAAATTACAATCGGTT","FALSE","NM_001879","ref|NM_001879|ens|ENST00000337774|gb|D17525|tc|THC2471555","MASP1","mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor)","ref|Homo sapiens mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) (MASP1), transcript variant 1, mRNA [NM_001879]","chr3",186935936,187009810,"GO:0001867(complement activation, lectin pathway);GO:0004252(serine-type endopeptidase activity);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006508(proteolysis);GO:0006898(receptor-mediated endocytosis);GO:0006956(complement activation);GO:0008233(peptidase activity);GO:0042803(protein homodimerization activity);GO:0045087(innate immune response);GO:0045916(negative regulation of complement activation);GO:0048306(calcium-dependent protein binding)","04610(Complement and coagulation cascades);05150(Staphylococcus aureus infection)","mRNA","agilent G3 V3"]
["A_23_P89431",5.83,{"v":7.5,"d":"7.50"},{"v":6.2,"d":"6.20"},6.12,5.98,5.18,{"v":1.13020833333333,"d":"1.13"},{"v":0.176588731723323,"d":"0.18"},"up",{"v":0.26906,"d":"0.27"},1,"no","GAAATTGCTTTTCCTCTTGAACCACAGTTCTACCCCTGGGATGTTTTGAGGGTCTTTGCA","FALSE","NM_002982","ref|NM_002982|ens|ENST00000582017|ens|ENST00000225831|gb|S69738","CCL2","chemokine (C-C motif) ligand 2","ref|Homo sapiens chemokine (C-C motif) ligand 2 (CCL2), mRNA [NM_002982]","chr17",32583228,32584222,"GO:0000165(MAPK cascade);GO:0001525(angiogenesis);GO:0001666(response to hypoxia);GO:0001912(positive regulation of leukocyte mediated cytotoxicity);GO:0001938(positive regulation of endothelial cell proliferation);GO:0002523(leukocyte migration involved in inflammatory response);GO:0002548(monocyte chemotaxis);GO:0002693(positive regulation of cellular extravasation);GO:0004672(protein kinase activity);GO:0005102(receptor binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005791(rough endoplasmic reticulum);GO:0006468(protein phosphorylation);GO:0006874(cellular calcium ion homeostasis);GO:0006935(chemotaxis);GO:0006954(inflammatory response);GO:0006959(humoral immune response);GO:0006987(activation of signaling protein activity involved in unfolded protein response);GO:0007010(cytoskeleton organization);GO:0007155(cell adhesion);GO:0007165(signal transduction);GO:0007166(cell surface receptor signaling pathway);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007187(G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger);GO:0007259(JAK-STAT cascade);GO:0007568(aging);GO:0008009(chemokine activity);GO:0008201(heparin binding);GO:0008360(regulation of cell shape);GO:0009408(response to heat);GO:0009611(response to wounding);GO:0009612(response to mechanical stimulus);GO:0009617(response to bacterium);GO:0009887(organ morphogenesis);GO:0010332(response to gamma radiation);GO:0010574(regulation of vascular endothelial growth factor production);GO:0010759(positive regulation of macrophage chemotaxis);GO:0014823(response to activity);GO:0016525(negative regulation of angiogenesis);GO:0019079(viral genome replication);GO:0019221(cytokine-mediated signaling pathway);GO:0019725(cellular homeostasis);GO:0030139(endocytic vesicle);GO:0030425(dendrite);GO:0030593(neutrophil chemotaxis);GO:0030968(endoplasmic reticulum unfolded protein response);GO:0031100(organ regeneration);GO:0031663(lipopolysaccharide-mediated signaling pathway);GO:0031727(CCR2 chemokine receptor binding);GO:0032570(response to progesterone stimulus);GO:0032760(positive regulation of tumor necrosis factor production);GO:0032869(cellular response to insulin stimulus);GO:0032967(positive regulation of collagen biosynthetic process);GO:0033552(response to vitamin B3);GO:0034351(negative regulation of glial cell apoptotic process);GO:0035684(helper T cell extravasation);GO:0035690(cellular response to drug);GO:0036006(cellular response to macrophage colony-stimulating factor stimulus);GO:0036120(cellular response to platelet-derived growth factor stimulus);GO:0043200(response to amino acid stimulus);GO:0043204(perikaryon);GO:0043491(protein kinase B signaling cascade);GO:0043524(negative regulation of neuron apoptotic process);GO:0043615(astrocyte cell migration);GO:0043679(axon terminus);GO:0044267(cellular protein metabolic process);GO:0044299(C-fiber);GO:0044344(cellular response to fibroblast growth factor stimulus);GO:0045202(synapse);GO:0045471(response to ethanol);GO:0046677(response to antibiotic)","04668(TNF signaling pathway);04060(Cytokine-cytokine receptor interaction);04621(NOD-like receptor signaling pathway);04062(Chemokine signaling pathway);05323(Rheumatoid arthritis);05164(Influenza A);05168(Herpes simplex infection);05144(Malaria);05142(Chagas disease (American trypanosomiasis))","mRNA","agilent G3 V3"]
["A_24_P20200",3.67,3.06,3.21,3.24,{"v":4.4,"d":"4.40"},3.76,{"v":0.871929824561404,"d":"0.87"},{"v":-0.197716067489818,"d":"-0.20"},"down",{"v":0.27206,"d":"0.27"},1,"no","CTGGAAATTTACACTCCAAGATTCTAGGACAAACACAGCGTATGTGGGCTCTGCAGTCAT","FALSE","NM_001267066","ref|NM_001267066|ref|NM_017958|ref|NM_001100623|ref|NM_001267064","PLEKHB2","pleckstrin homology domain containing, family B (evectins) member 2","ref|Homo sapiens pleckstrin homology domain containing, family B (evectins) member 2 (PLEKHB2), transcript variant 8, mRNA [NM_001267066]","chr2",131862416,131905370,"GO:0055038(recycling endosome membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3306272",5.74,4.98,5.69,5.24,4.84,5.26,{"v":1.06975228161669,"d":"1.07"},{"v":0.0972767560107794,"d":"0.10"},"up",{"v":0.27312,"d":"0.27"},1,"no","TTAAAACAAATTTGCACCCCACAGAACTCTTCTGCCTCAGATAACATAGAGGAACAGTAA","FALSE","NM_001145678","ref|NM_001145678|ens|ENST00000513200|ref|XM_006714588|gb|AK130941","KIAA0825","KIAA0825","ref|Homo sapiens KIAA0825 (KIAA0825), transcript variant 1, mRNA [NM_001145678]","chr5",93489712,93872831,null,null,"mRNA","agilent G3 V3"]
["A_23_P143559",5.21,5.26,5.65,5.39,{"v":5.1,"d":"5.10"},4.79,{"v":1.05497382198953,"d":"1.05"},{"v":0.0772072004922187,"d":"0.08"},"up",{"v":0.27606,"d":"0.28"},1,"no","CATGTCACTCCAGCAGCACAGGGGACGCAATGGGAGGCAGGGACACCTGGACAATATTTA","FALSE","NM_007098","ref|NM_007098|ref|NM_001835|ens|ENST00000412649|ens|ENST00000427926","CLTCL1","clathrin, heavy chain-like 1","ref|Homo sapiens clathrin, heavy chain-like 1 (CLTCL1), transcript variant 1, mRNA [NM_007098]","chr22",19166988,19279239,"GO:0004871(signal transducer activity);GO:0005198(structural molecule activity);GO:0005515(protein binding);GO:0005802(trans-Golgi network);GO:0005819(spindle);GO:0005905(coated pit);GO:0006886(intracellular protein transport);GO:0006898(receptor-mediated endocytosis);GO:0007067(mitosis);GO:0007165(signal transduction);GO:0009653(anatomical structure morphogenesis);GO:0016020(membrane);GO:0030130(clathrin coat of trans-Golgi network vesicle);GO:0030132(clathrin coat of coated pit);GO:0030135(coated vesicle);GO:0030136(clathrin-coated vesicle);GO:0046326(positive regulation of glucose import);GO:0070062(extracellular vesicular exosome)","04144(Endocytosis);04142(Lysosome);04961(Endocrine and other factor-regulated calcium reabsorption);04721(Synaptic vesicle cycle);05016(Huntington's disease);05100(Bacterial invasion of epithelial cells)","mRNA","agilent G3 V3"]
["A_33_P3374947",6.73,6.32,7.13,6.87,7.19,7.07,{"v":0.955040227165168,"d":"0.96"},{"v":-0.0663665928285835,"d":"-0.07"},"down",{"v":0.2769,"d":"0.28"},1,"no","ATCCAGATATGATCGAGTACCGGGGACGTCGTCGAACTCCCCGCATCGACCCGCCACTCA","FALSE","NM_138693","ref|NM_138693|gb|BC160035|gb|AF490374|tc|THC2719556","KLF14","Kruppel-like factor 14","ref|Homo sapiens Kruppel-like factor 14 (KLF14), mRNA [NM_138693]","chr7",130417400,130418888,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_33_P6579294",11.37,11.49,11.18,10.72,11.21,11.33,{"v":1.02345159350571,"d":"1.02"},{"v":0.0334428683986938,"d":"0.03"},"up",{"v":0.27798,"d":"0.28"},1,"no","ATTTTTGTATTTTTAGTAGAGACTGGGTTTCACCGTTGGCCAGGCGGGTCTCAAACTCCT","FALSE","ENST00000540766","ens|ENST00000540766|tc|THC2662381|tc|THC2653707","ELP2","elongator acetyltransferase complex subunit 2","ens|elongator acetyltransferase complex subunit 2 [Source:HGNC Symbol;Acc:HGNC:18248] [ENST00000540766]","chr18",33739720,33754995,"GO:0000123(histone acetyltransferase complex);GO:0000993(RNA polymerase II core binding);GO:0005737(cytoplasm);GO:0006325(chromatin organization);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0006368(transcription elongation from RNA polymerase II promoter);GO:0008023(transcription elongation factor complex);GO:0019901(protein kinase binding);GO:0033588(Elongator holoenzyme complex);GO:0046425(regulation of JAK-STAT cascade)",null,"mRNA","agilent G3 V3"]
["A_33_P3332135",14.89,{"v":14.9,"d":"14.90"},14.87,14.86,14.89,14.86,{"v":1.00112082492715,"d":"1.00"},{"v":0.00161610304889864,"d":"0.00"},"up",{"v":0.27944,"d":"0.28"},1,"no","TTTAAGCAGAACCAGCGAAACCCAAGCCCCTCCTTCCTCTGGTGTTTTACAACTATAAAG","FALSE","NM_001143804","ref|NM_001143804|ref|NM_178500|ens|ENST00000413580|ens|ENST00000310544","PHOSPHO1","phosphatase, orphan 1","ref|Homo sapiens phosphatase, orphan 1 (PHOSPHO1), transcript variant 1, mRNA [NM_001143804]","chr17",47300732,47308128,"GO:0001958(endochondral ossification);GO:0005829(cytosol);GO:0006644(phospholipid metabolic process);GO:0006646(phosphatidylethanolamine biosynthetic process);GO:0006656(phosphatidylcholine biosynthetic process);GO:0016311(dephosphorylation);GO:0016462(pyrophosphatase activity);GO:0016791(phosphatase activity);GO:0030500(regulation of bone mineralization);GO:0035630(bone mineralization involved in bone maturation);GO:0044281(small molecule metabolic process);GO:0046474(glycerophospholipid biosynthetic process);GO:0046872(metal ion binding);GO:0052731(phosphocholine phosphatase activity);GO:0052732(phosphoethanolamine phosphatase activity)","00564(Glycerophospholipid metabolism)","mRNA","agilent G3 V3"]
["A_33_P3339103",{"v":4.2,"d":"4.20"},6.42,4.05,5.78,6.29,5.57,{"v":0.831632653061225,"d":"0.83"},{"v":-0.265981689884131,"d":"-0.27"},"down",{"v":0.28124,"d":"0.28"},1,"no","GTGCCATAAAATGAGACTTTTTACGCCTTTATAAGGCCTTAGATGTAAATAAACTCACCC","FALSE","NM_203290","ref|NM_203290|ens|ENST00000372389|gb|BC008118|gb|AF008442","POLR1C","polymerase (RNA) I polypeptide C, 30kDa","ref|Homo sapiens polymerase (RNA) I polypeptide C, 30kDa (POLR1C), mRNA [NM_203290]","chr6",43484872,43489232,"GO:0001054(RNA polymerase I activity);GO:0001056(RNA polymerase III activity);GO:0003677(DNA binding);GO:0003899(DNA-directed RNA polymerase activity);GO:0005654(nucleoplasm);GO:0005666(DNA-directed RNA polymerase III complex);GO:0005736(DNA-directed RNA polymerase I complex);GO:0005829(cytosol);GO:0006360(transcription from RNA polymerase I promoter);GO:0006361(transcription initiation from RNA polymerase I promoter);GO:0006362(transcription elongation from RNA polymerase I promoter);GO:0006363(termination of RNA polymerase I transcription);GO:0006383(transcription from RNA polymerase III promoter);GO:0006385(transcription elongation from RNA polymerase III promoter);GO:0006386(termination of RNA polymerase III transcription);GO:0010467(gene expression);GO:0032481(positive regulation of type I interferon production);GO:0040029(regulation of gene expression, epigenetic);GO:0045087(innate immune response);GO:0045814(negative regulation of gene expression, epigenetic);GO:0046983(protein dimerization activity)","00230(Purine metabolism);00240(Pyrimidine metabolism);03020(RNA polymerase);04623(Cytosolic DNA-sensing pathway);05169(Epstein-Barr virus infection)","mRNA","agilent G3 V3"]
["A_23_P137423",6.74,{"v":6.4,"d":"6.40"},8.06,{"v":7.7,"d":"7.70"},{"v":7.8,"d":"7.80"},7.93,{"v":0.904822876653863,"d":"0.90"},{"v":-0.144292689412574,"d":"-0.14"},"down",{"v":0.28274,"d":"0.28"},1,"no","TACCATCACTTGCTGCTTCATGAAGAGGCTTCGAAAACGGTGATCCCTTACTCCCCAGGT","FALSE","NM_052868","ref|NM_052868|ref|NM_001206665|ens|ENST00000614243|ens|ENST00000314485","IGSF8","immunoglobulin superfamily, member 8","ref|Homo sapiens immunoglobulin superfamily, member 8 (IGSF8), transcript variant 1, mRNA [NM_052868]","chr1",160061136,160068479,"GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0006928(cellular component movement);GO:0007338(single fertilization);GO:0007399(nervous system development);GO:0007519(skeletal muscle tissue development);GO:0008283(cell proliferation);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0030424(axon);GO:0045202(synapse);GO:0070062(extracellular vesicular exosome);GO:2000145(regulation of cell motility)",null,"mRNA","agilent G3 V3"]
["A_23_P348323",{"v":11.7,"d":"11.70"},11.06,11.61,{"v":11.7,"d":"11.70"},{"v":11.8,"d":"11.80"},11.75,{"v":0.975035460992908,"d":"0.98"},{"v":-0.0364734058012212,"d":"-0.04"},"down",{"v":0.28378,"d":"0.28"},1,"no","AACTGGCTGCATATAGGAGTCAGTTAGAATTGTTTCTTTCTCTCCCCGTTTCTCTCCCCA","FALSE","NM_007144","ref|NM_007144|ens|ENST00000611883|ens|ENST00000616199|ens|ENST00000610440","PCGF2","polycomb group ring finger 2","ref|Homo sapiens polycomb group ring finger 2 (PCGF2), mRNA [NM_007144]","chr17",36890152,36904558,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000790(nuclear chromatin);GO:0001701(in utero embryonic development);GO:0001739(sex chromatin);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0004842(ubiquitin-protein ligase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-dependent);GO:0008270(zinc ion binding);GO:0009952(anterior/posterior pattern specification);GO:0016567(protein ubiquitination);GO:0016573(histone acetylation);GO:0016604(nuclear body);GO:0031519(PcG protein complex);GO:0035102(PRC1 complex);GO:0048704(embryonic skeletal system morphogenesis);GO:0070301(cellular response to hydrogen peroxide);GO:2001234(negative regulation of apoptotic signaling pathway)","04550(Signaling pathways regulating pluripotency of stem cells)","mRNA","agilent G3 V3"]
["A_24_P104538",4.78,1.86,4.97,5.43,5.36,5.19,{"v":0.726533166458073,"d":"0.73"},{"v":-0.46089943606241,"d":"-0.46"},"down",{"v":0.28564,"d":"0.29"},1,"no","TGTAATGATTGTAAACGGGCACAAGAGGGCAGCAGTGAGGAATTGTACTGTATCTGCAGA","FALSE","ENST00000579873","ens|ENST00000579873|ref|XM_006721770|ref|XM_005257152|gb|BC000924",null,null,"ref|PREDICTED: Homo sapiens bromodomain PHD finger transcription factor (BPTF), transcript variant X14, mRNA [XM_006721770]","chr17",62923864,62926923,null,null,"mRNA","agilent G3 V3"]
["A_33_P3237235",4.53,3.98,4.67,5.09,5.08,4.27,{"v":0.912742382271468,"d":"0.91"},{"v":-0.131720371879119,"d":"-0.13"},"down",{"v":0.28884,"d":"0.29"},1,"no","ATCTGCTGAACCCTGACTGGTAAACAACTGCTGTCAGAAAAGGGCTGGGCTTGGGAAGGG","FALSE","NM_001014765","ref|NM_001014765|ref|NM_033182|ref|NM_183412|ref|NM_183413","FBXO44","F-box protein 44","ref|Homo sapiens F-box protein 44 (FBXO44), transcript variant 4, mRNA [NM_001014765]","chr1",11714914,11723384,"GO:0005515(protein binding);GO:0019005(SCF ubiquitin ligase complex)",null,"mRNA","agilent G3 V3"]
["A_33_P3306624",5.32,1.95,4.87,5.42,5.49,5.77,{"v":0.727817745803357,"d":"0.73"},{"v":-0.458350867188982,"d":"-0.46"},"down",{"v":0.29014,"d":"0.29"},1,"no","TTGACAGCCTCAAGGTTCCTGGCTTTTTGAACCACCACAGACATCTCCTTTCCCGGCTAC","FALSE","NM_001524","ref|NM_001524|ens|ENST00000293330|gb|AF041240|gb|AW163686","HCRT","hypocretin (orexin) neuropeptide precursor","ref|Homo sapiens hypocretin (orexin) neuropeptide precursor (HCRT), mRNA [NM_001524]","chr17",40336080,40337470,"GO:0005576(extracellular region);GO:0005791(rough endoplasmic reticulum);GO:0007200(phospholipase C-activating G-protein coupled receptor signaling pathway);GO:0007204(elevation of cytosolic calcium ion concentration);GO:0007205(protein kinase C-activating G-protein coupled receptor signaling pathway);GO:0007218(neuropeptide signaling pathway);GO:0007268(synaptic transmission);GO:0008021(synaptic vesicle);GO:0008156(negative regulation of DNA replication);GO:0030054(cell junction);GO:0030141(secretory granule);GO:0031771(type 1 hypocretin receptor binding);GO:0031772(type 2 hypocretin receptor binding);GO:0042755(eating behavior);GO:0043267(negative regulation of potassium ion transport);GO:0046928(regulation of neurotransmitter secretion);GO:0048471(perinuclear region of cytoplasm);GO:0051928(positive regulation of calcium ion transport);GO:0051970(negative regulation of transmission of nerve impulse);GO:0051971(positive regulation of transmission of nerve impulse);GO:0060079(regulation of excitatory postsynaptic membrane potential)","04080(Neuroactive ligand-receptor interaction)","mRNA","agilent G3 V3"]
["A_23_P17134",{"v":6.8,"d":"6.80"},{"v":6.6,"d":"6.60"},6.82,7.17,6.71,6.89,{"v":0.973519499277804,"d":"0.97"},{"v":-0.0387182189416331,"d":"-0.04"},"down",{"v":0.29188,"d":"0.29"},1,"no","GCCCCATCTTGTGCCATGTTTTAAGTCTTCATGGATGTTCTGCATGTCATGGGGACTAAA","FALSE","NM_002371","ref|NM_002371|ref|NM_022438|ref|NM_022439|ref|NM_022440","MAL","mal, T-cell differentiation protein","ref|Homo sapiens mal, T-cell differentiation protein (MAL), transcript variant a, mRNA [NM_002371]","chr2",95691536,95719737,"GO:0001766(membrane raft polarization);GO:0005515(protein binding);GO:0005768(endosome);GO:0005783(endoplasmic reticulum);GO:0005887(integral to plasma membrane);GO:0006915(apoptotic process);GO:0007417(central nervous system development);GO:0008289(lipid binding);GO:0015267(channel activity);GO:0016324(apical plasma membrane);GO:0016505(apoptotic protease activator activity);GO:0019898(extrinsic to membrane);GO:0019911(structural constituent of myelin sheath);GO:0030154(cell differentiation);GO:0042552(myelination);GO:0045121(membrane raft);GO:0045176(apical protein localization);GO:0055085(transmembrane transport)",null,"mRNA","agilent G3 V3"]
["A_33_P3389578",3.95,2.68,3.69,3.61,4.31,3.98,{"v":0.867226890756303,"d":"0.87"},{"v":-0.205518602772052,"d":"-0.21"},"down",{"v":0.29448,"d":"0.29"},1,"no","TCCAGTAATCTCAGCACTTTGGTATGCTGGGGTGAGAGTATCACTTGAGGTCAGAAGTTT","FALSE",{"$nulls":5},"chr12",{"v":4219194,"d":"4219194.00"},4227298,null,null,"mRNA","agilent G3 V3"]
["A_33_P3278068",4.95,3.66,4.96,5.04,4.92,5.19,{"v":0.895709570957096,"d":"0.90"},{"v":-0.158897072941459,"d":"-0.16"},"down",{"v":0.29616,"d":"0.30"},1,"no","TGACGGGGATGAAACAATTGAAACTATTGAGGCTGCTGAGGCACTCCTCAATATGGATTC","FALSE","NM_001145353","ref|NM_001145353|ref|NM_172373|ens|ENST00000239882|ens|ENST00000498824","ELF1","E74-like factor 1 (ets domain transcription factor)","ref|Homo sapiens E74-like factor 1 (ets domain transcription factor) (ELF1), transcript variant 2, mRNA [NM_001145353]","chr13",41506056,41556418,"GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0000981(sequence-specific DNA binding RNA polymerase II transcription factor activity);GO:0001077(RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription);GO:0001817(regulation of cytokine production);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006366(transcription from RNA polymerase II promoter);GO:0030154(cell differentiation);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0050860(negative regulation of T cell receptor signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_33_P3258004",7.34,{"v":7.3,"d":"7.30"},7.33,7.26,7.22,6.62,{"v":1.04123222748815,"d":"1.04"},{"v":0.0582918708287289,"d":"0.06"},"up",{"v":0.2968,"d":"0.30"},1,"no","TACAAGCAAGAAAAGGGGGACACTCCTCCACACTTCCAGAAAGCTTTGAAAACAAACCCT","FALSE","NM_152788","ref|NM_152788|ref|NM_020140|ref|NM_001204081|ens|ENST00000546960","ANKS1B","ankyrin repeat and sterile alpha motif domain containing 1B","ref|Homo sapiens ankyrin repeat and sterile alpha motif domain containing 1B (ANKS1B), transcript variant 1, mRNA [NM_152788]","chr12",99139520,99548270,"GO:0005737(cytoplasm);GO:0014069(postsynaptic density);GO:0015030(Cajal body);GO:0030054(cell junction);GO:0043197(dendritic spine);GO:0045211(postsynaptic membrane);GO:0046875(ephrin receptor binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3249529",7.26,6.89,{"v":6.9,"d":"6.90"},6.69,7.03,6.76,{"v":1.02783203125,"d":"1.03"},{"v":0.0396045179537584,"d":"0.04"},"up",{"v":0.30036,"d":"0.30"},1,"no","GTGAGTGTGTGTGTGTCTGAGTGTTATTCTGAACAGCTTGTAAATATTGTAGTTGTTTAA","FALSE","NM_014982","ref|NM_014982|ens|ENST00000304743|ref|XM_005267420|ref|XM_005267421","PCNX","pecanex homolog (Drosophila)","ref|Homo sapiens pecanex homolog (Drosophila) (PCNX), mRNA [NM_014982]","chr14",71374120,71582099,"GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P257176",4.27,2.21,4.92,4.56,5.39,4.52,{"v":0.787836903939184,"d":"0.79"},{"v":-0.344031097479621,"d":"-0.34"},"down",{"v":0.30214,"d":"0.30"},1,"no","GGGGTGGCAGCGCTCAGCAGCATTCAGTTCACTAATAGGGTGAAGCTGTTGTTGATGCCA","FALSE","NM_031467","ref|NM_031467|ref|NM_001258426|ref|NM_001258428|ref|NM_001258427","SLC4A9","solute carrier family 4, sodium bicarbonate cotransporter, member 9","ref|Homo sapiens solute carrier family 4, sodium bicarbonate cotransporter, member 9 (SLC4A9), transcript variant 2, mRNA [NM_031467]","chr5",139739792,139754728,"GO:0005452(inorganic anion exchanger activity);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0006811(ion transport);GO:0008510(sodium:bicarbonate symporter activity);GO:0015701(bicarbonate transport);GO:0035725(sodium ion transmembrane transport);GO:0045177(apical part of cell);GO:0051453(regulation of intracellular pH);GO:0055085(transmembrane transport)",null,"mRNA","agilent G3 V3"]
["A_24_P168994",5.67,10.75,6.15,{"v":5.7,"d":"5.70"},5.03,5.12,{"v":1.42397476340694,"d":"1.42"},{"v":0.509923578165066,"d":"0.51"},"up",{"v":0.30372,"d":"0.30"},1,"no","ACCTTCCTGCCCAAAAAAGGAGGAACGAGGGTCAACCAGCAGCAGACCAGTCACAAAAAG","FALSE","NM_178571","ref|NM_178571|ens|ENST00000491819|ens|ENST00000469477|ens|ENST00000413242","TBC1D26","TBC1 domain family, member 26","ref|Homo sapiens TBC1 domain family, member 26 (TBC1D26), mRNA [NM_178571]","chr17",15635591,15648095,"GO:0005097(Rab GTPase activator activity);GO:0032851(positive regulation of Rab GTPase activity)",null,"mRNA","agilent G3 V3"]
["A_32_P511713",{"v":9.3,"d":"9.30"},9.09,9.48,9.09,9.07,9.26,{"v":1.0164113785558,"d":"1.02"},{"v":0.0234844313245832,"d":"0.02"},"up",{"v":0.30564,"d":"0.31"},1,"no","TCCGGCTACTTCGGTCATTACCTGTTGCCTTCTCCTGCCTCAAGTTTTCACTGCAGTCTA","FALSE","NM_173525","ref|NM_173525|ens|ENST00000316375|gb|BC031612|tc|THC2484466","C11orf42","chromosome 11 open reading frame 42","ref|Homo sapiens chromosome 11 open reading frame 42 (C11orf42), mRNA [NM_173525]","chr11",{"v":6226796,"d":"6226796.00"},6232362,null,null,"mRNA","agilent G3 V3"]
["A_23_P93213",7.38,6.02,7.26,6.88,6.22,5.47,{"v":1.11254711900915,"d":"1.11"},{"v":0.153866438929638,"d":"0.15"},"up",{"v":0.30716,"d":"0.31"},1,"no","AGAGAAAGAGTGCCCCAACCAGTCTTCAGGAGGAAGAGATGCCCATGAAGCAGGTCCAGA","FALSE","NM_153320","ref|NM_153320|ref|NM_006672|ens|ENST00000372585|ens|ENST00000372589","SLC22A7","solute carrier family 22 (organic anion transporter), member 7","ref|Homo sapiens solute carrier family 22 (organic anion transporter), member 7 (SLC22A7), transcript variant 2, mRNA [NM_153320]","chr6",43266000,43273276,"GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0015347(sodium-independent organic anion transmembrane transporter activity);GO:0015711(organic anion transport);GO:0016020(membrane);GO:0016323(basolateral plasma membrane);GO:0034220(ion transmembrane transport);GO:0035634(response to stilbenoid);GO:0055085(transmembrane transport)","04976(Bile secretion)","mRNA","agilent G3 V3"]
["A_24_P225518",5.75,5.68,4.19,4.17,4.57,4.94,{"v":1.14181286549708,"d":"1.14"},{"v":0.191326223256082,"d":"0.19"},"up",{"v":0.30884,"d":"0.31"},1,"no","TTTCTGAACAGCCTGGGCACCATCTTCTCATTCATCTCCAAGGACGTGGTCTCCAAGCTG","FALSE","NM_001029885","ref|NM_001029885|ens|ENST00000488011|ens|ENST00000464957|ens|ENST00000343938","CPTP","ceramide-1-phosphate transfer protein","ref|Homo sapiens ceramide-1-phosphate transfer protein (CPTP), mRNA [NM_001029885]","chr1",{"v":1260621,"d":"1260621.00"},1262851,"GO:0005543(phospholipid binding);GO:0005548(phospholipid transporter activity);GO:0005640(nuclear outer membrane);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0010008(endosome membrane);GO:0046836(glycolipid transport);GO:0051861(glycolipid binding)",null,"mRNA","agilent G3 V3"]
["A_24_P287075",4.04,2.17,4.07,4.15,4.39,3.97,{"v":0.821742605915268,"d":"0.82"},{"v":-0.283241524971941,"d":"-0.28"},"down",{"v":0.31008,"d":"0.31"},1,"no","GAAACAAGGATCTTCCGAGTGCTTGGGGCCCACAGAGACATCATCCTGGAGAGCATTCCC","FALSE","NM_004579","ref|NM_004579|ens|ENST00000433890|ens|ENST00000294066|ens|ENST00000470088","MAP4K2","mitogen-activated protein kinase kinase kinase kinase 2","ref|Homo sapiens mitogen-activated protein kinase kinase kinase kinase 2 (MAP4K2), mRNA [NM_004579]","chr11",64556288,64570634,"GO:0000139(Golgi membrane);GO:0004674(protein serine/threonine kinase activity);GO:0004702(receptor signaling protein serine/threonine kinase activity);GO:0005083(small GTPase regulator activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0006903(vesicle targeting);GO:0006955(immune response);GO:0007254(JNK cascade);GO:0007257(activation of JUN kinase activity);GO:0016323(basolateral plasma membrane);GO:0031435(mitogen-activated protein kinase kinase kinase binding);GO:0035556(intracellular signal transduction);GO:0045087(innate immune response);GO:0046330(positive regulation of JNK cascade)","04010(MAPK signaling pathway)","mRNA","agilent G3 V3"]
["A_33_P3234292",4.65,6.51,4.41,4.19,4.53,4.51,{"v":1.17687074829932,"d":"1.18"},{"v":0.23495588280036,"d":"0.23"},"up",{"v":0.31076,"d":"0.31"},1,"no","TGCTCCCACGTCACAAGAACCTGCATATACATTATATTCATTAATTCAGCCTTCCAGGAA","FALSE","NM_001166663","ref|NM_001166663|ref|NM_016382|ref|NM_001166664|ens|ENST00000481677","CD244","CD244 molecule, natural killer cell receptor 2B4","ref|Homo sapiens CD244 molecule, natural killer cell receptor 2B4 (CD244), transcript variant 2, mRNA [NM_001166663]","chr1",160802480,160832692,"GO:0004872(receptor activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0007165(signal transduction);GO:0007596(blood coagulation);GO:0009897(external side of plasma membrane);GO:0016021(integral to membrane);GO:0050900(leukocyte migration)","04650(Natural killer cell mediated cytotoxicity)","mRNA","agilent G3 V3"]
["A_23_P29747",11.75,13.12,11.53,12.71,12.75,12.95,{"v":0.947669877636032,"d":"0.95"},{"v":-0.0775435134450065,"d":"-0.08"},"down",{"v":0.3143,"d":"0.31"},1,"no","GCTTTGGATGTTGCCAACAAAATTGGGATCATCTAAACTGAGTCCAGCTGCCTAATTCTG","FALSE","NM_000984","ref|NM_000984|ens|ENST00000580755|ens|ENST00000422514|gb|U43701","RPL23A","ribosomal protein L23a","ref|Homo sapiens ribosomal protein L23a (RPL23A), mRNA [NM_000984]","chr9",{"v":6639139,"d":"6639139.00"},6639604,"GO:0000166(nucleotide binding);GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay);GO:0003735(structural constituent of ribosome);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0006412(translation);GO:0006413(translational initiation);GO:0006414(translational elongation);GO:0006415(translational termination);GO:0006614(SRP-dependent cotranslational protein targeting to membrane);GO:0008283(cell proliferation);GO:0010467(gene expression);GO:0016032(viral reproduction);GO:0019058(viral infectious cycle);GO:0019083(viral transcription);GO:0019843(rRNA binding);GO:0022625(cytosolic large ribosomal subunit);GO:0031932(TORC2 complex);GO:0044267(cellular protein metabolic process);GO:0070062(extracellular vesicular exosome)","03010(Ribosome)","mRNA","agilent G3 V3"]
["A_23_P257743",7.71,7.38,7.75,7.83,7.68,7.76,{"v":0.981521272024065,"d":"0.98"},{"v":-0.0269085600425057,"d":"-0.03"},"down",{"v":0.31542,"d":"0.32"},1,"no","ACGTTCTGGGTCAGAACAGCCCTCCGTTCGACAGTGTCCCGGAAGTCATCCACTACTACA","FALSE","NM_003028","ref|NM_003028|ens|ENST00000377707|gb|BC136581|gb|BC136582","SHB","Src homology 2 domain containing adaptor protein B","ref|Homo sapiens Src homology 2 domain containing adaptor protein B (SHB), mRNA [NM_003028]","chr9",37919132,38069208,"GO:0001525(angiogenesis);GO:0005070(SH3/SH2 adaptor activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006915(apoptotic process);GO:0007165(signal transduction);GO:0009967(positive regulation of signal transduction);GO:0030154(cell differentiation);GO:0048010(vascular endothelial growth factor receptor signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_23_P59772",7.53,7.46,7.72,{"v":7.6,"d":"7.60"},7.76,7.66,{"v":0.986533449174631,"d":"0.99"},{"v":-0.0195601274253425,"d":"-0.02"},"down",{"v":0.31778,"d":"0.32"},1,"no","TCCATCTTCCAGTCCCTGCTTCACTGCTTGCTGGGCAGAGCTCGCCCCACAAAGAAGAAA","FALSE","NM_000083","ref|NM_000083|ref|NR_046453|ens|ENST00000343257|gb|AB462980","CLCN1","chloride channel, voltage-sensitive 1","ref|Homo sapiens chloride channel, voltage-sensitive 1 (CLCN1), transcript variant 1, mRNA [NM_000083]","chr7",143013216,143049176,"GO:0005247(voltage-gated chloride channel activity);GO:0005254(chloride channel activity);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0006810(transport);GO:0006936(muscle contraction);GO:0019227(neuronal action potential propagation);GO:0034220(ion transmembrane transport);GO:0034707(chloride channel complex);GO:0034765(regulation of ion transmembrane transport);GO:0042383(sarcolemma);GO:0044070(regulation of anion transport);GO:0055085(transmembrane transport)",null,"mRNA","agilent G3 V3"]
["A_22_P00003220",{"v":8.4,"d":"8.40"},8.08,8.42,8.26,{"v":8.1,"d":"8.10"},8.13,{"v":1.01674152715394,"d":"1.02"},{"v":0.0239529683914649,"d":"0.02"},"up",{"v":0.32044,"d":"0.32"},1,"no","ATGTTCCCGGGGACTCCCTCCACTGAGCTGGCGCACTCCTAACAGCAGCCATCAGTTTGG","FALSE","ENST00000449188","ens|ENST00000449188|linc|lnc-CACNA1S-1:1|linc|TCONS_00000713","ASCL5","achaete-scute family bHLH transcription factor 5","ens|achaete-scute family bHLH transcription factor 5 [Source:HGNC Symbol;Acc:HGNC:33169] [ENST00000449188]","chr1",201083088,201096312,"GO:0003674(molecular_function);GO:0003677(DNA binding);GO:0005575(cellular_component);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0008150(biological_process);GO:0046983(protein dimerization activity)",null,"mRNA","agilent G3 V3"]
["A_23_P30649",{"v":2.4,"d":"2.40"},3.66,4.27,4.88,3.76,{"v":3.9,"d":"3.90"},{"v":0.823763955342903,"d":"0.82"},{"v":-0.279697093936979,"d":"-0.28"},"down",{"v":0.32278,"d":"0.32"},1,"no","ATCAAGCCTACCAGCCACTGATGCAGCCCTAATTTTTGTGCTGACCATAGGAGTCATTAT","FALSE","NM_030960","ref|NM_030960|ens|ENST00000237201|ens|ENST00000462227|ref|XR_241854","SPACA1","sperm acrosome associated 1","ref|Homo sapiens sperm acrosome associated 1 (SPACA1), mRNA [NM_030960]","chr6",88769168,88776550,"GO:0001675(acrosome assembly);GO:0002080(acrosomal membrane);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_32_P36235",7.26,8.16,7.62,7.76,8.95,7.88,{"v":0.936966246441643,"d":"0.94"},{"v":-0.09393101815377,"d":"-0.09"},"down",{"v":0.32408,"d":"0.32"},1,"no","AGGGGAACATCCTTGCCAGGGAGTTTCTGAGGGTCTGTTTTGTTTACCTTTCGTGCGGTG","FALSE","NM_004907","ref|NM_004907|ens|ENST00000588173|ens|ENST00000292433|gb|M62831","IER2","immediate early response 2","ref|Homo sapiens immediate early response 2 (IER2), mRNA [NM_004907]","chr19",13262789,13265722,"GO:0005737(cytoplasm)",null,"mRNA","agilent G3 V3"]
["A_23_P46755",5.65,5.12,5.97,5.46,5.28,{"v":5.1,"d":"5.10"},{"v":1.05681818181818,"d":"1.06"},{"v":0.0797271924707339,"d":"0.08"},"up",{"v":0.32686,"d":"0.33"},1,"no","ACACCCATCATTGTATGTTATTTCCCACAACCCAGTTGGAGGGGCATGGCTTCCAATTTA","FALSE","NM_016204","ref|NM_016204|ens|ENST00000581492|gb|AF188285|tc|THC2483043","GDF2","growth differentiation factor 2","ref|Homo sapiens growth differentiation factor 2 (GDF2), mRNA [NM_016204]","chr10",48413092,48416853,"GO:0001503(ossification);GO:0001525(angiogenesis);GO:0001569(patterning of blood vessels);GO:0001570(vasculogenesis);GO:0001649(osteoblast differentiation);GO:0001937(negative regulation of endothelial cell proliferation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0005125(cytokine activity);GO:0005160(transforming growth factor beta receptor binding);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0006879(cellular iron ion homeostasis);GO:0008083(growth factor activity);GO:0008156(negative regulation of DNA replication);GO:0010596(negative regulation of endothelial cell migration);GO:0010862(positive regulation of pathway-restricted SMAD protein phosphorylation);GO:0016525(negative regulation of angiogenesis);GO:0030308(negative regulation of cell growth);GO:0030509(BMP signaling pathway);GO:0030513(positive regulation of BMP signaling pathway);GO:0032757(positive regulation of interleukin-8 production);GO:0032924(activin receptor signaling pathway);GO:0040007(growth);GO:0042981(regulation of apoptotic process);GO:0043408(regulation of MAPK cascade);GO:0043537(negative regulation of blood vessel endothelial cell migration);GO:0045603(positive regulation of endothelial cell differentiation);GO:0045669(positive regulation of osteoblast differentiation);GO:0045766(positive regulation of angiogenesis);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048468(cell development);GO:0048514(blood vessel morphogenesis);GO:0051216(cartilage development);GO:0060389(pathway-restricted SMAD protein phosphorylation);GO:0060395(SMAD protein signal transduction);GO:0070062(extracellular vesicular exosome);GO:0071773(cellular response to BMP stimulus);GO:2000279(negative regulation of DNA biosynthetic process)",null,"mRNA","agilent G3 V3"]
["A_23_P43810",3.84,5.25,2.28,4.17,4.68,5.78,{"v":0.77717019822283,"d":"0.78"},{"v":-0.363697515246239,"d":"-0.36"},"down",{"v":0.3299,"d":"0.33"},1,"no","CATATGTAAAATTCAATGGAAGAGAGGTGGAACAGTGCTGTTATTTTAAACAGAAGGTTG","FALSE","NM_206943","ref|NM_206943|ref|NM_000627|ref|NM_001166264|ref|NM_001166265","LTBP1","latent transforming growth factor beta binding protein 1","ref|Homo sapiens latent transforming growth factor beta binding protein 1 (LTBP1), transcript variant 1, mRNA [NM_206943]","chr2",33516716,33623755,"GO:0001527(microfibril);GO:0005024(transforming growth factor beta-activated receptor activity);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005578(proteinaceous extracellular matrix);GO:0007178(transmembrane receptor protein serine/threonine kinase signaling pathway);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix);GO:0035583(sequestering of TGFbeta in extracellular matrix);GO:0043234(protein complex);GO:0050431(transforming growth factor beta binding);GO:0050436(microfibril binding)","04350(TGF-beta signaling pathway)","mRNA","agilent G3 V3"]
["A_33_P3303245",4.41,2.55,4.73,4.14,4.93,5.07,{"v":0.826732673267327,"d":"0.83"},{"v":-0.274507190277742,"d":"-0.27"},"down",{"v":0.33096,"d":"0.33"},1,"no","AGTTCAGCGAGAGTTAATGATTCTGGAGTGTTCATGTGTTATGCCAATAATACTTTTGGA","FALSE","NM_001093772","ref|NM_001093772|ref|NM_000222|ens|ENST00000288135|ref|XM_006714038","KIT","v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog","ref|Homo sapiens v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (KIT), transcript variant 2, mRNA [NM_001093772]","chr4",55524084,55606881,"GO:0000187(activation of MAPK activity);GO:0001541(ovarian follicle development);GO:0001669(acrosomal vesicle);GO:0002020(protease binding);GO:0002318(myeloid progenitor cell differentiation);GO:0002320(lymphoid progenitor cell differentiation);GO:0002327(immature B cell differentiation);GO:0002371(dendritic cell cytokine production);GO:0002551(mast cell chemotaxis);GO:0004713(protein tyrosine kinase activity);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0004716(receptor signaling protein tyrosine kinase activity);GO:0005020(stem cell factor receptor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005615(extracellular space);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0006687(glycosphingolipid metabolic process);GO:0006954(inflammatory response);GO:0007165(signal transduction);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007283(spermatogenesis);GO:0007286(spermatid development);GO:0008284(positive regulation of cell proliferation);GO:0008354(germ cell migration);GO:0008360(regulation of cell shape);GO:0008542(visual learning);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0008584(male gonad development);GO:0009897(external side of plasma membrane);GO:0009898(internal side of plasma membrane);GO:0010628(positive regulation of gene expression);GO:0010863(positive regulation of phospholipase C activity);GO:0014068(positive regulation of phosphatidylinositol 3-kinase cascade);GO:0016021(integral to membrane);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0019221(cytokine-mediated signaling pathway);GO:0019827(stem cell maintenance);GO:0019955(cytokine binding);GO:0023014(signal transduction by phosphorylation);GO:0030032(lamellipodium assembly);GO:0030097(hemopoiesis);GO:0030217(T cell differentiation);GO:0030218(erythrocyte differentiation);GO:0030318(melanocyte differentiation);GO:0030335(positive regulation of cell migration);GO:0031274(positive regulation of pseudopodium assembly);GO:0031532(actin cytoskeleton reorganization);GO:0032762(mast cell cytokine production);GO:0035019(somatic stem cell maintenance);GO:0035162(embryonic hemopoiesis);GO:0035234(germ cell programmed cell death);GO:0035855(megakaryocyte development);GO:0038093(Fc receptor signaling pathway);GO:0038095(Fc-epsilon receptor signaling pathway);GO:0038109(Kit signaling pathway);GO:0038162(erythropoietin-mediated signaling pathway);GO:0042127(regulation of cell proliferation);GO:0042511(positive regulation of tyrosine phosphorylation of Stat1 protein);GO:0042517(positive regulation of tyrosine phosphorylation of Stat3 protein);GO:0042523(positive regulation of tyrosine phosphorylation of Stat5 protein);GO:0042629(mast cell granule);GO:0042803(protein homodimerization activity);GO:0043069(negative regulation of programmed cell death);GO:0043303(mast cell degranulation);GO:0043410(positive regulation of MAPK cascade);GO:0043473(pigmentation);GO:0043552(positive regulation of phosphatidylinositol 3-kinase activity);GO:0045087(innate immune response)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04151(PI3K-Akt signaling pathway);04060(Cytokine-cytokine receptor interaction);04144(Endocytosis);04640(Hematopoietic cell lineage);04916(Melanogenesis);05200(Pathways in cancer);05230(Central carbon metabolism in cancer);05221(Acute myeloid leukemia)","mRNA","agilent G3 V3"]
["A_24_P200023",4.77,5.48,3.72,4.74,5.35,5.88,{"v":0.874765184721353,"d":"0.87"},{"v":-0.193032292001769,"d":"-0.19"},"down",{"v":0.33454,"d":"0.33"},1,"no","ATAATTTTCCTCCTAAACAAAAACACATTGAGTTTAAGTCTCTGACTCTTGCCTTTCCAC","FALSE","NM_000877","ref|NM_000877|ref|NM_001288706|ens|ENST00000410023|ref|XM_005263933","IL1R1","interleukin 1 receptor, type I","ref|Homo sapiens interleukin 1 receptor, type I (IL1R1), transcript variant 1, mRNA [NM_000877]","chr2",102770400,102796334,"GO:0002020(protease binding);GO:0004871(signal transducer activity);GO:0004888(transmembrane signaling receptor activity);GO:0004908(interleukin-1 receptor activity);GO:0004909(interleukin-1, Type I, activating receptor activity);GO:0005161(platelet-derived growth factor receptor binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0006955(immune response);GO:0007166(cell surface receptor signaling pathway);GO:0009986(cell surface);GO:0016020(membrane);GO:0050727(regulation of inflammatory response);GO:0070498(interleukin-1-mediated signaling pathway);GO:0070555(response to interleukin-1)","04010(MAPK signaling pathway);04064(NF-kappa B signaling pathway);04060(Cytokine-cytokine receptor interaction);04210(Apoptosis);04640(Hematopoietic cell lineage);04750(Inflammatory mediator regulation of TRP channels);04380(Osteoclast differentiation);05166(HTLV-I infection);05146(Amoebiasis)","mRNA","agilent G3 V3"]
["A_23_P68851",6.64,7.24,6.64,7.02,6.84,8.38,{"v":0.922661870503597,"d":"0.92"},{"v":-0.116126057116454,"d":"-0.12"},"down",{"v":0.3367,"d":"0.34"},1,"no","CATCGTGGGTCTCATGCACGTCAAGACCTTCCCACATCCAAACTCAGCTTCCAGCAGGGA","FALSE","NM_001039570","ref|NM_001039570|ens|ENST00000400335|gb|AK172861|tc|THC2471664","KREMEN1","kringle containing transmembrane protein 1","ref|Homo sapiens kringle containing transmembrane protein 1 (KREMEN1), transcript variant 3, mRNA [NM_001039570]","chr22",29469066,29542801,"GO:0005515(protein binding);GO:0007154(cell communication);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0016055(Wnt receptor signaling pathway);GO:0060828(regulation of canonical Wnt receptor signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_33_P3409266",{"v":5.3,"d":"5.30"},2.77,4.44,5.12,5.24,4.94,{"v":0.81764705882353,"d":"0.82"},{"v":-0.290449863414194,"d":"-0.29"},"down",{"v":0.33964,"d":"0.34"},1,"no","AGATGTGGAGCCTGTGACCAGATGTCATCTTTCCTCTCTTCAGTCTCACAGCTAATTCTA","FALSE","AF220234","gb|AF220234|tc|THC2486545","GAFA2","FGF-2 activity-associated protein 2","gb|Homo sapiens FGF-2 activity-associated protein 2 (GAFA2) mRNA, complete cds. [AF220234]","chr16",81497496,81498464,null,null,"mRNA","agilent G3 V3"]
["A_19_P00322762",6.77,8.95,6.14,6.48,6.07,6.51,{"v":1.14690451206716,"d":"1.15"},{"v":0.197745281761962,"d":"0.20"},"up",{"v":0.34036,"d":"0.34"},1,"no","CTTGGCTCTTCCTGGTTTTGTATTCTCTTTTGTGATTTTGCCGCATACATGCTTTTGATG","FALSE","ENST00000598190","ens|ENST00000598190|ens|ENST00000598199|ens|ENST00000595202|gb|AK307375","ZNF83","zinc finger protein 83","ens|zinc finger protein 83 [Source:HGNC Symbol;Acc:HGNC:13158] [ENST00000598190]","chr19",53158120,53193727,"GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3210516",4.36,1.91,3.52,4.17,4.34,3.97,{"v":0.784455128205128,"d":"0.78"},{"v":-0.350237169258553,"d":"-0.35"},"down",{"v":0.34258,"d":"0.34"},1,"no","ACCATGGAGATGCAAACTACCTCCTTTAAATCTGTGAGAATTCTAGCATGTTCACTGTTC","FALSE",{"$nulls":5},"chr2",20988648,21022870,null,null,"mRNA","agilent G3 V3"]
["A_21_P0014763",4.82,5.03,4.73,4.84,5.01,5.11,{"v":0.974598930481284,"d":"0.97"},{"v":-0.0371194555606994,"d":"-0.04"},"down",{"v":0.34636,"d":"0.35"},1,"no","TACTTGTTGCCGCAGTTGATGAGGCCGAACTGGATCTGCACCGCCTCGGCTGTGCCGTTG","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_24_P8371",5.01,7.63,{"v":5.9,"d":"5.90"},7.22,7.26,6.61,{"v":0.879089615931721,"d":"0.88"},{"v":-0.185917851168161,"d":"-0.19"},"down",{"v":0.34652,"d":"0.35"},1,"no","GCTGCTGATTGTGAATCTCAGAGTCTTAAGAGAGAAGCCAAATATATTCCTCTTGTAAAT","FALSE","NM_001124758","ref|NM_001124758|ens|ENST00000329078|ens|ENST00000570979|ref|XM_006721449","SPNS2","spinster homolog 2 (Drosophila)","ref|Homo sapiens spinster homolog 2 (Drosophila) (SPNS2), mRNA [NM_001124758]","chr17",{"v":4440057,"d":"4440057.00"},4442330,"GO:0001782(B cell homeostasis);GO:0002920(regulation of humoral immune response);GO:0003376(sphingosine-1-phosphate signaling pathway);GO:0005765(lysosomal membrane);GO:0006665(sphingolipid metabolic process);GO:0006869(lipid transport);GO:0016021(integral to membrane);GO:0031982(vesicle);GO:0040011(locomotion);GO:0043029(T cell homeostasis);GO:0046624(sphingolipid transporter activity);GO:0048073(regulation of eye pigmentation);GO:0048535(lymph node development);GO:0055085(transmembrane transport);GO:0060348(bone development);GO:0072676(lymphocyte migration)",null,"mRNA","agilent G3 V3"]
["A_22_P00015194",6.16,4.99,6.05,6.05,4.79,4.38,{"v":1.13009198423127,"d":"1.13"},{"v":0.176440206085915,"d":"0.18"},"up",{"v":0.35108,"d":"0.35"},1,"no","AATCCTGGCAGGACAAGGAAAACCCCGTCAAAGATTTGCATAAATTTTGCTGCTCTCCTG","FALSE","XR_433328","ref|XR_433328|ref|XR_433329|ref|XR_433330|ref|XR_433332","LOC100996842","uncharacterized LOC100996842","ref|PREDICTED: Homo sapiens uncharacterized LOC100996842 (LOC100996842), transcript variant X5, misc_RNA [XR_433328]","chr17",{"v":7485323,"d":"7485323.00"},7487390,null,null,"mRNA","agilent G3 V3"]
["A_33_P3273490",4.27,{"v":3.7,"d":"3.70"},4.03,{"v":4.2,"d":"4.20"},4.16,4.24,{"v":0.952380952380952,"d":"0.95"},{"v":-0.0703893278913979,"d":"-0.07"},"down",{"v":0.35338,"d":"0.35"},1,"no","TACGAGCAAGGCGTCAAGAAGGACAAGTTTCCCATCAACCATCCAAACCTGACCTTCTCC","FALSE","ENST00000379435","ens|ENST00000379435",null,null,"ens|T cell receptor beta variable 20/OR9-2 (non-functional) [Source:HGNC Symbol;Acc:HGNC:12197] [ENST00000379435]","chr9",33617760,33618504,null,null,"mRNA","agilent G3 V3"]
["A_23_P68740",9.86,10.16,9.75,10.24,9.85,10.24,{"v":0.981536432575008,"d":"0.98"},{"v":-0.0268862763861346,"d":"-0.03"},"down",{"v":0.35504,"d":"0.36"},1,"no","GCTCTGTGTTTCTGGGGACACCAGCCATCATGTGCCTGGAAATTAAACCCTGCCCCACTT","FALSE","NM_000383","ref|NM_000383|ens|ENST00000337909|ens|ENST00000397994|ens|ENST00000291582","AIRE","autoimmune regulator","ref|Homo sapiens autoimmune regulator (AIRE), mRNA [NM_000383]","chr21",45710688,45718102,"GO:0000977(RNA polymerase II regulatory region sequence-specific DNA binding);GO:0001228(RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription);GO:0003682(chromatin binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0006417(regulation of translation);GO:0006955(immune response);GO:0006959(humoral immune response);GO:0008270(zinc ion binding);GO:0042393(histone binding);GO:0042802(identical protein binding);GO:0044212(transcription regulatory region DNA binding);GO:0045182(translation regulator activity);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0045944(positive regulation of transcription from RNA polymerase II promoter)","04120(Ubiquitin mediated proteolysis);05340(Primary immunodeficiency)","mRNA","agilent G3 V3"]
["A_24_P194755",4.65,2.46,3.62,4.39,4.45,3.92,{"v":0.840909090909091,"d":"0.84"},{"v":-0.249978253008347,"d":"-0.25"},"down",{"v":0.35954,"d":"0.36"},1,"no","CCAGAATCCACCACAAAAATTGGACTCTTGCAAGTAAGAGGGGAGGAAACTCAGCGCAGA","FALSE","NM_032853","ref|NM_032853|ref|NR_024247|ens|ENST00000588810|ens|ENST00000590695","MUM1","melanoma associated antigen (mutated) 1","ref|Homo sapiens melanoma associated antigen (mutated) 1 (MUM1), transcript variant 1, mRNA [NM_032853]","chr19",{"v":1356323,"d":"1356323.00"},1378430,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0006281(DNA repair);GO:0006325(chromatin organization);GO:0031491(nucleosome binding)",null,"mRNA","agilent G3 V3"]
["A_24_P342944",{"v":6.3,"d":"6.30"},4.78,6.27,6.28,6.08,6.62,{"v":0.914120126448894,"d":"0.91"},{"v":-0.129544329555486,"d":"-0.13"},"down",{"v":0.35992,"d":"0.36"},1,"no","CCTGCTCAAGACGGAGAATACCAAGCTGCGTAGGACCAACAAATTCCGGACCCCATCTGA","FALSE","NM_006574","ref|NM_006574|ref|NM_001206942|ref|NM_001206945|ref|NM_001206943","CSPG5","chondroitin sulfate proteoglycan 5 (neuroglycan C)","ref|Homo sapiens chondroitin sulfate proteoglycan 5 (neuroglycan C) (CSPG5), transcript variant 1, mRNA [NM_006574]","chr3",47603728,47619623,"GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005789(endoplasmic reticulum membrane);GO:0005794(Golgi apparatus);GO:0005796(Golgi lumen);GO:0005887(integral to plasma membrane);GO:0005975(carbohydrate metabolic process);GO:0007399(nervous system development);GO:0008083(growth factor activity);GO:0009405(pathogenesis);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0030203(glycosaminoglycan metabolic process);GO:0030204(chondroitin sulfate metabolic process);GO:0030206(chondroitin sulfate biosynthetic process);GO:0030207(chondroitin sulfate catabolic process);GO:0030208(dermatan sulfate biosynthetic process);GO:0030660(Golgi-associated vesicle membrane);GO:0031103(axon regeneration);GO:0040008(regulation of growth);GO:0043202(lysosomal lumen);GO:0044281(small molecule metabolic process);GO:0046907(intracellular transport);GO:0050804(regulation of synaptic transmission)",null,"mRNA","agilent G3 V3"]
["A_24_P134789",6.89,6.58,6.63,6.55,7.04,7.15,{"v":0.969141755062681,"d":"0.97"},{"v":-0.045220392746935,"d":"-0.05"},"down",{"v":0.36294,"d":"0.36"},1,"no","TGTCTGCTCTAAGTCCGTCTGCTATGTGCCTGTGTGCTCTGGGGCTTCCACTTCATGCTG","FALSE","NM_181688","ref|NM_181688|ens|ENST00000380095|gb|BC156523|gb|BC172516","KRTAP10-10","keratin associated protein 10-10","ref|Homo sapiens keratin associated protein 10-10 (KRTAP10-10), mRNA [NM_181688]","chr21",46057272,46058370,"GO:0045095(keratin filament)",null,"mRNA","agilent G3 V3"]
["A_33_P3267665",1.88,4.82,1.88,3.49,3.72,4.53,{"v":0.730834752981261,"d":"0.73"},{"v":-0.452382855610507,"d":"-0.45"},"down",{"v":0.36408,"d":"0.36"},1,"no","GCTTAACTCGAACTTGAAGACACATACTTCAACTGTCCTTATTGTCCATTAAACTGATAA","FALSE","NM_016353","ref|NM_016353|gb|AK001608|gb|BC039253|tc|THC2462595","ZDHHC2","zinc finger, DHHC-type containing 2","ref|Homo sapiens zinc finger, DHHC-type containing 2 (ZDHHC2), mRNA [NM_016353]","chr8",17013538,17082308,"GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005887(integral to plasma membrane);GO:0008270(zinc ion binding);GO:0016409(palmitoyltransferase activity);GO:0018345(protein palmitoylation);GO:0019706(protein-cysteine S-palmitoleyltransferase activity);GO:0055038(recycling endosome membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3429864",4.66,1.95,4.03,4.34,4.45,4.72,{"v":0.787564766839378,"d":"0.79"},{"v":-0.344529523824495,"d":"-0.34"},"down",{"v":0.36664,"d":"0.37"},1,"no","TTCCTCTCTGACACCACTGGGCCCTGCAATGATGAACATGGTGGGCAGTGTGGGTATACC","FALSE","NM_014964","ref|NM_014964|ref|NM_148921|ref|NM_001102664|ens|ENST00000395618","EPN2","epsin 2","ref|Homo sapiens epsin 2 (EPN2), transcript variant 2, mRNA [NM_014964]","chr17",19140690,19240028,"GO:0001701(in utero embryonic development);GO:0005654(nucleoplasm);GO:0005794(Golgi apparatus);GO:0006897(endocytosis);GO:0007219(Notch signaling pathway);GO:0008289(lipid binding);GO:0030128(clathrin coat of endocytic vesicle);GO:0043231(intracellular membrane-bounded organelle);GO:0048568(embryonic organ development)","04144(Endocytosis)","mRNA","agilent G3 V3"]
["A_21_P0000359",11.52,11.77,11.66,11.62,11.55,11.55,{"v":1.00662442396313,"d":"1.01"},{"v":0.0095255078183195,"d":"0.01"},"up",{"v":0.37022,"d":"0.37"},1,"no","AGTGCTTCCCCGTGTTTGGAGGGTCCGCTCCTGTCCCTTTCAAACTCTGGAGCTTTCTCA","FALSE","NR_003018","ref|NR_003018","SNORA71D","small nucleolar RNA, H/ACA box 71D","ref|Homo sapiens small nucleolar RNA, H/ACA box 71D (SNORA71D), small nucleolar RNA [NR_003018]","chr20",37062504,37062642,null,null,"mRNA","agilent G3 V3"]
["A_23_P259594",{"v":4.5,"d":"4.50"},2.42,3.54,3.69,4.25,4.45,{"v":0.844229217110573,"d":"0.84"},{"v":-0.24429333589366,"d":"-0.24"},"down",{"v":0.37344,"d":"0.37"},1,"no","GAAGATAAGCTCCAGGTCTTATCGTATCCCTTGCCATCTGAACTTGTTTGCACTGCTTCT","FALSE","NM_016377","ref|NM_016377|ref|NM_138633|ref|NM_004842|ens|ENST00000342266","AKAP7","A kinase (PRKA) anchor protein 7","ref|Homo sapiens A kinase (PRKA) anchor protein 7 (AKAP7), transcript variant gamma, mRNA [NM_016377]","chr6",131466464,131604673,"GO:0000166(nucleotide binding);GO:0001508(regulation of action potential);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0008104(protein localization);GO:0008150(biological_process);GO:0016324(apical plasma membrane);GO:0016328(lateral plasma membrane);GO:0019901(protein kinase binding);GO:0034237(protein kinase A regulatory subunit binding);GO:0035556(intracellular signal transduction);GO:0051018(protein kinase A binding);GO:0060306(regulation of membrane repolarization);GO:0071320(cellular response to cAMP)",null,"mRNA","agilent G3 V3"]
["A_23_P218731",{"v":3.8,"d":"3.80"},5.54,4.37,3.63,3.68,{"v":4.6,"d":"4.60"},{"v":1.15113350125945,"d":"1.15"},{"v":0.203055157915112,"d":"0.20"},"up",{"v":0.37494,"d":"0.37"},1,"no","AAGATGATGAACCAGCTGTAAAACTACAACTACTACCACATAAACATGATATCATCACAC","FALSE","NM_145858","ref|NM_145858|ens|ENST00000437996|ens|ENST00000480893|ens|ENST00000381554","CRYZL1","crystallin, zeta (quinone reductase)-like 1","ref|Homo sapiens crystallin, zeta (quinone reductase)-like 1 (CRYZL1), mRNA [NM_145858]","chr21",34967436,34994348,"GO:0003960(NADPH:quinone reductase activity);GO:0005829(cytosol);GO:0008270(zinc ion binding);GO:0050661(NADP binding);GO:0055114(oxidation-reduction process)",null,"mRNA","agilent G3 V3"]
["A_33_P3403643",8.78,8.47,8.65,8.69,8.53,8.03,{"v":1.02574257425743,"d":"1.03"},{"v":0.0366687100473968,"d":"0.04"},"up",{"v":0.37682,"d":"0.38"},1,"no","GGCGAGTGTGGCGTCCCCTGGACAGAAGGGGGAGTGTGGCGTCCCCTGGAGAGAAGGGGC","FALSE","XM_003960862","ref|XM_003960862|ref|XM_003959933|ref|XM_006725147|ref|XM_003960482","LOC101059906","collagen alpha-2(VI) chain-like","ref|PREDICTED: Homo sapiens collagen alpha-2(VI) chain-like (LOC101059906), mRNA [XM_003960862]","chr11",{"v":528906,"d":"528906.00"},532261,null,null,"mRNA","agilent G3 V3"]
["A_23_P146084",5.54,5.53,4.77,5.92,5.93,{"v":5.1,"d":"5.10"},{"v":0.934513274336283,"d":"0.93"},{"v":-0.0977129379440966,"d":"-0.10"},"down",{"v":0.37972,"d":"0.38"},1,"no","AGACACGTGTGGCGGGCAGTGGGACCCATAGATCTTCTGAAATGAAACAAATAATCACAT","FALSE","NM_000637","ref|NM_000637|ref|NM_001195102|ref|NM_001195103|ref|NM_001195104","GSR","glutathione reductase","ref|Homo sapiens glutathione reductase (GSR), transcript variant 1, mRNA [NM_000637]","chr8",30535584,30585223,"GO:0000302(response to reactive oxygen species);GO:0004362(glutathione-disulfide reductase activity);GO:0005759(mitochondrial matrix);GO:0005829(cytosol);GO:0006749(glutathione metabolic process);GO:0009055(electron carrier activity);GO:0009897(external side of plasma membrane);GO:0015949(nucleobase-containing small molecule interconversion);GO:0016152(mercury (II) reductase activity);GO:0044281(small molecule metabolic process);GO:0045340(mercury ion binding);GO:0045454(cell redox homeostasis);GO:0050660(flavin adenine dinucleotide binding);GO:0050661(NADP binding);GO:0050787(detoxification of mercury ion);GO:0055086(nucleobase-containing small molecule metabolic process);GO:0055114(oxidation-reduction process);GO:0070062(extracellular vesicular exosome)","00480(Glutathione metabolism);04918(Thyroid hormone synthesis)","mRNA","agilent G3 V3"]
["A_24_P200427",5.32,6.37,4.91,6.48,5.96,5.63,{"v":0.918649695628113,"d":"0.92"},{"v":-0.122413264630312,"d":"-0.12"},"down",{"v":0.38276,"d":"0.38"},1,"no","GGCCCACGTTTTTATCATTAAGACCTATTTGTTAGCTAGTAGAGCTTTATGTTCGCTGTC","FALSE","NM_001079525","ref|NM_001079525|ref|NM_006452|ref|NM_001079524|ens|ENST00000264221","PAICS","phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase","ref|Homo sapiens phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase (PAICS), transcript variant 1, mRNA [NM_001079525]","chr4",57301916,57327534,"GO:0004638(phosphoribosylaminoimidazole carboxylase activity);GO:0004639(phosphoribosylaminoimidazolesuccinocarboxamide synthase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0006144(purine base metabolic process);GO:0006189('de novo' IMP biosynthetic process);GO:0009113(purine base biosynthetic process);GO:0009168(purine ribonucleoside monophosphate biosynthetic process);GO:0016020(membrane);GO:0042802(identical protein binding);GO:0044281(small molecule metabolic process);GO:0055086(nucleobase-containing small molecule metabolic process);GO:0070062(extracellular vesicular exosome)","00230(Purine metabolism)","mRNA","agilent G3 V3"]
["A_23_P62270",7.18,7.74,7.35,7.25,7.45,6.89,{"v":1.03149606299213,"d":"1.03"},{"v":0.0447383147652844,"d":"0.04"},"up",{"v":0.38586,"d":"0.39"},1,"no","GAGGAAACTTCACATAGCCGTGCTCACAGTTTTTTATTTTAAAGGAATTTGGCTGGGGAG","FALSE","NM_004187","ref|NM_004187|ref|NM_001282622|ref|NM_001146702|ens|ENST00000404049","KDM5C","lysine (K)-specific demethylase 5C","ref|Homo sapiens lysine (K)-specific demethylase 5C (KDM5C), transcript variant 1, mRNA [NM_004187]","chrX",53220504,53254604,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006325(chromatin organization);GO:0006351(transcription, DNA-dependent);GO:0008270(zinc ion binding);GO:0016706(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors);GO:0032453(histone demethylase activity (H3-K4 specific));GO:0034720(histone H3-K4 demethylation);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0048511(rhythmic process);GO:0055114(oxidation-reduction process)",null,"mRNA","agilent G3 V3"]
["A_23_P109442",2.19,6.22,2.16,4.99,5.19,4.84,{"v":0.703728362183755,"d":"0.70"},{"v":-0.506909436131589,"d":"-0.51"},"down",{"v":0.38708,"d":"0.39"},1,"no","TGTCAGTGAACTGATATCTGATGTTTATGATATGGTGTCTTTTTCTTGAAACAAGCTTCC","FALSE","NM_022081","ref|NM_022081|ref|NM_152841|ref|NR_073135|ref|NR_073136","HPS4","Hermansky-Pudlak syndrome 4","ref|Homo sapiens Hermansky-Pudlak syndrome 4 (HPS4), transcript variant 1, mRNA [NM_022081]","chr22",26847446,26875347,"GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0006605(protein targeting);GO:0007040(lysosome organization);GO:0007596(blood coagulation);GO:0007599(hemostasis);GO:0016020(membrane);GO:0030318(melanocyte differentiation);GO:0031085(BLOC-3 complex);GO:0042470(melanosome);GO:0042803(protein homodimerization activity);GO:0042827(platelet dense granule);GO:0046983(protein dimerization activity);GO:0048075(positive regulation of eye pigmentation);GO:0050821(protein stabilization)",null,"mRNA","agilent G3 V3"]
["A_24_P101561",4.28,4.31,3.72,{"v":4.3,"d":"4.30"},4.07,4.72,{"v":0.940412528647823,"d":"0.94"},{"v":-0.0886343354607836,"d":"-0.09"},"down",{"v":0.39046,"d":"0.39"},1,"no","ATTGTTTGAATATGCCAAAGACAATGAGCAGTTCATGGAGAATCACAATCCCATTAATTC","FALSE","ENST00000488019","ens|ENST00000488019",null,null,"ens|RWD domain containing 4 pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:23753] [ENST00000488019]","chr7",104941968,104942533,null,null,"mRNA","agilent G3 V3"]
["A_23_P58266",{"v":6.1,"d":"6.10"},5.89,5.33,5.76,6.08,6.26,{"v":0.956906077348066,"d":"0.96"},{"v":-0.0635507672438429,"d":"-0.06"},"down",{"v":0.39386,"d":"0.39"},1,"no","CCAAAAGTGTTTGTTGGCAATTATTCCCCTAGGCTGAGCCTGCTCATGTACCTCTGATTA","FALSE","NM_005980","ref|NM_005980|ens|ENST00000296370|ens|ENST00000513778|gb|X65614","S100P","S100 calcium binding protein P","ref|Homo sapiens S100 calcium binding protein P (S100P), mRNA [NM_005980]","chr4",{"v":6695605,"d":"6695605.00"},6698897,"GO:0000287(magnesium ion binding);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0010033(response to organic substance);GO:0031528(microvillus membrane);GO:0043542(endothelial cell migration);GO:0048306(calcium-dependent protein binding);GO:0050786(RAGE receptor binding);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3348752",3.76,4.78,{"v":3.5,"d":"3.50"},4.78,4.39,4.11,{"v":0.906626506024096,"d":"0.91"},{"v":-0.141419754587223,"d":"-0.14"},"down",{"v":0.39706,"d":"0.40"},1,"no","GATAAAAAGGAAGAAGATTTAGAAGACAAAAACAATTTTGGTGCTGAACCTCCACATCAG","FALSE","NM_006644","ref|NM_006644|ref|NM_001286503|ref|NM_001286504|ref|NM_001286505","HSPH1","heat shock 105kDa/110kDa protein 1","ref|Homo sapiens heat shock 105kDa/110kDa protein 1 (HSPH1), transcript variant 1, mRNA [NM_006644]","chr13",31711404,31736176,"GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005576(extracellular region);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005874(microtubule);GO:0006898(receptor-mediated endocytosis);GO:0006986(response to unfolded protein);GO:0043014(alpha-tubulin binding);GO:0045345(positive regulation of MHC class I biosynthetic process);GO:0051085(chaperone mediated protein folding requiring cofactor);GO:0051135(positive regulation of NK T cell activation);GO:0070062(extracellular vesicular exosome);GO:0071682(endocytic vesicle lumen)","04141(Protein processing in endoplasmic reticulum)","mRNA","agilent G3 V3"]
["A_23_P169428",3.41,5.28,3.34,4.73,4.72,4.61,{"v":0.855618776671408,"d":"0.86"},{"v":-0.224959951896459,"d":"-0.22"},"down",{"v":0.3991,"d":"0.40"},1,"no","ACTTGACCCAACTGAGAAGGAAAAACTTCTGTATGGAGGAAAAGACAGTAAACATGACAG","FALSE","NM_015679","ref|NM_015679|ens|ENST00000372890|gb|AK301986|gb|BC001457","TRUB2","TruB pseudouridine (psi) synthase family member 2","ref|Homo sapiens TruB pseudouridine (psi) synthase family member 2 (TRUB2), mRNA [NM_015679]","chr9",131071472,131084497,"GO:0001522(pseudouridine synthesis);GO:0005737(cytoplasm);GO:0008033(tRNA processing);GO:0009982(pseudouridine synthase activity)",null,"mRNA","agilent G3 V3"]
["A_24_P261470",5.52,4.66,5.35,{"v":5.6,"d":"5.60"},{"v":5.3,"d":"5.30"},5.41,{"v":0.952176578786021,"d":"0.95"},{"v":-0.0706989523245831,"d":"-0.07"},"down",{"v":0.40132,"d":"0.40"},1,"no","ACGCCATGTATAAGTACCGCAATCGTGATGAGGGCTCCTACCAGGTGGACCAGAGCCGAA","FALSE","NM_138732","ref|NM_138732|ref|NM_138734|ref|NM_015080|ens|ENST00000475737","NRXN2","neurexin 2","ref|Homo sapiens neurexin 2 (NRXN2), transcript variant alpha-2, mRNA [NM_138732]","chr11",64373648,64490660,"GO:0005246(calcium channel regulator activity);GO:0007158(neuron cell-cell adhesion);GO:0007268(synaptic transmission);GO:0007269(neurotransmitter secretion);GO:0007416(synapse assembly);GO:0016021(integral to membrane);GO:0030534(adult behavior);GO:0035176(social behavior);GO:0042297(vocal learning);GO:0046872(metal ion binding);GO:0050839(cell adhesion molecule binding);GO:0071625(vocalization behavior);GO:0097104(postsynaptic membrane assembly);GO:0097109(neuroligin family protein binding);GO:0097116(gephyrin clustering);GO:0097118(neuroligin clustering);GO:0097119(postsynaptic density protein 95 clustering)","04514(Cell adhesion molecules (CAMs))","mRNA","agilent G3 V3"]
["A_33_P3402817",5.13,3.62,5.31,5.12,5.27,5.37,{"v":0.892131979695431,"d":"0.89"},{"v":-0.164670940383841,"d":"-0.16"},"down",{"v":0.40464,"d":"0.40"},1,"no","ATCGTGCTCACCTACTCCACTGACCGGCTGCGCAAATGGATGTTCATCTGCATTGGCTGG","FALSE","NM_001303016","ref|NM_001303016|ref|NM_001145148|ref|NM_001256299|ref|NM_001145146","MGC57346-CRHR1","MGC57346-CRHR1 readthrough","ref|Homo sapiens MGC57346-CRHR1 readthrough (MGC57346-CRHR1), transcript variant 6, mRNA [NM_001303016]","chr17",43699268,43912137,null,null,"mRNA","agilent G3 V3"]
["A_33_P3270776",6.17,7.34,6.14,6.98,6.58,7.34,{"v":0.940191387559809,"d":"0.94"},{"v":-0.0889736298222763,"d":"-0.09"},"down",{"v":0.40876,"d":"0.41"},1,"no","GGCCACCATCAAAGACATCGACAAGAAGTCGGACATTGCCACCATCAAGATCCATCCCAA","FALSE","NM_001297559","ref|NM_001297559|ens|ENST00000382512|gb|AB528940|gb|DQ891188","HTRA3","HtrA serine peptidase 3","ref|Homo sapiens HtrA serine peptidase 3 (HTRA3), transcript variant 2, mRNA [NM_001297559]","chr4",{"v":8271504,"d":"8271504.00"},8298201,"GO:0001558(regulation of cell growth);GO:0004175(endopeptidase activity);GO:0004252(serine-type endopeptidase activity);GO:0005515(protein binding);GO:0005520(insulin-like growth factor binding);GO:0005576(extracellular region);GO:0006508(proteolysis);GO:0008236(serine-type peptidase activity);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0030514(negative regulation of BMP signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_23_P115467",6.42,4.97,5.66,5.57,5.31,{"v":4.9,"d":"4.90"},{"v":1.08048162230672,"d":"1.08"},{"v":0.111674533898076,"d":"0.11"},"up",{"v":0.41128,"d":"0.41"},1,"no","GGCCCTGACCACTATGGTGACCACGTTTCACAAATATTCGGGGAGAGAGGGTAGCAAACT","FALSE","NM_002962","ref|NM_002962|ens|ENST00000368717|ens|ENST00000368718|ref|XM_005245430","S100A5","S100 calcium binding protein A5","ref|Homo sapiens S100 calcium binding protein A5 (S100A5), mRNA [NM_002962]","chr1",153509616,153514241,"GO:0005507(copper ion binding);GO:0005509(calcium ion binding);GO:0005634(nucleus);GO:0008270(zinc ion binding);GO:0042803(protein homodimerization activity);GO:0043025(neuronal cell body)",null,"mRNA","agilent G3 V3"]
["A_23_P61707",5.43,{"v":3.6,"d":"3.60"},5.79,5.39,5.88,5.45,{"v":0.886363636363636,"d":"0.89"},{"v":-0.174029399775049,"d":"-0.17"},"down",{"v":0.41392,"d":"0.41"},1,"no","CTAAATGTCATAGCGTGATCTTAGCCTAGGTAGGCCACATCCATCCCAAAGGAAAATGTA","FALSE","NM_021828","ref|NM_021828|ref|NM_001166246|ref|NM_001166244|ref|NM_001166245","HPSE2","heparanase 2 (inactive)","ref|Homo sapiens heparanase 2 (inactive) (HPSE2), transcript variant 1, mRNA [NM_021828]","chr10",100219328,100995559,"GO:0005578(proteinaceous extracellular matrix);GO:0005622(intracellular);GO:0005886(plasma membrane);GO:0005975(carbohydrate metabolic process);GO:0006027(glycosaminoglycan catabolic process);GO:0008150(biological_process);GO:0009405(pathogenesis);GO:0030203(glycosaminoglycan metabolic process);GO:0030305(heparanase activity);GO:0043395(heparan sulfate proteoglycan binding);GO:0044281(small molecule metabolic process)","00531(Glycosaminoglycan degradation);05205(Proteoglycans in cancer)","mRNA","agilent G3 V3"]
["A_23_P48358",7.08,2.05,3.27,{"v":5.7,"d":"5.70"},5.76,5.55,{"v":0.728982951205173,"d":"0.73"},{"v":-0.456043020389148,"d":"-0.46"},"down",{"v":0.41748,"d":"0.42"},1,"no","AGTTGGAGAAGGGGATCTGCTCGTGGAGCTGGAATGAAGGATTTATAACCTTTCAGTCAT","FALSE","NM_000282","ref|NM_000282|ref|NM_001127692|ref|NM_001178004|ens|ENST00000376286","PCCA","propionyl CoA carboxylase, alpha polypeptide","ref|Homo sapiens propionyl CoA carboxylase, alpha polypeptide (PCCA), transcript variant 1, mRNA [NM_000282]","chr13",100741272,101182686,"GO:0004075(biotin carboxylase activity);GO:0004658(propionyl-CoA carboxylase activity);GO:0005524(ATP binding);GO:0005759(mitochondrial matrix);GO:0005829(cytosol);GO:0006635(fatty acid beta-oxidation);GO:0006766(vitamin metabolic process);GO:0006767(water-soluble vitamin metabolic process);GO:0006768(biotin metabolic process);GO:0009374(biotin binding);GO:0019626(short-chain fatty acid catabolic process);GO:0019899(enzyme binding);GO:0044255(cellular lipid metabolic process);GO:0044281(small molecule metabolic process);GO:0046872(metal ion binding)","00630(Glyoxylate and dicarboxylate metabolism);00640(Propanoate metabolism);00280(Valine, leucine and isoleucine degradation)","mRNA","agilent G3 V3"]
["A_23_P128663",6.27,6.61,6.42,6.43,6.15,6.37,{"v":1.01846965699208,"d":"1.02"},{"v":0.0264029990969886,"d":"0.03"},"up",{"v":0.4205,"d":"0.42"},1,"no","TTTACTTTTATTGGGAATAAGGAATGTTTGCACCTCCACATTTTATTGCTTCTGGATGTG","FALSE","NM_014363","ref|NM_014363|ref|NM_001278055|ens|ENST00000382292|ens|ENST00000402364","SACS","sacsin molecular chaperone","ref|Homo sapiens sacsin molecular chaperone (SACS), transcript variant 1, mRNA [NM_014363]","chr13",23902964,24007841,"GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0006457(protein folding);GO:0030424(axon);GO:0030425(dendrite);GO:0030544(Hsp70 protein binding);GO:0051087(chaperone binding);GO:0070628(proteasome binding);GO:0070852(cell body fiber);GO:0090084(negative regulation of inclusion body assembly)",null,"mRNA","agilent G3 V3"]
["A_23_P156562",6.34,5.81,5.87,6.23,{"v":6.2,"d":"6.20"},6.06,{"v":0.974580854515955,"d":"0.97"},{"v":-0.0371462135906572,"d":"-0.04"},"down",{"v":0.42262,"d":"0.42"},1,"no","CTCCATGGTAGGCCAGAGAGTCTAGACTTTCTCTGCCAATTTTTTCCCTTTCCCATTTCT","FALSE","NM_206922","ref|NM_206922|ens|ENST00000451294|ens|ENST00000372569|ref|XM_006715096","CRIP3","cysteine-rich protein 3","ref|Homo sapiens cysteine-rich protein 3 (CRIP3), mRNA [NM_206922]","chr6",43273964,43274867,"GO:0005737(cytoplasm);GO:0008270(zinc ion binding);GO:0042098(T cell proliferation)",null,"mRNA","agilent G3 V3"]
["A_24_P224116",5.21,2.03,{"v":4.6,"d":"4.60"},4.38,5.31,4.85,{"v":0.814305364511692,"d":"0.81"},{"v":-0.296358188290645,"d":"-0.30"},"down",{"v":0.42352,"d":"0.42"},1,"no","AGTATTGTCAGAGTTGAATATCACCTCTCAAAAGCATCACCTCTATCTGCCTCATCTCAC","FALSE","NM_000928","ref|NM_000928|ens|ENST00000308366|gb|M21054|gb|BC106725","PLA2G1B","phospholipase A2, group IB (pancreas)","ref|Homo sapiens phospholipase A2, group IB (pancreas) (PLA2G1B), mRNA [NM_000928]","chr12",120759920,120763896,"GO:0000187(activation of MAPK activity);GO:0002227(innate immune response in mucosa);GO:0002446(neutrophil mediated immunity);GO:0004623(phospholipase A2 activity);GO:0005102(receptor binding);GO:0005509(calcium ion binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006633(fatty acid biosynthetic process);GO:0006644(phospholipid metabolic process);GO:0006654(phosphatidic acid biosynthetic process);GO:0007015(actin filament organization);GO:0007165(signal transduction);GO:0009986(cell surface);GO:0010524(positive regulation of calcium ion transport into cytosol);GO:0015758(glucose transport);GO:0019370(leukotriene biosynthetic process);GO:0019731(antibacterial humoral response);GO:0030141(secretory granule);GO:0030593(neutrophil chemotaxis);GO:0032052(bile acid binding);GO:0032431(activation of phospholipase A2 activity);GO:0032637(interleukin-8 production);GO:0032869(cellular response to insulin stimulus);GO:0035556(intracellular signal transduction);GO:0036148(phosphatidylglycerol acyl-chain remodeling);GO:0036149(phosphatidylinositol acyl-chain remodeling);GO:0036150(phosphatidylserine acyl-chain remodeling);GO:0036151(phosphatidylcholine acyl-chain remodeling);GO:0036152(phosphatidylethanolamine acyl-chain remodeling);GO:0044240(multicellular organismal lipid catabolic process);GO:0044281(small molecule metabolic process);GO:0045740(positive regulation of DNA replication);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046470(phosphatidylcholine metabolic process);GO:0046474(glycerophospholipid biosynthetic process);GO:0047498(calcium-dependent phospholipase A2 activity);GO:0048146(positive regulation of fibroblast proliferation);GO:0050482(arachidonic acid secretion);GO:0050714(positive regulation of protein secretion);GO:0050778(positive regulation of immune response);GO:0050830(defense response to Gram-positive bacterium);GO:0051092(positive regulation of NF-kappaB transcription factor activity)","00564(Glycerophospholipid metabolism);00565(Ether lipid metabolism);00590(Arachidonic acid metabolism);00591(Linoleic acid metabolism);00592(alpha-Linolenic acid metabolism);04014(Ras signaling pathway);04270(Vascular smooth muscle contraction);04972(Pancreatic secretion);04975(Fat digestion and absorption)","mRNA","agilent G3 V3"]
["A_32_P25437",6.38,{"v":3.5,"d":"3.50"},4.65,3.79,3.98,4.25,{"v":1.20881863560732,"d":"1.21"},{"v":0.273597806921656,"d":"0.27"},"up",{"v":0.42762,"d":"0.43"},1,"no","CTAACTATTCATAATGTGGGGTGGGTAATACTGTCTGTGAAATAATGTAAGAAGCTTTTC","FALSE","NM_001046","ref|NM_001046|ref|NM_001256461|ref|NR_046207|ens|ENST00000262461","SLC12A2","solute carrier family 12 (sodium/potassium/chloride transporter), member 2","ref|Homo sapiens solute carrier family 12 (sodium/potassium/chloride transporter), member 2 (SLC12A2), transcript variant 1, mRNA [NM_001046]","chr5",127419536,127524134,"GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0006810(transport);GO:0006811(ion transport);GO:0006813(potassium ion transport);GO:0006814(sodium ion transport);GO:0006972(hyperosmotic response);GO:0007214(gamma-aminobutyric acid signaling pathway);GO:0008511(sodium:potassium:chloride symporter activity);GO:0008519(ammonium transmembrane transporter activity);GO:0015696(ammonium transport);GO:0016020(membrane);GO:0016323(basolateral plasma membrane);GO:0016324(apical plasma membrane);GO:0030321(transepithelial chloride transport);GO:0031982(vesicle);GO:0035264(multicellular organism growth);GO:0045795(positive regulation of cell volume);GO:0050910(detection of mechanical stimulus involved in sensory perception of sound);GO:0055085(transmembrane transport);GO:0060444(branching involved in mammary gland duct morphogenesis);GO:0060763(mammary duct terminal end bud growth);GO:0070062(extracellular vesicular exosome);GO:0070634(transepithelial ammonium transport);GO:0072488(ammonium transmembrane transport)","04970(Salivary secretion);04972(Pancreatic secretion);05110(Vibrio cholerae infection)","mRNA","agilent G3 V3"]
["A_22_P00010751",14.85,{"v":14.9,"d":"14.90"},15.63,15.12,{"v":15.5,"d":"15.50"},{"v":15.5,"d":"15.50"},{"v":0.983954900260191,"d":"0.98"},{"v":-0.0233359039794343,"d":"-0.02"},"down",{"v":0.43128,"d":"0.43"},1,"no","GCGGCGGCGGCGGCGGCTCTCGGGTTGCGGTGAAGAATGTCAGCCACTAGCGTGGATCAG","FALSE","NM_001277816","ref|NM_001277816|ref|NM_152758|ref|NM_001277815|ref|NM_001277813","YTHDF3","YTH N(6)-methyladenosine RNA binding protein 3","ref|Homo sapiens YTH N(6)-methyladenosine RNA binding protein 3 (YTHDF3), transcript variant 5, mRNA [NM_001277816]","chr8",64081112,64125346,"GO:0005515(protein binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3350493",{"v":4.9,"d":"4.90"},{"v":17.3,"d":"17.30"},4.65,5.19,{"v":4.4,"d":"4.40"},5.08,{"v":1.83026584867076,"d":"1.83"},{"v":0.872053217199385,"d":"0.87"},"up",{"v":0.43412,"d":"0.43"},1,"no","CCCTGGTTGCCACCAACTTGCTCCAAATCCAGCTCCTGAGACATTAAAGTCACTTCCTGT","FALSE","NM_001286550","ref|NM_001286550|ref|NM_207409|ref|NR_104467|ref|NR_104469","CLPSL2","colipase-like 2","ref|Homo sapiens colipase-like 2 (CLPSL2), transcript variant 1, mRNA [NM_001286550]","chr6",35744468,35747329,"GO:0005576(extracellular region);GO:0007586(digestion);GO:0008047(enzyme activator activity);GO:0016042(lipid catabolic process);GO:0043085(positive regulation of catalytic activity)",null,"mRNA","agilent G3 V3"]
["A_33_P3307402",5.92,4.78,5.81,5.41,6.19,6.03,{"v":0.936471922858763,"d":"0.94"},{"v":-0.094692354406924,"d":"-0.09"},"down",{"v":0.43822,"d":"0.44"},1,"no","ACACACATATACATACATATACACACATATACATACACGTACACACACAGACATATATAA","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_33_P3362567",3.43,7.07,3.52,3.27,3.54,4.07,{"v":1.28860294117647,"d":"1.29"},{"v":0.365807792760284,"d":"0.37"},"up",{"v":0.4398,"d":"0.44"},1,"no","AATGTGGGCGAAGCTGCCCTAAGGATCTTCCTTTAATTTGGAGTAATACTGTGCCATACT","FALSE",{"$nulls":5},"chr2",203066096,203066423,null,null,"mRNA","agilent G3 V3"]
["A_33_P3262635",5.94,6.27,5.96,6.14,5.98,5.46,{"v":1.03356086461888,"d":"1.03"},{"v":0.0476233490907116,"d":"0.05"},"up",{"v":0.44326,"d":"0.44"},1,"no","TAATCGGATATTTATTTCTGTGTCTACAGTCTTGCCCTGCCAGACTGTATGCCCCATGTG","FALSE","NM_001282225","ref|NM_001282225|ref|NM_001282226|ref|NM_001282228|ref|NM_001282227","CECR1","cat eye syndrome chromosome region, candidate 1","ref|Homo sapiens cat eye syndrome chromosome region, candidate 1 (CECR1), transcript variant 3, mRNA [NM_001282225]","chr22",17660196,17690779,"GO:0004000(adenosine deaminase activity);GO:0005615(extracellular space);GO:0005829(cytosol);GO:0006154(adenosine catabolic process);GO:0007275(multicellular organismal development);GO:0008083(growth factor activity);GO:0008201(heparin binding);GO:0008270(zinc ion binding);GO:0031685(adenosine receptor binding);GO:0042803(protein homodimerization activity);GO:0043103(hypoxanthine salvage);GO:0043394(proteoglycan binding);GO:0046103(inosine biosynthetic process)",null,"mRNA","agilent G3 V3"]
["A_23_P204609",2.06,{"v":6,"d":"6.00"},2.04,{"v":4.4,"d":"4.40"},4.55,4.91,{"v":0.728715728715729,"d":"0.73"},{"v":-0.456571964498056,"d":"-0.46"},"down",{"v":0.44414,"d":"0.44"},1,"no","ATGAATTATCATTTCTTGCCAGAATTTGCTACCTTAAGGTGATTGGGAAAATTCTGTTGC","FALSE","NM_017599","ref|NM_017599|ref|NR_038241|ref|NR_038242|ens|ENST00000261219","VEZT","vezatin, adherens junctions transmembrane protein","ref|Homo sapiens vezatin, adherens junctions transmembrane protein (VEZT), transcript variant 1, mRNA [NM_017599]","chr12",95611584,95694944,"GO:0001669(acrosomal vesicle);GO:0002142(stereocilia ankle link complex);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005912(adherens junction);GO:0016021(integral to membrane);GO:0016337(cell-cell adhesion);GO:0017022(myosin binding);GO:0043009(chordate embryonic development)",null,"mRNA","agilent G3 V3"]
["A_33_P3385387",5.98,5.25,6.12,5.71,6.09,6.39,{"v":0.953820780648708,"d":"0.95"},{"v":-0.068209880185863,"d":"-0.07"},"down",{"v":0.44884,"d":"0.45"},1,"no","CAGAAGAGTGAAGCTTCCTGTCCGGGAAAACAAAACGGCCGTGATTGTGGGGAGCATAAC","FALSE","ENST00000478088","ens|ENST00000478088|linc|TCONS_l2_00010290",null,null,"ens|ribosomal protein L18 pseudogene 13 [Source:HGNC Symbol;Acc:HGNC:35599] [ENST00000478088]","chr16",76268952,76269521,null,null,"mRNA","agilent G3 V3"]
["A_23_P204696",16.26,5.44,5.55,5.87,5.54,5.81,{"v":1.58246225319396,"d":"1.58"},{"v":0.662171087154807,"d":"0.66"},"up",0.45,1,"no","GCGCCTTTAATTGGGGCTCCGGCTAACTCTGAGGACACGCATTTGGTGGACCCAAAGACT","FALSE","NM_004064","ref|NM_004064|ens|ENST00000228872|gb|AB451423|gb|AK312461","CDKN1B","cyclin-dependent kinase inhibitor 1B (p27, Kip1)","ref|Homo sapiens cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B), mRNA [NM_004064]","chr12",12870756,12874402,"GO:0000079(regulation of cyclin-dependent protein kinase activity);GO:0000082(G1/S transition of mitotic cell cycle);GO:0000278(mitotic cell cycle);GO:0001666(response to hypoxia);GO:0004861(cyclin-dependent protein kinase inhibitor activity);GO:0005072(transforming growth factor beta receptor, cytoplasmic mediator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005829(cytosol);GO:0006813(potassium ion transport);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0006977(DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest);GO:0007050(cell cycle arrest);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007605(sensory perception of sound);GO:0008284(positive regulation of cell proliferation);GO:0008285(negative regulation of cell proliferation);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0008656(cysteine-type endopeptidase activator activity involved in apoptotic process);GO:0009749(response to glucose stimulus);GO:0010942(positive regulation of cell death);GO:0019903(protein phosphatase binding);GO:0030308(negative regulation of cell growth);GO:0030544(Hsp70 protein binding);GO:0031116(positive regulation of microtubule polymerization);GO:0031464(Cul4A-RING ubiquitin ligase complex);GO:0032355(response to estradiol stimulus);GO:0032403(protein complex binding);GO:0033673(negative regulation of kinase activity);GO:0038095(Fc-epsilon receptor signaling pathway);GO:0042326(negative regulation of phosphorylation);GO:0042493(response to drug);GO:0043066(negative regulation of apoptotic process);GO:0043200(response to amino acid stimulus);GO:0043434(response to peptide hormone stimulus);GO:0045087(innate immune response);GO:0045732(positive regulation of protein catabolic process);GO:0045736(negative regulation of cyclin-dependent protein kinase activity);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0045930(negative regulation of mitotic cell cycle);GO:0046686(response to cadmium ion);GO:0048011(nerve growth factor receptor signaling pathway);GO:0048015(phosphatidylinositol-mediated signaling);GO:0048102(autophagic cell death);GO:0048839(inner ear development);GO:0051087(chaperone binding);GO:0051271(negative regulation of cellular component movement);GO:0060770(negative regulation of epithelial cell proliferation involved in prostate gland development);GO:0071236(cellular response to antibiotic);GO:0071285(cellular response to lithium ion);GO:0071407(cellular response to organic cyclic compound);GO:0071850(mitotic cell cycle arrest)","04012(ErbB signaling pathway);04066(HIF-1 signaling pathway);04068(FoxO signaling pathway);04151(PI3K-Akt signaling pathway);04110(Cell cycle);05200(Pathways in cancer);05202(Transcriptional misregulation in cancers);05206(MicroRNAs in cancer);05203(Viral carcinogenesis);05220(Chronic myeloid leukemia);05215(Prostate cancer);05222(Small cell lung cancer);05162(Measles);05161(Hepatitis B);05169(Epstein-Barr virus infection)","mRNA","agilent G3 V3"]
["A_21_P0011773",6.37,{"v":4.3,"d":"4.30"},4.79,{"v":5.8,"d":"5.80"},5.78,5.45,{"v":0.907809747504404,"d":"0.91"},{"v":-0.139538115753695,"d":"-0.14"},"down",{"v":0.45602,"d":"0.46"},1,"no","AGTGGCAGAAGAATCCCAGACTTCTTAGAGAACCCAGTGACTTTTTGCACCTTAAATCTG","FALSE","ENST00000492393","ens|ENST00000492393|ref|XR_428866|ref|XR_253604|ref|XR_254460","CENPBD1P1","CENPBD1 pseudogene 1","ens|CENPBD1 pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:28421] [ENST00000492393]","chr19",59097652,59100861,null,null,"mRNA","agilent G3 V3"]
["A_23_P100386",6.21,4.68,{"v":5.4,"d":"5.40"},5.18,4.82,5.16,{"v":1.0745382585752,"d":"1.07"},{"v":0.103716850354426,"d":"0.10"},"up",{"v":0.45622,"d":"0.46"},1,"no","ACTTCAGTACATGAAACACTACTTCCCCATCAACTACAAGATCAGTGTGCCTTACGAGGG","FALSE","NM_152456","ref|NM_152456|ref|NM_001172771|ref|NM_001172772|ens|ENST00000429149","IL34","interleukin 34","ref|Homo sapiens interleukin 34 (IL34), transcript variant 1, mRNA [NM_152456]","chr16",70680464,70694585,"GO:0001934(positive regulation of protein phosphorylation);GO:0005125(cytokine activity);GO:0005157(macrophage colony-stimulating factor receptor binding);GO:0005615(extracellular space);GO:0006954(inflammatory response);GO:0008083(growth factor activity);GO:0008284(positive regulation of cell proliferation);GO:0045087(innate immune response)",null,"mRNA","agilent G3 V3"]
["A_33_P3420053",3.49,{"v":2.4,"d":"2.40"},4.19,{"v":3.5,"d":"3.50"},4.06,3.86,{"v":0.882661996497373,"d":"0.88"},{"v":-0.180067011862926,"d":"-0.18"},"down",{"v":0.45922,"d":"0.46"},1,"no","AGAGAAATCATATACACCTAACTGTGTGGCAGAGGCTTCATTTAGGTCTCACAACTCACT","FALSE","NM_001136038","ref|NM_001136038|ref|NM_001164309|ref|NM_018355|ref|NR_028343","ZNF415","zinc finger protein 415","ref|Homo sapiens zinc finger protein 415 (ZNF415), transcript variant 1, mRNA [NM_001136038]","chr19",53611132,53636148,"GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0015630(microtubule cytoskeleton);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3420810",5.04,4.27,5.23,5.06,4.36,4.14,{"v":1.07227138643068,"d":"1.07"},{"v":0.100670090783251,"d":"0.10"},"up",{"v":0.46392,"d":"0.46"},1,"no","TGGAACTCAGGAGACCCAAGTTCAAGTCCCAGCACTACCACTTACCAGGCGAGTGATTCT","FALSE",{"$nulls":5},"chr2",47272676,47335941,null,null,"mRNA","agilent G3 V3"]
["A_33_P3354001",{"v":7.9,"d":"7.90"},7.75,{"v":7.6,"d":"7.60"},7.59,7.79,7.61,{"v":1.01130926489778,"d":"1.01"},{"v":0.0162242501645762,"d":"0.02"},"up",{"v":0.46512,"d":"0.47"},1,"no","GACACATTGCTCTGTACTTAGTAATTACCCACCCTTCTTTTCCTTTCAATAAAATGTCCA","FALSE","NM_001167940","ref|NM_001167940|ref|NM_017954|ref|NM_001009571|ens|ENST00000615869","CADPS2","Ca++-dependent secretion activator 2","ref|Homo sapiens Ca++-dependent secretion activator 2 (CADPS2), transcript variant 3, mRNA [NM_001167940]","chr7",121958480,122526813,"GO:0008289(lipid binding);GO:0009267(cellular response to starvation);GO:0015031(protein transport);GO:0016082(synaptic vesicle priming);GO:0030054(cell junction);GO:0030659(cytoplasmic vesicle membrane);GO:0042734(presynaptic membrane);GO:0045211(postsynaptic membrane);GO:0045921(positive regulation of exocytosis);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3350658",6.81,4.68,7.16,6.63,5.43,3.97,{"v":1.16344354335621,"d":"1.16"},{"v":0.218401204988052,"d":"0.22"},"up",{"v":0.46858,"d":"0.47"},1,"no","GGAAACCCCATTGACCATCTGTACTCCATGCAGAATTCTTACTTCACATCTTGAGTCTTC","FALSE","NM_177398","ref|NM_177398|ref|NM_001174069|ens|ENST00000367893|ens|ENST00000489443","LMX1A","LIM homeobox transcription factor 1, alpha","ref|Homo sapiens LIM homeobox transcription factor 1, alpha (LMX1A), transcript variant 1, mRNA [NM_177398]","chr1",165173104,165324983,"GO:0001558(regulation of cell growth);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0007411(axon guidance);GO:0008270(zinc ion binding);GO:0021542(dentate gyrus development);GO:0021549(cerebellum development);GO:0021953(central nervous system neuron differentiation);GO:0030901(midbrain development);GO:0043565(sequence-specific DNA binding);GO:0045665(negative regulation of neuron differentiation);GO:0071542(dopaminergic neuron differentiation)",null,"mRNA","agilent G3 V3"]
["A_23_P252462",6.27,2.27,6.07,6.29,5.93,5.85,{"v":0.80852241283896,"d":"0.81"},{"v":-0.306640328061101,"d":"-0.31"},"down",{"v":0.471,"d":"0.47"},1,"no","CTCCGGCTGGTGGTACAGAGGTGCTCGGGGCAGAAGTGGATGATCAGAAACTGGATCAAA","FALSE","NM_021808","ref|NM_021808|ref|NM_001122636|ens|ENST00000541995|ens|ENST00000328957","GALNT9","polypeptide N-acetylgalactosaminyltransferase 9","ref|Homo sapiens polypeptide N-acetylgalactosaminyltransferase 9 (GALNT9), transcript variant B, mRNA [NM_021808]","chr12",132681056,132834281,"GO:0000139(Golgi membrane);GO:0004653(polypeptide N-acetylgalactosaminyltransferase activity);GO:0006493(protein O-linked glycosylation);GO:0016021(integral to membrane);GO:0016266(O-glycan processing);GO:0030246(carbohydrate binding);GO:0043687(post-translational protein modification);GO:0044267(cellular protein metabolic process);GO:0046872(metal ion binding)","00512(Mucin type O-glycan biosynthesis)","mRNA","agilent G3 V3"]
["A_23_P209032",3.93,15.79,2.92,3.72,4.18,3.89,{"v":1.92027141645462,"d":"1.92"},{"v":0.94131023985212,"d":"0.94"},"up",{"v":0.47392,"d":"0.47"},1,"no","TCAGAAAAATGTATACTGGGGAAAAGTTGTATGAAGGTGGTGAACATGGGAGACTTTTAG","FALSE","NM_018443","ref|NM_018443|ref|NM_018675|ref|NM_001289188|ref|NM_001289189","ZNF302","zinc finger protein 302","ref|Homo sapiens zinc finger protein 302 (ZNF302), transcript variant 1, mRNA [NM_018443]","chr19",35172188,35177296,"GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3246010",12.73,13.01,12.71,12.78,12.91,13.05,{"v":0.992514197212184,"d":"0.99"},{"v":-0.0108403557540645,"d":"-0.01"},"down",{"v":0.48026,"d":"0.48"},1,"no","CTGGCCTTAAGTGACCCTCCTGCCTGGGCCTCCCAGAGTGCTGAGATTCCAGGTATGAGC","FALSE","AK092494","gb|AK092494|tc|THC2636441",null,null,"gb|Homo sapiens cDNA FLJ35175 fis, clone PLACE6013400. [AK092494]","chr16",88772888,88781794,null,null,"mRNA","agilent G3 V3"]
["A_33_P3315824",{"v":3.9,"d":"3.90"},5.52,{"v":3.7,"d":"3.70"},3.62,3.84,4.25,{"v":1.12040990606319,"d":"1.12"},{"v":0.164026644116869,"d":"0.16"},"up",{"v":0.48068,"d":"0.48"},1,"no","TGATCAAAATTTTATTGTCACACTGCGGAGTGTCCCTGGCATCTAGGAGGTAGCATCTGA","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_24_P140788",6.02,5.72,5.54,{"v":5.9,"d":"5.90"},5.85,5.89,{"v":0.979591836734694,"d":"0.98"},{"v":-0.0297473433940522,"d":"-0.03"},"down",{"v":0.48392,"d":"0.48"},1,"no","CATCTGCGCCCAGGCCACGTGTCCCGATCTGGGATTAGAAAATATGGGTCCATTCCTTTC","FALSE","NM_173558","ref|NM_173558|ens|ENST00000373535|ens|ENST00000464083|ens|ENST00000493635","FGD2","FYVE, RhoGEF and PH domain containing 2","ref|Homo sapiens FYVE, RhoGEF and PH domain containing 2 (FGD2), mRNA [NM_173558]","chr6",36989320,36996845,"GO:0001726(ruffle);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0007010(cytoskeleton organization);GO:0007264(small GTPase mediated signal transduction);GO:0008360(regulation of cell shape);GO:0030027(lamellipodium);GO:0030036(actin cytoskeleton organization);GO:0031267(small GTPase binding);GO:0031901(early endosome membrane);GO:0032321(positive regulation of Rho GTPase activity);GO:0032587(ruffle membrane);GO:0043065(positive regulation of apoptotic process);GO:0043088(regulation of Cdc42 GTPase activity);GO:0043547(positive regulation of GTPase activity);GO:0046847(filopodium assembly);GO:0046872(metal ion binding);GO:0048011(nerve growth factor receptor signaling pathway);GO:0051056(regulation of small GTPase mediated signal transduction);GO:0097190(apoptotic signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_33_P3290577",3.43,3.71,4.93,4.14,4.46,4.57,{"v":0.916476841305998,"d":"0.92"},{"v":-0.125829669501493,"d":"-0.13"},"down",{"v":0.48598,"d":"0.49"},1,"no","ATATTACCTGAAGCCTCAACATCCCATATTGTGCAGTTCCCTGAAATACAACACCTACTT","FALSE","NM_001261828","ref|NM_001261828|ref|NM_001261827|ref|NM_032597|ref|NM_001079692","MS4A14","membrane-spanning 4-domains, subfamily A, member 14","ref|Homo sapiens membrane-spanning 4-domains, subfamily A, member 14 (MS4A14), transcript variant 4, mRNA [NM_001261828]","chr11",60163980,60183766,"GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P411806",5.35,{"v":4.3,"d":"4.30"},3.74,4.62,4.63,5.34,{"v":0.917751884852639,"d":"0.92"},{"v":-0.123823922593581,"d":"-0.12"},"down",{"v":0.4914,"d":"0.49"},1,"no","CTTTGTCATTCTGGTGGAGAATGCTTTGCGAGTGGCTACCATCAACACAGTAGGAGATTT","FALSE","NM_080546","ref|NM_080546|ref|NM_001286730|ens|ENST00000374724|ens|ENST00000374723","SLC44A1","solute carrier family 44 (choline transporter), member 1","ref|Homo sapiens solute carrier family 44 (choline transporter), member 1 (SLC44A1), transcript variant 1, mRNA [NM_080546]","chr9",108117760,108200782,"GO:0005741(mitochondrial outer membrane);GO:0005886(plasma membrane);GO:0006644(phospholipid metabolic process);GO:0006656(phosphatidylcholine biosynthetic process);GO:0015220(choline transmembrane transporter activity);GO:0015871(choline transport);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0044281(small molecule metabolic process);GO:0046474(glycerophospholipid biosynthetic process);GO:0055085(transmembrane transport);GO:0070062(extracellular vesicular exosome)","05231(Choline metabolism in cancer)","mRNA","agilent G3 V3"]
["A_33_P3316093",{"v":6,"d":"6.00"},5.34,5.44,5.23,5.74,{"v":5.2,"d":"5.20"},{"v":1.03772418058132,"d":"1.04"},{"v":0.0534230369661614,"d":"0.05"},"up",{"v":0.49324,"d":"0.49"},1,"no","TTGTTTCAGAAGGTAATGAGAATTCGTTGCCAGGTCGTTAAACTTCGCTCCTTCCTGGAG","FALSE",{"$nulls":5},"chr2",237076096,237203570,null,null,"mRNA","agilent G3 V3"]
["A_23_P218817",4.65,{"v":2.7,"d":"2.70"},3.73,{"v":4.7,"d":"4.70"},3.82,3.96,{"v":0.887820512820513,"d":"0.89"},{"v":-0.17166005281306,"d":"-0.17"},"down",{"v":0.49734,"d":"0.50"},1,"no","GAGAACACGATCTTCTTCCACATCTCCAGCAAGTTCTCAAGCTCAGAGACGAACGCCCAG","FALSE","NM_152246","ref|NM_152246|ref|NM_001145137|ref|NM_001145135|ref|NM_001145134","CPT1B","carnitine palmitoyltransferase 1B (muscle)","ref|Homo sapiens carnitine palmitoyltransferase 1B (muscle) (CPT1B), transcript variant 3, mRNA [NM_152246]","chr22",51007296,51021394,"GO:0004095(carnitine O-palmitoyltransferase activity);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0006635(fatty acid beta-oxidation);GO:0006853(carnitine shuttle);GO:0016021(integral to membrane);GO:0044255(cellular lipid metabolic process);GO:0044281(small molecule metabolic process)","01212(Fatty acid metabolism);00071(Fatty acid degradation);04152(AMPK signaling pathway);04922(Glucagon signaling pathway);04920(Adipocytokine signaling pathway);03320(PPAR signaling pathway)","mRNA","agilent G3 V3"]
["A_23_P3014",2.12,5.93,2.15,4.71,4.35,3.98,{"v":0.782208588957055,"d":"0.78"},{"v":-0.354374717372219,"d":"-0.35"},"down",{"v":0.50138,"d":"0.50"},1,"no","CAATTGCATCCACGTTTTCTTTTCTTTTGTTGATTTTCTTGTTCCCGTAGAAGAAAGAAG","FALSE","NM_005615","ref|NM_005615|ens|ENST00000304677|gb|BC020848|tc|THC2786468","RNASE6","ribonuclease, RNase A family, k6","ref|Homo sapiens ribonuclease, RNase A family, k6 (RNASE6), mRNA [NM_005615]","chr14",21249210,21250626,"GO:0003676(nucleic acid binding);GO:0004519(endonuclease activity);GO:0004540(ribonuclease activity);GO:0005576(extracellular region);GO:0006401(RNA catabolic process);GO:0006952(defense response);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P331748",5.81,4.48,6.13,5.56,5.11,4.44,{"v":1.08669755129054,"d":"1.09"},{"v":0.119950466612975,"d":"0.12"},"up",{"v":0.50766,"d":"0.51"},1,"no","GGGACCAAAGGCTGATTCTTGGAGATTTAACTCCCCACAGGCAATGGGTTTATAGACATT","FALSE","NM_001772","ref|NM_001772|ref|NM_001082618|ens|ENST00000421133|ens|ENST00000601785","CD33","CD33 molecule","ref|Homo sapiens CD33 molecule (CD33), transcript variant 1, mRNA [NM_001772]","chr19",51742520,51743270,"GO:0004872(receptor activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0007155(cell adhesion);GO:0007165(signal transduction);GO:0007267(cell-cell signaling);GO:0008285(negative regulation of cell proliferation);GO:0009897(external side of plasma membrane);GO:0030246(carbohydrate binding);GO:0070062(extracellular vesicular exosome)","04640(Hematopoietic cell lineage)","mRNA","agilent G3 V3"]
["A_22_P00012509",13.16,12.86,12.98,13.09,12.99,13.13,{"v":0.994644223412395,"d":"0.99"},{"v":-0.00774751787961638,"d":"-0.01"},"down",{"v":0.50882,"d":"0.51"},1,"no","AAGAAGCTGTTGAAAATACAGCTACAATCTTTTTCTGCTCTCCTCCCAACTCATCTTGCC","FALSE","XR_241120","ref|XR_241120|ref|XR_248615|ref|XR_250874|linc|lnc-PSMB4-1:1","LOC101927886","uncharacterized LOC101927886","ref|PREDICTED: Homo sapiens uncharacterized LOC101927886 (LOC101927886), ncRNA [XR_241120]","chr1",151319504,151320503,null,null,"mRNA","agilent G3 V3"]
["A_23_P436138",3.52,5.03,{"v":4.1,"d":"4.10"},3.73,3.93,3.94,{"v":1.09051724137931,"d":"1.09"},{"v":0.125012579566738,"d":"0.13"},"up",{"v":0.51402,"d":"0.51"},1,"no","TGATTGTTTTGACCCCTTACACAAATGTCTTACTCCTGGCTTTAATTAAGCTGCTTGAGG","FALSE","NM_145114","ref|NM_145114|ref|NM_001271068|ref|NR_073138|ens|ENST00000246163","MAX","MYC associated factor X","ref|Homo sapiens MYC associated factor X (MAX), transcript variant 4, mRNA [NM_145114]","chr14",65550464,65569227,"GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0003712(transcription cofactor activity);GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-dependent);GO:0006366(transcription from RNA polymerase II promoter);GO:0006461(protein complex assembly);GO:0009267(cellular response to starvation);GO:0010629(negative regulation of gene expression);GO:0016605(PML body);GO:0030425(dendrite);GO:0032403(protein complex binding);GO:0032868(response to insulin stimulus);GO:0042803(protein homodimerization activity);GO:0043565(sequence-specific DNA binding);GO:0046982(protein heterodimerization activity);GO:0048678(response to axon injury);GO:0051402(neuron apoptotic process);GO:0060041(retina development in camera-type eye);GO:0071339(MLL1 complex);GO:0071375(cellular response to peptide hormone stimulus)","04010(MAPK signaling pathway);05200(Pathways in cancer);05202(Transcriptional misregulation in cancers);05222(Small cell lung cancer)","mRNA","agilent G3 V3"]
["A_24_P363100",4.42,3.95,4.24,3.74,3.91,4.43,{"v":1.04387417218543,"d":"1.04"},{"v":0.0619478210031411,"d":"0.06"},"up",{"v":0.5166,"d":"0.52"},1,"no","GATAATAATTATCTTTCAGTTCAAGTGACAAACGTACCTGTGGTCCCTGGATCCAGTGCT","FALSE","NM_001012761","ref|NM_001012761|ens|ENST00000508978|ens|ENST00000513185|ens|ENST00000434027","RGMB","repulsive guidance molecule family member b","ref|Homo sapiens repulsive guidance molecule family member b (RGMB), mRNA [NM_001012761]","chr5",98115552,98134347,"GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005886(plasma membrane);GO:0007155(cell adhesion);GO:0007165(signal transduction);GO:0007411(axon guidance);GO:0015026(coreceptor activity);GO:0030509(BMP signaling pathway);GO:0042802(identical protein binding);GO:0045121(membrane raft);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0046658(anchored to plasma membrane)",null,"mRNA","agilent G3 V3"]
["A_21_P0012287",{"v":5.2,"d":"5.20"},3.19,5.34,3.29,4.65,4.12,{"v":1.13847429519071,"d":"1.14"},{"v":0.187101718247016,"d":"0.19"},"up",{"v":0.52454,"d":"0.52"},1,"no","ATCAGCACTATTTGAAACTTTTATCTCATCTGGCTTGGCGCCTGAGGTTCTCCCATTAGG","FALSE","ENST00000433066","ens|ENST00000433066|linc|TCONS_l2_00017901|linc|TCONS_l2_00018333|gb|CR742085",null,null,"ens|sphingomyelin phosphodiesterase 4, neutral membrane (neutral sphingomyelinase-3) pseudogene 1 [Source:HGNC Symbol;Acc:HGNC:39673] [ENST00000433066]","chr22",20992648,20993422,null,null,"mRNA","agilent G3 V3"]
["A_23_P308673",5.14,2.39,2.06,3.97,4.09,3.77,{"v":0.810650887573965,"d":"0.81"},{"v":-0.302847353321657,"d":"-0.30"},"down",{"v":0.526,"d":"0.53"},1,"no","GGTGGGTCTAGACATACTATATTCAGAGAACTATACTACCCTCACAGTGAGGCCCTCAGA","FALSE","NM_004783","ref|NM_004783|ens|ENST00000279394|gb|AB020688|gb|AK057589","TAOK2","TAO kinase 2","ref|Homo sapiens TAO kinase 2 (TAOK2), transcript variant 2, mRNA [NM_004783]","chr16",30001232,30003031,"GO:0000186(activation of MAPKK activity);GO:0001558(regulation of cell growth);GO:0004674(protein serine/threonine kinase activity);GO:0004709(MAP kinase kinase kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0006468(protein phosphorylation);GO:0006612(protein targeting to membrane);GO:0006915(apoptotic process);GO:0006950(response to stress);GO:0006974(response to DNA damage stimulus);GO:0008360(regulation of cell shape);GO:0016021(integral to membrane);GO:0016023(cytoplasmic membrane-bounded vesicle);GO:0016477(cell migration);GO:0030036(actin cytoskeleton organization);GO:0030425(dendrite);GO:0030659(cytoplasmic vesicle membrane);GO:0031434(mitogen-activated protein kinase kinase binding);GO:0031572(G2/M transition DNA damage checkpoint);GO:0032874(positive regulation of stress-activated MAPK cascade);GO:0043235(receptor complex);GO:0046330(positive regulation of JNK cascade);GO:0048041(focal adhesion assembly);GO:0051403(stress-activated MAPK cascade)","04010(MAPK signaling pathway)","mRNA","agilent G3 V3"]
["A_33_P3279610",7.08,6.15,6.99,7.04,6.77,7.05,{"v":0.969319271332694,"d":"0.97"},{"v":-0.0449561606167511,"d":"-0.04"},"down",{"v":0.5292,"d":"0.53"},1,"no","ACTCTGTTCCACAATAGCCACGTGAACCCTCTGCCCACGGGCTACGAACACCCCTGAGGC","FALSE","NM_005205","ref|NM_005205|ens|ENST00000287490|gb|M83308|gb|BC029818","COX6A2","cytochrome c oxidase subunit VIa polypeptide 2","ref|Homo sapiens cytochrome c oxidase subunit VIa polypeptide 2 (COX6A2), mRNA [NM_005205]","chr16",31439096,31439967,"GO:0004129(cytochrome-c oxidase activity);GO:0005751(mitochondrial respiratory chain complex IV);GO:0006091(generation of precursor metabolites and energy)","00190(Oxidative phosphorylation);04260(Cardiac muscle contraction);05010(Alzheimer's disease);05012(Parkinson's disease);05016(Huntington's disease);04932(Non-alcoholic fatty liver disease (NAFLD))","mRNA","agilent G3 V3"]
["A_24_P363745",3.39,{"v":5.3,"d":"5.30"},2.75,{"v":3.3,"d":"3.30"},4.81,5.32,{"v":0.851824274013403,"d":"0.85"},{"v":-0.231372252649053,"d":"-0.23"},"down",{"v":0.53442,"d":"0.53"},1,"no","ACCTGCGTCTAACTTTTGACACTATAAATAGGTTCAAGAAACTAATAAAACGTTCTGGTT","FALSE","NM_014665","ref|NM_014665|ref|NM_001272036|ens|ENST00000292524|gb|D25216","LRRC14","leucine rich repeat containing 14","ref|Homo sapiens leucine rich repeat containing 14 (LRRC14), transcript variant 2, mRNA [NM_014665]","chr8",145749040,145750255,null,null,"mRNA","agilent G3 V3"]
["A_23_P11286",2.06,5.82,2.13,4.32,3.68,4.58,{"v":0.79570747217806,"d":"0.80"},{"v":-0.329689948043296,"d":"-0.33"},"down",{"v":0.53704,"d":"0.54"},1,"no","CAAGTTAGTTATGTTGTAGGAGTGTACCTAAGCAGTAAGCGTATTTAGGTTAATGCAGTT","FALSE","NM_019597","ref|NM_019597|ref|NM_001199973|ref|NM_001199974|ref|NM_001032393","HNRNPH2","heterogeneous nuclear ribonucleoprotein H2 (H')","ref|Homo sapiens heterogeneous nuclear ribonucleoprotein H2 (H') (HNRNPH2), transcript variant 1, mRNA [NM_019597]","chrX",100663280,100669121,"GO:0000166(nucleotide binding);GO:0000398(nuclear mRNA splicing, via spliceosome);GO:0003723(RNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0008380(RNA splicing);GO:0010467(gene expression);GO:0016020(membrane);GO:0030529(ribonucleoprotein complex)",null,"mRNA","agilent G3 V3"]
["A_33_P3381361",2.52,2.69,6.44,4.92,4.77,4.78,{"v":0.80511402902557,"d":"0.81"},{"v":-0.312734966990082,"d":"-0.31"},"down",{"v":0.5392,"d":"0.54"},1,"no","ATGTGTTTGTTTCTCCCTTTTGCTTCTCTGCCGGCTCAGAGGAGAGGAGACGCCGTGAGC","FALSE","ENST00000562775","ens|ENST00000562775|gb|AF090912|tc|THC2611398","SPG7","spastic paraplegia 7 (pure and complicated autosomal recessive)","ens|spastic paraplegia 7 (pure and complicated autosomal recessive) [Source:HGNC Symbol;Acc:HGNC:11237] [ENST00000562775]","chr16",89590608,89596122,"GO:0004222(metalloendopeptidase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0006508(proteolysis);GO:0007005(mitochondrion organization);GO:0007399(nervous system development);GO:0008089(anterograde axon cargo transport);GO:0008233(peptidase activity);GO:0008270(zinc ion binding);GO:0016021(integral to membrane);GO:0031966(mitochondrial membrane);GO:0051082(unfolded protein binding)",null,"mRNA","agilent G3 V3"]
["A_23_P147605",7.02,{"v":6,"d":"6.00"},6.84,6.69,6.85,6.96,{"v":0.968780487804878,"d":"0.97"},{"v":-0.0457582868644346,"d":"-0.05"},"down",{"v":0.54618,"d":"0.55"},1,"no","ACCTTGTCACGCCGTAGCCTGTTAGTCCTCCTAACCTCTTAAGAGCAGTCTCTTCTGAGC","FALSE","NM_001003676","ref|NM_001003676|ref|NM_001278222|ref|NM_001003677|ref|NM_024113","C11orf49","chromosome 11 open reading frame 49","ref|Homo sapiens chromosome 11 open reading frame 49 (C11orf49), transcript variant 1, mRNA [NM_001003676]","chr11",46958248,47183462,"GO:0005654(nucleoplasm)",null,"mRNA","agilent G3 V3"]
["A_33_P3409631",5.56,4.69,6.16,5.44,5.15,4.94,{"v":1.05666452028332,"d":"1.06"},{"v":0.0795174091264117,"d":"0.08"},"up",{"v":0.55062,"d":"0.55"},1,"no","ATGCCACGTGACCCAGTTCCCAAACATACGAACCCACGTCTGGACCTCAGTGTGACTTAA","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_21_P0004860",{"v":10.3,"d":"10.30"},{"v":10.7,"d":"10.70"},10.52,10.36,10.83,10.68,{"v":0.989017885158456,"d":"0.99"},{"v":-0.0159314843214767,"d":"-0.02"},"down",{"v":0.55332,"d":"0.55"},1,"no","TGCCCAAGCTGGTTTCAGATAGGTCTCTCTCTCTGGCCTGCAGAGTTAAAACATCTCAAT","FALSE","NM_001197234","ref|NM_001197234|linc|lnc-BTN2A1-1:3|linc|lnc-BTN2A1-1:2|gb|AB209777","BTN2A1","butyrophilin, subfamily 2, member A1","ref|Homo sapiens butyrophilin, subfamily 2, member A1 (BTN2A1), transcript variant 4, mRNA [NM_001197234]","chr6",26458132,26476849,"GO:0003674(molecular_function);GO:0005887(integral to plasma membrane);GO:0006629(lipid metabolic process);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_24_P163405",7.55,9.08,7.94,8.75,8.49,8.26,{"v":0.963529411764706,"d":"0.96"},{"v":-0.0535993893840555,"d":"-0.05"},"down",{"v":0.55384,"d":"0.55"},1,"no","TACCCCAGCCTGATCCTCTCTGATAATCTGCGGCAAGTGCGGTACAGTTACCTCCAACAG","FALSE","NM_006510","ref|NM_006510|ens|ENST00000467742|ens|ENST00000468364|ens|ENST00000472315","TRIM27","tripartite motif containing 27","ref|Homo sapiens tripartite motif containing 27 (TRIM27), mRNA [NM_006510]","chr6",28872252,28875361,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0002820(negative regulation of adaptive immune response);GO:0003676(nucleic acid binding);GO:0003677(DNA binding);GO:0004714(transmembrane receptor protein tyrosine kinase activity);GO:0004842(ubiquitin-protein ligase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005768(endosome);GO:0005769(early endosome);GO:0005887(integral to plasma membrane);GO:0006351(transcription, DNA-dependent);GO:0006469(negative regulation of protein kinase activity);GO:0007283(spermatogenesis);GO:0008270(zinc ion binding);GO:0008283(cell proliferation);GO:0016020(membrane);GO:0016605(PML body);GO:0016874(ligase activity);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0030904(retromer complex);GO:0031965(nuclear membrane);GO:0032720(negative regulation of tumor necrosis factor production);GO:0032897(negative regulation of viral transcription);GO:0034314(Arp2/3 complex-mediated actin nucleation);GO:0042147(retrograde transport, endosome to Golgi);GO:0045087(innate immune response);GO:0045814(negative regulation of gene expression, epigenetic);GO:0046872(metal ion binding);GO:0051091(positive regulation of sequence-specific DNA binding transcription factor activity);GO:0070206(protein trimerization);GO:0070534(protein K63-linked ubiquitination);GO:0072643(interferon-gamma secretion);GO:0090281(negative regulation of calcium ion import);GO:1900041(negative regulation of interleukin-2 secretion)",null,"mRNA","agilent G3 V3"]
["A_23_P218858",4.94,2.05,3.11,3.58,3.92,4.25,{"v":0.859574468085106,"d":"0.86"},{"v":-0.218305463813205,"d":"-0.22"},"down",{"v":0.55986,"d":"0.56"},1,"no","CCCACCATAAATGTTACAATATCTGAATATGCTTTGTCAAACTATCCCTTTATGCAATCG","FALSE","NM_015429","ref|NM_015429|ens|ENST00000284322|ens|ENST00000470336|ref|XM_005247281","ABI3BP","ABI family, member 3 (NESH) binding protein","ref|Homo sapiens ABI family, member 3 (NESH) binding protein (ABI3BP), mRNA [NM_015429]","chr3",100469296,100556037,"GO:0005518(collagen binding);GO:0005614(interstitial matrix);GO:0005615(extracellular space);GO:0008201(heparin binding);GO:0010811(positive regulation of cell-substrate adhesion);GO:0030198(extracellular matrix organization);GO:0031012(extracellular matrix)",null,"mRNA","agilent G3 V3"]
["A_33_P3291559",6.24,5.92,{"v":6.3,"d":"6.30"},6.16,{"v":5.4,"d":"5.40"},6.32,{"v":1.0324384787472,"d":"1.03"},{"v":0.0460558164624562,"d":"0.05"},"up",{"v":0.56342,"d":"0.56"},1,"no","CTACCATCACCCCGTTTAGTCATCAAACAAGAACTAGGAAATTCCAGCGATAAGAAATGA","FALSE","AK022341","gb|AK022341|tc|NP1252151|tc|THC2638967",null,null,"gb|Homo sapiens cDNA FLJ12279 fis, clone MAMMA1001743, weakly similar to Y BOX BINDING PROTEIN-1. [AK022341]","chr7",151825968,151826771,null,null,"mRNA","agilent G3 V3"]
["A_19_P00322023",{"v":6.5,"d":"6.50"},6.51,{"v":6.6,"d":"6.60"},{"v":6.5,"d":"6.50"},6.26,7.88,{"v":0.950096899224806,"d":"0.95"},{"v":-0.0738534352311053,"d":"-0.07"},"down",{"v":0.56726,"d":"0.57"},1,"no","TACCATTCTGGCATCAATTTCAAGTGCTCAGTCCCTCAAGCTCTTTCCTCTTTACAAAAG","FALSE","ENST00000447625","ens|ENST00000447625|ens|ENST00000411780|linc|lnc-BLCAP-1:3|linc|lnc-BLCAP-1:2","BLCAP","bladder cancer associated protein","ens|bladder cancer associated protein [Source:HGNC Symbol;Acc:HGNC:1055] [ENST00000447625]","chr20",36120936,36124164,"GO:0005515(protein binding);GO:0007049(cell cycle);GO:0016021(integral to membrane);GO:0030262(apoptotic nuclear change)",null,"mRNA","agilent G3 V3"]
["A_23_P8240",2.34,5.58,2.33,3.47,{"v":4.4,"d":"4.40"},4.48,{"v":0.82995951417004,"d":"0.83"},{"v":-0.268887132079232,"d":"-0.27"},"down",{"v":0.56888,"d":"0.57"},1,"no","CTTGGTTGGTCTTTTCTGAGTATTTTAGTGTTGCCACCTGGATTTGCTGCATTGCTCTGC","FALSE","NM_012135","ref|NM_012135|gb|Y18503|gb|BC001261|ens|ENST00000380274","FAM50B","family with sequence similarity 50, member B","ref|Homo sapiens family with sequence similarity 50, member B (FAM50B), mRNA [NM_012135]","chr6",{"v":3849622,"d":"3849622.00"},3851551,"GO:0005634(nucleus)",null,"mRNA","agilent G3 V3"]
["A_24_P73669",2.05,5.01,2.21,3.35,3.63,4.08,{"v":0.838155515370705,"d":"0.84"},{"v":-0.254710141609176,"d":"-0.25"},"down",{"v":0.57712,"d":"0.58"},1,"no","TCTGTCCTTGGTACATTGGATTACCGTTTATTCCATATCTGGATAATTTGCCGAACTTCA","FALSE","NM_002094","ref|NM_002094|ref|NM_001130007|ref|NM_001130006|ens|ENST00000562794","GSPT1","G1 to S phase transition 1","ref|Homo sapiens G1 to S phase transition 1 (GSPT1), transcript variant 1, mRNA [NM_002094]","chr16",11961985,12009777,"GO:0000082(G1/S transition of mitotic cell cycle);GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay);GO:0003747(translation release factor activity);GO:0003924(GTPase activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005622(intracellular);GO:0006415(translational termination);GO:0006479(protein methylation)","03015(mRNA surveillance pathway)","mRNA","agilent G3 V3"]
["A_24_P256063",4.16,2.01,{"v":4.4,"d":"4.40"},3.58,3.75,4.76,{"v":0.874276261373036,"d":"0.87"},{"v":-0.19383886786644,"d":"-0.19"},"down",{"v":0.58082,"d":"0.58"},1,"no","CTCAGGACCATTCCAAGATCATGGCAGACATCCAGGCCCAATATAACGAGCTGTCTCGGA","FALSE","ENST00000439811","ens|ENST00000439811",null,null,"ens|keratin 18 pseudogene 65 [Source:HGNC Symbol;Acc:HGNC:48892] [ENST00000439811]","chr6",112683048,112683141,null,null,"mRNA","agilent G3 V3"]
["A_33_P3323463",2.86,7.35,{"v":4.1,"d":"4.10"},4.41,3.58,{"v":3.9,"d":"3.90"},{"v":1.20353238015139,"d":"1.20"},{"v":0.267274956981012,"d":"0.27"},"up",{"v":0.5851,"d":"0.59"},1,"no","ACCCTAGCACTGTCACAGACCTGGAGTCCATTGTAGTAATTTGTTTTATTTCCTACCAAG","FALSE","ENST00000532091","ens|ENST00000532091|tc|THC2543397|tc|THC2566156",null,null,"ens|heat shock 70kDa protein 8 [Source:HGNC Symbol;Acc:HGNC:5241] [ENST00000532091]","chr11",122930184,122932832,null,null,"mRNA","agilent G3 V3"]
["A_23_P401076",9.02,8.96,9.16,9.39,9.37,8.76,{"v":0.986191860465116,"d":"0.99"},{"v":-0.0200597492832436,"d":"-0.02"},"down",{"v":0.58754,"d":"0.59"},1,"no","TGGCCTCCCACTAACTAGCATTCCTTTAAAGAGACTGGGAAATGTTTTAAGCAAATCTAG","FALSE","NM_145006","ref|NM_145006|ref|NM_001287005|ref|NM_001287006|ref|NM_001287008","SUSD3","sushi domain containing 3","ref|Homo sapiens sushi domain containing 3 (SUSD3), transcript variant 1, mRNA [NM_145006]","chr9",95831384,95847412,"GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3349586",4.75,{"v":3,"d":"3.00"},4.36,4.11,4.42,4.54,{"v":0.9265493496557,"d":"0.93"},{"v":-0.110060276101105,"d":"-0.11"},"down",{"v":0.58908,"d":"0.59"},1,"no","TAAATCATAAATTAGCCCATCATAATCGCAGAGCATGCACCTCACACCAGCAAGGACTTC","FALSE","AK124269","gb|AK124269|tc|THC2483962","BAIAP2L1","BAI1-associated protein 2-like 1","gb|Homo sapiens cDNA FLJ42275 fis, clone TLIVE2001828. [AK124269]",{"$nulls":3},"GO:0003779(actin binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007009(plasma membrane organization);GO:0009617(response to bacterium);GO:0015629(actin cytoskeleton);GO:0030838(positive regulation of actin filament polymerization);GO:0046626(regulation of insulin receptor signaling pathway);GO:0070062(extracellular vesicular exosome);GO:0070064(proline-rich region binding);GO:2000251(positive regulation of actin cytoskeleton reorganization)",null,"mRNA","agilent G3 V3"]
["A_23_P72853",3.81,{"v":6.4,"d":"6.40"},2.02,4.73,{"v":4.9,"d":"4.90"},5.01,{"v":0.835382513661202,"d":"0.84"},{"v":-0.259491149756656,"d":"-0.26"},"down",{"v":0.59278,"d":"0.59"},1,"no","TGTGGATTATACTTTCCCAGCATGAGCTTCCTACGGAGAAAGGTGATCCCTGAGACAGAG","FALSE","NM_032889","ref|NM_032889|ref|NM_001170790|ens|ENST00000329548|ens|ENST00000534842","MFSD5","major facilitator superfamily domain containing 5","ref|Homo sapiens major facilitator superfamily domain containing 5 (MFSD5), transcript variant 2, mRNA [NM_032889]","chr12",53645368,53648189,"GO:0005886(plasma membrane);GO:0015098(molybdate ion transmembrane transporter activity);GO:0015689(molybdate ion transport);GO:0016020(membrane);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_24_P130026",3.34,{"v":5.7,"d":"5.70"},4.96,4.64,4.96,5.72,{"v":0.913838120104439,"d":"0.91"},{"v":-0.129989470092628,"d":"-0.13"},"down",{"v":0.59688,"d":"0.60"},1,"no","GAATTGTTCACATGGGTAATTGGTCATGGAAATGATCAGATTGACCTTGATTGACTGTCA","FALSE","NM_001015049","ref|NM_001015049|ref|NM_004873|ref|NM_001015048|ens|ENST00000445922","BAG5","BCL2-associated athanogene 5","ref|Homo sapiens BCL2-associated athanogene 5 (BAG5), transcript variant 1, mRNA [NM_001015049]","chr14",104022880,104029151,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0005739(mitochondrion);GO:0006457(protein folding);GO:0016020(membrane);GO:0016234(inclusion body);GO:0019901(protein kinase binding);GO:0031397(negative regulation of protein ubiquitination);GO:0031625(ubiquitin protein ligase binding);GO:0032435(negative regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0048471(perinuclear region of cytoplasm);GO:0051087(chaperone binding);GO:0051444(negative regulation of ubiquitin-protein ligase activity);GO:0061084(negative regulation of protein refolding);GO:0070997(neuron death);GO:0090083(regulation of inclusion body assembly)",null,"mRNA","agilent G3 V3"]
["A_23_P136964",5.09,4.65,4.18,5.28,4.76,4.48,{"v":0.958677685950413,"d":"0.96"},{"v":-0.0608822421470224,"d":"-0.06"},"down",{"v":0.60038,"d":"0.60"},1,"no","GACCAGAACCACATGAGTCAGAATCATCAGAATATCCCACCAACAAATACAGAGAGAAGA","FALSE","NM_000328","ref|NM_000328|ens|ENST00000474584|ens|ENST00000482855|ens|ENST00000476559","RPGR","retinitis pigmentosa GTPase regulator","ref|Homo sapiens retinitis pigmentosa GTPase regulator (RPGR), transcript variant A, mRNA [NM_000328]","chrX",38128424,38186788,"GO:0001750(photoreceptor outer segment);GO:0005085(guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005794(Golgi apparatus);GO:0005813(centrosome);GO:0006886(intracellular protein transport);GO:0007601(visual perception);GO:0036064(cilium basal body);GO:0036126(sperm flagellum);GO:0042073(intraflagellar transport);GO:0042384(cilium assembly);GO:0042462(eye photoreceptor cell development);GO:0043547(positive regulation of GTPase activity);GO:0050896(response to stimulus)",null,"mRNA","agilent G3 V3"]
["A_23_P95790",6.87,4.86,{"v":5.8,"d":"5.80"},6.03,5.17,5.24,{"v":1.06630170316302,"d":"1.07"},{"v":0.0926156970778556,"d":"0.09"},"up",{"v":0.6021,"d":"0.60"},1,"no","TCCTCCCAACCATGAGATCCCAAGGATGGAGAACAACTTACCCAGTAGCTAGAATGTTAA","FALSE","NM_017625","ref|NM_017625|ens|ENST00000326245|gb|AB036706|gb|AY065972","ITLN1","intelectin 1 (galactofuranose binding)","ref|Homo sapiens intelectin 1 (galactofuranose binding) (ITLN1), mRNA [NM_017625]","chr1",160846336,160854960,"GO:0001934(positive regulation of protein phosphorylation);GO:0009624(response to nematode);GO:0030246(carbohydrate binding);GO:0031225(anchored to membrane);GO:0031526(brush border membrane);GO:0043235(receptor complex);GO:0045121(membrane raft);GO:0046326(positive regulation of glucose import);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3422330",8.57,8.37,8.47,8.49,8.59,8.02,{"v":1.01235059760956,"d":"1.01"},{"v":0.0177090112152204,"d":"0.02"},"up",{"v":0.60618,"d":"0.61"},1,"no","GTGCACTGGGACCCCACACAGCAATACGAGTCCAACTTAATAAACACATTTCTGGGGTTC","FALSE","NM_198317","ref|NM_198317|ens|ENST00000338591|ref|XR_426605|ref|XR_426604","KLHL17","kelch-like family member 17","ref|Homo sapiens kelch-like family member 17 (KLHL17), mRNA [NM_198317]","chr1",{"v":895967,"d":"895967.00"},901095,"GO:0005615(extracellular space);GO:0007420(brain development);GO:0014069(postsynaptic density);GO:0015629(actin cytoskeleton);GO:0016567(protein ubiquitination);GO:0030036(actin cytoskeleton organization);GO:0030054(cell junction);GO:0031208(POZ domain binding);GO:0032839(dendrite cytoplasm);GO:0032947(protein complex scaffold);GO:0043025(neuronal cell body);GO:0045211(postsynaptic membrane);GO:0051015(actin filament binding)",null,"mRNA","agilent G3 V3"]
["A_23_P16189",8.71,8.68,8.54,{"v":8.7,"d":"8.70"},8.36,8.67,{"v":1.00777302759425,"d":"1.01"},{"v":0.0111707491194948,"d":"0.01"},"up",{"v":0.60998,"d":"0.61"},1,"no","GAGGAGGAGCTGTTTCAGGCCATCATGGAACAAACTGTCACCTACCCCAAGTCGCTTTCC","FALSE","NM_002739","ref|NM_002739|ens|ENST00000263431|gb|AK312302|gb|AB527732","PRKCG","protein kinase C, gamma","ref|Homo sapiens protein kinase C, gamma (PRKCG), mRNA [NM_002739]","chr19",54385456,54410441,"GO:0004672(protein kinase activity);GO:0004697(protein kinase C activity);GO:0004698(calcium-dependent protein kinase C activity);GO:0004712(protein serine/threonine/tyrosine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0006468(protein phosphorylation);GO:0007165(signal transduction);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007202(activation of phospholipase C activity);GO:0007268(synaptic transmission);GO:0007596(blood coagulation);GO:0007611(learning or memory);GO:0007635(chemosensory behavior);GO:0008270(zinc ion binding);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0016310(phosphorylation);GO:0030168(platelet activation);GO:0030425(dendrite);GO:0031397(negative regulation of protein ubiquitination);GO:0032095(regulation of response to food);GO:0032425(positive regulation of mismatch repair);GO:0035556(intracellular signal transduction);GO:0042177(negative regulation of protein catabolic process);GO:0042752(regulation of circadian rhythm);GO:0043278(response to morphine);GO:0043524(negative regulation of neuron apoptotic process);GO:0045087(innate immune response);GO:0046777(protein autophosphorylation);GO:0048011(nerve growth factor receptor signaling pathway);GO:0048265(response to pain);GO:0048471(perinuclear region of cytoplasm);GO:0048511(rhythmic process);GO:0060384(innervation);GO:0097060(synaptic membrane)","04014(Ras signaling pathway);04015(Rap1 signaling pathway);04010(MAPK signaling pathway);04012(ErbB signaling pathway);04310(Wnt signaling pathway);04370(VEGF signaling pathway);04066(HIF-1 signaling pathway);04020(Calcium signaling pathway);04070(Phosphatidylinositol signaling system);04071(Sphingolipid signaling pathway);04150(mTOR signaling pathway);04510(Focal adhesion);04530(Tight junction);04540(Gap junction);04650(Natural killer cell mediated cytotoxicity);04666(Fc gamma R-mediated phagocytosis);04670(Leukocyte transendothelial migration);04911(Insulin secretion);04921(Oxytocin signaling pathway);04918(Thyroid hormone synthesis);04919(Thyroid hormone signaling pathway);04916(Melanogenesis);04270(Vascular smooth muscle contraction);04970(Salivary secretion);04971(Gastric acid secretion);04972(Pancreatic secretion);04960(Aldosterone-regulated sodium reabsorption);04961(Endocrine and other factor-regulated calcium reabsorption);04724(Glutamatergic synapse);04727(GABAergic synapse);04725(Cholinergic synapse);04728(Dopaminergic synapse);04726(Serotonergic synapse);04720(Long-term potentiation);04730(Long-term depression);04723(Retrograde endocannabinoid signaling);04750(Inflammatory mediator regulation of TRP channels);04713(Circadian entrainment);05200(Pathways in cancer);05231(Choline metabolism in cancer);05206(MicroRNAs in cancer);05205(Proteoglycans in cancer);05214(Glioma);05223(Non-small cell lung cancer);05031(Amphetamine addiction);05032(Morphine addiction);05110(Vibrio cholerae infection);05161(Hepatitis B);05146(Amoebiasis);05143(African trypanosomiasis)","mRNA","agilent G3 V3"]
["A_24_P10233",{"v":4.5,"d":"4.50"},5.17,4.18,4.14,4.54,4.63,{"v":1.04057099924869,"d":"1.04"},{"v":0.0573754050246591,"d":"0.06"},"up",{"v":0.61262,"d":"0.61"},1,"no","AATATAAAGGACATCCTCATCATCACGGGGTGAAGGTCAGACTAAGGCAGCCTTCTTCAC","FALSE","NM_014326","ref|NM_014326|ens|ENST00000457488|ens|ENST00000559007|ens|ENST00000261891","DAPK2","death-associated protein kinase 2","ref|Homo sapiens death-associated protein kinase 2 (DAPK2), mRNA [NM_014326]","chr15",64199236,64332466,"GO:0004674(protein serine/threonine kinase activity);GO:0004683(calmodulin-dependent protein kinase activity);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0006915(apoptotic process);GO:0010506(regulation of autophagy);GO:0031410(cytoplasmic vesicle);GO:0034423(autophagic vacuole lumen);GO:0035556(intracellular signal transduction);GO:0042802(identical protein binding);GO:0042981(regulation of apoptotic process);GO:0043276(anoikis);GO:0046777(protein autophosphorylation);GO:2001242(regulation of intrinsic apoptotic signaling pathway)","05200(Pathways in cancer);05219(Bladder cancer)","mRNA","agilent G3 V3"]
["A_33_P3289192",3.66,6.97,2.04,5.19,5.24,4.83,{"v":0.830275229357798,"d":"0.83"},{"v":-0.268338437693721,"d":"-0.27"},"down",{"v":0.61344,"d":"0.61"},1,"no","GAATTAGTGGAAGCTGTTCCTTTGAAAGCCAAGATATTATTTAAGTTGTAAAGCCAGCTA","FALSE","NM_006620","ref|NM_006620|ref|NM_001145158|ens|ENST00000367826|ens|ENST00000527005","HBS1L","HBS1-like translational GTPase","ref|Homo sapiens HBS1-like translational GTPase (HBS1L), transcript variant 1, mRNA [NM_006620]","chr6",135285984,135371759,"GO:0003746(translation elongation factor activity);GO:0003924(GTPase activity);GO:0005525(GTP binding);GO:0006412(translation);GO:0006414(translational elongation);GO:0007165(signal transduction);GO:0016020(membrane);GO:0070062(extracellular vesicular exosome)","03015(mRNA surveillance pathway);05134(Legionellosis)","mRNA","agilent G3 V3"]
["A_21_P0013759",{"v":5.7,"d":"5.70"},3.09,5.51,5.17,5.45,5.17,{"v":0.90563647878404,"d":"0.91"},{"v":-0.142996024194485,"d":"-0.14"},"down",{"v":0.61632,"d":"0.62"},1,"no","TTTTGATGAAGGACGTGGGAGCTGCCCATTTGGAGAGAACTGTTTTTACAAGCATATGTA","FALSE","ENST00000444706","ens|ENST00000444706|linc|TCONS_l2_00030182|linc|TCONS_l2_00030181",null,null,"ens|makorin ring finger protein 4, pseudogene [Source:HGNC Symbol;Acc:HGNC:7115] [ENST00000444706]","chrX",40693736,40695258,null,null,"mRNA","agilent G3 V3"]
["A_23_P19778",{"v":5.7,"d":"5.70"},4.57,3.95,5.05,3.79,4.38,{"v":1.07564296520424,"d":"1.08"},{"v":0.105199288111724,"d":"0.11"},"up",{"v":0.6239,"d":"0.62"},1,"no","AGCTGGCCTGGGAGTCAACGTTATTGGACTGGTGATAGTAATGGTGGCCATCAACACCTG","FALSE","NM_012450","ref|NM_012450|ens|ENST00000471405|ens|ENST00000354042|ens|ENST00000491630","SLC13A4","solute carrier family 13 (sodium/sulfate symporter), member 4","ref|Homo sapiens solute carrier family 13 (sodium/sulfate symporter), member 4 (SLC13A4), mRNA [NM_012450]","chr7",135365984,135412952,"GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0008272(sulfate transport);GO:0015382(sodium:sulfate symporter activity);GO:0035725(sodium ion transmembrane transport);GO:0055085(transmembrane transport)",null,"mRNA","agilent G3 V3"]
["A_33_P3232557",{"v":8.3,"d":"8.30"},8.12,8.31,8.44,8.12,8.35,{"v":0.992773986350863,"d":"0.99"},{"v":-0.0104627818508982,"d":"-0.01"},"down",{"v":0.62512,"d":"0.63"},1,"no","ACCTGTGGCTGTTCCCACATCCCCTTGAATATCCCAGGAAAAATAAAACGGCAGAACTGC","FALSE","NM_001080418","ref|NM_001080418|ens|ENST00000373347|ens|ENST00000235180|ref|XM_005271091","DLGAP3","discs, large (Drosophila) homolog-associated protein 3","ref|Homo sapiens discs, large (Drosophila) homolog-associated protein 3 (DLGAP3), mRNA [NM_001080418]","chr1",35331036,35370984,"GO:0001540(beta-amyloid binding);GO:0005515(protein binding);GO:0007267(cell-cell signaling);GO:0014069(postsynaptic density);GO:0030054(cell junction);GO:0045211(postsynaptic membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P208334",3.68,3.02,4.59,3.58,4.26,4.25,{"v":0.933829611248966,"d":"0.93"},{"v":-0.0987687584761228,"d":"-0.10"},"down",{"v":0.6272,"d":"0.63"},1,"no","TGCACAGCCCAAGAGGCATTGACTGAGCAGGGATTGTCAGGAGTCGAGGAAGCTCTGGAT","FALSE","NM_006202","ref|NM_006202|ref|NM_001111307|ref|NM_001243121|ref|NM_001111308","PDE4A","phosphodiesterase 4A, cAMP-specific","ref|Homo sapiens phosphodiesterase 4A, cAMP-specific (PDE4A), transcript variant 4, mRNA [NM_006202]","chr19",10527619,10580305,"GO:0004115(3',5'-cyclic-AMP phosphodiesterase activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0006198(cAMP catabolic process);GO:0007165(signal transduction);GO:0007608(sensory perception of smell);GO:0010738(regulation of protein kinase A signaling cascade);GO:0016020(membrane);GO:0030552(cAMP binding);GO:0032587(ruffle membrane);GO:0035690(cellular response to drug);GO:0043949(regulation of cAMP-mediated signaling);GO:0046872(metal ion binding);GO:0048471(perinuclear region of cytoplasm)","00230(Purine metabolism);04024(cAMP signaling pathway);05032(Morphine addiction)","mRNA","agilent G3 V3"]
["A_23_P6344",{"v":7,"d":"7.00"},8.39,6.87,7.74,7.79,7.55,{"v":0.964471403812825,"d":"0.96"},{"v":-0.0521896313035231,"d":"-0.05"},"down",{"v":0.6343,"d":"0.63"},1,"no","CAGGGCCACTCTTGGCAGAGACTTTGGGTTTGTAGGGGTCCTCAAGTGCCTTTGTGATTA","FALSE","NM_022044","ref|NM_022044|ens|ENST00000248958|gb|AF277316|gb|AB043007","SDF2L1","stromal cell-derived factor 2-like 1","ref|Homo sapiens stromal cell-derived factor 2-like 1 (SDF2L1), mRNA [NM_022044]","chr22",21996550,21998587,"GO:0005788(endoplasmic reticulum lumen);GO:0016020(membrane);GO:0034976(response to endoplasmic reticulum stress);GO:0042981(regulation of apoptotic process);GO:0051087(chaperone binding);GO:0051117(ATPase binding);GO:0051787(misfolded protein binding);GO:0071712(ER-associated misfolded protein catabolic process)",null,"mRNA","agilent G3 V3"]
["A_24_P323072",4.67,2.24,4.98,4.81,{"v":4.5,"d":"4.50"},3.96,{"v":0.896006028636021,"d":"0.90"},{"v":-0.158419655624537,"d":"-0.16"},"down",{"v":0.63662,"d":"0.64"},1,"no","ACCTTGGACCCTCAGAGGCTCAGCACTGGTCCCATGGCTGGTACCCTGGAGGAAAGCGAG","FALSE","NM_178332","ref|NM_178332|ref|NM_178331|ref|NM_001501|ens|ENST00000380346","GNRH2","gonadotropin-releasing hormone 2","ref|Homo sapiens gonadotropin-releasing hormone 2 (GNRH2), transcript variant 2, mRNA [NM_178332]","chr20",{"v":3024268,"d":"3024268.00"},3026391,"GO:0005179(hormone activity);GO:0005576(extracellular region);GO:0007165(signal transduction);GO:0007275(multicellular organismal development)","04080(Neuroactive ligand-receptor interaction);04912(GnRH signaling pathway)","mRNA","agilent G3 V3"]
["A_23_P309381",4.47,1.95,4.83,4.35,4.05,4.34,{"v":0.883045525902669,"d":"0.88"},{"v":-0.179440276151901,"d":"-0.18"},"down",{"v":0.6404,"d":"0.64"},1,"no","CGACTTTCCCGATCGCCAGGCAGGAGTTTCTCTCGGTGACTACTATCGCTGTCATGTCTG","FALSE","NM_001040874","ref|NM_001040874|ref|NM_003516|ens|ENST00000607355|gb|L19779","HIST2H2AA4","histone cluster 2, H2aa4","ref|Homo sapiens histone cluster 2, H2aa4 (HIST2H2AA4), mRNA [NM_001040874]","chr1",149813504,149814478,"GO:0000786(nucleosome);GO:0003674(molecular_function);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0008150(biological_process);GO:0046982(protein heterodimerization activity);GO:0070062(extracellular vesicular exosome)","05322(Systemic lupus erythematosus);05034(Alcoholism)","mRNA","agilent G3 V3"]
["A_33_P3387320",4.53,2.06,4.58,3.11,3.14,3.65,{"v":1.12828282828283,"d":"1.13"},{"v":0.174128755516343,"d":"0.17"},"up",{"v":0.64462,"d":"0.64"},1,"no","ACTTAGGGTGTGTAGTATCTGCAGGGAAGCCCCTTAATTTAGTGGCTTATGAACTGAGAC","FALSE","THC2542446","tc|THC2542446",null,null,"tc|Q6IRZ0_HUMAN (Q6IRZ0) RPL31 protein, partial (64%) [THC2542446]","chr2",101619152,101622829,"GO:0003735(structural constituent of ribosome);GO:0005840(ribosome);GO:0006412(translation)",null,"mRNA","agilent G3 V3"]
["A_21_P0013653",4.68,2.33,4.45,4.07,{"v":4.2,"d":"4.20"},4.38,{"v":0.905928853754941,"d":"0.91"},{"v":-0.142530340824767,"d":"-0.14"},"down",{"v":0.65108,"d":"0.65"},1,"no","ATTTAAAATAACTTGCCTGTTCCCGTGGACTTTATCCACTAGTGAAGGAGGACAAGTGGA","FALSE","XM_006710244","ref|XM_006710244|linc|TCONS_l2_00029352|linc|TCONS_l2_00029351|linc|TCONS_l2_00029350","LOC102723390","protein FRG1-like","ref|PREDICTED: Homo sapiens protein FRG1-like (LOC102723390), transcript variant X1, mRNA [XM_006710244]","chrUn_gl000241",{"v":12257,"d":"12257.00"},36847,null,null,"mRNA","agilent G3 V3"]
["A_33_P3405434",5.92,6.01,6.06,{"v":5.2,"d":"5.20"},6.12,6.17,{"v":1.02858776443682,"d":"1.03"},{"v":0.0406648973298294,"d":"0.04"},"up",{"v":0.65248,"d":"0.65"},1,"no","TTCAGAATCAAAGTGTTCTCTCAACTTCTTGGTCCCATTGGCCTCCAAAACCCAGGAGAA","FALSE","ENST00000467486","ens|ENST00000467486|gb|AK057346|tc|THC2483044","VWA5B1","von Willebrand factor A domain containing 5B1","ens|von Willebrand factor A domain containing 5B1 [Source:HGNC Symbol;Acc:HGNC:26538] [ENST00000467486]","chr1",20617412,20675766,"GO:0005576(extracellular region)",null,"mRNA","agilent G3 V3"]
["A_23_P162525",4.78,3.11,4.13,4.38,4.37,3.99,{"v":0.943485086342229,"d":"0.94"},{"v":-0.083928381545115,"d":"-0.08"},"down",{"v":0.65796,"d":"0.66"},1,"no","GTAGCAATGGATCTTGGGATAGACAAGGTAAAGCCGTATCTCCCAATGATCATAGCTCCT","FALSE","NM_014503","ref|NM_014503|ens|ENST00000261637|gb|AF072718|gb|AK297739","UTP20","UTP20, small subunit (SSU) processome component, homolog (yeast)","ref|Homo sapiens UTP20, small subunit (SSU) processome component, homolog (yeast) (UTP20), mRNA [NM_014503]","chr12",101673888,101780394,"GO:0000447(endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0000462(maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0000472(endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0000480(endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006364(rRNA processing);GO:0008285(negative regulation of cell proliferation);GO:0030686(90S preribosome);GO:0030688(preribosome, small subunit precursor);GO:0032040(small-subunit processome)",null,"mRNA","agilent G3 V3"]
["A_24_P154037",2.09,5.37,2.27,2.87,4.05,4.45,{"v":0.855760773966579,"d":"0.86"},{"v":-0.224720544111136,"d":"-0.22"},"down",{"v":0.66346,"d":"0.66"},1,"no","GATGGTTCGTGTTCATACTGCAGCTTAAAACAAGCAAAATACACAGATGATAATATGCTA","FALSE","NM_003749","ref|NM_003749|gb|AF073310|gb|BC042858|gb|BC063516","IRS2","insulin receptor substrate 2","ref|Homo sapiens insulin receptor substrate 2 (IRS2), mRNA [NM_003749]","chr13",110406184,110438915,"GO:0002053(positive regulation of mesenchymal cell proliferation);GO:0002903(negative regulation of B cell apoptotic process);GO:0004871(signal transducer activity);GO:0005158(insulin receptor binding);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006006(glucose metabolic process);GO:0007165(signal transduction);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007420(brain development);GO:0008283(cell proliferation);GO:0008284(positive regulation of cell proliferation);GO:0008286(insulin receptor signaling pathway);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0009749(response to glucose stimulus);GO:0010748(negative regulation of plasma membrane long-chain fatty acid transport);GO:0010907(positive regulation of glucose metabolic process);GO:0019216(regulation of lipid metabolic process);GO:0019901(protein kinase binding);GO:0019903(protein phosphatase binding);GO:0019904(protein domain specific binding);GO:0030335(positive regulation of cell migration);GO:0030879(mammary gland development);GO:0030890(positive regulation of B cell proliferation);GO:0032000(positive regulation of fatty acid beta-oxidation);GO:0032024(positive regulation of insulin secretion);GO:0032869(cellular response to insulin stimulus);GO:0033673(negative regulation of kinase activity);GO:0038095(Fc-epsilon receptor signaling pathway);GO:0043548(phosphatidylinositol 3-kinase binding);GO:0045087(innate immune response);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0046326(positive regulation of glucose import);GO:0048011(nerve growth factor receptor signaling pathway);GO:0048015(phosphatidylinositol-mediated signaling);GO:0055088(lipid homeostasis);GO:0060397(JAK-STAT cascade involved in growth hormone signaling pathway);GO:0071333(cellular response to glucose stimulus);GO:0071889(14-3-3 protein binding)","04068(FoxO signaling pathway);04022(cGMP - PKG signaling pathway);04152(AMPK signaling pathway);04910(Insulin signaling pathway);04923(Regulation of lipolysis in adipocyte);04920(Adipocytokine signaling pathway);05206(MicroRNAs in cancer);04930(Type II diabetes mellitus);04932(Non-alcoholic fatty liver disease (NAFLD))","mRNA","agilent G3 V3"]
["A_33_P3317392",{"v":5.3,"d":"5.30"},4.87,5.71,4.82,5.88,5.75,{"v":0.965349544072948,"d":"0.97"},{"v":-0.0508766714796461,"d":"-0.05"},"down",{"v":0.66906,"d":"0.67"},1,"no","AGACAATCCAATGTATGTTCTGAGGTCACCTGGCTCTCTTCATGTCACCCTTTGGGAAAT","FALSE","NM_133638","ref|NM_133638|ens|ENST00000274487|tc|THC2601060","ADAMTS19","ADAM metallopeptidase with thrombospondin type 1 motif, 19","ref|Homo sapiens ADAM metallopeptidase with thrombospondin type 1 motif, 19 (ADAMTS19), mRNA [NM_133638]","chr5",128795960,129074376,"GO:0004222(metalloendopeptidase activity);GO:0005578(proteinaceous extracellular matrix);GO:0006508(proteolysis);GO:0008270(zinc ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P250283",4.62,4.12,2.84,3.91,3.95,4.49,{"v":0.937651821862348,"d":"0.94"},{"v":-0.0928757884828036,"d":"-0.09"},"down",{"v":0.67162,"d":"0.67"},1,"no","ACTGAGGTCAAACGTTGTTTCCTTAGGTTGAAATAGCAGCCAAAACATTCTTCACGCAGG","FALSE","NM_004161","ref|NM_004161|ref|NM_015543|ens|ENST00000409784|ref|XM_005264468","RAB1A","RAB1A, member RAS oncogene family","ref|Homo sapiens RAB1A, member RAS oncogene family (RAB1A), transcript variant 1, mRNA [NM_004161]","chr2",65313988,65357240,"GO:0000045(autophagic vacuole assembly);GO:0000139(Golgi membrane);GO:0000278(mitotic cell cycle);GO:0003924(GTPase activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005769(early endosome);GO:0005789(endoplasmic reticulum membrane);GO:0005829(cytosol);GO:0006184(GTP catabolic process);GO:0006886(intracellular protein transport);GO:0006888(ER to Golgi vesicle-mediated transport);GO:0006897(endocytosis);GO:0006914(autophagy);GO:0007030(Golgi organization);GO:0016192(vesicle-mediated transport);GO:0016477(cell migration);GO:0019003(GDP binding);GO:0019068(virion assembly);GO:0030252(growth hormone secretion);GO:0032402(melanosome transport);GO:0032482(Rab protein signal transduction);GO:0034446(substrate adhesion-dependent cell spreading);GO:0042384(cilium assembly);GO:0042470(melanosome);GO:0042742(defense response to bacterium);GO:0047496(vesicle transport along microtubule);GO:0070062(extracellular vesicular exosome);GO:0072606(interleukin-8 secretion);GO:0090110(cargo loading into COPII-coated vesicle)","05134(Legionellosis)","mRNA","agilent G3 V3"]
["A_33_P3291325",4.16,2.36,4.75,4.37,3.74,4.17,{"v":0.917752442996743,"d":"0.92"},{"v":-0.123823045197958,"d":"-0.12"},"down",{"v":0.67374,"d":"0.67"},1,"no","ATGAATTGGATGGGAAAAGGAGAAAAGAGGGTGTGAACCTGGTGATCCCATTTGTTCCCT","FALSE","NM_017553","ref|NM_017553|ref|NR_104038|ens|ENST00000616814|ens|ENST00000558357","INO80","INO80 complex subunit","ref|Homo sapiens INO80 complex subunit (INO80), transcript variant 1, mRNA [NM_017553]","chr15",41271092,41408351,"GO:0000070(mitotic sister chromatid segregation);GO:0000724(double-strand break repair via homologous recombination);GO:0003677(DNA binding);GO:0003678(DNA helicase activity);GO:0003779(actin binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005874(microtubule);GO:0006302(double-strand break repair);GO:0006338(chromatin remodeling);GO:0010571(positive regulation of DNA replication involved in S phase);GO:0016887(ATPase activity);GO:0030307(positive regulation of cell growth);GO:0031011(Ino80 complex);GO:0032508(DNA duplex unwinding);GO:0034644(cellular response to UV);GO:0043014(alpha-tubulin binding);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0051225(spindle assembly);GO:0051301(cell division);GO:0070914(UV-damage excision repair);GO:0071479(cellular response to ionizing radiation);GO:2000045(regulation of G1/S transition of mitotic cell cycle)",null,"mRNA","agilent G3 V3"]
["A_24_P131646",5.02,2.55,4.79,4.28,4.74,4.41,{"v":0.920327624720774,"d":"0.92"},{"v":-0.119780561523068,"d":"-0.12"},"down",{"v":0.67864,"d":"0.68"},1,"no","GAAGCCTTCATGCTGTTCGACCGCACACCCAAGTGTGAGATGAAGATCACCTACGGGCAG","FALSE","NM_000258","ref|NM_000258|ens|ENST00000292327|ens|ENST00000395869|gb|AK312044","MYL3","myosin, light chain 3, alkali; ventricular, skeletal, slow","ref|Homo sapiens myosin, light chain 3, alkali; ventricular, skeletal, slow (MYL3), mRNA [NM_000258]","chr3",46902468,46923659,"GO:0002026(regulation of the force of heart contraction);GO:0003774(motor activity);GO:0003785(actin monomer binding);GO:0005509(calcium ion binding);GO:0005829(cytosol);GO:0005859(muscle myosin complex);GO:0006942(regulation of striated muscle contraction);GO:0007519(skeletal muscle tissue development);GO:0008152(metabolic process);GO:0008307(structural constituent of muscle);GO:0030017(sarcomere);GO:0030049(muscle filament sliding);GO:0031672(A band);GO:0031674(I band);GO:0032038(myosin II heavy chain binding);GO:0032781(positive regulation of ATPase activity);GO:0055010(ventricular cardiac muscle tissue morphogenesis);GO:0060048(cardiac muscle contraction)","04260(Cardiac muscle contraction);04261(Adrenergic signaling in cardiomyocytes);05410(Hypertrophic cardiomyopathy (HCM));05414(Dilated cardiomyopathy (DCM))","mRNA","agilent G3 V3"]
["A_23_P122375",8.15,7.92,8.06,8.04,7.86,{"v":8.1,"d":"8.10"},{"v":1.00541666666667,"d":"1.01"},{"v":0.00779350971987073,"d":"0.01"},"up",{"v":0.68234,"d":"0.68"},1,"no","AACTGCAAATGTTTTTTGATCCGACGTACTGAAATAGGAAGTCATGCTCTTCCCACCCTC","FALSE","NM_021943","ref|NM_021943|ens|ENST00000287218|ref|XM_005249269|gb|AK023284","ZFAND3","zinc finger, AN1-type domain 3","ref|Homo sapiens zinc finger, AN1-type domain 3 (ZFAND3), mRNA [NM_021943]","chr6",37787576,38122400,"GO:0003677(DNA binding);GO:0008270(zinc ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P132515",4.44,3.71,3.52,3.91,3.57,{"v":3.8,"d":"3.80"},{"v":1.03457446808511,"d":"1.03"},{"v":0.0490374933085545,"d":"0.05"},"up",{"v":0.68494,"d":"0.68"},1,"no","TTTAAAGTCCCCAAATGTGTACTTAGCCTTCTGTTATTCCTTATTCTTTAAGCAGTGTTG","FALSE","NM_017699","ref|NM_017699|ens|ENST00000264852|ref|XM_005247558|gb|AK000181","SIDT1","SID1 transmembrane family, member 1","ref|Homo sapiens SID1 transmembrane family, member 1 (SIDT1), mRNA [NM_017699]","chr3",113251216,113348421,"GO:0016021(integral to membrane);GO:0033227(dsRNA transport);GO:0051033(RNA transmembrane transporter activity)",null,"mRNA","agilent G3 V3"]
["A_23_P502627",6.78,{"v":6.8,"d":"6.80"},6.88,6.56,7.19,6.95,{"v":0.988405797101449,"d":"0.99"},{"v":-0.0168246226413588,"d":"-0.02"},"down",{"v":0.68944,"d":"0.69"},1,"no","GACAGAATGATCTCAGTGATGCAGAGATAGTGTCTCTCTTCTCTGATGTACCTGACAGTA","FALSE","NM_007156","ref|NM_007156|ref|NM_007157|ens|ENST00000358697|ens|ENST00000374888","ZXDA","zinc finger, X-linked, duplicated A","ref|Homo sapiens zinc finger, X-linked, duplicated A (ZXDA), mRNA [NM_007156]","chrX",57931864,57937067,"GO:0003676(nucleic acid binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0046872(metal ion binding);GO:0070742(C2H2 zinc finger domain binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3289576",6.39,5.48,6.19,6.07,5.86,5.76,{"v":1.02091577162239,"d":"1.02"},{"v":0.0298638447904002,"d":"0.03"},"up",{"v":0.69332,"d":"0.69"},1,"no","GCATAGACCTCAAGCCCACACCTCATCGGAGGAACTTCAAGAAGTTTATGGAAAAAGACA","FALSE","NM_025184","ref|NM_025184|ens|ENST00000420999|gb|JF432302|gb|AK026496","EFHC2","EF-hand domain (C-terminal) containing 2","ref|Homo sapiens EF-hand domain (C-terminal) containing 2 (EFHC2), mRNA [NM_025184]","chrX",44007912,44202918,"GO:0005509(calcium ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P105619",6.03,4.45,5.01,{"v":5.6,"d":"5.60"},5.33,5.16,{"v":0.962709757613424,"d":"0.96"},{"v":-0.0548271819338778,"d":"-0.05"},"down",{"v":0.69826,"d":"0.70"},1,"no","AGGCTCGGCGTGATGCAGATACCCAGACACCATTATTATGCTCACAGAAGAGATTCTATA","FALSE","NM_138341","ref|NM_138341|ref|NM_001294314|ref|NM_001193531|ref|NM_001193453","TMEM116","transmembrane protein 116","ref|Homo sapiens transmembrane protein 116 (TMEM116), transcript variant 3, mRNA [NM_138341]","chr12",112369104,112450915,"GO:0003674(molecular_function);GO:0005575(cellular_component);GO:0008150(biological_process);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P347610",6.34,6.64,{"v":6.3,"d":"6.30"},6.28,{"v":6.1,"d":"6.10"},6.66,{"v":1.01260504201681,"d":"1.01"},{"v":0.0180715729220184,"d":"0.02"},"up",{"v":0.70528,"d":"0.71"},1,"no","TGGCATTCCAACATGTCAGTGATACTGGGTAGAGTAACTCTCCCACTCCAAACTGTGTAT","FALSE","NM_012206","ref|NM_012206|ref|NM_001099414|ref|NM_001173393|ref|NR_003603","HAVCR1","hepatitis A virus cellular receptor 1","ref|Homo sapiens hepatitis A virus cellular receptor 1 (HAVCR1), transcript variant 1, mRNA [NM_012206]","chr19",24345172,24346227,"GO:0001618(viral receptor activity);GO:0009615(response to virus);GO:0016021(integral to membrane);GO:0016032(viral reproduction)",null,"mRNA","agilent G3 V3"]
["A_33_P3591972",5.67,2.64,2.51,{"v":4,"d":"4.00"},4.26,3.91,{"v":0.889071487263763,"d":"0.89"},{"v":-0.169628668886913,"d":"-0.17"},"down",{"v":0.70682,"d":"0.71"},1,"no","TTTCAGCTGAGGCAAAACCTCTACCTGGTGGGCTTTGGCAAGGCTGTGCTGGGTATGGCA","FALSE","NM_001144951","ref|NM_001144951|ens|ENST00000473583|ens|ENST00000473032|ens|ENST00000305690","GLYCTK","glycerate kinase","ref|Homo sapiens glycerate kinase (GLYCTK), transcript variant 2, mRNA [NM_001144951]","chr3",52321836,52329272,"GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0006468(protein phosphorylation);GO:0008887(glycerate kinase activity)","00630(Glyoxylate and dicarboxylate metabolism);00561(Glycerolipid metabolism);00260(Glycine, serine and threonine metabolism)","mRNA","agilent G3 V3"]
["A_33_P3360227",6.21,4.28,5.39,4.66,5.26,5.25,{"v":1.04680290046144,"d":"1.05"},{"v":0.0659898268959242,"d":"0.07"},"up",{"v":0.71038,"d":"0.71"},1,"no","ATTCGATCCGAGGTTTCTAGTCCCCAGCTGGACATCACAGCACCAACTCCCACTCAGGAG","FALSE","DC397705","gb|DC397705",null,null,"gb|DC397705 TESTI2 Homo sapiens cDNA clone TESTI2031480 5', mRNA sequence [DC397705]","chr6",111195984,111215185,null,null,"mRNA","agilent G3 V3"]
["A_24_P139620",4.31,{"v":5.6,"d":"5.60"},3.85,4.64,4.34,4.14,{"v":1.04878048780488,"d":"1.05"},{"v":0.068712750084014,"d":"0.07"},"up",{"v":0.71472,"d":"0.71"},1,"no","GATGTCGGCAGAAAACTCGAAGTACCAAAAAGTTGACAGTACAAAGATTCCCTCGAATCC","FALSE","NM_001014443","ref|NM_001014443|ref|NM_012475|ens|ENST00000482385|ens|ENST00000493054","USP21","ubiquitin specific peptidase 21","ref|Homo sapiens ubiquitin specific peptidase 21 (USP21), transcript variant 3, mRNA [NM_001014443]","chr1",161129248,161135504,"GO:0003713(transcription coactivator activity);GO:0004197(cysteine-type endopeptidase activity);GO:0004843(ubiquitin-specific protease activity);GO:0005575(cellular_component);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0008234(cysteine-type peptidase activity);GO:0016578(histone deubiquitination);GO:0019784(NEDD8-specific protease activity);GO:0043161(proteasomal ubiquitin-dependent protein catabolic process);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0046872(metal ion binding);GO:0061136(regulation of proteasomal protein catabolic process)",null,"mRNA","agilent G3 V3"]
["A_23_P351138",3.65,5.72,4.14,4.07,4.29,4.42,{"v":1.05712050078247,"d":"1.06"},{"v":0.0801398383786899,"d":"0.08"},"up",{"v":0.72018,"d":"0.72"},1,"no","CCTGCTTGGCCTCCTGGTGGCCATCACAGGTGCCCAGTGTACCACGTGTGTGGAGGACGA","FALSE","NM_020982","ref|NM_020982|ens|ENST00000445369|gb|BC065830|gb|BC051870","CLDN9","claudin 9","ref|Homo sapiens claudin 9 (CLDN9), mRNA [NM_020982]","chr16",{"v":3062457,"d":"3062457.00"},3064506,"GO:0005198(structural molecule activity);GO:0005886(plasma membrane);GO:0005923(tight junction);GO:0016021(integral to membrane);GO:0016032(viral reproduction);GO:0016338(calcium-independent cell-cell adhesion);GO:0034329(cell junction assembly);GO:0042802(identical protein binding);GO:0045216(cell-cell junction organization);GO:0070830(tight junction assembly)","04514(Cell adhesion molecules (CAMs));04530(Tight junction);04670(Leukocyte transendothelial migration);05160(Hepatitis C)","mRNA","agilent G3 V3"]
["A_23_P16992",2.73,5.14,{"v":2.8,"d":"2.80"},3.41,4.16,4.04,{"v":0.919035314384151,"d":"0.92"},{"v":-0.121807796041142,"d":"-0.12"},"down",{"v":0.72352,"d":"0.72"},1,"no","TCAGATTGAGGTGAAAAGTCCATCTTGCTGATTTCATGATTGAAATGTGAAAGTGAAGTG","FALSE","NM_003628","ref|NM_003628|ref|NM_001005476|ens|ENST00000426248|ens|ENST00000480171","PKP4","plakophilin 4","ref|Homo sapiens plakophilin 4 (PKP4), transcript variant 1, mRNA [NM_003628]","chr2",159518752,159537938,"GO:0000922(spindle pole);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0007043(cell-cell junction assembly);GO:0007267(cell-cell signaling);GO:0009898(internal side of plasma membrane);GO:0014069(postsynaptic density);GO:0016337(cell-cell adhesion);GO:0030057(desmosome);GO:0030155(regulation of cell adhesion);GO:0030496(midbody);GO:0032321(positive regulation of Rho GTPase activity);GO:0032467(positive regulation of cytokinesis);GO:0044291(cell-cell contact zone);GO:0048471(perinuclear region of cytoplasm);GO:0051233(spindle midzone);GO:0072686(mitotic spindle)",null,"mRNA","agilent G3 V3"]
["A_33_P3416206",7.78,7.65,7.51,7.58,7.64,7.63,{"v":1.00393873085339,"d":"1.00"},{"v":0.00567122607039279,"d":"0.01"},"up",{"v":0.72714,"d":"0.73"},1,"no","ATGAGGCTTCCTTTCCTCCATCAAAGCAAGCAAATCCTTTAAAAGCTGCATCTCCAAGGG","FALSE","ENST00000573703","ens|ENST00000573703|gb|AF258580|tc|THC2488288","ARHGAP17","Rho GTPase activating protein 17","ens|Rho GTPase activating protein 17 [Source:HGNC Symbol;Acc:HGNC:18239] [ENST00000573703]","chr16",24930710,24932325,"GO:0005096(GTPase activator activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005923(tight junction);GO:0007264(small GTPase mediated signal transduction);GO:0017124(SH3 domain binding);GO:0043547(positive regulation of GTPase activity);GO:0051056(regulation of small GTPase mediated signal transduction)",null,"mRNA","agilent G3 V3"]
["A_24_P280803",8.71,9.98,{"v":8.8,"d":"8.80"},8.54,9.73,9.87,{"v":0.976901208244492,"d":"0.98"},{"v":-0.0337154217235794,"d":"-0.03"},"down",{"v":0.73108,"d":"0.73"},1,"no","TTCCCCTGGTTCTAGGAACTTTTGACTGGAGAGAATCACAGATGTGGAATATTTGTCATA","FALSE","ENST00000492356","ens|ENST00000492356|ens|ENST00000450116|ens|ENST00000370562|gb|BC018140","RPS21","ribosomal protein S21","ens|ribosomal protein S21 [Source:HGNC Symbol;Acc:HGNC:10409] [ENST00000492356]","chr20",60962376,60963575,"GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay);GO:0000447(endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0000461(endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0003735(structural constituent of ribosome);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006412(translation);GO:0006413(translational initiation);GO:0006414(translational elongation);GO:0006415(translational termination);GO:0006614(SRP-dependent cotranslational protein targeting to membrane);GO:0010467(gene expression);GO:0015935(small ribosomal subunit);GO:0016032(viral reproduction);GO:0019058(viral infectious cycle);GO:0019083(viral transcription);GO:0022627(cytosolic small ribosomal subunit);GO:0042274(ribosomal small subunit biogenesis);GO:0044267(cellular protein metabolic process);GO:0047485(protein N-terminus binding)","03010(Ribosome)","mRNA","agilent G3 V3"]
["A_23_P159721",{"v":5.2,"d":"5.20"},2.15,4.49,3.77,4.62,4.49,{"v":0.919254658385093,"d":"0.92"},{"v":-0.121463512485667,"d":"-0.12"},"down",{"v":0.73592,"d":"0.74"},1,"no","ATCTTCCATGCTATGCGGCACCCTATCATATTCTTCTCTGGCCTCATCAGTGATATTCGT","FALSE","NM_004224","ref|NM_004224|ens|ENST00000617907|ens|ENST00000218316|ref|XM_005274772","GPR50","G protein-coupled receptor 50","ref|Homo sapiens G protein-coupled receptor 50 (GPR50), mRNA [NM_004224]","chrX",150345120,150349937,"GO:0004930(G-protein coupled receptor activity);GO:0005515(protein binding);GO:0005887(integral to plasma membrane);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007267(cell-cell signaling);GO:0008502(melatonin receptor activity);GO:0042802(identical protein binding)","04080(Neuroactive ligand-receptor interaction)","mRNA","agilent G3 V3"]
["A_24_P75963",5.01,2.02,4.58,2.96,3.68,3.92,{"v":1.09943181818182,"d":"1.10"},{"v":0.136758137507113,"d":"0.14"},"up",{"v":0.73824,"d":"0.74"},1,"no","TTGGAAATACCAACTTTACCTCCATGGGCTCCACAAGAAATCAGATGGGAGAAGGGACAA","FALSE","ENST00000328264","ens|ENST00000328264|gb|HQ257978|gb|BC096162|gb|BC096163","DSCR4","Down syndrome critical region 4","ens|Down syndrome critical region gene 4 [Source:HGNC Symbol;Acc:HGNC:3045] [ENST00000328264]","chr21",39426312,39493454,"GO:0003674(molecular_function);GO:0005575(cellular_component);GO:0008150(biological_process)",null,"mRNA","agilent G3 V3"]
["A_32_P138004",4.33,6.34,4.41,5.17,5.13,5.48,{"v":0.955640050697085,"d":"0.96"},{"v":-0.0654607767447943,"d":"-0.07"},"down",{"v":0.74386,"d":"0.74"},1,"no","GAATATGAGATTAACTTCCTACAGGGGCCAAAACCAGAGAAAGGCTTCCAGCAACTTCAG","FALSE","NM_207009","ref|NM_207009|ref|NM_001303111|ref|NM_001303112|ref|NM_001303113","FAM45A","family with sequence similarity 45, member A","ref|Homo sapiens family with sequence similarity 45, member A (FAM45A), transcript variant 1, mRNA [NM_207009]","chrX",129629280,129630206,null,null,"mRNA","agilent G3 V3"]
["A_33_P3344229",6.49,5.87,6.48,6.34,6.43,5.77,{"v":1.01618122977346,"d":"1.02"},{"v":0.0231577209872526,"d":"0.02"},"up",{"v":0.7485,"d":"0.75"},1,"no","AGCGCCAGGGACGCACCCTTTATGGCTTTGGCGGTTAAGGTTGCTGATTTCTCCACAGCT","FALSE","NM_003538","ref|NM_003538|gb|BC066248|gb|BC066249|gb|BC067495","HIST1H4A","histone cluster 1, H4a","ref|Homo sapiens histone cluster 1, H4a (HIST1H4A), mRNA [NM_003538]","chr6",26021908,26022278,"GO:0000183(chromatin silencing at rDNA);GO:0000228(nuclear chromosome);GO:0000278(mitotic cell cycle);GO:0000723(telomere maintenance);GO:0000786(nucleosome);GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006325(chromatin organization);GO:0006334(nucleosome assembly);GO:0006335(DNA replication-dependent nucleosome assembly);GO:0006336(DNA replication-independent nucleosome assembly);GO:0010467(gene expression);GO:0016020(membrane);GO:0032776(DNA methylation on cytosine);GO:0034080(CenH3-containing nucleosome assembly at centromere);GO:0035574(histone H4-K20 demethylation);GO:0035575(histone demethylase activity (H4-K20 specific));GO:0040029(regulation of gene expression, epigenetic);GO:0043234(protein complex);GO:0045653(negative regulation of megakaryocyte differentiation);GO:0045814(negative regulation of gene expression, epigenetic);GO:0046982(protein heterodimerization activity);GO:0070062(extracellular vesicular exosome)","05203(Viral carcinogenesis);05322(Systemic lupus erythematosus);05034(Alcoholism)","mRNA","agilent G3 V3"]
["A_22_P00007426",5.73,2.74,{"v":5.5,"d":"5.50"},4.05,4.56,4.31,{"v":1.0812693498452,"d":"1.08"},{"v":0.112725950715539,"d":"0.11"},"up",{"v":0.75322,"d":"0.75"},1,"no","CTATTTCTGTGACTACCTCATGGCTTAACTCATTTAAATCTCCCCAAGTTTATCTGAAGG","FALSE","NM_001282199","ref|NM_001282199|ens|ENST00000518059|ens|ENST00000341403|linc|lnc-GS1-211B7.1.1-1:2","UBXN8","UBX domain protein 8","ref|Homo sapiens UBX domain protein 8 (UBXN8), transcript variant 3, mRNA [NM_001282199]","chr8",30601680,30624520,"GO:0005515(protein binding);GO:0007338(single fertilization);GO:0030176(integral to endoplasmic reticulum membrane);GO:0030433(ER-associated protein catabolic process)",null,"mRNA","agilent G3 V3"]
["A_33_P3215028",4.57,5.93,{"v":4.3,"d":"4.30"},{"v":5,"d":"5.00"},4.99,4.25,{"v":1.03932584269663,"d":"1.04"},{"v":0.0556480295499144,"d":"0.06"},"up",{"v":0.75654,"d":"0.76"},1,"no","GCTGCGAAACAAAGACAAGGTGAGGTGTTTTTCTTTTTTGTAATAATATAAAGCTGTGTG","FALSE","NM_152734","ref|NM_152734|ref|NM_001286636|ref|NM_001286635|ref|NM_001286637","C6orf89","chromosome 6 open reading frame 89","ref|Homo sapiens chromosome 6 open reading frame 89 (C6orf89), transcript variant 1, mRNA [NM_152734]","chr6",36853632,36896740,"GO:0000139(Golgi membrane);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0016021(integral to membrane);GO:0030496(midbody);GO:0042060(wound healing);GO:0045787(positive regulation of cell cycle);GO:0050673(epithelial cell proliferation)",null,"mRNA","agilent G3 V3"]
["A_33_P3270404",6.38,7.27,6.39,{"v":6.5,"d":"6.50"},6.59,6.64,{"v":1.01571211353269,"d":"1.02"},{"v":0.0224915524716495,"d":"0.02"},"up",{"v":0.76174,"d":"0.76"},1,"no","GATAGAAGCTGCCAAGCAGGGAGAACCTGTGCCAACTGTGGAGTGGGGAGGTTGGGCCTG","FALSE","NM_001077198","ref|NM_001077198|ref|NM_024085|ref|NR_104255|ens|ENST00000361242","ATG9A","autophagy related 9A","ref|Homo sapiens autophagy related 9A (ATG9A), transcript variant 1, mRNA [NM_001077198]","chr2",220085168,220094351,"GO:0000045(autophagic vacuole assembly);GO:0000407(pre-autophagosomal structure);GO:0000421(autophagic vacuole membrane);GO:0000422(mitochondrion degradation);GO:0005515(protein binding);GO:0005768(endosome);GO:0005770(late endosome);GO:0005776(autophagic vacuole);GO:0005789(endoplasmic reticulum membrane);GO:0005802(trans-Golgi network);GO:0015031(protein transport);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0031410(cytoplasmic vesicle);GO:0031902(late endosome membrane);GO:0034067(protein localization in Golgi apparatus);GO:0034497(protein localization to pre-autophagosomal structure);GO:0034727(piecemeal microautophagy of nucleus);GO:0045087(innate immune response);GO:0055037(recycling endosome)",null,"mRNA","agilent G3 V3"]
["A_23_P37441",11.04,11.79,10.76,11.27,10.92,11.09,{"v":1.00931490384615,"d":"1.01"},{"v":0.0133763620934062,"d":"0.01"},"up",{"v":0.7655,"d":"0.77"},1,"no","TTGTCTTTCAGCAAGGACTGGTCTTTCTATCTCTTGTACTACACTGAATTCACCCCCACT","FALSE","NM_004048","ref|NM_004048|ens|ENST00000557901|ens|ENST00000559907|ens|ENST00000561424","B2M","beta-2-microglobulin","ref|Homo sapiens beta-2-microglobulin (B2M), mRNA [NM_004048]","chr15",45003716,45008550,"GO:0000139(Golgi membrane);GO:0001895(retina homeostasis);GO:0001916(positive regulation of T cell mediated cytotoxicity);GO:0002237(response to molecule of bacterial origin);GO:0002474(antigen processing and presentation of peptide antigen via MHC class I);GO:0002479(antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent);GO:0002480(antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent);GO:0002481(antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0005788(endoplasmic reticulum lumen);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0009897(external side of plasma membrane);GO:0012507(ER to Golgi transport vesicle membrane);GO:0016020(membrane);GO:0016032(viral reproduction);GO:0019221(cytokine-mediated signaling pathway);GO:0030670(phagocytic vesicle membrane);GO:0031901(early endosome membrane);GO:0031905(early endosome lumen);GO:0033077(T cell differentiation in thymus);GO:0042026(protein refolding);GO:0042493(response to drug);GO:0042590(antigen processing and presentation of exogenous peptide antigen via MHC class I);GO:0042612(MHC class I protein complex);GO:0042802(identical protein binding);GO:0045087(innate immune response);GO:0046686(response to cadmium ion);GO:0050690(regulation of defense response to virus by virus);GO:0050776(regulation of immune response);GO:0055072(iron ion homeostasis);GO:0060333(interferon-gamma-mediated signaling pathway);GO:0070062(extracellular vesicular exosome)","04612(Antigen processing and presentation)","mRNA","agilent G3 V3"]
["A_23_P143414",11.27,12.42,11.39,11.87,11.71,11.87,{"v":0.989562764456982,"d":"0.99"},{"v":-0.0151368796821453,"d":"-0.02"},"down",{"v":0.76992,"d":"0.77"},1,"no","ACTACATCTGTCCCTTCCCATCAATCCCAGCCCATGTACTAATAAAAGAAAGTCTTTGAG","FALSE","NM_080748","ref|NM_080748|ens|ENST00000336695|ens|ENST00000374078|ens|ENST00000374077","ROMO1","reactive oxygen species modulator 1","ref|Homo sapiens reactive oxygen species modulator 1 (ROMO1), mRNA [NM_080748]","chr20",34287372,34288902,"GO:0001302(replicative cell aging);GO:0003674(molecular_function);GO:0005739(mitochondrion);GO:0005743(mitochondrial inner membrane);GO:0008284(positive regulation of cell proliferation);GO:0016021(integral to membrane);GO:0034614(cellular response to reactive oxygen species);GO:0042742(defense response to bacterium);GO:2000379(positive regulation of reactive oxygen species metabolic process)",null,"mRNA","agilent G3 V3"]
["A_33_P3237260",6.18,5.42,6.22,6.41,{"v":5.8,"d":"5.80"},5.91,{"v":0.983443708609271,"d":"0.98"},{"v":-0.0240856185243132,"d":"-0.02"},"down",{"v":0.77088,"d":"0.77"},1,"no","GGGCATTTATTTGTAATCCTCTCCACTGTAACCCCACTGAAATAAAACAGAATGTTAATT","FALSE","NM_198498","ref|NM_198498|ens|ENST00000280325|gb|BC039669|tc|THC2484202","C11orf53","chromosome 11 open reading frame 53","ref|Homo sapiens chromosome 11 open reading frame 53 (C11orf53), mRNA [NM_198498]","chr11",111126704,111157126,null,null,"mRNA","agilent G3 V3"]
["A_23_P201647",6.92,2.91,2.85,4.35,4.86,4.79,{"v":0.905714285714286,"d":"0.91"},{"v":-0.142872081692922,"d":"-0.14"},"down",{"v":0.7764,"d":"0.78"},1,"no","CAACATTCCAGTGTTTGAACTGTCACTGATTCTTGCGCCCTAGACAAGCTAACCAGGTTT","FALSE","NM_173156","ref|NM_173156|ref|NM_001174061|ref|NM_201568|ref|NM_201569","SMG7","SMG7 nonsense mediated mRNA decay factor","ref|Homo sapiens SMG7 nonsense mediated mRNA decay factor (SMG7), transcript variant 1, mRNA [NM_173156]","chr1",183441664,183523325,"GO:0000184(nuclear-transcribed mRNA catabolic process, nonsense-mediated decay);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006406(mRNA export from nucleus);GO:0010467(gene expression);GO:0035303(regulation of dephosphorylation);GO:0045111(intermediate filament cytoskeleton);GO:0051721(protein phosphatase 2A binding)","03015(mRNA surveillance pathway)","mRNA","agilent G3 V3"]
["A_33_P3499102",12.63,12.87,12.48,12.16,12.71,12.89,{"v":1.00582627118644,"d":"1.01"},{"v":0.00838114078765634,"d":"0.01"},"up",{"v":0.7815,"d":"0.78"},1,"no","CAGGGTTTCGTCATGTTTGCCAGGCTGGTCTTGAACTCCTGAGCTCAAGCAGTCCTCACG","FALSE","AK098115","gb|AK098115|gb|AW821509|tc|THC2758357|tc|THC2618035","RBM10","RNA binding motif protein 10","gb|Homo sapiens cDNA FLJ40796 fis, clone TRACH2007754, highly similar to DXS8237E PROTEIN. [AK098115]","chrX",47037116,47037263,"GO:0000166(nucleotide binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006397(mRNA processing);GO:0008150(biological_process);GO:0008270(zinc ion binding);GO:0008380(RNA splicing);GO:0032403(protein complex binding);GO:0042802(identical protein binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3343503",3.36,3.49,7.34,4.15,4.17,4.64,{"v":1.09490740740741,"d":"1.09"},{"v":0.130808871175926,"d":"0.13"},"up",{"v":0.78476,"d":"0.78"},1,"no","TTAAAGAAACATTTCCGTGCTACTGTCTGTCATCGTCTCTGGGGAAATCAGCCAGAACCA","FALSE","NM_001161576","ref|NM_001161576|ref|NM_015589|ens|ENST00000554335|ens|ENST00000251091","SAMD4A","sterile alpha motif domain containing 4A","ref|Homo sapiens sterile alpha motif domain containing 4A (SAMD4A), transcript variant 2, mRNA [NM_001161576]","chr14",55034352,55170585,"GO:0005737(cytoplasm);GO:0017148(negative regulation of translation);GO:0030054(cell junction);GO:0030371(translation repressor activity);GO:0030425(dendrite);GO:0045202(synapse);GO:0045727(positive regulation of translation)",null,"mRNA","agilent G3 V3"]
["A_23_P158041",4.88,1.96,5.33,5.12,4.24,3.79,{"v":0.925475285171103,"d":"0.93"},{"v":-0.111733631465936,"d":"-0.11"},"down",{"v":0.7862,"d":"0.79"},1,"no","GCAGAGGAAGATGGTGCGAGAGTTCCTGGCCGAGTTCATGAGCACATATGTCATGATGGT","FALSE","NM_001170","ref|NM_001170|ens|ENST00000624890|ens|ENST00000297988|ens|ENST00000623743","AQP7","aquaporin 7","ref|Homo sapiens aquaporin 7 (AQP7), mRNA [NM_001170]","chr9",33385248,33395233,"GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0005911(cell-cell junction);GO:0006091(generation of precursor metabolites and energy);GO:0006833(water transport);GO:0007588(excretion);GO:0009992(cellular water homeostasis);GO:0015204(urea transmembrane transporter activity);GO:0015250(water channel activity);GO:0015254(glycerol channel activity);GO:0015793(glycerol transport);GO:0034219(carbohydrate transmembrane transport);GO:0034220(ion transmembrane transport);GO:0055085(transmembrane transport);GO:0071918(urea transmembrane transport)","04923(Regulation of lipolysis in adipocyte);03320(PPAR signaling pathway)","mRNA","agilent G3 V3"]
["A_33_P3256957",4.26,2.01,4.81,3.56,4.11,4.15,{"v":0.937394247038917,"d":"0.94"},{"v":-0.0932721541283442,"d":"-0.09"},"down",{"v":0.79256,"d":"0.79"},1,"no","AGTAACCCTAGGCTGGAGGGCCCACCTGCGTATGTTTTTCTTCTCATTCTTTTTTACCTT","FALSE","BC040680","gb|BC040680|gb|AK124574|tc|THC2524945|tc|THC2525651",null,null,"gb|Homo sapiens cDNA clone IMAGE:4817893. [BC040680]","chr3",125534336,125539315,null,null,"mRNA","agilent G3 V3"]
["A_24_P350759",4.23,2.02,3.64,3.35,3.52,3.61,{"v":0.943702290076336,"d":"0.94"},{"v":-0.0835962907783395,"d":"-0.08"},"down",{"v":0.79532,"d":"0.80"},1,"no","TGTATGTCCAGAACAAAAGATAAAACTAATTGTATTCCTCACATTCACAATCCCCATTGG","FALSE","NM_004171","ref|NM_004171|ref|NM_001252652|ref|NM_001195728|ens|ENST00000395753","SLC1A2","solute carrier family 1 (glial high affinity glutamate transporter), member 2","ref|Homo sapiens solute carrier family 1 (glial high affinity glutamate transporter), member 2 (SLC1A2), transcript variant 1, mRNA [NM_004171]","chr11",35272772,35441610,"GO:0005313(L-glutamate transmembrane transporter activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0007268(synaptic transmission);GO:0007632(visual behavior);GO:0009611(response to wounding);GO:0010259(multicellular organismal aging);GO:0015501(glutamate:sodium symporter activity);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0017153(sodium:dicarboxylate symporter activity);GO:0021537(telencephalon development);GO:0030534(adult behavior);GO:0030673(axolemma);GO:0031668(cellular response to extracellular stimulus);GO:0035264(multicellular organism growth);GO:0042493(response to drug);GO:0043200(response to amino acid stimulus);GO:0046326(positive regulation of glucose import);GO:0051938(L-glutamate import);GO:0055085(transmembrane transport);GO:0070779(D-aspartate import)","04724(Glutamatergic synapse);05014(Amyotrophic lateral sclerosis (ALS))","mRNA","agilent G3 V3"]
["A_33_P3297126",4.31,2.19,4.98,3.78,4.06,4.35,{"v":0.941755537325677,"d":"0.94"},{"v":-0.0865754839445241,"d":"-0.09"},"down",{"v":0.79606,"d":"0.80"},1,"no","GATGTGAATCAGATCATCAAGGACTTGGCCTCCATGGTGTCAGAGCAAGGAGAAGCTGTT","FALSE","NM_145003","ref|NM_145003|ens|ENST00000307180|ens|ENST00000524325|gb|HQ258458","TSNARE1","t-SNARE domain containing 1","ref|Homo sapiens t-SNARE domain containing 1 (TSNARE1), transcript variant 1, mRNA [NM_145003]","chr8",143293440,143484543,"GO:0000149(SNARE binding);GO:0005484(SNAP receptor activity);GO:0006886(intracellular protein transport);GO:0006906(vesicle fusion);GO:0012505(endomembrane system);GO:0016021(integral to membrane);GO:0031201(SNARE complex);GO:0048278(vesicle docking)",null,"mRNA","agilent G3 V3"]
["A_33_P3325606",5.18,1.94,4.27,3.03,3.75,3.81,{"v":1.07554296506138,"d":"1.08"},{"v":0.105065157715775,"d":"0.11"},"up",{"v":0.8023,"d":"0.80"},1,"no","GAGTTGCTTGAACCTTTATTCTAACATTTCCTTAAACAAGCCTCACCATTGACCTTTCTT","FALSE","NM_001242575","ref|NM_001242575|ens|ENST00000360083|linc|lnc-IKZF2-3:2|gb|AK124960","LOC100130451","uncharacterized LOC100130451","ref|Homo sapiens uncharacterized LOC100130451 (LOC100130451), mRNA [NM_001242575]","chr2",214141280,214148929,null,null,"mRNA","agilent G3 V3"]
["A_23_P142424",4.28,4.71,5.73,5.23,{"v":4.8,"d":"4.80"},{"v":4.3,"d":"4.30"},{"v":1.02721563154222,"d":"1.03"},{"v":0.038739061794867,"d":"0.04"},"up",{"v":0.8103,"d":"0.81"},1,"no","ATGCATTGCGGGTGCTGTCCAAGCTTGGCTCATCTGGGGTTTGCTGGGCTTAACACCCAA","FALSE","NM_024660","ref|NM_024660|ens|ENST00000588018|ens|ENST00000589807|ens|ENST00000592889","IGFLR1","IGF-like family receptor 1","ref|Homo sapiens IGF-like family receptor 1 (IGFLR1), mRNA [NM_024660]","chr19",36230152,36236333,"GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3333267",5.72,5.51,4.97,5.42,5.68,5.29,{"v":0.988407565588774,"d":"0.99"},{"v":-0.0168220413274719,"d":"-0.02"},"down",{"v":0.81328,"d":"0.81"},1,"no","TTTTCACTGAGCACTTCCGGGAAGAGCAGGCACCCAGATCTCTGTCCTTGTCCTGGCACA","FALSE","NM_001204210","ref|NM_001204210|ref|NM_001204211|ref|NM_001204212|ens|ENST00000551068","TMEM235","transmembrane protein 235","ref|Homo sapiens transmembrane protein 235 (TMEM235), transcript variant 1, mRNA [NM_001204210]","chr17",76227392,76237067,"GO:0005198(structural molecule activity);GO:0005783(endoplasmic reticulum);GO:0005923(tight junction);GO:0016021(integral to membrane);GO:0016324(apical plasma membrane)",null,"mRNA","agilent G3 V3"]
["A_32_P231179",4.89,2.83,4.65,4.83,3.85,4.21,{"v":0.959658650116369,"d":"0.96"},{"v":-0.0594067633852812,"d":"-0.06"},"down",{"v":0.81928,"d":"0.82"},1,"no","CCACCTGCACAAGACACTGCGGGAAATCACAGATCAGGAACACAACGTGGCGGCACTGAA","FALSE","NM_144705","ref|NM_144705|ref|NM_001286559|ref|NR_037871|ref|NR_046439","TEKT4","tektin 4","ref|Homo sapiens tektin 4 (TEKT4), transcript variant 1, mRNA [NM_144705]","chr2",95537176,95542568,"GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005874(microtubule);GO:0030030(cell projection organization);GO:0031514(motile cilium)",null,"mRNA","agilent G3 V3"]
["A_23_P62840",4.66,6.17,{"v":4.8,"d":"4.80"},5.19,5.11,4.96,{"v":1.02424639580603,"d":"1.02"},{"v":0.0345628161651336,"d":"0.03"},"up",{"v":0.82352,"d":"0.82"},1,"no","AGTCTTTTTGGTGTAATAGTGGGATGTCTGCTTAGTTGGCAGGGGTTCAGTCCAAATGGA","FALSE","NM_024640","ref|NM_024640|ens|ENST00000373044|gb|AY172561|gb|AK129676","YRDC","yrdC N(6)-threonylcarbamoyltransferase domain containing","ref|Homo sapiens yrdC N(6)-threonylcarbamoyltransferase domain containing (YRDC), mRNA [NM_024640]","chr1",38268616,38273857,"GO:0003725(double-stranded RNA binding);GO:0005739(mitochondrion);GO:0016020(membrane);GO:0051051(negative regulation of transport)",null,"mRNA","agilent G3 V3"]
["A_33_P3267198",{"v":5.9,"d":"5.90"},{"v":3.6,"d":"3.60"},2.65,3.76,3.89,{"v":3.8,"d":"3.80"},{"v":1.06113537117904,"d":"1.06"},{"v":0.0856087155088372,"d":"0.09"},"up",{"v":0.83156,"d":"0.83"},1,"no","AACTGTGAGACAATCAATTTCTGCTGTGTAAGCCACCTGGTCTGCGGCACTTTGTTATAG","FALSE","AK125684","gb|AK125684|tc|THC2486395","LOC100131132","uncharacterized LOC100131132","gb|Homo sapiens cDNA FLJ43696 fis, clone TBAES2007964. [AK125684]","chr10",79626632,79629368,null,null,"mRNA","agilent G3 V3"]
["A_33_P3291244",4.82,4.06,5.41,4.69,4.68,4.64,{"v":1.01998572448251,"d":"1.02"},{"v":0.0285489606649985,"d":"0.03"},"up",{"v":0.83358,"d":"0.83"},1,"no","ATTCCTTCACCCTATTTACCTTCCTCAAGTACTGGAGAATAAAATTGAACTGAATGTTTG","FALSE","NM_178499","ref|NM_178499|ens|ENST00000327554|gb|BC040553|tc|THC2478140","CCDC60","coiled-coil domain containing 60","ref|Homo sapiens coiled-coil domain containing 60 (CCDC60), mRNA [NM_178499]","chr12",119772520,119978852,null,null,"mRNA","agilent G3 V3"]
["A_24_P48069",3.11,3.35,6.57,4.46,4.54,{"v":4.8,"d":"4.80"},{"v":0.944202898550725,"d":"0.94"},{"v":-0.0828311830973968,"d":"-0.08"},"down",{"v":0.84006,"d":"0.84"},1,"no","TTTAATACTTTAGGGTCCTGATTTGTGGGAACAGACCTTCTTGTAAATAACCACTATTTG","FALSE","NM_018110","ref|NM_018110|ens|ENST00000340099|ref|XM_005256042|ref|XM_005256043","DOK4","docking protein 4","ref|Homo sapiens docking protein 4 (DOK4), mRNA [NM_018110]","chr16",57505872,57520407,"GO:0000165(MAPK cascade);GO:0005057(receptor signaling protein activity);GO:0005158(insulin receptor binding);GO:0005515(protein binding);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007399(nervous system development)",null,"mRNA","agilent G3 V3"]
["A_23_P208747",4.19,2.71,4.81,3.92,4.45,3.76,{"v":0.965375103050289,"d":"0.97"},{"v":-0.0508384746192952,"d":"-0.05"},"down",{"v":0.84166,"d":"0.84"},1,"no","CTATGTGCTCAAAGGACACCGGGATGTGCAGCGTACACTCTCTCCAGGCAACCAGCTCTA","FALSE","NM_005091","ref|NM_005091|ens|ENST00000008938|gb|AB590879|gb|BC096154","PGLYRP1","peptidoglycan recognition protein 1","ref|Homo sapiens peptidoglycan recognition protein 1 (PGLYRP1), mRNA [NM_005091]","chr19",46522412,46526323,"GO:0002221(pattern recognition receptor signaling pathway);GO:0005576(extracellular region);GO:0006955(immune response);GO:0008270(zinc ion binding);GO:0008745(N-acetylmuramoyl-L-alanine amidase activity);GO:0009253(peptidoglycan catabolic process);GO:0016019(peptidoglycan receptor activity);GO:0016045(detection of bacterium);GO:0032689(negative regulation of interferon-gamma production);GO:0032827(negative regulation of natural killer cell differentiation involved in immune response);GO:0042834(peptidoglycan binding);GO:0044117(growth of symbiont in host);GO:0045087(innate immune response);GO:0050728(negative regulation of inflammatory response);GO:0050830(defense response to Gram-positive bacterium);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P4662",4.97,6.02,4.88,5.94,{"v":5.4,"d":"5.40"},4.83,{"v":0.981447124304267,"d":"0.98"},{"v":-0.02701755063848,"d":"-0.03"},"down",{"v":0.84716,"d":"0.85"},1,"no","TACCAGATAACTGAGGAGGGGAGAGGTGGGCCGTAACGGGCACGGATCACGATGTAAATT","FALSE","NM_005178","ref|NM_005178|ens|ENST00000164227|ref|XM_005259129|gb|M31732","BCL3","B-cell CLL/lymphoma 3","ref|Homo sapiens B-cell CLL/lymphoma 3 (BCL3), mRNA [NM_005178]","chr19",45261784,45262815,"GO:0000060(protein import into nucleus, translocation);GO:0002268(follicular dendritic cell differentiation);GO:0002315(marginal zone B cell differentiation);GO:0002455(humoral immune response mediated by circulating immunoglobulin);GO:0002467(germinal center formation);GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-dependent);GO:0006974(response to DNA damage stimulus);GO:0007249(I-kappaB kinase/NF-kappaB cascade);GO:0008134(transcription factor binding);GO:0009615(response to virus);GO:0010225(response to UV-C);GO:0019730(antimicrobial humoral response);GO:0030198(extracellular matrix organization);GO:0030330(DNA damage response, signal transduction by p53 class mediator);GO:0030674(protein binding, bridging);GO:0032729(positive regulation of interferon-gamma production);GO:0032996(Bcl3-Bcl10 complex);GO:0033257(Bcl3/NF-kappaB2 complex);GO:0042088(T-helper 1 type immune response);GO:0042345(regulation of NF-kappaB import into nucleus);GO:0042536(negative regulation of tumor necrosis factor biosynthetic process);GO:0042742(defense response to bacterium);GO:0042771(DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis);GO:0042832(defense response to protozoan);GO:0042981(regulation of apoptotic process);GO:0043066(negative regulation of apoptotic process);GO:0043234(protein complex);GO:0045064(T-helper 2 cell differentiation);GO:0045082(positive regulation of interleukin-10 biosynthetic process);GO:0045171(intercellular bridge);GO:0045415(negative regulation of interleukin-8 biosynthetic process);GO:0045727(positive regulation of translation);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048471(perinuclear region of cytoplasm);GO:0048536(spleen development);GO:0051101(regulation of DNA binding);GO:0051457(maintenance of protein location in nucleus)","04668(TNF signaling pathway)","mRNA","agilent G3 V3"]
["A_33_P3349619",5.82,5.07,5.63,5.81,5.71,5.18,{"v":0.989221556886228,"d":"0.99"},{"v":-0.0156344159419691,"d":"-0.02"},"down",{"v":0.85032,"d":"0.85"},1,"no","ACCACACACACTTGCTACAGTTCGATGGGGAGGGTGGCTGGAAGTTCGAGAAGCTAGGCT","FALSE","ENST00000445663","ens|ENST00000445663|ens|ENST00000562927",null,null,"ens|ATP-binding cassette, sub-family D (ALD), member 1, pseudogene 5 [Source:HGNC Symbol;Acc:HGNC:42662] [ENST00000445663]","chr2",92028624,92031828,null,null,"mRNA","agilent G3 V3"]
["A_21_P0013198",4.19,6.98,4.25,5.57,4.39,4.88,{"v":1.03908355795148,"d":"1.04"},{"v":0.0553116732942311,"d":"0.06"},"up",{"v":0.85348,"d":"0.85"},1,"no","TAGAAAGTTGGTACAGATGATCTGCACTGTCAAGTAAACTACAGTTAGGAATCCTCAAAG","FALSE","BC065228","gb|BC065228|gb|TCONS_l2_00025879|gb|BC015339|gb|BC105579","PSPHP1","phosphoserine phosphatase pseudogene 1","gb|Homo sapiens phosphoserine phosphatase-like, mRNA (cDNA clone IMAGE:5552627), partial cds. [BC065228]","chr7",55840872,55841376,"GO:0004647(phosphoserine phosphatase activity);GO:0008283(cell proliferation);GO:0016311(dephosphorylation)",null,"mRNA","agilent G3 V3"]
["A_21_P0000475",6.79,6.43,7.21,6.57,6.65,7.41,{"v":0.990305380513815,"d":"0.99"},{"v":-0.0140546171532576,"d":"-0.01"},"down",{"v":0.85818,"d":"0.86"},1,"no","TGTAAACAGCAGCTTCCTTGGTAGTGTATGCGGCCTGTTTGTTGTATAGGTTGCTCTAAG","FALSE","NR_003707","ref|NR_003707","SNORA70B","small nucleolar RNA, H/ACA box 70B","ref|Homo sapiens small nucleolar RNA, H/ACA box 70B (SNORA70B), small nucleolar RNA [NR_003707]","chr2",61644376,61644512,null,null,"mRNA","agilent G3 V3"]
["A_33_P3340862",16.67,16.57,16.85,{"v":16.6,"d":"16.60"},16.71,16.73,{"v":1.00099920063949,"d":"1.00"},{"v":0.00144082209208177,"d":"0.00"},"up",{"v":0.8641,"d":"0.86"},1,"no","GTCCGCGCCCGCCTAGCCCGGCGCCTCCGCCCGCTGCTGCCTCCGCCCGCTGGGACCCCC","FALSE","NM_001146685","ref|NM_001146685|ens|ENST00000378821","TMEM88B","transmembrane protein 88B","ref|Homo sapiens transmembrane protein 88B (TMEM88B), mRNA [NM_001146685]","chr1",{"v":1361508,"d":"1361508.00"},1363167,"GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3404411",{"v":5.5,"d":"5.50"},2.03,6.51,4.86,4.52,{"v":5.4,"d":"5.40"},{"v":0.949932341001353,"d":"0.95"},{"v":-0.0741033338415903,"d":"-0.07"},"down",{"v":0.8669,"d":"0.87"},1,"no","TGTCCAGAGCGGTCGCCTCCATGGTTTGGAAGGAGTGTTTTCTACAGGATCCTTTCAACA","FALSE","NM_005932","ref|NM_005932|ens|ENST00000382172|gb|DQ893610|gb|DQ896839","MIPEP","mitochondrial intermediate peptidase","ref|Homo sapiens mitochondrial intermediate peptidase (MIPEP), mRNA [NM_005932]","chr13",24304328,24463558,"GO:0004222(metalloendopeptidase activity);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0006508(proteolysis);GO:0006627(protein processing involved in protein targeting to mitochondrion);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_32_P150030",5.02,4.61,5.59,4.68,5.42,5.31,{"v":0.987670343932511,"d":"0.99"},{"v":-0.01789850301124,"d":"-0.02"},"down",{"v":0.87098,"d":"0.87"},1,"no","TTTCATCCCAGACCAATGGCATTATTAGGTCTTAAAGTAGTTACTCCCTTCTCGTGTTTG","FALSE","NM_003620","ref|NM_003620|ens|ENST00000392995|ens|ENST00000305921|gb|BC016480","PPM1D","protein phosphatase, Mg2+/Mn2+ dependent, 1D","ref|Homo sapiens protein phosphatase, Mg2+/Mn2+ dependent, 1D (PPM1D), mRNA [NM_003620]","chr17",58677632,58741834,"GO:0000086(G2/M transition of mitotic cell cycle);GO:0004722(protein serine/threonine phosphatase activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006470(protein dephosphorylation);GO:0008285(negative regulation of cell proliferation);GO:0009314(response to radiation);GO:0009617(response to bacterium);GO:0035970(peptidyl-threonine dephosphorylation);GO:0046872(metal ion binding)","04115(p53 signaling pathway)","mRNA","agilent G3 V3"]
["A_21_P0000388",5.71,5.11,{"v":6,"d":"6.00"},5.63,5.55,{"v":5.5,"d":"5.50"},{"v":1.0083932853717,"d":"1.01"},{"v":0.0120584168104806,"d":"0.01"},"up",{"v":0.87634,"d":"0.88"},1,"no","TATCGTCTGAACCTGTCTGAAGCATCTCAGTGATGCAATCTCTGTGTGGTTCTGAGACTT","FALSE","NR_003072","ref|NR_003072","SNORD91A","small nucleolar RNA, C/D box 91A","ref|Homo sapiens small nucleolar RNA, C/D box 91A (SNORD91A), small nucleolar RNA [NR_003072]","chr17",{"v":2233572,"d":"2233572.00"},2233664,null,null,"mRNA","agilent G3 V3"]
["A_23_P93302",10.54,{"v":7.1,"d":"7.10"},7.65,8.09,8.25,8.41,{"v":1.02181818181818,"d":"1.02"},{"v":0.031138511808904,"d":"0.03"},"up",{"v":0.88198,"d":"0.88"},1,"no","TTTGCACACGTCCATGTTTATCCATGTACTTTCCCTGTGTACCCTCCATGTACCTTGTGT","FALSE","NM_001470","ref|NM_001470|ref|NM_021904|ref|NM_021903|ens|ENST00000377034","GABBR1","gamma-aminobutyric acid (GABA) B receptor, 1","ref|Homo sapiens gamma-aminobutyric acid (GABA) B receptor, 1 (GABBR1), transcript variant 1, mRNA [NM_001470]","chr6",29570006,29600962,"GO:0004965(G-protein coupled GABA receptor activity);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0007193(adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway);GO:0007194(negative regulation of adenylate cyclase activity);GO:0007214(gamma-aminobutyric acid signaling pathway);GO:0007268(synaptic transmission);GO:0030054(cell junction);GO:0030425(dendrite);GO:0038039(G-protein coupled receptor heterodimeric complex);GO:0042734(presynaptic membrane);GO:0045211(postsynaptic membrane)","04024(cAMP signaling pathway);04080(Neuroactive ligand-receptor interaction);04915(Estrogen signaling pathway);04727(GABAergic synapse);05032(Morphine addiction)","mRNA","agilent G3 V3"]
["A_33_P3215948",5.63,6.95,5.35,5.95,5.94,{"v":5.8,"d":"5.80"},{"v":1.0135669869983,"d":"1.01"},{"v":0.0194414401779162,"d":"0.02"},"up",{"v":0.88662,"d":"0.89"},1,"no","GTAATATGGGCCTGTTGTTTAGTGTCTCCTTCCTAAAGAGCACTTTTGTATTGTAATTTA","FALSE","NM_005797","ref|NM_005797|gb|AF304447|gb|AF275945|gb|BU607934","MPZL2","myelin protein zero-like 2","ref|Homo sapiens myelin protein zero-like 2 (MPZL2), transcript variant 1, mRNA [NM_005797]","chr11",118124120,118134997,"GO:0005515(protein binding);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0007156(homophilic cell adhesion);GO:0009653(anatomical structure morphogenesis);GO:0016021(integral to membrane);GO:0033077(T cell differentiation in thymus)",null,"mRNA","agilent G3 V3"]
["A_33_P3300965",5.75,3.11,4.89,4.51,4.01,4.87,{"v":1.0268857356236,"d":"1.03"},{"v":0.0382756579750737,"d":"0.04"},"up",{"v":0.89026,"d":"0.89"},1,"no","CCTCCTGTATAAATCCAACCTCTGGGTCCGTTCTCGAATATTTAATAAAACTGATATTAT","FALSE","NM_004503","ref|NM_004503|ref|NM_153693|ens|ENST00000243108|tc|THC2475523","HOXC6","homeobox C6","ref|Homo sapiens homeobox C6 (HOXC6), transcript variant 1, mRNA [NM_004503]","chr12",54422144,54424607,"GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0003714(transcription corepressor activity);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-dependent);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0007275(multicellular organismal development);GO:0009952(anterior/posterior pattern specification);GO:0043565(sequence-specific DNA binding);GO:0048706(embryonic skeletal system development)",null,"mRNA","agilent G3 V3"]
["A_21_P0000402",4.42,3.38,5.31,4.18,{"v":4.2,"d":"4.20"},4.49,{"v":1.01864801864802,"d":"1.02"},{"v":0.0266556320010528,"d":"0.03"},"up",{"v":0.89454,"d":"0.89"},1,"no","ATGATGACCACTGGTGGCCTATGAGTCATACAATGAATACGTGTCTAGAACTCTGAGGTC","FALSE","NR_003197","ref|NR_003197","SNORD114-5","small nucleolar RNA, C/D box 114-5","ref|Homo sapiens small nucleolar RNA, C/D box 114-5 (SNORD114-5), small nucleolar RNA [NR_003197]","chr14",101421704,101421775,null,null,"mRNA","agilent G3 V3"]
["A_33_P3273063",1.98,5.69,1.99,3.08,3.27,3.81,{"v":0.950787401574803,"d":"0.95"},{"v":-0.0728053079363927,"d":"-0.07"},"down",{"v":0.9007,"d":"0.90"},1,"no","TGAGTATTTGGGATGTTAGACAAGGTACTATGCCTGTATCTCTGCTGAAGGCTCATGAAG","FALSE","NM_198887","ref|NM_198887|ref|NR_104456|ens|ENST00000367402|ens|ENST00000403890","NUP43","nucleoporin 43kDa","ref|Homo sapiens nucleoporin 43kDa (NUP43), transcript variant 1, mRNA [NM_198887]","chr6",150045456,150067814,"GO:0000278(mitotic cell cycle);GO:0000776(kinetochore);GO:0000777(condensed chromosome kinetochore);GO:0005515(protein binding);GO:0005635(nuclear envelope);GO:0005829(cytosol);GO:0005975(carbohydrate metabolic process);GO:0007059(chromosome segregation);GO:0007067(mitosis);GO:0007077(mitotic nuclear envelope disassembly);GO:0008645(hexose transport);GO:0009405(pathogenesis);GO:0010467(gene expression);GO:0010827(regulation of glucose transport);GO:0015031(protein transport);GO:0015758(glucose transport);GO:0016032(viral reproduction);GO:0019058(viral infectious cycle);GO:0019083(viral transcription);GO:0019221(cytokine-mediated signaling pathway);GO:0031080(Nup107-160 complex);GO:0044281(small molecule metabolic process);GO:0051028(mRNA transport);GO:0051301(cell division);GO:0055085(transmembrane transport)","03013(RNA transport)","mRNA","agilent G3 V3"]
["A_33_P3420841",4.38,1.96,4.95,3.55,3.82,4.27,{"v":0.969931271477663,"d":"0.97"},{"v":-0.044045572135283,"d":"-0.04"},"down",{"v":0.90724,"d":"0.91"},1,"no","TAAGACGGAGGGGTAACAACAAAGTCTTTCTGAAGTGGCCGAAAACTCCCTGACTTTTTG","FALSE","ENST00000402116","ens|ENST00000402116","EIF3D","eukaryotic translation initiation factor 3, subunit D","ens|eukaryotic translation initiation factor 3, subunit D [Source:HGNC Symbol;Acc:HGNC:3278] [ENST00000402116]","chr22",36919964,36924989,"GO:0001731(formation of translation preinitiation complex);GO:0001732(formation of translation initiation complex);GO:0003743(translation initiation factor activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005852(eukaryotic translation initiation factor 3 complex);GO:0006412(translation);GO:0006413(translational initiation);GO:0006446(regulation of translational initiation);GO:0010467(gene expression);GO:0016020(membrane);GO:0016282(eukaryotic 43S preinitiation complex);GO:0033290(eukaryotic 48S preinitiation complex);GO:0044267(cellular protein metabolic process);GO:0071541(eukaryotic translation initiation factor 3 complex, eIF3m)","03013(RNA transport)","mRNA","agilent G3 V3"]
["A_23_P257478",7.02,{"v":6.5,"d":"6.50"},6.95,6.78,{"v":6.9,"d":"6.90"},6.85,{"v":0.997077447637603,"d":"1.00"},{"v":-0.0042225250851915,"d":"-0.00"},"down",{"v":0.91024,"d":"0.91"},1,"no","AGAACTCGAAGCCCTTCCAGTGGTACCAGCTCACTCCCTGGGAAAGGGGTTGTCAAGAGA","FALSE","NM_000500","ref|NM_000500|ref|NM_001128590|ref|NR_040090|ens|ENST00000448314","CYP21A2","cytochrome P450, family 21, subfamily A, polypeptide 2","ref|Homo sapiens cytochrome P450, family 21, subfamily A, polypeptide 2 (CYP21A2), transcript variant 1, mRNA [NM_000500]","chr6",32006192,32009419,"GO:0004509(steroid 21-monooxygenase activity);GO:0005496(steroid binding);GO:0005506(iron ion binding);GO:0005789(endoplasmic reticulum membrane);GO:0006704(glucocorticoid biosynthetic process);GO:0006705(mineralocorticoid biosynthetic process);GO:0006805(xenobiotic metabolic process);GO:0008202(steroid metabolic process);GO:0008395(steroid hydroxylase activity);GO:0016125(sterol metabolic process);GO:0020037(heme binding);GO:0044281(small molecule metabolic process);GO:0055114(oxidation-reduction process)","00140(Steroid hormone biosynthesis)","mRNA","agilent G3 V3"]
["A_24_P703830",4.39,6.68,3.68,4.96,5.08,5.04,{"v":0.978116710875332,"d":"0.98"},{"v":-0.0319214741320981,"d":"-0.03"},"down",{"v":0.91446,"d":"0.91"},1,"no","GTTTCCCTAGTGCTGGGCATCCAGTCAGCCCTCAATAAATGCTTATGAATGGATCAACAA","FALSE","NM_001098622","ref|NM_001098622|ens|ENST00000591727|ens|ENST00000591161","NANOS3","nanos homolog 3 (Drosophila)","ref|Homo sapiens nanos homolog 3 (Drosophila) (NANOS3), mRNA [NM_001098622]","chr19",13988063,13991571,"GO:0000932(cytoplasmic mRNA processing body);GO:0003723(RNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006417(regulation of translation);GO:0007275(multicellular organismal development);GO:0007281(germ cell development);GO:0007283(spermatogenesis);GO:0008270(zinc ion binding);GO:0010494(cytoplasmic stress granule);GO:0017148(negative regulation of translation);GO:0048471(perinuclear region of cytoplasm);GO:0048477(oogenesis);GO:0051726(regulation of cell cycle);GO:1900153(positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay);GO:2001234(negative regulation of apoptotic signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_33_P3350744",5.35,{"v":2,"d":"2.00"},5.54,4.01,4.12,5.15,{"v":0.970632530120482,"d":"0.97"},{"v":-0.0430028829852737,"d":"-0.04"},"down",{"v":0.91932,"d":"0.92"},1,"no","GCTTCCTGGGACCAGGGAAGAATGGTCCCGTAAGTCTCACCCTAATGGCAAGTCTAGGAC","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_24_P390668",3.95,2.01,3.84,3.27,3.19,3.53,{"v":0.980980980980981,"d":"0.98"},{"v":-0.0277029287898476,"d":"-0.03"},"down",{"v":0.92564,"d":"0.93"},1,"no","CAGAAGGAGCCACTCATTTATGAGAGCGACCGTGATGGGGCCATTGAAGACATCATCACA","FALSE","NM_005892","ref|NM_005892|ens|ENST00000328118|ens|ENST00000331495|ens|ENST00000587856","FMNL1","formin-like 1","ref|Homo sapiens formin-like 1 (FMNL1), mRNA [NM_005892]","chr17",43299292,43324681,"GO:0003674(molecular_function);GO:0005515(protein binding);GO:0005522(profilin binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005938(cell cortex);GO:0006929(substrate-dependent cell migration);GO:0008360(regulation of cell shape);GO:0016020(membrane);GO:0030866(cortical actin cytoskeleton organization);GO:0032059(bleb);GO:0032794(GTPase activating protein binding);GO:0045335(phagocytic vesicle);GO:0048365(Rac GTPase binding);GO:0051014(actin filament severing);GO:0051015(actin filament binding);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3386932",6.74,5.06,5.35,6.05,5.65,{"v":5.6,"d":"5.60"},{"v":0.991329479768786,"d":"0.99"},{"v":-0.0125634614639123,"d":"-0.01"},"down",{"v":0.93038,"d":"0.93"},1,"no","TTTCCAAATCAGGAACCACAAACTGCCCTCTGATAAGACATCGGCTATCTAAGCTTGTGG","FALSE","NM_201400","ref|NM_201400|ref|NM_201598|ref|NM_001289029|ref|NR_024253","EEF2KMT","eukaryotic elongation factor 2 lysine methyltransferase","ref|Homo sapiens eukaryotic elongation factor 2 lysine methyltransferase (EEF2KMT), transcript variant 1, mRNA [NM_201400]","chr11",{"v":3431582,"d":"3431582.00"},3443726,"GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0016279(protein-lysine N-methyltransferase activity);GO:0018023(peptidyl-lysine trimethylation)",null,"mRNA","agilent G3 V3"]
["A_23_P99942",{"v":5.7,"d":"5.70"},6.65,6.13,6.03,6.14,6.39,{"v":0.995689655172414,"d":"1.00"},{"v":-0.00623195371151439,"d":"-0.01"},"down",{"v":0.93222,"d":"0.93"},1,"no","CAGAGGCACACATTCTGAGTGCACCCGCTTAGCCTTTACATTCCTCTCCACCGACAAAAG","FALSE","NM_024652","ref|NM_024652|ens|ENST00000532145|ens|ENST00000388948|ref|XM_005254979","LRRK1","leucine-rich repeat kinase 1","ref|Homo sapiens leucine-rich repeat kinase 1 (LRRK1), mRNA [NM_024652]","chr15",101459416,101613094,"GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0006468(protein phosphorylation);GO:0007264(small GTPase mediated signal transduction);GO:0036035(osteoclast development);GO:0042802(identical protein binding);GO:0045453(bone resorption);GO:0046872(metal ion binding);GO:0050731(positive regulation of peptidyl-tyrosine phosphorylation);GO:0050732(negative regulation of peptidyl-tyrosine phosphorylation)",null,"mRNA","agilent G3 V3"]
["A_24_P359545",2.61,6.92,2.74,{"v":3.6,"d":"3.60"},3.81,4.49,{"v":1.03109243697479,"d":"1.03"},{"v":0.044173675467599,"d":"0.04"},"up",{"v":0.9359,"d":"0.94"},1,"no","CCAAATTTATGTGGTTGTTACACTTCCATAGTTGTCTTAGCCGAATCCTTCCATATTCTT","FALSE","NM_019610","ref|NM_019610|ref|NM_001162536|ens|ENST00000399794|ens|ENST00000321792","RBMXL1","RNA binding motif protein, X-linked-like 1","ref|Homo sapiens RNA binding motif protein, X-linked-like 1 (RBMXL1), transcript variant 2, mRNA [NM_019610]","chr1",89445144,89458643,"GO:0000166(nucleotide binding);GO:0003727(single-stranded RNA binding);GO:0005681(spliceosomal complex);GO:0006376(mRNA splice site selection);GO:0045893(positive regulation of transcription, DNA-dependent)","03040(Spliceosome)","mRNA","agilent G3 V3"]
["A_23_P23839",9.09,{"v":9.1,"d":"9.10"},8.78,8.78,8.97,9.18,{"v":1.00148533234311,"d":"1.00"},{"v":0.00214129173393151,"d":"0.00"},"up",{"v":0.93604,"d":"0.94"},1,"no","CTTGGCCTTCCTCAGCTTCACCTTGATACTGGGCCTCTTCCTTGTCATGTCTGAAGCTGT","FALSE","NM_001017403","ref|NM_001017403|ref|NM_021636|ref|NM_001017404|ens|ENST00000487787","LGR6","leucine-rich repeat containing G protein-coupled receptor 6","ref|Homo sapiens leucine-rich repeat containing G protein-coupled receptor 6 (LGR6), transcript variant 1, mRNA [NM_001017403]","chr1",202183280,202288335,"GO:0004888(transmembrane signaling receptor activity);GO:0004930(G-protein coupled receptor activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0007186(G-protein coupled receptor signaling pathway);GO:0016055(Wnt receptor signaling pathway);GO:0030177(positive regulation of Wnt receptor signaling pathway);GO:0030335(positive regulation of cell migration);GO:0031982(vesicle);GO:0032588(trans-Golgi network membrane);GO:0090263(positive regulation of canonical Wnt receptor signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_23_P115366",5.22,3.84,3.07,4.14,{"v":3.7,"d":"3.70"},4.46,{"v":0.986178861788618,"d":"0.99"},{"v":-0.0200787651060921,"d":"-0.02"},"down",{"v":0.93632,"d":"0.94"},1,"no","TGGCCACTAAAATTCATATTGAGATTATCTTGGTTTCTTGGAAGAGATAGGAATGAGTTC","FALSE","NM_016308","ref|NM_016308|ref|NM_001136140|ref|NR_046394|ens|ENST00000371873","CMPK1","cytidine monophosphate (UMP-CMP) kinase 1, cytosolic","ref|Homo sapiens cytidine monophosphate (UMP-CMP) kinase 1, cytosolic (CMPK1), transcript variant 1, mRNA [NM_016308]","chr1",47799468,47844511,"GO:0004127(cytidylate kinase activity);GO:0004550(nucleoside diphosphate kinase activity);GO:0004849(uridine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006165(nucleoside diphosphate phosphorylation);GO:0006207('de novo' pyrimidine base biosynthetic process);GO:0006222(UMP biosynthetic process);GO:0006225(UDP biosynthetic process);GO:0006227(dUDP biosynthetic process);GO:0006240(dCDP biosynthetic process);GO:0009142(nucleoside triphosphate biosynthetic process);GO:0009220(pyrimidine ribonucleotide biosynthetic process);GO:0015949(nucleobase-containing small molecule interconversion);GO:0018963(phthalate metabolic process);GO:0022602(ovulation cycle process);GO:0033862(UMP kinase activity);GO:0044281(small molecule metabolic process);GO:0046705(CDP biosynthetic process);GO:0055086(nucleobase-containing small molecule metabolic process);GO:0070062(extracellular vesicular exosome)","00240(Pyrimidine metabolism)","mRNA","agilent G3 V3"]
["A_23_P96331",4.74,4.96,5.71,5.18,5.12,5.03,{"v":1.00521852576647,"d":"1.01"},{"v":0.00750916485600747,"d":"0.01"},"up",{"v":0.9366,"d":"0.94"},1,"no","AGATGAAGATGATGAATGGGATGACTGAGTGGCTGAGTTACTTGCTGCCCTGTGCTCCTC","FALSE","NM_000377","ref|NM_000377|ens|ENST00000376701|gb|U12707|gb|U19927","WAS","Wiskott-Aldrich syndrome","ref|Homo sapiens Wiskott-Aldrich syndrome (WAS), mRNA [NM_000377]","chrX",48542168,48549818,"GO:0003779(actin binding);GO:0005083(small GTPase regulator activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005911(cell-cell junction);GO:0006461(protein complex assembly);GO:0006952(defense response);GO:0006955(immune response);GO:0007596(blood coagulation);GO:0008154(actin polymerization or depolymerization);GO:0008544(epidermis development);GO:0012506(vesicle membrane);GO:0015629(actin cytoskeleton);GO:0016197(endosomal transport);GO:0017124(SH3 domain binding);GO:0019901(protein kinase binding);GO:0030041(actin filament polymerization);GO:0030048(actin filament-based movement);GO:0038096(Fc-gamma receptor signaling pathway involved in phagocytosis);GO:0042110(T cell activation);GO:0042802(identical protein binding);GO:0043274(phospholipase binding);GO:0045087(innate immune response);GO:0050790(regulation of catalytic activity);GO:0050852(T cell receptor signaling pathway);GO:0070062(extracellular vesicular exosome);GO:2000601(positive regulation of Arp2/3 complex-mediated actin nucleation)","04810(Regulation of actin cytoskeleton);04520(Adherens junction);04666(Fc gamma R-mediated phagocytosis);04062(Chemokine signaling pathway);05231(Choline metabolism in cancer);05130(Pathogenic Escherichia coli infection);05132(Salmonella infection);05131(Shigellosis);05100(Bacterial invasion of epithelial cells)","mRNA","agilent G3 V3"]
["A_33_P3343442",5.51,1.91,5.47,3.85,4.38,4.34,{"v":1.02545743834527,"d":"1.03"},{"v":0.0362676139411433,"d":"0.04"},"up",{"v":0.93756,"d":"0.94"},1,"no","TCCGAGCACCAGGCCGCGTTCGCCGGGCCCTCGGGCGCCTACCGGGAGGGCGTCCTGTGA","FALSE","NM_001278559","ref|NM_001278559|ens|ENST00000382252|ref|XM_006715629|ref|XM_006715630","ZNF316","zinc finger protein 316","ref|Homo sapiens zinc finger protein 316 (ZNF316), mRNA [NM_001278559]","chr7",{"v":6682041,"d":"6682041.00"},6694242,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P147805",5.24,4.49,4.46,5.58,4.44,4.29,{"v":0.991614255765199,"d":"0.99"},{"v":-0.0121490826661161,"d":"-0.01"},"down",{"v":0.93768,"d":"0.94"},1,"no","ACGGGAGCCAATGCAGAGAAAGCTGAAAGTCACAAGTCTGGAGCCCGGCACTGTGGTCAT","FALSE","NM_001287428","ref|NM_001287428|ref|NM_001287429|ref|NM_001287430|ens|ENST00000457596","UPP1","uridine phosphorylase 1","ref|Homo sapiens uridine phosphorylase 1 (UPP1), transcript variant 4, mRNA [NM_001287428]","chr7",48128324,48147899,"GO:0004850(uridine phosphorylase activity);GO:0005829(cytosol);GO:0006139(nucleobase-containing compound metabolic process);GO:0006206(pyrimidine base metabolic process);GO:0009166(nucleotide catabolic process);GO:0042149(cellular response to glucose starvation);GO:0043097(pyrimidine nucleoside salvage);GO:0044206(UMP salvage);GO:0044281(small molecule metabolic process);GO:0046108(uridine metabolic process);GO:0046135(pyrimidine nucleoside catabolic process);GO:0055086(nucleobase-containing small molecule metabolic process)","00240(Pyrimidine metabolism);00983(Drug metabolism - other enzymes)","mRNA","agilent G3 V3"]
["A_33_P3294504",{"v":7.3,"d":"7.30"},7.87,7.37,7.68,{"v":7.4,"d":"7.40"},7.41,{"v":1.0022232103157,"d":"1.00"},{"v":0.00320385439440425,"d":"0.00"},"up",{"v":0.93806,"d":"0.94"},1,"no","CAAGAGTTCACCTACCTCAACTCACCTACCCCAGGGCAGCTACAGCCTATATATGAAAAT","FALSE","NM_001159397","ref|NM_001159397|ref|NM_001159398|ref|NM_052938|ens|ENST00000368175","FCRL1","Fc receptor-like 1","ref|Homo sapiens Fc receptor-like 1 (FCRL1), transcript variant 2, mRNA [NM_001159397]","chr1",157765648,157789850,"GO:0005886(plasma membrane);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P251486",5.02,2.06,4.05,3.04,4.13,3.73,{"v":1.02110091743119,"d":"1.02"},{"v":0.0301254576776705,"d":"0.03"},"up",{"v":0.9381,"d":"0.94"},1,"no","CAATGATAAGATCTTTGAATCCAAGATGCCCAGATGTTTTACCAGTCACACCCTATGGCC","FALSE","NM_006438","ref|NM_006438|gb|AB002631|tc|THC2478678","COLEC10","collectin sub-family member 10 (C-type lectin)","ref|Homo sapiens collectin sub-family member 10 (C-type lectin) (COLEC10), mRNA [NM_006438]","chr8",120079480,120118821,"GO:0005537(mannose binding);GO:0005576(extracellular region);GO:0005581(collagen);GO:0005737(cytoplasm)",null,"mRNA","agilent G3 V3"]
["A_23_P193",3.55,9.24,1.95,5.02,4.57,4.57,{"v":1.0409604519774,"d":"1.04"},{"v":0.057915259012072,"d":"0.06"},"up",{"v":0.93846,"d":"0.94"},1,"no","TTTTTTATTTCCACAACCTCTAACCACATTCAGTCCAGGACCAAGGCTCAGGGATGAGTG","FALSE","NM_022774","ref|NM_022774|ens|ENST00000358527|ens|ENST00000372703|ens|ENST00000296380","EXO5","exonuclease 5","ref|Homo sapiens exonuclease 5 (EXO5), mRNA [NM_022774]","chr1",40974480,40980958,"GO:0000738(DNA catabolic process, exonucleolytic);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0008310(single-stranded DNA specific 3'-5' exodeoxyribonuclease activity);GO:0042803(protein homodimerization activity);GO:0045145(single-stranded DNA specific 5'-3' exodeoxyribonuclease activity);GO:0046872(metal ion binding);GO:0051539(4 iron, 4 sulfur cluster binding)",null,"mRNA","agilent G3 V3"]
["A_24_P74896",5.26,6.23,{"v":5.1,"d":"5.10"},5.43,5.74,5.51,{"v":0.994604316546763,"d":"0.99"},{"v":-0.00780540248880035,"d":"-0.01"},"down",{"v":0.93846,"d":"0.94"},1,"no","ACCGCCTGCTTCTGCAACCACAGCACCAGCTTTGCCATCCTGCTGCAAATCTATGAAGTA","FALSE","ENST00000622546","ens|ENST00000622546|ref|XM_006710216|ref|XM_006717348|ref|XM_006726503",null,null,"ens|G protein-coupled receptor 144 [Source:HGNC Symbol;Acc:HGNC:18651] [ENST00000622546]","chr9",127213424,127239379,null,null,"mRNA","agilent G3 V3"]
["A_23_P351215",4.84,3.62,5.46,5.06,{"v":4.4,"d":"4.40"},{"v":4.6,"d":"4.60"},{"v":0.990042674253201,"d":"0.99"},{"v":-0.0144373832238068,"d":"-0.01"},"down",{"v":0.93918,"d":"0.94"},1,"no","AGAACTCCAAGATGAACTCAGACAGGAACGGGAAGCAAGACAGAAGTTAGAGATGATGAT","FALSE","NM_005414","ref|NM_005414|ref|NM_001248008|ref|NM_001145097|ref|NM_001145098","SKIL","SKI-like proto-oncogene","ref|Homo sapiens SKI-like proto-oncogene (SKIL), transcript variant 1, mRNA [NM_005414]","chr3",170077408,170114623,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0001078(RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription);GO:0001669(acrosomal vesicle);GO:0001825(blastocyst formation);GO:0002260(lymphocyte homeostasis);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0003714(transcription corepressor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-dependent);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0007050(cell cycle arrest);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0007283(spermatogenesis);GO:0007519(skeletal muscle tissue development);GO:0010467(gene expression);GO:0016605(PML body);GO:0019904(protein domain specific binding);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0032403(protein complex binding);GO:0034097(response to cytokine stimulus);GO:0042981(regulation of apoptotic process);GO:0043234(protein complex);GO:0045596(negative regulation of cell differentiation);GO:0046332(SMAD binding);GO:0046677(response to antibiotic);GO:0050772(positive regulation of axonogenesis);GO:0070207(protein homotrimerization);GO:0070208(protein heterotrimerization);GO:0070306(lens fiber cell differentiation);GO:0070848(response to growth factor stimulus)","04550(Signaling pathways regulating pluripotency of stem cells)","mRNA","agilent G3 V3"]
["A_32_P66364",7.44,6.48,7.52,7.59,{"v":6.9,"d":"6.90"},6.85,{"v":1.00468603561387,"d":"1.00"},{"v":0.00674472963334756,"d":"0.01"},"up",{"v":0.9392,"d":"0.94"},1,"no","ACCCCACACTCATACAGTAGCTATGCACATCCTGGAAGTCTCCTTGACTGAACTTTAGAA","FALSE","NM_001080545","ref|NM_001080545|ref|NR_048567|ens|ENST00000479855|ens|ENST00000486067","PPP1R1C","protein phosphatase 1, regulatory (inhibitor) subunit 1C","ref|Homo sapiens protein phosphatase 1, regulatory (inhibitor) subunit 1C (PPP1R1C), transcript variant 3, mRNA [NM_001080545]","chr2",182850544,182982419,"GO:0004864(protein phosphatase inhibitor activity);GO:0004865(protein serine/threonine phosphatase inhibitor activity);GO:0005737(cytoplasm);GO:0006469(negative regulation of protein kinase activity);GO:0007049(cell cycle);GO:0030307(positive regulation of cell growth);GO:0035556(intracellular signal transduction);GO:0051301(cell division);GO:1900087(positive regulation of G1/S transition of mitotic cell cycle)",null,"mRNA","agilent G3 V3"]
["A_33_P3394933",6.37,{"v":5.4,"d":"5.40"},6.57,5.93,6.12,{"v":6.2,"d":"6.20"},{"v":1.00493150684931,"d":"1.00"},{"v":0.00709717494031234,"d":"0.01"},"up",{"v":0.93928,"d":"0.94"},1,"no","ATGAGACTTCAGGACACATACAGGCTGGACCCAGGCACAATTTCCAGAGGGGAACTTCCA","FALSE","NM_001017973","ref|NM_001017973|ref|NM_001142598|ref|NM_001017974|ref|NM_004199","P4HA2","prolyl 4-hydroxylase, alpha polypeptide II","ref|Homo sapiens prolyl 4-hydroxylase, alpha polypeptide II (P4HA2), transcript variant 2, mRNA [NM_001017973]","chr5",131528304,131562935,"GO:0004656(procollagen-proline 4-dioxygenase activity);GO:0005506(iron ion binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005783(endoplasmic reticulum);GO:0005788(endoplasmic reticulum lumen);GO:0009055(electron carrier activity);GO:0016222(procollagen-proline 4-dioxygenase complex);GO:0016702(oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen);GO:0018401(peptidyl-proline hydroxylation to 4-hydroxy-L-proline);GO:0031418(L-ascorbic acid binding);GO:0043231(intracellular membrane-bounded organelle);GO:0055114(oxidation-reduction process)","00330(Arginine and proline metabolism)","mRNA","agilent G3 V3"]
["A_33_P3239228",6.77,6.77,6.64,6.61,6.86,6.73,{"v":0.999009900990099,"d":"1.00"},{"v":-0.00142911853280001,"d":"-0.00"},"down",{"v":0.9407,"d":"0.94"},1,"no","TGGCCTTCACCAGCTCTTACACCTCGACTCCCGTGACACAGAAGCCAGTGACCACCGTCA","FALSE","NM_005960","ref|NM_005960|ref|XM_006710190|ref|XM_006726451|ens|ENST00000483366","MUC3A","mucin 3A, cell surface associated","ref|Homo sapiens mucin 3A, cell surface associated (MUC3A), mRNA [NM_005960]","chr7",100547256,100550424,"GO:0005201(extracellular matrix structural constituent);GO:0005576(extracellular region);GO:0005796(Golgi lumen);GO:0006493(protein O-linked glycosylation);GO:0016021(integral to membrane);GO:0016266(O-glycan processing);GO:0030197(extracellular matrix constituent, lubricant activity);GO:0043687(post-translational protein modification);GO:0044267(cellular protein metabolic process)",null,"mRNA","agilent G3 V3"]
["A_23_P35529",3.88,2.02,{"v":5,"d":"5.00"},3.53,3.34,3.81,{"v":1.02059925093633,"d":"1.02"},{"v":0.029416487976735,"d":"0.03"},"up",{"v":0.94116,"d":"0.94"},1,"no","TTTTCTTACCTTATTGCACTGGTTAGCAACCCCAATACAGAGACCACCAGAGCAGGTATA","FALSE","NM_000242","ref|NM_000242|ens|ENST00000373968|ref|XM_006717861|gb|X15422","MBL2","mannose-binding lectin (protein C) 2, soluble","ref|Homo sapiens mannose-binding lectin (protein C) 2, soluble (MBL2), mRNA [NM_000242]","chr10",54525140,54531460,"GO:0001867(complement activation, lectin pathway);GO:0005102(receptor binding);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005537(mannose binding);GO:0005576(extracellular region);GO:0005581(collagen);GO:0005615(extracellular space);GO:0006953(acute-phase response);GO:0006956(complement activation);GO:0006958(complement activation, classical pathway);GO:0006979(response to oxidative stress);GO:0008228(opsonization);GO:0009986(cell surface);GO:0042742(defense response to bacterium);GO:0044130(negative regulation of growth of symbiont in host);GO:0045087(innate immune response);GO:0048306(calcium-dependent protein binding);GO:0048525(negative regulation of viral reproduction);GO:0050766(positive regulation of phagocytosis);GO:0050830(defense response to Gram-positive bacterium);GO:0051873(killing by host of symbiont cells)","04145(Phagosome);04610(Complement and coagulation cascades);05150(Staphylococcus aureus infection)","mRNA","agilent G3 V3"]
["A_33_P3367647",5.64,2.39,5.48,4.48,4.35,4.93,{"v":0.981831395348837,"d":"0.98"},{"v":-0.0264527953764134,"d":"-0.03"},"down",{"v":0.94178,"d":"0.94"},1,"no","CCTGGAACGTTCTTAATGCTTCCCATTTTCCCAGCAAAGTAAAAAACAACTTTTGTTTAA","FALSE","NM_001077706","ref|NM_001077706|ens|ENST00000401414|ens|ENST00000541398|ref|XM_006715472","ECT2L","epithelial cell transforming 2 like","ref|Homo sapiens epithelial cell transforming 2 like (ECT2L), transcript variant 1, mRNA [NM_001077706]","chr6",139117264,139159541,"GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0032321(positive regulation of Rho GTPase activity)",null,"mRNA","agilent G3 V3"]
["A_33_P3246193",5.24,2.52,4.79,3.88,4.25,4.21,{"v":1.01701782820097,"d":"1.02"},{"v":0.0243449696887166,"d":"0.02"},"up",{"v":0.94186,"d":"0.94"},1,"no","AATGCAGGCCTGGCCTTAGCCCCTGACGCGTTTCAGATTGTGCTGGACAGTGAGAATGAG","FALSE","NM_001200049","ref|NM_001200049|tc|THC2686622|tc|THC2678051","CFAP46","cilia and flagella associated protein 46","ref|Homo sapiens cilia and flagella associated protein 46 (CFAP46), mRNA [NM_001200049]","chr10",134686096,134756089,"GO:0005930(axoneme);GO:0035082(axoneme assembly)",null,"mRNA","agilent G3 V3"]
["A_33_P3344044",6.44,6.89,{"v":6.4,"d":"6.40"},6.31,6.55,6.82,{"v":1.0025406504065,"d":"1.00"},{"v":0.003660735384319,"d":"0.00"},"up",{"v":0.94202,"d":"0.94"},1,"no","TTCATCACAGAGGAGACAGGCTTAATAAAAAAGTCCCTTACTCTCCTCGTAGTTGACTAA","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_23_P5731",5.19,{"v":5.6,"d":"5.60"},4.62,5.25,5.28,4.95,{"v":0.995478036175711,"d":"1.00"},{"v":-0.00653860962962496,"d":"-0.01"},"down",{"v":0.94232,"d":"0.94"},1,"no","ACTGGCAAATGAGACGTAATGGGAAACAATGGCTGCTGGGAAAAACCTTCGACACCTTCT","FALSE","NM_016044","ref|NM_016044|ens|ENST00000470100|ens|ENST00000447036|gb|HQ447862","FAHD2A","fumarylacetoacetate hydrolase domain containing 2A","ref|Homo sapiens fumarylacetoacetate hydrolase domain containing 2A (FAHD2A), mRNA [NM_016044]","chr2",96072688,96078530,"GO:0008152(metabolic process);GO:0016787(hydrolase activity);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_24_P113264",4.62,3.74,4.65,4.45,4.52,3.96,{"v":1.0061871616396,"d":"1.01"},{"v":0.00889868690754113,"d":"0.01"},"up",{"v":0.94236,"d":"0.94"},1,"no","AAGCCCTCAACTCATCTCTGAACTTAGAATCTCATCCTTAGGGCTCAGAGAGTCCCAGCC","FALSE","ENST00000509137","ens|ENST00000509137|ens|ENST00000292853|ref|XM_006723017|gb|BC030060","FBXO27","F-box protein 27","ens|F-box protein 27 [Source:HGNC Symbol;Acc:HGNC:18753] [ENST00000509137]","chr19",39514664,39523165,"GO:0001948(glycoprotein binding);GO:0005515(protein binding);GO:0019005(SCF ubiquitin ligase complex)",null,"mRNA","agilent G3 V3"]
["A_23_P133536",5.12,3.97,5.19,{"v":4.2,"d":"4.20"},4.28,5.96,{"v":0.988919667590028,"d":"0.99"},{"v":-0.0160747628580713,"d":"-0.02"},"down",{"v":0.94268,"d":"0.94"},1,"no","GGATAACTTTGATTCACCCTATGACAAAGATGGATTGGTGACCCCTGAGGAGTTCATGAA","FALSE","NM_144647","ref|NM_144647|ref|NM_001042625|ens|ENST00000513623|ens|ENST00000397366","CAPSL","calcyphosine-like","ref|Homo sapiens calcyphosine-like (CAPSL), transcript variant 1, mRNA [NM_144647]","chr5",35904396,35938881,"GO:0005509(calcium ion binding);GO:0005737(cytoplasm)",null,"mRNA","agilent G3 V3"]
["A_23_P318039",{"v":3.1,"d":"3.10"},3.82,5.44,4.32,3.99,4.22,{"v":0.986432561851556,"d":"0.99"},{"v":-0.0197076714174861,"d":"-0.02"},"down",{"v":0.94276,"d":"0.94"},1,"no","TGGTACTATTGCAGCACTTTTACAGGAAATTGTAAATATTTATCCATCTATCAACCCACC","FALSE","NM_005444","ref|NM_005444|ref|NM_001271635|ref|NM_001271634|ref|NR_073390","RQCD1","RCD1 required for cell differentiation1 homolog (S. pombe)","ref|Homo sapiens RCD1 required for cell differentiation1 homolog (S. pombe) (RQCD1), transcript variant 2, mRNA [NM_005444]","chr2",219433296,219461803,"GO:0000288(nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay);GO:0000289(nuclear-transcribed mRNA poly(A) tail shortening);GO:0000932(cytoplasmic mRNA processing body);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0006417(regulation of translation);GO:0007548(sex differentiation);GO:0010467(gene expression);GO:0016020(membrane);GO:0019221(cytokine-mediated signaling pathway);GO:0019904(protein domain specific binding);GO:0030014(CCR4-NOT complex);GO:0031047(gene silencing by RNA);GO:0033147(negative regulation of intracellular estrogen receptor signaling pathway);GO:0042803(protein homodimerization activity);GO:2000327(positive regulation of ligand-dependent nuclear receptor transcription coactivator activity)","03018(RNA degradation)","mRNA","agilent G3 V3"]
["A_24_P383478",{"v":7.5,"d":"7.50"},7.01,7.38,7.61,7.11,7.12,{"v":1.00228937728938,"d":"1.00"},{"v":0.00329909826109363,"d":"0.00"},"up",{"v":0.94358,"d":"0.94"},1,"no","ATGACCATGACCCTCCACACCAAAGCATCTGGGATGGCCCTACTGCATCAGATCCAAGGG","FALSE","NM_000125","ref|NM_000125|ref|NM_001291241|ref|NM_001122742|ref|NM_001122740","ESR1","estrogen receptor 1","ref|Homo sapiens estrogen receptor 1 (ESR1), transcript variant 1, mRNA [NM_000125]","chr6",152128448,152424409,"GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0001046(core promoter sequence-specific DNA binding);GO:0001077(RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription);GO:0001547(antral ovarian follicle growth);GO:0002064(epithelial cell development);GO:0003682(chromatin binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0003707(steroid hormone receptor activity);GO:0005496(steroid binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0006338(chromatin remodeling);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0007165(signal transduction);GO:0007200(phospholipase C-activating G-protein coupled receptor signaling pathway);GO:0007204(elevation of cytosolic calcium ion concentration);GO:0008013(beta-catenin binding);GO:0008134(transcription factor binding);GO:0008209(androgen metabolic process);GO:0008270(zinc ion binding);GO:0008584(male gonad development);GO:0010467(gene expression);GO:0010629(negative regulation of gene expression);GO:0010863(positive regulation of phospholipase C activity);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0019899(enzyme binding);GO:0030235(nitric-oxide synthase regulator activity);GO:0030284(estrogen receptor activity);GO:0030518(intracellular steroid hormone receptor signaling pathway);GO:0030520(intracellular estrogen receptor signaling pathway);GO:0032355(response to estradiol stimulus);GO:0034056(estrogen response element binding);GO:0035327(transcriptionally active chromatin);GO:0038052(estrogen-activated sequence-specific DNA binding RNA polymerase II transcription factor activity);GO:0042802(identical protein binding);GO:0042981(regulation of apoptotic process);GO:0043124(negative regulation of I-kappaB kinase/NF-kappaB cascade);GO:0043401(steroid hormone mediated signaling pathway);GO:0043433(negative regulation of sequence-specific DNA binding transcription factor activity);GO:0043627(response to estrogen stimulus);GO:0045429(positive regulation of nitric oxide biosynthetic process);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048146(positive regulation of fibroblast proliferation);GO:0048386(positive regulation of retinoic acid receptor signaling pathway);GO:0051000(positive regulation of nitric-oxide synthase activity);GO:0051091(positive regulation of sequence-specific DNA binding transcription factor activity);GO:0060065(uterus development);GO:0060068(vagina development);GO:0060523(prostate epithelial cord elongation);GO:0060527(prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis);GO:0060687(regulation of branching involved in prostate gland morphogenesis);GO:0060745(mammary gland branching involved in pregnancy);GO:0060749(mammary gland alveolus development)","04915(Estrogen signaling pathway);04917(Prolactin signaling pathway);04919(Thyroid hormone signaling pathway);04961(Endocrine and other factor-regulated calcium reabsorption);05205(Proteoglycans in cancer)","mRNA","agilent G3 V3"]
["A_33_P3214899",4.98,4.48,5.07,4.92,5.37,4.32,{"v":0.994524298425736,"d":"0.99"},{"v":-0.007921475170657,"d":"-0.01"},"down",{"v":0.94376,"d":"0.94"},1,"no","ACAGAACTGGTTGAGGCTGCTCCTTTGATTTTATGTCGTGTAAAGTCTTTGTTCCCCAGC","FALSE","NM_001136504","ref|NM_001136504|ref|NM_177402|ens|ENST00000367267|ens|ENST00000367268","SYT2","synaptotagmin II","ref|Homo sapiens synaptotagmin II (SYT2), transcript variant 2, mRNA [NM_001136504]","chr1",202559728,202679545,"GO:0005215(transporter activity);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005544(calcium-dependent phospholipid binding);GO:0005886(plasma membrane);GO:0006810(transport);GO:0009405(pathogenesis);GO:0016021(integral to membrane);GO:0030054(cell junction);GO:0030672(synaptic vesicle membrane);GO:0042584(chromaffin granule membrane);GO:0043231(intracellular membrane-bounded organelle)",null,"mRNA","agilent G3 V3"]
["A_23_P93988",2.49,{"v":4.6,"d":"4.60"},3.53,2.96,3.61,{"v":3.9,"d":"3.90"},{"v":1.01432664756447,"d":"1.01"},{"v":0.0205223238733452,"d":"0.02"},"up",{"v":0.94406,"d":"0.94"},1,"no","TGATAGCCGTATGTTAAACAGAATCTCACCTCAGTCTCCTGGAGGGAGATGTTTAAGAGG","FALSE","NM_005435","ref|NM_005435|ens|ENST00000056217|ref|XM_006716127|ref|XM_006716128","ARHGEF5","Rho guanine nucleotide exchange factor (GEF) 5","ref|Homo sapiens Rho guanine nucleotide exchange factor (GEF) 5 (ARHGEF5), mRNA [NM_005435]","chr7",144063232,144077149,"GO:0002408(myeloid dendritic cell chemotaxis);GO:0005089(Rho guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0030036(actin cytoskeleton organization);GO:0032319(regulation of Rho GTPase activity);GO:0032321(positive regulation of Rho GTPase activity);GO:0035556(intracellular signal transduction);GO:0071803(positive regulation of podosome assembly)",null,"mRNA","agilent G3 V3"]
["A_33_P3223825",5.95,4.98,5.91,6.18,5.67,5.09,{"v":0.994096812278631,"d":"0.99"},{"v":-0.0085417362658024,"d":"-0.01"},"down",{"v":0.9441,"d":"0.94"},1,"no","GGCCACAGCCACGGGAGCTACAGCAGTCGCAGCCATGGGACCCGCAGCCGGACACGCAGC","FALSE","NM_001291831","ref|NM_001291831|ref|NM_001110199|ens|ENST00000612155|gb|AK092590","SRRM3","serine/arginine repetitive matrix 3","ref|Homo sapiens serine/arginine repetitive matrix 3 (SRRM3), transcript variant 1, mRNA [NM_001291831]","chr7",75831216,75916603,null,null,"mRNA","agilent G3 V3"]
["A_33_P3293336",10.72,{"v":10.6,"d":"10.60"},10.58,10.62,10.62,10.65,{"v":1.00031357792411,"d":"1.00"},{"v":0.000452326399970844,"d":"0.00"},"up",{"v":0.94432,"d":"0.94"},1,"no","CCCTTTGGCCATCCTCTCACCCCAGAATATCCTAATAAACATTGTTTTCTTTTTTAAAAA","FALSE","NM_005264","ref|NM_005264|ref|NM_001145453|ref|NM_145793|ens|ENST00000369236","GFRA1","GDNF family receptor alpha 1","ref|Homo sapiens GDNF family receptor alpha 1 (GFRA1), transcript variant 1, mRNA [NM_005264]","chr10",117816448,118032796,"GO:0005102(receptor binding);GO:0005886(plasma membrane);GO:0007166(cell surface receptor signaling pathway);GO:0007411(axon guidance);GO:0016167(glial cell-derived neurotrophic factor receptor activity);GO:0019898(extrinsic to membrane);GO:0031225(anchored to membrane);GO:0035860(glial cell-derived neurotrophic factor receptor signaling pathway);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P56578",6.34,5.81,4.81,5.23,5.41,{"v":6.2,"d":"6.20"},{"v":1.00712589073634,"d":"1.01"},{"v":0.0102440314968031,"d":"0.01"},"up",{"v":0.94436,"d":"0.94"},1,"no","CAAAATAAATGTTCGGAATACAGTGCAGCCCTTACGACAGGCTTACGTAGAGCTTTTGTG","FALSE","NM_053276","ref|NM_053276|ref|NM_001177969|ref|NM_001177970|ref|NM_001177971","VIT","vitrin","ref|Homo sapiens vitrin (VIT), transcript variant 1, mRNA [NM_053276]","chr2",36923832,37041935,"GO:0005539(glycosaminoglycan binding);GO:0005614(interstitial matrix);GO:0010811(positive regulation of cell-substrate adhesion);GO:0030198(extracellular matrix organization)",null,"mRNA","agilent G3 V3"]
["A_23_P24044",5.07,3.06,5.01,4.59,4.12,4.28,{"v":1.01154734411085,"d":"1.01"},{"v":0.0165638448744484,"d":"0.02"},"up",{"v":0.94446,"d":"0.94"},1,"no","CCTTCCCACTAGAACATACTTTAACAGAAAACGAGTCGGACCTTCTAGCTGCACTCTGTA","FALSE","NM_017649","ref|NM_017649|ref|NM_199076|ens|ENST00000433628|gb|AK000071","CNNM2","cyclin and CBS domain divalent metal cation transport mediator 2","ref|Homo sapiens cyclin and CBS domain divalent metal cation transport mediator 2 (CNNM2), transcript variant 1, mRNA [NM_017649]","chr10",104678112,104838108,"GO:0010960(magnesium ion homeostasis);GO:0015693(magnesium ion transport);GO:0016021(integral to membrane);GO:0016323(basolateral plasma membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P94819",6.27,6.62,5.21,5.94,6.02,6.04,{"v":1.00555555555556,"d":"1.01"},{"v":0.00799279075353062,"d":"0.01"},"up",{"v":0.94462,"d":"0.94"},1,"no","CTCCCTCAGCCATGAATTCACTTCTCTTCAGGAGGTTTGGCTTGGCATGAAAATACTTCA","FALSE","NM_006987","ref|NM_006987|ref|NM_001190412|ref|NM_001190411|ref|NM_001190413","RPH3AL","rabphilin 3A-like (without C2 domains)","ref|Homo sapiens rabphilin 3A-like (without C2 domains) (RPH3AL), transcript variant 1, mRNA [NM_006987]","chr17",{"v":63115,"d":"63115.00"},65724,"GO:0005737(cytoplasm);GO:0006886(intracellular protein transport);GO:0006887(exocytosis);GO:0008092(cytoskeletal protein binding);GO:0017137(Rab GTPase binding);GO:0017158(regulation of calcium ion-dependent exocytosis);GO:0030274(LIM domain binding);GO:0030658(transport vesicle membrane);GO:0030667(secretory granule membrane);GO:0042493(response to drug);GO:0042593(glucose homeostasis);GO:0045744(negative regulation of G-protein coupled receptor protein signaling pathway);GO:0046872(metal ion binding);GO:0050714(positive regulation of protein secretion)",null,"mRNA","agilent G3 V3"]
["A_23_P380326",10.06,2.06,1.93,4.81,4.29,4.32,{"v":1.04694485842027,"d":"1.05"},{"v":0.0661854589081047,"d":"0.07"},"up",{"v":0.94496,"d":"0.94"},1,"no","GCCAAGTTCTAGTAGTTTCAGTTCTAGGCTTTCCTTCAAGAACAGTCAGATCACAAAGTG","FALSE","NM_018375","ref|NM_018375|ref|NM_001252148|ref|NM_001252151|ref|NM_001252152","SLC39A9","solute carrier family 39, member 9","ref|Homo sapiens solute carrier family 39, member 9 (SLC39A9), transcript variant 1, mRNA [NM_018375]","chr14",69921416,69925260,"GO:0006829(zinc ion transport);GO:0016021(integral to membrane);GO:0046873(metal ion transmembrane transporter activity);GO:0055085(transmembrane transport)",null,"mRNA","agilent G3 V3"]
["A_33_P3330731",6.38,5.86,6.29,6.29,{"v":6.2,"d":"6.20"},{"v":6,"d":"6.00"},{"v":1.00216333153056,"d":"1.00"},{"v":0.00311765662306969,"d":"0.00"},"up",{"v":0.94508,"d":"0.95"},1,"no","CTATCCCCGGTAACGGTCGAGGTGGAGCAGGCCCTTTAATCATCCCTCATCCGATATCCT","FALSE","ENST00000406335","ens|ENST00000406335","RHBDD3","rhomboid domain containing 3","ens|rhomboid domain containing 3 [Source:HGNC Symbol;Acc:HGNC:1308] [ENST00000406335]","chr22",29659946,29663717,"GO:0000165(MAPK cascade);GO:0001889(liver development);GO:0002673(regulation of acute inflammatory response);GO:0004252(serine-type endopeptidase activity);GO:0006508(proteolysis);GO:0009410(response to xenobiotic stimulus);GO:0016021(integral to membrane);GO:0032815(negative regulation of natural killer cell activation);GO:0045732(positive regulation of protein catabolic process);GO:0050708(regulation of protein secretion)",null,"mRNA","agilent G3 V3"]
["A_33_P3401322",6.71,5.79,6.47,6.96,5.96,6.14,{"v":0.995278069254984,"d":"1.00"},{"v":-0.00682844049846618,"d":"-0.01"},"down",{"v":0.94558,"d":"0.95"},1,"no","GGGAAAGCCTTCACGTCAGAACCCAACCCTATACCTTTTACTTCTTAAATGGTGCTAACC","FALSE","NM_001303095","ref|NM_001303095|ens|ENST00000368219|ens|ENST00000313146|ens|ENST00000472824","ISG20L2","interferon stimulated exonuclease gene 20kDa-like 2","ref|Homo sapiens interferon stimulated exonuclease gene 20kDa-like 2 (ISG20L2), mRNA [NM_001303095]","chr1",156693744,156697178,"GO:0004527(exonuclease activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0042254(ribosome biogenesis);GO:0090305(nucleic acid phosphodiester bond hydrolysis)",null,"mRNA","agilent G3 V3"]
["A_33_P3370751",4.48,1.96,4.47,3.21,3.18,4.32,{"v":1.0186741363212,"d":"1.02"},{"v":0.0266926215733512,"d":"0.03"},"up",{"v":0.94562,"d":"0.95"},1,"no","TATGGCGTAAATTACTTTGAAGAGTTCATTTTGGAAGTAAGGGAATCCCGCTTCCCTTGG","FALSE","NM_022739","ref|NM_022739","SMURF2","SMAD specific E3 ubiquitin protein ligase 2","ref|Homo sapiens SMAD specific E3 ubiquitin protein ligase 2 (SMURF2), mRNA [NM_022739]","chr17",62541184,62658046,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000151(ubiquitin ligase complex);GO:0004842(ubiquitin-protein ligase activity);GO:0005160(transforming growth factor beta receptor binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006351(transcription, DNA-dependent);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0006511(ubiquitin-dependent protein catabolic process);GO:0007179(transforming growth factor beta receptor signaling pathway);GO:0010467(gene expression);GO:0016874(ligase activity);GO:0017015(regulation of transforming growth factor beta receptor signaling pathway);GO:0030509(BMP signaling pathway);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0030579(ubiquitin-dependent SMAD protein catabolic process);GO:0042787(protein ubiquitination involved in ubiquitin-dependent protein catabolic process);GO:0042802(identical protein binding);GO:0045121(membrane raft);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0046332(SMAD binding);GO:0090263(positive regulation of canonical Wnt receptor signaling pathway)","04120(Ubiquitin mediated proteolysis);04350(TGF-beta signaling pathway);04144(Endocytosis)","mRNA","agilent G3 V3"]
["A_23_P8416",2.16,5.32,2.18,3.04,3.23,3.62,{"v":0.976744186046512,"d":"0.98"},{"v":-0.0339473319233377,"d":"-0.03"},"down",{"v":0.946,"d":"0.95"},1,"no","TAATGAAGAGCATGAATTGGTTTTAAATAGTCTCCTTTGTCTAGATATGTCAGAGACTCG","FALSE","NM_022087","ref|NM_022087|ens|ENST00000434507|ens|ENST00000430044|ref|XM_006716082","GALNT11","polypeptide N-acetylgalactosaminyltransferase 11","ref|Homo sapiens polypeptide N-acetylgalactosaminyltransferase 11 (GALNT11), mRNA [NM_022087]","chr7",151776352,151819245,"GO:0000139(Golgi membrane);GO:0004653(polypeptide N-acetylgalactosaminyltransferase activity);GO:0005112(Notch binding);GO:0006493(protein O-linked glycosylation);GO:0007220(Notch receptor processing);GO:0007368(determination of left/right symmetry);GO:0008593(regulation of Notch signaling pathway);GO:0016021(integral to membrane);GO:0016266(O-glycan processing);GO:0018243(protein O-linked glycosylation via threonine);GO:0030246(carbohydrate binding);GO:0043687(post-translational protein modification);GO:0044267(cellular protein metabolic process);GO:0046872(metal ion binding);GO:0060271(cilium morphogenesis);GO:0061314(Notch signaling involved in heart development)","00512(Mucin type O-glycan biosynthesis)","mRNA","agilent G3 V3"]
["A_33_P3362008",6.39,5.23,6.62,{"v":6.2,"d":"6.20"},5.78,6.36,{"v":0.994547437295529,"d":"0.99"},{"v":-0.00788790943031261,"d":"-0.01"},"down",{"v":0.94614,"d":"0.95"},1,"no","CACCGCAAAATGGTCCTCTACACCCTGCGGGCACCACGAAGCCCCAAGATGGTGCAAGGG","FALSE","NM_002521","ref|NM_002521|ens|ENST00000376468|gb|CR542003|gb|CR541976","NPPB","natriuretic peptide B","ref|Homo sapiens natriuretic peptide B (NPPB), mRNA [NM_002521]","chr1",11917521,11918988,"GO:0005102(receptor binding);GO:0005179(hormone activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006182(cGMP biosynthetic process);GO:0007166(cell surface receptor signaling pathway);GO:0007168(receptor guanylyl cyclase signaling pathway);GO:0007589(body fluid secretion);GO:0008217(regulation of blood pressure);GO:0008613(diuretic hormone activity);GO:0016525(negative regulation of angiogenesis);GO:0030308(negative regulation of cell growth);GO:0035810(positive regulation of urine volume);GO:0035815(positive regulation of renal sodium excretion);GO:0042312(regulation of vasodilation);GO:0043114(regulation of vascular permeability);GO:0043234(protein complex);GO:0050880(regulation of blood vessel size)","04022(cGMP - PKG signaling pathway);04270(Vascular smooth muscle contraction)","mRNA","agilent G3 V3"]
["A_33_P3229725",7.85,7.16,{"v":7.8,"d":"7.80"},8.07,7.55,7.26,{"v":0.996940559440559,"d":"1.00"},{"v":-0.00442060546625231,"d":"-0.00"},"down",{"v":0.94618,"d":"0.95"},1,"no","GGGAGGCTCAGGTGTCTGGAGGGGGTTTGTGCCTGATAACGTAATAACACCAGTGGAGAC","FALSE","NM_000487","ref|NM_000487|ref|NM_001085425|ref|NM_001085426|ref|NM_001085427","ARSA","arylsulfatase A","ref|Homo sapiens arylsulfatase A (ARSA), transcript variant 1, mRNA [NM_000487]","chr22",51063448,51066607,"GO:0001669(acrosomal vesicle);GO:0004065(arylsulfatase activity);GO:0004098(cerebroside-sulfatase activity);GO:0005509(calcium ion binding);GO:0005615(extracellular space);GO:0005764(lysosome);GO:0005768(endosome);GO:0005788(endoplasmic reticulum lumen);GO:0006665(sphingolipid metabolic process);GO:0006687(glycosphingolipid metabolic process);GO:0006914(autophagy);GO:0007339(binding of sperm to zona pellucida);GO:0007417(central nervous system development);GO:0007584(response to nutrient);GO:0008484(sulfuric ester hydrolase activity);GO:0009268(response to pH);GO:0016021(integral to membrane);GO:0031232(extrinsic to external side of plasma membrane);GO:0043202(lysosomal lumen);GO:0043627(response to estrogen stimulus);GO:0043687(post-translational protein modification);GO:0044267(cellular protein metabolic process);GO:0044281(small molecule metabolic process);GO:0045471(response to ethanol);GO:0051597(response to methylmercury);GO:0070062(extracellular vesicular exosome)","00600(Sphingolipid metabolism);04142(Lysosome)","mRNA","agilent G3 V3"]
["A_33_P3294449",3.09,4.11,4.92,3.74,4.14,4.36,{"v":0.990196078431373,"d":"0.99"},{"v":-0.0142138592197008,"d":"-0.01"},"down",{"v":0.94646,"d":"0.95"},1,"no","ATTCTACTCCTTTGCTATCTTCTCCAGACAGTGAACAAAGGCAGTCTGTTGAGGCATCTG","FALSE","NM_001017977","ref|NM_001017977|ref|NM_018442|ref|NM_001198956|ref|NM_001198957","DCAF6","DDB1 and CUL4 associated factor 6","ref|Homo sapiens DDB1 and CUL4 associated factor 6 (DCAF6), transcript variant 2, mRNA [NM_001017977]","chr1",167905936,168044869,"GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005925(focal adhesion);GO:0016567(protein ubiquitination);GO:0030374(ligand-dependent nuclear receptor transcription coactivator activity);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0080008(CUL4 RING ubiquitin ligase complex)",null,"mRNA","agilent G3 V3"]
["A_23_P112634",5.47,4.56,5.17,5.53,4.96,4.63,{"v":1.00529100529101,"d":"1.01"},{"v":0.00761318410987527,"d":"0.01"},"up",{"v":0.94676,"d":"0.95"},1,"no","GGGGTTGTCTGGGATTGTGTGAAAGAAAATTAGAACCACGCTGTATTTACATTTACCTTG","FALSE","NM_174921","ref|NM_174921|ens|ENST00000512441|gb|AK307146|gb|AK023351","SMIM14","small integral membrane protein 14","ref|Homo sapiens small integral membrane protein 14 (SMIM14), mRNA [NM_174921]","chr4",39553460,39640465,"GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_24_P56270",4.45,5.84,2.01,3.82,4.25,4.47,{"v":0.980861244019139,"d":"0.98"},{"v":-0.0278790325754367,"d":"-0.03"},"down",{"v":0.94722,"d":"0.95"},1,"no","GGCTTGGGTTTTTATCGAGCAACAACTTAGACACGTGACTGTAATATGCTGCAACTGTGT","FALSE","NM_006482","ref|NM_006482|ref|NM_003583|gb|BM986789","DYRK2","dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2","ref|Homo sapiens dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2), transcript variant 2, mRNA [NM_006482]","chr12",68042504,68059186,"GO:0000151(ubiquitin ligase complex);GO:0000287(magnesium ion binding);GO:0004674(protein serine/threonine kinase activity);GO:0004712(protein serine/threonine/tyrosine kinase activity);GO:0004713(protein tyrosine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0006974(response to DNA damage stimulus);GO:0007224(smoothened signaling pathway);GO:0018108(peptidyl-tyrosine phosphorylation);GO:0030145(manganese ion binding);GO:0030529(ribonucleoprotein complex);GO:0042771(DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis);GO:0043130(ubiquitin binding);GO:0045725(positive regulation of glycogen biosynthetic process);GO:0051534(negative regulation of NFAT protein import into nucleus)",null,"mRNA","agilent G3 V3"]
["A_23_P42884",8.85,{"v":9.5,"d":"9.50"},9.32,9.19,9.03,{"v":9.5,"d":"9.50"},{"v":0.998196248196248,"d":"1.00"},{"v":-0.00260461352725895,"d":"-0.00"},"down",{"v":0.9475,"d":"0.95"},1,"no","GCATCCCCTCAGAGGACTGAGGCATAGTCTCTCATCTGCTATTGAATAAAGACCTTCTAT","FALSE","NM_032014","ref|NM_032014|ref|NM_001204871|ens|ENST00000418740|ens|ENST00000317534","MRPS24","mitochondrial ribosomal protein S24","ref|Homo sapiens mitochondrial ribosomal protein S24 (MRPS24), mRNA [NM_032014]","chr7",43907148,43909106,"GO:0003735(structural constituent of ribosome);GO:0005743(mitochondrial inner membrane);GO:0005762(mitochondrial large ribosomal subunit);GO:0005763(mitochondrial small ribosomal subunit);GO:0006412(translation);GO:0006996(organelle organization);GO:0008150(biological_process);GO:0032543(mitochondrial translation);GO:0070124(mitochondrial translational initiation);GO:0070125(mitochondrial translational elongation);GO:0070126(mitochondrial translational termination)",null,"mRNA","agilent G3 V3"]
["A_32_P233938",3.66,3.95,3.55,3.52,4.02,3.66,{"v":0.996428571428572,"d":"1.00"},{"v":-0.0051617051157787,"d":"-0.01"},"down",{"v":0.94764,"d":"0.95"},1,"no","TTAGAATTATTCCTGGACTATTCAGTAGCCACTCAGATGCCACTGTGTGAAAGGGCCATA","FALSE","NM_001040057","ref|NM_001040057|ref|NM_001288584|ref|NM_152789|ref|NR_034169","FAM133B","family with sequence similarity 133, member B","ref|Homo sapiens family with sequence similarity 133, member B (FAM133B), transcript variant 2, mRNA [NM_001040057]","chr7",92191600,92219384,null,null,"mRNA","agilent G3 V3"]
["A_33_P3362601",7.14,6.77,{"v":7.2,"d":"7.20"},7.08,7.04,7.02,{"v":0.998580889309366,"d":"1.00"},{"v":-0.00204879803552716,"d":"-0.00"},"down",{"v":0.94792,"d":"0.95"},1,"no","TAAAAGCAACAAACTATTCGTTAGAACGCTACCCTCATCTCTCTAGGAAGCAAGGCCTGG","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_21_P0014808",4.97,5.34,7.15,6.05,5.78,5.78,{"v":0.991482112436116,"d":"0.99"},{"v":-0.0123413502017682,"d":"-0.01"},"down",{"v":0.94804,"d":"0.95"},1,"no","CCGGGAAGGAAAATTGGATCAAACATTTAACCTCTCATATTAAGTCTGTCAATGATGACT","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_24_P397613",3.53,4.82,4.26,4.27,3.24,4.97,{"v":1.01041666666667,"d":"1.01"},{"v":0.0149503414659716,"d":"0.01"},"up",{"v":0.94814,"d":"0.95"},1,"no","GACTCCCATTCACATTTACGTCATCATTAAAGCCTTGGTTACAATCCCAGAAACTACGTT","FALSE","NM_001008504","ref|NM_001008504|ref|NM_001145285|ref|NM_001145282|ref|NM_001285523","OPRM1","opioid receptor, mu 1","ref|Homo sapiens opioid receptor, mu 1 (OPRM1), transcript variant MOR-1A, mRNA [NM_001008504]","chr6",154360448,154415389,"GO:0001965(G-protein alpha-subunit binding);GO:0002438(acute inflammatory response to antigenic stimulus);GO:0004930(G-protein coupled receptor activity);GO:0004979(beta-endorphin receptor activity);GO:0005245(voltage-gated calcium channel activity);GO:0005515(protein binding);GO:0005783(endoplasmic reticulum);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0005925(focal adhesion);GO:0007187(G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger);GO:0007191(adenylate cyclase-activating dopamine receptor signaling pathway);GO:0007194(negative regulation of adenylate cyclase activity);GO:0007200(phospholipase C-activating G-protein coupled receptor signaling pathway);GO:0007204(elevation of cytosolic calcium ion concentration);GO:0007218(neuropeptide signaling pathway);GO:0007268(synaptic transmission);GO:0007600(sensory perception);GO:0007626(locomotory behavior);GO:0008285(negative regulation of cell proliferation);GO:0019233(sensory perception of pain);GO:0019904(protein domain specific binding);GO:0031005(filamin binding);GO:0031635(adenylate cyclase-inhibiting opioid receptor signaling pathway);GO:0031681(G-protein beta-subunit binding);GO:0032094(response to food);GO:0032100(positive regulation of appetite);GO:0032496(response to lipopolysaccharide);GO:0032590(dendrite membrane);GO:0032839(dendrite cytoplasm);GO:0033554(cellular response to stress);GO:0038047(morphine receptor activity);GO:0042060(wound healing);GO:0042220(response to cocaine);GO:0042383(sarcolemma);GO:0042923(neuropeptide binding);GO:0043005(neuron projection);GO:0043204(perikaryon);GO:0043950(positive regulation of cAMP-mediated signaling);GO:0043951(negative regulation of cAMP-mediated signaling);GO:0045019(negative regulation of nitric oxide biosynthetic process);GO:0045121(membrane raft);GO:0045429(positive regulation of nitric oxide biosynthetic process);GO:0048149(behavioral response to ethanol);GO:0050769(positive regulation of neurogenesis);GO:0051481(reduction of cytosolic calcium ion concentration);GO:0051930(regulation of sensory perception of pain);GO:0060079(regulation of excitatory postsynaptic membrane potential);GO:0061358(negative regulation of Wnt protein secretion);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0070588(calcium ion transmembrane transport);GO:0070848(response to growth factor stimulus);GO:0071315(cellular response to morphine);GO:2000310(regulation of N-methyl-D-aspartate selective glutamate receptor activity)","04080(Neuroactive ligand-receptor interaction);04915(Estrogen signaling pathway);05032(Morphine addiction)","mRNA","agilent G3 V3"]
["A_23_P54622",6.28,{"v":3,"d":"3.00"},{"v":5.6,"d":"5.60"},5.53,4.81,4.32,{"v":1.0150068212824,"d":"1.02"},{"v":0.0214894229742195,"d":"0.02"},"up",{"v":0.94814,"d":"0.95"},1,"no","TCCCCAAATGCCGAGATCCACATCCTGAAGAATAAAGGCCGGAAGAGAAAGCTGGAGTCC","FALSE","NM_007317","ref|NM_007317|ref|NM_001256270|ref|NM_001256269|ens|ENST00000160827","KIF22","kinesin family member 22","ref|Homo sapiens kinesin family member 22 (KIF22), transcript variant 1, mRNA [NM_007317]","chr16",29802040,29816705,"GO:0000776(kinetochore);GO:0000785(chromatin);GO:0003677(DNA binding);GO:0003777(microtubule motor activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005819(spindle);GO:0005829(cytosol);GO:0005871(kinesin complex);GO:0005874(microtubule);GO:0005925(focal adhesion);GO:0006281(DNA repair);GO:0007018(microtubule-based movement);GO:0007062(sister chromatid cohesion);GO:0007067(mitosis);GO:0007080(mitotic metaphase plate congression);GO:0007596(blood coagulation);GO:0008017(microtubule binding);GO:0016887(ATPase activity);GO:0019886(antigen processing and presentation of exogenous peptide antigen via MHC class II)",null,"mRNA","agilent G3 V3"]
["A_23_P119478",5.47,5.43,{"v":5.1,"d":"5.10"},5.06,5.59,5.31,{"v":1.00250626566416,"d":"1.00"},{"v":0.00361125355237915,"d":"0.00"},"up",{"v":0.94818,"d":"0.95"},1,"no","TCTAGCTGAGAAATGGAGATGTACTACTCTCTCCTTTACCTTTACCTTTACCACAGTGCA","FALSE","NM_005755","ref|NM_005755|ens|ENST00000221847|ref|XM_006722605|gb|BC015364","EBI3","Epstein-Barr virus induced 3","ref|Homo sapiens Epstein-Barr virus induced 3 (EBI3), mRNA [NM_005755]","chr19",{"v":4229495,"d":"4229495.00"},4237528,"GO:0004896(cytokine receptor activity);GO:0005125(cytokine activity);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005886(plasma membrane);GO:0006959(humoral immune response);GO:0019221(cytokine-mediated signaling pathway);GO:0042088(T-helper 1 type immune response);GO:0045078(positive regulation of interferon-gamma biosynthetic process);GO:0045523(interleukin-27 receptor binding);GO:0046641(positive regulation of alpha-beta T cell proliferation)",null,"mRNA","agilent G3 V3"]
["A_23_P214080",{"v":6.4,"d":"6.40"},5.86,7.57,5.13,{"v":8.7,"d":"8.70"},5.75,{"v":1.01276813074566,"d":"1.01"},{"v":0.0183039126251532,"d":"0.02"},"up",{"v":0.94846,"d":"0.95"},1,"no","AAACAAAGTGACTGTTTGGCTTATAAACACATTGAATGCGCTTTATTGCCCATGGGATAT","FALSE","NM_001964","ref|NM_001964|ens|ENST00000239938|gb|M80583|gb|M62829","EGR1","early growth response 1","ref|Homo sapiens early growth response 1 (EGR1), mRNA [NM_001964]","chr5",137801184,137805004,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000976(transcription regulatory region sequence-specific DNA binding);GO:0000979(RNA polymerase II core promoter sequence-specific DNA binding);GO:0001077(RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription);GO:0001975(response to amphetamine);GO:0003677(DNA binding);GO:0003690(double-stranded DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006366(transcription from RNA polymerase II promoter);GO:0007611(learning or memory);GO:0007623(circadian rhythm);GO:0008134(transcription factor binding);GO:0009749(response to glucose stimulus);GO:0019221(cytokine-mediated signaling pathway);GO:0030217(T cell differentiation);GO:0030509(BMP signaling pathway);GO:0031667(response to nutrient levels);GO:0032869(cellular response to insulin stimulus);GO:0033233(regulation of protein sumoylation);GO:0034465(response to carbon monoxide);GO:0035035(histone acetyltransferase binding);GO:0035690(cellular response to drug);GO:0035914(skeletal muscle cell differentiation);GO:0042220(response to cocaine);GO:0043066(negative regulation of apoptotic process);GO:0043525(positive regulation of neuron apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0045471(response to ethanol);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046872(metal ion binding);GO:0048169(regulation of long-term neuronal synaptic plasticity);GO:0048709(oligodendrocyte differentiation);GO:0051602(response to electrical stimulus);GO:0060291(long-term synaptic potentiation);GO:0060337(type I interferon-mediated signaling pathway);GO:0070498(interleukin-1-mediated signaling pathway);GO:0071236(cellular response to antibiotic);GO:0071260(cellular response to mechanical stimulus);GO:0071317(cellular response to isoquinoline alkaloid);GO:0071320(cellular response to cAMP);GO:0071363(cellular response to growth factor stimulus);GO:0071371(cellular response to gonadotropin stimulus);GO:0071372(cellular response to follicle-stimulating hormone stimulus);GO:0071383(cellular response to steroid hormone stimulus);GO:0071455(cellular response to hyperoxia);GO:0071456(cellular response to hypoxia);GO:0071480(cellular response to gamma radiation);GO:0071504(cellular response to heparin);GO:0071506(cellular response to mycophenolic acid);GO:0071873(response to norepinephrine stimulus);GO:0072110(glomerular mesangial cell proliferation);GO:0072303(positive regulation of glomerular metanephric mesangial cell proliferation);GO:0090090(negative regulation of canonical Wnt receptor signaling pathway)","05020(Prion diseases);05166(HTLV-I infection)","mRNA","agilent G3 V3"]
["A_23_P211136",3.68,3.75,4.57,3.89,3.79,4.39,{"v":0.994200497100248,"d":"0.99"},{"v":-0.00839127025914068,"d":"-0.01"},"down",{"v":0.94868,"d":"0.95"},1,"no","AAATCAGGCATTTTTCCAAAGGAAGTGCTAATGGGCCTATTTGACTTCTGAGTGAAGCAA","FALSE","NM_018963","ref|NM_018963|ref|NM_033656|gb|AJ292465|gb|AJ238556","BRWD1","bromodomain and WD repeat domain containing 1","ref|Homo sapiens bromodomain and WD repeat domain containing 1 (BRWD1), transcript variant 1, mRNA [NM_018963]","chr21",40562144,40685496,"GO:0003674(molecular_function);GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-dependent);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0007010(cytoskeleton organization);GO:0008360(regulation of cell shape)",null,"mRNA","agilent G3 V3"]
["A_23_P361820",4.26,4.92,4.62,5.07,4.57,4.09,{"v":1.00509832483613,"d":"1.01"},{"v":0.00733664151843092,"d":"0.01"},"up",{"v":0.94876,"d":"0.95"},1,"no","AAGGCCTACGACACAGTGCGAGAGGGCATCTTGGATACAGCTCAGACCATCTGTGACGTG","FALSE","NM_015104","ref|NM_015104|ens|ENST00000421419|ens|ENST00000377264|ref|XM_005273849","ATG2A","autophagy related 2A","ref|Homo sapiens autophagy related 2A (ATG2A), mRNA [NM_015104]","chr11",64662016,64680867,"GO:0000045(autophagic vacuole assembly);GO:0000407(pre-autophagosomal structure);GO:0000422(mitochondrion degradation);GO:0005515(protein binding);GO:0005811(lipid particle);GO:0006995(cellular response to nitrogen starvation);GO:0019898(extrinsic to membrane);GO:0034045(pre-autophagosomal structure membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3418662",5.04,1.93,4.48,3.68,3.87,4.11,{"v":0.981989708404803,"d":"0.98"},{"v":-0.02622019021619,"d":"-0.03"},"down",{"v":0.94878,"d":"0.95"},1,"no","TTTTCCTCACCAGTCCCATGCTGGCTGAAGAGGACCAGAGGAGCAGACCAGCACTTCAAC","FALSE","NM_000197","ref|NM_000197|ens|ENST00000375262|ens|ENST00000375263|ens|ENST00000464104","HSD17B3","hydroxysteroid (17-beta) dehydrogenase 3","ref|Homo sapiens hydroxysteroid (17-beta) dehydrogenase 3 (HSD17B3), mRNA [NM_000197]","chr9",98997744,99064386,"GO:0005789(endoplasmic reticulum membrane);GO:0006702(androgen biosynthetic process);GO:0008202(steroid metabolic process);GO:0030539(male genitalia development);GO:0043231(intracellular membrane-bounded organelle);GO:0044281(small molecule metabolic process);GO:0047045(testosterone 17-beta-dehydrogenase (NADP+) activity);GO:0055114(oxidation-reduction process);GO:0061370(testosterone biosynthetic process)","00140(Steroid hormone biosynthesis)","mRNA","agilent G3 V3"]
["A_33_P3390013",4.82,3.15,3.53,3.39,4.41,3.82,{"v":0.989672977624785,"d":"0.99"},{"v":-0.0149762075727914,"d":"-0.01"},"down",{"v":0.94882,"d":"0.95"},1,"no","GTGATCCTTTAAAGAAACCTAAACATTTCATAGACTTTTGCACAATGGCAGAATGCAGTT","FALSE","NM_006988","ref|NM_006988|ens|ENST00000464589|ens|ENST00000284984|gb|AK314475","ADAMTS1","ADAM metallopeptidase with thrombospondin type 1 motif, 1","ref|Homo sapiens ADAM metallopeptidase with thrombospondin type 1 motif, 1 (ADAMTS1), mRNA [NM_006988]","chr21",28210412,28212808,"GO:0001542(ovulation from ovarian follicle);GO:0001822(kidney development);GO:0004222(metalloendopeptidase activity);GO:0005604(basement membrane);GO:0005737(cytoplasm);GO:0006508(proteolysis);GO:0007229(integrin-mediated signaling pathway);GO:0008201(heparin binding);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0008285(negative regulation of cell proliferation);GO:0031410(cytoplasmic vesicle);GO:0060347(heart trabecula formation)",null,"mRNA","agilent G3 V3"]
["A_23_P105873",4.88,2.19,5.03,4.09,4.37,3.83,{"v":0.984540276647681,"d":"0.98"},{"v":-0.0224778682107048,"d":"-0.02"},"down",{"v":0.94928,"d":"0.95"},1,"no","GCAAAAGAAGAGGACTCTAGTATAGACTATGATCTAAACCTCCCAGACACAGTCACCCAC","FALSE","NM_016179","ref|NM_016179|ref|NM_003306|ref|NM_001135955|ref|NM_001135957","TRPC4","transient receptor potential cation channel, subfamily C, member 4","ref|Homo sapiens transient receptor potential cation channel, subfamily C, member 4 (TRPC4), transcript variant alpha, mRNA [NM_016179]","chr13",38210980,38443860,"GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005901(caveola);GO:0005911(cell-cell junction);GO:0006816(calcium ion transport);GO:0007411(axon guidance);GO:0008013(beta-catenin binding);GO:0009986(cell surface);GO:0014051(gamma-aminobutyric acid secretion);GO:0015279(store-operated calcium channel activity);GO:0016323(basolateral plasma membrane);GO:0030863(cortical cytoskeleton);GO:0034220(ion transmembrane transport);GO:0034704(calcium channel complex);GO:0045296(cadherin binding);GO:0048709(oligodendrocyte differentiation);GO:0055085(transmembrane transport);GO:0070509(calcium ion import);GO:0070588(calcium ion transmembrane transport);GO:0070679(inositol 1,4,5 trisphosphate binding)",null,"mRNA","agilent G3 V3"]
["A_23_P209200",8.73,8.48,8.96,8.74,{"v":8.7,"d":"8.70"},8.76,{"v":0.998854961832061,"d":"1.00"},{"v":-0.00165288737677743,"d":"-0.00"},"down",{"v":0.94946,"d":"0.95"},1,"no","GGGCTGCCCTCTCCACATTATCAGTTGACAGTGTACAATGCCTTTGATGAACTGTTTTGT","FALSE","NM_001238","ref|NM_001238|ens|ENST00000574121|ens|ENST00000262643|ens|ENST00000357943","CCNE1","cyclin E1","ref|Homo sapiens cyclin E1 (CCNE1), mRNA [NM_001238]","chr19",30302912,30315214,"GO:0000082(G1/S transition of mitotic cell cycle);GO:0000083(regulation of transcription involved in G1/S phase of mitotic cell cycle);GO:0000278(mitotic cell cycle);GO:0000307(cyclin-dependent protein kinase holoenzyme complex);GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006270(DNA-dependent DNA replication initiation);GO:0006468(protein phosphorylation);GO:0016055(Wnt receptor signaling pathway);GO:0016301(kinase activity);GO:0016538(cyclin-dependent protein kinase regulator activity);GO:0019901(protein kinase binding);GO:0030521(androgen receptor signaling pathway);GO:0045859(regulation of protein kinase activity);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0050681(androgen receptor binding);GO:0051301(cell division);GO:0051726(regulation of cell cycle)","04151(PI3K-Akt signaling pathway);04110(Cell cycle);04114(Oocyte meiosis);04115(p53 signaling pathway);05200(Pathways in cancer);05206(MicroRNAs in cancer);05203(Viral carcinogenesis);05215(Prostate cancer);05222(Small cell lung cancer);05162(Measles);05161(Hepatitis B)","mRNA","agilent G3 V3"]
["A_24_P49199",2.82,6.86,2.85,4.76,{"v":3.6,"d":"3.60"},3.89,{"v":1.02285714285714,"d":"1.02"},{"v":0.0326046654319277,"d":"0.03"},"up",{"v":0.94956,"d":"0.95"},1,"no","AGGTGAAAAGTCAAATGAAACAGTACAATTCTTGATGAGTGAGGTGTCATCTTCCAACCA","FALSE","NM_181789","ref|NM_181789|ens|ENST00000396399|ens|ENST00000335449|ref|XM_006720482","GLDN","gliomedin","ref|Homo sapiens gliomedin (GLDN), mRNA [NM_181789]","chr15",51669456,51700202,"GO:0005581(collagen);GO:0005615(extracellular space);GO:0005886(plasma membrane);GO:0016021(integral to membrane);GO:0032528(microvillus organization);GO:0034113(heterotypic cell-cell adhesion);GO:0045162(clustering of voltage-gated sodium channels);GO:0086080(protein binding involved in heterotypic cell-cell adhesion)",null,"mRNA","agilent G3 V3"]
["A_23_P75149",11.08,10.98,11.09,10.89,11.21,11.03,{"v":1.00060368246302,"d":"1.00"},{"v":0.000870666918935589,"d":"0.00"},"up",{"v":0.94956,"d":"0.95"},1,"no","TGAGTTTTAGGTGAATTTATGTGGTTCCTGCTTGAAAACCTTCCCCTCTCCAGGTTCGGT","FALSE","NM_213649","ref|NM_213649|ref|NR_110305|ens|ENST00000355697|ens|ENST00000484960","SFXN4","sideroflexin 4","ref|Homo sapiens sideroflexin 4 (SFXN4), transcript variant 1, mRNA [NM_213649]","chr10",120900440,120925175,"GO:0005743(mitochondrial inner membrane);GO:0015075(ion transmembrane transporter activity);GO:0016021(integral to membrane);GO:0034220(ion transmembrane transport);GO:0043231(intracellular membrane-bounded organelle);GO:0055072(iron ion homeostasis)",null,"mRNA","agilent G3 V3"]
["A_33_P3385909",4.19,{"v":2.2,"d":"2.20"},4.84,{"v":3.6,"d":"3.60"},{"v":4.1,"d":"4.10"},3.69,{"v":0.98595258999122,"d":"0.99"},{"v":-0.0204098193075105,"d":"-0.02"},"down",{"v":0.9506,"d":"0.95"},1,"no","GTGTGCAAAGAACAGAGCTCATGAGGTCTTCCCACACGTGACACTCTGTGACTTCTTCAC","FALSE","NM_001243467","ref|NM_001243467|ens|ENST00000291535|ref|XR_244316|gb|AK301279","UBASH3A","ubiquitin associated and SH3 domain containing A","ref|Homo sapiens ubiquitin associated and SH3 domain containing A (UBASH3A), transcript variant 3, mRNA [NM_001243467]","chr21",43824012,43830697,"GO:0001817(regulation of cytokine production);GO:0005634(nucleus);GO:0005829(cytosol);GO:0050860(negative regulation of T cell receptor signaling pathway);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_22_P00001744",6.24,3.18,4.41,5.17,4.46,4.38,{"v":0.987152034261242,"d":"0.99"},{"v":-0.0186557992803238,"d":"-0.02"},"down",{"v":0.95132,"d":"0.95"},1,"no","AGCTGAATCTGTCTCCCAAATTGCAATTCCTAAGACCTCAATAAAAACACCTTGTCTTGC","FALSE","NM_001100624","ref|NM_001100624|ref|NM_001270473|ref|NM_001270474|linc|lnc-ATMIN-1:1","CENPN","centromere protein N","ref|Homo sapiens centromere protein N (CENPN), transcript variant 2, mRNA [NM_001100624]","chr16",81040104,81065090,"GO:0000278(mitotic cell cycle);GO:0000777(condensed chromosome kinetochore);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005829(cytosol);GO:0006334(nucleosome assembly);GO:0007059(chromosome segregation);GO:0007067(mitosis);GO:0034080(CenH3-containing nucleosome assembly at centromere)",null,"mRNA","agilent G3 V3"]
["A_23_P2474",8.31,7.79,8.03,8.32,7.84,8.01,{"v":0.998345055854365,"d":"1.00"},{"v":-0.00238955754983123,"d":"-0.00"},"down",{"v":0.95144,"d":"0.95"},1,"no","CCCTAACCCCAAACATAGATCACACCTTCTCTAGGGAGGAGTCAAATGTAGGTCATGTTT","FALSE","NM_016319","ref|NM_016319|ref|NM_001164093|ref|NM_001164095|ref|NM_001164094","COPS7A","COP9 signalosome subunit 7A","ref|Homo sapiens COP9 signalosome subunit 7A (COPS7A), transcript variant 4, mRNA [NM_016319]","chr12",{"v":6838201,"d":"6838201.00"},6839869,"GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0008180(signalosome);GO:0010388(cullin deneddylation)",null,"mRNA","agilent G3 V3"]
["A_23_P34093",5.43,3.96,5.16,5.37,4.88,4.19,{"v":1.00761772853186,"d":"1.01"},{"v":0.0109484109084752,"d":"0.01"},"up",{"v":0.95152,"d":"0.95"},1,"no","CCACGGAGGCAGACGAGCTGATGAAGAGAGTGGGTTTCCAGTATGAGGGCACCTACAAGT","FALSE","NM_000402","ref|NM_000402|ref|NM_001042351|ens|ENST00000369620|ens|ENST00000393564","G6PD","glucose-6-phosphate dehydrogenase","ref|Homo sapiens glucose-6-phosphate dehydrogenase (G6PD), transcript variant 1, mRNA [NM_000402]","chrX",153760304,153761289,"GO:0001816(cytokine production);GO:0004345(glucose-6-phosphate dehydrogenase activity);GO:0005515(protein binding);GO:0005536(glucose binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005815(microtubule organizing center);GO:0005829(cytosol);GO:0005975(carbohydrate metabolic process);GO:0006098(pentose-phosphate shunt);GO:0006629(lipid metabolic process);GO:0006695(cholesterol biosynthetic process);GO:0006739(NADP metabolic process);GO:0006740(NADPH regeneration);GO:0006749(glutathione metabolic process);GO:0009051(pentose-phosphate shunt, oxidative branch);GO:0009405(pathogenesis);GO:0009898(internal side of plasma membrane);GO:0010734(negative regulation of protein glutathionylation);GO:0014070(response to organic cyclic compound);GO:0016020(membrane);GO:0019322(pentose biosynthetic process);GO:0021762(substantia nigra development);GO:0032094(response to food);GO:0034599(cellular response to oxidative stress);GO:0042802(identical protein binding);GO:0042803(protein homodimerization activity);GO:0043231(intracellular membrane-bounded organelle);GO:0043249(erythrocyte maturation);GO:0043523(regulation of neuron apoptotic process);GO:0044281(small molecule metabolic process);GO:0045471(response to ethanol);GO:0046390(ribose phosphate biosynthetic process);GO:0050661(NADP binding);GO:0051156(glucose 6-phosphate metabolic process);GO:0055114(oxidation-reduction process);GO:0070062(extracellular vesicular exosome)","01200(Carbon metabolism);00030(Pentose phosphate pathway);00480(Glutathione metabolism);05230(Central carbon metabolism in cancer)","mRNA","agilent G3 V3"]
["A_23_P143694",6.09,5.74,6.22,5.88,5.82,6.31,{"v":1.00222098833981,"d":"1.00"},{"v":0.00320065586825765,"d":"0.00"},"up",{"v":0.95256,"d":"0.95"},1,"no","CATCGGAGGCCTTACCACTCCTATGACTCCTGTTTTCTCTCTCACAGATAGTGAGGGTCT","FALSE","NM_006941","ref|NM_006941|ens|ENST00000396884|ens|ENST00000360880|gb|BC002824","SOX10","SRY (sex determining region Y)-box 10","ref|Homo sapiens SRY (sex determining region Y)-box 10 (SOX10), mRNA [NM_006941]","chr22",38368308,38383429,"GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0000980(RNA polymerase II distal enhancer sequence-specific DNA binding);GO:0001190(RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription);GO:0001701(in utero embryonic development);GO:0001755(neural crest cell migration);GO:0002052(positive regulation of neuroblast proliferation);GO:0003682(chromatin binding);GO:0003705(RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity);GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0006366(transcription from RNA polymerase II promoter);GO:0007422(peripheral nervous system development);GO:0008134(transcription factor binding);GO:0009653(anatomical structure morphogenesis);GO:0014015(positive regulation of gliogenesis);GO:0030318(melanocyte differentiation);GO:0031315(extrinsic to mitochondrial outer membrane);GO:0042802(identical protein binding);GO:0043066(negative regulation of apoptotic process);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0048469(cell maturation);GO:0048484(enteric nervous system development);GO:0048546(digestive tract morphogenesis);GO:0048589(developmental growth);GO:0048709(oligodendrocyte differentiation);GO:0090090(negative regulation of canonical Wnt receptor signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_23_P369641",7.22,6.54,{"v":6.9,"d":"6.90"},6.84,6.93,6.93,{"v":0.998067632850242,"d":"1.00"},{"v":-0.00279051352162802,"d":"-0.00"},"down",{"v":0.9526,"d":"0.95"},1,"no","CAGCATCCTAAGGCTCCTGGCGGGCATCCTCTCTGCTCAAAATTATTGACCTGTCTCCCG","FALSE","NM_001100878","ref|NM_001100878|ens|ENST00000533120|ens|ENST00000618551|ens|ENST00000533210","MROH6","maestro heat-like repeat family member 6","ref|Homo sapiens maestro heat-like repeat family member 6 (MROH6), mRNA [NM_001100878]","chr8",144649536,144651030,null,null,"mRNA","agilent G3 V3"]
["A_33_P3343182",4.95,{"v":5,"d":"5.00"},4.09,4.26,{"v":5,"d":"5.00"},4.85,{"v":0.995038979447201,"d":"1.00"},{"v":-0.00717505229270349,"d":"-0.01"},"down",{"v":0.95298,"d":"0.95"},1,"no","CAAGTTGGACTCTTCCTCTCATCAGTACTAGTTGTCAAATTTAAAATGTGACAGTTAAAG","FALSE","NM_024726","ref|NM_024726|ref|NM_001270584|ref|NM_001270585|ref|NR_073043","IQCA1","IQ motif containing with AAA domain 1","ref|Homo sapiens IQ motif containing with AAA domain 1 (IQCA1), transcript variant 1, mRNA [NM_024726]","chr2",237232800,237416092,"GO:0005524(ATP binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3323520",4.77,{"v":2.7,"d":"2.70"},4.41,4.67,3.28,3.79,{"v":1.01192504258944,"d":"1.01"},{"v":0.0171024276907135,"d":"0.02"},"up",{"v":0.95378,"d":"0.95"},1,"no","AGAAAAGGAACGCCTACAAATCGAGAAAGAGAGGCTGCGGCATTTAGACATGGAACATGA","FALSE","NM_032424","ref|NM_032424|ens|ENST00000617528|ens|ENST00000301919|ref|XM_005271697","MSANTD4","Myb/SANT-like DNA-binding domain containing 4 with coiled-coils","ref|Homo sapiens Myb/SANT-like DNA-binding domain containing 4 with coiled-coils (MSANTD4), mRNA [NM_032424]","chr11",105881432,105892977,"GO:0005634(nucleus)",null,"mRNA","agilent G3 V3"]
["A_33_P3348973",3.78,4.61,2.07,3.52,{"v":3.2,"d":"3.20"},{"v":3.6,"d":"3.60"},{"v":1.01356589147287,"d":"1.01"},{"v":0.0194398808236873,"d":"0.02"},"up",{"v":0.95384,"d":"0.95"},1,"no","ATAAAGTTTGATGACAGTGACACAGAACAGATAGCTGAAGAAGGTGACGATAATTTGGCT","FALSE","NM_001178000","ref|NM_001178000|ref|NM_152671|gb|HQ447333|gb|BC125053","PIKFYVE","phosphoinositide kinase, FYVE finger containing","ref|Homo sapiens phosphoinositide kinase, FYVE finger containing (PIKFYVE), transcript variant 4, mRNA [NM_001178000]","chr2",209131088,209200580,"GO:0000139(Golgi membrane);GO:0000285(1-phosphatidylinositol-3-phosphate 5-kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005829(cytosol);GO:0005911(cell-cell junction);GO:0006644(phospholipid metabolic process);GO:0006661(phosphatidylinositol biosynthetic process);GO:0006898(receptor-mediated endocytosis);GO:0010008(endosome membrane);GO:0016308(1-phosphatidylinositol-4-phosphate 5-kinase activity);GO:0031410(cytoplasmic vesicle);GO:0031901(early endosome membrane);GO:0031902(late endosome membrane);GO:0032288(myelin assembly);GO:0034504(protein localization to nucleus);GO:0035556(intracellular signal transduction);GO:0036092(phosphatidylinositol-3-phosphate biosynthetic process);GO:0042147(retrograde transport, endosome to Golgi);GO:0043813(phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity);GO:0044267(cellular protein metabolic process);GO:0044281(small molecule metabolic process);GO:0045121(membrane raft);GO:0046854(phosphatidylinositol phosphorylation);GO:0046872(metal ion binding);GO:0048471(perinuclear region of cytoplasm)","00562(Inositol phosphate metabolism);04070(Phosphatidylinositol signaling system);04145(Phagosome);04810(Regulation of actin cytoskeleton)","mRNA","agilent G3 V3"]
["A_33_P3257609",3.94,4.38,3.01,4.12,3.62,3.67,{"v":0.992988606485539,"d":"0.99"},{"v":-0.010150930468166,"d":"-0.01"},"down",{"v":0.95396,"d":"0.95"},1,"no","ACAAAACTTCAGGAAGCCCAGCTAGAGCTAGCAGATATAAAGTCCAAGCTTGAGAAGGTG","FALSE","NM_002481","ref|NM_002481|ref|NM_032103|ref|NM_001197131|ref|NM_032104","PPP1R12B","protein phosphatase 1, regulatory subunit 12B","ref|Homo sapiens protein phosphatase 1, regulatory subunit 12B (PPP1R12B), transcript variant 1, mRNA [NM_002481]","chr1",202431872,202557697,"GO:0000086(G2/M transition of mitotic cell cycle);GO:0000278(mitotic cell cycle);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006937(regulation of muscle contraction);GO:0007165(signal transduction);GO:0008047(enzyme activator activity);GO:0043085(positive regulation of catalytic activity)","04810(Regulation of actin cytoskeleton);04510(Focal adhesion);04921(Oxytocin signaling pathway);04270(Vascular smooth muscle contraction);05205(Proteoglycans in cancer)","mRNA","agilent G3 V3"]
["A_23_P6891",1.95,7.06,3.91,4.48,4.31,4.42,{"v":0.978046934140802,"d":"0.98"},{"v":-0.0320243965529027,"d":"-0.03"},"down",{"v":0.95414,"d":"0.95"},1,"no","ACATGGGGTATGTAGACTAGTAACACATAAGAAAATTGCAGTAAGATGGTAACAAAACCT","FALSE","NM_005875","ref|NM_005875|ens|ENST00000232905|gb|AK223448|gb|AF263452","EIF1B","eukaryotic translation initiation factor 1B","ref|Homo sapiens eukaryotic translation initiation factor 1B (EIF1B), mRNA [NM_005875]","chr3",40352120,40353163,"GO:0003743(translation initiation factor activity);GO:0005575(cellular_component);GO:0006413(translational initiation);GO:0006446(regulation of translational initiation)","03013(RNA transport)","mRNA","agilent G3 V3"]
["A_23_P431268",1.95,1.98,6.15,2.79,{"v":3.4,"d":"3.40"},3.63,{"v":1.02647657841141,"d":"1.03"},{"v":0.0377007091852235,"d":"0.04"},"up",{"v":0.95418,"d":"0.95"},1,"no","TTAGGTACTGAAGAATCCCAGTGAGTTCTGCATTTGTATCTTGCAAGTTTGTATAAACCC","FALSE","NM_014935","ref|NM_014935|ens|ENST00000272203|gb|AK092454|gb|AX747554","PLEKHA6","pleckstrin homology domain containing, family A member 6","ref|Homo sapiens pleckstrin homology domain containing, family A member 6 (PLEKHA6), mRNA [NM_014935]","chr1",204187984,204329044,null,null,"mRNA","agilent G3 V3"]
["A_33_P3265194",4.26,2.44,{"v":4.3,"d":"4.30"},3.47,3.69,3.72,{"v":1.01102941176471,"d":"1.01"},{"v":0.0158249671616828,"d":"0.02"},"up",{"v":0.95432,"d":"0.95"},1,"no","ATGACAGCTGCTTCCCTGTATGGCTTATTTAAATCTAAGAATATACTCTGTACCTTATGT","FALSE","ENST00000397671","ens|ENST00000397671","CPSF4L","cleavage and polyadenylation specific factor 4-like","ens|cleavage and polyadenylation specific factor 4-like [Source:HGNC Symbol;Acc:HGNC:33632] [ENST00000397671]","chr17",71245936,71258491,"GO:0003723(RNA binding);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_24_P184732",7.26,6.95,{"v":7,"d":"7.00"},{"v":6.8,"d":"6.80"},7.11,7.27,{"v":1.0014164305949,"d":"1.00"},{"v":0.00204203153821867,"d":"0.00"},"up",{"v":0.95542,"d":"0.96"},1,"no","TGTGGAGGGGGTGTCAGCTTCCGGGAGCGCCCCTGCTACTCCCAGAGGAGAGATGGAGGC","FALSE","NM_173462","ref|NM_173462|ens|ENST00000554301|ens|ENST00000555123|ens|ENST00000555445","PAPLN","papilin, proteoglycan-like sulfated glycoprotein","ref|Homo sapiens papilin, proteoglycan-like sulfated glycoprotein (PAPLN), mRNA [NM_173462]","chr14",73704208,73741348,"GO:0004222(metalloendopeptidase activity);GO:0004867(serine-type endopeptidase inhibitor activity);GO:0005604(basement membrane);GO:0006508(proteolysis);GO:0008270(zinc ion binding);GO:0010951(negative regulation of endopeptidase activity)",null,"mRNA","agilent G3 V3"]
["A_33_P3491294",6.29,{"v":6.4,"d":"6.40"},7.51,6.81,6.86,{"v":6.6,"d":"6.60"},{"v":0.996546620621608,"d":"1.00"},{"v":-0.00499079582774188,"d":"-0.00"},"down",{"v":0.95602,"d":"0.96"},1,"no","GTGGTTGGGGAGCTGGTCTCCAGGGAGTGAGTCGGGAGCCCTGCTGGATTGATGCCCAGC","FALSE","NM_015944","ref|NM_015944|ens|ENST00000563145|ens|ENST00000293971|gb|AF132948","AMDHD2","amidohydrolase domain containing 2","ref|Homo sapiens amidohydrolase domain containing 2 (AMDHD2), transcript variant 1, mRNA [NM_015944]","chr16",{"v":2578704,"d":"2578704.00"},2579533,"GO:0005634(nucleus);GO:0005975(carbohydrate metabolic process);GO:0006044(N-acetylglucosamine metabolic process);GO:0008448(N-acetylglucosamine-6-phosphate deacetylase activity);GO:0019262(N-acetylneuraminate catabolic process);GO:0046872(metal ion binding)","00520(Amino sugar and nucleotide sugar metabolism)","mRNA","agilent G3 V3"]
["A_33_P3256532",3.02,5.75,3.84,4.12,4.06,4.28,{"v":1.01203852327448,"d":"1.01"},{"v":0.0172642073042178,"d":"0.02"},"up",{"v":0.95646,"d":"0.96"},1,"no","CATACAAGTCATCCATTAAAACAAAGAAGAAGAATATAGAGTGCCAGCAGCAACTTAGTA","FALSE","NM_032120","ref|NM_032120|ens|ENST00000617438|ens|ENST00000265732|ref|XM_005250636","RBM48","RNA binding motif protein 48","ref|Homo sapiens RNA binding motif protein 48 (RBM48), mRNA [NM_032120]","chr7",92158088,92167319,"GO:0003723(RNA binding);GO:0005654(nucleoplasm)",null,"mRNA","agilent G3 V3"]
["A_23_P59202",2.78,3.81,5.74,3.21,4.16,4.79,{"v":1.01398026315789,"d":"1.01"},{"v":0.0200295709592535,"d":"0.02"},"up",{"v":0.95674,"d":"0.96"},1,"no","AGTATTTAACTGTCTTGACCAGTTGGAAGAAGATACGTGGGCCATAAGCATCTTCTGGAC","FALSE","NM_005643","ref|NM_005643|ref|NM_001270488|ens|ENST00000361288|ens|ENST00000420584","TAF11","TAF11 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 28kDa","ref|Homo sapiens TAF11 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 28kDa (TAF11), transcript variant 1, mRNA [NM_005643]","chr6",34845752,34855819,"GO:0003677(DNA binding);GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005669(transcription factor TFIID complex);GO:0005794(Golgi apparatus);GO:0006355(regulation of transcription, DNA-dependent);GO:0006366(transcription from RNA polymerase II promoter);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0006368(transcription elongation from RNA polymerase II promoter);GO:0010467(gene expression);GO:0016032(viral reproduction);GO:0042809(vitamin D receptor binding);GO:0043923(positive regulation by host of viral transcription);GO:0046966(thyroid hormone receptor binding);GO:0046982(protein heterodimerization activity);GO:0047485(protein N-terminus binding)","03022(Basal transcription factors)","mRNA","agilent G3 V3"]
["A_23_P210465",10.73,10.74,10.53,{"v":11.1,"d":"11.10"},10.59,10.35,{"v":0.998751560549313,"d":"1.00"},{"v":-0.00180224263398543,"d":"-0.00"},"down",{"v":0.95682,"d":"0.96"},1,"no","TCCTGCCCCATTATCTTGATCCGGTGCGCCATGTTGAATCCCCCTAACCGCTGCTTGAAA","FALSE","NM_002638","ref|NM_002638|ens|ENST00000243924|gb|CR542234|gb|AB590207","PI3","peptidase inhibitor 3, skin-derived","ref|Homo sapiens peptidase inhibitor 3, skin-derived (PI3), mRNA [NM_002638]","chr20",43803516,43805185,"GO:0004866(endopeptidase inhibitor activity);GO:0004867(serine-type endopeptidase inhibitor activity);GO:0005578(proteinaceous extracellular matrix);GO:0007620(copulation);GO:0010951(negative regulation of endopeptidase activity);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_21_P0014157",1.91,6.87,2.23,3.26,{"v":4,"d":"4.00"},4.04,{"v":0.974336283185841,"d":"0.97"},{"v":-0.037508303738181,"d":"-0.04"},"down",{"v":0.95792,"d":"0.96"},1,"no","TTATTCACTAAATACTGCTGGTCAGCTGGGTCCACTGGCGAACCTCACATCAATAAACCT","FALSE","THC2616237","tc|THC2616237",null,null,"tc|CJ095_HUMAN (Q9H7T3) Protein C10orf95, partial (6%) [THC2616237]",{"$nulls":5},"mRNA","agilent G3 V3"]
["A_33_P3233160",5.26,3.33,{"v":2.5,"d":"2.50"},3.35,3.82,3.78,{"v":1.01278538812785,"d":"1.01"},{"v":0.0183284956731742,"d":"0.02"},"up",{"v":0.95792,"d":"0.96"},1,"no","GCTCTGATGTGGTCAGTGACCTTGAACACGAAGAGATGAAAATCCTGAGGGAAGTTCTTA","FALSE","NM_001282761","ref|NM_001282761|ref|NM_080667|ens|ENST00000339012|ens|ENST00000490934","CFAP36","cilia and flagella associated protein 36","ref|Homo sapiens cilia and flagella associated protein 36 (CFAP36), transcript variant 1, mRNA [NM_001282761]","chr2",55758148,55771430,"GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0042995(cell projection)",null,"mRNA","agilent G3 V3"]
["A_23_P11237",4.61,3.07,{"v":4.2,"d":"4.20"},4.22,3.78,3.96,{"v":0.993311036789298,"d":"0.99"},{"v":-0.00968255339733939,"d":"-0.01"},"down",{"v":0.95818,"d":"0.96"},1,"no","GCATGCTTCAGGAGAACACAAGGATGGACATGGAAAATGAAGAAAGCATGATGTCCTATG","FALSE","NM_004606","ref|NM_004606|ref|NM_001286074|ref|NM_138923|ref|NR_104393","TAF1","TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa","ref|Homo sapiens TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa (TAF1), transcript variant 1, mRNA [NM_004606]","chrX",70586112,70685832,"GO:0002039(p53 binding);GO:0003713(transcription coactivator activity);GO:0004402(histone acetyltransferase activity);GO:0004674(protein serine/threonine kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0005669(transcription factor TFIID complex);GO:0006352(transcription initiation, DNA-dependent);GO:0006366(transcription from RNA polymerase II promoter);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0006368(transcription elongation from RNA polymerase II promoter);GO:0006974(response to DNA damage stimulus);GO:0007049(cell cycle);GO:0008134(transcription factor binding);GO:0010467(gene expression);GO:0016032(viral reproduction);GO:0016573(histone acetylation);GO:0017025(TBP-class protein binding);GO:0018105(peptidyl-serine phosphorylation);GO:0018107(peptidyl-threonine phosphorylation);GO:0032436(positive regulation of proteasomal ubiquitin-dependent protein catabolic process);GO:0043565(sequence-specific DNA binding);GO:0044212(transcription regulatory region DNA binding);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046777(protein autophosphorylation);GO:0051123(RNA polymerase II transcriptional preinitiation complex assembly);GO:0060261(positive regulation of transcription initiation from RNA polymerase II promoter);GO:0070577(histone acetyl-lysine binding);GO:0071339(MLL1 complex)","03022(Basal transcription factors)","mRNA","agilent G3 V3"]
["A_23_P387537",{"v":5.7,"d":"5.70"},5.88,5.94,5.52,5.98,6.05,{"v":0.998290598290598,"d":"1.00"},{"v":-0.00246825559074979,"d":"-0.00"},"down",{"v":0.95864,"d":"0.96"},1,"no","TGCCACCACAAAACAGCCTTAGCCTCCTTGTTGCCAAATAATTCCCTAACTGTGGAGTTT","FALSE","NM_024082","ref|NM_024082|ref|NR_033262|ens|ENST00000538575|ref|XM_005274747","PRRG3","proline rich Gla (G-carboxyglutamic acid) 3 (transmembrane)","ref|Homo sapiens proline rich Gla (G-carboxyglutamic acid) 3 (transmembrane) (PRRG3), transcript variant 1, mRNA [NM_024082]","chrX",150863728,150870063,"GO:0005509(calcium ion binding);GO:0005576(extracellular region);GO:0008150(biological_process);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3276475",5.67,7.47,4.94,6.09,6.01,5.85,{"v":1.00724233983287,"d":"1.01"},{"v":0.0104108337047738,"d":"0.01"},"up",{"v":0.95946,"d":"0.96"},1,"no","GGCCCATGAATTACTTCCTCACTTTTGCAGTTGATTACTGAAATGTAAATCACAAGAATT","FALSE","NM_020412","ref|NM_020412|ens|ENST00000526991|tc|THC2504138|tc|THC2556231","CHMP1B","charged multivesicular body protein 1B","ref|Homo sapiens charged multivesicular body protein 1B (CHMP1B), mRNA [NM_020412]","chr18",11853778,11854349,"GO:0000910(cytokinesis);GO:0000920(cytokinetic cell separation);GO:0005515(protein binding);GO:0005829(cytosol);GO:0006997(nucleus organization);GO:0007034(vacuolar transport);GO:0007080(mitotic metaphase plate congression);GO:0010824(regulation of centrosome duplication);GO:0015031(protein transport);GO:0019904(protein domain specific binding);GO:0031902(late endosome membrane);GO:0045184(establishment of protein localization);GO:0070062(extracellular vesicular exosome)","04144(Endocytosis)","mRNA","agilent G3 V3"]
["A_23_P144476",4.73,6.65,1.89,3.66,4.82,4.56,{"v":1.01763803680982,"d":"1.02"},{"v":0.0252245011391157,"d":"0.03"},"up",{"v":0.95972,"d":"0.96"},1,"no","CTCAAGTTGATATTTATAGCTGATCAATCTATATGTGTCACAGAACTATGCTGCCTAAAG","FALSE","NM_199327","ref|NM_199327|ref|NM_001258038|ref|NM_005841|ref|NM_001258039","SPRY1","sprouty homolog 1, antagonist of FGF signaling (Drosophila)","ref|Homo sapiens sprouty homolog 1, antagonist of FGF signaling (Drosophila) (SPRY1), transcript variant 2, mRNA [NM_199327]","chr4",124320664,124324910,"GO:0000132(establishment of mitotic spindle orientation);GO:0001656(metanephros development);GO:0001657(ureteric bud development);GO:0001759(organ induction);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0008285(negative regulation of cell proliferation);GO:0034261(negative regulation of Ras GTPase activity);GO:0040037(negative regulation of fibroblast growth factor receptor signaling pathway);GO:0042059(negative regulation of epidermal growth factor receptor signaling pathway);GO:0043407(negative regulation of MAP kinase activity);GO:0046580(negative regulation of Ras protein signal transduction);GO:0051387(negative regulation of nerve growth factor receptor signaling pathway);GO:0060449(bud elongation involved in lung branching);GO:0070373(negative regulation of ERK1 and ERK2 cascade)","04630(Jak-STAT signaling pathway)","mRNA","agilent G3 V3"]
["A_23_P153964",4.93,{"v":6.1,"d":"6.10"},4.07,4.65,3.35,7.31,{"v":0.986283474853037,"d":"0.99"},{"v":-0.0199257332873466,"d":"-0.02"},"down",{"v":0.9598,"d":"0.96"},1,"no","GTGAACTATGCAATTTAAAGGGTTGACCCACACTAGACGAAACTGGACTCGTACGACTCT","FALSE","NM_002193","ref|NM_002193|ens|ENST00000295228|gb|M31682|gb|BC030029","INHBB","inhibin, beta B","ref|Homo sapiens inhibin, beta B (INHBB), mRNA [NM_002193]","chr2",121103720,121109384,"GO:0001541(ovarian follicle development);GO:0005125(cytokine activity);GO:0005160(transforming growth factor beta receptor binding);GO:0005179(hormone activity);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0006952(defense response);GO:0008083(growth factor activity);GO:0009267(cellular response to starvation);GO:0009612(response to mechanical stimulus);GO:0010862(positive regulation of pathway-restricted SMAD protein phosphorylation);GO:0030154(cell differentiation);GO:0032869(cellular response to insulin stimulus);GO:0032924(activin receptor signaling pathway);GO:0040007(growth);GO:0042803(protein homodimerization activity);GO:0042981(regulation of apoptotic process);GO:0043408(regulation of MAPK cascade);GO:0044320(cellular response to leptin stimulus);GO:0045444(fat cell differentiation);GO:0046676(negative regulation of insulin secretion);GO:0046789(host cell surface receptor binding);GO:0046881(positive regulation of follicle-stimulating hormone secretion);GO:0046882(negative regulation of follicle-stimulating hormone secretion);GO:0048178(negative regulation of hepatocyte growth factor biosynthetic process);GO:0048468(cell development);GO:0048471(perinuclear region of cytoplasm);GO:0048599(oocyte development);GO:0060279(positive regulation of ovulation);GO:0060395(SMAD protein signal transduction);GO:2001235(positive regulation of apoptotic signaling pathway)","04350(TGF-beta signaling pathway);04060(Cytokine-cytokine receptor interaction);04550(Signaling pathways regulating pluripotency of stem cells)","mRNA","agilent G3 V3"]
["A_23_P168080",5.07,4.55,5.04,4.77,4.62,5.23,{"v":1.00273597811217,"d":"1.00"},{"v":0.00394179218137433,"d":"0.00"},"up",{"v":0.9599,"d":"0.96"},1,"no","GCGGGTGGCTTGTGCCATGAGCAGCCATGAGTTGCTCCTCACTGAGCTCATGTTTGACAA","FALSE","NM_006929","ref|NM_006929|ens|ENST00000464293|ens|ENST00000466355|ens|ENST00000484510","SKIV2L","superkiller viralicidic activity 2-like (S. cerevisiae)","ref|Homo sapiens superkiller viralicidic activity 2-like (S. cerevisiae) (SKIV2L), mRNA [NM_006929]","chr6",31926948,31937525,"GO:0003723(RNA binding);GO:0004004(ATP-dependent RNA helicase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0008152(metabolic process);GO:0055087(Ski complex)","03018(RNA degradation)","mRNA","agilent G3 V3"]
["A_24_P322741",3.61,6.29,1.89,3.94,3.73,4.34,{"v":0.981681931723564,"d":"0.98"},{"v":-0.0266724327258713,"d":"-0.03"},"down",{"v":0.95992,"d":"0.96"},1,"no","CTTCTGTTTTTCTCCTTTCCATTGTCGGATGAGAATGATGTTTTTGACAAGCTAAGTGTC","FALSE","NM_000628","ref|NM_000628|ens|ENST00000451065|ens|ENST00000493295|ens|ENST00000290200","IL10RB","interleukin 10 receptor, beta","ref|Homo sapiens interleukin 10 receptor, beta (IL10RB), mRNA [NM_000628]","chr21",34648916,34668655,"GO:0004872(receptor activity);GO:0004920(interleukin-10 receptor activity);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0006954(inflammatory response);GO:0006955(immune response);GO:0007165(signal transduction);GO:0016021(integral to membrane);GO:0019221(cytokine-mediated signaling pathway);GO:0032002(interleukin-28 receptor complex);GO:0051607(defense response to virus);GO:0070062(extracellular vesicular exosome)","04630(Jak-STAT signaling pathway);04060(Cytokine-cytokine receptor interaction);05152(Tuberculosis);05169(Epstein-Barr virus infection);05145(Toxoplasmosis)","mRNA","agilent G3 V3"]
["A_23_P106661",4.47,{"v":3.5,"d":"3.50"},{"v":5.1,"d":"5.10"},3.96,4.43,{"v":4.6,"d":"4.60"},{"v":1.00615858352579,"d":"1.01"},{"v":0.00885771034755221,"d":"0.01"},"up",{"v":0.96028,"d":"0.96"},1,"no","TCGCATGCTGTCACCCATTCCAGCCTAAATGTGACCATAAAATTAGGGCTGCTGCTTTTA","FALSE","NM_052999","ref|NM_052999|ref|NM_001204099|ref|NM_001204098|ref|NM_001202509","CMTM1","CKLF-like MARVEL transmembrane domain containing 1","ref|Homo sapiens CKLF-like MARVEL transmembrane domain containing 1 (CMTM1), transcript variant 17, mRNA [NM_052999]","chr16",66600648,66613038,"GO:0005125(cytokine activity);GO:0005615(extracellular space);GO:0006935(chemotaxis);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P160154",5.26,2.52,4.65,4.08,4.32,4.17,{"v":0.988862370723946,"d":"0.99"},{"v":-0.0161583533680228,"d":"-0.02"},"down",{"v":0.96044,"d":"0.96"},1,"no","CATGCCTCTGGCTGCATTGGTGAGGATCCCCAGGGCATACCCAACAACCTCATGCCTTAT","FALSE","NM_000403","ref|NM_000403|ref|NM_001127621|ref|NM_001008216|ens|ENST00000418277","GALE","UDP-galactose-4-epimerase","ref|Homo sapiens UDP-galactose-4-epimerase (GALE), transcript variant 1, mRNA [NM_000403]","chr1",24124186,24125926,"GO:0003974(UDP-N-acetylglucosamine 4-epimerase activity);GO:0003978(UDP-glucose 4-epimerase activity);GO:0005829(cytosol);GO:0005975(carbohydrate metabolic process);GO:0009405(pathogenesis);GO:0019388(galactose catabolic process);GO:0042803(protein homodimerization activity);GO:0044281(small molecule metabolic process);GO:0050662(coenzyme binding);GO:0070062(extracellular vesicular exosome)","00052(Galactose metabolism);00520(Amino sugar and nucleotide sugar metabolism)","mRNA","agilent G3 V3"]
["A_33_P3381899",7.76,7.62,7.74,{"v":7.8,"d":"7.80"},7.65,7.68,{"v":0.99956766104626,"d":"1.00"},{"v":-0.000623868135511811,"d":"-0.00"},"down",{"v":0.96054,"d":"0.96"},1,"no","TGTTCCCATCCCATGTCCCTGTGGGTAGTGACTGTCTCGTTTCTGTCATGGTGGTGCGTC","FALSE","NM_004209","ref|NM_004209|ens|ENST00000618464|ens|ENST00000248121|gb|AJ002309","SYNGR3","synaptogyrin 3","ref|Homo sapiens synaptogyrin 3 (SYNGR3), mRNA [NM_004209]","chr16",{"v":2042464,"d":"2042464.00"},2043299,"GO:0008021(synaptic vesicle);GO:0016021(integral to membrane);GO:0021762(substantia nigra development);GO:0030054(cell junction);GO:0030672(synaptic vesicle membrane);GO:0031594(neuromuscular junction);GO:0032411(positive regulation of transporter activity);GO:0042169(SH2 domain binding);GO:0047485(protein N-terminus binding)",null,"mRNA","agilent G3 V3"]
["A_21_P0014771",{"v":2.3,"d":"2.30"},5.61,4.15,3.26,4.48,4.16,{"v":1.01344537815126,"d":"1.01"},{"v":0.0192683337047789,"d":"0.02"},"up",{"v":0.961,"d":"0.96"},1,"no","GCACTCATCTTTTACATGGTTAAATGCATTTCCTAATTTGAGATCACCTAAACACTGGAA","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_23_P81463",5.74,4.73,{"v":5.6,"d":"5.60"},5.23,5.42,5.37,{"v":1.00312109862672,"d":"1.00"},{"v":0.00449578126638383,"d":"0.00"},"up",{"v":0.96108,"d":"0.96"},1,"no","ATAAGGTATGCCAGAGTGTATTTGAGAGAAACTACCCTAATAACCCCTTTTCCAGTTTTA","FALSE","NM_019030","ref|NM_019030|ens|ENST00000504778|ens|ENST00000621106|ens|ENST00000251636","DHX29","DEAH (Asp-Glu-Ala-His) box polypeptide 29","ref|Homo sapiens DEAH (Asp-Glu-Ala-His) box polypeptide 29 (DHX29), mRNA [NM_019030]","chr5",54552076,54603522,"GO:0003743(translation initiation factor activity);GO:0004004(ATP-dependent RNA helicase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005739(mitochondrion);GO:0006396(RNA processing);GO:0006413(translational initiation);GO:0016282(eukaryotic 43S preinitiation complex);GO:0043024(ribosomal small subunit binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3229122",4.94,6.16,4.53,5.31,4.87,5.37,{"v":1.00514469453376,"d":"1.01"},{"v":0.00740319798169926,"d":"0.01"},"up",{"v":0.96114,"d":"0.96"},1,"no","ACCAGCTCTAAGTAATTCTAACGTCTTCATACCCAATCCCAAAGGCTCTTTTAAGAGCCA","FALSE","NM_003522","ref|NM_003522|gb|BC096120|gb|BC096123|gb|BC056264","HIST1H2BF","histone cluster 1, H2bf","ref|Homo sapiens histone cluster 1, H2bf (HIST1H2BF), mRNA [NM_003522]","chr6",26199748,26200942,"GO:0000786(nucleosome);GO:0002227(innate immune response in mucosa);GO:0003677(DNA binding);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006325(chromatin organization);GO:0006334(nucleosome assembly);GO:0019731(antibacterial humoral response);GO:0046982(protein heterodimerization activity);GO:0050830(defense response to Gram-positive bacterium);GO:0070062(extracellular vesicular exosome)","05203(Viral carcinogenesis);05322(Systemic lupus erythematosus);05034(Alcoholism)","mRNA","agilent G3 V3"]
["A_24_P75190",7.19,7.62,9.78,7.15,{"v":8.7,"d":"8.70"},8.89,{"v":0.993936944219887,"d":"0.99"},{"v":-0.00877376538028745,"d":"-0.01"},"down",{"v":0.96146,"d":"0.96"},1,"no","TGATGGCCTGGCTCACCTGGACAACCTCAAGGGCACTTTTTCTCAGCTGAGTGAGCTGCA","FALSE","NM_000519","ref|NM_000519|ens|ENST00000429817|ens|ENST00000380299|gb|HQ448433","HBD","hemoglobin, delta","ref|Homo sapiens hemoglobin, delta (HBD), mRNA [NM_000519]","chr11",{"v":5255223,"d":"5255223.00"},5256600,"GO:0005344(oxygen transporter activity);GO:0005506(iron ion binding);GO:0005829(cytosol);GO:0005833(hemoglobin complex);GO:0007596(blood coagulation);GO:0015671(oxygen transport);GO:0019825(oxygen binding);GO:0020037(heme binding);GO:0072562(blood microparticle)",null,"mRNA","agilent G3 V3"]
["A_33_P3332126",6.29,3.85,7.05,6.47,5.33,5.23,{"v":1.0093951849677,"d":"1.01"},{"v":0.0134911097995187,"d":"0.01"},"up",{"v":0.9617,"d":"0.96"},1,"no","ACCCCAATGATTGCTGGCCTTGGGAAGGTGAGCCCTGGTGAGCTTGAGGAGATGAGTTGA","FALSE","ENST00000409736","ens|ENST00000409736|ens|ENST00000497951|gb|AK127520|gb|AF175767","SCLY","selenocysteine lyase","ens|selenocysteine lyase [Source:HGNC Symbol;Acc:HGNC:18161] [ENST00000409736]","chr2",238969632,238999928,"GO:0005829(cytosol);GO:0006520(cellular amino acid metabolic process);GO:0009000(selenocysteine lyase activity);GO:0016740(transferase activity);GO:0030170(pyridoxal phosphate binding)","00450(Selenocompound metabolism)","mRNA","agilent G3 V3"]
["A_33_P3361417",2.01,5.33,3.41,3.26,3.35,3.99,{"v":1.01415094339623,"d":"1.01"},{"v":0.020272395026261,"d":"0.02"},"up",{"v":0.96212,"d":"0.96"},1,"no","GAGATTGGGAACGAAAAGGACGCTGTATTGATTTTTAAGTCGCATATTCTTTAACTTCAA","FALSE","NM_145267","ref|NM_145267|ens|ENST00000370474|gb|BC104649|gb|BC018085","C6orf57","chromosome 6 open reading frame 57","ref|Homo sapiens chromosome 6 open reading frame 57 (C6orf57), mRNA [NM_145267]","chr6",71276624,71299272,"GO:0005759(mitochondrial matrix);GO:0045087(innate immune response)",null,"mRNA","agilent G3 V3"]
["A_33_P3245908",{"v":5,"d":"5.00"},4.43,4.17,4.72,4.38,4.54,{"v":0.997067448680352,"d":"1.00"},{"v":-0.00423699288647087,"d":"-0.00"},"down",{"v":0.96214,"d":"0.96"},1,"no","CACAGGTGATTGAGCTGTAGGTGAGCAGTGACGTGAAGAGGGGTTCTAGCCCCGTGGAAA","FALSE","NM_001288743","ref|NM_001288743|ref|NM_001288742|ref|NM_001288740|ref|NM_001010863","C10orf128","chromosome 10 open reading frame 128","ref|Homo sapiens chromosome 10 open reading frame 128 (C10orf128), transcript variant 5, mRNA [NM_001288743]","chr10",50364236,50396424,"GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3409337",4.68,2.02,4.15,3.49,3.68,3.55,{"v":1.01212686567164,"d":"1.01"},{"v":0.0173901368740692,"d":"0.02"},"up",{"v":0.96242,"d":"0.96"},1,"no","ATATCAGACTCTTCTGGTGAAGTGGTGCTACCCACTATTCCAAAAGAACCTCAGGAGTCT","FALSE","NM_025057","ref|NM_025057|ens|ENST00000492247|ens|ENST00000492026|ens|ENST00000394009","CCDC176","coiled-coil domain containing 176","ref|Homo sapiens coiled-coil domain containing 176 (CCDC176), mRNA [NM_025057]","chr14",74498496,74549566,"GO:0005737(cytoplasm);GO:0036064(cilium basal body);GO:0044458(motile cilium assembly)",null,"mRNA","agilent G3 V3"]
["A_23_P45488",6.75,5.24,6.83,7.03,6.16,5.53,{"v":1.00534188034188,"d":"1.01"},{"v":0.00768619314513221,"d":"0.01"},"up",{"v":0.96302,"d":"0.96"},1,"no","GTGCAGAACAAGAGCCCCTTTGAGCAGCACGTGAAGAACAGTAAGCACAGCAACAAGTAC","FALSE","NM_021806","ref|NM_021806|ref|NM_001282311|ref|NM_001171134|ref|NM_001171132","FAM3A","family with sequence similarity 3, member A","ref|Homo sapiens family with sequence similarity 3, member A (FAM3A), transcript variant 1, mRNA [NM_021806]","chrHG1497_PATCH",153673488,153684710,"GO:0003674(molecular_function);GO:0005575(cellular_component);GO:0005576(extracellular region);GO:0008150(biological_process)",null,"mRNA","agilent G3 V3"]
["A_24_P348203",5.23,5.26,5.11,5.16,4.89,5.58,{"v":0.998080614203455,"d":"1.00"},{"v":-0.00277174925005364,"d":"-0.00"},"down",{"v":0.9636,"d":"0.96"},1,"no","ATGGAGGGATTAACTCAGTCATGGCATTCTCCGACCAAAACCACACCTGTGTCTCTGGCA","FALSE","NM_025061","ref|NM_025061|ref|NM_001268284|ref|NM_001268285|ens|ENST00000306708","LRRC8E","leucine rich repeat containing 8 family, member E","ref|Homo sapiens leucine rich repeat containing 8 family, member E (LRRC8E), transcript variant 1, mRNA [NM_025061]","chr19",{"v":7953390,"d":"7953390.00"},7966901,"GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0006811(ion transport);GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_33_P3294017",5.36,6.32,3.79,4.76,5.32,5.28,{"v":1.00716145833333,"d":"1.01"},{"v":0.0102949807278794,"d":"0.01"},"up",{"v":0.9638,"d":"0.96"},1,"no","CCACAATCTGCAGATGTTCAAGTCCCTTACATAAAATGGCATAGTATTTATATGTAACCT","FALSE","NM_031314","ref|NM_031314|ref|NM_001077442|ref|NM_004500|ref|NM_001077443","HNRNPC","heterogeneous nuclear ribonucleoprotein C (C1/C2)","ref|Homo sapiens heterogeneous nuclear ribonucleoprotein C (C1/C2) (HNRNPC), transcript variant 1, mRNA [NM_031314]","chr14",21677296,21737638,"GO:0000166(nucleotide binding);GO:0000398(nuclear mRNA splicing, via spliceosome);GO:0000790(nuclear chromatin);GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0000980(RNA polymerase II distal enhancer sequence-specific DNA binding);GO:0001649(osteoblast differentiation);GO:0003723(RNA binding);GO:0003730(mRNA 3'-UTR binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005681(spliceosomal complex);GO:0005829(cytosol);GO:0008266(poly(U) RNA binding);GO:0008380(RNA splicing);GO:0010467(gene expression);GO:0016020(membrane);GO:0031492(nucleosomal DNA binding);GO:0042802(identical protein binding);GO:0043044(ATP-dependent chromatin remodeling);GO:0043234(protein complex);GO:0070062(extracellular vesicular exosome);GO:0070935(3'-UTR-mediated mRNA stabilization);GO:0071013(catalytic step 2 spliceosome)","03040(Spliceosome)","mRNA","agilent G3 V3"]
["A_32_P198303",2.26,4.55,4.25,{"v":3.7,"d":"3.70"},3.67,{"v":3.8,"d":"3.80"},{"v":0.990152193375112,"d":"0.99"},{"v":-0.0142778002486079,"d":"-0.01"},"down",{"v":0.964,"d":"0.96"},1,"no","AATCAAGTCAAAAGAATAAATGCTTACTAATCATCAGAAAATCTGTGGCCATTAGGGCTG","FALSE","NM_181706","ref|NM_181706|ens|ENST00000536040|gb|BC044931|gb|AL050199","DNAJC24","DnaJ (Hsp40) homolog, subfamily C, member 24","ref|Homo sapiens DnaJ (Hsp40) homolog, subfamily C, member 24 (DNAJC24), mRNA [NM_181706]","chr11",31391388,31453396,"GO:0001671(ATPase activator activity);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0008198(ferrous iron binding);GO:0008270(zinc ion binding);GO:0017183(peptidyl-diphthamide biosynthetic process from peptidyl-histidine);GO:0032781(positive regulation of ATPase activity);GO:0055114(oxidation-reduction process);GO:0061077(chaperone-mediated protein folding)",null,"mRNA","agilent G3 V3"]
["A_23_P102000",4.06,{"v":4.5,"d":"4.50"},5.77,4.99,5.21,4.04,{"v":1.0063202247191,"d":"1.01"},{"v":0.00908946329574803,"d":"0.01"},"up",{"v":0.96406,"d":"0.96"},1,"no","TGCTGGTTTTTCAGTTTTCAGGAGTGGGTTGATTTCAGCACCTACAGTGTACAGTCTTGT","FALSE","NM_001008540","ref|NM_001008540|ref|NM_003467|ens|ENST00000241393|ens|ENST00000409817","CXCR4","chemokine (C-X-C motif) receptor 4","ref|Homo sapiens chemokine (C-X-C motif) receptor 4 (CXCR4), transcript variant 1, mRNA [NM_001008540]","chr2",136872208,136875307,"GO:0000187(activation of MAPK activity);GO:0001569(patterning of blood vessels);GO:0001618(viral receptor activity);GO:0001666(response to hypoxia);GO:0001667(ameboidal cell migration);GO:0001764(neuron migration);GO:0002407(dendritic cell chemotaxis);GO:0003779(actin binding);GO:0004930(G-protein coupled receptor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0005769(early endosome);GO:0005770(late endosome);GO:0005886(plasma membrane);GO:0005911(cell-cell junction);GO:0006915(apoptotic process);GO:0006954(inflammatory response);GO:0007186(G-protein coupled receptor signaling pathway);GO:0007204(elevation of cytosolic calcium ion concentration);GO:0007281(germ cell development);GO:0007420(brain development);GO:0008045(motor axon guidance);GO:0008354(germ cell migration);GO:0009615(response to virus);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0015026(coreceptor activity);GO:0016021(integral to membrane);GO:0016023(cytoplasmic membrane-bounded vesicle);GO:0016032(viral reproduction);GO:0016494(C-X-C chemokine receptor activity);GO:0019722(calcium-mediated signaling);GO:0019955(cytokine binding);GO:0030260(entry into host cell);GO:0030334(regulation of cell migration);GO:0030426(growth cone);GO:0031252(cell leading edge);GO:0031410(cytoplasmic vesicle);GO:0031625(ubiquitin protein ligase binding);GO:0032027(myosin light chain binding);GO:0042098(T cell proliferation);GO:0042119(neutrophil activation);GO:0043130(ubiquitin binding);GO:0043217(myelin maintenance);GO:0048714(positive regulation of oligodendrocyte differentiation);GO:0050920(regulation of chemotaxis);GO:0061351(neural precursor cell proliferation);GO:0070062(extracellular vesicular exosome);GO:0070098(chemokine-mediated signaling pathway);GO:0071345(cellular response to cytokine stimulus)","04060(Cytokine-cytokine receptor interaction);04144(Endocytosis);04670(Leukocyte transendothelial migration);04672(Intestinal immune network for IgA production);04062(Chemokine signaling pathway);04360(Axon guidance);05200(Pathways in cancer)","mRNA","agilent G3 V3"]
["A_33_P3334673",3.71,5.22,2.07,{"v":3.5,"d":"3.50"},3.92,3.72,{"v":0.987432675044883,"d":"0.99"},{"v":-0.0182457089280098,"d":"-0.02"},"down",{"v":0.96406,"d":"0.96"},1,"no","AAATGGAAACAATCTATTACATATTGCGGCGTCACAGGGACACGCAGAGTGTCTACAGCA","FALSE","NM_005460","ref|NM_005460|ens|ENST00000395466|ens|ENST00000510003|ens|ENST00000504884","SNCAIP","synuclein, alpha interacting protein","ref|Homo sapiens synuclein, alpha interacting protein (SNCAIP), transcript variant 1, mRNA [NM_005460]","chr5",121726832,121787299,"GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0008021(synaptic vesicle);GO:0031625(ubiquitin protein ligase binding);GO:0042417(dopamine metabolic process);GO:0042734(presynaptic membrane);GO:0042802(identical protein binding);GO:0043025(neuronal cell body);GO:0046928(regulation of neurotransmitter secretion);GO:0090083(regulation of inclusion body assembly)","05012(Parkinson's disease)","mRNA","agilent G3 V3"]
["A_23_P67702",8.89,6.84,3.92,6.76,6.64,6.47,{"v":0.988928032209361,"d":"0.99"},{"v":-0.0160625601037013,"d":"-0.02"},"down",{"v":0.96412,"d":"0.96"},1,"no","TGCACACCTTACCACACATGAGGTAATTCATACTGGAGAGAAACCCTACAAATGTGAAAA","FALSE","NM_003429","ref|NM_003429|ref|NM_001256171|ref|NM_001256173|ens|ENST00000612293","ZNF85","zinc finger protein 85","ref|Homo sapiens zinc finger protein 85 (ZNF85), transcript variant 1, mRNA [NM_003429]","chr19",21119470,21133503,"GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0003714(transcription corepressor activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3305418",8.29,7.89,8.22,8.02,8.25,8.15,{"v":0.999180999180999,"d":"1.00"},{"v":-0.00118205253715485,"d":"-0.00"},"down",{"v":0.96434,"d":"0.96"},1,"no","AAGCTGCTGGCTTGAGTCGCCCCGTTATGAATGTGTGTGGGTCTGTGCCCCTTTCATGTG","FALSE","AK127935","gb|AK127935|tc|THC2488043",null,null,"gb|Homo sapiens cDNA FLJ46044 fis, clone STOMA2003894. [AK127935]","chr10",126226008,126228304,null,null,"mRNA","agilent G3 V3"]
["A_33_P3375435",5.12,3.04,4.42,4.93,3.88,3.87,{"v":0.99211356466877,"d":"0.99"},{"v":-0.011422823260118,"d":"-0.01"},"down",{"v":0.96456,"d":"0.96"},1,"no","GAAAAACAGTGGACCCAAAGATGAAAAGAAAAAGAAGCGGCATCTGCAGGATCTCCAGCT","FALSE","NM_133447","ref|NM_133447|ref|NM_014753|ref|NR_033857|ref|NR_026592","AGAP11","ankyrin repeat and GTPase domain Arf GTPase activating protein 11","ref|Homo sapiens ankyrin repeat and GTPase domain Arf GTPase activating protein 11 (AGAP11), mRNA [NM_133447]","chr10",81664656,81691557,"GO:0008060(ARF GTPase activator activity);GO:0008270(zinc ion binding);GO:0032312(regulation of ARF GTPase activity);GO:0043547(positive regulation of GTPase activity)",null,"mRNA","agilent G3 V3"]
["A_21_P0014481",{"v":4.2,"d":"4.20"},2.42,4.94,3.39,{"v":3.9,"d":"3.90"},4.16,{"v":1.00960698689956,"d":"1.01"},{"v":0.0137937995163723,"d":"0.01"},"up",{"v":0.96482,"d":"0.96"},1,"no","TAGATCCTTCCCAAGGCTCTGACTTCAATACTTTCAGTGCCTTGTCAATTATACCCCTTG","FALSE","BC128230","gb|BC128230|gb|BC141932",null,null,"gb|Homo sapiens cDNA clone IMAGE:40114634. [BC128230]","chr3",{"v":3842004,"d":"3842004.00"},3842672,null,null,"mRNA","agilent G3 V3"]
["A_23_P252155",6.84,6.63,6.59,{"v":6.7,"d":"6.70"},6.88,6.46,{"v":1.00099800399202,"d":"1.00"},{"v":0.00143909741697214,"d":"0.00"},"up",{"v":0.96536,"d":"0.97"},1,"no","CCAACATATCCTGTTCCCCACTACTCATTCTTTTAGCAAATGACAGAAGCTAATTCCTAT","FALSE","NM_018387","ref|NM_018387|ref|NM_001171137|ref|NR_033234|ens|ENST00000407982","STRBP","spermatid perinuclear RNA binding protein","ref|Homo sapiens spermatid perinuclear RNA binding protein (STRBP), transcript variant 1, mRNA [NM_018387]","chr9",125883912,126030855,"GO:0003677(DNA binding);GO:0003725(double-stranded RNA binding);GO:0003727(single-stranded RNA binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006928(cellular component movement);GO:0007275(multicellular organismal development);GO:0007286(spermatid development);GO:0007638(mechanosensory behavior);GO:0015630(microtubule cytoskeleton)",null,"mRNA","agilent G3 V3"]
["A_23_P165788",3.75,{"v":2.7,"d":"2.70"},4.16,3.44,3.54,3.69,{"v":0.994376757263355,"d":"0.99"},{"v":-0.00813551990966019,"d":"-0.01"},"down",{"v":0.96598,"d":"0.97"},1,"no","ATGATGATGTTGCCATGCCACGGAAAGGATATACCTTACAGAAAACTCTTTCCAGAATGT","FALSE","NM_001008489","ref|NM_001008489|ref|NM_001199286|ref|NM_001199287|ref|NM_001199288","PHOSPHO2","phosphatase, orphan 2","ref|Homo sapiens phosphatase, orphan 2 (PHOSPHO2), transcript variant 2, mRNA [NM_001008489]","chr2",170550992,170557628,"GO:0016311(dephosphorylation);GO:0016791(phosphatase activity);GO:0033883(pyridoxal phosphatase activity);GO:0046872(metal ion binding)","00750(Vitamin B6 metabolism)","mRNA","agilent G3 V3"]
["A_24_P269129",4.84,3.73,5.85,4.53,4.65,5.33,{"v":0.993797381116471,"d":"0.99"},{"v":-0.00897635482592192,"d":"-0.01"},"down",{"v":0.96598,"d":"0.97"},1,"no","CTCTCAGGATTCCACACCTACTTGATCAGCTCCAACCAGACAACAAATGAGGACATTAAA","FALSE","NM_153746","ref|NM_153746|ref|NM_024630|ens|ENST00000518214|ens|ENST00000517432","ZDHHC14","zinc finger, DHHC-type containing 14","ref|Homo sapiens zinc finger, DHHC-type containing 14 (ZDHHC14), transcript variant 2, mRNA [NM_153746]","chr6",157802160,158094977,"GO:0005783(endoplasmic reticulum);GO:0008270(zinc ion binding);GO:0016021(integral to membrane);GO:0016409(palmitoyltransferase activity);GO:0018345(protein palmitoylation);GO:0019706(protein-cysteine S-palmitoleyltransferase activity)",null,"mRNA","agilent G3 V3"]
["A_32_P225816",2.55,4.56,{"v":4.8,"d":"4.80"},3.23,3.35,{"v":5.2,"d":"5.20"},{"v":1.01103565365025,"d":"1.01"},{"v":0.015833874033653,"d":"0.02"},"up",{"v":0.96604,"d":"0.97"},1,"no","CTAGGAGAAGCCGATTTGGAGGTTAATGCTGTAGAATAGGACTGTATACCAAATGTAATC","FALSE","NM_022114","ref|NM_022114|ref|NM_199454|ens|ENST00000270722|ref|XM_005244772","PRDM16","PR domain containing 16","ref|Homo sapiens PR domain containing 16 (PRDM16), transcript variant 1, mRNA [NM_022114]","chr1",{"v":2985742,"d":"2985742.00"},3355183,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0017053(transcriptional repressor complex);GO:0022008(neurogenesis);GO:0030512(negative regulation of transforming growth factor beta receptor signaling pathway);GO:0030853(negative regulation of granulocyte differentiation);GO:0035019(somatic stem cell maintenance);GO:0043457(regulation of cellular respiration);GO:0043565(sequence-specific DNA binding);GO:0043586(tongue development);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0046332(SMAD binding);GO:0046872(metal ion binding);GO:0050872(white fat cell differentiation);GO:0050873(brown fat cell differentiation);GO:0060021(palate development)",null,"mRNA","agilent G3 V3"]
["A_21_P0000507",6.99,8.24,8.05,7.51,{"v":8.2,"d":"8.20"},7.63,{"v":0.997429305912596,"d":"1.00"},{"v":-0.00371350279906413,"d":"-0.00"},"down",{"v":0.96618,"d":"0.97"},1,"no","GTAGGCGAGGGTTCGAGGGCACGAGTTCGAGGCCAACCTGGTCCACATGGGTTGAAAAAA","FALSE","NR_024230","ref|NR_024230|ref|NR_024231|ref|NR_024221|ref|NR_024218","SNAR-B2","small ILF3/NF90-associated RNA B2","ref|Homo sapiens small ILF3/NF90-associated RNA B2 (SNAR-B2), small nuclear RNA [NR_024230]","chr19",50642376,50642494,null,null,"mRNA","agilent G3 V3"]
["A_23_P94103",7.93,9.67,6.97,8.08,7.61,{"v":9,"d":"9.00"},{"v":0.995139732685298,"d":"1.00"},{"v":-0.00702897878061711,"d":"-0.01"},"down",{"v":0.96628,"d":"0.97"},1,"no","CAATATGCTTGCCACTCCTTAAATGTCCTAATGATGAGAAACTCTCTTTCTGACCAATTG","FALSE","NM_173833","ref|NM_173833|ens|ENST00000380385|ens|ENST00000354914|gb|AY358150","SCARA5","scavenger receptor class A, member 5","ref|Homo sapiens scavenger receptor class A, member 5 (SCARA5), mRNA [NM_173833]","chr8",27727752,27850181,"GO:0005044(scavenger receptor activity);GO:0005887(integral to plasma membrane);GO:0006879(cellular iron ion homeostasis);GO:0006897(endocytosis);GO:0006898(receptor-mediated endocytosis);GO:0009986(cell surface);GO:0010468(regulation of gene expression);GO:0030193(regulation of blood coagulation);GO:0034605(cellular response to heat);GO:0034755(iron ion transmembrane transport);GO:0070207(protein homotrimerization);GO:0070287(ferritin receptor activity)",null,"mRNA","agilent G3 V3"]
["A_33_P3510335",6.55,6.46,6.34,6.35,6.27,6.71,{"v":1.00103466114847,"d":"1.00"},{"v":0.00149192882053701,"d":"0.00"},"up",{"v":0.96632,"d":"0.97"},1,"no","AATGCCCTTTATCCATCTGCCTCAGACAGTGTTACAAGAATCCCCACTTTTCTTCTGTTT","FALSE","NM_213655","ref|NM_213655|ref|NM_001184985|ens|ENST00000574564|ens|ENST00000340908","WNK1","WNK lysine deficient protein kinase 1","ref|Homo sapiens WNK lysine deficient protein kinase 1 (WNK1), transcript variant 3, mRNA [NM_213655]","chr12",{"v":862732,"d":"862732.00"},1017958,"GO:0004674(protein serine/threonine kinase activity);GO:0004860(protein kinase inhibitor activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0006469(negative regulation of protein kinase activity);GO:0006811(ion transport);GO:0010923(negative regulation of phosphatase activity);GO:0018107(peptidyl-threonine phosphorylation);GO:0019869(chloride channel inhibitor activity);GO:0019902(phosphatase binding);GO:0035556(intracellular signal transduction);GO:0048666(neuron development);GO:0050794(regulation of cellular process)",null,"mRNA","agilent G3 V3"]
["A_22_P00011215",{"v":6.6,"d":"6.60"},5.67,6.13,6.39,6.11,5.94,{"v":0.997830802603037,"d":"1.00"},{"v":-0.0031328894849627,"d":"-0.00"},"down",{"v":0.96654,"d":"0.97"},1,"no","AGCGCGGCCCGGCCTTCTGCGGCCTGTACGACACGTCCTCGCTGCTGCGATACTGCAACG","FALSE","NM_001193268","ref|NM_001193268|ens|ENST00000592901|ens|ENST00000585386|ens|ENST00000587152","EML2","echinoderm microtubule associated protein like 2","ref|Homo sapiens echinoderm microtubule associated protein like 2 (EML2), transcript variant 1, mRNA [NM_001193268]","chr19",46112656,46148887,"GO:0005102(receptor binding);GO:0005737(cytoplasm);GO:0005874(microtubule);GO:0005875(microtubule associated complex);GO:0007601(visual perception);GO:0007605(sensory perception of sound);GO:0008017(microtubule binding);GO:0008022(protein C-terminus binding);GO:0010968(regulation of microtubule nucleation);GO:0015631(tubulin binding);GO:0031115(negative regulation of microtubule polymerization);GO:0072686(mitotic spindle)",null,"mRNA","agilent G3 V3"]
["A_33_P3221761",11.24,11.08,11.36,11.72,{"v":11.2,"d":"11.20"},10.72,{"v":1.00118906064209,"d":"1.00"},{"v":0.0017144328112519,"d":"0.00"},"up",{"v":0.96668,"d":"0.97"},1,"no","CACCGTGGCCCCCAAAAGCACCACCTTCCTGAAGAATATCCGGCAGTTTATTATGCCTGT","FALSE","NM_014727","ref|NM_014727|ens|ENST00000420124|ref|XM_006723513|gb|AF186605","KMT2B","lysine (K)-specific methyltransferase 2B","ref|Homo sapiens lysine (K)-specific methyltransferase 2B (KMT2B), mRNA [NM_014727]","chr19",36208920,36212431,"GO:0001541(ovarian follicle development);GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006325(chromatin organization);GO:0006351(transcription, DNA-dependent);GO:0008270(zinc ion binding);GO:0009994(oocyte differentiation);GO:0016458(gene silencing);GO:0030728(ovulation);GO:0035097(histone methyltransferase complex);GO:0042800(histone methyltransferase activity (H3-K4 specific));GO:0048096(chromatin-mediated maintenance of transcription);GO:0051568(histone H3-K4 methylation);GO:0051569(regulation of histone H3-K4 methylation);GO:0080182(histone H3-K4 trimethylation)","00310(Lysine degradation)","mRNA","agilent G3 V3"]
["A_32_P213624",3.21,3.87,6.86,4.83,4.31,4.64,{"v":1.01161103047895,"d":"1.01"},{"v":0.0166546731641317,"d":"0.02"},"up",{"v":0.96674,"d":"0.97"},1,"no","TGGAAGCCAAACAATTAAGAGAAGTAAAATTTTAACCCTAGTAGGTTTCGCAGATTCATC","FALSE","NM_001130841","ref|NM_001130841|ref|NM_003729|ens|ENST00000370128|ref|XM_005271298","RTCA","RNA 3'-terminal phosphate cyclase","ref|Homo sapiens RNA 3'-terminal phosphate cyclase (RTCA), transcript variant 1, mRNA [NM_001130841]","chr1",100731760,100758325,"GO:0003723(RNA binding);GO:0003963(RNA-3'-phosphate cyclase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006396(RNA processing)",null,"mRNA","agilent G3 V3"]
["A_33_P3386288",4.13,{"v":2.3,"d":"2.30"},3.85,2.94,3.53,3.73,{"v":1.0078431372549,"d":"1.01"},{"v":0.0112711123350198,"d":"0.01"},"up",{"v":0.96758,"d":"0.97"},1,"no","TACATACTCATTGTAACCACTCCGAAAAGTGCTGCTTGATGCTGCGTGCTCTTTCTGTGT","FALSE","NM_024906","ref|NM_024906|ens|ENST00000273908|gb|AK024685|tc|NP331588","SCD5","stearoyl-CoA desaturase 5","ref|Homo sapiens stearoyl-CoA desaturase 5 (SCD5), transcript variant 2, mRNA [NM_024906]","chr4",83581040,83719925,"GO:0004768(stearoyl-CoA 9-desaturase activity);GO:0005506(iron ion binding);GO:0005789(endoplasmic reticulum membrane);GO:0006633(fatty acid biosynthetic process);GO:0016021(integral to membrane);GO:0055114(oxidation-reduction process)","01212(Fatty acid metabolism);01040(Biosynthesis of unsaturated fatty acids);04152(AMPK signaling pathway);03320(PPAR signaling pathway)","mRNA","agilent G3 V3"]
["A_21_P0013825",11.48,11.33,11.29,11.26,11.42,11.41,{"v":1.00029334115576,"d":"1.00"},{"v":0.000423139771588584,"d":"0.00"},"up",{"v":0.9678,"d":"0.97"},1,"no","ACATCTTCTACAGCTGAAGCCACAGGTTTAAAAGGAAGTTCTCCTACTCCCCCTTGTTCT","FALSE","NM_001164380","ref|NM_001164380|ref|NM_001164381|ref|NM_001164383|ref|NM_001164382","STAU2","staufen double-stranded RNA binding protein 2","ref|Homo sapiens staufen double-stranded RNA binding protein 2 (STAU2), transcript variant 1, mRNA [NM_001164380]","chr8",74332600,74659162,"GO:0003725(double-stranded RNA binding);GO:0005515(protein binding);GO:0005730(nucleolus);GO:0005783(endoplasmic reticulum);GO:0005874(microtubule);GO:0006810(transport);GO:0016020(membrane)",null,"mRNA","agilent G3 V3"]
["A_21_P0012220",5.27,4.56,5.03,4.52,5.09,5.29,{"v":0.997315436241611,"d":"1.00"},{"v":-0.00387821481092762,"d":"-0.00"},"down",{"v":0.96786,"d":"0.97"},1,"no","ATGGCAATTGAAGGACCTCCTGCAAAACATCCTTCCTTGAAGCCTAGCACTGAAATGGAA","FALSE","ENST00000429521","ens|ENST00000429521|ens|ENST00000432875|linc|TCONS_l2_00017424|linc|TCONS_l2_00017423","ANKRD20A11P","ankyrin repeat domain 20 family, member A11, pseudogene","ens|ankyrin repeat domain 20 family, member A11, pseudogene [Source:HGNC Symbol;Acc:HGNC:42024] [ENST00000429521]","chr21",15316065,15344450,null,null,"mRNA","agilent G3 V3"]
["A_23_P148984",1.86,5.58,1.87,2.76,3.12,3.59,{"v":0.983104540654699,"d":"0.98"},{"v":-0.0245832579095914,"d":"-0.02"},"down",{"v":0.9683,"d":"0.97"},1,"no","TAGTGTTTTCAAATCATGTTTCTCATACCCAGATAGTAGATTATTCACTTAGGACAGAGG","FALSE","NM_018122","ref|NM_018122|ens|ENST00000361951|ref|XM_005245299|ref|XM_006711426","DARS2","aspartyl-tRNA synthetase 2, mitochondrial","ref|Homo sapiens aspartyl-tRNA synthetase 2, mitochondrial (DARS2), mRNA [NM_018122]","chr1",173793792,173827682,"GO:0000049(tRNA binding);GO:0004815(aspartate-tRNA ligase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0006418(tRNA aminoacylation for protein translation);GO:0010467(gene expression);GO:0042803(protein homodimerization activity);GO:0043039(tRNA aminoacylation);GO:0050560(aspartate-tRNA(Asn) ligase activity);GO:0070145(mitochondrial asparaginyl-tRNA aminoacylation)","00970(Aminoacyl-tRNA biosynthesis)","mRNA","agilent G3 V3"]
["A_23_P79015",2.16,2.15,8.62,3.99,4.27,4.38,{"v":1.02294303797468,"d":"1.02"},{"v":0.0327258116331514,"d":"0.03"},"up",{"v":0.96834,"d":"0.97"},1,"no","GAGGAGTTTGTCAAGATCCTGCGCTATGAGAATGAGGTGTTGCAGCTGGAGGAGGATGAG","FALSE","NM_199037","ref|NM_199037|ref|NM_001037|ens|ENST00000596348|ens|ENST00000262631","SCN1B","sodium channel, voltage gated, type I beta subunit","ref|Homo sapiens sodium channel, voltage gated, type I beta subunit (SCN1B), transcript variant b, mRNA [NM_199037]","chr19",35521588,35531352,"GO:0001518(voltage-gated sodium channel complex);GO:0005248(voltage-gated sodium channel activity);GO:0005576(extracellular region);GO:0007155(cell adhesion);GO:0007268(synaptic transmission);GO:0007411(axon guidance);GO:0010765(positive regulation of sodium ion transport);GO:0010976(positive regulation of neuron projection development);GO:0014704(intercalated disc);GO:0017080(sodium channel regulator activity);GO:0019227(neuronal action potential propagation);GO:0019871(sodium channel inhibitor activity);GO:0021966(corticospinal neuron axon guidance);GO:0030315(T-tubule);GO:0033268(node of Ranvier);GO:0035725(sodium ion transmembrane transport);GO:0040011(locomotion);GO:0046684(response to pyrethroid);GO:0051899(membrane depolarization);GO:0060048(cardiac muscle contraction);GO:0060307(regulation of ventricular cardiomyocyte membrane repolarization);GO:0060371(regulation of atrial cardiomyocyte membrane depolarization);GO:0061337(cardiac conduction);GO:0086002(regulation of cardiac muscle cell action potential involved in contraction);GO:0086006(voltage-gated sodium channel activity involved in regulation of cardiac muscle cell action potential);GO:0086012(membrane depolarization involved in regulation of cardiac muscle cell action potential);GO:0086047(membrane depolarization involved in regulation of Purkinje myocyte cell action potential);GO:0086062(voltage-gated sodium channel activity involved in regulation of Purkinje myocyte action potential);GO:0086091(regulation of heart rate by cardiac conduction);GO:2000649(regulation of sodium ion transmembrane transporter activity)","04261(Adrenergic signaling in cardiomyocytes)","mRNA","agilent G3 V3"]
["A_23_P76435",3.94,4.36,4.08,4.03,4.04,4.33,{"v":0.998387096774194,"d":"1.00"},{"v":-0.00232880605997288,"d":"-0.00"},"down",{"v":0.96834,"d":"0.97"},1,"no","ACTGTGCTGATGAATTACTACAAAACTCCCATCGCGTCGTGGAGGAGTACTTTGTGGCCC","FALSE","NM_176818","ref|NM_176818|ref|NR_033684|ens|ENST00000548171|ens|ENST00000551765","GATC","glutamyl-tRNA(Gln) amidotransferase, subunit C","ref|Homo sapiens glutamyl-tRNA(Gln) amidotransferase, subunit C (GATC), transcript variant 1, mRNA [NM_176818]","chr12",120884384,120897724,"GO:0005524(ATP binding);GO:0005739(mitochondrion);GO:0006450(regulation of translational fidelity);GO:0030956(glutamyl-tRNA(Gln) amidotransferase complex);GO:0032543(mitochondrial translation);GO:0050567(glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity);GO:0070681(glutaminyl-tRNAGln biosynthesis via transamidation)","00970(Aminoacyl-tRNA biosynthesis)","mRNA","agilent G3 V3"]
["A_33_P3210368",5.46,1.86,5.92,5.31,4.24,3.86,{"v":0.987322893363162,"d":"0.99"},{"v":-0.0184061150972562,"d":"-0.02"},"down",{"v":0.96864,"d":"0.97"},1,"no","ATGGGAAGGGCTTAGGGCAGAACTCGGACCACATCCAGTGCCTGAGGCCGCCTTGCTAGA","FALSE","NM_001286526","ref|NM_001286526|ens|ENST00000574418|ens|ENST00000380317|gb|BC058863","BCL7C","B-cell CLL/lymphoma 7C","ref|Homo sapiens B-cell CLL/lymphoma 7C (BCL7C), transcript variant 1, mRNA [NM_001286526]","chr16",30845976,30852075,"GO:0006915(apoptotic process)",null,"mRNA","agilent G3 V3"]
["A_23_P383819",5.47,3.35,5.87,5.88,4.99,3.94,{"v":0.991897366644159,"d":"0.99"},{"v":-0.0117372447325678,"d":"-0.01"},"down",{"v":0.96884,"d":"0.97"},1,"no","GGGGATTTAAAGGGAAGGAGTGGGCAAAACACATAAAATGAATTTATTATATCTAAGCTC","FALSE","NM_016569","ref|NM_016569|ref|NM_005996|ens|ENST00000257566|ens|ENST00000349155","TBX3","T-box 3","ref|Homo sapiens T-box 3 (TBX3), transcript variant 2, mRNA [NM_016569]","chr12",115108064,115121395,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0001078(RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in negative regulation of transcription);GO:0001085(RNA polymerase II transcription factor binding);GO:0001102(RNA polymerase II activating transcription factor binding);GO:0001501(skeletal system development);GO:0001568(blood vessel development);GO:0001701(in utero embryonic development);GO:0001947(heart looping);GO:0003151(outflow tract morphogenesis);GO:0003167(atrioventricular bundle cell differentiation);GO:0005515(protein binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0007569(cell aging);GO:0008284(positive regulation of cell proliferation);GO:0008595(anterior/posterior axis specification, embryo);GO:0009887(organ morphogenesis);GO:0010159(specification of organ position);GO:0019827(stem cell maintenance);GO:0021761(limbic system development);GO:0030539(male genitalia development);GO:0030540(female genitalia development);GO:0030857(negative regulation of epithelial cell differentiation);GO:0030879(mammary gland development);GO:0032275(luteinizing hormone secretion);GO:0035115(embryonic forelimb morphogenesis);GO:0035136(forelimb morphogenesis);GO:0042733(embryonic digit morphogenesis);GO:0043066(negative regulation of apoptotic process);GO:0043565(sequence-specific DNA binding);GO:0045662(negative regulation of myoblast differentiation);GO:0045787(positive regulation of cell cycle);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0046884(follicle-stimulating hormone secretion);GO:0048332(mesoderm morphogenesis);GO:0060021(palate development);GO:0060412(ventricular septum morphogenesis);GO:0060444(branching involved in mammary gland duct morphogenesis);GO:0060596(mammary placode formation);GO:0060923(cardiac muscle cell fate commitment);GO:0060931(sinoatrial node cell development);GO:0090398(cellular senescence);GO:2000648(positive regulation of stem cell proliferation)","04550(Signaling pathways regulating pluripotency of stem cells)","mRNA","agilent G3 V3"]
["A_33_P3271276",4.19,5.14,4.43,4.68,4.28,4.76,{"v":1.00291545189504,"d":"1.00"},{"v":0.00419998852928544,"d":"0.00"},"up",{"v":0.96892,"d":"0.97"},1,"no","CCTCTCCTTAATCCAATATAGCAGCCGTGAAGTCATTTCTGTATTTCAGGAAGACTGGCA","FALSE","NM_001130014","ref|NM_001130014|ref|NM_002781|ref|NM_031246|ens|ENST00000599214","PSG5","pregnancy specific beta-1-glycoprotein 5","ref|Homo sapiens pregnancy specific beta-1-glycoprotein 5 (PSG5), transcript variant 2, mRNA [NM_001130014]","chr19",43672272,43674717,"GO:0005515(protein binding);GO:0005576(extracellular region);GO:0007565(female pregnancy)",null,"mRNA","agilent G3 V3"]
["A_23_P35256",4.38,3.09,4.14,{"v":4,"d":"4.00"},3.75,3.91,{"v":0.995711835334477,"d":"1.00"},{"v":-0.00619981633492998,"d":"-0.01"},"down",{"v":0.96898,"d":"0.97"},1,"no","GGAGGCAATTTGAAACCAAAGAGAATAAGCGTCTACTAGAAAAATCTCAGAGGGTAGAAG","FALSE","ENST00000334163","ens|ENST00000334163|ref|XM_005272927|ref|XM_005272928|gb|AB464047",null,null,"ens|polymerase (RNA) III (DNA directed) polypeptide C (62kD) [Source:HGNC Symbol;Acc:HGNC:30076] [ENST00000334163]","chrHG1287_PATCH",146510640,146528920,null,null,"mRNA","agilent G3 V3"]
["A_33_P3422035",{"v":3.9,"d":"3.90"},6.34,3.61,4.15,4.74,4.85,{"v":1.0080058224163,"d":"1.01"},{"v":0.0115039721184504,"d":"0.01"},"up",{"v":0.9692,"d":"0.97"},1,"no","TGTAGATGTGGGAGAGGGGTTTCTTCCAGATGCAGACTCTCAGTAATATCCCTTGTTTCT","FALSE","ENST00000392217","ens|ENST00000392217|gb|AF177940|tc|THC2761274","FXYD5","FXYD domain containing ion transport regulator 5","ens|FXYD domain containing ion transport regulator 5 [Source:HGNC Symbol;Acc:HGNC:4029] [ENST00000392217]","chr19",35654936,35660784,"GO:0003779(actin binding);GO:0005216(ion channel activity);GO:0016021(integral to membrane);GO:0030033(microvillus assembly);GO:0034220(ion transmembrane transport);GO:0045296(cadherin binding);GO:0046588(negative regulation of calcium-dependent cell-cell adhesion)",null,"mRNA","agilent G3 V3"]
["A_21_P0013969",6.47,5.48,6.31,{"v":6.1,"d":"6.10"},6.08,6.12,{"v":0.997814207650273,"d":"1.00"},{"v":-0.00315688318718302,"d":"-0.00"},"down",{"v":0.9693,"d":"0.97"},1,"no","TGCAGCACAGCCCAACAGCGTTTTCCCCTTTCGGTTTTCTAGAGTAGTCTTGCAGAACTA","FALSE","AK097528","gb|AK097528|tc|THC2484855","LOC100130156","uncharacterized LOC100130156","gb|Homo sapiens cDNA FLJ40209 fis, clone TESTI2020999. [AK097528]","chr20",55097308,55099380,null,null,"mRNA","agilent G3 V3"]
["A_23_P253932",4.54,5.02,4.35,4.89,4.67,4.38,{"v":0.997847919655667,"d":"1.00"},{"v":-0.00310814132618389,"d":"-0.00"},"down",{"v":0.96978,"d":"0.97"},1,"no","GGGAACCATGACTGTTACATAAAGGCTGTCAGTAGTGGGAAGCGGAAAGAAGGGATTATT","FALSE","NM_001033030","ref|NM_001033030|ref|NM_001033031|ref|NM_001033032|ref|NM_018147","FAIM","Fas apoptotic inhibitory molecule","ref|Homo sapiens Fas apoptotic inhibitory molecule (FAIM), transcript variant 1, mRNA [NM_001033030]","chr3",138340048,138351945,"GO:0005737(cytoplasm);GO:0006915(apoptotic process);GO:0043066(negative regulation of apoptotic process)",null,"mRNA","agilent G3 V3"]
["A_24_P304449",2.59,6.87,4.16,4.54,4.63,4.61,{"v":0.988388969521045,"d":"0.99"},{"v":-0.0168491846922203,"d":"-0.02"},"down",{"v":0.96986,"d":"0.97"},1,"no","ATTTCAGTATGAGGAAAAACAACAACAAACTGAAGTGCGCTTTCCGTCCTTTCAAAGGAC","FALSE","ENST00000228506","ens|ENST00000228506|gb|D63486|gb|CR936818|gb|NM_014730","MLEC","malectin","ens|malectin [Source:HGNC Symbol;Acc:HGNC:28973] [ENST00000228506]","chr12",121134208,121138744,"GO:0005783(endoplasmic reticulum);GO:0005789(endoplasmic reticulum membrane);GO:0006457(protein folding);GO:0016020(membrane);GO:0016021(integral to membrane);GO:0018279(protein N-linked glycosylation via asparagine);GO:0019899(enzyme binding);GO:0030246(carbohydrate binding);GO:0043687(post-translational protein modification);GO:0044267(cellular protein metabolic process)",null,"mRNA","agilent G3 V3"]
["A_21_P0009735",3.66,4.24,{"v":4.8,"d":"4.80"},4.17,4.37,{"v":4.2,"d":"4.20"},{"v":0.996860282574568,"d":"1.00"},{"v":-0.00453678059677204,"d":"-0.00"},"down",{"v":0.97016,"d":"0.97"},1,"no","AATGGACACCATCACCTCAGTCTGGTCGGGAGTGGAATGGGACACGGGTTGTCGGAACTT","FALSE","XR_430169","ref|XR_430169|ref|XR_433537|linc|lnc-C19orf26-1:1|linc|lnc-C19orf26-1:2","LOC102723811","uncharacterized LOC102723811","ref|PREDICTED: Homo sapiens uncharacterized LOC102723811 (LOC102723811), ncRNA [XR_430169]","chr19",{"v":1246275,"d":"1246275.00"},1246794,null,null,"mRNA","agilent G3 V3"]
["A_23_P254507",{"v":3.7,"d":"3.70"},{"v":4.7,"d":"4.70"},4.86,{"v":3.6,"d":"3.60"},4.39,{"v":5.2,"d":"5.20"},{"v":1.00530705079606,"d":"1.01"},{"v":0.00763621086104292,"d":"0.01"},"up",{"v":0.97022,"d":"0.97"},1,"no","GGAACACATTTCCTTCTGAACTTACTTCCCTAAGTCACTTTCCTTATGTATCATCTAATA","FALSE","NM_139211","ref|NM_139211|ref|NM_001145460|ref|NM_032495|ref|NM_139212","HOPX","HOP homeobox","ref|Homo sapiens HOP homeobox (HOPX), transcript variant 2, mRNA [NM_139211]","chr4",57514156,57547872,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0001829(trophectodermal cell differentiation);GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0007507(heart development);GO:0008016(regulation of heart contraction);GO:0016575(histone deacetylation);GO:0043393(regulation of protein binding);GO:0043415(positive regulation of skeletal muscle tissue regeneration);GO:0045596(negative regulation of cell differentiation);GO:0048286(lung alveolus development);GO:0051155(positive regulation of striated muscle cell differentiation)",null,"mRNA","agilent G3 V3"]
["A_33_P3353791",6.23,1.95,{"v":6.6,"d":"6.60"},{"v":5.6,"d":"5.60"},5.24,4.12,{"v":0.987967914438503,"d":"0.99"},{"v":-0.0174639057414858,"d":"-0.02"},"down",{"v":0.97112,"d":"0.97"},1,"no","CAGGGTTCATTCAAACCCCCAAGCTGTGAGAGTGTGTTTATTTTTAATTTTTTAAAAGGT","FALSE","NM_181501","ref|NM_181501|gb|BC050277|tc|THC2462514","ITGA1","integrin, alpha 1","ref|Homo sapiens integrin, alpha 1 (ITGA1), mRNA [NM_181501]","chr5",52226984,52252321,"GO:0000187(activation of MAPK activity);GO:0001669(acrosomal vesicle);GO:0005102(receptor binding);GO:0005515(protein binding);GO:0005518(collagen binding);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0006936(muscle contraction);GO:0007160(cell-matrix adhesion);GO:0007229(integrin-mediated signaling pathway);GO:0007411(axon guidance);GO:0007596(blood coagulation);GO:0008285(negative regulation of cell proliferation);GO:0008305(integrin complex);GO:0009897(external side of plasma membrane);GO:0009986(cell surface);GO:0016020(membrane);GO:0019903(protein phosphatase binding);GO:0030198(extracellular matrix organization);GO:0030593(neutrophil chemotaxis);GO:0032516(positive regulation of phosphoprotein phosphatase activity);GO:0034665(alpha1-beta1 integrin complex);GO:0042059(negative regulation of epidermal growth factor receptor signaling pathway);GO:0042311(vasodilation);GO:0043005(neuron projection);GO:0043204(perikaryon);GO:0043525(positive regulation of neuron apoptotic process);GO:0045121(membrane raft);GO:0045123(cellular extravasation);GO:0045178(basal part of cell);GO:0046872(metal ion binding);GO:0070062(extracellular vesicular exosome)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04810(Regulation of actin cytoskeleton);04510(Focal adhesion);04640(Hematopoietic cell lineage);05410(Hypertrophic cardiomyopathy (HCM));05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC));05414(Dilated cardiomyopathy (DCM))","mRNA","agilent G3 V3"]
["A_33_P3209741",6.07,2.13,5.48,4.45,{"v":4.5,"d":"4.50"},4.88,{"v":0.989154013015184,"d":"0.99"},{"v":-0.0157329262645962,"d":"-0.02"},"down",{"v":0.97136,"d":"0.97"},1,"no","TGGATGGGCTGGCACGCTCAGAAGATCTCGTATTTGTCTTAGCAGCTTCTAACCTGCCGT","FALSE","NM_031303","ref|NM_031303|ens|ENST00000245121|ref|XM_006722554|ref|XM_005258357","KATNAL2","katanin p60 subunit A-like 2","ref|Homo sapiens katanin p60 subunit A-like 2 (KATNAL2), mRNA [NM_031303]","chr18",44595956,44625319,"GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005874(microtubule);GO:0008017(microtubule binding);GO:0008152(metabolic process);GO:0008568(microtubule-severing ATPase activity);GO:0031122(cytoplasmic microtubule organization);GO:0051013(microtubule severing)",null,"mRNA","agilent G3 V3"]
["A_23_P54144",4.77,5.54,4.66,4.92,4.41,5.59,{"v":1.00335120643432,"d":"1.00"},{"v":0.0048266858031787,"d":"0.00"},"up",{"v":0.97158,"d":"0.97"},1,"no","GGACACGAGACTGGTCCACCACAATGTGACACGGTGGGAAACTTTTGATGTGAGCCCTGC","FALSE","NM_001202","ref|NM_001202|ref|NM_130851|ref|NM_130850|ens|ENST00000558984","BMP4","bone morphogenetic protein 4","ref|Homo sapiens bone morphogenetic protein 4 (BMP4), transcript variant 1, mRNA [NM_001202]","chr14",54416456,54421270,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000186(activation of MAPKK activity);GO:0001649(osteoblast differentiation);GO:0001657(ureteric bud development);GO:0001658(branching involved in ureteric bud morphogenesis);GO:0001822(kidney development);GO:0001823(mesonephros development);GO:0001843(neural tube closure);GO:0001934(positive regulation of protein phosphorylation);GO:0001938(positive regulation of endothelial cell proliferation);GO:0001958(endochondral ossification);GO:0002043(blood vessel endothelial cell proliferation involved in sprouting angiogenesis);GO:0002062(chondrocyte differentiation);GO:0002244(hemopoietic progenitor cell differentiation);GO:0002320(lymphoid progenitor cell differentiation);GO:0003014(renal system process);GO:0003130(BMP signaling pathway involved in heart induction);GO:0003139(secondary heart field specification);GO:0003197(endocardial cushion development);GO:0003279(cardiac septum development);GO:0003323(type B pancreatic cell development);GO:0003337(mesenchymal to epithelial transition involved in metanephros morphogenesis);GO:0005125(cytokine activity);GO:0005160(transforming growth factor beta receptor binding);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005578(proteinaceous extracellular matrix);GO:0005615(extracellular space);GO:0007182(common-partner SMAD protein phosphorylation);GO:0007224(smoothened signaling pathway);GO:0007281(germ cell development);GO:0007500(mesodermal cell fate determination);GO:0008083(growth factor activity);GO:0008201(heparin binding);GO:0008285(negative regulation of cell proliferation);GO:0009791(post-embryonic development);GO:0009948(anterior/posterior axis specification);GO:0010159(specification of organ position);GO:0010453(regulation of cell fate commitment);GO:0010595(positive regulation of endothelial cell migration);GO:0010862(positive regulation of pathway-restricted SMAD protein phosphorylation);GO:0010942(positive regulation of cell death);GO:0021537(telencephalon development);GO:0021904(dorsal/ventral neural tube patterning);GO:0021978(telencephalon regionalization);GO:0021983(pituitary gland development);GO:0030198(extracellular matrix organization);GO:0030218(erythrocyte differentiation);GO:0030224(monocyte differentiation);GO:0030225(macrophage differentiation);GO:0030501(positive regulation of bone mineralization);GO:0030509(BMP signaling pathway);GO:0030513(positive regulation of BMP signaling pathway);GO:0032092(positive regulation of protein binding);GO:0032331(negative regulation of chondrocyte differentiation);GO:0032967(positive regulation of collagen biosynthetic process);GO:0033085(negative regulation of T cell differentiation in thymus);GO:0033088(negative regulation of immature T cell proliferation in thymus);GO:0034504(protein localization to nucleus);GO:0035116(embryonic hindlimb morphogenesis);GO:0035990(tendon cell differentiation);GO:0035993(deltoid tuberosity development);GO:0042056(chemoattractant activity);GO:0042306(regulation of protein import into nucleus);GO:0042326(negative regulation of phosphorylation)","04340(Hedgehog signaling pathway);04350(TGF-beta signaling pathway);04390(Hippo signaling pathway);04060(Cytokine-cytokine receptor interaction);04550(Signaling pathways regulating pluripotency of stem cells);04919(Thyroid hormone signaling pathway);05200(Pathways in cancer);05217(Basal cell carcinoma)","mRNA","agilent G3 V3"]
["A_23_P56213",5.59,4.28,3.71,5.03,4.33,4.15,{"v":1.00518134715026,"d":"1.01"},{"v":0.00745580491904761,"d":"0.01"},"up",{"v":0.97168,"d":"0.97"},1,"no","AACTCGTGGAGCGGCATTGAAGACTATTTCCACCATCTGGAGCGAGAGCTCGCCAAGGCT","FALSE","NM_020895","ref|NM_020895|ref|NM_001136199|ens|ENST00000600231|ens|ENST00000411896","GRAMD1A","GRAM domain containing 1A","ref|Homo sapiens GRAM domain containing 1A (GRAMD1A), transcript variant 1, mRNA [NM_020895]","chr19",35485688,35517375,"GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_23_P72157",6.51,5.91,{"v":6.8,"d":"6.80"},6.33,6.49,6.37,{"v":1.00156331422616,"d":"1.00"},{"v":0.00225362457836995,"d":"0.00"},"up",{"v":0.97186,"d":"0.97"},1,"no","GGTGATCACGTAGCTGAGCGCCTTGTAGTCCAGGTTGCCCGCCACATCGATGGAGGCGAA","FALSE","NM_032219","ref|NM_032219|ref|NM_001294341|ref|NM_001294342|ens|ENST00000404286","MFSD7","major facilitator superfamily domain containing 7","ref|Homo sapiens major facilitator superfamily domain containing 7 (MFSD7), transcript variant 2, mRNA [NM_032219]","chr4",{"v":675651,"d":"675651.00"},681114,"GO:0016021(integral to membrane);GO:0055085(transmembrane transport)",null,"mRNA","agilent G3 V3"]
["A_23_P396858",6.01,{"v":2.7,"d":"2.70"},2.05,3.25,3.38,3.99,{"v":1.01318267419962,"d":"1.01"},{"v":0.0188943117524707,"d":"0.02"},"up",{"v":0.97194,"d":"0.97"},1,"no","ACTGACCTTAGGCATGGAGAAAATTACTTGTTAAACTCTAGTTCTTAAGTTGTTAGCCAA","FALSE","NM_031866","ref|NM_031866|ens|ENST00000374694|gb|AB043703|tc|THC2471645","FZD8","frizzled class receptor 8","ref|Homo sapiens frizzled class receptor 8 (FZD8), mRNA [NM_031866]","chr10",35927176,35930362,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0001525(angiogenesis);GO:0004930(G-protein coupled receptor activity);GO:0005102(receptor binding);GO:0005515(protein binding);GO:0005794(Golgi apparatus);GO:0005886(plasma membrane);GO:0007186(G-protein coupled receptor signaling pathway);GO:0016021(integral to membrane);GO:0017147(Wnt-protein binding);GO:0030165(PDZ domain binding);GO:0030182(neuron differentiation);GO:0031625(ubiquitin protein ligase binding);GO:0033077(T cell differentiation in thymus);GO:0035567(non-canonical Wnt receptor signaling pathway);GO:0042813(Wnt-activated receptor activity);GO:0043507(positive regulation of JUN kinase activity);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0060070(canonical Wnt receptor signaling pathway)","04310(Wnt signaling pathway);04390(Hippo signaling pathway);04550(Signaling pathways regulating pluripotency of stem cells);04916(Melanogenesis);05200(Pathways in cancer);05205(Proteoglycans in cancer);05217(Basal cell carcinoma);05166(HTLV-I infection)","mRNA","agilent G3 V3"]
["A_33_P3407742",5.18,{"v":4.8,"d":"4.80"},3.57,4.41,4.22,4.98,{"v":0.995591476855254,"d":"1.00"},{"v":-0.00637421526276058,"d":"-0.01"},"down",{"v":0.97206,"d":"0.97"},1,"no","TAACATGAGTATTGTACTAGTTTGCTTTTCAAATGCTCCCAAGGTCTCAGATGAAGCGGT","FALSE","NM_002706","ref|NM_002706|ref|NM_177969|ref|NM_001033557|ens|ENST00000409486","PPM1B","protein phosphatase, Mg2+/Mn2+ dependent, 1B","ref|Homo sapiens protein phosphatase, Mg2+/Mn2+ dependent, 1B (PPM1B), transcript variant 1, mRNA [NM_002706]","chr2",44396000,44436571,"GO:0000287(magnesium ion binding);GO:0004722(protein serine/threonine phosphatase activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0006470(protein dephosphorylation);GO:0006499(N-terminal protein myristoylation);GO:0016020(membrane);GO:0019221(cytokine-mediated signaling pathway);GO:0030145(manganese ion binding);GO:0032688(negative regulation of interferon-beta production);GO:0035970(peptidyl-threonine dephosphorylation);GO:0042347(negative regulation of NF-kappaB import into nucleus);GO:0043124(negative regulation of I-kappaB kinase/NF-kappaB cascade);GO:0050687(negative regulation of defense response to virus)","04010(MAPK signaling pathway)","mRNA","agilent G3 V3"]
["A_23_P157038",7.27,6.86,6.79,7.59,6.79,{"v":6.5,"d":"6.50"},{"v":1.00191570881226,"d":"1.00"},{"v":0.00276113967705691,"d":"0.00"},"up",{"v":0.97212,"d":"0.97"},1,"no","GCCCCTTAATTGGCAGGTGTATGTGCTGACAGTACTGAAAGCTTTCCTCTTTAACTGATC","FALSE","NM_152755","ref|NM_152755|ens|ENST00000462193|ens|ENST00000262932|gb|AK075537","CNPY4","canopy FGF signaling regulator 4","ref|Homo sapiens canopy FGF signaling regulator 4 (CNPY4), mRNA [NM_152755]","chr7",99719880,99722803,"GO:0005102(receptor binding);GO:0005576(extracellular region)",null,"mRNA","agilent G3 V3"]
["A_24_P258051",5.25,2.74,{"v":5.4,"d":"5.40"},4.89,4.59,4.01,{"v":0.992587101556709,"d":"0.99"},{"v":-0.010734387623957,"d":"-0.01"},"down",{"v":0.97224,"d":"0.97"},1,"no","GCCTACAGTGGTTCATATCCCATGGCTATAACCCCTACTCAAAAAAGAAGATCCTGTATG","FALSE","NM_032844","ref|NM_032844|ref|NM_001172304|ref|NM_001172303|ens|ENST00000342386","MASTL","microtubule associated serine/threonine kinase-like","ref|Homo sapiens microtubule associated serine/threonine kinase-like (MASTL), transcript variant 2, mRNA [NM_032844]","chr10",27458872,27475647,"GO:0000086(G2/M transition of mitotic cell cycle);GO:0000278(mitotic cell cycle);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0006468(protein phosphorylation);GO:0006974(response to DNA damage stimulus);GO:0007067(mitosis);GO:0016301(kinase activity);GO:0032154(cleavage furrow);GO:0034048(negative regulation of protein phosphatase type 2A activity);GO:0051301(cell division);GO:0051721(protein phosphatase 2A binding);GO:0051726(regulation of cell cycle)",null,"mRNA","agilent G3 V3"]
["A_33_P3392580",4.92,6.03,5.26,5.65,5.09,5.51,{"v":0.997538461538462,"d":"1.00"},{"v":-0.00355562728563758,"d":"-0.00"},"down",{"v":0.9729,"d":"0.97"},1,"no","GCTAAGGATCCCCTAGAAATCATAGACCTCTGAAATTATATGCAGAATTCTTTATGTGTT","FALSE","NM_013411","ref|NM_013411|ref|NM_001199199|ref|NR_037591|ens|ENST00000373449","AK2","adenylate kinase 2","ref|Homo sapiens adenylate kinase 2 (AK2), transcript variant 2, mRNA [NM_013411]","chr1",33473584,33502471,"GO:0001889(liver development);GO:0004017(adenylate kinase activity);GO:0005524(ATP binding);GO:0005743(mitochondrial inner membrane);GO:0005758(mitochondrial intermembrane space);GO:0005829(cytosol);GO:0006119(oxidative phosphorylation);GO:0006172(ADP biosynthetic process);GO:0007420(brain development);GO:0015949(nucleobase-containing small molecule interconversion);GO:0044281(small molecule metabolic process);GO:0046033(AMP metabolic process);GO:0046060(dATP metabolic process);GO:0046939(nucleotide phosphorylation);GO:0055086(nucleobase-containing small molecule metabolic process);GO:0070062(extracellular vesicular exosome);GO:0097066(response to thyroid hormone stimulus);GO:0097226(sperm mitochondrial sheath)","00230(Purine metabolism)","mRNA","agilent G3 V3"]
["A_24_P242820",4.83,3.64,2.63,{"v":3.8,"d":"3.80"},3.46,3.91,{"v":0.99373321396598,"d":"0.99"},{"v":-0.00906950924584631,"d":"-0.01"},"down",{"v":0.97308,"d":"0.97"},1,"no","TAGAACAATTTTCTTGTGACAGCTCTTTTTGTGAAGTTAGGTTCTTAAAAGTGCCCATGA","FALSE","NM_004622","ref|NM_004622|ref|NM_001261401|ref|NR_048559|ref|NR_048556","TSN","translin","ref|Homo sapiens translin (TSN), transcript variant 1, mRNA [NM_004622]","chr2",122513240,122524755,"GO:0003677(DNA binding);GO:0003697(single-stranded DNA binding);GO:0003729(mRNA binding);GO:0004521(endoribonuclease activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006310(DNA recombination);GO:0010467(gene expression);GO:0032403(protein complex binding);GO:0043565(sequence-specific DNA binding)",null,"mRNA","agilent G3 V3"]
["A_23_P162300",2.86,{"v":4.2,"d":"4.20"},5.61,4.17,{"v":4.3,"d":"4.30"},4.29,{"v":0.99294670846395,"d":"0.99"},{"v":-0.0102118046240594,"d":"-0.01"},"down",{"v":0.97332,"d":"0.97"},1,"no","TTGTCTCATGACCAAATCCACGCTCAATTAGAGCCATTCAAAATTCCTTAAGATCATGGG","FALSE","NM_007199","ref|NM_007199|ref|NM_001142523|ens|ENST00000261233|gb|AF113136","IRAK3","interleukin-1 receptor-associated kinase 3","ref|Homo sapiens interleukin-1 receptor-associated kinase 3 (IRAK3), transcript variant 1, mRNA [NM_007199]","chr12",66583036,66642153,"GO:0000287(magnesium ion binding);GO:0001960(negative regulation of cytokine-mediated signaling pathway);GO:0002224(toll-like receptor signaling pathway);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0004674(protein serine/threonine kinase activity);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0009615(response to virus);GO:0010933(positive regulation of macrophage tolerance induction);GO:0010936(negative regulation of macrophage cytokine production);GO:0019221(cytokine-mediated signaling pathway);GO:0032088(negative regulation of NF-kappaB transcription factor activity);GO:0032494(response to peptidoglycan);GO:0032496(response to lipopolysaccharide);GO:0032695(negative regulation of interleukin-12 production);GO:0032715(negative regulation of interleukin-6 production);GO:0032720(negative regulation of tumor necrosis factor production);GO:0034122(negative regulation of toll-like receptor signaling pathway);GO:0042177(negative regulation of protein catabolic process);GO:0042803(protein homodimerization activity);GO:0043242(negative regulation of protein complex disassembly);GO:0043244(regulation of protein complex disassembly);GO:0043330(response to exogenous dsRNA);GO:0043407(negative regulation of MAP kinase activity);GO:0045323(interleukin-1 receptor complex);GO:0045824(negative regulation of innate immune response);GO:0046777(protein autophosphorylation);GO:0046982(protein heterodimerization activity);GO:0051092(positive regulation of NF-kappaB transcription factor activity);GO:0070498(interleukin-1-mediated signaling pathway);GO:0070555(response to interleukin-1)","04210(Apoptosis);04722(Neurotrophin signaling pathway)","mRNA","agilent G3 V3"]
["A_23_P410965",4.16,8.39,4.19,5.34,5.82,5.42,{"v":1.00965018094089,"d":"1.01"},{"v":0.0138555210545937,"d":"0.01"},"up",{"v":0.97332,"d":"0.97"},1,"no","GGTAAATGAGCTTGACCTAGAGTAAATGGAGAGACCAAAAGCCTCTGATTTTTAATTTCC","FALSE","NM_020888","ref|NM_020888|ref|NM_001198972|ref|NM_001198973|ens|ENST00000401073","KIAA1522","KIAA1522","ref|Homo sapiens KIAA1522 (KIAA1522), transcript variant 1, mRNA [NM_020888]","chr1",33231268,33240571,null,null,"mRNA","agilent G3 V3"]
["A_23_P36266",4.12,2.62,3.78,3.24,3.43,{"v":3.8,"d":"3.80"},{"v":1.00477554918816,"d":"1.00"},{"v":0.00687326236149403,"d":"0.01"},"up",{"v":0.97412,"d":"0.97"},1,"no","CCTAGAGAATCCTATCCGACTTGCCTAGTCCTCAAAGATAAGAAGTTGGTGTTCAGCTTA","FALSE","NM_003477","ref|NM_003477|ref|NM_001135024|ref|NM_001166158|ens|ENST00000227868","PDHX","pyruvate dehydrogenase complex, component X","ref|Homo sapiens pyruvate dehydrogenase complex, component X (PDHX), transcript variant 1, mRNA [NM_003477]","chr11",34938180,35016822,"GO:0005759(mitochondrial matrix);GO:0006090(pyruvate metabolic process);GO:0010510(regulation of acetyl-CoA biosynthetic process from pyruvate);GO:0016746(transferase activity, transferring acyl groups);GO:0044237(cellular metabolic process);GO:0044281(small molecule metabolic process)","00010(Glycolysis / Gluconeogenesis);00020(Citrate cycle (TCA cycle));00620(Pyruvate metabolism)","mRNA","agilent G3 V3"]
["A_33_P3305958",2.95,5.71,2.22,3.22,3.68,3.87,{"v":1.01021355617456,"d":"1.01"},{"v":0.0146603067061321,"d":"0.01"},"up",{"v":0.97454,"d":"0.97"},1,"no","ATTCTCTGGCTGAGGAAGATGACATTAGAACTGAAATGCCACACTGTCACCATGCACATG","FALSE","NM_001172631","ref|NM_001172631|ref|NM_014844|ens|ENST00000558678|ens|ENST00000359520","TECPR2","tectonin beta-propeller repeat containing 2","ref|Homo sapiens tectonin beta-propeller repeat containing 2 (TECPR2), transcript variant 2, mRNA [NM_001172631]","chr14",102829416,102932008,"GO:0005515(protein binding);GO:0006914(autophagy)",null,"mRNA","agilent G3 V3"]
["A_24_P356601",4.71,2.88,5.49,4.48,4.12,4.56,{"v":0.993920972644377,"d":"0.99"},{"v":-0.00879694823715918,"d":"-0.01"},"down",{"v":0.97454,"d":"0.97"},1,"no","CATGAACCCCATGAAATTATTTGTAGACTTGTATGTACATTTTTCTGGGGAGAAGGTTCA","FALSE","NM_006460","ref|NM_006460|ens|ENST00000332499|gb|AB021179|tc|THC2466542","HEXIM1","hexamethylene bis-acetamide inducible 1","ref|Homo sapiens hexamethylene bis-acetamide inducible 1 (HEXIM1), mRNA [NM_006460]","chr17",43224684,43229468,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0004861(cyclin-dependent protein kinase inhibitor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006351(transcription, DNA-dependent);GO:0007507(heart development);GO:0017069(snRNA binding);GO:0045736(negative regulation of cyclin-dependent protein kinase activity);GO:0045892(negative regulation of transcription, DNA-dependent)",null,"mRNA","agilent G3 V3"]
["A_24_P307306",3.77,4.89,3.77,3.93,4.38,4.16,{"v":0.996792301523657,"d":"1.00"},{"v":-0.00463516877718518,"d":"-0.00"},"down",{"v":0.9747,"d":"0.97"},1,"no","TATGAACCATGAGAAATATAACAACAGCCTCAAGATCATCAACAGTGTTTCTTGTACCAC","FALSE","ENST00000443168","ens|ENST00000443168",null,null,"ens|glyceraldehyde 3 phosphate dehydrogenase pseudogene 33 [Source:HGNC Symbol;Acc:HGNC:37785] [ENST00000443168]","chr1",120138792,120139802,null,null,"mRNA","agilent G3 V3"]
["A_23_P83351",{"v":6.4,"d":"6.40"},6.99,6.22,7.16,6.37,6.04,{"v":1.00204394481349,"d":"1.00"},{"v":0.0029457795653449,"d":"0.00"},"up",{"v":0.97534,"d":"0.98"},1,"no","AGATGGGGCCAACAAACCGCCTGGACTTCTGGAGCCCACGTCCACTCTGGTCCGTGTGAA","FALSE","NM_015404","ref|NM_015404|ref|NM_001173425|ref|NM_001083885|ens|ENST00000362057","DFNB31","deafness, autosomal recessive 31","ref|Homo sapiens deafness, autosomal recessive 31 (DFNB31), transcript variant 1, mRNA [NM_015404]","chr9",117164360,117265453,"GO:0001895(retina homeostasis);GO:0002142(stereocilia ankle link complex);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005884(actin filament);GO:0007605(sensory perception of sound);GO:0010628(positive regulation of gene expression);GO:0030426(growth cone);GO:0032391(photoreceptor connecting cilium);GO:0032420(stereocilium);GO:0050953(sensory perception of light stimulus);GO:0060122(inner ear receptor stereocilium organization)",null,"mRNA","agilent G3 V3"]
["A_23_P404536",1.87,5.55,3.59,3.68,3.64,{"v":3.8,"d":"3.80"},{"v":0.990107913669065,"d":"0.99"},{"v":-0.0143423191591387,"d":"-0.01"},"down",{"v":0.97564,"d":"0.98"},1,"no","TGAAGGTAAACCAGAAGCTCTTTGGGTTGAAGAAAGATTTACAGCTCACATTGCCCGGGT","FALSE","NM_005021","ref|NM_005021|ens|ENST00000357639|ens|ENST00000358229|ens|ENST00000414305","ENPP3","ectonucleotide pyrophosphatase/phosphodiesterase 3","ref|Homo sapiens ectonucleotide pyrophosphatase/phosphodiesterase 3 (ENPP3), mRNA [NM_005021]","chr6",131949600,132068553,"GO:0003676(nucleic acid binding);GO:0004528(phosphodiesterase I activity);GO:0004551(nucleotide diphosphatase activity);GO:0005044(scavenger receptor activity);GO:0005887(integral to plasma membrane);GO:0006796(phosphate-containing compound metabolic process);GO:0006898(receptor-mediated endocytosis);GO:0006955(immune response);GO:0009143(nucleoside triphosphate catabolic process);GO:0030247(polysaccharide binding);GO:0030505(inorganic diphosphate transport);GO:0035529(NADH pyrophosphatase activity);GO:0046872(metal ion binding);GO:0047429(nucleoside-triphosphate diphosphatase activity);GO:0048471(perinuclear region of cytoplasm);GO:0070062(extracellular vesicular exosome);GO:0090305(nucleic acid phosphodiester bond hydrolysis)","00500(Starch and sucrose metabolism);00230(Purine metabolism);00760(Nicotinate and nicotinamide metabolism);00770(Pantothenate and CoA biosynthesis)","mRNA","agilent G3 V3"]
["A_24_P25346",5.57,{"v":4.8,"d":"4.80"},6.17,5.63,5.58,5.29,{"v":1.00242424242424,"d":"1.00"},{"v":0.00349321003809658,"d":"0.00"},"up",{"v":0.97564,"d":"0.98"},1,"no","ATTTCCTCCCACGAATGAATCAGATGTCATCCGGAGGCGCACAGCTCATGCTTTTAAAAT","FALSE","NM_032830","ref|NM_032830|ens|ENST00000352319|ens|ENST00000314423|ens|ENST00000575702","CIRH1A","cirrhosis, autosomal recessive 1A (cirhin)","ref|Homo sapiens cirrhosis, autosomal recessive 1A (cirhin) (CIRH1A), mRNA [NM_032830]","chr16",69201008,69265033,"GO:0005515(protein binding);GO:0005730(nucleolus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0030490(maturation of SSU-rRNA);GO:0034455(t-UTP complex)","03008(Ribosome biogenesis in eukaryotes)","mRNA","agilent G3 V3"]
["A_33_P3345186",5.33,2.94,4.54,{"v":4.3,"d":"4.30"},4.23,4.21,{"v":1.00549450549451,"d":"1.01"},{"v":0.00790519808534584,"d":"0.01"},"up",{"v":0.97656,"d":"0.98"},1,"no","TGGCCTTCCTGTTCGTGCGGGAGCCCTTCGAGCGCCTGGCATCGGCTTACCGCAACAAGC","FALSE","NM_152889","ref|NM_152889|ens|ENST00000615522|ens|ENST00000319340|gb|BC103896","CHST13","carbohydrate (chondroitin 4) sulfotransferase 13","ref|Homo sapiens carbohydrate (chondroitin 4) sulfotransferase 13 (CHST13), mRNA [NM_152889]","chr3",126243128,126262134,"GO:0000139(Golgi membrane);GO:0001537(N-acetylgalactosamine 4-O-sulfotransferase activity);GO:0005975(carbohydrate metabolic process);GO:0009405(pathogenesis);GO:0016021(integral to membrane);GO:0016051(carbohydrate biosynthetic process);GO:0030203(glycosaminoglycan metabolic process);GO:0030204(chondroitin sulfate metabolic process);GO:0030206(chondroitin sulfate biosynthetic process);GO:0044281(small molecule metabolic process);GO:0047756(chondroitin 4-sulfotransferase activity)","00532(Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate)","mRNA","agilent G3 V3"]
["A_22_P00018321",7.15,6.98,7.32,7.54,6.96,6.97,{"v":0.99906846762925,"d":"1.00"},{"v":-0.00134454347186502,"d":"-0.00"},"down",{"v":0.97678,"d":"0.98"},1,"no","ACTGGTGCCCCAACATCCTTACTGCCTACCAAGAGCGCCGCTTCTGCAACCTGCGAGCCT","FALSE","NM_198455","ref|NM_198455|ens|ENST00000620923|ens|ENST00000623373|ens|ENST00000378016","SSPO","SCO-spondin","ref|Homo sapiens SCO-spondin (SSPO), mRNA [NM_198455]","chr7",149473136,149531053,"GO:0005615(extracellular space);GO:0005737(cytoplasm);GO:0007155(cell adhesion);GO:0007399(nervous system development);GO:0010466(negative regulation of peptidase activity);GO:0030154(cell differentiation);GO:0030414(peptidase inhibitor activity)",null,"mRNA","agilent G3 V3"]
["A_23_P418597",8.39,5.54,6.35,6.92,{"v":6.9,"d":"6.90"},6.38,{"v":1.0039603960396,"d":"1.00"},{"v":0.00570235936418342,"d":"0.01"},"up",{"v":0.97692,"d":"0.98"},1,"no","TACCTCCCAAGCCAGAGAAATCCTCAGGGTCAGAAGGATCGTCGCCCAACTGGCTTCAAG","FALSE","NM_033396","ref|NM_033396|ens|ENST00000427750|ens|ENST00000532437|ens|ENST00000358252","TNKS1BP1","tankyrase 1 binding protein 1, 182kDa","ref|Homo sapiens tankyrase 1 binding protein 1, 182kDa (TNKS1BP1), mRNA [NM_033396]","chr11",57067116,57092401,"GO:0000288(nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay);GO:0000289(nuclear-transcribed mRNA poly(A) tail shortening);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005724(nuclear telomeric heterochromatin);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0007004(telomere maintenance via telomerase);GO:0010467(gene expression);GO:0019899(enzyme binding);GO:0030014(CCR4-NOT complex);GO:0030506(ankyrin binding)",null,"mRNA","agilent G3 V3"]
["A_24_P54178",1.99,6.96,2.08,3.45,3.63,4.11,{"v":0.985701519213583,"d":"0.99"},{"v":-0.0207772453850116,"d":"-0.02"},"down",{"v":0.9772,"d":"0.98"},1,"no","GCTCTGATATGCATTTGGATGATTAATGTTATGCTGTTCTTTCATGTGAATGTCAAGACA","FALSE","NM_016040","ref|NM_016040|ref|NM_001167830|ref|NR_030761|ens|ENST00000370290","TMED5","transmembrane emp24 protein transport domain containing 5","ref|Homo sapiens transmembrane emp24 protein transport domain containing 5 (TMED5), transcript variant 1, mRNA [NM_016040]","chr1",93617416,93646073,"GO:0005515(protein binding);GO:0005789(endoplasmic reticulum membrane);GO:0005793(endoplasmic reticulum-Golgi intermediate compartment);GO:0005794(Golgi apparatus);GO:0005801(cis-Golgi network);GO:0015031(protein transport);GO:0016021(integral to membrane);GO:0033116(endoplasmic reticulum-Golgi intermediate compartment membrane);GO:0070971(endoplasmic reticulum exit site);GO:0090161(Golgi ribbon formation)",null,"mRNA","agilent G3 V3"]
["A_23_P336506",4.86,2.07,4.06,3.15,3.61,4.15,{"v":1.00733272227314,"d":"1.01"},{"v":0.0105402846256238,"d":"0.01"},"up",{"v":0.97724,"d":"0.98"},1,"no","TCATGCTTGCGATTCTTCTGGGGTCCTTTCTTATCTCTTTAATTATTAGTGTTCCAAAGA","FALSE","NM_023917","ref|NM_023917|ens|ENST00000240691|ens|ENST00000573524|ens|ENST00000616297","TAS2R9","taste receptor, type 2, member 9","ref|Homo sapiens taste receptor, type 2, member 9 (TAS2R9), mRNA [NM_023917]","chr12",10961693,10962767,"GO:0005886(plasma membrane);GO:0007186(G-protein coupled receptor signaling pathway);GO:0008150(biological_process);GO:0008527(taste receptor activity);GO:0016021(integral to membrane);GO:0050912(detection of chemical stimulus involved in sensory perception of taste)","04742(Taste transduction)","mRNA","agilent G3 V3"]
["A_33_P3258617",4.41,{"v":2.1,"d":"2.10"},5.05,3.92,{"v":3.6,"d":"3.60"},4.12,{"v":0.993127147766323,"d":"0.99"},{"v":-0.00994966040760533,"d":"-0.01"},"down",{"v":0.978,"d":"0.98"},1,"no","TTTCCCAACCTGGATCTGGATGTATGTTTGAAAAATAATGGCCACTTCCTTACTTCCTGA","FALSE","ENST00000380464","ens|ENST00000380464|ens|ENST00000380465|tc|THC2632368|tc|THC2636617","PLIN2","perilipin 2","ens|perilipin 2 [Source:HGNC Symbol;Acc:HGNC:248] [ENST00000380464]","chr9",19123312,19127488,"GO:0005576(extracellular region);GO:0005634(nucleus);GO:0005783(endoplasmic reticulum);GO:0005811(lipid particle);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0014070(response to organic cyclic compound);GO:0015909(long-chain fatty acid transport);GO:0019915(lipid storage);GO:0042493(response to drug);GO:0044255(cellular lipid metabolic process);GO:0044281(small molecule metabolic process)",null,"mRNA","agilent G3 V3"]
["A_33_P3354141",9.32,9.36,8.88,9.41,9.28,8.85,{"v":1.00072621641249,"d":"1.00"},{"v":0.00104732856932738,"d":"0.00"},"up",{"v":0.97814,"d":"0.98"},1,"no","CAGGGCTGCTTTGTTGAAATGTGATGATTTTCATATGCCTTCTTTCTCTTTCTCTCTCTC","FALSE","NM_030885","ref|NM_030885|gb|AK091042|gb|BC051843|ens|ENST00000439356","MAP4","microtubule-associated protein 4","ref|Homo sapiens microtubule-associated protein 4 (MAP4), transcript variant 3, mRNA [NM_030885]","chr3",48014576,48130314,"GO:0005198(structural molecule activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005874(microtubule);GO:0005875(microtubule associated complex);GO:0005886(plasma membrane);GO:0007052(mitotic spindle organization);GO:0008017(microtubule binding);GO:0015630(microtubule cytoskeleton);GO:0051012(microtubule sliding);GO:0051294(establishment of spindle orientation);GO:0051301(cell division);GO:0070062(extracellular vesicular exosome);GO:0072686(mitotic spindle)",null,"mRNA","agilent G3 V3"]
["A_32_P196047",3.62,6.99,2.75,4.73,4.14,4.37,{"v":1.00906344410876,"d":"1.01"},{"v":0.0130168856668343,"d":"0.01"},"up",{"v":0.97832,"d":"0.98"},1,"no","ATATTAAGATAGTTGCAGGCAGTGTACCTCAGGTTGACTCTGTACATCTGAATAGTGAGT","FALSE","NM_181787","ref|NM_181787|ens|ENST00000414645|ref|XM_005250894|ref|XM_005250895","DPY19L4","dpy-19-like 4 (C. elegans)","ref|Homo sapiens dpy-19-like 4 (C. elegans) (DPY19L4), mRNA [NM_181787]","chr8",95732128,95806064,"GO:0000030(mannosyltransferase activity);GO:0005637(nuclear inner membrane);GO:0016021(integral to membrane);GO:0018406(protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan)",null,"mRNA","agilent G3 V3"]
["A_33_P3237760",4.07,6.78,2.51,3.03,3.27,7.22,{"v":0.988165680473373,"d":"0.99"},{"v":-0.0171751438081319,"d":"-0.02"},"down",{"v":0.97832,"d":"0.98"},1,"no","ATCCAAAATACAATTCTGACTATGAACAACCTGCAGGGTCAGTCCAGGTGTGGCTGTGAA","FALSE","THC2552980","tc|THC2552980",null,null,"tc|ZSWM1_HUMAN (Q9BR11) Zinc finger SWIM domain-containing protein 1, partial (79%) [THC2552980]","chr8",145538256,145538801,"GO:0003677(DNA binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0006355(regulation of transcription, DNA-dependent);GO:0006457(protein folding);GO:0006986(response to unfolded protein);GO:0007283(spermatogenesis);GO:0008270(zinc ion binding);GO:0008285(negative regulation of cell proliferation);GO:0043565(sequence-specific DNA binding);GO:0045120(pronucleus);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P2083",4.94,{"v":3.1,"d":"3.10"},4.37,4.54,{"v":3.8,"d":"3.80"},4.12,{"v":0.995987158908507,"d":"1.00"},{"v":-0.00580095289364526,"d":"-0.01"},"down",{"v":0.97862,"d":"0.98"},1,"no","CCCTGATAAAGCTGAGACCAAGAATAACCCTGGAAAAGTTTCCTCCATGATAGCAACCAC","FALSE","NM_020646","ref|NM_020646|ens|ENST00000531618|gb|AB464448|gb|BC141565","ASCL3","achaete-scute family bHLH transcription factor 3","ref|Homo sapiens achaete-scute family bHLH transcription factor 3 (ASCL3), mRNA [NM_020646]","chr11",{"v":8959119,"d":"8959119.00"},8964580,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0005667(transcription factor complex);GO:0006351(transcription, DNA-dependent);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0046983(protein dimerization activity)",null,"mRNA","agilent G3 V3"]
["A_33_P3686706",4.67,2.05,3.48,2.76,3.75,3.62,{"v":1.00691016781836,"d":"1.01"},{"v":0.00993497805771992,"d":"0.01"},"up",{"v":0.97862,"d":"0.98"},1,"no","TAGTCGTTTCCTCAAATGGGATACTGTTGTAGAGCTGATCTTGTGCTTCTCACCCTGTCA","FALSE","THC2638457","tc|THC2638457",null,null,"tc|Q73KV7_TREDE (Q73KV7) Orotidine 5'-phosphate decarboxylase  , partial (6%) [THC2638457]","chr14",107218672,107219365,null,null,"mRNA","agilent G3 V3"]
["A_32_P198923",5.13,7.08,4.53,5.72,5.68,5.41,{"v":0.995835812016657,"d":"1.00"},{"v":-0.00602019668582336,"d":"-0.01"},"down",{"v":0.97874,"d":"0.98"},1,"no","AAACAGCAGATGGCTCGCGAATACAGAGAGAAAATTGAGACGGAGCTAAGAGATATCTGC","FALSE","NM_145690","ref|NM_145690|ref|NM_001135702|ref|NM_001135701|ref|NM_001135699","YWHAZ","tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta","ref|Homo sapiens tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta (YWHAZ), transcript variant 2, mRNA [NM_145690]","chr8",101930808,101964357,"GO:0002553(histamine secretion by mast cell);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005829(cytosol);GO:0005925(focal adhesion);GO:0006626(protein targeting to mitochondrion);GO:0006915(apoptotic process);GO:0007165(signal transduction);GO:0007596(blood coagulation);GO:0008134(transcription factor binding);GO:0010467(gene expression);GO:0014069(postsynaptic density);GO:0019901(protein kinase binding);GO:0019904(protein domain specific binding);GO:0030168(platelet activation);GO:0030659(cytoplasmic vesicle membrane);GO:0031252(cell leading edge);GO:0032403(protein complex binding);GO:0042470(melanosome);GO:0042493(response to drug);GO:0042629(mast cell granule);GO:0042802(identical protein binding);GO:0043066(negative regulation of apoptotic process);GO:0043234(protein complex);GO:0048471(perinuclear region of cytoplasm);GO:0051683(establishment of Golgi localization);GO:0061024(membrane organization);GO:0070062(extracellular vesicular exosome);GO:0072562(blood microparticle);GO:0090168(Golgi reassembly);GO:0097193(intrinsic apoptotic signaling pathway);GO:1900740(positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway)","04390(Hippo signaling pathway);04151(PI3K-Akt signaling pathway);04110(Cell cycle);04114(Oocyte meiosis);05203(Viral carcinogenesis);05130(Pathogenic Escherichia coli infection);05161(Hepatitis B);05169(Epstein-Barr virus infection)","mRNA","agilent G3 V3"]
["A_23_P19657",5.58,3.01,4.64,5.24,3.76,{"v":4.3,"d":"4.30"},{"v":0.994736842105263,"d":"0.99"},{"v":-0.00761318410987521,"d":"-0.01"},"down",{"v":0.9798,"d":"0.98"},1,"no","AAACCCCAGACTTTGAATTAGTAACAGCTCTAAGATGGTCATGCAGTGAGATAGGAAATC","FALSE","NM_032832","ref|NM_032832|ens|ENST00000239367|gb|AK027641|gb|BC043141","LRP11","low density lipoprotein receptor-related protein 11","ref|Homo sapiens low density lipoprotein receptor-related protein 11 (LRP11), mRNA [NM_032832]","chr6",150141072,150186199,"GO:0016021(integral to membrane)",null,"mRNA","agilent G3 V3"]
["A_24_P345451",6.18,{"v":6.8,"d":"6.80"},6.68,6.29,6.54,6.85,{"v":0.998983739837398,"d":"1.00"},{"v":-0.00146689899865921,"d":"-0.00"},"down",{"v":0.97996,"d":"0.98"},1,"no","CCCTCATTTTTTGGATAGTCACCAGACCGCAATGGAAACGTCCTAAGGAGCCAAATTCTA","FALSE","NM_024843","ref|NM_024843|ref|NM_001127383|ref|NM_001256909|ens|ENST00000375252","CYBRD1","cytochrome b reductase 1","ref|Homo sapiens cytochrome b reductase 1 (CYBRD1), transcript variant 1, mRNA [NM_024843]","chr2",172379584,172411117,"GO:0000293(ferric-chelate reductase activity);GO:0005886(plasma membrane);GO:0006879(cellular iron ion homeostasis);GO:0010039(response to iron ion);GO:0016021(integral to membrane);GO:0016722(oxidoreductase activity, oxidizing metal ions);GO:0031526(brush border membrane);GO:0046872(metal ion binding);GO:0055085(transmembrane transport);GO:0055114(oxidation-reduction process);GO:0070062(extracellular vesicular exosome)","04978(Mineral absorption)","mRNA","agilent G3 V3"]
["A_23_P128698",5.21,3.25,3.94,{"v":3.7,"d":"3.70"},3.97,4.78,{"v":0.995983935742972,"d":"1.00"},{"v":-0.00580562168120564,"d":"-0.01"},"down",{"v":0.98104,"d":"0.98"},1,"no","AGAACTTGGTGACCCATGTATTGCATAAGCTAAAGCAACACAGACACTCCTAGGCAAAGT","FALSE","NM_005842","ref|NM_005842|ens|ENST00000540649|ens|ENST00000377102|ens|ENST00000377104","SPRY2","sprouty homolog 2 (Drosophila)","ref|Homo sapiens sprouty homolog 2 (Drosophila) (SPRY2), mRNA [NM_005842]","chr13",80910896,80914243,"GO:0000132(establishment of mitotic spindle orientation);GO:0005515(protein binding);GO:0005829(cytosol);GO:0005874(microtubule);GO:0005886(plasma membrane);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007605(sensory perception of sound);GO:0008285(negative regulation of cell proliferation);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0010628(positive regulation of gene expression);GO:0010801(negative regulation of peptidyl-threonine phosphorylation);GO:0015630(microtubule cytoskeleton);GO:0019901(protein kinase binding);GO:0030291(protein serine/threonine kinase inhibitor activity);GO:0032587(ruffle membrane);GO:0033138(positive regulation of peptidyl-serine phosphorylation);GO:0034261(negative regulation of Ras GTPase activity);GO:0040037(negative regulation of fibroblast growth factor receptor signaling pathway);GO:0042059(negative regulation of epidermal growth factor receptor signaling pathway);GO:0042472(inner ear morphogenesis);GO:0043066(negative regulation of apoptotic process);GO:0043407(negative regulation of MAP kinase activity);GO:0043539(protein serine/threonine kinase activator activity);GO:0045165(cell fate commitment);GO:0046580(negative regulation of Ras protein signal transduction);GO:0051387(negative regulation of nerve growth factor receptor signaling pathway);GO:0051897(positive regulation of protein kinase B signaling cascade);GO:0060437(lung growth);GO:0060449(bud elongation involved in lung branching);GO:0070373(negative regulation of ERK1 and ERK2 cascade);GO:0070374(positive regulation of ERK1 and ERK2 cascade);GO:0071902(positive regulation of protein serine/threonine kinase activity)","04630(Jak-STAT signaling pathway);05206(MicroRNAs in cancer)","mRNA","agilent G3 V3"]
["A_23_P32707",6.36,5.43,5.91,{"v":6,"d":"6.00"},5.85,5.83,{"v":1.00113122171946,"d":"1.00"},{"v":0.00163108557892821,"d":"0.00"},"up",{"v":0.98174,"d":"0.98"},1,"no","CTGGTTGCCCCTTGTTTCTGGGTAATCTCTGGGATGTGACTGACCGCGACATTGACCGCT","FALSE","NM_012291","ref|NM_012291|ens|ENST00000552462|ens|ENST00000549154|ens|ENST00000552671","ESPL1","extra spindle pole bodies homolog 1 (S. cerevisiae)","ref|Homo sapiens extra spindle pole bodies homolog 1 (S. cerevisiae) (ESPL1), mRNA [NM_012291]","chr12",53662116,53687419,"GO:0000070(mitotic sister chromatid segregation);GO:0000212(meiotic spindle organization);GO:0000278(mitotic cell cycle);GO:0000910(cytokinesis);GO:0003824(catalytic activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005813(centrosome);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0006915(apoptotic process);GO:0008234(cysteine-type peptidase activity);GO:0040001(establishment of mitotic spindle localization);GO:0045143(homologous chromosome segregation);GO:0045842(positive regulation of mitotic metaphase/anaphase transition);GO:0045875(negative regulation of sister chromatid cohesion)","04110(Cell cycle);04114(Oocyte meiosis)","mRNA","agilent G3 V3"]
["A_23_P68155",2.83,5.04,4.81,3.27,3.83,5.51,{"v":1.00555114988105,"d":"1.01"},{"v":0.00798646981118739,"d":"0.01"},"up",{"v":0.982,"d":"0.98"},1,"no","CTACGTCCTGGTTGCTCACAGTGGTTCAGGAGTTATCGAACGTGAGACAGTTAATGATTT","FALSE","NM_022168","ref|NM_022168|ens|ENST00000263642|gb|BC111750|gb|AK056293","IFIH1","interferon induced with helicase C domain 1","ref|Homo sapiens interferon induced with helicase C domain 1 (IFIH1), mRNA [NM_022168]","chr2",163123584,163175213,"GO:0003677(DNA binding);GO:0003725(double-stranded RNA binding);GO:0003727(single-stranded RNA binding);GO:0004386(helicase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005829(cytosol);GO:0008270(zinc ion binding);GO:0009597(detection of virus);GO:0009615(response to virus);GO:0016032(viral reproduction);GO:0016925(protein sumoylation);GO:0032480(negative regulation of type I interferon production);GO:0032727(positive regulation of interferon-alpha production);GO:0032728(positive regulation of interferon-beta production);GO:0034344(regulation of type III interferon production);GO:0039528(cytoplasmic pattern recognition receptor signaling pathway in response to virus);GO:0042981(regulation of apoptotic process);GO:0043021(ribonucleoprotein complex binding);GO:0045087(innate immune response)","04622(RIG-I-like receptor signaling pathway);05162(Measles);05164(Influenza A);05161(Hepatitis B);05168(Herpes simplex infection)","mRNA","agilent G3 V3"]
["A_23_P128817",5.55,4.15,5.88,5.36,4.85,5.41,{"v":0.997439180537772,"d":"1.00"},{"v":-0.00369922008031037,"d":"-0.00"},"down",{"v":0.98214,"d":"0.98"},1,"no","CTGGGCAAACCCTGGAAACCTGGTGACAAGGAGCCCTGTGCACATCCCAACTCTCGATTT","FALSE","NM_004563","ref|NM_004563|ref|NM_001291556|ens|ENST00000559503|ens|ENST00000216780","PCK2","phosphoenolpyruvate carboxykinase 2 (mitochondrial)","ref|Homo sapiens phosphoenolpyruvate carboxykinase 2 (mitochondrial) (PCK2), transcript variant 1, mRNA [NM_004563]","chr14",24563262,24573334,"GO:0004611(phosphoenolpyruvate carboxykinase activity);GO:0004613(phosphoenolpyruvate carboxykinase (GTP) activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005739(mitochondrion);GO:0005759(mitochondrial matrix);GO:0005975(carbohydrate metabolic process);GO:0006006(glucose metabolic process);GO:0006090(pyruvate metabolic process);GO:0006094(gluconeogenesis);GO:0006107(oxaloacetate metabolic process);GO:0006116(NADH oxidation);GO:0009405(pathogenesis);GO:0032024(positive regulation of insulin secretion);GO:0044281(small molecule metabolic process);GO:0046872(metal ion binding);GO:0051384(response to glucocorticoid stimulus);GO:0070062(extracellular vesicular exosome);GO:0071333(cellular response to glucose stimulus)","00010(Glycolysis / Gluconeogenesis);00020(Citrate cycle (TCA cycle));00620(Pyruvate metabolism);04068(FoxO signaling pathway);04151(PI3K-Akt signaling pathway);04152(AMPK signaling pathway);04910(Insulin signaling pathway);04922(Glucagon signaling pathway);04920(Adipocytokine signaling pathway);03320(PPAR signaling pathway);04964(Proximal tubule bicarbonate reclamation)","mRNA","agilent G3 V3"]
["A_23_P356694",4.37,4.18,4.64,4.38,{"v":4.4,"d":"4.40"},4.42,{"v":0.999242424242424,"d":"1.00"},{"v":-0.00109336499427105,"d":"-0.00"},"down",{"v":0.9824,"d":"0.98"},1,"no","CCATGAAAATGCAGATGAAGCTCCCAGTGGATTCCCACACTCTATCAATAAACACCTCTG","FALSE","NM_153324","ref|NM_153324|ref|NR_126450|ens|ENST00000376309|gb|AY358859","DEFB123","defensin, beta 123","ref|Homo sapiens defensin, beta 123 (DEFB123), transcript variant 1, mRNA [NM_153324]","chr20",30028322,30038060,"GO:0005576(extracellular region);GO:0009986(cell surface);GO:0042742(defense response to bacterium);GO:0045087(innate immune response)",null,"mRNA","agilent G3 V3"]
["A_33_P3409294",5.16,4.81,4.27,{"v":4.5,"d":"4.50"},4.93,4.79,{"v":1.0014064697609,"d":"1.00"},{"v":0.00202768134698255,"d":"0.00"},"up",{"v":0.98266,"d":"0.98"},1,"no","TTCTACAAGGCCATCGTGTGCGGCAAGGAGATAATCCGTACTGGGGACTGTGCCGTGTTC","FALSE","ENST00000417666","ens|ENST00000417666|ens|ENST00000441896",null,null,"ens|trinucleotide repeat containing 18 pseudogene 2 [Source:HGNC Symbol;Acc:HGNC:34014] [ENST00000417666]","chr7",57059596,57076856,null,null,"mRNA","agilent G3 V3"]
["A_33_P3303507",5.38,2.01,{"v":5.4,"d":"5.40"},3.75,4.49,4.47,{"v":1.00629425649095,"d":"1.01"},{"v":0.00905223387667784,"d":"0.01"},"up",{"v":0.98266,"d":"0.98"},1,"no","TATCTTATATATCTGTATTCGCATGGTAACATATCTTCGGCCTTCCTGAGCCGCTGGGCT","FALSE","THC2683968","tc|THC2683968|tc|THC2654810",null,null,"tc|HSP76_HUMAN (P17066) Heat shock 70 kDa protein 6 (Heat shock 70 kDa protein B'), partial (7%) [THC2683968]","chr1",161569360,161574927,null,null,"mRNA","agilent G3 V3"]
["A_23_P141459",7.05,6.11,6.73,7.28,6.45,6.13,{"v":1.00151057401813,"d":"1.00"},{"v":0.00217765330537011,"d":"0.00"},"up",{"v":0.98296,"d":"0.98"},1,"no","AGCCCTCAACCTCGAGGCCCCAGGTACGCGGAAGGGACTTTCATCAGTGACTACAGTATT","FALSE","NM_004123","ref|NM_004123|ens|ENST00000357424|gb|BC096146|gb|BC096147","GIP","gastric inhibitory polypeptide","ref|Homo sapiens gastric inhibitory polypeptide (GIP), mRNA [NM_004123]","chr17",47035916,47045958,"GO:0005179(hormone activity);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005788(endoplasmic reticulum lumen);GO:0007165(signal transduction);GO:0007565(female pregnancy);GO:0007613(memory);GO:0008344(adult locomotory behavior);GO:0009749(response to glucose stimulus);GO:0010269(response to selenium ion);GO:0010828(positive regulation of glucose transport);GO:0014070(response to organic cyclic compound);GO:0019233(sensory perception of pain);GO:0031018(endocrine pancreas development);GO:0032024(positive regulation of insulin secretion);GO:0033993(response to lipid);GO:0034774(secretory granule lumen);GO:0035640(exploration behavior);GO:0042493(response to drug);GO:0042594(response to starvation);GO:0043025(neuronal cell body);GO:0043200(response to amino acid stimulus);GO:0043434(response to peptide hormone stimulus);GO:0043950(positive regulation of cAMP-mediated signaling);GO:0044267(cellular protein metabolic process);GO:0048678(response to axon injury);GO:0050796(regulation of insulin secretion);GO:0055123(digestive system development);GO:0060291(long-term synaptic potentiation);GO:0070094(positive regulation of glucagon secretion);GO:0070328(triglyceride homeostasis)","04080(Neuroactive ligand-receptor interaction);04911(Insulin secretion)","mRNA","agilent G3 V3"]
["A_23_P374149",4.37,6.65,4.87,5.18,5.41,5.35,{"v":0.996863237139272,"d":"1.00"},{"v":-0.00453250464195252,"d":"-0.00"},"down",{"v":0.98306,"d":"0.98"},1,"no","TTCTTCCCTAATAGGAGGTACAATCTGCTTTTGTTTGTCGTTAAGTGGTCACTCCCATTT","FALSE","NM_015050","ref|NM_015050|ens|ENST00000373451|ref|XM_006715028|gb|AK124393","CMTR1","cap methyltransferase 1","ref|Homo sapiens cap methyltransferase 1 (CMTR1), mRNA [NM_015050]","chr6",37400996,37449282,"GO:0003676(nucleic acid binding);GO:0004483(mRNA (nucleoside-2'-O-)-methyltransferase activity);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006370(mRNA capping);GO:0080009(mRNA methylation);GO:0097309(cap1 mRNA methylation)",null,"mRNA","agilent G3 V3"]
["A_24_P267997",3.44,4.78,3.64,3.95,3.97,3.91,{"v":1.00253592561285,"d":"1.00"},{"v":0.00365393620621533,"d":"0.00"},"up",{"v":0.98308,"d":"0.98"},1,"no","AGAGACACTTGGAACAAGTCTAGGCCTAAAGGAAGTTGAAGAAAAAGTAAGAGATTTTCT","FALSE","NM_015602","ref|NM_015602|ref|NM_001267578|ens|ENST00000528443|gb|JF432539","TOR1AIP1","torsin A interacting protein 1","ref|Homo sapiens torsin A interacting protein 1 (TOR1AIP1), transcript variant 2, mRNA [NM_015602]","chr1",179873104,179887306,"GO:0001671(ATPase activator activity);GO:0005521(lamin binding);GO:0005634(nucleus);GO:0005637(nuclear inner membrane);GO:0008092(cytoskeletal protein binding);GO:0016021(integral to membrane);GO:0032781(positive regulation of ATPase activity);GO:0034504(protein localization to nucleus);GO:0051117(ATPase binding);GO:0071763(nuclear membrane organization)",null,"mRNA","agilent G3 V3"]
["A_23_P119377",5.95,6.37,6.12,6.19,5.99,6.27,{"v":0.999457994579946,"d":"1.00"},{"v":-0.000782160518420303,"d":"-0.00"},"down",{"v":0.98308,"d":"0.98"},1,"no","CTTGGTGGAGAATGAACTGCTGCAGAACACACCCGAGGAGATCGCCCGCTTCCTGTACAA","FALSE","NM_004228","ref|NM_004228|ref|NM_017457|ens|ENST00000474049|ens|ENST00000462117","CYTH2","cytohesin 2","ref|Homo sapiens cytohesin 2 (CYTH2), transcript variant 2, mRNA [NM_004228]","chr19",48972464,48985571,"GO:0005086(ARF guanyl-nucleotide exchange factor activity);GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005802(trans-Golgi network);GO:0005886(plasma membrane);GO:0006897(endocytosis);GO:0008289(lipid binding);GO:0016020(membrane);GO:0016192(vesicle-mediated transport);GO:0030036(actin cytoskeleton organization);GO:0030155(regulation of cell adhesion);GO:0032012(regulation of ARF protein signal transduction);GO:0043547(positive regulation of GTPase activity);GO:0070679(inositol 1,4,5 trisphosphate binding)","04144(Endocytosis)","mRNA","agilent G3 V3"]
["A_21_P0014240",4.72,4.46,4.79,4.44,4.78,4.76,{"v":0.99928469241774,"d":"1.00"},{"v":-0.00103233996597344,"d":"-0.00"},"down",{"v":0.98322,"d":"0.98"},1,"no","CGATTATAAATTTCTCTTCCGCTTTCCCAGTGTAGCTTTGCAAGTGTAAACTATCAATTT","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_21_P0006375",4.01,{"v":1.9,"d":"1.90"},4.13,2.97,3.23,3.79,{"v":1.00500500500501,"d":"1.01"},{"v":0.00720268615835366,"d":"0.01"},"up",{"v":0.98362,"d":"0.98"},1,"no","TCTCAAGCATCTTGGTCTCTGCTAAGAAGAGGCTCAGAGGCTTAGAAGCCCTGCCTCGCC","FALSE","NM_199001","ref|NM_199001|ens|ENST00000409414|linc|lnc-RNF224-1:1|ref|XM_005266084","CYSRT1","cysteine-rich tail protein 1","ref|Homo sapiens cysteine-rich tail protein 1 (CYSRT1), mRNA [NM_199001]","chr9",140119088,140120763,"GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3214803",6.86,6.48,6.92,6.68,{"v":6.9,"d":"6.90"},6.67,{"v":1.00049382716049,"d":"1.00"},{"v":0.000712266141788602,"d":"0.00"},"up",{"v":0.98406,"d":"0.98"},1,"no","ACTCAAGTGCAAAGTCTGTCTGCGGCCCTTCGGCGACCCCAGCAATCTCAACAAGCACAT","FALSE","NM_021620","ref|NM_021620|ens|ENST00000369215|ens|ENST00000369214|gb|BC156413","PRDM13","PR domain containing 13","ref|Homo sapiens PR domain containing 13 (PRDM13), mRNA [NM_021620]","chr6",100054648,100063454,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0008168(methyltransferase activity);GO:0022008(neurogenesis);GO:0032259(methylation);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_24_P16950",4.45,4.02,{"v":4.4,"d":"4.40"},4.19,4.46,4.23,{"v":0.999223602484472,"d":"1.00"},{"v":-0.00112053989391534,"d":"-0.00"},"down",{"v":0.98434,"d":"0.98"},1,"no","AACTCACACCTTGCAAATCATCAAAGGACTCACACCGGAGAGAAACCTTACCGATGCAAT","FALSE","NM_198893","ref|NM_198893|ref|NM_001102603|ref|NM_033288|ens|ENST00000429604","ZNF160","zinc finger protein 160","ref|Homo sapiens zinc finger protein 160 (ZNF160), transcript variant 2, mRNA [NM_198893]","chr19",53569868,53606687,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0030097(hemopoiesis);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_23_P18672",3.14,3.98,4.77,3.84,4.03,3.99,{"v":1.00252951096121,"d":"1.00"},{"v":0.00364470519965226,"d":"0.00"},"up",{"v":0.98508,"d":"0.99"},1,"no","ATTCGGCCCATATTTTGTGTGTTTGGACAAGTACATCTCCCTTTTGCCTAATGAACTTTT","FALSE","NM_020973","ref|NM_020973|ref|NM_001277225|ref|NM_001128432|ref|NR_102355","GBA3","glucosidase, beta, acid 3 (gene/pseudogene)","ref|Homo sapiens glucosidase, beta, acid 3 (gene/pseudogene) (GBA3), transcript variant 1, mRNA [NM_020973]","chr4",22756036,22820905,"GO:0004565(beta-galactosidase activity);GO:0005829(cytosol);GO:0005975(carbohydrate metabolic process);GO:0006665(sphingolipid metabolic process);GO:0006687(glycosphingolipid metabolic process);GO:0008422(beta-glucosidase activity);GO:0016139(glycoside catabolic process);GO:0017042(glycosylceramidase activity);GO:0044281(small molecule metabolic process);GO:0046477(glycosylceramide catabolic process)","00500(Starch and sucrose metabolism);00460(Cyanoamino acid metabolism)","mRNA","agilent G3 V3"]
["A_23_P86532",4.59,3.07,4.33,3.96,4.14,3.92,{"v":0.997504159733777,"d":"1.00"},{"v":-0.00360523729696182,"d":"-0.00"},"down",{"v":0.9851,"d":"0.99"},1,"no","TCCCCAGATTAGAATGTGTTTATTTGGGTTGGAGTATCACTGACTGTGGCCTCTCTGACT","FALSE","ENST00000263103","ens|ENST00000263103|gb|AK026129|gb|AK225429|gb|AK225427","BICC1","BicC family RNA binding protein 1","ens|BicC family RNA binding protein 1 [Source:HGNC Symbol;Acc:HGNC:19351] [ENST00000263103]","chr10",60553296,60574074,"GO:0005737(cytoplasm);GO:0007275(multicellular organismal development);GO:0090090(negative regulation of canonical Wnt receptor signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_23_P57413",4.89,5.32,4.99,5.66,4.92,{"v":4.6,"d":"4.60"},{"v":1.00131752305665,"d":"1.00"},{"v":0.00189953291548163,"d":"0.00"},"up",{"v":0.98528,"d":"0.99"},1,"no","CACACAGACCAGAACGGCAGGATGAGAAGGCGCGCATTGAAGCATTGGGTGGCTTTGTGT","FALSE","NM_014634","ref|NM_014634|ens|ENST00000484588|ens|ENST00000263212|gb|AF520615","PPM1F","protein phosphatase, Mg2+/Mn2+ dependent, 1F","ref|Homo sapiens protein phosphatase, Mg2+/Mn2+ dependent, 1F (PPM1F), mRNA [NM_014634]","chr22",22273792,22307209,"GO:0004722(protein serine/threonine phosphatase activity);GO:0005515(protein binding);GO:0005829(cytosol);GO:0006469(negative regulation of protein kinase activity);GO:0010628(positive regulation of gene expression);GO:0010634(positive regulation of epithelial cell migration);GO:0010811(positive regulation of cell-substrate adhesion);GO:0016576(histone dephosphorylation);GO:0016791(phosphatase activity);GO:0033137(negative regulation of peptidyl-serine phosphorylation);GO:0033192(calmodulin-dependent protein phosphatase activity);GO:0035690(cellular response to drug);GO:0035970(peptidyl-threonine dephosphorylation);GO:0043234(protein complex);GO:0043280(positive regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0044387(negative regulation of protein kinase activity by regulation of protein phosphorylation);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0045927(positive regulation of growth);GO:0046872(metal ion binding);GO:0048471(perinuclear region of cytoplasm);GO:0050921(positive regulation of chemotaxis);GO:0051496(positive regulation of stress fiber assembly);GO:0051894(positive regulation of focal adhesion assembly);GO:0097193(intrinsic apoptotic signaling pathway)",null,"mRNA","agilent G3 V3"]
["A_33_P3312222",4.09,2.69,5.04,3.58,{"v":4.1,"d":"4.10"},4.18,{"v":0.996627318718381,"d":"1.00"},{"v":-0.00487397436847112,"d":"-0.00"},"down",{"v":0.98588,"d":"0.99"},1,"no","AGGATGACAACCCTGCTGTCTTCCATGTCTGAGGAGCAGCTGTCCCGCTACGAAGTGTGT","FALSE","ENST00000512357","ens|ENST00000512357|ens|ENST00000510838|ens|ENST00000503531|ens|ENST00000510009",{"$nulls":3},"chr5",17632196,17632792,null,null,"mRNA","agilent G3 V3"]
["A_23_P117980",5.59,4.11,4.04,4.47,4.74,4.56,{"v":0.997821350762527,"d":"1.00"},{"v":-0.00314655531686438,"d":"-0.00"},"down",{"v":0.98618,"d":"0.99"},1,"no","CCGTCCTGCCACAGATTGAGAAGCTTCTGCAGAGCAAGTATGAGAGCTACGTCCAGACGG","FALSE","NM_005886","ref|NM_005886|ens|ENST00000562542|ens|ENST00000569018|ens|ENST00000379661","KATNB1","katanin p80 (WD repeat containing) subunit B 1","ref|Homo sapiens katanin p80 (WD repeat containing) subunit B 1 (KATNB1), mRNA [NM_005886]","chrHG1208_PATCH",57769640,57791162,"GO:0000922(spindle pole);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005813(centrosome);GO:0005874(microtubule);GO:0005886(plasma membrane);GO:0006605(protein targeting);GO:0007026(negative regulation of microtubule depolymerization);GO:0007079(mitotic chromosome movement towards spindle pole);GO:0008017(microtubule binding);GO:0008152(metabolic process);GO:0008352(katanin complex);GO:0008568(microtubule-severing ATPase activity);GO:0010942(positive regulation of cell death);GO:0010976(positive regulation of neuron projection development);GO:0015630(microtubule cytoskeleton);GO:0016020(membrane);GO:0030424(axon);GO:0030426(growth cone);GO:0030496(midbody);GO:0031117(positive regulation of microtubule depolymerization);GO:0043025(neuronal cell body);GO:0045502(dynein binding);GO:0046982(protein heterodimerization activity);GO:0051013(microtubule severing);GO:0051301(cell division)",null,"mRNA","agilent G3 V3"]
["A_23_P99076",{"v":4.2,"d":"4.20"},4.22,6.97,5.43,5.12,4.89,{"v":0.996761658031088,"d":"1.00"},{"v":-0.00467952093987022,"d":"-0.00"},"down",{"v":0.9866,"d":"0.99"},1,"no","TCAGGGACCACCTTTGGGAGGACAGCAATCTCAACCCTCTGCTGGTGATGGGAACCAGAA","FALSE","NM_005042","ref|NM_005042|ref|NM_001110213|ref|NM_001291314|ref|NM_001291315","PRH2","proline-rich protein HaeIII subfamily 2","ref|Homo sapiens proline-rich protein HaeIII subfamily 2 (PRH2), transcript variant 1, mRNA [NM_005042]","chr12",11081835,11084940,"GO:0005515(protein binding);GO:0005615(extracellular space)","04970(Salivary secretion)","mRNA","agilent G3 V3"]
["A_32_P22622",5.81,6.38,5.25,5.55,5.71,6.16,{"v":1.00114810562572,"d":"1.00"},{"v":0.00165541617806157,"d":"0.00"},"up",{"v":0.98662,"d":"0.99"},1,"no","TTTCTTTTGGAATACGTTGGCGATTTGGCTACAGATGACCCACCAGACCTCACAGTCATT","FALSE","NM_003703","ref|NM_003703|ref|NM_001291979|ref|NM_001291978|ens|ENST00000398071","NOP14","NOP14 nucleolar protein","ref|Homo sapiens NOP14 nucleolar protein (NOP14), transcript variant 2, mRNA [NM_003703]","chr4",{"v":2939840,"d":"2939840.00"},2965060,"GO:0000447(endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0000462(maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0000472(endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0000480(endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA));GO:0005634(nucleus);GO:0005730(nucleolus);GO:0005739(mitochondrion);GO:0006364(rRNA processing);GO:0016020(membrane);GO:0019899(enzyme binding);GO:0030490(maturation of SSU-rRNA);GO:0030515(snoRNA binding);GO:0030686(90S preribosome);GO:0030692(Noc4p-Nop14p complex);GO:0032040(small-subunit processome);GO:0042274(ribosomal small subunit biogenesis)",null,"mRNA","agilent G3 V3"]
["A_23_P19712",4.21,5.03,{"v":2.1,"d":"2.10"},3.08,4.05,4.16,{"v":1.0044286979628,"d":"1.00"},{"v":0.00637515416922807,"d":"0.01"},"up",{"v":0.98668,"d":"0.99"},1,"no","CATAATGCCAACTCTGGAATCAAATTTCCTTGTTTGAATCCTGGGACCCTATTGCATTAA","FALSE","NM_015895","ref|NM_015895|ref|NM_001251989|ref|NM_001251990|ref|NM_001251991","GMNN","geminin, DNA replication inhibitor","ref|Homo sapiens geminin, DNA replication inhibitor (GMNN), transcript variant 1, mRNA [NM_015895]","chr6",24775640,24785935,"GO:0000278(mitotic cell cycle);GO:0003714(transcription corepressor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006461(protein complex assembly);GO:0008156(negative regulation of DNA replication);GO:0009887(organ morphogenesis);GO:0042826(histone deacetylase binding);GO:0045786(negative regulation of cell cycle);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0070491(repressing transcription factor binding)",null,"mRNA","agilent G3 V3"]
["A_21_P0000450",7.81,6.84,8.04,7.45,7.51,7.71,{"v":1.00088222320247,"d":"1.00"},{"v":0.00127221793155134,"d":"0.00"},"up",{"v":0.9867,"d":"0.99"},1,"no","GAATCTGAACAAAATGAGTGACCAAATCATTTCTGTGCCACTTCTGTGAGCTGAGGTCCA","FALSE","NR_003340","ref|NR_003340|ref|NR_003339|gb|AV682586","SNORD116-26","small nucleolar RNA, C/D box 116-26","ref|Homo sapiens small nucleolar RNA, C/D box 116-26 (SNORD116-26), small nucleolar RNA [NR_003340]","chr15",25344644,25344742,null,null,"mRNA","agilent G3 V3"]
["A_33_P3262043",4.71,5.05,8.65,{"v":5.9,"d":"5.90"},6.22,6.22,{"v":1.00381679389313,"d":"1.00"},{"v":0.005495987754852,"d":"0.01"},"up",{"v":0.98696,"d":"0.99"},1,"no","TTCCCTTCCGGTGCGTGTGAAGCCACGGAAGGCTTGGTCCCATCGGAAGTTTTGGGTTTT","FALSE","NM_004322","ref|NM_004322|ref|NM_032989|ens|ENST00000309032|ens|ENST00000394532","BAD","BCL2-associated agonist of cell death","ref|Homo sapiens BCL2-associated agonist of cell death (BAD), transcript variant 1, mRNA [NM_004322]","chr11",64037780,64040328,"GO:0001836(release of cytochrome c from mitochondria);GO:0005515(protein binding);GO:0005543(phospholipid binding);GO:0005739(mitochondrion);GO:0005741(mitochondrial outer membrane);GO:0005829(cytosol);GO:0006007(glucose catabolic process);GO:0006915(apoptotic process);GO:0006919(activation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0008289(lipid binding);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0008625(induction of apoptosis via death domain receptors);GO:0008630(DNA damage response, signal transduction resulting in induction of apoptosis);GO:0008656(cysteine-type endopeptidase activator activity involved in apoptotic process);GO:0009749(response to glucose stimulus);GO:0010508(positive regulation of autophagy);GO:0010918(positive regulation of mitochondrial membrane potential);GO:0019050(suppression by virus of host apoptosis);GO:0019221(cytokine-mediated signaling pathway);GO:0019901(protein kinase binding);GO:0030346(protein phosphatase 2B binding);GO:0032024(positive regulation of insulin secretion);GO:0032355(response to estradiol stimulus);GO:0032570(response to progesterone stimulus);GO:0033133(positive regulation of glucokinase activity);GO:0033574(response to testosterone stimulus);GO:0034201(response to oleic acid);GO:0035774(positive regulation of insulin secretion involved in cellular response to glucose stimulus);GO:0038095(Fc-epsilon receptor signaling pathway);GO:0042493(response to drug);GO:0042542(response to hydrogen peroxide);GO:0042593(glucose homeostasis);GO:0043065(positive regulation of apoptotic process);GO:0043200(response to amino acid stimulus);GO:0043280(positive regulation of cysteine-type endopeptidase activity involved in apoptotic process);GO:0043422(protein kinase B binding);GO:0044342(type B pancreatic cell proliferation);GO:0045087(innate immune response);GO:0045471(response to ethanol);GO:0045579(positive regulation of B cell differentiation);GO:0045582(positive regulation of T cell differentiation);GO:0045862(positive regulation of proteolysis);GO:0046031(ADP metabolic process);GO:0046034(ATP metabolic process);GO:0046902(regulation of mitochondrial membrane permeability);GO:0046931(pore complex assembly);GO:0046982(protein heterodimerization activity);GO:0048011(nerve growth factor receptor signaling pathway);GO:0048015(phosphatidylinositol-mediated signaling);GO:0050679(positive regulation of epithelial cell proliferation);GO:0051384(response to glucocorticoid stimulus);GO:0051592(response to calcium ion);GO:0060139(positive regulation of apoptotic process by virus);GO:0060154(cellular process regulating host cell cycle in response to virus);GO:0071247(cellular response to chromate);GO:0071260(cellular response to mechanical stimulus);GO:0071316(cellular response to nicotine);GO:0071396(cellular response to lipid);GO:0071456(cellular response to hypoxia);GO:0090200(positive regulation of release of cytochrome c from mitochondria);GO:0097190(apoptotic signaling pathway);GO:0097191(extrinsic apoptotic signaling pathway)","04014(Ras signaling pathway);04012(ErbB signaling pathway);04370(VEGF signaling pathway);04024(cAMP signaling pathway);04022(cGMP - PKG signaling pathway);04151(PI3K-Akt signaling pathway);04210(Apoptosis);04510(Focal adhesion);04910(Insulin signaling pathway);04919(Thyroid hormone signaling pathway);04722(Neurotrophin signaling pathway);05200(Pathways in cancer);05203(Viral carcinogenesis);05210(Colorectal cancer);05212(Pancreatic cancer);05221(Acute myeloid leukemia);05220(Chronic myeloid leukemia);05218(Melanoma);05215(Prostate cancer);05213(Endometrial cancer);05223(Non-small cell lung cancer);05010(Alzheimer's disease);05014(Amyotrophic lateral sclerosis (ALS));05152(Tuberculosis);05161(Hepatitis B);05160(Hepatitis C);05145(Toxoplasmosis)","mRNA","agilent G3 V3"]
["A_33_P3375185",7.54,6.93,7.32,7.37,7.36,7.05,{"v":1.00045913682277,"d":"1.00"},{"v":0.00066224239899986,"d":"0.00"},"up",{"v":0.98792,"d":"0.99"},1,"no","CGCGATGGGCTGGCCTCGGTCTCCTACACCAACACCTCGCTCTTCGCGGTGGCCACGGTC","FALSE","NM_001013632","ref|NM_001013632|ens|ENST00000339355|ref|XM_005270819|ref|XM_006710614","TCTEX1D4","Tctex1 domain containing 4","ref|Homo sapiens Tctex1 domain containing 4 (TCTEX1D4), mRNA [NM_001013632]","chr1",45271588,45272957,"GO:0001669(acrosomal vesicle);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005815(microtubule organizing center);GO:0005930(axoneme);GO:0036126(sperm flagellum)",null,"mRNA","agilent G3 V3"]
["A_23_P41380",6.66,6.08,6.55,6.61,6.45,6.22,{"v":1.00051867219917,"d":"1.00"},{"v":0.000748091819141878,"d":"0.00"},"up",{"v":0.98814,"d":"0.99"},1,"no","AGGCAACATTAATGCAAAAGTCCCCAGATGGCAATACAAAGTATCCCCTGGTACCACATA","FALSE","NM_002940","ref|NM_002940|ref|NM_001040876|ens|ENST00000296577|gb|BC016988","ABCE1","ATP-binding cassette, sub-family E (OABP), member 1","ref|Homo sapiens ATP-binding cassette, sub-family E (OABP), member 1 (ABCE1), transcript variant 1, mRNA [NM_002940]","chr4",146044016,146048795,"GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0006401(RNA catabolic process);GO:0008428(ribonuclease inhibitor activity);GO:0009615(response to virus);GO:0016020(membrane);GO:0016032(viral reproduction);GO:0016887(ATPase activity);GO:0043086(negative regulation of catalytic activity);GO:0051536(iron-sulfur cluster binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3414422",2.27,5.84,3.93,3.55,4.38,4.16,{"v":0.99586435070306,"d":"1.00"},{"v":-0.00597885248942156,"d":"-0.01"},"down",{"v":0.98822,"d":"0.99"},1,"no","GATCTTGTACAGATATTAGTGTTACCAGCATTCATGTGGAAATCAAGAGCAAAGACAAAA","FALSE","NM_020806","ref|NM_020806|ref|NM_001024218|ens|ENST00000315266|ens|ENST00000478722","GPHN","gephyrin","ref|Homo sapiens gephyrin (GPHN), transcript variant 1, mRNA [NM_020806]","chr14",67647568,67648509,"GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005856(cytoskeleton);GO:0005886(plasma membrane);GO:0006766(vitamin metabolic process);GO:0006767(water-soluble vitamin metabolic process);GO:0006777(Mo-molybdopterin cofactor biosynthetic process);GO:0007529(establishment of synaptic specificity at neuromuscular junction);GO:0016740(transferase activity);GO:0018315(molybdenum incorporation into molybdenum-molybdopterin complex);GO:0030054(cell junction);GO:0032324(molybdopterin cofactor biosynthetic process);GO:0044281(small molecule metabolic process);GO:0045211(postsynaptic membrane);GO:0046872(metal ion binding);GO:0060077(inhibitory synapse);GO:0072579(glycine receptor clustering)","04727(GABAergic synapse)","mRNA","agilent G3 V3"]
["A_33_P3245278",5.46,2.61,3.71,3.84,4.09,3.89,{"v":0.996615905245347,"d":"1.00"},{"v":-0.00489049634707165,"d":"-0.00"},"down",{"v":0.98868,"d":"0.99"},1,"no","ACGCTGGCTGCTGTCATGCCATCTGGGTATGCATTAAACATTAATGATGATCAGCACTGA","FALSE","NM_002841","ref|NM_002841|ens|ENST00000615556|ens|ENST00000618938|gb|AB209871","PTPRG","protein tyrosine phosphatase, receptor type, G","ref|Homo sapiens protein tyrosine phosphatase, receptor type, G (PTPRG), mRNA [NM_002841]","chr3",61547584,62283288,"GO:0004725(protein tyrosine phosphatase activity);GO:0005001(transmembrane receptor protein tyrosine phosphatase activity);GO:0005515(protein binding);GO:0005615(extracellular space);GO:0005887(integral to plasma membrane);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007420(brain development);GO:0010633(negative regulation of epithelial cell migration);GO:0010977(negative regulation of neuron projection development);GO:0035335(peptidyl-tyrosine dephosphorylation);GO:0042802(identical protein binding);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P128174",{"v":4.9,"d":"4.90"},{"v":3.2,"d":"3.20"},5.24,4.49,4.52,{"v":4.3,"d":"4.30"},{"v":1.0022539444027,"d":"1.00"},{"v":0.00324809527269359,"d":"0.00"},"up",{"v":0.98886,"d":"0.99"},1,"no","ATTTCCAAGGAGTGAGCCTAAGACTTTTTTCCCCTTTTGCAAATTGCTCTAAGAAGTACC","FALSE","NM_175623","ref|NM_175623|ref|NM_175625|ref|NM_022456|ref|NM_175624","RAB3IP","RAB3A interacting protein","ref|Homo sapiens RAB3A interacting protein (RAB3IP), transcript variant alpha 2, mRNA [NM_175623]","chr12",70132640,70209503,"GO:0005515(protein binding);GO:0005634(nucleus);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005856(cytoskeleton);GO:0006612(protein targeting to membrane);GO:0006893(Golgi to plasma membrane transport);GO:0006996(organelle organization);GO:0017112(Rab guanyl-nucleotide exchange factor activity);GO:0030027(lamellipodium);GO:0032851(positive regulation of Rab GTPase activity);GO:0033365(protein localization to organelle);GO:0036064(cilium basal body);GO:0042384(cilium assembly)",null,"mRNA","agilent G3 V3"]
["A_33_P3215838",4.96,8.22,5.12,5.86,6.86,5.63,{"v":0.997275204359673,"d":"1.00"},{"v":-0.00393641455917037,"d":"-0.00"},"down",{"v":0.9889,"d":"0.99"},1,"no","ATGTCTCTTGGTAACTGGCTTCGGTTGTGTCTCTCCGTGTGACTATTTTGTTCTCTCTCT","FALSE","ENST00000595151","ens|ENST00000595151|tc|THC2480105","KLK3","kallikrein-related peptidase 3","ens|kallikrein-related peptidase 3 [Source:HGNC Symbol;Acc:HGNC:6364] [ENST00000595151]","chr19",51358176,51359985,"GO:0004252(serine-type endopeptidase activity);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005634(nucleus);GO:0006508(proteolysis);GO:0008236(serine-type peptidase activity);GO:0016525(negative regulation of angiogenesis);GO:0044267(cellular protein metabolic process);GO:0070062(extracellular vesicular exosome)","05200(Pathways in cancer);05215(Prostate cancer)","mRNA","agilent G3 V3"]
["A_32_P106732",1.87,7.74,1.87,3.69,4.04,3.66,{"v":1.00790166812994,"d":"1.01"},{"v":0.0113548949675758,"d":"0.01"},"up",{"v":0.98918,"d":"0.99"},1,"no","AATCAAGCTGCTCAAGATGGGGTTTTCAAAGACCTCTCACAATATTAAATGCACTTCAAT","FALSE","NM_020937","ref|NM_020937|ens|ENST00000267430|ref|XM_005267929|gb|AK001672","FANCM","Fanconi anemia, complementation group M","ref|Homo sapiens Fanconi anemia, complementation group M (FANCM), mRNA [NM_020937]","chr14",45667640,45669174,"GO:0000712(resolution of meiotic recombination intermediates);GO:0003677(DNA binding);GO:0003682(chromatin binding);GO:0004386(helicase activity);GO:0004518(nuclease activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005654(nucleoplasm);GO:0006281(DNA repair);GO:0031297(replication fork processing);GO:0043240(Fanconi anaemia nuclear complex);GO:0071821(FANCM-MHF complex);GO:0090305(nucleic acid phosphodiester bond hydrolysis)","03460(Fanconi anemia pathway)","mRNA","agilent G3 V3"]
["A_33_P3230658",{"v":4.5,"d":"4.50"},6.35,2.59,4.47,{"v":4.3,"d":"4.30"},4.62,{"v":1.00373412994772,"d":"1.00"},{"v":0.00537717745444955,"d":"0.01"},"up",{"v":0.98918,"d":"0.99"},1,"no","GTGGAAGCTGTCTCTTTTCAACACTTCATCAAAACACGATCATTAATTAGTATGGATGAA","FALSE","NM_005999","ref|NM_005999|ref|NR_028399|ref|NR_028397|ref|NR_028398","TSNAX","translin-associated factor X","ref|Homo sapiens translin-associated factor X (TSNAX), mRNA [NM_005999]","chr1",231669872,231702270,"GO:0003677(DNA binding);GO:0003697(single-stranded DNA binding);GO:0004521(endoribonuclease activity);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0007275(multicellular organismal development);GO:0007283(spermatogenesis);GO:0008565(protein transporter activity);GO:0010467(gene expression);GO:0015031(protein transport);GO:0030154(cell differentiation);GO:0043565(sequence-specific DNA binding);GO:0046872(metal ion binding);GO:0048471(perinuclear region of cytoplasm)",null,"mRNA","agilent G3 V3"]
["A_21_P0000274",11.36,11.47,11.11,11.08,11.14,11.73,{"v":0.999705449189985,"d":"1.00"},{"v":-0.000425009589430927,"d":"-0.00"},"down",{"v":0.98928,"d":"0.99"},1,"no","GTGATGACCCCAACATGCCATCTGAGTGTCGGTGCTGAAATCCAGAGGCTGTTTCTGAGC","FALSE","NR_002591","ref|NR_002591|ens|ENST00000503170|tc|THC2514057|tc|THC2507077","SNORD95","small nucleolar RNA, C/D box 95","ref|Homo sapiens small nucleolar RNA, C/D box 95 (SNORD95), small nucleolar RNA [NR_002591]","chr5",180670320,180670376,null,null,"mRNA","agilent G3 V3"]
["A_21_P0000076",4.07,1.91,5.05,3.51,3.51,3.97,{"v":1.00363967242948,"d":"1.00"},{"v":0.00524140464215184,"d":"0.01"},"up",{"v":0.98936,"d":"0.99"},1,"no","TTGGACTTTCTGCTTTTATGTCTTGCTTAAGTCTTCCTCACTCAAAGATCGAATGTATTA","FALSE","NM_001170406","ref|NM_001170406|ref|NM_001170407|ens|ENST00000475504|gb|AK295741","CDK1","cyclin-dependent kinase 1","ref|Homo sapiens cyclin-dependent kinase 1 (CDK1), transcript variant 4, mRNA [NM_001170406]","chr10",62538088,62546827,"GO:0000082(G1/S transition of mitotic cell cycle);GO:0000083(regulation of transcription involved in G1/S phase of mitotic cell cycle);GO:0000086(G2/M transition of mitotic cell cycle);GO:0000165(MAPK cascade);GO:0000186(activation of MAPKK activity);GO:0000187(activation of MAPK activity);GO:0000226(microtubule cytoskeleton organization);GO:0000278(mitotic cell cycle);GO:0002224(toll-like receptor signaling pathway);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0002756(MyD88-independent toll-like receptor signaling pathway);GO:0004672(protein kinase activity);GO:0004674(protein serine/threonine kinase activity);GO:0004693(cyclin-dependent protein kinase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005813(centrosome);GO:0005829(cytosol);GO:0005876(spindle microtubule);GO:0006260(DNA replication);GO:0006281(DNA repair);GO:0006461(protein complex assembly);GO:0006915(apoptotic process);GO:0006996(organelle organization);GO:0007067(mitosis);GO:0007077(mitotic nuclear envelope disassembly);GO:0007095(mitotic cell cycle G2/M transition DNA damage checkpoint);GO:0007098(centrosome cycle);GO:0007173(epidermal growth factor receptor signaling pathway);GO:0007264(small GTPase mediated signal transduction);GO:0007265(Ras protein signal transduction);GO:0007344(pronuclear fusion);GO:0007411(axon guidance);GO:0007569(cell aging);GO:0008286(insulin receptor signaling pathway);GO:0008353(RNA polymerase II carboxy-terminal domain kinase activity);GO:0008543(fibroblast growth factor receptor signaling pathway);GO:0009636(response to toxin);GO:0010628(positive regulation of gene expression);GO:0014038(regulation of Schwann cell differentiation);GO:0014070(response to organic cyclic compound);GO:0014075(response to amine stimulus);GO:0014823(response to activity);GO:0016020(membrane);GO:0016477(cell migration);GO:0016572(histone phosphorylation);GO:0018105(peptidyl-serine phosphorylation);GO:0018107(peptidyl-threonine phosphorylation);GO:0030261(chromosome condensation);GO:0030332(cyclin binding);GO:0030496(midbody);GO:0030544(Hsp70 protein binding);GO:0030855(epithelial cell differentiation);GO:0031100(organ regeneration);GO:0031145(anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process);GO:0033160(positive regulation of protein import into nucleus, translocation);GO:0034134(toll-like receptor 2 signaling pathway);GO:0034138(toll-like receptor 3 signaling pathway);GO:0034142(toll-like receptor 4 signaling pathway);GO:0034146(toll-like receptor 5 signaling pathway);GO:0034162(toll-like receptor 9 signaling pathway);GO:0034166(toll-like receptor 10 signaling pathway);GO:0034501(protein localization to kinetochore);GO:0035173(histone kinase activity);GO:0035666(TRIF-dependent toll-like receptor signaling pathway);GO:0038095(Fc-epsilon receptor signaling pathway);GO:0038123(toll-like receptor TLR1:TLR2 signaling pathway);GO:0038124(toll-like receptor TLR6:TLR2 signaling pathway);GO:0042493(response to drug);GO:0043066(negative regulation of apoptotic process)","04110(Cell cycle);04114(Oocyte meiosis);04115(p53 signaling pathway);04540(Gap junction);04914(Progesterone-mediated oocyte maturation);05203(Viral carcinogenesis);05168(Herpes simplex infection);05169(Epstein-Barr virus infection)","mRNA","agilent G3 V3"]
["A_23_P82823",{"v":6.1,"d":"6.10"},4.24,6.43,6.03,5.57,{"v":5.2,"d":"5.20"},{"v":0.998214285714286,"d":"1.00"},{"v":-0.00257854410177651,"d":"-0.00"},"down",{"v":0.98962,"d":"0.99"},1,"no","AGAACAAGCCCCAGGTTCCAGTTCCAGGGTCTGACATTTCTGAGACGCAGGTGGAACGTA","FALSE","NM_017884","ref|NM_017884|ref|NM_001284356|ens|ENST00000519088|ens|ENST00000314787","PINX1","PIN2/TERF1 interacting, telomerase inhibitor 1","ref|Homo sapiens PIN2/TERF1 interacting, telomerase inhibitor 1 (PINX1), transcript variant 1, mRNA [NM_017884]","chr8",10622475,10697386,"GO:0000228(nuclear chromosome);GO:0000776(kinetochore);GO:0000777(condensed chromosome kinetochore);GO:0000781(chromosome, telomeric region);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005730(nucleolus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0005819(spindle);GO:0007004(telomere maintenance via telomerase);GO:0007080(mitotic metaphase plate congression);GO:0008285(negative regulation of cell proliferation);GO:0010521(telomerase inhibitor activity);GO:0043231(intracellular membrane-bounded organelle);GO:0051972(regulation of telomerase activity);GO:0051974(negative regulation of telomerase activity);GO:0070034(telomeric RNA binding)",null,"mRNA","agilent G3 V3"]
["A_24_P48403",3.28,3.83,3.99,3.61,3.55,3.95,{"v":0.999099909990999,"d":"1.00"},{"v":-0.00129914015162341,"d":"-0.00"},"down",{"v":0.98994,"d":"0.99"},1,"no","CTGGTACTAAAAATTGTGGTTGTTTTTTCTGTTTACGTAACCTGCTTAGTATTGACACTC","FALSE","NM_005433","ref|NM_005433|ens|ENST00000314574|ens|ENST00000584307|ref|XM_005258139","YES1","YES proto-oncogene 1, Src family tyrosine kinase","ref|Homo sapiens YES proto-oncogene 1, Src family tyrosine kinase (YES1), mRNA [NM_005433]","chr18",{"v":721748,"d":"721748.00"},812239,"GO:0004713(protein tyrosine kinase activity);GO:0004715(non-membrane spanning protein tyrosine kinase activity);GO:0005102(receptor binding);GO:0005154(epidermal growth factor receptor binding);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005815(microtubule organizing center);GO:0005829(cytosol);GO:0005884(actin filament);GO:0005886(plasma membrane);GO:0005925(focal adhesion);GO:0006464(cellular protein modification process);GO:0007169(transmembrane receptor protein tyrosine kinase signaling pathway);GO:0007411(axon guidance);GO:0007596(blood coagulation);GO:0015758(glucose transport);GO:0019899(enzyme binding);GO:0030154(cell differentiation);GO:0031234(extrinsic to internal side of plasma membrane);GO:0031295(T cell costimulation);GO:0036120(cellular response to platelet-derived growth factor stimulus);GO:0038083(peptidyl-tyrosine autophosphorylation);GO:0038096(Fc-gamma receptor signaling pathway involved in phagocytosis);GO:0042127(regulation of cell proliferation);GO:0043114(regulation of vascular permeability);GO:0044325(ion channel binding);GO:0045087(innate immune response);GO:0048013(ephrin receptor signaling pathway);GO:0050900(leukocyte migration);GO:0070062(extracellular vesicular exosome);GO:0071375(cellular response to peptide hormone stimulus)","04520(Adherens junction);04530(Tight junction)","mRNA","agilent G3 V3"]
["A_21_P0000054",2.08,5.76,2.07,2.93,{"v":3.4,"d":"3.40"},3.63,{"v":0.994979919678715,"d":"0.99"},{"v":-0.00726068488159285,"d":"-0.01"},"down",{"v":0.98996,"d":"0.99"},1,"no","CCTGTGTGAAGGTTTGTTTTTCCAACCTGTGAAAGAAACGTGAATGTAAAAGAGACCTAA","FALSE","NM_001164811","ref|NM_001164811|ens|ENST00000432901|tc|THC2612109","PET117","PET117 homolog (S. cerevisiae)","ref|Homo sapiens PET117 homolog (S. cerevisiae) (PET117), mRNA [NM_001164811]","chr20",18118498,18123812,"GO:0005739(mitochondrion)",null,"mRNA","agilent G3 V3"]
["A_33_P3288491",5.31,5.24,4.72,{"v":5.2,"d":"5.20"},5.34,4.74,{"v":0.99934554973822,"d":"1.00"},{"v":-0.000944481238897243,"d":"-0.00"},"down",{"v":0.99038,"d":"0.99"},1,"no","GACAAGAAACCTTCTGCCCTAGTCAAAATGCCTTCTGTCGCCAGGGACACAAACCCAGCT","FALSE","NM_001081675","ref|NM_001081675|ens|ENST00000325995|ref|XM_005250901|gb|BC127886","KLHL38","kelch-like family member 38","ref|Homo sapiens kelch-like family member 38 (KLHL38), mRNA [NM_001081675]","chr8",124657768,124665190,"GO:0005515(protein binding)",null,"mRNA","agilent G3 V3"]
["A_23_P147826",1.86,6.29,1.87,3.28,3.16,3.64,{"v":0.994047619047619,"d":"0.99"},{"v":-0.00861313030470819,"d":"-0.01"},"down",{"v":0.99046,"d":"0.99"},1,"no","ACCTCAATCATGGCCATACCGAGCAGATAAAACTCAGAGGAAATTTGCACAGATGCTGCT","FALSE","NM_021183","ref|NM_021183|ref|NM_001271186|ref|NM_001271187|ref|NR_073150","RAP2C","RAP2C, member of RAS oncogene family","ref|Homo sapiens RAP2C, member of RAS oncogene family (RAP2C), transcript variant 2, mRNA [NM_021183]","chrX",131337056,131352152,"GO:0003713(transcription coactivator activity);GO:0005525(GTP binding);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0005923(tight junction);GO:0006184(GTP catabolic process);GO:0019003(GDP binding);GO:0030033(microvillus assembly);GO:0030336(negative regulation of cell migration);GO:0031954(positive regulation of protein autophosphorylation);GO:0032486(Rap protein signal transduction);GO:0044291(cell-cell contact zone);GO:0055038(recycling endosome membrane);GO:0061097(regulation of protein tyrosine kinase activity);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_33_P3372074",4.19,5.63,3.41,3.68,5.22,4.36,{"v":0.997737556561086,"d":"1.00"},{"v":-0.00326771383391114,"d":"-0.00"},"down",{"v":0.99048,"d":"0.99"},1,"no","GTAGTGGGCTGGGTTTTAAGTTATAAATGTTAACTGCCTCTGGGTGAAAAAGTTTTTAAT","FALSE","NM_001031803","ref|NM_001031803|ref|NM_004524|ens|ENST00000578638|ens|ENST00000392550","LLGL2","lethal giant larvae homolog 2 (Drosophila)","ref|Homo sapiens lethal giant larvae homolog 2 (Drosophila) (LLGL2), transcript variant 3, mRNA [NM_001031803]","chr17",73570232,73571288,"GO:0005515(protein binding);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006887(exocytosis);GO:0007049(cell cycle);GO:0030165(PDZ domain binding);GO:0032878(regulation of establishment or maintenance of cell polarity);GO:0043231(intracellular membrane-bounded organelle);GO:0051301(cell division)","04390(Hippo signaling pathway);04530(Tight junction)","mRNA","agilent G3 V3"]
["A_33_P3212930",5.05,3.26,5.06,{"v":4.7,"d":"4.70"},4.48,4.21,{"v":0.998506348020911,"d":"1.00"},{"v":-0.00215649523095811,"d":"-0.00"},"down",{"v":0.99186,"d":"0.99"},1,"no","AAACCTGCTCAAAAAATGTATCCTTCTCAATCCCAGCAAGAGAGGCCCTTCAGAGCACAT","FALSE","ENST00000605714","ens|ENST00000605714",{"$nulls":3},"chr10",91597368,91599091,null,null,"mRNA","agilent G3 V3"]
["A_33_P3383351",6.67,{"v":6.1,"d":"6.10"},6.45,5.87,6.67,6.67,{"v":1.00052056220718,"d":"1.00"},{"v":0.000750817108223001,"d":"0.00"},"up",{"v":0.99204,"d":"0.99"},1,"no","GTCTCTCTGTGTGACCCACAAGGACATTTGTCGTTGGATTTAGGGCCCATCCTAATCTAG","FALSE","ENST00000464187","ens|ENST00000464187|gb|AK057231|tc|THC2607593","COL5A1","collagen, type V, alpha 1","ens|collagen, type V, alpha 1 [Source:HGNC Symbol;Acc:HGNC:2209] [ENST00000464187]","chr9",137545024,137601073,"GO:0001568(blood vessel development);GO:0003007(heart morphogenesis);GO:0005178(integrin binding);GO:0005201(extracellular matrix structural constituent);GO:0005576(extracellular region);GO:0005588(collagen type V);GO:0005604(basement membrane);GO:0005788(endoplasmic reticulum lumen);GO:0007155(cell adhesion);GO:0007411(axon guidance);GO:0008201(heparin binding);GO:0016477(cell migration);GO:0022617(extracellular matrix disassembly);GO:0030198(extracellular matrix organization);GO:0030199(collagen fibril organization);GO:0030574(collagen catabolic process);GO:0031012(extracellular matrix);GO:0032964(collagen biosynthetic process);GO:0035313(wound healing, spreading of epidermal cells);GO:0035989(tendon development);GO:0043206(fibril organization);GO:0043394(proteoglycan binding);GO:0043588(skin development);GO:0045112(integrin biosynthetic process);GO:0046872(metal ion binding);GO:0048407(platelet-derived growth factor binding);GO:0048592(eye morphogenesis);GO:0051128(regulation of cellular component organization);GO:0070062(extracellular vesicular exosome)","04151(PI3K-Akt signaling pathway);04512(ECM-receptor interaction);04510(Focal adhesion);04611(Platelet activation);04974(Protein digestion and absorption);05146(Amoebiasis)","mRNA","agilent G3 V3"]
["A_33_P3332066",{"v":4.8,"d":"4.80"},4.07,4.41,4.01,4.82,4.46,{"v":0.999247554552295,"d":"1.00"},{"v":-0.00108595792924956,"d":"-0.00"},"down",{"v":0.99206,"d":"0.99"},1,"no","TGAGAAGAGGAAGCAATATGTGAAATCTCTCTCCAGGGTGTTGAAAGTAAAAGGCTTTTT","FALSE","NM_212554","ref|NM_212554|ens|ENST00000468738|ens|ENST00000498770|ens|ENST00000464099","METTL10","methyltransferase like 10","ref|Homo sapiens methyltransferase like 10 (METTL10), mRNA [NM_212554]","chr10",126449040,126454360,"GO:0008168(methyltransferase activity);GO:0032259(methylation)",null,"mRNA","agilent G3 V3"]
["A_33_P3328736",4.49,5.49,{"v":5.1,"d":"5.10"},4.91,5.32,4.86,{"v":0.999337309476474,"d":"1.00"},{"v":-0.000956377258019004,"d":"-0.00"},"down",{"v":0.99232,"d":"0.99"},1,"no","GCTTGCTGAAGAGACTTGTTTTCTTCTTCTAAGACAGTGGTTTTGTTTTTTGGGTTTTTT","FALSE","NM_199342","ref|NM_199342|ens|ENST00000372521|ens|ENST00000372522|gb|AK291356","CCDC23","coiled-coil domain containing 23","ref|Homo sapiens coiled-coil domain containing 23 (CCDC23), mRNA [NM_199342]","chr1",43272840,43282954,"GO:0009306(protein secretion);GO:0010596(negative regulation of endothelial cell migration);GO:0031397(negative regulation of protein ubiquitination);GO:0045177(apical part of cell)",null,"mRNA","agilent G3 V3"]
["A_33_P3284508",10.18,{"v":11,"d":"11.00"},10.06,10.67,10.38,10.18,{"v":1.00032020493116,"d":"1.00"},{"v":0.00046188412140602,"d":"0.00"},"up",{"v":0.99238,"d":"0.99"},1,"no","GTTGAGGACTTTTCGACCAATTCAACCCTTTGCCCCACCTTTATTAAAATCTTAAACAAC","FALSE","NM_001174104","ref|NM_001174104|ref|NM_000591|ref|NM_001040021|ref|NM_001174105","CD14","CD14 molecule","ref|Homo sapiens CD14 molecule (CD14), transcript variant 3, mRNA [NM_001174104]","chr5",140011312,140013286,"GO:0001530(lipopolysaccharide binding);GO:0001847(opsonin receptor activity);GO:0002224(toll-like receptor signaling pathway);GO:0002755(MyD88-dependent toll-like receptor signaling pathway);GO:0002756(MyD88-independent toll-like receptor signaling pathway);GO:0005515(protein binding);GO:0005576(extracellular region);GO:0005615(extracellular space);GO:0005886(plasma membrane);GO:0006909(phagocytosis);GO:0006915(apoptotic process);GO:0006954(inflammatory response);GO:0007166(cell surface receptor signaling pathway);GO:0007249(I-kappaB kinase/NF-kappaB cascade);GO:0009408(response to heat);GO:0009986(cell surface);GO:0010008(endosome membrane);GO:0016019(peptidoglycan receptor activity);GO:0031225(anchored to membrane);GO:0032026(response to magnesium ion);GO:0032760(positive regulation of tumor necrosis factor production);GO:0034134(toll-like receptor 2 signaling pathway);GO:0034138(toll-like receptor 3 signaling pathway);GO:0034142(toll-like receptor 4 signaling pathway);GO:0034612(response to tumor necrosis factor);GO:0035666(TRIF-dependent toll-like receptor signaling pathway);GO:0038123(toll-like receptor TLR1:TLR2 signaling pathway);GO:0038124(toll-like receptor TLR6:TLR2 signaling pathway);GO:0045087(innate immune response);GO:0045121(membrane raft);GO:0045471(response to ethanol);GO:0045807(positive regulation of endocytosis);GO:0050715(positive regulation of cytokine secretion);GO:0051602(response to electrical stimulus);GO:0070062(extracellular vesicular exosome);GO:0070891(lipoteichoic acid binding);GO:0071222(cellular response to lipopolysaccharide);GO:0071223(cellular response to lipoteichoic acid)","04010(MAPK signaling pathway);04064(NF-kappa B signaling pathway);04145(Phagosome);04810(Regulation of actin cytoskeleton);04640(Hematopoietic cell lineage);04620(Toll-like receptor signaling pathway);05202(Transcriptional misregulation in cancers);05130(Pathogenic Escherichia coli infection);05132(Salmonella infection);05133(Pertussis);05134(Legionellosis);05152(Tuberculosis);05146(Amoebiasis)","mRNA","agilent G3 V3"]
["A_23_P27744",2.37,7.99,2.39,3.99,4.55,4.15,{"v":1.00472813238771,"d":"1.00"},{"v":0.00680517790511438,"d":"0.01"},"up",{"v":0.99246,"d":"0.99"},1,"no","TTTCTTTAAGAATCCTTTGGTCAACCAGGACCTTGATTTTTCAGGCATTTTGGTCTGGGG","FALSE","NM_001080469","ref|NM_001080469|ens|ENST00000317683|gb|BC046245|gb|BC008046","FBXO46","F-box protein 46","ref|Homo sapiens F-box protein 46 (FBXO46), mRNA [NM_001080469]","chr19",46213888,46234162,"GO:0005515(protein binding)",null,"mRNA","agilent G3 V3"]
["A_23_P148194",7.25,6.36,7.11,7.29,6.78,6.64,{"v":1.00048285852245,"d":"1.00"},{"v":0.000696449466041831,"d":"0.00"},"up",{"v":0.99264,"d":"0.99"},1,"no","GAACTAACACGCGCCTCGTAAAGGTCCCCAATGTAATGACTGAGCAGAAAATCAATCACT","FALSE","NM_018269","ref|NM_018269|ref|XM_005264696|gb|AB158319|gb|AF403478","ADI1","acireductone dioxygenase 1","ref|Homo sapiens acireductone dioxygenase 1 (ADI1), mRNA [NM_018269]","chr2",{"v":3502432,"d":"3502432.00"},3504587,"GO:0000096(sulfur amino acid metabolic process);GO:0005506(iron ion binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005794(Golgi apparatus);GO:0005829(cytosol);GO:0005886(plasma membrane);GO:0006595(polyamine metabolic process);GO:0010309(acireductone dioxygenase [iron(II)-requiring] activity);GO:0016491(oxidoreductase activity);GO:0019509(L-methionine salvage from methylthioadenosine);GO:0034641(cellular nitrogen compound metabolic process);GO:0044281(small molecule metabolic process);GO:0055114(oxidation-reduction process)","00270(Cysteine and methionine metabolism)","mRNA","agilent G3 V3"]
["A_33_P3316683",5.29,4.64,5.68,{"v":4.9,"d":"4.90"},5.21,5.51,{"v":0.999359795134443,"d":"1.00"},{"v":-0.000923916164070418,"d":"-0.00"},"down",{"v":0.99288,"d":"0.99"},1,"no","GACGAGGAGGCTGGCCCTGACCAGCTGCCCCTCGGGGATGGGACGTCAGGAGAAGACGCA","FALSE","NM_152897","ref|NM_152897|ens|ENST00000466252|ens|ENST00000614929|ens|ENST00000462307","SNX21","sorting nexin family member 21","ref|Homo sapiens sorting nexin family member 21 (SNX21), transcript variant 2, mRNA [NM_152897]","chr20",44463216,44471520,"GO:0015031(protein transport);GO:0030659(cytoplasmic vesicle membrane);GO:0035091(phosphatidylinositol binding)",null,"mRNA","agilent G3 V3"]
["A_22_P00019640",2.06,8.03,2.04,4.12,3.87,4.08,{"v":1.0049710024855,"d":"1.00"},{"v":0.00715387436548873,"d":"0.01"},"up",{"v":0.99292,"d":"0.99"},1,"no","ATTGACACACCTGGACAGATTGAGGTATTCACCTGGTCAGCTTCTGGGACAATTATCACT","FALSE","NM_007266","ref|NM_007266|ref|NM_001145047|ref|NM_001145048|ref|NM_001145049","GPN1","GPN-loop GTPase 1","ref|Homo sapiens GPN-loop GTPase 1 (GPN1), transcript variant 1, mRNA [NM_007266]","chr2",27851862,27873713,"GO:0003924(GTPase activity);GO:0005515(protein binding);GO:0005525(GTP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0008152(metabolic process)",null,"mRNA","agilent G3 V3"]
["A_23_P251795",6.15,4.97,5.77,5.84,5.72,5.34,{"v":0.999408284023669,"d":"1.00"},{"v":-0.00085391836816072,"d":"-0.00"},"down",{"v":0.9934,"d":"0.99"},1,"no","TGCTTGAGTAGGATGTGAGACTTCATGGGCCTGGGTCCTGTTGAGTTTTTTCAGTATCAA","FALSE","ENST00000471050","ens|ENST00000471050|ens|ENST00000292377|ref|XM_006715892|ref|XM_006715893","GPC2","glypican 2","ens|glypican 2 [Source:HGNC Symbol;Acc:HGNC:4450] [ENST00000471050]","chr7",99767248,99772347,"GO:0001523(retinoid metabolic process);GO:0005578(proteinaceous extracellular matrix);GO:0005615(extracellular space);GO:0005783(endoplasmic reticulum);GO:0005796(Golgi lumen);GO:0005886(plasma membrane);GO:0005975(carbohydrate metabolic process);GO:0006024(glycosaminoglycan biosynthetic process);GO:0006027(glycosaminoglycan catabolic process);GO:0007224(smoothened signaling pathway);GO:0007603(phototransduction, visible light);GO:0009405(pathogenesis);GO:0030182(neuron differentiation);GO:0030203(glycosaminoglycan metabolic process);GO:0030204(chondroitin sulfate metabolic process);GO:0031225(anchored to membrane);GO:0043202(lysosomal lumen);GO:0043395(heparan sulfate proteoglycan binding);GO:0044281(small molecule metabolic process)",null,"mRNA","agilent G3 V3"]
["A_33_P3290082",5.75,4.53,5.06,4.92,4.96,5.45,{"v":1.00065231572081,"d":"1.00"},{"v":0.00094078584415598,"d":"0.00"},"up",{"v":0.99362,"d":"0.99"},1,"no","CAGGTCATTTTGCCTTCCTACATGTGCCTGTTCCAGATGGCAGGGCTCCTTACTGCAAGG","FALSE","NM_022081","ref|NM_022081|ref|NM_152841|ref|NR_073135|ref|NR_073136","HPS4","Hermansky-Pudlak syndrome 4","ref|Homo sapiens Hermansky-Pudlak syndrome 4 (HPS4), transcript variant 1, mRNA [NM_022081]","chr22",26847446,26875347,"GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0005764(lysosome);GO:0006605(protein targeting);GO:0007040(lysosome organization);GO:0007596(blood coagulation);GO:0007599(hemostasis);GO:0016020(membrane);GO:0030318(melanocyte differentiation);GO:0031085(BLOC-3 complex);GO:0042470(melanosome);GO:0042803(protein homodimerization activity);GO:0042827(platelet dense granule);GO:0046983(protein dimerization activity);GO:0048075(positive regulation of eye pigmentation);GO:0050821(protein stabilization)",null,"mRNA","agilent G3 V3"]
["A_24_P15292",4.88,2.39,4.55,4.39,3.62,3.83,{"v":0.998310810810811,"d":"1.00"},{"v":-0.00243904545141727,"d":"-0.00"},"down",{"v":0.99386,"d":"0.99"},1,"no","ACAGGCCACCGTATTACGGCTATGTCAAACGAGCTACTAACAGGGAACCCTCTGCTCATG","FALSE","NM_032018","ref|NM_032018|ref|NM_001010984|ref|NM_001261462|ens|ENST00000469904","SPRTN","SprT-like N-terminal domain","ref|Homo sapiens SprT-like N-terminal domain (SPRTN), transcript variant 1, mRNA [NM_032018]","chr1",231483424,231488500,"GO:0003677(DNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005694(chromosome);GO:0006974(response to DNA damage stimulus);GO:0009411(response to UV);GO:0016607(nuclear speck);GO:0019985(translesion synthesis);GO:0031398(positive regulation of protein ubiquitination);GO:0043130(ubiquitin binding);GO:0046872(metal ion binding);GO:0070530(K63-linked polyubiquitin binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3246883",4.44,3.45,6.26,{"v":4.5,"d":"4.50"},4.74,4.89,{"v":1.00141542816702,"d":"1.00"},{"v":0.00204058738530551,"d":"0.00"},"up",{"v":0.99432,"d":"0.99"},1,"no","CAACCAGCATGCGTATCCCACTGCCTATGGTGGGAAGTACTCAGTCAAGACCCCTGCAAA","FALSE","NM_033317","ref|NM_033317|ref|NM_001126056|ref|NM_001190347|ref|NM_001126059","DMKN","dermokine","ref|Homo sapiens dermokine (DMKN), transcript variant 2, mRNA [NM_033317]","chr19",35991440,36001291,"GO:0005515(protein binding);GO:0005615(extracellular space);GO:0070062(extracellular vesicular exosome)",null,"mRNA","agilent G3 V3"]
["A_23_P95453",4.57,3.21,4.35,{"v":4.3,"d":"4.30"},3.81,4.01,{"v":1.00082508250825,"d":"1.00"},{"v":0.00118985164755924,"d":"0.00"},"up",{"v":0.99438,"d":"0.99"},1,"no","GTCCCTAAAGAAATGAACCTTTCCTTATCAAATAGAATATCACTGATATACTGCTGCATG","FALSE","NM_004801","ref|NM_004801|ref|NM_001135659|ref|NM_138735|ens|ENST00000406316","NRXN1","neurexin 1","ref|Homo sapiens neurexin 1 (NRXN1), transcript variant alpha1, mRNA [NM_004801]","chr2",50147488,51259674,"GO:0001525(angiogenesis);GO:0004872(receptor activity);GO:0005102(receptor binding);GO:0005246(calcium channel regulator activity);GO:0005509(calcium ion binding);GO:0005515(protein binding);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0007157(heterophilic cell-cell adhesion);GO:0007158(neuron cell-cell adhesion);GO:0007268(synaptic transmission);GO:0007269(neurotransmitter secretion);GO:0007411(axon guidance);GO:0007416(synapse assembly);GO:0007612(learning);GO:0009986(cell surface);GO:0016021(integral to membrane);GO:0016339(calcium-dependent cell-cell adhesion);GO:0021707(cerebellar granule cell differentiation);GO:0023041(neuronal signal transduction);GO:0030054(cell junction);GO:0030139(endocytic vesicle);GO:0030198(extracellular matrix organization);GO:0030534(adult behavior);GO:0033130(acetylcholine receptor binding);GO:0035176(social behavior);GO:0035418(protein localization to synapse);GO:0042297(vocal learning);GO:0042734(presynaptic membrane);GO:0044295(axonal growth cone);GO:0045184(establishment of protein localization);GO:0046872(metal ion binding);GO:0048306(calcium-dependent protein binding);GO:0050839(cell adhesion molecule binding);GO:0050885(neuromuscular process controlling balance);GO:0051490(negative regulation of filopodium assembly);GO:0051965(positive regulation of synapse assembly);GO:0051968(positive regulation of synaptic transmission, glutamatergic);GO:0060134(prepulse inhibition);GO:0061178(regulation of insulin secretion involved in cellular response to glucose stimulus);GO:0071625(vocalization behavior);GO:0090004(positive regulation of establishment of protein localization in plasma membrane);GO:0090126(protein complex assembly involved in synapse maturation);GO:0090129(positive regulation of synapse maturation);GO:0097091(synaptic vesicle clustering);GO:0097104(postsynaptic membrane assembly);GO:0097105(presynaptic membrane assembly);GO:0097109(neuroligin family protein binding);GO:0097112(gamma-aminobutyric acid receptor clustering);GO:0097114(N-methyl-D-aspartate receptor clustering);GO:0097116(gephyrin clustering);GO:0097117(guanylate kinase-associated protein clustering);GO:0097118(neuroligin clustering);GO:0097119(postsynaptic density protein 95 clustering);GO:0097120(receptor localization to synapse);GO:2000310(regulation of N-methyl-D-aspartate selective glutamate receptor activity);GO:2000311(regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity);GO:2000463(positive regulation of excitatory postsynaptic membrane potential);GO:2000821(regulation of grooming behavior)","04514(Cell adhesion molecules (CAMs))","mRNA","agilent G3 V3"]
["A_23_P64129",2.18,5.17,{"v":3.7,"d":"3.70"},3.23,3.81,3.99,{"v":1.00181323662738,"d":"1.00"},{"v":0.00261357868741115,"d":"0.00"},"up",{"v":0.9944,"d":"0.99"},1,"no","AAAGTCAGCATGTTTTAACTTTGTTGTTTTACTATCCTCAGGCATCCATTCCAATCAAGA","FALSE","NM_006410","ref|NM_006410|ref|NM_001098522|ref|NM_001098520|ref|NM_001098521","HTATIP2","HIV-1 Tat interactive protein 2, 30kDa","ref|Homo sapiens HIV-1 Tat interactive protein 2, 30kDa (HTATIP2), transcript variant 2, mRNA [NM_006410]","chr11",20397564,20405324,"GO:0001525(angiogenesis);GO:0003713(transcription coactivator activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005635(nuclear envelope);GO:0005737(cytoplasm);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0006915(apoptotic process);GO:0016020(membrane);GO:0016032(viral reproduction);GO:0016491(oxidoreductase activity);GO:0030154(cell differentiation);GO:0043066(negative regulation of apoptotic process);GO:0045765(regulation of angiogenesis);GO:0051170(nuclear import);GO:0055114(oxidation-reduction process)",null,"mRNA","agilent G3 V3"]
["A_33_P3314121",4.04,5.19,2.02,3.24,3.96,4.07,{"v":0.998225377107365,"d":"1.00"},{"v":-0.00256251406782166,"d":"-0.00"},"down",{"v":0.9948,"d":"0.99"},1,"no","TAAAATTCTATGTTCCTGCTGAACTCTAACCTTCCAATGTTGCCTTCCAAGCAAATTGAA","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_23_P419714",{"v":3.9,"d":"3.90"},7.92,2.64,{"v":4.4,"d":"4.40"},4.75,5.28,{"v":1.002079002079,"d":"1.00"},{"v":0.00299625245991992,"d":"0.00"},"up",{"v":0.99534,"d":"1.00"},1,"no","TGGGGACAGCCAAGTTTTGTTGATAAACCTATTTCCTAGCATGCCTTCAGGAAGTTGTGC","FALSE","NM_001018072","ref|NM_001018072|ref|NM_001017523|ens|ENST00000280758|ens|ENST00000357167","BTBD11","BTB (POZ) domain containing 11","ref|Homo sapiens BTB (POZ) domain containing 11 (BTBD11), transcript variant a, mRNA [NM_001018072]","chr12",107974424,108053419,"GO:0016021(integral to membrane);GO:0046982(protein heterodimerization activity);GO:0060395(SMAD protein signal transduction)",null,"mRNA","agilent G3 V3"]
["A_23_P132936",4.52,6.33,{"v":5.4,"d":"5.40"},5.54,5.14,5.58,{"v":0.999384993849939,"d":"1.00"},{"v":-0.000887539271848366,"d":"-0.00"},"down",{"v":0.99538,"d":"1.00"},1,"no","GAATGTCACTTTGACCCTGTCTTGGAACGTCGTACCAAATGCTGGAATTCTACCTCTTGT","FALSE","NM_021928","ref|NM_021928|ens|ENST00000507678|ens|ENST00000503362|gb|EU831652","SPCS3","signal peptidase complex subunit 3 homolog (S. cerevisiae)","ref|Homo sapiens signal peptidase complex subunit 3 homolog (S. cerevisiae) (SPCS3), mRNA [NM_021928]","chr4",177248112,177249504,"GO:0005783(endoplasmic reticulum);GO:0005787(signal peptidase complex);GO:0005789(endoplasmic reticulum membrane);GO:0006412(translation);GO:0006465(signal peptide processing);GO:0006508(proteolysis);GO:0006614(SRP-dependent cotranslational protein targeting to membrane);GO:0008233(peptidase activity);GO:0010467(gene expression);GO:0016021(integral to membrane);GO:0044267(cellular protein metabolic process);GO:0050796(regulation of insulin secretion)","03060(Protein export)","mRNA","agilent G3 V3"]
["A_24_P239076",2.51,9.71,5.88,6.23,6.23,{"v":5.6,"d":"5.60"},{"v":1.00221483942414,"d":"1.00"},{"v":0.00319180448970939,"d":"0.00"},"up",{"v":0.99548,"d":"1.00"},1,"no","AACAAGGCCACACTGGTGTGTCTCATGAATGACTTCTATCTGGGAATCTTGACGGTGACC","FALSE","NM_020070","ref|NM_020070|ref|NM_152855|ref|NR_029395|ens|ENST00000412472","IGLL1","immunoglobulin lambda-like polypeptide 1","ref|Homo sapiens immunoglobulin lambda-like polypeptide 1 (IGLL1), transcript variant 1, mRNA [NM_020070]","chr22",25714224,25716047,"GO:0006955(immune response);GO:0016020(membrane);GO:0070062(extracellular vesicular exosome)","05340(Primary immunodeficiency)","mRNA","agilent G3 V3"]
["A_33_P3260986",4.32,{"v":4.5,"d":"4.50"},6.01,4.31,4.87,5.66,{"v":0.999326145552561,"d":"1.00"},{"v":-0.000972494166172845,"d":"-0.00"},"down",{"v":0.99624,"d":"1.00"},1,"no","TTCCTTTAACTAATGAAAGACTCGCTGTTGTCGGGATCCCCATTTCAAAGTTTCCGGGTC","FALSE","XR_252345","ref|XR_252345|ref|XR_158818|gb|TCONS_l2_00027238|gb|AL162052","LOC100134040","uncharacterized LOC100134040","ref|PREDICTED: Homo sapiens uncharacterized LOC100134040 (LOC100134040), misc_RNA [XR_252345]","chr7",149737616,149773744,null,null,"mRNA","agilent G3 V3"]
["A_21_P0014345",4.83,3.79,5.44,3.96,4.52,5.57,{"v":1.00071174377224,"d":"1.00"},{"v":0.00102646396424705,"d":"0.00"},"up",{"v":0.9963,"d":"1.00"},1,"no","TTCAGGTCCCTCAACGTGGCATACACTGGAGCTCTGGGATGGATCTGAAGCCAGACGTAC","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_33_P3399980",4.68,2.61,4.53,4.22,3.79,3.82,{"v":0.999154691462384,"d":"1.00"},{"v":-0.00122003816225596,"d":"-0.00"},"down",{"v":0.99632,"d":"1.00"},1,"no","GGTCTAACAAATGCCCTACTCTCTTATGCATTAGTATCACAAAACCACCTGGTTGAATAT","FALSE","NM_000550","ref|NM_000550|ens|ENST00000381142|ens|ENST00000473504|ens|ENST00000388918","TYRP1","tyrosinase-related protein 1","ref|Homo sapiens tyrosinase-related protein 1 (TYRP1), mRNA [NM_000550]","chr9",12693386,12710266,"GO:0005507(copper ion binding);GO:0005515(protein binding);GO:0010008(endosome membrane);GO:0016021(integral to membrane);GO:0016716(oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen);GO:0030318(melanocyte differentiation);GO:0030669(clathrin-coated endocytic vesicle membrane);GO:0032438(melanosome organization);GO:0033162(melanosome membrane);GO:0042438(melanin biosynthetic process);GO:0042470(melanosome);GO:0042803(protein homodimerization activity);GO:0043438(acetoacetic acid metabolic process);GO:0046982(protein heterodimerization activity);GO:0055114(oxidation-reduction process)","00350(Tyrosine metabolism);04916(Melanogenesis)","mRNA","agilent G3 V3"]
["A_33_P3315874",10.53,5.12,3.85,6.54,6.68,6.31,{"v":0.998463901689708,"d":"1.00"},{"v":-0.00221782524981852,"d":"-0.00"},"down",{"v":0.99656,"d":"1.00"},1,"no","CTGGGGCTGTGTACAGAGTGCAAATGTTTATTTAAAATAAAGTTCTATTTATCCCTTGTG","FALSE","NM_014966","ref|NM_014966|ref|NM_138615|ens|ENST00000395745|ens|ENST00000445061","DHX30","DEAH (Asp-Glu-Ala-His) box helicase 30","ref|Homo sapiens DEAH (Asp-Glu-Ala-His) box helicase 30 (DHX30), transcript variant 2, mRNA [NM_014966]","chr3",47844400,47891685,"GO:0003682(chromatin binding);GO:0003725(double-stranded RNA binding);GO:0004004(ATP-dependent RNA helicase activity);GO:0005515(protein binding);GO:0005524(ATP binding);GO:0005634(nucleus);GO:0005737(cytoplasm);GO:0005739(mitochondrion);GO:0006396(RNA processing);GO:0042645(mitochondrial nucleoid)",null,"mRNA","agilent G3 V3"]
["A_24_P261052",2.06,{"v":6.4,"d":"6.40"},{"v":2.2,"d":"2.20"},3.17,3.61,{"v":3.9,"d":"3.90"},{"v":0.99812734082397,"d":"1.00"},{"v":-0.00270420892837809,"d":"-0.00"},"down",{"v":0.99672,"d":"1.00"},1,"no","TCTGATGAGAGTTTACTGACTTCTAGAGCCATTCTCTTTAACCGTCTGCAGGTCTAAGGA","FALSE","NM_015458","ref|NM_015458|ens|ENST00000221086|gb|AJ297823|tc|THC2533237","MTMR9","myotubularin related protein 9","ref|Homo sapiens myotubularin related protein 9 (MTMR9), mRNA [NM_015458]","chr8",11142336,11182036,"GO:0005515(protein binding);GO:0005737(cytoplasm);GO:0016311(dephosphorylation);GO:0016791(phosphatase activity);GO:0030234(enzyme regulator activity);GO:0050790(regulation of catalytic activity)",null,"mRNA","agilent G3 V3"]
["A_33_P3410093",5.81,{"v":3.2,"d":"3.20"},5.69,5.15,4.79,4.77,{"v":0.999320190346703,"d":"1.00"},{"v":-0.000981091531103332,"d":"-0.00"},"down",{"v":0.99726,"d":"1.00"},1,"no","TGATGGAGAAACACCTGACCCAGAAGACCCAAGCAGGAAAATATACAAATTCATCCAAAA","FALSE","NM_001256644","ref|NM_001256644|ref|NM_000895|ref|NM_001256643|ens|ENST00000548852","LTA4H","leukotriene A4 hydrolase","ref|Homo sapiens leukotriene A4 hydrolase (LTA4H), transcript variant 3, mRNA [NM_001256644]","chr12",96396768,96429419,"GO:0004177(aminopeptidase activity);GO:0004301(epoxide hydrolase activity);GO:0004463(leukotriene-A4 hydrolase activity);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0005829(cytosol);GO:0006508(proteolysis);GO:0006691(leukotriene metabolic process);GO:0006954(inflammatory response);GO:0008233(peptidase activity);GO:0008237(metallopeptidase activity);GO:0008270(zinc ion binding);GO:0019369(arachidonic acid metabolic process);GO:0019370(leukotriene biosynthetic process);GO:0043171(peptide catabolic process);GO:0044281(small molecule metabolic process);GO:0070062(extracellular vesicular exosome)","00590(Arachidonic acid metabolism)","mRNA","agilent G3 V3"]
["A_33_P3364607",5.31,2.54,4.98,4.93,4.18,3.71,{"v":1.00078003120125,"d":"1.00"},{"v":0.00112490847094144,"d":"0.00"},"up",{"v":0.99734,"d":"1.00"},1,"no","TCTGAAGGCCAGAAGGGTGTCGGCAGCCACGGAGAGAACAAGTACAGTTAACCCTGGGAA","FALSE","AK127296","gb|AK127296","LOC100130051","uncharacterized LOC100130051","gb|Homo sapiens cDNA FLJ45363 fis, clone BRHIP3015854. [AK127296]","chr16",{"v":1014986,"d":"1014986.00"},1022082,null,null,"mRNA","agilent G3 V3"]
["A_21_P0011503",5.06,2.22,4.99,4.09,4.21,3.98,{"v":0.999185667752443,"d":"1.00"},{"v":-0.00117531170727455,"d":"-0.00"},"down",{"v":0.99748,"d":"1.00"},1,"no","CGATGGCAAAGTCATCCCCAGGAACACAGAGGGGTGCCTGGTTACTTGGAATCAGCACAC","FALSE","ENST00000595170","ens|ENST00000595170|ref|XM_006726629|ref|XM_006710000|ref|XM_006720997",null,null,"ens|Protein LOC388210 {ECO:0000313|Ensembl:ENSP00000471908}  [Source:UniProtKB/TrEMBL;Acc:M0R1J3] [ENST00000595170]","chr16",11536047,11585611,null,null,"mRNA","agilent G3 V3"]
["A_21_P0011620",{"v":3.5,"d":"3.50"},{"v":5.8,"d":"5.80"},2.15,3.54,4.19,3.73,{"v":0.99912739965096,"d":"1.00"},{"v":-0.00125944577259857,"d":"-0.00"},"down",{"v":0.9977,"d":"1.00"},1,"no","CAAATAGATCAGAGGTTGGATTTATGCAAACCTGGGCCAAAGGACAGTTAGAAGACGACG","FALSE","ENST00000578883","ens|ENST00000578883|linc|lnc-RNF135-1:1|linc|TCONS_l2_00011546|gb|AF086476",null,null,"gb|Homo sapiens full length insert cDNA clone ZD88F12. [AF086476]","chr17",29351360,29361180,null,null,"mRNA","agilent G3 V3"]
["A_33_P3357000",5.28,{"v":2.1,"d":"2.10"},5.47,4.36,4.18,{"v":4.3,"d":"4.30"},{"v":1.00077881619938,"d":"1.00"},{"v":0.00112315695893761,"d":"0.00"},"up",{"v":0.99784,"d":"1.00"},1,"no","ATCACAAGTGTTACCTTCCAAGGACAGTGTCATTCTGGTTATAATCAGCTTGCTCCCCTG","FALSE",{"$nulls":10},"mRNA","agilent G3 V3"]
["A_32_P407245",10.01,10.08,9.97,10.07,10.08,9.91,1,{"v":3.20342650381492e-16,"d":"0.00"},"up",1,1,"no","AGCTATGTGGCAGAAACCTTTGGCTCCTTCTTGAATTGGTTCAGCTTCTTCCCCCTTCTT","FALSE","NM_024902","ref|NM_024902|ens|ENST00000395069|ref|XM_005269157|ref|XM_005269156","DNAJC22","DnaJ (Hsp40) homolog, subfamily C, member 22","ref|Homo sapiens DnaJ (Hsp40) homolog, subfamily C, member 22 (DNAJC22), mRNA [NM_024902]","chr12",49740820,49745697,"GO:0016021(integral to membrane);GO:0042026(protein refolding);GO:0051082(unfolded protein binding);GO:0051087(chaperone binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3291650",5.69,5.04,5.27,5.01,5.41,5.58,1,0,"down",1,1,"no","ATTTGTATTGGTTTCTGCAGAAAGCCAGGCCAGTCTCCACGCTCCTGATCTATGAAGTTT","FALSE","ENST00000390268","ens|ENST00000390268|ens|ENST00000518305|gb|AY271360|gb|EU146366",null,null,"ens|immunoglobulin kappa variable 2D-26 [Source:HGNC Symbol;Acc:HGNC:5798] [ENST00000390268]","chr2",90024736,90025512,null,null,"mRNA","agilent G3 V3"]
["A_23_P150590",4.72,3.15,5.65,{"v":4.9,"d":"4.90"},4.62,{"v":4,"d":"4.00"},1,0,"down",1,1,"no","AAGCCTCTGTTTGACACCATCCAGGATGAGAAAAATGAGAGAAAAGACCCCAGAGAACCA","FALSE","NM_080866","ref|NM_080866|ens|ENST00000279178|ref|XM_006718429|gb|HQ258285","SLC22A9","solute carrier family 22 (organic anion transporter), member 9","ref|Homo sapiens solute carrier family 22 (organic anion transporter), member 9 (SLC22A9), mRNA [NM_080866]","chr11",63137280,63177766,"GO:0009914(hormone transport);GO:0015301(anion:anion antiporter activity);GO:0015347(sodium-independent organic anion transmembrane transporter activity);GO:0015636(short-chain fatty acid uptake transporter activity);GO:0015913(short-chain fatty acid import);GO:0016021(integral to membrane);GO:0016323(basolateral plasma membrane);GO:0043252(sodium-independent organic anion transport);GO:0055085(transmembrane transport)",null,"mRNA","agilent G3 V3"]
["A_23_P39647",5.58,4.94,2.93,{"v":5,"d":"5.00"},4.58,3.87,1,0,"down",1,1,"no","GATGCTGAACCAAACTTCGATGAGGATGGCCAGGATGAGTACAATGAGCTGCACATGCCA","FALSE","NM_005070","ref|NM_005070|ref|NM_201574|ref|NR_048551|ens|ENST00000425141","SLC4A3","solute carrier family 4 (anion exchanger), member 3","ref|Homo sapiens solute carrier family 4 (anion exchanger), member 3 (SLC4A3), transcript variant 1, mRNA [NM_005070]","chr2",220492288,220506701,"GO:0005452(inorganic anion exchanger activity);GO:0005886(plasma membrane);GO:0005887(integral to plasma membrane);GO:0006810(transport);GO:0006811(ion transport);GO:0015701(bicarbonate transport);GO:0016020(membrane);GO:0051453(regulation of intracellular pH);GO:0055085(transmembrane transport)",null,"mRNA","agilent G3 V3"]
["A_33_P3256334",14.12,13.82,14.01,14.15,14.01,13.79,1,{"v":-3.20342650381492e-16,"d":"-0.00"},"down",1,1,"no","CCTCCACCTCCTCAAGGGGGCAGACCACACAGACCTCCCCAGGGACAGCCTCCCCAGTAA","FALSE","NM_006249","ref|NM_006249|ens|ENST00000617030|ens|ENST00000381842|ens|ENST00000617491","PRB3","proline-rich protein BstNI subfamily 3","ref|Homo sapiens proline-rich protein BstNI subfamily 3 (PRB3), mRNA [NM_006249]","chr12",11418890,11422641,"GO:0005576(extracellular region);GO:0008150(biological_process);GO:0050829(defense response to Gram-negative bacterium)",null,"mRNA","agilent G3 V3"]
["A_33_P3255131",14.41,14.38,14.34,14.58,14.47,14.08,1,{"v":-1.60171325190746e-16,"d":"-0.00"},"down",1,1,"no","CCTCATGCCCCACCCGCCAAGTCTCATTTTAATTGGAGATAGCCCAGAATGCATGTGCCC","FALSE","NM_001100915","ref|NM_001100915|ens|ENST00000304372|ens|ENST00000569333|ens|ENST00000566392","KCTD19","potassium channel tetramerization domain containing 19","ref|Homo sapiens potassium channel tetramerization domain containing 19 (KCTD19), mRNA [NM_001100915]","chr16",67323352,67360666,"GO:0051260(protein homooligomerization)",null,"mRNA","agilent G3 V3"]
["A_23_P158938",5.97,5.15,5.89,5.77,5.83,5.41,1,{"v":3.20342650381492e-16,"d":"0.00"},"up",1,1,"no","GGCGGCTGCACATTGTAACAGTAAAGGCAGAAAGCTGTAGTGATAACCTCTCTCCTAAAA","FALSE","NM_207012","ref|NM_207012|ref|NM_012095|ens|ENST00000372745|ens|ENST00000355264","AP3M1","adaptor-related protein complex 3, mu 1 subunit","ref|Homo sapiens adaptor-related protein complex 3, mu 1 subunit (AP3M1), transcript variant 1, mRNA [NM_207012]","chr10",75882720,75910600,"GO:0005515(protein binding);GO:0005764(lysosome);GO:0005765(lysosomal membrane);GO:0005794(Golgi apparatus);GO:0006622(protein targeting to lysosome);GO:0008089(anterograde axon cargo transport);GO:0017137(Rab GTPase binding);GO:0030131(clathrin adaptor complex);GO:0030659(cytoplasmic vesicle membrane);GO:0048490(anterograde synaptic vesicle transport)","04142(Lysosome)","mRNA","agilent G3 V3"]
["A_32_P223017",7.45,7.87,7.55,7.55,7.61,7.71,1,0,"down",1,1,"no","GAATGTGGATTCAGGCACCATCCAAATGCTGTTGAACCATAGCTTCACCCTCCACACTCT","FALSE","NM_004672","ref|NM_004672|ref|NM_001297609|ens|ENST00000357582|ens|ENST00000470890","MAP3K6","mitogen-activated protein kinase kinase kinase 6","ref|Homo sapiens mitogen-activated protein kinase kinase kinase 6 (MAP3K6), transcript variant 1, mRNA [NM_004672]","chr1",27681676,27693349,"GO:0000186(activation of MAPKK activity);GO:0000287(magnesium ion binding);GO:0004709(MAP kinase kinase kinase activity);GO:0005524(ATP binding);GO:0005737(cytoplasm);GO:0006468(protein phosphorylation);GO:0007165(signal transduction);GO:0007257(activation of JUN kinase activity)","04010(MAPK signaling pathway)","mRNA","agilent G3 V3"]
["A_23_P318396",4.96,4.56,5.76,5.13,5.33,4.82,1,{"v":-1.60171325190746e-16,"d":"-0.00"},"down",1,1,"no","GTGCTGCCAAATTGGTTTTGCTAGAACGACTGCTGAAGGGGAAATATTTAAACTTGCATT","FALSE","NM_198700","ref|NM_198700|ref|NM_001172640|ref|NM_001172639|ref|NM_006560","CELF1","CUGBP, Elav-like family member 1","ref|Homo sapiens CUGBP, Elav-like family member 1 (CELF1), transcript variant 2, mRNA [NM_198700]","chr11",47487496,47510576,"GO:0000166(nucleotide binding);GO:0000900(translation repressor activity, nucleic acid binding);GO:0003723(RNA binding);GO:0003729(mRNA binding);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005737(cytoplasm);GO:0006376(mRNA splice site selection);GO:0006397(mRNA processing);GO:0007281(germ cell development);GO:0007286(spermatid development);GO:0009790(embryo development);GO:0016020(membrane);GO:0016246(RNA interference);GO:0017148(negative regulation of translation);GO:0030529(ribonucleoprotein complex);GO:0031369(translation initiation factor binding);GO:0040018(positive regulation of multicellular organism growth);GO:0042835(BRE binding);GO:0043484(regulation of RNA splicing)",null,"mRNA","agilent G3 V3"]
["A_21_P0013366",4.74,5.23,4.42,4.57,4.79,5.03,1,0,"down",1,1,"no","TCCTTTGCCCATGCCAGGCCTCTTGCTAGGAATATCCTTCAGACATCAGATCATTCTGTT","FALSE","ENST00000430530","ens|ENST00000430530|ens|ENST00000442665|linc|TCONS_l2_00027037|linc|TCONS_l2_00027038",null,null,"ens|zinc finger protein 815, pseudogene [Source:HGNC Symbol;Acc:HGNC:22029] [ENST00000430530]","chr7",{"v":5862820,"d":"5862820.00"},5878783,null,null,"mRNA","agilent G3 V3"]
["A_33_P3240757",6.14,5.32,6.11,6.13,5.69,5.75,1,0,"down",1,1,"no","TATCCTGAAGACCACCCACAACTCCGCCTTCGAATACGGTACTTACGTGGAGGAGGAGGG","FALSE","NM_001007237","ref|NM_001007237|ref|NM_001542|ens|ENST00000625078|ens|ENST00000445234","IGSF3","immunoglobulin superfamily, member 3","ref|Homo sapiens immunoglobulin superfamily, member 3 (IGSF3), transcript variant 2, mRNA [NM_001007237]","chr2",91924752,91955465,"GO:0003674(molecular_function);GO:0009986(cell surface);GO:0016021(integral to membrane);GO:0032808(lacrimal gland development)",null,"mRNA","agilent G3 V3"]
["A_33_P3377294",12.69,12.56,12.37,{"v":12.7,"d":"12.70"},12.34,12.58,1,0,"down",1,1,"no","AGGATTCAGACACCCCTACCCCACAGCTCTGACCGTCAATGCTTCCATGTCCAGGTGAGT","FALSE","ENST00000349937","ens|ENST00000349937|ens|ENST00000369395|tc|THC2504286","TCF7L2","transcription factor 7-like 2 (T-cell specific, HMG-box)","ens|transcription factor 7-like 2 (T-cell specific, HMG-box) [Source:HGNC Symbol;Acc:HGNC:11641] [ENST00000349937]","chr10",114710432,114905862,"GO:0000122(negative regulation of transcription from RNA polymerase II promoter);GO:0000790(nuclear chromatin);GO:0000978(RNA polymerase II core promoter proximal region sequence-specific DNA binding);GO:0001103(RNA polymerase II repressing transcription factor binding);GO:0001568(blood vessel development);GO:0003682(chromatin binding);GO:0003700(sequence-specific DNA binding transcription factor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0005667(transcription factor complex);GO:0005737(cytoplasm);GO:0005977(glycogen metabolic process);GO:0006006(glucose metabolic process);GO:0006351(transcription, DNA-dependent);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0007050(cell cycle arrest);GO:0007420(brain development);GO:0008013(beta-catenin binding);GO:0008134(transcription factor binding);GO:0008283(cell proliferation);GO:0009267(cellular response to starvation);GO:0009749(response to glucose stimulus);GO:0009791(post-embryonic development);GO:0010867(positive regulation of triglyceride biosynthetic process);GO:0010909(positive regulation of heparan sulfate proteoglycan biosynthetic process);GO:0014003(oligodendrocyte development);GO:0016605(PML body);GO:0019901(protein kinase binding);GO:0021915(neural tube development);GO:0021983(pituitary gland development);GO:0030282(bone mineralization);GO:0030514(negative regulation of BMP signaling pathway);GO:0030538(embryonic genitalia morphogenesis);GO:0031016(pancreas development);GO:0031641(regulation of myelination);GO:0032024(positive regulation of insulin secretion);GO:0032092(positive regulation of protein binding);GO:0032252(secretory granule localization);GO:0032350(regulation of hormone metabolic process);GO:0032993(protein-DNA complex);GO:0035019(somatic stem cell maintenance);GO:0035257(nuclear hormone receptor binding);GO:0035264(multicellular organism growth);GO:0035411(catenin import into nucleus);GO:0040037(negative regulation of fibroblast growth factor receptor signaling pathway);GO:0042475(odontogenesis of dentin-containing tooth);GO:0042593(glucose homeostasis);GO:0043065(positive regulation of apoptotic process);GO:0043433(negative regulation of sequence-specific DNA binding transcription factor activity);GO:0043565(sequence-specific DNA binding);GO:0043570(maintenance of DNA repeat elements);GO:0043588(skin development);GO:0044212(transcription regulatory region DNA binding);GO:0044334(canonical Wnt receptor signaling pathway involved in positive regulation of epithelial to mesenchymal transition);GO:0045295(gamma-catenin binding);GO:0045444(fat cell differentiation);GO:0045599(negative regulation of fat cell differentiation);GO:0045722(positive regulation of gluconeogenesis);GO:0045892(negative regulation of transcription, DNA-dependent);GO:0045944(positive regulation of transcription from RNA polymerase II promoter);GO:0046621(negative regulation of organ growth);GO:0046827(positive regulation of protein export from nucleus);GO:0048557(embryonic digestive tract morphogenesis);GO:0048619(embryonic hindgut morphogenesis);GO:0048625(myoblast cell fate commitment)","04310(Wnt signaling pathway);04390(Hippo signaling pathway);04520(Adherens junction);04916(Melanogenesis);05200(Pathways in cancer);05210(Colorectal cancer);05216(Thyroid cancer);05221(Acute myeloid leukemia);05217(Basal cell carcinoma);05215(Prostate cancer);05213(Endometrial cancer);05412(Arrhythmogenic right ventricular cardiomyopathy (ARVC))","mRNA","agilent G3 V3"]
["A_19_P00808033",{"v":7,"d":"7.00"},6.75,7.29,7.04,6.93,7.07,1,0,"down",1,1,"no","GCATAAAGATTCATAATGGCAAAACGAAGCATGTCCCATCATACCCCTTCATTCCTACCT","FALSE","NM_003162","ref|NM_003162|tc|THC2648538","STRN","striatin, calmodulin binding protein","ref|Homo sapiens striatin, calmodulin binding protein (STRN), mRNA [NM_003162]","chr2",37070784,37193615,"GO:0000159(protein phosphatase type 2A complex);GO:0005515(protein binding);GO:0005516(calmodulin binding);GO:0005737(cytoplasm);GO:0005923(tight junction);GO:0007626(locomotory behavior);GO:0008285(negative regulation of cell proliferation);GO:0014069(postsynaptic density);GO:0016020(membrane);GO:0016055(Wnt receptor signaling pathway);GO:0016358(dendrite development);GO:0030331(estrogen receptor binding);GO:0032403(protein complex binding);GO:0043025(neuronal cell body);GO:0043197(dendritic spine);GO:0045211(postsynaptic membrane);GO:0051721(protein phosphatase 2A binding);GO:0070016(armadillo repeat domain binding);GO:0070830(tight junction assembly)",null,"mRNA","agilent G3 V3"]
["A_23_P376735",5.69,5.86,{"v":6.2,"d":"6.20"},5.69,6.14,5.92,1,0,"down",1,1,"no","GTCTTCCCGTTGTGGGAGCAGGTGGAGGGTGGAGACCTAAACTTTGGGGTCCAGCTGCCT","FALSE","NM_153219","ref|NM_153219|ens|ENST00000301073|ens|ENST00000591046|gb|BC067748","ZNF524","zinc finger protein 524","ref|Homo sapiens zinc finger protein 524 (ZNF524), mRNA [NM_153219]","chr19",56113244,56114504,"GO:0003677(DNA binding);GO:0005634(nucleus);GO:0006351(transcription, DNA-dependent);GO:0006355(regulation of transcription, DNA-dependent);GO:0046872(metal ion binding)",null,"mRNA","agilent G3 V3"]
["A_33_P3258542",4.42,4.05,{"v":4.6,"d":"4.60"},4.95,3.96,4.16,1,{"v":-1.60171325190746e-16,"d":"-0.00"},"down",1,1,"no","GGTTGCCTCTTCAAATATATCCCCTTTAATTACTAATGGTTGGATCAAACTCGTTGATTT","FALSE","NM_001080525","ref|NM_001080525|ens|ENST00000434006|tc|THC2756510","SPINK8","serine peptidase inhibitor, Kazal type 8 (putative)","ref|Homo sapiens serine peptidase inhibitor, Kazal type 8 (putative) (SPINK8), mRNA [NM_001080525]","chr3",48348336,48369831,"GO:0004867(serine-type endopeptidase inhibitor activity);GO:0005576(extracellular region);GO:0010951(negative regulation of endopeptidase activity)",null,"mRNA","agilent G3 V3"]
["A_23_P124760",12.28,12.16,11.94,12.09,12.25,12.04,1,0,"down",1,1,"no","CCTCTTCCCCCTGGACGATGTGCAGCCTTCGAAGTTGATGCGACTGCTGAGCTCTAATGA","FALSE","NM_014815","ref|NM_014815|ref|NM_001267797|ref|NM_001079518|ref|NR_052017","MED24","mediator complex subunit 24","ref|Homo sapiens mediator complex subunit 24 (MED24), transcript variant 1, mRNA [NM_014815]","chr17",38178664,38179904,"GO:0001104(RNA polymerase II transcription cofactor activity);GO:0003712(transcription cofactor activity);GO:0004402(histone acetyltransferase activity);GO:0004872(receptor activity);GO:0005515(protein binding);GO:0005634(nucleus);GO:0005654(nucleoplasm);GO:0006357(regulation of transcription from RNA polymerase II promoter);GO:0006367(transcription initiation from RNA polymerase II promoter);GO:0010467(gene expression);GO:0016573(histone acetylation);GO:0016592(mediator complex);GO:0019827(stem cell maintenance);GO:0030374(ligand-dependent nuclear receptor transcription coactivator activity);GO:0030518(intracellular steroid hormone receptor signaling pathway);GO:0030521(androgen receptor signaling pathway);GO:0042809(vitamin D receptor binding);GO:0045893(positive regulation of transcription, DNA-dependent);GO:0046966(thyroid hormone receptor binding);GO:0051291(protein heterooligomerization)","04919(Thyroid hormone signaling pathway)","mRNA","agilent G3 V3"]